No/DT formal/JJ drug/NN /drug/NN interaction/NN studies/NNS with/IN Plenaxis/NN @/NN were/VBD performed/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ formal) (NN drug) (NN /drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (NN Plenaxis) (NN @)))) (VP (VBD were) (VP (VBN performed)))) (. .))))

det(studies-6, No-1)
amod(studies-6, formal-2)
nn(studies-6, drug-3)
nn(studies-6, /drug-4)
nn(studies-6, interaction-5)
nsubjpass(performed-11, studies-6)
nn(@-9, Plenaxis-8)
prep_with(studies-6, @-9)
auxpass(performed-11, were-10)
root(ROOT-0, performed-11)

Cytochrome/NN P-450/NN is/VBZ not/RB known/VBN to/TO be/VB involved/VBN in/IN the/DT metabolism/NN of/IN Plenaxis/NN @./NNS

(ROOT (S1 (S (NP (NP (NN Cytochrome) (NN P-450)) (VP (VBZ is) (RB not) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN Plenaxis) (NNS @.)))))))))))))))

nn(P-450-2, Cytochrome-1)
root(ROOT-0, P-450-2)
xsubj(involved-8, P-450-2)
auxpass(known-5, is-3)
neg(known-5, not-4)
dep(P-450-2, known-5)
aux(involved-8, to-6)
auxpass(involved-8, be-7)
xcomp(known-5, involved-8)
det(metabolism-11, the-10)
prep_in(involved-8, metabolism-11)
nn(@.-14, Plenaxis-13)
prep_of(metabolism-11, @.-14)

Plenaxis/NN @/NN is/VBZ highly/RB bound/VBN to/TO plasma/NN proteins/NNS (/-LRB- 96/CD to/TO 99/CD %)./NN

(ROOT (S1 (S (NP (NP (NP (NN Plenaxis) (NN @)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (NN plasma) (NNS proteins)))))) (-LRB- -LRB-) (NP (QP (CD 96) (TO to) (CD 99)) (NN %-RRB-.))))))

nn(@-2, Plenaxis-1)
root(ROOT-0, @-2)
auxpass(bound-5, is-3)
advmod(bound-5, highly-4)
dep(@-2, bound-5)
nn(proteins-8, plasma-7)
prep_to(bound-5, proteins-8)
number(99-12, 96-10)
dep(99-12, to-11)
num(%-RRB-.-13, 99-12)
dep(@-2, %-RRB-.-13)

Laboratory/NN Tests/NNS Response/NN to/TO Plenaxis/NN @/NN should/MD be/VB monitored/VBN by/IN measuring/VBG serum/NN total/JJ testosterone/NN concentrations/NNS just/RB prior/RB to/TO administration/NN on/IN Day/NN 29/CD and/CC every/DT 8/CD weeks/NNS thereafter/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Laboratory) (NNS Tests)) (VP (NN Response) (PP (TO to) (NP (NN Plenaxis) (NN @))))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN by) (S (VP (VBG measuring) (NP (NP (NN serum) (JJ total) (NN testosterone) (NNS concentrations)) (ADVP (ADVP (RB just) (RB prior)) (PP (TO to) (NP (NN administration))))) (PP (IN on) (NP (NP (NN Day) (CD 29)) (CC and) (NP (NP (DT every) (CD 8) (NNS weeks)) (ADVP (RB thereafter)))))))))))) (. .))))

nn(Tests-2, Laboratory-1)
nsubjpass(monitored-9, Tests-2)
dep(Tests-2, Response-3)
nn(@-6, Plenaxis-5)
prep_to(Response-3, @-6)
aux(monitored-9, should-7)
auxpass(monitored-9, be-8)
root(ROOT-0, monitored-9)
agent(monitored-9, measuring-11)
nn(concentrations-15, serum-12)
amod(concentrations-15, total-13)
nn(concentrations-15, testosterone-14)
dobj(measuring-11, concentrations-15)
advmod(concentrations-15, just-16)
prep_prior_to(concentrations-15, administration-19)
prep_on(measuring-11, Day-21)
num(Day-21, 29-22)
det(weeks-26, every-24)
num(weeks-26, 8-25)
conj_and(Day-21, weeks-26)
advmod(weeks-26, thereafter-27)

Serum/NN transaminase/NN levels/NNS should/MD be/VB obtained/VBN before/IN starting/VBG treatment/NN with/IN Plenaxis/NN @/NN and/CC periodically/RB during/IN treatment/NN ./.

(ROOT (S1 (S (S (NP (NN Serum) (NN transaminase) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN obtained) (PP (PP (IN before) (S (VP (VBG starting) (NP (NP (NN treatment)) (PP (IN with) (NP (NN Plenaxis) (NN @))))))) (CC and) (ADVP (RB periodically)) (PP (IN during) (NP (NN treatment)))))))) (. .))))

nn(levels-3, Serum-1)
nn(levels-3, transaminase-2)
nsubjpass(obtained-6, levels-3)
aux(obtained-6, should-4)
auxpass(obtained-6, be-5)
root(ROOT-0, obtained-6)
conj_and(obtained-6, obtained-6')
prepc_before(obtained-6, starting-8)
dobj(starting-8, treatment-9)
nn(@-12, Plenaxis-11)
prep_with(treatment-9, @-12)
advmod(obtained-6, periodically-14)
conj(obtained-6, periodically-14)
prep_during(obtained-6', treatment-16)

Certain/JJ drugs/NNS tend/VBP to/TO produce/VB hyperglycemia/NN and/CC may/MD lead/VB to/TO loss/NN of/IN blood/NN glucose/NN control/NN ./.

(ROOT (S1 (S (S (NP (JJ Certain) (NNS drugs)) (VP (VP (VBP tend) (S (VP (TO to) (VP (VB produce) (NP (NN hyperglycemia)))))) (CC and) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NN loss)) (PP (IN of) (NP (NN blood) (NN glucose) (NN control))))))))) (. .))))

amod(drugs-2, Certain-1)
nsubj(tend-3, drugs-2)
xsubj(produce-5, drugs-2)
root(ROOT-0, tend-3)
aux(produce-5, to-4)
xcomp(tend-3, produce-5)
dobj(produce-5, hyperglycemia-6)
aux(lead-9, may-8)
conj_and(tend-3, lead-9)
prep_to(lead-9, loss-11)
nn(control-15, blood-13)
nn(control-15, glucose-14)
prep_of(loss-11, control-15)

These/DT drugs/NNS include/VBP the/DT thiazides/NNS and/CC other/JJ diuretics/NNS ,/, corticosteroids/NNS ,/, phenothiazines/NNS ,/, thyroid/NN products/NNS ,/, estrogens/NNS ,/, oral/JJ contraceptives/NNS ,/, phenytoin/NN ,/, nicotinic/JJ acid/NN ,/, sympathomimetics/NNS ,/, calcium/NN channel-blocking/JJ drugs/NNS ,/, and/CC isoniazid/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS drugs)) (VP (VBP include) (NP (NP (DT the) (NNS thiazides)) (CC and) (NP (NP (JJ other) (NNS diuretics)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NN thyroid) (NNS products)) (, ,) (NP (NNS estrogens)) (, ,) (NP (JJ oral) (NNS contraceptives)) (, ,) (NP (NN phenytoin)) (, ,) (NP (JJ nicotinic) (NN acid)) (, ,) (NP (NNS sympathomimetics)) (, ,) (NP (NN calcium) (JJ channel-blocking) (NNS drugs)) (, ,) (CC and) (NP (NN isoniazid)))))) (. .))))

det(drugs-2, These-1)
nsubj(include-3, drugs-2)
root(ROOT-0, include-3)
det(thiazides-5, the-4)
dobj(include-3, thiazides-5)
amod(diuretics-8, other-7)
conj_and(thiazides-5, diuretics-8)
conj_and(diuretics-8, corticosteroids-10)
conj_and(diuretics-8, phenothiazines-12)
nn(products-15, thyroid-14)
conj_and(diuretics-8, products-15)
conj_and(diuretics-8, estrogens-17)
amod(contraceptives-20, oral-19)
conj_and(diuretics-8, contraceptives-20)
conj_and(diuretics-8, phenytoin-22)
amod(acid-25, nicotinic-24)
conj_and(diuretics-8, acid-25)
conj_and(diuretics-8, sympathomimetics-27)
nn(drugs-31, calcium-29)
amod(drugs-31, channel-blocking-30)
conj_and(diuretics-8, drugs-31)
conj_and(diuretics-8, isoniazid-34)

When/WRB such/JJ drugs/NNS are/VBP administered/VBN to/TO a/DT patient/NN receiving/VBG Acarbose/NN ,/, the/DT patient/NN should/MD be/VB closely/RB observed/VBN for/IN loss/NN of/IN blood/NN glucose/NN control/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN Acarbose))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN observed) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NN blood) (NN glucose) (NN control))))))))) (. .))))

advmod(administered-5, When-1)
amod(drugs-3, such-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, are-4)
advcl(observed-17, administered-5)
det(patient-8, a-7)
prep_to(administered-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, Acarbose-10)
det(patient-13, the-12)
nsubjpass(observed-17, patient-13)
aux(observed-17, should-14)
auxpass(observed-17, be-15)
advmod(observed-17, closely-16)
root(ROOT-0, observed-17)
prep_for(observed-17, loss-19)
nn(control-23, blood-21)
nn(control-23, glucose-22)
prep_of(loss-19, control-23)

When/WRB such/JJ drugs/NNS are/VBP withdrawn/VBN from/IN patients/NNS receiving/VBG Acarbose/NN in/IN combination/NN with/IN sulfonylureas/NN or/CC insulin/NN ,/, patients/NNS should/MD be/VB observed/VBN closely/RB for/IN any/DT evidence/NN of/IN hypoglycemia/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN withdrawn) (PP (IN from) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN Acarbose)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN sulfonylureas)) (CC or) (NP (NN insulin))))))))))))) (, ,) (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (DT any) (NN evidence)) (PP (IN of) (NP (NN hypoglycemia))))))))) (. .))))

advmod(withdrawn-5, When-1)
amod(drugs-3, such-2)
nsubjpass(withdrawn-5, drugs-3)
auxpass(withdrawn-5, are-4)
advcl(observed-20, withdrawn-5)
prep_from(withdrawn-5, patients-7)
partmod(patients-7, receiving-8)
dobj(receiving-8, Acarbose-9)
prep_in(receiving-8, combination-11)
prep_with(combination-11, sulfonylureas-13)
conj_or(sulfonylureas-13, insulin-15)
nsubjpass(observed-20, patients-17)
aux(observed-20, should-18)
auxpass(observed-20, be-19)
root(ROOT-0, observed-20)
advmod(observed-20, closely-21)
det(evidence-24, any-23)
prep_for(observed-20, evidence-24)
prep_of(evidence-24, hypoglycemia-26)

Intestinal/JJ adsorbents/NNS (/-LRB- e./FW g./FW ,/, charcoal/NN )/-RRB- and/CC digestive/JJ enzyme/NN preparations/NNS containing/VBG carbohydrate-splitting/JJ enzymes/NNS (/-LRB- e./FW g./FW ,/, amylase/NN ,/, pancreatin/NN )/-RRB- may/MD reduce/VB the/DT effect/NN of/IN Acarbose/NN and/CC should/MD not/RB be/VB taken/VBN concomitantly/RB ./.

(ROOT (S1 (S (NP (NP (NP (JJ Intestinal) (NNS adsorbents)) (PRN (-LRB- -LRB-) (NP (NP (FW e.) (FW g.)) (, ,) (NP (NN charcoal))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (JJ digestive) (NN enzyme) (NNS preparations)) (VP (VBG containing) (NP (JJ carbohydrate-splitting) (NNS enzymes)))) (PRN (-LRB- -LRB-) (NP (NP (FW e.) (FW g.)) (, ,) (NP (NN amylase)) (, ,) (NP (NN pancreatin))) (-RRB- -RRB-)))) (VP (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN Acarbose)))))) (CC and) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (ADVP (RB concomitantly)))))) (. .))))

amod(adsorbents-2, Intestinal-1)
nsubj(reduce-25, adsorbents-2)
nn(g.-5, e.-4)
dep(adsorbents-2, g.-5)
appos(g.-5, charcoal-7)
amod(preparations-12, digestive-10)
nn(preparations-12, enzyme-11)
conj_and(adsorbents-2, preparations-12)
partmod(preparations-12, containing-13)
amod(enzymes-15, carbohydrate-splitting-14)
dobj(containing-13, enzymes-15)
nn(g.-18, e.-17)
dep(preparations-12, g.-18)
appos(g.-18, amylase-20)
appos(g.-18, pancreatin-22)
aux(reduce-25, may-24)
root(ROOT-0, reduce-25)
det(effect-27, the-26)
dobj(reduce-25, effect-27)
prep_of(effect-27, Acarbose-29)
aux(taken-34, should-31)
neg(taken-34, not-32)
auxpass(taken-34, be-33)
conj_and(reduce-25, taken-34)
advmod(taken-34, concomitantly-35)

Acarbose/NN has/VBZ been/VBN shown/VBN to/TO change/VB the/DT bioavailabillty/NN digoxin/NN when/WRB they/PRP are/VBP co-administered/VBN ,/, which/WDT may/MD require/VB digoxin/NN dose/NN adjustment/NN ./.

(ROOT (S1 (S (S (NP (NN Acarbose)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB change) (NP (DT the) (NN bioavailabillty) (NN digoxin)) (SBAR (WHADVP (WRB when)) (S (NP (PRP they)) (VP (VBP are) (VP (VBN co-administered) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB require) (NP (NN digoxin) (NN dose) (NN adjustment))))))))))))))))) (. .))))

nsubjpass(shown-4, Acarbose-1)
xsubj(change-6, Acarbose-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(change-6, to-5)
xcomp(shown-4, change-6)
det(digoxin-9, the-7)
nn(digoxin-9, bioavailabillty-8)
dobj(change-6, digoxin-9)
advmod(co-administered-13, when-10)
nsubjpass(co-administered-13, they-11)
auxpass(co-administered-13, are-12)
advcl(change-6, co-administered-13)
nsubj(require-17, which-15)
aux(require-17, may-16)
ccomp(co-administered-13, require-17)
nn(adjustment-20, digoxin-18)
nn(adjustment-20, dose-19)
dobj(require-17, adjustment-20)

Studies/NNS in/IN healthy/JJ volunteers/NNS have/VBP shown/VBN that/IN Acarbose/NN has/VBZ no/DT effect/NN on/IN either/CC the/DT pharmacokinetics/NNS or/CC pharmacodynamics/NNS of/IN digoxin/NN ,/, nifedipine/NN ,/, propranolol/NN ,/, or/CC ranitidine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Studies)) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN Acarbose)) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (CC either) (DT the) (NP (NNS pharmacokinetics)) (CC or) (NP (NNS pharmacodynamics))) (PP (IN of) (NP (NP (NN digoxin)) (, ,) (NP (NN nifedipine)) (, ,) (NP (NN propranolol)) (, ,) (CC or) (NP (NN ranitidine)))))))))))) (. .))))

nsubj(shown-6, Studies-1)
amod(volunteers-4, healthy-3)
prep_in(Studies-1, volunteers-4)
aux(shown-6, have-5)
root(ROOT-0, shown-6)
complm(has-9, that-7)
nsubj(has-9, Acarbose-8)
ccomp(shown-6, has-9)
det(effect-11, no-10)
dobj(has-9, effect-11)
preconj(pharmacokinetics-15, either-13)
dep(pharmacokinetics-15, the-14)
prep_on(has-9, pharmacokinetics-15)
conj_or(pharmacokinetics-15, pharmacodynamics-17)
prep_of(pharmacokinetics-15, digoxin-19)
conj_or(digoxin-19, nifedipine-21)
conj_or(digoxin-19, propranolol-23)
conj_or(digoxin-19, ranitidine-26)

Acarbose/NN did/VBD not/RB interfere/VB with/IN the/DT absorption/NN or/CC disposition/NN of/IN the/DT sulfonylurea/NN glyburide/NN in/IN diabetic/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (NN Acarbose)) (VP (VBD did) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NP (NN absorption)) (CC or) (NP (NN disposition))) (PP (IN of) (NP (DT the) (NN sulfonylurea) (NN glyburide))) (PP (IN in) (NP (JJ diabetic) (NNS patients)))))))) (. .))))

nsubj(interfere-4, Acarbose-1)
aux(interfere-4, did-2)
neg(interfere-4, not-3)
root(ROOT-0, interfere-4)
dep(absorption-7, the-6)
prep_with(interfere-4, absorption-7)
conj_or(absorption-7, disposition-9)
det(glyburide-13, the-11)
nn(glyburide-13, sulfonylurea-12)
prep_of(absorption-7, glyburide-13)
amod(patients-16, diabetic-15)
prep_in(absorption-7, patients-16)

Acarbose/NN may/MD affect/VB digoxin/NN bioavailabillty/NN and/CC may/MD require/VB dose/NN adjustment/NN of/IN digoxin/NN by/IN 16/CD %/NN (/-LRB- 90/CD %/NN confidence/NN interval/NN :/: 8-23/CD %/NN )/-RRB- ,/, decrease/VB mean/NN C/NN max/NN digoxin/NN by/IN 26/CD %/NN (/-LRB- 90/CD %/NN confidence/NN interval/NN :/: 16-34/CD %/NN )/-RRB- and/CC decrease/VB mean/JJ trough/NN concentrations/NNS of/IN digoxin/NN by/IN 9/CD %/NN (/-LRB- 90/CD %/NN confidence/NN limit/NN :/: 19/CD %/NN decrease/NN to/TO 2/CD %/NN increase/NN )./NN

(ROOT (S1 (S (S (NP (NN Acarbose)) (VP (VP (MD may) (VP (VB affect) (NP (NN digoxin) (NN bioavailabillty)))) (CC and) (VP (MD may) (VP (VP (VB require) (NP (NP (NN dose) (NN adjustment)) (PP (IN of) (NP (NN digoxin)))) (PP (IN by) (NP (NP (CD 16) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 90) (NN %) (NN confidence) (NN interval) (: :) (CD 8-23) (NN %)) (-RRB- -RRB-))))) (, ,) (VP (VB decrease) (NP (NN mean) (NN C) (NN max) (NN digoxin)) (PP (IN by) (NP (NP (CD 26) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 90) (NN %) (NN confidence) (NN interval) (: :) (CD 16-34) (NN %)) (-RRB- -RRB-))))) (CC and) (VP (VB decrease) (NP (NP (JJ mean) (NN trough) (NNS concentrations)) (PP (IN of) (NP (NN digoxin)))) (PP (IN by) (NP (NP (CD 9) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 90) (NN %) (NN confidence) (NN limit)))))))))) (: :) (NP (NP (ADJP (CD 19) (NN %)) (NN decrease)) (PP (TO to) (NP (NP (ADJP (CD 2) (NN %)) (NN increase)) (NN -RRB-.)))))))

nsubj(affect-3, Acarbose-1)
aux(affect-3, may-2)
root(ROOT-0, affect-3)
nn(bioavailabillty-5, digoxin-4)
dobj(affect-3, bioavailabillty-5)
aux(require-8, may-7)
conj_and(affect-3, require-8)
nn(adjustment-10, dose-9)
dobj(require-8, adjustment-10)
prep_of(adjustment-10, digoxin-12)
num(%-15, 16-14)
prep_by(require-8, %-15)
num(%-23, 90-17)
nn(%-23, %-18)
nn(%-23, confidence-19)
nn(%-23, interval-20)
num(%-23, 8-23-22)
appos(%-15, %-23)
conj_and(require-8, decrease-26)
nn(digoxin-30, mean-27)
nn(digoxin-30, C-28)
nn(digoxin-30, max-29)
dobj(decrease-26, digoxin-30)
num(%-33, 26-32)
prep_by(decrease-26, %-33)
num(%-41, 90-35)
nn(%-41, %-36)
nn(%-41, confidence-37)
nn(%-41, interval-38)
num(%-41, 16-34-40)
appos(%-33, %-41)
conj_and(require-8, decrease-44)
amod(concentrations-47, mean-45)
nn(concentrations-47, trough-46)
dobj(decrease-44, concentrations-47)
prep_of(concentrations-47, digoxin-49)
num(%-52, 9-51)
prep_by(decrease-44, %-52)
num(limit-57, 90-54)
nn(limit-57, %-55)
nn(limit-57, confidence-56)
dep(%-52, limit-57)
number(%-60, 19-59)
amod(decrease-61, %-60)
dep(affect-3, decrease-61)
number(%-64, 2-63)
amod(increase-65, %-64)
nn(-RRB-.-66, increase-65)
prep_to(decrease-61, -RRB-.-66)

The/DT amount/NN of/IN metformin/NN absorbed/VBD while/IN taking/VBG Acarbose/NN was/VBD bioequivalent/JJ to/TO the/DT amount/NN absorbed/VBN when/WRB taking/VBG placebo/NN ,/, as/IN indicated/VBN by/IN the/DT plasma/NN AUC/NN values/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN amount)) (PP (IN of) (NP (NN metformin)))) (VP (VBD absorbed) (SBAR (IN while) (S (PP (VBG taking) (NP (NN Acarbose))) (VP (VBD was) (ADJP (JJ bioequivalent) (PP (TO to) (NP (NP (DT the) (NN amount)) (VP (VBN absorbed) (SBAR (WHADVP (WRB when)) (S (VP (VBG taking) (NP (NN placebo))))))))) (, ,) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN by) (NP (DT the) (NN plasma) (NN AUC) (NNS values))))))))))) (. .))))

det(amount-2, The-1)
nsubj(absorbed-5, amount-2)
prep_of(amount-2, metformin-4)
root(ROOT-0, absorbed-5)
mark(bioequivalent-10, while-6)
prep_taking(bioequivalent-10, Acarbose-8)
cop(bioequivalent-10, was-9)
advcl(absorbed-5, bioequivalent-10)
det(amount-13, the-12)
prep_to(bioequivalent-10, amount-13)
partmod(amount-13, absorbed-14)
advmod(taking-16, when-15)
advcl(absorbed-14, taking-16)
dobj(taking-16, placebo-17)
mark(indicated-20, as-19)
advcl(bioequivalent-10, indicated-20)
det(values-25, the-22)
nn(values-25, plasma-23)
nn(values-25, AUC-24)
prep_by(indicated-20, values-25)

However/RB ,/, the/DT peak/JJ plasma/NN level/NN of/IN metformin/NN was/VBD reduced/VBN by/IN approximately/RB 20/CD %/NN when/WRB taking/VBG Acarbose/NN due/IN to/TO a/DT slight/JJ delay/NN in/IN the/DT absorption/NN of/IN metformin/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ peak) (NN plasma) (NN level)) (PP (IN of) (NP (NN metformin)))) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (QP (RB approximately) (CD 20)) (NN %))) (SBAR (WHADVP (WRB when)) (S (VP (VBG taking) (NP (NN Acarbose)) (PP (IN due) (TO to) (NP (NP (DT a) (JJ slight) (NN delay)) (PP (IN in) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN metformin))))))))))))) (. .))))

advmod(reduced-10, However-1)
det(level-6, the-3)
amod(level-6, peak-4)
nn(level-6, plasma-5)
nsubjpass(reduced-10, level-6)
prep_of(level-6, metformin-8)
auxpass(reduced-10, was-9)
root(ROOT-0, reduced-10)
quantmod(20-13, approximately-12)
num(%-14, 20-13)
agent(reduced-10, %-14)
advmod(taking-16, when-15)
advcl(reduced-10, taking-16)
dobj(taking-16, Acarbose-17)
det(delay-22, a-20)
amod(delay-22, slight-21)
prep_due_to(taking-16, delay-22)
det(absorption-25, the-24)
prep_in(delay-22, absorption-25)
prep_of(absorption-25, metformin-27)

There/EX is/VBZ little/JJ if/IN any/DT clinically/RB significant/JJ interaction/NN between/IN Acarbose/NN and/CC metformin/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (ADJP (JJ little) (PP (IN if) (NP (NP (DT any) (ADJP (RB clinically) (JJ significant)) (NN interaction)) (PP (IN between) (NP (NP (NN Acarbose)) (CC and) (NP (NN metformin))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
acomp(is-2, little-3)
det(interaction-8, any-5)
advmod(significant-7, clinically-6)
amod(interaction-8, significant-7)
prep_if(little-3, interaction-8)
prep_between(interaction-8, Acarbose-10)
conj_and(Acarbose-10, metformin-12)

Catecholamine-depleting/JJ drugs/NNS ,/, such/JJ as/IN reserpine/NN ,/, may/MD have/VB an/DT additive/JJ effect/NN when/WRB given/VBN with/IN beta-blocking/JJ agent/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Catecholamine-depleting) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NN reserpine))) (, ,)) (VP (MD may) (VP (VB have) (NP (DT an) (JJ additive) (NN effect)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN with) (NP (JJ beta-blocking) (NN agent) (NNS s))))))))) (. .))))

amod(drugs-2, Catecholamine-depleting-1)
nsubj(have-9, drugs-2)
prep_such_as(drugs-2, reserpine-6)
aux(have-9, may-8)
root(ROOT-0, have-9)
det(effect-12, an-10)
amod(effect-12, additive-11)
dobj(have-9, effect-12)
advmod(given-14, when-13)
advcl(have-9, given-14)
amod(s-18, beta-blocking-16)
nn(s-18, agent-17)
prep_with(given-14, s-18)

Patients/NNS treated/VBN with/IN acebutolol/NN plus/CC catecholamine/NN depletors/NNS should/MD ,/, therefore/RB ,/, be/VB observed/VBN closely/RB for/IN evidence/NN of/IN marked/JJ bradycardia/NN or/CC hypotension/NN which/WDT may/MD present/VBP as/IN vertigo/NN ,/, syncope/presyncope/NN ,/, or/CC orthostatic/JJ changes/NNS in/IN blood/NN pressure/NN without/IN compensatory/JJ tachycardia/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NN acebutolol)) (CC plus) (NP (NN catecholamine) (NNS depletors)))))) (VP (MD should) (, ,) (ADVP (RB therefore)) (, ,) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NP (JJ marked) (NN bradycardia)) (CC or) (NP (NN hypotension))) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VBP present) (PP (IN as) (NP (NP (NN vertigo)) (, ,) (NP (NN syncope/presyncope)) (, ,) (CC or) (NP (NP (JJ orthostatic) (NNS changes)) (PP (IN in) (NP (NN blood) (NN pressure))) (PP (IN without) (NP (JJ compensatory) (NN tachycardia)))))))))))))))))) (. .))))

nsubjpass(observed-13, Patients-1)
partmod(Patients-1, treated-2)
prep_with(treated-2, acebutolol-4)
nn(depletors-7, catecholamine-6)
conj_plus(acebutolol-4, depletors-7)
aux(observed-13, should-8)
advmod(observed-13, therefore-10)
auxpass(observed-13, be-12)
root(ROOT-0, observed-13)
advmod(observed-13, closely-14)
prep_for(observed-13, evidence-16)
amod(bradycardia-19, marked-18)
prep_of(evidence-16, bradycardia-19)
nsubj(present-24, bradycardia-19)
conj_or(bradycardia-19, hypotension-21)
aux(present-24, may-23)
rcmod(bradycardia-19, present-24)
prep_as(present-24, vertigo-26)
conj_or(vertigo-26, syncope/presyncope-28)
amod(changes-32, orthostatic-31)
conj_or(vertigo-26, changes-32)
nn(pressure-35, blood-34)
prep_in(changes-32, pressure-35)
amod(tachycardia-38, compensatory-37)
prep_without(changes-32, tachycardia-38)

Exaggerated/JJ hypertensive/JJ responses/NNS have/VBP been/VBN reported/VBN from/IN the/DT combined/JJ use/NN of/IN beta-adrenergic/JJ antagonist/NN s/NN and/CC alpha-adrenergic/JJ stimulants/NNS ,/, including/VBG those/DT contained/VBN in/IN proprietary/JJ cold/JJ remedies/NNS and/CC vasoconstrictive/JJ nasal/JJ drops/NN ./.

(ROOT (S1 (S (S (NP (JJ Exaggerated) (JJ hypertensive) (NNS responses)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN from) (NP (NP (DT the) (JJ combined) (NN use)) (PP (IN of) (NP (NP (JJ beta-adrenergic) (NN antagonist) (NN s)) (CC and) (NP (JJ alpha-adrenergic) (NNS stimulants)))))) (, ,) (PP (VBG including) (NP (NP (DT those)) (VP (VBN contained) (PP (IN in) (NP (NP (JJ proprietary) (JJ cold) (NNS remedies)) (CC and) (NP (JJ vasoconstrictive) (JJ nasal) (NN drops))))))))))) (. .))))

amod(responses-3, Exaggerated-1)
amod(responses-3, hypertensive-2)
nsubjpass(reported-6, responses-3)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
det(use-10, the-8)
amod(use-10, combined-9)
prep_from(reported-6, use-10)
amod(s-14, beta-adrenergic-12)
nn(s-14, antagonist-13)
prep_of(use-10, s-14)
amod(stimulants-17, alpha-adrenergic-16)
conj_and(s-14, stimulants-17)
prep_including(reported-6, those-20)
partmod(those-20, contained-21)
amod(remedies-25, proprietary-23)
amod(remedies-25, cold-24)
prep_in(contained-21, remedies-25)
amod(drops-29, vasoconstrictive-27)
amod(drops-29, nasal-28)
conj_and(remedies-25, drops-29)

Patients/NNS receiving/VBG beta-blockers/NN should/MD be/VB warned/VBN of/IN this/DT potential/JJ hazard/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NN beta-blockers)))) (VP (MD should) (VP (VB be) (VP (VBN warned) (PP (IN of) (NP (DT this) (JJ potential) (NN hazard))))))) (. .))))

nsubjpass(warned-6, Patients-1)
partmod(Patients-1, receiving-2)
dobj(receiving-2, beta-blockers-3)
aux(warned-6, should-4)
auxpass(warned-6, be-5)
root(ROOT-0, warned-6)
det(hazard-10, this-8)
amod(hazard-10, potential-9)
prep_of(warned-6, hazard-10)

Blunting/NN of/IN the/DT antihypertensive/JJ effect/NN of/IN beta-adrenoceptor/NN blocking/NN agent/NN s/NNS by/IN nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Blunting)) (PP (IN of) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NN beta-adrenoceptor) (NN blocking) (NN agent) (NNS s))))) (PP (IN by) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))))) (. .))))

nsubjpass(reported-17, Blunting-1)
det(effect-5, the-3)
amod(effect-5, antihypertensive-4)
prep_of(Blunting-1, effect-5)
nn(s-10, beta-adrenoceptor-7)
nn(s-10, blocking-8)
nn(s-10, agent-9)
prep_of(effect-5, s-10)
amod(drugs-14, nonsteroidal-12)
amod(drugs-14, anti-inflammatory-13)
prep_by(Blunting-1, drugs-14)
aux(reported-17, has-15)
auxpass(reported-17, been-16)
root(ROOT-0, reported-17)

No/DT significant/JJ interactions/NNS with/IN digoxin/NN ,/, hydrochlorothiazide/NN ,/, hydralazine/NN ,/, sulfinpyrazone/NN ,/, oral/JJ contraceptives/NNS ,/, tolbutamide/NN ,/, or/CC warfarin/NN have/VBP been/VBN observed/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ significant) (NNS interactions)) (PP (IN with) (NP (NP (NN digoxin)) (, ,) (NP (NN hydrochlorothiazide)) (, ,) (NP (NN hydralazine)) (, ,) (NP (NN sulfinpyrazone)) (, ,) (NP (JJ oral) (NNS contraceptives)) (, ,) (NP (NN tolbutamide)) (, ,) (CC or) (NP (NN warfarin))))) (VP (VBP have) (VP (VBN been) (VP (VBN observed))))) (. .))))

det(interactions-3, No-1)
amod(interactions-3, significant-2)
nsubjpass(observed-22, interactions-3)
prep_with(interactions-3, digoxin-5)
conj_or(digoxin-5, hydrochlorothiazide-7)
conj_or(digoxin-5, hydralazine-9)
conj_or(digoxin-5, sulfinpyrazone-11)
amod(contraceptives-14, oral-13)
conj_or(digoxin-5, contraceptives-14)
conj_or(digoxin-5, tolbutamide-16)
conj_or(digoxin-5, warfarin-19)
aux(observed-22, have-20)
auxpass(observed-22, been-21)
root(ROOT-0, observed-22)

DIAMOX/NN modifies/VBZ phenytoin/NN metabolism/NN with/IN increased/VBN serum/NN levels/NNS of/IN phenytoin/NN ./.

(ROOT (S1 (S (S (NP (NN DIAMOX)) (VP (VBZ modifies) (NP (NN phenytoin) (NN metabolism)) (PP (IN with) (NP (NP (VBN increased) (NN serum) (NNS levels)) (PP (IN of) (NP (NN phenytoin))))))) (. .))))

nsubj(modifies-2, DIAMOX-1)
root(ROOT-0, modifies-2)
nn(metabolism-4, phenytoin-3)
dobj(modifies-2, metabolism-4)
amod(levels-8, increased-6)
nn(levels-8, serum-7)
prep_with(modifies-2, levels-8)
prep_of(levels-8, phenytoin-10)

This/DT may/MD increase/VB or/CC enhance/VB the/DT occurrence/NN of/IN osteomalacia/NN in/IN some/DT patients/NNS receiving/VBG chronic/JJ phenytoin/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VP (VB increase)) (CC or) (VP (VB enhance) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NN osteomalacia))) (PP (IN in) (NP (NP (DT some) (NNS patients)) (VP (VBG receiving) (NP (JJ chronic) (NN phenytoin) (NN therapy)))))))))) (. .))))

nsubj(increase-3, This-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
conj_or(increase-3, enhance-5)
det(occurrence-7, the-6)
dobj(enhance-5, occurrence-7)
prep_of(occurrence-7, osteomalacia-9)
det(patients-12, some-11)
prep_in(occurrence-7, patients-12)
partmod(patients-12, receiving-13)
amod(therapy-16, chronic-14)
nn(therapy-16, phenytoin-15)
dobj(receiving-13, therapy-16)

By/IN decreasing/VBG the/DT gastrointestinal/JJ absorption/NN of/IN primidone/NN ,/, DIAMOX/NN may/MD decrease/VB serum/NN concentrations/NNS of/IN primidone/NN and/CC its/PRP$ metabolites/NNS ,/, with/IN a/DT consequent/JJ possible/JJ decrease/NN in/IN anticonvulsant/JJ effect/NN ./.

(ROOT (S1 (S (S (PP (IN By) (S (VP (VBG decreasing) (NP (NP (DT the) (JJ gastrointestinal) (NN absorption)) (PP (IN of) (NP (NN primidone))))))) (, ,) (NP (NN DIAMOX)) (VP (MD may) (VP (VB decrease) (NP (NP (NN serum) (NNS concentrations)) (PP (IN of) (NP (NP (NN primidone)) (CC and) (NP (PRP$ its) (NNS metabolites))))) (, ,) (PP (IN with) (NP (NP (DT a) (JJ consequent) (JJ possible) (NN decrease)) (PP (IN in) (NP (JJ anticonvulsant) (NN effect)))))))) (. .))))

prepc_by(decrease-11, decreasing-2)
det(absorption-5, the-3)
amod(absorption-5, gastrointestinal-4)
dobj(decreasing-2, absorption-5)
prep_of(absorption-5, primidone-7)
nsubj(decrease-11, DIAMOX-9)
aux(decrease-11, may-10)
root(ROOT-0, decrease-11)
nn(concentrations-13, serum-12)
dobj(decrease-11, concentrations-13)
prep_of(concentrations-13, primidone-15)
poss(metabolites-18, its-17)
conj_and(primidone-15, metabolites-18)
det(decrease-24, a-21)
amod(decrease-24, consequent-22)
amod(decrease-24, possible-23)
prep_with(decrease-11, decrease-24)
amod(effect-27, anticonvulsant-26)
prep_in(decrease-24, effect-27)

Caution/NN is/VBZ advised/JJ when/WRB beginning/VBG ,/, discontinuing/VBG ,/, or/CC changing/VBG the/DT dose/NN of/IN DIAMOX/NN in/IN patients/NNS receiving/VBG primidone/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (VBZ is) (ADJP (JJ advised)) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG beginning)) (, ,) (VP (VBG discontinuing)) (, ,) (CC or) (VP (VBG changing) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN DIAMOX))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN primidone)))))))))))) (. .))))

nsubj(advised-3, Caution-1)
cop(advised-3, is-2)
root(ROOT-0, advised-3)
advmod(beginning-5, when-4)
advcl(advised-3, beginning-5)
conj_or(beginning-5, discontinuing-7)
conj_or(beginning-5, changing-10)
det(dose-12, the-11)
dobj(changing-10, dose-12)
prep_of(dose-12, DIAMOX-14)
prep_in(dose-12, patients-16)
partmod(patients-16, receiving-17)
dobj(receiving-17, primidone-18)

Because/IN of/IN possible/JJ additive/JJ effects/NNS with/IN other/JJ carbonic/JJ anhydrase/NN inhibitors/NNS ,/, concomitant/JJ use/NN is/VBZ not/RB advisable/JJ ./.

(ROOT (S1 (S (S (PP (IN Because) (PP (IN of) (NP (NP (JJ possible) (JJ additive) (NNS effects)) (PP (IN with) (NP (JJ other) (NP (JJ carbonic) (NN anhydrase)) (NNS inhibitors)))))) (, ,) (NP (JJ concomitant) (NN use)) (VP (VBZ is) (RB not) (ADJP (JJ advisable)))) (. .))))

prepc_because_of(advisable-16, of-2)
amod(effects-5, possible-3)
amod(effects-5, additive-4)
pobj(advisable-16, effects-5)
amod(inhibitors-10, other-7)
amod(anhydrase-9, carbonic-8)
nn(inhibitors-10, anhydrase-9)
prep_with(effects-5, inhibitors-10)
amod(use-13, concomitant-12)
nsubj(advisable-16, use-13)
cop(advisable-16, is-14)
neg(advisable-16, not-15)
root(ROOT-0, advisable-16)

Acetazolamide/NN may/MD increase/VB the/DT effects/NNS of/IN other/JJ folic/JJ acid/NN antagonists/NNS ./.

(ROOT (S1 (S (S (NP (NN Acetazolamide)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ other) (JJ folic) (NN acid) (NNS antagonists))))))) (. .))))

nsubj(increase-3, Acetazolamide-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
det(effects-5, the-4)
dobj(increase-3, effects-5)
amod(antagonists-10, other-7)
amod(antagonists-10, folic-8)
nn(antagonists-10, acid-9)
prep_of(effects-5, antagonists-10)

Acetazolamide/NN may/MD increase/VB or/CC decrease/VB blood/NN glucose/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Acetazolamide)) (VP (MD may) (VP (VP (VB increase)) (CC or) (VP (VB decrease) (NP (NN blood) (NN glucose) (NNS levels)))))) (. .))))

nsubj(increase-3, Acetazolamide-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
conj_or(increase-3, decrease-5)
nn(levels-8, blood-6)
nn(levels-8, glucose-7)
dobj(decrease-5, levels-8)

Consideration/NN should/MD be/VB taken/VBN in/IN patients/NNS being/VBG treated/VBN with/IN antidiabetic/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Consideration)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (JJ antidiabetic) (NNS agents))))))))))) (. .))))

nsubjpass(taken-4, Consideration-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
prep_in(taken-4, patients-6)
auxpass(treated-8, being-7)
partmod(patients-6, treated-8)
amod(agents-11, antidiabetic-10)
prep_with(treated-8, agents-11)

Acetazolamide/NN decreases/VBZ urinary/JJ excretion/NN of/IN amphetamine/NN and/CC may/MD enhance/VB the/DT magnitude/NN and/CC duration/NN of/IN their/PRP$ effect/NN ./.

(ROOT (S1 (S (S (NP (NN Acetazolamide)) (VP (VP (VBZ decreases) (NP (NP (JJ urinary) (NN excretion)) (PP (IN of) (NP (NN amphetamine))))) (CC and) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NP (NP (NN magnitude)) (CC and) (NP (NN duration)))) (PP (IN of) (NP (PRP$ their) (NN effect)))))))) (. .))))

nsubj(decreases-2, Acetazolamide-1)
root(ROOT-0, decreases-2)
amod(excretion-4, urinary-3)
dobj(decreases-2, excretion-4)
prep_of(excretion-4, amphetamine-6)
aux(enhance-9, may-8)
conj_and(decreases-2, enhance-9)
det(magnitude-11, the-10)
dobj(enhance-9, magnitude-11)
conj_and(magnitude-11, duration-13)
poss(effect-16, their-15)
prep_of(magnitude-11, effect-16)

Acetazolamide/NN reduces/VBZ urinary/JJ excretion/NN of/IN quinidine/NN and/CC may/MD enhance/VB its/PRP$ effect/NN ./.

(ROOT (S1 (S (S (NP (NN Acetazolamide)) (VP (VP (VBZ reduces) (NP (NP (JJ urinary) (NN excretion)) (PP (IN of) (NP (NN quinidine))))) (CC and) (VP (MD may) (VP (VB enhance) (NP (PRP$ its) (NN effect)))))) (. .))))

nsubj(reduces-2, Acetazolamide-1)
root(ROOT-0, reduces-2)
amod(excretion-4, urinary-3)
dobj(reduces-2, excretion-4)
prep_of(excretion-4, quinidine-6)
aux(enhance-9, may-8)
conj_and(reduces-2, enhance-9)
poss(effect-11, its-10)
dobj(enhance-9, effect-11)

Acetazolamide/NN may/MD prevent/VB the/DT urinary/JJ antiseptic/JJ effect/NN of/IN methenamine/NN ./.

(ROOT (S1 (S (S (NP (NN Acetazolamide)) (VP (MD may) (VP (VB prevent) (NP (NP (DT the) (JJ urinary) (JJ antiseptic) (NN effect)) (PP (IN of) (NP (NN methenamine))))))) (. .))))

nsubj(prevent-3, Acetazolamide-1)
aux(prevent-3, may-2)
root(ROOT-0, prevent-3)
det(effect-7, the-4)
amod(effect-7, urinary-5)
amod(effect-7, antiseptic-6)
dobj(prevent-3, effect-7)
prep_of(effect-7, methenamine-9)

Acetazolamide/NN increases/VBZ lithium/NN excretion/NN and/CC the/DT lithium/NN may/MD be/VB decreased/VBN ./.

(ROOT (S1 (S (S (S (NP (NN Acetazolamide)) (VP (VBZ increases) (NP (NN lithium) (NN excretion)))) (CC and) (S (NP (DT the) (NN lithium)) (VP (MD may) (VP (VB be) (VP (VBN decreased)))))) (. .))))

nsubj(increases-2, Acetazolamide-1)
root(ROOT-0, increases-2)
nn(excretion-4, lithium-3)
dobj(increases-2, excretion-4)
det(lithium-7, the-6)
nsubjpass(decreased-10, lithium-7)
aux(decreased-10, may-8)
auxpass(decreased-10, be-9)
conj_and(increases-2, decreased-10)

Acetazolamide/NN and/CC sodium/NN bicarbonate/NN used/VBN concurrently/RB increases/VBZ the/DT risk/NN of/IN renal/JJ calculus/NNS formation/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Acetazolamide)) (CC and) (NP (NN sodium) (NN bicarbonate))) (VP (VBN used) (ADVP (RB concurrently)))) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ renal) (NNS calculus) (NN formation)))))) (. .))))

nsubj(increases-7, Acetazolamide-1)
nn(bicarbonate-4, sodium-3)
conj_and(Acetazolamide-1, bicarbonate-4)
partmod(Acetazolamide-1, used-5)
advmod(used-5, concurrently-6)
root(ROOT-0, increases-7)
det(risk-9, the-8)
dobj(increases-7, risk-9)
amod(formation-13, renal-11)
nn(formation-13, calculus-12)
prep_of(risk-9, formation-13)

Acetazolamide/NN may/MD elevate/VBP cyclosporine/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Acetazolamide)) (VP (MD may) (VP (VBP elevate) (NP (NN cyclosporine) (NNS levels))))) (. .))))

nsubj(elevate-3, Acetazolamide-1)
aux(elevate-3, may-2)
root(ROOT-0, elevate-3)
nn(levels-5, cyclosporine-4)
dobj(elevate-3, levels-5)

As/IN DIFFERIN/NN Gel/NN has/VBZ the/DT potential/NN to/TO produce/VB local/JJ irritation/NN in/IN some/DT patients/NNS ,/, concomitant/JJ use/NN of/IN other/JJ potentially/RB irritating/JJ topical/JJ products/NNS (/-LRB- medicated/JJ or/CC abrasive/JJ soaps/NNS and/CC cleansers/NNS ,/, soaps/NNS and/CC cosmetics/NNS that/WDT have/VBP a/DT strong/JJ drying/NN effect/NN ,/, and/CC products/NNS with/IN high/JJ concentrations/NNS of/IN alcohol/NN ,/, astringents/NNS ,/, spices/NNS or/CC lime/NN )/-RRB- should/MD be/VB approached/VBN with/IN caution/NN ./.

(ROOT (S1 (S (SBAR (IN As) (S (NP (NN DIFFERIN) (NN Gel)) (VP (VBZ has) (NP (NP (DT the) (NN potential)) (VP (TO to) (VP (VB produce) (NP (JJ local) (NN irritation)) (PP (IN in) (NP (DT some) (NNS patients))))))))) (, ,) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (JJ other) (ADJP (RB potentially) (JJ irritating)) (JJ topical) (NNS products)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (ADJP (ADJP (JJ medicated)) (CC or) (ADJP (JJ abrasive))) (NP (NP (NNS soaps)) (CC and) (NP (NNS cleansers)))) (, ,) (NP (NP (NP (NNS soaps)) (CC and) (NP (NNS cosmetics))) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (DT a) (JJ strong) (NN drying) (NN effect)))))) (, ,) (CC and) (NP (NNS products))) (PP (IN with) (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (NN alcohol)))))) (, ,) (NP (NNS astringents)) (, ,) (NP (NNS spices)) (CC or) (NP (NN lime))) (-RRB- -RRB-))))) (VP (MD should) (VP (VB be) (VP (VBN approached) (PP (IN with) (NP (NN caution)))))) (. .))))

mark(has-4, As-1)
nn(Gel-3, DIFFERIN-2)
nsubj(has-4, Gel-3)
advcl(approached-57, has-4)
det(potential-6, the-5)
dobj(has-4, potential-6)
aux(produce-8, to-7)
dep(potential-6, produce-8)
amod(irritation-10, local-9)
dobj(produce-8, irritation-10)
det(patients-13, some-12)
prep_in(produce-8, patients-13)
amod(use-16, concomitant-15)
nsubjpass(approached-57, use-16)
amod(products-22, other-18)
advmod(irritating-20, potentially-19)
amod(products-22, irritating-20)
amod(products-22, topical-21)
prep_of(use-16, products-22)
amod(soaps-27, medicated-24)
conj_or(medicated-24, abrasive-26)
dep(products-22, soaps-27)
conj_and(soaps-27, cleansers-29)
conj_and(soaps-27, soaps-31)
nsubj(have-35, soaps-31)
conj_and(soaps-31, cosmetics-33)
rcmod(soaps-31, have-35)
det(effect-39, a-36)
amod(effect-39, strong-37)
nn(effect-39, drying-38)
dobj(have-35, effect-39)
conj_and(soaps-27, products-42)
amod(concentrations-45, high-44)
prep_with(soaps-27, concentrations-45)
prep_of(concentrations-45, alcohol-47)
conj_and(soaps-27, astringents-49)
conj_and(soaps-27, spices-51)
conj_or(soaps-27, lime-53)
aux(approached-57, should-55)
auxpass(approached-57, be-56)
root(ROOT-0, approached-57)
prep_with(approached-57, caution-59)

Particular/JJ caution/NN should/MD be/VB exercised/VBN in/IN using/VBG preparations/NNS containing/VBG sulfur/NN ,/, resorcinol/JJ ,/, or/CC salicylic/JJ acid/NN in/IN combination/NN with/IN DIFFERIN/NN Gel/NN ./.

(ROOT (S1 (S (S (NP (JJ Particular) (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (PP (IN in) (S (VP (VBG using) (NP (NP (NNS preparations)) (VP (VBG containing) (NP (NP (NN sulfur)) (, ,) (NP (ADJP (JJ resorcinol))) (, ,) (CC or) (NP (JJ salicylic) (NN acid))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN DIFFERIN) (NN Gel)))))))))))))) (. .))))

amod(caution-2, Particular-1)
nsubjpass(exercised-5, caution-2)
aux(exercised-5, should-3)
auxpass(exercised-5, be-4)
root(ROOT-0, exercised-5)
prepc_in(exercised-5, using-7)
dobj(using-7, preparations-8)
partmod(preparations-8, containing-9)
dobj(containing-9, sulfur-10)
conj_or(sulfur-10, resorcinol-12)
amod(acid-16, salicylic-15)
conj_or(sulfur-10, acid-16)
prep_in(containing-9, combination-18)
nn(Gel-21, DIFFERIN-20)
prep_with(combination-18, Gel-21)

If/IN these/DT preparations/NNS have/VBP been/VBN used/VBN it/PRP is/VBZ advisable/JJ not/RB to/TO start/NN therapy/NN with/IN DIFFERIN/NN Gel/NN until/IN the/DT effects/NNS of/IN such/JJ preparations/NNS in/IN the/DT skin/NN have/VBP subsided/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT these) (NNS preparations)) (VP (VBP have) (VP (VBN been) (VP (VBN used)))))) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ advisable) (PP (RB not) (TO to) (NP (NP (NN start) (NN therapy)) (PP (IN with) (NP (NN DIFFERIN) (NN Gel)))))) (SBAR (IN until) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ such) (NNS preparations))) (PP (IN in) (NP (DT the) (NN skin)))) (VP (VBP have) (VP (VBN subsided))))))) (. .))))

mark(used-6, If-1)
det(preparations-3, these-2)
nsubjpass(used-6, preparations-3)
aux(used-6, have-4)
auxpass(used-6, been-5)
advcl(advisable-9, used-6)
nsubj(advisable-9, it-7)
cop(advisable-9, is-8)
root(ROOT-0, advisable-9)
neg(advisable-9, not-10)
nn(therapy-13, start-12)
prep_to(advisable-9, therapy-13)
nn(Gel-16, DIFFERIN-15)
prep_with(therapy-13, Gel-16)
mark(subsided-27, until-17)
det(effects-19, the-18)
nsubj(subsided-27, effects-19)
amod(preparations-22, such-21)
prep_of(effects-19, preparations-22)
det(skin-25, the-24)
prep_in(effects-19, skin-25)
aux(subsided-27, have-26)
advcl(advisable-9, subsided-27)

Before/IN using/VBG this/DT medication/NN ,/, tell/NN your/NN doctor/NN or/CC pharmacist/NN of/IN all/DT prescription/NN and/CC nonprescription/NN products/NNS you/VBZ may/MD use/VB ,/, especially/RB of/IN :/: aminoglycosides/NN (/-LRB- e.g./FW ,/, gentamicin/NN ,/, amikacin/NN )/-RRB- ,/, amphotericin/NN B/NN ,/, cyclosporine/NN ,/, non-steroidal/JJ anti-inflammatory/JJ drugs/NNS (/-LRB- e.g./FW ,/, ibuprofen/NN )/-RRB- ,/, tacrolimus/NN ,/, vancomycin/NN ./.

(ROOT (S1 (S (PP (IN Before) (S (VP (VBG using) (NP (DT this) (NN medication))))) (, ,) (NP (NP (NP (NN tell) (NN your) (NN doctor)) (CC or) (NP (NN pharmacist))) (PP (IN of) (NP (DT all) (NN prescription) (CC and) (NN nonprescription) (NNS products)))) (VP (VBZ you) (S (VP (MD may) (VP (VB use) (, ,) (ADVP (RB especially)) (PP (IN of) (: :) (NP (NP (NP (NN aminoglycosides)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN gentamicin))) (, ,) (NP (NN amikacin)) (-RRB- -RRB-))) (, ,) (NP (NN amphotericin) (NN B)) (, ,) (NP (NN cyclosporine)) (, ,) (NP (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN ibuprofen)) (-RRB- -RRB-))) (, ,) (NP (NN tacrolimus)) (, ,) (NP (NN vancomycin)))))))) (. .))))

prepc_before(you-17, using-2)
det(medication-4, this-3)
dobj(using-2, medication-4)
nn(doctor-8, tell-6)
nn(doctor-8, your-7)
nsubj(you-17, doctor-8)
conj_or(doctor-8, pharmacist-10)
det(products-16, all-12)
nn(products-16, prescription-13)
conj_and(prescription-13, nonprescription-15)
prep_of(doctor-8, products-16)
root(ROOT-0, you-17)
aux(use-19, may-18)
ccomp(you-17, use-19)
advmod(use-19, especially-21)
prep_of(use-19, aminoglycosides-24)
dep(amikacin-30, e.g.-26)
pobj(e.g.-26, gentamicin-28)
appos(aminoglycosides-24, amikacin-30)
nn(B-34, amphotericin-33)
appos(aminoglycosides-24, B-34)
appos(aminoglycosides-24, cyclosporine-36)
amod(drugs-40, non-steroidal-38)
amod(drugs-40, anti-inflammatory-39)
appos(aminoglycosides-24, drugs-40)
dep(ibuprofen-44, e.g.-42)
appos(drugs-40, ibuprofen-44)
appos(aminoglycosides-24, tacrolimus-47)
appos(aminoglycosides-24, vancomycin-49)

Do/VBP not/RB start/VBP or/CC stop/NN any/DT medicine/NN without/IN doctor/NN or/CC pharmacist/NN approval/NN ./.

(ROOT (S1 (S (S (VP (VP (VBP Do) (RB not) (VP (VBP start))) (CC or) (VP (NN stop) (NP (DT any) (NN medicine)) (PP (IN without) (NP (NP (NN doctor)) (CC or) (NP (NN pharmacist)) (NP (NN approval))))))) (. .))))

aux(start-3, Do-1)
neg(start-3, not-2)
root(ROOT-0, start-3)
conj_or(start-3, stop-5)
det(medicine-7, any-6)
dobj(stop-5, medicine-7)
prep_without(stop-5, doctor-9)
conj_or(doctor-9, pharmacist-11)
dep(doctor-9, approval-12)

Drug/NN /Laboratory/NN Interactions/NNS :/: No/DT formal/JJ drug/NN interaction/NN studies/NNS have/VBP been/VBN performed/VBN with/IN Campath/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NNS Interactions)) (: :) (S (NP (DT No) (JJ formal) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN performed) (PP (IN with) (NP (NN Campath))))))) (. .)))))

nn(Interactions-3, Drug-1)
nn(Interactions-3, /Laboratory-2)
root(ROOT-0, Interactions-3)
det(studies-9, No-5)
amod(studies-9, formal-6)
nn(studies-9, drug-7)
nn(studies-9, interaction-8)
nsubjpass(performed-12, studies-9)
aux(performed-12, have-10)
auxpass(performed-12, been-11)
dep(Interactions-3, performed-12)
prep_with(performed-12, Campath-14)

An/DT immune/JJ response/NN to/TO Campath/NN may/MD interfere/VB with/IN subsequent/JJ diagnostic/JJ serum/NN tests/NNS that/WDT utilize/VBP antibodies/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ immune) (NN response)) (PP (TO to) (NP (NN Campath)))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (JJ subsequent) (JJ diagnostic) (NN serum) (NNS tests)) (SBAR (WHNP (WDT that)) (S (VP (VBP utilize) (NP (NNS antibodies)))))))))) (. .))))

det(response-3, An-1)
amod(response-3, immune-2)
nsubj(interfere-7, response-3)
prep_to(response-3, Campath-5)
aux(interfere-7, may-6)
root(ROOT-0, interfere-7)
amod(tests-12, subsequent-9)
amod(tests-12, diagnostic-10)
nn(tests-12, serum-11)
prep_with(interfere-7, tests-12)
nsubj(utilize-14, tests-12)
rcmod(tests-12, utilize-14)
dobj(utilize-14, antibodies-15)

Because/IN alosetron/NN is/VBZ metabolized/VBN by/IN a/DT variety/NN of/IN hepatic/JJ CYP/JJ drug-metabolizing/JJ enzymes/NNS ,/, inducers/NNS or/CC inhibitors/NNS of/IN these/DT enzymes/NNS may/MD change/VB the/DT clearance/NN of/IN alosetron/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN alosetron)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ hepatic) (JJ CYP) (JJ drug-metabolizing) (NNS enzymes))))))))) (, ,) (NP (NP (NP (NNS inducers)) (CC or) (NP (NNS inhibitors))) (PP (IN of) (NP (DT these) (NNS enzymes)))) (VP (MD may) (VP (VB change) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN alosetron))))))) (. .))))

mark(metabolized-4, Because-1)
nsubjpass(metabolized-4, alosetron-2)
auxpass(metabolized-4, is-3)
advcl(change-21, metabolized-4)
det(variety-7, a-6)
agent(metabolized-4, variety-7)
amod(enzymes-12, hepatic-9)
amod(enzymes-12, CYP-10)
amod(enzymes-12, drug-metabolizing-11)
prep_of(variety-7, enzymes-12)
nsubj(change-21, inducers-14)
conj_or(inducers-14, inhibitors-16)
det(enzymes-19, these-18)
prep_of(inducers-14, enzymes-19)
aux(change-21, may-20)
root(ROOT-0, change-21)
det(clearance-23, the-22)
dobj(change-21, clearance-23)
prep_of(clearance-23, alosetron-25)

Fluvoxamine/NN is/VBZ a/DT known/JJ strong/JJ inhibitor/NN of/IN CYP1A2/NN and/CC also/RB inhibits/VBZ CYP3A4/NN ,/, CYP2C9/NN ,/, and/CC CYP2C19/NN ./.

(ROOT (S1 (S (S (S (NP (NN Fluvoxamine)) (VP (VBZ is) (NP (NP (DT a) (JJ known) (JJ strong) (NN inhibitor)) (PP (IN of) (NP (NN CYP1A2)))))) (CC and) (S (ADVP (RB also)) (VP (VBZ inhibits) (NP (NP (NN CYP3A4)) (, ,) (NP (NN CYP2C9)) (, ,) (CC and) (NP (NN CYP2C19)))))) (. .))))

nsubj(inhibitor-6, Fluvoxamine-1)
cop(inhibitor-6, is-2)
det(inhibitor-6, a-3)
amod(inhibitor-6, known-4)
amod(inhibitor-6, strong-5)
root(ROOT-0, inhibitor-6)
prep_of(inhibitor-6, CYP1A2-8)
advmod(inhibits-11, also-10)
conj_and(inhibitor-6, inhibits-11)
dobj(inhibits-11, CYP3A4-12)
conj_and(CYP3A4-12, CYP2C9-14)
conj_and(CYP3A4-12, CYP2C19-17)

In/IN a/DT pharmacokinetic/JJ study/NN ,/, 40/CD healthy/JJ female/NN subjects/NNS received/VBD fluvoxamine/NN in/IN escalating/JJ doses/NNS from/IN 50/CD to/TO 200/CD mg/NN per/IN day/NN for/IN 16/CD days/NNS ,/, with/IN coadministration/NN of/IN alosetron/NN 1/CD mg/NN on/IN the/DT last/JJ day/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (DT a) (JJ pharmacokinetic) (NN study))) (, ,) (NP (CD 40) (JJ healthy) (NN female) (NNS subjects)) (VP (VBD received) (NP (NP (NN fluvoxamine)) (PP (IN in) (NP (NP (JJ escalating) (NNS doses)) (PP (IN from) (NP (NP (QP (CD 50) (TO to) (CD 200)) (NN mg)) (PP (IN per) (NP (NN day))) (PP (IN for) (NP (CD 16) (NNS days)))))))) (, ,) (PP (IN with) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN alosetron) (CD 1) (NN mg)) (PP (IN on) (NP (DT the) (JJ last) (NN day)))))))) (. .))))

det(study-4, a-2)
amod(study-4, pharmacokinetic-3)
prep_in(received-10, study-4)
num(subjects-9, 40-6)
amod(subjects-9, healthy-7)
nn(subjects-9, female-8)
nsubj(received-10, subjects-9)
root(ROOT-0, received-10)
dobj(received-10, fluvoxamine-11)
amod(doses-14, escalating-13)
prep_in(fluvoxamine-11, doses-14)
number(200-18, 50-16)
dep(200-18, to-17)
num(mg-19, 200-18)
prep_from(doses-14, mg-19)
prep_per(mg-19, day-21)
num(days-24, 16-23)
prep_for(mg-19, days-24)
prep_with(received-10, coadministration-27)
nn(mg-31, alosetron-29)
num(mg-31, 1-30)
prep_of(coadministration-27, mg-31)
det(day-35, the-33)
amod(day-35, last-34)
prep_on(mg-31, day-35)

Fluvoxamine/NN increased/VBD mean/JJ alosetron/NN plasma/NN concentrations/NNS (/-LRB- AUC/NN )/-RRB- approximately/RB 6-fold/RB and/CC prolonged/VBD the/DT half-life/NN by/IN approximately/RB 3-fold/RB ./.

(ROOT (S1 (S (S (NP (NN Fluvoxamine)) (VP (VP (VBD increased) (NP (NP (JJ mean) (NN alosetron) (NN plasma) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (ADVP (RB approximately) (RB 6-fold))) (CC and) (VP (VBD prolonged) (NP (DT the) (NN half-life)) (PP (IN by) (NP (RB approximately) (RB 3-fold)))))) (. .))))

nsubj(increased-2, Fluvoxamine-1)
root(ROOT-0, increased-2)
amod(concentrations-6, mean-3)
nn(concentrations-6, alosetron-4)
nn(concentrations-6, plasma-5)
dobj(increased-2, concentrations-6)
abbrev(concentrations-6, AUC-8)
advmod(6-fold-11, approximately-10)
advmod(increased-2, 6-fold-11)
conj_and(increased-2, prolonged-13)
det(half-life-15, the-14)
dobj(prolonged-13, half-life-15)
prep(prolonged-13, by-16)
advmod(3-fold-18, approximately-17)
pobj(by-16, 3-fold-18)

Concomitant/JJ administration/NN of/IN alosetron/NN and/CC fluvoxamine/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN alosetron)) (CC and) (NP (NN fluvoxamine))))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(contraindicated-8, administration-2)
prep_of(administration-2, alosetron-4)
conj_and(alosetron-4, fluvoxamine-6)
auxpass(contraindicated-8, is-7)
root(ROOT-0, contraindicated-8)

Concomitant/JJ administration/NN of/IN alosetron/NN and/CC moderate/JJ CYP1A2/NN inhibitors/NNS ,/, including/VBG quinolone/NN antibiotic/JJ s/NN and/CC cimetidine/NN ,/, has/VBZ not/RB been/VBN evaluated/VBN ,/, but/CC should/MD be/VB avoided/VBN unless/IN clinically/RB necessary/JJ because/IN of/IN similar/JJ potential/JJ drug/NN interactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN alosetron)) (CC and) (NP (NP (JJ moderate) (NN CYP1A2) (NNS inhibitors)) (, ,) (PP (VBG including) (NP (NP (NN quinolone) (JJ antibiotic) (NN s)) (CC and) (NP (NN cimetidine)))) (, ,))))) (VP (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN evaluated)))) (, ,) (CC but) (VP (MD should) (VP (VB be) (VP (VBN avoided) (PP (IN unless) (ADJP (RB clinically) (JJ necessary))) (PP (IN because) (IN of) (NP (JJ similar) (JJ potential) (NN drug) (NNS interactions)))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(evaluated-20, administration-2)
prep_of(administration-2, alosetron-4)
amod(inhibitors-8, moderate-6)
nn(inhibitors-8, CYP1A2-7)
conj_and(alosetron-4, inhibitors-8)
nn(s-13, quinolone-11)
amod(s-13, antibiotic-12)
prep_including(inhibitors-8, s-13)
conj_and(s-13, cimetidine-15)
aux(evaluated-20, has-17)
neg(evaluated-20, not-18)
auxpass(evaluated-20, been-19)
root(ROOT-0, evaluated-20)
aux(avoided-25, should-23)
auxpass(avoided-25, be-24)
conj_but(evaluated-20, avoided-25)
advmod(necessary-28, clinically-27)
prep_unless(avoided-25, necessary-28)
amod(interactions-34, similar-31)
amod(interactions-34, potential-32)
nn(interactions-34, drug-33)
prep_because_of(avoided-25, interactions-34)

Ketoconazole/NN is/VBZ a/DT known/JJ strong/JJ inhibitor/NN of/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Ketoconazole)) (VP (VBZ is) (NP (NP (DT a) (JJ known) (JJ strong) (NN inhibitor)) (PP (IN of) (NP (NN CYP3A4)))))) (. .))))

nsubj(inhibitor-6, Ketoconazole-1)
cop(inhibitor-6, is-2)
det(inhibitor-6, a-3)
amod(inhibitor-6, known-4)
amod(inhibitor-6, strong-5)
root(ROOT-0, inhibitor-6)
prep_of(inhibitor-6, CYP3A4-8)

In/IN a/DT pharmacokinetic/JJ study/NN ,/, 38/CD healthy/JJ female/JJ subjects/NNS received/VBD ketoconazole/NN 200/CD mg/NN twice/RB daily/JJ for/IN 7/CD days/NNS ,/, with/IN coadministration/NN of/IN alosetron/NN 1/CD mg/NN on/IN the/DT last/JJ day/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT a) (JJ pharmacokinetic) (NN study))) (, ,) (NP (CD 38) (JJ healthy) (JJ female) (NNS subjects)) (VP (VBD received) (NP (NP (NN ketoconazole) (CD 200) (NN mg)) (ADJP (RB twice) (JJ daily) (PP (IN for) (NP (CD 7) (NNS days))))) (, ,) (PP (IN with) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN alosetron) (CD 1) (NN mg)) (PP (IN on) (NP (DT the) (JJ last) (NN day))))))))) (. .))))

det(study-4, a-2)
amod(study-4, pharmacokinetic-3)
prep_in(received-10, study-4)
num(subjects-9, 38-6)
amod(subjects-9, healthy-7)
amod(subjects-9, female-8)
nsubj(received-10, subjects-9)
root(ROOT-0, received-10)
nn(mg-13, ketoconazole-11)
num(mg-13, 200-12)
dobj(received-10, mg-13)
advmod(daily-15, twice-14)
amod(mg-13, daily-15)
num(days-18, 7-17)
prep_for(daily-15, days-18)
prep_with(received-10, coadministration-21)
nn(mg-25, alosetron-23)
num(mg-25, 1-24)
prep_of(coadministration-21, mg-25)
det(day-29, the-27)
amod(day-29, last-28)
prep_on(mg-25, day-29)

Ketoconazole/NN increased/VBD mean/JJ alosetron/NN plasma/NN concentrations/NNS (/-LRB- AUC/NN )/-RRB- by/IN 29/CD %./NN

(ROOT (S1 (S (NP (NN Ketoconazole)) (VP (VBD increased) (NP (NP (JJ mean) (NN alosetron) (NN plasma) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (PP (IN by) (NP (CD 29) (NN %.)))))))

nsubj(increased-2, Ketoconazole-1)
root(ROOT-0, increased-2)
amod(concentrations-6, mean-3)
nn(concentrations-6, alosetron-4)
nn(concentrations-6, plasma-5)
dobj(increased-2, concentrations-6)
abbrev(concentrations-6, AUC-8)
num(%.-12, 29-11)
prep_by(increased-2, %.-12)

Caution/NN should/MD be/VB used/VBN when/WRB alosetron/NN and/CC ketoconazole/NN are/VBP administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN alosetron)) (CC and) (NP (NN ketoconazole))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)))))))) (. .))))

nsubjpass(used-4, Caution-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
advmod(administered-10, when-5)
nsubjpass(administered-10, alosetron-6)
conj_and(alosetron-6, ketoconazole-8)
auxpass(administered-10, are-9)
advcl(used-4, administered-10)
advmod(administered-10, concomitantly-11)

Coadministration/NN of/IN alosetron/JJ and/CC strong/JJ CYP3A4/JJ inhibitors/NNS ,/, such/JJ as/IN clarithromycin/NN ,/, telithromycin/NN ,/, protease/NN inhibitors/NNS ,/, voriconazole/NN ,/, and/CC itraconazole/NN has/VBZ not/RB been/VBN evaluated/VBN but/CC should/MD be/VB undertaken/VBN with/IN caution/NN because/IN of/IN similar/JJ potential/JJ drug/NN interactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ alosetron)) (CC and) (ADJP (JJ strong))) (JJ CYP3A4) (NNS inhibitors)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN clarithromycin)) (, ,) (NP (NN telithromycin)) (, ,) (NP (NN protease) (NNS inhibitors)) (, ,) (NP (NN voriconazole)) (, ,) (CC and) (NP (NN itraconazole))))))) (VP (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN evaluated)))) (CC but) (VP (MD should) (VP (VB be) (VP (VBN undertaken) (PP (IN with) (NP (NN caution))) (PP (IN because) (IN of) (NP (JJ similar) (JJ potential) (NN drug) (NNS interactions)))))))) (. .))))

nsubjpass(evaluated-25, Coadministration-1)
amod(inhibitors-7, alosetron-3)
conj_and(alosetron-3, strong-5)
amod(inhibitors-7, CYP3A4-6)
prep_of(Coadministration-1, inhibitors-7)
prep_such_as(inhibitors-7, clarithromycin-11)
conj_and(clarithromycin-11, telithromycin-13)
nn(inhibitors-16, protease-15)
conj_and(clarithromycin-11, inhibitors-16)
conj_and(clarithromycin-11, voriconazole-18)
conj_and(clarithromycin-11, itraconazole-21)
aux(evaluated-25, has-22)
neg(evaluated-25, not-23)
auxpass(evaluated-25, been-24)
root(ROOT-0, evaluated-25)
aux(undertaken-29, should-27)
auxpass(undertaken-29, be-28)
conj_but(evaluated-25, undertaken-29)
prep_with(undertaken-29, caution-31)
amod(interactions-37, similar-34)
amod(interactions-37, potential-35)
nn(interactions-37, drug-36)
prep_because_of(undertaken-29, interactions-37)

The/DT effect/NN of/IN induction/NN or/CC inhibition/NN of/IN other/JJ pathways/NNS on/IN exposure/NN to/TO alosetron/NN and/CC its/PRP$ metabolites/NNS is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NP (NN induction)) (CC or) (NP (NN inhibition))) (PP (IN of) (NP (JJ other) (NNS pathways))))) (PP (IN on) (NP (NP (NN exposure)) (PP (TO to) (NP (NP (NN alosetron)) (CC and) (NP (PRP$ its) (NNS metabolites))))))) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

det(effect-2, The-1)
nsubjpass(known-19, effect-2)
prep_of(effect-2, induction-4)
conj_or(induction-4, inhibition-6)
amod(pathways-9, other-8)
prep_of(induction-4, pathways-9)
prep_on(effect-2, exposure-11)
prep_to(exposure-11, alosetron-13)
poss(metabolites-16, its-15)
conj_and(alosetron-13, metabolites-16)
auxpass(known-19, is-17)
neg(known-19, not-18)
root(ROOT-0, known-19)

In/FW vitro/FW human/JJ liver/NN microsome/NN studies/NNS and/CC an/DT in/FW vivo/FW metabolic/JJ probe/NN study/NN demonstrated/VBD that/IN alosetron/NN did/VBD not/RB inhibit/VB CYP/NN enzyme/NN s/NN 2D6/NN ,/, 3A4/NN ,/, 2C9/NN ,/, or/CC 2C19/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (JJ human) (NN liver) (NN microsome) (NNS studies)) (CC and) (NP (DT an) (ADJP (FW in) (FW vivo)) (JJ metabolic) (NN probe) (NN study))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NN alosetron)) (VP (VBD did) (RB not) (VP (VB inhibit) (NP (NP (NN CYP) (NN enzyme) (NN s) (NN 2D6)) (, ,) (NP (NN 3A4)) (, ,) (NP (NN 2C9)) (, ,) (CC or) (NP (NN 2C19))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-6, vitro-2)
amod(studies-6, human-3)
nn(studies-6, liver-4)
nn(studies-6, microsome-5)
nsubj(demonstrated-14, studies-6)
det(study-13, an-8)
nn(vivo-10, in-9)
amod(study-13, vivo-10)
amod(study-13, metabolic-11)
nn(study-13, probe-12)
conj_and(studies-6, study-13)
root(ROOT-0, demonstrated-14)
complm(inhibit-19, that-15)
nsubj(inhibit-19, alosetron-16)
aux(inhibit-19, did-17)
neg(inhibit-19, not-18)
ccomp(demonstrated-14, inhibit-19)
nn(2D6-23, CYP-20)
nn(2D6-23, enzyme-21)
nn(2D6-23, s-22)
dobj(inhibit-19, 2D6-23)
conj_or(2D6-23, 3A4-25)
conj_or(2D6-23, 2C9-27)
conj_or(2D6-23, 2C19-30)

In/FW vitro/FW ,/, at/IN total/JJ drug/NN concentrations/NNS 27-fold/RB higher/JJR than/IN peak/NN plasma/NN concentrations/NNS observed/VBN with/IN the/DT 1-mg/JJ dosage/NN ,/, alosetron/NN inhibited/VBD CYP/NN enzyme/NN s/NN 1A2/NN (/-LRB- 60/CD %/NN )/-RRB- and/CC 2E1/NN (/-LRB- 50%)./NN

(ROOT (S1 (S (ADVP (FW In) (FW vitro)) (, ,) (PP (IN at) (NP (NP (JJ total) (NN drug) (NNS concentrations)) (ADJP (RB 27-fold) (JJR higher) (PP (IN than) (NP (NP (NN peak) (NN plasma) (NNS concentrations)) (VP (VBN observed) (PP (IN with) (NP (DT the) (JJ 1-mg) (NN dosage))))))))) (, ,) (NP (NN alosetron)) (VP (VBD inhibited) (NP (NP (NP (NN CYP) (NN enzyme) (NN s) (NN 1A2)) (PRN (-LRB- -LRB-) (NP (CD 60) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NN 2E1)))) (PRN (-LRB- -LRB-) (NP (NN 50%-RRB-.))))))

nn(vitro-2, In-1)
advmod(inhibited-21, vitro-2)
amod(concentrations-7, total-5)
nn(concentrations-7, drug-6)
prep_at(inhibited-21, concentrations-7)
advmod(higher-9, 27-fold-8)
amod(concentrations-7, higher-9)
nn(concentrations-13, peak-11)
nn(concentrations-13, plasma-12)
prep_than(higher-9, concentrations-13)
partmod(concentrations-13, observed-14)
det(dosage-18, the-16)
amod(dosage-18, 1-mg-17)
prep_with(observed-14, dosage-18)
nsubj(inhibited-21, alosetron-20)
root(ROOT-0, inhibited-21)
nn(1A2-25, CYP-22)
nn(1A2-25, enzyme-23)
nn(1A2-25, s-24)
dobj(inhibited-21, 1A2-25)
num(%-28, 60-27)
appos(1A2-25, %-28)
conj_and(1A2-25, 2E1-31)
dep(inhibited-21, 50%-RRB-.-33)

In/IN an/DT in/FW vivo/FW metabolic/JJ probe/NN study/NN ,/, alosetron/NN did/VBD not/RB inhibit/VB CYP2E1/NN but/CC did/VBD produce/VB 30/CD %/NN inhibition/NN of/IN both/CC CYP1A2/NN and/CC N-acetyltransferase/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT an) (ADJP (FW in) (FW vivo)) (JJ metabolic) (NN probe) (NN study))) (, ,) (NP (NN alosetron)) (VP (VP (VBD did) (RB not) (VP (VB inhibit) (NP (NN CYP2E1)))) (CC but) (VP (VBD did) (VP (VB produce) (NP (NP (ADJP (CD 30) (NN %)) (NN inhibition)) (PP (IN of) (NP (CC both) (NP (NN CYP1A2)) (CC and) (NP (NN N-acetyltransferase))))))))) (. .))))

det(study-7, an-2)
nn(vivo-4, in-3)
amod(study-7, vivo-4)
amod(study-7, metabolic-5)
nn(study-7, probe-6)
prep_in(inhibit-12, study-7)
nsubj(inhibit-12, alosetron-9)
aux(inhibit-12, did-10)
neg(inhibit-12, not-11)
root(ROOT-0, inhibit-12)
dobj(inhibit-12, CYP2E1-13)
aux(produce-16, did-15)
conj_but(inhibit-12, produce-16)
number(%-18, 30-17)
amod(inhibition-19, %-18)
dobj(produce-16, inhibition-19)
preconj(CYP1A2-22, both-21)
prep_of(inhibition-19, CYP1A2-22)
conj_and(CYP1A2-22, N-acetyltransferase-24)

Although/IN not/RB studied/VBN with/IN alosetron/NN ,/, inhibition/NN of/IN N-/NN acetyltransferase/NN may/MD have/VB clinically/RB relevant/JJ consequences/NNS for/IN drugs/NNS such/JJ as/IN isoniazid/NN ,/, procainamide/NN ,/, and/CC hydralazine/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (VP (RB not) (VBN studied) (PP (IN with) (NP (NN alosetron)))))) (, ,) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN N-) (NN acetyltransferase)))) (VP (MD may) (VP (VB have) (NP (ADJP (RB clinically) (JJ relevant)) (NNS consequences)) (PP (IN for) (NP (NP (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NN isoniazid)) (, ,) (NP (NN procainamide)) (, ,) (CC and) (NP (NN hydralazine))))))))) (. .))))

mark(studied-3, Although-1)
neg(studied-3, not-2)
advcl(have-12, studied-3)
prep_with(studied-3, alosetron-5)
nsubj(have-12, inhibition-7)
nn(acetyltransferase-10, N--9)
prep_of(inhibition-7, acetyltransferase-10)
aux(have-12, may-11)
root(ROOT-0, have-12)
advmod(relevant-14, clinically-13)
amod(consequences-15, relevant-14)
dobj(have-12, consequences-15)
prep_for(have-12, drugs-17)
prep_such_as(drugs-17, isoniazid-20)
conj_and(isoniazid-20, procainamide-22)
conj_and(isoniazid-20, hydralazine-25)

The/DT effect/NN on/IN CYP1A2/NN was/VBD explored/VBN further/RB in/IN a/DT clinical/JJ interaction/NN study/NN with/IN theophylline/NN and/CC no/DT effect/NN on/IN metabolism/NN was/VBD observed/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (NN effect)) (PP (IN on) (NP (NN CYP1A2)))) (VP (VBD was) (VP (VBN explored) (ADVP (RB further)) (PP (IN in) (NP (NP (DT a) (JJ clinical) (NN interaction) (NN study)) (PP (IN with) (NP (NN theophylline)))))))) (CC and) (S (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NN metabolism)))) (VP (VBD was) (VP (VBN observed))))) (. .))))

det(effect-2, The-1)
nsubjpass(explored-6, effect-2)
prep_on(effect-2, CYP1A2-4)
auxpass(explored-6, was-5)
root(ROOT-0, explored-6)
advmod(explored-6, further-7)
det(study-12, a-9)
amod(study-12, clinical-10)
nn(study-12, interaction-11)
prep_in(explored-6, study-12)
prep_with(study-12, theophylline-14)
det(effect-17, no-16)
nsubjpass(observed-21, effect-17)
prep_on(effect-17, metabolism-19)
auxpass(observed-21, was-20)
conj_and(explored-6, observed-21)

Another/DT study/NN showed/VBD that/IN alosetron/NN had/VBD no/DT clinically/RB significant/JJ effect/NN on/IN plasma/NN concentrations/NNS of/IN the/DT oral/JJ contraceptive/JJ agent/NN s/NN ethinyl/NN estradiol/NN and/CC levonorgestrel/NN (/-LRB- CYP3A4/NN substrates/NNS )./CD

(ROOT (S1 (S (NP (DT Another) (NN study)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN alosetron)) (VP (VBD had) (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NN effect)) (PP (IN on) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (DT the) (JJ oral) (JJ contraceptive) (NN agent) (NN s) (NN ethinyl) (NN estradiol)) (CC and) (NP (NN levonorgestrel)))))) (PRN (-LRB- -LRB-) (NP (NN CYP3A4) (NNS substrates) (CD -RRB-.))))))))))

det(study-2, Another-1)
nsubj(showed-3, study-2)
root(ROOT-0, showed-3)
complm(had-6, that-4)
nsubj(had-6, alosetron-5)
ccomp(showed-3, had-6)
det(effect-10, no-7)
advmod(significant-9, clinically-8)
amod(effect-10, significant-9)
dobj(had-6, effect-10)
nn(concentrations-13, plasma-12)
prep_on(had-6, concentrations-13)
det(estradiol-21, the-15)
amod(estradiol-21, oral-16)
amod(estradiol-21, contraceptive-17)
nn(estradiol-21, agent-18)
nn(estradiol-21, s-19)
nn(estradiol-21, ethinyl-20)
prep_of(concentrations-13, estradiol-21)
conj_and(estradiol-21, levonorgestrel-23)
nn(substrates-26, CYP3A4-25)
dep(had-6, substrates-26)
num(substrates-26, -RRB-.-27)

A/DT clinical/JJ interaction/NN study/NN was/VBD also/RB conducted/VBN with/IN alosetron/NN and/CC the/DT CYP3A4/NN substrate/NN cisapride/NN ./.

(ROOT (S1 (S (S (NP (DT A) (JJ clinical) (NN interaction) (NN study)) (VP (VBD was) (ADVP (RB also)) (VP (VBN conducted) (PP (IN with) (NP (NP (NN alosetron)) (CC and) (NP (DT the) (NN CYP3A4) (NN substrate) (NN cisapride))))))) (. .))))

det(study-4, A-1)
amod(study-4, clinical-2)
nn(study-4, interaction-3)
nsubjpass(conducted-7, study-4)
auxpass(conducted-7, was-5)
advmod(conducted-7, also-6)
root(ROOT-0, conducted-7)
prep_with(conducted-7, alosetron-9)
det(cisapride-14, the-11)
nn(cisapride-14, CYP3A4-12)
nn(cisapride-14, substrate-13)
conj_and(alosetron-9, cisapride-14)

No/DT significant/JJ effects/NNS on/IN cisapride/NN metabolism/NN or/CC QT/NN interval/NN were/VBD noted/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ significant) (NNS effects)) (PP (IN on) (NP (NP (NN cisapride) (NN metabolism)) (CC or) (NP (NN QT) (NN interval))))) (VP (VBD were) (VP (VBN noted)))) (. .))))

det(effects-3, No-1)
amod(effects-3, significant-2)
nsubjpass(noted-11, effects-3)
nn(metabolism-6, cisapride-5)
prep_on(effects-3, metabolism-6)
nn(interval-9, QT-8)
conj_or(metabolism-6, interval-9)
auxpass(noted-11, were-10)
root(ROOT-0, noted-11)

The/DT effect/NN of/IN alosetron/NN on/IN monoamine/NN oxidases/NNS and/CC on/IN intestinal/JJ first/JJ pass/NN secondary/JJ to/TO high/JJ intraluminal/JJ concentrations/NNS have/VBP not/RB been/VBN examined/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN alosetron))) (PP (PP (IN on) (NP (NN monoamine) (NNS oxidases))) (CC and) (PP (IN on) (NP (NP (JJ intestinal) (JJ first) (NN pass)) (ADJP (JJ secondary) (PP (TO to) (NP (JJ high) (JJ intraluminal) (NNS concentrations)))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN examined))))) (. .))))

det(effect-2, The-1)
nsubjpass(examined-21, effect-2)
prep_of(effect-2, alosetron-4)
nn(oxidases-7, monoamine-6)
prep_on(effect-2, oxidases-7)
amod(pass-12, intestinal-10)
amod(pass-12, first-11)
conj_and(oxidases-7, pass-12)
amod(pass-12, secondary-13)
amod(concentrations-17, high-15)
amod(concentrations-17, intraluminal-16)
prep_to(secondary-13, concentrations-17)
aux(examined-21, have-18)
neg(examined-21, not-19)
auxpass(examined-21, been-20)
root(ROOT-0, examined-21)

Based/VBN on/IN the/DT above/JJ data/NNS from/IN in/FW vitro/FW and/CC in/FW vivo/FW studies/NNS ,/, it/PRP is/VBZ unlikely/JJ that/IN alosetron/NN will/MD inhibit/VB the/DT hepatic/JJ metabolic/JJ clearance/NN of/IN drugs/NNS metabolized/VBN by/IN the/DT major/JJ CYP/NN enzyme/NN 3A4/NN ,/, as/RB well/RB as/IN the/DT CYP/NN enzyme/NN s/NN 2D6/NN ,/, 2C9/NN ,/, 2C19/NN ,/, 2E1/NN ,/, or/CC 1A2/NN ./.

(ROOT (S1 (S (S (PP (VBN Based) (PP (IN on) (NP (NP (DT the) (JJ above) (NNS data)) (PP (IN from) (NP (ADJP (ADJP (FW in) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NNS studies)))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unlikely) (SBAR (IN that) (S (NP (NN alosetron)) (VP (MD will) (VP (VB inhibit) (NP (NP (DT the) (JJ hepatic) (JJ metabolic) (NN clearance)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NP (DT the) (JJ major) (NN CYP) (NN enzyme) (NN 3A4)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN CYP) (NN enzyme) (NN s) (NN 2D6)) (, ,) (NP (NN 2C9)) (, ,) (NP (NN 2C19)) (, ,) (NP (NN 2E1)) (, ,) (CC or) (NP (NN 1A2))))))))))))))) (. .))))

prepc_based_on(unlikely-16, on-2)
det(data-5, the-3)
amod(data-5, above-4)
pobj(unlikely-16, data-5)
nn(vitro-8, in-7)
amod(studies-12, vitro-8)
nn(vivo-11, in-10)
conj_and(vitro-8, vivo-11)
prep_from(data-5, studies-12)
nsubj(unlikely-16, it-14)
cop(unlikely-16, is-15)
root(ROOT-0, unlikely-16)
complm(inhibit-20, that-17)
nsubj(inhibit-20, alosetron-18)
aux(inhibit-20, will-19)
ccomp(unlikely-16, inhibit-20)
det(clearance-24, the-21)
amod(clearance-24, hepatic-22)
amod(clearance-24, metabolic-23)
dobj(inhibit-20, clearance-24)
prep_of(clearance-24, drugs-26)
partmod(drugs-26, metabolized-27)
det(3A4-33, the-29)
amod(3A4-33, major-30)
nn(3A4-33, CYP-31)
nn(3A4-33, enzyme-32)
agent(metabolized-27, 3A4-33)
det(2D6-42, the-38)
nn(2D6-42, CYP-39)
nn(2D6-42, enzyme-40)
nn(2D6-42, s-41)
conj_and(3A4-33, 2D6-42)
conj_and(3A4-33, 2C9-44)
conj_and(3A4-33, 2C19-46)
conj_and(3A4-33, 2E1-48)
conj_or(3A4-33, 1A2-51)

Alosetron/NN does/VBZ not/RB appear/VB to/TO induce/VB the/DT major/JJ cytochrome/NN P450/NN (/-LRB- CYP/NN )/-RRB- drug/NN metabolizing/NN enzyme/NN 3A/NN ./.

(ROOT (S1 (S (S (NP (NN Alosetron)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB induce) (NP (NP (NP (DT the) (JJ major) (NN cytochrome) (NN P450)) (PRN (-LRB- -LRB-) (NP (NN CYP)) (-RRB- -RRB-))) (NP (NN drug) (NN metabolizing) (NN enzyme) (NN 3A))))))))) (. .))))

nsubj(appear-4, Alosetron-1)
xsubj(induce-6, Alosetron-1)
aux(appear-4, does-2)
neg(appear-4, not-3)
root(ROOT-0, appear-4)
aux(induce-6, to-5)
xcomp(appear-4, induce-6)
det(P450-10, the-7)
amod(P450-10, major-8)
nn(P450-10, cytochrome-9)
dobj(induce-6, P450-10)
iobj(induce-6, P450-10)
abbrev(P450-10, CYP-12)
nn(3A-17, drug-14)
nn(3A-17, metabolizing-15)
nn(3A-17, enzyme-16)
dobj(induce-6, 3A-17)
dep(P450-10, 3A-17)

Alosetron/NN also/RB does/VBZ not/RB appear/VB to/TO induce/VB CYP/NN enzyme/NN s/NNS 2E1/NN or/CC 2C19/NN ./.

(ROOT (S1 (S (S (NP (NN Alosetron)) (ADVP (RB also)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB induce) (NP (NN CYP) (NN enzyme) (NNS s) (NP (NP (NN 2E1)) (CC or) (NP (NN 2C19)))))))))) (. .))))

nsubj(appear-5, Alosetron-1)
xsubj(induce-7, Alosetron-1)
advmod(appear-5, also-2)
aux(appear-5, does-3)
neg(appear-5, not-4)
root(ROOT-0, appear-5)
aux(induce-7, to-6)
xcomp(appear-5, induce-7)
nn(s-10, CYP-8)
nn(s-10, enzyme-9)
dobj(induce-7, s-10)
dep(s-10, 2E1-11)
conj_or(2E1-11, 2C19-13)

It/PRP is/VBZ not/RB known/VBN whether/IN alosetron/NN might/MD induce/VBP other/JJ enzymes/NNS ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (NN alosetron)) (VP (MD might) (VP (VBP induce) (NP (JJ other) (NNS enzymes))))))))) (. .))))

nsubjpass(known-4, It-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
complm(induce-8, whether-5)
nsubj(induce-8, alosetron-6)
aux(induce-8, might-7)
ccomp(known-4, induce-8)
amod(enzymes-10, other-9)
dobj(induce-8, enzymes-10)

The/DT interaction/NN of/IN Activase/NN with/IN other/JJ cardioactive/JJ or/CC cerebroactive/JJ drugs/NNS has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN of) (NP (NN Activase))) (PP (IN with) (NP (JJ other) (ADJP (ADJP (JJ cardioactive)) (CC or) (ADJP (JJ cerebroactive))) (NNS drugs)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(interaction-2, The-1)
nsubjpass(studied-14, interaction-2)
prep_of(interaction-2, Activase-4)
amod(drugs-10, other-6)
amod(drugs-10, cardioactive-7)
conj_or(cardioactive-7, cerebroactive-9)
prep_with(interaction-2, drugs-10)
aux(studied-14, has-11)
neg(studied-14, not-12)
auxpass(studied-14, been-13)
root(ROOT-0, studied-14)

In/IN addition/NN to/TO bleeding/JJ associated/VBN with/IN heparin/NN and/CC vitamin/NN K/NN antagonists/NNS ,/, drugs/NNS that/WDT alter/VBP platelet/NN function/NN (/-LRB- such/JJ as/IN acetylsalicylic/JJ acid/NN ,/, dipyridamole/NN and/CC Abciximab/NN )/-RRB- may/MD increase/VB the/DT risk/NN of/IN bleeding/JJ if/IN administered/VBN prior/RB to/TO ,/, during/IN ,/, or/CC after/IN Activase/NN therapy/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NP (JJ bleeding)) (VP (VBN associated) (PP (IN with) (NP (NP (NN heparin)) (CC and) (NP (NN vitamin) (NN K) (NNS antagonists))))))))) (, ,) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP alter) (NP (NN platelet) (NN function)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (JJ acetylsalicylic) (NN acid)) (, ,) (NP (NN dipyridamole)) (CC and) (NP (NN Abciximab))))) (-RRB- -RRB-)))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (JJ bleeding)) (SBAR (IN if) (S (VP (VBN administered) (ADVP (ADVP (RB prior)) (PP (TO to))))))))) (, ,) (PP (PP (IN during)) (, ,) (CC or) (PP (IN after) (NP (NN Activase) (NN therapy))))))) (. .))))

prep_in_addition_to(increase-29, bleeding-4)
partmod(bleeding-4, associated-5)
prep_with(associated-5, heparin-7)
nn(antagonists-11, vitamin-9)
nn(antagonists-11, K-10)
conj_and(heparin-7, antagonists-11)
nsubj(alter-15, drugs-13)
nsubj(increase-29, drugs-13)
rcmod(drugs-13, alter-15)
nn(function-17, platelet-16)
dobj(alter-15, function-17)
amod(acid-22, acetylsalicylic-21)
prep_such_as(alter-15, acid-22)
conj_and(acid-22, dipyridamole-24)
conj_and(acid-22, Abciximab-26)
aux(increase-29, may-28)
root(ROOT-0, increase-29)
det(risk-31, the-30)
dobj(increase-29, risk-31)
prep_of(risk-31, bleeding-33)
mark(administered-35, if-34)
dep(bleeding-33, administered-35)
advmod(administered-35, prior-36)
prep(prior-36, to-37)
prep(increase-29, during-39)
conj_or(during-39, after-42)
nn(therapy-44, Activase-43)
pobj(after-42, therapy-44)

Use/NN of/IN Antithrombotics/NN Aspirin/NN and/CC heparin/NN have/VBP been/VBN administered/VBN concomitantly/RB with/IN and/CC following/VBG infusions/NNS of/IN Activase/NN in/IN the/DT management/NN of/IN acute/JJ myocardial/JJ infarction/NN or/CC pulmonary/JJ embolism/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN of) (NP (NP (NN Antithrombotics) (NN Aspirin)) (CC and) (NP (NN heparin))))) (VP (VBP have) (VP (VBN been) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (CC and) (VBG following) (NNS infusions)) (PP (IN of) (NP (NN Activase))))) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NP (JJ acute) (JJ myocardial) (NN infarction)) (CC or) (NP (JJ pulmonary) (NN embolism)))))))))) (. .))))

nsubjpass(administered-9, Use-1)
nn(Aspirin-4, Antithrombotics-3)
prep_of(Use-1, Aspirin-4)
conj_and(Aspirin-4, heparin-6)
aux(administered-9, have-7)
auxpass(administered-9, been-8)
root(ROOT-0, administered-9)
advmod(administered-9, concomitantly-10)
cc(infusions-14, and-12)
dep(infusions-14, following-13)
prep_with(administered-9, infusions-14)
prep_of(infusions-14, Activase-16)
det(management-19, the-18)
prep_in(administered-9, management-19)
amod(infarction-23, acute-21)
amod(infarction-23, myocardial-22)
prep_of(management-19, infarction-23)
amod(embolism-26, pulmonary-25)
conj_or(infarction-23, embolism-26)

Because/IN heparin/NN ,/, aspirin/NN ,/, or/CC Activase/NN may/MD cause/VB bleeding/JJ complications/NNS ,/, careful/JJ monitoring/NN for/IN bleeding/JJ is/VBZ advised/JJ ,/, especially/RB at/IN arterial/JJ puncture/NN sites/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NP (NN heparin)) (, ,) (NP (NN aspirin)) (, ,) (CC or) (NP (NN Activase))) (VP (MD may) (VP (VB cause) (NP (JJ bleeding) (NNS complications)))))) (, ,) (NP (NP (JJ careful) (NN monitoring)) (PP (IN for) (NP (JJ bleeding)))) (VP (VBZ is) (ADJP (JJ advised)) (, ,) (PP (ADVP (RB especially)) (IN at) (NP (JJ arterial) (NN puncture) (NNS sites))))) (. .))))

mark(cause-9, Because-1)
nsubj(cause-9, heparin-2)
conj_or(heparin-2, aspirin-4)
conj_or(heparin-2, Activase-7)
aux(cause-9, may-8)
advcl(advised-18, cause-9)
amod(complications-11, bleeding-10)
dobj(cause-9, complications-11)
amod(monitoring-14, careful-13)
nsubj(advised-18, monitoring-14)
prep_for(monitoring-14, bleeding-16)
cop(advised-18, is-17)
root(ROOT-0, advised-18)
advmod(advised-18, especially-20)
amod(sites-24, arterial-22)
nn(sites-24, puncture-23)
prep_at(advised-18, sites-24)

The/DT concomitant/JJ use/NN of/IN heparin/NN or/CC aspirin/NN during/IN the/DT first/JJ 24/CD hours/NNS following/VBG symptom/NN onset/NN were/VBD prohibit/VB ed/NN in/IN The/DT NINDS/NN t-PA/NN Stroke/JJ Trial/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN heparin)) (CC or) (NP (NN aspirin)))) (PP (IN during) (NP (NP (DT the) (JJ first) (CD 24) (NNS hours)) (PP (VBG following) (NP (NN symptom) (NN onset)))))) (VP (VBD were) (VP (VB prohibit) (NP (NN ed)) (PP (IN in) (NP (DT The) (NN NINDS) (NN t-PA) (JJ Stroke) (NN Trial)))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubj(prohibit-17, use-3)
prep_of(use-3, heparin-5)
conj_or(heparin-5, aspirin-7)
det(hours-12, the-9)
amod(hours-12, first-10)
num(hours-12, 24-11)
prep_during(use-3, hours-12)
nn(onset-15, symptom-14)
prep_following(hours-12, onset-15)
aux(prohibit-17, were-16)
root(ROOT-0, prohibit-17)
dobj(prohibit-17, ed-18)
det(Trial-24, The-20)
nn(Trial-24, NINDS-21)
nn(Trial-24, t-PA-22)
amod(Trial-24, Stroke-23)
prep_in(prohibit-17, Trial-24)

The/DT safety/NN of/IN such/JJ concomitant/JJ use/NN with/IN Activase/NN for/IN the/DT management/NN of/IN acute/JJ ischemic/JJ stroke/NN is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN safety)) (PP (IN of) (NP (NP (JJ such) (JJ concomitant) (NN use)) (PP (IN with) (NP (NN Activase))))) (PP (IN for) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (JJ acute) (JJ ischemic) (NN stroke)))))) (VP (VBZ is) (ADJP (JJ unknown)))) (. .))))

det(safety-2, The-1)
nsubj(unknown-17, safety-2)
amod(use-6, such-4)
amod(use-6, concomitant-5)
prep_of(safety-2, use-6)
prep_with(use-6, Activase-8)
det(management-11, the-10)
prep_for(safety-2, management-11)
amod(stroke-15, acute-13)
amod(stroke-15, ischemic-14)
prep_of(management-11, stroke-15)
cop(unknown-17, is-16)
root(ROOT-0, unknown-17)

Special/JJ consideration/NN should/MD be/VB given/VBN to/TO the/DT administration/NN of/IN ETHYOL/NN @/NN in/IN patients/NNS receiving/VBG antihypertensive/JJ medications/NNS or/CC other/JJ drugs/NNS that/WDT could/MD cause/VB or/CC potentiate/VB hypotension/NN ./.

(ROOT (S1 (S (S (NP (JJ Special) (NN consideration)) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NN ETHYOL) (NN @)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NP (JJ antihypertensive) (NNS medications)) (CC or) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VP (VB cause)) (CC or) (VP (VB potentiate) (NP (NN hypotension))))))))))))))))))) (. .))))

amod(consideration-2, Special-1)
nsubjpass(given-5, consideration-2)
aux(given-5, should-3)
auxpass(given-5, be-4)
root(ROOT-0, given-5)
det(administration-8, the-7)
prep_to(given-5, administration-8)
nn(@-11, ETHYOL-10)
prep_of(administration-8, @-11)
prep_in(@-11, patients-13)
partmod(patients-13, receiving-14)
amod(medications-16, antihypertensive-15)
dobj(receiving-14, medications-16)
nsubj(cause-22, medications-16)
amod(drugs-19, other-18)
conj_or(medications-16, drugs-19)
aux(cause-22, could-21)
rcmod(medications-16, cause-22)
conj_or(cause-22, potentiate-24)
dobj(potentiate-24, hypotension-25)

Renal/JJ clearance/NN measurements/NNS of/IN PAH/NN cannot/MD be/VB made/VBN with/IN any/DT significant/JJ accuracy/NN in/IN patients/NNS receiving/VBG sulfonamides/NNS ,/, procaine/NN ,/, or/CC thiazolesulfone/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Renal) (NN clearance) (NNS measurements)) (PP (IN of) (NP (NN PAH)))) (VP (MD cannot) (VP (VB be) (VP (VBN made) (PP (IN with) (NP (NP (DT any) (JJ significant) (NN accuracy)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NNS sulfonamides)) (, ,) (NP (NN procaine)) (, ,) (CC or) (NP (NN thiazolesulfone)))))))))))) (. .))))

amod(measurements-3, Renal-1)
nn(measurements-3, clearance-2)
nsubj(cannot-6, measurements-3)
prep_of(measurements-3, PAH-5)
root(ROOT-0, cannot-6)
auxpass(made-8, be-7)
dep(cannot-6, made-8)
det(accuracy-12, any-10)
amod(accuracy-12, significant-11)
prep_with(made-8, accuracy-12)
prep_in(accuracy-12, patients-14)
partmod(patients-14, receiving-15)
dobj(receiving-15, sulfonamides-16)
conj_or(sulfonamides-16, procaine-18)
conj_or(sulfonamides-16, thiazolesulfone-21)

Probenecid/NN depresses/VBZ tubular/JJ secretion/NN of/IN certain/JJ weak/JJ acids/NNS such/JJ as/IN PAH/NN ./.

(ROOT (S1 (S (S (NP (NN Probenecid)) (VP (VBZ depresses) (NP (NP (JJ tubular) (NN secretion)) (PP (IN of) (NP (NP (JJ certain) (JJ weak) (NNS acids)) (PP (JJ such) (IN as) (NP (NN PAH)))))))) (. .))))

nsubj(depresses-2, Probenecid-1)
root(ROOT-0, depresses-2)
amod(secretion-4, tubular-3)
dobj(depresses-2, secretion-4)
amod(acids-8, certain-6)
amod(acids-8, weak-7)
prep_of(secretion-4, acids-8)
prep_such_as(acids-8, PAH-11)

Therefore/RB ,/, patients/NNS receiving/VBG probenecid/NN will/MD have/VB erroneously/RB low/JJ ERPF/NN and/CC Tm/NN PAH/NN values/NNS ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN probenecid)))) (VP (MD will) (VP (VB have) (NP (NP (ADJP (RB erroneously) (JJ low)) (NN ERPF)) (CC and) (NP (NN Tm) (NN PAH) (NNS values))))) (. .))))

advmod(have-7, Therefore-1)
nsubj(have-7, patients-3)
partmod(patients-3, receiving-4)
dobj(receiving-4, probenecid-5)
aux(have-7, will-6)
root(ROOT-0, have-7)
advmod(low-9, erroneously-8)
amod(ERPF-10, low-9)
dobj(have-7, ERPF-10)
nn(values-14, Tm-12)
nn(values-14, PAH-13)
conj_and(ERPF-10, values-14)

Aminosalicylic/JJ acid/NN may/MD decrease/VB the/DT amount/NN of/IN digoxin/NN (/-LRB- Lanoxin/NNP ,/, Lanoxicaps/NNP )/-RRB- that/WDT gets/VBZ absorbed/VBN into/IN your/JJ body/NN ./.

(ROOT (S1 (S (S (NP (JJ Aminosalicylic) (NN acid)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NP (NN digoxin)) (PRN (-LRB- -LRB-) (NP (NNP Lanoxin) (, ,) (NNP Lanoxicaps)) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (VBZ gets) (VP (VBN absorbed) (PP (IN into) (NP (JJ your) (NN body))))))))))))) (. .))))

amod(acid-2, Aminosalicylic-1)
nsubj(decrease-4, acid-2)
aux(decrease-4, may-3)
root(ROOT-0, decrease-4)
det(amount-6, the-5)
dobj(decrease-4, amount-6)
prep_of(amount-6, digoxin-8)
nsubjpass(absorbed-16, digoxin-8)
nn(Lanoxicaps-12, Lanoxin-10)
appos(digoxin-8, Lanoxicaps-12)
auxpass(absorbed-16, gets-15)
rcmod(digoxin-8, absorbed-16)
amod(body-19, your-18)
prep_into(absorbed-16, body-19)

In/IN the/DT case/NN that/WDT you/RB are/VBP taking/VBG digoxin/NN while/IN taking/VBG aminosalicylic/JJ acid/NN ,/, higher/JJR doses/NNS of/IN digoxin/NN may/MD be/VB needed/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (SBAR (WHNP (WDT that)) (S (ADVP (RB you)) (VP (VBP are) (VP (VBG taking) (NP (NN digoxin)) (PP (IN while) (S (VP (VBG taking) (NP (JJ aminosalicylic) (NN acid))))))))))) (, ,) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN digoxin)))) (VP (MD may) (VP (VB be) (VP (VBN needed))))) (. .))))

det(case-3, the-2)
nsubj(taking-7, case-3)
prep_in(needed-20, case-3)
advmod(taking-7, you-5)
aux(taking-7, are-6)
rcmod(case-3, taking-7)
dobj(taking-7, digoxin-8)
prepc_while(taking-7, taking-10)
amod(acid-12, aminosalicylic-11)
dobj(taking-10, acid-12)
amod(doses-15, higher-14)
nsubjpass(needed-20, doses-15)
prep_of(doses-15, digoxin-17)
aux(needed-20, may-18)
auxpass(needed-20, be-19)
root(ROOT-0, needed-20)

Aminosalicylic/JJ acid/NN may/MD also/RB decrease/VB the/DT absorption/NN of/IN vitamin/NN B12/NN ,/, which/WDT can/MD lead/VB to/TO a/NN deficiency/NN ./.

(ROOT (S1 (S (S (NP (JJ Aminosalicylic) (NN acid)) (VP (MD may) (ADVP (RB also)) (VP (VB decrease) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN vitamin) (NN B12))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NN a) (NN deficiency))))))))))) (. .))))

amod(acid-2, Aminosalicylic-1)
nsubj(decrease-5, acid-2)
aux(decrease-5, may-3)
advmod(decrease-5, also-4)
root(ROOT-0, decrease-5)
det(absorption-7, the-6)
dobj(decrease-5, absorption-7)
nsubj(lead-14, absorption-7)
nn(B12-10, vitamin-9)
prep_of(absorption-7, B12-10)
aux(lead-14, can-13)
rcmod(absorption-7, lead-14)
nn(deficiency-17, a-16)
prep_to(lead-14, deficiency-17)

Therefore/RB you/NN may/MD need/VBP to/TO take/VB a/DT vitamin/NN B12/NN supplement/NN while/IN taking/VBG aminosalicylic/JJ acid/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (NP (NN you)) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB take) (NP (DT a) (NN vitamin) (NN B12) (NN supplement)) (SBAR (IN while) (S (VP (VBG taking) (NP (JJ aminosalicylic) (NN acid))))))))))) (. .))))

advmod(need-4, Therefore-1)
nsubj(need-4, you-2)
xsubj(take-6, you-2)
aux(need-4, may-3)
root(ROOT-0, need-4)
aux(take-6, to-5)
xcomp(need-4, take-6)
det(supplement-10, a-7)
nn(supplement-10, vitamin-8)
nn(supplement-10, B12-9)
dobj(take-6, supplement-10)
mark(taking-12, while-11)
advcl(take-6, taking-12)
amod(acid-14, aminosalicylic-13)
dobj(taking-12, acid-14)

Amiodarone/NN is/VBZ metabolized/VBN to/TO desethylamiodarone/NN by/IN the/DT cytochrome/NN P450/NN (/-LRB- CYP450/NN )/-RRB- enzyme/NN group/NN ,/, specifically/RB cytochromes/NN P450/NN 3A4/NN (/-LRB- CYP3A4/NN )/-RRB- and/CC CYP2C8/NN ./.

(ROOT (S1 (S (S (NP (NN Amiodarone)) (VP (VBZ is) (VP (VBN metabolized) (PP (TO to) (NP (NN desethylamiodarone))) (PP (IN by) (NP (NP (NP (DT the) (NP (NP (NN cytochrome) (NN P450)) (PRN (-LRB- -LRB-) (NP (NN CYP450)) (-RRB- -RRB-))) (NN enzyme) (NN group)) (, ,) (NP (ADVP (RB specifically)) (NP (NP (NN cytochromes) (NN P450) (NN 3A4)) (PRN (-LRB- -LRB-) (NP (NN CYP3A4)) (-RRB- -RRB-))))) (CC and) (NP (NN CYP2C8))))))) (. .))))

nsubjpass(metabolized-3, Amiodarone-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
prep_to(metabolized-3, desethylamiodarone-5)
det(group-14, the-7)
nn(P450-9, cytochrome-8)
nn(group-14, P450-9)
abbrev(P450-9, CYP450-11)
nn(group-14, enzyme-13)
agent(metabolized-3, group-14)
advmod(3A4-19, specifically-16)
nn(3A4-19, cytochromes-17)
nn(3A4-19, P450-18)
appos(group-14, 3A4-19)
abbrev(3A4-19, CYP3A4-21)
conj_and(group-14, CYP2C8-24)

The/DT CYP3A4/NN isoenzyme/NN is/VBZ present/JJ in/IN both/CC the/DT liver/NN and/CC intestines/NNS ./.

(ROOT (S1 (S (S (NP (DT The) (NN CYP3A4) (NN isoenzyme)) (VP (VBZ is) (ADJP (JJ present) (PP (IN in) (NP (CC both) (DT the) (NP (NN liver)) (CC and) (NP (NNS intestines))))))) (. .))))

det(isoenzyme-3, The-1)
nn(isoenzyme-3, CYP3A4-2)
nsubj(present-5, isoenzyme-3)
cop(present-5, is-4)
root(ROOT-0, present-5)
preconj(liver-9, both-7)
dep(liver-9, the-8)
prep_in(present-5, liver-9)
conj_and(liver-9, intestines-11)

Amiodarone/NN is/VBZ also/RB known/VBN to/TO be/VB an/DT inhibitor/NN of/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Amiodarone)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN CYP3A4)))))))))) (. .))))

nsubjpass(known-4, Amiodarone-1)
xsubj(inhibitor-8, Amiodarone-1)
auxpass(known-4, is-2)
advmod(known-4, also-3)
root(ROOT-0, known-4)
aux(inhibitor-8, to-5)
cop(inhibitor-8, be-6)
det(inhibitor-8, an-7)
xcomp(known-4, inhibitor-8)
prep_of(inhibitor-8, CYP3A4-10)

Therefore/RB ,/, amiodarone/NN has/VBZ the/DT potential/NN for/IN interactions/NNS with/IN drugs/NNS or/CC substances/NNS that/WDT may/MD be/VB substrates/NNS ,/, inhibitors/NNS or/CC inducers/NNS of/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN amiodarone)) (VP (VBZ has) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (NNS interactions)) (PP (IN with) (NP (NP (NP (NNS drugs)) (CC or) (NP (NNS substances))) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (NP (NP (NP (NNS substrates)) (, ,) (NP (NNS inhibitors)) (CC or) (NP (NNS inducers))) (PP (IN of) (NP (NN CYP3A4))))))))))))))) (. .))))

advmod(has-4, Therefore-1)
nsubj(has-4, amiodarone-3)
root(ROOT-0, has-4)
det(potential-6, the-5)
dobj(has-4, potential-6)
prep_for(potential-6, interactions-8)
prep_with(interactions-8, drugs-10)
nsubj(substrates-16, drugs-10)
conj_or(drugs-10, substances-12)
aux(substrates-16, may-14)
cop(substrates-16, be-15)
rcmod(drugs-10, substrates-16)
conj_or(substrates-16, inhibitors-18)
conj_or(substrates-16, inducers-20)
prep_of(substrates-16, CYP3A4-22)

While/IN only/RB a/DT limited/JJ number/NN of/IN in/FW vivo/FW drug-drug/JJ interactions/NNS with/IN amiodarone/NN have/VBP been/VBN reported/VBN ,/, chiefly/RB with/IN the/DT oral/JJ formulation/NN ,/, the/DT potential/NN for/IN other/JJ interactions/NNS should/MD be/VB anticipated/VBN ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (NP (RB only) (DT a) (JJ limited) (NN number)) (PP (IN of) (NP (NP (ADJP (FW in) (FW vivo)) (JJ drug-drug) (NNS interactions)) (PP (IN with) (NP (NN amiodarone)))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (, ,) (ADVP (RB chiefly)) (PP (IN with) (NP (DT the) (JJ oral) (NN formulation)))))))) (, ,) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (JJ other) (NNS interactions)))) (VP (MD should) (VP (VB be) (VP (VBN anticipated))))) (. .))))

mark(reported-15, While-1)
advmod(number-5, only-2)
det(number-5, a-3)
amod(number-5, limited-4)
nsubjpass(reported-15, number-5)
nn(vivo-8, in-7)
amod(interactions-10, vivo-8)
amod(interactions-10, drug-drug-9)
prep_of(number-5, interactions-10)
prep_with(interactions-10, amiodarone-12)
aux(reported-15, have-13)
auxpass(reported-15, been-14)
advcl(anticipated-30, reported-15)
advmod(reported-15, chiefly-17)
det(formulation-21, the-19)
amod(formulation-21, oral-20)
prep_with(reported-15, formulation-21)
det(potential-24, the-23)
nsubjpass(anticipated-30, potential-24)
amod(interactions-27, other-26)
prep_for(potential-24, interactions-27)
aux(anticipated-30, should-28)
auxpass(anticipated-30, be-29)
root(ROOT-0, anticipated-30)

This/DT is/VBZ especially/RB important/JJ for/IN drugs/NNS associated/VBN with/IN serious/JJ toxicity/NN ,/, such/JJ as/IN other/JJ antiarrhythmics/NNS ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ is) (ADJP (RB especially) (JJ important) (PP (IN for) (NP (NP (NNS drugs)) (VP (VBN associated) (PP (IN with) (NP (JJ serious) (NN toxicity)))) (, ,) (PP (JJ such) (IN as) (NP (JJ other) (NNS antiarrhythmics)))))))) (. .))))

nsubj(important-4, This-1)
cop(important-4, is-2)
advmod(important-4, especially-3)
root(ROOT-0, important-4)
prep_for(important-4, drugs-6)
partmod(drugs-6, associated-7)
amod(toxicity-10, serious-9)
prep_with(associated-7, toxicity-10)
amod(antiarrhythmics-15, other-14)
prep_such_as(drugs-6, antiarrhythmics-15)

If/IN such/JJ drugs/NNS are/VBP needed/VBN ,/, their/PRP$ dose/NN should/MD be/VB reassessed/VBN and/CC ,/, where/WRB appropriate/JJ ,/, plasma/NN concentration/NN measured/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN needed))))) (, ,) (NP (PRP$ their) (NN dose)) (VP (VP (MD should) (VP (VB be) (VP (VBN reassessed)))) (CC and) (, ,) (SBAR (WHADVP (WRB where)) (FRAG (JJ appropriate))) (, ,) (NP (NP (NN plasma) (NN concentration)) (VP (VBN measured))))) (. .))))

mark(needed-5, If-1)
amod(drugs-3, such-2)
nsubjpass(needed-5, drugs-3)
auxpass(needed-5, are-4)
advcl(reassessed-11, needed-5)
poss(dose-8, their-7)
nsubjpass(reassessed-11, dose-8)
aux(reassessed-11, should-9)
auxpass(reassessed-11, be-10)
root(ROOT-0, reassessed-11)
advmod(appropriate-15, where-14)
advcl(reassessed-11, appropriate-15)
nn(concentration-18, plasma-17)
conj_and(reassessed-11, concentration-18)
dobj(reassessed-11, concentration-18)
partmod(concentration-18, measured-19)

In/IN view/NN of/IN the/DT long/JJ and/CC variable/JJ half-life/NN of/IN amiodarone/NN ,/, potential/NN for/IN drug/NN interactions/NNS exists/VBZ not/RB only/RB with/IN concomitant/JJ medication/NN but/CC also/RB with/IN drugs/NNS administered/VBN after/IN discontinuation/NN of/IN amiodarone/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NN view)) (PP (IN of) (NP (NP (DT the) (ADJP (ADJP (JJ long)) (CC and) (ADJP (JJ variable))) (NN half-life)) (PP (IN of) (NP (NN amiodarone))))))) (, ,) (NP (NP (NN potential)) (PP (IN for) (NP (NN drug) (NNS interactions)))) (VP (VBZ exists) (PP (CONJP (RB not) (RB only)) (PP (IN with) (NP (JJ concomitant) (NN medication))) (CONJP (CC but) (RB also)) (PP (IN with) (NP (NP (NNS drugs)) (VP (VBN administered) (PP (IN after) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN amiodarone))))))))))) (. .))))

prep_in(exists-16, view-2)
det(half-life-8, the-4)
amod(half-life-8, long-5)
conj_and(long-5, variable-7)
prep_of(view-2, half-life-8)
prep_of(half-life-8, amiodarone-10)
nsubj(exists-16, potential-12)
nn(interactions-15, drug-14)
prep_for(potential-12, interactions-15)
root(ROOT-0, exists-16)
neg(only-18, not-17)
preconj(exists-16, only-18)
amod(medication-21, concomitant-20)
prep_with(exists-16, medication-21)
conj_and(medication-21, drugs-25)
partmod(drugs-25, administered-26)
prep_after(administered-26, discontinuation-28)
prep_of(discontinuation-28, amiodarone-30)

Since/IN amiodarone/NN is/VBZ a/DT substrate/NN for/IN CYP3A4/NN and/CC CYP2C8/NN ,/, drugs/NNS /substances/NNS that/WDT inhibit/VBP these/DT isoenzymes/NNS may/MD decrease/VB the/DT metabolism/NN and/CC increase/VB serum/NN concentration/NN of/IN amiodarone/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN amiodarone)) (VP (VBZ is) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NP (NN CYP3A4)) (CC and) (NP (NN CYP2C8)))))))) (, ,) (NP (NP (NNS drugs) (NNS /substances)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (DT these) (NNS isoenzymes)))))) (VP (MD may) (VP (VP (VB decrease) (NP (DT the) (NN metabolism))) (CC and) (VP (VB increase) (NP (NP (NN serum) (NN concentration)) (PP (IN of) (NP (NN amiodarone)))))))) (. .))))

mark(substrate-5, Since-1)
nsubj(substrate-5, amiodarone-2)
cop(substrate-5, is-3)
det(substrate-5, a-4)
advcl(decrease-18, substrate-5)
prep_for(substrate-5, CYP3A4-7)
conj_and(CYP3A4-7, CYP2C8-9)
nn(/substances-12, drugs-11)
nsubj(inhibit-14, /substances-12)
nsubj(decrease-18, /substances-12)
rcmod(/substances-12, inhibit-14)
det(isoenzymes-16, these-15)
dobj(inhibit-14, isoenzymes-16)
aux(decrease-18, may-17)
root(ROOT-0, decrease-18)
det(metabolism-20, the-19)
dobj(decrease-18, metabolism-20)
conj_and(decrease-18, increase-22)
nn(concentration-24, serum-23)
dobj(increase-22, concentration-24)
prep_of(concentration-24, amiodarone-26)

Reported/VBN examples/NNS include/VBP the/DT following/NN :/: Protease/NN Inhibitors/NNS :/: Protease/NN inhibitors/NNS are/VBP known/VBN to/TO inhibit/VB CYP3A4/NN to/TO varying/VBG degrees/NNS ./.

(ROOT (S1 (S (S (NP (VBN Reported) (NNS examples)) (VP (VBP include) (NP (NP (DT the) (NN following)) (: :) (NP (NN Protease) (NNS Inhibitors)) (: :) (S (NP (NN Protease) (NNS inhibitors)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NN CYP3A4)) (PP (TO to) (NP (VBG varying) (NNS degrees))))))))))))) (. .))))

amod(examples-2, Reported-1)
nsubj(include-3, examples-2)
root(ROOT-0, include-3)
det(following-5, the-4)
dobj(include-3, following-5)
nn(Inhibitors-8, Protease-7)
dep(following-5, Inhibitors-8)
nn(inhibitors-11, Protease-10)
nsubjpass(known-13, inhibitors-11)
xsubj(inhibit-15, inhibitors-11)
auxpass(known-13, are-12)
dep(following-5, known-13)
aux(inhibit-15, to-14)
xcomp(known-13, inhibit-15)
dobj(inhibit-15, CYP3A4-16)
amod(degrees-19, varying-18)
prep_to(CYP3A4-16, degrees-19)

A/DT case/NN report/NN of/IN one/CD patient/NN taking/VBG amiodarone/NN 200/CD mg/NN and/CC indinavir/NN 800/CD mg/NN three/CD times/NNS a/DT day/NN resulted/VBD in/IN increases/NNS in/IN amiodarone/NN concentrations/NNS from/IN 0.9/CD mg/L/NN to/TO 1.3/CD mg/L/NN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (NN case) (NN report)) (PP (IN of) (NP (NP (CD one) (NN patient)) (VP (VBG taking) (NP (NP (NN amiodarone) (CD 200) (NN mg)) (CC and) (NP (NN indinavir) (CD 800) (NN mg)) (NP (NP (CD three) (NNS times)) (NP (DT a) (NN day)))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN amiodarone) (NNS concentrations)) (PP (IN from) (NP (QP (CD 0.9) (NN mg/L) (TO to) (CD 1.3)) (NN mg/L))))))))) (. .))))

det(report-3, A-1)
nn(report-3, case-2)
nsubj(resulted-19, report-3)
num(patient-6, one-5)
prep_of(report-3, patient-6)
partmod(patient-6, taking-7)
nn(mg-10, amiodarone-8)
num(mg-10, 200-9)
dobj(taking-7, mg-10)
nn(mg-14, indinavir-12)
num(mg-14, 800-13)
conj_and(mg-10, mg-14)
num(times-16, three-15)
dobj(taking-7, times-16)
dep(mg-10, times-16)
det(day-18, a-17)
dep(times-16, day-18)
root(ROOT-0, resulted-19)
prep_in(resulted-19, increases-21)
nn(concentrations-24, amiodarone-23)
prep_in(increases-21, concentrations-24)
number(mg/L-27, 0.9-26)
num(mg/L-30, mg/L-27)
dep(mg/L-27, to-28)
number(mg/L-27, 1.3-29)
prep_from(concentrations-24, mg/L-30)

Monitoring/NN for/IN amiodarone/NN toxicity/NN and/CC serial/JJ measurement/NN of/IN amiodarone/NN serum/NN concentration/NN during/IN concomitant/JJ protease/NN inhibitor/NN therapy/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Monitoring)) (PP (IN for) (NP (NN amiodarone) (NN toxicity)))) (CC and) (NP (NP (JJ serial) (NN measurement)) (PP (IN of) (NP (NN amiodarone) (NN serum) (NN concentration))))) (PP (IN during) (NP (JJ concomitant) (NN protease) (NN inhibitor) (NN therapy)))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

nsubjpass(considered-19, Monitoring-1)
nn(toxicity-4, amiodarone-3)
prep_for(Monitoring-1, toxicity-4)
amod(measurement-7, serial-6)
conj_and(Monitoring-1, measurement-7)
nn(concentration-11, amiodarone-9)
nn(concentration-11, serum-10)
prep_of(measurement-7, concentration-11)
amod(therapy-16, concomitant-13)
nn(therapy-16, protease-14)
nn(therapy-16, inhibitor-15)
prep_during(Monitoring-1, therapy-16)
aux(considered-19, should-17)
auxpass(considered-19, be-18)
root(ROOT-0, considered-19)

Histamine/NN H2/NN antagonists/NNS :/: Cimetidine/NN inhibits/VBZ CYP3A4/NN and/CC can/MD increase/VB serum/NN amiodarone/NN levels/NNS ./.

(ROOT (S1 (S (NP (NP (NN Histamine) (NN H2) (NNS antagonists)) (: :) (S (NP (NN Cimetidine)) (VP (VP (VBZ inhibits) (NP (NN CYP3A4))) (CC and) (VP (MD can) (VP (VB increase) (NP (NN serum) (NN amiodarone) (NNS levels)))))) (. .)))))

nn(antagonists-3, Histamine-1)
nn(antagonists-3, H2-2)
root(ROOT-0, antagonists-3)
nsubj(inhibits-6, Cimetidine-5)
dep(antagonists-3, inhibits-6)
dobj(inhibits-6, CYP3A4-7)
aux(increase-10, can-9)
conj_and(inhibits-6, increase-10)
nn(levels-13, serum-11)
nn(levels-13, amiodarone-12)
dobj(increase-10, levels-13)

Other/JJ substances/NNS :/: Grapefruit/NN juice/NN given/VBN to/TO healthy/JJ volunteers/NNS increased/VBD amiodarone/NN AUC/NN by/IN 50/CD %/NN and/CC Cmax/NN by/IN 84/CD %/NN ,/, resulting/VBG in/IN increased/VBN plasma/NN levels/NNS of/IN amiodarone/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NNS substances)) (: :) (S (NP (NP (NN Grapefruit) (NN juice)) (VP (VBN given) (PP (TO to) (NP (JJ healthy) (NNS volunteers))))) (VP (VBD increased) (NP (NN amiodarone) (NN AUC)) (PP (IN by) (NP (NP (CD 50) (NN %)) (CC and) (NP (NN Cmax)))) (PP (IN by) (NP (CD 84) (NN %))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN amiodarone))))))))) (. .)))))

amod(substances-2, Other-1)
root(ROOT-0, substances-2)
nn(juice-5, Grapefruit-4)
nsubj(increased-10, juice-5)
partmod(juice-5, given-6)
amod(volunteers-9, healthy-8)
prep_to(given-6, volunteers-9)
dep(substances-2, increased-10)
nn(AUC-12, amiodarone-11)
dobj(increased-10, AUC-12)
num(%-15, 50-14)
prep_by(increased-10, %-15)
conj_and(%-15, Cmax-17)
num(%-20, 84-19)
prep_by(increased-10, %-20)
partmod(increased-10, resulting-22)
xcomp(increased-10, resulting-22)
amod(levels-26, increased-24)
nn(levels-26, plasma-25)
prep_in(resulting-22, levels-26)
prep_of(levels-26, amiodarone-28)

Grapefruit/NN juice/NN should/MD not/RB be/VB taken/VBN during/IN treatment/NN with/IN oral/JJ amiodarone/NN ./.

(ROOT (S1 (S (S (NP (NN Grapefruit) (NN juice)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN during) (NP (NP (NN treatment)) (PP (IN with) (NP (JJ oral) (NN amiodarone))))))))) (. .))))

nn(juice-2, Grapefruit-1)
nsubjpass(taken-6, juice-2)
aux(taken-6, should-3)
neg(taken-6, not-4)
auxpass(taken-6, be-5)
root(ROOT-0, taken-6)
prep_during(taken-6, treatment-8)
amod(amiodarone-11, oral-10)
prep_with(treatment-8, amiodarone-11)

This/DT information/NN should/MD be/VB considered/VBN when/WRB changing/VBG from/IN intravenous/JJ amiodarone/NN to/TO oral/JJ amiodarone/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN information)) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (VP (VBG changing) (PP (IN from) (NP (NP (JJ intravenous) (NN amiodarone)) (PP (TO to) (NP (JJ oral) (NN amiodarone)))))))))))) (. .))))

det(information-2, This-1)
nsubjpass(considered-5, information-2)
aux(considered-5, should-3)
auxpass(considered-5, be-4)
root(ROOT-0, considered-5)
advmod(changing-7, when-6)
advcl(considered-5, changing-7)
amod(amiodarone-10, intravenous-9)
prep_from(changing-7, amiodarone-10)
amod(amiodarone-13, oral-12)
prep_to(amiodarone-10, amiodarone-13)

Amiodarone/NN may/MD suppress/VBP certain/JJ CYP450/NN enzymes/NNS ,/, including/VBG CYP1A2/NN ,/, CYP2C9/NN ,/, CYP2D6/NN ,/, and/CC CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Amiodarone)) (VP (MD may) (VP (VBP suppress) (NP (NP (JJ certain) (NN CYP450) (NNS enzymes)) (, ,) (PP (VBG including) (NP (NP (NN CYP1A2)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2D6)) (, ,) (CC and) (NP (NN CYP3A4)))))))) (. .))))

nsubj(suppress-3, Amiodarone-1)
aux(suppress-3, may-2)
root(ROOT-0, suppress-3)
amod(enzymes-6, certain-4)
nn(enzymes-6, CYP450-5)
dobj(suppress-3, enzymes-6)
prep_including(enzymes-6, CYP1A2-9)
conj_and(CYP1A2-9, CYP2C9-11)
conj_and(CYP1A2-9, CYP2D6-13)
conj_and(CYP1A2-9, CYP3A4-16)

This/DT inhibition/NN can/MD result/VB in/IN unexpectedly/RB high/JJ plasma/NN levels/NNS of/IN other/JJ drugs/NNS which/WDT are/VBP metabolized/VBN by/IN those/DT CYP450/CD enzymes/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN inhibition)) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (ADJP (RB unexpectedly) (JJ high)) (NN plasma) (NNS levels)) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT those) (CD CYP450) (NNS enzymes)))))))))))))) (. .))))

det(inhibition-2, This-1)
nsubj(result-4, inhibition-2)
aux(result-4, can-3)
root(ROOT-0, result-4)
advmod(high-7, unexpectedly-6)
amod(levels-9, high-7)
nn(levels-9, plasma-8)
prep_in(result-4, levels-9)
amod(drugs-12, other-11)
prep_of(levels-9, drugs-12)
nsubjpass(metabolized-15, drugs-12)
auxpass(metabolized-15, are-14)
rcmod(drugs-12, metabolized-15)
det(enzymes-19, those-17)
num(enzymes-19, CYP450-18)
agent(metabolized-15, enzymes-19)

Reported/VBN examples/NNS of/IN this/DT interaction/NN include/VBP the/DT following/NN :/: Immunosuppressive/JJ s/NN :/: Cyclosporine/NN (/-LRB- CYP3A4/NN substrate/NN )/-RRB- administered/VBN in/IN combination/NN with/IN oral/JJ amiodarone/NN has/VBZ been/VBN reported/VBN to/TO produce/VB persistently/RB elevated/JJ plasma/NN concentrations/NNS of/IN cyclosporine/NN resulting/VBG in/IN elevated/JJ creatinine/NN ,/, despite/IN reduction/NN in/IN dose/NN of/IN cyclosporine/NN ./.

(ROOT (S1 (S (S (NP (NP (VBN Reported) (NNS examples)) (PP (IN of) (NP (DT this) (NN interaction)))) (VP (VBP include) (NP (NP (DT the) (NN following)) (: :) (S (NP (NP (NP (JJ Immunosuppressive) (NN s) (: :) (NN Cyclosporine)) (PRN (-LRB- -LRB-) (NP (NN CYP3A4) (NN substrate)) (-RRB- -RRB-))) (VP (VBN administered) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ oral) (NN amiodarone))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB produce) (NP (NP (ADJP (RB persistently) (JJ elevated)) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN cyclosporine)) (VP (VBG resulting) (PP (IN in) (NP (JJ elevated) (NN creatinine))))))) (, ,) (PP (IN despite) (NP (NP (NN reduction)) (PP (IN in) (NP (NP (NN dose)) (PP (IN of) (NP (NN cyclosporine))))))))))))))))) (. .))))

amod(examples-2, Reported-1)
nsubj(include-6, examples-2)
det(interaction-5, this-4)
prep_of(examples-2, interaction-5)
root(ROOT-0, include-6)
det(following-8, the-7)
dobj(include-6, following-8)
amod(Cyclosporine-13, Immunosuppressive-10)
nn(Cyclosporine-13, s-11)
nsubjpass(reported-26, Cyclosporine-13)
xsubj(produce-28, Cyclosporine-13)
nn(substrate-16, CYP3A4-15)
abbrev(Cyclosporine-13, substrate-16)
partmod(Cyclosporine-13, administered-18)
prep_in(administered-18, combination-20)
amod(amiodarone-23, oral-22)
prep_with(combination-20, amiodarone-23)
aux(reported-26, has-24)
auxpass(reported-26, been-25)
dep(following-8, reported-26)
aux(produce-28, to-27)
xcomp(reported-26, produce-28)
advmod(elevated-30, persistently-29)
amod(concentrations-32, elevated-30)
nn(concentrations-32, plasma-31)
dobj(produce-28, concentrations-32)
prep_of(concentrations-32, cyclosporine-34)
partmod(cyclosporine-34, resulting-35)
amod(creatinine-38, elevated-37)
prep_in(resulting-35, creatinine-38)
prep_despite(produce-28, reduction-41)
prep_in(reduction-41, dose-43)
prep_of(dose-43, cyclosporine-45)

HMG-CoA/NN Reductase/NN Inhibitors/NNS :/: Simvastatin/NN (/-LRB- CYP3A4/NN substrate/NN )/-RRB- in/IN combination/NN with/IN amiodarone/NN has/VBZ been/VBN associated/VBN with/IN reports/NNS of/IN myopathy/rhabdomyolysis/NN ./.

(ROOT (S1 (S (NP (NP (NN HMG-CoA) (NN Reductase) (NNS Inhibitors)) (: :) (S (NP (NP (NP (NN Simvastatin)) (PRN (-LRB- -LRB-) (NP (NN CYP3A4) (NN substrate)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN amiodarone)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NNS reports)) (PP (IN of) (NP (NN myopathy/rhabdomyolysis))))))))) (. .)))))

nn(Inhibitors-3, HMG-CoA-1)
nn(Inhibitors-3, Reductase-2)
root(ROOT-0, Inhibitors-3)
nsubjpass(associated-16, Simvastatin-5)
nn(substrate-8, CYP3A4-7)
abbrev(Simvastatin-5, substrate-8)
prep_in(Simvastatin-5, combination-11)
prep_with(combination-11, amiodarone-13)
aux(associated-16, has-14)
auxpass(associated-16, been-15)
dep(Inhibitors-3, associated-16)
prep_with(associated-16, reports-18)
prep_of(reports-18, myopathy/rhabdomyolysis-20)

Cardiovasculars/NN :/: Cardiac/JJ glycosides/NNS :/: In/IN patients/NNS receiving/VBG digoxin/NN therapy/NN ,/, administration/NN of/IN oral/JJ amiodarone/NN regularly/RB results/VBZ in/IN an/DT increase/NN in/IN serum/NN digoxin/NN concentration/NN that/WDT may/MD reach/VB toxic/JJ levels/NNS with/IN resultant/JJ clinical/JJ toxicity/NN ./.

(ROOT (S1 (S (NP (NP (NN Cardiovasculars) (: :) (JJ Cardiac) (NNS glycosides)) (: :) (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN digoxin) (NN therapy))))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (JJ oral) (NN amiodarone)))) (ADVP (RB regularly)) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN serum) (NN digoxin) (NN concentration)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB reach) (NP (JJ toxic) (NNS levels)) (PP (IN with) (NP (JJ resultant) (JJ clinical) (NN toxicity))))))))))))) (. .)))))

nn(glycosides-4, Cardiovasculars-1)
amod(glycosides-4, Cardiac-3)
root(ROOT-0, glycosides-4)
prep_in(results-17, patients-7)
partmod(patients-7, receiving-8)
nn(therapy-10, digoxin-9)
dobj(receiving-8, therapy-10)
nsubj(results-17, administration-12)
amod(amiodarone-15, oral-14)
prep_of(administration-12, amiodarone-15)
advmod(results-17, regularly-16)
dep(glycosides-4, results-17)
det(increase-20, an-19)
prep_in(results-17, increase-20)
nn(concentration-24, serum-22)
nn(concentration-24, digoxin-23)
prep_in(increase-20, concentration-24)
nsubj(reach-27, concentration-24)
aux(reach-27, may-26)
rcmod(concentration-24, reach-27)
amod(levels-29, toxic-28)
dobj(reach-27, levels-29)
amod(toxicity-33, resultant-31)
amod(toxicity-33, clinical-32)
prep_with(reach-27, toxicity-33)

Amiodarone/NN taken/VBN concomitantly/RB with/IN digoxin/NN increases/VBZ the/DT serum/NN digoxin/NN concentration/NN by/IN 70/CD %/NN after/IN one/CD day/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Amiodarone)) (VP (VBN taken) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN digoxin))))) (VP (VBZ increases) (NP (DT the) (NN serum) (NN digoxin) (NN concentration)) (PP (IN by) (NP (CD 70) (NN %))) (PP (IN after) (NP (CD one) (NN day))))) (. .))))

nsubj(increases-6, Amiodarone-1)
partmod(Amiodarone-1, taken-2)
advmod(taken-2, concomitantly-3)
prep_with(taken-2, digoxin-5)
root(ROOT-0, increases-6)
det(concentration-10, the-7)
nn(concentration-10, serum-8)
nn(concentration-10, digoxin-9)
dobj(increases-6, concentration-10)
num(%-13, 70-12)
prep_by(increases-6, %-13)
num(day-16, one-15)
prep_after(increases-6, day-16)

On/IN administration/NN of/IN oral/JJ amiodarone/NN ,/, the/DT need/NN for/IN digitalis/NN therapy/NN should/MD be/VB reviewed/VBN and/CC the/DT dose/NN reduced/VBD by/IN approximately/RB 50/CD %/NN or/CC discontinued/VBD ./.

(ROOT (S1 (S (S (S (PP (IN On) (NP (NP (NN administration)) (PP (IN of) (NP (JJ oral) (NN amiodarone))))) (, ,) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NN digitalis) (NN therapy)))) (VP (MD should) (VP (VB be) (VP (VBN reviewed))))) (CC and) (S (NP (DT the) (NN dose)) (VP (VP (VBD reduced) (PP (IN by) (NP (QP (RB approximately) (CD 50)) (NN %)))) (CC or) (VP (VBD discontinued))))) (. .))))

prep_on(reviewed-14, administration-2)
amod(amiodarone-5, oral-4)
prep_of(administration-2, amiodarone-5)
det(need-8, the-7)
nsubjpass(reviewed-14, need-8)
nn(therapy-11, digitalis-10)
prep_for(need-8, therapy-11)
aux(reviewed-14, should-12)
auxpass(reviewed-14, be-13)
root(ROOT-0, reviewed-14)
det(dose-17, the-16)
nsubj(reduced-18, dose-17)
conj_and(reviewed-14, reduced-18)
quantmod(50-21, approximately-20)
num(%-22, 50-21)
prep_by(reduced-18, %-22)
conj_or(reduced-18, discontinued-24)

If/IN digitalis/NN treatment/NN is/VBZ continued/VBN ,/, serum/NN levels/NNS should/MD be/VB closely/RB monitored/VBN and/CC patients/NNS observed/VBN for/IN clinical/JJ evidence/NN of/IN toxicity/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN digitalis) (NN treatment)) (VP (VBZ is) (VP (VBN continued))))) (, ,) (S (NP (NN serum) (NNS levels)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored))))) (CC and) (S (NP (NNS patients)) (VP (VBN observed) (PP (IN for) (NP (NP (JJ clinical) (NN evidence)) (PP (IN of) (NP (NN toxicity)))))))) (. .))))

mark(continued-5, If-1)
nn(treatment-3, digitalis-2)
nsubjpass(continued-5, treatment-3)
auxpass(continued-5, is-4)
advcl(monitored-12, continued-5)
nn(levels-8, serum-7)
nsubjpass(monitored-12, levels-8)
aux(monitored-12, should-9)
auxpass(monitored-12, be-10)
advmod(monitored-12, closely-11)
root(ROOT-0, monitored-12)
nsubj(observed-15, patients-14)
conj_and(monitored-12, observed-15)
amod(evidence-18, clinical-17)
prep_for(observed-15, evidence-18)
prep_of(evidence-18, toxicity-20)

These/DT precautions/NNS probably/RB should/MD apply/VB to/TO digitoxin/NN administration/NN as/IN well/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS precautions)) (VP (ADVP (RB probably)) (MD should) (VP (VB apply) (PP (TO to) (NP (NN digitoxin) (NN administration))) (PP (IN as) (NP (NN well)))))) (. .))))

det(precautions-2, These-1)
nsubj(apply-5, precautions-2)
advmod(apply-5, probably-3)
aux(apply-5, should-4)
root(ROOT-0, apply-5)
nn(administration-8, digitoxin-7)
prep_to(apply-5, administration-8)
prep_as(apply-5, well-10)

Antiarrhythmics/NNS :/: Other/JJ antiarrhythmic/JJ drugs/NNS ,/, such/JJ as/IN quinidine/NN ,/, procainamide/NN ,/, disopyramide/NN ,/, and/CC phenytoin/NN ,/, have/VBP been/VBN used/VBN concurrently/RB with/IN amiodarone/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antiarrhythmics)) (: :) (S (NP (NP (JJ Other) (JJ antiarrhythmic) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN quinidine)) (, ,) (NP (NN procainamide)) (, ,) (NP (NN disopyramide)) (, ,) (CC and) (NP (NN phenytoin)))) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NN amiodarone))))))) (. .)))))

root(ROOT-0, Antiarrhythmics-1)
amod(drugs-5, Other-3)
amod(drugs-5, antiarrhythmic-4)
nsubjpass(used-20, drugs-5)
prep_such_as(drugs-5, quinidine-9)
conj_and(quinidine-9, procainamide-11)
conj_and(quinidine-9, disopyramide-13)
conj_and(quinidine-9, phenytoin-16)
aux(used-20, have-18)
auxpass(used-20, been-19)
dep(Antiarrhythmics-1, used-20)
advmod(used-20, concurrently-21)
prep_with(used-20, amiodarone-23)

There/EX have/VBP been/VBN case/NN reports/NNS of/IN increased/VBN steady-state/JJ levels/NNS of/IN quinidine/NN ,/, procainamide/NN ,/, and/CC phenytoin/NN during/IN concomitant/JJ therapy/NN with/IN amiodarone/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NN case) (NNS reports)) (PP (IN of) (NP (NP (VBN increased) (JJ steady-state) (NNS levels)) (PP (IN of) (NP (NP (NN quinidine)) (, ,) (NP (NN procainamide)) (, ,) (CC and) (NP (NN phenytoin))))))) (PP (IN during) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NN amiodarone)))))))) (. .))))

expl(reports-5, There-1)
aux(reports-5, have-2)
cop(reports-5, been-3)
nn(reports-5, case-4)
root(ROOT-0, reports-5)
amod(levels-9, increased-7)
amod(levels-9, steady-state-8)
prep_of(reports-5, levels-9)
prep_of(levels-9, quinidine-11)
conj_and(quinidine-11, procainamide-13)
conj_and(quinidine-11, phenytoin-16)
amod(therapy-19, concomitant-18)
prep_during(reports-5, therapy-19)
prep_with(therapy-19, amiodarone-21)

Phenytoin/NN decreases/VBZ serum/NN amiodarone/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Phenytoin)) (VP (VBZ decreases) (NP (NN serum) (NN amiodarone) (NNS levels)))) (. .))))

nsubj(decreases-2, Phenytoin-1)
root(ROOT-0, decreases-2)
nn(levels-5, serum-3)
nn(levels-5, amiodarone-4)
dobj(decreases-2, levels-5)

Amiodarone/NN taken/VBN concomitantly/RB with/IN quinidine/NN increases/VBZ quinidine/NN serum/NN concentration/NN by/IN 33/CD %/NN after/IN two/CD days/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Amiodarone)) (VP (VBN taken) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN quinidine))))) (VP (VBZ increases) (NP (NN quinidine) (NN serum) (NN concentration)) (PP (IN by) (NP (CD 33) (NN %))) (PP (IN after) (NP (CD two) (NNS days))))) (. .))))

nsubj(increases-6, Amiodarone-1)
partmod(Amiodarone-1, taken-2)
advmod(taken-2, concomitantly-3)
prep_with(taken-2, quinidine-5)
root(ROOT-0, increases-6)
nn(concentration-9, quinidine-7)
nn(concentration-9, serum-8)
dobj(increases-6, concentration-9)
num(%-12, 33-11)
prep_by(increases-6, %-12)
num(days-15, two-14)
prep_after(increases-6, days-15)

Amiodarone/NN taken/VBN concomitantly/RB with/IN procainamide/NN for/IN less/JJR than/IN seven/CD days/NNS increases/VBZ plasma/NN concentrations/NNS of/IN procainamide/NN and/CC n-acetyl/JJ procainamide/NN by/IN 55/CD %/NN and/CC 33/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Amiodarone)) (VP (VBN taken) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN procainamide))) (PP (IN for) (NP (QP (JJR less) (IN than) (CD seven)) (NNS days))))) (VP (VBZ increases) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN procainamide)) (CC and) (NP (JJ n-acetyl) (NN procainamide))))) (PP (IN by) (NP (NP (CD 55) (NN %)) (CC and) (NP (CD 33) (NN %)) (, ,) (ADVP (RB respectively)))))) (. .))))

nsubj(increases-11, Amiodarone-1)
partmod(Amiodarone-1, taken-2)
advmod(taken-2, concomitantly-3)
prep_with(taken-2, procainamide-5)
mwe(than-8, less-7)
quantmod(seven-9, than-8)
num(days-10, seven-9)
prep_for(taken-2, days-10)
root(ROOT-0, increases-11)
nn(concentrations-13, plasma-12)
dobj(increases-11, concentrations-13)
prep_of(concentrations-13, procainamide-15)
amod(procainamide-18, n-acetyl-17)
conj_and(procainamide-15, procainamide-18)
num(%-21, 55-20)
prep_by(increases-11, %-21)
num(%-24, 33-23)
conj_and(%-21, %-24)
advmod(%-21, respectively-26)
conj_and(%-21, respectively-26)

Quinidine/NN and/CC procainamide/NN doses/NNS should/MD be/VB reduced/VBN by/IN one-third/CD when/WRB either/DT is/VBZ administered/VBN with/IN amiodarone/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Quinidine)) (CC and) (NP (NN procainamide))) (NNS doses)) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (CD one-third))) (SBAR (WHADVP (WRB when)) (S (NP (DT either)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (NN amiodarone))))))))))) (. .))))

nn(doses-4, Quinidine-1)
conj_and(Quinidine-1, procainamide-3)
nsubjpass(reduced-7, doses-4)
aux(reduced-7, should-5)
auxpass(reduced-7, be-6)
root(ROOT-0, reduced-7)
agent(reduced-7, one-third-9)
advmod(administered-13, when-10)
nsubjpass(administered-13, either-11)
auxpass(administered-13, is-12)
advcl(reduced-7, administered-13)
prep_with(administered-13, amiodarone-15)

Plasma/NN levels/NNS of/IN flecainide/NN have/VBP been/VBN reported/VBN to/TO increase/VB in/IN the/DT presence/NN of/IN oral/JJ amiodarone/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Plasma) (NNS levels)) (PP (IN of) (NP (NN flecainide)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB increase) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ oral) (NN amiodarone))))))))))) (: ;)) (. .))))

nn(levels-2, Plasma-1)
nsubjpass(reported-7, levels-2)
xsubj(increase-9, levels-2)
prep_of(levels-2, flecainide-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
aux(increase-9, to-8)
xcomp(reported-7, increase-9)
det(presence-12, the-11)
prep_in(increase-9, presence-12)
amod(amiodarone-15, oral-14)
prep_of(presence-12, amiodarone-15)

because/IN of/IN this/DT ,/, the/DT dosage/NN of/IN flecainide/NN should/MD be/VB adjusted/VBN when/WRB these/DT drugs/NNS are/VBP administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (PP (IN because) (IN of) (NP (DT this))) (, ,) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (NN flecainide)))) (VP (MD should) (VP (VB be) (VP (VBN adjusted) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)))))))))) (. .))))

prep_because_of(adjusted-11, this-3)
det(dosage-6, the-5)
nsubjpass(adjusted-11, dosage-6)
prep_of(dosage-6, flecainide-8)
aux(adjusted-11, should-9)
auxpass(adjusted-11, be-10)
root(ROOT-0, adjusted-11)
advmod(administered-16, when-12)
det(drugs-14, these-13)
nsubjpass(administered-16, drugs-14)
auxpass(administered-16, are-15)
advcl(adjusted-11, administered-16)
advmod(administered-16, concomitantly-17)

In/IN general/JJ ,/, any/DT added/VBN antiarrhythmic/JJ drug/NN should/MD be/VB initiated/VBN at/IN a/DT lower/JJR than/IN usual/JJ dose/NN with/IN careful/JJ monitoring/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ general))) (, ,) (NP (DT any) (VBN added) (JJ antiarrhythmic) (NN drug)) (VP (MD should) (VP (VB be) (VP (VBN initiated) (PP (IN at) (NP (NP (DT a) (JJR lower) (IN than) (JJ usual) (NN dose)) (PP (IN with) (NP (JJ careful) (NN monitoring))))))))) (. .))))

prep_in(initiated-10, general-2)
det(drug-7, any-4)
amod(drug-7, added-5)
amod(drug-7, antiarrhythmic-6)
nsubjpass(initiated-10, drug-7)
aux(initiated-10, should-8)
auxpass(initiated-10, be-9)
root(ROOT-0, initiated-10)
det(dose-16, a-12)
amod(dose-16, lower-13)
amod(dose-16, than-14)
amod(dose-16, usual-15)
prep_at(initiated-10, dose-16)
amod(monitoring-19, careful-18)
prep_with(dose-16, monitoring-19)

Combination/NN of/IN amiodarone/NN with/IN other/JJ antiarrhythmic/JJ therapy/NN should/MD be/VB reserved/VBN for/IN patients/NNS with/IN life-threatening/JJ ventricular/JJ arrhythmias/NNS who/WP are/VBP incompletely/RB responsive/JJ to/TO a/DT single/JJ agent/NN or/CC incompletely/RB responsive/JJ to/TO amiodarone/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Combination)) (PP (IN of) (NP (NN amiodarone))) (PP (IN with) (NP (JJ other) (JJ antiarrhythmic) (NN therapy)))) (VP (MD should) (VP (VB be) (VP (VBN reserved) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ life-threatening) (JJ ventricular) (NNS arrhythmias))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB incompletely)) (ADJP (ADJP (JJ responsive) (PP (TO to) (NP (DT a) (JJ single) (NN agent)))) (CC or) (ADJP (RB incompletely) (JJ responsive) (PP (TO to) (NP (NN amiodarone)))))))))))))) (. .))))

nsubjpass(reserved-10, Combination-1)
prep_of(Combination-1, amiodarone-3)
amod(therapy-7, other-5)
amod(therapy-7, antiarrhythmic-6)
prep_with(Combination-1, therapy-7)
aux(reserved-10, should-8)
auxpass(reserved-10, be-9)
root(ROOT-0, reserved-10)
prep_for(reserved-10, patients-12)
nsubj(responsive-20, patients-12)
amod(arrhythmias-16, life-threatening-14)
amod(arrhythmias-16, ventricular-15)
prep_with(patients-12, arrhythmias-16)
cop(responsive-20, are-18)
advmod(responsive-20, incompletely-19)
rcmod(patients-12, responsive-20)
det(agent-24, a-22)
amod(agent-24, single-23)
prep_to(responsive-20, agent-24)
advmod(responsive-27, incompletely-26)
conj_or(responsive-20, responsive-27)
prep_to(responsive-27, amiodarone-29)

During/IN transfer/NN to/TO oral/JJ amiodarone/NN ,/, the/DT dose/NN levels/NNS of/IN previously/RB administered/VBN agents/NNS should/MD be/VB reduced/VBN by/IN 30/CD to/TO 50/CD %/NN several/JJ days/NNS after/IN the/DT addition/NN of/IN oral/JJ amiodarone/NN ./.

(ROOT (S1 (S (S (PP (IN During) (NP (NP (NN transfer)) (PP (TO to) (NP (JJ oral) (NN amiodarone))))) (, ,) (NP (NP (DT the) (NN dose) (NNS levels)) (PP (IN of) (NP (ADJP (RB previously) (VBN administered)) (NNS agents)))) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (QP (CD 30) (TO to) (CD 50)) (NN %))) (PP (NP (JJ several) (NNS days)) (IN after) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (JJ oral) (NN amiodarone))))))))) (. .))))

prep_during(reduced-16, transfer-2)
amod(amiodarone-5, oral-4)
prep_to(transfer-2, amiodarone-5)
det(levels-9, the-7)
nn(levels-9, dose-8)
nsubjpass(reduced-16, levels-9)
advmod(administered-12, previously-11)
amod(agents-13, administered-12)
prep_of(levels-9, agents-13)
aux(reduced-16, should-14)
auxpass(reduced-16, be-15)
root(ROOT-0, reduced-16)
number(50-20, 30-18)
dep(50-20, to-19)
num(%-21, 50-20)
agent(reduced-16, %-21)
amod(days-23, several-22)
npadvmod(reduced-16, days-23)
det(addition-26, the-25)
prep_after(reduced-16, addition-26)
amod(amiodarone-29, oral-28)
prep_of(addition-26, amiodarone-29)

The/DT continued/JJ need/NN for/IN the/DT other/JJ antiarrhythmic/JJ agent/NN should/MD be/VB reviewed/VBN after/IN the/DT effects/NNS of/IN amiodarone/NN have/VBP been/VBN established/VBN ,/, and/CC discontinuation/NN ordinarily/RB should/MD be/VB attempted/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (JJ continued) (NN need)) (PP (IN for) (NP (DT the) (JJ other) (JJ antiarrhythmic) (NN agent)))) (VP (MD should) (VP (VB be) (VP (VBN reviewed) (SBAR (IN after) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN amiodarone)))) (VP (VBP have) (VP (VBN been) (VP (VBN established)))))))))) (, ,) (CC and) (S (NP (NN discontinuation)) (ADVP (RB ordinarily)) (VP (MD should) (VP (VB be) (VP (VBN attempted)))))) (. .))))

det(need-3, The-1)
amod(need-3, continued-2)
nsubjpass(reviewed-11, need-3)
det(agent-8, the-5)
amod(agent-8, other-6)
amod(agent-8, antiarrhythmic-7)
prep_for(need-3, agent-8)
aux(reviewed-11, should-9)
auxpass(reviewed-11, be-10)
root(ROOT-0, reviewed-11)
mark(established-19, after-12)
det(effects-14, the-13)
nsubjpass(established-19, effects-14)
prep_of(effects-14, amiodarone-16)
aux(established-19, have-17)
auxpass(established-19, been-18)
advcl(reviewed-11, established-19)
nsubjpass(attempted-26, discontinuation-22)
advmod(attempted-26, ordinarily-23)
aux(attempted-26, should-24)
auxpass(attempted-26, be-25)
conj_and(reviewed-11, attempted-26)

If/IN the/DT treatment/NN is/VBZ continued/VBN ,/, these/DT patients/NNS should/MD be/VB particularly/RB carefully/RB monitored/VBN for/IN adverse/JJ effects/NNS ,/, especially/RB conduction/NN disturbances/NNS and/CC exacerbation/NN of/IN tachyarrhythmias/NN ,/, as/IN amiodarone/NN is/VBZ continued/VBN ./.

(ROOT (S1 (S (SBAR (IN If) (S (NP (DT the) (NN treatment)) (VP (VBZ is) (VP (VBN continued))))) (, ,) (NP (DT these) (NNS patients)) (VP (MD should) (VP (VB be) (ADVP (RB particularly)) (VP (ADVP (RB carefully)) (VBN monitored) (PP (IN for) (NP (NP (JJ adverse) (NNS effects)) (, ,) (ADVP (RB especially)) (NP (NN conduction) (NNS disturbances)) (CC and) (NP (NP (NN exacerbation)) (PP (IN of) (NP (NN tachyarrhythmias)))))) (, ,) (SBAR (IN as) (S (NP (NN amiodarone)) (VP (VBZ is) (VP (VBN continued)))))))) (. .))))

mark(continued-5, If-1)
det(treatment-3, the-2)
nsubjpass(continued-5, treatment-3)
auxpass(continued-5, is-4)
advcl(monitored-13, continued-5)
det(patients-8, these-7)
nsubjpass(monitored-13, patients-8)
aux(monitored-13, should-9)
auxpass(monitored-13, be-10)
advmod(monitored-13, particularly-11)
advmod(monitored-13, carefully-12)
root(ROOT-0, monitored-13)
amod(effects-16, adverse-15)
prep_for(monitored-13, effects-16)
advmod(effects-16, especially-18)
conj_and(effects-16, especially-18)
nn(disturbances-20, conduction-19)
dep(effects-16, disturbances-20)
conj_and(effects-16, exacerbation-22)
prep_of(exacerbation-22, tachyarrhythmias-24)
mark(continued-29, as-26)
nsubjpass(continued-29, amiodarone-27)
auxpass(continued-29, is-28)
advcl(monitored-13, continued-29)

In/IN amiodarone/NN -treated/JJ patients/NNS who/WP require/VBP additional/JJ antiarrhythmic/NN therapy/NN ,/, the/DT initial/JJ dose/NN of/IN such/JJ agents/NNS should/MD be/VB approximately/RB half/NN of/IN the/DT usual/JJ recommended/VBN dose/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NN amiodarone) (JJ -treated) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP require) (NP (JJ additional) (NN antiarrhythmic) (NN therapy))))))) (, ,) (NP (NP (DT the) (JJ initial) (NN dose)) (PP (IN of) (NP (JJ such) (NNS agents)))) (VP (MD should) (VP (VB be) (NP (NP (RB approximately) (NN half)) (PP (IN of) (NP (DT the) (JJ usual) (VBN recommended) (NN dose))))))) (. .))))

nn(patients-4, amiodarone-2)
amod(patients-4, -treated-3)
nsubj(require-6, patients-4)
prep_in(half-20, patients-4)
rcmod(patients-4, require-6)
amod(therapy-9, additional-7)
nn(therapy-9, antiarrhythmic-8)
dobj(require-6, therapy-9)
det(dose-13, the-11)
amod(dose-13, initial-12)
nsubj(half-20, dose-13)
amod(agents-16, such-15)
prep_of(dose-13, agents-16)
aux(half-20, should-17)
cop(half-20, be-18)
advmod(half-20, approximately-19)
root(ROOT-0, half-20)
det(dose-25, the-22)
amod(dose-25, usual-23)
amod(dose-25, recommended-24)
prep_of(half-20, dose-25)

Antihypertensives/NNS :/: Amiodarone/NN should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS receiving/VBG @/NN -/CC receptor/NN blocking/NN agents/NNS (/-LRB- e.g./FW ,/, propranolol/NN ,/, a/DT CYP3A4/NN inhibitor/NN )/-RRB- or/CC calcium/NN channel/NN antagonists/NNS (/-LRB- e.g./FW ,/, verapamil/NN ,/, a/DT CYP3A4/NN substrate/NN ,/, and/CC diltiazem/NN ,/, a/DT CYP3A4/NN inhibitor/NN )/-RRB- because/IN of/IN the/DT possible/JJ potentiation/NN of/IN bradycardia/NN ,/, sinus/NN arrest/NN ,/, and/CC AV/NN block/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NNS Antihypertensives)) (: :) (S (NP (NN Amiodarone)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NP (NN caution)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NP (NN @) (CC -) (NN receptor) (NN blocking) (NNS agents)) (PRN (-LRB- -LRB-) (NP (FW e.g.) (, ,) (NP (NN propranolol)) (, ,) (NP (DT a) (NN CYP3A4) (NN inhibitor))) (-RRB- -RRB-))) (CC or) (NP (NP (NN calcium) (NN channel) (NNS antagonists)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN verapamil)) (, ,) (NP (DT a) (NN CYP3A4) (NN substrate)) (, ,) (CC and) (NP (NN diltiazem)))) (, ,) (NP (DT a) (NN CYP3A4) (NN inhibitor)) (-RRB- -RRB-))))))))) (PP (IN because) (IN of) (NP (NP (DT the) (JJ possible) (NN potentiation)) (PP (IN of) (NP (NP (NN bradycardia)) (, ,) (NP (NN sinus) (NN arrest)) (, ,) (CC and) (NP (NN AV) (NN block))))))))) (: ;)) (. .)))))

root(ROOT-0, Antihypertensives-1)
nsubjpass(used-6, Amiodarone-3)
aux(used-6, should-4)
auxpass(used-6, be-5)
dep(Antihypertensives-1, used-6)
prep_with(used-6, caution-8)
prep_in(caution-8, patients-10)
partmod(patients-10, receiving-11)
nn(agents-16, @-12)
conj(@-12, receptor-14)
nn(agents-16, blocking-15)
dobj(receiving-11, agents-16)
dep(propranolol-20, e.g.-18)
dep(agents-16, propranolol-20)
det(inhibitor-24, a-22)
nn(inhibitor-24, CYP3A4-23)
appos(propranolol-20, inhibitor-24)
nn(antagonists-29, calcium-27)
nn(antagonists-29, channel-28)
conj_or(agents-16, antagonists-29)
dep(inhibitor-44, e.g.-31)
pobj(e.g.-31, verapamil-33)
det(substrate-37, a-35)
nn(substrate-37, CYP3A4-36)
conj_and(verapamil-33, substrate-37)
conj_and(verapamil-33, diltiazem-40)
det(inhibitor-44, a-42)
nn(inhibitor-44, CYP3A4-43)
appos(antagonists-29, inhibitor-44)
det(potentiation-50, the-48)
amod(potentiation-50, possible-49)
prep_because_of(used-6, potentiation-50)
prep_of(potentiation-50, bradycardia-52)
nn(arrest-55, sinus-54)
conj_and(bradycardia-52, arrest-55)
nn(block-59, AV-58)
conj_and(bradycardia-52, block-59)

if/IN necessary/JJ ,/, amiodarone/NN can/MD continue/VBP to/TO be/VB used/VBN after/IN insertion/NN of/IN a/DT pacemaker/NN in/IN patients/NNS with/IN severe/JJ bradycardia/NN or/CC sinus/NN arrest/NN ./.

(ROOT (S1 (S (S (SBAR (IN if) (FRAG (JJ necessary))) (, ,) (NP (NN amiodarone)) (VP (MD can) (VP (VBP continue) (S (VP (TO to) (VP (VB be) (VP (VBN used) (PP (IN after) (NP (NP (NN insertion)) (PP (IN of) (NP (DT a) (NN pacemaker))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ severe) (NN bradycardia)) (CC or) (NP (NN sinus) (NN arrest))))))))))))))) (. .))))

mark(necessary-2, if-1)
advcl(continue-6, necessary-2)
nsubj(continue-6, amiodarone-4)
xsubj(used-9, amiodarone-4)
aux(continue-6, can-5)
root(ROOT-0, continue-6)
aux(used-9, to-7)
auxpass(used-9, be-8)
xcomp(continue-6, used-9)
prep_after(used-9, insertion-11)
det(pacemaker-14, a-13)
prep_of(insertion-11, pacemaker-14)
prep_in(insertion-11, patients-16)
amod(bradycardia-19, severe-18)
prep_with(patients-16, bradycardia-19)
nn(arrest-22, sinus-21)
conj_or(bradycardia-19, arrest-22)

Anticoagulants/NNS :/: Potentiation/NN of/IN warfarin/NN -type/JJ (/-LRB- CYP2C9/NN and/CC CYP3A4/NN substrate/NN )/-RRB- anticoagulant/NN response/NN is/VBZ almost/RB always/RB seen/VBN in/IN patients/NNS receiving/VBG amiodarone/NN and/CC can/MD result/VB in/IN serious/JJ or/CC fatal/JJ bleeding/JJ ./.

(ROOT (S1 (S (NP (NP (NNS Anticoagulants)) (: :) (S (NP (NP (NN Potentiation)) (PP (IN of) (NP (ADJP (ADJP (NN warfarin) (JJ -type)) (PRN (-LRB- -LRB-) (NP (NP (NN CYP2C9)) (CC and) (NP (NN CYP3A4)) (NP (NN substrate))) (-RRB- -RRB-))) (NN anticoagulant) (NN response)))) (VP (VP (VBZ is) (ADVP (RB almost) (RB always)) (VP (VBN seen) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN amiodarone))))))) (CC and) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (ADJP (JJ serious))) (CC or) (NP (JJ fatal) (JJ bleeding)))))))) (. .)))))

root(ROOT-0, Anticoagulants-1)
nsubjpass(seen-18, Potentiation-3)
dep(-type-6, warfarin-5)
amod(response-14, -type-6)
dep(-type-6, CYP2C9-8)
conj_and(CYP2C9-8, CYP3A4-10)
dep(CYP2C9-8, substrate-11)
nn(response-14, anticoagulant-13)
prep_of(Potentiation-3, response-14)
auxpass(seen-18, is-15)
advmod(always-17, almost-16)
advmod(seen-18, always-17)
dep(Anticoagulants-1, seen-18)
prep_in(seen-18, patients-20)
partmod(patients-20, receiving-21)
dobj(receiving-21, amiodarone-22)
aux(result-25, can-24)
conj_and(seen-18, result-25)
prep_in(result-25, serious-27)
amod(bleeding-30, fatal-29)
conj_or(serious-27, bleeding-30)

Since/IN the/DT concomitant/JJ administration/NN of/IN warfarin/NN with/IN amiodarone/NN increases/VBZ the/DT prothrombin/NN time/NN by/IN 100/CD %/NN after/IN 3/CD to/TO 4/CD days/NNS ,/, the/DT dose/NN of/IN the/DT anticoagulant/NN should/MD be/VB reduced/VBN by/IN one-third/CD to/TO one-half/NN ,/, and/CC prothrombin/NN times/NNS should/MD be/VB monitored/VBN closely/RB ./.

(ROOT (S1 (S (SBAR (IN Since) (S (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN warfarin))) (PP (IN with) (NP (NN amiodarone)))) (VP (VBZ increases) (NP (DT the) (NN prothrombin) (NN time)) (PP (IN by) (NP (CD 100) (NN %))) (PP (IN after) (NP (QP (CD 3) (TO to) (CD 4)) (NNS days)))))) (, ,) (S (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (DT the) (NN anticoagulant)))) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (NP (CD one-third)) (PP (TO to) (NP (NN one-half))))))))) (, ,) (CC and) (S (NP (NN prothrombin) (NNS times)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely))))))) (. .))))

mark(increases-9, Since-1)
det(administration-4, the-2)
amod(administration-4, concomitant-3)
nsubj(increases-9, administration-4)
prep_of(administration-4, warfarin-6)
prep_with(administration-4, amiodarone-8)
advcl(reduced-29, increases-9)
det(time-12, the-10)
nn(time-12, prothrombin-11)
dobj(increases-9, time-12)
num(%-15, 100-14)
prep_by(increases-9, %-15)
number(4-19, 3-17)
dep(4-19, to-18)
num(days-20, 4-19)
prep_after(increases-9, days-20)
det(dose-23, the-22)
nsubjpass(reduced-29, dose-23)
det(anticoagulant-26, the-25)
prep_of(dose-23, anticoagulant-26)
aux(reduced-29, should-27)
auxpass(reduced-29, be-28)
root(ROOT-0, reduced-29)
agent(reduced-29, one-third-31)
prep_to(one-third-31, one-half-33)
nn(times-37, prothrombin-36)
nsubjpass(monitored-40, times-37)
aux(monitored-40, should-38)
auxpass(monitored-40, be-39)
conj_and(reduced-29, monitored-40)
advmod(monitored-40, closely-41)

Some/DT drugs/NNS /substances/RB are/VBP known/VBN to/TO accelerate/VB the/DT metabolism/NN of/IN amiodarone/NN by/IN stimulating/VBG the/DT synthesis/NN of/IN CYP3A4/NN (/-LRB- enzyme/NN induction/NN )./NN

(ROOT (S1 (S (NP (DT Some) (NNS drugs)) (ADVP (RB /substances)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB accelerate) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN amiodarone)))) (PP (IN by) (S (VP (VBG stimulating) (NP (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NN CYP3A4)))) (-LRB- -LRB-) (NP (NN enzyme) (NN induction) (NN -RRB-.))))))))))))))

det(drugs-2, Some-1)
nsubjpass(known-5, drugs-2)
xsubj(accelerate-7, drugs-2)
advmod(known-5, /substances-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
aux(accelerate-7, to-6)
xcomp(known-5, accelerate-7)
det(metabolism-9, the-8)
dobj(accelerate-7, metabolism-9)
prep_of(metabolism-9, amiodarone-11)
prepc_by(accelerate-7, stimulating-13)
det(synthesis-15, the-14)
dobj(stimulating-13, synthesis-15)
iobj(stimulating-13, synthesis-15)
prep_of(synthesis-15, CYP3A4-17)
nn(-RRB-.-21, enzyme-19)
nn(-RRB-.-21, induction-20)
dep(synthesis-15, -RRB-.-21)

This/DT may/MD lead/VB to/TO low/JJ amiodarone/NN serum/NN levels/NNS and/CC potential/JJ decrease/NN in/IN efficacy/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (JJ low) (NN amiodarone) (NN serum) (NNS levels)) (CC and) (NP (NP (JJ potential) (NN decrease)) (PP (IN in) (NP (NN efficacy))))))))) (. .))))

nsubj(lead-3, This-1)
aux(lead-3, may-2)
root(ROOT-0, lead-3)
amod(levels-8, low-5)
nn(levels-8, amiodarone-6)
nn(levels-8, serum-7)
prep_to(lead-3, levels-8)
amod(decrease-11, potential-10)
conj_and(levels-8, decrease-11)
prep_in(decrease-11, efficacy-13)

Reported/VBN examples/NNS of/IN this/DT interaction/NN include/VBP the/DT following/NN :/: Antibiotics/NNS :/: Rifampin/NN is/VBZ a/DT potent/JJ inducer/NN of/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (VBN Reported) (NNS examples)) (PP (IN of) (NP (DT this) (NN interaction)))) (VP (VBP include) (NP (NP (DT the) (NN following)) (: :) (NP (NNS Antibiotics)) (: :) (NP (NP (NN Rifampin)) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN inducer)) (PP (IN of) (NP (NN CYP3A4))))))))) (. .))))

amod(examples-2, Reported-1)
nsubj(include-6, examples-2)
det(interaction-5, this-4)
prep_of(examples-2, interaction-5)
root(ROOT-0, include-6)
det(following-8, the-7)
dobj(include-6, following-8)
dep(following-8, Antibiotics-10)
dep(following-8, Rifampin-12)
cop(inducer-16, is-13)
det(inducer-16, a-14)
amod(inducer-16, potent-15)
dep(Rifampin-12, inducer-16)
prep_of(inducer-16, CYP3A4-18)

Administration/NN of/IN rifampin/NN concomitantly/RB with/IN oral/JJ amiodarone/NN has/VBZ been/VBN shown/VBN to/TO result/VB in/IN decreases/NNS in/IN serum/NN concentrations/NNS of/IN amiodarone/NN and/CC desethylamiodarone/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN rifampin))) (PP (ADVP (RB concomitantly)) (IN with) (NP (JJ oral) (NN amiodarone)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (NP (NNS decreases)) (PP (IN in) (NP (NP (NN serum) (NNS concentrations)) (PP (IN of) (NP (NP (NN amiodarone)) (CC and) (NP (NN desethylamiodarone))))))))))))))) (. .))))

nsubjpass(shown-10, Administration-1)
xsubj(result-12, Administration-1)
prep_of(Administration-1, rifampin-3)
advmod(Administration-1, concomitantly-4)
amod(amiodarone-7, oral-6)
prep_with(Administration-1, amiodarone-7)
aux(shown-10, has-8)
auxpass(shown-10, been-9)
root(ROOT-0, shown-10)
aux(result-12, to-11)
xcomp(shown-10, result-12)
prep_in(result-12, decreases-14)
nn(concentrations-17, serum-16)
prep_in(decreases-14, concentrations-17)
prep_of(concentrations-17, amiodarone-19)
conj_and(amiodarone-19, desethylamiodarone-21)

Other/JJ substances/NNS ,/, including/VBG herbal/NN preparations/NNS :/: St./NN John/NN @/NN s/NN Wort/NN (/-LRB- Hypericum/NN perforatum/NN )/-RRB- induces/VBZ CYP3A4/NN ./.

(ROOT (S1 (S (NP (NP (NP (JJ Other) (NNS substances)) (, ,) (PP (VBG including) (NP (NN herbal) (NNS preparations)))) (: :) (S (NP (NP (NN St.) (NN John) (NN @) (NN s) (NN Wort)) (PRN (-LRB- -LRB-) (NP (NN Hypericum) (NN perforatum)) (-RRB- -RRB-))) (VP (VBZ induces) (NP (NN CYP3A4)))) (. .)))))

amod(substances-2, Other-1)
root(ROOT-0, substances-2)
nn(preparations-6, herbal-5)
prep_including(substances-2, preparations-6)
nn(Wort-12, St.-8)
nn(Wort-12, John-9)
nn(Wort-12, @-10)
nn(Wort-12, s-11)
nsubj(induces-17, Wort-12)
nn(perforatum-15, Hypericum-14)
appos(Wort-12, perforatum-15)
dep(substances-2, induces-17)
dobj(induces-17, CYP3A4-18)

Since/IN amiodarone/NN is/VBZ a/DT substrate/NN for/IN CYP3A4/NN ,/, there/EX is/VBZ the/DT potential/NN that/IN the/DT use/NN of/IN St./NN John/NN @/NN s/NN Wort/NN in/IN patients/NNS receiving/VBG amiodarone/NN could/MD result/VB in/IN reduced/VBN amiodarone/NN levels/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN amiodarone)) (VP (VBZ is) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN CYP3A4))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (DT the) (NN potential) (SBAR (IN that) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN St.) (NN John) (NN @) (NN s) (NN Wort))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN amiodarone)))))) (VP (MD could) (VP (VB result) (PP (IN in) (NP (VBN reduced) (NN amiodarone) (NNS levels)))))))))) (. .))))

mark(substrate-5, Since-1)
nsubj(substrate-5, amiodarone-2)
cop(substrate-5, is-3)
det(substrate-5, a-4)
advcl(is-10, substrate-5)
prep_for(substrate-5, CYP3A4-7)
expl(is-10, there-9)
root(ROOT-0, is-10)
det(potential-12, the-11)
nsubj(is-10, potential-12)
complm(result-27, that-13)
det(use-15, the-14)
nsubj(result-27, use-15)
nn(Wort-21, St.-17)
nn(Wort-21, John-18)
nn(Wort-21, @-19)
nn(Wort-21, s-20)
prep_of(use-15, Wort-21)
prep_in(use-15, patients-23)
partmod(patients-23, receiving-24)
dobj(receiving-24, amiodarone-25)
aux(result-27, could-26)
ccomp(potential-12, result-27)
amod(levels-31, reduced-29)
nn(levels-31, amiodarone-30)
prep_in(result-27, levels-31)

Other/JJ reported/VBN interactions/NNS with/IN amiodarone/NN :/: Fentanyl/NN (/-LRB- CYP3A4/NN substrate/NN )/-RRB- in/IN combination/NN with/IN amiodarone/NN may/MD cause/VB hypotension/NN ,/, bradycardia/NN ,/, and/CC decreased/VBN cardiac/JJ output/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Other) (VBN reported) (NNS interactions)) (PP (IN with) (NP (NN amiodarone)))) (: :) (NP (NP (NP (NN Fentanyl)) (PRN (-LRB- -LRB-) (NP (NN CYP3A4) (NN substrate)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN amiodarone))))))) (VP (MD may) (VP (VB cause) (NP (NP (NN hypotension)) (, ,) (NP (NN bradycardia)) (, ,) (CC and) (NP (VBN decreased) (JJ cardiac) (NN output)))))) (. .))))

amod(interactions-3, Other-1)
amod(interactions-3, reported-2)
nsubj(cause-17, interactions-3)
prep_with(interactions-3, amiodarone-5)
dep(interactions-3, Fentanyl-7)
nn(substrate-10, CYP3A4-9)
abbrev(Fentanyl-7, substrate-10)
prep_in(Fentanyl-7, combination-13)
prep_with(combination-13, amiodarone-15)
aux(cause-17, may-16)
root(ROOT-0, cause-17)
dobj(cause-17, hypotension-18)
conj_and(hypotension-18, bradycardia-20)
amod(output-25, decreased-23)
amod(output-25, cardiac-24)
conj_and(hypotension-18, output-25)

Sinus/NN bradycardia/NN has/VBZ been/VBN reported/VBN with/IN oral/JJ amiodarone/NN in/IN combination/NN with/IN lidocaine/NN (/-LRB- CYP3A4/NN substrate/NN )/-RRB- given/VBN for/IN local/JJ anesthesia/NN ./.

(ROOT (S1 (S (S (NP (NN Sinus) (NN bradycardia)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (JJ oral) (NN amiodarone)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NP (NN lidocaine)) (PRN (-LRB- -LRB-) (NP (NN CYP3A4) (NN substrate)) (-RRB- -RRB-))) (VP (VBN given) (PP (IN for) (NP (JJ local) (NN anesthesia)))))))))))))) (. .))))

nn(bradycardia-2, Sinus-1)
nsubjpass(reported-5, bradycardia-2)
aux(reported-5, has-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
amod(amiodarone-8, oral-7)
prep_with(reported-5, amiodarone-8)
prep_in(amiodarone-8, combination-10)
prep_with(combination-10, lidocaine-12)
nn(substrate-15, CYP3A4-14)
abbrev(lidocaine-12, substrate-15)
partmod(lidocaine-12, given-17)
amod(anesthesia-20, local-19)
prep_for(given-17, anesthesia-20)

Seizure/NN ,/, associated/VBN with/IN increased/VBN lidocaine/NN concentrations/NNS ,/, has/VBZ been/VBN reported/VBN with/IN concomitant/JJ administration/NN of/IN intravenous/JJ amiodarone/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Seizure)) (, ,) (VP (VBN associated) (PP (IN with) (NP (VBN increased) (NN lidocaine) (NNS concentrations)))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (JJ intravenous) (NN amiodarone))))))))) (. .))))

nsubjpass(reported-11, Seizure-1)
partmod(Seizure-1, associated-3)
amod(concentrations-7, increased-5)
nn(concentrations-7, lidocaine-6)
prep_with(associated-3, concentrations-7)
aux(reported-11, has-9)
auxpass(reported-11, been-10)
root(ROOT-0, reported-11)
amod(administration-14, concomitant-13)
prep_with(reported-11, administration-14)
amod(amiodarone-17, intravenous-16)
prep_of(administration-14, amiodarone-17)

Dextromethorphan/NN is/VBZ a/DT substrate/NN for/IN both/CC CYP2D6/NN and/CC CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Dextromethorphan)) (VP (VBZ is) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (CC both) (NP (NN CYP2D6)) (CC and) (NP (NN CYP3A4))))))) (. .))))

nsubj(substrate-4, Dextromethorphan-1)
cop(substrate-4, is-2)
det(substrate-4, a-3)
root(ROOT-0, substrate-4)
preconj(CYP2D6-7, both-6)
prep_for(substrate-4, CYP2D6-7)
conj_and(CYP2D6-7, CYP3A4-9)

Amiodarone/NN inhibits/VBZ CYP2D6/NN ./.

(ROOT (S1 (S (S (NP (NN Amiodarone)) (VP (VBZ inhibits) (NP (NN CYP2D6)))) (. .))))

nsubj(inhibits-2, Amiodarone-1)
root(ROOT-0, inhibits-2)
dobj(inhibits-2, CYP2D6-3)

Cholestyramine/NN increases/VBZ enterohepatic/JJ elimination/NN of/IN amiodarone/NN and/CC may/MD reduce/VB its/PRP$ serum/NN levels/NNS and/CC t1/NN /2/CD ./.

(ROOT (S1 (S (S (NP (NN Cholestyramine)) (VP (VP (VBZ increases) (NP (NP (JJ enterohepatic) (NN elimination)) (PP (IN of) (NP (NN amiodarone))))) (CC and) (VP (MD may) (VP (VB reduce) (NP (NP (PRP$ its) (NN serum) (NNS levels)) (CC and) (NP (NN t1) (CD /2))))))) (. .))))

nsubj(increases-2, Cholestyramine-1)
root(ROOT-0, increases-2)
amod(elimination-4, enterohepatic-3)
dobj(increases-2, elimination-4)
prep_of(elimination-4, amiodarone-6)
aux(reduce-9, may-8)
conj_and(increases-2, reduce-9)
poss(levels-12, its-10)
nn(levels-12, serum-11)
dobj(reduce-9, levels-12)
conj_and(levels-12, t1-14)
num(t1-14, /2-15)

Disopyramide/NN increases/VBZ QT/NN prolongation/NN which/WDT could/MD cause/VB arrhythmia/NN ./.

(ROOT (S1 (S (S (NP (NN Disopyramide)) (VP (VBZ increases) (NP (NP (NN QT) (NN prolongation)) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB cause) (NP (NN arrhythmia))))))))) (. .))))

nsubj(increases-2, Disopyramide-1)
root(ROOT-0, increases-2)
nn(prolongation-4, QT-3)
dobj(increases-2, prolongation-4)
nsubj(cause-7, prolongation-4)
aux(cause-7, could-6)
rcmod(prolongation-4, cause-7)
dobj(cause-7, arrhythmia-8)

Fluoroquinolones/NNS ,/, macrolide/NN antibiotics/NNS ,/, and/CC azoles/NNS are/VBP known/VBN to/TO cause/VB QTc/NN prolongation/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Fluoroquinolones)) (, ,) (NP (NN macrolide) (NNS antibiotics)) (, ,) (CC and) (NP (NNS azoles))) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB cause) (NP (NN QTc) (NN prolongation)))))))) (. .))))

nsubjpass(known-9, Fluoroquinolones-1)
xsubj(cause-11, Fluoroquinolones-1)
nn(antibiotics-4, macrolide-3)
conj_and(Fluoroquinolones-1, antibiotics-4)
conj_and(Fluoroquinolones-1, azoles-7)
auxpass(known-9, are-8)
root(ROOT-0, known-9)
aux(cause-11, to-10)
xcomp(known-9, cause-11)
nn(prolongation-13, QTc-12)
dobj(cause-11, prolongation-13)

There/EX have/VBP been/VBN reports/NNS of/IN QTc/NN prolongation/NN ,/, with/IN or/CC without/IN TdP/NN ,/, in/IN patients/NNS taking/VBG amiodarone/NN when/WRB fluoroquinolones/NNS ,/, macrolide/NN antibiotics/NNS ,/, or/CC azoles/NNS were/VBD administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (NN QTc) (NN prolongation)))) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN TdP)))) (, ,) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN amiodarone)))))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NNS fluoroquinolones)) (, ,) (NP (NN macrolide) (NNS antibiotics)) (, ,) (CC or) (NP (NNS azoles))) (VP (VBD were) (VP (VBN administered) (ADVP (RB concomitantly)))))))) (. .))))

expl(reports-4, There-1)
aux(reports-4, have-2)
cop(reports-4, been-3)
root(ROOT-0, reports-4)
nn(prolongation-7, QTc-6)
prep_of(reports-4, prolongation-7)
prep(reports-4, with-9)
conj_or(with-9, without-11)
pobj(without-11, TdP-12)
prep_in(reports-4, patients-15)
partmod(patients-15, taking-16)
dobj(taking-16, amiodarone-17)
advmod(administered-27, when-18)
nsubjpass(administered-27, fluoroquinolones-19)
nn(antibiotics-22, macrolide-21)
conj_or(fluoroquinolones-19, antibiotics-22)
conj_or(fluoroquinolones-19, azoles-25)
auxpass(administered-27, were-26)
advcl(reports-4, administered-27)
advmod(administered-27, concomitantly-28)

Hemodynamic/JJ and/CC electrophysiologic/JJ interactions/NNS have/VBP also/RB been/VBN observed/VBN after/IN concomitant/JJ administration/NN with/IN propranolol/NN ,/, diltiazem/NN ,/, and/CC verapamil/NN ./.

(ROOT (S1 (S (S (NP (ADJP (ADJP (JJ Hemodynamic)) (CC and) (ADJP (JJ electrophysiologic))) (NNS interactions)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN observed) (PP (IN after) (NP (NP (JJ concomitant) (NN administration)) (PP (IN with) (NP (NP (NN propranolol)) (, ,) (NP (NN diltiazem)) (, ,) (CC and) (NP (NN verapamil)))))))))) (. .))))

amod(interactions-4, Hemodynamic-1)
conj_and(Hemodynamic-1, electrophysiologic-3)
nsubjpass(observed-8, interactions-4)
aux(observed-8, have-5)
advmod(observed-8, also-6)
auxpass(observed-8, been-7)
root(ROOT-0, observed-8)
amod(administration-11, concomitant-10)
prep_after(observed-8, administration-11)
prep_with(administration-11, propranolol-13)
conj_and(propranolol-13, diltiazem-15)
conj_and(propranolol-13, verapamil-18)

Volatile/JJ Anesthetic/JJ Agents/NNS :/: ./.

(ROOT (S1 (S (NP (NP (NP (JJ Volatile) (JJ Anesthetic) (NNS Agents)) (: :)) (. .)))))

amod(Agents-3, Volatile-1)
amod(Agents-3, Anesthetic-2)
root(ROOT-0, Agents-3)

In/IN addition/NN to/TO the/DT interactions/NNS noted/VBN above/RB ,/, chronic/JJ (/-LRB- 2/CD weeks/NNS )/-RRB- oral/JJ Cordarone/NN administration/NN impairs/VBZ metabolism/NN of/IN phenytoin/NN ,/, dextromethorphan/NN ,/, and/CC methotrexate/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NN addition) (TO to) (NP (NP (DT the) (NNS interactions)) (VP (VBN noted) (ADVP (RB above))))) (, ,) (NP (JJ chronic) (PRN (-LRB- -LRB-) (NP (CD 2) (NNS weeks)) (-RRB- -RRB-)) (JJ oral) (NN Cordarone) (NN administration)) (VP (VBZ impairs) (NP (NP (NN metabolism)) (PP (IN of) (NP (NP (NN phenytoin)) (, ,) (NP (NN dextromethorphan)) (, ,) (CC and) (NP (NN methotrexate))))))) (. .))))

det(interactions-5, the-4)
prep_in_addition_to(impairs-17, interactions-5)
partmod(interactions-5, noted-6)
advmod(noted-6, above-7)
amod(administration-16, chronic-9)
num(weeks-12, 2-11)
appos(administration-16, weeks-12)
amod(administration-16, oral-14)
nn(administration-16, Cordarone-15)
nsubj(impairs-17, administration-16)
root(ROOT-0, impairs-17)
dobj(impairs-17, metabolism-18)
prep_of(metabolism-18, phenytoin-20)
conj_and(phenytoin-20, dextromethorphan-22)
conj_and(phenytoin-20, methotrexate-25)

Electrolyte/NN Disturbances/NNS Patients/NNS with/IN hypokalemia/NN or/CC hypomagnesemia/NN should/MD have/VB the/DT condition/NN corrected/VBN whenever/NN possible/JJ before/IN being/VBG treated/VBN with/IN Cordarone/NN I.V./NN ,/, as/IN these/DT disorders/NNS can/MD exaggerate/VB the/DT degree/NN of/IN QTc/NN prolongation/NN and/CC increase/VB the/DT potential/NN for/IN TdP/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Electrolyte) (NNS Disturbances)) (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NN hypokalemia)) (CC or) (NP (NN hypomagnesemia)))))) (VP (MD should) (VP (VB have) (NP (NP (DT the) (NN condition)) (VP (VBN corrected) (S (ADJP (NN whenever) (JJ possible) (PP (IN before) (S (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN Cordarone) (NN I.V.))))))))))) (, ,) (SBAR (IN as) (S (NP (DT these) (NNS disorders)) (VP (MD can) (VP (VP (VB exaggerate) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NN QTc) (NN prolongation))))) (CC and) (VP (VB increase) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NN TdP)))))))))))) (. .))))

nn(Disturbances-2, Electrolyte-1)
nsubj(have-9, Disturbances-2)
dep(Disturbances-2, Patients-3)
prep_with(Patients-3, hypokalemia-5)
conj_or(hypokalemia-5, hypomagnesemia-7)
aux(have-9, should-8)
root(ROOT-0, have-9)
det(condition-11, the-10)
dobj(have-9, condition-11)
partmod(condition-11, corrected-12)
dep(possible-14, whenever-13)
acomp(corrected-12, possible-14)
auxpass(treated-17, being-16)
prepc_before(possible-14, treated-17)
nn(I.V.-20, Cordarone-19)
prep_with(treated-17, I.V.-20)
mark(exaggerate-26, as-22)
det(disorders-24, these-23)
nsubj(exaggerate-26, disorders-24)
aux(exaggerate-26, can-25)
advcl(have-9, exaggerate-26)
det(degree-28, the-27)
dobj(exaggerate-26, degree-28)
nn(prolongation-31, QTc-30)
prep_of(degree-28, prolongation-31)
conj_and(exaggerate-26, increase-33)
det(potential-35, the-34)
dobj(increase-33, potential-35)
prep_for(potential-35, TdP-37)

Special/JJ attention/NN should/MD be/VB given/VBN to/TO electrolyte/NN and/CC acid-base/NN balance/NN in/IN patients/NNS experiencing/VBG severe/JJ or/CC prolonged/JJ diarrhea/NN or/CC in/IN patients/NNS receiving/VBG concomitant/JJ diuretics/NNS ./.

(ROOT (S1 (S (S (NP (JJ Special) (NN attention)) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (NP (NN electrolyte)) (CC and) (NP (NN acid-base) (NN balance))) (PP (PP (IN in) (NP (NP (NNS patients)) (VP (VBG experiencing) (NP (ADJP (ADJP (JJ severe)) (CC or) (ADJP (JJ prolonged))) (NN diarrhea))))) (CC or) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NNS diuretics)))))))))))) (. .))))

amod(attention-2, Special-1)
nsubjpass(given-5, attention-2)
aux(given-5, should-3)
auxpass(given-5, be-4)
root(ROOT-0, given-5)
prep_to(given-5, electrolyte-7)
nn(balance-10, acid-base-9)
conj_and(electrolyte-7, balance-10)
prep_in(electrolyte-7, patients-12)
partmod(patients-12, experiencing-13)
amod(diarrhea-17, severe-14)
conj_or(severe-14, prolonged-16)
dobj(experiencing-13, diarrhea-17)
conj_or(patients-12, patients-20)
partmod(patients-20, receiving-21)
amod(diuretics-23, concomitant-22)
dobj(receiving-21, diuretics-23)

In/FW vitro/FW data/NNS indicate/VBP that/IN NORVASC/NN has/VBZ no/DT effect/NN on/IN the/DT human/JJ plasma/NN protein/NN binding/NN of/IN digoxin/NN ,/, phenytoin/NN ,/, warfarin/NN ,/, and/CC indomethacin/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN NORVASC)) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ human) (NN plasma) (NN protein) (NN binding)) (PP (IN of) (NP (NP (NN digoxin)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN warfarin)) (, ,) (CC and) (NP (NN indomethacin))))))))))) (. .))))

nn(vitro-2, In-1)
amod(data-3, vitro-2)
nsubj(indicate-4, data-3)
root(ROOT-0, indicate-4)
complm(has-7, that-5)
nsubj(has-7, NORVASC-6)
ccomp(indicate-4, has-7)
det(effect-9, no-8)
dobj(has-7, effect-9)
det(binding-15, the-11)
amod(binding-15, human-12)
nn(binding-15, plasma-13)
nn(binding-15, protein-14)
prep_on(has-7, binding-15)
prep_of(binding-15, digoxin-17)
conj_and(digoxin-17, phenytoin-19)
conj_and(digoxin-17, warfarin-21)
conj_and(digoxin-17, indomethacin-24)

Effect/NN of/IN other/JJ agents/NNS on/IN NORVASC/NN ./.

(ROOT (S1 (S (NP (NP (NN Effect)) (PP (IN of) (NP (JJ other) (NNS agents))) (PP (IN on) (NP (NN NORVASC))) (. .)))))

root(ROOT-0, Effect-1)
amod(agents-4, other-3)
prep_of(Effect-1, agents-4)
prep_on(Effect-1, NORVASC-6)

CIMETIDINE/NN :/: Co-administration/NN of/IN NORVASC/NN with/IN cimetidine/NN did/VBD not/RB alter/VB the/DT pharmacokinetics/NNS of/IN NORVASC/NN ./.

(ROOT (S1 (S (S (NP (NP (NN CIMETIDINE) (: :) (NN Co-administration)) (PP (IN of) (NP (NN NORVASC))) (PP (IN with) (NP (NN cimetidine)))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN NORVASC))))))) (. .))))

nn(Co-administration-3, CIMETIDINE-1)
nsubj(alter-10, Co-administration-3)
prep_of(Co-administration-3, NORVASC-5)
prep_with(Co-administration-3, cimetidine-7)
aux(alter-10, did-8)
neg(alter-10, not-9)
root(ROOT-0, alter-10)
det(pharmacokinetics-12, the-11)
dobj(alter-10, pharmacokinetics-12)
prep_of(pharmacokinetics-12, NORVASC-14)

GRAPEFRUIT/NN JUICE/NN :/: Co-administration/NN of/IN 240/CD mL/NN of/IN grapefruit/NN juice/NN with/IN a/DT single/JJ oral/JJ dose/NN of/IN amlodipine/NN 10/CD mg/NN in/IN 20/CD healthy/JJ volunteers/NNS had/VBD no/DT significant/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN amlodipine/NN ./.

(ROOT (S1 (S (NP (NP (NN GRAPEFRUIT) (NN JUICE)) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (CD 240) (NN mL)) (PP (IN of) (NP (NN grapefruit) (NN juice))))) (PP (IN with) (NP (NP (DT a) (JJ single) (JJ oral) (NN dose)) (PP (IN of) (NP (NP (NN amlodipine) (CD 10) (NN mg)) (PP (IN in) (NP (CD 20) (JJ healthy) (NNS volunteers)))))))) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN amlodipine))))))) (. .)))))

nn(JUICE-2, GRAPEFRUIT-1)
root(ROOT-0, JUICE-2)
nsubj(had-24, Co-administration-4)
num(mL-7, 240-6)
prep_of(Co-administration-4, mL-7)
nn(juice-10, grapefruit-9)
prep_of(mL-7, juice-10)
det(dose-15, a-12)
amod(dose-15, single-13)
amod(dose-15, oral-14)
prep_with(Co-administration-4, dose-15)
nn(mg-19, amlodipine-17)
num(mg-19, 10-18)
prep_of(dose-15, mg-19)
num(volunteers-23, 20-21)
amod(volunteers-23, healthy-22)
prep_in(mg-19, volunteers-23)
dep(JUICE-2, had-24)
det(effect-27, no-25)
amod(effect-27, significant-26)
dobj(had-24, effect-27)
det(pharmacokinetics-30, the-29)
prep_on(had-24, pharmacokinetics-30)
prep_of(pharmacokinetics-30, amlodipine-32)

MAALOX/NN (/-LRB- antacid/JJ )/-RRB- :/: Co-administration/NN of/IN the/DT antacid/JJ Maalox/NN with/IN a/DT single/JJ dose/NN of/IN NORVASC/NN had/VBD no/DT significant/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN NORVASC/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN MAALOX)) (PRN (-LRB- -LRB-) (NP (JJ antacid)) (-RRB- -RRB-))) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (DT the) (JJ antacid) (NN Maalox))) (PP (IN with) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NN NORVASC)))))) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN NORVASC))))))) (. .)))))

root(ROOT-0, MAALOX-1)
dep(MAALOX-1, antacid-3)
nsubj(had-17, Co-administration-6)
det(Maalox-10, the-8)
amod(Maalox-10, antacid-9)
prep_of(Co-administration-6, Maalox-10)
det(dose-14, a-12)
amod(dose-14, single-13)
prep_with(Co-administration-6, dose-14)
prep_of(dose-14, NORVASC-16)
dep(MAALOX-1, had-17)
det(effect-20, no-18)
amod(effect-20, significant-19)
dobj(had-17, effect-20)
det(pharmacokinetics-23, the-22)
prep_on(had-17, pharmacokinetics-23)
prep_of(pharmacokinetics-23, NORVASC-25)

SILDENAFIL/NN :/: A/DT single/JJ 100/CD mg/NN dose/NN of/IN sildenafil/NN (/-LRB- Viagra/NN @/NN )/-RRB- in/IN subjects/NNS with/IN essential/JJ hypertension/NN had/VBD no/DT effect/NN on/IN the/DT pharmacokinetic/JJ parameters/NNS of/IN NORVASC/NN ./.

(ROOT (S1 (S (NP (NP (NN SILDENAFIL)) (: :) (S (NP (NP (NP (NP (DT A) (JJ single) (ADJP (CD 100) (NN mg)) (NN dose)) (PP (IN of) (NP (NN sildenafil)))) (PRN (-LRB- -LRB-) (NP (NN Viagra) (NN @)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS subjects)) (PP (IN with) (NP (JJ essential) (NN hypertension)))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ pharmacokinetic) (NNS parameters)) (PP (IN of) (NP (NN NORVASC))))))) (. .)))))

root(ROOT-0, SILDENAFIL-1)
det(dose-7, A-3)
amod(dose-7, single-4)
number(mg-6, 100-5)
amod(dose-7, mg-6)
nsubj(had-19, dose-7)
prep_of(dose-7, sildenafil-9)
nn(@-12, Viagra-11)
appos(dose-7, @-12)
prep_in(dose-7, subjects-15)
amod(hypertension-18, essential-17)
prep_with(subjects-15, hypertension-18)
dep(SILDENAFIL-1, had-19)
det(effect-21, no-20)
dobj(had-19, effect-21)
det(parameters-25, the-23)
amod(parameters-25, pharmacokinetic-24)
prep_on(had-19, parameters-25)
prep_of(parameters-25, NORVASC-27)

When/WRB NORVASC/NN and/CC sildenafil/NN were/VBD used/VBN in/IN combination/NN ,/, each/DT agent/NN independently/RB exerted/VBD its/PRP$ own/JJ blood/NN pressure/NN lowering/JJ effect/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN NORVASC)) (CC and) (NP (NN sildenafil))) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (NN combination))))))) (, ,) (NP (DT each) (NN agent)) (ADVP (RB independently)) (VP (VBD exerted) (NP (PRP$ its) (JJ own) (NN blood) (NN pressure) (JJ lowering) (NN effect)))) (. .))))

advmod(used-6, When-1)
nsubjpass(used-6, NORVASC-2)
conj_and(NORVASC-2, sildenafil-4)
auxpass(used-6, were-5)
advcl(exerted-13, used-6)
prep_in(used-6, combination-8)
det(agent-11, each-10)
nsubj(exerted-13, agent-11)
advmod(exerted-13, independently-12)
root(ROOT-0, exerted-13)
poss(effect-19, its-14)
amod(effect-19, own-15)
nn(effect-19, blood-16)
nn(effect-19, pressure-17)
amod(effect-19, lowering-18)
dobj(exerted-13, effect-19)

Effect/NN of/IN NORVASC/NN on/IN other/JJ agents/NNS ./.

(ROOT (S1 (S (NP (NP (NN Effect)) (PP (IN of) (NP (NN NORVASC))) (PP (IN on) (NP (JJ other) (NNS agents))) (. .)))))

root(ROOT-0, Effect-1)
prep_of(Effect-1, NORVASC-3)
amod(agents-6, other-5)
prep_on(Effect-1, agents-6)

ATORVASTATIN/NN :/: Co-administration/NN of/IN multiple/JJ 10/CD mg/NN doses/NNS of/IN NORVASC/NN with/IN 80/CD mg/NN of/IN atorvastatin/NN resulted/VBD in/IN no/DT significant/JJ change/NN in/IN the/DT steady/JJ state/NN pharmacokinetic/JJ parameters/NNS of/IN atorvastatin/NN ./.

(ROOT (S1 (S (NP (NP (NN ATORVASTATIN)) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (JJ multiple) (CD 10) (NN mg) (NNS doses)) (PP (IN of) (NP (NN NORVASC))))) (PP (IN with) (NP (NP (CD 80) (NN mg)) (PP (IN of) (NP (NN atorvastatin)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT no) (JJ significant) (NN change)) (PP (IN in) (NP (NP (DT the) (JJ steady) (NN state) (JJ pharmacokinetic) (NNS parameters)) (PP (IN of) (NP (NN atorvastatin))))))))) (. .)))))

root(ROOT-0, ATORVASTATIN-1)
nsubj(resulted-16, Co-administration-3)
amod(doses-8, multiple-5)
num(doses-8, 10-6)
nn(doses-8, mg-7)
prep_of(Co-administration-3, doses-8)
prep_of(doses-8, NORVASC-10)
num(mg-13, 80-12)
prep_with(Co-administration-3, mg-13)
prep_of(mg-13, atorvastatin-15)
dep(ATORVASTATIN-1, resulted-16)
det(change-20, no-18)
amod(change-20, significant-19)
prep_in(resulted-16, change-20)
det(parameters-26, the-22)
amod(parameters-26, steady-23)
nn(parameters-26, state-24)
amod(parameters-26, pharmacokinetic-25)
prep_in(change-20, parameters-26)
prep_of(parameters-26, atorvastatin-28)

DIGOXIN/NN :/: Co-administration/NN of/IN NORVASC/NN with/IN digoxin/NN did/VBD not/RB change/VB serum/NN digoxin/NN levels/NNS or/CC digoxin/NN renal/JJ clearance/NN in/IN normal/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN DIGOXIN) (: :) (NN Co-administration)) (PP (IN of) (NP (NN NORVASC))) (PP (IN with) (NP (NN digoxin)))) (VP (VBD did) (RB not) (VP (VB change) (NP (NP (NP (NN serum) (NN digoxin) (NNS levels)) (CC or) (NP (NN digoxin) (JJ renal) (NN clearance))) (PP (IN in) (NP (JJ normal) (NNS volunteers))))))) (. .))))

nn(Co-administration-3, DIGOXIN-1)
nsubj(change-10, Co-administration-3)
prep_of(Co-administration-3, NORVASC-5)
prep_with(Co-administration-3, digoxin-7)
aux(change-10, did-8)
neg(change-10, not-9)
root(ROOT-0, change-10)
nn(levels-13, serum-11)
nn(levels-13, digoxin-12)
dobj(change-10, levels-13)
nn(clearance-17, digoxin-15)
amod(clearance-17, renal-16)
conj_or(levels-13, clearance-17)
amod(volunteers-20, normal-19)
prep_in(levels-13, volunteers-20)

ETHANOL/NN (/-LRB- alcohol/NN )/-RRB- :/: Single/JJ and/CC multiple/JJ 10/CD mg/NN doses/NNS of/IN NORVASC/NN had/VBD no/DT significant/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN ethanol/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (ADJP (NN ETHANOL) (-LRB- -LRB-) (NN alcohol) (-RRB- -RRB-) (: :) (ADJP (JJ Single)) (CC and) (ADJP (JJ multiple))) (ADJP (CD 10) (NN mg))) (NNS doses)) (PP (IN of) (NP (NN NORVASC)))) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN ethanol))))))) (. .))))

dep(alcohol-3, ETHANOL-1)
amod(doses-11, alcohol-3)
conj_and(alcohol-3, Single-6)
conj_and(alcohol-3, multiple-8)
number(mg-10, 10-9)
dep(alcohol-3, mg-10)
nsubj(had-14, doses-11)
prep_of(doses-11, NORVASC-13)
root(ROOT-0, had-14)
det(effect-17, no-15)
amod(effect-17, significant-16)
dobj(had-14, effect-17)
det(pharmacokinetics-20, the-19)
prep_on(had-14, pharmacokinetics-20)
prep_of(pharmacokinetics-20, ethanol-22)

WARFARIN/NN :/: Co-administration/NN of/IN NORVASC/NN with/IN warfarin/NN did/VBD not/RB change/VB the/DT warfarin/NN prothrombin/NN response/NN time/NN ./.

(ROOT (S1 (S (S (NP (NN WARFARIN)) (: :) (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN NORVASC))) (PP (IN with) (NP (NN warfarin)))) (VP (VBD did) (RB not) (VP (VB change) (NP (DT the) (NN warfarin) (NN prothrombin) (NN response) (NN time))))) (. .))))

nsubj(change-10, WARFARIN-1)
nsubj(change-10, Co-administration-3)
prep_of(Co-administration-3, NORVASC-5)
prep_with(Co-administration-3, warfarin-7)
aux(change-10, did-8)
neg(change-10, not-9)
root(ROOT-0, change-10)
det(time-15, the-11)
nn(time-15, warfarin-12)
nn(time-15, prothrombin-13)
nn(time-15, response-14)
dobj(change-10, time-15)

In/IN clinical/JJ trials/NNS ,/, NORVASC/NN has/VBZ been/VBN safely/RB administered/VBN with/IN thiazide/NN diuretics/NNS ,/, beta-blockers/NNS ,/, angiotensin-converting/JJ enzyme/NN inhibitors/NNS ,/, long-acting/JJ nitrates/NNS ,/, sublingual/JJ nitroglycerin/NN ,/, digoxin/NN ,/, warfarin/NN ,/, non-steroidal/JJ anti-inflammatory/JJ drugs/NNS ,/, antibiotics/NNS ,/, and/CC oral/JJ hypoglycemic/JJ drugs/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NN NORVASC)) (VP (VBZ has) (VP (VBN been) (ADVP (RB safely)) (VP (VBN administered) (PP (IN with) (NP (NP (NN thiazide) (NNS diuretics)) (, ,) (NP (NNS beta-blockers)) (, ,) (NP (JJ angiotensin-converting) (NN enzyme) (NNS inhibitors)) (, ,) (NP (JJ long-acting) (NNS nitrates)) (, ,) (NP (JJ sublingual) (NN nitroglycerin)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN warfarin)) (, ,) (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (, ,) (NP (NNS antibiotics)) (, ,) (CC and) (NP (JJ oral) (JJ hypoglycemic) (NNS drugs))))))) (. .))))

amod(trials-3, clinical-2)
prep_in(administered-9, trials-3)
nsubjpass(administered-9, NORVASC-5)
aux(administered-9, has-6)
auxpass(administered-9, been-7)
advmod(administered-9, safely-8)
root(ROOT-0, administered-9)
nn(diuretics-12, thiazide-11)
prep_with(administered-9, diuretics-12)
conj_and(diuretics-12, beta-blockers-14)
amod(inhibitors-18, angiotensin-converting-16)
nn(inhibitors-18, enzyme-17)
conj_and(diuretics-12, inhibitors-18)
amod(nitrates-21, long-acting-20)
conj_and(diuretics-12, nitrates-21)
amod(nitroglycerin-24, sublingual-23)
conj_and(diuretics-12, nitroglycerin-24)
conj_and(diuretics-12, digoxin-26)
conj_and(diuretics-12, warfarin-28)
amod(drugs-32, non-steroidal-30)
amod(drugs-32, anti-inflammatory-31)
conj_and(diuretics-12, drugs-32)
conj_and(diuretics-12, antibiotics-34)
amod(drugs-39, oral-37)
amod(drugs-39, hypoglycemic-38)
conj_and(diuretics-12, drugs-39)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: None/NN known/VBN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NN None)) (VP (VBN known))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
nsubj(known-7, None-6)
dep(Interactions-4, known-7)

Probenecid/NN decreases/VBZ the/DT renal/JJ tubular/JJ secretion/NN of/IN amoxicillin/NN ./.

(ROOT (S1 (S (S (NP (NN Probenecid)) (VP (VBZ decreases) (NP (NP (DT the) (JJ renal) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NN amoxicillin)))))) (. .))))

nsubj(decreases-2, Probenecid-1)
root(ROOT-0, decreases-2)
det(secretion-6, the-3)
amod(secretion-6, renal-4)
amod(secretion-6, tubular-5)
dobj(decreases-2, secretion-6)
prep_of(secretion-6, amoxicillin-8)

Concurrent/JJ use/NN of/IN amoxicillin/NN and/CC probenecid/NN may/MD result/VB in/IN increased/VBN and/CC prolonged/JJ blood/NN levels/NNS of/IN amoxicillin/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NP (NN amoxicillin)) (CC and) (NP (NN probenecid))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (ADJP (ADJP (VBN increased)) (CC and) (ADJP (JJ prolonged))) (NN blood) (NNS levels)) (PP (IN of) (NP (NN amoxicillin)))))))) (. .))))

amod(use-2, Concurrent-1)
nsubj(result-8, use-2)
prep_of(use-2, amoxicillin-4)
conj_and(amoxicillin-4, probenecid-6)
aux(result-8, may-7)
root(ROOT-0, result-8)
amod(levels-14, increased-10)
conj_and(increased-10, prolonged-12)
nn(levels-14, blood-13)
prep_in(result-8, levels-14)
prep_of(levels-14, amoxicillin-16)

Chloramphenicol/NN ,/, macrolides/NN ,/, sulfonamides/NNS ,/, and/CC tetracy-clines/NNS may/MD interfere/VB with/IN the/DT bactericidal/JJ effects/NNS of/IN penicillin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Chloramphenicol)) (, ,) (NP (NN macrolides)) (, ,) (NP (NNS sulfonamides)) (, ,) (CC and) (NP (NNS tetracy-clines))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (JJ bactericidal) (NNS effects)) (PP (IN of) (NP (NN penicillin)))))))) (. .))))

nsubj(interfere-10, Chloramphenicol-1)
conj_and(Chloramphenicol-1, macrolides-3)
conj_and(Chloramphenicol-1, sulfonamides-5)
conj_and(Chloramphenicol-1, tetracy-clines-8)
aux(interfere-10, may-9)
root(ROOT-0, interfere-10)
det(effects-14, the-12)
amod(effects-14, bactericidal-13)
prep_with(interfere-10, effects-14)
prep_of(effects-14, penicillin-16)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: High/JJ urine/NN concentrations/NNS of/IN ampicillin/NN may/MD result/VB in/IN false-positive/JJ reactions/NNS when/WRB testing/VBG for/IN the/DT presence/NN of/IN glucose/NN in/IN urine/NN using/VBG CLINITEST/NN @/NN ,/, Benedict/NN @/NN s/NN Solution/NN ,/, or/CC Fehling/NN @/NN s/NN Solution/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (JJ High) (NN urine) (NNS concentrations)) (PP (IN of) (NP (NN ampicillin)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (JJ false-positive) (NNS reactions))) (SBAR (WHADVP (WRB when)) (S (VP (VBG testing) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN glucose))))) (PP (IN in) (NP (NP (NN urine)) (VP (VBG using) (NP (NP (NN CLINITEST) (NN @)) (, ,) (NP (NN Benedict) (NN @) (NN s) (NN Solution)) (, ,) (CC or) (NP (NN Fehling) (NN @) (NN s) (NN Solution)))))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
amod(concentrations-8, High-6)
nn(concentrations-8, urine-7)
nsubj(result-12, concentrations-8)
prep_of(concentrations-8, ampicillin-10)
aux(result-12, may-11)
dep(Interactions-4, result-12)
amod(reactions-15, false-positive-14)
prep_in(result-12, reactions-15)
advmod(testing-17, when-16)
advcl(result-12, testing-17)
det(presence-20, the-19)
prep_for(testing-17, presence-20)
prep_of(presence-20, glucose-22)
prep_in(testing-17, urine-24)
partmod(urine-24, using-25)
nn(@-27, CLINITEST-26)
dobj(using-25, @-27)
nn(Solution-32, Benedict-29)
nn(Solution-32, @-30)
nn(Solution-32, s-31)
conj_or(@-27, Solution-32)
nn(Solution-38, Fehling-35)
nn(Solution-38, @-36)
nn(Solution-38, s-37)
conj_or(@-27, Solution-38)

Since/IN this/DT effect/NN may/MD also/RB occur/VB with/IN amoxicillin/NN ,/, it/PRP is/VBZ recommended/VBN that/IN glucose/NN tests/NNS based/VBN on/IN enzymatic/JJ glucose/NN oxi-dase/NN reactions/NNS (/-LRB- such/JJ as/IN CLINISTIX/NN @/NN )/-RRB- be/VB used/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (DT this) (NN effect)) (VP (MD may) (ADVP (RB also)) (VP (VB occur) (PP (IN with) (NP (NN amoxicillin))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (NN glucose) (NNS tests)) (VP (VBN based) (PP (IN on) (NP (NP (JJ enzymatic) (NN glucose) (NN oxi-dase) (NNS reactions)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN CLINISTIX) (NN @)))) (-RRB- -RRB-)))))) (VP (VB be) (VP (VBN used)))))))) (. .))))

mark(occur-6, Since-1)
det(effect-3, this-2)
nsubj(occur-6, effect-3)
aux(occur-6, may-4)
advmod(occur-6, also-5)
advcl(recommended-12, occur-6)
prep_with(occur-6, amoxicillin-8)
nsubjpass(recommended-12, it-10)
auxpass(recommended-12, is-11)
root(ROOT-0, recommended-12)
complm(used-29, that-13)
nn(tests-15, glucose-14)
nsubjpass(used-29, tests-15)
partmod(tests-15, based-16)
amod(reactions-21, enzymatic-18)
nn(reactions-21, glucose-19)
nn(reactions-21, oxi-dase-20)
prep_on(based-16, reactions-21)
nn(@-26, CLINISTIX-25)
prep_such_as(reactions-21, @-26)
auxpass(used-29, be-28)
ccomp(recommended-12, used-29)

Following/VBG administration/NN of/IN ampicillin/NN to/TO pregnant/JJ women/NNS ,/, a/DT transient/JJ decrease/NN in/IN plasma/NN concentration/NN of/IN total/JJ conjugated/VBN estriol/NN ,/, estriol-glucuronide/NN ,/, conjugated/VBN estrone/NN ,/, and/CC estradiol/NN has/VBZ been/VBN noted/VBN ./.

(ROOT (S1 (S (S (PP (VBG Following) (NP (NP (NN administration)) (PP (IN of) (NP (NN ampicillin))) (PP (TO to) (NP (JJ pregnant) (NNS women))))) (, ,) (NP (NP (DT a) (JJ transient) (NN decrease)) (PP (IN in) (NP (NP (NN plasma) (NN concentration)) (PP (IN of) (NP (NP (JJ total) (VBN conjugated) (NN estriol)) (, ,) (NP (NN estriol-glucuronide)) (, ,) (NP (VBN conjugated) (NN estrone)) (, ,) (CC and) (NP (NN estradiol))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN noted))))) (. .))))

prep_following(noted-29, administration-2)
prep_of(administration-2, ampicillin-4)
amod(women-7, pregnant-6)
prep_to(administration-2, women-7)
det(decrease-11, a-9)
amod(decrease-11, transient-10)
nsubjpass(noted-29, decrease-11)
nn(concentration-14, plasma-13)
prep_in(decrease-11, concentration-14)
amod(estriol-18, total-16)
amod(estriol-18, conjugated-17)
prep_of(concentration-14, estriol-18)
conj_and(estriol-18, estriol-glucuronide-20)
amod(estrone-23, conjugated-22)
conj_and(estriol-18, estrone-23)
conj_and(estriol-18, estradiol-26)
aux(noted-29, has-27)
auxpass(noted-29, been-28)
root(ROOT-0, noted-29)

This/DT effect/NN may/MD also/RB occur/VB with/IN amoxicillin/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN effect)) (VP (MD may) (ADVP (RB also)) (VP (VB occur) (PP (IN with) (NP (NN amoxicillin)))))) (. .))))

det(effect-2, This-1)
nsubj(occur-5, effect-2)
aux(occur-5, may-3)
advmod(occur-5, also-4)
root(ROOT-0, occur-5)
prep_with(occur-5, amoxicillin-7)

Studies/NNS to/TO detect/VB mutagenic/JJ potential/NN of/IN amoxicillin/NN alone/RB have/VBP not/RB been/VBN conducted/VBN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Studies)) (VP (TO to) (VP (VB detect) (NP (NP (JJ mutagenic) (NN potential)) (PP (IN of) (NP (NP (NN amoxicillin)) (ADVP (RB alone)))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted)))) (: ;)) (. .))))

nsubjpass(conducted-12, Studies-1)
aux(detect-3, to-2)
dep(Studies-1, detect-3)
amod(potential-5, mutagenic-4)
dobj(detect-3, potential-5)
prep_of(potential-5, amoxicillin-7)
advmod(amoxicillin-7, alone-8)
aux(conducted-12, have-9)
neg(conducted-12, not-10)
auxpass(conducted-12, been-11)
root(ROOT-0, conducted-12)

however/RB ,/, the/DT following/VBG information/NN is/VBZ available/JJ from/IN tests/NNS on/IN a/DT 4:1/JJ mixture/NN of/IN amoxicillin/NN and/CC potassium/NN clavulanate/NN (/-LRB- AUGMENTIN/NN )/-RRB- ./.

(ROOT (S1 (S (S (ADVP (RB however)) (, ,) (NP (DT the) (VBG following) (NN information)) (VP (VBZ is) (ADJP (JJ available) (PP (IN from) (NP (NP (NNS tests)) (PP (IN on) (NP (NP (NP (DT a) (JJ 4:1) (NN mixture)) (PP (IN of) (NP (NN amoxicillin)))) (CC and) (NP (NP (NN potassium) (NN clavulanate)) (PRN (-LRB- -LRB-) (NP (NN AUGMENTIN)) (-RRB- -RRB-)))))))))) (. .))))

advmod(available-7, however-1)
det(information-5, the-3)
amod(information-5, following-4)
nsubj(available-7, information-5)
cop(available-7, is-6)
root(ROOT-0, available-7)
prep_from(available-7, tests-9)
det(mixture-13, a-11)
amod(mixture-13, 4:1-12)
prep_on(tests-9, mixture-13)
prep_of(mixture-13, amoxicillin-15)
nn(clavulanate-18, potassium-17)
conj_and(mixture-13, clavulanate-18)
abbrev(clavulanate-18, AUGMENTIN-20)

AUGMENTIN/NN was/VBD non-mutagenic/JJ in/IN the/DT Ame/NN s/NN bacterial/JJ mutation/NN assay/NN ,/, and/CC the/DT yeast/NN gene/NN conversion/NN assay/NN ./.

(ROOT (S1 (S (S (NP (NN AUGMENTIN)) (VP (VBD was) (ADJP (JJ non-mutagenic)) (PP (IN in) (NP (NP (DT the) (NN Ame) (NN s) (JJ bacterial) (NN mutation) (NN assay)) (, ,) (CC and) (NP (DT the) (NN yeast) (NN gene) (NN conversion) (NN assay)))))) (. .))))

nsubj(non-mutagenic-3, AUGMENTIN-1)
cop(non-mutagenic-3, was-2)
root(ROOT-0, non-mutagenic-3)
det(assay-10, the-5)
nn(assay-10, Ame-6)
nn(assay-10, s-7)
amod(assay-10, bacterial-8)
nn(assay-10, mutation-9)
prep_in(non-mutagenic-3, assay-10)
det(assay-17, the-13)
nn(assay-17, yeast-14)
nn(assay-17, gene-15)
nn(assay-17, conversion-16)
conj_and(assay-10, assay-17)

AUGMENTIN/NN was/VBD weakly/RB positive/JJ in/IN the/DT mouse/NN lymphoma/NN assay/NN ,/, but/CC the/DT trend/NN toward/IN increased/VBN mutation/NN frequencies/NNS in/IN this/DT assay/NN occurred/VBD at/IN doses/NNS that/WDT were/VBD also/RB associated/VBN with/IN decreased/VBN cell/NN survival/NN ./.

(ROOT (S1 (S (S (S (NP (NN AUGMENTIN)) (VP (VBD was) (ADJP (RB weakly) (JJ positive)) (PP (IN in) (NP (DT the) (NN mouse) (NN lymphoma) (NN assay))))) (, ,) (CC but) (S (NP (NP (DT the) (NN trend)) (PP (IN toward) (NP (NP (VBN increased) (NN mutation) (NNS frequencies)) (PP (IN in) (NP (DT this) (NN assay)))))) (VP (VBD occurred) (PP (IN at) (NP (NP (NNS doses)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADVP (RB also)) (VP (VBN associated) (PP (IN with) (NP (VBN decreased) (NN cell) (NN survival)))))))))))) (. .))))

nsubj(positive-4, AUGMENTIN-1)
cop(positive-4, was-2)
advmod(positive-4, weakly-3)
root(ROOT-0, positive-4)
det(assay-9, the-6)
nn(assay-9, mouse-7)
nn(assay-9, lymphoma-8)
prep_in(positive-4, assay-9)
det(trend-13, the-12)
nsubj(occurred-21, trend-13)
amod(frequencies-17, increased-15)
nn(frequencies-17, mutation-16)
prep_toward(trend-13, frequencies-17)
det(assay-20, this-19)
prep_in(frequencies-17, assay-20)
conj_but(positive-4, occurred-21)
prep_at(occurred-21, doses-23)
nsubjpass(associated-27, doses-23)
auxpass(associated-27, were-25)
advmod(associated-27, also-26)
rcmod(doses-23, associated-27)
amod(survival-31, decreased-29)
nn(survival-31, cell-30)
prep_with(associated-27, survival-31)

AUGMENTIN/NN was/VBD negative/JJ in/IN the/DT mouse/NN micronucleus/NN test/NN ,/, and/CC in/IN the/DT dominant/JJ lethal/JJ assay/NN in/IN mice/NNS ./.

(ROOT (S1 (S (S (NP (NN AUGMENTIN)) (VP (VBD was) (ADJP (JJ negative)) (PP (PP (IN in) (NP (DT the) (NN mouse) (NN micronucleus) (NN test))) (, ,) (CC and) (PP (IN in) (NP (NP (DT the) (JJ dominant) (JJ lethal) (NN assay)) (PP (IN in) (NP (NNS mice)))))))) (. .))))

nsubj(negative-3, AUGMENTIN-1)
cop(negative-3, was-2)
root(ROOT-0, negative-3)
det(test-8, the-5)
nn(test-8, mouse-6)
nn(test-8, micronucleus-7)
prep_in(negative-3, test-8)
det(assay-15, the-12)
amod(assay-15, dominant-13)
amod(assay-15, lethal-14)
conj_and(test-8, assay-15)
prep_in(assay-15, mice-17)

Potassium/NN clavulanate/NN alone/RB was/VBD tested/VBN in/IN the/DT Ame/NN s/NN bacterial/JJ mutation/NN assay/NN and/CC in/IN the/DT mouse/NN micronucleus/NN test/NN ,/, and/CC was/VBD negative/JJ in/IN each/DT of/IN these/DT assays/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Potassium) (NN clavulanate)) (ADVP (RB alone))) (VP (VP (VBD was) (VP (VBN tested) (PP (PP (IN in) (NP (DT the) (NN Ame) (NN s) (JJ bacterial) (NN mutation) (NN assay))) (CC and) (PP (IN in) (NP (DT the) (NN mouse) (NN micronucleus) (NN test)))))) (, ,) (CC and) (VP (VBD was) (ADJP (JJ negative)) (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (DT these) (NNS assays)))))))) (. .))))

nn(clavulanate-2, Potassium-1)
nsubjpass(tested-5, clavulanate-2)
advmod(clavulanate-2, alone-3)
auxpass(tested-5, was-4)
root(ROOT-0, tested-5)
det(assay-12, the-7)
nn(assay-12, Ame-8)
nn(assay-12, s-9)
amod(assay-12, bacterial-10)
nn(assay-12, mutation-11)
prep_in(tested-5, assay-12)
det(test-18, the-15)
nn(test-18, mouse-16)
nn(test-18, micronucleus-17)
conj_and(assay-12, test-18)
cop(negative-22, was-21)
conj_and(tested-5, negative-22)
prep_in(negative-22, each-24)
det(assays-27, these-26)
prep_of(each-24, assays-27)

Reproduction/NN studies/NNS have/VBP been/VBN performed/VBN in/IN mice/NNS and/CC rats/NNS at/IN doses/NNS up/RB to/TO 10/CD times/NNS the/DT human/JJ dose/NN and/CC have/VBP revealed/VBN no/DT evidence/NN of/IN impaired/JJ fertility/NN or/CC harm/NN to/TO the/DT fetus/NN due/JJ to/TO amoxicillin/NN ./.

(ROOT (S1 (S (S (NP (NN Reproduction) (NNS studies)) (VP (VP (VBP have) (VP (VBN been) (VP (VBN performed) (PP (IN in) (NP (NP (NNS mice)) (CC and) (NP (NNS rats)))) (PP (IN at) (NP (NP (NNS doses)) (NP (QP (RB up) (TO to) (CD 10) (NNS times)) (NP (DT the) (JJ human) (NN dose)))))))) (CC and) (VP (VBP have) (VP (VBN revealed) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (JJ impaired) (NN fertility)) (CC or) (NP (NP (NN harm)) (PP (TO to) (NP (NP (DT the) (NN fetus)) (ADJP (JJ due) (PP (TO to) (NP (NN amoxicillin)))))))))))))) (. .))))

nn(studies-2, Reproduction-1)
nsubjpass(performed-5, studies-2)
aux(performed-5, have-3)
auxpass(performed-5, been-4)
root(ROOT-0, performed-5)
prep_in(performed-5, mice-7)
conj_and(mice-7, rats-9)
prep_at(performed-5, doses-11)
quantmod(times-15, up-12)
dep(times-15, to-13)
number(times-15, 10-14)
num(dose-18, times-15)
det(dose-18, the-16)
amod(dose-18, human-17)
dep(doses-11, dose-18)
aux(revealed-21, have-20)
conj_and(performed-5, revealed-21)
det(evidence-23, no-22)
dobj(revealed-21, evidence-23)
amod(fertility-26, impaired-25)
prep_of(evidence-23, fertility-26)
conj_or(fertility-26, harm-28)
det(fetus-31, the-30)
prep_to(harm-28, fetus-31)
prep_due_to(fetus-31, amoxicillin-34)

Because/IN animal/NN reproduction/NN studies/NNS are/VBP not/RB always/RB predictive/JJ of/IN human/JJ response/NN ,/, this/DT drug/NN should/MD be/VB used/VBN during/IN pregnancy/NN only/RB if/IN clearly/RB needed/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN animal) (NN reproduction) (NNS studies)) (VP (VBP are) (RB not) (ADVP (RB always)) (ADJP (JJ predictive) (PP (IN of) (NP (JJ human) (NN response))))))) (, ,) (NP (DT this) (NN drug)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN during) (NP (NN pregnancy))) (SBAR (RB only) (IN if) (S (ADVP (RB clearly)) (VP (VBN needed)))))))) (. .))))

mark(predictive-8, Because-1)
nn(studies-4, animal-2)
nn(studies-4, reproduction-3)
nsubj(predictive-8, studies-4)
cop(predictive-8, are-5)
neg(predictive-8, not-6)
advmod(predictive-8, always-7)
advcl(used-17, predictive-8)
amod(response-11, human-10)
prep_of(predictive-8, response-11)
det(drug-14, this-13)
nsubjpass(used-17, drug-14)
aux(used-17, should-15)
auxpass(used-17, be-16)
root(ROOT-0, used-17)
prep_during(used-17, pregnancy-19)
advmod(needed-23, only-20)
dep(needed-23, if-21)
advmod(needed-23, clearly-22)
ccomp(used-17, needed-23)

Labor/NN and/CC Delivery/NN :/: Oral/JJ ampicillin/NN -class/NN antibiotics/NNS are/VBP poorly/RB absorbed/VBN during/IN labor/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Labor)) (CC and) (NP (NN Delivery))) (: :) (S (NP (JJ Oral) (NN ampicillin) (NN -class) (NNS antibiotics)) (VP (VBP are) (ADVP (RB poorly)) (VP (VBN absorbed) (PP (IN during) (NP (NN labor)))))) (. .)))))

root(ROOT-0, Labor-1)
conj_and(Labor-1, Delivery-3)
amod(antibiotics-8, Oral-5)
nn(antibiotics-8, ampicillin-6)
nn(antibiotics-8, -class-7)
nsubjpass(absorbed-11, antibiotics-8)
auxpass(absorbed-11, are-9)
advmod(absorbed-11, poorly-10)
dep(Labor-1, absorbed-11)
prep_during(absorbed-11, labor-13)

Studies/NNS in/IN guinea/NN pigs/NNS showed/VBD that/IN intravenous/JJ administration/NN of/IN ampicillin/NN slightly/RB decreased/VBD the/DT uterine/NN tone/NN and/CC frequency/NN of/IN contractions/NNS but/CC moderately/RB increased/VBD the/DT height/NN and/CC duration/NN of/IN contractions/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Studies)) (PP (IN in) (NP (NN guinea) (NNS pigs)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (JJ intravenous) (NN administration)) (PP (IN of) (NP (NN ampicillin)))) (ADVP (RB slightly)) (VP (VP (VBD decreased) (NP (NP (DT the) (NP (NN uterine) (NN tone)) (CC and) (NP (NN frequency))) (PP (IN of) (NP (NNS contractions))))) (CC but) (VP (ADVP (RB moderately)) (VBD increased) (NP (NP (DT the) (NP (NN height)) (CC and) (NP (NN duration))) (PP (IN of) (NP (NNS contractions)))))))))) (. .))))

nsubj(showed-5, Studies-1)
nn(pigs-4, guinea-3)
prep_in(Studies-1, pigs-4)
root(ROOT-0, showed-5)
complm(decreased-12, that-6)
amod(administration-8, intravenous-7)
nsubj(decreased-12, administration-8)
prep_of(administration-8, ampicillin-10)
advmod(decreased-12, slightly-11)
ccomp(showed-5, decreased-12)
dep(tone-15, the-13)
nn(tone-15, uterine-14)
dobj(decreased-12, tone-15)
conj_and(tone-15, frequency-17)
prep_of(tone-15, contractions-19)
advmod(increased-22, moderately-21)
conj_but(decreased-12, increased-22)
dep(height-24, the-23)
dobj(increased-22, height-24)
conj_and(height-24, duration-26)
prep_of(height-24, contractions-28)

However/RB ,/, it/PRP is/VBZ not/RB known/VBN whether/IN use/NN of/IN amoxicillin/NN in/IN humans/NNS during/IN labor/NN or/CC delivery/NN has/VBZ immediate/JJ or/CC delayed/VBN adverse/JJ effects/NNS on/IN the/DT fetus/NN ,/, prolongs/VBZ the/DT duration/NN of/IN labor/NN ,/, or/CC increases/VBZ the/DT likelihood/NN that/IN forceps/NN delivery/NN or/CC other/JJ obstetrical/JJ intervention/NN or/CC resuscitation/NN of/IN the/DT newborn/JJ will/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (NP (NN use)) (PP (IN of) (NP (NN amoxicillin))) (PP (IN in) (NP (NP (NNS humans)) (PP (IN during) (NP (NP (NN labor)) (CC or) (NP (NN delivery))))))) (VP (VP (VBZ has) (NP (NP (ADJP (ADJP (JJ immediate)) (CC or) (ADJP (VBN delayed))) (JJ adverse) (NNS effects)) (PP (IN on) (NP (DT the) (NN fetus))))) (, ,) (VP (VBZ prolongs) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NN labor))))) (, ,) (CC or) (VP (VBZ increases) (NP (DT the) (NN likelihood) (SBAR (IN that) (S (NP (NP (NN forceps) (NN delivery)) (CC or) (NP (NP (NP (JJ other) (JJ obstetrical) (NN intervention)) (CC or) (NP (NN resuscitation))) (PP (IN of) (NP (DT the) (JJ newborn))))) (VP (MD will) (VP (VB be) (ADJP (JJ necessary))))))))))))) (. .))))

advmod(known-6, However-1)
nsubjpass(known-6, it-3)
auxpass(known-6, is-4)
neg(known-6, not-5)
root(ROOT-0, known-6)
complm(has-17, whether-7)
nsubj(has-17, use-8)
prep_of(use-8, amoxicillin-10)
prep_in(use-8, humans-12)
prep_during(humans-12, labor-14)
conj_or(labor-14, delivery-16)
ccomp(known-6, has-17)
amod(effects-22, immediate-18)
conj_or(immediate-18, delayed-20)
amod(effects-22, adverse-21)
dobj(has-17, effects-22)
det(fetus-25, the-24)
prep_on(effects-22, fetus-25)
conj_or(has-17, prolongs-27)
det(duration-29, the-28)
dobj(prolongs-27, duration-29)
prep_of(duration-29, labor-31)
conj_or(has-17, increases-34)
det(likelihood-36, the-35)
dobj(increases-34, likelihood-36)
complm(necessary-51, that-37)
nn(delivery-39, forceps-38)
nsubj(necessary-51, delivery-39)
amod(intervention-43, other-41)
amod(intervention-43, obstetrical-42)
conj_or(delivery-39, intervention-43)
conj_or(intervention-43, resuscitation-45)
det(newborn-48, the-47)
prep_of(intervention-43, newborn-48)
aux(necessary-51, will-49)
cop(necessary-51, be-50)
ccomp(likelihood-36, necessary-51)

Nursing/VBG Mothers/NNS :/: Penicillins/NNS have/VBP been/VBN shown/VBN to/TO be/VB excreted/VBN in/IN human/JJ milk/NN ./.

(ROOT (S1 (S (S (S (VP (VBG Nursing) (NP (NNS Mothers)))) (: :) (S (NP (NNS Penicillins)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN excreted) (PP (IN in) (NP (JJ human) (NN milk)))))))))))) (. .))))

root(ROOT-0, Nursing-1)
dobj(Nursing-1, Mothers-2)
nsubjpass(shown-7, Penicillins-4)
xsubj(excreted-10, Penicillins-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
parataxis(Nursing-1, shown-7)
aux(excreted-10, to-8)
auxpass(excreted-10, be-9)
xcomp(shown-7, excreted-10)
amod(milk-13, human-12)
prep_in(excreted-10, milk-13)

Amoxicillin/JJ use/NN by/IN nursing/JJ mothers/NNS may/MD lead/VB to/TO sensitization/NN of/IN infants/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Amoxicillin) (NN use)) (PP (IN by) (NP (JJ nursing) (NNS mothers)))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NN sensitization)) (PP (IN of) (NP (NNS infants)))))))) (. .))))

amod(use-2, Amoxicillin-1)
nsubj(lead-7, use-2)
amod(mothers-5, nursing-4)
prep_by(use-2, mothers-5)
aux(lead-7, may-6)
root(ROOT-0, lead-7)
prep_to(lead-7, sensitization-9)
prep_of(sensitization-9, infants-11)

Caution/NN should/MD be/VB exercised/VBN when/WRB amoxicillin/NN is/VBZ administered/VBN to/TO a/DT nursing/JJ woman/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (NN amoxicillin)) (VP (VBZ is) (VP (VBN administered) (PP (TO to) (NP (DT a) (JJ nursing) (NN woman))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(administered-8, when-5)
nsubjpass(administered-8, amoxicillin-6)
auxpass(administered-8, is-7)
advcl(exercised-4, administered-8)
det(woman-12, a-10)
amod(woman-12, nursing-11)
prep_to(administered-8, woman-12)

Pediatric/JJ Use/NN :/: Because/IN of/IN incompletely/RB developed/VBN renal/JJ function/NN in/IN neonates/NNS and/CC young/JJ infants/NNS ,/, the/DT elimination/NN of/IN amoxicillin/NN may/MD be/VB delayed/VBN ./.

(ROOT (S1 (S (S (NP (JJ Pediatric) (NN Use)) (: :) (PP (IN Because) (PP (IN of) (NP (NP (ADJP (RB incompletely) (VBN developed)) (JJ renal) (NN function)) (PP (IN in) (NP (NP (NNS neonates)) (CC and) (NP (JJ young) (NNS infants))))))) (, ,) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (NN amoxicillin)))) (VP (MD may) (VP (VB be) (VP (VBN delayed))))) (. .))))

amod(Use-2, Pediatric-1)
nsubjpass(delayed-22, Use-2)
prepc_because_of(delayed-22, of-5)
advmod(developed-7, incompletely-6)
amod(function-9, developed-7)
amod(function-9, renal-8)
pobj(delayed-22, function-9)
prep_in(function-9, neonates-11)
amod(infants-14, young-13)
conj_and(neonates-11, infants-14)
det(elimination-17, the-16)
nsubjpass(delayed-22, elimination-17)
prep_of(elimination-17, amoxicillin-19)
aux(delayed-22, may-20)
auxpass(delayed-22, be-21)
root(ROOT-0, delayed-22)

Dosing/NN of/IN AMOXIL/NN should/MD be/VB modified/VBN in/IN pediatric/JJ patients/NNS 12/CD weeks/NNS or/CC younger/JJR (/-LRB- @/NN 3/CD months/NNS )./NN

(ROOT (S1 (S (S (NP (NP (NN Dosing)) (PP (IN of) (NP (NN AMOXIL)))) (VP (MD should) (VP (VB be) (VP (VBN modified) (PP (IN in) (NP (JJ pediatric) (NNS patients))))))) (NP (ADJP (NP (NP (CD 12) (NNS weeks)) (CC or) (NP (JJR younger))) (-LRB- -LRB-) (NN @) (CD 3) (NNS months)) (NN -RRB-.)))))

nsubjpass(modified-6, Dosing-1)
prep_of(Dosing-1, AMOXIL-3)
aux(modified-6, should-4)
auxpass(modified-6, be-5)
root(ROOT-0, modified-6)
amod(patients-9, pediatric-8)
prep_in(modified-6, patients-9)
num(weeks-11, 12-10)
dep(months-17, weeks-11)
conj_or(weeks-11, younger-13)
dep(months-17, @-15)
number(months-17, 3-16)
amod(-RRB-.-18, months-17)
dep(modified-6, -RRB-.-18)

Toxicologic/JJ and/CC toxicokinetic/JJ studies/NNS in/IN rats/NNS did/VBD not/RB demonstrate/VB any/DT alterations/NNS in/IN the/DT clearance/NN or/CC toxicologic/JJ profile/NN of/IN either/CC methotrexate/NN or/CC Kineret/NN @/NN when/WRB the/DT two/CD agents/NNS were/VBD administered/VBN together/RB ./.

(ROOT (S1 (S (S (NP (NP (ADJP (ADJP (JJ Toxicologic)) (CC and) (ADJP (JJ toxicokinetic))) (NNS studies)) (PP (IN in) (NP (NNS rats)))) (VP (VBD did) (RB not) (VP (VB demonstrate) (NP (NP (DT any) (NNS alterations)) (PP (IN in) (NP (NP (DT the) (NP (NN clearance)) (CC or) (NP (JJ toxicologic) (NN profile))) (PP (IN of) (NP (CC either) (NP (NN methotrexate)) (CC or) (NP (NN Kineret) (NN @)))))))) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (CD two) (NNS agents)) (VP (VBD were) (VP (VBN administered) (ADVP (RB together)))))))) (. .))))

amod(studies-4, Toxicologic-1)
conj_and(Toxicologic-1, toxicokinetic-3)
nsubj(demonstrate-9, studies-4)
prep_in(studies-4, rats-6)
aux(demonstrate-9, did-7)
neg(demonstrate-9, not-8)
root(ROOT-0, demonstrate-9)
det(alterations-11, any-10)
dobj(demonstrate-9, alterations-11)
dep(clearance-14, the-13)
prep_in(alterations-11, clearance-14)
amod(profile-17, toxicologic-16)
conj_or(clearance-14, profile-17)
preconj(methotrexate-20, either-19)
prep_of(clearance-14, methotrexate-20)
nn(@-23, Kineret-22)
conj_or(methotrexate-20, @-23)
advmod(administered-29, when-24)
det(agents-27, the-25)
num(agents-27, two-26)
nsubjpass(administered-29, agents-27)
auxpass(administered-29, were-28)
advcl(demonstrate-9, administered-29)
advmod(administered-29, together-30)

In/IN a/DT study/NN in/IN which/WDT patients/NNS with/IN active/JJ RA/NN were/VBD treated/VBN for/IN up/RB to/TO 24/CD weeks/NNS with/IN concurrent/JJ Kineret/NN @/NN and/CC etanercept/NN therapy/NN ,/, a/DT 7/CD %/NN rate/NN of/IN serious/JJ infections/NNS was/VBD observed/VBN ,/, which/WDT was/VBD higher/JJR than/IN that/DT observed/VBN with/IN etanercept/NN alone/RB (/-LRB- 0%)./NN

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (NN study)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NNS patients)) (PP (IN with) (NP (JJ active) (NN RA)))) (VP (VBD were) (VP (VBN treated) (PP (IN for) (NP (QP (RB up) (TO to) (CD 24)) (NNS weeks))) (PP (IN with) (NP (NP (JJ concurrent) (NN Kineret) (NN @)) (CC and) (NP (NN etanercept) (NN therapy)))))))))) (, ,) (NP (NP (DT a) (ADJP (CD 7) (NN %)) (NN rate)) (PP (IN of) (NP (JJ serious) (NNS infections)))) (VP (VBD was) (VP (VBN observed) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NP (DT that)) (VP (VBN observed) (PP (IN with) (NP (NP (NN etanercept)) (ADVP (RB alone)))))))) (PRN (-LRB- -LRB-) (NP (NN 0%-RRB-.)))))))))))

det(study-3, a-2)
prep_in(observed-33, study-3)
rel(treated-11, which-5)
nsubjpass(treated-11, patients-6)
amod(RA-9, active-8)
prep_with(patients-6, RA-9)
auxpass(treated-11, were-10)
rcmod(study-3, treated-11)
quantmod(24-15, up-13)
dep(24-15, to-14)
num(weeks-16, 24-15)
prep_for(treated-11, weeks-16)
amod(@-20, concurrent-18)
nn(@-20, Kineret-19)
prep_with(treated-11, @-20)
nn(therapy-23, etanercept-22)
conj_and(@-20, therapy-23)
det(rate-28, a-25)
number(%-27, 7-26)
amod(rate-28, %-27)
nsubjpass(observed-33, rate-28)
amod(infections-31, serious-30)
prep_of(rate-28, infections-31)
auxpass(observed-33, was-32)
root(ROOT-0, observed-33)
nsubj(higher-37, which-35)
cop(higher-37, was-36)
ccomp(observed-33, higher-37)
prep_than(higher-37, that-39)
partmod(that-39, observed-40)
prep_with(observed-40, etanercept-42)
advmod(etanercept-42, alone-43)
dep(higher-37, 0%-RRB-.-45)

Two/CD percent/NN of/IN patients/NNS treated/VBN concurrently/RB with/IN Kineret/NN @/NN and/CC etanercept/NN developed/VBD neutropenia/NN (/-LRB- ANC/NN 1/CD x/NN 109/L/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (CD Two) (NN percent)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN treated) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NN Kineret) (NN @)) (CC and) (NP (NN etanercept)))))))) (VP (VBD developed) (NP (NP (NN neutropenia)) (PRN (-LRB- -LRB-) (NP (NN ANC) (CD 1) (NN x) (NN 109/L)) (-RRB- -RRB-))))) (. .))))

num(percent-2, Two-1)
nsubj(developed-12, percent-2)
prep_of(percent-2, patients-4)
partmod(patients-4, treated-5)
advmod(treated-5, concurrently-6)
nn(@-9, Kineret-8)
prep_with(treated-5, @-9)
conj_and(@-9, etanercept-11)
root(ROOT-0, developed-12)
dobj(developed-12, neutropenia-13)
nn(109/L-18, ANC-15)
num(109/L-18, 1-16)
nn(109/L-18, x-17)
appos(neutropenia-13, 109/L-18)

No/DT clinically/RB relevant/JJ drug-drug/JJ interactions/NNS have/VBP been/VBN observed/VBN with/IN drugs/NNS likely/RB to/TO be/VB co-administered/VBN with/IN anidulafungin/NN ./.

(ROOT (S1 (S (S (NP (DT No) (ADJP (RB clinically) (JJ relevant)) (JJ drug-drug) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (SBAR (IN with) (S (NP (NNS drugs)) (ADVP (RB likely)) (VP (TO to) (VP (VB be) (VP (VBN co-administered) (PP (IN with) (NP (NN anidulafungin)))))))))))) (. .))))

det(interactions-5, No-1)
advmod(relevant-3, clinically-2)
amod(interactions-5, relevant-3)
amod(interactions-5, drug-drug-4)
nsubjpass(observed-8, interactions-5)
aux(observed-8, have-6)
auxpass(observed-8, been-7)
root(ROOT-0, observed-8)
mark(co-administered-14, with-9)
nsubjpass(co-administered-14, drugs-10)
advmod(co-administered-14, likely-11)
aux(co-administered-14, to-12)
auxpass(co-administered-14, be-13)
advcl(observed-8, co-administered-14)
xcomp(observed-8, co-administered-14)
prep_with(co-administered-14, anidulafungin-16)

Caution/NN should/MD be/VB observed/VBN when/WRB anileridine/NN is/VBZ coadministered/VBN with/IN other/JJ opioids/NNS ,/, sedatives/NNS ,/, phenothiazines/NNS ,/, or/CC anesthetics/NNS ,/, as/IN these/DT agents/NNS may/MD increase/VB respiratory/JJ and/CC circulatory/JJ depression/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NN anileridine)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (NP (JJ other) (NNS opioids)) (, ,) (NP (NNS sedatives)) (, ,) (NP (NNS phenothiazines)) (, ,) (CC or) (NP (NNS anesthetics))))) (, ,) (SBAR (IN as) (S (NP (DT these) (NNS agents)) (VP (MD may) (VP (VB increase) (NP (ADJP (ADJP (JJ respiratory)) (CC and) (ADJP (JJ circulatory))) (NN depression))))))))))))) (. .))))

nsubjpass(observed-4, Caution-1)
aux(observed-4, should-2)
auxpass(observed-4, be-3)
root(ROOT-0, observed-4)
advmod(coadministered-8, when-5)
nsubjpass(coadministered-8, anileridine-6)
auxpass(coadministered-8, is-7)
advcl(observed-4, coadministered-8)
amod(opioids-11, other-10)
prep_with(coadministered-8, opioids-11)
conj_or(opioids-11, sedatives-13)
conj_or(opioids-11, phenothiazines-15)
conj_or(opioids-11, anesthetics-18)
mark(increase-24, as-20)
det(agents-22, these-21)
nsubj(increase-24, agents-22)
aux(increase-24, may-23)
advcl(coadministered-8, increase-24)
amod(depression-28, respiratory-25)
conj_and(respiratory-25, circulatory-27)
dobj(increase-24, depression-28)

Ketoconazole/NN //: Itraconazole/NN ,/, Macrolides/NN ,/, Including/VBG Erythromycin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ketoconazole)) (: /) (NP (NN Itraconazole)) (, ,) (NP (NN Macrolides)) (, ,)) (VP (VBG Including) (NP (NN Erythromycin)))) (. .))))

nsubj(Including-7, Ketoconazole-1)
punct(Ketoconazole-1, /-2)
dep(Ketoconazole-1, Itraconazole-3)
appos(Ketoconazole-1, Macrolides-5)
root(ROOT-0, Including-7)
dobj(Including-7, Erythromycin-8)

Atovaquone/NN is/VBZ highly/RB bound/VBN to/TO plasma/NN protein/NN (/-LRB- 99.9%)./NN

(ROOT (S1 (S (NP (NN Atovaquone)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (NN plasma) (NN protein) (-LRB- -LRB-) (NN 99.9%-RRB-.))))))))

nsubjpass(bound-4, Atovaquone-1)
auxpass(bound-4, is-2)
advmod(bound-4, highly-3)
root(ROOT-0, bound-4)
nn(99.9%-RRB-.-9, plasma-6)
nn(99.9%-RRB-.-9, protein-7)
prep_to(bound-4, 99.9%-RRB-.-9)

Therefore/RB ,/, caution/NN should/MD be/VB used/VBN when/WRB administering/VBG MEPRON/NN concurrently/RB with/IN other/JJ highly/RB plasma/NN protein-/NN bound/VBN drugs/NNS with/IN narrow/JJ therapeutic/JJ indices/NNS ,/, as/IN competition/NN for/IN binding/NN sites/NNS may/MD occur/VB ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NP (NN MEPRON)) (PP (ADVP (RB concurrently)) (IN with) (NP (JJ other) (ADJP (RB highly) (NP (NN plasma) (NN protein-)) (VBN bound)) (NNS drugs)))) (PP (IN with) (NP (JJ narrow) (JJ therapeutic) (NNS indices)))))))) (, ,) (SBAR (IN as) (S (NP (NP (NN competition)) (PP (IN for) (NP (NN binding) (NNS sites)))) (VP (MD may) (VP (VB occur))))))) (. .))))

advmod(used-6, Therefore-1)
nsubjpass(used-6, caution-3)
aux(used-6, should-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
advmod(administering-8, when-7)
advcl(used-6, administering-8)
dobj(administering-8, MEPRON-9)
advmod(MEPRON-9, concurrently-10)
amod(drugs-17, other-12)
advmod(bound-16, highly-13)
nn(protein--15, plasma-14)
dep(bound-16, protein--15)
amod(drugs-17, bound-16)
prep_with(MEPRON-9, drugs-17)
amod(indices-21, narrow-19)
amod(indices-21, therapeutic-20)
prep_with(administering-8, indices-21)
mark(occur-29, as-23)
nsubj(occur-29, competition-24)
nn(sites-27, binding-26)
prep_for(competition-24, sites-27)
aux(occur-29, may-28)
advcl(used-6, occur-29)

The/DT extent/NN of/IN plasma/NN protein/NN binding/NN of/IN atovaquone/NN in/IN human/JJ plasma/NN is/VBZ not/RB affected/VBN by/IN the/DT presence/NN of/IN therapeutic/JJ concentrations/NNS of/IN phenytoin/NN (/-LRB- 15/CD mcg//NN mL/NN )/-RRB- ,/, nor/CC is/VBZ the/DT binding/NN of/IN phenytoin/NN affected/VBN by/IN the/DT presence/NN of/IN atovaquone/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN extent)) (PP (IN of) (NP (NP (NN plasma) (NN protein) (NN binding)) (PP (IN of) (NP (NN atovaquone))) (PP (IN in) (NP (JJ human) (NN plasma)))))) (VP (VP (VBZ is) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ therapeutic) (NNS concentrations)) (PP (IN of) (NP (NP (NN phenytoin)) (PRN (-LRB- -LRB-) (NP (CD 15) (NN mcg/) (NN mL)) (-RRB- -RRB-)))))))))) (, ,) (CC nor) (VP (VBZ is) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (NN phenytoin)) (VP (VBN affected) (PP (IN by) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN atovaquone)))))))))))) (. .))))

det(extent-2, The-1)
nsubjpass(affected-14, extent-2)
nn(binding-6, plasma-4)
nn(binding-6, protein-5)
prep_of(extent-2, binding-6)
prep_of(binding-6, atovaquone-8)
amod(plasma-11, human-10)
prep_in(binding-6, plasma-11)
auxpass(affected-14, is-12)
neg(affected-14, not-13)
root(ROOT-0, affected-14)
det(presence-17, the-16)
agent(affected-14, presence-17)
amod(concentrations-20, therapeutic-19)
prep_of(presence-17, concentrations-20)
prep_of(concentrations-20, phenytoin-22)
num(mL-26, 15-24)
nn(mL-26, mcg/-25)
appos(phenytoin-22, mL-26)
cop(binding-32, is-30)
det(binding-32, the-31)
conj_nor(affected-14, binding-32)
prep_of(binding-32, phenytoin-34)
partmod(phenytoin-34, affected-35)
det(presence-38, the-37)
agent(affected-35, presence-38)
prep_of(presence-38, atovaquone-40)

Rifampin/NN :/: Coadministration/NN of/IN rifampin/NN and/CC MEPRON/NN Suspension/NN results/VBZ in/IN a/DT significant/JJ decrease/NN in/IN average/JJ steady-/JJ state/NN plasma/NN atovaquone/NN concentrations/NNS ./.

(ROOT (S1 (S (NP (NP (NN Rifampin)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN rifampin)) (CC and) (NP (NN MEPRON)) (NP (NN Suspension))))) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (JJ average) (JJ steady-) (NN state) (NN plasma) (NN atovaquone) (NNS concentrations))))))) (. .)))))

root(ROOT-0, Rifampin-1)
nsubj(results-9, Coadministration-3)
prep_of(Coadministration-3, rifampin-5)
conj_and(rifampin-5, MEPRON-7)
dep(rifampin-5, Suspension-8)
dep(Rifampin-1, results-9)
det(decrease-13, a-11)
amod(decrease-13, significant-12)
prep_in(results-9, decrease-13)
amod(concentrations-20, average-15)
amod(concentrations-20, steady--16)
nn(concentrations-20, state-17)
nn(concentrations-20, plasma-18)
nn(concentrations-20, atovaquone-19)
prep_in(decrease-13, concentrations-20)

Alternatives/NNS to/TO rifampin/NN should/MD be/VB considered/VBN during/IN the/DT course/NN of/IN PCP/NN treatment/NN with/IN MEPRON/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Alternatives)) (PP (TO to) (NP (NN rifampin)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN during) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (NP (NN PCP) (NN treatment)) (PP (IN with) (NP (NN MEPRON))))))))))) (. .))))

nsubjpass(considered-6, Alternatives-1)
prep_to(Alternatives-1, rifampin-3)
aux(considered-6, should-4)
auxpass(considered-6, be-5)
root(ROOT-0, considered-6)
det(course-9, the-8)
prep_during(considered-6, course-9)
nn(treatment-12, PCP-11)
prep_of(course-9, treatment-12)
prep_with(treatment-12, MEPRON-14)

Rifabutin/NN ,/, another/DT rifamycin/NN ,/, is/VBZ structurally/RB similar/JJ to/TO rifampin/NN and/CC may/MD possibly/RB have/VB some/DT of/IN the/DT same/JJ drug/NN interactions/NNS as/IN rifampin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Rifabutin)) (, ,) (NP (DT another) (NN rifamycin)) (, ,)) (VP (VP (VBZ is) (ADJP (RB structurally) (JJ similar) (PP (TO to) (NP (NN rifampin))))) (CC and) (VP (MD may) (ADVP (RB possibly)) (VP (VB have) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (JJ same) (NN drug) (NNS interactions)) (PP (IN as) (NP (NN rifampin)))))))))) (. .))))

nsubj(similar-8, Rifabutin-1)
det(rifamycin-4, another-3)
appos(Rifabutin-1, rifamycin-4)
cop(similar-8, is-6)
advmod(similar-8, structurally-7)
root(ROOT-0, similar-8)
prep_to(similar-8, rifampin-10)
aux(have-14, may-12)
advmod(have-14, possibly-13)
conj_and(similar-8, have-14)
dobj(have-14, some-15)
det(interactions-20, the-17)
amod(interactions-20, same-18)
nn(interactions-20, drug-19)
prep_of(some-15, interactions-20)
prep_as(interactions-20, rifampin-22)

No/NN interaction/NN trials/NNS have/VBP been/VBN conducted/VBN with/IN MEPRON/NN and/CC rifabutin/NN ./.

(ROOT (S1 (S (S (NP (NN No) (NN interaction) (NNS trials)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (PP (IN with) (NP (NP (NN MEPRON)) (CC and) (NP (NN rifabutin)))))))) (. .))))

nn(trials-3, No-1)
nn(trials-3, interaction-2)
nsubjpass(conducted-6, trials-3)
aux(conducted-6, have-4)
auxpass(conducted-6, been-5)
root(ROOT-0, conducted-6)
prep_with(conducted-6, MEPRON-8)
conj_and(MEPRON-8, rifabutin-10)

Drug/NN //: Laboratory/NN Test/NN Interactions/NNS :/: It/PRP is/VBZ not/RB known/VBN if/IN MEPRON/NN interferes/VBZ with/IN clinical/JJ laboratory/JJ test/NN or/NN assay/NN results/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (: /) (NN Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN if) (S (NP (NN MEPRON)) (VP (VBZ interferes) (PP (IN with) (NP (JJ clinical) (JJ laboratory) (NN test) (NN or) (NN assay) (NNS results))))))))) (. .)))))

nn(Interactions-5, Drug-1)
punct(Interactions-5, /-2)
nn(Interactions-5, Laboratory-3)
nn(Interactions-5, Test-4)
root(ROOT-0, Interactions-5)
nsubjpass(known-10, It-7)
auxpass(known-10, is-8)
neg(known-10, not-9)
dep(Interactions-5, known-10)
mark(interferes-13, if-11)
nsubj(interferes-13, MEPRON-12)
advcl(known-10, interferes-13)
amod(results-20, clinical-15)
amod(results-20, laboratory-16)
nn(results-20, test-17)
nn(results-20, or-18)
nn(results-20, assay-19)
prep_with(interferes-13, results-20)

When/WRB atropine/NN and/CC pralidoxime/NN are/VBP used/VBN together/RB ,/, the/DT signs/NNS of/IN atropinization/NN (/-LRB- flushing/NN ,/, mydriasis/NN ,/, tachycardia/NN ,/, dryness/NN of/IN the/DT mouth/NN and/CC nose/NN )/-RRB- may/MD occur/VB earlier/RBR than/IN might/MD be/VB expected/VBN than/IN when/WRB atropine/NN is/VBZ used/VBN alone/RB because/IN pralidoxime/NN may/MD potentiate/VB the/DT effect/NN of/IN atropine/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN atropine)) (CC and) (NP (NN pralidoxime))) (VP (VBP are) (VP (VBN used) (ADVP (RB together)))))) (, ,) (NP (NP (DT the) (NNS signs)) (PP (IN of) (NP (NP (NN atropinization)) (PRN (-LRB- -LRB-) (NP (NP (NN flushing)) (, ,) (NP (NN mydriasis)) (, ,) (NP (NN tachycardia)) (, ,) (NP (NP (NN dryness)) (PP (IN of) (NP (DT the) (NN mouth)))) (CC and) (NP (NN nose))) (-RRB- -RRB-))))) (VP (MD may) (VP (VB occur) (ADVP (RBR earlier)) (PP (IN than) (S (VP (MD might) (VP (VB be) (VP (VBN expected) (PP (IN than) (SBAR (WHADVP (WRB when)) (S (NP (NN atropine)) (VP (VBZ is) (VP (VBN used) (ADVP (RB alone)) (SBAR (IN because) (S (NP (NN pralidoxime)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN atropine))))))))))))))))))))) (. .))))

advmod(used-6, When-1)
nsubjpass(used-6, atropine-2)
conj_and(atropine-2, pralidoxime-4)
auxpass(used-6, are-5)
advcl(occur-28, used-6)
advmod(used-6, together-7)
det(signs-10, the-9)
nsubj(occur-28, signs-10)
prep_of(signs-10, atropinization-12)
dep(atropinization-12, flushing-14)
conj_and(flushing-14, mydriasis-16)
conj_and(flushing-14, tachycardia-18)
conj_and(flushing-14, dryness-20)
det(mouth-23, the-22)
prep_of(dryness-20, mouth-23)
conj_and(flushing-14, nose-25)
aux(occur-28, may-27)
root(ROOT-0, occur-28)
advmod(occur-28, earlier-29)
aux(expected-33, might-31)
auxpass(expected-33, be-32)
prepc_than(occur-28, expected-33)
advmod(used-38, when-35)
nsubjpass(used-38, atropine-36)
auxpass(used-38, is-37)
prepc_than(expected-33, used-38)
advmod(used-38, alone-39)
mark(potentiate-43, because-40)
nsubj(potentiate-43, pralidoxime-41)
aux(potentiate-43, may-42)
advcl(used-38, potentiate-43)
det(effect-45, the-44)
dobj(potentiate-43, effect-45)
prep_of(effect-45, atropine-47)

The/DT following/JJ precautions/NNS should/MD be/VB kept/VBN in/IN mind/NN in/IN the/DT treatment/NN of/IN anticholinesterase/NN poisoning/NN although/IN they/PRP do/VBP not/RB bear/VB directly/RB on/IN the/DT use/NN of/IN atropine/NN and/CC pralidoxime/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (NNS precautions)) (VP (MD should) (VP (VB be) (VP (VBN kept) (PP (IN in) (NP (NN mind))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN anticholinesterase) (NN poisoning))))) (SBAR (IN although) (S (NP (PRP they)) (VP (VBP do) (RB not) (VP (VB bear) (ADVP (RB directly)) (PP (IN on) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NN atropine)) (CC and) (NP (NN pralidoxime)))))))))))))) (. .))))

det(precautions-3, The-1)
amod(precautions-3, following-2)
nsubjpass(kept-6, precautions-3)
aux(kept-6, should-4)
auxpass(kept-6, be-5)
root(ROOT-0, kept-6)
prep_in(kept-6, mind-8)
det(treatment-11, the-10)
prep_in(kept-6, treatment-11)
nn(poisoning-14, anticholinesterase-13)
prep_of(treatment-11, poisoning-14)
mark(bear-19, although-15)
nsubj(bear-19, they-16)
aux(bear-19, do-17)
neg(bear-19, not-18)
advcl(kept-6, bear-19)
advmod(bear-19, directly-20)
det(use-23, the-22)
prep_on(bear-19, use-23)
prep_of(use-23, atropine-25)
conj_and(atropine-25, pralidoxime-27)

Since/IN barbiturates/NNS are/VBP potentiated/VBN by/IN the/DT anticholinesterases/NNS ,/, they/PRP should/MD be/VB used/VBN cautiously/RB in/IN the/DT treatment/NN of/IN convulsions/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NNS barbiturates)) (VP (VBP are) (VP (VBN potentiated) (PP (IN by) (NP (DT the) (NNS anticholinesterases))))))) (, ,) (NP (PRP they)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS convulsions))))))))) (. .))))

mark(potentiated-4, Since-1)
nsubjpass(potentiated-4, barbiturates-2)
auxpass(potentiated-4, are-3)
advcl(used-12, potentiated-4)
det(anticholinesterases-7, the-6)
agent(potentiated-4, anticholinesterases-7)
nsubjpass(used-12, they-9)
aux(used-12, should-10)
auxpass(used-12, be-11)
root(ROOT-0, used-12)
advmod(used-12, cautiously-13)
det(treatment-16, the-15)
prep_in(used-12, treatment-16)
prep_of(treatment-16, convulsions-18)

Co-administration/NN of/IN nelfinavir/NN at/IN steady-state/NN with/IN a/DT single/JJ dose/NN of/IN azithromycin/NN (/-LRB- 2/CD span/NN class=/NN c94/NN @/NN ?/.

(ROOT (S1 (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN nelfinavir))) (PP (IN at) (NP (NN steady-state))) (PP (IN with) (NP (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NN azithromycin)))) (PRN (-LRB- -LRB-) (NP (CD 2) (NN span) (NN class=) (NN c94) (NN @))))) (. ?)))))

root(ROOT-0, Co-administration-1)
prep_of(Co-administration-1, nelfinavir-3)
prep_at(Co-administration-1, steady-state-5)
det(dose-9, a-7)
amod(dose-9, single-8)
prep_with(Co-administration-1, dose-9)
prep_of(dose-9, azithromycin-11)
num(@-17, 2-13)
nn(@-17, span-14)
nn(@-17, class=-15)
nn(@-17, c94-16)
dep(dose-9, @-17)

600/CD mg/NN tablets/NNS )/-RRB- results/VBZ in/IN increased/VBN azithromycin/NN serum/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (CD 600) (NN mg)) (NNS tablets) (-RRB- -RRB-)) (VP (VBZ results) (PP (IN in) (NP (VBN increased) (NN azithromycin) (NN serum) (NNS concentrations))))) (. .))))

number(mg-2, 600-1)
amod(tablets-3, mg-2)
nsubj(results-5, tablets-3)
root(ROOT-0, results-5)
amod(concentrations-10, increased-7)
nn(concentrations-10, azithromycin-8)
nn(concentrations-10, serum-9)
prep_in(results-5, concentrations-10)

Although/IN a/DT dose/NN adjustment/NN of/IN azithromycin/NN is/VBZ not/RB recommended/VBN when/WRB administered/VBN in/IN combination/NN with/IN nelfinavir/NN ,/, close/JJ monitoring/NN for/IN known/JJ side/JJ effects/NNS of/IN azithromycin/NN ,/, such/JJ as/IN liver/NN enzyme/NN abnormalities/NNS and/CC hearing/NN impairment/NN ,/, is/VBZ warranted/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (DT a) (NN dose) (NN adjustment)) (PP (IN of) (NP (NN azithromycin)))) (VP (VBZ is) (RB not) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN nelfinavir)))))))))))) (, ,) (NP (NP (JJ close) (NN monitoring)) (PP (IN for) (NP (NP (JJ known) (JJ side) (NNS effects)) (PP (IN of) (NP (NN azithromycin))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN liver) (NN enzyme) (NNS abnormalities)) (CC and) (NP (NN hearing) (NN impairment)))) (, ,)))) (VP (VBZ is) (VP (VBN warranted)))) (. .))))

mark(recommended-9, Although-1)
det(adjustment-4, a-2)
nn(adjustment-4, dose-3)
nsubjpass(recommended-9, adjustment-4)
prep_of(adjustment-4, azithromycin-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
advcl(warranted-36, recommended-9)
advmod(administered-11, when-10)
advcl(recommended-9, administered-11)
prep_in(administered-11, combination-13)
prep_with(combination-13, nelfinavir-15)
amod(monitoring-18, close-17)
nsubjpass(warranted-36, monitoring-18)
amod(effects-22, known-20)
amod(effects-22, side-21)
prep_for(monitoring-18, effects-22)
prep_of(effects-22, azithromycin-24)
nn(abnormalities-30, liver-28)
nn(abnormalities-30, enzyme-29)
prep_such_as(effects-22, abnormalities-30)
nn(impairment-33, hearing-32)
conj_and(abnormalities-30, impairment-33)
auxpass(warranted-36, is-35)
root(ROOT-0, warranted-36)

Azithromycin/NN did/VBD not/RB affect/VB the/DT prothrombin/NN time/NN response/NN to/TO a/DT single/JJ dose/NN of/IN warfarin/NN ./.

(ROOT (S1 (S (S (NP (NN Azithromycin)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN prothrombin) (NN time) (NN response)) (PP (TO to) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NN warfarin))))))))) (. .))))

nsubj(affect-4, Azithromycin-1)
aux(affect-4, did-2)
neg(affect-4, not-3)
root(ROOT-0, affect-4)
det(response-8, the-5)
nn(response-8, prothrombin-6)
nn(response-8, time-7)
dobj(affect-4, response-8)
det(dose-12, a-10)
amod(dose-12, single-11)
prep_to(response-8, dose-12)
prep_of(dose-12, warfarin-14)

However/RB ,/, prudent/JJ medical/JJ practice/NN dictates/VBZ careful/JJ monitoring/NN of/IN prothrombin/NN time/NN in/IN all/DT patients/NNS treated/VBN with/IN azithromycin/NN and/CC warfarin/NN concomitantly/RB ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (JJ prudent) (JJ medical) (NN practice)) (VP (VBZ dictates) (NP (NP (JJ careful) (NN monitoring)) (PP (IN of) (NP (NN prothrombin) (NN time))) (PP (IN in) (NP (NP (DT all) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NN azithromycin)) (CC and) (NP (NN warfarin)))) (ADVP (RB concomitantly)))))))) (. .))))

advmod(dictates-6, However-1)
amod(practice-5, prudent-3)
amod(practice-5, medical-4)
nsubj(dictates-6, practice-5)
root(ROOT-0, dictates-6)
amod(monitoring-8, careful-7)
dobj(dictates-6, monitoring-8)
nn(time-11, prothrombin-10)
prep_of(monitoring-8, time-11)
det(patients-14, all-13)
prep_in(monitoring-8, patients-14)
partmod(patients-14, treated-15)
prep_with(treated-15, azithromycin-17)
conj_and(azithromycin-17, warfarin-19)
advmod(treated-15, concomitantly-20)

Concurrent/JJ use/NN of/IN macrolides/NN and/CC warfarin/NN in/IN clinical/JJ practice/NN has/VBZ been/VBN associated/VBN with/IN increased/VBN anticoagulant/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NP (NN macrolides)) (CC and) (NP (NN warfarin)))) (PP (IN in) (NP (JJ clinical) (NN practice)))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (VBN increased) (JJ anticoagulant) (NNS effects))))))) (. .))))

amod(use-2, Concurrent-1)
nsubjpass(associated-12, use-2)
prep_of(use-2, macrolides-4)
conj_and(macrolides-4, warfarin-6)
amod(practice-9, clinical-8)
prep_in(use-2, practice-9)
aux(associated-12, has-10)
auxpass(associated-12, been-11)
root(ROOT-0, associated-12)
amod(effects-16, increased-14)
amod(effects-16, anticoagulant-15)
prep_with(associated-12, effects-16)

Drug/NN interaction/NN studies/NNS were/VBD performed/VBN with/IN azithromycin/NN and/CC other/JJ drugs/NNS likely/RB to/TO be/VB co-administered/VBN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN interaction) (NNS studies)) (VP (VBD were) (VP (VBN performed) (PP (IN with) (NP (NP (NN azithromycin)) (CC and) (NP (JJ other) (NNS drugs)))) (S (ADVP (RB likely)) (VP (TO to) (VP (VB be) (VP (VBN co-administered)))))))) (. .))))

nn(studies-3, Drug-1)
nn(studies-3, interaction-2)
nsubjpass(performed-5, studies-3)
xsubj(co-administered-14, studies-3)
auxpass(performed-5, were-4)
root(ROOT-0, performed-5)
prep_with(performed-5, azithromycin-7)
amod(drugs-10, other-9)
conj_and(azithromycin-7, drugs-10)
advmod(co-administered-14, likely-11)
aux(co-administered-14, to-12)
auxpass(co-administered-14, be-13)
xcomp(performed-5, co-administered-14)

When/WRB used/VBN in/IN therapeutic/JJ doses/NNS ,/, azithromycin/NN had/VBD a/DT modest/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN atorvastatin/NN ,/, carbamazepine/NN ,/, cetirizine/NN ,/, didanosine/NN ,/, efavirenz/NN ,/, fluconazole/NN ,/, indinavir/NN ,/, midazolam/NN ,/, rifabutin/NN ,/, sildenafil/NN ,/, theophylline/NN (/-LRB- intravenous/JJ and/CC oral/JJ )/-RRB- ,/, triazolam/NN ,/, trimethoprim/NN //: sulfamethoxazole/NN or/CC zidovudine/NN ./.

(ROOT (S1 (S (SBAR (WHADVP (WRB When)) (S (VP (VBN used) (PP (IN in) (NP (JJ therapeutic) (NNS doses)))))) (, ,) (NP (NN azithromycin)) (VP (VBD had) (NP (DT a) (JJ modest) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN atorvastatin)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN cetirizine)) (, ,) (NP (NN didanosine)) (, ,) (NP (NN efavirenz)) (, ,) (NP (NN fluconazole)) (, ,) (NP (NN indinavir)) (, ,) (NP (NN midazolam)) (, ,) (NP (NN rifabutin)) (, ,) (NP (NN sildenafil)) (, ,) (NP (NP (NP (NN theophylline)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ intravenous)) (CC and) (ADJP (JJ oral))) (-RRB- -RRB-))) (, ,) (NP (NN triazolam)) (, ,) (NP (NN trimethoprim)) (: /) (NP (NN sulfamethoxazole))) (CC or) (NP (NN zidovudine))))))) (. .))))

advmod(used-2, When-1)
advcl(had-8, used-2)
amod(doses-5, therapeutic-4)
prep_in(used-2, doses-5)
nsubj(had-8, azithromycin-7)
root(ROOT-0, had-8)
det(effect-11, a-9)
amod(effect-11, modest-10)
dobj(had-8, effect-11)
det(pharmacokinetics-14, the-13)
prep_on(had-8, pharmacokinetics-14)
prep_of(pharmacokinetics-14, atorvastatin-16)
conj_or(atorvastatin-16, carbamazepine-18)
conj_or(atorvastatin-16, cetirizine-20)
conj_or(atorvastatin-16, didanosine-22)
conj_or(atorvastatin-16, efavirenz-24)
conj_or(atorvastatin-16, fluconazole-26)
conj_or(atorvastatin-16, indinavir-28)
conj_or(atorvastatin-16, midazolam-30)
conj_or(atorvastatin-16, rifabutin-32)
conj_or(atorvastatin-16, sildenafil-34)
conj_or(atorvastatin-16, theophylline-36)
dep(theophylline-36, intravenous-38)
conj_and(intravenous-38, oral-40)
appos(theophylline-36, triazolam-43)
appos(theophylline-36, trimethoprim-45)
punct(theophylline-36, /-46)
dep(theophylline-36, sulfamethoxazole-47)
conj_or(atorvastatin-16, zidovudine-49)

Co-administration/NN with/IN efavirenz/NN or/CC fluconazole/NN had/VBD a/DT modest/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN azithromycin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN with) (NP (NP (NN efavirenz)) (CC or) (NP (NN fluconazole))))) (VP (VBD had) (NP (DT a) (JJ modest) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN azithromycin))))))) (. .))))

nsubj(had-6, Co-administration-1)
prep_with(Co-administration-1, efavirenz-3)
conj_or(efavirenz-3, fluconazole-5)
root(ROOT-0, had-6)
det(effect-9, a-7)
amod(effect-9, modest-8)
dobj(had-6, effect-9)
det(pharmacokinetics-12, the-11)
prep_on(had-6, pharmacokinetics-12)
prep_of(pharmacokinetics-12, azithromycin-14)

No/DT dosage/JJ adjustment/NN of/IN either/DT drug/NN is/VBZ recommended/VBN when/WRB azithromycin/NN is/VBZ co/RB administered/VBN with/IN any/DT of/IN the/DT above/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ dosage) (NN adjustment)) (PP (IN of) (NP (DT either) (NN drug)))) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (NP (NN azithromycin)) (VP (VBZ is) (ADVP (RB co)) (VP (VBN administered) (PP (IN with) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (JJ above) (NNS agents)))))))))))) (. .))))

det(adjustment-3, No-1)
amod(adjustment-3, dosage-2)
nsubjpass(recommended-8, adjustment-3)
det(drug-6, either-5)
prep_of(adjustment-3, drug-6)
auxpass(recommended-8, is-7)
root(ROOT-0, recommended-8)
advmod(administered-13, when-9)
nsubjpass(administered-13, azithromycin-10)
auxpass(administered-13, is-11)
advmod(administered-13, co-12)
advcl(recommended-8, administered-13)
prep_with(administered-13, any-15)
det(agents-19, the-17)
amod(agents-19, above-18)
prep_of(any-15, agents-19)

Interactions/NNS with/IN the/DT drugs/NNS listed/VBN below/IN have/VBP not/RB been/VBN reported/VBN in/IN clinical/JJ trials/NNS with/IN azithromycin/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Interactions)) (PP (IN with) (NP (NP (DT the) (NNS drugs)) (VP (VBN listed) (PP (IN below)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (JJ clinical) (NNS trials)) (PP (IN with) (NP (NN azithromycin))) (: ;))))))) (. .))))

nsubjpass(reported-10, Interactions-1)
det(drugs-4, the-3)
prep_with(Interactions-1, drugs-4)
partmod(drugs-4, listed-5)
prep(listed-5, below-6)
aux(reported-10, have-7)
neg(reported-10, not-8)
auxpass(reported-10, been-9)
root(ROOT-0, reported-10)
amod(trials-13, clinical-12)
prep_in(reported-10, trials-13)
prep_with(trials-13, azithromycin-15)

Nonetheless/RB ,/, they/PRP have/VBP been/VBN observed/VBN with/IN macrolide/NN products/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Nonetheless)) (, ,) (NP (PRP they)) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (IN with) (NP (NN macrolide) (NNS products))))))) (. .))))

advmod(observed-6, Nonetheless-1)
nsubjpass(observed-6, they-3)
aux(observed-6, have-4)
auxpass(observed-6, been-5)
root(ROOT-0, observed-6)
nn(products-9, macrolide-8)
prep_with(observed-6, products-9)

Until/IN further/JJ data/NNS are/VBP developed/VBN regarding/VBG drug/NN interactions/NNS when/WRB azithromycin/NN and/CC these/DT drugs/NNS are/VBP used/VBN concomitantly/RB ,/, careful/JJ monitoring/NN of/IN patients/NNS is/VBZ advised/VBN :/: Digoxin/NN @/NN elevated/JJ digoxin/NN concentrations/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Until) (S (NP (JJ further) (NNS data)) (VP (VBP are) (VP (VBN developed) (S (VP (VBG regarding) (NP (NP (NN drug) (NNS interactions)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN azithromycin)) (CC and) (NP (DT these) (NNS drugs))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly))))))))))))) (, ,) (NP (NP (JJ careful) (NN monitoring)) (PP (IN of) (NP (NNS patients)))) (VP (VBZ is) (VP (VBN advised) (: :) (NP (NN Digoxin) (NN @) (JJ elevated) (NN digoxin) (NNS concentrations))))) (. .))))

mark(developed-5, Until-1)
amod(data-3, further-2)
nsubjpass(developed-5, data-3)
auxpass(developed-5, are-4)
advcl(advised-23, developed-5)
xcomp(developed-5, regarding-6)
nn(interactions-8, drug-7)
dobj(regarding-6, interactions-8)
tmod(used-15, interactions-8)
advmod(used-15, when-9)
nsubjpass(used-15, azithromycin-10)
det(drugs-13, these-12)
conj_and(azithromycin-10, drugs-13)
auxpass(used-15, are-14)
dep(interactions-8, used-15)
advmod(used-15, concomitantly-16)
amod(monitoring-19, careful-18)
nsubjpass(advised-23, monitoring-19)
prep_of(monitoring-19, patients-21)
auxpass(advised-23, is-22)
root(ROOT-0, advised-23)
nn(concentrations-29, Digoxin-25)
nn(concentrations-29, @-26)
amod(concentrations-29, elevated-27)
nn(concentrations-29, digoxin-28)
dobj(advised-23, concentrations-29)

Ergotamine/NN or/CC dihydro/NN ergot/NN amine/NN @/NN acute/JJ ergot/NN toxicity/NN characterized/VBN by/IN severe/JJ peripheral/JJ vasospasm/NN and/CC dysesthesia/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ergotamine)) (CC or) (NP (NN dihydro) (NN ergot) (NN amine) (NN @) (JJ acute) (NN ergot) (NN toxicity))) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ severe) (JJ peripheral) (NN vasospasm)) (CC and) (NP (NN dysesthesia)))))) (. .))))

nsubj(characterized-10, Ergotamine-1)
nn(toxicity-9, dihydro-3)
nn(toxicity-9, ergot-4)
nn(toxicity-9, amine-5)
nn(toxicity-9, @-6)
amod(toxicity-9, acute-7)
nn(toxicity-9, ergot-8)
conj_or(Ergotamine-1, toxicity-9)
root(ROOT-0, characterized-10)
amod(vasospasm-14, severe-12)
amod(vasospasm-14, peripheral-13)
prep_by(characterized-10, vasospasm-14)
conj_and(vasospasm-14, dysesthesia-16)

Cyclosporine/NN ,/, hexobarbital/NN and/CC phenytoin/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Cyclosporine)) (, ,) (NP (NN hexobarbital)) (CC and) (NP (NN phenytoin))) (VP (NNS concentrations))) (. .))))

nsubj(concentrations-6, Cyclosporine-1)
conj_and(Cyclosporine-1, hexobarbital-3)
conj_and(Cyclosporine-1, phenytoin-5)
root(ROOT-0, concentrations-6)

Repeat/NN Treatment/NN Studies/NNS evaluating/VBG the/DT use/NN of/IN repeated/JJ courses/NNS of/IN Zmax/NN have/VBP not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Repeat) (NN Treatment) (NNS Studies)) (VP (VBG evaluating) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (JJ repeated) (NNS courses)) (PP (IN of) (NP (NN Zmax)))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

nn(Studies-3, Repeat-1)
nn(Studies-3, Treatment-2)
nsubjpass(conducted-15, Studies-3)
partmod(Studies-3, evaluating-4)
det(use-6, the-5)
dobj(evaluating-4, use-6)
amod(courses-9, repeated-8)
prep_of(use-6, courses-9)
prep_of(courses-9, Zmax-11)
aux(conducted-15, have-12)
neg(conducted-15, not-13)
auxpass(conducted-15, been-14)
root(ROOT-0, conducted-15)

Azlocillin/NN should/MD not/RB be/VB administered/VBN concomitantly/RB with/IN amikacin/NN ,/, ciprofloxacin/NN ,/, gentamicin/NN ,/, netilmicin/NN ,/, or/CC tobramycin/NN ./.

(ROOT (S1 (S (S (NP (NN Azlocillin)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN amikacin)) (, ,) (NP (NN ciprofloxacin)) (, ,) (NP (NN gentamicin)) (, ,) (NP (NN netilmicin)) (, ,) (CC or) (NP (NN tobramycin)))))))) (. .))))

nsubjpass(administered-5, Azlocillin-1)
aux(administered-5, should-2)
neg(administered-5, not-3)
auxpass(administered-5, be-4)
root(ROOT-0, administered-5)
advmod(administered-5, concomitantly-6)
prep_with(administered-5, amikacin-8)
conj_or(amikacin-8, ciprofloxacin-10)
conj_or(amikacin-8, gentamicin-12)
conj_or(amikacin-8, netilmicin-14)
conj_or(amikacin-8, tobramycin-17)

Injection/NN :/: There/EX is/VBZ inadequate/JJ systematic/JJ experience/VBP with/IN the/DT use/NN of/IN baclofen/NN injection/NN in/IN combination/NN with/IN other/JJ medications/NNS to/TO predict/VB specific/JJ drug-drug/JJ interactions/NNS ./.

(ROOT (S1 (S (NP (NP (NN Injection)) (: :) (S (NP (EX There)) (VP (VBZ is) (NP (NP (JJ inadequate) (JJ systematic) (VBP experience)) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN baclofen) (NN injection))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (NNS medications))) (S (VP (TO to) (VP (VB predict) (NP (JJ specific) (JJ drug-drug) (NNS interactions)))))))))))) (. .)))))

root(ROOT-0, Injection-1)
expl(is-4, There-3)
dep(Injection-1, is-4)
amod(systematic-6, inadequate-5)
nsubj(is-4, systematic-6)
dep(systematic-6, experience-7)
det(use-10, the-9)
prep_with(systematic-6, use-10)
nn(injection-13, baclofen-12)
prep_of(use-10, injection-13)
prep_in(use-10, combination-15)
amod(medications-18, other-17)
prep_with(combination-15, medications-18)
aux(predict-20, to-19)
infmod(combination-15, predict-20)
amod(interactions-23, specific-21)
amod(interactions-23, drug-drug-22)
dobj(predict-20, interactions-23)

Interactions/NNS attributed/VBN to/TO the/DT combined/JJ use/NN of/IN baclofen/JJ injection/NN and/CC epidural/JJ morphine/NN include/VBP hypotension/NN and/CC dyspnea/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Interactions)) (VP (VBN attributed) (PP (TO to) (NP (NP (DT the) (JJ combined) (NN use)) (PP (IN of) (NP (NP (JJ baclofen) (NN injection)) (CC and) (NP (JJ epidural) (NN morphine)))))))) (VP (VBP include) (NP (NP (NN hypotension)) (CC and) (NP (NN dyspnea))))) (. .))))

nsubj(include-13, Interactions-1)
partmod(Interactions-1, attributed-2)
det(use-6, the-4)
amod(use-6, combined-5)
prep_to(attributed-2, use-6)
amod(injection-9, baclofen-8)
prep_of(use-6, injection-9)
amod(morphine-12, epidural-11)
conj_and(injection-9, morphine-12)
root(ROOT-0, include-13)
dobj(include-13, hypotension-14)
conj_and(hypotension-14, dyspnea-16)

SIDE/JJ EFFECTS/NNS (/-LRB- KEMSTRO/NN )/-RRB- :/: The/DT most/RBS common/JJ adverse/JJ reaction/NN during/IN treatment/NN with/IN baclofen/NN is/VBZ transient/JJ drowsiness/NN (/-LRB- 10-63%)./CD

(ROOT (S1 (S (NP (NP (NP (JJ SIDE) (NNS EFFECTS)) (PRN (-LRB- -LRB-) (NP (NN KEMSTRO)) (-RRB- -RRB-))) (: :) (S (NP (NP (DT The) (ADJP (RBS most) (JJ common)) (JJ adverse) (NN reaction)) (PP (IN during) (NP (NN treatment))) (PP (IN with) (NP (NN baclofen)))) (VP (VBZ is) (NP (JJ transient) (NN drowsiness)))) (-LRB- -LRB-) (CD 10-63%-RRB-.)))))

amod(EFFECTS-2, SIDE-1)
root(ROOT-0, EFFECTS-2)
abbrev(EFFECTS-2, KEMSTRO-4)
det(reaction-11, The-7)
advmod(common-9, most-8)
amod(reaction-11, common-9)
amod(reaction-11, adverse-10)
nsubj(drowsiness-18, reaction-11)
prep_during(reaction-11, treatment-13)
prep_with(reaction-11, baclofen-15)
cop(drowsiness-18, is-16)
amod(drowsiness-18, transient-17)
dep(EFFECTS-2, drowsiness-18)
num(EFFECTS-2, 10-63%-RRB-.-20)

In/IN one/CD controlled/JJ study/NN of/IN 175/CD patients/NNS ,/, transient/JJ drowsiness/NN was/VBD observed/VBN in/IN 63/CD %/NN of/IN those/DT receiving/VBG baclofen/NN tablets/NNS compared/VBN to/TO 36/CD %/NN of/IN those/DT in/IN the/DT placebo/NN group/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (CD one) (JJ controlled) (NN study)) (PP (IN of) (NP (CD 175) (NNS patients))))) (, ,) (NP (JJ transient) (NN drowsiness)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (CD 63) (NN %)) (PP (IN of) (NP (DT those) (VBG receiving) (NN baclofen) (NNS tablets))))) (PP (VBN compared) (PP (TO to) (NP (NP (CD 36) (NN %)) (PP (IN of) (NP (NP (DT those)) (PP (IN in) (NP (DT the) (NN placebo) (NN group)))))))))) (. .))))

num(study-4, one-2)
amod(study-4, controlled-3)
prep_in(observed-12, study-4)
num(patients-7, 175-6)
prep_of(study-4, patients-7)
amod(drowsiness-10, transient-9)
nsubjpass(observed-12, drowsiness-10)
auxpass(observed-12, was-11)
root(ROOT-0, observed-12)
num(%-15, 63-14)
prep_in(observed-12, %-15)
det(tablets-20, those-17)
amod(tablets-20, receiving-18)
nn(tablets-20, baclofen-19)
prep_of(%-15, tablets-20)
prepc_compared_to(observed-12, to-22)
num(%-24, 36-23)
pobj(observed-12, %-24)
prep_of(%-24, those-26)
det(group-30, the-28)
nn(group-30, placebo-29)
prep_in(those-26, group-30)

The/DT following/JJ laboratory/NN tests/NNS have/VBP been/VBN found/VBN to/TO be/VB abnormal/JJ in/IN a/DT few/JJ patients/NNS receiving/VBG baclofen/NN :/: increased/VBN SGOT/NN ,/, elevated/JJ alkaline/NN phosphatase/NN ,/, and/CC elevation/NN of/IN blood/NN sugar/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (NN laboratory) (NNS tests)) (VP (VBP have) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJ abnormal) (PP (IN in) (NP (NP (NP (DT a) (JJ few) (NNS patients)) (VP (VBG receiving) (NP (NN baclofen)))) (: :) (NP (NP (VBN increased) (NN SGOT)) (, ,) (NP (JJ elevated) (NN alkaline) (NN phosphatase)) (, ,) (CC and) (NP (NP (NN elevation)) (PP (IN of) (NP (NN blood) (NN sugar))))))))))))))) (. .))))

det(tests-4, The-1)
amod(tests-4, following-2)
nn(tests-4, laboratory-3)
nsubjpass(found-7, tests-4)
xsubj(abnormal-10, tests-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
aux(abnormal-10, to-8)
cop(abnormal-10, be-9)
xcomp(found-7, abnormal-10)
det(patients-14, a-12)
amod(patients-14, few-13)
prep_in(abnormal-10, patients-14)
partmod(patients-14, receiving-15)
dobj(receiving-15, baclofen-16)
amod(SGOT-19, increased-18)
dep(patients-14, SGOT-19)
amod(phosphatase-23, elevated-21)
nn(phosphatase-23, alkaline-22)
conj_and(SGOT-19, phosphatase-23)
conj_and(SGOT-19, elevation-26)
nn(sugar-29, blood-28)
prep_of(elevation-26, sugar-29)

The/DT adverse/JJ experience/VBP profile/NN seen/VBN with/IN KEMSTROTM/NN was/VBD similar/JJ to/TO that/DT seen/VBN with/IN baclofen/JJ tablets/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ adverse) (VBP experience) (NN profile)) (VP (VBN seen) (PP (IN with) (NP (NN KEMSTROTM))))) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN seen) (PP (IN with) (NP (JJ baclofen) (NNS tablets))))))))) (. .))))

det(profile-4, The-1)
amod(profile-4, adverse-2)
dep(profile-4, experience-3)
nsubj(similar-9, profile-4)
partmod(profile-4, seen-5)
prep_with(seen-5, KEMSTROTM-7)
cop(similar-9, was-8)
root(ROOT-0, similar-9)
prep_to(similar-9, that-11)
partmod(that-11, seen-12)
amod(tablets-15, baclofen-14)
prep_with(seen-12, tablets-15)

Bentiromide/NN may/MD interact/VB with/IN acetaminophen/NN (/-LRB- e.g./FW ,/, Tylenol/NN )/-RRB- ,/, chloramphenicol/NN (/-LRB- e.g./FW ,/, Chloromycetin/NN )/-RRB- ,/, local/JJ anesthetics/NNS (/-LRB- e.g./FW ,/, benzocaine/NN and/CC lidocaine/NN )/-RRB- ,/, para-aminobenzoic/JJ acid/NN (/-LRB- PABA/NN )/-RRB- -containing/JJ preparations/NNS (/-LRB- e.g./FW ,/, sunscreens/NNS and/CC some/DT multivitamins/NNS )/-RRB- ,/, procainamide/NN (/-LRB- e.g./FW ,/, Pronestyl/NN )/-RRB- ,/, sulfonamides/NNS (/-LRB- sulfa/NN medicines/NNS )/-RRB- ,/, thiazide/NN diuretics/NNS (/-LRB- use/NN of/IN these/DT medicines/NNS during/IN the/DT test/NN period/NN will/MD affect/VB the/DT test/NN results/NNS )/-RRB- ,/, and/CC pancreatic/JJ supplements/NNS (/-LRB- use/NN of/IN pancreatic/JJ supplements/NNS may/MD give/VB false/JJ test/NN results/NNS )./RB

(ROOT (S1 (S (NP (NN Bentiromide)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (NP (NN acetaminophen)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Tylenol)) (-RRB- -RRB-))) (, ,) (NP (NP (NN chloramphenicol)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Chloromycetin)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ local) (NNS anesthetics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN benzocaine)) (CC and) (NP (NN lidocaine)))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ para-aminobenzoic) (ADJP (NN acid) (-LRB- -LRB-) (NN PABA) (-RRB- -RRB-) (JJ -containing)) (NNS preparations)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NNS sunscreens)) (CC and) (NP (DT some) (NNS multivitamins))) (-RRB- -RRB-))) (, ,) (NP (NP (NN procainamide)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Pronestyl))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS sulfonamides)) (PRN (-LRB- -LRB-) (NP (NN sulfa) (NNS medicines)) (-RRB- -RRB-))) (, ,) (NP (NP (NN thiazide) (NNS diuretics)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN use)) (PP (IN of) (NP (DT these) (NNS medicines))) (PP (IN during) (NP (DT the) (NN test) (NN period)))) (VP (MD will) (VP (VB affect) (NP (DT the) (NN test) (NNS results))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ pancreatic) (NNS supplements)))) (-LRB- -LRB-) (NP (NP (NN use)) (PP (IN of) (NP (JJ pancreatic) (NNS supplements)))))) (VP (MD may) (VP (VB give) (NP (JJ false) (NN test) (NNS results)) (ADVP (RB -RRB-.)))))))

nsubj(interact-3, Bentiromide-1)
aux(interact-3, may-2)
root(ROOT-0, interact-3)
prep_with(interact-3, acetaminophen-5)
dep(Tylenol-9, e.g.-7)
appos(acetaminophen-5, Tylenol-9)
conj_and(acetaminophen-5, chloramphenicol-12)
dep(Chloromycetin-16, e.g.-14)
appos(chloramphenicol-12, Chloromycetin-16)
amod(anesthetics-20, local-19)
conj_and(acetaminophen-5, anesthetics-20)
dep(anesthetics-20, e.g.-22)
pobj(e.g.-22, benzocaine-24)
conj_and(benzocaine-24, lidocaine-26)
amod(preparations-35, para-aminobenzoic-29)
dep(-containing-34, acid-30)
dep(-containing-34, PABA-32)
amod(preparations-35, -containing-34)
conj_and(acetaminophen-5, preparations-35)
dep(sunscreens-39, e.g.-37)
dep(preparations-35, sunscreens-39)
det(multivitamins-42, some-41)
conj_and(sunscreens-39, multivitamins-42)
conj_and(acetaminophen-5, procainamide-45)
dep(procainamide-45, e.g.-47)
pobj(e.g.-47, Pronestyl-49)
conj_and(acetaminophen-5, sulfonamides-52)
nn(medicines-55, sulfa-54)
appos(sulfonamides-52, medicines-55)
nn(diuretics-59, thiazide-58)
conj_and(acetaminophen-5, diuretics-59)
dep(diuretics-59, use-61)
det(medicines-64, these-63)
prep_of(use-61, medicines-64)
det(period-68, the-66)
nn(period-68, test-67)
prep_during(use-61, period-68)
aux(affect-70, will-69)
dep(use-61, affect-70)
det(results-73, the-71)
nn(results-73, test-72)
dobj(affect-70, results-73)
amod(supplements-78, pancreatic-77)
conj_and(acetaminophen-5, supplements-78)
dobj(interact-3, use-80)
amod(supplements-83, pancreatic-82)
prep_of(use-80, supplements-83)
aux(give-85, may-84)
dep(interact-3, give-85)
amod(results-88, false-86)
nn(results-88, test-87)
dobj(give-85, results-88)
advmod(give-85, -RRB-.-89)

Hypertensive/JJ crises/NNS have/VBP resulted/VBD when/WRB sympathomimetic/JJ amines/NNS have/VBP been/VBN used/VBN concomitantly/RB within14/CD days/NNS following/VBG use/NN of/IN monoamine/NN oxidase/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (JJ Hypertensive) (NNS crises)) (VP (VBP have) (S (VP (VBD resulted) (SBAR (WHADVP (WRB when)) (S (NP (JJ sympathomimetic) (NNS amines)) (VP (VBP have) (VP (VBN been) (VP (VBN used) (ADVP (RB concomitantly)) (PP (NP (CD within14) (NNS days)) (VBG following) (NP (NP (NN use)) (PP (IN of) (NP (NN monoamine) (NN oxidase) (NNS inhibitors)))))))))))))) (. .))))

amod(crises-2, Hypertensive-1)
nsubj(have-3, crises-2)
root(ROOT-0, have-3)
ccomp(have-3, resulted-4)
advmod(used-10, when-5)
amod(amines-7, sympathomimetic-6)
nsubjpass(used-10, amines-7)
aux(used-10, have-8)
auxpass(used-10, been-9)
advcl(resulted-4, used-10)
advmod(used-10, concomitantly-11)
num(days-13, within14-12)
dep(used-10, days-13)
prep_following(used-10, use-15)
nn(inhibitors-19, monoamine-17)
nn(inhibitors-19, oxidase-18)
prep_of(use-15, inhibitors-19)

DIDREX/NN should/MD not/RB be/VB used/VBN concomitantly/RB with/IN other/JJ CNS/NN stimulants/NNS ./.

(ROOT (S1 (S (S (NP (NN DIDREX)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ other) (NN CNS) (NNS stimulants))))))) (. .))))

nsubjpass(used-5, DIDREX-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
advmod(used-5, concomitantly-6)
amod(stimulants-10, other-8)
nn(stimulants-10, CNS-9)
prep_with(used-5, stimulants-10)

Amphetamines/NN may/MD decrease/VB the/DT hypotensive/JJ effect/NN of/IN antihypertensives/NNS ./.

(ROOT (S1 (S (S (NP (NN Amphetamines)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (NNS antihypertensives))))))) (. .))))

nsubj(decrease-3, Amphetamines-1)
aux(decrease-3, may-2)
root(ROOT-0, decrease-3)
det(effect-6, the-4)
amod(effect-6, hypotensive-5)
dobj(decrease-3, effect-6)
prep_of(effect-6, antihypertensives-8)

Amphetamines/NN may/MD enhance/VB the/DT effects/NNS of/IN tricyclic/JJ antidepressants/NNS ./.

(ROOT (S1 (S (S (NP (NN Amphetamines)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants))))))) (. .))))

nsubj(enhance-3, Amphetamines-1)
aux(enhance-3, may-2)
root(ROOT-0, enhance-3)
det(effects-5, the-4)
dobj(enhance-3, effects-5)
amod(antidepressants-8, tricyclic-7)
prep_of(effects-5, antidepressants-8)

Urinary/JJ alkalinizing/NN agents/NNS increase/VBP blood/NN levels/NNS and/CC decrease/VBP excretion/NN of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (JJ Urinary) (NN alkalinizing) (NNS agents)) (VP (VP (VBP increase) (NP (NN blood) (NNS levels))) (CC and) (VP (VBP decrease) (NP (NP (NN excretion)) (PP (IN of) (NP (NN amphetamines))))))) (. .))))

amod(agents-3, Urinary-1)
nn(agents-3, alkalinizing-2)
nsubj(increase-4, agents-3)
root(ROOT-0, increase-4)
nn(levels-6, blood-5)
dobj(increase-4, levels-6)
conj_and(increase-4, decrease-8)
dobj(decrease-8, excretion-9)
prep_of(excretion-9, amphetamines-11)

Urinary/JJ acidifying/JJ agents/NNS decrease/VB blood/NN levels/NNS and/CC increase/VB excretion/NN of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (JJ Urinary) (JJ acidifying) (NNS agents)) (VP (VP (VB decrease) (NP (NN blood) (NNS levels))) (CC and) (VP (VB increase) (NP (NP (NN excretion)) (PP (IN of) (NP (NN amphetamines))))))) (. .))))

amod(agents-3, Urinary-1)
amod(agents-3, acidifying-2)
nsubj(decrease-4, agents-3)
root(ROOT-0, decrease-4)
nn(levels-6, blood-5)
dobj(decrease-4, levels-6)
conj_and(decrease-4, increase-8)
dobj(increase-8, excretion-9)
prep_of(excretion-9, amphetamines-11)

Benzthiazide/NN may/MD interact/VB with/IN alcohol/NN ,/, blood/NN thinner/NN s/NNS ,/, decongestant/JJ drugs/NNS (/-LRB- allergy/NN ,/, cold/NN ,/, and/CC sinus/NN medicines/NNS )/-RRB- ,/, diabetic/JJ drugs/NNS ,/, lithium/NN ,/, norepinephrine/NN ,/, NSAIDs/NNS like/IN Aleve/NN or/CC Ibuprofen/NN ,/, and/CC high/JJ blood/NN pressure/NN medications/NNS ./.

(ROOT (S1 (S (S (NP (NN Benzthiazide)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (NN alcohol)) (, ,) (NP (NN blood) (NN thinner) (NNS s)) (, ,) (NP (NP (JJ decongestant) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NP (NN allergy)) (, ,) (NP (NN cold)) (, ,) (CC and) (NP (NN sinus) (NNS medicines))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ diabetic) (NNS drugs)) (, ,) (NP (NP (NN lithium)) (, ,) (NP (NN norepinephrine)) (, ,) (NP (NP (NNS NSAIDs)) (PP (IN like) (NP (NN Aleve)))) (CC or) (NP (NN Ibuprofen))) (, ,)) (CC and) (NP (JJ high) (NN blood) (NN pressure)) (NP (NNS medications))))))) (. .))))

nsubj(interact-3, Benzthiazide-1)
aux(interact-3, may-2)
root(ROOT-0, interact-3)
prep_with(interact-3, alcohol-5)
nn(s-9, blood-7)
nn(s-9, thinner-8)
conj_and(alcohol-5, s-9)
amod(drugs-12, decongestant-11)
conj_and(alcohol-5, drugs-12)
dep(drugs-12, allergy-14)
conj_and(allergy-14, cold-16)
nn(medicines-20, sinus-19)
conj_and(allergy-14, medicines-20)
amod(drugs-24, diabetic-23)
conj_and(alcohol-5, drugs-24)
appos(drugs-24, lithium-26)
conj_or(lithium-26, norepinephrine-28)
conj_or(lithium-26, NSAIDs-30)
prep_like(NSAIDs-30, Aleve-32)
conj_or(lithium-26, Ibuprofen-34)
amod(pressure-39, high-37)
nn(pressure-39, blood-38)
conj_and(alcohol-5, pressure-39)
dep(alcohol-5, medications-40)

No/DT formal/JJ drug/NN interaction/NN studies/NNS with/IN anti-neoplastic/JJ agents/NNS have/VBP been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ formal) (NN drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (JJ anti-neoplastic) (NNS agents)))) (VP (VBP have) (VP (VBN been) (VP (VBN conducted))))) (. .))))

det(studies-5, No-1)
amod(studies-5, formal-2)
nn(studies-5, drug-3)
nn(studies-5, interaction-4)
nsubjpass(conducted-11, studies-5)
amod(agents-8, anti-neoplastic-7)
prep_with(studies-5, agents-8)
aux(conducted-11, have-9)
auxpass(conducted-11, been-10)
root(ROOT-0, conducted-11)

In/IN Study/NN 1/CD ,/, patients/NNS with/IN colorectal/JJ cancer/NN were/VBD given/VBN irinotecan/NN /5-FU/leucovorin/NN (/-LRB- bolus-IFL/NN )/-RRB- with/IN or/CC without/IN AVASTIN/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN Study) (CD 1))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ colorectal) (NN cancer)))) (VP (VBD were) (VP (VBN given) (NP (NP (NN irinotecan) (NN /5-FU/leucovorin)) (PRN (-LRB- -LRB-) (NP (NN bolus-IFL)) (-RRB- -RRB-))) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN AVASTIN))))))) (. .))))

prep_in(given-10, Study-2)
num(Study-2, 1-3)
nsubjpass(given-10, patients-5)
amod(cancer-8, colorectal-7)
prep_with(patients-5, cancer-8)
auxpass(given-10, were-9)
root(ROOT-0, given-10)
nn(/5-FU/leucovorin-12, irinotecan-11)
dobj(given-10, /5-FU/leucovorin-12)
appos(/5-FU/leucovorin-12, bolus-IFL-14)
prep(given-10, with-16)
conj_or(with-16, without-18)
pobj(without-18, AVASTIN-19)

Irinotecan/NN concentrations/NNS were/VBD similar/JJ in/IN patients/NNS receiving/VBG bolus-IFL/NN alone/RB and/CC in/IN combination/NN with/IN AVASTIN/NN ./.

(ROOT (S1 (S (S (NP (NN Irinotecan) (NNS concentrations)) (VP (VBD were) (ADJP (JJ similar) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN bolus-IFL)))))) (UCP (ADVP (RB alone)) (CC and) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN AVASTIN)))))))) (. .))))

nn(concentrations-2, Irinotecan-1)
nsubj(similar-4, concentrations-2)
cop(similar-4, were-3)
root(ROOT-0, similar-4)
prep_in(similar-4, patients-6)
partmod(patients-6, receiving-7)
dobj(receiving-7, bolus-IFL-8)
dep(similar-4, alone-9)
conj_and(alone-9, in-11)
pobj(in-11, combination-12)
prep_with(combination-12, AVASTIN-14)

The/DT concentrations/NNS of/IN SN38/NN ,/, the/DT active/JJ metabolite/NN of/IN irinotecan/NN ,/, were/VBD on/IN average/NN 33/CD %/NN higher/JJR in/IN patients/NNS receiving/VBG bolus-IFL/NN in/IN combination/NN with/IN AVASTIN/NN when/WRB compared/VBN with/IN bolus-IFL/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS concentrations)) (PP (IN of) (NP (NP (NN SN38)) (, ,) (NP (NP (DT the) (JJ active) (NN metabolite)) (PP (IN of) (NP (NN irinotecan)))) (, ,)))) (VP (VBD were) (PP (IN on) (NP (NN average))) (ADJP (NP (CD 33) (NN %)) (JJR higher) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN bolus-IFL)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN AVASTIN))))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NP (NN bolus-IFL)) (ADVP (RB alone))))))))) (. .))))

det(concentrations-2, The-1)
nsubj(higher-17, concentrations-2)
prep_of(concentrations-2, SN38-4)
det(metabolite-8, the-6)
amod(metabolite-8, active-7)
appos(SN38-4, metabolite-8)
prep_of(metabolite-8, irinotecan-10)
cop(higher-17, were-12)
prep_on(higher-17, average-14)
num(%-16, 33-15)
npadvmod(higher-17, %-16)
root(ROOT-0, higher-17)
prep_in(higher-17, patients-19)
partmod(patients-19, receiving-20)
dobj(receiving-20, bolus-IFL-21)
prep_in(receiving-20, combination-23)
prep_with(combination-23, AVASTIN-25)
advmod(compared-27, when-26)
advcl(higher-17, compared-27)
prep_with(compared-27, bolus-IFL-29)
advmod(bolus-IFL-29, alone-30)

In/IN Study/NN 1/CD ,/, patients/NNS receiving/VBG bolus-IFL/NN plus/CC AVASTIN/NN had/VBD a/DT higher/JJR incidence/NN of/IN Grade/NN 3-4/JJ diarrhea/NN and/CC neutropenia/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN Study) (CD 1))) (, ,) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN bolus-IFL)) (CC plus) (NP (NN AVASTIN))))) (VP (VBD had) (NP (NP (DT a) (JJR higher) (NN incidence)) (PP (IN of) (NP (NP (NN Grade) (JJ 3-4) (NN diarrhea)) (CC and) (NP (NN neutropenia))))))) (. .))))

prep_in(had-10, Study-2)
num(Study-2, 1-3)
nsubj(had-10, patients-5)
partmod(patients-5, receiving-6)
dobj(receiving-6, bolus-IFL-7)
conj_plus(bolus-IFL-7, AVASTIN-9)
root(ROOT-0, had-10)
det(incidence-13, a-11)
amod(incidence-13, higher-12)
dobj(had-10, incidence-13)
nn(diarrhea-17, Grade-15)
amod(diarrhea-17, 3-4-16)
prep_of(incidence-13, diarrhea-17)
conj_and(diarrhea-17, neutropenia-19)

Due/JJ to/TO high/JJ inter-patient/JJ variability/NN and/CC limited/JJ sampling/NN ,/, the/DT extent/NN of/IN the/DT increase/NN in/IN SN38/NN levels/NNS in/IN patients/NNS receiving/VBG concurrent/JJ irinotecan/NN and/CC AVASTIN/NN is/VBZ uncertain/JJ ./.

(ROOT (S1 (S (S (PP (JJ Due) (TO to) (NP (NP (JJ high) (JJ inter-patient) (NN variability)) (CC and) (NP (JJ limited) (NN sampling)))) (, ,) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN SN38) (NNS levels))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ concurrent) (NN irinotecan)))))) (CC and) (NP (NN AVASTIN))))) (VP (VBZ is) (ADJP (JJ uncertain)))) (. .))))

amod(variability-5, high-3)
amod(variability-5, inter-patient-4)
prep_due_to(uncertain-26, variability-5)
amod(sampling-8, limited-7)
conj_and(variability-5, sampling-8)
det(extent-11, the-10)
nsubj(uncertain-26, extent-11)
det(increase-14, the-13)
prep_of(extent-11, increase-14)
nn(levels-17, SN38-16)
prep_in(increase-14, levels-17)
prep_in(increase-14, patients-19)
partmod(patients-19, receiving-20)
amod(irinotecan-22, concurrent-21)
dobj(receiving-20, irinotecan-22)
conj_and(increase-14, AVASTIN-24)
cop(uncertain-26, is-25)
root(ROOT-0, uncertain-26)

In/FW vitro/FW studies/NNS have/VBP shown/VBN CASODEX/NN can/MD displace/VB coumarin/NN anticoagulant/NN s/NNS ,/, such/JJ as/IN warfarin/NN ,/, from/IN their/PRP$ protein/NN -binding/JJ sites/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN shown) (S (NP (NN CASODEX)) (VP (MD can) (VP (VB displace) (NP (NP (NN coumarin) (NN anticoagulant) (NNS s)) (, ,) (ADJP (JJ such) (PP (IN as) (NP (NN warfarin)))) (, ,)) (PP (IN from) (NP (PRP$ their) (ADJP (NN protein) (JJ -binding)) (NNS sites))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
nsubj(displace-8, CASODEX-6)
aux(displace-8, can-7)
ccomp(shown-5, displace-8)
nn(s-11, coumarin-9)
nn(s-11, anticoagulant-10)
dobj(displace-8, s-11)
prep_such_as(s-11, warfarin-15)
poss(sites-21, their-18)
dep(-binding-20, protein-19)
amod(sites-21, -binding-20)
prep_from(displace-8, sites-21)

It/PRP is/VBZ recommended/VBN that/IN if/IN CASODEX/NN is/VBZ started/VBN in/IN patients/NNS already/RB receiving/VBG coumarin/NN anticoagulant/NN s/NNS ,/, prothrombin/NN times/NNS should/MD be/VB closely/RB monitored/VBN and/CC adjustment/NN of/IN the/DT anticoagulant/JJ dose/NN may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (SBAR (IN if) (S (NP (NN CASODEX)) (VP (VBZ is) (VP (VBN started) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB already)) (VBG receiving) (NP (NN coumarin) (NN anticoagulant) (NNS s))))))))) (, ,) (S (S (NP (NN prothrombin) (NNS times)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored))))) (CC and) (S (NP (NP (NN adjustment)) (PP (IN of) (NP (DT the) (JJ anticoagulant) (NN dose)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(monitored-22, that-4)
mark(started-8, if-5)
nsubjpass(started-8, CASODEX-6)
auxpass(started-8, is-7)
advcl(monitored-22, started-8)
prep_in(started-8, patients-10)
advmod(receiving-12, already-11)
partmod(patients-10, receiving-12)
nn(s-15, coumarin-13)
nn(s-15, anticoagulant-14)
dobj(receiving-12, s-15)
nn(times-18, prothrombin-17)
nsubjpass(monitored-22, times-18)
aux(monitored-22, should-19)
auxpass(monitored-22, be-20)
advmod(monitored-22, closely-21)
ccomp(recommended-3, monitored-22)
nsubj(necessary-31, adjustment-24)
det(dose-28, the-26)
amod(dose-28, anticoagulant-27)
prep_of(adjustment-24, dose-28)
aux(necessary-31, may-29)
cop(necessary-31, be-30)
conj_and(monitored-22, necessary-31)

No/DT formal/JJ drug/NN interaction/NN studies/NNS have/VBP been/VBN conducted/VBN with/IN VELCADE/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ formal) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (PP (IN with) (NP (NN VELCADE))))))) (. .))))

det(studies-5, No-1)
amod(studies-5, formal-2)
nn(studies-5, drug-3)
nn(studies-5, interaction-4)
nsubjpass(conducted-8, studies-5)
aux(conducted-8, have-6)
auxpass(conducted-8, been-7)
root(ROOT-0, conducted-8)
prep_with(conducted-8, VELCADE-10)

In/FW vitro/FW studies/NNS with/IN human/JJ liver/NN microsomes/NNS indicate/VBP that/IN bortezomib/NN is/VBZ primarily/RB a/DT substrate/NN for/IN cytochrome/NN P450/NN 3A4/NN ,/, 2C19/NN ,/, and/CC 1A2/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (PP (IN with) (NP (JJ human) (NN liver) (NNS microsomes)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN bortezomib)) (VP (VBZ is) (ADVP (RB primarily)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NP (NN cytochrome) (NN P450) (NN 3A4)) (, ,) (NP (NN 2C19)) (, ,) (CC and) (NP (NN 1A2)))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicate-8, studies-3)
amod(microsomes-7, human-5)
nn(microsomes-7, liver-6)
prep_with(studies-3, microsomes-7)
root(ROOT-0, indicate-8)
complm(substrate-14, that-9)
nsubj(substrate-14, bortezomib-10)
cop(substrate-14, is-11)
advmod(substrate-14, primarily-12)
det(substrate-14, a-13)
ccomp(indicate-8, substrate-14)
nn(3A4-18, cytochrome-16)
nn(3A4-18, P450-17)
prep_for(substrate-14, 3A4-18)
conj_and(3A4-18, 2C19-20)
conj_and(3A4-18, 1A2-23)

Patients/NNS who/WP are/VBP concomitantly/RB receiving/VBG VELCADE/NN and/CC drugs/NNS that/WDT are/VBP inhibitors/NNS or/CC inducers/NNS of/IN cytochrome/NN P450/NN 3A4/NN should/MD be/VB closely/RB monitored/VBN for/IN either/CC toxicities/NNS or/CC reduced/VBN efficacy/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB concomitantly)) (VP (VBG receiving) (NP (NP (NP (NN VELCADE)) (CC and) (NP (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NP (NNS inhibitors)) (CC or) (NP (NNS inducers))) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN 3A4))))))))))))) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored) (PP (IN for) (NP (CC either) (NP (NNS toxicities)) (CC or) (NP (VBN reduced) (NN efficacy)))))))) (. .))))

nsubj(receiving-5, Patients-1)
nsubjpass(monitored-21, Patients-1)
aux(receiving-5, are-3)
advmod(receiving-5, concomitantly-4)
rcmod(Patients-1, receiving-5)
dobj(receiving-5, VELCADE-6)
nsubj(inhibitors-11, VELCADE-6)
conj_and(VELCADE-6, drugs-8)
cop(inhibitors-11, are-10)
rcmod(VELCADE-6, inhibitors-11)
conj_or(inhibitors-11, inducers-13)
nn(3A4-17, cytochrome-15)
nn(3A4-17, P450-16)
prep_of(inhibitors-11, 3A4-17)
aux(monitored-21, should-18)
auxpass(monitored-21, be-19)
advmod(monitored-21, closely-20)
root(ROOT-0, monitored-21)
preconj(toxicities-24, either-23)
prep_for(monitored-21, toxicities-24)
amod(efficacy-27, reduced-26)
conj_or(toxicities-24, efficacy-27)

During/IN clinical/JJ trials/NNS ,/, hypoglycemia/NN and/CC hyperglycemia/NN were/VBD reported/VBN in/IN diabetic/JJ patients/NNS receiving/VBG oral/JJ hypoglycemics/NNS ./.

(ROOT (S1 (S (S (PP (IN During) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NP (NN hypoglycemia)) (CC and) (NP (NN hyperglycemia))) (VP (VBD were) (VP (VBN reported) (PP (IN in) (NP (NP (JJ diabetic) (NNS patients)) (VP (VBG receiving) (NP (JJ oral) (NNS hypoglycemics)))))))) (. .))))

amod(trials-3, clinical-2)
prep_during(reported-9, trials-3)
nsubjpass(reported-9, hypoglycemia-5)
conj_and(hypoglycemia-5, hyperglycemia-7)
auxpass(reported-9, were-8)
root(ROOT-0, reported-9)
amod(patients-12, diabetic-11)
prep_in(reported-9, patients-12)
partmod(patients-12, receiving-13)
amod(hypoglycemics-15, oral-14)
dobj(receiving-13, hypoglycemics-15)

Patients/NNS on/IN oral/JJ antidiabetic/JJ agents/NNS receiving/VBG VELCADE/NN treatment/NN may/MD require/VB close/JJ monitoring/NN of/IN their/PRP$ blood/NN glucose/NN levels/NNS and/CC adjustment/NN of/IN the/DT dose/NN of/IN their/PRP$ antidiabetic/JJ medication/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN on) (NP (NP (JJ oral) (JJ antidiabetic) (NNS agents)) (VP (VBG receiving) (NP (NN VELCADE) (NN treatment)))))) (VP (MD may) (VP (VB require) (NP (NP (NP (JJ close) (NN monitoring)) (PP (IN of) (NP (PRP$ their) (NN blood) (NN glucose) (NNS levels)))) (CC and) (NP (NP (NN adjustment)) (PP (IN of) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (PRP$ their) (JJ antidiabetic) (NN medication)))))))))) (. .))))

nsubj(require-10, Patients-1)
amod(agents-5, oral-3)
amod(agents-5, antidiabetic-4)
prep_on(Patients-1, agents-5)
partmod(agents-5, receiving-6)
nn(treatment-8, VELCADE-7)
dobj(receiving-6, treatment-8)
aux(require-10, may-9)
root(ROOT-0, require-10)
amod(monitoring-12, close-11)
dobj(require-10, monitoring-12)
poss(levels-17, their-14)
nn(levels-17, blood-15)
nn(levels-17, glucose-16)
prep_of(monitoring-12, levels-17)
conj_and(monitoring-12, adjustment-19)
det(dose-22, the-21)
prep_of(adjustment-19, dose-22)
poss(medication-26, their-24)
amod(medication-26, antidiabetic-25)
prep_of(dose-22, medication-26)

Co-administration/NN of/IN BOTOX/NN @/NN and/CC aminoglycosides/NNS or/CC other/JJ agents/NNS interfering/VBG with/IN neuromuscular/JJ transmission/NN (/-LRB- e.g./FW ,/, curare/NN -like/JJ compounds/NNS )/-RRB- should/MD only/RB be/VB performed/VBN with/IN caution/NN as/IN the/DT effect/NN of/IN the/DT toxin/NN may/MD be/VB potentiated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN BOTOX) (NN @)) (CC and) (NP (NP (NP (NNS aminoglycosides)) (CC or) (NP (NP (JJ other) (NNS agents)) (VP (VBG interfering) (PP (IN with) (NP (JJ neuromuscular) (NN transmission)))))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN curare) (JJ -like) (NNS compounds)) (-RRB- -RRB-)))))) (VP (MD should) (ADVP (RB only)) (VP (VB be) (VP (VBN performed) (PP (IN with) (NP (NN caution))) (SBAR (IN as) (S (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (DT the) (NN toxin)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated)))))))))) (. .))))

nsubjpass(performed-24, Co-administration-1)
nn(@-4, BOTOX-3)
prep_of(Co-administration-1, @-4)
conj_and(@-4, aminoglycosides-6)
amod(agents-9, other-8)
conj_or(aminoglycosides-6, agents-9)
partmod(agents-9, interfering-10)
amod(transmission-13, neuromuscular-12)
prep_with(interfering-10, transmission-13)
dep(compounds-19, e.g.-15)
nn(compounds-19, curare-17)
amod(compounds-19, -like-18)
appos(aminoglycosides-6, compounds-19)
aux(performed-24, should-21)
advmod(performed-24, only-22)
auxpass(performed-24, be-23)
root(ROOT-0, performed-24)
prep_with(performed-24, caution-26)
mark(potentiated-35, as-27)
det(effect-29, the-28)
nsubjpass(potentiated-35, effect-29)
det(toxin-32, the-31)
prep_of(effect-29, toxin-32)
aux(potentiated-35, may-33)
auxpass(potentiated-35, be-34)
advcl(performed-24, potentiated-35)

The/DT effect/NN of/IN administering/VBG different/JJ botulinum/NN neurotoxin/NN serotypes/NNS at/IN the/DT same/JJ time/NN or/CC within/IN several/JJ months/NNS of/IN each/DT other/JJ is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (S (VP (VBG administering) (NP (JJ different) (NN botulinum) (NN neurotoxin) (NNS serotypes)) (PP (PP (IN at) (NP (DT the) (JJ same) (NN time))) (CC or) (PP (IN within) (NP (NP (JJ several) (NNS months)) (PP (IN of) (NP (DT each) (JJ other)))))))))) (VP (VBZ is) (ADJP (JJ unknown)))) (. .))))

det(effect-2, The-1)
nsubj(unknown-21, effect-2)
prepc_of(effect-2, administering-4)
conj_or(administering-4, administering-4')
amod(serotypes-8, different-5)
nn(serotypes-8, botulinum-6)
nn(serotypes-8, neurotoxin-7)
dobj(administering-4, serotypes-8)
det(time-12, the-10)
amod(time-12, same-11)
prep_at(administering-4, time-12)
amod(months-16, several-15)
prep_within(administering-4', months-16)
det(other-19, each-18)
prep_of(months-16, other-19)
cop(unknown-21, is-20)
root(ROOT-0, unknown-21)

Excessive/JJ neuromuscular/NN weakness/NN may/MD be/VB exacerbated/JJ by/IN administration/NN of/IN another/DT botulinum/NN toxin/NN prior/JJ to/TO the/DT resolution/NN of/IN the/DT effects/NNS of/IN a/DT previously/RB administered/VBN botulinum/NN toxin/NN ./.

(ROOT (S1 (S (S (NP (JJ Excessive) (NN neuromuscular) (NN weakness)) (VP (MD may) (VP (VB be) (ADJP (JJ exacerbated) (PP (IN by) (NP (NP (NN administration)) (PP (IN of) (NP (NP (DT another) (NN botulinum) (NN toxin)) (ADJP (JJ prior) (PP (TO to) (NP (NP (DT the) (NN resolution)) (PP (IN of) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT a) (ADJP (RB previously) (VBN administered)) (NN botulinum) (NN toxin)))))))))))))))) (. .))))

amod(weakness-3, Excessive-1)
nn(weakness-3, neuromuscular-2)
nsubj(exacerbated-6, weakness-3)
aux(exacerbated-6, may-4)
cop(exacerbated-6, be-5)
root(ROOT-0, exacerbated-6)
prep_by(exacerbated-6, administration-8)
det(toxin-12, another-10)
nn(toxin-12, botulinum-11)
prep_of(administration-8, toxin-12)
det(resolution-16, the-15)
prep_prior_to(toxin-12, resolution-16)
det(effects-19, the-18)
prep_of(resolution-16, effects-19)
det(toxin-25, a-21)
advmod(administered-23, previously-22)
amod(toxin-25, administered-23)
nn(toxin-25, botulinum-24)
prep_of(effects-19, toxin-25)

Digitalis/NN toxicity/NN may/MD be/VB aggravated/VBN by/IN the/DT initial/JJ release/NN of/IN norepinephrine/NN caused/VBN by/IN Bretylium/NN Tosylate/NN Injection/NN ./.

(ROOT (S1 (S (S (NP (NN Digitalis) (NN toxicity)) (VP (MD may) (VP (VB be) (VP (VBN aggravated) (PP (IN by) (NP (NP (DT the) (JJ initial) (NN release)) (PP (IN of) (NP (NP (NN norepinephrine)) (VP (VBN caused) (PP (IN by) (NP (NP (NN Bretylium) (NN Tosylate)) (NN Injection)))))))))))) (. .))))

nn(toxicity-2, Digitalis-1)
nsubjpass(aggravated-5, toxicity-2)
aux(aggravated-5, may-3)
auxpass(aggravated-5, be-4)
root(ROOT-0, aggravated-5)
det(release-9, the-7)
amod(release-9, initial-8)
agent(aggravated-5, release-9)
prep_of(release-9, norepinephrine-11)
partmod(norepinephrine-11, caused-12)
nn(Tosylate-15, Bretylium-14)
nn(Injection-16, Tosylate-15)
agent(caused-12, Injection-16)

The/DT pressor/NN effects/NNS of/IN catecholamines/NNS such/JJ as/IN dopamine/NN or/CC norepinephrine/NN are/VBP enhanced/VBN by/IN Bretylium/NN Tosylate/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN pressor) (NNS effects)) (PP (IN of) (NP (NNS catecholamines))) (PP (JJ such) (IN as) (NP (NP (NN dopamine)) (CC or) (NP (NN norepinephrine))))) (VP (VBP are) (VP (VBN enhanced) (PP (IN by) (NP (NN Bretylium) (NN Tosylate)))))) (. .))))

det(effects-3, The-1)
nn(effects-3, pressor-2)
nsubjpass(enhanced-12, effects-3)
prep_of(effects-3, catecholamines-5)
prep_such_as(effects-3, dopamine-8)
conj_or(dopamine-8, norepinephrine-10)
auxpass(enhanced-12, are-11)
root(ROOT-0, enhanced-12)
nn(Tosylate-15, Bretylium-14)
agent(enhanced-12, Tosylate-15)

Although/IN there/EX is/VBZ little/JJ published/VBN information/NN on/IN concomitant/JJ administration/NN of/IN lidocaine/NN and/CC Bretylium/NN Tosylate/NN ,/, these/DT drugs/NNS are/VBP often/RB administered/VBN concurrently/RB without/IN any/DT evidence/NN of/IN interactions/NNS resulting/VBG in/IN adverse/JJ effects/NNS or/CC diminished/VBN efficacy/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBZ is) (NP (NP (JJ little) (VBN published) (NN information)) (PP (IN on) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN lidocaine)) (CC and) (NP (NN Bretylium) (NN Tosylate)))))))))) (, ,) (NP (DT these) (NNS drugs)) (VP (VBP are) (ADVP (RB often)) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN without) (NP (NP (DT any) (NN evidence)) (PP (IN of) (NP (NP (NNS interactions)) (VP (VBG resulting) (PP (IN in) (NP (NP (JJ adverse) (NNS effects)) (CC or) (NP (VBN diminished) (NN efficacy)))))))))))) (. .))))

mark(is-3, Although-1)
expl(is-3, there-2)
advcl(administered-20, is-3)
amod(information-6, little-4)
amod(information-6, published-5)
nsubj(is-3, information-6)
amod(administration-9, concomitant-8)
prep_on(information-6, administration-9)
prep_of(administration-9, lidocaine-11)
nn(Tosylate-14, Bretylium-13)
conj_and(lidocaine-11, Tosylate-14)
det(drugs-17, these-16)
nsubjpass(administered-20, drugs-17)
auxpass(administered-20, are-18)
advmod(administered-20, often-19)
root(ROOT-0, administered-20)
advmod(administered-20, concurrently-21)
det(evidence-24, any-23)
prep_without(administered-20, evidence-24)
prep_of(evidence-24, interactions-26)
partmod(interactions-26, resulting-27)
amod(effects-30, adverse-29)
prep_in(resulting-27, effects-30)
amod(efficacy-33, diminished-32)
conj_or(effects-30, efficacy-33)

Concomitant/JJ oral/JJ administration/NN of/IN ketoconazole/NN (/-LRB- a/DT known/JJ inhibitor/NN of/IN CYP3A4/NN activity/NN in/IN the/DT liver/NN and/CC in/IN the/DT intestinal/JJ mucosa/NN )/-RRB- caused/VBD an/DT eight-fold/JJ increase/NN of/IN the/DT systemic/JJ exposure/NN to/TO oral/JJ budesonide/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (JJ oral) (NN administration)) (PP (IN of) (NP (NP (NN ketoconazole)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (JJ known) (NN inhibitor)) (PP (IN of) (NP (NP (NN CYP3A4) (NN activity)) (PP (PP (IN in) (NP (DT the) (NN liver))) (CC and) (PP (IN in) (NP (DT the) (JJ intestinal) (NN mucosa))))))) (-RRB- -RRB-))))) (VP (VBD caused) (NP (NP (DT an) (JJ eight-fold) (NN increase)) (PP (IN of) (NP (NP (DT the) (JJ systemic) (NN exposure)) (PP (TO to) (NP (JJ oral) (NN budesonide)))))))) (. .))))

amod(administration-3, Concomitant-1)
amod(administration-3, oral-2)
nsubj(caused-22, administration-3)
prep_of(administration-3, ketoconazole-5)
det(inhibitor-9, a-7)
amod(inhibitor-9, known-8)
dep(ketoconazole-5, inhibitor-9)
nn(activity-12, CYP3A4-11)
prep_of(inhibitor-9, activity-12)
det(liver-15, the-14)
prep_in(activity-12, liver-15)
det(mucosa-20, the-18)
amod(mucosa-20, intestinal-19)
conj_and(liver-15, mucosa-20)
root(ROOT-0, caused-22)
det(increase-25, an-23)
amod(increase-25, eight-fold-24)
dobj(caused-22, increase-25)
det(exposure-29, the-27)
amod(exposure-29, systemic-28)
prep_of(increase-25, exposure-29)
amod(budesonide-32, oral-31)
prep_to(exposure-29, budesonide-32)

If/IN treatment/NN with/IN inhibitors/NNS of/IN CYP3A4/NN activity/NN (/-LRB- such/JJ as/IN ketoconazole/NN ,/, intraconazole/NN ,/, ritonavir/NN ,/, indinavir/NN ,/, saquinavir/NN ,/, erythromycin/NN ,/, etc./NN )/-RRB- is/VBZ indicated/VBN ,/, reduction/NN of/IN the/DT budesonide/NN dose/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NP (NN CYP3A4) (NN activity)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (JJ such) (PP (IN as) (NP (NN ketoconazole))))) (, ,) (NP (NN intraconazole)) (, ,) (NP (NP (NN ritonavir)) (, ,) (NP (NN indinavir)) (, ,) (NP (NN saquinavir)) (, ,) (NP (NN erythromycin))) (, ,) (NP (NN etc.))) (-RRB- -RRB-))))))) (VP (VBZ is) (VP (VBN indicated))))) (, ,) (NP (NP (NN reduction)) (PP (IN of) (NP (DT the) (NN budesonide) (NN dose)))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

mark(indicated-26, If-1)
nsubjpass(indicated-26, treatment-2)
prep_with(treatment-2, inhibitors-4)
nn(activity-7, CYP3A4-6)
prep_of(inhibitors-4, activity-7)
prep_such_as(activity-7, ketoconazole-11)
appos(activity-7, intraconazole-13)
appos(activity-7, ritonavir-15)
appos(ritonavir-15, indinavir-17)
appos(ritonavir-15, saquinavir-19)
appos(ritonavir-15, erythromycin-21)
appos(activity-7, etc.-23)
auxpass(indicated-26, is-25)
advcl(considered-35, indicated-26)
nsubjpass(considered-35, reduction-28)
det(dose-32, the-30)
nn(dose-32, budesonide-31)
prep_of(reduction-28, dose-32)
aux(considered-35, should-33)
auxpass(considered-35, be-34)
root(ROOT-0, considered-35)

After/IN extensive/JJ intake/NN of/IN grapefruit/NN juice/NN (/-LRB- which/WDT inhibits/VBZ CYP3A4/NN activity/NN predominantly/RB in/IN the/DT intestinal/JJ mucosa/NN )/-RRB- ,/, the/DT systemic/JJ exposure/NN for/IN oral/JJ budesonide/NN increased/VBD about/RB two/CD times/NNS ./.

(ROOT (S1 (S (S (PP (IN After) (NP (NP (JJ extensive) (NN intake)) (PP (IN of) (NP (NP (NN grapefruit) (NN juice)) (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (VP (VBZ inhibits) (NP (NN CYP3A4) (NN activity)) (ADVP (RB predominantly)) (PP (IN in) (NP (DT the) (JJ intestinal) (NN mucosa)))))) (-RRB- -RRB-))))) (, ,) (NP (NP (DT the) (JJ systemic) (NN exposure)) (PP (IN for) (NP (JJ oral) (NN budesonide)))) (VP (VBD increased) (NP (QP (RB about) (CD two)) (NNS times)))) (. .))))

amod(intake-3, extensive-2)
prep_after(increased-25, intake-3)
nn(juice-6, grapefruit-5)
prep_of(intake-3, juice-6)
nsubj(inhibits-9, which-8)
rcmod(juice-6, inhibits-9)
nn(activity-11, CYP3A4-10)
dobj(inhibits-9, activity-11)
advmod(inhibits-9, predominantly-12)
det(mucosa-16, the-14)
amod(mucosa-16, intestinal-15)
prep_in(inhibits-9, mucosa-16)
det(exposure-21, the-19)
amod(exposure-21, systemic-20)
nsubj(increased-25, exposure-21)
amod(budesonide-24, oral-23)
prep_for(exposure-21, budesonide-24)
root(ROOT-0, increased-25)
quantmod(two-27, about-26)
num(times-28, two-27)
dobj(increased-25, times-28)

As/IN with/IN other/JJ drugs/NNS primarily/RB being/VBG metabolized/VBN through/IN CYP3A4/NN ,/, ingestion/NN of/IN grapefruit/NN or/CC grapefruit/NN juice/NN should/MD be/VB avoided/VBN in/IN connection/NN with/IN budesonide/NN administration/NN ./.

(ROOT (S1 (S (S (PP (IN As) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (ADVP (RB primarily)) (VBG being) (VP (VBN metabolized) (PP (IN through) (NP (NN CYP3A4)))))))) (, ,) (NP (NP (NN ingestion)) (PP (IN of) (NP (NP (NN grapefruit)) (CC or) (NP (NN grapefruit)) (NP (NN juice))))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (PP (IN in) (NP (NP (NN connection)) (PP (IN with) (NP (NN budesonide) (NN administration))))))))) (. .))))

prep(avoided-19, As-1)
pcomp(As-1, with-2)
amod(drugs-4, other-3)
prep_with(As-1, drugs-4)
advmod(metabolized-7, primarily-5)
auxpass(metabolized-7, being-6)
partmod(drugs-4, metabolized-7)
prep_through(metabolized-7, CYP3A4-9)
nsubjpass(avoided-19, ingestion-11)
prep_of(ingestion-11, grapefruit-13)
conj_or(grapefruit-13, grapefruit-15)
dep(grapefruit-13, juice-16)
aux(avoided-19, should-17)
auxpass(avoided-19, be-18)
root(ROOT-0, avoided-19)
prep_in(avoided-19, connection-21)
nn(administration-24, budesonide-23)
prep_with(connection-21, administration-24)

The/DT administration/NN of/IN local/JJ anesthetic/JJ solutions/NNS containing/VBG epinephrine/NN or/CC norepinephrine/NN to/TO patients/NNS receiving/VBG monoamine/NN oxidase/NN inhibitors/NNS or/CC tricyclic/JJ antidepressants/NNS may/MD produce/VB severe/JJ ,/, prolonged/JJ hypertension/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NP (JJ local) (JJ anesthetic) (NNS solutions)) (VP (VBG containing) (NP (NP (NN epinephrine)) (CC or) (NP (NN norepinephrine))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN monoamine) (NN oxidase) (NNS inhibitors)) (CC or) (NP (JJ tricyclic) (NNS antidepressants)))))))))) (VP (MD may) (VP (VB produce) (NP (ADJP (ADJP (JJ severe)) (, ,) (ADJP (JJ prolonged))) (NN hypertension))))) (. .))))

det(administration-2, The-1)
nsubj(produce-21, administration-2)
amod(solutions-6, local-4)
amod(solutions-6, anesthetic-5)
prep_of(administration-2, solutions-6)
partmod(solutions-6, containing-7)
dobj(containing-7, epinephrine-8)
conj_or(epinephrine-8, norepinephrine-10)
prep_to(containing-7, patients-12)
partmod(patients-12, receiving-13)
nn(inhibitors-16, monoamine-14)
nn(inhibitors-16, oxidase-15)
dobj(receiving-13, inhibitors-16)
amod(antidepressants-19, tricyclic-18)
conj_or(inhibitors-16, antidepressants-19)
aux(produce-21, may-20)
root(ROOT-0, produce-21)
amod(hypertension-25, severe-22)
dep(severe-22, prolonged-24)
dobj(produce-21, hypertension-25)

Concurrent/JJ administration/NN of/IN vasopressor/JJ drugs/NNS and/CC of/IN ergot-type/JJ oxytocic/JJ drugs/NNS may/MD cause/VB severe/JJ ,/, persistent/JJ hypertension/NN or/CC cerebrovascular/JJ accidents/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (PP (IN of) (NP (JJ vasopressor) (NNS drugs))) (CC and) (PP (IN of) (NP (JJ ergot-type) (JJ oxytocic) (NNS drugs))))) (VP (MD may) (VP (VB cause) (NP (JJ severe) (, ,) (NP (NP (JJ persistent) (NN hypertension)) (CC or) (NP (JJ cerebrovascular) (NN accidents))))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(cause-12, administration-2)
amod(drugs-5, vasopressor-4)
prep_of(administration-2, drugs-5)
amod(drugs-10, ergot-type-8)
amod(drugs-10, oxytocic-9)
conj_and(drugs-5, drugs-10)
aux(cause-12, may-11)
root(ROOT-0, cause-12)
amod(hypertension-16, severe-13)
amod(hypertension-16, persistent-15)
dobj(cause-12, hypertension-16)
amod(accidents-19, cerebrovascular-18)
conj_or(hypertension-16, accidents-19)

Phenothiazines/NNS and/CC butyrophenones/NNS may/MD reduce/VB or/CC reverse/VB the/DT pressor/JJ effect/NN of/IN epinephrine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Phenothiazines)) (CC and) (NP (NNS butyrophenones))) (VP (MD may) (VP (VP (VB reduce)) (CC or) (VP (VB reverse) (NP (NP (DT the) (JJ pressor) (NN effect)) (PP (IN of) (NP (NN epinephrine)))))))) (. .))))

nsubj(reduce-5, Phenothiazines-1)
conj_and(Phenothiazines-1, butyrophenones-3)
aux(reduce-5, may-4)
root(ROOT-0, reduce-5)
conj_or(reduce-5, reverse-7)
det(effect-10, the-8)
amod(effect-10, pressor-9)
dobj(reverse-7, effect-10)
prep_of(effect-10, epinephrine-12)

The/DT CNS/NN effects/NNS of/IN butalbital/NN may/MD be/VB enhanced/VBN by/IN monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN CNS) (NNS effects)) (PP (IN of) (NP (NN butalbital)))) (VP (MD may) (VP (VB be) (VP (VBN enhanced) (PP (IN by) (NP (NP (NP (NN monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors))))))) (. .))))

det(effects-3, The-1)
nn(effects-3, CNS-2)
nsubjpass(enhanced-8, effects-3)
prep_of(effects-3, butalbital-5)
aux(enhanced-8, may-6)
auxpass(enhanced-8, be-7)
root(ROOT-0, enhanced-8)
nn(oxidase-11, monoamine-10)
nn(inhibitors-15, oxidase-11)
abbrev(oxidase-11, MAO-13)
agent(enhanced-8, inhibitors-15)

Butalbital/NN ,/, acetaminophen/NN and/CC caffeine/NN may/MD enhance/VB the/DT effects/NNS of/IN :/: other/JJ narcotic/JJ analgesic/JJ s/NNS ,/, alcohol/NN ,/, general/JJ anesthetics/NNS ,/, tranquilizers/NNS such/JJ as/IN chlordiazepoxide/NN ,/, sedative-hypnotics/NN ,/, or/CC other/JJ CNS/NN depressants/NNS ,/, causing/VBG increased/VBN CNS/NN depression/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Butalbital)) (, ,) (NP (NN acetaminophen)) (CC and) (NP (NN caffeine))) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (: :) (NP (NP (JJ other) (JJ narcotic) (JJ analgesic) (NNS s)) (, ,) (NP (NN alcohol)) (, ,) (NP (JJ general) (NNS anesthetics)) (, ,) (NP (NP (NNS tranquilizers)) (PP (JJ such) (IN as) (NP (NN chlordiazepoxide)))) (, ,) (NP (NN sedative-hypnotics)) (, ,) (CC or) (NP (JJ other) (NN CNS) (NNS depressants))))) (, ,) (S (VP (VBG causing) (NP (VBN increased) (NN CNS) (NN depression))))))) (. .))))

nsubj(enhance-7, Butalbital-1)
conj_and(Butalbital-1, acetaminophen-3)
conj_and(Butalbital-1, caffeine-5)
aux(enhance-7, may-6)
root(ROOT-0, enhance-7)
det(effects-9, the-8)
dobj(enhance-7, effects-9)
amod(s-15, other-12)
amod(s-15, narcotic-13)
amod(s-15, analgesic-14)
prep_of(effects-9, s-15)
conj_or(s-15, alcohol-17)
amod(anesthetics-20, general-19)
conj_or(s-15, anesthetics-20)
conj_or(s-15, tranquilizers-22)
prep_such_as(tranquilizers-22, chlordiazepoxide-25)
conj_or(s-15, sedative-hypnotics-27)
amod(depressants-32, other-30)
nn(depressants-32, CNS-31)
conj_or(s-15, depressants-32)
partmod(enhance-7, causing-34)
xcomp(enhance-7, causing-34)
amod(depression-37, increased-35)
nn(depression-37, CNS-36)
dobj(causing-34, depression-37)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Acetaminophen/NN may/MD produce/VB false-positive/JJ test/NN results/NNS for/IN urinary/JJ 5-hydroxyindoleacetic/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions) (NP (NN Acetaminophen))) (VP (MD may) (VP (VB produce) (NP (NP (JJ false-positive) (NN test) (NNS results)) (PP (IN for) (NP (JJ urinary) (JJ 5-hydroxyindoleacetic) (NN acid))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nsubj(produce-7, Interactions-4)
dep(Interactions-4, Acetaminophen-5)
aux(produce-7, may-6)
root(ROOT-0, produce-7)
amod(results-10, false-positive-8)
nn(results-10, test-9)
dobj(produce-7, results-10)
amod(acid-14, urinary-12)
amod(acid-14, 5-hydroxyindoleacetic-13)
prep_for(results-10, acid-14)

Interactions/NNS may/MD occur/VB with/IN the/DT following/NN :/: adrenocorticoids/NNS (/-LRB- cortisone/NN -like/JJ medicine/NN )/-RRB- ,/, anticoagulants/NNS (/-LRB- blood/NN thinner/NN s/NNS )/-RRB- ,/, carbamazepine/NN ,/, corticotropin/NN (/-LRB- barbiturates/NNS may/MD decrease/VB the/DT effects/NNS of/IN these/DT medicines/NNS )/-RRB- ,/, central/JJ nervous/JJ system/NN (/-LRB- CNS/NN )/-RRB- depressants/NNS (/-LRB- using/VBG these/DT medicines/NNS with/IN barbiturates/NNS may/MD result/VB in/IN increased/VBN CNS/NN depressant/NN effects/NNS )/-RRB- ,/, divalproex/NN sodium/NN ,/, valproic/JJ acid/NN (/-LRB- using/VBG these/DT medicines/NNS with/IN barbiturates/NNS may/MD change/VB the/DT amount/NN of/IN either/DT medicine/NN that/WDT you/RB need/VBP to/TO take/VB )/-RRB- ,/, and/CC oral/JJ contraceptives/NNS containing/VBG estrogens/NNS (/-LRB- barbiturates/NNS may/MD decrease/VB the/DT effectiveness/NN of/IN these/DT oral/JJ contraceptives/NNS ,/, and/CC you/RB may/MD need/VBP to/TO change/NN to/TO a/DT different/JJ type/NN of/IN birth/NN control/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NNS Interactions)) (VP (MD may) (VP (VB occur) (PP (IN with) (NP (DT the) (NN following)))))) (: :) (S (NP (NP (NP (NP (NP (NNS adrenocorticoids)) (PRN (-LRB- -LRB-) (NP (NN cortisone) (JJ -like) (NN medicine)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS anticoagulants)) (PRN (-LRB- -LRB-) (NP (NN blood) (NN thinner) (NNS s)) (-RRB- -RRB-))) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN corticotropin)) (-LRB- -LRB-) (NP (NNS barbiturates)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT these) (NNS medicines)))))) (-RRB- -RRB-)) (, ,) (NP (NP (NP (NP (JJ central) (JJ nervous) (NN system)) (PRN (-LRB- -LRB-) (NP (NN CNS)) (-RRB- -RRB-))) (NNS depressants)) (PRN (-LRB- -LRB-) (VP (VBG using) (NP (DT these) (NNS medicines)) (PP (IN with) (NP (NP (NNS barbiturates)) (VP (MD may) (VP (VB result) (PP (IN in) (NP (VBN increased) (NN CNS) (NN depressant) (NNS effects)))))))) (-RRB- -RRB-))) (, ,) (NP (NN divalproex) (NN sodium)) (, ,) (NP (NP (JJ valproic) (NN acid)) (PRN (-LRB- -LRB-) (VP (VBG using) (NP (NP (DT these) (NNS medicines)) (PP (IN with) (NP (NP (NNS barbiturates)) (VP (MD may) (VP (VB change) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (DT either) (NN medicine)) (SBAR (WHNP (WDT that)) (S (ADVP (RB you)) (VP (VBP need) (S (VP (TO to) (VP (VB take)))))))))))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ oral) (NNS contraceptives))) (VP (VBG containing) (NP (NNS estrogens)))) (-LRB- -LRB-) (NP (NNS barbiturates)) (VP (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (DT these) (JJ oral) (NNS contraceptives)))))) (, ,) (CC and) (ADVP (RB you)) (VP (MD may) (VP (VBP need) (PP (TO to) (NP (NN change))) (PP (TO to) (NP (NP (DT a) (JJ different) (NN type)) (PP (IN of) (NP (NN birth) (NN control)))))))) (-RRB- -RRB-)) (. .))))

nsubj(occur-3, Interactions-1)
aux(occur-3, may-2)
root(ROOT-0, occur-3)
det(following-6, the-5)
prep_with(occur-3, following-6)
nsubj(decrease-91, adrenocorticoids-8)
nn(medicine-12, cortisone-10)
amod(medicine-12, -like-11)
appos(adrenocorticoids-8, medicine-12)
appos(adrenocorticoids-8, anticoagulants-15)
nn(s-19, blood-17)
nn(s-19, thinner-18)
appos(anticoagulants-15, s-19)
appos(adrenocorticoids-8, carbamazepine-22)
appos(adrenocorticoids-8, corticotropin-24)
dep(adrenocorticoids-8, barbiturates-26)
aux(decrease-28, may-27)
dep(adrenocorticoids-8, decrease-28)
det(effects-30, the-29)
dobj(decrease-28, effects-30)
det(medicines-33, these-32)
prep_of(effects-30, medicines-33)
amod(system-38, central-36)
amod(system-38, nervous-37)
nn(depressants-42, system-38)
abbrev(system-38, CNS-40)
conj_and(adrenocorticoids-8, depressants-42)
dep(depressants-42, using-44)
det(medicines-46, these-45)
dobj(using-44, medicines-46)
prep_with(using-44, barbiturates-48)
aux(result-50, may-49)
dep(barbiturates-48, result-50)
amod(effects-55, increased-52)
nn(effects-55, CNS-53)
nn(effects-55, depressant-54)
prep_in(result-50, effects-55)
nn(sodium-59, divalproex-58)
conj_and(adrenocorticoids-8, sodium-59)
amod(acid-62, valproic-61)
conj_and(adrenocorticoids-8, acid-62)
dep(acid-62, using-64)
det(medicines-66, these-65)
dobj(using-64, medicines-66)
prep_with(medicines-66, barbiturates-68)
aux(change-70, may-69)
dep(barbiturates-68, change-70)
det(amount-72, the-71)
dobj(change-70, amount-72)
det(medicine-75, either-74)
prep_of(amount-72, medicine-75)
nsubj(need-78, medicine-75)
advmod(need-78, you-77)
rcmod(medicine-75, need-78)
aux(take-80, to-79)
xcomp(need-78, take-80)
amod(contraceptives-85, oral-84)
conj_and(adrenocorticoids-8, contraceptives-85)
partmod(adrenocorticoids-8, containing-86)
dobj(containing-86, estrogens-87)
nsubj(decrease-91, barbiturates-89)
aux(decrease-91, may-90)
parataxis(occur-3, decrease-91)
det(effectiveness-93, the-92)
dobj(decrease-91, effectiveness-93)
det(contraceptives-97, these-95)
amod(contraceptives-97, oral-96)
prep_of(effectiveness-93, contraceptives-97)
advmod(decrease-91, you-100)
conj_and(decrease-91, you-100)
aux(need-102, may-101)
conj_and(decrease-91, need-102)
prep_to(need-102, change-104)
det(type-108, a-106)
amod(type-108, different-107)
prep_to(need-102, type-108)
nn(control-111, birth-110)
prep_of(type-108, control-111)

DOSTINEX/NN should/MD not/RB be/VB administered/VBN concurrently/RB with/IN D2-antagonists/NNS ,/, such/JJ as/IN phenothiazines/NNS ,/, butyrophenones/NNS ,/, thioxanthines/NNS ,/, or/CC metoclopramide/NN ./.

(ROOT (S1 (S (S (NP (NN DOSTINEX)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NNS D2-antagonists)) (, ,) (PP (JJ such) (IN as) (NP (NP (NNS phenothiazines)) (, ,) (NP (NNS butyrophenones)) (, ,) (NP (NNS thioxanthines)) (, ,) (CC or) (NP (NN metoclopramide)))))))))) (. .))))

nsubjpass(administered-5, DOSTINEX-1)
aux(administered-5, should-2)
neg(administered-5, not-3)
auxpass(administered-5, be-4)
root(ROOT-0, administered-5)
advmod(administered-5, concurrently-6)
prep_with(administered-5, D2-antagonists-8)
prep_such_as(D2-antagonists-8, phenothiazines-12)
conj_or(phenothiazines-12, butyrophenones-14)
conj_or(phenothiazines-12, thioxanthines-16)
conj_or(phenothiazines-12, metoclopramide-19)

No/DT significant/JJ drug/NN interactions/NNS have/VBP been/VBN reported/VBN in/IN studies/NNS of/IN candesartan/NN cilexetil/NN given/VBN with/IN other/JJ drugs/NNS such/JJ as/IN glyburide/NN ,/, nifedipine/NN ,/, digoxin/NN ,/, warfarin/NN ,/, hydrochlorothiazide/NN ,/, and/CC oral/JJ contraceptives/NNS in/IN healthy/JJ volunteers/NNS ,/, or/CC given/VBN with/IN enalapril/NN to/TO patients/NNS with/IN heart/NN failure/NN (/-LRB- NYHA/NN class/NN II/CD and/CC III/CD )./NN

(ROOT (S1 (S (NP (DT No) (JJ significant) (NN drug) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NP (NNS studies)) (PP (IN of) (NP (NP (NN candesartan) (NN cilexetil)) (VP (VP (VBN given) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NN glyburide)) (, ,) (NP (NN nifedipine)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN hydrochlorothiazide)) (, ,) (CC and) (NP (JJ oral) (NNS contraceptives)))))) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))) (, ,) (CC or) (VP (VBN given) (PP (IN with) (NP (NN enalapril))) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (NN heart) (NN failure)))))))))) (-LRB- -LRB-) (NP (NP (NN NYHA) (NN class) (CD II)) (CC and) (NP (CD III) (NN -RRB-.)))))))))))

det(interactions-4, No-1)
amod(interactions-4, significant-2)
nn(interactions-4, drug-3)
nsubjpass(reported-7, interactions-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
prep_in(reported-7, studies-9)
nn(cilexetil-12, candesartan-11)
prep_of(studies-9, cilexetil-12)
dep(cilexetil-12, given-13)
amod(drugs-16, other-15)
prep_with(given-13, drugs-16)
prep_such_as(drugs-16, glyburide-19)
conj_and(glyburide-19, nifedipine-21)
conj_and(glyburide-19, digoxin-23)
conj_and(glyburide-19, warfarin-25)
conj_and(glyburide-19, hydrochlorothiazide-27)
amod(contraceptives-31, oral-30)
conj_and(glyburide-19, contraceptives-31)
amod(volunteers-34, healthy-33)
prep_in(given-13, volunteers-34)
conj_or(given-13, given-37)
prep_with(given-37, enalapril-39)
prep_to(given-37, patients-41)
nn(failure-44, heart-43)
prep_with(patients-41, failure-44)
nn(class-47, NYHA-46)
dep(studies-9, class-47)
num(class-47, II-48)
num(-RRB-.-51, III-50)
conj_and(class-47, -RRB-.-51)

Because/IN candesartan/NN is/VBZ not/RB significantly/RB metabolized/VBN by/IN the/DT cytochrome/NN P450/NN system/NN and/CC at/IN therapeutic/JJ concentrations/NNS has/VBZ no/DT effects/NNS on/IN P450/NN enzymes/NNS ,/, interactions/NNS with/IN drugs/NNS that/WDT inhibit/VBP or/CC are/VBP metabolized/VBN by/IN those/DT enzymes/NNS would/MD not/RB be/VB expected/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN candesartan)) (VP (VP (VBZ is) (RB not) (ADVP (RB significantly)) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN cytochrome) (NN P450) (NN system))))) (CC and) (PP (IN at) (NP (JJ therapeutic) (NNS concentrations))) (VP (VBZ has) (NP (NP (DT no) (NNS effects)) (PP (IN on) (NP (NN P450) (NNS enzymes)))))))) (, ,) (NP (NP (NNS interactions)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP inhibit)) (CC or) (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT those) (NNS enzymes))))))))))) (VP (MD would) (RB not) (VP (VB be) (VP (VBN expected))))) (. .))))

mark(metabolized-6, Because-1)
nsubjpass(metabolized-6, candesartan-2)
auxpass(metabolized-6, is-3)
neg(metabolized-6, not-4)
advmod(metabolized-6, significantly-5)
advcl(expected-37, metabolized-6)
det(system-11, the-8)
nn(system-11, cytochrome-9)
nn(system-11, P450-10)
agent(metabolized-6, system-11)
conj_and(metabolized-6, at-13)
amod(concentrations-15, therapeutic-14)
prep_at(metabolized-6, concentrations-15)
dep(metabolized-6, has-16)
det(effects-18, no-17)
dobj(has-16, effects-18)
nn(enzymes-21, P450-20)
prep_on(effects-18, enzymes-21)
nsubjpass(expected-37, interactions-23)
prep_with(interactions-23, drugs-25)
nsubj(inhibit-27, drugs-25)
rcmod(drugs-25, inhibit-27)
auxpass(metabolized-30, are-29)
conj_or(inhibit-27, metabolized-30)
det(enzymes-33, those-32)
agent(metabolized-30, enzymes-33)
aux(expected-37, would-34)
neg(expected-37, not-35)
auxpass(expected-37, be-36)
root(ROOT-0, expected-37)

Lithium/NN @/NN Reversible/JJ increases/NNS in/IN serum/NN lithium/NN concentrations/NNS and/CC toxicity/NN have/VBP been/VBN reported/VBN during/IN concomitant/JJ administration/NN of/IN lithium/NN with/IN ACE/NN inhibitors/NNS ,/, and/CC with/IN some/DT angiotensin/NN II/CD receptor/NN antagonists/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium) (NN @) (JJ Reversible) (NNS increases)) (PP (IN in) (NP (NP (NN serum) (NN lithium) (NNS concentrations)) (CC and) (NP (NN toxicity))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN lithium))) (PP (PP (IN with) (NP (NN ACE) (NNS inhibitors))) (, ,) (CC and) (PP (IN with) (NP (DT some) (NN angiotensin) (CD II) (NN receptor) (NNS antagonists)))))))))) (. .))))

nn(increases-4, Lithium-1)
nn(increases-4, @-2)
amod(increases-4, Reversible-3)
nsubjpass(reported-13, increases-4)
nn(concentrations-8, serum-6)
nn(concentrations-8, lithium-7)
prep_in(increases-4, concentrations-8)
conj_and(concentrations-8, toxicity-10)
aux(reported-13, have-11)
auxpass(reported-13, been-12)
root(ROOT-0, reported-13)
amod(administration-16, concomitant-15)
prep_during(reported-13, administration-16)
prep_of(administration-16, lithium-18)
nn(inhibitors-21, ACE-20)
prep_with(administration-16, inhibitors-21)
det(antagonists-29, some-25)
nn(antagonists-29, angiotensin-26)
num(antagonists-29, II-27)
nn(antagonists-29, receptor-28)
conj_and(inhibitors-21, antagonists-29)

An/DT increase/NN in/IN serum/NN lithium/NN concentration/NN has/VBZ been/VBN reported/VBN during/IN concomitant/JJ administration/NN of/IN lithium/NN with/IN ATACAND/NN ,/, so/IN careful/JJ monitoring/NN of/IN serum/NN lithium/NN levels/NNS is/VBZ recommended/VBN during/IN concomitant/JJ use/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (NN increase)) (PP (IN in) (NP (NN serum) (NN lithium) (NN concentration)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN lithium))) (PP (IN with) (NP (NN ATACAND))))))) (, ,) (SBAR (IN so) (S (NP (NP (JJ careful) (NN monitoring)) (PP (IN of) (NP (NN serum) (NN lithium) (NNS levels)))) (VP (VBZ is) (VP (VBN recommended) (PP (IN during) (NP (JJ concomitant) (NN use))))))))) (. .))))

det(increase-2, An-1)
nsubjpass(reported-9, increase-2)
nn(concentration-6, serum-4)
nn(concentration-6, lithium-5)
prep_in(increase-2, concentration-6)
aux(reported-9, has-7)
auxpass(reported-9, been-8)
root(ROOT-0, reported-9)
amod(administration-12, concomitant-11)
prep_during(reported-9, administration-12)
prep_of(administration-12, lithium-14)
prep_with(administration-12, ATACAND-16)
mark(recommended-26, so-18)
amod(monitoring-20, careful-19)
nsubjpass(recommended-26, monitoring-20)
nn(levels-24, serum-22)
nn(levels-24, lithium-23)
prep_of(monitoring-20, levels-24)
auxpass(recommended-26, is-25)
advcl(reported-9, recommended-26)
amod(use-29, concomitant-28)
prep_during(recommended-26, use-29)

Geocillin/NN (/-LRB- carbenicillin/NN indanyl/NN sodium/NN )/-RRB- blood/NN levels/NNS may/MD be/VB increased/VBN and/CC prolonged/VBD by/IN concurrent/JJ administration/NN of/IN probenecid/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Geocillin)) (PRN (-LRB- -LRB-) (NP (NN carbenicillin) (NN indanyl) (NN sodium)) (-RRB- -RRB-))) (NN blood) (NNS levels)) (VP (VP (MD may) (VP (VB be) (VP (VBN increased)))) (CC and) (VP (VBD prolonged) (PP (IN by) (NP (NP (JJ concurrent) (NN administration)) (PP (IN of) (NP (NN probenecid)))))))) (. .))))

nn(levels-8, Geocillin-1)
nn(sodium-5, carbenicillin-3)
nn(sodium-5, indanyl-4)
appos(Geocillin-1, sodium-5)
nn(levels-8, blood-7)
nsubjpass(increased-11, levels-8)
aux(increased-11, may-9)
auxpass(increased-11, be-10)
root(ROOT-0, increased-11)
conj_and(increased-11, prolonged-13)
amod(administration-16, concurrent-15)
prep_by(prolonged-13, administration-16)
prep_of(administration-16, probenecid-18)

Iodine/NN or/CC iodine/NN excess/NN may/MD decrease/VB the/DT effect/NN of/IN Carbimazole/NN ,/, and/CC an/DT iodine/NN deficiency/NN can/MD increase/VB the/DT effect/NN of/IN Carbimazole/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Iodine)) (CC or) (NP (NN iodine) (NN excess))) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN Carbimazole))))))) (, ,) (CC and) (S (NP (DT an) (NN iodine) (NN deficiency)) (VP (MD can) (VP (VB increase) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN Carbimazole)))))))) (. .))))

nsubj(decrease-6, Iodine-1)
nn(excess-4, iodine-3)
conj_or(Iodine-1, excess-4)
aux(decrease-6, may-5)
root(ROOT-0, decrease-6)
det(effect-8, the-7)
dobj(decrease-6, effect-8)
prep_of(effect-8, Carbimazole-10)
det(deficiency-15, an-13)
nn(deficiency-15, iodine-14)
nsubj(increase-17, deficiency-15)
aux(increase-17, can-16)
conj_and(decrease-6, increase-17)
det(effect-19, the-18)
dobj(increase-17, effect-19)
prep_of(effect-19, Carbimazole-21)

Serum/NN concentration/NN of/IN digoxin/NN and/CC digitoxin/NN may/MD increase/VB when/WRB patients/NNS take/VBP antithyroid/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Serum) (NN concentration)) (PP (IN of) (NP (NP (NN digoxin)) (CC and) (NP (NN digitoxin))))) (VP (MD may) (VP (VB increase) (SBAR (WHADVP (WRB when)) (S (NP (NNS patients)) (VP (VBP take) (NP (JJ antithyroid) (NNS agents)))))))) (. .))))

nn(concentration-2, Serum-1)
nsubj(increase-8, concentration-2)
prep_of(concentration-2, digoxin-4)
conj_and(digoxin-4, digitoxin-6)
aux(increase-8, may-7)
root(ROOT-0, increase-8)
advmod(take-11, when-9)
nsubj(take-11, patients-10)
advcl(increase-8, take-11)
amod(agents-13, antithyroid-12)
dobj(take-11, agents-13)

Antithyroid/JJ agents/NNS may/MD decrease/VB thyroid/NN al/FW uptake/NN of/IN sodium/NN iodide/NN I131/CD ,/, a/DT rebound/NN in/IN uptake/NN may/MD occur/VB up/RB to/TO 5/CD days/NNS after/IN sudden/CD withdrawal/NN of/IN Carbimazole/NN ./.

(ROOT (S1 (S (S (NP (JJ Antithyroid) (NNS agents)) (VP (MD may) (VP (VB decrease) (NP (NP (NN thyroid) (FW al) (NN uptake)) (PP (IN of) (NP (NN sodium) (NN iodide) (CD I131))))))) (, ,) (S (NP (NP (DT a) (NN rebound)) (PP (IN in) (NP (NN uptake)))) (VP (MD may) (VP (VB occur) (NP (QP (RB up) (TO to) (CD 5)) (NNS days)) (PP (IN after) (NP (NP (CD sudden) (NN withdrawal)) (PP (IN of) (NP (NN Carbimazole)))))))) (. .))))

amod(agents-2, Antithyroid-1)
nsubj(decrease-4, agents-2)
aux(decrease-4, may-3)
root(ROOT-0, decrease-4)
nn(uptake-7, thyroid-5)
nn(uptake-7, al-6)
dobj(decrease-4, uptake-7)
nn(iodide-10, sodium-9)
prep_of(uptake-7, iodide-10)
num(iodide-10, I131-11)
det(rebound-14, a-13)
nsubj(occur-18, rebound-14)
prep_in(rebound-14, uptake-16)
aux(occur-18, may-17)
ccomp(decrease-4, occur-18)
quantmod(5-21, up-19)
dep(5-21, to-20)
num(days-22, 5-21)
tmod(occur-18, days-22)
num(withdrawal-25, sudden-24)
prep_after(occur-18, withdrawal-25)
prep_of(withdrawal-25, Carbimazole-27)

Patients/NNS response/NN to/TO oral/JJ anticoagulants/NNS may/MD be/VB affected/VBN by/IN his/her/JJ thyroid/NN and/CC metabolic/JJ status/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients) (NN response)) (PP (TO to) (NP (JJ oral) (NNS anticoagulants)))) (VP (MD may) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (NP (JJ his/her) (NN thyroid)) (CC and) (NP (JJ metabolic) (NN status)))))))) (. .))))

nn(response-2, Patients-1)
nsubjpass(affected-8, response-2)
amod(anticoagulants-5, oral-4)
prep_to(response-2, anticoagulants-5)
aux(affected-8, may-6)
auxpass(affected-8, be-7)
root(ROOT-0, affected-8)
amod(thyroid-11, his/her-10)
agent(affected-8, thyroid-11)
amod(status-14, metabolic-13)
conj_and(thyroid-11, status-14)

An/DT evaluation/NN of/IN prothrombin/NN time/NN and/CC an/DT adjustment/NN of/IN anticoagulant/JJ dosage/NN are/VBP recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (DT An) (NN evaluation)) (PP (IN of) (NP (NN prothrombin) (NN time)))) (CC and) (NP (NP (DT an) (NN adjustment)) (PP (IN of) (NP (JJ anticoagulant) (NN dosage))))) (VP (VBP are) (VP (VBN recommended)))) (. .))))

det(evaluation-2, An-1)
nsubjpass(recommended-13, evaluation-2)
nn(time-5, prothrombin-4)
prep_of(evaluation-2, time-5)
det(adjustment-8, an-7)
conj_and(evaluation-2, adjustment-8)
amod(dosage-11, anticoagulant-10)
prep_of(adjustment-8, dosage-11)
auxpass(recommended-13, are-12)
root(ROOT-0, recommended-13)

The/DT renal/JJ effects/NNS of/IN nephrotoxic/JJ compounds/NNS may/MD be/VB potentiated/VBN by/IN Carboplatin/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ renal) (NNS effects)) (PP (IN of) (NP (JJ nephrotoxic) (NNS compounds)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (NN Carboplatin))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, renal-2)
nsubjpass(potentiated-9, effects-3)
amod(compounds-6, nephrotoxic-5)
prep_of(effects-3, compounds-6)
aux(potentiated-9, may-7)
auxpass(potentiated-9, be-8)
root(ROOT-0, potentiated-9)
agent(potentiated-9, Carboplatin-11)

Inhibitors/NNS of/IN CYP2D6/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NNS Inhibitors)) (PP (IN of) (NP (NN CYP2D6))) (: ;)) (. .)))))

root(ROOT-0, Inhibitors-1)
prep_of(Inhibitors-1, CYP2D6-3)

poor/JJ metabolizers/NNS of/IN debrisoquin/NN :/: Interactions/NNS of/IN carvedilol/NN with/IN strong/JJ inhibitors/NNS of/IN CYP2D6/NN (/-LRB- such/JJ as/IN quinidine/NN ,/, fluoxetine/NN ,/, paroxetine/NN ,/, and/CC propafenone/NN )/-RRB- have/VBP not/RB been/VBN studied/VBN ,/, but/CC these/DT drugs/NNS would/MD be/VB expected/VBN to/TO increase/VB blood/NN levels/NNS of/IN the/DT R/NN (/-LRB- +/CC )/-RRB- enantiomer/NN of/IN carvedilol/NN ./.

(ROOT (S1 (S (NP (NP (NP (JJ poor) (NNS metabolizers)) (PP (IN of) (NP (NN debrisoquin)))) (: :) (S (S (NP (NP (NNS Interactions)) (PP (IN of) (NP (NN carvedilol))) (PP (IN with) (NP (NP (NP (JJ strong) (NNS inhibitors)) (PP (IN of) (NP (NN CYP2D6)))) (PRN (-LRB- -LRB-) (CONJP (JJ such) (IN as)) (NP (NP (NN quinidine)) (, ,) (NP (NN fluoxetine)) (, ,) (NP (NN paroxetine)) (, ,) (CC and) (NP (NN propafenone))) (-RRB- -RRB-))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (, ,) (CC but) (S (NP (DT these) (NNS drugs)) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (NP (NP (NN blood) (NNS levels)) (PP (IN of) (NP (NP (DT the) (NP (NP (NN R)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (NN enantiomer)) (PP (IN of) (NP (NN carvedilol)))))))))))))) (. .)))))

amod(metabolizers-2, poor-1)
root(ROOT-0, metabolizers-2)
prep_of(metabolizers-2, debrisoquin-4)
nsubjpass(studied-29, Interactions-6)
prep_of(Interactions-6, carvedilol-8)
amod(inhibitors-11, strong-10)
prep_with(Interactions-6, inhibitors-11)
prep_of(inhibitors-11, CYP2D6-13)
dep(quinidine-17, such-15)
dep(such-15, as-16)
dep(inhibitors-11, quinidine-17)
conj_and(quinidine-17, fluoxetine-19)
conj_and(quinidine-17, paroxetine-21)
conj_and(quinidine-17, propafenone-24)
aux(studied-29, have-26)
neg(studied-29, not-27)
auxpass(studied-29, been-28)
dep(metabolizers-2, studied-29)
det(drugs-33, these-32)
nsubjpass(expected-36, drugs-33)
aux(expected-36, would-34)
auxpass(expected-36, be-35)
conj_but(studied-29, expected-36)
aux(increase-38, to-37)
xcomp(expected-36, increase-38)
nn(levels-40, blood-39)
dobj(increase-38, levels-40)
det(enantiomer-47, the-42)
nn(enantiomer-47, R-43)
cc(R-43, +-45)
prep_of(levels-40, enantiomer-47)
prep_of(enantiomer-47, carvedilol-49)

Retrospective/JJ analysis/NN of/IN side/JJ effects/NNS in/IN clinical/JJ trials/NNS showed/VBD that/IN poor/JJ 2D6/NN metabolizers/NNS had/VBD a/DT higher/JJR rate/NN of/IN dizziness/NN during/IN up-titration/NN ,/, presumably/RB resulting/VBG from/IN vasodilating/JJ effects/NNS of/IN the/DT higher/JJR concentrations/NNS of/IN the/DT a-blocking/JJ R/NN (/-LRB- +/CC )/-RRB- enantiomer/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Retrospective) (NN analysis)) (PP (IN of) (NP (NP (JJ side) (NNS effects)) (PP (IN in) (NP (JJ clinical) (NNS trials)))))) (VP (VBD showed) (SBAR (IN that) (S (NP (JJ poor) (NN 2D6) (NNS metabolizers)) (VP (VBD had) (NP (NP (DT a) (JJR higher) (NN rate)) (PP (IN of) (NP (NN dizziness)))) (PP (IN during) (NP (NN up-titration))) (, ,) (S (ADVP (RB presumably)) (VP (VBG resulting) (PP (IN from) (NP (NP (JJ vasodilating) (NNS effects)) (PP (IN of) (NP (NP (DT the) (JJR higher) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ a-blocking) (NP (NP (NN R)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (NN enantiomer)))))))))))))) (. .))))

amod(analysis-2, Retrospective-1)
nsubj(showed-9, analysis-2)
amod(effects-5, side-4)
prep_of(analysis-2, effects-5)
amod(trials-8, clinical-7)
prep_in(effects-5, trials-8)
root(ROOT-0, showed-9)
complm(had-14, that-10)
amod(metabolizers-13, poor-11)
nn(metabolizers-13, 2D6-12)
nsubj(had-14, metabolizers-13)
ccomp(showed-9, had-14)
det(rate-17, a-15)
amod(rate-17, higher-16)
dobj(had-14, rate-17)
prep_of(rate-17, dizziness-19)
prep_during(had-14, up-titration-21)
advmod(resulting-24, presumably-23)
partmod(had-14, resulting-24)
xcomp(had-14, resulting-24)
amod(effects-27, vasodilating-26)
prep_from(resulting-24, effects-27)
det(concentrations-31, the-29)
amod(concentrations-31, higher-30)
prep_of(effects-27, concentrations-31)
det(enantiomer-39, the-33)
amod(enantiomer-39, a-blocking-34)
nn(enantiomer-39, R-35)
cc(R-35, +-37)
prep_of(concentrations-31, enantiomer-39)

Catecholamine-depleting/JJ Agents/NNS :/: Patients/NNS taking/VBG both/DT agents/NNS with/IN b-blocking/JJ properties/NNS and/CC a/DT drug/NN that/WDT can/MD deplete/VB catecholamines/NNS (/-LRB- e.g./FW ,/, reserpine/NN and/CC monoamine/NN oxidase/NN inhibitors/NNS )/-RRB- should/MD be/VB observed/VBN closely/RB for/IN signs/NNS of/IN hypotension/NN and/or/CC severe/JJ bradycardia/NN ./.

(ROOT (S1 (S (NP (NP (JJ Catecholamine-depleting) (NNS Agents)) (: :) (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (DT both) (NNS agents)) (PP (IN with) (NP (NP (JJ b-blocking) (NNS properties)) (CC and) (NP (NP (DT a) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB deplete) (NP (NP (NNS catecholamines)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN reserpine)) (CC and) (NP (NN monoamine) (NN oxidase) (NNS inhibitors)))) (-RRB- -RRB-)))))))))))) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (NP (NN hypotension)) (CC and/or) (NP (JJ severe) (NN bradycardia)))))))))) (. .)))))

amod(Agents-2, Catecholamine-depleting-1)
root(ROOT-0, Agents-2)
nsubjpass(observed-29, Patients-4)
partmod(Patients-4, taking-5)
det(agents-7, both-6)
dobj(taking-5, agents-7)
amod(properties-10, b-blocking-9)
prep_with(taking-5, properties-10)
det(drug-13, a-12)
conj_and(properties-10, drug-13)
nsubj(deplete-16, drug-13)
aux(deplete-16, can-15)
rcmod(drug-13, deplete-16)
dobj(deplete-16, catecholamines-17)
dep(catecholamines-17, e.g.-19)
pobj(e.g.-19, reserpine-21)
nn(inhibitors-25, monoamine-23)
nn(inhibitors-25, oxidase-24)
conj_and(reserpine-21, inhibitors-25)
aux(observed-29, should-27)
auxpass(observed-29, be-28)
dep(Agents-2, observed-29)
advmod(observed-29, closely-30)
prep_for(observed-29, signs-32)
prep_of(signs-32, hypotension-34)
amod(bradycardia-37, severe-36)
conj_and/or(hypotension-34, bradycardia-37)

Clonidine/NN :/: Concomitant/JJ administration/NN of/IN clonidine/NN with/IN agents/NNS with/IN b-blocking/JJ properties/NNS may/MD potentiate/VB blood-pressure-/JJ and/CC heart-rate-lowering/JJ effects/NNS ./.

(ROOT (S1 (S (NP (NP (NN Clonidine)) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN clonidine))) (PP (IN with) (NP (NP (NNS agents)) (PP (IN with) (NP (JJ b-blocking) (NNS properties)))))) (VP (MD may) (VP (VB potentiate) (NP (ADJP (ADJP (JJ blood-pressure-)) (CC and) (ADJP (JJ heart-rate-lowering))) (NNS effects))))) (. .)))))

root(ROOT-0, Clonidine-1)
amod(administration-4, Concomitant-3)
nsubj(potentiate-13, administration-4)
prep_of(administration-4, clonidine-6)
prep_with(administration-4, agents-8)
amod(properties-11, b-blocking-10)
prep_with(agents-8, properties-11)
aux(potentiate-13, may-12)
dep(Clonidine-1, potentiate-13)
amod(effects-17, blood-pressure--14)
conj_and(blood-pressure--14, heart-rate-lowering-16)
dobj(potentiate-13, effects-17)

When/WRB concomitant/JJ treatment/NN with/IN agents/NNS with/IN b-blocking/JJ properties/NNS and/CC clonidine/NN is/VBZ to/TO be/VB terminated/VBN ,/, the/DT b-blocking/JJ agent/NN should/MD be/VB discontinued/VBN first/RB ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (JJ concomitant) (NN treatment)) (PP (IN with) (NP (NNS agents))) (PP (IN with) (NP (NP (JJ b-blocking) (NNS properties)) (CC and) (NP (NN clonidine))))) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN terminated)))))))) (, ,) (NP (DT the) (JJ b-blocking) (NN agent)) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (ADVP (RB first)))))) (. .))))

advmod(is-11, When-1)
amod(treatment-3, concomitant-2)
nsubj(is-11, treatment-3)
xsubj(terminated-14, treatment-3)
prep_with(treatment-3, agents-5)
amod(properties-8, b-blocking-7)
prep_with(treatment-3, properties-8)
conj_and(properties-8, clonidine-10)
advcl(discontinued-21, is-11)
aux(terminated-14, to-12)
auxpass(terminated-14, be-13)
xcomp(is-11, terminated-14)
det(agent-18, the-16)
amod(agent-18, b-blocking-17)
nsubjpass(discontinued-21, agent-18)
aux(discontinued-21, should-19)
auxpass(discontinued-21, be-20)
root(ROOT-0, discontinued-21)
advmod(discontinued-21, first-22)

Clonidine/NN therapy/NN can/MD then/RB be/VB discontinued/VBN several/JJ days/NNS later/RB by/IN gradually/RB decreasing/VBG the/DT dosage/NN ./.

(ROOT (S1 (S (S (NP (NN Clonidine) (NN therapy)) (VP (MD can) (ADVP (RB then)) (VP (VB be) (VP (VBN discontinued) (ADVP (NP (JJ several) (NNS days)) (RB later)) (PP (IN by) (S (VP (ADVP (RB gradually)) (VBG decreasing) (NP (DT the) (NN dosage))))))))) (. .))))

nn(therapy-2, Clonidine-1)
nsubjpass(discontinued-6, therapy-2)
aux(discontinued-6, can-3)
advmod(discontinued-6, then-4)
auxpass(discontinued-6, be-5)
root(ROOT-0, discontinued-6)
amod(days-8, several-7)
npadvmod(later-9, days-8)
advmod(discontinued-6, later-9)
advmod(decreasing-12, gradually-11)
agent(discontinued-6, decreasing-12)
det(dosage-14, the-13)
dobj(decreasing-12, dosage-14)

Cyclosporine/NN :/: Modest/JJ increases/NNS in/IN mean/JJ trough/NN cyclosporine/NN concentrations/NNS were/VBD observed/VBN following/VBG initiation/NN of/IN carvedilol/NN treatment/NN in/IN 21/CD renal/JJ transplant/NN patients/NNS suffering/VBG from/IN chronic/JJ vascular/JJ rejection/NN ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporine)) (: :) (S (NP (NP (JJ Modest) (NNS increases)) (PP (IN in) (NP (JJ mean) (NN trough) (NN cyclosporine) (NNS concentrations)))) (VP (VBD were) (VP (VBN observed) (PP (VBG following) (NP (NP (NN initiation)) (PP (IN of) (NP (NN carvedilol) (NN treatment))) (PP (IN in) (NP (NP (CD 21) (JJ renal) (NN transplant) (NNS patients)) (VP (VBG suffering) (PP (IN from) (NP (JJ chronic) (JJ vascular) (NN rejection))))))))))) (. .)))))

root(ROOT-0, Cyclosporine-1)
amod(increases-4, Modest-3)
nsubjpass(observed-11, increases-4)
amod(concentrations-9, mean-6)
nn(concentrations-9, trough-7)
nn(concentrations-9, cyclosporine-8)
prep_in(increases-4, concentrations-9)
auxpass(observed-11, were-10)
dep(Cyclosporine-1, observed-11)
prep_following(observed-11, initiation-13)
nn(treatment-16, carvedilol-15)
prep_of(initiation-13, treatment-16)
num(patients-21, 21-18)
amod(patients-21, renal-19)
nn(patients-21, transplant-20)
prep_in(initiation-13, patients-21)
partmod(patients-21, suffering-22)
amod(rejection-26, chronic-24)
amod(rejection-26, vascular-25)
prep_from(suffering-22, rejection-26)

In/IN about/RB 30/CD %/NN of/IN patients/NNS ,/, the/DT dose/NN of/IN cyclosporine/NN had/VBD to/TO be/VB reduced/VBN in/IN order/NN to/TO maintain/VB cyclosporine/NN concentrations/NNS within/IN the/DT therapeutic/JJ range/NN ,/, while/IN in/IN the/DT remainder/NN no/DT adjustment/NN was/VBD needed/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (QP (RB about) (CD 30)) (NN %)) (PP (IN of) (NP (NNS patients))))) (, ,) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN cyclosporine)))) (VP (VBD had) (S (VP (TO to) (VP (VB be) (VP (VBN reduced) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB maintain) (NP (NN cyclosporine) (NNS concentrations)) (PP (IN within) (NP (DT the) (JJ therapeutic) (NN range))))))))))) (, ,) (SBAR (IN while) (S (PP (IN in) (NP (DT the) (NN remainder))) (NP (DT no) (NN adjustment)) (VP (VBD was) (VP (VBN needed))))))) (. .))))

quantmod(30-3, about-2)
num(%-4, 30-3)
prep_in(had-12, %-4)
prep_of(%-4, patients-6)
det(dose-9, the-8)
nsubj(had-12, dose-9)
xsubj(reduced-15, dose-9)
prep_of(dose-9, cyclosporine-11)
root(ROOT-0, had-12)
aux(reduced-15, to-13)
auxpass(reduced-15, be-14)
xcomp(had-12, reduced-15)
mark(maintain-19, in-16)
dep(maintain-19, order-17)
aux(maintain-19, to-18)
purpcl(reduced-15, maintain-19)
nn(concentrations-21, cyclosporine-20)
dobj(maintain-19, concentrations-21)
det(range-25, the-23)
amod(range-25, therapeutic-24)
prep_within(maintain-19, range-25)
mark(needed-34, while-27)
det(remainder-30, the-29)
prep_in(needed-34, remainder-30)
det(adjustment-32, no-31)
nsubjpass(needed-34, adjustment-32)
auxpass(needed-34, was-33)
advcl(had-12, needed-34)

On/IN the/DT average/NN for/IN the/DT group/NN ,/, the/DT dose/NN of/IN cyclosporine/NN was/VBD reduced/VBN about/RB 20/CD %/NN in/IN these/DT patients/NNS ./.

(ROOT (S1 (S (S (PP (IN On) (NP (NP (DT the) (NN average)) (PP (IN for) (NP (DT the) (NN group))))) (, ,) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN cyclosporine)))) (VP (VBD was) (VP (VBN reduced) (NP (QP (RB about) (CD 20)) (NN %)) (PP (IN in) (NP (DT these) (NNS patients)))))) (. .))))

det(average-3, the-2)
prep_on(reduced-13, average-3)
det(group-6, the-5)
prep_for(average-3, group-6)
det(dose-9, the-8)
nsubjpass(reduced-13, dose-9)
prep_of(dose-9, cyclosporine-11)
auxpass(reduced-13, was-12)
root(ROOT-0, reduced-13)
quantmod(20-15, about-14)
num(%-16, 20-15)
dobj(reduced-13, %-16)
det(patients-19, these-18)
prep_in(reduced-13, patients-19)

Due/JJ to/TO wide/JJ interindividual/JJ variability/NN in/IN the/DT dose/NN adjustment/NN required/VBN ,/, it/PRP is/VBZ recommended/VBN that/IN cyclosporine/NN concentrations/NNS be/VB monitored/VBN closely/RB after/IN initiation/NN of/IN carvedilol/NN therapy/NN and/CC that/IN the/DT dose/NN of/IN cyclosporine/NN be/VB adjusted/VBN as/IN appropriate/JJ ./.

(ROOT (S1 (S (S (PP (JJ Due) (TO to) (NP (NP (JJ wide) (JJ interindividual) (NN variability)) (PP (IN in) (NP (NP (DT the) (NN dose) (NN adjustment)) (VP (VBN required)))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (SBAR (IN that) (S (NP (NN cyclosporine) (NNS concentrations)) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NN carvedilol) (NN therapy))))))))) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN cyclosporine)))) (VP (VB be) (VP (VBN adjusted) (PP (IN as) (NP (JJ appropriate))))))))))) (. .))))

amod(variability-5, wide-3)
amod(variability-5, interindividual-4)
prep_due_to(recommended-14, variability-5)
det(adjustment-9, the-7)
nn(adjustment-9, dose-8)
prep_in(variability-5, adjustment-9)
partmod(adjustment-9, required-10)
nsubjpass(recommended-14, it-12)
auxpass(recommended-14, is-13)
root(ROOT-0, recommended-14)
complm(monitored-19, that-15)
nn(concentrations-17, cyclosporine-16)
nsubjpass(monitored-19, concentrations-17)
auxpass(monitored-19, be-18)
ccomp(recommended-14, monitored-19)
advmod(monitored-19, closely-20)
prep_after(monitored-19, initiation-22)
nn(therapy-25, carvedilol-24)
prep_of(initiation-22, therapy-25)
complm(adjusted-33, that-27)
det(dose-29, the-28)
nsubjpass(adjusted-33, dose-29)
prep_of(dose-29, cyclosporine-31)
auxpass(adjusted-33, be-32)
conj_and(monitored-19, adjusted-33)
prep_as(adjusted-33, appropriate-35)

Digoxin/NN :/: Digoxin/NN concentrations/NNS are/VBP increased/VBN by/IN about/RB 15/CD %/NN when/WRB digoxin/NN and/CC carvedilol/NN are/VBP administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Digoxin) (: :) (NN Digoxin) (NNS concentrations)) (VP (VBP are) (VP (VBN increased) (PP (IN by) (NP (QP (RB about) (CD 15)) (NN %))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN digoxin)) (CC and) (NP (NN carvedilol))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly))))))))) (. .))))

nn(concentrations-4, Digoxin-1)
nn(concentrations-4, Digoxin-3)
nsubjpass(increased-6, concentrations-4)
auxpass(increased-6, are-5)
root(ROOT-0, increased-6)
quantmod(15-9, about-8)
num(%-10, 15-9)
agent(increased-6, %-10)
advmod(administered-16, when-11)
nsubjpass(administered-16, digoxin-12)
conj_and(digoxin-12, carvedilol-14)
auxpass(administered-16, are-15)
advcl(increased-6, administered-16)
advmod(administered-16, concomitantly-17)

Both/CC digoxin/NN and/CC COREG/NN slow/JJ AV/NN conduction/NN ./.

(ROOT (S1 (S (S (NP (CC Both) (NP (NN digoxin)) (CC and) (NP (NN COREG))) (VP (JJ slow) (NP (NN AV) (NN conduction)))) (. .))))

preconj(digoxin-2, Both-1)
nsubj(slow-5, digoxin-2)
conj_and(digoxin-2, COREG-4)
root(ROOT-0, slow-5)
nn(conduction-7, AV-6)
dobj(slow-5, conduction-7)

Therefore/RB ,/, increased/VBN monitoring/NN of/IN digoxin/NN is/VBZ recommended/VBN when/WRB initiating/VBG ,/, adjusting/VBG ,/, or/CC discontinuing/VBG COREG/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (VBN increased) (NN monitoring)) (PP (IN of) (NP (NN digoxin)))) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG initiating)) (, ,) (VP (VBG adjusting)) (, ,) (CC or) (VP (VBG discontinuing) (NP (NN COREG))))))))) (. .))))

advmod(recommended-8, Therefore-1)
amod(monitoring-4, increased-3)
nsubjpass(recommended-8, monitoring-4)
prep_of(monitoring-4, digoxin-6)
auxpass(recommended-8, is-7)
root(ROOT-0, recommended-8)
advmod(initiating-10, when-9)
advcl(recommended-8, initiating-10)
conj_or(initiating-10, adjusting-12)
conj_or(initiating-10, discontinuing-15)
dobj(discontinuing-15, COREG-16)

Inducers/NNS and/CC Inhibitors/NNS of/IN Hepatic/JJ Metabolism/NN :/: Rifampin/NN reduced/VBD plasma/NN concentrations/NNS of/IN carvedilol/NN by/IN about/RB 70/CD %./NN

(ROOT (S1 (S (NP (NP (NP (NP (NNS Inducers)) (CC and) (NP (NNS Inhibitors))) (PP (IN of) (NP (JJ Hepatic) (NN Metabolism)))) (: :) (NP (NP (NN Rifampin)) (VP (VBD reduced) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN carvedilol)))) (PP (IN by) (NP (QP (RB about) (CD 70)) (NN %.)))))))))

root(ROOT-0, Inducers-1)
conj_and(Inducers-1, Inhibitors-3)
amod(Metabolism-6, Hepatic-5)
prep_of(Inducers-1, Metabolism-6)
dep(Inducers-1, Rifampin-8)
partmod(Rifampin-8, reduced-9)
nn(concentrations-11, plasma-10)
dobj(reduced-9, concentrations-11)
prep_of(concentrations-11, carvedilol-13)
quantmod(70-16, about-15)
num(%.-17, 70-16)
agent(reduced-9, %.-17)

Cimetidine/NN increased/VBD AUC/NN by/IN about/RB 30/CD %/NN but/CC caused/VBD no/DT change/NN in/IN Cmax/NN ./.

(ROOT (S1 (S (S (NP (NN Cimetidine)) (VP (VP (VBD increased) (NP (NN AUC)) (PP (IN by) (NP (QP (RB about) (CD 30)) (NN %)))) (CC but) (VP (VBD caused) (NP (DT no) (NN change)) (PP (IN in) (NP (NN Cmax)))))) (. .))))

nsubj(increased-2, Cimetidine-1)
root(ROOT-0, increased-2)
dobj(increased-2, AUC-3)
quantmod(30-6, about-5)
num(%-7, 30-6)
prep_by(increased-2, %-7)
conj_but(increased-2, caused-9)
det(change-11, no-10)
dobj(caused-9, change-11)
prep_in(caused-9, Cmax-13)

Calcium/NN Channel/NN Blockers/NNS :/: Isolated/VBN cases/NNS of/IN conduction/NN disturbance/NN (/-LRB- rarely/RB with/IN hemodynamic/JJ compromise/VB )/-RRB- have/VBP been/VBN observed/VBN when/WRB COREG/NN is/VBZ co-administered/VBN with/IN diltiazem/NN ./.

(ROOT (S1 (S (NP (NP (NN Calcium) (NN Channel) (NNS Blockers)) (: :) (S (NP (NP (VBN Isolated) (NNS cases)) (PP (IN of) (NP (NP (NN conduction) (NN disturbance)) (PRN (-LRB- -LRB-) (ADVP (RB rarely)) (PP (IN with) (NP (JJ hemodynamic) (VB compromise))) (-RRB- -RRB-))))) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NN COREG)) (VP (VBZ is) (VP (VBN co-administered) (PP (IN with) (NP (NN diltiazem))))))))))) (. .)))))

nn(Blockers-3, Calcium-1)
nn(Blockers-3, Channel-2)
root(ROOT-0, Blockers-3)
amod(cases-6, Isolated-5)
nsubjpass(observed-18, cases-6)
nn(disturbance-9, conduction-8)
prep_of(cases-6, disturbance-9)
dep(with-12, rarely-11)
dep(disturbance-9, with-12)
pobj(with-12, hemodynamic-13)
dep(hemodynamic-13, compromise-14)
aux(observed-18, have-16)
auxpass(observed-18, been-17)
dep(Blockers-3, observed-18)
advmod(co-administered-22, when-19)
nsubjpass(co-administered-22, COREG-20)
auxpass(co-administered-22, is-21)
advcl(observed-18, co-administered-22)
prep_with(co-administered-22, diltiazem-24)

As/IN with/IN other/JJ agents/NNS with/IN b-blocking/JJ properties/NNS ,/, if/IN COREG/NN is/VBZ to/TO be/VB administered/VBN orally/RB with/IN calcium/NN channel/NN blockers/NNS of/IN the/DT verapamil/NN or/CC diltiazem/NN type/NN ,/, it/PRP is/VBZ recommended/VBN that/IN ECG/NN and/CC blood/NN pressure/NN be/VB monitored/VBN ./.

(ROOT (S1 (S (S (PP (IN As) (PP (IN with) (NP (NP (JJ other) (NNS agents)) (PP (IN with) (NP (JJ b-blocking) (NNS properties)))))) (, ,) (SBAR (IN if) (S (NP (NN COREG)) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN administered) (ADVP (RB orally)) (PP (IN with) (NP (NP (NN calcium) (NN channel) (NNS blockers)) (PP (IN of) (NP (DT the) (NP (NN verapamil)) (CC or) (NP (NN diltiazem)) (NP (NN type))))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (NN ECG)) (CC and) (NP (NN blood) (NN pressure))) (VP (VB be) (VP (VBN monitored)))))))) (. .))))

prep(recommended-29, As-1)
pcomp(As-1, with-2)
amod(agents-4, other-3)
prep_with(As-1, agents-4)
amod(properties-7, b-blocking-6)
prep_with(agents-4, properties-7)
mark(is-11, if-9)
nsubj(is-11, COREG-10)
xsubj(administered-14, COREG-10)
advcl(recommended-29, is-11)
aux(administered-14, to-12)
auxpass(administered-14, be-13)
xcomp(is-11, administered-14)
advmod(administered-14, orally-15)
nn(blockers-19, calcium-17)
nn(blockers-19, channel-18)
prep_with(administered-14, blockers-19)
dep(verapamil-22, the-21)
prep_of(blockers-19, verapamil-22)
conj_or(verapamil-22, diltiazem-24)
dep(verapamil-22, type-25)
nsubjpass(recommended-29, it-27)
auxpass(recommended-29, is-28)
root(ROOT-0, recommended-29)
complm(monitored-36, that-30)
nsubjpass(monitored-36, ECG-31)
nn(pressure-34, blood-33)
conj_and(ECG-31, pressure-34)
auxpass(monitored-36, be-35)
ccomp(recommended-29, monitored-36)

Insulin/NN or/CC Oral/JJ Hypoglycemics/NN :/: Agents/NNS with/IN b-blocking/JJ properties/NNS may/MD enhance/VB the/DT blood-sugar-reducing/JJ effect/NN of/IN insulin/NN and/CC oral/JJ hypoglycemics/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Insulin)) (CC or) (NP (JJ Oral) (NN Hypoglycemics))) (: :) (S (NP (NP (NNS Agents)) (PP (IN with) (NP (JJ b-blocking) (NNS properties)))) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (JJ blood-sugar-reducing) (NN effect)) (PP (IN of) (NP (NP (NN insulin)) (CC and) (NP (JJ oral) (NN hypoglycemics)))))))) (. .)))))

root(ROOT-0, Insulin-1)
amod(Hypoglycemics-4, Oral-3)
conj_or(Insulin-1, Hypoglycemics-4)
nsubj(enhance-11, Agents-6)
amod(properties-9, b-blocking-8)
prep_with(Agents-6, properties-9)
aux(enhance-11, may-10)
dep(Insulin-1, enhance-11)
det(effect-14, the-12)
amod(effect-14, blood-sugar-reducing-13)
dobj(enhance-11, effect-14)
prep_of(effect-14, insulin-16)
amod(hypoglycemics-19, oral-18)
conj_and(insulin-16, hypoglycemics-19)

Therefore/RB ,/, in/IN patients/NNS taking/VBG insulin/NN or/CC oral/JJ hypoglycemics/NN ,/, regular/JJ monitoring/NN of/IN blood/NN glucose/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NN insulin)) (CC or) (NP (JJ oral) (NN hypoglycemics)))))) (, ,) (NP (NP (JJ regular) (NN monitoring)) (PP (IN of) (NP (NN blood) (NN glucose)))) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

advmod(recommended-17, Therefore-1)
prep_in(recommended-17, patients-4)
partmod(patients-4, taking-5)
dobj(taking-5, insulin-6)
amod(hypoglycemics-9, oral-8)
conj_or(insulin-6, hypoglycemics-9)
amod(monitoring-12, regular-11)
nsubjpass(recommended-17, monitoring-12)
nn(glucose-15, blood-14)
prep_of(monitoring-12, glucose-15)
auxpass(recommended-17, is-16)
root(ROOT-0, recommended-17)

Studies/NNS in/FW vitro/FW show/VBP that/IN caspofungin/NN acetate/NN is/VBZ not/RB an/DT inhibitor/NN of/IN any/DT enzyme/NN in/IN the/DT cytochrome/NN P450/NN (/-LRB- CYP/NN )/-RRB- system/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Studies)) (ADVP (FW in) (FW vitro))) (VP (VBP show) (SBAR (IN that) (S (NP (NN caspofungin) (NN acetate)) (VP (VBZ is) (RB not) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (DT any) (NN enzyme))) (PP (IN in) (NP (DT the) (NP (NP (NN cytochrome) (NN P450)) (PRN (-LRB- -LRB-) (NP (NN CYP)) (-RRB- -RRB-))) (NN system))))))))) (. .))))

nsubj(show-4, Studies-1)
nn(vitro-3, in-2)
advmod(Studies-1, vitro-3)
root(ROOT-0, show-4)
complm(inhibitor-11, that-5)
nn(acetate-7, caspofungin-6)
nsubj(inhibitor-11, acetate-7)
cop(inhibitor-11, is-8)
neg(inhibitor-11, not-9)
det(inhibitor-11, an-10)
ccomp(show-4, inhibitor-11)
det(enzyme-14, any-13)
prep_of(inhibitor-11, enzyme-14)
det(system-22, the-16)
nn(P450-18, cytochrome-17)
nn(system-22, P450-18)
abbrev(P450-18, CYP-20)
prep_in(inhibitor-11, system-22)

In/IN clinical/JJ studies/NNS ,/, caspofungin/NN did/VBD not/RB induce/VB the/DT CYP3A4/NN metabolism/NN of/IN other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS studies))) (, ,) (NP (NN caspofungin)) (VP (VBD did) (RB not) (VP (VB induce) (NP (NP (DT the) (NN CYP3A4) (NN metabolism)) (PP (IN of) (NP (JJ other) (NNS drugs))))))) (. .))))

amod(studies-3, clinical-2)
prep_in(induce-8, studies-3)
nsubj(induce-8, caspofungin-5)
aux(induce-8, did-6)
neg(induce-8, not-7)
root(ROOT-0, induce-8)
det(metabolism-11, the-9)
nn(metabolism-11, CYP3A4-10)
dobj(induce-8, metabolism-11)
amod(drugs-14, other-13)
prep_of(metabolism-11, drugs-14)

Caspofungin/NN is/VBZ not/RB a/DT substrate/NN for/IN P-/NN glycoprotein/NN and/CC is/VBZ a/DT poor/JJ substrate/NN for/IN cytochrome/NN P450/NN enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NN Caspofungin)) (VP (VP (VBZ is) (RB not) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN P-) (NN glycoprotein))))) (CC and) (VP (VBZ is) (NP (NP (DT a) (JJ poor) (NN substrate)) (PP (IN for) (NP (NN cytochrome) (NN P450) (NNS enzymes))))))) (. .))))

nsubj(substrate-5, Caspofungin-1)
cop(substrate-5, is-2)
neg(substrate-5, not-3)
det(substrate-5, a-4)
root(ROOT-0, substrate-5)
nn(glycoprotein-8, P--7)
prep_for(substrate-5, glycoprotein-8)
cop(substrate-13, is-10)
det(substrate-13, a-11)
amod(substrate-13, poor-12)
conj_and(substrate-5, substrate-13)
nn(enzymes-17, cytochrome-15)
nn(enzymes-17, P450-16)
prep_for(substrate-13, enzymes-17)

Clinical/JJ studies/NNS in/IN healthy/JJ volunteers/NNS show/VBP that/IN the/DT pharmacokinetics/NNS of/IN CANCIDAS/NNS are/VBP not/RB altered/VBN by/IN itraconazole/NN ,/, amphotericin/NN B/NN ,/, mycophenolate/NN ,/, nelfinavir/NN ,/, or/CC tacrolimus/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Clinical) (NNS studies)) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NNS CANCIDAS)))) (VP (VBP are) (RB not) (VP (VBN altered) (PP (IN by) (NP (NP (NN itraconazole)) (, ,) (NP (NN amphotericin) (NN B)) (, ,) (NP (NN mycophenolate)) (, ,) (NP (NN nelfinavir)) (, ,) (CC or) (NP (NN tacrolimus)))))))))) (. .))))

amod(studies-2, Clinical-1)
nsubj(show-6, studies-2)
amod(volunteers-5, healthy-4)
prep_in(studies-2, volunteers-5)
root(ROOT-0, show-6)
complm(altered-14, that-7)
det(pharmacokinetics-9, the-8)
nsubjpass(altered-14, pharmacokinetics-9)
prep_of(pharmacokinetics-9, CANCIDAS-11)
auxpass(altered-14, are-12)
neg(altered-14, not-13)
ccomp(show-6, altered-14)
agent(altered-14, itraconazole-16)
nn(B-19, amphotericin-18)
conj_or(itraconazole-16, B-19)
conj_or(itraconazole-16, mycophenolate-21)
conj_or(itraconazole-16, nelfinavir-23)
conj_or(itraconazole-16, tacrolimus-26)

CANCIDAS/NN has/VBZ no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN itraconazole/NN ,/, amphotericin/NN B/NN ,/, or/CC the/DT active/JJ metabolite/NN of/IN mycophenolate/NN ./.

(ROOT (S1 (S (S (NP (NN CANCIDAS)) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN itraconazole)) (, ,) (NP (NN amphotericin) (NN B)) (, ,) (CC or) (NP (NP (DT the) (JJ active) (NN metabolite)) (PP (IN of) (NP (NN mycophenolate)))))))))) (. .))))

nsubj(has-2, CANCIDAS-1)
root(ROOT-0, has-2)
det(effect-4, no-3)
dobj(has-2, effect-4)
det(pharmacokinetics-7, the-6)
prep_on(has-2, pharmacokinetics-7)
prep_of(pharmacokinetics-7, itraconazole-9)
nn(B-12, amphotericin-11)
conj_or(itraconazole-9, B-12)
det(metabolite-17, the-15)
amod(metabolite-17, active-16)
conj_or(itraconazole-9, metabolite-17)
prep_of(metabolite-17, mycophenolate-19)

CANCIDAS/NN reduced/VBD the/DT blood/NN AUC0-12/CD of/IN tacrolimus/NN (/-LRB- FK-506/NN ,/, Prograf/NN span/NN class=/NN c4/NN @/NN 3/CD )/-RRB- by/IN approximately/RB 20/CD %/NN ,/, peak/JJ blood/NN concentration/NN (/-LRB- Cmax/NN )/-RRB- by/IN 16/CD %/NN ,/, and/CC 12-hour/JJ blood/NN concentration/NN (/-LRB- C12hr/NN )/-RRB- by/IN 26/CD %/NN in/IN healthy/JJ subjects/NNS when/WRB tacrolimus/NN (/-LRB- 2/CD doses/NNS of/IN 0.1/CD mg/kg/NN 12/CD hours/NNS apart/RB )/-RRB- was/VBD administered/VBN on/IN the/DT 10th/JJ day/NN of/IN CANCIDAS/NN 70/CD mg/NN daily/RB ,/, as/IN compared/VBN to/TO results/NNS from/IN a/DT control/NN period/NN in/IN which/WDT tacrolimus/NN was/VBD administered/VBN alone/RB ./.

(ROOT (S1 (S (NP (NN CANCIDAS)) (VP (VBD reduced) (NP (NP (DT the) (NN blood) (CD AUC0-12)) (PP (IN of) (NP (NP (NP (NP (NN tacrolimus)) (PRN (-LRB- -LRB-) (NP (NN FK-506)) (, ,) (NP (NN Prograf) (NN span) (NN class=) (NN c4) (NN @) (CD 3)) (-RRB- -RRB-))) (PP (IN by) (NP (QP (RB approximately) (CD 20)) (NN %)))) (, ,) (NP (NP (NP (JJ peak) (NN blood) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NN Cmax)) (-RRB- -RRB-))) (PP (IN by) (NP (CD 16) (NN %)))) (, ,) (CC and) (NP (NP (JJ 12-hour) (NN blood) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NN C12hr)) (-RRB- -RRB-)))))) (PP (IN by) (NP (NP (CD 26) (NN %)) (PP (IN in) (NP (JJ healthy) (NNS subjects))))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN tacrolimus)) (PRN (-LRB- -LRB-) (NP (NP (CD 2) (NNS doses)) (PP (IN of) (NP (QP (CD 0.1) (NN mg/kg) (CD 12)) (NNS hours))) (ADVP (RB apart))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN administered) (PP (IN on) (NP (NP (DT the) (JJ 10th) (NN day)) (PP (IN of) (NP (NP (NN CANCIDAS) (CD 70) (NN mg)) (ADVP (RB daily)))))))))) (, ,) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (NP (NNS results)) (PP (IN from) (NP (NP (DT a) (NN control) (NN period)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN tacrolimus)) (VP (VBD was) (VP (VBN administered) (ADVP (RB alone)))))))))))))) (. .))))

nsubj(reduced-2, CANCIDAS-1)
root(ROOT-0, reduced-2)
det(blood-4, the-3)
dobj(reduced-2, blood-4)
num(blood-4, AUC0-12-5)
prep_of(blood-4, tacrolimus-7)
appos(tacrolimus-7, FK-506-9)
nn(@-15, Prograf-11)
nn(@-15, span-12)
nn(@-15, class=-13)
nn(@-15, c4-14)
dep(FK-506-9, @-15)
num(@-15, 3-16)
quantmod(20-20, approximately-19)
num(%-21, 20-20)
prep_by(tacrolimus-7, %-21)
amod(concentration-25, peak-23)
nn(concentration-25, blood-24)
conj_and(tacrolimus-7, concentration-25)
appos(concentration-25, Cmax-27)
num(%-31, 16-30)
prep_by(concentration-25, %-31)
amod(concentration-36, 12-hour-34)
nn(concentration-36, blood-35)
conj_and(tacrolimus-7, concentration-36)
appos(concentration-36, C12hr-38)
num(%-42, 26-41)
prep_by(reduced-2, %-42)
amod(subjects-45, healthy-44)
prep_in(%-42, subjects-45)
advmod(administered-59, when-46)
nsubjpass(administered-59, tacrolimus-47)
num(doses-50, 2-49)
dep(tacrolimus-47, doses-50)
number(mg/kg-53, 0.1-52)
num(hours-55, mg/kg-53)
number(mg/kg-53, 12-54)
prep_of(doses-50, hours-55)
advmod(doses-50, apart-56)
auxpass(administered-59, was-58)
advcl(reduced-2, administered-59)
det(day-63, the-61)
amod(day-63, 10th-62)
prep_on(administered-59, day-63)
nn(mg-67, CANCIDAS-65)
num(mg-67, 70-66)
prep_of(day-63, mg-67)
advmod(mg-67, daily-68)
mark(compared-71, as-70)
advcl(reduced-2, compared-71)
prep_to(compared-71, results-73)
det(period-77, a-75)
nn(period-77, control-76)
prep_from(results-73, period-77)
rel(administered-82, which-79)
nsubjpass(administered-82, tacrolimus-80)
auxpass(administered-82, was-81)
rcmod(period-77, administered-82)
advmod(administered-82, alone-83)

For/IN patients/NNS receiving/VBG both/DT therapies/NNS ,/, standard/JJ monitoring/NN of/IN tacrolimus/NN blood/NN concentrations/NNS and/CC appropriate/JJ tacrolimus/NN dosage/NN adjustments/NNS are/VBP recommended/VBN ./.

(ROOT (S1 (S (S (PP (IN For) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (DT both) (NNS therapies))))) (, ,) (NP (NP (JJ standard) (NN monitoring)) (PP (IN of) (NP (NP (NN tacrolimus) (NN blood) (NNS concentrations)) (CC and) (NP (JJ appropriate) (NN tacrolimus) (NN dosage) (NNS adjustments))))) (VP (VBP are) (VP (VBN recommended)))) (. .))))

prep_for(recommended-19, patients-2)
partmod(patients-2, receiving-3)
det(therapies-5, both-4)
dobj(receiving-3, therapies-5)
amod(monitoring-8, standard-7)
nsubjpass(recommended-19, monitoring-8)
nn(concentrations-12, tacrolimus-10)
nn(concentrations-12, blood-11)
prep_of(monitoring-8, concentrations-12)
amod(adjustments-17, appropriate-14)
nn(adjustments-17, tacrolimus-15)
nn(adjustments-17, dosage-16)
conj_and(concentrations-12, adjustments-17)
auxpass(recommended-19, are-18)
root(ROOT-0, recommended-19)

In/IN two/CD clinical/JJ studies/NNS ,/, cyclosporine/NN (/-LRB- one/CD 4/CD mg/kg/NN dose/NN or/CC two/CD 3/CD mg/kg/NN doses/NNS )/-RRB- increased/VBD the/DT AUC/NN of/IN caspofungin/NN by/IN approximately/RB 35/CD %./NN

(ROOT (S1 (S (PP (IN In) (NP (CD two) (JJ clinical) (NNS studies))) (, ,) (NP (NP (NN cyclosporine)) (PRN (-LRB- -LRB-) (NP (NP (CD one) (ADJP (CD 4) (NN mg/kg)) (NN dose)) (CC or) (NP (CD two) (CD 3) (NN mg/kg) (NNS doses))) (-RRB- -RRB-))) (VP (VBD increased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN caspofungin)))) (PP (IN by) (NP (QP (RB approximately) (CD 35)) (NN %.)))))))

num(studies-4, two-2)
amod(studies-4, clinical-3)
prep_in(increased-18, studies-4)
nsubj(increased-18, cyclosporine-6)
num(dose-11, one-8)
number(mg/kg-10, 4-9)
amod(dose-11, mg/kg-10)
dep(cyclosporine-6, dose-11)
num(doses-16, two-13)
num(doses-16, 3-14)
nn(doses-16, mg/kg-15)
conj_or(dose-11, doses-16)
root(ROOT-0, increased-18)
det(AUC-20, the-19)
dobj(increased-18, AUC-20)
prep_of(AUC-20, caspofungin-22)
quantmod(35-25, approximately-24)
num(%.-26, 35-25)
prep_by(increased-18, %.-26)

CANCIDAS/NN did/VBD not/RB increase/VB the/DT plasma/NN levels/NNS of/IN cyclosporine/NN ./.

(ROOT (S1 (S (S (NP (NN CANCIDAS)) (VP (VBD did) (RB not) (VP (VB increase) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN cyclosporine))))))) (. .))))

nsubj(increase-4, CANCIDAS-1)
aux(increase-4, did-2)
neg(increase-4, not-3)
root(ROOT-0, increase-4)
det(levels-7, the-5)
nn(levels-7, plasma-6)
dobj(increase-4, levels-7)
prep_of(levels-7, cyclosporine-9)

There/EX were/VBD transient/JJ increases/NNS in/IN liver/NN ALT/NN and/CC AST/NN when/WRB CANCIDAS/NN and/CC cyclosporine/NN were/VBD co-administered/VBN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD were) (NP (NP (JJ transient) (NNS increases)) (PP (IN in) (NP (NP (NN liver) (NN ALT)) (CC and) (NP (NN AST))))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN CANCIDAS)) (CC and) (NP (NN cyclosporine))) (VP (VBD were) (VP (VBN co-administered))))))) (. .))))

expl(were-2, There-1)
root(ROOT-0, were-2)
amod(increases-4, transient-3)
nsubj(were-2, increases-4)
nn(ALT-7, liver-6)
prep_in(increases-4, ALT-7)
conj_and(ALT-7, AST-9)
advmod(co-administered-15, when-10)
nsubjpass(co-administered-15, CANCIDAS-11)
conj_and(CANCIDAS-11, cyclosporine-13)
auxpass(co-administered-15, were-14)
advcl(were-2, co-administered-15)

A/DT drug-drug/JJ interaction/NN study/NN with/IN rifampin/NN in/IN healthy/JJ volunteers/NNS has/VBZ shown/VBN a/DT 30/CD %/NN decrease/NN in/IN caspofungin/NN trough/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ drug-drug) (NN interaction) (NN study)) (PP (IN with) (NP (NN rifampin))) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))) (VP (VBZ has) (VP (VBN shown) (NP (NP (DT a) (ADJP (CD 30) (NN %)) (NN decrease)) (PP (IN in) (NP (NN caspofungin) (NN trough) (NNS concentrations))))))) (. .))))

det(study-4, A-1)
amod(study-4, drug-drug-2)
nn(study-4, interaction-3)
nsubj(shown-11, study-4)
prep_with(study-4, rifampin-6)
amod(volunteers-9, healthy-8)
prep_in(study-4, volunteers-9)
aux(shown-11, has-10)
root(ROOT-0, shown-11)
det(decrease-15, a-12)
number(%-14, 30-13)
amod(decrease-15, %-14)
dobj(shown-11, decrease-15)
nn(concentrations-19, caspofungin-17)
nn(concentrations-19, trough-18)
prep_in(decrease-15, concentrations-19)

Patients/NNS on/IN rifampin/NN should/MD receive/VBP 70/CD mg/NN of/IN CANCIDAS/NNS daily/RB ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN on) (NP (NN rifampin)))) (VP (MD should) (VP (VBP receive) (NP (NP (CD 70) (NN mg)) (PP (IN of) (NP (NNS CANCIDAS)))) (ADVP (RB daily))))) (. .))))

nsubj(receive-5, Patients-1)
prep_on(Patients-1, rifampin-3)
aux(receive-5, should-4)
root(ROOT-0, receive-5)
num(mg-7, 70-6)
dobj(receive-5, mg-7)
prep_of(mg-7, CANCIDAS-9)
advmod(receive-5, daily-10)

In/IN addition/NN ,/, results/NNS from/IN regression/NN analyses/NNS of/IN patient/NN pharmacokinetic/JJ data/NNS suggest/VBP that/IN co-administration/NN of/IN other/JJ inducers/NNS of/IN drug/NN clearance/NN (/-LRB- efavirenz/NN ,/, nevirapine/NN ,/, phenytoin/NN ,/, dexamethasone/NN ,/, or/CC carbamazepine/NN )/-RRB- with/IN CANCIDAS/NN may/MD result/VB in/IN clinically/RB meaningful/JJ reductions/NNS in/IN caspofungin/NN concentrations/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNS results)) (PP (IN from) (NP (NP (NN regression) (NNS analyses)) (PP (IN of) (NP (NN patient) (JJ pharmacokinetic) (NNS data)))))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (JJ other) (NNS inducers)) (PP (IN of) (NP (NP (NN drug) (NN clearance)) (PRN (-LRB- -LRB-) (NP (NP (NN efavirenz)) (, ,) (NP (NN nevirapine)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN dexamethasone)) (, ,) (CC or) (NP (NN carbamazepine))) (-RRB- -RRB-)))))) (PP (IN with) (NP (NN CANCIDAS)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (ADJP (RB clinically) (JJ meaningful)) (NNS reductions)) (PP (IN in) (NP (NN caspofungin) (NNS concentrations)))))))))) (. .))))

prep_in(suggest-12, addition-2)
nsubj(suggest-12, results-4)
nn(analyses-7, regression-6)
prep_from(results-4, analyses-7)
nn(data-11, patient-9)
amod(data-11, pharmacokinetic-10)
prep_of(analyses-7, data-11)
root(ROOT-0, suggest-12)
complm(result-36, that-13)
nsubj(result-36, co-administration-14)
amod(inducers-17, other-16)
prep_of(co-administration-14, inducers-17)
nn(clearance-20, drug-19)
prep_of(inducers-17, clearance-20)
dep(clearance-20, efavirenz-22)
conj_or(efavirenz-22, nevirapine-24)
conj_or(efavirenz-22, phenytoin-26)
conj_or(efavirenz-22, dexamethasone-28)
conj_or(efavirenz-22, carbamazepine-31)
prep_with(co-administration-14, CANCIDAS-34)
aux(result-36, may-35)
ccomp(suggest-12, result-36)
advmod(meaningful-39, clinically-38)
amod(reductions-40, meaningful-39)
prep_in(result-36, reductions-40)
nn(concentrations-43, caspofungin-42)
prep_in(reductions-40, concentrations-43)

It/PRP is/VBZ not/RB known/VBN which/WDT drug/NN clearance/NN mechanism/NN involved/VBN in/IN caspofungin/NN disposition/NN may/MD be/VB inducible/JJ ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (WHNP (WDT which)) (S (NP (NP (NN drug) (NN clearance) (NN mechanism)) (VP (VBN involved) (PP (IN in) (NP (NN caspofungin) (NN disposition))))) (VP (MD may) (VP (VB be) (ADJP (JJ inducible))))))))) (. .))))

nsubjpass(known-4, It-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
dobj(inducible-15, which-5)
nn(mechanism-8, drug-6)
nn(mechanism-8, clearance-7)
nsubj(inducible-15, mechanism-8)
partmod(mechanism-8, involved-9)
nn(disposition-12, caspofungin-11)
prep_in(involved-9, disposition-12)
aux(inducible-15, may-13)
cop(inducible-15, be-14)
ccomp(known-4, inducible-15)

When/WRB CANCIDAS/NN is/VBZ co-administered/VBN with/IN inducers/NNS of/IN drug/NN clearance/NN ,/, such/JJ as/IN efavirenz/NN ,/, nevirapine/NN ,/, phenytoin/NN ,/, dexamethasone/NN ,/, or/CC carbamazepine/NN ,/, use/NN of/IN a/DT daily/JJ dose/NN of/IN 70/CD mg/NN of/IN CANCIDAS/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (SBAR (WHADVP (WRB When)) (S (NP (NN CANCIDAS)) (VP (VBZ is) (VP (VBN co-administered) (PP (IN with) (NP (NP (NNS inducers)) (PP (IN of) (NP (NN drug) (NN clearance))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN efavirenz)) (, ,) (NP (NN nevirapine)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN dexamethasone)) (, ,) (CC or) (NP (NN carbamazepine)))))))))) (, ,) (NP (NP (NN use)) (PP (IN of) (NP (NP (DT a) (JJ daily) (NN dose)) (PP (IN of) (NP (NP (CD 70) (NN mg)) (PP (IN of) (NP (NN CANCIDAS)))))))) (VP (MD should) (VP (VB be) (VP (VBN considered)))) (. .))))

advmod(co-administered-4, When-1)
nsubjpass(co-administered-4, CANCIDAS-2)
auxpass(co-administered-4, is-3)
advcl(considered-36, co-administered-4)
prep_with(co-administered-4, inducers-6)
nn(clearance-9, drug-8)
prep_of(inducers-6, clearance-9)
prep_such_as(inducers-6, efavirenz-13)
conj_or(efavirenz-13, nevirapine-15)
conj_or(efavirenz-13, phenytoin-17)
conj_or(efavirenz-13, dexamethasone-19)
conj_or(efavirenz-13, carbamazepine-22)
nsubjpass(considered-36, use-24)
det(dose-28, a-26)
amod(dose-28, daily-27)
prep_of(use-24, dose-28)
num(mg-31, 70-30)
prep_of(dose-28, mg-31)
prep_of(mg-31, CANCIDAS-33)
aux(considered-36, should-34)
auxpass(considered-36, be-35)
root(ROOT-0, considered-36)

Probenecid/NN may/MD decrease/VB renal/JJ tubular/JJ secretion/NN of/IN cephalosporins/NNS when/WRB used/VBN concurrently/RB ,/, resulting/VBG in/IN increased/VBN and/CC more/RBR prolonged/JJ cephalosporin/NN blood/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Probenecid)) (VP (MD may) (VP (VB decrease) (NP (NP (JJ renal) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NNS cephalosporins)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (ADVP (RB concurrently))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (ADJP (ADJP (VBN increased)) (CC and) (ADJP (RBR more) (JJ prolonged))) (NN cephalosporin) (NN blood) (NNS levels)))))))) (. .))))

nsubj(decrease-3, Probenecid-1)
aux(decrease-3, may-2)
root(ROOT-0, decrease-3)
amod(secretion-6, renal-4)
amod(secretion-6, tubular-5)
dobj(decrease-3, secretion-6)
prep_of(secretion-6, cephalosporins-8)
advmod(used-10, when-9)
advcl(decrease-3, used-10)
advmod(used-10, concurrently-11)
xcomp(decrease-3, resulting-13)
amod(levels-21, increased-15)
advmod(prolonged-18, more-17)
conj_and(increased-15, prolonged-18)
nn(levels-21, cephalosporin-19)
nn(levels-21, blood-20)
prep_in(resulting-13, levels-21)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: A/DT false/JJ positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN may/MD occur/VB with/IN Benedicts/NN solution/NN ,/, Fehlings/NN solution/NN or/CC with/IN CLINITEST/NN @/NN tablets/NNS ,/, but/CC not/RB with/IN enzyme-based/JJ tests/NNS such/JJ as/IN CLINISTIX/JJ @./NNS

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT A) (ADJP (ADJP (JJ false)) (ADJP (JJ positive))) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB occur) (PP (IN with) (NP (NP (NN Benedicts) (NN solution)) (, ,) (NP (NN Fehlings) (NN solution)))) (PP (CC or) (PP (IN with) (NP (NN CLINITEST) (NN @) (NNS tablets))) (, ,) (CC but) (PP (RB not) (IN with) (NP (NP (JJ enzyme-based) (NNS tests)) (PP (JJ such) (IN as) (NP (JJ CLINISTIX) (NNS @.)))))))))))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(reaction-9, A-6)
amod(reaction-9, false-7)
dep(false-7, positive-8)
nsubj(occur-16, reaction-9)
prep_for(reaction-9, glucose-11)
det(urine-14, the-13)
prep_in(reaction-9, urine-14)
aux(occur-16, may-15)
dep(Interactions-4, occur-16)
nn(solution-19, Benedicts-18)
prep_with(occur-16, solution-19)
nn(solution-22, Fehlings-21)
appos(solution-19, solution-22)
cc(occur-16, or-23)
nn(tablets-27, CLINITEST-25)
nn(tablets-27, @-26)
prep_with(occur-16, tablets-27)
neg(occur-16, not-30)
amod(tests-33, enzyme-based-32)
conj_but(tablets-27, tests-33)
amod(@.-37, CLINISTIX-36)
prep_such_as(tests-33, @.-37)

Positive/JJ direct/JJ and/CC indirect/JJ antiglobulin/NN (/-LRB- Coombs/NN )/-RRB- tests/NNS have/VBP occurred/VBN ;/: ./.

(ROOT (S1 (S (S (NP (JJ Positive) (ADJP (ADJP (JJ direct)) (CC and) (ADJP (JJ indirect))) (NN antiglobulin) (-LRB- -LRB-) (NN Coombs) (-RRB- -RRB-) (NNS tests)) (VP (VBP have) (VP (VBN occurred))) (: ;)) (. .))))

amod(tests-9, Positive-1)
amod(tests-9, direct-2)
conj_and(direct-2, indirect-4)
nn(tests-9, antiglobulin-5)
nn(tests-9, Coombs-7)
nsubj(occurred-11, tests-9)
aux(occurred-11, have-10)
root(ROOT-0, occurred-11)

these/DT may/MD also/RB occur/VB in/IN neonates/NNS whose/WP$ mothers/NNS received/VBD cephalosporins/NN before/IN delivery/NN ./.

(ROOT (S1 (S (S (NP (DT these)) (VP (MD may) (ADVP (RB also)) (VP (VB occur) (PP (IN in) (NP (NP (NNS neonates)) (SBAR (WHNP (WP$ whose) (NNS mothers)) (S (VP (VBD received) (NP (NN cephalosporins)) (PP (IN before) (NP (NN delivery))))))))))) (. .))))

nsubj(occur-4, these-1)
aux(occur-4, may-2)
advmod(occur-4, also-3)
root(ROOT-0, occur-4)
prep_in(occur-4, neonates-6)
poss(mothers-8, neonates-6)
nsubj(received-9, mothers-8)
rcmod(neonates-6, received-9)
dobj(received-9, cephalosporins-10)
prep_before(received-9, delivery-12)

Oral/JJ Contraceptives/NN Multiple/JJ doses/NNS of/IN cefditoren/CD pivoxil/NN had/VBD no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN ethinyl/NN estradiol/NN ,/, the/DT estrogenic/JJ component/NN in/IN most/JJS oral/JJ contraceptives/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Oral) (NN Contraceptives) (JJ Multiple) (NNS doses)) (PP (IN of) (NP (CD cefditoren) (NN pivoxil)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN ethinyl) (NN estradiol)) (, ,) (NP (NP (DT the) (JJ estrogenic) (NN component)) (PP (IN in) (NP (JJS most) (JJ oral) (NNS contraceptives)))))))))) (. .))))

amod(doses-4, Oral-1)
nn(doses-4, Contraceptives-2)
amod(doses-4, Multiple-3)
nsubj(had-8, doses-4)
num(pivoxil-7, cefditoren-6)
prep_of(doses-4, pivoxil-7)
root(ROOT-0, had-8)
det(effect-10, no-9)
dobj(had-8, effect-10)
det(pharmacokinetics-13, the-12)
prep_on(had-8, pharmacokinetics-13)
nn(estradiol-16, ethinyl-15)
prep_of(pharmacokinetics-13, estradiol-16)
det(component-20, the-18)
amod(component-20, estrogenic-19)
appos(estradiol-16, component-20)
amod(contraceptives-24, most-22)
amod(contraceptives-24, oral-23)
prep_in(component-20, contraceptives-24)

Antacids/NNS Co-administration/NN of/IN a/DT single/JJ dose/NN of/IN an/DT antacid/JJ which/WDT contained/VBD both/CC magnesium/NN (/-LRB- 800/CD mg/NN )/-RRB- and/CC aluminum/NN (/-LRB- 900/CD mg/NN )/-RRB- hydroxides/NNS reduced/VBD the/DT oral/JJ absorption/NN of/IN a/DT single/JJ 400/CD mg/NN dose/NN of/IN cefditoren/CD pivoxil/NN administered/VBN following/VBG a/DT meal/NN ,/, as/IN evidenced/VBN by/IN a/DT 14/CD %/NN decrease/NN in/IN mean/JJ Cmax/NN and/CC an/DT 11/CD %/NN decrease/NN in/IN mean/JJ AUC/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antacids) (NN Co-administration)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (DT an) (JJ antacid)) (SBAR (WHNP (WDT which)) (S (VP (VBD contained) (NP (NP (NP (CC both) (NP (NP (NN magnesium)) (PRN (-LRB- -LRB-) (NP (CD 800) (NN mg)) (-RRB- -RRB-))) (CC and) (NP (NN aluminum))) (PRN (-LRB- -LRB-) (NP (CD 900) (NN mg)) (-RRB- -RRB-))) (NNS hydroxides)))))))))) (VP (VBD reduced) (NP (NP (DT the) (JJ oral) (NN absorption)) (PP (IN of) (NP (NP (NP (DT a) (JJ single) (ADJP (CD 400) (NN mg)) (NN dose)) (PP (IN of) (NP (CD cefditoren) (NN pivoxil)))) (VP (VBN administered) (PP (VBG following) (NP (DT a) (NN meal))))))) (, ,) (SBAR (IN as) (S (VP (VBN evidenced) (PP (IN by) (NP (NP (NP (DT a) (ADJP (CD 14) (NN %)) (NN decrease)) (PP (IN in) (NP (JJ mean) (NN Cmax)))) (CC and) (NP (NP (DT an) (ADJP (CD 11) (NN %)) (NN decrease)) (PP (IN in) (NP (JJ mean) (NN AUC)))))))))) (. .))))

nn(Co-administration-2, Antacids-1)
nsubj(reduced-25, Co-administration-2)
det(dose-6, a-4)
amod(dose-6, single-5)
prep_of(Co-administration-2, dose-6)
det(antacid-9, an-8)
prep_of(dose-6, antacid-9)
nsubj(contained-11, antacid-9)
rcmod(antacid-9, contained-11)
preconj(magnesium-13, both-12)
nn(hydroxides-24, magnesium-13)
num(mg-16, 800-15)
appos(magnesium-13, mg-16)
conj_and(magnesium-13, aluminum-19)
num(mg-22, 900-21)
appos(magnesium-13, mg-22)
dobj(contained-11, hydroxides-24)
root(ROOT-0, reduced-25)
det(absorption-28, the-26)
amod(absorption-28, oral-27)
dobj(reduced-25, absorption-28)
det(dose-34, a-30)
amod(dose-34, single-31)
number(mg-33, 400-32)
amod(dose-34, mg-33)
prep_of(absorption-28, dose-34)
num(pivoxil-37, cefditoren-36)
prep_of(dose-34, pivoxil-37)
partmod(dose-34, administered-38)
det(meal-41, a-40)
prep_following(administered-38, meal-41)
mark(evidenced-44, as-43)
advcl(reduced-25, evidenced-44)
det(decrease-49, a-46)
number(%-48, 14-47)
amod(decrease-49, %-48)
prep_by(evidenced-44, decrease-49)
amod(Cmax-52, mean-51)
prep_in(decrease-49, Cmax-52)
det(decrease-57, an-54)
number(%-56, 11-55)
amod(decrease-57, %-56)
conj_and(decrease-49, decrease-57)
amod(AUC-60, mean-59)
prep_in(decrease-57, AUC-60)

Although/IN the/DT clinical/JJ significance/NN is/VBZ not/RB known/VBN ,/, it/PRP is/VBZ not/RB recommended/VBN that/IN cefditoren/CD pivoxil/NN be/VB taken/VBN concomitantly/RB with/IN antacids/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (DT the) (JJ clinical) (NN significance)) (VP (VBZ is) (RB not) (VP (VBN known))))) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN recommended) (SBAR (IN that) (S (NP (CD cefditoren) (NN pivoxil)) (VP (VB be) (VP (VBN taken) (ADVP (RB concomitantly)) (PP (IN with) (NP (NNS antacids)))))))))) (. .))))

mark(known-7, Although-1)
det(significance-4, the-2)
amod(significance-4, clinical-3)
nsubjpass(known-7, significance-4)
auxpass(known-7, is-5)
neg(known-7, not-6)
advcl(recommended-12, known-7)
nsubjpass(recommended-12, it-9)
auxpass(recommended-12, is-10)
neg(recommended-12, not-11)
root(ROOT-0, recommended-12)
complm(taken-17, that-13)
num(pivoxil-15, cefditoren-14)
nsubjpass(taken-17, pivoxil-15)
auxpass(taken-17, be-16)
ccomp(recommended-12, taken-17)
advmod(taken-17, concomitantly-18)
prep_with(taken-17, antacids-20)

H2-Receptor/JJ Antagonists/NNS Co-administration/NN of/IN a/DT single/JJ dose/NN of/IN intravenously/RB administered/VBN famotidine/NN (/-LRB- 20/CD mg/NN )/-RRB- reduced/VBD the/DT oral/JJ absorption/NN of/IN a/DT single/JJ 400/CD mg/NN dose/NN of/IN cefditoren/CD pivoxil/NN administered/VBN following/VBG a/DT meal/NN ,/, as/IN evidenced/VBN by/IN a/DT 27/CD %/NN decrease/NN in/IN mean/JJ Cmax/NN and/CC a/DT 22/CD %/NN decrease/NN in/IN mean/JJ AUC/NN ./.

(ROOT (S1 (S (NP (NP (JJ H2-Receptor) (NNS Antagonists) (NN Co-administration)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (ADJP (RB intravenously) (VBN administered)) (NN famotidine)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg)) (-RRB- -RRB-))))))) (VP (VBD reduced) (NP (NP (DT the) (JJ oral) (NN absorption)) (PP (IN of) (NP (NP (NP (DT a) (JJ single) (ADJP (CD 400) (NN mg)) (NN dose)) (PP (IN of) (NP (CD cefditoren) (NN pivoxil)))) (VP (VBN administered) (PP (VBG following) (NP (DT a) (NN meal))))))) (, ,) (SBAR (IN as) (S (VP (VBN evidenced) (PP (IN by) (NP (NP (NP (DT a) (ADJP (CD 27) (NN %)) (NN decrease)) (PP (IN in) (NP (JJ mean) (NN Cmax)))) (CC and) (NP (NP (DT a) (ADJP (CD 22) (NN %)) (NN decrease)) (PP (IN in) (NP (JJ mean) (NN AUC)))))))))) (. .))))

amod(Co-administration-3, H2-Receptor-1)
nn(Co-administration-3, Antagonists-2)
nsubj(reduced-16, Co-administration-3)
det(dose-7, a-5)
amod(dose-7, single-6)
prep_of(Co-administration-3, dose-7)
advmod(administered-10, intravenously-9)
amod(famotidine-11, administered-10)
prep_of(dose-7, famotidine-11)
num(mg-14, 20-13)
appos(famotidine-11, mg-14)
root(ROOT-0, reduced-16)
det(absorption-19, the-17)
amod(absorption-19, oral-18)
dobj(reduced-16, absorption-19)
det(dose-25, a-21)
amod(dose-25, single-22)
number(mg-24, 400-23)
amod(dose-25, mg-24)
prep_of(absorption-19, dose-25)
num(pivoxil-28, cefditoren-27)
prep_of(dose-25, pivoxil-28)
partmod(dose-25, administered-29)
det(meal-32, a-31)
prep_following(administered-29, meal-32)
mark(evidenced-35, as-34)
advcl(reduced-16, evidenced-35)
det(decrease-40, a-37)
number(%-39, 27-38)
amod(decrease-40, %-39)
prep_by(evidenced-35, decrease-40)
amod(Cmax-43, mean-42)
prep_in(decrease-40, Cmax-43)
det(decrease-48, a-45)
number(%-47, 22-46)
amod(decrease-48, %-47)
conj_and(decrease-40, decrease-48)
amod(AUC-51, mean-50)
prep_in(decrease-48, AUC-51)

Although/IN the/DT clinical/JJ significance/NN is/VBZ not/RB known/VBN ,/, it/PRP is/VBZ not/RB recommended/VBN that/IN cefditoren/CD pivoxil/NN be/VB taken/VBN concomitantly/RB with/IN H2/NN receptor/NN antagonists/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (DT the) (JJ clinical) (NN significance)) (VP (VBZ is) (RB not) (VP (VBN known))))) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN recommended) (SBAR (IN that) (S (NP (CD cefditoren) (NN pivoxil)) (VP (VB be) (VP (VBN taken) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN H2) (NN receptor) (NNS antagonists)))))))))) (. .))))

mark(known-7, Although-1)
det(significance-4, the-2)
amod(significance-4, clinical-3)
nsubjpass(known-7, significance-4)
auxpass(known-7, is-5)
neg(known-7, not-6)
advcl(recommended-12, known-7)
nsubjpass(recommended-12, it-9)
auxpass(recommended-12, is-10)
neg(recommended-12, not-11)
root(ROOT-0, recommended-12)
complm(taken-17, that-13)
num(pivoxil-15, cefditoren-14)
nsubjpass(taken-17, pivoxil-15)
auxpass(taken-17, be-16)
ccomp(recommended-12, taken-17)
advmod(taken-17, concomitantly-18)
nn(antagonists-22, H2-20)
nn(antagonists-22, receptor-21)
prep_with(taken-17, antagonists-22)

Probenecid/NN :/: As/IN with/IN other/JJ b-lactam/NN antibiotics/NNS ,/, co-administration/NN of/IN probenecid/NN with/IN cefditoren/CD pivoxil/NN resulted/VBD in/IN an/DT increase/NN in/IN the/DT plasma/NN exposure/NN of/IN cefditoren/NN ,/, with/IN a/DT 49/CD %/NN increase/NN in/IN mean/NN Cmax/NN ,/, a/DT 122/CD %/NN increase/NN in/IN mean/JJ AUC/NN ,/, and/CC a/DT 53/CD %/NN increase/NN in/IN half-life/NN ./.

(ROOT (S1 (S (NP (NP (NN Probenecid)) (: :) (S (PP (IN As) (PP (IN with) (NP (JJ other) (NN b-lactam) (NNS antibiotics)))) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (NN probenecid))) (PP (IN with) (NP (CD cefditoren) (NN pivoxil)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN plasma) (NN exposure)) (PP (IN of) (NP (NN cefditoren))))))) (, ,) (PP (IN with) (NP (NP (NP (DT a) (ADJP (CD 49) (NN %)) (NN increase)) (PP (IN in) (NP (NN mean) (NN Cmax)))) (, ,) (NP (NP (DT a) (CD 122) (NN %) (NN increase)) (PP (IN in) (NP (JJ mean) (NN AUC)))) (, ,) (CC and) (NP (NP (DT a) (CD 53) (NN %) (NN increase)) (PP (IN in) (NP (NN half-life)))))))) (. .)))))

root(ROOT-0, Probenecid-1)
prep(resulted-15, As-3)
pcomp(As-3, with-4)
amod(antibiotics-7, other-5)
nn(antibiotics-7, b-lactam-6)
prep_with(As-3, antibiotics-7)
nsubj(resulted-15, co-administration-9)
prep_of(co-administration-9, probenecid-11)
num(pivoxil-14, cefditoren-13)
prep_with(co-administration-9, pivoxil-14)
dep(Probenecid-1, resulted-15)
det(increase-18, an-17)
prep_in(resulted-15, increase-18)
det(exposure-22, the-20)
nn(exposure-22, plasma-21)
prep_in(increase-18, exposure-22)
prep_of(exposure-22, cefditoren-24)
det(increase-30, a-27)
number(%-29, 49-28)
amod(increase-30, %-29)
prep_with(resulted-15, increase-30)
nn(Cmax-33, mean-32)
prep_in(increase-30, Cmax-33)
det(increase-38, a-35)
num(increase-38, 122-36)
nn(increase-38, %-37)
conj_and(increase-30, increase-38)
amod(AUC-41, mean-40)
prep_in(increase-38, AUC-41)
det(increase-47, a-44)
num(increase-47, 53-45)
nn(increase-47, %-46)
conj_and(increase-30, increase-47)
prep_in(increase-47, half-life-49)

Drug/NN /Laboratory/JJ Test/NN Interactions/NNS Cephalosporins/NNS are/VBP known/VBN to/TO occasionally/RB induce/VB a/DT positive/JJ direct/JJ Coombs/NN test/NN ./.

(ROOT (S1 (S (S (NP (NN Drug) (JJ /Laboratory) (NN Test) (NNS Interactions) (NNS Cephalosporins)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (ADVP (RB occasionally)) (VP (VB induce) (NP (DT a) (JJ positive) (JJ direct) (NN Coombs) (NN test)))))))) (. .))))

nn(Cephalosporins-5, Drug-1)
amod(Cephalosporins-5, /Laboratory-2)
nn(Cephalosporins-5, Test-3)
nn(Cephalosporins-5, Interactions-4)
nsubjpass(known-7, Cephalosporins-5)
xsubj(induce-10, Cephalosporins-5)
auxpass(known-7, are-6)
root(ROOT-0, known-7)
aux(induce-10, to-8)
advmod(induce-10, occasionally-9)
xcomp(known-7, induce-10)
det(test-15, a-11)
amod(test-15, positive-12)
amod(test-15, direct-13)
nn(test-15, Coombs-14)
dobj(induce-10, test-15)

A/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN may/MD occur/VB with/IN copper/NN reduction/NN tests/NNS (/-LRB- Benedicts/NNP or/CC Fehlings/NNP solution/NN or/CC with/IN CLINITEST/JJ tablets/NNS )/-RRB- ,/, but/CC not/RB with/IN enzyme-based/JJ tests/NNS for/IN glycosuria/NN (/-LRB- e.g./FW ,/, CLINISTIX/NN ,/, TES-TAPE/JJ )./NN

(ROOT (S1 (S (NP (NP (DT A) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB occur) (PP (PP (IN with) (NP (NP (NN copper) (NN reduction) (NNS tests)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Benedicts)) (CC or) (NP (NNP Fehlings))) (NP (NN solution))) (CC or) (PP (IN with) (NP (JJ CLINITEST) (NNS tablets))) (-RRB- -RRB-)))) (, ,) (CC but) (PP (RB not) (IN with) (NP (NP (JJ enzyme-based) (NNS tests)) (PP (IN for) (NP (NN glycosuria)))))))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN CLINISTIX)) (, ,) (NP (JJ TES-TAPE) (NN -RRB-.)))))))

det(reaction-3, A-1)
amod(reaction-3, false-positive-2)
nsubj(occur-10, reaction-3)
prep_for(reaction-3, glucose-5)
det(urine-8, the-7)
prep_in(reaction-3, urine-8)
aux(occur-10, may-9)
root(ROOT-0, occur-10)
nn(tests-14, copper-12)
nn(tests-14, reduction-13)
prep_with(occur-10, tests-14)
dep(tests-14, Benedicts-16)
conj_or(Benedicts-16, Fehlings-18)
dep(Benedicts-16, solution-19)
dep(Benedicts-16, or-20)
dep(Benedicts-16, with-21)
amod(tablets-23, CLINITEST-22)
pobj(with-21, tablets-23)
neg(occur-10, not-27)
amod(tests-30, enzyme-based-29)
conj_but(tests-14, tests-30)
prep_for(tests-30, glycosuria-32)
dep(CLINISTIX-36, e.g.-34)
dep(occur-10, CLINISTIX-36)
amod(-RRB-.-39, TES-TAPE-38)
appos(CLINISTIX-36, -RRB-.-39)

As/IN a/DT false-negative/JJ result/NN may/MD occur/VB in/IN the/DT ferricyanide/NN test/NN ,/, it/PRP is/VBZ recommended/VBN that/IN either/CC the/DT glucose/NN oxidase/NN or/CC hexokinase/NN method/NN be/VB used/VBN to/TO determine/VB blood/plasma/NN glucose/NN levels/NNS in/IN patients/NNS receiving/VBG cefditoren/NN pivoxil/NN ./.

(ROOT (S1 (S (SBAR (IN As) (S (NP (DT a) (JJ false-negative) (NN result)) (VP (MD may) (VP (VB occur) (PP (IN in) (NP (DT the) (NN ferricyanide) (NN test))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (CC either) (NP (DT the) (NN glucose) (NN oxidase)) (CC or) (NP (NN hexokinase) (NN method))) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (NP (NN blood/plasma) (NN glucose) (NNS levels)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN cefditoren) (NN pivoxil))))))))))))))) (. .))))

mark(occur-6, As-1)
det(result-4, a-2)
amod(result-4, false-negative-3)
nsubj(occur-6, result-4)
aux(occur-6, may-5)
advcl(recommended-14, occur-6)
det(test-10, the-8)
nn(test-10, ferricyanide-9)
prep_in(occur-6, test-10)
nsubjpass(recommended-14, it-12)
auxpass(recommended-14, is-13)
root(ROOT-0, recommended-14)
complm(used-24, that-15)
preconj(oxidase-19, either-16)
det(oxidase-19, the-17)
nn(oxidase-19, glucose-18)
nsubjpass(used-24, oxidase-19)
nn(method-22, hexokinase-21)
conj_or(oxidase-19, method-22)
auxpass(used-24, be-23)
ccomp(recommended-14, used-24)
aux(determine-26, to-25)
xcomp(used-24, determine-26)
nn(levels-29, blood/plasma-27)
nn(levels-29, glucose-28)
dobj(determine-26, levels-29)
prep_in(levels-29, patients-31)
partmod(patients-31, receiving-32)
nn(pivoxil-34, cefditoren-33)
dobj(receiving-32, pivoxil-34)

Increased/VBN nephrotoxicity/NN has/VBZ been/VBN reported/VBN following/VBG concomitant/JJ administration/NN of/IN cephalosporins/NNS and/CC aminoglycoside/NN antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (VBN Increased) (NN nephrotoxicity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (VBG following) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NNS cephalosporins)) (CC and) (NP (NN aminoglycoside) (NNS antibiotics)))))))))) (. .))))

amod(nephrotoxicity-2, Increased-1)
nsubjpass(reported-5, nephrotoxicity-2)
aux(reported-5, has-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
amod(administration-8, concomitant-7)
prep_following(reported-5, administration-8)
prep_of(administration-8, cephalosporins-10)
nn(antibiotics-13, aminoglycoside-12)
conj_and(cephalosporins-10, antibiotics-13)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: As/IN with/IN cephalothin/NN ,/, high/JJ concentrations/NNS of/IN cefoxitin/NN (/-LRB- 100/CD micrograms/mL/NNS )/-RRB- may/MD interfere/VB with/IN measurement/NN of/IN serum/NN and/CC urine/NN creatinine/NN levels/NNS by/IN the/DT Jaff/NN @/NN reaction/NN ,/, and/CC produce/VBP false/JJ increases/NNS of/IN modest/JJ degree/NN in/IN the/DT levels/NNS of/IN creatinine/NN reported/VBD ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (PP (IN As) (PP (IN with) (NP (NN cephalothin)))) (, ,) (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (NP (NN cefoxitin)) (PRN (-LRB- -LRB-) (NP (CD 100) (NNS micrograms/mL)) (-RRB- -RRB-))))) (VP (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (NN measurement)) (PP (IN of) (NP (NP (NN serum)) (CC and) (NP (NN urine)) (NP (NN creatinine) (NNS levels)))))) (PP (IN by) (NP (DT the) (NN Jaff) (NN @) (NN reaction))))) (, ,) (CC and) (VP (VBP produce) (NP (NP (JJ false) (NNS increases)) (PP (IN of) (NP (JJ modest) (NN degree))) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN creatinine)) (VP (VBD reported)))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
prep(interfere-19, As-6)
pcomp(As-6, with-7)
prep_with(As-6, cephalothin-8)
amod(concentrations-11, high-10)
nsubj(interfere-19, concentrations-11)
prep_of(concentrations-11, cefoxitin-13)
num(micrograms/mL-16, 100-15)
appos(cefoxitin-13, micrograms/mL-16)
aux(interfere-19, may-18)
dep(Interactions-4, interfere-19)
prep_with(interfere-19, measurement-21)
prep_of(measurement-21, serum-23)
conj_and(serum-23, urine-25)
nn(levels-27, creatinine-26)
dep(serum-23, levels-27)
det(reaction-32, the-29)
nn(reaction-32, Jaff-30)
nn(reaction-32, @-31)
prep_by(interfere-19, reaction-32)
conj_and(interfere-19, produce-35)
amod(increases-37, false-36)
dobj(produce-35, increases-37)
amod(degree-40, modest-39)
prep_of(increases-37, degree-40)
det(levels-43, the-42)
prep_in(increases-37, levels-43)
prep_of(levels-43, creatinine-45)
partmod(creatinine-45, reported-46)

Serum/NN samples/NNS from/IN patients/NNS treated/VBN with/IN cefoxitin/NN should/MD not/RB be/VB analyzed/VBN for/IN creatinine/NN if/IN withdrawn/VBN within/IN 2/CD hours/NNS of/IN drug/NN administration/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Serum) (NNS samples)) (PP (IN from) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN cefoxitin))))))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN analyzed) (PP (IN for) (NP (NN creatinine))) (SBAR (IN if) (S (VP (VBN withdrawn) (PP (IN within) (NP (NP (CD 2) (NNS hours)) (PP (IN of) (NP (NN drug) (NN administration)))))))))))) (. .))))

nn(samples-2, Serum-1)
nsubjpass(analyzed-11, samples-2)
prep_from(samples-2, patients-4)
partmod(patients-4, treated-5)
prep_with(treated-5, cefoxitin-7)
aux(analyzed-11, should-8)
neg(analyzed-11, not-9)
auxpass(analyzed-11, be-10)
root(ROOT-0, analyzed-11)
prep_for(analyzed-11, creatinine-13)
mark(withdrawn-15, if-14)
advcl(analyzed-11, withdrawn-15)
num(hours-18, 2-17)
prep_within(withdrawn-15, hours-18)
nn(administration-21, drug-20)
prep_of(hours-18, administration-21)

High/JJ concentrations/NNS of/IN cefoxitin/NN in/IN the/DT urine/NN may/MD interfere/VB with/IN measurement/NN of/IN urinary/JJ 17-hydroxy-/JJ corticosteroids/NNS by/IN the/DT Porter-Silber/NN reaction/NN ,/, and/CC produce/VB false/JJ increases/NNS of/IN modest/JJ degree/NN in/IN the/DT levels/NNS reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ High) (NNS concentrations)) (PP (IN of) (NP (NN cefoxitin))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VP (VB interfere) (PP (IN with) (NP (NP (NN measurement)) (PP (IN of) (NP (JJ urinary) (JJ 17-hydroxy-) (NNS corticosteroids))))) (PP (IN by) (NP (DT the) (NN Porter-Silber) (NN reaction)))) (, ,) (CC and) (VP (VB produce) (NP (NP (JJ false) (NNS increases)) (PP (IN of) (NP (JJ modest) (NN degree))) (PP (IN in) (NP (NP (DT the) (NNS levels)) (VP (VBN reported))))))))) (. .))))

amod(concentrations-2, High-1)
nsubj(interfere-9, concentrations-2)
prep_of(concentrations-2, cefoxitin-4)
det(urine-7, the-6)
prep_in(concentrations-2, urine-7)
aux(interfere-9, may-8)
root(ROOT-0, interfere-9)
prep_with(interfere-9, measurement-11)
amod(corticosteroids-15, urinary-13)
amod(corticosteroids-15, 17-hydroxy--14)
prep_of(measurement-11, corticosteroids-15)
det(reaction-19, the-17)
nn(reaction-19, Porter-Silber-18)
prep_by(interfere-9, reaction-19)
conj_and(interfere-9, produce-22)
amod(increases-24, false-23)
dobj(produce-22, increases-24)
amod(degree-27, modest-26)
prep_of(increases-24, degree-27)
det(levels-30, the-29)
prep_in(increases-24, levels-30)
partmod(levels-30, reported-31)

A/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN may/MD occur/VB ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB occur)))) (. .))))

det(reaction-3, A-1)
amod(reaction-3, false-positive-2)
nsubj(occur-10, reaction-3)
prep_for(reaction-3, glucose-5)
det(urine-8, the-7)
prep_in(reaction-3, urine-8)
aux(occur-10, may-9)
root(ROOT-0, occur-10)

@/NN Registered/JJ trademark/NN of/IN Ame/NN s/NN Company/NN ,/, Division/NN of/IN Miles/NN Laboratories/NNS ,/, Inc./NNP ./.

(ROOT (S1 (S (S (NP (NP (NP (NN @) (JJ Registered) (NN trademark)) (PP (IN of) (NP (NN Ame) (NN s) (NN Company)))) (, ,) (NP (NP (NN Division)) (PP (IN of) (NP (NN Miles) (NNS Laboratories)))) (, ,)) (NP (NNP Inc.))) (. .))))

nn(trademark-3, @-1)
amod(trademark-3, Registered-2)
dep(Inc.-14, trademark-3)
nn(Company-7, Ame-5)
nn(Company-7, s-6)
prep_of(trademark-3, Company-7)
appos(trademark-3, Division-9)
nn(Laboratories-12, Miles-11)
prep_of(Division-9, Laboratories-12)
root(ROOT-0, Inc.-14)

Immunosuppressive/JJ Drugs/NNS ,/, Fibric/JJ Acid/NN Derivatives/NNS ,/, Niacin/NN (/-LRB- Nicotinic/JJ Acid/NN ,/, Erythromycin/NN ,/, Azole/JJ Antifungals/NNS :/: Skeletal/JJ Muscle/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Immunosuppressive) (NNS Drugs)) (, ,) (NP (JJ Fibric) (NN Acid) (NNS Derivatives)) (, ,) (NP (NP (NN Niacin)) (-LRB- -LRB-) (NP (JJ Nicotinic) (NN Acid)) (, ,) (NP (NN Erythromycin)) (, ,) (NP (JJ Azole) (NNS Antifungals)))) (: :) (NP (JJ Skeletal) (NN Muscle))) (. .))))

amod(Drugs-2, Immunosuppressive-1)
dep(Muscle-19, Drugs-2)
amod(Derivatives-6, Fibric-4)
nn(Derivatives-6, Acid-5)
appos(Drugs-2, Derivatives-6)
appos(Drugs-2, Niacin-8)
amod(Acid-11, Nicotinic-10)
dep(Niacin-8, Acid-11)
appos(Niacin-8, Erythromycin-13)
amod(Antifungals-16, Azole-15)
appos(Niacin-8, Antifungals-16)
amod(Muscle-19, Skeletal-18)
root(ROOT-0, Muscle-19)

ANTACID/JJ (/-LRB- Magnesium-Aluminum/NN Hydroxide/NN )/-RRB- :/: Cerivastatin/NN plasma/NN concentrations/NNS were/VBD not/RB affected/VBN by/IN co-administration/NN of/IN antacid/JJ ./.

(ROOT (S1 (S (S (NP (ADJP (ADJP (JJ ANTACID)) (-LRB- -LRB-) (NP (NN Magnesium-Aluminum) (NN Hydroxide)) (-RRB- -RRB-) (: :)) (NN Cerivastatin) (NN plasma) (NNS concentrations)) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN co-administration)) (PP (IN of) (NP (JJ antacid)))))))) (. .))))

amod(concentrations-9, ANTACID-1)
nn(Hydroxide-4, Magnesium-Aluminum-3)
dep(ANTACID-1, Hydroxide-4)
nn(concentrations-9, Cerivastatin-7)
nn(concentrations-9, plasma-8)
nsubjpass(affected-12, concentrations-9)
auxpass(affected-12, were-10)
neg(affected-12, not-11)
root(ROOT-0, affected-12)
agent(affected-12, co-administration-14)
prep_of(co-administration-14, antacid-16)

CIMETlDINE/NN :/: Cerivastatin/NN plasma/NN concentrations/NNS were/VBD not/RB affected/VBN by/IN co-administration/NN of/IN cimetidine/NN ./.

(ROOT (S1 (S (S (NP (NN CIMETlDINE) (: :) (NN Cerivastatin) (NN plasma) (NNS concentrations)) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN co-administration)) (PP (IN of) (NP (NN cimetidine)))))))) (. .))))

nn(concentrations-5, CIMETlDINE-1)
nn(concentrations-5, Cerivastatin-3)
nn(concentrations-5, plasma-4)
nsubjpass(affected-8, concentrations-5)
auxpass(affected-8, were-6)
neg(affected-8, not-7)
root(ROOT-0, affected-8)
agent(affected-8, co-administration-10)
prep_of(co-administration-10, cimetidine-12)

CHOLESTYRAMINE/NN :/: The/DT influence/NN of/IN the/DT bile-acidsequestering/JJ agent/NN cholestyramine/NN on/IN the/DT pharmacokinetits/NNS of/IN cerivastatin/NN sodium/NN was/VBD evaluated/VBN in/IN 12/CD healthy/JJ males/NNS in/IN 2/CD separate/JJ randomized/JJ crossover/NN studies/NNS ./.

(ROOT (S1 (S (NP (NP (NN CHOLESTYRAMINE)) (: :) (S (NP (NP (DT The) (NN influence)) (PP (IN of) (NP (DT the) (JJ bile-acidsequestering) (NN agent) (NN cholestyramine))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetits)) (PP (IN of) (NP (NN cerivastatin) (NN sodium)))))) (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (NP (CD 12) (JJ healthy) (NNS males)) (PP (IN in) (NP (CD 2) (JJ separate) (JJ randomized) (NN crossover) (NNS studies)))))))) (. .)))))

root(ROOT-0, CHOLESTYRAMINE-1)
det(influence-4, The-3)
nsubjpass(evaluated-17, influence-4)
det(cholestyramine-9, the-6)
amod(cholestyramine-9, bile-acidsequestering-7)
nn(cholestyramine-9, agent-8)
prep_of(influence-4, cholestyramine-9)
det(pharmacokinetits-12, the-11)
prep_on(influence-4, pharmacokinetits-12)
nn(sodium-15, cerivastatin-14)
prep_of(pharmacokinetits-12, sodium-15)
auxpass(evaluated-17, was-16)
dep(CHOLESTYRAMINE-1, evaluated-17)
num(males-21, 12-19)
amod(males-21, healthy-20)
prep_in(evaluated-17, males-21)
num(studies-27, 2-23)
amod(studies-27, separate-24)
amod(studies-27, randomized-25)
nn(studies-27, crossover-26)
prep_in(males-21, studies-27)

In/IN the/DT first/JJ study/NN ,/, concomitant/JJ administration/NN of/IN 0.2/CD mg/NN cerivastatin/NN sodium/NN and/CC 12/CD g/NN cholestyramine/NN resulted/VBD in/IN decreases/NNS of/IN more/JJR than/IN 22/CD %/NN for/IN AUC/NN and/CC 40/CD %/NN for/IN Cmax/NN when/WRB compared/VBN to/TO dosing/NN cerivastatin/NN sodium/NN alone/RB ./.

(ROOT (S1 (S (PP (IN In) (NP (DT the) (JJ first) (NN study))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (ADJP (CD 0.2) (NN mg)) (NN cerivastatin) (NN sodium)) (CC and) (NP (CD 12) (NN g) (NN cholestyramine))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS decreases)) (PP (IN of) (NP (NP (NP (QP (JJR more) (IN than) (CD 22)) (NN %)) (PP (IN for) (NP (NN AUC)))) (CC and) (NP (NP (CD 40) (NN %)) (PP (IN for) (NP (NN Cmax)))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NN dosing) (NN cerivastatin) (NN sodium))) (ADVP (RB alone)))))) (. .))))

det(study-4, the-2)
amod(study-4, first-3)
prep_in(resulted-17, study-4)
amod(administration-7, concomitant-6)
nsubj(resulted-17, administration-7)
number(mg-10, 0.2-9)
amod(sodium-12, mg-10)
nn(sodium-12, cerivastatin-11)
prep_of(administration-7, sodium-12)
num(cholestyramine-16, 12-14)
nn(cholestyramine-16, g-15)
conj_and(sodium-12, cholestyramine-16)
root(ROOT-0, resulted-17)
prep_in(resulted-17, decreases-19)
mwe(than-22, more-21)
quantmod(22-23, than-22)
num(%-24, 22-23)
prep_of(decreases-19, %-24)
prep_for(%-24, AUC-26)
num(%-29, 40-28)
conj_and(%-24, %-29)
prep_for(%-29, Cmax-31)
advmod(compared-33, when-32)
advcl(resulted-17, compared-33)
nn(sodium-37, dosing-35)
nn(sodium-37, cerivastatin-36)
prep_to(compared-33, sodium-37)
advmod(compared-33, alone-38)

However/RB ,/, in/IN the/DT second/JJ study/NN ,/, administration/NN of/IN 12/CD g/NN cholestyramine/NN 1/CD hour/NN before/IN the/DT evening/NN meal/NN and/CC 0.3/CD mg/NN cerivastatin/NN sodium/NN approximately/RB 4/CD hours/NNS after/IN the/DT same/JJ evening/NN meal/NN resulted/VBD in/IN a/DT decrease/NN in/IN the/DT cerivastatin/NN AUC/NN of/IN less/JJR than/IN 8/CD %/NN ,/, and/CC a/DT decrease/NN in/IN Cmax/NN of/IN about/RB 30/CD %/NN when/WRB compared/VBN to/TO dosing/NN cerivastatin/NN sodium/NN alone/RB ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (DT the) (JJ second) (NN study))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (CD 12) (NN g) (NN cholestyramine) (CD 1) (NN hour))) (PP (IN before) (NP (NP (DT the) (NN evening) (NN meal)) (CC and) (NP (ADJP (CD 0.3) (NN mg)) (NN cerivastatin) (NN sodium)) (NP (NP (QP (RB approximately) (CD 4)) (NNS hours)) (PP (IN after) (NP (DT the) (JJ same) (NN evening) (NN meal))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN cerivastatin) (NN AUC)) (PP (IN of) (NP (QP (JJR less) (IN than) (CD 8)) (NN %)))))) (, ,) (CC and) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NN Cmax)) (PP (IN of) (NP (QP (RB about) (CD 30)) (NN %)))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NN dosing) (NN cerivastatin) (NN sodium))) (ADVP (RB alone)))))) (. .))))

advmod(resulted-32, However-1)
det(study-6, the-4)
amod(study-6, second-5)
prep_in(resulted-32, study-6)
nsubj(resulted-32, administration-8)
num(hour-14, 12-10)
nn(hour-14, g-11)
nn(hour-14, cholestyramine-12)
num(hour-14, 1-13)
prep_of(administration-8, hour-14)
det(meal-18, the-16)
nn(meal-18, evening-17)
prep_before(administration-8, meal-18)
number(mg-21, 0.3-20)
amod(sodium-23, mg-21)
nn(sodium-23, cerivastatin-22)
conj_and(meal-18, sodium-23)
quantmod(4-25, approximately-24)
num(hours-26, 4-25)
dep(meal-18, hours-26)
det(meal-31, the-28)
amod(meal-31, same-29)
nn(meal-31, evening-30)
prep_after(hours-26, meal-31)
root(ROOT-0, resulted-32)
det(decrease-35, a-34)
prep_in(resulted-32, decrease-35)
det(AUC-39, the-37)
nn(AUC-39, cerivastatin-38)
prep_in(decrease-35, AUC-39)
mwe(than-42, less-41)
quantmod(8-43, than-42)
num(%-44, 8-43)
prep_of(AUC-39, %-44)
det(decrease-48, a-47)
conj_and(decrease-35, decrease-48)
prep_in(decrease-48, Cmax-50)
quantmod(30-53, about-52)
num(%-54, 30-53)
prep_of(Cmax-50, %-54)
advmod(compared-56, when-55)
advcl(resulted-32, compared-56)
nn(sodium-60, dosing-58)
nn(sodium-60, cerivastatin-59)
prep_to(compared-56, sodium-60)
advmod(compared-56, alone-61)

Therefore/RB ,/, it/PRP would/MD be/VB expected/VBN that/IN a/DT dosing/NN schedule/NN of/IN cerivastatin/NN sodium/NN given/VBN at/IN bedtime/NN and/CC cholestyramine/NN given/VBN before/IN the/DT evening/NN meal/NN would/MD not/RB result/VB in/IN a/DT significant/JJ decrease/NN in/IN the/DT clinical/JJ effect/NN of/IN cerivastatin/NN sodium/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP it)) (VP (MD would) (VP (VB be) (VP (VBN expected) (SBAR (IN that) (S (NP (NP (DT a) (NN dosing) (NN schedule)) (PP (IN of) (NP (NP (NN cerivastatin) (NN sodium)) (VP (VBN given) (PP (IN at) (NP (NP (NN bedtime)) (CC and) (NP (NN cholestyramine))))))) (VP (VBN given) (PP (IN before) (NP (DT the) (NN evening) (NN meal))))) (VP (MD would) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NP (DT the) (JJ clinical) (NN effect)) (PP (IN of) (NP (NN cerivastatin) (NN sodium))))))))))))))) (. .))))

advmod(expected-6, Therefore-1)
nsubjpass(expected-6, it-3)
aux(expected-6, would-4)
auxpass(expected-6, be-5)
root(ROOT-0, expected-6)
complm(result-26, that-7)
det(schedule-10, a-8)
nn(schedule-10, dosing-9)
nsubj(result-26, schedule-10)
nn(sodium-13, cerivastatin-12)
prep_of(schedule-10, sodium-13)
partmod(sodium-13, given-14)
prep_at(given-14, bedtime-16)
conj_and(bedtime-16, cholestyramine-18)
partmod(schedule-10, given-19)
det(meal-23, the-21)
nn(meal-23, evening-22)
prep_before(given-19, meal-23)
aux(result-26, would-24)
neg(result-26, not-25)
ccomp(expected-6, result-26)
det(decrease-30, a-28)
amod(decrease-30, significant-29)
prep_in(result-26, decrease-30)
det(effect-34, the-32)
amod(effect-34, clinical-33)
prep_in(decrease-30, effect-34)
nn(sodium-37, cerivastatin-36)
prep_of(effect-34, sodium-37)

DIGOXIN/NN :/: Plasma/NN digoxin/NN levels/NNS and/CC digoxin/NN clearance/NN at/IN steady-state/NN were/VBD not/RB affected/VBN by/IN co-administration/NN of/IN 0.2/CD mg/NN cerivastatin/NN sodium/NN ./.

(ROOT (S1 (S (NP (NP (NN DIGOXIN)) (: :) (S (NP (NP (NN Plasma) (NN digoxin) (NNS levels)) (CC and) (NP (NP (NN digoxin) (NN clearance)) (PP (IN at) (NP (NN steady-state))))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN co-administration)) (PP (IN of) (NP (ADJP (CD 0.2) (NN mg)) (NN cerivastatin) (NN sodium)))))))) (. .)))))

root(ROOT-0, DIGOXIN-1)
nn(levels-5, Plasma-3)
nn(levels-5, digoxin-4)
nsubjpass(affected-13, levels-5)
nn(clearance-8, digoxin-7)
conj_and(levels-5, clearance-8)
prep_at(clearance-8, steady-state-10)
auxpass(affected-13, were-11)
neg(affected-13, not-12)
dep(DIGOXIN-1, affected-13)
agent(affected-13, co-administration-15)
number(mg-18, 0.2-17)
amod(sodium-20, mg-18)
nn(sodium-20, cerivastatin-19)
prep_of(co-administration-15, sodium-20)

Cerivastatin/NN plasma/NN concentrations/NNS were/VBD also/RB not/RB affected/VBN by/IN co-administration/NN of/IN digoxin/NN ./.

(ROOT (S1 (S (S (NP (NN Cerivastatin) (NN plasma) (NNS concentrations)) (VP (VBD were) (ADVP (RB also)) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN co-administration)) (PP (IN of) (NP (NN digoxin)))))))) (. .))))

nn(concentrations-3, Cerivastatin-1)
nn(concentrations-3, plasma-2)
nsubjpass(affected-7, concentrations-3)
auxpass(affected-7, were-4)
advmod(affected-7, also-5)
neg(affected-7, not-6)
root(ROOT-0, affected-7)
agent(affected-7, co-administration-9)
prep_of(co-administration-9, digoxin-11)

WARFARIN/NN :/: Co-/NN administration/NN of/IN warfarin/NN and/CC cerivastatin/NN to/TO healthy/JJ volunteers/NNS did/VBD not/RB result/VB in/IN any/DT changes/NNS in/IN prothrombin/NN time/NN or/CC clotting/NN factor/NN VII/NN when/WRB compared/VBN to/TO co-administration/NN of/IN warfarin/NN and/CC placebo/NN ./.

(ROOT (S1 (S (NP (NP (NN WARFARIN)) (: :) (S (NP (NP (NN Co-) (NN administration)) (PP (IN of) (NP (NP (NN warfarin)) (CC and) (NP (NN cerivastatin)))) (PP (TO to) (NP (JJ healthy) (NNS volunteers)))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT any) (NNS changes)) (PP (IN in) (NP (NP (NN prothrombin) (NN time)) (CC or) (NP (NN clotting) (NN factor) (NN VII))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (NN warfarin)) (CC and) (NP (NN placebo))))))))))) (. .)))))

root(ROOT-0, WARFARIN-1)
nn(administration-4, Co--3)
nsubj(result-14, administration-4)
prep_of(administration-4, warfarin-6)
conj_and(warfarin-6, cerivastatin-8)
amod(volunteers-11, healthy-10)
prep_to(administration-4, volunteers-11)
aux(result-14, did-12)
neg(result-14, not-13)
dep(WARFARIN-1, result-14)
det(changes-17, any-16)
prep_in(result-14, changes-17)
nn(time-20, prothrombin-19)
prep_in(changes-17, time-20)
nn(VII-24, clotting-22)
nn(VII-24, factor-23)
conj_or(time-20, VII-24)
advmod(compared-26, when-25)
advcl(result-14, compared-26)
prep_to(compared-26, co-administration-28)
prep_of(co-administration-28, warfarin-30)
conj_and(warfarin-30, placebo-32)

The/DT AUC/NN and/CC Cmax/NN of/IN both/DT the/DT (/-LRB- R/NN )/-RRB- and/CC (/-LRB- S/NN )/-RRB- isomers/NNS of/IN warfarin/NN were/VBD unaffected/VBN by/IN concurrent/JJ dosing/NN of/IN 0.3/CD mg/NN cerivastatin/NN sodium/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NP (NN AUC)) (CC and) (NP (NN Cmax))) (PP (IN of) (NP (NP (DT both) (NP (NP (DT the)) (PRN (-LRB- -LRB-) (NP (NN R)) (-RRB- -RRB-)) (CC and) (PRN (-LRB- -LRB-) (NP (NN S)) (-RRB- -RRB-))) (NNS isomers)) (PP (IN of) (NP (NN warfarin)))))) (VP (VBD were) (VP (VBN unaffected) (PP (IN by) (NP (NP (JJ concurrent) (NN dosing)) (PP (IN of) (NP (ADJP (CD 0.3) (NN mg)) (NN cerivastatin) (NN sodium)))))))) (. .))))

dep(AUC-2, The-1)
nsubjpass(unaffected-19, AUC-2)
conj_and(AUC-2, Cmax-4)
preconj(isomers-15, both-6)
nn(isomers-15, the-7)
appos(the-7, R-9)
cc(the-7, and-11)
appos(the-7, S-13)
prep_of(AUC-2, isomers-15)
prep_of(isomers-15, warfarin-17)
auxpass(unaffected-19, were-18)
root(ROOT-0, unaffected-19)
amod(dosing-22, concurrent-21)
agent(unaffected-19, dosing-22)
number(mg-25, 0.3-24)
amod(sodium-27, mg-25)
nn(sodium-27, cerivastatin-26)
prep_of(dosing-22, sodium-27)

Co-administration/NN of/IN warfarin/NN and/CC cerivastatin/NN did/VBD not/RB alter/VB the/DT pharmacokinetics/NNS of/IN cerivastatin/NN sodium/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN warfarin)) (CC and) (NP (NN cerivastatin))))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN cerivastatin) (NN sodium))))))) (. .))))

nsubj(alter-8, Co-administration-1)
prep_of(Co-administration-1, warfarin-3)
conj_and(warfarin-3, cerivastatin-5)
aux(alter-8, did-6)
neg(alter-8, not-7)
root(ROOT-0, alter-8)
det(pharmacokinetics-10, the-9)
dobj(alter-8, pharmacokinetics-10)
nn(sodium-13, cerivastatin-12)
prep_of(pharmacokinetics-10, sodium-13)

ERYTHROMYCIN/NN :/: In/IN hypercholesterolemic/JJ patients/NNS ,/, steady-state/JJ cerivastatin/NN AUC/NN and/CC Cmax/NN increased/VBD approximately/RB 50/CD %/NN and/CC 24/CD %/NN respectively/RB after/IN 10/CD days/NNS with/IN co-administration/NN of/IN erythromycin/NN ,/, a/DT known/JJ inhibitor/NN of/IN cytochrome/NN P450/NN 3A4/NN ./.

(ROOT (S1 (S (NP (NP (NN ERYTHROMYCIN)) (: :) (S (PP (IN In) (NP (JJ hypercholesterolemic) (NNS patients))) (, ,) (NP (NP (JJ steady-state) (NN cerivastatin) (NN AUC)) (CC and) (NP (NN Cmax))) (VP (VBD increased) (NP (NP (QP (RB approximately) (CD 50)) (NN %)) (CC and) (NP (CD 24) (NN %))) (ADVP (RB respectively)) (PP (IN after) (NP (NP (CD 10) (NNS days)) (PP (IN with) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (NN erythromycin)) (, ,) (NP (NP (DT a) (JJ known) (NN inhibitor)) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN 3A4)))))))))))) (. .)))))

root(ROOT-0, ERYTHROMYCIN-1)
amod(patients-5, hypercholesterolemic-4)
prep_in(increased-12, patients-5)
amod(AUC-9, steady-state-7)
nn(AUC-9, cerivastatin-8)
nsubj(increased-12, AUC-9)
conj_and(AUC-9, Cmax-11)
dep(ERYTHROMYCIN-1, increased-12)
quantmod(50-14, approximately-13)
num(%-15, 50-14)
dobj(increased-12, %-15)
num(%-18, 24-17)
conj_and(%-15, %-18)
advmod(increased-12, respectively-19)
num(days-22, 10-21)
prep_after(increased-12, days-22)
prep_with(days-22, co-administration-24)
prep_of(co-administration-24, erythromycin-26)
det(inhibitor-30, a-28)
amod(inhibitor-30, known-29)
appos(erythromycin-26, inhibitor-30)
nn(3A4-34, cytochrome-32)
nn(3A4-34, P450-33)
prep_of(inhibitor-30, 3A4-34)

OTHER/JJ CONCOMITANT/JJ THERAPY/NN :/: Although/IN specific/JJ interaction/NN studies/NNS were/VBD not/RB performed/VBN ,/, in/IN clinical/JJ studies/NNS ,/, cerivastatin/NN sodium/NN was/VBD used/VBN concomitantly/RB with/IN angiotensin-/NN converting/NN enzyme/NN (/-LRB- ACE/NN )/-RRB- inhibitors/NNS ,/, betablockers/NNS ,/, calcium-channel/NN blockers/NNS ,/, diuretics/NN ,/, and/CC nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS (/-LRB- NSAIDs/NNS )/-RRB- without/IN evidence/NN of/IN clinically/RB significant/JJ adverse/JJ interactions/NNS ./.

(ROOT (S1 (S (NP (NP (JJ OTHER) (JJ CONCOMITANT) (NN THERAPY)) (: :) (S (PP (IN Although) (NP (NP (JJ specific) (NN interaction) (NNS studies)) (VP (VBD were) (RB not) (VP (VBN performed) (, ,) (PP (IN in) (NP (JJ clinical) (NNS studies))))))) (, ,) (NP (NN cerivastatin) (NN sodium)) (VP (VBD was) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN angiotensin-) (NN converting) (NN enzyme) (-LRB- -LRB-) (NN ACE) (-RRB- -RRB-) (NNS inhibitors)) (, ,) (NP (NNS betablockers)) (, ,) (NP (NN calcium-channel) (NNS blockers)) (, ,) (NP (NN diuretics)) (, ,) (CC and) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNS NSAIDs)) (-RRB- -RRB-))))) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (ADJP (RB clinically) (JJ significant)) (JJ adverse) (NNS interactions)))))))) (. .)))))

amod(THERAPY-3, OTHER-1)
amod(THERAPY-3, CONCOMITANT-2)
root(ROOT-0, THERAPY-3)
amod(studies-8, specific-6)
nn(studies-8, interaction-7)
prep_although(used-20, studies-8)
auxpass(performed-11, were-9)
neg(performed-11, not-10)
partmod(studies-8, performed-11)
amod(studies-15, clinical-14)
prep_in(performed-11, studies-15)
nn(sodium-18, cerivastatin-17)
nsubjpass(used-20, sodium-18)
auxpass(used-20, was-19)
dep(THERAPY-3, used-20)
advmod(used-20, concomitantly-21)
nn(inhibitors-29, angiotensin--23)
nn(inhibitors-29, converting-24)
nn(inhibitors-29, enzyme-25)
nn(inhibitors-29, ACE-27)
prep_with(used-20, inhibitors-29)
conj_and(inhibitors-29, betablockers-31)
nn(blockers-34, calcium-channel-33)
conj_and(inhibitors-29, blockers-34)
conj_and(inhibitors-29, diuretics-36)
amod(drugs-41, nonsteroidal-39)
amod(drugs-41, anti-inflammatory-40)
conj_and(inhibitors-29, drugs-41)
appos(drugs-41, NSAIDs-43)
prep_without(used-20, evidence-46)
advmod(significant-49, clinically-48)
amod(interactions-51, significant-49)
amod(interactions-51, adverse-50)
prep_of(evidence-46, interactions-51)

Although/IN clinical/JJ studies/NNS have/VBP not/RB established/VBN a/DT cause/NN and/CC effect/NN relationship/NN ,/, physicians/NNS should/MD be/VB aware/NN that/IN variable/JJ effects/NNS an/DT blood/NN coagulation/NN have/VBP been/VBN reported/VBN very/RB rarely/RB in/IN patients/NNS receiving/VBG oral/JJ anticoagulants/NNS and/CC chlordiazepoxide/NN ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (JJ clinical) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN established) (NP (NP (DT a) (NN cause)) (CC and) (NP (NN effect)) (NP (NN relationship))))))) (, ,) (NP (NNS physicians)) (VP (MD should) (VP (VB be) (NP (NN aware)) (SBAR (IN that) (S (NP (NP (JJ variable) (NNS effects)) (NP (DT an) (NN blood) (NN coagulation))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (ADVP (RB very) (RB rarely)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ oral) (NNS anticoagulants)) (CC and) (NP (NN chlordiazepoxide))))))))))))) (. .))))

mark(established-6, Although-1)
amod(studies-3, clinical-2)
nsubj(established-6, studies-3)
aux(established-6, have-4)
neg(established-6, not-5)
advcl(aware-16, established-6)
det(cause-8, a-7)
dobj(established-6, cause-8)
conj_and(cause-8, effect-10)
dobj(established-6, relationship-11)
dep(cause-8, relationship-11)
nsubj(aware-16, physicians-13)
aux(aware-16, should-14)
cop(aware-16, be-15)
root(ROOT-0, aware-16)
complm(reported-25, that-17)
amod(effects-19, variable-18)
nsubjpass(reported-25, effects-19)
det(coagulation-22, an-20)
nn(coagulation-22, blood-21)
dep(effects-19, coagulation-22)
aux(reported-25, have-23)
auxpass(reported-25, been-24)
ccomp(aware-16, reported-25)
advmod(rarely-27, very-26)
advmod(reported-25, rarely-27)
prep_in(reported-25, patients-29)
partmod(patients-29, receiving-30)
amod(anticoagulants-32, oral-31)
dobj(receiving-30, anticoagulants-32)
conj_and(anticoagulants-32, chlordiazepoxide-34)

The/DT concomitant/JJ use/NN of/IN alcohol/NN or/CC other/JJ central/JJ nervous/JJ system/NN depressants/NNS may/MD have/VB an/DT additive/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN alcohol)) (CC or) (NP (JJ other) (JJ central) (JJ nervous) (NN system)) (NP (NNS depressants))))) (VP (MD may) (VP (VB have) (NP (DT an) (JJ additive) (NN effect))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubj(have-13, use-3)
prep_of(use-3, alcohol-5)
amod(system-10, other-7)
amod(system-10, central-8)
amod(system-10, nervous-9)
conj_or(alcohol-5, system-10)
dep(alcohol-5, depressants-11)
aux(have-13, may-12)
root(ROOT-0, have-13)
det(effect-16, an-14)
amod(effect-16, additive-15)
dobj(have-13, effect-16)

The/DT administration/NN of/IN local/JJ anesthetic/JJ solutions/NNS containing/VBG epinephrine/NN or/CC norepinephrine/NN to/TO patients/NNS receiving/VBG monoamine/NN oxidase/NN inhibitors/NNS ,/, tricyclic/JJ antidepressants/NNS or/CC phenothiazines/NNS may/MD produce/VB severe/JJ ,/, prolonged/JJ hypotension/NN or/CC hypertension/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NP (JJ local) (JJ anesthetic) (NNS solutions)) (VP (VBG containing) (NP (NP (NN epinephrine)) (CC or) (NP (NN norepinephrine)))))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NP (NN monoamine) (NN oxidase)) (NNS inhibitors)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (CC or) (NP (NNS phenothiazines))))))) (VP (MD may) (VP (VB produce) (NP (ADJP (ADJP (JJ severe)) (, ,) (ADJP (JJ prolonged))) (NP (NN hypotension)) (CC or) (NP (NN hypertension)))))) (. .))))

det(administration-2, The-1)
nsubj(produce-23, administration-2)
amod(solutions-6, local-4)
amod(solutions-6, anesthetic-5)
prep_of(administration-2, solutions-6)
partmod(solutions-6, containing-7)
dobj(containing-7, epinephrine-8)
conj_or(epinephrine-8, norepinephrine-10)
prep_to(administration-2, patients-12)
partmod(patients-12, receiving-13)
nn(oxidase-15, monoamine-14)
nn(inhibitors-16, oxidase-15)
dobj(receiving-13, inhibitors-16)
amod(antidepressants-19, tricyclic-18)
conj_or(inhibitors-16, antidepressants-19)
conj_or(inhibitors-16, phenothiazines-21)
aux(produce-23, may-22)
root(ROOT-0, produce-23)
amod(hypotension-27, severe-24)
dep(severe-24, prolonged-26)
dobj(produce-23, hypotension-27)
conj_or(hypotension-27, hypertension-29)

Concurrent/JJ administration/NN of/IN vasopressor/JJ drugs/NNS (/-LRB- for/IN the/DT treatment/NN of/IN hypotension/NN related/JJ to/TO obstetric/JJ blocks/NNS )/-RRB- and/CC ergot-type/JJ oxytocic/JJ drugs/NNS may/MD cause/VB severe/JJ ,/, persistent/JJ hypertension/NN or/CC cerebrovascular/JJ accidents/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NP (JJ vasopressor) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN hypotension))) (ADJP (JJ related) (PP (TO to) (NP (JJ obstetric) (NNS blocks)))))) (-RRB- -RRB-))) (CC and) (NP (JJ ergot-type) (JJ oxytocic) (NNS drugs))))) (VP (MD may) (VP (VB cause) (NP (NP (JJ severe) (, ,) (JJ persistent) (NN hypertension)) (CC or) (NP (JJ cerebrovascular) (NN accidents)))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(cause-22, administration-2)
amod(drugs-5, vasopressor-4)
prep_of(administration-2, drugs-5)
dep(drugs-5, for-7)
det(treatment-9, the-8)
pobj(for-7, treatment-9)
prep_of(treatment-9, hypotension-11)
amod(treatment-9, related-12)
amod(blocks-15, obstetric-14)
prep_to(related-12, blocks-15)
amod(drugs-20, ergot-type-18)
amod(drugs-20, oxytocic-19)
conj_and(drugs-5, drugs-20)
aux(cause-22, may-21)
root(ROOT-0, cause-22)
amod(hypertension-26, severe-23)
amod(hypertension-26, persistent-25)
dobj(cause-22, hypertension-26)
amod(accidents-29, cerebrovascular-28)
conj_or(hypertension-26, accidents-29)

The/DT para-aminobenzoic/JJ acid/NN metabolite/NN of/IN chloroprocaine/NN inhibits/VBZ the/DT action/NN of/IN sulfonamides/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ para-aminobenzoic) (NN acid) (NN metabolite)) (PP (IN of) (NP (NN chloroprocaine)))) (VP (VBZ inhibits) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NNS sulfonamides)))))) (. .))))

det(metabolite-4, The-1)
amod(metabolite-4, para-aminobenzoic-2)
nn(metabolite-4, acid-3)
nsubj(inhibits-7, metabolite-4)
prep_of(metabolite-4, chloroprocaine-6)
root(ROOT-0, inhibits-7)
det(action-9, the-8)
dobj(inhibits-7, action-9)
prep_of(action-9, sulfonamides-11)

Therefore/RB ,/, chloroprocaine/NN should/MD not/RB be/VB used/VBN in/IN any/DT condition/NN in/IN which/WDT a/DT sulfonamide/NN drug/NN is/VBZ being/VBG employed/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN chloroprocaine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (DT any) (NN condition)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT a) (NN sulfonamide) (NN drug)) (VP (VBZ is) (VP (VBG being) (VP (VBN employed)))))))))))) (. .))))

advmod(used-7, Therefore-1)
nsubjpass(used-7, chloroprocaine-3)
aux(used-7, should-4)
neg(used-7, not-5)
auxpass(used-7, be-6)
root(ROOT-0, used-7)
det(condition-10, any-9)
prep_in(used-7, condition-10)
rel(employed-18, which-12)
det(drug-15, a-13)
nn(drug-15, sulfonamide-14)
nsubjpass(employed-18, drug-15)
aux(employed-18, is-16)
auxpass(employed-18, being-17)
rcmod(condition-10, employed-18)

When/WRB given/VBN concurrently/RB the/DT following/JJ drugs/NNS may/MD interact/VB with/IN thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN given) (ADVP (RB concurrently))))) (NP (DT the) (JJ following) (NNS drugs)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NN thiazide) (NNS diuretics)))))) (. .))))

advmod(given-2, When-1)
advcl(interact-8, given-2)
advmod(given-2, concurrently-3)
det(drugs-6, the-4)
amod(drugs-6, following-5)
nsubj(interact-8, drugs-6)
aux(interact-8, may-7)
root(ROOT-0, interact-8)
nn(diuretics-11, thiazide-10)
prep_with(interact-8, diuretics-11)

-/CC Alcohol/NN ,/, barbiturates/NNS ,/, or/CC narcotics/NNS :/: Potentiation/NN of/IN otthostatic/JJ hypotension/NN may/MD occur/VB ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NN Alcohol)) (, ,) (NP (NNS barbiturates)) (, ,) (CC or) (NP (NNS narcotics))) (: :) (NP (NP (NN Potentiation)) (PP (IN of) (NP (JJ otthostatic) (NN hypotension))))) (VP (MD may) (VP (VB occur)))) (. .))))

nsubj(occur-14, Alcohol-2)
conj_or(Alcohol-2, barbiturates-4)
conj_or(Alcohol-2, narcotics-7)
dep(Alcohol-2, Potentiation-9)
amod(hypotension-12, otthostatic-11)
prep_of(Potentiation-9, hypotension-12)
aux(occur-14, may-13)
root(ROOT-0, occur-14)

-/CC Antidiabetic/JJ drugs/NNS :/: (/-LRB- Oral/JJ agents/NNS and/CC insulin/NN )/-RRB- Dosage/NN adjustment/NN of/IN the/DT antidiabetic/JJ drug/NN may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NP (JJ Antidiabetic) (NNS drugs) (: :)) (PRN (-LRB- -LRB-) (NP (NP (JJ Oral) (NNS agents)) (CC and) (NP (NN insulin))) (-RRB- -RRB-))) (NN Dosage) (NN adjustment)) (PP (IN of) (NP (DT the) (JJ antidiabetic) (NN drug)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

amod(drugs-3, Antidiabetic-2)
nn(adjustment-12, drugs-3)
amod(agents-7, Oral-6)
dep(drugs-3, agents-7)
conj_and(agents-7, insulin-9)
nn(adjustment-12, Dosage-11)
nsubjpass(required-19, adjustment-12)
det(drug-16, the-14)
amod(drug-16, antidiabetic-15)
prep_of(adjustment-12, drug-16)
aux(required-19, may-17)
auxpass(required-19, be-18)
root(ROOT-0, required-19)

-/CC Other/JJ antihypertensive/JJ drugs/NNS :/: Additive/JJ effect/NN or/CC potentiation/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (JJ Other) (JJ antihypertensive) (NNS drugs)) (: :) (NP (NP (JJ Additive) (NN effect)) (CC or) (NP (NN potentiation))) (. .)))))

dep(drugs-4, Other-2)
amod(drugs-4, antihypertensive-3)
root(ROOT-0, drugs-4)
amod(effect-7, Additive-6)
dep(drugs-4, effect-7)
conj_or(effect-7, potentiation-9)

-/CC Cholestyramine/NN and/CC colestipol/NN resins/NNS :/: Cholestytamine/NN and/CC colestipol/NN resins/NNS have/VBP the/DT potential/NN of/IN binding/NN thiazide/NN diuretics/NNS and/CC reducing/VBG diuretic/JJ absorption/NN from/IN the/DT gastrointestinal/JJ tract/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (NP (NN Cholestyramine)) (CC and) (NP (NN colestipol)) (NP (NNS resins))) (: :) (S (NP (NP (NP (NN Cholestytamine)) (CC and) (NP (NN colestipol))) (NNS resins)) (VP (VP (VBP have) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NN binding) (NN thiazide) (NNS diuretics))))) (CC and) (VP (VBG reducing) (NP (NP (JJ diuretic) (NN absorption)) (PP (IN from) (NP (DT the) (JJ gastrointestinal) (NN tract))))))) (. .)))))

root(ROOT-0, Cholestyramine-2)
conj_and(Cholestyramine-2, colestipol-4)
dep(Cholestyramine-2, resins-5)
nn(resins-10, Cholestytamine-7)
conj_and(Cholestytamine-7, colestipol-9)
nsubj(have-11, resins-10)
dep(Cholestyramine-2, have-11)
det(potential-13, the-12)
dobj(have-11, potential-13)
nn(diuretics-17, binding-15)
nn(diuretics-17, thiazide-16)
prep_of(potential-13, diuretics-17)
conj_and(have-11, reducing-19)
amod(absorption-21, diuretic-20)
dobj(reducing-19, absorption-21)
det(tract-25, the-23)
amod(tract-25, gastrointestinal-24)
prep_from(absorption-21, tract-25)

-/: Corticosteroids/NNS ,/, ACTH/NN :/: Intensified/JJ electrolyte/NN depletion/NN ,/, particularly/RB hypokalemia/NN ./.

(ROOT (S1 (S (S (PRN (: -) (NP (NNS Corticosteroids)) (, ,) (NP (NN ACTH)) (: :) (NP (JJ Intensified) (NN electrolyte) (NN depletion)) (, ,) (NP (ADVP (RB particularly)) (NP (NN hypokalemia))))) (. .))))

root(ROOT-0, Corticosteroids-2)
dep(Corticosteroids-2, ACTH-4)
amod(depletion-8, Intensified-6)
nn(depletion-8, electrolyte-7)
dep(Corticosteroids-2, depletion-8)
advmod(hypokalemia-11, particularly-10)
dep(Corticosteroids-2, hypokalemia-11)

-/CC Pressor/NN amines/NNS (/-LRB- e.g./FW ,/, norepinephrine/NN )/-RRB- :/: Possible/JJ decreased/VBD response/NN to/TO pressor/JJ amines/NNS but/CC not/RB sufficient/JJ to/TO preclude/VB their/PRP$ use/NN ./.

(ROOT (S1 (S (NP (NP (NP (CC -) (NN Pressor) (NNS amines)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN norepinephrine))) (-RRB- -RRB-))) (: :) (S (NP (JJ Possible)) (VP (VP (VBD decreased) (NP (NP (NN response)) (PP (TO to) (NP (JJ pressor) (NNS amines))))) (CC but) (RB not) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB preclude) (NP (PRP$ their) (NN use)))))))) (. .)))))

nn(amines-3, Pressor-2)
root(ROOT-0, amines-3)
dep(amines-3, e.g.-5)
pobj(e.g.-5, norepinephrine-7)
nsubj(decreased-11, Possible-10)
dep(amines-3, decreased-11)
dobj(decreased-11, response-12)
amod(amines-15, pressor-14)
prep_to(response-12, amines-15)
conj_but(decreased-11, not-17)
neg(decreased-11, not-17)
acomp(decreased-11, sufficient-18)
aux(preclude-20, to-19)
xcomp(sufficient-18, preclude-20)
poss(use-22, their-21)
dobj(preclude-20, use-22)

-/CC Skeletal/JJ muscle/NN relaxants/NNS ,/, nondepolarizing/JJ (/-LRB- e.g./FW ,/, tubocurarine/NN )/-RRB- :/: Possible/JJ increased/VBN responsiveness/NN to/TO the/DT muscle/NN relaxant/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (NP (JJ Skeletal) (NN muscle) (NNS relaxants)) (, ,) (NP (NP (JJ nondepolarizing)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN tubocurarine))) (-RRB- -RRB-)))) (: :) (NP (NP (JJ Possible) (VBN increased) (NN responsiveness)) (PP (TO to) (NP (DT the) (NN muscle) (NN relaxant)))) (. .)))))

amod(relaxants-4, Skeletal-2)
nn(relaxants-4, muscle-3)
root(ROOT-0, relaxants-4)
dep(relaxants-4, nondepolarizing-6)
dep(nondepolarizing-6, e.g.-8)
pobj(e.g.-8, tubocurarine-10)
amod(responsiveness-15, Possible-13)
amod(responsiveness-15, increased-14)
dep(relaxants-4, responsiveness-15)
det(relaxant-19, the-17)
nn(relaxant-19, muscle-18)
prep_to(responsiveness-15, relaxant-19)

-/CC Lithium/NN :/: Generally/RB should/MD not/RB be/VB given/VBN with/IN diuretics/NN ./.

(ROOT (S1 (S (S (NP (CC -) (NP (NN Lithium) (: :)) (ADVP (RB Generally))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN given) (PP (IN with) (NP (NN diuretics))))))) (. .))))

nsubjpass(given-8, Lithium-2)
advmod(Lithium-2, Generally-4)
aux(given-8, should-5)
neg(given-8, not-6)
auxpass(given-8, be-7)
root(ROOT-0, given-8)
prep_with(given-8, diuretics-10)

Diuretic/JJ agents/NNS reduce/VBP the/DT renal/JJ clearance/NN of/IN lithium/NN and/CC add/VBP a/DT high/JJ risk/NN of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (JJ Diuretic) (NNS agents)) (VP (VP (VBP reduce) (NP (NP (DT the) (JJ renal) (NN clearance)) (PP (IN of) (NP (NN lithium))))) (CC and) (VP (VBP add) (NP (NP (DT a) (JJ high) (NN risk)) (PP (IN of) (NP (NN lithium) (NN toxicity))))))) (. .))))

amod(agents-2, Diuretic-1)
nsubj(reduce-3, agents-2)
root(ROOT-0, reduce-3)
det(clearance-6, the-4)
amod(clearance-6, renal-5)
dobj(reduce-3, clearance-6)
prep_of(clearance-6, lithium-8)
conj_and(reduce-3, add-10)
det(risk-13, a-11)
amod(risk-13, high-12)
dobj(add-10, risk-13)
nn(toxicity-16, lithium-15)
prep_of(risk-13, toxicity-16)

Refer/VBP to/TO the/DT package/JJ insert/NN for/IN lithium/NN preparation/NN s/NNS before/IN use/NN of/IN such/JJ preparations/NNS with/IN chlorothiazide/NN ./.

(ROOT (S1 (S (S (VP (VBP Refer) (PP (TO to) (NP (NP (DT the) (JJ package) (NN insert)) (PP (IN for) (NP (NP (NN lithium) (NN preparation) (NNS s)) (PP (IN before) (NP (NP (NN use)) (PP (IN of) (NP (NP (JJ such) (NNS preparations)) (PP (IN with) (NP (NN chlorothiazide))))))))))))) (. .))))

root(ROOT-0, Refer-1)
det(insert-5, the-3)
amod(insert-5, package-4)
prep_to(Refer-1, insert-5)
nn(s-9, lithium-7)
nn(s-9, preparation-8)
prep_for(insert-5, s-9)
prep_before(s-9, use-11)
amod(preparations-14, such-13)
prep_of(use-11, preparations-14)
prep_with(preparations-14, chlorothiazide-16)

-/CC Non-steroidal/JJ Anti-inflammatory/JJ Drugs/NNS :/: In/IN some/DT patients/NNS ,/, the/DT administration/NN of/IN a/DT non-steroidal/JJ anti-inflammatory/JJ agent/NN can/MD reduce/VB the/DT diuretic/JJ ,/, natriuretic/JJ ,/, and/CC antihypertensive/JJ effects/NNS of/IN loop/NN ,/, potassium/NN -sparing/NN and/CC thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (NP (NP (CC -) (JJ Non-steroidal) (JJ Anti-inflammatory) (NNS Drugs)) (: :) (S (PP (IN In) (NP (DT some) (NNS patients))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (DT a) (JJ non-steroidal) (JJ anti-inflammatory) (NN agent)))) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (ADJP (ADJP (JJ diuretic)) (, ,) (ADJP (JJ natriuretic)) (, ,) (CC and) (ADJP (JJ antihypertensive))) (NNS effects)) (PP (IN of) (NP (NP (NN loop)) (, ,) (NP (NN potassium) (NN -sparing)) (CC and) (NP (NN thiazide) (NNS diuretics)))))))) (. .)))))

dep(Drugs-4, Non-steroidal-2)
amod(Drugs-4, Anti-inflammatory-3)
root(ROOT-0, Drugs-4)
det(patients-8, some-7)
prep_in(reduce-18, patients-8)
det(administration-11, the-10)
nsubj(reduce-18, administration-11)
det(agent-16, a-13)
amod(agent-16, non-steroidal-14)
amod(agent-16, anti-inflammatory-15)
prep_of(administration-11, agent-16)
aux(reduce-18, can-17)
dep(Drugs-4, reduce-18)
det(effects-26, the-19)
amod(effects-26, diuretic-20)
conj_and(diuretic-20, natriuretic-22)
conj_and(diuretic-20, antihypertensive-25)
dobj(reduce-18, effects-26)
prep_of(effects-26, loop-28)
nn(-sparing-31, potassium-30)
conj_and(loop-28, -sparing-31)
nn(diuretics-34, thiazide-33)
conj_and(loop-28, diuretics-34)

Therefore/RB ,/, when/WRB chlorothiazide/NN and/CC non-steroidal/JJ anti-inflammatory/JJ agents/NNS are/VBP used/VBN concomitantly/RB ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB to/TO determine/VB if/IN the/DT desired/JJ effect/NN of/IN the/DT diuretic/NN is/VBZ obtained/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN chlorothiazide)) (CC and) (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS agents))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ desired) (NN effect)) (PP (IN of) (NP (DT the) (NN diuretic)))) (VP (VBZ is) (VP (VBN obtained)))))))))))) (. .))))

advmod(observed-17, Therefore-1)
advmod(used-10, when-3)
nsubjpass(used-10, chlorothiazide-4)
amod(agents-8, non-steroidal-6)
amod(agents-8, anti-inflammatory-7)
conj_and(chlorothiazide-4, agents-8)
auxpass(used-10, are-9)
advcl(observed-17, used-10)
advmod(used-10, concomitantly-11)
det(patient-14, the-13)
nsubjpass(observed-17, patient-14)
aux(observed-17, should-15)
auxpass(observed-17, be-16)
root(ROOT-0, observed-17)
advmod(observed-17, closely-18)
aux(determine-20, to-19)
xcomp(observed-17, determine-20)
mark(obtained-29, if-21)
det(effect-24, the-22)
amod(effect-24, desired-23)
nsubjpass(obtained-29, effect-24)
det(diuretic-27, the-26)
prep_of(effect-24, diuretic-27)
auxpass(obtained-29, is-28)
advcl(determine-20, obtained-29)

-/CC Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: Thiazides/NNS should/MD be/VB discontinued/VBN before/IN carrying/VBG out/RP tests/NNS for/IN parathyroid/JJ function/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NNS Thiazides)) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (PP (IN before) (S (VP (VBG carrying) (PRT (RP out)) (NP (NP (NNS tests)) (PP (IN for) (NP (JJ parathyroid) (NN function))))))))))) (. .)))))

nn(Interactions-5, Drug-2)
nn(Interactions-5, /Laboratory-3)
nn(Interactions-5, Test-4)
root(ROOT-0, Interactions-5)
nsubjpass(discontinued-10, Thiazides-7)
aux(discontinued-10, should-8)
auxpass(discontinued-10, be-9)
dep(Interactions-5, discontinued-10)
prepc_before(discontinued-10, carrying-12)
prt(carrying-12, out-13)
dobj(carrying-12, tests-14)
amod(function-17, parathyroid-16)
prep_for(tests-14, function-17)

Interactions/NNS for/IN vitamin/NN D/NN analogues/NNS (/-LRB- Vitamin/NN D2/NN ,/, Vitamin/NN D3/NN ,/, Calcitriol/NN ,/, and/CC Calcidiol/NN )/-RRB- :/: Cholestyramine/NN :/: Cholestyramine/NN has/VBZ been/VBN reported/VBN to/TO reduce/VB intestinal/JJ absorption/NN of/IN fat/JJ soluble/JJ vitamins/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NNS Interactions)) (PP (IN for) (NP (NP (NN vitamin) (NN D) (NNS analogues)) (PRN (-LRB- -LRB-) (NP (NP (NN Vitamin) (NN D2)) (, ,) (NP (NN Vitamin) (NN D3)) (, ,) (NP (NN Calcitriol)) (, ,) (CC and) (NP (NN Calcidiol))) (-RRB- -RRB-))))) (: :) (NP (NP (NN Cholestyramine)) (: :) (S (NP (NN Cholestyramine)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB reduce) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (JJ fat) (JJ soluble) (NNS vitamins))))))))))) (: ;)) (. .)))))

root(ROOT-0, Interactions-1)
nn(analogues-5, vitamin-3)
nn(analogues-5, D-4)
prep_for(Interactions-1, analogues-5)
nn(D2-8, Vitamin-7)
dep(analogues-5, D2-8)
nn(D3-11, Vitamin-10)
conj_and(D2-8, D3-11)
conj_and(D2-8, Calcitriol-13)
conj_and(D2-8, Calcidiol-16)
dep(Interactions-1, Cholestyramine-19)
nsubjpass(reported-24, Cholestyramine-21)
xsubj(reduce-26, Cholestyramine-21)
aux(reported-24, has-22)
auxpass(reported-24, been-23)
dep(Cholestyramine-19, reported-24)
aux(reduce-26, to-25)
xcomp(reported-24, reduce-26)
amod(absorption-28, intestinal-27)
dobj(reduce-26, absorption-28)
amod(vitamins-32, fat-30)
amod(vitamins-32, soluble-31)
prep_of(absorption-28, vitamins-32)

as/IN such/JJ it/PRP may/MD impair/VB intestinal/JJ absorption/NN of/IN any/DT of/IN vitamin/NN D/NN ./.

(ROOT (S1 (S (S (PP (IN as) (NP (JJ such))) (NP (PRP it)) (VP (MD may) (VP (VB impair) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (NN vitamin) (NN D))))))))) (. .))))

prep_such_as(impair-5, such-2)
nsubj(impair-5, it-3)
aux(impair-5, may-4)
root(ROOT-0, impair-5)
amod(absorption-7, intestinal-6)
dobj(impair-5, absorption-7)
prep_of(absorption-7, any-9)
nn(D-12, vitamin-11)
prep_of(any-9, D-12)

Phenytoin/NN //: Phenobarbital/NN :/: The/DT coadministration/NN of/IN phenytoin/NN or/CC phenobarbital/NN will/MD not/RB affect/VB plasma/NN concentrations/NNS of/IN vitamin/NN D/NN ,/, but/CC may/MD reduce/VB endogenous/JJ plasma/NN levels/NNS of/IN calcitriol/NN /ergocalcitriol/NN by/IN accelerating/VBG metabolism/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Phenytoin)) (: /) (NP (NN Phenobarbital)) (: :) (NP (NP (DT The) (NN coadministration)) (PP (IN of) (NP (NP (NN phenytoin)) (CC or) (NP (NN phenobarbital)))))) (VP (MD will) (RB not) (VP (VB affect) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN vitamin) (NN D))))) (, ,) (CC but) (VP (MD may) (VP (VB reduce) (NP (NP (JJ endogenous) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN calcitriol) (NN /ergocalcitriol)))) (PP (IN by) (S (VP (VBG accelerating) (NP (NN metabolism))))))))) (. .))))

nsubj(affect-13, Phenytoin-1)
punct(Phenytoin-1, /-2)
dep(Phenytoin-1, Phenobarbital-3)
det(coadministration-6, The-5)
dep(Phenytoin-1, coadministration-6)
prep_of(coadministration-6, phenytoin-8)
conj_or(phenytoin-8, phenobarbital-10)
aux(affect-13, will-11)
neg(affect-13, not-12)
root(ROOT-0, affect-13)
nn(concentrations-15, plasma-14)
dobj(affect-13, concentrations-15)
nn(D-18, vitamin-17)
prep_of(concentrations-15, D-18)
aux(reduce-22, may-21)
conj_but(affect-13, reduce-22)
amod(levels-25, endogenous-23)
nn(levels-25, plasma-24)
dobj(reduce-22, levels-25)
nn(/ergocalcitriol-28, calcitriol-27)
prep_of(levels-25, /ergocalcitriol-28)
prepc_by(reduce-22, accelerating-30)
dobj(accelerating-30, metabolism-31)

Since/IN blood/NN level/NN of/IN calcitriol/NN /ergocalcitriol/NN will/MD be/VB reduced/VBN ,/, higher/JJR doses/NNS of/IN Rocaltrol/NN may/MD be/VB necessary/JJ if/IN these/DT drugs/NNS are/VBP administered/VBN simultaneously/RB ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NP (NN blood) (NN level)) (PP (IN of) (NP (NN calcitriol) (NN /ergocalcitriol)))) (VP (MD will) (VP (VB be) (VP (VBN reduced)))))) (, ,) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN Rocaltrol)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary)) (SBAR (IN if) (S (NP (DT these) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (ADVP (RB simultaneously))))))))) (. .))))

mark(reduced-9, Since-1)
nn(level-3, blood-2)
nsubjpass(reduced-9, level-3)
nn(/ergocalcitriol-6, calcitriol-5)
prep_of(level-3, /ergocalcitriol-6)
aux(reduced-9, will-7)
auxpass(reduced-9, be-8)
advcl(necessary-17, reduced-9)
amod(doses-12, higher-11)
nsubj(necessary-17, doses-12)
prep_of(doses-12, Rocaltrol-14)
aux(necessary-17, may-15)
cop(necessary-17, be-16)
root(ROOT-0, necessary-17)
mark(administered-22, if-18)
det(drugs-20, these-19)
nsubjpass(administered-22, drugs-20)
auxpass(administered-22, are-21)
advcl(necessary-17, administered-22)
advmod(administered-22, simultaneously-23)

Thiazides/NNS :/: Thiazides/NNS are/VBP known/VBN to/TO induce/VB hypercalcemia/NN by/IN the/DT reduction/NN of/IN calcium/NN excretion/NN in/IN urine/NN ./.

(ROOT (S1 (S (NP (NP (NNS Thiazides)) (: :) (S (NP (NNS Thiazides)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB induce) (NP (NN hypercalcemia)) (PP (IN by) (NP (NP (DT the) (NN reduction)) (PP (IN of) (NP (NN calcium) (NN excretion))) (PP (IN in) (NP (NN urine))))))))))) (. .)))))

root(ROOT-0, Thiazides-1)
nsubjpass(known-5, Thiazides-3)
xsubj(induce-7, Thiazides-3)
auxpass(known-5, are-4)
dep(Thiazides-1, known-5)
aux(induce-7, to-6)
xcomp(known-5, induce-7)
dobj(induce-7, hypercalcemia-8)
det(reduction-11, the-10)
prep_by(induce-7, reduction-11)
nn(excretion-14, calcium-13)
prep_of(reduction-11, excretion-14)
prep_in(reduction-11, urine-16)

Some/DT reports/NNS have/VBP shown/VBN that/IN the/DT concomitant/JJ administration/NN of/IN thiazides/NNS with/IN vitamin/NN D/NN causes/VBZ hypercalcemia/NN ./.

(ROOT (S1 (S (S (NP (DT Some) (NNS reports)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NNS thiazides))) (PP (IN with) (NP (NN vitamin) (NN D)))) (VP (VBZ causes) (NP (NN hypercalcemia)))))))) (. .))))

det(reports-2, Some-1)
nsubj(shown-4, reports-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
complm(causes-14, that-5)
det(administration-8, the-6)
amod(administration-8, concomitant-7)
nsubj(causes-14, administration-8)
prep_of(administration-8, thiazides-10)
nn(D-13, vitamin-12)
prep_with(administration-8, D-13)
ccomp(shown-4, causes-14)
dobj(causes-14, hypercalcemia-15)

Digitalis/NN :/: Vitamin/NN D/NN dosage/NN must/MD be/VB determined/VBN with/IN care/NN in/IN patients/NNS undergoing/VBG treatment/NN with/IN digitalis/NN ,/, as/IN hypercalcemia/NN in/IN such/JJ patients/NNS may/MD precipitate/VB cardiac/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (NP (NP (NN Digitalis)) (: :) (S (NP (NN Vitamin) (NN D) (NN dosage)) (VP (MD must) (VP (VB be) (VP (VBN determined) (PP (IN with) (NP (NP (NN care)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NP (NN treatment)) (PP (IN with) (NP (NN digitalis))))))))) (, ,) (SBAR (IN as) (S (NP (NP (NN hypercalcemia)) (PP (IN in) (NP (JJ such) (NNS patients)))) (VP (MD may) (VP (VB precipitate) (NP (JJ cardiac) (NNS arrhythmias)))))))))) (. .)))))

root(ROOT-0, Digitalis-1)
nn(dosage-5, Vitamin-3)
nn(dosage-5, D-4)
nsubjpass(determined-8, dosage-5)
aux(determined-8, must-6)
auxpass(determined-8, be-7)
dep(Digitalis-1, determined-8)
prep_with(determined-8, care-10)
prep_in(care-10, patients-12)
partmod(patients-12, undergoing-13)
dobj(undergoing-13, treatment-14)
prep_with(treatment-14, digitalis-16)
mark(precipitate-24, as-18)
nsubj(precipitate-24, hypercalcemia-19)
amod(patients-22, such-21)
prep_in(hypercalcemia-19, patients-22)
aux(precipitate-24, may-23)
advcl(determined-8, precipitate-24)
amod(arrhythmias-26, cardiac-25)
dobj(precipitate-24, arrhythmias-26)

Ketoconazole/NN :/: Ketoconazole/NN may/MD inhibit/VBP both/CC synthetic/JJ and/CC catabolic/JJ enzymes/NNS of/IN vitamin/NN D/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NN Ketoconazole)) (VP (MD may) (VP (VBP inhibit) (NP (NP (ADJP (CC both) (ADJP (JJ synthetic)) (CC and) (ADJP (JJ catabolic))) (NNS enzymes)) (PP (IN of) (NP (NN vitamin) (NN D))))))) (. .)))))

root(ROOT-0, Ketoconazole-1)
nsubj(inhibit-5, Ketoconazole-3)
aux(inhibit-5, may-4)
dep(Ketoconazole-1, inhibit-5)
preconj(synthetic-7, both-6)
amod(enzymes-10, synthetic-7)
conj_and(synthetic-7, catabolic-9)
dobj(inhibit-5, enzymes-10)
nn(D-13, vitamin-12)
prep_of(enzymes-10, D-13)

Reductions/NNS in/IN serum/NN endogenous/JJ vitamin/NN D/NN concentrations/NNS have/VBP been/VBN observed/VBN following/VBG the/DT administration/NN of/IN 300/CD mg/day/NN to/TO 1200/CD mg/day/NN ketoconazole/NN for/IN a/DT week/NN to/TO healthy/JJ men/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Reductions)) (PP (IN in) (NP (NN serum) (NP (JJ endogenous) (NN vitamin) (NN D)) (NNS concentrations)))) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (CD 300) (NN mg/day))) (PP (TO to) (NP (NP (ADJP (CD 1200) (NN mg/day)) (NN ketoconazole)) (PP (IN for) (NP (NP (DT a) (NN week)) (PP (TO to) (NP (JJ healthy) (NNS men))))))))))))) (. .))))

nsubjpass(observed-10, Reductions-1)
nn(concentrations-7, serum-3)
amod(D-6, endogenous-4)
nn(D-6, vitamin-5)
nn(concentrations-7, D-6)
prep_in(Reductions-1, concentrations-7)
aux(observed-10, have-8)
auxpass(observed-10, been-9)
root(ROOT-0, observed-10)
det(administration-13, the-12)
prep_following(observed-10, administration-13)
num(mg/day-16, 300-15)
prep_of(administration-13, mg/day-16)
number(mg/day-19, 1200-18)
amod(ketoconazole-20, mg/day-19)
prep_to(administration-13, ketoconazole-20)
det(week-23, a-22)
prep_for(ketoconazole-20, week-23)
amod(men-26, healthy-25)
prep_to(week-23, men-26)

However/RB ,/, in/FW vivo/FW drug/NN interaction/NN studies/NNS of/IN ketoconazole/NN with/IN vitamin/NN D/NN have/VBP not/RB been/VBN investigated/VBN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (ADJP (FW in) (FW vivo)) (NN drug) (NN interaction) (NNS studies)) (PP (IN of) (NP (NN ketoconazole))) (PP (IN with) (NP (NN vitamin) (NN D)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN investigated))))) (. .))))

advmod(investigated-16, However-1)
nn(vivo-4, in-3)
amod(studies-7, vivo-4)
nn(studies-7, drug-5)
nn(studies-7, interaction-6)
nsubjpass(investigated-16, studies-7)
prep_of(studies-7, ketoconazole-9)
nn(D-12, vitamin-11)
prep_with(studies-7, D-12)
aux(investigated-16, have-13)
neg(investigated-16, not-14)
auxpass(investigated-16, been-15)
root(ROOT-0, investigated-16)

Corticosteroids/NNS :/: A/DT relationship/NN of/IN functional/JJ antagonism/NN exists/VBZ between/IN vitamin/NN D/NN analogues/NNS ,/, which/WDT promote/VBP calcium/NN absorption/NN ,/, and/CC corticosteroids/NNS ,/, which/WDT inhibit/VBP calcium/NN absorption/NN ./.

(ROOT (S1 (S (NP (NP (NNS Corticosteroids)) (: :) (S (NP (NP (DT A) (NN relationship)) (PP (IN of) (NP (JJ functional) (NN antagonism)))) (VP (VBZ exists) (PP (IN between) (NP (NP (NP (NP (NN vitamin) (NN D) (NNS analogues)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP promote) (NP (NN calcium) (NN absorption))))) (, ,)) (CC and) (NP (NNS corticosteroids))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP inhibit) (NP (NN calcium) (NN absorption))))))))) (. .)))))

root(ROOT-0, Corticosteroids-1)
det(relationship-4, A-3)
nsubj(exists-8, relationship-4)
amod(antagonism-7, functional-6)
prep_of(relationship-4, antagonism-7)
dep(Corticosteroids-1, exists-8)
nn(analogues-12, vitamin-10)
nn(analogues-12, D-11)
prep_between(exists-8, analogues-12)
nsubj(promote-15, analogues-12)
nsubj(inhibit-23, analogues-12)
rcmod(analogues-12, promote-15)
nn(absorption-17, calcium-16)
dobj(promote-15, absorption-17)
conj_and(analogues-12, corticosteroids-20)
rcmod(analogues-12, inhibit-23)
nn(absorption-25, calcium-24)
dobj(inhibit-23, absorption-25)

Phosphate-Binding/JJ Agents/NNS :/: Since/IN vitamin/NN D/NN also/RB has/VBZ an/DT effect/NN on/IN phosphate/NN transport/NN in/IN the/DT intestine/NN ,/, kidneys/NN and/CC bones/NN ,/, the/DT dosage/NN of/IN phosphate-binding/JJ agents/NNS must/MD be/VB adjusted/VBN in/IN accordance/NN with/IN the/DT serum/NN phosphate/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (JJ Phosphate-Binding) (NNS Agents)) (: :) (S (SBAR (IN Since) (S (NP (NN vitamin) (NN D)) (ADVP (RB also)) (VP (VBZ has) (NP (NP (DT an) (NN effect)) (PP (IN on) (NP (NN phosphate) (NN transport)))) (PP (IN in) (NP (DT the) (NP (NP (NN intestine)) (, ,) (NP (NN kidneys)) (CC and) (NP (NN bones)))))))) (, ,) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (JJ phosphate-binding) (NNS agents)))) (VP (MD must) (VP (VB be) (VP (VBN adjusted) (PP (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (DT the) (NN serum) (NN phosphate) (NN concentration))))))))) (. .)))))

amod(Agents-2, Phosphate-Binding-1)
root(ROOT-0, Agents-2)
mark(has-8, Since-4)
nn(D-6, vitamin-5)
nsubj(has-8, D-6)
advmod(has-8, also-7)
advcl(adjusted-29, has-8)
det(effect-10, an-9)
dobj(has-8, effect-10)
nn(transport-13, phosphate-12)
prep_on(effect-10, transport-13)
det(intestine-16, the-15)
prep_in(has-8, intestine-16)
conj_and(intestine-16, kidneys-18)
conj_and(intestine-16, bones-20)
det(dosage-23, the-22)
nsubjpass(adjusted-29, dosage-23)
amod(agents-26, phosphate-binding-25)
prep_of(dosage-23, agents-26)
aux(adjusted-29, must-27)
auxpass(adjusted-29, be-28)
dep(Agents-2, adjusted-29)
det(concentration-36, the-33)
nn(concentration-36, serum-34)
nn(concentration-36, phosphate-35)
prep_in_accordance_with(adjusted-29, concentration-36)

Vitamin/NN D/NN :/: The/DT coadministration/NN of/IN any/DT of/IN the/DT vitamin/NN D/NN analogues/NNS should/MD be/VB avoided/VBN as/IN this/DT could/MD create/VB possible/JJ additive/JJ effects/NNS and/CC hypercalcemia/NN ./.

(ROOT (S1 (S (NP (NP (NN Vitamin) (NN D)) (: :) (S (NP (NP (DT The) (NN coadministration)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NN vitamin) (NN D) (NNS analogues)))))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (IN as) (S (NP (DT this)) (VP (MD could) (VP (VB create) (NP (NP (JJ possible) (JJ additive) (NNS effects)) (CC and) (NP (NN hypercalcemia))))))))))) (. .)))))

nn(D-2, Vitamin-1)
root(ROOT-0, D-2)
det(coadministration-5, The-4)
nsubjpass(avoided-15, coadministration-5)
prep_of(coadministration-5, any-7)
det(analogues-12, the-9)
nn(analogues-12, vitamin-10)
nn(analogues-12, D-11)
prep_of(any-7, analogues-12)
aux(avoided-15, should-13)
auxpass(avoided-15, be-14)
dep(D-2, avoided-15)
mark(create-19, as-16)
nsubj(create-19, this-17)
aux(create-19, could-18)
advcl(avoided-15, create-19)
amod(effects-22, possible-20)
amod(effects-22, additive-21)
dobj(create-19, effects-22)
conj_and(effects-22, hypercalcemia-24)

Calcium/NN Supplements/NNS :/: Uncontrolled/JJ intake/NN of/IN additional/JJ calcium-containing/JJ preparations/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (NP (NN Calcium) (NNS Supplements)) (: :) (NP (NP (JJ Uncontrolled) (NN intake)) (PP (IN of) (NP (JJ additional) (JJ calcium-containing) (NNS preparations)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

nn(Supplements-2, Calcium-1)
nsubjpass(avoided-12, Supplements-2)
amod(intake-5, Uncontrolled-4)
nsubjpass(avoided-12, intake-5)
amod(preparations-9, additional-7)
amod(preparations-9, calcium-containing-8)
prep_of(intake-5, preparations-9)
aux(avoided-12, should-10)
auxpass(avoided-12, be-11)
root(ROOT-0, avoided-12)

Magnesium/NN :/: Magnesium-containing/JJ preparations/NNS (/-LRB- eg/FW ,/, antacids/NNS )/-RRB- may/MD cause/VB hypermagnesemia/NN and/CC should/MD therefore/RB not/RB be/VB taken/VBN during/IN therapy/NN with/IN vitamin/NN D/NN by/IN patients/NNS on/IN chronic/JJ renal/JJ dialysis/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Magnesium)) (: :) (NP (NP (JJ Magnesium-containing) (NNS preparations)) (PRN (-LRB- -LRB-) (PP (FW eg)) (, ,) (NP (NNS antacids)) (-RRB- -RRB-)))) (VP (VP (MD may) (VP (VB cause) (NP (NN hypermagnesemia)))) (CC and) (VP (MD should) (ADVP (RB therefore)) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN during) (NP (NP (NN therapy)) (PP (IN with) (NP (NN vitamin) (NN D))))) (PP (IN by) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ chronic) (JJ renal) (NN dialysis)))))))))) (. .))))

nsubj(cause-11, Magnesium-1)
amod(preparations-4, Magnesium-containing-3)
dep(Magnesium-1, preparations-4)
dep(antacids-8, eg-6)
appos(preparations-4, antacids-8)
aux(cause-11, may-10)
root(ROOT-0, cause-11)
dobj(cause-11, hypermagnesemia-12)
aux(taken-18, should-14)
advmod(taken-18, therefore-15)
neg(taken-18, not-16)
auxpass(taken-18, be-17)
conj_and(cause-11, taken-18)
prep_during(taken-18, therapy-20)
nn(D-23, vitamin-22)
prep_with(therapy-20, D-23)
agent(taken-18, patients-25)
amod(dialysis-29, chronic-27)
amod(dialysis-29, renal-28)
prep_on(patients-25, dialysis-29)

Elevated/JJ plasma/NN levels/NNS of/IN theophylline/NN have/VBP been/VBN reported/VBN with/IN concomitant/JJ use/NN of/IN some/DT quinolones/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Elevated) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN theophylline)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (DT some) (NNS quinolones))))))))) (. .))))

amod(levels-3, Elevated-1)
nn(levels-3, plasma-2)
nsubjpass(reported-8, levels-3)
prep_of(levels-3, theophylline-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
amod(use-11, concomitant-10)
prep_with(reported-8, use-11)
det(quinolones-14, some-13)
prep_of(use-11, quinolones-14)

There/EX have/VBP been/VBN reports/NNS of/IN theophylline/NN -related/JJ side-effects/NNS in/IN patients/NNS on/IN concomitant/JJ theophylline/NN -quinolone/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (NN theophylline) (JJ -related) (NNS side-effects)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ concomitant) (NN theophylline) (NN -quinolone) (NN therapy))))))))))) (. .))))

expl(reports-4, There-1)
aux(reports-4, have-2)
cop(reports-4, been-3)
root(ROOT-0, reports-4)
nn(side-effects-8, theophylline-6)
amod(side-effects-8, -related-7)
prep_of(reports-4, side-effects-8)
prep_in(side-effects-8, patients-10)
amod(therapy-15, concomitant-12)
nn(therapy-15, theophylline-13)
nn(therapy-15, -quinolone-14)
prep_on(patients-10, therapy-15)

Therefore/RB ,/, monitoring/NN of/IN theophylline/NN plasma/NN levels/NNS should/MD be/VB considered/VBN and/CC dosage/NN of/IN theophylline/NN adjusted/VBN as/IN required/VBN ./.

(ROOT (S1 (S (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN monitoring)) (PP (IN of) (NP (NN theophylline) (NN plasma) (NNS levels)))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (CC and) (S (NP (NP (NN dosage)) (PP (IN of) (NP (NN theophylline)))) (VP (VBN adjusted) (PP (IN as) (NP (VBN required)))))) (. .))))

advmod(considered-10, Therefore-1)
nsubjpass(considered-10, monitoring-3)
nn(levels-7, theophylline-5)
nn(levels-7, plasma-6)
prep_of(monitoring-3, levels-7)
aux(considered-10, should-8)
auxpass(considered-10, be-9)
root(ROOT-0, considered-10)
nsubj(adjusted-15, dosage-12)
prep_of(dosage-12, theophylline-14)
conj_and(considered-10, adjusted-15)
prep_as(adjusted-15, required-17)

Quinolones/NNS have/VBP also/RB been/VBN shown/VBN to/TO interfere/VB with/IN the/DT metabolism/NN of/IN caffeine/NN ./.

(ROOT (S1 (S (S (NP (NNS Quinolones)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN caffeine)))))))))))) (. .))))

nsubjpass(shown-5, Quinolones-1)
xsubj(interfere-7, Quinolones-1)
aux(shown-5, have-2)
advmod(shown-5, also-3)
auxpass(shown-5, been-4)
root(ROOT-0, shown-5)
aux(interfere-7, to-6)
xcomp(shown-5, interfere-7)
det(metabolism-10, the-9)
prep_with(interfere-7, metabolism-10)
prep_of(metabolism-10, caffeine-12)

This/DT may/MD lead/VB to/TO reduced/VBN clearance/NN of/IN caffeine/NN and/CC a/DT prolongation/NN of/IN its/PRP$ plasma/NN half-life/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NP (VBN reduced) (NN clearance)) (PP (IN of) (NP (NN caffeine)))) (CC and) (NP (NP (DT a) (NN prolongation)) (PP (IN of) (NP (PRP$ its) (NN plasma) (NN half-life))))))))) (. .))))

nsubj(lead-3, This-1)
aux(lead-3, may-2)
root(ROOT-0, lead-3)
amod(clearance-6, reduced-5)
prep_to(lead-3, clearance-6)
prep_of(clearance-6, caffeine-8)
det(prolongation-11, a-10)
conj_and(clearance-6, prolongation-11)
poss(half-life-15, its-13)
nn(half-life-15, plasma-14)
prep_of(prolongation-11, half-life-15)

Although/IN this/DT interaction/NN has/VBZ not/RB been/VBN reported/VBN with/IN cinoxacin/NN ,/, caution/NN should/MD be/VB exercised/VBN when/WRB cinoxacin/NN is/VBZ given/VBN concomitantly/RB with/IN caffeine-containing/JJ products/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (DT this) (NN interaction)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NN cinoxacin)))))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (NN cinoxacin)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ caffeine-containing) (NNS products))))))))))) (. .))))

mark(reported-7, Although-1)
det(interaction-3, this-2)
nsubjpass(reported-7, interaction-3)
aux(reported-7, has-4)
neg(reported-7, not-5)
auxpass(reported-7, been-6)
advcl(exercised-14, reported-7)
prep_with(reported-7, cinoxacin-9)
nsubjpass(exercised-14, caution-11)
aux(exercised-14, should-12)
auxpass(exercised-14, be-13)
root(ROOT-0, exercised-14)
advmod(given-18, when-15)
nsubjpass(given-18, cinoxacin-16)
auxpass(given-18, is-17)
advcl(exercised-14, given-18)
advmod(given-18, concomitantly-19)
amod(products-22, caffeine-containing-21)
prep_with(given-18, products-22)

Antacids/NNS or/CC sucralfate/NN substantially/RB interfere/VBP with/IN the/DT absorption/NN of/IN some/DT quinolones/NNS ,/, resulting/VBG in/IN low/JJ urine/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Antacids)) (CC or) (NP (NN sucralfate))) (ADVP (RB substantially)) (VP (VBP interfere) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (DT some) (NNS quinolones))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (JJ low) (NN urine) (NNS levels))))))) (. .))))

nsubj(interfere-5, Antacids-1)
conj_or(Antacids-1, sucralfate-3)
advmod(interfere-5, substantially-4)
root(ROOT-0, interfere-5)
det(absorption-8, the-7)
prep_with(interfere-5, absorption-8)
det(quinolones-11, some-10)
prep_of(absorption-8, quinolones-11)
xcomp(interfere-5, resulting-13)
amod(levels-17, low-15)
nn(levels-17, urine-16)
prep_in(resulting-13, levels-17)

Also/RB ,/, concomitant/JJ administration/NN of/IN quinolones/NNS with/IN products/NNS containing/VBG iron/NN ,/, multivitamins/NN containing/NN zinc/NN ,/, or/CC Videx/NN (/-LRB- didanosine/NN )/-RRB- chewable//NN buffer/NN ed/NN tablets/NNS or/CC the/DT pediatric/JJ powder/NN for/IN oral/JJ solution/NN may/MD result/VB in/IN low/JJ urine/NN levels/NNS ./.

(ROOT (S1 (S (ADVP (RB Also)) (, ,) (NP (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NNS quinolones)) (PP (IN with) (NP (NP (NNS products)) (VP (VBG containing) (NP (NP (NN iron)) (, ,) (NP (NN multivitamins) (NN containing) (NN zinc)) (, ,) (CC or) (NP (NP (NN Videx)) (PRN (-LRB- -LRB-) (NP (NN didanosine)) (-RRB- -RRB-))) (NP (NN chewable/) (NN buffer) (NN ed) (NNS tablets))))))))) (CC or) (NP (NP (DT the) (JJ pediatric) (NN powder)) (PP (IN for) (NP (JJ oral) (NN solution))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (JJ low) (NN urine) (NNS levels))))) (. .))))

advmod(result-33, Also-1)
amod(administration-4, concomitant-3)
nsubj(result-33, administration-4)
prep_of(administration-4, quinolones-6)
prep_with(quinolones-6, products-8)
partmod(products-8, containing-9)
dobj(containing-9, iron-10)
nn(zinc-14, multivitamins-12)
nn(zinc-14, containing-13)
conj_or(iron-10, zinc-14)
conj_or(iron-10, Videx-17)
appos(Videx-17, didanosine-19)
nn(tablets-24, chewable/-21)
nn(tablets-24, buffer-22)
nn(tablets-24, ed-23)
dobj(containing-9, tablets-24)
dep(iron-10, tablets-24)
det(powder-28, the-26)
amod(powder-28, pediatric-27)
conj_or(administration-4, powder-28)
amod(solution-31, oral-30)
prep_for(powder-28, solution-31)
aux(result-33, may-32)
root(ROOT-0, result-33)
amod(levels-37, low-35)
nn(levels-37, urine-36)
prep_in(result-33, levels-37)

Quinolones/NNS ,/, including/VBG cinoxacin/NN ,/, may/MD enhance/VB the/DT effects/NNS of/IN oral/JJ anticoagulants/NNS ,/, such/JJ as/IN warfarin/NN or/CC its/PRP$ derivatives/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Quinolones)) (, ,) (PP (VBG including) (NP (NN cinoxacin))) (, ,)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ oral) (NNS anticoagulants)))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN warfarin)) (CC or) (NP (PRP$ its) (NNS derivatives))))))) (. .))))

nsubj(enhance-7, Quinolones-1)
prep_including(Quinolones-1, cinoxacin-4)
aux(enhance-7, may-6)
root(ROOT-0, enhance-7)
det(effects-9, the-8)
dobj(enhance-7, effects-9)
amod(anticoagulants-12, oral-11)
prep_of(effects-9, anticoagulants-12)
prep_such_as(enhance-7, warfarin-16)
poss(derivatives-19, its-18)
conj_or(warfarin-16, derivatives-19)

Seizures/NNS have/VBP been/VBN reported/VBN in/IN patients/NNS taking/VBG another/DT quinolone/NN class/NN antimicrobial/NN and/CC the/DT nonsteroidal/JJ anti-inflammatory/JJ drug/NN fenbufen/VBN concurrently/RB ./.

(ROOT (S1 (S (S (NP (NNS Seizures)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (DT another) (NP (NN quinolone) (NN class) (NN antimicrobial)) (CC and) (NP (DT the) (JJ nonsteroidal) (JJ anti-inflammatory) (NN drug))) (VP (VBN fenbufen) (ADVP (RB concurrently))))))))))) (. .))))

nsubjpass(reported-4, Seizures-1)
aux(reported-4, have-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
prep_in(reported-4, patients-6)
partmod(patients-6, taking-7)
dep(antimicrobial-11, another-8)
nn(antimicrobial-11, quinolone-9)
nn(antimicrobial-11, class-10)
dobj(taking-7, antimicrobial-11)
det(drug-16, the-13)
amod(drug-16, nonsteroidal-14)
amod(drug-16, anti-inflammatory-15)
conj_and(antimicrobial-11, drug-16)
partmod(antimicrobial-11, fenbufen-17)
advmod(fenbufen-17, concurrently-18)

Animal/NN studies/NNS also/RB suggest/VBP an/DT increased/VBN potential/NN for/IN seizures/NNS when/WRB these/DT 2/CD drugs/NNS are/VBP given/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Animal) (NNS studies)) (ADVP (RB also)) (VP (VBP suggest) (NP (NP (DT an) (VBN increased) (NN potential)) (PP (IN for) (NP (NNS seizures)))) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (CD 2) (NNS drugs)) (VP (VBP are) (VP (VBN given) (ADVP (RB concomitantly)))))))) (. .))))

nn(studies-2, Animal-1)
nsubj(suggest-4, studies-2)
advmod(suggest-4, also-3)
root(ROOT-0, suggest-4)
det(potential-7, an-5)
amod(potential-7, increased-6)
dobj(suggest-4, potential-7)
prep_for(potential-7, seizures-9)
advmod(given-15, when-10)
det(drugs-13, these-11)
num(drugs-13, 2-12)
nsubjpass(given-15, drugs-13)
auxpass(given-15, are-14)
advcl(suggest-4, given-15)
advmod(given-15, concomitantly-16)

Fenbufen/NN is/VBZ not/RB approved/JJ in/IN the/DT United/JJ States/NNS at/IN this/DT time/NN ./.

(ROOT (S1 (S (S (NP (NN Fenbufen)) (VP (VBZ is) (RB not) (ADJP (JJ approved)) (PP (IN in) (NP (DT the) (JJ United) (NNS States))) (PP (IN at) (NP (DT this) (NN time))))) (. .))))

nsubj(approved-4, Fenbufen-1)
cop(approved-4, is-2)
neg(approved-4, not-3)
root(ROOT-0, approved-4)
det(States-8, the-6)
amod(States-8, United-7)
prep_in(approved-4, States-8)
det(time-11, this-10)
prep_at(approved-4, time-11)

Physicians/NNS are/VBP provided/VBN this/DT information/NN to/TO increase/VB awareness/NN of/IN the/DT potential/NN for/IN serious/JJ interactions/NNS when/WRB cinoxacin/NN and/CC certain/JJ nonsteroidal/JJ anti-inflammatory/JJ agents/NNS are/VBP administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NNS Physicians)) (VP (VBP are) (VP (VBN provided) (NP (DT this) (NN information)) (S (VP (TO to) (VP (VB increase) (NP (NP (NN awareness)) (PP (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (JJ serious) (NNS interactions)))))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN cinoxacin)) (CC and) (NP (JJ certain) (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)))))))))))) (. .))))

nsubjpass(provided-3, Physicians-1)
auxpass(provided-3, are-2)
root(ROOT-0, provided-3)
det(information-5, this-4)
dobj(provided-3, information-5)
aux(increase-7, to-6)
xcomp(provided-3, increase-7)
dobj(increase-7, awareness-8)
det(potential-11, the-10)
prep_of(awareness-8, potential-11)
amod(interactions-14, serious-13)
prep_for(potential-11, interactions-14)
advmod(administered-23, when-15)
nsubjpass(administered-23, cinoxacin-16)
amod(agents-21, certain-18)
amod(agents-21, nonsteroidal-19)
amod(agents-21, anti-inflammatory-20)
conj_and(cinoxacin-16, agents-21)
auxpass(administered-23, are-22)
advcl(increase-7, administered-23)
advmod(administered-23, concomitantly-24)

Elevated/JJ cyclosporine/NN serum/NN levels/NNS have/VBP been/VBN reported/VBN with/IN the/DT concomitant/JJ use/NN of/IN quinolones/NN and/CC cyclosporine/NN ./.

(ROOT (S1 (S (S (NP (JJ Elevated) (NN cyclosporine) (NN serum) (NNS levels)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN quinolones)) (CC and) (NP (NN cyclosporine)))))))))) (. .))))

amod(levels-4, Elevated-1)
nn(levels-4, cyclosporine-2)
nn(levels-4, serum-3)
nsubjpass(reported-7, levels-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
det(use-11, the-9)
amod(use-11, concomitant-10)
prep_with(reported-7, use-11)
prep_of(use-11, quinolones-13)
conj_and(quinolones-13, cyclosporine-15)

Plasma/NN levels/NNS of/IN anticonvulsant/JJ agent/NN s/NNS may/MD become/VB subtherapeutic/JJ during/IN cisplatin/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Plasma) (NNS levels)) (PP (IN of) (NP (JJ anticonvulsant) (NN agent) (NNS s)))) (VP (MD may) (VP (VB become) (ADJP (JJ subtherapeutic)) (PP (IN during) (NP (NN cisplatin) (NN therapy)))))) (. .))))

nn(levels-2, Plasma-1)
nsubj(subtherapeutic-9, levels-2)
amod(s-6, anticonvulsant-4)
nn(s-6, agent-5)
prep_of(levels-2, s-6)
aux(subtherapeutic-9, may-7)
cop(subtherapeutic-9, become-8)
root(ROOT-0, subtherapeutic-9)
nn(therapy-12, cisplatin-11)
prep_during(subtherapeutic-9, therapy-12)

In/IN a/DT randomized/JJ trial/NN in/IN advanced/JJ ovarian/JJ cancer/NN ,/, response/NN duration/NN was/VBD adversely/RB affected/VBN when/WRB pyridoxine/NN was/VBD used/VBN in/IN combination/NN with/IN altretamine/NN (/-LRB- hexamethylmelamine/NN )/-RRB- and/CC cisplatin/NN .1/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (JJ randomized) (NN trial)) (PP (IN in) (NP (JJ advanced) (JJ ovarian) (NN cancer))))) (, ,) (NP (NN response) (NN duration)) (VP (VBD was) (VP (ADVP (RB adversely)) (VBN affected) (SBAR (WHADVP (WRB when)) (S (NP (NN pyridoxine)) (VP (VBD was) (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NP (NN altretamine)) (PRN (-LRB- -LRB-) (NP (NN hexamethylmelamine)) (-RRB- -RRB-))) (CC and) (NP (NN cisplatin) (NN .1))))))))))))) (. .))))

det(trial-4, a-2)
amod(trial-4, randomized-3)
prep_in(affected-14, trial-4)
amod(cancer-8, advanced-6)
amod(cancer-8, ovarian-7)
prep_in(trial-4, cancer-8)
nn(duration-11, response-10)
nsubjpass(affected-14, duration-11)
auxpass(affected-14, was-12)
advmod(affected-14, adversely-13)
root(ROOT-0, affected-14)
advmod(used-18, when-15)
nsubjpass(used-18, pyridoxine-16)
auxpass(used-18, was-17)
advcl(affected-14, used-18)
prep_in(used-18, combination-20)
prep_with(combination-20, altretamine-22)
appos(altretamine-22, hexamethylmelamine-24)
nn(.1-28, cisplatin-27)
conj_and(altretamine-22, .1-28)

Central/JJ nervous/JJ system/NN depressant/JJ (/-LRB- CNS/NN )/-RRB- drugs/NNS including/VBG alcohol/NN ,/, antidepressants/NNS ,/, antihistamines/NNS ,/, antipsychotics/NNS ,/, blood/NN pressure/NN medications/NNS (/-LRB- reserpine/NN ,/, methyldopa/NN ,/, beta-blockers/NN )/-RRB- ,/, motion/NN sickness/NN medications/NNS ,/, muscle/NN relaxants/NNS ,/, narcotics/NNS ,/, sedatives/NNS ,/, sleeping/JJ pills/NNS and/CC tranquilizers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Central) (JJ nervous) (NN system) (JJ depressant)) (PRN (-LRB- -LRB-) (NP (NN CNS)) (-RRB- -RRB-))) (NNS drugs)) (VP (VBG including) (NP (NP (NN alcohol)) (, ,) (NP (NP (NNS antidepressants)) (, ,) (NP (NNS antihistamines)) (, ,) (NP (NNS antipsychotics)) (, ,) (NP (NP (NN blood) (NN pressure) (NNS medications)) (PRN (-LRB- -LRB-) (NP (NP (NN reserpine)) (, ,) (NP (NN methyldopa)) (, ,) (NP (NN beta-blockers))) (-RRB- -RRB-))) (, ,) (NP (NN motion) (NN sickness) (NNS medications)) (, ,) (NP (NN muscle) (NNS relaxants)) (, ,) (NP (NNS narcotics)) (, ,) (NP (NNS sedatives)) (, ,) (NP (JJ sleeping) (NNS pills)) (CC and) (NP (NNS tranquilizers)))))) (. .))))

amod(system-3, Central-1)
amod(system-3, nervous-2)
nn(drugs-8, system-3)
amod(system-3, depressant-4)
abbrev(system-3, CNS-6)
nsubj(including-9, drugs-8)
root(ROOT-0, including-9)
dobj(including-9, alcohol-10)
appos(alcohol-10, antidepressants-12)
conj_and(antidepressants-12, antihistamines-14)
conj_and(antidepressants-12, antipsychotics-16)
nn(medications-20, blood-18)
nn(medications-20, pressure-19)
conj_and(antidepressants-12, medications-20)
dep(medications-20, reserpine-22)
appos(reserpine-22, methyldopa-24)
appos(reserpine-22, beta-blockers-26)
nn(medications-31, motion-29)
nn(medications-31, sickness-30)
conj_and(antidepressants-12, medications-31)
nn(relaxants-34, muscle-33)
conj_and(antidepressants-12, relaxants-34)
conj_and(antidepressants-12, narcotics-36)
conj_and(antidepressants-12, sedatives-38)
amod(pills-41, sleeping-40)
conj_and(antidepressants-12, pills-41)
conj_and(antidepressants-12, tranquilizers-43)

Amantadine/NN ,/, tricyclic/JJ antidepressants/NNS ,/, and/CC MAOIs/NN may/MD increase/VB anticholinergic/JJ effect/NN of/IN clidinium/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Amantadine)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (CC and) (NP (NN MAOIs))) (VP (MD may) (VP (VB increase) (NP (NP (JJ anticholinergic) (NN effect)) (PP (IN of) (NP (NN clidinium))))))) (. .))))

nsubj(increase-9, Amantadine-1)
amod(antidepressants-4, tricyclic-3)
conj_and(Amantadine-1, antidepressants-4)
conj_and(Amantadine-1, MAOIs-7)
aux(increase-9, may-8)
root(ROOT-0, increase-9)
amod(effect-11, anticholinergic-10)
dobj(increase-9, effect-11)
prep_of(effect-11, clidinium-13)

Clidinium/NN may/MD decrease/VB the/DT effect/NN of/IN phenothiazines/NNS ,/, levodopa/NN ,/, and/CC ketoconazole/NN ./.

(ROOT (S1 (S (S (NP (NN Clidinium)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS phenothiazines)) (, ,) (NP (NN levodopa)) (, ,) (CC and) (NP (NN ketoconazole)))))))) (. .))))

nsubj(decrease-3, Clidinium-1)
aux(decrease-3, may-2)
root(ROOT-0, decrease-3)
det(effect-5, the-4)
dobj(decrease-3, effect-5)
prep_of(effect-5, phenothiazines-7)
conj_and(phenothiazines-7, levodopa-9)
conj_and(phenothiazines-7, ketoconazole-12)

Clindamycin/NN has/VBZ been/VBN shown/VBN to/TO have/VBP neuromuscular/JJ blocking/NN properties/NNS that/WDT may/MD enhance/VB the/DT action/NN of/IN other/JJ neuromuscular/NN blocking/VBG agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Clindamycin)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VBP have) (NP (NP (JJ neuromuscular) (NN blocking) (NNS properties)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (JJ other) (NN neuromuscular) (VBG blocking) (NNS agents)))))))))))))))) (. .))))

nsubjpass(shown-4, Clindamycin-1)
xsubj(have-6, Clindamycin-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(have-6, to-5)
xcomp(shown-4, have-6)
amod(properties-9, neuromuscular-7)
nn(properties-9, blocking-8)
dobj(have-6, properties-9)
nsubj(enhance-12, properties-9)
aux(enhance-12, may-11)
rcmod(properties-9, enhance-12)
det(action-14, the-13)
dobj(enhance-12, action-14)
amod(agents-19, other-16)
nn(agents-19, neuromuscular-17)
amod(agents-19, blocking-18)
prep_of(action-14, agents-19)

Antagonism/NN has/VBZ been/VBN demonstrated/VBN between/IN clindamycin/NN and/CC erythromycin/NN in/FW vitro/FW ./.

(ROOT (S1 (S (S (NP (NN Antagonism)) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (IN between) (NP (NP (NN clindamycin)) (CC and) (NP (NN erythromycin)))) (ADVP (FW in) (FW vitro)))))) (. .))))

nsubjpass(demonstrated-4, Antagonism-1)
aux(demonstrated-4, has-2)
auxpass(demonstrated-4, been-3)
root(ROOT-0, demonstrated-4)
prep_between(demonstrated-4, clindamycin-6)
conj_and(clindamycin-6, erythromycin-8)
nn(vitro-10, in-9)
advmod(demonstrated-4, vitro-10)

Because/IN of/IN possible/JJ clinical/JJ significance/NN ,/, these/DT two/CD drugs/NNS should/MD not/RB be/VB administered/VBN concurrently/RB ./.

(ROOT (S1 (S (S (PP (IN Because) (PP (IN of) (NP (JJ possible) (JJ clinical) (NN significance)))) (, ,) (NP (DT these) (CD two) (NNS drugs)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concurrently)))))) (. .))))

prepc_because_of(administered-13, of-2)
amod(significance-5, possible-3)
amod(significance-5, clinical-4)
pobj(administered-13, significance-5)
det(drugs-9, these-7)
num(drugs-9, two-8)
nsubjpass(administered-13, drugs-9)
aux(administered-13, should-10)
neg(administered-13, not-11)
auxpass(administered-13, be-12)
root(ROOT-0, administered-13)
advmod(administered-13, concurrently-14)

Alcohol/NN (/-LRB- increases/VBZ bioavailability/NN by/IN 50/CD %/NN )/-RRB- ,/, cimetidine/NN ,/, and/CC valproates/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Alcohol)) (PRN (-LRB- -LRB-) (S (VP (VBZ increases) (NP (NN bioavailability)) (PP (IN by) (NP (CD 50) (NN %))))) (-RRB- -RRB-))) (, ,) (NP (NN cimetidine)) (, ,) (CC and) (NP (NN valproates)))) (. .))))

root(ROOT-0, Alcohol-1)
dep(Alcohol-1, increases-3)
dobj(increases-3, bioavailability-4)
num(%-7, 50-6)
prep_by(increases-3, %-7)
conj_and(Alcohol-1, cimetidine-10)
conj_and(Alcohol-1, valproates-13)

Although/IN no/DT clinical/JJ drug-drug/JJ interaction/NN studies/NNS have/VBP been/VBN conducted/VBN to/TO date/NN ,/, on/IN the/DT basis/NN of/IN the/DT in/FW vitro/FW studies/NNS ,/, cytochrome/NN p450/NN inhibitors/NNS and/CC inducers/NNS are/VBP unlikely/JJ to/TO affect/VB the/DT metabolism/NN of/IN clofarabine/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (DT no) (JJ clinical) (JJ drug-drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (PP (TO to) (NP (NN date)))))))) (, ,) (PP (IN on) (DT the) (NN basis) (IN of) (NP (DT the) (ADJP (FW in) (FW vitro)) (NNS studies))) (, ,) (NP (NP (NN cytochrome) (NN p450) (NNS inhibitors)) (CC and) (NP (NNS inducers))) (VP (VBP are) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB affect) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN clofarabine)))))))))) (. .))))

mark(conducted-9, Although-1)
det(studies-6, no-2)
amod(studies-6, clinical-3)
amod(studies-6, drug-drug-4)
nn(studies-6, interaction-5)
nsubjpass(conducted-9, studies-6)
aux(conducted-9, have-7)
auxpass(conducted-9, been-8)
advcl(unlikely-28, conducted-9)
prep_to(conducted-9, date-11)
dep(unlikely-28, on-13)
dep(unlikely-28, the-14)
dep(unlikely-28, basis-15)
det(studies-20, the-17)
nn(vitro-19, in-18)
amod(studies-20, vitro-19)
prep_of(unlikely-28, studies-20)
nn(inhibitors-24, cytochrome-22)
nn(inhibitors-24, p450-23)
nsubj(unlikely-28, inhibitors-24)
conj_and(inhibitors-24, inducers-26)
cop(unlikely-28, are-27)
root(ROOT-0, unlikely-28)
aux(affect-30, to-29)
xcomp(unlikely-28, affect-30)
det(metabolism-32, the-31)
dobj(affect-30, metabolism-32)
prep_of(metabolism-32, clofarabine-34)

The/DT effect/NN of/IN clofarabine/NN on/IN the/DT metabolism/NN of/IN cytochrome/NN p450/NN substrates/NNS has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN clofarabine))) (PP (IN on) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN cytochrome) (NN p450) (NNS substrates)))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(effect-2, The-1)
nsubjpass(studied-15, effect-2)
prep_of(effect-2, clofarabine-4)
det(metabolism-7, the-6)
prep_on(effect-2, metabolism-7)
nn(substrates-11, cytochrome-9)
nn(substrates-11, p450-10)
prep_of(metabolism-7, substrates-11)
aux(studied-15, has-12)
neg(studied-15, not-13)
auxpass(studied-15, been-14)
root(ROOT-0, studied-15)

Drug/NN /Laboratory/NN Tests/NNS Interactions/NNS :/: There/EX are/VBP no/RB known/VBN clinically/RB significant/JJ interactions/NNS of/IN CLOLAR/NN @/NN with/IN other/JJ medications/NNS or/CC laboratory/NN tests/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NNS Tests) (NNS Interactions)) (: :) (S (NP (EX There)) (VP (VBP are) (ADVP (RB no)) (VP (VBN known) (NP (NP (ADJP (RB clinically) (JJ significant)) (NNS interactions)) (PP (IN of) (NP (NN CLOLAR) (NN @))) (PP (IN with) (NP (NP (JJ other) (NNS medications)) (CC or) (NP (NN laboratory) (NNS tests)))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Tests-3)
root(ROOT-0, Interactions-4)
expl(known-9, There-6)
auxpass(known-9, are-7)
advmod(known-9, no-8)
dep(Interactions-4, known-9)
advmod(significant-11, clinically-10)
amod(interactions-12, significant-11)
dobj(known-9, interactions-12)
nsubjpass(known-9, interactions-12)
nn(@-15, CLOLAR-14)
prep_of(interactions-12, @-15)
amod(medications-18, other-17)
prep_with(interactions-12, medications-18)
nn(tests-21, laboratory-20)
conj_or(medications-18, tests-21)

No/DT formal/JJ drug/NN /laboratory/NN test/NN interaction/NN studies/NNS have/VBP been/VBN conducted/VBN with/IN CLOLAR/JJ @/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ formal) (NN drug) (NN /laboratory) (NN test) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (PP (IN with) (NP (JJ CLOLAR) (NN @))))))) (. .))))

det(studies-7, No-1)
amod(studies-7, formal-2)
nn(studies-7, drug-3)
nn(studies-7, /laboratory-4)
nn(studies-7, test-5)
nn(studies-7, interaction-6)
nsubjpass(conducted-10, studies-7)
aux(conducted-10, have-8)
auxpass(conducted-10, been-9)
root(ROOT-0, conducted-10)
amod(@-13, CLOLAR-12)
prep_with(conducted-10, @-13)

Preliminary/JJ data/NNS which/WDT suggest/VBP that/IN dapsone/NN may/MD inhibit/VB the/DT anti-inflammatory/JJ activity/NN of/IN Lamprene/NN have/VBP not/RB been/VBN confirmed/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Preliminary) (NNS data)) (SBAR (WHNP (WDT which)) (S (VP (VBP suggest) (SBAR (IN that) (S (NP (NN dapsone)) (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (JJ anti-inflammatory) (NN activity)) (PP (IN of) (NP (NN Lamprene)))))))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN confirmed))))) (. .))))

amod(data-2, Preliminary-1)
nsubj(suggest-4, data-2)
nsubjpass(confirmed-17, data-2)
rcmod(data-2, suggest-4)
complm(inhibit-8, that-5)
nsubj(inhibit-8, dapsone-6)
aux(inhibit-8, may-7)
ccomp(suggest-4, inhibit-8)
det(activity-11, the-9)
amod(activity-11, anti-inflammatory-10)
dobj(inhibit-8, activity-11)
prep_of(activity-11, Lamprene-13)
aux(confirmed-17, have-14)
neg(confirmed-17, not-15)
auxpass(confirmed-17, been-16)
root(ROOT-0, confirmed-17)

If/IN leprosy/NN -associated/JJ inflammatory/JJ reactions/NNS develop/VBP in/IN patients/NNS being/VBG treated/VBN with/IN dapsone/NN and/CC clofazimine/NN ,/, it/PRP is/VBZ still/RB advisable/JJ to/TO continue/VBP treatment/NN with/IN both/DT drugs/NNS ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN leprosy) (JJ -associated) (JJ inflammatory) (NNS reactions)) (VP (VBP develop) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NP (NN dapsone)) (CC and) (NP (NN clofazimine))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ advisable) (S (VP (TO to) (VP (VBP continue) (NP (NP (NN treatment)) (PP (IN with) (NP (DT both) (NNS drugs)))))))))) (. .))))

mark(develop-6, If-1)
nn(reactions-5, leprosy-2)
amod(reactions-5, -associated-3)
amod(reactions-5, inflammatory-4)
nsubj(develop-6, reactions-5)
advcl(advisable-19, develop-6)
prep_in(develop-6, patients-8)
auxpass(treated-10, being-9)
partmod(patients-8, treated-10)
prep_with(treated-10, dapsone-12)
conj_and(dapsone-12, clofazimine-14)
nsubj(advisable-19, it-16)
cop(advisable-19, is-17)
advmod(advisable-19, still-18)
root(ROOT-0, advisable-19)
aux(continue-21, to-20)
xcomp(advisable-19, continue-21)
dobj(continue-21, treatment-22)
det(drugs-25, both-24)
prep_with(treatment-22, drugs-25)

Tablet/NN :/: If/IN a/DT patient/NN receiving/VBG clonidine/NN hydrochloride/NN is/VBZ also/RB taking/VBG tricyclic/JJ antidepressants/NNS ,/, the/DT effect/NN of/IN clonidine/NN may/MD be/VB reduced/VBN ,/, thus/RB necessitating/VBG an/DT increase/NN in/IN dosage/NN ./.

(ROOT (S1 (S (NP (NP (NN Tablet)) (: :) (S (SBAR (IN If) (S (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN clonidine) (NN hydrochloride)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBG taking) (NP (JJ tricyclic) (NNS antidepressants)))))) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN clonidine)))) (VP (MD may) (VP (VB be) (VP (VBN reduced))) (, ,) (S (ADVP (RB thus)) (VP (VBG necessitating) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN dosage)))))))) (. .)))))

root(ROOT-0, Tablet-1)
mark(taking-11, If-3)
det(patient-5, a-4)
nsubj(taking-11, patient-5)
partmod(patient-5, receiving-6)
nn(hydrochloride-8, clonidine-7)
dobj(receiving-6, hydrochloride-8)
aux(taking-11, is-9)
advmod(taking-11, also-10)
advcl(reduced-21, taking-11)
amod(antidepressants-13, tricyclic-12)
dobj(taking-11, antidepressants-13)
det(effect-16, the-15)
nsubjpass(reduced-21, effect-16)
prep_of(effect-16, clonidine-18)
aux(reduced-21, may-19)
auxpass(reduced-21, be-20)
dep(Tablet-1, reduced-21)
advmod(necessitating-24, thus-23)
xcomp(reduced-21, necessitating-24)
det(increase-26, an-25)
dobj(necessitating-24, increase-26)
prep_in(increase-26, dosage-28)

Clonidine/NN hydrochloride/NN may/MD enhance/VB the/DT CNS-depressive/JJ effects/NNS of/IN alcohol/NN ,/, barbiturates/NNS or/CC other/JJ sedatives/NNS ./.

(ROOT (S1 (S (S (NP (NN Clonidine) (NN hydrochloride)) (VP (MD may) (VP (VB enhance) (NP (NP (NP (DT the) (JJ CNS-depressive) (NNS effects)) (PP (IN of) (NP (NN alcohol)))) (, ,) (NP (NP (NNS barbiturates)) (CC or) (NP (JJ other) (NNS sedatives))))))) (. .))))

nn(hydrochloride-2, Clonidine-1)
nsubj(enhance-4, hydrochloride-2)
aux(enhance-4, may-3)
root(ROOT-0, enhance-4)
det(effects-7, the-5)
amod(effects-7, CNS-depressive-6)
dobj(enhance-4, effects-7)
prep_of(effects-7, alcohol-9)
appos(effects-7, barbiturates-11)
amod(sedatives-14, other-13)
conj_or(barbiturates-11, sedatives-14)

Amitriptyline/NN in/IN combination/NN with/IN clonidine/NN enhances/VBZ the/DT manifestation/NN of/IN corneal/NN lesions/NNS in/IN rats/NNS Epidural/JJ Injection/NN Clonidine/NN may/MD potentiate/VB the/DT CNS-depressive/JJ effect/NN of/IN alcohol/NN ,/, barbiturates/NNS or/CC other/JJ sedating/JJ drugs/NNS ./.

(ROOT (S1 (S (S (S (NP (NP (NN Amitriptyline)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN clonidine)))))) (VP (VBZ enhances) (NP (NP (DT the) (NN manifestation)) (PP (IN of) (NP (NN corneal) (NNS lesions))) (PP (IN in) (NP (NNS rats)))))) (S (NP (NP (JJ Epidural) (NN Injection)) (NN Clonidine)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ CNS-depressive) (NN effect)) (PP (IN of) (NP (NP (NN alcohol)) (, ,) (NP (NNS barbiturates)) (CC or) (NP (JJ other) (JJ sedating) (NNS drugs))))))))) (. .))))

nsubj(enhances-6, Amitriptyline-1)
prep_in(Amitriptyline-1, combination-3)
prep_with(combination-3, clonidine-5)
root(ROOT-0, enhances-6)
det(manifestation-8, the-7)
dobj(enhances-6, manifestation-8)
nn(lesions-11, corneal-10)
prep_of(manifestation-8, lesions-11)
prep_in(manifestation-8, rats-13)
amod(Injection-15, Epidural-14)
nn(Clonidine-16, Injection-15)
nsubj(potentiate-18, Clonidine-16)
aux(potentiate-18, may-17)
dep(enhances-6, potentiate-18)
det(effect-21, the-19)
amod(effect-21, CNS-depressive-20)
dobj(potentiate-18, effect-21)
prep_of(effect-21, alcohol-23)
conj_or(alcohol-23, barbiturates-25)
amod(drugs-29, other-27)
amod(drugs-29, sedating-28)
conj_or(alcohol-23, drugs-29)

Narcotic/JJ analgesics/NNS may/MD potentiate/VB the/DT hypotensive/JJ effects/NNS of/IN clonidine/NN ./.

(ROOT (S1 (S (S (NP (JJ Narcotic) (NNS analgesics)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ hypotensive) (NNS effects)) (PP (IN of) (NP (NN clonidine))))))) (. .))))

amod(analgesics-2, Narcotic-1)
nsubj(potentiate-4, analgesics-2)
aux(potentiate-4, may-3)
root(ROOT-0, potentiate-4)
det(effects-7, the-5)
amod(effects-7, hypotensive-6)
dobj(potentiate-4, effects-7)
prep_of(effects-7, clonidine-9)

Tricyclic/JJ antidepressants/NNS may/MD antagonize/VB the/DT hypotensive/JJ effects/NNS of/IN clonidine/NN ./.

(ROOT (S1 (S (S (NP (JJ Tricyclic) (NNS antidepressants)) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (JJ hypotensive) (NNS effects)) (PP (IN of) (NP (NN clonidine))))))) (. .))))

amod(antidepressants-2, Tricyclic-1)
nsubj(antagonize-4, antidepressants-2)
aux(antagonize-4, may-3)
root(ROOT-0, antagonize-4)
det(effects-7, the-5)
amod(effects-7, hypotensive-6)
dobj(antagonize-4, effects-7)
prep_of(effects-7, clonidine-9)

The/DT effects/NNS of/IN tricyclic/JJ antidepressants/NNS on/IN clonidine/NN s/NN analgesic/JJ actions/NNS are/VBP not/RB known/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants))) (PP (IN on) (NP (NN clonidine) (NN s) (JJ analgesic) (NNS actions)))) (VP (VBP are) (RB not) (VP (VBN known)))) (. .))))

det(effects-2, The-1)
nsubjpass(known-13, effects-2)
amod(antidepressants-5, tricyclic-4)
prep_of(effects-2, antidepressants-5)
nn(actions-10, clonidine-7)
nn(actions-10, s-8)
amod(actions-10, analgesic-9)
prep_on(effects-2, actions-10)
auxpass(known-13, are-11)
neg(known-13, not-12)
root(ROOT-0, known-13)

Beta/NN blockers/NNS may/MD exacerbate/VB the/DT hypertensive/JJ response/NN seen/VBN with/IN clonidine/NN withdrawl/NN ./.

(ROOT (S1 (S (S (NP (NN Beta) (NNS blockers)) (VP (MD may) (VP (VB exacerbate) (NP (NP (DT the) (JJ hypertensive) (NN response)) (VP (VBN seen) (PP (IN with) (NP (NN clonidine) (NN withdrawl)))))))) (. .))))

nn(blockers-2, Beta-1)
nsubj(exacerbate-4, blockers-2)
aux(exacerbate-4, may-3)
root(ROOT-0, exacerbate-4)
det(response-7, the-5)
amod(response-7, hypertensive-6)
dobj(exacerbate-4, response-7)
partmod(response-7, seen-8)
nn(withdrawl-11, clonidine-10)
prep_with(seen-8, withdrawl-11)

Also/RB ,/, due/JJ to/TO the/DT potential/NN for/IN additive/JJ effects/NNS such/JJ as/IN bradycardia/NN and/CC AV/NN block/NN ,/, caution/NN is/VBZ warranted/VBN in/IN patients/NNS receiving/VBG clonidine/NN with/IN agents/NNS known/VBN to/TO affect/VB sinus/NN node/NN function/NN or/CC AV/NN nodal/JJ conduction/NN (/-LRB- e.g./FW ,/, digitalis/NN ,/, calcium/NN channel/NN blockers/NNS ,/, and/CC beta-blockers/NNS ./. )/-RRB- ./.

(ROOT (S1 (S (ADVP (RB Also)) (, ,) (PP (JJ due) (TO to) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (JJ additive) (NNS effects)) (PP (JJ such) (IN as) (NP (NP (NN bradycardia)) (CC and) (NP (NN AV) (NN block)))))))) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN warranted) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN clonidine)) (PP (IN with) (NP (NP (NNS agents)) (VP (VBN known) (S (VP (TO to) (VP (VB affect) (NP (NP (NP (NN sinus) (NN node)) (NN function)) (CC or) (NP (NP (NN AV) (JJ nodal) (NN conduction)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN digitalis)) (, ,) (NP (NN calcium) (NN channel) (NNS blockers)) (, ,) (CC and) (NP (NNS beta-blockers)) (. .))) (-RRB- -RRB-)))))))))))))))) (. .))))

advmod(warranted-19, Also-1)
det(potential-6, the-5)
prep_due_to(warranted-19, potential-6)
amod(effects-9, additive-8)
prep_for(potential-6, effects-9)
prep_such_as(effects-9, bradycardia-12)
nn(block-15, AV-14)
conj_and(bradycardia-12, block-15)
nsubjpass(warranted-19, caution-17)
auxpass(warranted-19, is-18)
root(ROOT-0, warranted-19)
prep_in(warranted-19, patients-21)
partmod(patients-21, receiving-22)
dobj(receiving-22, clonidine-23)
prep_with(clonidine-23, agents-25)
xsubj(affect-28, agents-25)
partmod(agents-25, known-26)
aux(affect-28, to-27)
xcomp(known-26, affect-28)
nn(node-30, sinus-29)
nn(function-31, node-30)
dobj(affect-28, function-31)
nn(conduction-35, AV-33)
amod(conduction-35, nodal-34)
conj_or(function-31, conduction-35)
dep(conduction-35, e.g.-37)
pobj(e.g.-37, digitalis-39)
nn(blockers-43, calcium-41)
nn(blockers-43, channel-42)
conj_and(digitalis-39, blockers-43)
conj_and(digitalis-39, beta-blockers-46)

There/EX is/VBZ one/CD reported/VBN case/NN of/IN a/DT patient/NN with/IN acute/JJ delirium/NN associated/VBN with/IN the/DT simultaneous/JJ use/NN of/IN fluphenazine/NN and/CC oral/JJ clonidine/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (CD one) (VBN reported) (NN case)) (PP (IN of) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (JJ acute) (NN delirium)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJ simultaneous) (NN use)) (PP (IN of) (NP (NP (NN fluphenazine)) (CC and) (NP (JJ oral) (NN clonidine)))))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
num(case-5, one-3)
amod(case-5, reported-4)
nsubj(is-2, case-5)
det(patient-8, a-7)
prep_of(case-5, patient-8)
amod(delirium-11, acute-10)
prep_with(patient-8, delirium-11)
partmod(delirium-11, associated-12)
det(use-16, the-14)
amod(use-16, simultaneous-15)
prep_with(associated-12, use-16)
prep_of(use-16, fluphenazine-18)
amod(clonidine-21, oral-20)
conj_and(fluphenazine-18, clonidine-21)

Symptoms/NNS resolved/VBN when/WRB clonidine/NN was/VBD withdrawn/VBN and/CC recurred/VBN when/WRB the/DT patient/NN was/VBD rechallenged/VBN with/IN clonidine/NN ./.

(ROOT (S1 (S (S (NP (NNS Symptoms)) (VP (VP (VBN resolved) (SBAR (WHADVP (WRB when)) (S (NP (NN clonidine)) (VP (VBD was) (VP (VBN withdrawn)))))) (CC and) (VP (VBN recurred) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN rechallenged) (PP (IN with) (NP (NN clonidine)))))))))) (. .))))

nsubj(resolved-2, Symptoms-1)
root(ROOT-0, resolved-2)
advmod(withdrawn-6, when-3)
nsubjpass(withdrawn-6, clonidine-4)
auxpass(withdrawn-6, was-5)
advcl(resolved-2, withdrawn-6)
conj_and(resolved-2, recurred-8)
advmod(rechallenged-13, when-9)
det(patient-11, the-10)
nsubjpass(rechallenged-13, patient-11)
auxpass(rechallenged-13, was-12)
advcl(recurred-8, rechallenged-13)
prep_with(rechallenged-13, clonidine-15)

Epidural/JJ clonidine/NN may/MD prolong/VB the/DT duration/NN of/IN pharmacologic/JJ effects/NNS of/IN epidural/JJ local/JJ anesthetics/NN ,/, including/VBG both/CC sensory/NN and/CC motor/NN blockade/NN ./.

(ROOT (S1 (S (S (NP (JJ Epidural) (NN clonidine)) (VP (MD may) (VP (VB prolong) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (JJ pharmacologic) (NNS effects)) (PP (IN of) (NP (JJ epidural) (JJ local) (NN anesthetics))) (, ,) (PP (VBG including) (NP (CC both) (NP (NN sensory)) (CC and) (NP (NN motor)) (NP (NN blockade)))))))))) (. .))))

amod(clonidine-2, Epidural-1)
nsubj(prolong-4, clonidine-2)
aux(prolong-4, may-3)
root(ROOT-0, prolong-4)
det(duration-6, the-5)
dobj(prolong-4, duration-6)
amod(effects-9, pharmacologic-8)
prep_of(duration-6, effects-9)
amod(anesthetics-13, epidural-11)
amod(anesthetics-13, local-12)
prep_of(effects-9, anesthetics-13)
preconj(sensory-17, both-16)
prep_including(effects-9, sensory-17)
conj_and(sensory-17, motor-19)
dep(sensory-17, blockade-20)

Colchicine/NN is/VBZ inhibited/VBN by/IN acidifying/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Colchicine)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (JJ acidifying) (NNS agents)))))) (. .))))

nsubjpass(inhibited-3, Colchicine-1)
auxpass(inhibited-3, is-2)
root(ROOT-0, inhibited-3)
amod(agents-6, acidifying-5)
agent(inhibited-3, agents-6)

The/DT action/NN of/IN colchicine/NN is/VBZ potentiated/VBN by/IN alkalinizing/NN agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN action)) (PP (IN of) (NP (NN colchicine)))) (VP (VBZ is) (VP (VBN potentiated) (PP (IN by) (NP (NN alkalinizing) (NNS agents)))))) (. .))))

det(action-2, The-1)
nsubjpass(potentiated-6, action-2)
prep_of(action-2, colchicine-4)
auxpass(potentiated-6, is-5)
root(ROOT-0, potentiated-6)
nn(agents-9, alkalinizing-8)
agent(potentiated-6, agents-9)

Colchicine/NN may/MD increase/VB sensitivity/NN to/TO the/DT CNS/NN depressants/NNS ./.

(ROOT (S1 (S (S (NP (NN Colchicine)) (VP (MD may) (VP (VB increase) (NP (NP (NN sensitivity)) (PP (TO to) (NP (DT the) (NN CNS) (NNS depressants))))))) (. .))))

nsubj(increase-3, Colchicine-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
dobj(increase-3, sensitivity-4)
det(depressants-8, the-6)
nn(depressants-8, CNS-7)
prep_to(sensitivity-4, depressants-8)

Response/NN to/TO sympathomimetic/JJ agents/NNS may/MD be/VB enhanced/VBN by/IN colchicine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Response)) (PP (TO to) (NP (JJ sympathomimetic) (NNS agents)))) (VP (MD may) (VP (VB be) (VP (VBN enhanced) (PP (IN by) (NP (NN colchicine))))))) (. .))))

nsubjpass(enhanced-7, Response-1)
amod(agents-4, sympathomimetic-3)
prep_to(Response-1, agents-4)
aux(enhanced-7, may-5)
auxpass(enhanced-7, be-6)
root(ROOT-0, enhanced-7)
agent(enhanced-7, colchicine-9)

Corticotropin/NN may/MD accentuate/VB the/DT electrolyte/NN loss/NN associated/VBN with/IN diuretic/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NN Corticotropin)) (VP (MD may) (VP (VB accentuate) (NP (NP (DT the) (NN electrolyte) (NN loss)) (VP (VBN associated) (PP (IN with) (NP (JJ diuretic) (NN therapy)))))))) (. .))))

nsubj(accentuate-3, Corticotropin-1)
aux(accentuate-3, may-2)
root(ROOT-0, accentuate-3)
det(loss-6, the-4)
nn(loss-6, electrolyte-5)
dobj(accentuate-3, loss-6)
partmod(loss-6, associated-7)
amod(therapy-10, diuretic-9)
prep_with(associated-7, therapy-10)

Drugs/NNS that/WDT induce/VBP hepatic/JJ enzymes/NNS such/JJ as/IN phenobarbital/NN ,/, phenytoin/NN and/CC rifampin/NN may/MD increase/VB the/DT clearance/NN of/IN corticosteroids/NNS and/CC may/MD require/VB increases/NNS in/IN corticosteroid/NN dose/NN to/TO achieve/VB the/DT desired/JJ response/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (NP (JJ hepatic) (NNS enzymes)) (PP (JJ such) (IN as) (NP (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin)) (CC and) (NP (NN rifampin))))))))) (VP (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NNS corticosteroids)))))) (CC and) (VP (MD may) (VP (VB require) (NP (NP (NNS increases)) (PP (IN in) (NP (NN corticosteroid) (NN dose)))) (S (VP (TO to) (VP (VB achieve) (NP (DT the) (JJ desired) (NN response))))))))) (. .))))

nsubj(induce-3, Drugs-1)
nsubj(increase-14, Drugs-1)
rcmod(Drugs-1, induce-3)
amod(enzymes-5, hepatic-4)
dobj(induce-3, enzymes-5)
prep_such_as(enzymes-5, phenobarbital-8)
conj_and(phenobarbital-8, phenytoin-10)
conj_and(phenobarbital-8, rifampin-12)
aux(increase-14, may-13)
root(ROOT-0, increase-14)
det(clearance-16, the-15)
dobj(increase-14, clearance-16)
prep_of(clearance-16, corticosteroids-18)
aux(require-21, may-20)
conj_and(increase-14, require-21)
dobj(require-21, increases-22)
nn(dose-25, corticosteroid-24)
prep_in(increases-22, dose-25)
aux(achieve-27, to-26)
xcomp(require-21, achieve-27)
det(response-30, the-28)
amod(response-30, desired-29)
dobj(achieve-27, response-30)

Drugs/NNS such/JJ as/IN troleandomycin/NN and/CC ketoconazole/NN may/MD inhibit/VB the/DT metabolism/NN of/IN corticosteroids/NNS and/CC thus/RB decrease/VB their/PRP$ clearance/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (PP (JJ such) (IN as) (NP (NP (NN troleandomycin)) (CC and) (NP (NN ketoconazole))))) (VP (MD may) (VP (VP (VB inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NNS corticosteroids))))) (CC and) (ADVP (RB thus)) (VP (VB decrease) (NP (PRP$ their) (NN clearance)))))) (. .))))

nsubj(inhibit-8, Drugs-1)
prep_such_as(Drugs-1, troleandomycin-4)
conj_and(troleandomycin-4, ketoconazole-6)
aux(inhibit-8, may-7)
root(ROOT-0, inhibit-8)
det(metabolism-10, the-9)
dobj(inhibit-8, metabolism-10)
prep_of(metabolism-10, corticosteroids-12)
advmod(inhibit-8, thus-14)
conj_and(inhibit-8, thus-14)
conj_and(inhibit-8, decrease-15)
poss(clearance-17, their-16)
dobj(decrease-15, clearance-17)

Therefore/RB ,/, the/DT dose/NN of/IN corticosteroid/NN should/MD be/VB titrated/VBN to/TO avoid/VB steroid/NN toxicity/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN corticosteroid)))) (VP (MD should) (VP (VB be) (VP (VBN titrated) (S (VP (TO to) (VP (VB avoid) (NP (NN steroid) (NN toxicity))))))))) (. .))))

advmod(titrated-9, Therefore-1)
det(dose-4, the-3)
nsubjpass(titrated-9, dose-4)
prep_of(dose-4, corticosteroid-6)
aux(titrated-9, should-7)
auxpass(titrated-9, be-8)
root(ROOT-0, titrated-9)
aux(avoid-11, to-10)
xcomp(titrated-9, avoid-11)
nn(toxicity-13, steroid-12)
dobj(avoid-11, toxicity-13)

Corticosteroids/NNS may/MD increase/VB the/DT clearance/NN of/IN chronic/JJ high/JJ dose/NN aspirin/NN ./.

(ROOT (S1 (S (S (NP (NNS Corticosteroids)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (JJ chronic) (JJ high) (NN dose) (NN aspirin))))))) (. .))))

nsubj(increase-3, Corticosteroids-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
det(clearance-5, the-4)
dobj(increase-3, clearance-5)
amod(aspirin-10, chronic-7)
amod(aspirin-10, high-8)
nn(aspirin-10, dose-9)
prep_of(clearance-5, aspirin-10)

This/DT could/MD lead/VB to/TO decreased/VBN salicylate/NN serum/NN levels/NNS or/CC increase/VBP the/DT risk/NN of/IN salicylate/NN toxicity/NN when/WRB corticosteroid/NN is/VBZ withdrawn/VBN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VP (MD could) (VP (VB lead) (PP (TO to) (NP (VBN decreased) (NN salicylate) (NN serum) (NNS levels))))) (CC or) (VP (VBP increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN salicylate) (NN toxicity)))) (SBAR (WHADVP (WRB when)) (S (NP (NN corticosteroid)) (VP (VBZ is) (VP (VBN withdrawn)))))))) (. .))))

nsubj(lead-3, This-1)
aux(lead-3, could-2)
root(ROOT-0, lead-3)
amod(levels-8, decreased-5)
nn(levels-8, salicylate-6)
nn(levels-8, serum-7)
prep_to(lead-3, levels-8)
conj_or(lead-3, increase-10)
det(risk-12, the-11)
dobj(increase-10, risk-12)
nn(toxicity-15, salicylate-14)
prep_of(risk-12, toxicity-15)
advmod(withdrawn-19, when-16)
nsubjpass(withdrawn-19, corticosteroid-17)
auxpass(withdrawn-19, is-18)
advcl(increase-10, withdrawn-19)

Aspirin/NN should/MD be/VB used/VBN cautiously/RB in/IN conjunction/NN with/IN cortico-steroids/NNS in/IN patients/NNS suffering/VBG from/IN hypopro-thrombinemia/NN ./.

(ROOT (S1 (S (S (NP (NN Aspirin)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (NNS cortico-steroids)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG suffering) (PP (IN from) (NP (NN hypopro-thrombinemia)))))))))))))) (. .))))

nsubjpass(used-4, Aspirin-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
advmod(used-4, cautiously-5)
prep_in(used-4, conjunction-7)
prep_with(conjunction-7, cortico-steroids-9)
prep_in(cortico-steroids-9, patients-11)
partmod(patients-11, suffering-12)
prep_from(suffering-12, hypopro-thrombinemia-14)

The/DT effect/NN of/IN corticosteroids/NNS on/IN oral/JJ anticoagulants/NNS is/VBZ variable/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NNS corticosteroids))) (PP (IN on) (NP (JJ oral) (NNS anticoagulants)))) (VP (VBZ is) (NP (NN variable)))) (. .))))

det(effect-2, The-1)
nsubj(variable-9, effect-2)
prep_of(effect-2, corticosteroids-4)
amod(anticoagulants-7, oral-6)
prep_on(effect-2, anticoagulants-7)
cop(variable-9, is-8)
root(ROOT-0, variable-9)

There/EX are/VBP reports/NNS of/IN enhanced/VBN as/RB well/RB as/IN diminished/VBN effects/NNS of/IN anticoagulants/NNS when/WRB given/VBN concurrently/RB with/IN corticosteroids/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (VBN enhanced)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (VBN diminished) (NNS effects)) (PP (IN of) (NP (NNS anticoagulants))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB concurrently)) (PP (IN with) (NP (NNS corticosteroids)))))))) (. .))))

expl(are-2, There-1)
root(ROOT-0, are-2)
nsubj(are-2, reports-3)
prep_of(reports-3, enhanced-5)
amod(effects-10, diminished-9)
conj_and(enhanced-5, effects-10)
prep_of(effects-10, anticoagulants-12)
advmod(given-14, when-13)
advcl(are-2, given-14)
advmod(given-14, concurrently-15)
prep_with(given-14, corticosteroids-17)

Drug/NN Interaction/NN During/IN Pregnancy/NN :/: Cromolyn/NN sodium/NN and/CC isoproterenol/NN were/VBD studied/VBN following/VBG subcutaneous/JJ injections/NNS in/IN pregnant/JJ mice/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN Interaction)) (PP (IN During) (NP (NN Pregnancy)))) (: :) (NP (NN Cromolyn) (NP (NP (NN sodium)) (CC and) (NP (NN isoproterenol)))) (VP (VBD were) (VP (VBN studied) (PP (VBG following) (NP (NP (JJ subcutaneous) (NNS injections)) (PP (IN in) (NP (JJ pregnant) (NNS mice)))))))) (. .))))

nn(Interaction-2, Drug-1)
nsubjpass(studied-11, Interaction-2)
prep_during(Interaction-2, Pregnancy-4)
nsubjpass(studied-11, Cromolyn-6)
dep(Cromolyn-6, sodium-7)
conj_and(sodium-7, isoproterenol-9)
auxpass(studied-11, were-10)
root(ROOT-0, studied-11)
amod(injections-14, subcutaneous-13)
prep_following(studied-11, injections-14)
amod(mice-17, pregnant-16)
prep_in(injections-14, mice-17)

Cromolyn/NN sodium/NN alone/RB in/IN doses/NNS up/RB to/TO 540/CD mg/kg/day/NN (/-LRB- approximately/RB 340/CD times/NNS the/DT maximum/JJ recommended/VBN daily/JJ inhalation/NN dose/NN in/IN adults/NNS on/IN a/DT mg/m2/JJ basis/NN )/-RRB- did/VBD not/RB cause/VB significant/JJ increases/NNS in/IN resorptions/NNS or/CC major/JJ malformations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Cromolyn) (NN sodium)) (ADVP (RB alone))) (PP (IN in) (NP (NP (NNS doses)) (NP (NP (QP (RB up) (TO to) (CD 540)) (NN mg/kg/day)) (-LRB- -LRB-) (NP (QP (RB approximately) (CD 340) (NNS times)) (NP (NP (DT the) (JJ maximum) (VBN recommended) (JJ daily) (NN inhalation) (NN dose)) (PP (IN in) (NP (NP (NNS adults)) (PP (IN on) (NP (DT a) (JJ mg/m2) (NN basis))))))) (-RRB- -RRB-))))) (VP (VBD did) (RB not) (VP (VB cause) (NP (NP (JJ significant) (NNS increases)) (PP (IN in) (NP (NP (NNS resorptions)) (CC or) (NP (JJ major) (NNS malformations)))))))) (. .))))

nn(sodium-2, Cromolyn-1)
nsubj(cause-29, sodium-2)
advmod(sodium-2, alone-3)
prep_in(sodium-2, doses-5)
quantmod(540-8, up-6)
dep(540-8, to-7)
num(mg/kg/day-9, 540-8)
dep(doses-5, mg/kg/day-9)
quantmod(times-13, approximately-11)
number(times-13, 340-12)
num(dose-19, times-13)
det(dose-19, the-14)
amod(dose-19, maximum-15)
amod(dose-19, recommended-16)
amod(dose-19, daily-17)
nn(dose-19, inhalation-18)
dep(mg/kg/day-9, dose-19)
prep_in(dose-19, adults-21)
det(basis-25, a-23)
amod(basis-25, mg/m2-24)
prep_on(adults-21, basis-25)
aux(cause-29, did-27)
neg(cause-29, not-28)
root(ROOT-0, cause-29)
amod(increases-31, significant-30)
dobj(cause-29, increases-31)
prep_in(increases-31, resorptions-33)
amod(malformations-36, major-35)
conj_or(resorptions-33, malformations-36)

Isoproterenol/NN alone/RB at/IN a/DT dose/NN of/IN 2.7/CD mg/kg/day/NN (/-LRB- approximately/RB 7/CD times/NNS the/DT maximum/JJ recommended/VBN daily/JJ inhalation/NN dose/NN in/IN adults/NNS on/IN a/DT mg/m2/JJ basis/NN )/-RRB- increased/VBD both/CC resorptions/NNS and/CC malformations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Isoproterenol)) (ADVP (RB alone)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 2.7) (NN mg/kg/day)) (-LRB- -LRB-) (NP (QP (RB approximately) (CD 7) (NNS times)) (NP (NP (DT the) (JJ maximum) (VBN recommended) (JJ daily) (NN inhalation) (NN dose)) (PP (IN in) (NP (NNS adults))))) (PP (IN on) (NP (DT a) (JJ mg/m2) (NN basis))) (-RRB- -RRB-)))))) (VP (VBD increased) (NP (CC both) (NP (NNS resorptions)) (CC and) (NP (NNS malformations))))) (. .))))

nsubj(increased-26, Isoproterenol-1)
advmod(Isoproterenol-1, alone-2)
det(dose-5, a-4)
prep_at(Isoproterenol-1, dose-5)
num(mg/kg/day-8, 2.7-7)
prep_of(dose-5, mg/kg/day-8)
quantmod(times-12, approximately-10)
number(times-12, 7-11)
num(dose-18, times-12)
det(dose-18, the-13)
amod(dose-18, maximum-14)
amod(dose-18, recommended-15)
amod(dose-18, daily-16)
nn(dose-18, inhalation-17)
dep(mg/kg/day-8, dose-18)
prep_in(dose-18, adults-20)
det(basis-24, a-22)
amod(basis-24, mg/m2-23)
prep_on(mg/kg/day-8, basis-24)
root(ROOT-0, increased-26)
preconj(resorptions-28, both-27)
dobj(increased-26, resorptions-28)
conj_and(resorptions-28, malformations-30)

The/DT addition/NN of/IN 540/CD mg/kg/day/NN of/IN cromolyn/NN sodium/NN (/-LRB- approximately/RB 340/CD times/NNS the/DT maximum/JJ recommended/VBN daily/JJ inhalation/NN dose/NN in/IN adults/NNS on/IN a/DT mg/m2/NN basis/NN )/-RRB- to/TO 2.7/CD mg/kg/day/NN of/IN isoproterenol/NN (/-LRB- approximately/RB 7/CD times/NNS the/DT maximum/JJ recommended/VBN daily/JJ inhalation/NN dose/NN in/IN adults/NNS on/IN a/DT mg/m2/NN basis/NN )/-RRB- appears/VBZ to/TO have/VB increased/VBD the/DT incidence/NN of/IN both/CC resorptions/NNS and/CC malformations/NNS ./.

(ROOT (S1 (S (NP (NP (DT The) (NN addition)) (PP (IN of) (NP (NP (NP (CD 540) (NN mg/kg/day)) (PP (IN of) (NP (NN cromolyn) (NN sodium)))) (-LRB- -LRB-) (NP (QP (RB approximately) (CD 340) (NNS times)) (NP (NP (NP (DT the) (JJ maximum) (VBN recommended) (JJ daily) (NN inhalation) (NN dose)) (PP (IN in) (NP (NNS adults)))) (PP (IN on) (NP (DT a) (NN mg/m2) (NN basis))))) (-RRB- -RRB-))) (PP (TO to) (NP (NP (NP (CD 2.7) (NN mg/kg/day)) (PP (IN of) (NP (NN isoproterenol)))) (-LRB- -LRB-) (NP (QP (RB approximately) (CD 7) (NNS times)) (NP (NP (NP (DT the) (JJ maximum) (VBN recommended) (JJ daily) (NN inhalation) (NN dose)) (PP (IN in) (NP (NNS adults)))) (PP (IN on) (NP (DT a) (NN mg/m2) (NN basis))))) (-RRB- -RRB-)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB have) (VP (VBD increased) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (CC both) (NP (NNS resorptions)) (CC and) (NP (NNS malformations)))))))))) (. .))))

det(addition-2, The-1)
nsubj(appears-48, addition-2)
xsubj(increased-51, addition-2)
num(mg/kg/day-5, 540-4)
prep_of(addition-2, mg/kg/day-5)
nn(sodium-8, cromolyn-7)
prep_of(mg/kg/day-5, sodium-8)
quantmod(times-12, approximately-10)
number(times-12, 340-11)
num(dose-18, times-12)
det(dose-18, the-13)
amod(dose-18, maximum-14)
amod(dose-18, recommended-15)
amod(dose-18, daily-16)
nn(dose-18, inhalation-17)
dep(mg/kg/day-5, dose-18)
prep_in(dose-18, adults-20)
det(basis-24, a-22)
nn(basis-24, mg/m2-23)
prep_on(dose-18, basis-24)
num(mg/kg/day-28, 2.7-27)
prep_to(addition-2, mg/kg/day-28)
prep_of(mg/kg/day-28, isoproterenol-30)
quantmod(times-34, approximately-32)
number(times-34, 7-33)
num(dose-40, times-34)
det(dose-40, the-35)
amod(dose-40, maximum-36)
amod(dose-40, recommended-37)
amod(dose-40, daily-38)
nn(dose-40, inhalation-39)
dep(mg/kg/day-28, dose-40)
prep_in(dose-40, adults-42)
det(basis-46, a-44)
nn(basis-46, mg/m2-45)
prep_on(dose-40, basis-46)
root(ROOT-0, appears-48)
aux(increased-51, to-49)
aux(increased-51, have-50)
xcomp(appears-48, increased-51)
det(incidence-53, the-52)
dobj(increased-51, incidence-53)
preconj(resorptions-56, both-55)
prep_of(incidence-53, resorptions-56)
conj_and(resorptions-56, malformations-58)

May/MD interact/VB with/IN wthionamide/NN (/-LRB- Trecator-SC/NN )/-RRB- and/CC isoniazid/NN (/-LRB- Nydrazid/NN )/-RRB- ./.

(ROOT (S1 (S (S (VP (MD May) (VP (VB interact) (PP (IN with) (NP (NP (NP (NN wthionamide)) (PRN (-LRB- -LRB-) (NP (NN Trecator-SC)) (-RRB- -RRB-))) (CC and) (NP (NP (NN isoniazid)) (PRN (-LRB- -LRB-) (NP (NN Nydrazid)) (-RRB- -RRB-)))))))) (. .))))

aux(interact-2, May-1)
root(ROOT-0, interact-2)
prep_with(interact-2, wthionamide-4)
appos(wthionamide-4, Trecator-SC-6)
conj_and(wthionamide-4, isoniazid-9)
appos(isoniazid-9, Nydrazid-11)

Warfarin/JJ Concomitant/JJ administration/NN of/IN daptomycin/NN (/-LRB- 6/CD mg/kg/NN once/RB every/DT 24/CD hours/NNS for/IN 5/CD days/NNS )/-RRB- and/CC warfarin/NN (/-LRB- 25/CD mg/NN single/JJ oral/JJ dose/NN )/-RRB- had/VBD no/DT significant/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN either/DT drug/NN ,/, and/CC the/DT INR/NN was/VBD not/RB significantly/RB altered/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (JJ Warfarin) (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NP (NN daptomycin)) (PRN (-LRB- -LRB-) (NP (CD 6) (NN mg/kg) (RB once) (NP (DT every) (CD 24) (NNS hours)) (PP (IN for) (NP (CD 5) (NNS days)))) (-RRB- -RRB-))) (CC and) (NP (NP (NN warfarin)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN mg) (JJ single) (JJ oral) (NN dose)) (-RRB- -RRB-)))))) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN drug))))))) (, ,) (CC and) (S (NP (DT the) (NN INR)) (VP (VBD was) (RB not) (ADVP (RB significantly)) (VP (VBN altered))))) (. .))))

amod(administration-3, Warfarin-1)
amod(administration-3, Concomitant-2)
nsubj(had-26, administration-3)
prep_of(administration-3, daptomycin-5)
num(mg/kg-8, 6-7)
appos(daptomycin-5, mg/kg-8)
advmod(mg/kg-8, once-9)
det(hours-12, every-10)
num(hours-12, 24-11)
dep(mg/kg-8, hours-12)
num(days-15, 5-14)
prep_for(mg/kg-8, days-15)
conj_and(daptomycin-5, warfarin-18)
num(dose-24, 25-20)
nn(dose-24, mg-21)
amod(dose-24, single-22)
amod(dose-24, oral-23)
appos(warfarin-18, dose-24)
root(ROOT-0, had-26)
det(effect-29, no-27)
amod(effect-29, significant-28)
dobj(had-26, effect-29)
det(pharmacokinetics-32, the-31)
prep_on(had-26, pharmacokinetics-32)
det(drug-35, either-34)
prep_of(pharmacokinetics-32, drug-35)
det(INR-39, the-38)
nsubjpass(altered-43, INR-39)
auxpass(altered-43, was-40)
neg(altered-43, not-41)
advmod(altered-43, significantly-42)
conj_and(had-26, altered-43)

As/IN experience/VBP with/IN the/DT concomitant/JJ administration/NN of/IN daptomycin/NN and/CC warfarin/NN is/VBZ limited/JJ to/TO volunteer/NN studies/NNS ,/, anticoagulant/JJ activity/NN in/IN patients/NNS receiving/VBG daptomycin/NN and/CC warfarin/NN should/MD be/VB monitored/VBN for/IN the/DT first/JJ several/JJ days/NNS after/IN initiating/VBG therapy/NN with/IN Fentanyl/NN ./.

(ROOT (S1 (S (SBAR (IN As) (S (NP (NP (VBP experience)) (PP (IN with) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN daptomycin)) (CC and) (NP (NN warfarin))))))) (VP (VBZ is) (ADJP (JJ limited) (PP (TO to) (NP (NN volunteer) (NNS studies))))))) (, ,) (NP (NP (JJ anticoagulant) (NN activity)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN daptomycin)) (CC and) (NP (NN warfarin))))))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN for) (NP (NP (DT the) (JJ first) (JJ several) (NNS days)) (PP (IN after) (S (VP (VBG initiating) (NP (NP (NN therapy)) (PP (IN with) (NP (NN Fentanyl)))))))))))) (. .))))

mark(limited-12, As-1)
nsubj(limited-12, experience-2)
det(administration-6, the-4)
amod(administration-6, concomitant-5)
prep_with(experience-2, administration-6)
prep_of(administration-6, daptomycin-8)
conj_and(daptomycin-8, warfarin-10)
cop(limited-12, is-11)
advcl(monitored-27, limited-12)
nn(studies-15, volunteer-14)
prep_to(limited-12, studies-15)
amod(activity-18, anticoagulant-17)
nsubjpass(monitored-27, activity-18)
prep_in(activity-18, patients-20)
partmod(patients-20, receiving-21)
dobj(receiving-21, daptomycin-22)
conj_and(daptomycin-22, warfarin-24)
aux(monitored-27, should-25)
auxpass(monitored-27, be-26)
root(ROOT-0, monitored-27)
det(days-32, the-29)
amod(days-32, first-30)
amod(days-32, several-31)
prep_for(monitored-27, days-32)
prepc_after(days-32, initiating-34)
dobj(initiating-34, therapy-35)
prep_with(therapy-35, Fentanyl-37)

HMG-CoA/NN Reductase/NN Inhibitors/NNS Inhibitors/NNS of/IN HMG-CoA/NN reductase/NN may/MD cause/VB myopathy/NN ,/, which/WDT is/VBZ manifested/VBN as/IN muscle/NN pain/NN or/CC weakness/NN associated/VBN with/IN elevated/JJ levels/NNS of/IN CPK/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN HMG-CoA) (NN Reductase) (NNS Inhibitors)) (NNS Inhibitors)) (PP (IN of) (NP (NN HMG-CoA) (NN reductase)))) (VP (MD may) (VP (VB cause) (NP (NP (NN myopathy)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN manifested) (PP (IN as) (NP (NP (NP (NN muscle) (NN pain)) (CC or) (NP (NN weakness))) (VP (VBN associated) (PP (IN with) (NP (NP (JJ elevated) (NNS levels)) (PP (IN of) (NP (NN CPK)))))))))))))))) (. .))))

nn(Inhibitors-3, HMG-CoA-1)
nn(Inhibitors-3, Reductase-2)
nn(Inhibitors-4, Inhibitors-3)
nsubj(cause-9, Inhibitors-4)
nn(reductase-7, HMG-CoA-6)
prep_of(Inhibitors-4, reductase-7)
aux(cause-9, may-8)
root(ROOT-0, cause-9)
dobj(cause-9, myopathy-10)
nsubjpass(manifested-14, myopathy-10)
auxpass(manifested-14, is-13)
rcmod(myopathy-10, manifested-14)
nn(pain-17, muscle-16)
prep_as(manifested-14, pain-17)
conj_or(pain-17, weakness-19)
partmod(pain-17, associated-20)
amod(levels-23, elevated-22)
prep_with(associated-20, levels-23)
prep_of(levels-23, CPK-25)

There/EX were/VBD no/DT reports/NNS of/IN skeletal/JJ myopathy/NN in/IN a/DT placebo-controlled/JJ Phase/NN :/: I/NN trial/NN in/IN which/WDT 10/CD healthy/JJ subjects/NNS on/IN stable/JJ simvastatin/NN therapy/NN were/VBD treated/VBN concurrently/RB with/IN daptomycin/NN (/-LRB- 4/CD mg/kg/NN once/RB every/DT 24/CD hours/NNS )/-RRB- for/IN 14/CD days/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS reports)) (PP (IN of) (NP (JJ skeletal) (NN myopathy)))) (PP (IN in) (NP (NP (DT a) (JJ placebo-controlled) (NN Phase) (: :) (NN I) (NN trial)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (CD 10) (JJ healthy) (NNS subjects)) (PP (IN on) (NP (JJ stable) (NN simvastatin) (NN therapy)))) (VP (VBD were) (VP (VBN treated) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NN daptomycin)) (PRN (-LRB- -LRB-) (NP (CD 4) (NN mg/kg) (RB once) (NP (DT every) (CD 24) (NNS hours))) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 14) (NNS days))))))))))) (. .))))

expl(were-2, There-1)
root(ROOT-0, were-2)
det(reports-4, no-3)
nsubj(were-2, reports-4)
amod(myopathy-7, skeletal-6)
prep_of(reports-4, myopathy-7)
det(trial-14, a-9)
amod(trial-14, placebo-controlled-10)
nn(trial-14, Phase-11)
nn(trial-14, I-13)
prep_in(were-2, trial-14)
rel(treated-25, which-16)
num(subjects-19, 10-17)
amod(subjects-19, healthy-18)
nsubjpass(treated-25, subjects-19)
amod(therapy-23, stable-21)
nn(therapy-23, simvastatin-22)
prep_on(subjects-19, therapy-23)
auxpass(treated-25, were-24)
rcmod(trial-14, treated-25)
advmod(treated-25, concurrently-26)
prep_with(treated-25, daptomycin-28)
num(mg/kg-31, 4-30)
appos(daptomycin-28, mg/kg-31)
advmod(mg/kg-31, once-32)
det(hours-35, every-33)
num(hours-35, 24-34)
dep(mg/kg-31, hours-35)
num(days-39, 14-38)
prep_for(treated-25, days-39)

Experience/VBP with/IN co-administration/NN of/IN HMG-CoA/NN reduc-tase/NN inhibitors/NNS and/CC Fentanyl/NN in/IN patients/NNS is/VBZ limited/VBN ,/, therefore/RB ,/, consideration/NN should/MD be/VB given/VBN to/TO temporarily/RB suspending/JJ use/NN of/IN HMG-CoA/NN reductase/NN inhibitors/NNS in/IN patients/NNS receiving/VBG Fentanyl/NN ./.

(ROOT (S1 (S (S (VP (VBP Experience) (SBAR (IN with) (S (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (NN HMG-CoA) (NN reduc-tase) (NNS inhibitors)) (CC and) (NP (NN Fentanyl)))) (PP (IN in) (NP (NNS patients)))) (VP (VBZ is) (VP (VBN limited))))) (, ,) (S (ADVP (RB therefore)) (, ,) (NP (NN consideration)) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (ADJP (RB temporarily) (JJ suspending)) (NN use)) (PP (IN of) (NP (NN HMG-CoA) (NN reductase) (NNS inhibitors))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN Fentanyl))))))))))))) (. .))))

root(ROOT-0, Experience-1)
mark(limited-13, with-2)
nsubjpass(limited-13, co-administration-3)
nn(inhibitors-7, HMG-CoA-5)
nn(inhibitors-7, reduc-tase-6)
prep_of(co-administration-3, inhibitors-7)
conj_and(inhibitors-7, Fentanyl-9)
prep_in(co-administration-3, patients-11)
auxpass(limited-13, is-12)
advcl(Experience-1, limited-13)
advmod(given-20, therefore-15)
nsubjpass(given-20, consideration-17)
aux(given-20, should-18)
auxpass(given-20, be-19)
ccomp(Experience-1, given-20)
advmod(suspending-23, temporarily-22)
amod(use-24, suspending-23)
prep_to(given-20, use-24)
nn(inhibitors-28, HMG-CoA-26)
nn(inhibitors-28, reductase-27)
prep_of(use-24, inhibitors-28)
prep_in(use-24, patients-30)
partmod(patients-30, receiving-31)
dobj(receiving-31, Fentanyl-32)

Use/NN of/IN Cerubidine/NN in/IN a/DT patient/NN who/WP has/VBZ previously/RB received/VBN doxorubicin/NN increases/VBZ the/DT risk/NN of/IN cardiotoxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN of) (NP (NN Cerubidine))) (PP (IN in) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBZ has) (ADVP (RB previously)) (VP (VBN received) (NP (NN doxorubicin))))))))) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN cardiotoxicity)))))) (. .))))

nsubj(increases-12, Use-1)
prep_of(Use-1, Cerubidine-3)
det(patient-6, a-5)
prep_in(Use-1, patient-6)
nsubj(received-10, patient-6)
aux(received-10, has-8)
advmod(received-10, previously-9)
rcmod(patient-6, received-10)
dobj(received-10, doxorubicin-11)
root(ROOT-0, increases-12)
det(risk-14, the-13)
dobj(increases-12, risk-14)
prep_of(risk-14, cardiotoxicity-16)

Cerubidine/NN should/MD not/RB be/VB used/VBN in/IN patients/NNS who/WP have/VBP previously/RB received/VBN the/DT recommended/VBN maximum/JJ cumulative/JJ doses/NNS of/IN doxorubicin/NN or/CC Cerubidine/NN ./.

(ROOT (S1 (S (S (NP (NN Cerubidine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (ADVP (RB previously)) (VP (VBN received) (NP (NP (DT the) (VBN recommended) (JJ maximum) (JJ cumulative) (NNS doses)) (PP (IN of) (NP (NP (NN doxorubicin)) (CC or) (NP (NN Cerubidine))))))))))))))) (. .))))

nsubjpass(used-5, Cerubidine-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
prep_in(used-5, patients-7)
nsubj(received-11, patients-7)
aux(received-11, have-9)
advmod(received-11, previously-10)
rcmod(patients-7, received-11)
det(doses-16, the-12)
amod(doses-16, recommended-13)
amod(doses-16, maximum-14)
amod(doses-16, cumulative-15)
dobj(received-11, doses-16)
prep_of(doses-16, doxorubicin-18)
conj_or(doxorubicin-18, Cerubidine-20)

Cyclophosphamide/NN used/VBN concurrently/RB with/IN Cerubidine/NN may/MD also/RB result/VB in/IN increased/VBN cardiotoxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cyclophosphamide)) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NN Cerubidine))))) (VP (MD may) (ADVP (RB also)) (VP (VB result) (PP (IN in) (NP (VBN increased) (NN cardiotoxicity)))))) (. .))))

nsubj(result-8, Cyclophosphamide-1)
partmod(Cyclophosphamide-1, used-2)
advmod(used-2, concurrently-3)
prep_with(used-2, Cerubidine-5)
aux(result-8, may-6)
advmod(result-8, also-7)
root(ROOT-0, result-8)
amod(cardiotoxicity-11, increased-10)
prep_in(result-8, cardiotoxicity-11)

Dosage/JJ reduction/NN of/IN Cerubidine/NN may/MD be/VB required/VBN when/WRB used/VBN concurrently/RB with/IN other/JJ myelosuppressive/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Dosage) (NN reduction)) (PP (IN of) (NP (NN Cerubidine)))) (VP (MD may) (VP (VB be) (VP (VBN required) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (JJ other) (JJ myelosuppressive) (NNS agents)))))))))) (. .))))

amod(reduction-2, Dosage-1)
nsubjpass(required-7, reduction-2)
prep_of(reduction-2, Cerubidine-4)
aux(required-7, may-5)
auxpass(required-7, be-6)
root(ROOT-0, required-7)
advmod(used-9, when-8)
advcl(required-7, used-9)
advmod(used-9, concurrently-10)
amod(agents-14, other-12)
amod(agents-14, myelosuppressive-13)
prep_with(used-9, agents-14)

Hepatotoxic/JJ medications/NNS ,/, such/JJ as/IN high-dose/JJ methotrexate/NN ,/, may/MD impair/VB liver/NN function/NN and/CC increase/VB the/DT risk/NN of/IN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Hepatotoxic) (NNS medications)) (, ,) (PP (JJ such) (IN as) (NP (JJ high-dose) (NN methotrexate))) (, ,)) (VP (MD may) (VP (VP (VB impair) (NP (NN liver) (NN function))) (CC and) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN toxicity)))))))) (. .))))

amod(medications-2, Hepatotoxic-1)
nsubj(impair-10, medications-2)
amod(methotrexate-7, high-dose-6)
prep_such_as(medications-2, methotrexate-7)
aux(impair-10, may-9)
root(ROOT-0, impair-10)
nn(function-12, liver-11)
dobj(impair-10, function-12)
conj_and(impair-10, increase-14)
det(risk-16, the-15)
dobj(increase-14, risk-16)
prep_of(risk-16, toxicity-18)

Drug/NN interaction/NN studies/NNS with/IN decitabine/NN have/VBP not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (NN decitabine)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

nn(studies-3, Drug-1)
nn(studies-3, interaction-2)
nsubjpass(conducted-9, studies-3)
prep_with(studies-3, decitabine-5)
aux(conducted-9, have-6)
neg(conducted-9, not-7)
auxpass(conducted-9, been-8)
root(ROOT-0, conducted-9)

In/FW vitro/FW studies/NNS in/IN human/JJ liver/NN microsomes/NNS suggest/VBP that/IN decitabine/NN is/VBZ unlikely/JJ to/TO inhibit/VB or/CC induce/VB cytochrome/NN P450/NN enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (PP (IN in) (NP (JJ human) (NN liver) (NNS microsomes)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN decitabine)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VP (VB inhibit)) (CC or) (VP (VB induce) (NP (NN cytochrome) (NN P450) (NNS enzymes)))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(suggest-8, studies-3)
amod(microsomes-7, human-5)
nn(microsomes-7, liver-6)
prep_in(studies-3, microsomes-7)
root(ROOT-0, suggest-8)
complm(unlikely-12, that-9)
nsubj(unlikely-12, decitabine-10)
cop(unlikely-12, is-11)
ccomp(suggest-8, unlikely-12)
aux(inhibit-14, to-13)
xcomp(unlikely-12, inhibit-14)
conj_or(inhibit-14, induce-16)
nn(enzymes-19, cytochrome-17)
nn(enzymes-19, P450-18)
dobj(induce-16, enzymes-19)

In/FW vitro/FW metabolism/NN studies/NNS have/VBP suggested/VBN that/IN decitabine/NN is/VBZ not/RB a/DT substrate/NN for/IN the/DT human/JJ liver/NN cytochrome/NN P450/NN enzyme/NN s/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NN metabolism) (NNS studies)) (VP (VBP have) (VP (VBN suggested) (SBAR (IN that) (S (NP (NN decitabine)) (VP (VBZ is) (RB not) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (DT the) (NP (JJ human) (NN liver) (NN cytochrome) (NN P450)) (NN enzyme) (NN s)))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-4, vitro-2)
nn(studies-4, metabolism-3)
nsubj(suggested-6, studies-4)
aux(suggested-6, have-5)
root(ROOT-0, suggested-6)
complm(substrate-12, that-7)
nsubj(substrate-12, decitabine-8)
cop(substrate-12, is-9)
neg(substrate-12, not-10)
det(substrate-12, a-11)
ccomp(suggested-6, substrate-12)
det(s-20, the-14)
amod(P450-18, human-15)
nn(P450-18, liver-16)
nn(P450-18, cytochrome-17)
nn(s-20, P450-18)
nn(s-20, enzyme-19)
prep_for(substrate-12, s-20)

As/IN plasma/NN protein/NN binding/NN of/IN decitabine/NN is/VBZ negligible/JJ (/-LRB- 1/CD %/NN )/-RRB- ,/, interactions/NNS due/JJ to/TO displacement/NN of/IN more/RBR highly/RB protein/NN bound/JJ drugs/NNS from/IN plasma/NN proteins/NNS are/VBP not/RB expected/VBN ./.

(ROOT (S1 (S (S (SBAR (IN As) (S (NP (NP (NN plasma) (NN protein) (NN binding)) (PP (IN of) (NP (NN decitabine)))) (VP (VBZ is) (ADJP (ADJP (JJ negligible)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN %)) (-RRB- -RRB-)))))) (, ,) (NP (NP (NNS interactions)) (ADJP (JJ due) (PP (TO to) (NP (NP (NN displacement)) (PP (IN of) (NP (ADJP (RBR more) (RB highly) (NN protein) (JJ bound)) (NNS drugs))) (PP (IN from) (NP (NN plasma) (NNS proteins))))))) (VP (VBP are) (RB not) (VP (VBN expected)))) (. .))))

mark(negligible-8, As-1)
nn(binding-4, plasma-2)
nn(binding-4, protein-3)
nsubj(negligible-8, binding-4)
prep_of(binding-4, decitabine-6)
cop(negligible-8, is-7)
advcl(expected-29, negligible-8)
num(%-11, 1-10)
dep(negligible-8, %-11)
nsubjpass(expected-29, interactions-14)
prep_due_to(interactions-14, displacement-17)
advmod(bound-22, more-19)
advmod(bound-22, highly-20)
dep(bound-22, protein-21)
amod(drugs-23, bound-22)
prep_of(displacement-17, drugs-23)
nn(proteins-26, plasma-25)
prep_from(displacement-17, proteins-26)
auxpass(expected-29, are-27)
neg(expected-29, not-28)
root(ROOT-0, expected-29)

Because/IN the/DT tetracyclines/NNS have/VBP been/VBN shown/VBN to/TO depress/VB plasma/NN prothrombin/NN activity/NN ,/, patients/NNS who/WP are/VBP on/IN anticoagulant/NN therapy/NN may/MD require/VB downward/JJ adjustment/NN of/IN their/PRP$ anticoagulant/JJ dosage/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (DT the) (NNS tetracyclines)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB depress) (NP (NN plasma) (NN prothrombin) (NN activity)))))))))) (, ,) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (PP (IN on) (NP (NN anticoagulant) (NN therapy))))))) (VP (MD may) (VP (VB require) (NP (NP (JJ downward) (NN adjustment)) (PP (IN of) (NP (PRP$ their) (JJ anticoagulant) (NN dosage))))))) (. .))))

mark(shown-6, Because-1)
det(tetracyclines-3, the-2)
nsubjpass(shown-6, tetracyclines-3)
xsubj(depress-8, tetracyclines-3)
aux(shown-6, have-4)
auxpass(shown-6, been-5)
advcl(require-20, shown-6)
aux(depress-8, to-7)
xcomp(shown-6, depress-8)
nn(activity-11, plasma-9)
nn(activity-11, prothrombin-10)
dobj(depress-8, activity-11)
nsubj(are-15, patients-13)
nsubj(require-20, patients-13)
rcmod(patients-13, are-15)
nn(therapy-18, anticoagulant-17)
prep_on(are-15, therapy-18)
aux(require-20, may-19)
root(ROOT-0, require-20)
amod(adjustment-22, downward-21)
dobj(require-20, adjustment-22)
poss(dosage-26, their-24)
amod(dosage-26, anticoagulant-25)
prep_of(adjustment-22, dosage-26)

Since/IN bacteriostat/NN ic/NN drugs/NNS ,/, such/JJ as/IN the/DT tetracycline/NN class/NN of/IN antibiotics/NNS ,/, may/MD interfere/VB with/IN the/DT bactericidal/JJ action/NN of/IN penicillins/NNS ,/, it/PRP is/VBZ not/RB advisable/JJ to/TO administer/VB these/DT drugs/NNS concomitantly/RB ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NP (NN bacteriostat) (NN ic) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN tetracycline) (NN class)) (PP (IN of) (NP (NNS antibiotics))))) (, ,)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (JJ bactericidal) (NN action)) (PP (IN of) (NP (NNS penicillins))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (ADJP (JJ advisable) (S (VP (TO to) (VP (VB administer) (NP (DT these) (NNS drugs)) (ADVP (RB concomitantly)))))))) (. .))))

mark(interfere-15, Since-1)
nn(drugs-4, bacteriostat-2)
nn(drugs-4, ic-3)
nsubj(interfere-15, drugs-4)
det(class-10, the-8)
nn(class-10, tetracycline-9)
prep_such_as(drugs-4, class-10)
prep_of(class-10, antibiotics-12)
aux(interfere-15, may-14)
advcl(advisable-26, interfere-15)
det(action-19, the-17)
amod(action-19, bactericidal-18)
prep_with(interfere-15, action-19)
prep_of(action-19, penicillins-21)
nsubj(advisable-26, it-23)
cop(advisable-26, is-24)
neg(advisable-26, not-25)
root(ROOT-0, advisable-26)
aux(administer-28, to-27)
xcomp(advisable-26, administer-28)
det(drugs-30, these-29)
dobj(administer-28, drugs-30)
advmod(administer-28, concomitantly-31)

Concurrent/JJ use/NN of/IN tetracyclines/NNS with/IN oral/JJ contraceptives/NNS may/MD render/VB oral/JJ contraceptives/NNS less/CC effect/VB ive/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NP (NNS tetracyclines)) (PP (IN with) (NP (JJ oral) (NNS contraceptives)))))) (VP (MD may) (VP (VP (VB render) (NP (JJ oral) (NNS contraceptives))) (CC less) (VP (VB effect) (NP (NN ive)))))) (. .))))

amod(use-2, Concurrent-1)
nsubj(render-9, use-2)
prep_of(use-2, tetracyclines-4)
amod(contraceptives-7, oral-6)
prep_with(tetracyclines-4, contraceptives-7)
aux(render-9, may-8)
root(ROOT-0, render-9)
amod(contraceptives-11, oral-10)
dobj(render-9, contraceptives-11)
conj_less(render-9, effect-13)
dobj(effect-13, ive-14)

Drugs/NNS Metabolized/VBN by/IN P450/NN 2D6/NN :/: The/DT biochemical/JJ activity/NN of/IN the/DT drug/NN metabolizing/NN isozyme/NN cytochrome/NN P450/NN 2D6/NN (/-LRB- debrisoquin/NN hydroxylase/NN )/-RRB- is/VBZ reduced/VBN in/IN a/DT subset/NN of/IN the/DT caucasian/NN population/NN (/-LRB- about/RB 7/CD to/TO 10/CD %/NN of/IN caucasians/NNS are/VBP so/RB called/VBN poor/JJ metabolizers/NNS )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))) (: :) (S (NP (NP (DT The) (JJ biochemical) (NN activity)) (PP (IN of) (NP (NP (DT the) (NN drug) (NN metabolizing) (NN isozyme) (NN cytochrome) (NN P450) (NN 2D6)) (PRN (-LRB- -LRB-) (NP (NN debrisoquin) (NN hydroxylase)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN reduced) (PP (IN in) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (DT the) (NN caucasian) (NN population))))) (PRN (-LRB- -LRB-) (S (NP (NP (QP (RB about) (CD 7) (TO to) (CD 10)) (NN %)) (PP (IN of) (NP (NNS caucasians)))) (VP (VBP are) (NP (ADJP (RB so) (VBN called)) (JJ poor) (NNS metabolizers)))) (-RRB- -RRB-)))) (: ;)) (. .)))))

root(ROOT-0, Drugs-1)
partmod(Drugs-1, Metabolized-2)
nn(2D6-5, P450-4)
agent(Metabolized-2, 2D6-5)
det(activity-9, The-7)
amod(activity-9, biochemical-8)
nsubjpass(reduced-23, activity-9)
det(2D6-17, the-11)
nn(2D6-17, drug-12)
nn(2D6-17, metabolizing-13)
nn(2D6-17, isozyme-14)
nn(2D6-17, cytochrome-15)
nn(2D6-17, P450-16)
prep_of(activity-9, 2D6-17)
nn(hydroxylase-20, debrisoquin-19)
appos(2D6-17, hydroxylase-20)
auxpass(reduced-23, is-22)
dep(Drugs-1, reduced-23)
det(subset-26, a-25)
prep_in(reduced-23, subset-26)
det(population-30, the-28)
nn(population-30, caucasian-29)
prep_of(subset-26, population-30)
quantmod(10-35, about-32)
number(10-35, 7-33)
dep(10-35, to-34)
num(%-36, 10-35)
nsubj(metabolizers-43, %-36)
prep_of(%-36, caucasians-38)
cop(metabolizers-43, are-39)
advmod(called-41, so-40)
amod(metabolizers-43, called-41)
amod(metabolizers-43, poor-42)
parataxis(reduced-23, metabolizers-43)

reliable/JJ estimates/NNS of/IN the/DT prevalence/NN of/IN reduced/VBN P450/NN 2D6/NN isozyme/NN activity/NN among/IN Asian/JJ ,/, African/JJ and/CC other/JJ populations/NNS are/VBP not/RB yet/RB available/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ reliable) (NNS estimates)) (PP (IN of) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (VBN reduced) (NN P450) (NN 2D6) (NN isozyme) (NN activity))) (PP (IN among) (NP (ADJP (ADJP (JJ Asian)) (, ,) (ADJP (JJ African)) (CC and) (ADJP (JJ other))) (NNS populations)))))) (VP (VBP are) (RB not) (ADVP (RB yet)) (ADJP (JJ available)))) (. .))))

amod(estimates-2, reliable-1)
nsubj(available-22, estimates-2)
det(prevalence-5, the-4)
prep_of(estimates-2, prevalence-5)
amod(activity-11, reduced-7)
nn(activity-11, P450-8)
nn(activity-11, 2D6-9)
nn(activity-11, isozyme-10)
prep_of(prevalence-5, activity-11)
amod(populations-18, Asian-13)
conj_and(Asian-13, African-15)
conj_and(Asian-13, other-17)
prep_among(prevalence-5, populations-18)
cop(available-22, are-19)
neg(available-22, not-20)
advmod(available-22, yet-21)
root(ROOT-0, available-22)

Poor/JJ metabolizers/NNS have/VBP higher/JJR than/IN expected/VBN plasma/NN concentrations/NNS of/IN tricyclic/JJ antidepressants/NNS (/-LRB- TCAs/NNS )/-RRB- when/WRB given/VBN usual/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (JJ Poor) (NNS metabolizers)) (VP (VBP have) (NP (NP (JJR higher) (IN than) (VBN expected) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NNS TCAs)) (-RRB- -RRB-))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (JJ usual) (NNS doses))))))) (. .))))

amod(metabolizers-2, Poor-1)
nsubj(have-3, metabolizers-2)
root(ROOT-0, have-3)
amod(concentrations-8, higher-4)
amod(concentrations-8, than-5)
amod(concentrations-8, expected-6)
nn(concentrations-8, plasma-7)
dobj(have-3, concentrations-8)
amod(antidepressants-11, tricyclic-10)
prep_of(concentrations-8, antidepressants-11)
appos(antidepressants-11, TCAs-13)
advmod(given-16, when-15)
advcl(have-3, given-16)
amod(doses-18, usual-17)
dobj(given-16, doses-18)

Depending/VBG on/IN the/DT traction/NN of/IN drug/NN metabolized/VBN by/IN P450/NN 2D6/NN ,/, the/DT increase/NN in/IN plasma/NN concentration/NN may/MD be/VB small/JJ ,/, or/CC quite/RB large/JJ (/-LRB- 8/CD fold/JJ increase/NN in/IN plasma/NN AUC/NN of/IN the/DT TCA/NN )./NN

(ROOT (S1 (S (PP (VBG Depending) (PP (IN on) (NP (NP (DT the) (NN traction)) (PP (IN of) (NP (NP (NN drug)) (VP (VBN metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))))))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN plasma) (NN concentration)))) (VP (MD may) (VP (VB be) (ADJP (ADJP (JJ small)) (, ,) (CC or) (RB quite) (ADJP (JJ large))))) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 8) (JJ fold)) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NN AUC)) (PP (IN of) (NP (DT the) (NN TCA) (NN -RRB-.))))))))))

prepc_depending_on(small-19, on-2)
det(traction-4, the-3)
pobj(small-19, traction-4)
prep_of(traction-4, drug-6)
partmod(drug-6, metabolized-7)
nn(2D6-10, P450-9)
agent(metabolized-7, 2D6-10)
det(increase-13, the-12)
nsubj(small-19, increase-13)
nn(concentration-16, plasma-15)
prep_in(increase-13, concentration-16)
aux(small-19, may-17)
cop(small-19, be-18)
root(ROOT-0, small-19)
advmod(small-19, quite-22)
conj_or(small-19, quite-22)
dep(small-19, large-23)
number(fold-26, 8-25)
amod(increase-27, fold-26)
dep(small-19, increase-27)
nn(AUC-30, plasma-29)
prep_in(increase-27, AUC-30)
det(-RRB-.-34, the-32)
nn(-RRB-.-34, TCA-33)
prep_of(AUC-30, -RRB-.-34)

In/IN addition/NN ,/, certain/JJ drugs/NNS inhibit/VB the/DT activity/NN of/IN this/DT isozyme/NN and/CC make/VB normal/JJ metabolizers/NNS resemble/VBP p.o./NN

(ROOT (S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ certain) (NNS drugs)) (VP (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN isozyme))))) (CC and) (VP (VB make) (NP (JJ normal) (NNS metabolizers)))) (VP (VBP resemble) (NP (NN p.o.))))))

prep_in(inhibit-6, addition-2)
amod(drugs-5, certain-4)
nsubj(inhibit-6, drugs-5)
root(ROOT-0, inhibit-6)
det(activity-8, the-7)
dobj(inhibit-6, activity-8)
det(isozyme-11, this-10)
prep_of(activity-8, isozyme-11)
conj_and(inhibit-6, make-13)
amod(metabolizers-15, normal-14)
dobj(make-13, metabolizers-15)
cop(p.o.-17, resemble-16)
dep(inhibit-6, p.o.-17)

An/DT individual/JJ who/WP is/VBZ stable/JJ on/IN a/DT given/JJ dose/NN of/IN TCA/NN may/MD become/VB abruptly/RB toxic/JJ when/WRB given/VBN one/CD of/IN these/DT inhibiting/JJ drugs/NNS as/IN concomitant/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ individual)) (SBAR (WHNP (WP who)) (S (VP (VBZ is) (ADJP (JJ stable) (PP (IN on) (NP (NP (DT a) (JJ given) (NN dose)) (PP (IN of) (NP (NN TCA)))))))))) (VP (MD may) (VP (VB become) (ADJP (RB abruptly) (JJ toxic)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT these) (JJ inhibiting) (NNS drugs)) (PP (IN as) (NP (JJ concomitant) (NN therapy)))))))))))) (. .))))

det(individual-2, An-1)
nsubj(stable-5, individual-2)
nsubj(toxic-15, individual-2)
cop(stable-5, is-4)
rcmod(individual-2, stable-5)
det(dose-9, a-7)
amod(dose-9, given-8)
prep_on(stable-5, dose-9)
prep_of(dose-9, TCA-11)
aux(toxic-15, may-12)
cop(toxic-15, become-13)
advmod(toxic-15, abruptly-14)
root(ROOT-0, toxic-15)
advmod(given-17, when-16)
advcl(toxic-15, given-17)
dobj(given-17, one-18)
det(drugs-22, these-20)
amod(drugs-22, inhibiting-21)
prep_of(one-18, drugs-22)
amod(therapy-25, concomitant-24)
prep_as(drugs-22, therapy-25)

The/DT drugs/NNS that/WDT inhibit/VBP cytochrome/NN P450/NN 2D6/NN include/VBP some/DT that/WDT are/VBP not/RB metabolized/VBN by/IN the/DT enzyme/NN (/-LRB- quinidine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6)))))) (VP (VBP include) (NP (NP (DT some)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN enzyme) (-LRB- -LRB-) (NN quinidine) (: ;)))))))))) (. .))))

det(drugs-2, The-1)
nsubj(inhibit-4, drugs-2)
nsubj(include-8, drugs-2)
rcmod(drugs-2, inhibit-4)
nn(2D6-7, cytochrome-5)
nn(2D6-7, P450-6)
dobj(inhibit-4, 2D6-7)
root(ROOT-0, include-8)
dobj(include-8, some-9)
nsubjpass(metabolized-13, some-9)
auxpass(metabolized-13, are-11)
neg(metabolized-13, not-12)
rcmod(some-9, metabolized-13)
det(quinidine-18, the-15)
nn(quinidine-18, enzyme-16)
agent(metabolized-13, quinidine-18)

cimetidine/NN )/-RRB- and/CC many/JJ that/WDT are/VBP substrates/NNS for/IN P450/NN 2D6/NN (/-LRB- many/JJ other/JJ antidepressants/NNS ,/, phenothiazines/NNS ,/, and/CC the/DT Type/NN 1C/NN antiarrhythrnics/NNS propatenone/NN and/CC flecainide/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NN cimetidine) (-RRB- -RRB-)) (CC and) (NP (NP (JJ many)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN for) (NP (NN P450) (NN 2D6)))) (PRN (-LRB- -LRB-) (NP (NP (JJ many) (JJ other) (NNS antidepressants)) (, ,) (NP (NNS phenothiazines)) (, ,) (CC and) (NP (NP (DT the) (NN Type) (NN 1C) (NNS antiarrhythrnics)) (NP (NP (NN propatenone)) (CC and) (NP (NN flecainide))))) (-RRB- -RRB-))))))) (. .)))))

root(ROOT-0, cimetidine-1)
conj_and(cimetidine-1, many-4)
nsubj(substrates-7, many-4)
cop(substrates-7, are-6)
rcmod(many-4, substrates-7)
nn(2D6-10, P450-9)
prep_for(substrates-7, 2D6-10)
amod(antidepressants-14, many-12)
amod(antidepressants-14, other-13)
dep(substrates-7, antidepressants-14)
conj_and(antidepressants-14, phenothiazines-16)
det(antiarrhythrnics-22, the-19)
nn(antiarrhythrnics-22, Type-20)
nn(antiarrhythrnics-22, 1C-21)
conj_and(antidepressants-14, antiarrhythrnics-22)
dep(antiarrhythrnics-22, propatenone-23)
conj_and(propatenone-23, flecainide-25)

While/IN all/PDT the/DT selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- ,/, e.g./FW ,/, fluoxetine/NN ,/, seriraline/NN ,/, and/CC paroxetine/NN ,/, inhibit/VBP P450/NN 2D6/NN ,/, they/PRP may/MD vary/VB in/IN the/DT extent/NN of/IN inhibition/NN ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (NP (NP (PDT all) (DT the) (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-))) (, ,) (PP (FW e.g.) (, ,) (NP (NP (NN fluoxetine)) (, ,) (NP (NN seriraline)) (, ,) (CC and) (NP (NN paroxetine)))) (, ,)) (VP (VBP inhibit) (NP (NN P450) (NN 2D6))))) (, ,) (NP (PRP they)) (VP (MD may) (VP (VB vary) (PP (IN in) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN inhibition)))))))) (. .))))

mark(inhibit-21, While-1)
predet(inhibitors-7, all-2)
det(inhibitors-7, the-3)
amod(inhibitors-7, selective-4)
nn(inhibitors-7, serotonin-5)
nn(inhibitors-7, reuptake-6)
nsubj(inhibit-21, inhibitors-7)
abbrev(inhibitors-7, SSRIs-9)
prep(inhibitors-7, e.g.-12)
pobj(e.g.-12, fluoxetine-14)
conj_and(fluoxetine-14, seriraline-16)
conj_and(fluoxetine-14, paroxetine-19)
advcl(vary-27, inhibit-21)
nn(2D6-23, P450-22)
dobj(inhibit-21, 2D6-23)
nsubj(vary-27, they-25)
aux(vary-27, may-26)
root(ROOT-0, vary-27)
det(extent-30, the-29)
prep_in(vary-27, extent-30)
prep_of(extent-30, inhibition-32)

Nevertheless/RB ,/, caution/NN is/VBZ indicated/VBN in/IN the/DT co-administration/NN of/IN T/NN .A./NNS with/IN any/DT of/IN the/DT SSRIs/NNS and/CC also/RB in/IN switching/NN from/IN one/CD class/NN to/TO the/DT other/JJ ./.

(ROOT (S1 (S (ADVP (RB Nevertheless)) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN indicated) (PP (PP (IN in) (NP (NP (DT the) (NN co-administration)) (PP (IN of) (NP (NN T) (NNS .A.))) (PP (IN with) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NNS SSRIs))))))) (CC and) (ADVP (RB also)) (PP (IN in) (NP (NP (NN switching)) (PP (IN from) (NP (CD one) (NN class))) (PP (TO to) (NP (DT the) (JJ other)))))))) (. .))))

advmod(indicated-5, Nevertheless-1)
nsubjpass(indicated-5, caution-3)
auxpass(indicated-5, is-4)
root(ROOT-0, indicated-5)
det(co-administration-8, the-7)
prep_in(indicated-5, co-administration-8)
nn(.A.-11, T-10)
prep_of(co-administration-8, .A.-11)
prep_with(co-administration-8, any-13)
det(SSRIs-16, the-15)
prep_of(any-13, SSRIs-16)
advmod(indicated-5, also-18)
conj(indicated-5, also-18)
conj_and(co-administration-8, switching-20)
num(class-23, one-22)
prep_from(switching-20, class-23)
det(other-26, the-25)
prep_to(switching-20, other-26)

Of/IN particular/JJ importance/NN ,/, sufficient/JJ time/NN must/MD elapse/VB before/IN initiating/VBG TCA/NN treatment/NN in/IN a/DT patient/NN being/VBG withdrawn/NN from/IN fluoxetine/NN ,/, given/IN the/DT long/JJ half-life/NN of/IN the/DT parent/JJ and/CC active/JJ metabolite/NN (/-LRB- at/IN least/JJS 5/CD weeks/NNS may/MD be/VB necessary/JJ )./NN

(ROOT (S1 (S (PP (IN Of) (NP (JJ particular) (NN importance))) (, ,) (S (NP (JJ sufficient) (NN time)) (VP (MD must) (VP (VB elapse) (PP (IN before) (S (VP (VBG initiating) (NP (NN TCA) (NN treatment))))) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG being) (NP (NP (NN withdrawn)) (PP (IN from) (NP (NN fluoxetine))))))) (, ,) (SBAR (IN given) (S (NP (NP (DT the) (JJ long) (NN half-life)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ parent)) (CC and) (ADJP (JJ active))) (NN metabolite) (-LRB- -LRB-) (QP (IN at) (JJS least) (CD 5)) (NNS weeks)))) (VP (MD may) (VP (VB be) (NP (JJ necessary) (NN -RRB-.))))))))))))

amod(importance-3, particular-2)
prep_of(elapse-8, importance-3)
amod(time-6, sufficient-5)
nsubj(elapse-8, time-6)
aux(elapse-8, must-7)
root(ROOT-0, elapse-8)
prepc_before(elapse-8, initiating-10)
nn(treatment-12, TCA-11)
dobj(initiating-10, treatment-12)
det(patient-15, a-14)
prep_in(elapse-8, patient-15)
cop(withdrawn-17, being-16)
partmod(patient-15, withdrawn-17)
prep_from(withdrawn-17, fluoxetine-19)
mark(-RRB-.-39, given-21)
det(half-life-24, the-22)
amod(half-life-24, long-23)
nsubj(-RRB-.-39, half-life-24)
det(weeks-35, the-26)
amod(weeks-35, parent-27)
conj_and(parent-27, active-29)
nn(weeks-35, metabolite-30)
quantmod(5-34, at-32)
mwe(at-32, least-33)
pobj(at-32, least-33)
num(weeks-35, 5-34)
prep_of(half-life-24, weeks-35)
aux(-RRB-.-39, may-36)
cop(-RRB-.-39, be-37)
amod(-RRB-.-39, necessary-38)
advcl(elapse-8, -RRB-.-39)

Concomitant/JJ use/NN of/IN tricyclic/JJ antidepressants/NNS with/IN drugs/NNS that/WDT can/MD inhibit/VB cytochrome/NN P450/NN 2D6/NN may/MD require/VB lower/JJR doses/NNS than/IN usually/RB prescribed/VBN for/IN either/CC the/DT tricyclic/JJ antidepressant/JJ or/CC the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6))))))))))) (VP (MD may) (VP (VB require) (NP (NP (JJR lower) (NNS doses)) (VP (ADVP (IN than) (RB usually)) (VBN prescribed) (PP (IN for) (NP (CC either) (NP (DT the) (JJ tricyclic) (JJ antidepressant)) (CC or) (NP (DT the) (JJ other) (NN drug))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(require-15, use-2)
amod(antidepressants-5, tricyclic-4)
prep_of(use-2, antidepressants-5)
prep_with(antidepressants-5, drugs-7)
nsubj(inhibit-10, drugs-7)
aux(inhibit-10, can-9)
rcmod(drugs-7, inhibit-10)
nn(2D6-13, cytochrome-11)
nn(2D6-13, P450-12)
dobj(inhibit-10, 2D6-13)
aux(require-15, may-14)
root(ROOT-0, require-15)
amod(doses-17, lower-16)
dobj(require-15, doses-17)
advmod(prescribed-20, than-18)
advmod(than-18, usually-19)
partmod(doses-17, prescribed-20)
preconj(antidepressant-25, either-22)
det(antidepressant-25, the-23)
amod(antidepressant-25, tricyclic-24)
prep_for(prescribed-20, antidepressant-25)
det(drug-29, the-27)
amod(drug-29, other-28)
conj_or(antidepressant-25, drug-29)

Furthermore/RB ,/, whenever/RB one/CD of/IN these/DT other/JJ drugs/NNS is/VBZ withdrawn/VBN from/IN co-therapy/NN ,/, an/DT increased/VBN dose/NN of/IN tricyclic/JJ antidepressant/JJ may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Furthermore)) (, ,) (S (ADVP (RB whenever)) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (JJ other) (NNS drugs)))) (VP (VBZ is) (VP (VBN withdrawn) (PP (IN from) (NP (NN co-therapy)))))) (, ,) (NP (NP (DT an) (VBN increased) (NN dose)) (PP (IN of) (NP (JJ tricyclic) (JJ antidepressant)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(required-22, Furthermore-1)
advmod(withdrawn-10, whenever-3)
nsubjpass(withdrawn-10, one-4)
det(drugs-8, these-6)
amod(drugs-8, other-7)
prep_of(one-4, drugs-8)
auxpass(withdrawn-10, is-9)
ccomp(required-22, withdrawn-10)
prep_from(withdrawn-10, co-therapy-12)
det(dose-16, an-14)
amod(dose-16, increased-15)
nsubjpass(required-22, dose-16)
amod(antidepressant-19, tricyclic-18)
prep_of(dose-16, antidepressant-19)
aux(required-22, may-20)
auxpass(required-22, be-21)
root(ROOT-0, required-22)

It/PRP is/VBZ desirable/JJ to/TO monitor/VB TCA/NN plasma/NN levels/NNS whenever/RB a/DT TCA/NN is/VBZ going/JJ to/TO be/VB co-administered/VBN with/IN another/DT drug/NN known/VBN to/TO be/VB an/DT inhibitor/NN of/IN P450/NN 2D6/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ desirable)) (S (VP (TO to) (VP (VB monitor) (NP (NN TCA) (NN plasma) (NNS levels)) (S (ADVP (RB whenever)) (NP (DT a) (NN TCA)) (VP (VBZ is) (ADJP (JJ going) (S (VP (TO to) (VP (VB be) (VP (VBN co-administered) (PP (IN with) (NP (NP (DT another) (NN drug)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN P450) (NN 2D6)))))))))))))))))))))) (. .))))

nsubj(desirable-3, It-1)
xsubj(monitor-5, It-1)
cop(desirable-3, is-2)
root(ROOT-0, desirable-3)
aux(monitor-5, to-4)
xcomp(desirable-3, monitor-5)
nn(levels-8, TCA-6)
nn(levels-8, plasma-7)
dobj(monitor-5, levels-8)
advmod(going-13, whenever-9)
det(TCA-11, a-10)
nsubj(going-13, TCA-11)
cop(going-13, is-12)
dep(monitor-5, going-13)
aux(co-administered-16, to-14)
auxpass(co-administered-16, be-15)
xcomp(going-13, co-administered-16)
det(drug-19, another-18)
prep_with(co-administered-16, drug-19)
partmod(drug-19, known-20)
aux(inhibitor-24, to-21)
cop(inhibitor-24, be-22)
det(inhibitor-24, an-23)
xcomp(known-20, inhibitor-24)
nn(2D6-27, P450-26)
prep_of(inhibitor-24, 2D6-27)

Close/JJ supervision/NN and/CC careful/JJ adjustment/NN of/IN dosage/NN are/VBP required/VBN when/WRB this/DT drug/NN is/VBZ given/VBN concomitantly/RB with/IN anticholinergic/JJ or/CC sympathomimetic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Close) (NN supervision)) (CC and) (NP (JJ careful) (NN adjustment))) (PP (IN of) (NP (NN dosage)))) (VP (VBP are) (VP (VBN required) (SBAR (WHADVP (WRB when)) (S (NP (DT this) (NN drug)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (ADJP (ADJP (JJ anticholinergic)) (CC or) (ADJP (JJ sympathomimetic))) (NNS drugs)))))))))) (. .))))

amod(supervision-2, Close-1)
nsubjpass(required-9, supervision-2)
amod(adjustment-5, careful-4)
conj_and(supervision-2, adjustment-5)
prep_of(supervision-2, dosage-7)
auxpass(required-9, are-8)
root(ROOT-0, required-9)
advmod(given-14, when-10)
det(drug-12, this-11)
nsubjpass(given-14, drug-12)
auxpass(given-14, is-13)
advcl(required-9, given-14)
advmod(given-14, concomitantly-15)
amod(drugs-20, anticholinergic-17)
conj_or(anticholinergic-17, sympathomimetic-19)
prep_with(given-14, drugs-20)

Clinical/JJ experience/VBP in/IN the/DT concurrent/JJ administration/NN of/IN ECT/NN and/CC antidepressant/JJ drugs/NNS is/VBZ limited/VBN ./.

(ROOT (S1 (S (S (NP (JJ Clinical)) (VP (VBP experience) (SBAR (IN in) (S (NP (NP (DT the) (JJ concurrent) (NN administration)) (PP (IN of) (NP (NP (NN ECT)) (CC and) (NP (JJ antidepressant) (NNS drugs))))) (VP (VBZ is) (VP (VBN limited))))))) (. .))))

nsubj(experience-2, Clinical-1)
root(ROOT-0, experience-2)
mark(limited-13, in-3)
det(administration-6, the-4)
amod(administration-6, concurrent-5)
nsubjpass(limited-13, administration-6)
prep_of(administration-6, ECT-8)
amod(drugs-11, antidepressant-10)
conj_and(ECT-8, drugs-11)
auxpass(limited-13, is-12)
advcl(experience-2, limited-13)

If/IN desipramine/NN hydrochloride/NN is/VBZ to/TO be/VB combined/VBN with/IN other/JJ psychotropic/JJ agents/NNS such/JJ as/IN tranquilizers/NNS or/CC sedative/JJ //: hypnotics/NNS ,/, careful/JJ consideration/NN should/MD be/VB given/VBN to/TO the/DT pharmacology/NN of/IN the/DT agents/NNS employed/VBN since/IN the/DT sedative/JJ effects/NNS of/IN desipramine/NN and/CC benzodiazepines/NN (/-LRB- e.g./FW ,/, chlordiazepoxide/NN or/CC diazepam/NN )/-RRB- are/VBP additive/JJ ./.

(ROOT (S1 (S (SBAR (IN If) (S (NP (NN desipramine) (NN hydrochloride)) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN combined) (PP (IN with) (NP (NP (JJ other) (JJ psychotropic) (NNS agents)) (PP (JJ such) (IN as) (NP (NP (NNS tranquilizers)) (CC or) (NP (ADJP (ADJP (JJ sedative)) (: /)) (NNS hypnotics))))))))))))) (, ,) (NP (JJ careful) (NN consideration)) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (DT the) (NN pharmacology)) (PP (IN of) (NP (NP (DT the) (NNS agents)) (VP (VBN employed) (SBAR (IN since) (S (NP (NP (DT the) (JJ sedative) (NNS effects)) (PP (IN of) (NP (NP (NP (NN desipramine)) (CC and) (NP (NN benzodiazepines))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN chlordiazepoxide)) (CC or) (NP (NN diazepam)))) (-RRB- -RRB-))))) (VP (VBP are) (ADJP (JJ additive))))))))))))) (. .))))

mark(is-4, If-1)
nn(hydrochloride-3, desipramine-2)
nsubj(is-4, hydrochloride-3)
xsubj(combined-7, hydrochloride-3)
advcl(given-24, is-4)
aux(combined-7, to-5)
auxpass(combined-7, be-6)
xcomp(is-4, combined-7)
amod(agents-11, other-9)
amod(agents-11, psychotropic-10)
prep_with(combined-7, agents-11)
prep_such_as(agents-11, tranquilizers-14)
amod(hypnotics-18, sedative-16)
punct(sedative-16, /-17)
conj_or(tranquilizers-14, hypnotics-18)
amod(consideration-21, careful-20)
nsubjpass(given-24, consideration-21)
aux(given-24, should-22)
auxpass(given-24, be-23)
root(ROOT-0, given-24)
det(pharmacology-27, the-26)
prep_to(given-24, pharmacology-27)
det(agents-30, the-29)
prep_of(pharmacology-27, agents-30)
partmod(agents-30, employed-31)
mark(additive-48, since-32)
det(effects-35, the-33)
amod(effects-35, sedative-34)
nsubj(additive-48, effects-35)
prep_of(effects-35, desipramine-37)
conj_and(desipramine-37, benzodiazepines-39)
dep(desipramine-37, e.g.-41)
pobj(e.g.-41, chlordiazepoxide-43)
conj_or(chlordiazepoxide-43, diazepam-45)
cop(additive-48, are-47)
advcl(employed-31, additive-48)

Both/CC the/DT sedative/JJ and/CC anticholinergic/JJ effects/NNS of/IN the/DT major/JJ tranquilizers/NNS are/VBP also/RB additive/JJ to/TO those/DT of/IN desipramine/NN ./.

(ROOT (S1 (S (S (NP (NP (CC Both) (DT the) (ADJP (ADJP (JJ sedative)) (CC and) (ADJP (JJ anticholinergic))) (NNS effects)) (PP (IN of) (NP (DT the) (JJ major) (NNS tranquilizers)))) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ additive) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (NN desipramine)))))))) (. .))))

dep(effects-6, Both-1)
det(effects-6, the-2)
amod(effects-6, sedative-3)
conj_and(sedative-3, anticholinergic-5)
nsubj(additive-13, effects-6)
det(tranquilizers-10, the-8)
amod(tranquilizers-10, major-9)
prep_of(effects-6, tranquilizers-10)
cop(additive-13, are-11)
advmod(additive-13, also-12)
root(ROOT-0, additive-13)
prep_to(additive-13, those-15)
prep_of(those-15, desipramine-17)

Concurrent/JJ administration/NN of/IN cimetidine/NN and/CC tricyclic/JJ antidepressants/NNS can/MD produce/VBP clinically/RB significant/JJ increases/NNS in/IN the/DT plasma/NN levels/NNS of/IN the/DT tricyclic/JJ antidepressants/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NN cimetidine)) (CC and) (NP (JJ tricyclic) (NNS antidepressants))))) (VP (MD can) (VP (VBP produce) (NP (NP (ADJP (RB clinically) (JJ significant)) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (DT the) (JJ tricyclic) (NNS antidepressants))))))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(produce-9, administration-2)
prep_of(administration-2, cimetidine-4)
amod(antidepressants-7, tricyclic-6)
conj_and(cimetidine-4, antidepressants-7)
aux(produce-9, can-8)
root(ROOT-0, produce-9)
advmod(significant-11, clinically-10)
amod(increases-12, significant-11)
dobj(produce-9, increases-12)
det(levels-16, the-14)
nn(levels-16, plasma-15)
prep_in(increases-12, levels-16)
det(antidepressants-20, the-18)
amod(antidepressants-20, tricyclic-19)
prep_of(levels-16, antidepressants-20)

Conversely/RB ,/, decreases/NNS in/IN plasma/NN levels/NNS of/IN the/DT tricyclic/JJ antidepressants/NNS have/VBP been/VBN reported/VBN upon/IN discontinuation/NN of/IN cimetidine/NN which/WDT may/MD result/VB in/IN the/DT loss/NN of/IN the/DT therapeutic/JJ efficacy/NN of/IN the/DT tricyclic/JJ antidepressant/JJ 6/CD ./.

(ROOT (S1 (S (S (ADVP (RB Conversely)) (, ,) (NP (NP (NNS decreases)) (PP (IN in) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (DT the) (JJ tricyclic) (NNS antidepressants)))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN upon) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NP (NN cimetidine)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NP (DT the) (JJ therapeutic) (NN efficacy)) (PP (IN of) (NP (DT the) (JJ tricyclic) (JJ antidepressant) (CD 6))))))))))))))))))) (. .))))

advmod(reported-13, Conversely-1)
nsubjpass(reported-13, decreases-3)
nn(levels-6, plasma-5)
prep_in(decreases-3, levels-6)
det(antidepressants-10, the-8)
amod(antidepressants-10, tricyclic-9)
prep_of(levels-6, antidepressants-10)
aux(reported-13, have-11)
auxpass(reported-13, been-12)
root(ROOT-0, reported-13)
prep_upon(reported-13, discontinuation-15)
prep_of(discontinuation-15, cimetidine-17)
nsubj(result-20, cimetidine-17)
aux(result-20, may-19)
rcmod(cimetidine-17, result-20)
det(loss-23, the-22)
prep_in(result-20, loss-23)
det(efficacy-27, the-25)
amod(efficacy-27, therapeutic-26)
prep_of(loss-23, efficacy-27)
det(6-32, the-29)
amod(6-32, tricyclic-30)
amod(6-32, antidepressant-31)
prep_of(efficacy-27, 6-32)

There/EX have/VBP been/VBN greater/JJR than/IN two-fold/JJ increases/NNS of/IN previously/RB stable/JJ plasma/NN levels/NNS of/IN tricyclic/JJ antidepressants/NNS when/WRB fluoxetine/NN has/VBZ been/VBN administered/VBN in/IN combination/NN with/IN these/DT agents/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (NP (JJ two-fold) (NNS increases)) (PP (IN of) (NP (NP (ADJP (RB previously) (JJ stable)) (NN plasma) (NNS levels)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants)))))))) (SBAR (WHADVP (WRB when)) (S (NP (NN fluoxetine)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (DT these) (NNS agents))))))))))))) (. .))))

expl(greater-4, There-1)
aux(greater-4, have-2)
cop(greater-4, been-3)
root(ROOT-0, greater-4)
amod(increases-7, two-fold-6)
prep_than(greater-4, increases-7)
advmod(stable-10, previously-9)
amod(levels-12, stable-10)
nn(levels-12, plasma-11)
prep_of(increases-7, levels-12)
amod(antidepressants-15, tricyclic-14)
prep_of(levels-12, antidepressants-15)
advmod(administered-20, when-16)
nsubjpass(administered-20, fluoxetine-17)
aux(administered-20, has-18)
auxpass(administered-20, been-19)
advcl(greater-4, administered-20)
prep_in(administered-20, combination-22)
det(agents-25, these-24)
prep_with(combination-22, agents-25)

General/JJ :/: In/FW vitro/FW studies/NNS in/IN human/JJ liver/NN microsomes/NNS demonstrated/VBD no/DT evidence/NN of/IN cytochrome/NN P450-mediated/JJ drug/NN interactions/NNS that/WDT are/VBP likely/JJ to/TO be/VB of/IN clinical/JJ relevance/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ General) (ADJP (: :) (ADJP (FW In) (FW vitro))) (NNS studies)) (PP (IN in) (NP (JJ human) (NN liver) (NNS microsomes)))) (VP (VBD demonstrated) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (NN cytochrome) (JJ P450-mediated) (NN drug) (NNS interactions)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (JJ clinical) (NN relevance))))))))))))))) (. .))))

amod(studies-5, General-1)
nn(vitro-4, In-3)
amod(studies-5, vitro-4)
nsubj(demonstrated-10, studies-5)
amod(microsomes-9, human-7)
nn(microsomes-9, liver-8)
prep_in(studies-5, microsomes-9)
root(ROOT-0, demonstrated-10)
det(evidence-12, no-11)
dobj(demonstrated-10, evidence-12)
nn(interactions-17, cytochrome-14)
amod(interactions-17, P450-mediated-15)
nn(interactions-17, drug-16)
prep_of(evidence-12, interactions-17)
nsubj(likely-20, interactions-17)
cop(likely-20, are-19)
rcmod(interactions-17, likely-20)
aux(be-22, to-21)
xcomp(likely-20, be-22)
amod(relevance-25, clinical-24)
prep_of(be-22, relevance-25)

Anesthetics/NNS //: Sedatives/NNS //: Hypnotics/NNS //: Opioids/NNS Co-administration/NN of/IN PRECEDEX/NN with/IN anesthetics/NNS ,/, sedatives/NNS ,/, hypnotics/NNS ,/, and/CC opioids/NNS is/VBZ likely/JJ to/TO lead/VB to/TO an/DT enhancement/NN of/IN effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NNS Anesthetics)) (: /) (NP (NNS Sedatives)) (: /) (NP (NNS Hypnotics)) (: /) (NP (NNS Opioids))) (NN Co-administration)) (PP (IN of) (NP (NN PRECEDEX))) (PP (IN with) (NP (NP (NNS anesthetics)) (, ,) (NP (NNS sedatives)) (, ,) (NP (NNS hypnotics)) (, ,) (CC and) (NP (NNS opioids))))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB lead) (PP (TO to) (NP (NP (DT an) (NN enhancement)) (PP (IN of) (NP (NNS effects))))))))))) (. .))))

nn(Co-administration-8, Anesthetics-1)
punct(Anesthetics-1, /-2)
dep(Anesthetics-1, Sedatives-3)
punct(Anesthetics-1, /-4)
dep(Anesthetics-1, Hypnotics-5)
punct(Anesthetics-1, /-6)
dep(Anesthetics-1, Opioids-7)
nsubj(likely-21, Co-administration-8)
prep_of(Co-administration-8, PRECEDEX-10)
prep_with(Co-administration-8, anesthetics-12)
conj_and(anesthetics-12, sedatives-14)
conj_and(anesthetics-12, hypnotics-16)
conj_and(anesthetics-12, opioids-19)
cop(likely-21, is-20)
root(ROOT-0, likely-21)
aux(lead-23, to-22)
xcomp(likely-21, lead-23)
det(enhancement-26, an-25)
prep_to(lead-23, enhancement-26)
prep_of(enhancement-26, effects-28)

Specific/JJ studies/NNS have/VBP confirmed/VBN these/DT effects/NNS with/IN sevoflurane/NN ,/, isoflurane/NN ,/, propofol/NN ,/, alfentanil/NN ,/, and/CC midazolam/NN ./.

(ROOT (S1 (S (S (NP (JJ Specific) (NNS studies)) (VP (VBP have) (VP (VBN confirmed) (NP (DT these) (NNS effects)) (PP (IN with) (NP (NP (NN sevoflurane)) (, ,) (NP (NN isoflurane)) (, ,) (NP (NN propofol)) (, ,) (NP (NN alfentanil)) (, ,) (CC and) (NP (NN midazolam))))))) (. .))))

amod(studies-2, Specific-1)
nsubj(confirmed-4, studies-2)
aux(confirmed-4, have-3)
root(ROOT-0, confirmed-4)
det(effects-6, these-5)
dobj(confirmed-4, effects-6)
prep_with(confirmed-4, sevoflurane-8)
conj_and(sevoflurane-8, isoflurane-10)
conj_and(sevoflurane-8, propofol-12)
conj_and(sevoflurane-8, alfentanil-14)
conj_and(sevoflurane-8, midazolam-17)

No/DT pharmacokinetic/JJ interactions/NNS between/IN dexmedetomidine/NN and/CC isoflurane/NN ,/, propofol/NN ,/, alfentanil/NN ,/, and/CC midazolam/NN have/VBP been/VBN demonstrated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ pharmacokinetic) (NNS interactions)) (PP (IN between) (NP (NP (NN dexmedetomidine)) (CC and) (NP (NN isoflurane)) (, ,) (NP (NN propofol)) (, ,) (NP (NN alfentanil)) (, ,) (CC and) (NP (NN midazolam))))) (VP (VBP have) (VP (VBN been) (VP (VBN demonstrated))))) (. .))))

det(interactions-3, No-1)
amod(interactions-3, pharmacokinetic-2)
nsubjpass(demonstrated-17, interactions-3)
prep_between(interactions-3, dexmedetomidine-5)
conj_and(dexmedetomidine-5, isoflurane-7)
conj_and(dexmedetomidine-5, propofol-9)
conj_and(dexmedetomidine-5, alfentanil-11)
conj_and(dexmedetomidine-5, midazolam-14)
aux(demonstrated-17, have-15)
auxpass(demonstrated-17, been-16)
root(ROOT-0, demonstrated-17)

However/RB ,/, due/IN to/TO possible/JJ pharmacodynamic/JJ interactions/NNS ,/, when/WRB co-administered/VBN with/IN PRECEDEX/NN ,/, a/DT reduction/NN in/IN dosage/NN of/IN PRECEDEX/NN on/IN the/DT concomitant/JJ anesthetic/NN ,/, sedative/JJ ,/, hypnotic/JJ or/CC opioid/JJ may/MD be/VB required/VBN ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (PP (IN due) (PP (TO to) (NP (JJ possible) (JJ pharmacodynamic) (NNS interactions)))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-administered) (PP (IN with) (NP (NN PRECEDEX)))))) (, ,) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (NN dosage)) (PP (IN of) (NP (NN PRECEDEX))))) (PP (IN on) (NP (NP (DT the) (JJ concomitant) (NN anesthetic)) (, ,) (ADJP (ADJP (JJ sedative)) (, ,) (ADJP (JJ hypnotic)) (CC or) (ADJP (JJ opioid)))))) (VP (MD may) (VP (VB be) (VP (VBN required)))) (. .))))

advmod(required-32, However-1)
prepc_due_to(required-32, to-4)
amod(interactions-7, possible-5)
amod(interactions-7, pharmacodynamic-6)
pobj(required-32, interactions-7)
advmod(co-administered-10, when-9)
advcl(required-32, co-administered-10)
prep_with(co-administered-10, PRECEDEX-12)
det(reduction-15, a-14)
nsubjpass(required-32, reduction-15)
prep_in(reduction-15, dosage-17)
prep_of(dosage-17, PRECEDEX-19)
det(anesthetic-23, the-21)
amod(anesthetic-23, concomitant-22)
prep_on(reduction-15, anesthetic-23)
amod(anesthetic-23, sedative-25)
conj_or(sedative-25, hypnotic-27)
conj_or(sedative-25, opioid-29)
aux(required-32, may-30)
auxpass(required-32, be-31)
root(ROOT-0, required-32)

Neuromuscular/JJ Blockers/NNS :/: In/IN one/CD study/NN of/IN 10/CD healthy/JJ volunteers/NNS ,/, administration/NN of/IN PRECEDEX/NN for/IN 45/CD minutes/NNS at/IN a/DT plasma/NN concentration/NN of/IN 1/CD (/-LRB- one/CD )/-RRB- ng/mL/NN resulted/VBD in/IN no/DT clinically/RB meaningful/JJ increases/NNS in/IN the/DT magnitude/NN or/CC neuromuscular/JJ blockade/NN associated/VBN with/IN rocuronium/NN administration/NN ./.

(ROOT (S1 (S (NP (NP (JJ Neuromuscular) (NNS Blockers)) (: :) (S (PP (IN In) (NP (NP (CD one) (NN study)) (PP (IN of) (NP (CD 10) (JJ healthy) (NNS volunteers))))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NN PRECEDEX))) (PP (IN for) (NP (CD 45) (NNS minutes))) (PP (IN at) (NP (NP (DT a) (NN plasma) (NN concentration)) (PP (IN of) (NP (CD 1) (-LRB- -LRB-) (CD one) (-RRB- -RRB-) (NN ng/mL)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT no) (ADJP (RB clinically) (JJ meaningful)) (NNS increases)) (PP (IN in) (NP (NP (NP (DT the) (NN magnitude)) (CC or) (NP (JJ neuromuscular) (NN blockade))) (VP (VBN associated) (PP (IN with) (NP (NN rocuronium) (NN administration)))))))))) (. .)))))

amod(Blockers-2, Neuromuscular-1)
root(ROOT-0, Blockers-2)
num(study-6, one-5)
prep_in(resulted-28, study-6)
num(volunteers-10, 10-8)
amod(volunteers-10, healthy-9)
prep_of(study-6, volunteers-10)
nsubj(resulted-28, administration-12)
prep_of(administration-12, PRECEDEX-14)
num(minutes-17, 45-16)
prep_for(administration-12, minutes-17)
det(concentration-21, a-19)
nn(concentration-21, plasma-20)
prep_at(administration-12, concentration-21)
num(ng/mL-27, 1-23)
num(ng/mL-27, one-25)
prep_of(concentration-21, ng/mL-27)
dep(Blockers-2, resulted-28)
det(increases-33, no-30)
advmod(meaningful-32, clinically-31)
amod(increases-33, meaningful-32)
prep_in(resulted-28, increases-33)
det(magnitude-36, the-35)
prep_in(increases-33, magnitude-36)
amod(blockade-39, neuromuscular-38)
conj_or(magnitude-36, blockade-39)
partmod(magnitude-36, associated-40)
nn(administration-43, rocuronium-42)
prep_with(associated-40, administration-43)

May/MD interact/VB anticoagulants/NNS (/-LRB- altered/JJ hypo-prothrombinemic/JJ effect/NN )/-RRB- ,/, barbiturates/NNS ,/, rifampin/NN and/CC other/JJ inducers/NNS of/IN hepatic/JJ microsomal/JJ enzyme/NN oxidation/NN system/NN (/-LRB- decreased/VBN effect/NN of/IN diethylstilbestrol/NN )/-RRB- ,/, corticosteroids/NNS (/-LRB- increased/VBN effect/NN of/IN corticosteroids/NNS )/-RRB- ./.

(ROOT (S1 (S (S (VP (MD May) (VP (VB interact) (NP (NP (NP (NNS anticoagulants)) (PRN (-LRB- -LRB-) (NP (JJ altered) (JJ hypo-prothrombinemic) (NN effect)) (-RRB- -RRB-))) (, ,) (NP (NNS barbiturates)) (, ,) (NP (NP (NP (NN rifampin)) (CC and) (NP (JJ other) (NNS inducers))) (PP (IN of) (NP (NP (JJ hepatic) (JJ microsomal) (NN enzyme) (NN oxidation) (NN system)) (PRN (-LRB- -LRB-) (NP (NP (VBN decreased) (NN effect)) (PP (IN of) (NP (NN diethylstilbestrol)))) (-RRB- -RRB-))))) (, ,) (NP (NP (NNS corticosteroids)) (PRN (-LRB- -LRB-) (NP (NP (VBN increased) (NN effect)) (PP (IN of) (NP (NNS corticosteroids)))) (-RRB- -RRB-))))))) (. .))))

aux(interact-2, May-1)
root(ROOT-0, interact-2)
dobj(interact-2, anticoagulants-3)
amod(effect-7, altered-5)
amod(effect-7, hypo-prothrombinemic-6)
appos(anticoagulants-3, effect-7)
appos(anticoagulants-3, barbiturates-10)
appos(anticoagulants-3, rifampin-12)
amod(inducers-15, other-14)
conj_and(rifampin-12, inducers-15)
amod(system-21, hepatic-17)
amod(system-21, microsomal-18)
nn(system-21, enzyme-19)
nn(system-21, oxidation-20)
prep_of(rifampin-12, system-21)
amod(effect-24, decreased-23)
dep(system-21, effect-24)
prep_of(effect-24, diethylstilbestrol-26)
appos(anticoagulants-3, corticosteroids-29)
amod(effect-32, increased-31)
dep(corticosteroids-29, effect-32)
prep_of(effect-32, corticosteroids-34)

Administration/NN of/IN thiazide/NN diuretics/NNS to/TO hypoparathyroid/JJ patients/NNS who/WP are/VBP concurrently/RB being/VBG treated/VBN with/IN dihydrotachysterol/NN may/MD cause/VB hypercalcemia/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN thiazide) (NNS diuretics))) (PP (TO to) (NP (NP (JJ hypoparathyroid) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB concurrently)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN dihydrotachysterol))))))))))) (VP (MD may) (VP (VB cause) (NP (NN hypercalcemia))))) (. .))))

nsubj(cause-16, Administration-1)
nn(diuretics-4, thiazide-3)
prep_of(Administration-1, diuretics-4)
amod(patients-7, hypoparathyroid-6)
prep_to(Administration-1, patients-7)
nsubjpass(treated-12, patients-7)
aux(treated-12, are-9)
advmod(treated-12, concurrently-10)
auxpass(treated-12, being-11)
rcmod(patients-7, treated-12)
prep_with(treated-12, dihydrotachysterol-14)
aux(cause-16, may-15)
root(ROOT-0, cause-16)
dobj(cause-16, hypercalcemia-17)

Diphenhydramine/NN hydrochloride/NN has/VBZ additive/JJ effects/NNS with/IN alcohol/NN and/CC other/JJ CNS/NN depressants/NNS (/-LRB- hypnotics/NN ,/, sedatives/NNS ,/, tranquilizers/NNS ,/, etc/NN )./CD

(ROOT (S1 (S (NP (NN Diphenhydramine) (NN hydrochloride)) (VP (VBZ has) (NP (JJ additive) (NNS effects)) (PP (IN with) (NP (NP (NN alcohol)) (CC and) (NP (NP (NP (JJ other) (NN CNS) (NNS depressants)) (PRN (-LRB- -LRB-) (NP (NN hypnotics)))) (, ,) (NP (NNS sedatives)) (, ,) (NP (NNS tranquilizers)) (, ,) (NP (NN etc) (CD -RRB-.)))))))))

nn(hydrochloride-2, Diphenhydramine-1)
nsubj(has-3, hydrochloride-2)
root(ROOT-0, has-3)
amod(effects-5, additive-4)
dobj(has-3, effects-5)
prep_with(has-3, alcohol-7)
amod(depressants-11, other-9)
nn(depressants-11, CNS-10)
conj_and(alcohol-7, depressants-11)
dep(depressants-11, hypnotics-13)
appos(depressants-11, sedatives-15)
appos(depressants-11, tranquilizers-17)
appos(depressants-11, etc-19)
num(etc-19, -RRB-.-20)

MAO/NN inhibitors/NNS prolong/VBP and/CC intensify/VB the/DT anticholinergic/JJ (/-LRB- drying/NN )/-RRB- effects/NNS of/IN antihistamines/NNS ./.

(ROOT (S1 (S (S (NP (NN MAO) (NNS inhibitors)) (VP (VP (VBP prolong)) (CC and) (VP (VB intensify) (NP (NP (DT the) (ADJP (ADJP (JJ anticholinergic)) (PRN (-LRB- -LRB-) (NP (NN drying)) (-RRB- -RRB-))) (NNS effects)) (PP (IN of) (NP (NNS antihistamines))))))) (. .))))

nn(inhibitors-2, MAO-1)
nsubj(prolong-3, inhibitors-2)
root(ROOT-0, prolong-3)
conj_and(prolong-3, intensify-5)
det(effects-11, the-6)
amod(effects-11, anticholinergic-7)
dep(anticholinergic-7, drying-9)
dobj(intensify-5, effects-11)
prep_of(effects-11, antihistamines-13)

CNS/NN depression/NN @/NN producing/NN medications/NNS -/CC concurrent/JJ use/NN may/MD potentiate/VB the/DT effects/NNS of/IN either/CC these/DT medications/NNS or/CC diphenidol/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN CNS) (NN depression) (NN @) (NN producing) (NNS medications)) (CC -) (NP (JJ concurrent) (NN use))) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (CC either) (DT these) (NP (NNS medications)) (CC or) (NP (NN diphenidol))))))) (: ;)) (. .))))

nn(medications-5, CNS-1)
nn(medications-5, depression-2)
nn(medications-5, @-3)
nn(medications-5, producing-4)
nsubj(potentiate-10, medications-5)
amod(use-8, concurrent-7)
conj(medications-5, use-8)
aux(potentiate-10, may-9)
root(ROOT-0, potentiate-10)
det(effects-12, the-11)
dobj(potentiate-10, effects-12)
preconj(medications-16, either-14)
dep(medications-16, these-15)
prep_of(effects-12, medications-16)
conj_or(medications-16, diphenidol-18)

anticholinergics/NN or/CC other/JJ medications/NNS with/IN anticholinergic/JJ activity/NN -/CC anticholinergic/JJ effects/NNS may/MD be/VB potentiated/VBN when/WRB these/DT medications/NNS are/VBP used/VBN concurrently/RB with/IN diphenidol/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN anticholinergics)) (CC or) (NP (JJ other) (NNS medications))) (PP (IN with) (NP (JJ anticholinergic) (NN activity)))) (CC -) (NP (JJ anticholinergic) (NNS effects))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS medications)) (VP (VBP are) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NN diphenidol)))))))))) (: ;)) (. .))))

nsubjpass(potentiated-13, anticholinergics-1)
amod(medications-4, other-3)
conj_or(anticholinergics-1, medications-4)
amod(activity-7, anticholinergic-6)
prep_with(anticholinergics-1, activity-7)
amod(effects-10, anticholinergic-9)
conj_or(anticholinergics-1, effects-10)
aux(potentiated-13, may-11)
auxpass(potentiated-13, be-12)
root(ROOT-0, potentiated-13)
advmod(used-18, when-14)
det(medications-16, these-15)
nsubjpass(used-18, medications-16)
auxpass(used-18, are-17)
advcl(potentiated-13, used-18)
advmod(used-18, concurrently-19)
prep_with(used-18, diphenidol-21)

apomorphine/NN -/CC prior/JJ ingestion/NN of/IN diphenidol/NN may/MD decrease/VB the/DT emetic/JJ response/NN to/TO apomorphine/NN in/IN the/DT treatment/NN of/IN poisoning/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN apomorphine)) (CC -) (NP (JJ prior) (NN ingestion))) (PP (IN of) (NP (NN diphenidol)))) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (JJ emetic) (NN response)) (PP (TO to) (NP (NN apomorphine))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN poisoning))))))))) (. .))))

nsubj(decrease-8, apomorphine-1)
amod(ingestion-4, prior-3)
conj(apomorphine-1, ingestion-4)
prep_of(apomorphine-1, diphenidol-6)
aux(decrease-8, may-7)
root(ROOT-0, decrease-8)
det(response-11, the-9)
amod(response-11, emetic-10)
dobj(decrease-8, response-11)
prep_to(response-11, apomorphine-13)
det(treatment-16, the-15)
prep_in(response-11, treatment-16)
prep_of(treatment-16, poisoning-18)

Known/JJ drug/NN interactions/NNS include/VBP barbiturates/NNS ,/, tranquilizers/NNS ,/, and/CC alcohol/NN ./.

(ROOT (S1 (S (S (NP (JJ Known) (NN drug) (NNS interactions)) (VP (VBP include) (NP (NP (NNS barbiturates)) (, ,) (NP (NNS tranquilizers)) (, ,) (CC and) (NP (NN alcohol))))) (. .))))

amod(interactions-3, Known-1)
nn(interactions-3, drug-2)
nsubj(include-4, interactions-3)
root(ROOT-0, include-4)
dobj(include-4, barbiturates-5)
conj_and(barbiturates-5, tranquilizers-7)
conj_and(barbiturates-5, alcohol-10)

Diphenoxylate/NN HCl/NN and/CC atropine/NN sulfate/NN may/MD interact/VB with/IN MAO/NN inhibitors/NNS In/IN studies/NNS with/IN male/JJ rats/NNS ,/, diphenoxylate/NN hydrochloride/NN was/VBD found/VBN to/TO inhibit/VB the/DT hepatic/JJ microsomal/JJ enzyme/NN system/NN at/IN a/DT dose/NN of/IN 2/CD mg/kg/day/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Diphenoxylate) (NN HCl)) (CC and) (NP (NN atropine) (NN sulfate))) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NN MAO) (NNS inhibitors))) (PP (IN In) (NP (NP (NNS studies)) (PP (IN with) (NP (JJ male) (NNS rats)))))))) (, ,) (NP (NN diphenoxylate) (NN hydrochloride)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB inhibit) (NP (DT the) (JJ hepatic) (JJ microsomal) (NN enzyme) (NN system)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 2) (NN mg/kg/day))))))))))) (. .))))

nn(HCl-2, Diphenoxylate-1)
nsubj(interact-7, HCl-2)
nn(sulfate-5, atropine-4)
conj_and(HCl-2, sulfate-5)
aux(interact-7, may-6)
ccomp(found-20, interact-7)
nn(inhibitors-10, MAO-9)
prep_with(interact-7, inhibitors-10)
prep_in(interact-7, studies-12)
amod(rats-15, male-14)
prep_with(studies-12, rats-15)
nn(hydrochloride-18, diphenoxylate-17)
nsubjpass(found-20, hydrochloride-18)
xsubj(inhibit-22, hydrochloride-18)
auxpass(found-20, was-19)
root(ROOT-0, found-20)
aux(inhibit-22, to-21)
xcomp(found-20, inhibit-22)
det(system-27, the-23)
amod(system-27, hepatic-24)
amod(system-27, microsomal-25)
nn(system-27, enzyme-26)
dobj(inhibit-22, system-27)
det(dose-30, a-29)
prep_at(inhibit-22, dose-30)
num(mg/kg/day-33, 2-32)
prep_of(dose-30, mg/kg/day-33)

Therefore/RB ,/, diphenoxylate/NN has/VBZ the/DT potential/NN to/TO prolong/VB the/DT biological/JJ half-lives/NNS of/IN drugs/NNS for/IN which/WDT the/DT rate/NN of/IN elimination/NN is/VBZ dependent/JJ on/IN the/DT microsomal/JJ drug/NN metabolizing/NN enzyme/NN system/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN diphenoxylate)) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB prolong) (NP (NP (DT the) (JJ biological) (NNS half-lives)) (PP (IN of) (NP (NP (NNS drugs)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN elimination)))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (DT the) (JJ microsomal) (NN drug) (NN metabolizing) (NN enzyme) (NN system)))))))))))))))) (. .))))

advmod(has-4, Therefore-1)
nsubj(has-4, diphenoxylate-3)
root(ROOT-0, has-4)
det(potential-6, the-5)
dobj(has-4, potential-6)
aux(prolong-8, to-7)
infmod(potential-6, prolong-8)
det(half-lives-11, the-9)
amod(half-lives-11, biological-10)
dobj(prolong-8, half-lives-11)
prep_of(half-lives-11, drugs-13)
rel(dependent-21, which-15)
det(rate-17, the-16)
nsubj(dependent-21, rate-17)
prep_of(rate-17, elimination-19)
cop(dependent-21, is-20)
rcmod(drugs-13, dependent-21)
det(system-28, the-23)
amod(system-28, microsomal-24)
nn(system-28, drug-25)
nn(system-28, metabolizing-26)
nn(system-28, enzyme-27)
prep_on(dependent-21, system-28)

Disulfiram/NN appears/VBZ to/TO decrease/VB the/DT rate/NN at/IN which/WDT certain/JJ drugs/NNS are/VBP metabolized/VBN and/CC therefore/RB may/MD increase/VB the/DT blood/NN levels/NNS and/CC the/DT possibility/NN of/IN clinical/JJ toxicity/NN of/IN drugs/NNS given/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Disulfiram)) (VP (VP (VBZ appears) (S (VP (TO to) (VP (VB decrease) (NP (NP (DT the) (NN rate)) (SBAR (WHPP (IN at) (WHNP (WDT which))) (S (NP (JJ certain) (NNS drugs)) (VP (VBP are) (VP (VBN metabolized)))))))))) (CC and) (ADVP (RB therefore)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN blood) (NNS levels)) (CC and) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (JJ clinical) (NN toxicity)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN given) (ADVP (RB concomitantly))))))))))))) (. .))))

nsubj(appears-2, Disulfiram-1)
xsubj(decrease-4, Disulfiram-1)
root(ROOT-0, appears-2)
aux(decrease-4, to-3)
xcomp(appears-2, decrease-4)
det(rate-6, the-5)
dobj(decrease-4, rate-6)
rel(metabolized-12, which-8)
amod(drugs-10, certain-9)
nsubjpass(metabolized-12, drugs-10)
auxpass(metabolized-12, are-11)
rcmod(rate-6, metabolized-12)
advmod(appears-2, therefore-14)
conj_and(appears-2, therefore-14)
aux(increase-16, may-15)
conj_and(appears-2, increase-16)
det(levels-19, the-17)
nn(levels-19, blood-18)
dobj(increase-16, levels-19)
det(possibility-22, the-21)
conj_and(levels-19, possibility-22)
amod(toxicity-25, clinical-24)
prep_of(possibility-22, toxicity-25)
prep_of(toxicity-25, drugs-27)
partmod(drugs-27, given-28)
advmod(given-28, concomitantly-29)

DISULFIRAM/NN SHOULD/MD BE/VB USED/VBN WITH/IN CAUTION/NN IN/IN THOSE/DT PATIENTS/NNS REVEIVING/VBG PHENYTOIN/NN AND/CC ITS/PRP$ CONGENER/NN S/NNS ./.

(ROOT (S1 (S (S (NP (NN DISULFIRAM)) (VP (MD SHOULD) (VP (VB BE) (VP (VBN USED) (PP (IN WITH) (NP (NP (NN CAUTION)) (PP (IN IN) (NP (NP (DT THOSE) (NNS PATIENTS)) (VP (VBG REVEIVING) (NP (NP (NN PHENYTOIN)) (CC AND) (NP (PRP$ ITS) (NN CONGENER) (NNS S)))))))))))) (. .))))

nsubjpass(USED-4, DISULFIRAM-1)
aux(USED-4, SHOULD-2)
auxpass(USED-4, BE-3)
root(ROOT-0, USED-4)
prep_with(USED-4, CAUTION-6)
det(PATIENTS-9, THOSE-8)
prep_in(CAUTION-6, PATIENTS-9)
partmod(PATIENTS-9, REVEIVING-10)
dobj(REVEIVING-10, PHENYTOIN-11)
poss(S-15, ITS-13)
nn(S-15, CONGENER-14)
conj_and(PHENYTOIN-11, S-15)

SINCE/IN THE/DT CONCOMITANT/JJ ADMINISTRATION/NN OF/IN THESE/DT TWO/CD DRUGS/NNS CAN/MD LEAD/VB TO/TO PHENYTOIN/NN INTOXICATION/NN ,/, PRIOR/JJ TO/TO ADMINISTERING/VBG DISULFIRAM/NN TO/TO A/DT PATIENT/NN ON/IN PHENYTOIN/NN THERAPY/NN ,/, A/DT BASELINE/NN PHENYTOIN/NN SERUM/NN LEVEL/NN SHOULD/MD BE/VB OBTAINED/VBN ./.

(ROOT (S1 (S (SBAR (IN SINCE) (S (NP (NP (DT THE) (JJ CONCOMITANT) (NN ADMINISTRATION)) (PP (IN OF) (NP (DT THESE) (CD TWO) (NNS DRUGS)))) (VP (MD CAN) (VP (VB LEAD) (PP (TO TO) (NP (NN PHENYTOIN) (NN INTOXICATION))))))) (, ,) (PP (JJ PRIOR) (TO TO) (S (VP (VBG ADMINISTERING) (NP (NN DISULFIRAM)) (PP (TO TO) (NP (NP (DT A) (NN PATIENT)) (PP (IN ON) (NP (NN PHENYTOIN) (NN THERAPY)))))))) (, ,) (NP (DT A) (NN BASELINE) (NN PHENYTOIN) (NN SERUM) (NN LEVEL)) (VP (MD SHOULD) (VP (VB BE) (VP (VBN OBTAINED)))) (. .))))

mark(LEAD-10, SINCE-1)
det(ADMINISTRATION-4, THE-2)
amod(ADMINISTRATION-4, CONCOMITANT-3)
nsubj(LEAD-10, ADMINISTRATION-4)
det(DRUGS-8, THESE-6)
num(DRUGS-8, TWO-7)
prep_of(ADMINISTRATION-4, DRUGS-8)
aux(LEAD-10, CAN-9)
advcl(OBTAINED-33, LEAD-10)
nn(INTOXICATION-13, PHENYTOIN-12)
prep_to(LEAD-10, INTOXICATION-13)
prepc_prior_to(OBTAINED-33, ADMINISTERING-17)
dobj(ADMINISTERING-17, DISULFIRAM-18)
det(PATIENT-21, A-20)
prep_to(ADMINISTERING-17, PATIENT-21)
nn(THERAPY-24, PHENYTOIN-23)
prep_on(PATIENT-21, THERAPY-24)
det(LEVEL-30, A-26)
nn(LEVEL-30, BASELINE-27)
nn(LEVEL-30, PHENYTOIN-28)
nn(LEVEL-30, SERUM-29)
nsubjpass(OBTAINED-33, LEVEL-30)
aux(OBTAINED-33, SHOULD-31)
auxpass(OBTAINED-33, BE-32)
root(ROOT-0, OBTAINED-33)

SERUM/NN LEVELS/NNS OF/IN PHENYTOIN/NN SHOULD/MD BE/VB DETERMINED/VBN ON/IN DIFFERENT/JJ DAYS/NNS FOR/IN EVIDENCE/NN OF/IN AN/DT INCREASE/NN OR/CC FOR/IN A/DT CONTINUING/VBG RISE/NN IN/IN LEVELS/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN SERUM) (NNS LEVELS)) (PP (IN OF) (NP (NN PHENYTOIN)))) (VP (MD SHOULD) (VP (VB BE) (VP (VBN DETERMINED) (PP (IN ON) (NP (NP (JJ DIFFERENT) (NNS DAYS)) (PP (PP (IN FOR) (NP (NP (NN EVIDENCE)) (PP (IN OF) (NP (DT AN) (NN INCREASE))))) (CC OR) (PP (IN FOR) (NP (NP (DT A) (VBG CONTINUING) (NN RISE)) (PP (IN IN) (NP (NNS LEVELS)))))))))))) (. .))))

nn(LEVELS-2, SERUM-1)
nsubjpass(DETERMINED-7, LEVELS-2)
prep_of(LEVELS-2, PHENYTOIN-4)
aux(DETERMINED-7, SHOULD-5)
auxpass(DETERMINED-7, BE-6)
root(ROOT-0, DETERMINED-7)
amod(DAYS-10, DIFFERENT-9)
prep_on(DETERMINED-7, DAYS-10)
prep_for(DAYS-10, EVIDENCE-12)
det(INCREASE-15, AN-14)
prep_of(EVIDENCE-12, INCREASE-15)
det(RISE-20, A-18)
amod(RISE-20, CONTINUING-19)
conj_or(EVIDENCE-12, RISE-20)
prep_in(RISE-20, LEVELS-22)

It/PRP may/MD be/VB necessary/JJ to/TO adjust/VB the/DT dosage/NN of/IN oral/JJ anticoagulants/NNS upon/IN beginning/NN or/CC stopping/JJ disulfiram/NN ./. since/IN disulfiram/NN may/MD prolong/VB prothrombin/NN time/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (MD may) (VP (VB be) (ADJP (JJ necessary) (S (S (VP (TO to) (VP (VB adjust) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (JJ oral) (NNS anticoagulants)))) (PP (IN upon) (NP (NP (NN beginning)) (CC or) (NP (JJ stopping) (NN disulfiram))))))) (. .))) (SBAR (IN since) (S (NP (NN disulfiram)) (VP (MD may) (VP (VB prolong) (NP (NN prothrombin) (NN time))))))))) (. .))))

nsubj(necessary-4, It-1)
aux(necessary-4, may-2)
cop(necessary-4, be-3)
root(ROOT-0, necessary-4)
aux(adjust-6, to-5)
dep(necessary-4, adjust-6)
det(dosage-8, the-7)
dobj(adjust-6, dosage-8)
amod(anticoagulants-11, oral-10)
prep_of(dosage-8, anticoagulants-11)
prep_upon(adjust-6, beginning-13)
amod(disulfiram-16, stopping-15)
conj_or(beginning-13, disulfiram-16)
mark(prolong-21, since-18)
nsubj(prolong-21, disulfiram-19)
aux(prolong-21, may-20)
advcl(necessary-4, prolong-21)
nn(time-23, prothrombin-22)
dobj(prolong-21, time-23)

Patients/NNS taking/VBG isoniazid/NN when/WRB disulfiram/NN is/VBZ given/VBN should/MD be/VB observed/VBN for/IN the/DT appearance/NN of/IN unsteady/NN gait/NN or/CC marked/JJ changes/NNS in/IN mental/JJ status/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NP (NN isoniazid)) (SBAR (WHADVP (WRB when)) (S (NP (NN disulfiram)) (VP (VBZ is) (VP (VBN given)))))))) (VP (MD should) (VP (VB be) (VP (VBN observed) (PP (IN for) (NP (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NN unsteady) (NN gait)))) (CC or) (NP (NP (JJ marked) (NNS changes)) (PP (IN in) (NP (JJ mental) (NN status))))))))) (: ;)) (. .))))

nsubjpass(observed-10, Patients-1)
partmod(Patients-1, taking-2)
dobj(taking-2, isoniazid-3)
tmod(given-7, isoniazid-3)
advmod(given-7, when-4)
nsubjpass(given-7, disulfiram-5)
auxpass(given-7, is-6)
dep(isoniazid-3, given-7)
aux(observed-10, should-8)
auxpass(observed-10, be-9)
root(ROOT-0, observed-10)
det(appearance-13, the-12)
prep_for(observed-10, appearance-13)
nn(gait-16, unsteady-15)
prep_of(appearance-13, gait-16)
amod(changes-19, marked-18)
conj_or(appearance-13, changes-19)
amod(status-22, mental-21)
prep_in(changes-19, status-22)

the/DT disulfiram/NN should/MD be/VB discontinued/VBN if/IN such/JJ signs/NNS appear/VBP ./.

(ROOT (S1 (S (S (NP (DT the) (NN disulfiram)) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (SBAR (IN if) (S (NP (JJ such) (NNS signs)) (VP (VBP appear)))))))) (. .))))

det(disulfiram-2, the-1)
nsubjpass(discontinued-5, disulfiram-2)
aux(discontinued-5, should-3)
auxpass(discontinued-5, be-4)
root(ROOT-0, discontinued-5)
mark(appear-9, if-6)
amod(signs-8, such-7)
nsubj(appear-9, signs-8)
advcl(discontinued-5, appear-9)

In/IN rats/NNS ,/, simultaneous/JJ ingestion/NN of/IN disulfiram/NN and/CC nitrite/NN in/IN the/DT diet/NN for/IN 78/CD weeks/NNS has/VBZ been/VBN reported/VBN to/TO cause/VB tumors/NNS ,/, and/CC it/PRP has/VBZ been/VBN suggested/VBN that/IN disulfiram/NN may/MD react/VB with/IN nitrites/NNS in/IN the/DT rat/NN stomach/NN to/TO form/VB a/DT nitrosamine/NN ,/, which/WDT is/VBZ tumorigenic/JJ ./.

(ROOT (S1 (S (S (S (PP (IN In) (NP (NNS rats))) (, ,) (NP (NP (JJ simultaneous) (NN ingestion)) (PP (IN of) (NP (NP (NN disulfiram)) (CC and) (NP (NN nitrite)))) (PP (IN in) (NP (NP (DT the) (NN diet)) (PP (IN for) (NP (CD 78) (NNS weeks)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (NNS tumors))))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (SBAR (IN that) (S (NP (NN disulfiram)) (VP (MD may) (VP (VB react) (PP (IN with) (NP (NP (NNS nitrites)) (PP (IN in) (NP (DT the) (NN rat) (NN stomach))))) (S (VP (TO to) (VP (VB form) (NP (NP (DT a) (NN nitrosamine)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ tumorigenic)))))))))))))))))) (. .))))

prep_in(reported-18, rats-2)
amod(ingestion-5, simultaneous-4)
nsubjpass(reported-18, ingestion-5)
xsubj(cause-20, ingestion-5)
prep_of(ingestion-5, disulfiram-7)
conj_and(disulfiram-7, nitrite-9)
det(diet-12, the-11)
prep_in(ingestion-5, diet-12)
num(weeks-15, 78-14)
prep_for(diet-12, weeks-15)
aux(reported-18, has-16)
auxpass(reported-18, been-17)
root(ROOT-0, reported-18)
aux(cause-20, to-19)
xcomp(reported-18, cause-20)
dobj(cause-20, tumors-21)
nsubjpass(suggested-27, it-24)
aux(suggested-27, has-25)
auxpass(suggested-27, been-26)
conj_and(reported-18, suggested-27)
complm(react-31, that-28)
nsubj(react-31, disulfiram-29)
xsubj(form-39, disulfiram-29)
aux(react-31, may-30)
ccomp(suggested-27, react-31)
prep_with(react-31, nitrites-33)
det(stomach-37, the-35)
nn(stomach-37, rat-36)
prep_in(nitrites-33, stomach-37)
aux(form-39, to-38)
xcomp(react-31, form-39)
det(nitrosamine-41, a-40)
dobj(form-39, nitrosamine-41)
nsubj(tumorigenic-45, nitrosamine-41)
cop(tumorigenic-45, is-44)
rcmod(nitrosamine-41, tumorigenic-45)

Disulfiram/NN alone/RB in/IN the/DT rat/NN @/NN s/NN diet/NN did/VBD not/RB lead/VB to/TO such/JJ tumors/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Disulfiram)) (ADVP (RB alone)) (PP (IN in) (NP (DT the) (NN rat) (NN @) (NN s) (NN diet)))) (VP (VBD did) (RB not) (VP (VB lead) (PP (TO to) (NP (JJ such) (NNS tumors)))))) (. .))))

nsubj(lead-11, Disulfiram-1)
advmod(Disulfiram-1, alone-2)
det(diet-8, the-4)
nn(diet-8, rat-5)
nn(diet-8, @-6)
nn(diet-8, s-7)
prep_in(Disulfiram-1, diet-8)
aux(lead-11, did-9)
neg(lead-11, not-10)
root(ROOT-0, lead-11)
amod(tumors-14, such-13)
prep_to(lead-11, tumors-14)

There/EX have/VBP been/VBN no/DT formal/JJ clinical/JJ studies/NNS to/TO evaluate/VB the/DT drug/NN interactions/NNS of/IN TAXOTERE/NN with/IN other/JJ medications/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (DT no) (JJ formal) (JJ clinical) (NNS studies)) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN drug) (NNS interactions)) (PP (IN of) (NP (NN TAXOTERE))) (PP (IN with) (NP (JJ other) (NNS medications)))))))))) (. .))))

expl(studies-7, There-1)
aux(studies-7, have-2)
cop(studies-7, been-3)
det(studies-7, no-4)
amod(studies-7, formal-5)
amod(studies-7, clinical-6)
root(ROOT-0, studies-7)
aux(evaluate-9, to-8)
xcomp(studies-7, evaluate-9)
det(interactions-12, the-10)
nn(interactions-12, drug-11)
dobj(evaluate-9, interactions-12)
prep_of(interactions-12, TAXOTERE-14)
amod(medications-17, other-16)
prep_with(interactions-12, medications-17)

In/FW vitro/FW studies/NNS have/VBP shown/VBN that/IN the/DT metabolism/NN of/IN docetaxel/NN may/MD be/VB modified/VBN by/IN the/DT concomitant/JJ administration/NN of/IN compounds/NNS that/WDT induce/VBP ,/, inhibit/VBP ,/, or/CC are/VBP metabolized/VBN by/IN cytochrome/NN P450/NN 3A4/NN ,/, such/JJ as/IN cyclosporine/NN ,/, terfenadine/NN ,/, ketoconazole/NN ,/, erythromycin/NN ,/, and/CC troleandomycin/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN docetaxel)))) (VP (MD may) (VP (VB be) (VP (VBN modified) (PP (IN by) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NNS compounds)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP induce)) (, ,) (VP (VBP inhibit)) (, ,) (CC or) (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (NN cytochrome) (NN P450) (NN 3A4)))))))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN cyclosporine)) (, ,) (NP (NN terfenadine)) (, ,) (NP (NN ketoconazole)) (, ,) (NP (NN erythromycin)) (, ,) (CC and) (NP (NN troleandomycin)))))))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
complm(modified-13, that-6)
det(metabolism-8, the-7)
nsubjpass(modified-13, metabolism-8)
prep_of(metabolism-8, docetaxel-10)
aux(modified-13, may-11)
auxpass(modified-13, be-12)
ccomp(shown-5, modified-13)
det(administration-17, the-15)
amod(administration-17, concomitant-16)
agent(modified-13, administration-17)
prep_of(administration-17, compounds-19)
nsubj(induce-21, compounds-19)
rcmod(compounds-19, induce-21)
conj_or(induce-21, inhibit-23)
auxpass(metabolized-27, are-26)
conj_or(induce-21, metabolized-27)
nn(3A4-31, cytochrome-29)
nn(3A4-31, P450-30)
agent(metabolized-27, 3A4-31)
prep_such_as(compounds-19, cyclosporine-35)
conj_and(cyclosporine-35, terfenadine-37)
conj_and(cyclosporine-35, ketoconazole-39)
conj_and(cyclosporine-35, erythromycin-41)
conj_and(cyclosporine-35, troleandomycin-44)

Caution/NN should/MD be/VB exercised/VBN with/IN these/DT drugs/NNS when/WRB treating/VBG patients/NNS receiving/VBG TAXOTERE/NN as/IN there/EX is/VBZ a/DT potential/NN for/IN a/DT significant/JJ interaction/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (PP (IN with) (NP (DT these) (NNS drugs))) (SBAR (WHADVP (WRB when)) (S (VP (VBG treating) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN TAXOTERE) (SBAR (IN as) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN potential)) (PP (IN for) (NP (DT a) (JJ significant) (NN interaction))))))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
det(drugs-7, these-6)
prep_with(exercised-4, drugs-7)
advmod(treating-9, when-8)
advcl(exercised-4, treating-9)
dobj(treating-9, patients-10)
partmod(patients-10, receiving-11)
dobj(receiving-11, TAXOTERE-12)
mark(is-15, as-13)
expl(is-15, there-14)
ccomp(TAXOTERE-12, is-15)
det(potential-17, a-16)
nsubj(is-15, potential-17)
det(interaction-21, a-19)
amod(interaction-21, significant-20)
prep_for(potential-17, interaction-21)

Clinical/JJ trials/NNS have/VBP indicated/VBN that/IN Pulmozyme/NN can/MD be/VB effectively/RB and/CC safely/RB used/VBN in/IN conjunction/NN with/IN standard/JJ cystic/JJ fibrosis/NN therapies/NNS including/VBG oral/JJ ,/, inhaled/JJ and/or/CC parenteral/JJ antibiotics/NNS ,/, bronchodilators/NNS ,/, enzyme/NN supplements/NNS ,/, vitamins/NNS ,/, oral/JJ or/CC inhaled/JJ corticosteroids/NNS ,/, and/CC analgesics/NNS ./.

(ROOT (S1 (S (S (NP (JJ Clinical) (NNS trials)) (VP (VBP have) (VP (VBN indicated) (SBAR (IN that) (S (NP (NN Pulmozyme)) (VP (MD can) (VP (VB be) (ADVP (ADVP (RB effectively)) (CC and) (ADVP (RB safely))) (VP (VBN used) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (NP (JJ standard) (JJ cystic) (NN fibrosis)) (NNS therapies)) (PP (VBG including) (NP (NP (ADJP (ADJP (JJ oral)) (, ,) (ADJP (JJ inhaled)) (CC and/or) (ADJP (JJ parenteral))) (NNS antibiotics)) (, ,) (NP (NNS bronchodilators)) (, ,) (NP (NN enzyme) (NNS supplements)) (, ,) (NP (NNS vitamins)) (, ,) (NP (JJ oral) (CC or) (JJ inhaled) (NNS corticosteroids)) (, ,) (CC and) (NP (NNS analgesics)))))))))))))))) (. .))))

amod(trials-2, Clinical-1)
nsubj(indicated-4, trials-2)
aux(indicated-4, have-3)
root(ROOT-0, indicated-4)
complm(used-12, that-5)
nsubjpass(used-12, Pulmozyme-6)
aux(used-12, can-7)
auxpass(used-12, be-8)
advmod(used-12, effectively-9)
conj_and(effectively-9, safely-11)
ccomp(indicated-4, used-12)
prep_in(used-12, conjunction-14)
amod(fibrosis-18, standard-16)
amod(fibrosis-18, cystic-17)
nn(therapies-19, fibrosis-18)
prep_with(conjunction-14, therapies-19)
amod(antibiotics-26, oral-21)
conj_and/or(oral-21, inhaled-23)
conj_and/or(oral-21, parenteral-25)
prep_including(therapies-19, antibiotics-26)
conj_and(antibiotics-26, bronchodilators-28)
nn(supplements-31, enzyme-30)
conj_and(antibiotics-26, supplements-31)
conj_and(antibiotics-26, vitamins-33)
amod(corticosteroids-38, oral-35)
conj_or(oral-35, inhaled-37)
conj_and(antibiotics-26, corticosteroids-38)
conj_and(antibiotics-26, analgesics-41)

Prior/JJ administration/NN of/IN succinylcholine/NN has/VBZ no/DT clinically/RB important/JJ effect/NN on/IN the/DT neuromuscular/JJ blocking/NN action/NN of/IN NUROMAX/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Prior) (NN administration)) (PP (IN of) (NP (NN succinylcholine)))) (VP (VBZ has) (NP (DT no) (ADJP (RB clinically) (JJ important)) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ neuromuscular) (NN blocking) (NN action)) (PP (IN of) (NP (NN NUROMAX))))))) (. .))))

amod(administration-2, Prior-1)
nsubj(has-5, administration-2)
prep_of(administration-2, succinylcholine-4)
root(ROOT-0, has-5)
det(effect-9, no-6)
advmod(important-8, clinically-7)
amod(effect-9, important-8)
dobj(has-5, effect-9)
det(action-14, the-11)
amod(action-14, neuromuscular-12)
nn(action-14, blocking-13)
prep_on(has-5, action-14)
prep_of(action-14, NUROMAX-16)

The/DT use/NN of/IN NUROMAX/NN before/IN succinylcholine/NN to/TO attenuate/VB some/DT of/IN the/DT side/JJ effects/NNS of/IN succinylcholine/NN has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN NUROMAX))) (PP (IN before) (NP (NP (NN succinylcholine)) (VP (TO to) (VP (VB attenuate) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (JJ side) (NNS effects)) (PP (IN of) (NP (NN succinylcholine))))))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(use-2, The-1)
nsubjpass(studied-19, use-2)
prep_of(use-2, NUROMAX-4)
prep_before(use-2, succinylcholine-6)
aux(attenuate-8, to-7)
dep(succinylcholine-6, attenuate-8)
dobj(attenuate-8, some-9)
det(effects-13, the-11)
amod(effects-13, side-12)
prep_of(some-9, effects-13)
prep_of(effects-13, succinylcholine-15)
aux(studied-19, has-16)
neg(studied-19, not-17)
auxpass(studied-19, been-18)
root(ROOT-0, studied-19)

There/EX are/VBP no/DT clinical/JJ data/NNS on/IN concomitant/JJ use/NN of/IN NUROMAX/NN and/CC other/JJ nondepolarizing/JJ neuromuscular/NN blocking/NN agents/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ clinical) (NNS data)) (PP (IN on) (NP (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN NUROMAX)))) (CC and) (NP (JJ other) (JJ nondepolarizing) (NN neuromuscular) (NN blocking) (NNS agents))))))) (. .))))

expl(are-2, There-1)
root(ROOT-0, are-2)
det(data-5, no-3)
amod(data-5, clinical-4)
nsubj(are-2, data-5)
amod(use-8, concomitant-7)
prep_on(data-5, use-8)
prep_of(use-8, NUROMAX-10)
amod(agents-16, other-12)
amod(agents-16, nondepolarizing-13)
nn(agents-16, neuromuscular-14)
nn(agents-16, blocking-15)
conj_and(use-8, agents-16)

Isoflurane/NN ,/, enflurane/NN ,/, and/CC halothane/NN decrease/VBP the/DT ED50/NN of/IN NUROMAX/NN by/IN 30/CD %/NN to/TO 45/CD %./NN

(ROOT (S1 (S (NP (NP (NN Isoflurane)) (, ,) (NP (NN enflurane)) (, ,) (CC and) (NP (NN halothane))) (VP (VBP decrease) (NP (NP (DT the) (NN ED50)) (PP (IN of) (NP (NN NUROMAX)))) (PP (IN by) (NP (CD 30) (NN %))) (PP (TO to) (NP (CD 45) (NN %.)))))))

nsubj(decrease-7, Isoflurane-1)
conj_and(Isoflurane-1, enflurane-3)
conj_and(Isoflurane-1, halothane-6)
root(ROOT-0, decrease-7)
det(ED50-9, the-8)
dobj(decrease-7, ED50-9)
prep_of(ED50-9, NUROMAX-11)
num(%-14, 30-13)
prep_by(decrease-7, %-14)
num(%.-17, 45-16)
prep_to(decrease-7, %.-17)

Other/JJ drugs/NNS which/WDT may/MD enhance/VB the/DT neuromuscular/JJ blocking/NN action/NN of/IN nondepolarizing/NN agent/NN s/NNS such/JJ as/IN NUROMAX/NN include/VBP certain/JJ antibiotics/NNS (/-LRB- e./FW g./FW ,/, aminoglycosides/NNS ,/, tetracyclines/NNS ,/, bacitracin/NN ,/, polymyxins/NNS ,/, lincomycin/NN ,/, clindamycin/NN ,/, colistin/NN ,/, and/CC sodium/NN colistimethate/NN )/-RRB- ,/, magnesium/NN salt/NN s/NNS ,/, lithium/NN ,/, local/JJ anesthetics/NNS ,/, procainamide/NN ,/, and/CC quinidine/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (JJ neuromuscular) (NN blocking) (NN action)) (PP (IN of) (NP (NP (NN nondepolarizing) (NN agent) (NNS s)) (PP (JJ such) (IN as) (NP (NN NUROMAX))))))))))) (VP (VBP include) (NP (NP (NP (JJ certain) (NNS antibiotics)) (PRN (-LRB- -LRB-) (FRAG (NP (FW e.) (FW g.)) (, ,) (NP (NNS aminoglycosides)) (, ,) (NP (NNS tetracyclines)) (, ,) (NP (NN bacitracin)) (, ,) (NP (NP (NNS polymyxins)) (, ,) (NP (NN lincomycin)) (, ,) (NP (NN clindamycin)) (, ,) (NP (NN colistin)) (, ,) (CC and) (NP (NN sodium) (NN colistimethate)))) (-RRB- -RRB-))) (, ,) (NP (NN magnesium) (NN salt) (NNS s)) (, ,) (NP (NN lithium)) (, ,) (NP (JJ local) (NNS anesthetics)) (, ,) (NP (NN procainamide)) (, ,) (CC and) (NP (NN quinidine))))) (. .))))

amod(drugs-2, Other-1)
nsubj(enhance-5, drugs-2)
nsubj(include-17, drugs-2)
aux(enhance-5, may-4)
rcmod(drugs-2, enhance-5)
det(action-9, the-6)
amod(action-9, neuromuscular-7)
nn(action-9, blocking-8)
dobj(enhance-5, action-9)
nn(s-13, nondepolarizing-11)
nn(s-13, agent-12)
prep_of(action-9, s-13)
prep_such_as(s-13, NUROMAX-16)
root(ROOT-0, include-17)
amod(antibiotics-19, certain-18)
dobj(include-17, antibiotics-19)
nn(g.-22, e.-21)
dep(antibiotics-19, g.-22)
dep(g.-22, aminoglycosides-24)
dep(g.-22, tetracyclines-26)
dep(g.-22, bacitracin-28)
dep(g.-22, polymyxins-30)
conj_and(polymyxins-30, lincomycin-32)
conj_and(polymyxins-30, clindamycin-34)
conj_and(polymyxins-30, colistin-36)
nn(colistimethate-40, sodium-39)
conj_and(polymyxins-30, colistimethate-40)
nn(s-45, magnesium-43)
nn(s-45, salt-44)
conj_and(antibiotics-19, s-45)
conj_and(antibiotics-19, lithium-47)
amod(anesthetics-50, local-49)
conj_and(antibiotics-19, anesthetics-50)
conj_and(antibiotics-19, procainamide-52)
conj_and(antibiotics-19, quinidine-55)

As/IN with/IN some/DT other/JJ nondepolarizing/JJ neuromuscular/JJ blocking/NN agents/NNS ,/, the/DT time/NN of/IN onset/NN of/IN neuromuscular/JJ block/NN induced/VBN by/IN NUROMAX/NN is/VBZ lengthened/VBN and/CC the/DT duration/NN of/IN block/NN is/VBZ shortened/VBD in/IN patients/NNS receiving/VBG phenytoin/NN or/CC carbamazepine/NN ./.

(ROOT (S1 (S (S (S (PP (IN As) (PP (IN with) (NP (DT some) (JJ other) (JJ nondepolarizing) (JJ neuromuscular) (NN blocking) (NNS agents)))) (, ,) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NP (NN onset)) (PP (IN of) (NP (NP (JJ neuromuscular) (NN block)) (VP (VBN induced) (PP (IN by) (NP (NN NUROMAX))))))))) (VP (VBZ is) (VP (VBN lengthened)))) (CC and) (S (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NN block)))) (VP (VBZ is) (VP (VBD shortened) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN phenytoin)) (CC or) (NP (NN carbamazepine)))))))))) (. .))))

prep(lengthened-21, As-1)
pcomp(As-1, with-2)
det(agents-8, some-3)
amod(agents-8, other-4)
amod(agents-8, nondepolarizing-5)
amod(agents-8, neuromuscular-6)
nn(agents-8, blocking-7)
prep_with(As-1, agents-8)
det(time-11, the-10)
nsubjpass(lengthened-21, time-11)
prep_of(time-11, onset-13)
amod(block-16, neuromuscular-15)
prep_of(onset-13, block-16)
partmod(block-16, induced-17)
agent(induced-17, NUROMAX-19)
auxpass(lengthened-21, is-20)
root(ROOT-0, lengthened-21)
det(duration-24, the-23)
nsubjpass(shortened-28, duration-24)
prep_of(duration-24, block-26)
auxpass(shortened-28, is-27)
conj_and(lengthened-21, shortened-28)
prep_in(shortened-28, patients-30)
partmod(patients-30, receiving-31)
dobj(receiving-31, phenytoin-32)
conj_or(phenytoin-32, carbamazepine-34)

Administration/NN of/IN doxapram/NN to/TO patients/NNS who/WP are/VBP receiving/VBG sympathomimetic/NN or/CC monoamine/NN oxidase/NN inhibiting/NN drugs/NNS may/MD result/VB in/IN an/DT additive/JJ pressor/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN doxapram))) (PP (TO to) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG receiving) (NP (NP (NP (NN sympathomimetic)) (CC or) (NP (NN monoamine) (NN oxidase))) (NN inhibiting) (NNS drugs))))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (DT an) (JJ additive) (JJ pressor) (NN effect)))))) (. .))))

nsubj(result-16, Administration-1)
prep_of(Administration-1, doxapram-3)
prep_to(Administration-1, patients-5)
nsubj(receiving-8, patients-5)
aux(receiving-8, are-7)
rcmod(patients-5, receiving-8)
nn(drugs-14, sympathomimetic-9)
nn(oxidase-12, monoamine-11)
conj_or(sympathomimetic-9, oxidase-12)
nn(drugs-14, inhibiting-13)
dobj(receiving-8, drugs-14)
aux(result-16, may-15)
root(ROOT-0, result-16)
det(effect-21, an-18)
amod(effect-21, additive-19)
amod(effect-21, pressor-20)
prep_in(result-16, effect-21)

In/IN patients/NNS who/WP have/VBP received/VBN muscle/NN relaxants/NNS ,/, doxapram/NN may/MD temporarily/RB mask/VB the/DT residual/JJ effects/NNS of/IN muscle/NN relaxant/NN drugs/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN received) (NP (NN muscle) (NNS relaxants)))))))) (, ,) (NP (NN doxapram)) (VP (MD may) (ADVP (RB temporarily)) (VP (VB mask) (NP (NP (DT the) (JJ residual) (NNS effects)) (PP (IN of) (NP (NN muscle) (NN relaxant) (NNS drugs))))))) (. .))))

nsubj(received-5, patients-2)
prep_in(mask-12, patients-2)
aux(received-5, have-4)
rcmod(patients-2, received-5)
nn(relaxants-7, muscle-6)
dobj(received-5, relaxants-7)
nsubj(mask-12, doxapram-9)
aux(mask-12, may-10)
advmod(mask-12, temporarily-11)
root(ROOT-0, mask-12)
det(effects-15, the-13)
amod(effects-15, residual-14)
dobj(mask-12, effects-15)
nn(drugs-19, muscle-17)
nn(drugs-19, relaxant-18)
prep_of(effects-15, drugs-19)

In/IN patients/NNS who/WP have/VBP received/VBN general/JJ anesthesia/NN utilizing/VBG a/DT volatile/JJ agent/NN known/VBN to/TO sensitize/VB the/DT myocardium/NN to/TO catecholamines/NNS ,/, administration/NN of/IN doxapram/NN should/MD be/VB delayed/VBN until/IN the/DT volatile/JJ agent/NN has/VBZ been/VBN excreted/VBN in/IN order/NN to/TO lessen/VB the/DT potential/NN for/IN arrhythmias/NNS ,/, including/VBG ventricular/JJ tachycardia/NN and/CC ventricular/JJ fibrillation/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN received) (NP (NP (JJ general) (NN anesthesia)) (VP (VBG utilizing) (NP (NP (DT a) (JJ volatile) (NN agent)) (VP (VBN known) (S (VP (TO to) (VP (VB sensitize) (NP (NP (DT the) (NN myocardium)) (PP (TO to) (NP (NNS catecholamines))))))))))))))))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NN doxapram)))) (VP (MD should) (VP (VB be) (VP (VBN delayed) (SBAR (IN until) (S (NP (DT the) (JJ volatile) (NN agent)) (VP (VBZ has) (VP (VBN been) (VP (VBN excreted) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB lessen) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (NNS arrhythmias)) (, ,) (PP (VBG including) (NP (NP (JJ ventricular) (NN tachycardia)) (CC and) (NP (JJ ventricular) (NN fibrillation)))))))))))))))))))) (. .))))

nsubj(received-5, patients-2)
prep_in(delayed-25, patients-2)
aux(received-5, have-4)
rcmod(patients-2, received-5)
amod(anesthesia-7, general-6)
dobj(received-5, anesthesia-7)
partmod(anesthesia-7, utilizing-8)
det(agent-11, a-9)
amod(agent-11, volatile-10)
dobj(utilizing-8, agent-11)
xsubj(sensitize-14, agent-11)
partmod(agent-11, known-12)
aux(sensitize-14, to-13)
xcomp(known-12, sensitize-14)
det(myocardium-16, the-15)
dobj(sensitize-14, myocardium-16)
prep_to(myocardium-16, catecholamines-18)
nsubjpass(delayed-25, administration-20)
prep_of(administration-20, doxapram-22)
aux(delayed-25, should-23)
auxpass(delayed-25, be-24)
root(ROOT-0, delayed-25)
mark(excreted-32, until-26)
det(agent-29, the-27)
amod(agent-29, volatile-28)
nsubjpass(excreted-32, agent-29)
aux(excreted-32, has-30)
auxpass(excreted-32, been-31)
advcl(delayed-25, excreted-32)
mark(lessen-36, in-33)
dep(lessen-36, order-34)
aux(lessen-36, to-35)
purpcl(excreted-32, lessen-36)
det(potential-38, the-37)
dobj(lessen-36, potential-38)
prep_for(potential-38, arrhythmias-40)
amod(tachycardia-44, ventricular-43)
prep_including(arrhythmias-40, tachycardia-44)
amod(fibrillation-47, ventricular-46)
conj_and(tachycardia-44, fibrillation-47)

Drug/NN interaction/NN studies/NNS with/IN Xigris/NN have/VBP not/RB been/VBN performed/VBN in/IN patients/NNS with/IN severe/JJ sepsis/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (NN Xigris)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN performed) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ severe) (NN sepsis))))))))) (. .))))

nn(studies-3, Drug-1)
nn(studies-3, interaction-2)
nsubjpass(performed-9, studies-3)
prep_with(studies-3, Xigris-5)
aux(performed-9, have-6)
neg(performed-9, not-7)
auxpass(performed-9, been-8)
root(ROOT-0, performed-9)
prep_in(performed-9, patients-11)
amod(sepsis-14, severe-13)
prep_with(patients-11, sepsis-14)

However/RB ,/, since/IN there/EX is/VBZ an/DT increased/VBN risk/NN of/IN bleeding/JJ with/IN Xigris/NN ,/, caution/NN should/MD be/VB employed/VBN when/WRB Xigris/NN is/VBZ used/VBN with/IN other/JJ drugs/NNS that/WDT affect/VBP hemostasis/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (SBAR (IN since) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (JJ bleeding))) (PP (IN with) (NP (NN Xigris))))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN employed) (SBAR (WHADVP (WRB when)) (S (NP (NN Xigris)) (VP (VBZ is) (VP (VBN used) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NN hemostasis))))))))))))))) (. .))))

advmod(employed-17, However-1)
mark(is-5, since-3)
expl(is-5, there-4)
advcl(employed-17, is-5)
det(risk-8, an-6)
amod(risk-8, increased-7)
nsubj(is-5, risk-8)
prep_of(risk-8, bleeding-10)
prep_with(risk-8, Xigris-12)
nsubjpass(employed-17, caution-14)
aux(employed-17, should-15)
auxpass(employed-17, be-16)
root(ROOT-0, employed-17)
advmod(used-21, when-18)
nsubjpass(used-21, Xigris-19)
auxpass(used-21, is-20)
advcl(employed-17, used-21)
amod(drugs-24, other-23)
prep_with(used-21, drugs-24)
nsubj(affect-26, drugs-24)
rcmod(drugs-24, affect-26)
dobj(affect-26, hemostasis-27)

Approximately/RB 2/3/CD of/IN the/DT patients/NNS in/IN the/DT Phase/NN 3/CD study/NN received/VBD either/DT prophylactic/JJ low/JJ dose/NN heparin/NN (/-LRB- unfractionated/JJ heparin/NN up/RB to/TO 15,000/CD units/day/NN )/-RRB- or/CC prophylactic/JJ doses/NNS of/IN low/JJ molecular/JJ weight/NN heparins/NNS as/IN indicated/VBN in/IN the/DT prescribing/JJ information/NN for/IN the/DT specific/JJ products/NNS ./.

(ROOT (S1 (S (S (NP (NP (RB Approximately) (CD 2/3)) (PP (IN of) (NP (NP (DT the) (NNS patients)) (PP (IN in) (NP (DT the) (NN Phase) (CD 3) (NN study)))))) (VP (VBD received) (NP (NP (NP (DT either) (JJ prophylactic) (JJ low) (NN dose) (NN heparin)) (PRN (-LRB- -LRB-) (NP (NP (JJ unfractionated) (NN heparin)) (ADJP (QP (RB up) (TO to) (CD 15,000)) (NN units/day))) (-RRB- -RRB-))) (CC or) (NP (NP (JJ prophylactic) (NNS doses)) (PP (IN of) (NP (NP (JJ low) (JJ molecular) (NN weight) (NNS heparins)) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN in) (NP (NP (DT the) (JJ prescribing) (NN information)) (PP (IN for) (NP (DT the) (JJ specific) (NNS products)))))))))))))) (. .))))

advmod(2/3-2, Approximately-1)
nsubj(received-11, 2/3-2)
det(patients-5, the-4)
prep_of(2/3-2, patients-5)
det(study-10, the-7)
nn(study-10, Phase-8)
num(study-10, 3-9)
prep_in(patients-5, study-10)
root(ROOT-0, received-11)
det(heparin-16, either-12)
amod(heparin-16, prophylactic-13)
amod(heparin-16, low-14)
nn(heparin-16, dose-15)
dobj(received-11, heparin-16)
amod(heparin-19, unfractionated-18)
dep(heparin-16, heparin-19)
quantmod(15,000-22, up-20)
dep(15,000-22, to-21)
dep(units/day-23, 15,000-22)
dep(heparin-19, units/day-23)
amod(doses-27, prophylactic-26)
conj_or(heparin-16, doses-27)
amod(heparins-32, low-29)
amod(heparins-32, molecular-30)
nn(heparins-32, weight-31)
prep_of(doses-27, heparins-32)
mark(indicated-34, as-33)
dep(heparins-32, indicated-34)
det(information-38, the-36)
amod(information-38, prescribing-37)
prep_in(indicated-34, information-38)
det(products-42, the-40)
amod(products-42, specific-41)
prep_for(information-38, products-42)

Concomitant/JJ use/NN of/IN prophylactic/JJ low/JJ dose/NN heparin/NN did/VBD not/RB appear/VB to/TO affect/VB safety/NN ,/, however/RB ,/, its/PRP$ effects/NNS on/IN the/DT efficacy/NN of/IN Xigris/NN have/VBP not/RB been/VBN evaluated/VBN in/IN an/DT adequate/JJ and/CC well-controlled/JJ clinical/JJ trial/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (JJ prophylactic) (JJ low) (NN dose) (NN heparin)))) (VP (VBD did) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB affect) (NP (NN safety)) (, ,) (S (ADVP (RB however)) (, ,) (NP (NP (PRP$ its) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NN Xigris)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN evaluated) (PP (IN in) (NP (DT an) (ADJP (ADJP (JJ adequate)) (CC and) (ADJP (JJ well-controlled))) (JJ clinical) (NN trial))))))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(appear-10, use-2)
xsubj(affect-12, use-2)
amod(heparin-7, prophylactic-4)
amod(heparin-7, low-5)
nn(heparin-7, dose-6)
prep_of(use-2, heparin-7)
aux(appear-10, did-8)
neg(appear-10, not-9)
root(ROOT-0, appear-10)
aux(affect-12, to-11)
xcomp(appear-10, affect-12)
dobj(affect-12, safety-13)
advmod(evaluated-27, however-15)
poss(effects-18, its-17)
nsubjpass(evaluated-27, effects-18)
det(efficacy-21, the-20)
prep_on(effects-18, efficacy-21)
prep_of(efficacy-21, Xigris-23)
aux(evaluated-27, have-24)
neg(evaluated-27, not-25)
auxpass(evaluated-27, been-26)
dep(affect-12, evaluated-27)
det(trial-34, an-29)
amod(trial-34, adequate-30)
conj_and(adequate-30, well-controlled-32)
amod(trial-34, clinical-33)
prep_in(evaluated-27, trial-34)

Drug/NN /Laboratory/NN Test/NN Interaction/NN Because/IN Xigris/NN may/MD affect/VB the/DT APTT/NN assay/NN ,/, Xigris/NN present/NN in/IN plasma/NN samples/NNS may/MD interfere/VB with/IN one-stage/JJ coagulation/NN assays/NNS based/VBN on/IN the/DT APTT/NN (/-LRB- such/JJ as/IN factor/NN VIII/NN ,/, IX/NN ,/, and/CC XI/NN assays/NNS )./CD

(ROOT (S1 (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NN Interaction)) (SBAR (IN Because) (S (NP (NN Xigris)) (VP (MD may) (VP (VB affect) (NP (DT the) (NN APTT) (NN assay)))))) (, ,) (S (NP (NP (NN Xigris) (NN present)) (PP (IN in) (NP (NN plasma) (NNS samples)))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (NP (JJ one-stage) (NN coagulation) (NNS assays)) (VP (VBN based) (PP (IN on) (NP (DT the) (NN APTT)))) (-LRB- -LRB-) (PP (JJ such) (IN as) (NP (NN factor) (NN VIII)))) (, ,) (NP (NN IX)) (, ,) (CC and) (NP (NN XI) (NNS assays) (CD -RRB-.))))))))))

nn(Interaction-4, Drug-1)
nn(Interaction-4, /Laboratory-2)
nn(Interaction-4, Test-3)
dep(interfere-19, Interaction-4)
mark(affect-8, Because-5)
nsubj(affect-8, Xigris-6)
aux(affect-8, may-7)
dep(interfere-19, affect-8)
det(assay-11, the-9)
nn(assay-11, APTT-10)
dobj(affect-8, assay-11)
nn(present-14, Xigris-13)
nsubj(interfere-19, present-14)
nn(samples-17, plasma-16)
prep_in(present-14, samples-17)
aux(interfere-19, may-18)
root(ROOT-0, interfere-19)
amod(assays-23, one-stage-21)
nn(assays-23, coagulation-22)
prep_with(interfere-19, assays-23)
partmod(assays-23, based-24)
det(APTT-27, the-26)
prep_on(based-24, APTT-27)
nn(VIII-32, factor-31)
prep_such_as(assays-23, VIII-32)
conj_and(assays-23, IX-34)
nn(assays-38, XI-37)
conj_and(assays-23, assays-38)
num(assays-38, -RRB-.-39)

Xigris/NN present/JJ in/IN plasma/NN samples/NNS does/VBZ not/RB interfere/VB with/IN one-stage/JJ factor/NN assays/NNS based/VBN on/IN the/DT PT/NN (/-LRB- such/JJ as/IN factor/NN II/CD ,/, V/NN ,/, VII/NN ,/, and/CC X/NN assays/NNS )./NN

(ROOT (S1 (S (NP (NP (NN Xigris)) (ADJP (JJ present) (PP (IN in) (NP (NN plasma) (NNS samples))))) (VP (VBZ does) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (JJ one-stage) (NN factor) (NNS assays)) (VP (VBN based) (PP (IN on) (NP (DT the) (NN PT) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN factor) (CD II)) (, ,) (NP (NN V)) (, ,) (NP (NN VII)) (, ,) (CC and) (NP (NN X) (NNS assays)))))) (NN -RRB-.)))))))))))

nsubj(interfere-8, Xigris-1)
amod(Xigris-1, present-2)
nn(samples-5, plasma-4)
prep_in(present-2, samples-5)
aux(interfere-8, does-6)
neg(interfere-8, not-7)
root(ROOT-0, interfere-8)
amod(assays-12, one-stage-10)
nn(assays-12, factor-11)
prep_with(interfere-8, assays-12)
partmod(assays-12, based-13)
det(-RRB-.-30, the-15)
nn(-RRB-.-30, PT-16)
prep_such_as(-RRB-.-30, factor-20)
num(factor-20, II-21)
conj_and(factor-20, V-23)
conj_and(factor-20, VII-25)
nn(assays-29, X-28)
conj_and(factor-20, assays-29)
prep_on(based-13, -RRB-.-30)

Steroids/NNS enhance/VBP the/DT renal/JJ toxicity/NN of/IN edetate/NN calcium/NN disodium/NN in/IN animals./NN 7/CD Edetate/NN calcium/NN disodium/NN interferes/VBZ with/IN the/DT action/NN of/IN zinc/NN insulin/NN preparations/NNS by/IN chelating/NN the/DT zinc/NN ./. 7/CD ./.

(ROOT (S1 (S (S (NP (NNS Steroids)) (VP (VBP enhance) (NP (NP (DT the) (JJ renal) (NN toxicity)) (PP (IN of) (NP (NN edetate) (NN calcium) (NN disodium))) (SBAR (IN in) (S (NP (NN animals.) (CD 7) (NN Edetate) (NN calcium) (NN disodium)) (VP (VBZ interferes) (PP (IN with) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN zinc) (NN insulin) (NNS preparations))))) (PP (IN by) (S (VP (NN chelating) (NP (DT the) (NN zinc)))))))) (. .) (CD 7)))) (. .))))

nsubj(enhance-2, Steroids-1)
root(ROOT-0, enhance-2)
det(toxicity-5, the-3)
amod(toxicity-5, renal-4)
dobj(enhance-2, toxicity-5)
dobj(interferes-16, toxicity-5)
nn(disodium-9, edetate-7)
nn(disodium-9, calcium-8)
prep_of(toxicity-5, disodium-9)
mark(interferes-16, in-10)
nn(disodium-15, animals.-11)
num(disodium-15, 7-12)
nn(disodium-15, Edetate-13)
nn(disodium-15, calcium-14)
nsubj(interferes-16, disodium-15)
dep(toxicity-5, interferes-16)
det(action-19, the-18)
prep_with(interferes-16, action-19)
nn(preparations-23, zinc-21)
nn(preparations-23, insulin-22)
prep_of(action-19, preparations-23)
prepc_by(interferes-16, chelating-25)
det(zinc-27, the-26)
dobj(chelating-25, zinc-27)
num(toxicity-5, 7-29)

Efavirenz/NN has/VBZ been/VBN shown/VBN in/FW vivo/FW to/TO induce/VB CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Efavirenz)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (ADVP (FW in) (FW vivo)) (S (VP (TO to) (VP (VB induce) (NP (NN CYP3A4))))))))) (. .))))

nsubjpass(shown-4, Efavirenz-1)
xsubj(induce-8, Efavirenz-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
nn(vivo-6, in-5)
advmod(shown-4, vivo-6)
aux(induce-8, to-7)
xcomp(shown-4, induce-8)
dobj(induce-8, CYP3A4-9)

Other/JJ compounds/NNS that/WDT are/VBP substrates/NNS of/IN CYP3A4/NN may/MD have/VBP decreased/VBN plasma/NN concentrations/NNS when/WRB coadministered/VBN with/IN SUSTIVA/NN (/-LRB- efavirenz/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (NNS compounds)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN of) (NP (NN CYP3A4)))))))) (VP (MD may) (VP (VBP have) (NP (VBN decreased) (NN plasma) (NNS concentrations)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NP (NN SUSTIVA)) (PRN (-LRB- -LRB-) (NP (NN efavirenz)) (-RRB- -RRB-)))))))))) (. .))))

amod(compounds-2, Other-1)
nsubj(substrates-5, compounds-2)
nsubj(have-9, compounds-2)
cop(substrates-5, are-4)
rcmod(compounds-2, substrates-5)
prep_of(substrates-5, CYP3A4-7)
aux(have-9, may-8)
root(ROOT-0, have-9)
amod(concentrations-12, decreased-10)
nn(concentrations-12, plasma-11)
dobj(have-9, concentrations-12)
advmod(coadministered-14, when-13)
advcl(have-9, coadministered-14)
prep_with(coadministered-14, SUSTIVA-16)
appos(SUSTIVA-16, efavirenz-18)

In/FW vitro/FW studies/NNS have/VBP demonstrated/VBN that/IN efavirenz/NN inhibits/VBZ 2C9/NN ,/, 2C19/NN ,/, and/CC 3A4/NN isozymes/NNS in/IN the/DT range/NN of/IN observed/VBN efavirenz/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN efavirenz)) (VP (VBZ inhibits) (NP (NP (NN 2C9)) (, ,) (NP (NN 2C19)) (, ,) (CC and) (NP (NN 3A4) (NNS isozymes))) (PP (IN in) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (VBN observed) (NN efavirenz) (NN plasma) (NNS concentrations))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(demonstrated-5, studies-3)
aux(demonstrated-5, have-4)
root(ROOT-0, demonstrated-5)
complm(inhibits-8, that-6)
nsubj(inhibits-8, efavirenz-7)
ccomp(demonstrated-5, inhibits-8)
dobj(inhibits-8, 2C9-9)
conj_and(2C9-9, 2C19-11)
nn(isozymes-15, 3A4-14)
conj_and(2C9-9, isozymes-15)
det(range-18, the-17)
prep_in(inhibits-8, range-18)
amod(concentrations-23, observed-20)
nn(concentrations-23, efavirenz-21)
nn(concentrations-23, plasma-22)
prep_of(range-18, concentrations-23)

Coadministration/NN of/IN efavirenz/NN with/IN drugs/NNS primarily/RB metabolized/VBN by/IN these/DT isozymes/NNS may/MD result/VB in/IN altered/JJ plasma/NN concentrations/NNS of/IN the/DT coadministered/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN efavirenz))) (PP (IN with) (NP (NP (NNS drugs)) (VP (ADVP (RB primarily)) (VBN metabolized) (PP (IN by) (NP (DT these) (NNS isozymes))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (JJ altered) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ coadministered) (NN drug)))))))) (. .))))

nsubj(result-12, Coadministration-1)
prep_of(Coadministration-1, efavirenz-3)
prep_with(Coadministration-1, drugs-5)
advmod(metabolized-7, primarily-6)
partmod(drugs-5, metabolized-7)
det(isozymes-10, these-9)
agent(metabolized-7, isozymes-10)
aux(result-12, may-11)
root(ROOT-0, result-12)
amod(concentrations-16, altered-14)
nn(concentrations-16, plasma-15)
prep_in(result-12, concentrations-16)
det(drug-20, the-18)
amod(drug-20, coadministered-19)
prep_of(concentrations-16, drug-20)

Therefore/RB ,/, appropriate/JJ dose/NN adjustments/NNS may/MD be/VB necessary/JJ for/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (JJ appropriate) (NN dose) (NNS adjustments)) (VP (MD may) (VP (VB be) (ADJP (JJ necessary) (PP (IN for) (NP (DT these) (NNS drugs))))))) (. .))))

advmod(necessary-8, Therefore-1)
amod(adjustments-5, appropriate-3)
nn(adjustments-5, dose-4)
nsubj(necessary-8, adjustments-5)
aux(necessary-8, may-6)
cop(necessary-8, be-7)
root(ROOT-0, necessary-8)
det(drugs-11, these-10)
prep_for(necessary-8, drugs-11)

Drugs/NNS which/WDT induce/VBP CYP3A4/NN activity/NN (/-LRB- eg/NN ,/, phenobarbital/NN ,/, rifampin/NN ,/, rifabutin/NN )/-RRB- would/MD be/VB expected/VBN to/TO increase/VB the/DT clearance/NN of/IN efavirenz/NN resulting/VBG in/IN lowered/JJ plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP induce) (NP (NP (NN CYP3A4) (NN activity)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN rifampin)) (, ,) (NP (NN rifabutin))) (-RRB- -RRB-))))))) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NP (NN efavirenz)) (VP (VBG resulting) (PP (IN in) (NP (JJ lowered) (NN plasma) (NNS concentrations)))))))))))))) (. .))))

nsubj(induce-3, Drugs-1)
nsubjpass(expected-17, Drugs-1)
rcmod(Drugs-1, induce-3)
nn(activity-5, CYP3A4-4)
dobj(induce-3, activity-5)
dep(activity-5, eg-7)
appos(eg-7, phenobarbital-9)
appos(eg-7, rifampin-11)
appos(eg-7, rifabutin-13)
aux(expected-17, would-15)
auxpass(expected-17, be-16)
root(ROOT-0, expected-17)
aux(increase-19, to-18)
xcomp(expected-17, increase-19)
det(clearance-21, the-20)
dobj(increase-19, clearance-21)
prep_of(clearance-21, efavirenz-23)
partmod(efavirenz-23, resulting-24)
amod(concentrations-28, lowered-26)
nn(concentrations-28, plasma-27)
prep_in(resulting-24, concentrations-28)

Drug/NN interactions/NNS with/IN SUSTIVA/NN are/VBP summarized/VBN in/IN Table/NN 5/CD ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NNS interactions)) (PP (IN with) (NP (NN SUSTIVA)))) (VP (VBP are) (VP (VBN summarized) (PP (IN in) (NP (NN Table) (CD 5)))))) (. .))))

nn(interactions-2, Drug-1)
nsubjpass(summarized-6, interactions-2)
prep_with(interactions-2, SUSTIVA-4)
auxpass(summarized-6, are-5)
root(ROOT-0, summarized-6)
prep_in(summarized-6, Table-8)
num(Table-8, 5-9)

Table/JJ 5a/NN :/: Drugs/NNS That/WDT Should/MD Not/RB Be/VB Coadministered/VBN With/IN SUSTIVA/NN ./.

(ROOT (S1 (S (NP (NP (JJ Table) (NN 5a)) (: :) (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (MD Should) (RB Not) (VP (VB Be) (VP (VBN Coadministered) (PP (IN With) (NP (NN SUSTIVA))))))))) (. .)))))

amod(5a-2, Table-1)
root(ROOT-0, 5a-2)
dep(5a-2, Drugs-4)
nsubjpass(Coadministered-9, Drugs-4)
aux(Coadministered-9, Should-6)
neg(Coadministered-9, Not-7)
auxpass(Coadministered-9, Be-8)
rcmod(Drugs-4, Coadministered-9)
prep_with(Coadministered-9, SUSTIVA-11)

Drug/NN Class/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN Class)) (. .)))))

nn(Class-2, Drug-1)
root(ROOT-0, Class-2)

Drugs/NNS Within/IN Class/NN Not/RB To/TO Be/VB Coadministered/VBN With/IN SUSTIVA/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (PP (IN Within) (NP (NN Class)))) (VP (RB Not) (TO To) (VP (VB Be) (VP (VBN Coadministered) (PP (IN With) (NP (NN SUSTIVA))))))) (. .))))

nsubjpass(Coadministered-7, Drugs-1)
prep_within(Drugs-1, Class-3)
neg(Coadministered-7, Not-4)
aux(Coadministered-7, To-5)
auxpass(Coadministered-7, Be-6)
root(ROOT-0, Coadministered-7)
prep_with(Coadministered-7, SUSTIVA-9)

Antihistamines/NNS Benzodiazepines/NN GI/NN Motility/NN Agents/NNS Anti-Migraine/JJ Antifungal/JJ ./.

(ROOT (S1 (S (S (NP (NNS Antihistamines)) (VP (NN Benzodiazepines) (NP (NN GI) (NN Motility) (NNS Agents) (JJ Anti-Migraine) (JJ Antifungal)))) (. .))))

nsubj(Benzodiazepines-2, Antihistamines-1)
root(ROOT-0, Benzodiazepines-2)
nn(Agents-5, GI-3)
nn(Agents-5, Motility-4)
dobj(Benzodiazepines-2, Agents-5)
amod(Agents-5, Anti-Migraine-6)
amod(Agents-5, Antifungal-7)

astemizole/NN midazolam/NNS ,/, triazolam/NN cisapride/NN ergot/NN derivatives/NNS voriconazole/NN ./.

(ROOT (S1 (S (S (NP (NP (NN astemizole) (NNS midazolam)) (, ,) (NP (NN triazolam) (NN cisapride) (NN ergot) (NNS derivatives))) (NP (NN voriconazole))) (. .))))

nn(midazolam-2, astemizole-1)
dep(voriconazole-8, midazolam-2)
nn(derivatives-7, triazolam-4)
nn(derivatives-7, cisapride-5)
nn(derivatives-7, ergot-6)
appos(midazolam-2, derivatives-7)
root(ROOT-0, voriconazole-8)

Drug/NN Name/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN Name)) (. .)))))

nn(Name-2, Drug-1)
root(ROOT-0, Name-2)

Atazanavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Atazanavir)) (. .)))))

root(ROOT-0, Atazanavir-1)

When/WRB coadministered/VBN with/IN SUSTIVA/NN in/IN treatment-naive/JJ patients/NNS ,/, the/DT recommended/VBN dose/NN of/IN atazanavir/NN is/VBZ 300/CD mg/NN with/IN ritonavir/NN 100/CD mg/NN and/CC SUSTIVA/NN 600/CD mg/NN (/-LRB- all/DT once/RB daily/JJ )./NN

(ROOT (S1 (S (SBAR (WHADVP (WRB When)) (S (VP (VBN coadministered) (PP (IN with) (NP (NP (NN SUSTIVA)) (PP (IN in) (NP (JJ treatment-naive) (NNS patients)))))))) (, ,) (NP (NP (DT the) (VBN recommended) (NN dose)) (PP (IN of) (NP (NN atazanavir)))) (VP (VBZ is) (NP (NP (CD 300) (NN mg)) (PP (IN with) (NP (NP (NP (NN ritonavir) (CD 100) (NN mg)) (CC and) (NP (NN SUSTIVA) (CD 600) (NN mg))) (PRN (-LRB- -LRB-) (NP (DT all) (ADJP (RB once) (JJ daily)) (NN -RRB-.))))))))))

advmod(coadministered-2, When-1)
advcl(mg-16, coadministered-2)
prep_with(coadministered-2, SUSTIVA-4)
amod(patients-7, treatment-naive-6)
prep_in(SUSTIVA-4, patients-7)
det(dose-11, the-9)
amod(dose-11, recommended-10)
nsubj(mg-16, dose-11)
prep_of(dose-11, atazanavir-13)
cop(mg-16, is-14)
num(mg-16, 300-15)
root(ROOT-0, mg-16)
nn(mg-20, ritonavir-18)
num(mg-20, 100-19)
prep_with(mg-16, mg-20)
nn(mg-24, SUSTIVA-22)
num(mg-24, 600-23)
conj_and(mg-20, mg-24)
det(-RRB-.-29, all-26)
advmod(daily-28, once-27)
amod(-RRB-.-29, daily-28)
dep(mg-20, -RRB-.-29)

Dosing/NN recommendations/NNS for/IN SUSTIVA/NN and/CC atazanavir/NN in/IN treatment-experienced/JJ patients/NNS have/VBP not/RB been/VBN established/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Dosing) (NNS recommendations)) (PP (IN for) (NP (NP (NP (NN SUSTIVA)) (CC and) (NP (NN atazanavir))) (PP (IN in) (NP (JJ treatment-experienced) (NNS patients)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN established))))) (. .))))

nn(recommendations-2, Dosing-1)
nsubjpass(established-13, recommendations-2)
prep_for(recommendations-2, SUSTIVA-4)
conj_and(SUSTIVA-4, atazanavir-6)
amod(patients-9, treatment-experienced-8)
prep_in(SUSTIVA-4, patients-9)
aux(established-13, have-10)
neg(established-13, not-11)
auxpass(established-13, been-12)
root(ROOT-0, established-13)

Drug/NN Name/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN Name)) (. .)))))

nn(Name-2, Drug-1)
root(ROOT-0, Name-2)

Clarithromycin/NN ./.

(ROOT (S1 (S (NP (NP (NN Clarithromycin)) (. .)))))

root(ROOT-0, Clarithromycin-1)

@/NN @/NN clarithromycin/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN clarithromycin) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, clarithromycin-3)
root(ROOT-0, concentration-4)

Plasma/NN concentrations/NNS decreased/VBD by/IN SUSTIVA/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Plasma) (NNS concentrations)) (VP (VBD decreased) (PP (IN by) (NP (NN SUSTIVA)))) (: ;)) (. .))))

nn(concentrations-2, Plasma-1)
nsubj(decreased-3, concentrations-2)
root(ROOT-0, decreased-3)
prep_by(decreased-3, SUSTIVA-5)

In/IN uninfected/JJ volunteers/NNS ,/, 46/CD %/NN developed/VBD rash/NN while/IN receiving/VBG SUSTIVA/NN and/CC clarithromycin/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ uninfected) (NNS volunteers))) (, ,) (NP (CD 46) (NN %)) (VP (VBD developed) (NP (NN rash)) (PP (IN while) (S (VP (VBG receiving) (NP (NP (NN SUSTIVA)) (CC and) (NP (NN clarithromycin)))))))) (. .))))

amod(volunteers-3, uninfected-2)
prep_in(developed-7, volunteers-3)
num(%-6, 46-5)
nsubj(developed-7, %-6)
root(ROOT-0, developed-7)
dobj(developed-7, rash-8)
prepc_while(developed-7, receiving-10)
dobj(receiving-10, SUSTIVA-11)
conj_and(SUSTIVA-11, clarithromycin-13)

No/DT dose/NN adjustment/NN of/IN SUSTIVA/NN is/VBZ recommended/VBN when/WRB given/VBN with/IN clarithromycin/NN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NN dose) (NN adjustment)) (PP (IN of) (NP (NN SUSTIVA)))) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN with) (NP (NN clarithromycin))))))))) (. .))))

det(adjustment-3, No-1)
nn(adjustment-3, dose-2)
nsubjpass(recommended-7, adjustment-3)
prep_of(adjustment-3, SUSTIVA-5)
auxpass(recommended-7, is-6)
root(ROOT-0, recommended-7)
advmod(given-9, when-8)
advcl(recommended-7, given-9)
prep_with(given-9, clarithromycin-11)

Alternatives/NNS to/TO clarithromycin/NN ,/, such/JJ as/IN azithromycin/NN ,/, should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Alternatives)) (PP (TO to) (NP (NN clarithromycin))) (, ,) (PP (JJ such) (IN as) (NP (NN azithromycin))) (, ,)) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

nsubjpass(considered-11, Alternatives-1)
prep_to(Alternatives-1, clarithromycin-3)
prep_such_as(Alternatives-1, azithromycin-7)
aux(considered-11, should-9)
auxpass(considered-11, be-10)
root(ROOT-0, considered-11)

Other/JJ macrolide/NN antibiotics/NNS ,/, such/JJ as/IN erythromycin/NN ,/, have/VBP not/RB been/VBN studied/VBN in/IN combination/NN with/IN SUSTIVA/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (NN macrolide) (NNS antibiotics)) (, ,) (PP (JJ such) (IN as) (NP (NN erythromycin))) (, ,)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN SUSTIVA))))))))) (. .))))

amod(antibiotics-3, Other-1)
nn(antibiotics-3, macrolide-2)
nsubjpass(studied-12, antibiotics-3)
prep_such_as(antibiotics-3, erythromycin-7)
aux(studied-12, have-9)
neg(studied-12, not-10)
auxpass(studied-12, been-11)
root(ROOT-0, studied-12)
prep_in(studied-12, combination-14)
prep_with(combination-14, SUSTIVA-16)

Indinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Indinavir)) (. .)))))

root(ROOT-0, Indinavir-1)

@/NN @/NN indinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN indinavir) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, indinavir-3)
root(ROOT-0, concentration-4)

The/DT optimal/JJ dose/NN of/IN indinavir/NN ,/, when/WRB given/VBN in/IN combination/NN with/IN SUSTIVA/NN ,/, is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ optimal) (NN dose)) (PP (IN of) (NP (NN indinavir))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN SUSTIVA)))))))) (, ,)) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

det(dose-3, The-1)
amod(dose-3, optimal-2)
nsubjpass(known-16, dose-3)
prep_of(dose-3, indinavir-5)
advmod(given-8, when-7)
dep(dose-3, given-8)
prep_in(given-8, combination-10)
prep_with(combination-10, SUSTIVA-12)
auxpass(known-16, is-14)
neg(known-16, not-15)
root(ROOT-0, known-16)

Increasing/VBG the/DT indinavir/NN dose/NN to/TO 1000/CD mg/NN every/DT 8/CD hours/NNS does/VBZ not/RB compensate/VB for/IN the/DT increased/VBN indinavir/NN metabolism/NN due/JJ to/TO SUSTIVA/NN ./.

(ROOT (S1 (S (S (NP (VBG Increasing) (NP (NP (DT the) (NN indinavir) (NN dose) (TO to) (CD 1000) (NN mg)) (NP (DT every) (CD 8) (NNS hours)))) (VP (VBZ does) (RB not) (VP (VB compensate) (PP (IN for) (NP (NP (DT the) (VBN increased) (NN indinavir) (NN metabolism)) (ADJP (JJ due) (PP (TO to) (NP (NN SUSTIVA))))))))) (. .))))

amod(mg-7, Increasing-1)
det(mg-7, the-2)
nn(mg-7, indinavir-3)
nn(mg-7, dose-4)
dep(mg-7, to-5)
num(mg-7, 1000-6)
nsubj(compensate-13, mg-7)
det(hours-10, every-8)
num(hours-10, 8-9)
dep(mg-7, hours-10)
aux(compensate-13, does-11)
neg(compensate-13, not-12)
root(ROOT-0, compensate-13)
det(metabolism-18, the-15)
amod(metabolism-18, increased-16)
nn(metabolism-18, indinavir-17)
prep_for(compensate-13, metabolism-18)
prep_due_to(metabolism-18, SUSTIVA-21)

When/WRB indinavir/NN at/IN an/DT increased/VBN dose/NN (/-LRB- 1000/CD mg/NN every/DT 8/CD hours/NNS )/-RRB- was/VBD given/VBN with/IN SUSTIVA/NN (/-LRB- 600/CD mg/NN once/RB daily/JJ )/-RRB- ,/, the/DT indinavir/JJ AUC/NN and/CC Cmin/NN were/VBD decreased/VBN on/IN average/NN by/IN 33-46/CD %/NN and/CC 39-57/CD %/NN ,/, respectively/RB ,/, compared/VBN to/TO when/WRB indinavir/NN (/-LRB- 800/CD mg/NN every/DT 8/CD hours/NNS )/-RRB- was/VBD given/VBN alone/RB ./.

(ROOT (S1 (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN indinavir)) (PP (IN at) (NP (NP (DT an) (VBN increased) (NN dose)) (PRN (-LRB- -LRB-) (NP (NP (CD 1000) (NN mg)) (NP (DT every) (CD 8) (NNS hours))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN given) (PP (IN with) (NP (NP (NN SUSTIVA)) (PRN (-LRB- -LRB-) (NP (NP (CD 600) (NN mg)) (ADJP (RB once) (JJ daily))) (-RRB- -RRB-)))))))) (, ,) (NP (NP (DT the) (JJ indinavir) (NN AUC)) (CC and) (NP (NN Cmin))) (VP (VBD were) (VP (VBN decreased) (PP (IN on) (NP (NN average))) (PP (IN by) (NP (NP (CD 33-46) (NN %)) (CC and) (NP (CD 39-57) (NN %)) (, ,) (ADVP (RB respectively)))) (, ,) (PP (VBN compared) (PP (TO to) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN indinavir)) (PRN (-LRB- -LRB-) (NP (CD 800) (NN mg) (NP (DT every) (CD 8) (NNS hours))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN given) (ADVP (RB alone)))))))))) (. .))))

advmod(given-15, When-1)
nsubjpass(given-15, indinavir-2)
det(dose-6, an-4)
amod(dose-6, increased-5)
prep_at(indinavir-2, dose-6)
num(mg-9, 1000-8)
dep(dose-6, mg-9)
det(hours-12, every-10)
num(hours-12, 8-11)
dep(mg-9, hours-12)
auxpass(given-15, was-14)
advcl(decreased-31, given-15)
prep_with(given-15, SUSTIVA-17)
num(mg-20, 600-19)
dep(SUSTIVA-17, mg-20)
advmod(daily-22, once-21)
amod(mg-20, daily-22)
det(AUC-27, the-25)
amod(AUC-27, indinavir-26)
nsubjpass(decreased-31, AUC-27)
conj_and(AUC-27, Cmin-29)
auxpass(decreased-31, were-30)
root(ROOT-0, decreased-31)
prep_on(decreased-31, average-33)
num(%-36, 33-46-35)
agent(decreased-31, %-36)
num(%-39, 39-57-38)
conj_and(%-36, %-39)
advmod(%-36, respectively-41)
conj_and(%-36, respectively-41)
prepc_compared_to(decreased-31, to-44)
advmod(given-55, when-45)
nsubjpass(given-55, indinavir-46)
num(mg-49, 800-48)
appos(indinavir-46, mg-49)
det(hours-52, every-50)
num(hours-52, 8-51)
dep(mg-49, hours-52)
auxpass(given-55, was-54)
pcomp(decreased-31, given-55)
advmod(given-55, alone-56)

Lopinavir/NN //: ritonavir/NN ./.

(ROOT (S1 (S (S (NP (NN Lopinavir)) (: /) (NP (NN ritonavir))) (. .))))

dep(ritonavir-3, Lopinavir-1)
punct(ritonavir-3, /-2)
root(ROOT-0, ritonavir-3)

@/NN @/NN lopinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN lopinavir) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, lopinavir-3)
root(ROOT-0, concentration-4)

A/DT dose/NN increase/NN of/IN lopinavir/NN //: ritonavir/NN to/TO 533/133/CD mg/NN (/-LRB- 4/CD capsules/NNS or/CC 6.5/CD mL/NN )/-RRB- twice/RB daily/RB taken/VBN with/IN food/NN is/VBZ recommended/VBN when/WRB used/VBN in/IN combination/NN with/IN SUSTIVA/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (DT A) (NN dose) (NN increase)) (PP (IN of) (NP (NN lopinavir)))) (: /) (NP (NP (NP (NP (NN ritonavir) (TO to) (CD 533/133) (NN mg)) (PRN (-LRB- -LRB-) (NP (CD 4) (NNS capsules) (CC or) (CD 6.5) (NN mL)) (-RRB- -RRB-))) (ADVP (RB twice) (RB daily))) (VP (VBN taken) (PP (IN with) (NP (NN food)))))) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN SUSTIVA))))))))))) (. .))))

det(increase-3, A-1)
nn(increase-3, dose-2)
nsubjpass(recommended-24, increase-3)
prep_of(increase-3, lopinavir-5)
punct(increase-3, /-6)
nn(mg-10, ritonavir-7)
dep(mg-10, to-8)
num(mg-10, 533/133-9)
dep(increase-3, mg-10)
num(capsules-13, 4-12)
dep(mg-10, capsules-13)
num(mL-16, 6.5-15)
conj_or(capsules-13, mL-16)
advmod(daily-19, twice-18)
advmod(mg-10, daily-19)
partmod(mg-10, taken-20)
prep_with(taken-20, food-22)
auxpass(recommended-24, is-23)
root(ROOT-0, recommended-24)
advmod(used-26, when-25)
advcl(recommended-24, used-26)
prep_in(used-26, combination-28)
prep_with(combination-28, SUSTIVA-30)

Methadone/NN ./.

(ROOT (S1 (S (NP (NP (NN Methadone)) (. .)))))

root(ROOT-0, Methadone-1)

@/NN @/NN methadone/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN methadone) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, methadone-3)
root(ROOT-0, concentration-4)

Coadministration/NN in/IN HIV-infected/JJ individuals/NNS with/IN a/DT history/NN of/IN injection/NN drug/NN use/NN resulted/VBD in/IN decreased/VBN plasma/NN levels/NNS of/IN methadone/NN and/CC signs/NNS of/IN opiate/NN withdrawal/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN in) (NP (JJ HIV-infected) (NNS individuals))) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN injection) (NN drug) (NN use)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (VBN decreased) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN methadone)))) (CC and) (NP (NP (NNS signs)) (PP (IN of) (NP (NN opiate) (NN withdrawal)))))))) (. .))))

nsubj(resulted-12, Coadministration-1)
amod(individuals-4, HIV-infected-3)
prep_in(Coadministration-1, individuals-4)
det(history-7, a-6)
prep_with(Coadministration-1, history-7)
nn(use-11, injection-9)
nn(use-11, drug-10)
prep_of(history-7, use-11)
root(ROOT-0, resulted-12)
amod(levels-16, decreased-14)
nn(levels-16, plasma-15)
prep_in(resulted-12, levels-16)
prep_of(levels-16, methadone-18)
conj_and(levels-16, signs-20)
nn(withdrawal-23, opiate-22)
prep_of(signs-20, withdrawal-23)

Ethinyl/NN estradiol/NN ./.

(ROOT (S1 (S (NP (NP (NN Ethinyl) (NN estradiol)) (. .)))))

nn(estradiol-2, Ethinyl-1)
root(ROOT-0, estradiol-2)

@/NN @/NN ethinyl/NN estradiol/NN concentration/NN ./.

(ROOT (S1 (S (S (NP (NN @) (NN @) (NN ethinyl) (NN estradiol)) (NP (NN concentration))) (. .))))

nn(estradiol-4, @-1)
nn(estradiol-4, @-2)
nn(estradiol-4, ethinyl-3)
dep(concentration-5, estradiol-4)
root(ROOT-0, concentration-5)

Plasma/NN concentrations/NNS increased/VBD by/IN SUSTIVA/NN (/-LRB- efavirenz/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (S (NP (NN Plasma) (NNS concentrations)) (VP (VBD increased) (PP (IN by) (NP (NP (NN SUSTIVA)) (PRN (-LRB- -LRB-) (NP (NN efavirenz)) (-RRB- -RRB-))))) (: ;)) (. .))))

nn(concentrations-2, Plasma-1)
nsubj(increased-3, concentrations-2)
root(ROOT-0, increased-3)
prep_by(increased-3, SUSTIVA-5)
appos(SUSTIVA-5, efavirenz-7)

Because/IN the/DT potential/JJ interaction/NN of/IN efavirenz/NN with/IN oral/JJ contraceptives/NNS has/VBZ not/RB been/VBN fully/RB characterized/VBN ,/, a/DT reliable/JJ method/NN of/IN barrier/NN contraception/NN should/MD be/VB used/VBN in/IN addition/NN to/TO oral/JJ contraceptives/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NP (DT the) (JJ potential) (NN interaction)) (PP (IN of) (NP (NN efavirenz))) (PP (IN with) (NP (JJ oral) (NNS contraceptives)))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN characterized)))))) (, ,) (NP (NP (DT a) (JJ reliable) (NN method)) (PP (IN of) (NP (NN barrier) (NN contraception)))) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (JJ oral) (NNS contraceptives))))))))) (. .))))

mark(characterized-14, Because-1)
det(interaction-4, the-2)
amod(interaction-4, potential-3)
nsubjpass(characterized-14, interaction-4)
prep_of(interaction-4, efavirenz-6)
amod(contraceptives-9, oral-8)
prep_with(interaction-4, contraceptives-9)
aux(characterized-14, has-10)
neg(characterized-14, not-11)
auxpass(characterized-14, been-12)
advmod(characterized-14, fully-13)
advcl(used-24, characterized-14)
det(method-18, a-16)
amod(method-18, reliable-17)
nsubjpass(used-24, method-18)
nn(contraception-21, barrier-20)
prep_of(method-18, contraception-21)
aux(used-24, should-22)
auxpass(used-24, be-23)
root(ROOT-0, used-24)
amod(contraceptives-29, oral-28)
prep_in_addition_to(used-24, contraceptives-29)

Rifabutin/NN ./.

(ROOT (S1 (S (NP (NP (NN Rifabutin)) (. .)))))

root(ROOT-0, Rifabutin-1)

@/NN @/NN rifabutin/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN rifabutin) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, rifabutin-3)
root(ROOT-0, concentration-4)

Increase/NN daily/JJ dose/NN of/IN rifabutin/NN by/IN 50/CD %./NN

(ROOT (S1 (S (NP (NP (NN Increase) (JJ daily) (NN dose)) (PP (IN of) (NP (NN rifabutin))) (PP (IN by) (NP (CD 50) (NN %.)))))))

nn(dose-3, Increase-1)
amod(dose-3, daily-2)
root(ROOT-0, dose-3)
prep_of(dose-3, rifabutin-5)
num(%.-8, 50-7)
prep_by(dose-3, %.-8)

Consider/VB doubling/VBG the/DT rifabutin/NN dose/NN in/IN regimens/NNS where/WRB rifabutin/NN is/VBZ given/VBN 2/CD or/CC 3/CD times/NNS a/DT week/NN ./.

(ROOT (S1 (S (S (NP (VB Consider)) (VP (VBG doubling) (NP (DT the) (NN rifabutin) (NN dose)) (PP (IN in) (NP (NP (NNS regimens)) (SBAR (WHADVP (WRB where)) (S (NP (NN rifabutin)) (VP (VBZ is) (VP (VBN given) (NP (NP (QP (CD 2) (CC or) (CD 3)) (NNS times)) (NP (DT a) (NN week))))))))))) (. .))))

nsubj(doubling-2, Consider-1)
root(ROOT-0, doubling-2)
det(dose-5, the-3)
nn(dose-5, rifabutin-4)
dobj(doubling-2, dose-5)
prep_in(doubling-2, regimens-7)
advmod(given-11, where-8)
nsubjpass(given-11, rifabutin-9)
auxpass(given-11, is-10)
rcmod(regimens-7, given-11)
num(times-15, 2-12)
conj_or(2-12, 3-14)
dobj(given-11, times-15)
det(week-17, a-16)
dep(times-15, week-17)

Rifampin/NN ./.

(ROOT (S1 (S (NP (NP (NN Rifampin)) (. .)))))

root(ROOT-0, Rifampin-1)

@/NN @/NN efavirenz/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN efavirenz) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, efavirenz-3)
root(ROOT-0, concentration-4)

Clinical/JJ significance/NN of/IN reduced/VBN efavirenz/NN concentrations/NNS unknown/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Clinical) (NN significance)) (PP (IN of) (NP (VBN reduced) (NN efavirenz) (NNS concentrations)))) (VP (JJ unknown))) (. .))))

amod(significance-2, Clinical-1)
nsubj(unknown-7, significance-2)
amod(concentrations-6, reduced-4)
nn(concentrations-6, efavirenz-5)
prep_of(significance-2, concentrations-6)
root(ROOT-0, unknown-7)

Ritonavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Ritonavir)) (. .)))))

root(ROOT-0, Ritonavir-1)

@/NN @/NN ritonavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN ritonavir) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, ritonavir-3)
root(ROOT-0, concentration-4)

Monitoring/NN of/IN liver/NN enzymes/NNS is/VBZ recommended/VBN when/WRB SUSTIVA/NN is/VBZ used/VBN in/IN combination/NN with/IN ritonavir/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Monitoring)) (PP (IN of) (NP (NN liver) (NNS enzymes)))) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (NP (NN SUSTIVA)) (VP (VBZ is) (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN ritonavir)))))))))))) (. .))))

nsubjpass(recommended-6, Monitoring-1)
nn(enzymes-4, liver-3)
prep_of(Monitoring-1, enzymes-4)
auxpass(recommended-6, is-5)
root(ROOT-0, recommended-6)
advmod(used-10, when-7)
nsubjpass(used-10, SUSTIVA-8)
auxpass(used-10, is-9)
advcl(recommended-6, used-10)
prep_in(used-10, combination-12)
prep_with(combination-12, ritonavir-14)

@/NN @/NN efavirenz/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN efavirenz) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, efavirenz-3)
root(ROOT-0, concentration-4)

Saquinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Saquinavir)) (. .)))))

root(ROOT-0, Saquinavir-1)

@/NN @/NN saquinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN saquinavir) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, saquinavir-3)
root(ROOT-0, concentration-4)

Should/MD not/RB be/VB used/VBN as/IN sole/JJ protease/NN inhibitor/NN in/IN combination/NN with/IN SUSTIVA/NN ./.

(ROOT (S1 (S (S (VP (MD Should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (JJ sole) (NN protease) (NN inhibitor)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN SUSTIVA))))))))))) (. .))))

aux(used-4, Should-1)
neg(used-4, not-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
amod(inhibitor-8, sole-6)
nn(inhibitor-8, protease-7)
prep_as(used-4, inhibitor-8)
prep_in(inhibitor-8, combination-10)
prep_with(combination-10, SUSTIVA-12)

Sertraline/NN ./.

(ROOT (S1 (S (NP (NP (NN Sertraline)) (. .)))))

root(ROOT-0, Sertraline-1)

@/NN @/NN sertraline/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN sertraline) (NN concentration)) (. .)))))

nn(concentration-4, @-1)
nn(concentration-4, @-2)
nn(concentration-4, sertraline-3)
root(ROOT-0, concentration-4)

Other/JJ Potentially/RB Clinically/RB Significant/JJ Drug/NN or/CC Herbal/NN Product/NN Interactions/NNS With/IN SUSTIVAb/NN ./.

(ROOT (S1 (S (S (NP (JJ Other) (ADJP (RB Potentially) (RB Clinically) (JJ Significant)) (NN Drug) (CC or) (NN Herbal) (NN Product)) (VP (NNS Interactions) (PP (IN With) (NP (NN SUSTIVAb))))) (. .))))

amod(Drug-5, Other-1)
advmod(Significant-4, Potentially-2)
advmod(Significant-4, Clinically-3)
amod(Drug-5, Significant-4)
nsubj(Interactions-9, Drug-5)
nn(Product-8, Herbal-7)
conj_or(Drug-5, Product-8)
root(ROOT-0, Interactions-9)
prep_with(Interactions-9, SUSTIVAb-11)

Anticoagulants/NNS :/: Warfarin/NN ./.

(ROOT (S1 (S (S (NP (NNS Anticoagulants)) (: :) (NP (NN Warfarin))) (. .))))

dep(Warfarin-3, Anticoagulants-1)
root(ROOT-0, Warfarin-3)

Plasma/NN concentrations/NNS and/CC effects/NNS potentially/RB increased/VBN or/CC decreased/VBN by/IN SUSTIVA/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Plasma) (NNS concentrations)) (CC and) (NP (NNS effects))) (ADVP (RB potentially)) (VP (VP (VBN increased)) (CC or) (VP (VBN decreased) (PP (IN by) (NP (NN SUSTIVA)))))) (. .))))

nn(concentrations-2, Plasma-1)
nsubj(increased-6, concentrations-2)
conj_and(concentrations-2, effects-4)
advmod(increased-6, potentially-5)
root(ROOT-0, increased-6)
conj_or(increased-6, decreased-8)
prep_by(decreased-8, SUSTIVA-10)

Anticonvulsants/NNS :/: Phenytoin/NN Phenobarbital/NN Carbamazepine/NN ./.

(ROOT (S1 (S (S (NP (NNS Anticonvulsants)) (: :) (NP (NN Phenytoin) (NN Phenobarbital) (NN Carbamazepine))) (. .))))

dep(Carbamazepine-5, Anticonvulsants-1)
nn(Carbamazepine-5, Phenytoin-3)
nn(Carbamazepine-5, Phenobarbital-4)
root(ROOT-0, Carbamazepine-5)

Potential/JJ for/IN reduction/NN in/IN anticonvulsant/JJ and/or/CC efavirenz/NN plasma/NN levels/NNS ;/: ./.

(ROOT (S1 (S (S (ADJP (JJ Potential) (PP (IN for) (NP (NP (NN reduction)) (PP (IN in) (NP (JJ anticonvulsant) (CC and/or) (NN efavirenz) (NN plasma) (NNS levels))) (: ;))))) (. .))))

root(ROOT-0, Potential-1)
prep_for(Potential-1, reduction-3)
amod(levels-9, anticonvulsant-5)
conj_and/or(anticonvulsant-5, efavirenz-7)
nn(levels-9, plasma-8)
prep_in(reduction-3, levels-9)

periodic/JJ monitoring/NN of/IN anticonvulsant/JJ plasma/NN levels/NNS should/MD be/VB conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ periodic) (NN monitoring)) (PP (IN of) (NP (JJ anticonvulsant) (NN plasma) (NNS levels)))) (VP (MD should) (VP (VB be) (VP (VBN conducted))))) (. .))))

amod(monitoring-2, periodic-1)
nsubjpass(conducted-9, monitoring-2)
amod(levels-6, anticonvulsant-4)
nn(levels-6, plasma-5)
prep_of(monitoring-2, levels-6)
aux(conducted-9, should-7)
auxpass(conducted-9, be-8)
root(ROOT-0, conducted-9)

Antifungals/NNS :/: Itraconazole/NN Ketoconazole/NN ./.

(ROOT (S1 (S (S (NP (NNS Antifungals)) (: :) (NP (NN Itraconazole) (NN Ketoconazole))) (. .))))

dep(Ketoconazole-4, Antifungals-1)
nn(Ketoconazole-4, Itraconazole-3)
root(ROOT-0, Ketoconazole-4)

Drug/NN interaction/NN studies/NNS with/IN SUSTIVA/NNP and/CC these/DT imidazole/JJ and/CC triazole/JJ antifungals/NNS have/VBP not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (NNP SUSTIVA) (CC and) (DT these) (ADJP (ADJP (JJ imidazole)) (CC and) (ADJP (JJ triazole))) (NNS antifungals)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

nn(studies-3, Drug-1)
nn(studies-3, interaction-2)
nsubjpass(conducted-15, studies-3)
prep_with(studies-3, SUSTIVA-5)
det(antifungals-11, these-7)
amod(antifungals-11, imidazole-8)
conj_and(imidazole-8, triazole-10)
conj_and(SUSTIVA-5, antifungals-11)
aux(conducted-15, have-12)
neg(conducted-15, not-13)
auxpass(conducted-15, been-14)
root(ROOT-0, conducted-15)

SUSTIVA/NN has/VBZ the/DT potential/NN to/TO decrease/NN plasma/NN concentrations/NNS of/IN itraconazole/NN and/CC ketoconazole/NN ./.

(ROOT (S1 (S (S (NP (NN SUSTIVA)) (VP (VBZ has) (NP (NP (DT the) (NN potential)) (PP (TO to) (NP (NP (NN decrease) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN itraconazole)) (CC and) (NP (NN ketoconazole))))))))) (. .))))

nsubj(has-2, SUSTIVA-1)
root(ROOT-0, has-2)
det(potential-4, the-3)
dobj(has-2, potential-4)
nn(concentrations-8, decrease-6)
nn(concentrations-8, plasma-7)
prep_to(potential-4, concentrations-8)
prep_of(concentrations-8, itraconazole-10)
conj_and(itraconazole-10, ketoconazole-12)

Anti-HIV/NN protease/NN inhibitors/NNS :/: Saquinavir/NN //: ritonavir/NN combination/NN ./.

(ROOT (S1 (S (S (NP (NN Anti-HIV) (NN protease) (NNS inhibitors)) (: :) (NP (NN Saquinavir)) (: /) (NP (NN ritonavir) (NN combination))) (. .))))

nn(inhibitors-3, Anti-HIV-1)
nn(inhibitors-3, protease-2)
dep(combination-8, inhibitors-3)
dep(combination-8, Saquinavir-5)
punct(combination-8, /-6)
nn(combination-8, ritonavir-7)
root(ROOT-0, combination-8)

Amprenavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Amprenavir)) (. .)))))

root(ROOT-0, Amprenavir-1)

SUSTIVAhas/NNS the/DT potential/NN to/TO decrease/NN serum/NN concentrations/NNS of/IN amprenavir/NN ./.

(ROOT (S1 (S (S (VP (NNS SUSTIVAhas) (NP (DT the) (NN potential)) (PP (TO to) (NP (NP (NN decrease) (NN serum) (NNS concentrations)) (PP (IN of) (NP (NN amprenavir))))))) (. .))))

root(ROOT-0, SUSTIVAhas-1)
det(potential-3, the-2)
dobj(SUSTIVAhas-1, potential-3)
nn(concentrations-7, decrease-5)
nn(concentrations-7, serum-6)
prep_to(SUSTIVAhas-1, concentrations-7)
prep_of(concentrations-7, amprenavir-9)

Non-nucleoside/JJ reverse/NN transcriptase/NN inhibitors/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Non-nucleoside) (NN reverse) (NN transcriptase) (NNS inhibitors)) (. .)))))

amod(inhibitors-4, Non-nucleoside-1)
nn(inhibitors-4, reverse-2)
nn(inhibitors-4, transcriptase-3)
root(ROOT-0, inhibitors-4)

St./NN John/NN @/NN s/NN wort/NN (/-LRB- Hypericum/NN perforatum/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NN St.) (NN John) (NN @) (NN s) (NN wort)) (PRN (-LRB- -LRB-) (NP (NN Hypericum) (NN perforatum)) (-RRB- -RRB-))) (. .)))))

nn(wort-5, St.-1)
nn(wort-5, John-2)
nn(wort-5, @-3)
nn(wort-5, s-4)
root(ROOT-0, wort-5)
nn(perforatum-8, Hypericum-7)
appos(wort-5, perforatum-8)

Expected/VBN to/TO substantially/RB decrease/VB plasma/NN levels/NNS of/IN efavirenz/NN ;/: has/VBZ not/RB been/VBN studied/VBN in/IN combination/NN with/IN SUSTIVA/NN ./.

(ROOT (S1 (S (S (S (VP (VBN Expected) (S (VP (TO to) (ADVP (RB substantially)) (VP (VB decrease) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN efavirenz))))))))) (: ;) (S (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN SUSTIVA)))))))))) (. .))))

root(ROOT-0, Expected-1)
aux(decrease-4, to-2)
advmod(decrease-4, substantially-3)
xcomp(Expected-1, decrease-4)
nn(levels-6, plasma-5)
dobj(decrease-4, levels-6)
prep_of(levels-6, efavirenz-8)
aux(studied-13, has-10)
neg(studied-13, not-11)
auxpass(studied-13, been-12)
parataxis(Expected-1, studied-13)
prep_in(studied-13, combination-15)
prep_with(combination-15, SUSTIVA-17)

Other/JJ Drugs/NNS :/: Based/NN on/IN the/DT results/NNS of/IN drug/NN interaction/NN studies/NNS ,/, no/DT dosage/JJ adjustment/NN is/VBZ recommended/VBN when/WRB SUSTIVA/NN (/-LRB- efavirenz/NN )/-RRB- is/VBZ given/VBN with/IN the/DT following/NN :/: aluminum//NN magnesium/NN hydroxide/NN antacids/NNS ,/, azithromycin/NN ,/, cetirizine/NN ,/, famotidine/NN ,/, fluconazole/NN ,/, lamivudine/NN ,/, lorazepam/NN ,/, nelfinavir/NN ,/, paroxetine/NN ,/, and/CC zidovudine/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NNS Drugs)) (: :) (S (NP (NP (NN Based)) (PP (IN on) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (NN drug) (NN interaction) (NNS studies)) (, ,) (NP (DT no) (JJ dosage) (NN adjustment))))))) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN SUSTIVA)) (PRN (-LRB- -LRB-) (NP (NN efavirenz)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN given) (PP (IN with) (NP (NP (DT the) (NN following)) (: :) (NP (NP (NN aluminum/) (NN magnesium) (NN hydroxide) (NNS antacids)) (, ,) (NP (NP (NN azithromycin)) (, ,) (NP (NN cetirizine)) (, ,) (NP (NN famotidine)) (, ,) (NP (NN fluconazole)) (, ,) (NP (NN lamivudine)) (, ,) (NP (NN lorazepam)) (, ,) (NP (NN nelfinavir)) (, ,) (NP (NN paroxetine)) (, ,) (CC and) (NP (NN zidovudine))))))))))))) (. .)))))

amod(Drugs-2, Other-1)
root(ROOT-0, Drugs-2)
nsubjpass(recommended-17, Based-4)
det(results-7, the-6)
prep_on(Based-4, results-7)
nn(studies-11, drug-9)
nn(studies-11, interaction-10)
prep_of(results-7, studies-11)
det(adjustment-15, no-13)
amod(adjustment-15, dosage-14)
appos(studies-11, adjustment-15)
auxpass(recommended-17, is-16)
dep(Drugs-2, recommended-17)
advmod(given-24, when-18)
nsubjpass(given-24, SUSTIVA-19)
appos(SUSTIVA-19, efavirenz-21)
auxpass(given-24, is-23)
advcl(recommended-17, given-24)
det(following-27, the-26)
prep_with(given-24, following-27)
nn(antacids-32, aluminum/-29)
nn(antacids-32, magnesium-30)
nn(antacids-32, hydroxide-31)
dep(following-27, antacids-32)
appos(antacids-32, azithromycin-34)
conj_and(azithromycin-34, cetirizine-36)
conj_and(azithromycin-34, famotidine-38)
conj_and(azithromycin-34, fluconazole-40)
conj_and(azithromycin-34, lamivudine-42)
conj_and(azithromycin-34, lorazepam-44)
conj_and(azithromycin-34, nelfinavir-46)
conj_and(azithromycin-34, paroxetine-48)
conj_and(azithromycin-34, zidovudine-51)

Specific/JJ drug/NN interaction/NN studies/NNS have/VBP not/RB been/VBN performed/VBN with/IN SUSTIVA/NN and/CC NRTIs/NN other/JJ than/IN lamivudine/NN and/CC zidovudine/NN ./.

(ROOT (S1 (S (S (NP (JJ Specific) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN performed) (PP (IN with) (NP (NP (NN SUSTIVA)) (CC and) (NP (NN NRTIs)) (CONJP (JJ other) (IN than)) (NP (NP (NN lamivudine)) (CC and) (NP (NN zidovudine))))))))) (. .))))

amod(studies-4, Specific-1)
nn(studies-4, drug-2)
nn(studies-4, interaction-3)
nsubjpass(performed-8, studies-4)
aux(performed-8, have-5)
neg(performed-8, not-6)
auxpass(performed-8, been-7)
root(ROOT-0, performed-8)
prep_with(performed-8, SUSTIVA-10)
conj_and(SUSTIVA-10, NRTIs-12)
conj_other(SUSTIVA-10, lamivudine-15)
conj_and(lamivudine-15, zidovudine-17)

Clinically/RB significant/JJ interactions/NNS would/MD not/RB be/VB expected/VBN since/IN the/DT NRTIs/NNS are/VBP metabolized/VBN via/IN a/DT different/JJ route/NN than/IN efavirenz/NN and/CC would/MD be/VB unlikely/JJ to/TO compete/VB for/IN the/DT same/JJ metabolic/JJ enzymes/NNS and/CC elimination/NN pathways/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (RB Clinically) (JJ significant)) (NNS interactions)) (VP (VP (MD would) (RB not) (VP (VB be) (VP (VBN expected) (SBAR (IN since) (S (NP (DT the) (NNS NRTIs)) (VP (VBP are) (VP (VBN metabolized) (PP (IN via) (NP (NP (DT a) (JJ different) (NN route)) (PP (IN than) (NP (NN efavirenz)))))))))))) (CC and) (VP (MD would) (VP (VB be) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB compete) (PP (IN for) (NP (NP (DT the) (JJ same) (JJ metabolic) (NNS enzymes)) (CC and) (NP (NN elimination) (NNS pathways)))))))))))) (. .))))

advmod(significant-2, Clinically-1)
amod(interactions-3, significant-2)
nsubjpass(expected-7, interactions-3)
aux(expected-7, would-4)
neg(expected-7, not-5)
auxpass(expected-7, be-6)
root(ROOT-0, expected-7)
mark(metabolized-12, since-8)
det(NRTIs-10, the-9)
nsubjpass(metabolized-12, NRTIs-10)
auxpass(metabolized-12, are-11)
advcl(expected-7, metabolized-12)
det(route-16, a-14)
amod(route-16, different-15)
prep_via(metabolized-12, route-16)
prep_than(route-16, efavirenz-18)
aux(unlikely-22, would-20)
cop(unlikely-22, be-21)
conj_and(expected-7, unlikely-22)
aux(compete-24, to-23)
xcomp(unlikely-22, compete-24)
det(enzymes-29, the-26)
amod(enzymes-29, same-27)
amod(enzymes-29, metabolic-28)
prep_for(compete-24, enzymes-29)
nn(pathways-32, elimination-31)
conj_and(enzymes-29, pathways-32)

Inhibitors/NNS of/IN CYP3A4/NN -Eplerenone/NN metabolism/NN is/VBZ predominantly/RB mediated/VBN via/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Inhibitors)) (PP (IN of) (NP (NN CYP3A4) (NN -Eplerenone) (NN metabolism)))) (VP (VBZ is) (ADVP (RB predominantly)) (VP (VBN mediated) (PP (IN via) (NP (NN CYP3A4)))))) (. .))))

nsubjpass(mediated-8, Inhibitors-1)
nn(metabolism-5, CYP3A4-3)
nn(metabolism-5, -Eplerenone-4)
prep_of(Inhibitors-1, metabolism-5)
auxpass(mediated-8, is-6)
advmod(mediated-8, predominantly-7)
root(ROOT-0, mediated-8)
prep_via(mediated-8, CYP3A4-10)

A/DT pharmacokinetic/JJ study/NN evaluating/VBG the/DT administration/NN of/IN a/DT single/JJ dose/NN of/IN INSPRA/NN 100/CD mg/NN with/IN ketoconazole/NN 200/CD mg/NN BID/NN ,/, a/DT potent/JJ inhibitor/NN of/IN the/DT CYP3A4/NN pathway/NN ,/, showed/VBD a/DT 1.7-fold/JJ increase/NN in/IN Cmax/NN of/IN eplerenone/NN and/CC a/DT 5.4-fold/JJ increase/NN in/IN AUC/NN of/IN eplerenone/NN ./.

(ROOT (S1 (S (NP (NP (DT A) (JJ pharmacokinetic) (NN study)) (VP (VBG evaluating) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NN INSPRA) (CD 100) (NN mg)) (PP (IN with) (NP (NP (NN ketoconazole) (CD 200) (NN mg) (NN BID)) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (DT the) (NN CYP3A4) (NN pathway)))) (, ,)))))))))) (VP (VBD showed) (NP (NP (NP (DT a) (JJ 1.7-fold) (NN increase)) (PP (IN in) (NP (NP (NN Cmax)) (PP (IN of) (NP (NN eplerenone)))))) (CC and) (NP (NP (DT a) (JJ 5.4-fold) (NN increase)) (PP (IN in) (NP (NP (NN AUC)) (PP (IN of) (NP (NN eplerenone)))))))) (. .))))

det(study-3, A-1)
amod(study-3, pharmacokinetic-2)
nsubj(showed-29, study-3)
partmod(study-3, evaluating-4)
det(administration-6, the-5)
dobj(evaluating-4, administration-6)
det(dose-10, a-8)
amod(dose-10, single-9)
prep_of(administration-6, dose-10)
nn(mg-14, INSPRA-12)
num(mg-14, 100-13)
prep_of(dose-10, mg-14)
nn(BID-19, ketoconazole-16)
num(BID-19, 200-17)
nn(BID-19, mg-18)
prep_with(mg-14, BID-19)
det(inhibitor-23, a-21)
amod(inhibitor-23, potent-22)
appos(BID-19, inhibitor-23)
det(pathway-27, the-25)
nn(pathway-27, CYP3A4-26)
prep_of(inhibitor-23, pathway-27)
root(ROOT-0, showed-29)
det(increase-32, a-30)
amod(increase-32, 1.7-fold-31)
dobj(showed-29, increase-32)
prep_in(increase-32, Cmax-34)
prep_of(Cmax-34, eplerenone-36)
det(increase-40, a-38)
amod(increase-40, 5.4-fold-39)
conj_and(increase-32, increase-40)
prep_in(increase-40, AUC-42)
prep_of(AUC-42, eplerenone-44)

INSPRA/NN should/MD not/RB be/VB used/VBN with/IN drugs/NNS described/VBN as/IN strong/JJ inhibitors/NNS of/IN CYP3A4/NN in/IN their/PRP$ labeling/NN ./.

(ROOT (S1 (S (S (NP (NN INSPRA)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NP (NNS drugs)) (VP (VBN described) (PP (IN as) (NP (NP (JJ strong) (NNS inhibitors)) (PP (IN of) (NP (NN CYP3A4))))) (PP (IN in) (NP (PRP$ their) (NN labeling)))))))))) (. .))))

nsubjpass(used-5, INSPRA-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
prep_with(used-5, drugs-7)
partmod(drugs-7, described-8)
amod(inhibitors-11, strong-10)
prep_as(described-8, inhibitors-11)
prep_of(inhibitors-11, CYP3A4-13)
poss(labeling-16, their-15)
prep_in(described-8, labeling-16)

Administration/NN of/IN eplerenone/NN with/IN other/JJ CYP3A4/JJ inhibitors/NNS (/-LRB- e.g./FW ,/, erythromycin/NN 500/CD mg/NN BID/NN ,/, verapamil/NN 240/NN mg/NN QD/NN ,/, saquinavir/NN 1200/CD mg/NN TID/NN ,/, fluconazole/NN 200/CD mg/NN QD/NN )/-RRB- resulted/VBD in/IN increases/NNS in/IN Cmax/NN of/IN eplerenone/NN ranging/VBG from/IN 1.4-/NN to/TO 1.6-/JJ fold/NN and/CC AUC/NN from/IN 2.0-/NN to/TO 2.9-/NN fold/NN ./.

(ROOT (S1 (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN eplerenone))) (PP (IN with) (NP (NP (JJ other) (JJ CYP3A4) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NP (NN erythromycin) (CD 500) (NN mg)) (NP (NN BID))) (, ,) (NP (NN verapamil) (NN 240) (NN mg) (NN QD)) (, ,) (NP (NP (NN saquinavir) (CD 1200) (NN mg)) (NP (NN TID))) (, ,) (NP (NN fluconazole) (CD 200) (NN mg)))) (NP (NN QD)) (-RRB- -RRB-))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NP (NN Cmax)) (PP (IN of) (NP (NP (NN eplerenone)) (VP (VBG ranging) (PP (IN from) (NP (NN 1.4-))) (PP (TO to) (NP (JJ 1.6-) (NN fold))))))) (CC and) (NP (NP (NN AUC)) (PP (IN from) (NP (NP (NN 2.0-)) (PP (TO to) (NP (NN 2.9-) (NN fold))))))))))) (. .))))

nsubj(resulted-31, Administration-1)
prep_of(Administration-1, eplerenone-3)
amod(inhibitors-7, other-5)
amod(inhibitors-7, CYP3A4-6)
prep_with(Administration-1, inhibitors-7)
dep(QD-29, e.g.-9)
nn(mg-13, erythromycin-11)
num(mg-13, 500-12)
pobj(e.g.-9, mg-13)
dep(mg-13, BID-14)
nn(QD-19, verapamil-16)
nn(QD-19, 240-17)
nn(QD-19, mg-18)
appos(mg-13, QD-19)
nn(mg-23, saquinavir-21)
num(mg-23, 1200-22)
appos(mg-13, mg-23)
dep(mg-23, TID-24)
nn(mg-28, fluconazole-26)
num(mg-28, 200-27)
appos(mg-13, mg-28)
appos(inhibitors-7, QD-29)
root(ROOT-0, resulted-31)
prep_in(resulted-31, increases-33)
prep_in(increases-33, Cmax-35)
prep_of(Cmax-35, eplerenone-37)
partmod(eplerenone-37, ranging-38)
prep_from(ranging-38, 1.4--40)
amod(fold-43, 1.6--42)
prep_to(ranging-38, fold-43)
conj_and(Cmax-35, AUC-45)
prep_from(AUC-45, 2.0--47)
nn(fold-50, 2.9--49)
prep_to(2.0--47, fold-50)

ACE/NN Inhibitors/NNS and/CC Angiotensin/NN II/NN Receptor/NN Antagonists/NNS (/-LRB- Congestive/JJ Heart/NN Failure/NN Post-Myocardial/JJ Infarction/NN )/-RRB- -/: In/FW EPHESUS/FW ,/, 3020/CD (/-LRB- 91/CD %/NN )/-RRB- patients/NNS receiving/VBG INSPRA/FW 25/CD to/TO 50/CD mg/NN also/RB received/VBD ACE/NN inhibitors/NNS or/CC angiotensin/NN II/NN receptor/NN antagonists/NNS (/-LRB- ACEI/ARB)./CD

(ROOT (S1 (S (NP (NP (NP (NP (NN ACE) (NNS Inhibitors)) (CC and) (NP (NN Angiotensin) (NN II) (NN Receptor) (NNS Antagonists))) (PRN (-LRB- -LRB-) (NP (NP (JJ Congestive) (NN Heart) (NN Failure)) (JJ Post-Myocardial) (NN Infarction)) (-RRB- -RRB-))) (: -) (S (ADVP (FW In) (FW EPHESUS)) (, ,) (NP (NP (CD 3020) (PRN (-LRB- -LRB-) (NP (CD 91) (NN %)) (-RRB- -RRB-)) (NNS patients)) (VP (VBG receiving) (NP (QP (FW INSPRA) (CD 25) (TO to) (CD 50)) (NN mg)))) (ADVP (RB also)) (VP (VBD received) (NP (NP (NN ACE) (NNS inhibitors)) (CC or) (NP (NN angiotensin) (NN II) (NN receptor) (NNS antagonists))))) (-LRB- -LRB-) (CD ACEI/ARB-RRB-.)))))

nn(Inhibitors-2, ACE-1)
root(ROOT-0, Inhibitors-2)
nn(Antagonists-7, Angiotensin-4)
nn(Antagonists-7, II-5)
nn(Antagonists-7, Receptor-6)
conj_and(Inhibitors-2, Antagonists-7)
amod(Failure-11, Congestive-9)
nn(Failure-11, Heart-10)
nn(Infarction-13, Failure-11)
amod(Infarction-13, Post-Myocardial-12)
appos(Inhibitors-2, Infarction-13)
nn(EPHESUS-17, In-16)
advmod(received-32, EPHESUS-17)
num(patients-24, 3020-19)
num(%-22, 91-21)
appos(patients-24, %-22)
nsubj(received-32, patients-24)
partmod(patients-24, receiving-25)
dep(50-29, INSPRA-26)
number(50-29, 25-27)
dep(50-29, to-28)
num(mg-30, 50-29)
dobj(receiving-25, mg-30)
advmod(received-32, also-31)
dep(Inhibitors-2, received-32)
nn(inhibitors-34, ACE-33)
dobj(received-32, inhibitors-34)
nn(antagonists-39, angiotensin-36)
nn(antagonists-39, II-37)
nn(antagonists-39, receptor-38)
conj_or(inhibitors-34, antagonists-39)
num(Inhibitors-2, ACEI/ARB-RRB-.-41)

ACE/NN Inhibitors/NNS and/CC Angiotensin/NN II/NN Receptor/NN Antagonists/NNS (/-LRB- Hypertension/NN )/-RRB- -/: In/IN clinical/JJ studies/NNS of/IN patients/NNS with/IN hypertension/NN ,/, the/DT addition/NN of/IN INSPRA/NN 50/CD to/TO 100/CD mg/NN to/TO ACE/NN inhibitors/NNS and/CC angiotensin/NN II/NN receptor/NN antagonists/NNS increased/VBD mean/NN serum/NN potassium/NN slightly/RB (/-LRB- about/RB 0.09-0.13/CD mEq/L/NN )./NN

(ROOT (S1 (S (NP (NP (NP (NP (NN ACE) (NNS Inhibitors)) (CC and) (NP (NN Angiotensin) (NN II) (NN Receptor) (NNS Antagonists))) (PRN (-LRB- -LRB-) (NP (NN Hypertension)) (-RRB- -RRB-))) (: -) (S (PP (IN In) (NP (NP (JJ clinical) (NNS studies)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN hypertension))))))) (, ,) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN INSPRA) (CD 50) (TO to) (CD 100) (NN mg))) (PP (TO to) (NP (NP (NN ACE) (NNS inhibitors)) (CC and) (NP (NN angiotensin) (NN II) (NN receptor) (NNS antagonists))))) (VP (VBD increased) (NP (NN mean) (NN serum) (NN potassium)) (ADVP (RB slightly)) (-LRB- -LRB-) (NP (ADJP (QP (RB about) (CD 0.09-0.13)) (NN mEq/L)) (NN -RRB-.))))))))

nn(Inhibitors-2, ACE-1)
root(ROOT-0, Inhibitors-2)
nn(Antagonists-7, Angiotensin-4)
nn(Antagonists-7, II-5)
nn(Antagonists-7, Receptor-6)
conj_and(Inhibitors-2, Antagonists-7)
appos(Inhibitors-2, Hypertension-9)
amod(studies-14, clinical-13)
prep_in(increased-36, studies-14)
prep_of(studies-14, patients-16)
prep_with(patients-16, hypertension-18)
det(addition-21, the-20)
nsubj(increased-36, addition-21)
nn(mg-27, INSPRA-23)
num(mg-27, 50-24)
dep(mg-27, to-25)
num(mg-27, 100-26)
prep_of(addition-21, mg-27)
nn(inhibitors-30, ACE-29)
prep_to(addition-21, inhibitors-30)
nn(antagonists-35, angiotensin-32)
nn(antagonists-35, II-33)
nn(antagonists-35, receptor-34)
conj_and(inhibitors-30, antagonists-35)
dep(Inhibitors-2, increased-36)
nn(potassium-39, mean-37)
nn(potassium-39, serum-38)
dobj(increased-36, potassium-39)
advmod(increased-36, slightly-40)
quantmod(0.09-0.13-43, about-42)
dep(mEq/L-44, 0.09-0.13-43)
dep(-RRB-.-45, mEq/L-44)
dobj(increased-36, -RRB-.-45)

In/IN a/DT study/NN in/IN diabetics/NNS with/IN microalbuminuria/NN INSPRA/NN 200/CD mg/NN combined/VBN with/IN the/DT ACE/NN inhibitor/NN enalapril/NN 10/CD mg/NN increased/VBD the/DT frequency/NN of/IN hyperkalemia/NN (/-LRB- serum/NN potassium/NN 5.5/CD mEq/L/NN )/-RRB- from/IN 17/CD %/NN on/IN enalapril/NN alone/RB to/TO 38/CD %./NN

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (NP (NNS diabetics)) (PP (IN with) (NP (NP (NN microalbuminuria) (NN INSPRA) (CD 200) (NN mg)) (VP (VBN combined) (PP (IN with) (NP (NP (DT the) (NN ACE) (NN inhibitor) (NN enalapril)) (ADJP (CD 10) (NN mg))))))))))) (VP (VBD increased) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NP (NN hyperkalemia)) (PRN (-LRB- -LRB-) (NP (NN serum) (NN potassium) (CD 5.5) (NN mEq/L)) (-RRB- -RRB-))))) (PP (IN from) (NP (NP (CD 17) (NN %)) (PP (IN on) (NP (NP (NN enalapril)) (ADVP (RB alone)))))) (PP (TO to) (NP (CD 38) (NN %.)))))))

det(study-3, a-2)
prep_in(increased-19, study-3)
prep_in(study-3, diabetics-5)
nn(mg-10, microalbuminuria-7)
nn(mg-10, INSPRA-8)
num(mg-10, 200-9)
prep_with(diabetics-5, mg-10)
partmod(mg-10, combined-11)
det(enalapril-16, the-13)
nn(enalapril-16, ACE-14)
nn(enalapril-16, inhibitor-15)
prep_with(combined-11, enalapril-16)
number(mg-18, 10-17)
amod(enalapril-16, mg-18)
root(ROOT-0, increased-19)
det(frequency-21, the-20)
dobj(increased-19, frequency-21)
prep_of(frequency-21, hyperkalemia-23)
nn(mEq/L-28, serum-25)
nn(mEq/L-28, potassium-26)
num(mEq/L-28, 5.5-27)
appos(hyperkalemia-23, mEq/L-28)
num(%-32, 17-31)
prep_from(increased-19, %-32)
prep_on(%-32, enalapril-34)
advmod(enalapril-34, alone-35)
num(%.-38, 38-37)
prep_to(increased-19, %.-38)

Lithium/NN -A/NN drug/NN interaction/NN study/NN of/IN eplerenone/NN with/IN lithium/NN has/VBZ not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium) (NN -A) (NN drug) (NN interaction) (NN study)) (PP (IN of) (NP (NN eplerenone))) (PP (IN with) (NP (NN lithium)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

nn(study-5, Lithium-1)
nn(study-5, -A-2)
nn(study-5, drug-3)
nn(study-5, interaction-4)
nsubjpass(conducted-13, study-5)
prep_of(study-5, eplerenone-7)
prep_with(study-5, lithium-9)
aux(conducted-13, has-10)
neg(conducted-13, not-11)
auxpass(conducted-13, been-12)
root(ROOT-0, conducted-13)

Lithium/NN toxicity/NN has/VBZ been/VBN reported/VBN in/IN patients/NNS receiving/VBG lithium/NN concomitantly/RB with/IN diuretics/NNS and/CC ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NN Lithium) (NN toxicity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN lithium)) (PP (ADVP (RB concomitantly)) (IN with) (NP (NP (NNS diuretics)) (CC and) (NP (NN ACE) (NNS inhibitors)))))))))))) (. .))))

nn(toxicity-2, Lithium-1)
nsubjpass(reported-5, toxicity-2)
aux(reported-5, has-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
prep_in(reported-5, patients-7)
partmod(patients-7, receiving-8)
dobj(receiving-8, lithium-9)
advmod(lithium-9, concomitantly-10)
prep_with(lithium-9, diuretics-12)
nn(inhibitors-15, ACE-14)
conj_and(diuretics-12, inhibitors-15)

Serum/NN lithium/NN levels/NNS should/MD be/VB monitored/VBN frequently/RB if/IN INSPRA/NN is/VBZ administered/VBN concomitantly/RB with/IN lithium/NN ./.

(ROOT (S1 (S (S (NP (NN Serum) (NN lithium) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB frequently)) (SBAR (IN if) (S (NP (NN INSPRA)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN lithium))))))))))) (. .))))

nn(levels-3, Serum-1)
nn(levels-3, lithium-2)
nsubjpass(monitored-6, levels-3)
aux(monitored-6, should-4)
auxpass(monitored-6, be-5)
root(ROOT-0, monitored-6)
advmod(monitored-6, frequently-7)
mark(administered-11, if-8)
nsubjpass(administered-11, INSPRA-9)
auxpass(administered-11, is-10)
advcl(monitored-6, administered-11)
advmod(administered-11, concomitantly-12)
prep_with(administered-11, lithium-14)

Nonsteroidal/JJ Anti-Inflammatory/JJ Drugs/NNS (/-LRB- NSAIDs/NNS )/-RRB- -A/NN drug/NN interaction/NN study/NN of/IN eplerenone/NN with/IN an/DT NSAID/NN has/VBZ not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (JJ Nonsteroidal) (JJ Anti-Inflammatory) (NNS Drugs)) (PRN (-LRB- -LRB-) (NP (NNS NSAIDs)) (-RRB- -RRB-))) (NN -A) (NN drug) (NN interaction) (NN study)) (PP (IN of) (NP (NN eplerenone))) (PP (IN with) (NP (DT an) (NN NSAID)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

amod(Drugs-3, Nonsteroidal-1)
amod(Drugs-3, Anti-Inflammatory-2)
nn(study-10, Drugs-3)
appos(Drugs-3, NSAIDs-5)
nn(study-10, -A-7)
nn(study-10, drug-8)
nn(study-10, interaction-9)
nsubjpass(conducted-19, study-10)
prep_of(study-10, eplerenone-12)
det(NSAID-15, an-14)
prep_with(study-10, NSAID-15)
aux(conducted-19, has-16)
neg(conducted-19, not-17)
auxpass(conducted-19, been-18)
root(ROOT-0, conducted-19)

The/DT administration/NN of/IN other/JJ potassium-sparing/JJ antihypertensives/NNS with/IN NSAIDs/NNS has/VBZ been/VBN shown/VBN to/TO reduce/VB the/DT antihypertensive/JJ effect/NN in/IN some/DT patients/NNS and/CC result/VB in/IN severe/JJ hyperkalemia/NN in/IN patients/NNS with/IN impaired/JJ renal/JJ function/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NP (JJ other) (JJ potassium-sparing) (NNS antihypertensives)) (PP (IN with) (NP (NNS NSAIDs)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VP (VB reduce) (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN in) (NP (DT some) (NNS patients)))) (CC and) (VP (VB result) (PP (IN in) (NP (JJ severe) (NN hyperkalemia))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ impaired) (JJ renal) (NN function))))))))))))) (. .))))

det(administration-2, The-1)
nsubjpass(shown-11, administration-2)
xsubj(reduce-13, administration-2)
amod(antihypertensives-6, other-4)
amod(antihypertensives-6, potassium-sparing-5)
prep_of(administration-2, antihypertensives-6)
prep_with(antihypertensives-6, NSAIDs-8)
aux(shown-11, has-9)
auxpass(shown-11, been-10)
root(ROOT-0, shown-11)
aux(reduce-13, to-12)
xcomp(shown-11, reduce-13)
det(effect-16, the-14)
amod(effect-16, antihypertensive-15)
dobj(reduce-13, effect-16)
det(patients-19, some-18)
prep_in(reduce-13, patients-19)
conj_and(reduce-13, result-21)
amod(hyperkalemia-24, severe-23)
prep_in(result-21, hyperkalemia-24)
prep_in(result-21, patients-26)
amod(function-30, impaired-28)
amod(function-30, renal-29)
prep_with(patients-26, function-30)

Therefore/RB ,/, when/WRB INSPRA/NN and/CC NSAIDs/NN are/VBP used/VBN concomitantly/RB ,/, patients/NNS should/MD be/VB observed/VBN to/TO determine/VB whether/IN the/DT desired/JJ effect/NN on/IN blood/NN pressure/NN is/VBZ obtained/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN INSPRA)) (CC and) (NP (NN NSAIDs))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)))))) (, ,) (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN observed) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (JJ desired) (NN effect)) (PP (IN on) (NP (NN blood) (NN pressure)))) (VP (VBZ is) (VP (VBN obtained)))))))))))) (. .))))

advmod(observed-14, Therefore-1)
advmod(used-8, when-3)
nsubjpass(used-8, INSPRA-4)
conj_and(INSPRA-4, NSAIDs-6)
auxpass(used-8, are-7)
advcl(observed-14, used-8)
advmod(used-8, concomitantly-9)
nsubjpass(observed-14, patients-11)
aux(observed-14, should-12)
auxpass(observed-14, be-13)
root(ROOT-0, observed-14)
aux(determine-16, to-15)
xcomp(observed-14, determine-16)
complm(obtained-25, whether-17)
det(effect-20, the-18)
amod(effect-20, desired-19)
nsubjpass(obtained-25, effect-20)
nn(pressure-23, blood-22)
prep_on(effect-20, pressure-23)
auxpass(obtained-25, is-24)
ccomp(determine-16, obtained-25)

Co-treatment/NN with/IN the/DT potent/JJ CYP3A4/NN inhibitor/NN ketoconazole/NN increases/VBZ erlotinib/NN AUC/NN by/IN 2/3/CD ./.

(ROOT (S1 (S (S (NP (NP (NN Co-treatment)) (PP (IN with) (NP (DT the) (JJ potent) (NN CYP3A4) (NN inhibitor) (NN ketoconazole)))) (VP (VBZ increases) (NP (NN erlotinib) (NN AUC)) (PP (IN by) (NP (CD 2/3))))) (. .))))

nsubj(increases-8, Co-treatment-1)
det(ketoconazole-7, the-3)
amod(ketoconazole-7, potent-4)
nn(ketoconazole-7, CYP3A4-5)
nn(ketoconazole-7, inhibitor-6)
prep_with(Co-treatment-1, ketoconazole-7)
root(ROOT-0, increases-8)
nn(AUC-10, erlotinib-9)
dobj(increases-8, AUC-10)
prep_by(increases-8, 2/3-12)

Caution/NN should/MD be/VB used/VBN when/WRB administering/VBG or/CC taking/VBG TARCEVA/NN with/IN ketoconazole/NN and/CC other/JJ strong/JJ CYP3A4/NN inhibitors/NNS such/JJ as/IN ,/, but/CC not/RB limited/JJ to/TO ,/, atazanavir/NN ,/, clarithromycin/NN ,/, indinavir/NN ,/, itraconazole/NN ,/, nefazodone/NN ,/, nelfinavir/NN ,/, ritonavir/NN ,/, saquinavir/NN ,/, telithromycin/NN ,/, troleandomycin/NN (/-LRB- TAO/CD )/-RRB- ,/, and/CC voriconazole/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (CC or) (NP (NP (VBG taking) (NN TARCEVA)) (PP (IN with) (NP (NN ketoconazole)))) (CC and) (NP (NP (JJ other) (JJ strong) (NN CYP3A4) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (, ,) (CONJP (CC but) (RB not)) (NP (ADJP (JJ limited) (PP (TO to))) (, ,) (NN atazanavir) (, ,) (NN clarithromycin) (, ,) (NN indinavir) (, ,) (NN itraconazole) (, ,) (NN nefazodone) (, ,) (NN nelfinavir) (, ,) (NN ritonavir) (, ,) (NN saquinavir) (, ,) (NN telithromycin) (, ,) (NN troleandomycin) (-LRB- -LRB-) (CD TAO) (-RRB- -RRB-)) (, ,) (CC and) (NP (NN voriconazole))))))))))))) (. .))))

nsubjpass(used-4, Caution-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
advmod(administering-6, when-5)
advcl(used-4, administering-6)
amod(TARCEVA-9, taking-8)
dobj(administering-6, TARCEVA-9)
prep_with(TARCEVA-9, ketoconazole-11)
amod(inhibitors-16, other-13)
amod(inhibitors-16, strong-14)
nn(inhibitors-16, CYP3A4-15)
conj_and(TARCEVA-9, inhibitors-16)
amod(troleandomycin-43, limited-22)
prep(limited-22, to-23)
dep(troleandomycin-43, atazanavir-25)
dep(troleandomycin-43, clarithromycin-27)
dep(troleandomycin-43, indinavir-29)
dep(troleandomycin-43, itraconazole-31)
dep(troleandomycin-43, nefazodone-33)
dep(troleandomycin-43, nelfinavir-35)
dep(troleandomycin-43, ritonavir-37)
dep(troleandomycin-43, saquinavir-39)
dep(troleandomycin-43, telithromycin-41)
prep_such_as(inhibitors-16, troleandomycin-43)
num(troleandomycin-43, TAO-45)
conj_and(troleandomycin-43, voriconazole-49)

Pre-treatment/NN with/IN the/DT CYP3A4/NN inducer/NN rifampicin/NN decreased/VBD erlotinib/NN AUC/NN by/IN about/RB 2/3/CD ./.

(ROOT (S1 (S (S (NP (NP (NN Pre-treatment)) (PP (IN with) (NP (DT the) (NN CYP3A4) (NN inducer) (NN rifampicin)))) (VP (VBD decreased) (NP (NN erlotinib) (NN AUC)) (PP (IN by) (NP (RB about) (CD 2/3))))) (. .))))

nsubj(decreased-7, Pre-treatment-1)
det(rifampicin-6, the-3)
nn(rifampicin-6, CYP3A4-4)
nn(rifampicin-6, inducer-5)
prep_with(Pre-treatment-1, rifampicin-6)
root(ROOT-0, decreased-7)
nn(AUC-9, erlotinib-8)
dobj(decreased-7, AUC-9)
advmod(2/3-12, about-11)
prep_by(decreased-7, 2/3-12)

Alternate/JJ treatments/NNS lacking/VBG CYP3A4/NN inducing/NN activity/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Alternate) (NNS treatments)) (VP (VBG lacking) (NP (NN CYP3A4) (NN inducing) (NN activity)))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

amod(treatments-2, Alternate-1)
nsubjpass(considered-9, treatments-2)
partmod(treatments-2, lacking-3)
nn(activity-6, CYP3A4-4)
nn(activity-6, inducing-5)
dobj(lacking-3, activity-6)
aux(considered-9, should-7)
auxpass(considered-9, be-8)
root(ROOT-0, considered-9)

If/IN an/DT alternative/JJ treatment/NN is/VBZ unavailable/JJ ,/, a/DT TARCEVA/NN dose/NN greater/JJR than/IN 150/CD mg/NN should/MD be/VB considered/VBN for/IN NSCLC/NN patients/NNS ,/, and/CC greater/JJR than/IN 100/CD mg/NN considered/VBN for/IN pancreatic/JJ cancer/NN patients/NNS ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT an) (JJ alternative) (NN treatment)) (VP (VBZ is) (ADJP (JJ unavailable))))) (, ,) (NP (NP (DT a) (NN TARCEVA) (NN dose)) (ADJP (QP (JJR greater) (IN than) (CD 150)) (NN mg))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN for) (NP (NP (NP (NN NSCLC) (NNS patients)) (, ,) (CC and) (NP (ADJP (JJR greater) (PP (IN than) (NP (CD 100) (NN mg)))))) (VP (VBN considered) (PP (IN for) (NP (JJ pancreatic) (NN cancer) (NNS patients)))))))))) (. .))))

mark(unavailable-6, If-1)
det(treatment-4, an-2)
amod(treatment-4, alternative-3)
nsubj(unavailable-6, treatment-4)
cop(unavailable-6, is-5)
advcl(considered-17, unavailable-6)
det(dose-10, a-8)
nn(dose-10, TARCEVA-9)
nsubjpass(considered-17, dose-10)
mwe(than-12, greater-11)
quantmod(150-13, than-12)
dep(mg-14, 150-13)
dep(dose-10, mg-14)
aux(considered-17, should-15)
auxpass(considered-17, be-16)
root(ROOT-0, considered-17)
nn(patients-20, NSCLC-19)
prep_for(considered-17, patients-20)
conj_and(patients-20, greater-23)
num(mg-26, 100-25)
prep_than(greater-23, mg-26)
partmod(patients-20, considered-27)
amod(patients-31, pancreatic-29)
nn(patients-31, cancer-30)
prep_for(considered-27, patients-31)

If/IN the/DT TARCEVA/NN dose/NN is/VBZ adjusted/VBN upward/NN ,/, the/DT dose/NN will/MD need/VBP to/TO be/VB reduced/VBN upon/IN discontinuation/NN of/IN rifampicin/NN or/CC other/JJ inducers/NNS ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT the) (NN TARCEVA) (NN dose)) (VP (VBZ is) (VP (VBN adjusted) (S (NP (NN upward))))))) (, ,) (NP (DT the) (NN dose)) (VP (MD will) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN reduced) (PP (IN upon) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NP (NN rifampicin)) (CC or) (NP (JJ other) (NNS inducers))))))))))))) (. .))))

mark(adjusted-6, If-1)
det(dose-4, the-2)
nn(dose-4, TARCEVA-3)
nsubjpass(adjusted-6, dose-4)
auxpass(adjusted-6, is-5)
advcl(need-12, adjusted-6)
xcomp(adjusted-6, upward-7)
det(dose-10, the-9)
nsubj(need-12, dose-10)
xsubj(reduced-15, dose-10)
aux(need-12, will-11)
root(ROOT-0, need-12)
aux(reduced-15, to-13)
auxpass(reduced-15, be-14)
xcomp(need-12, reduced-15)
prep_upon(reduced-15, discontinuation-17)
prep_of(discontinuation-17, rifampicin-19)
amod(inducers-22, other-21)
conj_or(rifampicin-19, inducers-22)

Other/JJ CYP3A4/NN inducers/NNS include/VBP ,/, but/CC are/VBP not/RB limited/JJ to/TO ,/, rifabutin/NN ,/, rifapentine/NN ,/, phenytoin/NN ,/, carbamazepine/NN ,/, phenobarbital/NN and/CC St./NN Johns/NNP Wort/NNP ./.

(ROOT (S1 (S (S (NP (JJ Other) (NN CYP3A4) (NNS inducers)) (VP (VP (VBP include)) (, ,) (CC but) (VP (VBP are) (RB not) (ADJP (JJ limited) (PP (TO to) (NP (, ,) (NP (NN rifabutin)) (, ,) (NP (NN rifapentine)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN phenobarbital)) (CC and) (NP (NN St.)) (NP (NNP Johns) (NNP Wort)))))))) (. .))))

amod(inducers-3, Other-1)
nn(inducers-3, CYP3A4-2)
nsubj(include-4, inducers-3)
root(ROOT-0, include-4)
cop(limited-9, are-7)
neg(limited-9, not-8)
conj_but(include-4, limited-9)
prep_to(limited-9, rifabutin-12)
conj_and(rifabutin-12, rifapentine-14)
conj_and(rifabutin-12, phenytoin-16)
conj_and(rifabutin-12, carbamazepine-18)
conj_and(rifabutin-12, phenobarbital-20)
conj_and(rifabutin-12, St.-22)
nn(Wort-24, Johns-23)
dep(rifabutin-12, Wort-24)

Hepatotoxicity/NN Asymptomatic/JJ increases/NNS in/IN liver/NN transaminases/NNS have/VBP been/VBN observed/VBN in/IN TARCEVA/NN treated/JJ patients/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Hepatotoxicity) (JJ Asymptomatic) (NNS increases)) (PP (IN in) (NP (NN liver) (NNS transaminases)))) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (IN in) (NP (NN TARCEVA) (JJ treated) (NNS patients)))))) (: ;)) (. .))))

nn(increases-3, Hepatotoxicity-1)
amod(increases-3, Asymptomatic-2)
nsubjpass(observed-9, increases-3)
nn(transaminases-6, liver-5)
prep_in(increases-3, transaminases-6)
aux(observed-9, have-7)
auxpass(observed-9, been-8)
root(ROOT-0, observed-9)
nn(patients-13, TARCEVA-11)
amod(patients-13, treated-12)
prep_in(observed-9, patients-13)

therefore/RB ,/, periodic/JJ liver/NN function/NN testing/NN (/-LRB- transaminases/NN ,/, bilirubin/NN ,/, and/CC alkaline/NN phosphatase/NN )/-RRB- should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NP (JJ periodic) (NN liver) (NN function) (NN testing)) (PRN (-LRB- -LRB-) (NP (NP (NN transaminases)) (, ,) (NP (NN bilirubin)) (, ,) (CC and) (NP (NN alkaline) (NN phosphatase))) (-RRB- -RRB-))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

advmod(considered-18, therefore-1)
amod(testing-6, periodic-3)
nn(testing-6, liver-4)
nn(testing-6, function-5)
nsubjpass(considered-18, testing-6)
dep(testing-6, transaminases-8)
conj_and(transaminases-8, bilirubin-10)
nn(phosphatase-14, alkaline-13)
conj_and(transaminases-8, phosphatase-14)
aux(considered-18, should-16)
auxpass(considered-18, be-17)
root(ROOT-0, considered-18)

Dose/NN reduction/NN or/CC interruption/NN of/IN TARCEVA/NN should/MD be/VB considered/VBN if/IN changes/NNS in/IN liver/NN function/NN are/VBP severe/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Dose) (NN reduction)) (CC or) (NP (NP (NN interruption)) (PP (IN of) (NP (NN TARCEVA))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (IN if) (S (NP (NP (NNS changes)) (PP (IN in) (NP (NN liver) (NN function)))) (VP (VBP are) (ADJP (JJ severe))))))))) (. .))))

nn(reduction-2, Dose-1)
nsubjpass(considered-9, reduction-2)
conj_or(reduction-2, interruption-4)
prep_of(interruption-4, TARCEVA-6)
aux(considered-9, should-7)
auxpass(considered-9, be-8)
root(ROOT-0, considered-9)
mark(severe-16, if-10)
nsubj(severe-16, changes-11)
nn(function-14, liver-13)
prep_in(changes-11, function-14)
cop(severe-16, are-15)
advcl(considered-9, severe-16)

Patients/NNS with/IN Hepatic/JJ Impairment/NN :/: In/FW vitro/FW and/CC in/FW vivo/FW evidence/NN suggest/VBP that/IN erlotinib/NN is/VBZ cleared/VBN primarily/RB by/IN the/DT liver/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN with) (NP (JJ Hepatic) (NN Impairment)))) (: :) (NP (ADJP (ADJP (FW In) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NN evidence)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN erlotinib)) (VP (VBZ is) (VP (VBN cleared) (ADVP (RB primarily)) (PP (IN by) (NP (DT the) (NN liver))))))))) (. .))))

nsubj(suggest-12, Patients-1)
amod(Impairment-4, Hepatic-3)
prep_with(Patients-1, Impairment-4)
nn(vitro-7, In-6)
amod(evidence-11, vitro-7)
nn(vivo-10, in-9)
conj_and(vitro-7, vivo-10)
nsubj(suggest-12, evidence-11)
root(ROOT-0, suggest-12)
complm(cleared-16, that-13)
nsubjpass(cleared-16, erlotinib-14)
auxpass(cleared-16, is-15)
ccomp(suggest-12, cleared-16)
advmod(cleared-16, primarily-17)
det(liver-20, the-19)
agent(cleared-16, liver-20)

Therefore/RB ,/, erlotinib/NN exposure/NN may/MD be/VB increased/VBN in/IN patients/NNS with/IN hepatic/JJ dysfunction/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN erlotinib) (NN exposure)) (VP (MD may) (VP (VB be) (VP (VBN increased) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ hepatic) (NN dysfunction))))))))) (. .))))

advmod(increased-7, Therefore-1)
nn(exposure-4, erlotinib-3)
nsubjpass(increased-7, exposure-4)
aux(increased-7, may-5)
auxpass(increased-7, be-6)
root(ROOT-0, increased-7)
prep_in(increased-7, patients-9)
amod(dysfunction-12, hepatic-11)
prep_with(patients-9, dysfunction-12)

Elevated/JJ International/NNP Normalized/VBN Ratio/NN and/CC Potential/JJ Bleeding/JJ International/NNP Normalized/VBN Ratio/NN (/-LRB- INR/NN )/-RRB- elevations/NNS and/CC infrequent/JJ reports/NNS of/IN bleeding/JJ events/NNS including/VBG gastrointestinal/JJ and/CC non-gastrointestinal/JJ bleedings/NNS have/VBP been/VBN reported/VBN in/IN clinical/JJ studies/NNS ,/, some/DT associated/VBN with/IN concomitant/JJ warfarin/NN administration/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (JJ Elevated) (NNP International) (VBN Normalized) (NN Ratio)) (CC and) (NP (NP (JJ Potential) (JJ Bleeding) (NNP International) (VBN Normalized) (NN Ratio)) (PRN (-LRB- -LRB-) (NP (NN INR)) (-RRB- -RRB-)))) (NNS elevations)) (CC and) (NP (NP (JJ infrequent) (NNS reports)) (PP (IN of) (NP (NP (JJ bleeding) (NNS events)) (PP (VBG including) (NP (ADJP (ADJP (JJ gastrointestinal)) (CC and) (ADJP (JJ non-gastrointestinal))) (NNS bleedings))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (JJ clinical) (NNS studies)) (, ,) (NP (NP (DT some)) (VP (VBN associated) (PP (IN with) (NP (JJ concomitant) (NN warfarin) (NN administration))))))))))) (. .))))

amod(Ratio-4, Elevated-1)
nn(Ratio-4, International-2)
amod(Ratio-4, Normalized-3)
nn(elevations-14, Ratio-4)
amod(Ratio-10, Potential-6)
amod(Ratio-10, Bleeding-7)
nn(Ratio-10, International-8)
amod(Ratio-10, Normalized-9)
conj_and(Ratio-4, Ratio-10)
abbrev(Ratio-10, INR-12)
nsubjpass(reported-28, elevations-14)
amod(reports-17, infrequent-16)
conj_and(elevations-14, reports-17)
amod(events-20, bleeding-19)
prep_of(reports-17, events-20)
amod(bleedings-25, gastrointestinal-22)
conj_and(gastrointestinal-22, non-gastrointestinal-24)
prep_including(events-20, bleedings-25)
aux(reported-28, have-26)
auxpass(reported-28, been-27)
root(ROOT-0, reported-28)
amod(studies-31, clinical-30)
prep_in(reported-28, studies-31)
appos(studies-31, some-33)
partmod(some-33, associated-34)
amod(administration-38, concomitant-36)
nn(administration-38, warfarin-37)
prep_with(associated-34, administration-38)

Patients/NNS taking/VBG warfarin/NN or/CC other/JJ coumarin-derivative/JJ anticoagulants/NNS should/MD be/VB monitored/VBN regularly/RB for/IN changes/NNS in/IN prothrombin/NN time/NN or/CC INR/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NN warfarin)))) (CC or) (NP (JJ other) (JJ coumarin-derivative) (NNS anticoagulants))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB regularly)) (PP (IN for) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN prothrombin) (NN time)) (CC or) (NP (NN INR)))))))))) (. .))))

nsubjpass(monitored-10, Patients-1)
partmod(Patients-1, taking-2)
dobj(taking-2, warfarin-3)
amod(anticoagulants-7, other-5)
amod(anticoagulants-7, coumarin-derivative-6)
conj_or(Patients-1, anticoagulants-7)
aux(monitored-10, should-8)
auxpass(monitored-10, be-9)
root(ROOT-0, monitored-10)
advmod(monitored-10, regularly-11)
prep_for(monitored-10, changes-13)
nn(time-16, prothrombin-15)
prep_in(changes-13, time-16)
conj_or(time-16, INR-18)

When/WRB ertapenem/NN is/VBZ co-administered/VBN with/IN probenecid/NN (/-LRB- 500/CD mg/NN p.o./NN every/DT 6/CD hours/NNS )/-RRB- ,/, probenecid/NN competes/VBZ for/IN active/JJ tubular/JJ secretion/NN and/CC reduces/VBZ the/DT renal/JJ clearance/NN of/IN ertapenem/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN ertapenem)) (VP (VBZ is) (VP (VBN co-administered) (PP (IN with) (NP (NP (NN probenecid)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 500) (NN mg)) (NN p.o.)) (NP (DT every) (CD 6) (NNS hours))) (-RRB- -RRB-)))))))) (, ,) (NP (NN probenecid)) (VP (VP (VBZ competes) (PP (IN for) (NP (JJ active) (JJ tubular) (NN secretion)))) (CC and) (VP (VBZ reduces) (NP (NP (DT the) (JJ renal) (NN clearance)) (PP (IN of) (NP (NN ertapenem))))))) (. .))))

advmod(co-administered-4, When-1)
nsubjpass(co-administered-4, ertapenem-2)
auxpass(co-administered-4, is-3)
advcl(competes-17, co-administered-4)
prep_with(co-administered-4, probenecid-6)
number(mg-9, 500-8)
amod(p.o.-10, mg-9)
dep(probenecid-6, p.o.-10)
det(hours-13, every-11)
num(hours-13, 6-12)
dep(p.o.-10, hours-13)
nsubj(competes-17, probenecid-16)
root(ROOT-0, competes-17)
amod(secretion-21, active-19)
amod(secretion-21, tubular-20)
prep_for(competes-17, secretion-21)
conj_and(competes-17, reduces-23)
det(clearance-26, the-24)
amod(clearance-26, renal-25)
dobj(reduces-23, clearance-26)
prep_of(clearance-26, ertapenem-28)

Based/VBN on/IN total/JJ ertapenem/NN concentrations/NNS ,/, probenecid/NN increased/VBD the/DT AUC/NN by/IN 25/CD %/NN and/CC reduced/VBD the/DT plasma/NN and/CC renal/JJ clearances/NNS by/IN 20/CD %/NN and/CC 35/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (PP (VBN Based) (PP (IN on) (NP (JJ total) (NN ertapenem) (NNS concentrations)))) (, ,) (NP (NN probenecid)) (VP (VP (VBD increased) (NP (DT the) (NN AUC)) (PP (IN by) (NP (CD 25) (NN %)))) (CC and) (VP (VBD reduced) (NP (DT the) (NN plasma) (CC and) (JJ renal) (NNS clearances)) (PP (IN by) (NP (NP (CD 20) (NN %)) (CC and) (NP (CD 35) (NN %)) (, ,) (ADVP (RB respectively))))))) (. .))))

prepc_based_on(increased-8, on-2)
amod(concentrations-5, total-3)
nn(concentrations-5, ertapenem-4)
pobj(increased-8, concentrations-5)
nsubj(increased-8, probenecid-7)
root(ROOT-0, increased-8)
det(AUC-10, the-9)
dobj(increased-8, AUC-10)
num(%-13, 25-12)
prep_by(increased-8, %-13)
conj_and(increased-8, reduced-15)
det(clearances-20, the-16)
nn(clearances-20, plasma-17)
conj_and(plasma-17, renal-19)
dobj(reduced-15, clearances-20)
num(%-23, 20-22)
prep_by(reduced-15, %-23)
num(%-26, 35-25)
conj_and(%-23, %-26)
advmod(%-23, respectively-28)
conj_and(%-23, respectively-28)

Because/IN of/IN the/DT small/JJ effect/NN on/IN half-life/NN ,/, the/DT coadministration/NN with/IN probenecid/NN to/TO extend/VB the/DT half-life/NN of/IN ertapenem/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (JJ small) (NN effect)) (PP (IN on) (NP (NN half-life)))))) (, ,) (NP (NP (DT the) (NN coadministration)) (PP (IN with) (NP (NN probenecid))) (S (VP (TO to) (VP (VB extend) (NP (NP (DT the) (NN half-life)) (PP (IN of) (NP (NN ertapenem)))))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

prepc_because_of(recommended-21, of-2)
det(effect-5, the-3)
amod(effect-5, small-4)
pobj(recommended-21, effect-5)
prep_on(effect-5, half-life-7)
det(coadministration-10, the-9)
nsubjpass(recommended-21, coadministration-10)
prep_with(coadministration-10, probenecid-12)
aux(extend-14, to-13)
infmod(coadministration-10, extend-14)
det(half-life-16, the-15)
dobj(extend-14, half-life-16)
prep_of(half-life-16, ertapenem-18)
auxpass(recommended-21, is-19)
neg(recommended-21, not-20)
root(ROOT-0, recommended-21)

In/FW vitro/FW studies/NNS indicate/VBP that/IN ertapenem/NN does/VBZ not/RB inhibit/VB P-/NN glycoprotein/NN -mediated/JJ transport/NN of/IN digoxin/NN or/CC vinblastine/NN and/CC that/IN ertapenem/NN is/VBZ not/RB a/DT substrate/NN for/IN P-/NN glycoprotein/NN -mediated/JJ transport/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NN ertapenem)) (VP (VBZ does) (RB not) (VP (VB inhibit) (NP (NP (NN P-) (NN glycoprotein) (JJ -mediated) (NN transport)) (PP (IN of) (NP (NP (NN digoxin)) (CC or) (NP (NN vinblastine))))))))) (CC and) (SBAR (IN that) (S (NP (NN ertapenem)) (VP (VBZ is) (RB not) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (ADJP (NN P-) (NN glycoprotein) (JJ -mediated)) (NN transport)))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicate-4, studies-3)
root(ROOT-0, indicate-4)
complm(inhibit-9, that-5)
nsubj(inhibit-9, ertapenem-6)
aux(inhibit-9, does-7)
neg(inhibit-9, not-8)
ccomp(indicate-4, inhibit-9)
nn(transport-13, P--10)
nn(transport-13, glycoprotein-11)
amod(transport-13, -mediated-12)
dobj(inhibit-9, transport-13)
prep_of(transport-13, digoxin-15)
conj_or(digoxin-15, vinblastine-17)
complm(substrate-24, that-19)
nsubj(substrate-24, ertapenem-20)
cop(substrate-24, is-21)
neg(substrate-24, not-22)
det(substrate-24, a-23)
conj_and(inhibit-9, substrate-24)
dep(-mediated-28, P--26)
dep(-mediated-28, glycoprotein-27)
amod(transport-29, -mediated-28)
prep_for(substrate-24, transport-29)

In/FW vitro/FW studies/NNS in/IN human/JJ liver/NN microsomes/NNS indicate/VBP that/IN ertapenem/NN does/VBZ not/RB inhibit/VB metabolism/NN mediated/VBN by/IN any/DT of/IN the/DT following/JJ six/CD cytochrome/NN p450/NN (/-LRB- CYP/NN )/-RRB- isoforms/NNS :/: 1A2/NN ,/, 2C9/NN ,/, 2C19/NN ,/, 2D6/NN ,/, 2E1/NN and/CC 3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (PP (IN in) (NP (JJ human) (NN liver) (NNS microsomes)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN ertapenem)) (VP (VBZ does) (RB not) (VP (VB inhibit) (NP (NP (NN metabolism)) (VP (VBN mediated) (PP (IN by) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (JJ following) (NP (NP (CD six) (NN cytochrome) (NN p450)) (PRN (-LRB- -LRB-) (NP (NN CYP)) (-RRB- -RRB-))) (NNS isoforms)) (: :) (NP (NP (NN 1A2)) (, ,) (NP (NN 2C9)) (, ,) (NP (NN 2C19)) (, ,) (NP (NN 2D6)) (, ,) (NP (NN 2E1)) (CC and) (NP (NN 3A4))))))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicate-8, studies-3)
amod(microsomes-7, human-5)
nn(microsomes-7, liver-6)
prep_in(studies-3, microsomes-7)
root(ROOT-0, indicate-8)
complm(inhibit-13, that-9)
nsubj(inhibit-13, ertapenem-10)
aux(inhibit-13, does-11)
neg(inhibit-13, not-12)
ccomp(indicate-8, inhibit-13)
dobj(inhibit-13, metabolism-14)
partmod(metabolism-14, mediated-15)
agent(mediated-15, any-17)
det(isoforms-27, the-19)
amod(isoforms-27, following-20)
num(p450-23, six-21)
nn(p450-23, cytochrome-22)
nn(isoforms-27, p450-23)
abbrev(p450-23, CYP-25)
prep_of(any-17, isoforms-27)
dep(isoforms-27, 1A2-29)
conj_and(1A2-29, 2C9-31)
conj_and(1A2-29, 2C19-33)
conj_and(1A2-29, 2D6-35)
conj_and(1A2-29, 2E1-37)
conj_and(1A2-29, 3A4-39)

Drug/NN interactions/NNS caused/VBN by/IN inhibition/NN of/IN P-/NN glycoprotein/NN -mediated/JJ drug/NN clearance/NN or/CC CYP/NN -mediated/JJ drug/NN clearance/NN with/IN the/DT listed/JJ isoforms/NNS are/VBP unlikely/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NNS interactions)) (VP (VBN caused) (PP (IN by) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (ADJP (NN P-) (NN glycoprotein) (JJ -mediated)) (NN drug) (NN clearance)) (CC or) (NP (ADJP (NN CYP) (JJ -mediated)) (NN drug) (NN clearance)))) (PP (IN with) (NP (DT the) (JJ listed) (NNS isoforms))))))) (VP (VBP are) (ADJP (JJ unlikely)))) (. .))))

nn(interactions-2, Drug-1)
nsubj(unlikely-22, interactions-2)
partmod(interactions-2, caused-3)
agent(caused-3, inhibition-5)
dep(-mediated-9, P--7)
dep(-mediated-9, glycoprotein-8)
amod(clearance-11, -mediated-9)
nn(clearance-11, drug-10)
prep_of(inhibition-5, clearance-11)
dep(-mediated-14, CYP-13)
amod(clearance-16, -mediated-14)
nn(clearance-16, drug-15)
conj_or(clearance-11, clearance-16)
det(isoforms-20, the-18)
amod(isoforms-20, listed-19)
prep_with(inhibition-5, isoforms-20)
cop(unlikely-22, are-21)
root(ROOT-0, unlikely-22)

Other/JJ than/IN with/IN probenecid/NN ,/, no/DT specific/JJ clinical/JJ drug/NN interaction/NN studies/NNS have/VBP been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (ADVP (JJ Other) (PP (IN than) (PP (IN with) (NP (NN probenecid))))) (, ,) (NP (DT no) (JJ specific) (JJ clinical) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted))))) (. .))))

advmod(conducted-14, Other-1)
prep(Other-1, than-2)
pcomp(than-2, with-3)
prep_with(than-2, probenecid-4)
det(studies-11, no-6)
amod(studies-11, specific-7)
amod(studies-11, clinical-8)
nn(studies-11, drug-9)
nn(studies-11, interaction-10)
nsubjpass(conducted-14, studies-11)
aux(conducted-14, have-12)
auxpass(conducted-14, been-13)
root(ROOT-0, conducted-14)

Drug/NN and/CC Laboratory/NN Test/NN Interactions/NNS 1/CD ./.

(ROOT (S1 (S (S (NP (NP (NN Drug)) (CC and) (NP (NN Laboratory) (NN Test) (NNS Interactions))) (NP (CD 1))) (. .))))

dep(1-6, Drug-1)
nn(Interactions-5, Laboratory-3)
nn(Interactions-5, Test-4)
conj_and(Drug-1, Interactions-5)
root(ROOT-0, 1-6)

increased/VBN factors/NNS II/CD ,/, VII/NN antigen/NN ,/, VIII/NN antigen/NN ,/, VIII/NN coagulant/NN activity/NN ,/, IX/NN ,/, X/NN ,/, XII/NN ,/, VII-X/NN complex/NN ,/, II-VII-X/NN complex/NN ,/, and/CC beta-thromboglobulin/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (VBN increased) (NNS factors) (NP (CD II))) (, ,) (NP (NP (NN VII) (NN antigen)) (, ,) (NP (NN VIII) (NN antigen)) (, ,) (NP (NN VIII) (NN coagulant) (NN activity)) (, ,) (NP (NN IX)) (, ,) (NP (NN X)) (, ,) (NP (NN XII)) (, ,) (NP (NN VII-X) (NN complex)) (, ,) (NP (NN II-VII-X) (NN complex)) (, ,) (CC and) (NP (NN beta-thromboglobulin))) (: ;)) (. .)))))

amod(factors-2, increased-1)
root(ROOT-0, factors-2)
dep(factors-2, II-3)
nn(antigen-6, VII-5)
appos(factors-2, antigen-6)
nn(antigen-9, VIII-8)
conj_and(antigen-6, antigen-9)
nn(activity-13, VIII-11)
nn(activity-13, coagulant-12)
conj_and(antigen-6, activity-13)
conj_and(antigen-6, IX-15)
conj_and(antigen-6, X-17)
conj_and(antigen-6, XII-19)
nn(complex-22, VII-X-21)
conj_and(antigen-6, complex-22)
nn(complex-25, II-VII-X-24)
conj_and(antigen-6, complex-25)
conj_and(antigen-6, beta-thromboglobulin-28)

decreased/VBN levels/NNS of/IN anti-factor/NN Xa/NN and/CC antithrombin/NN III/CD ,/, decreased/VBD antithrombin/NN III/CD activity/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (VBN decreased) (NNS levels)) (PP (IN of) (NP (NP (NN anti-factor) (NN Xa)) (CC and) (NP (NN antithrombin) (CD III)))) (, ,)) (VP (VBD decreased) (NP (NN antithrombin) (CD III) (NN activity))) (: ;)) (. .))))

amod(levels-2, decreased-1)
nsubj(decreased-10, levels-2)
nn(Xa-5, anti-factor-4)
prep_of(levels-2, Xa-5)
conj_and(Xa-5, antithrombin-7)
num(antithrombin-7, III-8)
root(ROOT-0, decreased-10)
nn(activity-13, antithrombin-11)
num(activity-13, III-12)
dobj(decreased-10, activity-13)

increased/VBN levels/NNS of/IN fibrinogen/NN and/CC fibrinogen/NN activity/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NP (NN fibrinogen)) (CC and) (NP (NN fibrinogen)) (NP (NN activity)))) (: ;)) (. .)))))

amod(levels-2, increased-1)
root(ROOT-0, levels-2)
prep_of(levels-2, fibrinogen-4)
conj_and(fibrinogen-4, fibrinogen-6)
dep(fibrinogen-4, activity-7)

Increased/VBN thyroid-binding/JJ globulin/NN (/-LRB- TBG/NN )/-RRB- leading/VBG to/TO increased/VBN circulating/JJ total/JJ thyroid/NN hormone/NN levels/NNS ,/, as/IN measured/VBN by/IN protein-bound/JJ iodine/NN (/-LRB- PBI/NN )/-RRB- ,/, T4/NN levels/NNS (/-LRB- by/IN column/NN or/CC by/IN radioimmunoassay/NN )/-RRB- or/CC T3/NN levels/NNS by/IN radioimmunoassay/NN ./.

(ROOT (S1 (S (S (VP (VBN Increased) (NP (NP (NP (JJ thyroid-binding) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NN TBG)) (-RRB- -RRB-))) (VP (VBG leading) (PP (TO to) (NP (VBN increased) (JJ circulating) (JJ total) (NN thyroid) (NN hormone) (NNS levels))))) (, ,) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NP (NP (JJ protein-bound) (NN iodine)) (PRN (-LRB- -LRB-) (NP (NN PBI)) (-RRB- -RRB-))) (, ,) (NP (NP (NN T4) (NNS levels)) (PRN (-LRB- -LRB-) (PP (PP (IN by) (NP (NN column))) (CC or) (PP (IN by) (NP (NN radioimmunoassay)))) (-RRB- -RRB-))) (CC or) (NP (NN T3) (NNS levels)))) (PP (IN by) (NP (NN radioimmunoassay)))))))) (. .))))

root(ROOT-0, Increased-1)
amod(globulin-3, thyroid-binding-2)
dobj(Increased-1, globulin-3)
abbrev(globulin-3, TBG-5)
partmod(globulin-3, leading-7)
amod(levels-14, increased-9)
amod(levels-14, circulating-10)
amod(levels-14, total-11)
nn(levels-14, thyroid-12)
nn(levels-14, hormone-13)
prep_to(leading-7, levels-14)
mark(measured-17, as-16)
advcl(Increased-1, measured-17)
amod(iodine-20, protein-bound-19)
prep_by(measured-17, iodine-20)
abbrev(iodine-20, PBI-22)
nn(levels-26, T4-25)
conj_or(iodine-20, levels-26)
dep(levels-26, by-28)
pobj(by-28, column-29)
conj_or(by-28, by-31)
pobj(by-31, radioimmunoassay-32)
nn(levels-36, T3-35)
conj_or(iodine-20, levels-36)
prep_by(measured-17, radioimmunoassay-38)

Free/JJ T4/NN and/CC T3/NN concentrations/NNS are/VBP unaltered/JJ ./.

(ROOT (S1 (S (S (NP (JJ Free) (NP (NP (NN T4)) (CC and) (NP (NN T3))) (NNS concentrations)) (VP (VBP are) (ADJP (JJ unaltered)))) (. .))))

amod(concentrations-5, Free-1)
nn(concentrations-5, T4-2)
conj_and(T4-2, T3-4)
nsubj(unaltered-7, concentrations-5)
cop(unaltered-7, are-6)
root(ROOT-0, unaltered-7)

Patients/NNS on/IN thyroid/NN replacement/NN therapy/NN may/MD require/VBP higher/JJR doses/NNS of/IN thyroid/NN hormone/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN on) (NP (NN thyroid) (NN replacement) (NN therapy)))) (VP (MD may) (VP (VBP require) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN thyroid) (NN hormone))))))) (. .))))

nsubj(require-7, Patients-1)
nn(therapy-5, thyroid-3)
nn(therapy-5, replacement-4)
prep_on(Patients-1, therapy-5)
aux(require-7, may-6)
root(ROOT-0, require-7)
amod(doses-9, higher-8)
dobj(require-7, doses-9)
nn(hormone-12, thyroid-11)
prep_of(doses-9, hormone-12)

Other/JJ binding/NN proteins/NNS may/MD be/VB elevated/VBN in/IN serum/NN ,/, i.e./FW ,/, corticosteroid/NN binding/NN globulin/NN (/-LRB- CBG/NN )/-RRB- ,/, sex/NN hormone-binding/NN globulin/NN (/-LRB- SHBG/NN )/-RRB- ,/, leading/VBG to/TO increased/VBN total/JJ circulating/JJ corticosteroids/NNS and/CC sex/NN steroids/NNS ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (JJ Other) (NN binding) (NNS proteins)) (VP (MD may) (VP (VB be) (VP (VBN elevated) (PP (IN in) (NP (NP (NN serum)) (, ,) (FW i.e.) (, ,) (NP (NP (NN corticosteroid) (NN binding) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NN CBG)) (-RRB- -RRB-))) (, ,) (NP (NP (NN sex) (NN hormone-binding) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NN SHBG)) (-RRB- -RRB-))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (VBN increased) (JJ total) (JJ circulating) (NNS corticosteroids)) (CC and) (NP (NN sex) (NNS steroids)))) (, ,) (ADVP (RB respectively)))))) (. .))))

amod(proteins-3, Other-1)
nn(proteins-3, binding-2)
nsubjpass(elevated-6, proteins-3)
aux(elevated-6, may-4)
auxpass(elevated-6, be-5)
root(ROOT-0, elevated-6)
prep_in(elevated-6, serum-8)
dep(serum-8, i.e.-10)
nn(globulin-14, corticosteroid-12)
nn(globulin-14, binding-13)
appos(serum-8, globulin-14)
abbrev(globulin-14, CBG-16)
nn(globulin-21, sex-19)
nn(globulin-21, hormone-binding-20)
appos(serum-8, globulin-21)
abbrev(globulin-21, SHBG-23)
xcomp(elevated-6, leading-26)
amod(corticosteroids-31, increased-28)
amod(corticosteroids-31, total-29)
amod(corticosteroids-31, circulating-30)
prep_to(leading-26, corticosteroids-31)
nn(steroids-34, sex-33)
conj_and(corticosteroids-31, steroids-34)
advmod(leading-26, respectively-36)

Other/JJ plasma/NN proteins/NNS may/MD be/VB increased/VBN (/-LRB- angiotensinogen/NN /renin/NN substrate/NN ,/, alpha-1-antitrypsin/JJ ,/, ceruloplasmin/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (JJ Other) (NN plasma) (NNS proteins)) (VP (MD may) (VP (VB be) (VP (VBN increased) (PRN (-LRB- -LRB-) (NP (NP (NN angiotensinogen) (NN /renin) (NN substrate)) (, ,) (NP (ADJP (JJ alpha-1-antitrypsin))) (, ,) (NP (NN ceruloplasmin))) (-RRB- -RRB-)))))) (. .))))

amod(proteins-3, Other-1)
nn(proteins-3, plasma-2)
nsubjpass(increased-6, proteins-3)
aux(increased-6, may-4)
auxpass(increased-6, be-5)
root(ROOT-0, increased-6)
nn(substrate-10, angiotensinogen-8)
nn(substrate-10, /renin-9)
dep(increased-6, substrate-10)
appos(substrate-10, alpha-1-antitrypsin-12)
appos(substrate-10, ceruloplasmin-14)

Increased/VBN plasma/NN HDL/NN and/CC HDL2/NN cholesterol/NN subfraction/NN concentrations/NNS ,/, reduced/VBD LDL/NN cholesterol/NN concentration/NN ,/, increased/VBD triglyceride/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (VBN Increased) (NN plasma) (NN HDL) (CC and) (NN HDL2) (NN cholesterol) (NN subfraction) (NNS concentrations)) (, ,) (VP (VP (VBD reduced) (NP (NN LDL) (NN cholesterol) (NN concentration))) (, ,) (VP (VBD increased) (NP (NN triglyceride) (NNS levels))))) (. .))))

amod(HDL-3, Increased-1)
nn(HDL-3, plasma-2)
nsubj(reduced-10, HDL-3)
nn(concentrations-8, HDL2-5)
nn(concentrations-8, cholesterol-6)
nn(concentrations-8, subfraction-7)
conj_and(HDL-3, concentrations-8)
root(ROOT-0, reduced-10)
nn(concentration-13, LDL-11)
nn(concentration-13, cholesterol-12)
dobj(reduced-10, concentration-13)
dep(reduced-10, increased-15)
nn(levels-17, triglyceride-16)
dobj(increased-15, levels-17)

However/RB ,/, it/PRP was/VBD observed/VBN that/IN the/DT pharmacokinetics/NNS of/IN ENBREL/NN @/NN was/VBD unaltered/JJ by/IN concomitant/JJ methotrexate/NN in/IN rheumatoid/JJ arthritis/NN patients/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN observed) (SBAR (IN that) (S (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN ENBREL) (NN @)))) (VP (VBD was) (ADJP (JJ unaltered) (PP (IN by) (NP (NP (JJ concomitant) (NN methotrexate)) (PP (IN in) (NP (NP (JJ rheumatoid) (NN arthritis)) (NNS patients)))))))))))) (. .))))

advmod(observed-5, However-1)
nsubjpass(observed-5, it-3)
auxpass(observed-5, was-4)
root(ROOT-0, observed-5)
complm(unaltered-13, that-6)
det(pharmacokinetics-8, the-7)
nsubj(unaltered-13, pharmacokinetics-8)
nn(@-11, ENBREL-10)
prep_of(pharmacokinetics-8, @-11)
cop(unaltered-13, was-12)
ccomp(observed-5, unaltered-13)
amod(methotrexate-16, concomitant-15)
prep_by(unaltered-13, methotrexate-16)
amod(arthritis-19, rheumatoid-18)
nn(patients-20, arthritis-19)
prep_in(methotrexate-16, patients-20)

In/IN a/DT study/NN in/IN which/WDT patients/NNS with/IN active/JJ RA/NN were/VBD treated/VBN for/IN up/RB to/TO 24/CD weeks/NNS with/IN concurrent/JJ ENBREL/NN @/NN and/CC anakinra/NN therapy/NN ,/, a/DT 7/CD %/NN rate/NN of/IN serious/JJ infections/NNS was/VBD observed/VBN ,/, which/WDT was/VBD higher/JJR than/IN that/DT observed/VBN with/IN ENBREL/NN @/NN alone/RB (/-LRB- 0%)./JJ

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (NN study)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NNS patients)) (PP (IN with) (NP (JJ active) (NN RA)))) (VP (VBD were) (VP (VBN treated) (PP (IN for) (NP (QP (RB up) (TO to) (CD 24)) (NNS weeks))) (PP (IN with) (NP (NP (JJ concurrent) (NN ENBREL) (NN @)) (CC and) (NP (NN anakinra) (NN therapy)))))))))) (, ,) (NP (NP (DT a) (ADJP (CD 7) (NN %)) (NN rate)) (PP (IN of) (NP (JJ serious) (NNS infections)))) (VP (VBD was) (VP (VBN observed) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NP (DT that)) (VP (VBN observed) (PP (IN with) (NP (NP (NN ENBREL) (NN @)) (ADVP (RB alone)))))))) (PRN (-LRB- -LRB-) (NP (JJ 0%-RRB-.)))))))))))

det(study-3, a-2)
prep_in(observed-33, study-3)
rel(treated-11, which-5)
nsubjpass(treated-11, patients-6)
amod(RA-9, active-8)
prep_with(patients-6, RA-9)
auxpass(treated-11, were-10)
rcmod(study-3, treated-11)
quantmod(24-15, up-13)
dep(24-15, to-14)
num(weeks-16, 24-15)
prep_for(treated-11, weeks-16)
amod(@-20, concurrent-18)
nn(@-20, ENBREL-19)
prep_with(treated-11, @-20)
nn(therapy-23, anakinra-22)
conj_and(@-20, therapy-23)
det(rate-28, a-25)
number(%-27, 7-26)
amod(rate-28, %-27)
nsubjpass(observed-33, rate-28)
amod(infections-31, serious-30)
prep_of(rate-28, infections-31)
auxpass(observed-33, was-32)
root(ROOT-0, observed-33)
nsubj(higher-37, which-35)
cop(higher-37, was-36)
ccomp(observed-33, higher-37)
prep_than(higher-37, that-39)
partmod(that-39, observed-40)
nn(@-43, ENBREL-42)
prep_with(observed-40, @-43)
advmod(@-43, alone-44)
dep(higher-37, 0%-RRB-.-46)

Two/CD percent/NN of/IN patients/NNS treated/VBN concurrently/RB with/IN ENBREL/NN @/NN and/CC anakinra/NN developed/VBD neutropenia/NN (/-LRB- ANC/NN 1/CD x/NN 109/L/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (CD Two) (NN percent)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN treated) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NN ENBREL) (NN @)) (CC and) (NP (NN anakinra)))))))) (VP (VBD developed) (NP (NP (NN neutropenia)) (PRN (-LRB- -LRB-) (NP (NN ANC) (CD 1) (NN x) (NN 109/L)) (-RRB- -RRB-))))) (. .))))

num(percent-2, Two-1)
nsubj(developed-12, percent-2)
prep_of(percent-2, patients-4)
partmod(patients-4, treated-5)
advmod(treated-5, concurrently-6)
nn(@-9, ENBREL-8)
prep_with(treated-5, @-9)
conj_and(@-9, anakinra-11)
root(ROOT-0, developed-12)
dobj(developed-12, neutropenia-13)
nn(109/L-18, ANC-15)
num(109/L-18, 1-16)
nn(109/L-18, x-17)
appos(neutropenia-13, 109/L-18)

Patients/NNS in/IN a/DT clinical/JJ study/NN who/WP were/VBD on/IN established/JJ therapy/NN with/IN sulfasalazine/NN ,/, to/TO which/WDT ENBREL/NN was/VBD added/VBN ,/, were/VBD noted/VBN to/TO develop/VB a/DT mild/JJ decrease/NN in/IN mean/NN neutrophil/NN counts/NNS in/IN comparison/NN to/TO groups/NNS treated/VBN with/IN either/CC ENBREL/NN CI/CD or/CC sulfasalazine/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN in) (NP (DT a) (JJ clinical) (NN study))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (PP (IN on) (NP (NP (JJ established) (NN therapy)) (PP (IN with) (NP (NP (NN sulfasalazine)) (, ,) (SBAR (WHPP (TO to) (WHNP (WDT which))) (S (NP (NN ENBREL)) (VP (VBD was) (VP (VBN added))))) (, ,))))))))) (VP (VBD were) (VP (VBN noted) (S (VP (TO to) (VP (VB develop) (NP (NP (DT a) (JJ mild) (NN decrease)) (PP (IN in) (NP (NP (NN mean) (NN neutrophil) (NNS counts)) (PP (IN in) (NP (NP (NN comparison)) (PP (TO to) (NP (NP (NNS groups)) (VP (VBN treated) (PP (IN with) (NP (CC either) (NP (NN ENBREL) (CD CI)) (CC or) (NP (NN sulfasalazine)))) (ADVP (RB alone)))))))))))))))) (. .))))

nsubj(were-7, Patients-1)
nsubjpass(noted-21, Patients-1)
xsubj(develop-23, Patients-1)
det(study-5, a-3)
amod(study-5, clinical-4)
prep_in(Patients-1, study-5)
rcmod(Patients-1, were-7)
amod(therapy-10, established-9)
prep_on(were-7, therapy-10)
prep_with(therapy-10, sulfasalazine-12)
rel(added-18, which-15)
nsubjpass(added-18, ENBREL-16)
auxpass(added-18, was-17)
rcmod(sulfasalazine-12, added-18)
auxpass(noted-21, were-20)
root(ROOT-0, noted-21)
aux(develop-23, to-22)
xcomp(noted-21, develop-23)
det(decrease-26, a-24)
amod(decrease-26, mild-25)
dobj(develop-23, decrease-26)
nn(counts-30, mean-28)
nn(counts-30, neutrophil-29)
prep_in(decrease-26, counts-30)
prep_in(counts-30, comparison-32)
prep_to(comparison-32, groups-34)
partmod(groups-34, treated-35)
preconj(ENBREL-38, either-37)
prep_with(treated-35, ENBREL-38)
num(ENBREL-38, CI-39)
conj_or(ENBREL-38, sulfasalazine-41)
advmod(treated-35, alone-42)

Dicumarol/NN and/CC warfarin/NN may/MD decrease/VB hypoprothrombinemic/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Dicumarol)) (CC and) (NP (NN warfarin))) (VP (MD may) (VP (VB decrease) (NP (JJ hypoprothrombinemic) (NN effect))))) (. .))))

nsubj(decrease-5, Dicumarol-1)
conj_and(Dicumarol-1, warfarin-3)
aux(decrease-5, may-4)
root(ROOT-0, decrease-5)
amod(effect-7, hypoprothrombinemic-6)
dobj(decrease-5, effect-7)

Other/JJ depressasnts/NNS such/JJ as/IN alcohol/NN ,/, barbiturates/NNS ,/, and/CC MAOIs/NNS may/MD enhance/VB CNS/NN depression/NN when/WRB administered/VBN with/IN ethchlorvynol/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (NNS depressasnts)) (PP (JJ such) (IN as) (NP (NP (NN alcohol)) (, ,) (NP (NNS barbiturates)) (, ,) (CC and) (NP (NNS MAOIs))))) (VP (MD may) (VP (VB enhance) (NP (NN CNS) (NN depression)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NN ethchlorvynol))))))))) (. .))))

amod(depressasnts-2, Other-1)
nsubj(enhance-12, depressasnts-2)
prep_such_as(depressasnts-2, alcohol-5)
conj_and(alcohol-5, barbiturates-7)
conj_and(alcohol-5, MAOIs-10)
aux(enhance-12, may-11)
root(ROOT-0, enhance-12)
nn(depression-14, CNS-13)
dobj(enhance-12, depression-14)
advmod(administered-16, when-15)
advcl(enhance-12, administered-16)
prep_with(administered-16, ethchlorvynol-18)

Certain/JJ endocrine/NN and/CC liver/NN function/NN tests/NNS may/MD be/VB affected/VBN by/IN estrogen/NN -containing/JJ oral/JJ contraceptives/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Certain) (NN endocrine)) (CC and) (NP (NN liver) (NN function) (NNS tests))) (VP (MD may) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (ADJP (NN estrogen) (JJ -containing)) (JJ oral) (NNS contraceptives))))))) (. .))))

amod(endocrine-2, Certain-1)
nsubjpass(affected-9, endocrine-2)
nn(tests-6, liver-4)
nn(tests-6, function-5)
conj_and(endocrine-2, tests-6)
aux(affected-9, may-7)
auxpass(affected-9, be-8)
root(ROOT-0, affected-9)
dep(-containing-12, estrogen-11)
amod(contraceptives-14, -containing-12)
amod(contraceptives-14, oral-13)
agent(affected-9, contraceptives-14)

The/DT following/JJ similar/JJ changes/NNS may/MD be/VB expected/VBN with/IN larger/JJR doses/NNS of/IN estrogen/NN :/: Increased/VBN sulfobromophthalein/NN retention/NN ;/: ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (JJ similar) (NNS changes)) (VP (MD may) (VP (VB be) (VP (VBN expected) (PP (IN with) (NP (NP (JJR larger) (NNS doses)) (PP (IN of) (NP (NN estrogen)))))))) (: :) (NP (VBN Increased) (NN sulfobromophthalein) (NN retention)) (: ;)) (. .))))

det(changes-4, The-1)
amod(changes-4, following-2)
amod(changes-4, similar-3)
nsubjpass(expected-7, changes-4)
aux(expected-7, may-5)
auxpass(expected-7, be-6)
root(ROOT-0, expected-7)
amod(doses-10, larger-9)
prep_with(expected-7, doses-10)
prep_of(doses-10, estrogen-12)
amod(retention-16, Increased-14)
nn(retention-16, sulfobromophthalein-15)
dep(expected-7, retention-16)

increased/VBN prothrombin/NN and/CC factors/NNS VII/NN ,/, VIII/NN ,/, IX/NN ,/, and/CC X/NN ;/: ./.

(ROOT (S1 (S (S (VP (VBN increased) (NP (NP (NN prothrombin)) (CC and) (NP (NP (NP (NNS factors) (NN VII)) (, ,) (NP (NN VIII)) (, ,) (NP (NN IX)) (, ,) (CC and) (NP (NN X))) (: ;))))) (. .))))

root(ROOT-0, increased-1)
dobj(increased-1, prothrombin-2)
nn(VII-5, factors-4)
conj_and(prothrombin-2, VII-5)
conj_and(VII-5, VIII-7)
conj_and(VII-5, IX-9)
conj_and(VII-5, X-12)

decreased/VBN antithrombin/NN 3/CD ;/: ./.

(ROOT (S1 (S (S (VP (VBN decreased) (NP (NN antithrombin) (CD 3))) (: ;)) (. .))))

root(ROOT-0, decreased-1)
dobj(decreased-1, antithrombin-2)
num(antithrombin-2, 3-3)

increased/VBN norepinephrine/NN -induced/JJ platel/NNP et/FW aggregation/NN ;/: ./.

(ROOT (S1 (S (S (NP (VBN increased) (NN norepinephrine)) (VP (JJ -induced) (NP (NNP platel) (FW et) (NP (NN aggregation)))) (: ;)) (. .))))

amod(norepinephrine-2, increased-1)
nsubj(-induced-3, norepinephrine-2)
root(ROOT-0, -induced-3)
dobj(-induced-3, platel-4)
dep(platel-4, et-5)
dep(platel-4, aggregation-6)

increased/VBN thyroid/NN binding/NN globulin/NN (/-LRB- TBG/NN )/-RRB- leading/VBG to/TO increased/VBN circulating/VBG total/JJ thyroid/NN hormone/NN ,/, as/IN measured/VBN by/IN PBI/NN ,/, T4/NN by/IN column/NN ,/, or/CC T4/NN by/IN radioimmunoassay/NN ./.

(ROOT (S1 (S (S (NP (NP (VBN increased) (NN thyroid) (NN binding) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NN TBG)) (-RRB- -RRB-))) (VP (VBG leading) (PP (TO to) (NP (VBN increased) (VBG circulating) (JJ total) (NN thyroid) (NN hormone))) (, ,) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NP (NN PBI)) (, ,) (NP (NP (NN T4)) (PP (IN by) (NP (NN column)))) (, ,) (CC or) (NP (NN T4)))) (PP (IN by) (NP (NN radioimmunoassay)))))))) (. .))))

amod(globulin-4, increased-1)
nn(globulin-4, thyroid-2)
nn(globulin-4, binding-3)
nsubj(leading-8, globulin-4)
abbrev(globulin-4, TBG-6)
root(ROOT-0, leading-8)
amod(hormone-14, increased-10)
amod(hormone-14, circulating-11)
amod(hormone-14, total-12)
nn(hormone-14, thyroid-13)
prep_to(leading-8, hormone-14)
mark(measured-17, as-16)
advcl(leading-8, measured-17)
prep_by(measured-17, PBI-19)
conj_or(PBI-19, T4-21)
prep_by(T4-21, column-23)
conj_or(PBI-19, T4-26)
prep_by(measured-17, radioimmunoassay-28)

increased/VBN serum/NN triglyceride/NN and/CC phospholipid/NN concentration/NN ./.

(ROOT (S1 (S (S (VP (VBN increased) (NP (NP (NN serum) (NN triglyceride)) (CC and) (NP (NN phospholipid) (NN concentration))))) (. .))))

root(ROOT-0, increased-1)
nn(triglyceride-3, serum-2)
dobj(increased-1, triglyceride-3)
nn(concentration-6, phospholipid-5)
conj_and(triglyceride-3, concentration-6)

Ethinyl/NN estradiol/NN :/: Substrate/NN of/IN CYP3A4/NN (/-LRB- major/JJ )/-RRB- ,/, 3A5-7/NN (/-LRB- minor/JJ )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NP (NN Ethinyl) (NN estradiol)) (: :) (NP (NP (NP (NN Substrate)) (PP (IN of) (NP (NP (NN CYP3A4)) (PRN (-LRB- -LRB-) (NP (JJ major)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN 3A5-7)) (PRN (-LRB- -LRB-) (NP (JJ minor)) (-RRB- -RRB-))) (: ;)) (. .)))))

nn(estradiol-2, Ethinyl-1)
root(ROOT-0, estradiol-2)
dep(estradiol-2, Substrate-4)
prep_of(Substrate-4, CYP3A4-6)
dep(CYP3A4-6, major-8)
appos(Substrate-4, 3A5-7-11)
dep(3A5-7-11, minor-13)

Inhibits/VBZ CYP1A2/NN (/-LRB- weak/JJ )/-RRB- ,/, 2B6/NN (/-LRB- weak/JJ )/-RRB- ,/, 2C19/NN (/-LRB- weak/JJ )/-RRB- ,/, 3A4/NN (/-LRB- weak)./NN

(ROOT (S1 (S (SINV (VBZ Inhibits) (NP (NP (NP (NN CYP1A2)) (PRN (-LRB- -LRB-) (NP (JJ weak)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN 2B6)) (PRN (-LRB- -LRB-) (NP (JJ weak)) (-RRB- -RRB-))) (, ,) (NP (NP (NN 2C19)) (PRN (-LRB- -LRB-) (NP (JJ weak)) (-RRB- -RRB-))) (, ,) (NP (NN 3A4)) (-LRB- -LRB-) (NP (NN weak-RRB-.))))))))

root(ROOT-0, Inhibits-1)
nsubj(Inhibits-1, CYP1A2-2)
dep(CYP1A2-2, weak-4)
appos(CYP1A2-2, 2B6-7)
dep(2B6-7, weak-9)
appos(2B6-7, 2C19-12)
dep(2C19-12, weak-14)
appos(2B6-7, 3A4-17)
dep(2B6-7, weak-RRB-.-19)

Acetaminophen/NN :/: May/MD increase/VB plasma/NN concentration/NN of/IN synthetic/JJ estrogens/NNS ,/, possibly/RB by/IN inhibiting/VBG conjugation/NN ./.

(ROOT (S1 (S (S (NP (NN Acetaminophen) (: :)) (VP (MD May) (VP (VB increase) (NP (NP (NN plasma) (NN concentration)) (PP (IN of) (NP (JJ synthetic) (NNS estrogens)))) (, ,) (PP (ADVP (RB possibly)) (IN by) (S (VP (VBG inhibiting) (NP (NN conjugation)))))))) (. .))))

nsubj(increase-4, Acetaminophen-1)
aux(increase-4, May-3)
root(ROOT-0, increase-4)
nn(concentration-6, plasma-5)
dobj(increase-4, concentration-6)
amod(estrogens-9, synthetic-8)
prep_of(concentration-6, estrogens-9)
advmod(increase-4, possibly-11)
prepc_by(increase-4, inhibiting-13)
dobj(inhibiting-13, conjugation-14)

Combination/NN hormonal/JJ contraceptives/NNS may/MD also/RB decrease/VB the/DT plasma/NN concentration/NN of/IN acetaminophen/NN ./.

(ROOT (S1 (S (S (NP (NN Combination) (JJ hormonal) (NNS contraceptives)) (VP (MD may) (ADVP (RB also)) (VP (VB decrease) (NP (NP (DT the) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN acetaminophen))))))) (. .))))

nn(contraceptives-3, Combination-1)
amod(contraceptives-3, hormonal-2)
nsubj(decrease-6, contraceptives-3)
aux(decrease-6, may-4)
advmod(decrease-6, also-5)
root(ROOT-0, decrease-6)
det(concentration-9, the-7)
nn(concentration-9, plasma-8)
dobj(decrease-6, concentration-9)
prep_of(concentration-9, acetaminophen-11)

Acitretin/NN :/: Interferes/VBZ with/IN the/DT contraceptive/JJ effect/NN of/IN microdosed/JJ progestin/NN -containing/JJ minipill/NN preparations/NNS ./.

(ROOT (S1 (S (S (NP (NN Acitretin) (: :)) (VP (VBZ Interferes) (PP (IN with) (NP (NP (DT the) (JJ contraceptive) (NN effect)) (PP (IN of) (NP (JJ microdosed) (NN progestin) (JJ -containing) (NN minipill) (NNS preparations))))))) (. .))))

nsubj(Interferes-3, Acitretin-1)
root(ROOT-0, Interferes-3)
det(effect-7, the-5)
amod(effect-7, contraceptive-6)
prep_with(Interferes-3, effect-7)
amod(preparations-13, microdosed-9)
nn(preparations-13, progestin-10)
amod(preparations-13, -containing-11)
nn(preparations-13, minipill-12)
prep_of(effect-7, preparations-13)

The/DT effect/NN on/IN other/JJ progestational/JJ contraceptives/NNS (/-LRB- eg/FW ,/, implants/NNS ,/, injectables/NNS )/-RRB- is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN on) (NP (NP (JJ other) (JJ progestational) (NNS contraceptives)) (PRN (-LRB- -LRB-) (PP (FW eg) (, ,) (NP (NNS implants))) (, ,) (NP (NNS injectables)) (-RRB- -RRB-))))) (VP (VBZ is) (ADJP (JJ unknown)))) (. .))))

det(effect-2, The-1)
nsubj(unknown-15, effect-2)
amod(contraceptives-6, other-4)
amod(contraceptives-6, progestational-5)
prep_on(effect-2, contraceptives-6)
dep(injectables-12, eg-8)
pobj(eg-8, implants-10)
appos(contraceptives-6, injectables-12)
cop(unknown-15, is-14)
root(ROOT-0, unknown-15)

Aminoglutethimide/NN :/: May/MD increase/VBP CYP/NN metabolism/NN of/IN progestins/NNS leading/VBG to/TO possible/JJ decrease/NN in/IN contraceptive/JJ effectiveness/NN ./.

(ROOT (S1 (S (S (NP (NN Aminoglutethimide) (: :)) (VP (MD May) (VP (VBP increase) (NP (NP (NN CYP) (NN metabolism)) (PP (IN of) (NP (NP (NNS progestins)) (VP (VBG leading) (PP (TO to) (NP (NP (JJ possible) (NN decrease)) (PP (IN in) (NP (JJ contraceptive) (NN effectiveness)))))))))))) (. .))))

nsubj(increase-4, Aminoglutethimide-1)
aux(increase-4, May-3)
root(ROOT-0, increase-4)
nn(metabolism-6, CYP-5)
dobj(increase-4, metabolism-6)
prep_of(metabolism-6, progestins-8)
partmod(progestins-8, leading-9)
amod(decrease-12, possible-11)
prep_to(leading-9, decrease-12)
amod(effectiveness-15, contraceptive-14)
prep_in(decrease-12, effectiveness-15)

Use/NN of/IN a/DT nonhormonal/JJ contraceptive/JJ product/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN of) (NP (DT a) (JJ nonhormonal) (JJ contraceptive) (NN product)))) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

nsubjpass(recommended-8, Use-1)
det(product-6, a-3)
amod(product-6, nonhormonal-4)
amod(product-6, contraceptive-5)
prep_of(Use-1, product-6)
auxpass(recommended-8, is-7)
root(ROOT-0, recommended-8)

Antibiotics/NNS (/-LRB- ampicillin/NN ,/, tetracycline/NN )/-RRB- :/: Pregnancy/NN has/VBZ been/VBN reported/VBN following/VBG concomitant/JJ use/NN ,/, however/RB ,/, pharmacokinetic/JJ studies/NNS have/VBP not/RB shown/VBN consistent/JJ effects/NNS with/IN these/DT antibiotics/NNS on/IN plasma/NN concentrations/NNS of/IN synthetic/JJ steroids/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Antibiotics)) (PRN (-LRB- -LRB-) (NP (NP (NN ampicillin)) (, ,) (NP (NN tetracycline))) (-RRB- -RRB-))) (: :) (S (NP (NN Pregnancy)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (VBG following) (NP (JJ concomitant) (NN use)))))))) (, ,) (ADVP (RB however)) (, ,) (NP (JJ pharmacokinetic) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN shown) (NP (NP (JJ consistent) (NNS effects)) (PP (IN with) (NP (DT these) (NNS antibiotics))) (PP (IN on) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (JJ synthetic) (NNS steroids))))))))) (. .))))

nsubj(shown-22, Antibiotics-1)
dep(Antibiotics-1, ampicillin-3)
appos(ampicillin-3, tetracycline-5)
nsubjpass(reported-11, Pregnancy-8)
aux(reported-11, has-9)
auxpass(reported-11, been-10)
dep(Antibiotics-1, reported-11)
amod(use-14, concomitant-13)
prep_following(reported-11, use-14)
advmod(shown-22, however-16)
amod(studies-19, pharmacokinetic-18)
nsubj(shown-22, studies-19)
aux(shown-22, have-20)
neg(shown-22, not-21)
root(ROOT-0, shown-22)
amod(effects-24, consistent-23)
dobj(shown-22, effects-24)
det(antibiotics-27, these-26)
prep_with(effects-24, antibiotics-27)
nn(concentrations-30, plasma-29)
prep_on(effects-24, concentrations-30)
amod(steroids-33, synthetic-32)
prep_of(concentrations-30, steroids-33)

Use/NN of/IN a/DT nonhormonal/JJ contraceptive/JJ product/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN of) (NP (DT a) (JJ nonhormonal) (JJ contraceptive) (NN product)))) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

nsubjpass(recommended-8, Use-1)
det(product-6, a-3)
amod(product-6, nonhormonal-4)
amod(product-6, contraceptive-5)
prep_of(Use-1, product-6)
auxpass(recommended-8, is-7)
root(ROOT-0, recommended-8)

Anticoagulants/NNS :/: Combination/NN hormonal/JJ contraceptives/NNS may/MD increase/VB or/CC decrease/VB the/DT effects/NNS of/IN coumarin/NN derivatives/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Anticoagulants)) (: :) (S (NP (NN Combination) (JJ hormonal) (NNS contraceptives)) (VP (MD may) (VP (VP (VB increase)) (CC or) (VP (VB decrease) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN coumarin) (NNS derivatives)))))))) (. .)))))

root(ROOT-0, Anticoagulants-1)
nn(contraceptives-5, Combination-3)
amod(contraceptives-5, hormonal-4)
nsubj(increase-7, contraceptives-5)
aux(increase-7, may-6)
dep(Anticoagulants-1, increase-7)
conj_or(increase-7, decrease-9)
det(effects-11, the-10)
dobj(decrease-9, effects-11)
nn(derivatives-14, coumarin-13)
prep_of(effects-11, derivatives-14)

Combination/NN hormonal/JJ contraceptives/NNS may/MD also/RB increase/VB risk/NN of/IN thromboembolic/JJ disorders/NNS ./.

(ROOT (S1 (S (S (NP (NN Combination) (JJ hormonal) (NNS contraceptives)) (VP (MD may) (ADVP (RB also)) (VP (VB increase) (NP (NP (NN risk)) (PP (IN of) (NP (JJ thromboembolic) (NNS disorders))))))) (. .))))

nn(contraceptives-3, Combination-1)
amod(contraceptives-3, hormonal-2)
nsubj(increase-6, contraceptives-3)
aux(increase-6, may-4)
advmod(increase-6, also-5)
root(ROOT-0, increase-6)
dobj(increase-6, risk-7)
amod(disorders-10, thromboembolic-9)
prep_of(risk-7, disorders-10)

Anticonvulsants/NNS (/-LRB- carbamazepine/NN ,/, felbamate/NN ,/, phenobarbital/NN ,/, phenytoin/NN ,/, topiramate/NN )/-RRB- :/: Increase/NN the/DT metabolism/NN of/IN ethinyl/NN estradiol/NN and/or/CC some/DT progestins/NNS ,/, leading/VBG to/TO possible/JJ decrease/NN in/IN contraceptive/JJ effectiveness/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Anticonvulsants)) (PRN (-LRB- -LRB-) (NP (NP (NN carbamazepine)) (, ,) (NP (NN felbamate)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN topiramate))) (-RRB- -RRB-))) (: :) (NP (NP (NP (NN Increase)) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN ethinyl) (NN estradiol))))) (CC and/or) (NP (NP (DT some) (NNS progestins)) (, ,) (VP (VBG leading) (PP (TO to) (NP (NP (JJ possible) (NN decrease)) (PP (IN in) (NP (JJ contraceptive) (NN effectiveness)))))))) (. .)))))

root(ROOT-0, Anticonvulsants-1)
dep(Anticonvulsants-1, carbamazepine-3)
appos(carbamazepine-3, felbamate-5)
appos(carbamazepine-3, phenobarbital-7)
appos(carbamazepine-3, phenytoin-9)
appos(carbamazepine-3, topiramate-11)
dep(Anticonvulsants-1, Increase-14)
det(metabolism-16, the-15)
dep(Increase-14, metabolism-16)
nn(estradiol-19, ethinyl-18)
prep_of(metabolism-16, estradiol-19)
det(progestins-22, some-21)
conj_and/or(Increase-14, progestins-22)
partmod(progestins-22, leading-24)
amod(decrease-27, possible-26)
prep_to(leading-24, decrease-27)
amod(effectiveness-30, contraceptive-29)
prep_in(decrease-27, effectiveness-30)

Use/NN of/IN a/DT nonhormonal/JJ contraceptive/JJ product/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN of) (NP (DT a) (JJ nonhormonal) (JJ contraceptive) (NN product)))) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

nsubjpass(recommended-8, Use-1)
det(product-6, a-3)
amod(product-6, nonhormonal-4)
amod(product-6, contraceptive-5)
prep_of(Use-1, product-6)
auxpass(recommended-8, is-7)
root(ROOT-0, recommended-8)

Ascorbic/JJ acid/NN :/: Doses/NNS of/IN ascorbic/JJ acid/NN (/-LRB- vitamin/NN C/NN )/-RRB- 1/CD g/day/NN have/VBP been/VBN reported/VBN to/TO increase/VB plasma/NN concentration/NN of/IN synthetic/JJ estrogens/NNS by/IN ~47/CD %/NN ,/, possibly/RB by/IN inhibiting/VBG conjugation/NN ;/: ./.

(ROOT (S1 (S (NP (NP (JJ Ascorbic) (NN acid)) (: :) (S (NP (NP (NNS Doses)) (PP (IN of) (NP (NP (NP (JJ ascorbic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN vitamin) (NN C)) (-RRB- -RRB-))) (CD 1) (NN g/day)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB increase) (NP (NP (NN plasma) (NN concentration)) (PP (IN of) (NP (JJ synthetic) (NNS estrogens)))) (PP (IN by) (NP (CD ~47) (NN %))) (, ,) (PP (ADVP (RB possibly)) (IN by) (S (VP (VBG inhibiting) (NP (NN conjugation))))))))))) (: ;)) (. .)))))

amod(acid-2, Ascorbic-1)
root(ROOT-0, acid-2)
nsubjpass(reported-16, Doses-4)
xsubj(increase-18, Doses-4)
amod(acid-7, ascorbic-6)
nn(g/day-13, acid-7)
nn(C-10, vitamin-9)
appos(acid-7, C-10)
num(g/day-13, 1-12)
prep_of(Doses-4, g/day-13)
aux(reported-16, have-14)
auxpass(reported-16, been-15)
dep(acid-2, reported-16)
aux(increase-18, to-17)
xcomp(reported-16, increase-18)
nn(concentration-20, plasma-19)
dobj(increase-18, concentration-20)
amod(estrogens-23, synthetic-22)
prep_of(concentration-20, estrogens-23)
num(%-26, ~47-25)
prep_by(increase-18, %-26)
advmod(increase-18, possibly-28)
prepc_by(increase-18, inhibiting-30)
dobj(inhibiting-30, conjugation-31)

Atorvastatin/NN :/: Atorvastatin/NN increases/VBZ the/DT AUC/NN for/IN norethindrone/NN and/CC ethinyl/NN estradiol/NN ./.

(ROOT (S1 (S (NP (NP (NN Atorvastatin)) (: :) (S (NP (NN Atorvastatin)) (VP (VBZ increases) (NP (NP (DT the) (NN AUC)) (PP (IN for) (NP (NP (NN norethindrone)) (CC and) (NP (NN ethinyl) (NN estradiol))))))) (. .)))))

root(ROOT-0, Atorvastatin-1)
nsubj(increases-4, Atorvastatin-3)
dep(Atorvastatin-1, increases-4)
det(AUC-6, the-5)
dobj(increases-4, AUC-6)
prep_for(AUC-6, norethindrone-8)
nn(estradiol-11, ethinyl-10)
conj_and(norethindrone-8, estradiol-11)

Benzodiazepines/NNS :/: Combination/NN hormonal/JJ contraceptives/NNS may/MD decrease/VB the/DT clearance/NN of/IN some/DT benzodiazepines/NNS (/-LRB- alprazolam/NN ,/, chlordiazepoxide/NN ,/, diazepam/NN )/-RRB- and/CC increase/VB the/DT clearance/NN of/IN others/NNS (/-LRB- lorazepam/NN ,/, oxazepam/NN ,/, temazepam/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NNS Benzodiazepines)) (: :) (S (NP (NN Combination) (JJ hormonal) (NNS contraceptives)) (VP (MD may) (VP (VP (VP (VB decrease) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NP (DT some) (NNS benzodiazepines)) (PRN (-LRB- -LRB-) (NP (NP (NN alprazolam)) (, ,) (NP (NN chlordiazepoxide)) (, ,) (NP (NN diazepam))) (-RRB- -RRB-)))))) (CC and) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NNS others)))))) (PRN (-LRB- -LRB-) (NP (NP (NN lorazepam)) (, ,) (NP (NN oxazepam)) (, ,) (NP (NN temazepam))) (-RRB- -RRB-))))) (. .)))))

root(ROOT-0, Benzodiazepines-1)
nn(contraceptives-5, Combination-3)
amod(contraceptives-5, hormonal-4)
nsubj(decrease-7, contraceptives-5)
aux(decrease-7, may-6)
dep(Benzodiazepines-1, decrease-7)
det(clearance-9, the-8)
dobj(decrease-7, clearance-9)
det(benzodiazepines-12, some-11)
prep_of(clearance-9, benzodiazepines-12)
dep(benzodiazepines-12, alprazolam-14)
appos(alprazolam-14, chlordiazepoxide-16)
appos(alprazolam-14, diazepam-18)
conj_and(decrease-7, increase-21)
det(clearance-23, the-22)
dobj(increase-21, clearance-23)
prep_of(clearance-23, others-25)
dep(decrease-7, lorazepam-27)
appos(lorazepam-27, oxazepam-29)
appos(lorazepam-27, temazepam-31)

Clofibric/JJ acid/NN :/: Combination/NN hormonal/JJ contraceptives/NNS may/MD increase/VB the/DT clearance/NN of/IN clofibric/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (JJ Clofibric) (NN acid) (: :) (NN Combination) (JJ hormonal) (NNS contraceptives)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (JJ clofibric) (NN acid))))))) (. .))))

amod(contraceptives-6, Clofibric-1)
nn(contraceptives-6, acid-2)
nn(contraceptives-6, Combination-4)
amod(contraceptives-6, hormonal-5)
nsubj(increase-8, contraceptives-6)
aux(increase-8, may-7)
root(ROOT-0, increase-8)
det(clearance-10, the-9)
dobj(increase-8, clearance-10)
amod(acid-13, clofibric-12)
prep_of(clearance-10, acid-13)

Cyclosporine/NN :/: Combination/NN hormonal/JJ contraceptives/NNS may/MD inhibit/VB the/DT metabolism/NN of/IN cyclosporine/NN ,/, leading/VBG to/TO increased/VBN plasma/NN concentrations/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NN Cyclosporine) (: :) (NN Combination) (JJ hormonal) (NNS contraceptives)) (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN cyclosporine)))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (VBN increased) (NN plasma) (NNS concentrations))))))) (: ;)) (. .))))

nn(contraceptives-5, Cyclosporine-1)
nn(contraceptives-5, Combination-3)
amod(contraceptives-5, hormonal-4)
nsubj(inhibit-7, contraceptives-5)
aux(inhibit-7, may-6)
root(ROOT-0, inhibit-7)
det(metabolism-9, the-8)
dobj(inhibit-7, metabolism-9)
prep_of(metabolism-9, cyclosporine-11)
partmod(inhibit-7, leading-13)
xcomp(inhibit-7, leading-13)
amod(concentrations-17, increased-15)
nn(concentrations-17, plasma-16)
prep_to(leading-13, concentrations-17)

monitor/VB cyclosporine/NN levels/NNS ./.

(ROOT (S1 (S (S (VP (VB monitor) (NP (NN cyclosporine) (NNS levels)))) (. .))))

root(ROOT-0, monitor-1)
nn(levels-3, cyclosporine-2)
dobj(monitor-1, levels-3)

CYP3A4/JJ inducers/NNS :/: CYP3A4/NN inducers/NNS may/MD decrease/VB the/DT levels/effects/NNS of/IN ethinyl/NN estradiol/NN ./.

(ROOT (S1 (S (NP (NP (JJ CYP3A4) (NNS inducers)) (: :) (S (NP (NN CYP3A4) (NNS inducers)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NNS levels/effects)) (PP (IN of) (NP (NN ethinyl) (NN estradiol))))))) (. .)))))

amod(inducers-2, CYP3A4-1)
root(ROOT-0, inducers-2)
nn(inducers-5, CYP3A4-4)
nsubj(decrease-7, inducers-5)
aux(decrease-7, may-6)
dep(inducers-2, decrease-7)
det(levels/effects-9, the-8)
dobj(decrease-7, levels/effects-9)
nn(estradiol-12, ethinyl-11)
prep_of(levels/effects-9, estradiol-12)

Example/NN inducers/NNS include/VBP aminoglutethimide/NN ,/, carbamazepine/NN ,/, nafcillin/NN ,/, nevirapine/NN ,/, phenobarbital/NN ,/, phenytoin/NN ,/, and/CC rifamycins/NN ./.

(ROOT (S1 (S (S (NP (NN Example) (NNS inducers)) (VP (VBP include) (NP (NP (NN aminoglutethimide)) (, ,) (NP (NP (NN carbamazepine)) (, ,) (NP (NN nafcillin)) (, ,) (NP (NN nevirapine)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin)) (, ,) (CC and) (NP (NN rifamycins)))))) (. .))))

nn(inducers-2, Example-1)
nsubj(include-3, inducers-2)
root(ROOT-0, include-3)
dobj(include-3, aminoglutethimide-4)
appos(aminoglutethimide-4, carbamazepine-6)
conj_and(carbamazepine-6, nafcillin-8)
conj_and(carbamazepine-6, nevirapine-10)
conj_and(carbamazepine-6, phenobarbital-12)
conj_and(carbamazepine-6, phenytoin-14)
conj_and(carbamazepine-6, rifamycins-17)

Griseofulvin/NN :/: Griseofulvin/NN may/MD induce/VB the/DT metabolism/NN of/IN combination/NN hormonal/JJ contraceptives/NNS causing/VBG menstrual/JJ changes/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NN Griseofulvin) (: :) (NN Griseofulvin)) (VP (MD may) (VP (VB induce) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN combination) (JJ hormonal) (NNS contraceptives)) (VP (VBG causing) (NP (JJ menstrual) (NNS changes)))))))) (: ;)) (. .))))

nn(Griseofulvin-3, Griseofulvin-1)
nsubj(induce-5, Griseofulvin-3)
aux(induce-5, may-4)
root(ROOT-0, induce-5)
det(metabolism-7, the-6)
dobj(induce-5, metabolism-7)
nn(contraceptives-11, combination-9)
amod(contraceptives-11, hormonal-10)
prep_of(metabolism-7, contraceptives-11)
partmod(contraceptives-11, causing-12)
amod(changes-14, menstrual-13)
dobj(causing-12, changes-14)

Use/NN of/IN barrier/NN form/NN of/IN contraception/NN is/VBZ suggested/VBN while/IN on/IN griseofulvin/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN of) (NP (NP (NN barrier) (NN form)) (PP (IN of) (NP (NN contraception)))))) (VP (VBZ is) (VP (VBN suggested) (PP (IN while) (PP (IN on) (NP (NN griseofulvin) (NN therapy))))))) (. .))))

nsubjpass(suggested-8, Use-1)
nn(form-4, barrier-3)
prep_of(Use-1, form-4)
prep_of(form-4, contraception-6)
auxpass(suggested-8, is-7)
root(ROOT-0, suggested-8)
prep(suggested-8, while-9)
pcomp(while-9, on-10)
nn(therapy-12, griseofulvin-11)
prep_on(while-9, therapy-12)

Morphine/NN :/: Combination/NN hormonal/JJ contraceptives/NNS may/MD increase/VB the/DT clearance/NN of/IN morphine/NN ./.

(ROOT (S1 (S (S (NP (NN Morphine) (: :) (NN Combination) (JJ hormonal) (NNS contraceptives)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN morphine))))))) (. .))))

nn(contraceptives-5, Morphine-1)
nn(contraceptives-5, Combination-3)
amod(contraceptives-5, hormonal-4)
nsubj(increase-7, contraceptives-5)
aux(increase-7, may-6)
root(ROOT-0, increase-7)
det(clearance-9, the-8)
dobj(increase-7, clearance-9)
prep_of(clearance-9, morphine-11)

Non-nucleoside/JJ reverse/NN transcriptase/NN inhibitors/NNS (/-LRB- NNRTIs/NN )/-RRB- :/: Nevirapine/NN may/MD decrease/VB plasma/NN levels/NNS of/IN combination/NN hormonal/JJ contraceptives/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NP (JJ Non-nucleoside) (NN reverse) (NN transcriptase) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN NNRTIs)) (-RRB- -RRB-))) (: :) (S (NP (NN Nevirapine)) (VP (MD may) (VP (VB decrease) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN combination) (JJ hormonal) (NNS contraceptives)))))) (: ;)) (. .)))))

amod(inhibitors-4, Non-nucleoside-1)
nn(inhibitors-4, reverse-2)
nn(inhibitors-4, transcriptase-3)
root(ROOT-0, inhibitors-4)
abbrev(inhibitors-4, NNRTIs-6)
nsubj(decrease-11, Nevirapine-9)
aux(decrease-11, may-10)
dep(inhibitors-4, decrease-11)
nn(levels-13, plasma-12)
dobj(decrease-11, levels-13)
nn(contraceptives-17, combination-15)
amod(contraceptives-17, hormonal-16)
prep_of(levels-13, contraceptives-17)

use/NN of/IN a/DT nonhormonal/JJ contraceptive/JJ product/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN use)) (PP (IN of) (NP (DT a) (JJ nonhormonal) (JJ contraceptive) (NN product)))) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

nsubjpass(recommended-8, use-1)
det(product-6, a-3)
amod(product-6, nonhormonal-4)
amod(product-6, contraceptive-5)
prep_of(use-1, product-6)
auxpass(recommended-8, is-7)
root(ROOT-0, recommended-8)

No/NN data/NNS for/IN delavirdine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN No)) (VP (NNS data) (PP (IN for) (NP (NN delavirdine)))) (: ;)) (. .))))

nsubj(data-2, No-1)
root(ROOT-0, data-2)
prep_for(data-2, delavirdine-4)

incomplete/JJ data/NNS for/IN efavirenz/NN ./.

(ROOT (S1 (S (NP (NP (JJ incomplete) (NNS data)) (PP (IN for) (NP (NN efavirenz))) (. .)))))

amod(data-2, incomplete-1)
root(ROOT-0, data-2)
prep_for(data-2, efavirenz-4)

Prednisolone/NN :/: Ethinyl/NN estradiol/NN may/MD inhibit/VB the/DT metabolism/NN of/IN prednisolone/NN ,/, leading/VBG to/TO increased/VBN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NN Prednisolone) (: :) (NN Ethinyl) (NN estradiol)) (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN prednisolone)))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (VBN increased) (NN plasma) (NNS concentrations)))))))) (. .))))

nn(estradiol-4, Prednisolone-1)
nn(estradiol-4, Ethinyl-3)
nsubj(inhibit-6, estradiol-4)
aux(inhibit-6, may-5)
root(ROOT-0, inhibit-6)
det(metabolism-8, the-7)
dobj(inhibit-6, metabolism-8)
prep_of(metabolism-8, prednisolone-10)
partmod(inhibit-6, leading-12)
xcomp(inhibit-6, leading-12)
amod(concentrations-16, increased-14)
nn(concentrations-16, plasma-15)
prep_to(leading-12, concentrations-16)

Protease/NN inhibitors/NNS :/: Amprenavir/NN ,/, lopinavir/NN ,/, nelfinavir/NN ,/, and/CC ritonavir/NN have/VBP been/VBN shown/VBN to/TO decrease/VB plasma/NN levels/NNS of/IN combination/NN hormonal/JJ contraceptives/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Protease) (NNS inhibitors)) (: :) (NP (NP (NN Amprenavir)) (, ,) (NP (NN lopinavir)) (, ,) (NP (NN nelfinavir)) (, ,) (CC and) (NP (NN ritonavir)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB decrease) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN combination) (JJ hormonal) (NNS contraceptives)))))))))) (: ;)) (. .))))

nn(inhibitors-2, Protease-1)
nsubjpass(shown-14, inhibitors-2)
xsubj(decrease-16, inhibitors-2)
dep(inhibitors-2, Amprenavir-4)
conj_and(Amprenavir-4, lopinavir-6)
conj_and(Amprenavir-4, nelfinavir-8)
conj_and(Amprenavir-4, ritonavir-11)
aux(shown-14, have-12)
auxpass(shown-14, been-13)
root(ROOT-0, shown-14)
aux(decrease-16, to-15)
xcomp(shown-14, decrease-16)
nn(levels-18, plasma-17)
dobj(decrease-16, levels-18)
nn(contraceptives-22, combination-20)
amod(contraceptives-22, hormonal-21)
prep_of(levels-18, contraceptives-22)

use/NN of/IN a/DT nonhormonal/JJ contraceptive/JJ product/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN use)) (PP (IN of) (NP (DT a) (JJ nonhormonal) (JJ contraceptive) (NN product)))) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

nsubjpass(recommended-8, use-1)
det(product-6, a-3)
amod(product-6, nonhormonal-4)
amod(product-6, contraceptive-5)
prep_of(use-1, product-6)
auxpass(recommended-8, is-7)
root(ROOT-0, recommended-8)

Indinavir/NN has/VBZ been/VBN shown/VBN to/TO increase/VB plasma/NN levels/NNS of/IN combination/NN hormonal/JJ contraceptives/NNS ./.

(ROOT (S1 (S (S (NP (NN Indinavir)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN combination) (JJ hormonal) (NNS contraceptives))))))))))) (. .))))

nsubjpass(shown-4, Indinavir-1)
xsubj(increase-6, Indinavir-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(increase-6, to-5)
xcomp(shown-4, increase-6)
nn(levels-8, plasma-7)
dobj(increase-6, levels-8)
nn(contraceptives-12, combination-10)
amod(contraceptives-12, hormonal-11)
prep_of(levels-8, contraceptives-12)

No/DT data/NNS for/IN saquinavir/NN ./.

(ROOT (S1 (S (S (NP (DT No) (NNS data)) (PP (IN for) (NP (NN saquinavir)))) (. .))))

det(data-2, No-1)
root(ROOT-0, data-2)
dep(data-2, for-3)
pobj(for-3, saquinavir-4)

Rifampin/NN :/: Rifampin/NN increases/VBZ the/DT metabolism/NN of/IN ethinyl/NN estradiol/NN and/CC some/DT progestins/NNS (/-LRB- norethindrone/NN )/-RRB- resulting/VBG in/IN decreased/VBN contraceptive/JJ effectiveness/NN and/CC increased/VBN menstrual/JJ irregularities/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Rifampin)) (: :) (NP (NN Rifampin))) (VP (VBZ increases) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN ethinyl) (NN estradiol)) (CC and) (NP (NP (NP (DT some) (NNS progestins)) (PRN (-LRB- -LRB-) (NP (NN norethindrone)) (-RRB- -RRB-))) (VP (VBG resulting) (PP (IN in) (NP (NP (VBN decreased) (JJ contraceptive) (NN effectiveness)) (CC and) (NP (VBN increased) (JJ menstrual) (NNS irregularities))))))))))) (. .))))

nsubj(increases-4, Rifampin-1)
dep(Rifampin-1, Rifampin-3)
root(ROOT-0, increases-4)
det(metabolism-6, the-5)
dobj(increases-4, metabolism-6)
nn(estradiol-9, ethinyl-8)
prep_of(metabolism-6, estradiol-9)
det(progestins-12, some-11)
conj_and(estradiol-9, progestins-12)
appos(progestins-12, norethindrone-14)
partmod(progestins-12, resulting-16)
amod(effectiveness-20, decreased-18)
amod(effectiveness-20, contraceptive-19)
prep_in(resulting-16, effectiveness-20)
amod(irregularities-24, increased-22)
amod(irregularities-24, menstrual-23)
conj_and(effectiveness-20, irregularities-24)

Use/NN of/IN a/DT nonhormonal/JJ contraceptive/JJ product/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN of) (NP (DT a) (JJ nonhormonal) (JJ contraceptive) (NN product)))) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

nsubjpass(recommended-8, Use-1)
det(product-6, a-3)
amod(product-6, nonhormonal-4)
amod(product-6, contraceptive-5)
prep_of(Use-1, product-6)
auxpass(recommended-8, is-7)
root(ROOT-0, recommended-8)

Salicylic/JJ acid/NN :/: Combination/NN hormonal/JJ contraceptives/NNS may/MD increase/VB the/DT clearance/NN of/IN salicylic/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (JJ Salicylic) (NN acid) (: :) (NN Combination) (JJ hormonal) (NNS contraceptives)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (JJ salicylic) (NN acid))))))) (. .))))

amod(contraceptives-6, Salicylic-1)
nn(contraceptives-6, acid-2)
nn(contraceptives-6, Combination-4)
amod(contraceptives-6, hormonal-5)
nsubj(increase-8, contraceptives-6)
aux(increase-8, may-7)
root(ROOT-0, increase-8)
det(clearance-10, the-9)
dobj(increase-8, clearance-10)
amod(acid-13, salicylic-12)
prep_of(clearance-10, acid-13)

Selegiline/NN :/: Combination/NN hormonal/JJ contraceptives/NNS may/MD increase/VB the/DT serum/NN concentration/NN of/IN selegiline/NN ./.

(ROOT (S1 (S (S (NP (NN Selegiline) (: :) (NN Combination) (JJ hormonal) (NNS contraceptives)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN serum) (NN concentration)) (PP (IN of) (NP (NN selegiline))))))) (. .))))

nn(contraceptives-5, Selegiline-1)
nn(contraceptives-5, Combination-3)
amod(contraceptives-5, hormonal-4)
nsubj(increase-7, contraceptives-5)
aux(increase-7, may-6)
root(ROOT-0, increase-7)
det(concentration-10, the-8)
nn(concentration-10, serum-9)
dobj(increase-7, concentration-10)
prep_of(concentration-10, selegiline-12)

Theophylline/NN :/: Ethinyl/NN estradiol/NN may/MD inhibit/VB the/DT metabolism/NN of/IN theophylline/NN ,/, leading/VBG to/TO increased/VBN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Theophylline)) (: :) (NP (NN Ethinyl) (NN estradiol))) (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN theophylline)))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (VBN increased) (NN plasma) (NNS concentrations)))))))) (. .))))

nsubj(inhibit-6, Theophylline-1)
nn(estradiol-4, Ethinyl-3)
dep(Theophylline-1, estradiol-4)
aux(inhibit-6, may-5)
root(ROOT-0, inhibit-6)
det(metabolism-8, the-7)
dobj(inhibit-6, metabolism-8)
prep_of(metabolism-8, theophylline-10)
partmod(inhibit-6, leading-12)
xcomp(inhibit-6, leading-12)
amod(concentrations-16, increased-14)
nn(concentrations-16, plasma-15)
prep_to(leading-12, concentrations-16)

Tricyclic/JJ antidepressants/NNS (/-LRB- amitriptyline/NN ,/, imipramine/NN ,/, nortriptyline/NN )/-RRB- :/: Metabolism/NN may/MD be/VB inhibited/VBN by/IN combination/NN hormonal/JJ contraceptives/NNS ,/, increasing/VBG plasma/NN levels/NNS of/IN antidepressant/JJ ;/: ./.

(ROOT (S1 (S (NP (NP (NP (JJ Tricyclic) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NP (NN amitriptyline)) (, ,) (NP (NN imipramine)) (, ,) (NP (NN nortriptyline))) (-RRB- -RRB-))) (: :) (S (NP (NN Metabolism)) (VP (MD may) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NN combination) (JJ hormonal) (NNS contraceptives))) (, ,) (S (VP (VBG increasing) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (JJ antidepressant) (: ;)))))))))) (. .)))))

amod(antidepressants-2, Tricyclic-1)
root(ROOT-0, antidepressants-2)
dep(antidepressants-2, amitriptyline-4)
appos(amitriptyline-4, imipramine-6)
appos(amitriptyline-4, nortriptyline-8)
nsubjpass(inhibited-14, Metabolism-11)
aux(inhibited-14, may-12)
auxpass(inhibited-14, be-13)
dep(antidepressants-2, inhibited-14)
nn(contraceptives-18, combination-16)
amod(contraceptives-18, hormonal-17)
agent(inhibited-14, contraceptives-18)
xcomp(inhibited-14, increasing-20)
nn(levels-22, plasma-21)
dobj(increasing-20, levels-22)
prep_of(levels-22, antidepressant-24)

ETHANOL/NN //: NUTRITION/NN //: HERB/NN INTERACTIONS/NNS :/: Food/NN :/: CNS/NN effects/NNS of/IN caffeine/NN may/MD be/VB enhanced/VBN if/IN combination/NN hormonal/JJ contraceptives/NNS are/VBP used/VBN concurrently/RB with/IN caffeine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN ETHANOL)) (: /) (NP (NN NUTRITION)) (: /) (NP (NN HERB) (NNS INTERACTIONS)) (: :) (NP (NN Food)) (: :) (NP (NP (NN CNS) (NNS effects)) (PP (IN of) (NP (NN caffeine))))) (VP (MD may) (VP (VB be) (VP (VBN enhanced) (SBAR (IN if) (S (NP (NN combination) (JJ hormonal) (NNS contraceptives)) (VP (VBP are) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NN caffeine))))))))))) (. .))))

nsubjpass(enhanced-16, ETHANOL-1)
punct(ETHANOL-1, /-2)
dep(ETHANOL-1, NUTRITION-3)
punct(ETHANOL-1, /-4)
nn(INTERACTIONS-6, HERB-5)
dep(ETHANOL-1, INTERACTIONS-6)
dep(ETHANOL-1, Food-8)
nn(effects-11, CNS-10)
dep(ETHANOL-1, effects-11)
prep_of(effects-11, caffeine-13)
aux(enhanced-16, may-14)
auxpass(enhanced-16, be-15)
root(ROOT-0, enhanced-16)
mark(used-22, if-17)
nn(contraceptives-20, combination-18)
amod(contraceptives-20, hormonal-19)
nsubjpass(used-22, contraceptives-20)
auxpass(used-22, are-21)
advcl(enhanced-16, used-22)
advmod(used-22, concurrently-23)
prep_with(used-22, caffeine-25)

Grapefruit/NN juice/NN increases/VBZ ethinyl/NN estradiol/NN concentrations/NNS and/CC would/MD be/VB expected/VBN to/TO increase/VB progesterone/NN serum/NN levels/NNS as/IN well/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Grapefruit) (NN juice)) (VP (VP (VBZ increases) (NP (NN ethinyl) (NN estradiol) (NNS concentrations))) (CC and) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (NP (NN progesterone) (NN serum) (NNS levels)) (PP (IN as) (NP (NN well)))))))))) (: ;)) (. .))))

nn(juice-2, Grapefruit-1)
nsubj(increases-3, juice-2)
root(ROOT-0, increases-3)
nn(concentrations-6, ethinyl-4)
nn(concentrations-6, estradiol-5)
dobj(increases-3, concentrations-6)
aux(expected-10, would-8)
auxpass(expected-10, be-9)
conj_and(increases-3, expected-10)
aux(increase-12, to-11)
xcomp(expected-10, increase-12)
nn(levels-15, progesterone-13)
nn(levels-15, serum-14)
dobj(increase-12, levels-15)
prep_as(increase-12, well-17)

Herb/Nutraceutical/NN :/: St/JJ Johns/NNP wort/NN may/MD decrease/VB the/DT effectiveness/NN of/IN combination/NN hormonal/JJ contraceptives/NNS by/IN inducing/VBG hepatic/JJ enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Herb/Nutraceutical)) (: :) (NP (JJ St) (NNP Johns) (NN wort))) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NN combination) (JJ hormonal) (NNS contraceptives)))) (PP (IN by) (S (VP (VBG inducing) (NP (JJ hepatic) (NNS enzymes)))))))) (. .))))

nsubj(decrease-7, Herb/Nutraceutical-1)
amod(wort-5, St-3)
nn(wort-5, Johns-4)
dep(Herb/Nutraceutical-1, wort-5)
aux(decrease-7, may-6)
root(ROOT-0, decrease-7)
det(effectiveness-9, the-8)
dobj(decrease-7, effectiveness-9)
nn(contraceptives-13, combination-11)
amod(contraceptives-13, hormonal-12)
prep_of(effectiveness-9, contraceptives-13)
prepc_by(decrease-7, inducing-15)
amod(enzymes-17, hepatic-16)
dobj(inducing-15, enzymes-17)

Avoid/VB dong/JJ quai/NN and/CC black/JJ cohosh/NN (/-LRB- have/VB estrogen/NN activity/NN )./RB

(ROOT (S1 (S (VP (VB Avoid) (NP (NP (JJ dong) (NN quai)) (CC and) (NP (JJ black) (NN cohosh))) (-LRB- -LRB-) (S (VP (VB have) (NP (NN estrogen) (NN activity)) (ADVP (RB -RRB-.))))))))

root(ROOT-0, Avoid-1)
amod(quai-3, dong-2)
dobj(Avoid-1, quai-3)
amod(cohosh-6, black-5)
conj_and(quai-3, cohosh-6)
dep(Avoid-1, have-8)
nn(activity-10, estrogen-9)
dobj(have-8, activity-10)
advmod(have-8, -RRB-.-11)

Avoid/VB saw/VB palmetto/NN ,/, red/JJ clover/NN ,/, ginseng/NN ./.

(ROOT (S1 (S (S (VP (VB Avoid) (S (VP (VB saw) (NP (NP (NN palmetto)) (, ,) (NP (JJ red) (NN clover)) (, ,) (NP (NN ginseng))))))) (. .))))

root(ROOT-0, Avoid-1)
ccomp(Avoid-1, saw-2)
dobj(saw-2, palmetto-3)
amod(clover-6, red-5)
appos(palmetto-3, clover-6)
appos(palmetto-3, ginseng-8)

CYP3A4/JJ Inhibitors/NNS @/NN Felodipine/NN is/VBZ metabolized/VBN by/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ CYP3A4) (NNS Inhibitors)) (NN @) (NN Felodipine)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP3A4)))))) (. .))))

amod(Inhibitors-2, CYP3A4-1)
nn(Felodipine-4, Inhibitors-2)
nn(Felodipine-4, @-3)
nsubjpass(metabolized-6, Felodipine-4)
auxpass(metabolized-6, is-5)
root(ROOT-0, metabolized-6)
agent(metabolized-6, CYP3A4-8)

Co-administration/NN of/IN CYP3A4/JJ inhibitors/NNS (/-LRB- eg/NN ,/, ketoconazole/NN ,/, itraconazole/NN ,/, erythromycin/NN ,/, grapefruit/NN juice/NN ,/, cimetidine/NN )/-RRB- with/IN felodipine/NN may/MD lead/VB to/TO several-/JJ fold/JJ increases/NNS in/IN the/DT plasma/NN levels/NNS of/IN felodipine/NN ,/, either/CC due/JJ to/TO an/DT increase/NN in/IN bioavailability/NN or/CC due/JJ to/TO a/DT decrease/NN in/IN metabolism/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (JJ CYP3A4) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN eg)) (, ,) (NP (NP (NN ketoconazole)) (, ,) (NP (NN itraconazole)) (, ,) (NP (NN erythromycin)) (, ,) (NP (NN grapefruit) (NN juice)) (, ,) (NP (NN cimetidine))) (-RRB- -RRB-)))) (PP (IN with) (NP (NN felodipine)))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (JJ several-) (JJ fold) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NP (NN felodipine)) (, ,) (ADJP (CC either) (ADJP (JJ due) (PP (TO to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN bioavailability)))))) (CC or) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NN metabolism)))))))))))))))) (. .))))

nsubj(lead-22, Co-administration-1)
amod(inhibitors-4, CYP3A4-3)
prep_of(Co-administration-1, inhibitors-4)
dep(inhibitors-4, eg-6)
dep(eg-6, ketoconazole-8)
appos(ketoconazole-8, itraconazole-10)
appos(ketoconazole-8, erythromycin-12)
nn(juice-15, grapefruit-14)
appos(ketoconazole-8, juice-15)
appos(ketoconazole-8, cimetidine-17)
prep_with(Co-administration-1, felodipine-20)
aux(lead-22, may-21)
root(ROOT-0, lead-22)
amod(increases-26, several--24)
amod(increases-26, fold-25)
prep_to(lead-22, increases-26)
det(levels-30, the-28)
nn(levels-30, plasma-29)
prep_in(increases-26, levels-30)
prep_of(levels-30, felodipine-32)
preconj(due-35, either-34)
amod(felodipine-32, due-35)
det(increase-38, an-37)
prep_to(due-35, increase-38)
prep_in(increase-38, bioavailability-40)
conj_or(due-35, due-42)
det(decrease-45, a-44)
prep_to(due-42, decrease-45)
prep_in(decrease-45, metabolism-47)

These/DT effects/NNS have/VBP been/VBN observed/VBN with/IN co-administration/NN of/IN itraconazole/NN (/-LRB- a/DT potent/JJ CYP3A4/NN inhibitor/NN )./NN

(ROOT (S1 (S (NP (DT These) (NNS effects)) (VP (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (IN with) (NP (NP (NN co-administration)) (PP (IN of) (NP (NN itraconazole)))))))) (-LRB- -LRB-) (NP (DT a) (JJ potent) (NN CYP3A4) (NN inhibitor) (NN -RRB-.))))))

det(effects-2, These-1)
nsubjpass(observed-5, effects-2)
aux(observed-5, have-3)
auxpass(observed-5, been-4)
root(ROOT-0, observed-5)
prep_with(observed-5, co-administration-7)
prep_of(co-administration-7, itraconazole-9)
det(-RRB-.-15, a-11)
amod(-RRB-.-15, potent-12)
nn(-RRB-.-15, CYP3A4-13)
nn(-RRB-.-15, inhibitor-14)
dobj(observed-5, -RRB-.-15)

Caution/NN should/MD be/VB used/VBN when/WRB CYP3A4/JJ inhibitors/NNS are/VBP co-administered/VBN with/IN felodipine/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used))) (SBAR (WHADVP (WRB when)) (S (NP (JJ CYP3A4) (NNS inhibitors)) (VP (VBP are) (VP (VBN co-administered) (PP (IN with) (NP (NN felodipine))))))))) (. .))))

nsubjpass(used-4, Caution-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
advmod(co-administered-9, when-5)
amod(inhibitors-7, CYP3A4-6)
nsubjpass(co-administered-9, inhibitors-7)
auxpass(co-administered-9, are-8)
advcl(used-4, co-administered-9)
prep_with(co-administered-9, felodipine-11)

A/DT conservative/JJ approach/NN to/TO dosing/NN felodipine/NN should/MD be/VB taken/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ conservative) (NN approach)) (PP (TO to) (NP (NN dosing) (NN felodipine)))) (VP (MD should) (VP (VB be) (VP (VBN taken))))) (. .))))

det(approach-3, A-1)
amod(approach-3, conservative-2)
nsubjpass(taken-9, approach-3)
nn(felodipine-6, dosing-5)
prep_to(approach-3, felodipine-6)
aux(taken-9, should-7)
auxpass(taken-9, be-8)
root(ROOT-0, taken-9)

The/DT following/JJ specific/JJ interactions/NNS have/VBP been/VBN reported/VBN :/: Itraconazole/NN @/NN Co-administration/NN of/IN another/DT extended/VBN release/NN formulation/NN of/IN felodipine/NN with/IN itraconazole/NN resulted/VBD in/IN approximately/RB 8-fold/JJ increase/NN in/IN the/DT AUC/NN ,/, more/JJR than/IN 6-/CD fold/NN increase/NN in/IN the/DT Cmax/NN ,/, and/CC 2-fold/JJ prolongation/NN in/IN the/DT half-/JJ life/NN of/IN felodipine/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (JJ specific) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported))))) (: :) (S (NP (NP (NN Itraconazole) (NN @) (NN Co-administration)) (PP (IN of) (NP (NP (DT another) (VBN extended) (NN release) (NN formulation)) (PP (IN of) (NP (NN felodipine))))) (PP (IN with) (NP (NN itraconazole)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (ADJP (RB approximately) (JJ 8-fold)) (NN increase)) (PP (IN in) (NP (DT the) (NN AUC)))) (, ,) (NP (NP (QP (JJR more) (IN than) (CD 6-)) (NN fold) (NN increase)) (PP (IN in) (NP (DT the) (NN Cmax)))) (, ,) (CC and) (NP (NP (JJ 2-fold) (NN prolongation)) (PP (IN in) (NP (NP (DT the) (JJ half-) (NN life)) (PP (IN of) (NP (NN felodipine)))))))))) (. .))))

det(interactions-4, The-1)
amod(interactions-4, following-2)
amod(interactions-4, specific-3)
nsubjpass(reported-7, interactions-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
nn(Co-administration-11, Itraconazole-9)
nn(Co-administration-11, @-10)
nsubj(resulted-21, Co-administration-11)
det(formulation-16, another-13)
amod(formulation-16, extended-14)
nn(formulation-16, release-15)
prep_of(Co-administration-11, formulation-16)
prep_of(formulation-16, felodipine-18)
prep_with(Co-administration-11, itraconazole-20)
parataxis(reported-7, resulted-21)
advmod(8-fold-24, approximately-23)
amod(increase-25, 8-fold-24)
prep_in(resulted-21, increase-25)
det(AUC-28, the-27)
prep_in(increase-25, AUC-28)
mwe(than-31, more-30)
quantmod(6--32, than-31)
num(increase-34, 6--32)
nn(increase-34, fold-33)
conj_and(increase-25, increase-34)
det(Cmax-37, the-36)
prep_in(increase-34, Cmax-37)
amod(prolongation-41, 2-fold-40)
conj_and(increase-25, prolongation-41)
det(life-45, the-43)
amod(life-45, half--44)
prep_in(prolongation-41, life-45)
prep_of(life-45, felodipine-47)

Erythromycin/NN @/NN Co-administration/NN of/IN felodipine/NN (/-LRB- PLENDIL/NN )/-RRB- with/IN erythromycin/NN resulted/VBD in/IN approximately/RB 2.5-/CD fold/JJ increase/NN in/IN the/DT AUC/NN and/CC Cmax/NN ,/, and/CC about/RB 2-/CD fold/NN prolongation/NN in/IN the/DT half-/JJ life/NN of/IN felodipine/NN ./.

(ROOT (S1 (S (NP (NP (NN Erythromycin) (NN @) (NN Co-administration)) (PP (IN of) (NP (NP (NN felodipine)) (PRN (-LRB- -LRB-) (NP (NN PLENDIL)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN erythromycin)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (ADJP (QP (RB approximately) (CD 2.5-)) (JJ fold)) (NN increase)) (PP (IN in) (NP (DT the) (NP (NP (NN AUC)) (CC and) (NP (NN Cmax)))))) (, ,) (CC and) (NP (NP (ADJP (QP (RB about) (CD 2-)) (NN fold)) (NN prolongation)) (PP (IN in) (NP (NP (DT the) (JJ half-) (NN life)) (PP (IN of) (NP (NN felodipine))))))))) (. .))))

nn(Co-administration-3, Erythromycin-1)
nn(Co-administration-3, @-2)
nsubj(resulted-11, Co-administration-3)
prep_of(Co-administration-3, felodipine-5)
abbrev(felodipine-5, PLENDIL-7)
prep_with(Co-administration-3, erythromycin-10)
root(ROOT-0, resulted-11)
quantmod(2.5--14, approximately-13)
dep(fold-15, 2.5--14)
dep(increase-16, fold-15)
prep_in(resulted-11, increase-16)
det(AUC-19, the-18)
prep_in(increase-16, AUC-19)
conj_and(AUC-19, Cmax-21)
quantmod(2--25, about-24)
dep(fold-26, 2--25)
dep(prolongation-27, fold-26)
conj_and(increase-16, prolongation-27)
det(life-31, the-29)
amod(life-31, half--30)
prep_in(prolongation-27, life-31)
prep_of(life-31, felodipine-33)

Grapefruit/NN juice/NN @/NN Co-administration/NN of/IN felodipine/NN with/IN grapefruit/NN juice/NN resulted/VBD in/IN more/JJR than/IN 2-fold/JJ increase/NN in/IN the/DT AUC/NN and/CC Cmax/NN ,/, but/CC no/DT prolongation/NN in/IN the/DT half-/JJ life/NN of/IN felodipine/NN ./.

(ROOT (S1 (S (NP (NP (NN Grapefruit) (NN juice) (NN @) (NN Co-administration)) (PP (IN of) (NP (NN felodipine))) (PP (IN with) (NP (NN grapefruit) (NN juice)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (ADJP (JJR more) (IN than) (JJ 2-fold)) (NN increase)) (PP (IN in) (NP (DT the) (NP (NN AUC)) (CC and) (NP (NN Cmax))))) (, ,) (CC but) (NP (NP (DT no) (NN prolongation)) (PP (IN in) (NP (NP (DT the) (JJ half-) (NN life)) (PP (IN of) (NP (NN felodipine))))))))) (. .))))

nn(Co-administration-4, Grapefruit-1)
nn(Co-administration-4, juice-2)
nn(Co-administration-4, @-3)
nsubj(resulted-10, Co-administration-4)
prep_of(Co-administration-4, felodipine-6)
nn(juice-9, grapefruit-8)
prep_with(Co-administration-4, juice-9)
root(ROOT-0, resulted-10)
dep(2-fold-14, more-12)
dep(2-fold-14, than-13)
amod(increase-15, 2-fold-14)
prep_in(resulted-10, increase-15)
dep(AUC-18, the-17)
prep_in(increase-15, AUC-18)
conj_and(AUC-18, Cmax-20)
det(prolongation-24, no-23)
conj_but(increase-15, prolongation-24)
det(life-28, the-26)
amod(life-28, half--27)
prep_in(prolongation-24, life-28)
prep_of(life-28, felodipine-30)

Cimetidine/NN @/NN Co-administration/NN of/IN felodipine/NN with/IN cimetidine/NN (/-LRB- a/DT non-specific/JJ CYP-450/NN inhibitor/NN )/-RRB- resulted/VBD in/IN an/DT increase/NN of/IN approximately/RB 50/CD %/NN in/IN the/DT AUC/NN and/CC the/DT Cmax/NN ,/, of/IN felodipine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cimetidine) (NN @) (NN Co-administration)) (PP (IN of) (NP (NN felodipine))) (PP (IN with) (NP (NP (NN cimetidine)) (PRN (-LRB- -LRB-) (NP (DT a) (JJ non-specific) (NN CYP-450) (NN inhibitor)) (-RRB- -RRB-))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (QP (RB approximately) (CD 50)) (NN %))) (PP (IN in) (NP (DT the) (NP (NN AUC)) (CC and) (NP (NP (DT the) (NN Cmax)) (, ,) (PP (IN of) (NP (NN felodipine)))))))))) (. .))))

nn(Co-administration-3, Cimetidine-1)
nn(Co-administration-3, @-2)
nsubj(resulted-14, Co-administration-3)
prep_of(Co-administration-3, felodipine-5)
prep_with(Co-administration-3, cimetidine-7)
det(inhibitor-12, a-9)
amod(inhibitor-12, non-specific-10)
nn(inhibitor-12, CYP-450-11)
abbrev(cimetidine-7, inhibitor-12)
root(ROOT-0, resulted-14)
det(increase-17, an-16)
prep_in(resulted-14, increase-17)
quantmod(50-20, approximately-19)
num(%-21, 50-20)
prep_of(increase-17, %-21)
dep(AUC-24, the-23)
prep_in(increase-17, AUC-24)
det(Cmax-27, the-26)
conj_and(AUC-24, Cmax-27)
prep_of(Cmax-27, felodipine-30)

Beta-Blocking/JJ Agents/NNS @/NN :/: A/DT pharmacokinetic/JJ study/NN of/IN felodipine/NN in/IN conjunction/NN with/IN metoprolol/NN demonstrated/VBD no/DT significant/JJ effects/NNS on/IN the/DT pharmacokinetics/NNS of/IN felodipine/NN ./.

(ROOT (S1 (S (NP (NP (JJ Beta-Blocking) (NNS Agents) (NN @)) (: :) (S (NP (NP (DT A) (JJ pharmacokinetic) (NN study)) (PP (IN of) (NP (NN felodipine))) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NN metoprolol)))))) (VP (VBD demonstrated) (NP (NP (DT no) (JJ significant) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN felodipine)))))))) (. .)))))

amod(@-3, Beta-Blocking-1)
nn(@-3, Agents-2)
root(ROOT-0, @-3)
det(study-7, A-5)
amod(study-7, pharmacokinetic-6)
nsubj(demonstrated-14, study-7)
prep_of(study-7, felodipine-9)
prep_in(study-7, conjunction-11)
prep_with(conjunction-11, metoprolol-13)
dep(@-3, demonstrated-14)
det(effects-17, no-15)
amod(effects-17, significant-16)
dobj(demonstrated-14, effects-17)
det(pharmacokinetics-20, the-19)
prep_on(effects-17, pharmacokinetics-20)
prep_of(pharmacokinetics-20, felodipine-22)

The/DT AUC/NN and/CC Cmax/NN of/IN metoprolol/NN ,/, however/RB ,/, were/VBD increased/VBN approximately/RB 31/CD and/CC 38/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NP (NN AUC)) (CC and) (NP (NN Cmax))) (PP (IN of) (NP (NN metoprolol)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBD were) (VP (VBN increased) (NP (QP (RB approximately) (CD 31) (CC and) (CD 38)) (NN %)) (, ,) (ADVP (RB respectively))))) (. .))))

dep(AUC-2, The-1)
nsubjpass(increased-11, AUC-2)
conj_and(AUC-2, Cmax-4)
prep_of(AUC-2, metoprolol-6)
advmod(increased-11, however-8)
auxpass(increased-11, were-10)
root(ROOT-0, increased-11)
quantmod(31-13, approximately-12)
num(%-16, 31-13)
conj_and(31-13, 38-15)
dobj(increased-11, %-16)
advmod(increased-11, respectively-18)

In/IN controlled/JJ clinical/JJ trials/NNS ,/, however/RB ,/, beta/NN blockers/NNS including/VBG metoprolol/NN were/VBD concurrently/RB administered/VBN with/IN felodipine/NN and/CC were/VBD well/RB tolerated/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ controlled) (JJ clinical) (NNS trials))) (, ,) (ADVP (RB however)) (, ,) (NP (NP (NN beta) (NNS blockers)) (PP (VBG including) (NP (NN metoprolol)))) (VP (VP (VBD were) (VP (ADVP (RB concurrently)) (VBN administered) (PP (IN with) (NP (NN felodipine))))) (CC and) (VP (VBD were) (VP (ADVP (RB well)) (VBN tolerated))))) (. .))))

amod(trials-4, controlled-2)
amod(trials-4, clinical-3)
prep_in(administered-14, trials-4)
advmod(administered-14, however-6)
nn(blockers-9, beta-8)
nsubjpass(administered-14, blockers-9)
prep_including(blockers-9, metoprolol-11)
auxpass(administered-14, were-12)
advmod(administered-14, concurrently-13)
root(ROOT-0, administered-14)
prep_with(administered-14, felodipine-16)
auxpass(tolerated-20, were-18)
advmod(tolerated-20, well-19)
conj_and(administered-14, tolerated-20)

Digoxin/NN @/NN :/: When/WRB given/VBN concomitantly/RB with/IN PLENDIL/NN the/DT pharmacokinetics/NNS of/IN digoxin/NN in/IN patients/NNS with/IN heart/NN failure/NN were/VBD not/RB significantly/RB altered/VBN ./.

(ROOT (S1 (S (NP (NP (NN Digoxin) (NN @)) (: :) (S (SBAR (WHADVP (WRB When)) (S (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN PLENDIL)))))) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN digoxin))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN heart) (NN failure)))))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN altered)))) (. .)))))

nn(@-2, Digoxin-1)
root(ROOT-0, @-2)
advmod(given-5, When-4)
advcl(altered-21, given-5)
advmod(given-5, concomitantly-6)
prep_with(given-5, PLENDIL-8)
det(pharmacokinetics-10, the-9)
nsubjpass(altered-21, pharmacokinetics-10)
prep_of(pharmacokinetics-10, digoxin-12)
prep_in(pharmacokinetics-10, patients-14)
nn(failure-17, heart-16)
prep_with(patients-14, failure-17)
auxpass(altered-21, were-18)
neg(altered-21, not-19)
advmod(altered-21, significantly-20)
dep(@-2, altered-21)

Anticonvulsants/NNS @/NN :/: In/IN a/DT pharmacokinetic/JJ study/NN ,/, maximum/JJ plasma/NN concentrations/NNS of/IN felodipine/NN were/VBD considerably/RB lower/JJR in/IN epileptic/JJ patients/NNS on/IN long-term/JJ anticonvulsant/JJ therapy/NN (/-LRB- eg/NN ,/, phenytoin/NN ,/, carbamazepine/NN ,/, or/CC phenobarbital/NN )/-RRB- than/IN in/IN healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Anticonvulsants) (NN @)) (: :) (S (PP (IN In) (NP (DT a) (JJ pharmacokinetic) (NN study))) (, ,) (NP (NP (JJ maximum) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN felodipine)))) (VP (VBD were) (ADJP (ADJP (RB considerably) (JJR lower)) (PP (IN in) (NP (NP (JJ epileptic) (NNS patients)) (PP (IN on) (NP (NP (JJ long-term) (JJ anticonvulsant) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (CC or) (NP (NN phenobarbital))) (-RRB- -RRB-)))))) (PP (IN than) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))))) (. .)))))

nn(@-2, Anticonvulsants-1)
root(ROOT-0, @-2)
det(study-7, a-5)
amod(study-7, pharmacokinetic-6)
prep_in(lower-16, study-7)
amod(concentrations-11, maximum-9)
nn(concentrations-11, plasma-10)
nsubj(lower-16, concentrations-11)
prep_of(concentrations-11, felodipine-13)
cop(lower-16, were-14)
advmod(lower-16, considerably-15)
dep(@-2, lower-16)
amod(patients-19, epileptic-18)
prep_in(lower-16, patients-19)
amod(therapy-23, long-term-21)
amod(therapy-23, anticonvulsant-22)
prep_on(patients-19, therapy-23)
dep(therapy-23, eg-25)
conj_or(eg-25, phenytoin-27)
conj_or(eg-25, carbamazepine-29)
conj_or(eg-25, phenobarbital-32)
prep(lower-16, than-34)
pcomp(than-34, in-35)
amod(volunteers-37, healthy-36)
prep_in(than-34, volunteers-37)

In/IN such/JJ patients/NNS ,/, the/DT mean/JJ area/NN under/IN the/DT felodipine/NN plasma/NN concentration-time/NN curve/NN was/VBD also/RB reduced/VBN to/TO approximately/RB 6/CD %/NN of/IN that/DT observed/VBN in/IN healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ such) (NNS patients))) (, ,) (NP (NP (DT the) (JJ mean) (NN area)) (PP (IN under) (NP (DT the) (NN felodipine) (NN plasma) (NN concentration-time) (NN curve)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN reduced) (PP (TO to) (NP (NP (QP (RB approximately) (CD 6)) (NN %)) (PP (IN of) (NP (NP (DT that)) (VP (VBN observed) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))))))))) (. .))))

amod(patients-3, such-2)
prep_in(reduced-16, patients-3)
det(area-7, the-5)
amod(area-7, mean-6)
nsubjpass(reduced-16, area-7)
det(curve-13, the-9)
nn(curve-13, felodipine-10)
nn(curve-13, plasma-11)
nn(curve-13, concentration-time-12)
prep_under(area-7, curve-13)
auxpass(reduced-16, was-14)
advmod(reduced-16, also-15)
root(ROOT-0, reduced-16)
quantmod(6-19, approximately-18)
num(%-20, 6-19)
prep_to(reduced-16, %-20)
prep_of(%-20, that-22)
partmod(that-22, observed-23)
amod(volunteers-26, healthy-25)
prep_in(observed-23, volunteers-26)

Since/IN a/DT clinically/RB significant/JJ interaction/NN may/MD be/VB anticipated/VBN ,/, alternative/JJ antihypertensive/JJ therapy/NN should/MD be/VB considered/VBN in/IN these/DT patients/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (DT a) (ADJP (RB clinically) (JJ significant)) (NN interaction)) (VP (MD may) (VP (VB be) (VP (VBN anticipated)))))) (, ,) (NP (JJ alternative) (JJ antihypertensive) (NN therapy)) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (DT these) (NNS patients))))))) (. .))))

mark(anticipated-8, Since-1)
det(interaction-5, a-2)
advmod(significant-4, clinically-3)
amod(interaction-5, significant-4)
nsubjpass(anticipated-8, interaction-5)
aux(anticipated-8, may-6)
auxpass(anticipated-8, be-7)
advcl(considered-15, anticipated-8)
amod(therapy-12, alternative-10)
amod(therapy-12, antihypertensive-11)
nsubjpass(considered-15, therapy-12)
aux(considered-15, should-13)
auxpass(considered-15, be-14)
root(ROOT-0, considered-15)
det(patients-18, these-17)
prep_in(considered-15, patients-18)

Tacrolimus/NN @/NN Felodipine/NN may/MD increase/VB the/DT blood/NN concentration/NN of/IN tacrolimus/NN ./.

(ROOT (S1 (S (S (NP (NN Tacrolimus) (NN @) (NN Felodipine)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN blood) (NN concentration)) (PP (IN of) (NP (NN tacrolimus))))))) (. .))))

nn(Felodipine-3, Tacrolimus-1)
nn(Felodipine-3, @-2)
nsubj(increase-5, Felodipine-3)
aux(increase-5, may-4)
root(ROOT-0, increase-5)
det(concentration-8, the-6)
nn(concentration-8, blood-7)
dobj(increase-5, concentration-8)
prep_of(concentration-8, tacrolimus-10)

When/WRB given/VBN concomitantly/RB with/IN felodipine/NN ,/, the/DT tacrolimus/NN blood/NN concentration/NN should/MD be/VB followed/VBN and/CC the/DT tacrolimus/NN dose/NN may/MD need/VBP to/TO be/VB adjusted/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN felodipine)))))) (, ,) (S (S (NP (DT the) (NN tacrolimus) (NN blood) (NN concentration)) (VP (MD should) (VP (VB be) (VP (VBN followed))))) (CC and) (S (NP (DT the) (NN tacrolimus) (NN dose)) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN adjusted)))))))))) (. .))))

advmod(given-2, When-1)
advcl(followed-13, given-2)
advmod(given-2, concomitantly-3)
prep_with(given-2, felodipine-5)
det(concentration-10, the-7)
nn(concentration-10, tacrolimus-8)
nn(concentration-10, blood-9)
nsubjpass(followed-13, concentration-10)
aux(followed-13, should-11)
auxpass(followed-13, be-12)
root(ROOT-0, followed-13)
det(dose-17, the-15)
nn(dose-17, tacrolimus-16)
nsubj(need-19, dose-17)
xsubj(adjusted-22, dose-17)
aux(need-19, may-18)
conj_and(followed-13, need-19)
aux(adjusted-22, to-20)
auxpass(adjusted-22, be-21)
xcomp(need-19, adjusted-22)

Other/JJ Concomitant/JJ Therapy/NN @/NN :/: In/IN healthy/JJ subjects/NNS there/EX were/VBD no/DT clinically/RB significant/JJ interactions/NNS when/WRB felodipine/NN was/VBD given/VBN concomitantly/RB with/IN indomethacin/NN or/CC spironolactone/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (JJ Concomitant) (NN Therapy) (NN @)) (: :) (S (PP (IN In) (NP (JJ healthy) (NNS subjects))) (NP (EX there)) (VP (VBD were) (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NNS interactions)) (SBAR (WHADVP (WRB when)) (S (NP (NN felodipine)) (VP (VBD was) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN indomethacin)) (CC or) (NP (NN spironolactone)))))))))) (. .)))))

amod(@-4, Other-1)
amod(@-4, Concomitant-2)
nn(@-4, Therapy-3)
root(ROOT-0, @-4)
amod(subjects-8, healthy-7)
prep_in(were-10, subjects-8)
expl(were-10, there-9)
dep(@-4, were-10)
det(interactions-14, no-11)
advmod(significant-13, clinically-12)
amod(interactions-14, significant-13)
nsubj(were-10, interactions-14)
advmod(given-18, when-15)
nsubjpass(given-18, felodipine-16)
auxpass(given-18, was-17)
advcl(were-10, given-18)
advmod(given-18, concomitantly-19)
prep_with(given-18, indomethacin-21)
conj_or(indomethacin-21, spironolactone-23)

Fenfluramine/NN may/MD increase/VB slightly/RB the/DT effect/NN of/IN antihypertensive/JJ drugs/NNS ,/, e.g./FW ,/, guanethidine/NN ,/, methyldopa/NN ,/, reserpine/NN ./.

(ROOT (S1 (S (S (NP (NN Fenfluramine)) (VP (MD may) (VP (VB increase) (ADVP (RB slightly)) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ antihypertensive) (NNS drugs)))) (, ,) (PP (FW e.g.) (, ,) (NP (NP (NN guanethidine)) (, ,) (NP (NN methyldopa)) (, ,) (NP (NN reserpine))))))) (. .))))

nsubj(increase-3, Fenfluramine-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
advmod(increase-3, slightly-4)
det(effect-6, the-5)
dobj(increase-3, effect-6)
amod(drugs-9, antihypertensive-8)
prep_of(effect-6, drugs-9)
prep(increase-3, e.g.-11)
pobj(e.g.-11, guanethidine-13)
appos(guanethidine-13, methyldopa-15)
appos(guanethidine-13, reserpine-17)

Other/JJ CNS/NN depressant/NN drugs/NNS should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS taking/VBG fenfluramine/NN ,/, since/IN the/DT effects/NNS may/MD be/VB additive/JJ ./.

(ROOT (S1 (S (S (NP (JJ Other) (NN CNS) (NN depressant) (NNS drugs)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN fenfluramine))))) (, ,) (SBAR (IN since) (S (NP (DT the) (NNS effects)) (VP (MD may) (VP (VB be) (ADJP (JJ additive)))))))))) (. .))))

amod(drugs-4, Other-1)
nn(drugs-4, CNS-2)
nn(drugs-4, depressant-3)
nsubjpass(used-7, drugs-4)
aux(used-7, should-5)
auxpass(used-7, be-6)
root(ROOT-0, used-7)
prep_with(used-7, caution-9)
prep_in(used-7, patients-11)
partmod(patients-11, taking-12)
dobj(taking-12, fenfluramine-13)
mark(additive-20, since-15)
det(effects-17, the-16)
nsubj(additive-20, effects-17)
aux(additive-20, may-18)
cop(additive-20, be-19)
advcl(used-7, additive-20)

Oral/JJ Anticoagulants/NNS CAUTION/NN SHOULD/MD BE/VB EXERCISED/VBN WHEN/WRB COUMARIN/NN ANTICOAGULANT/NN S/NNS ARE/VBP GIVEN/VBN IN/IN CONJUNCTION/NN WITH/IN TRICOR/NN ./.

(ROOT (S1 (S (S (NP (JJ Oral) (NNS Anticoagulants) (NN CAUTION)) (VP (MD SHOULD) (VP (VB BE) (VP (VBN EXERCISED) (SBAR (WHADVP (WRB WHEN)) (S (NP (NN COUMARIN) (NN ANTICOAGULANT) (NNS S)) (VP (VBP ARE) (VP (VBN GIVEN) (PP (IN IN) (NP (NP (NN CONJUNCTION)) (PP (IN WITH) (NP (NN TRICOR))))))))))))) (. .))))

amod(CAUTION-3, Oral-1)
nn(CAUTION-3, Anticoagulants-2)
nsubjpass(EXERCISED-6, CAUTION-3)
aux(EXERCISED-6, SHOULD-4)
auxpass(EXERCISED-6, BE-5)
root(ROOT-0, EXERCISED-6)
advmod(GIVEN-12, WHEN-7)
nn(S-10, COUMARIN-8)
nn(S-10, ANTICOAGULANT-9)
nsubjpass(GIVEN-12, S-10)
auxpass(GIVEN-12, ARE-11)
advcl(EXERCISED-6, GIVEN-12)
prep_in(GIVEN-12, CONJUNCTION-14)
prep_with(CONJUNCTION-14, TRICOR-16)

THE/DT DOSAGE/NN OF/IN THE/DT ANTICOAGULANTS/NNS SHOULD/MD BE/VB REDUCED/VBN TO/TO MAINTAIN/VB THE/DT PROTHROMBIN/NN TIME/INR/NN AT/IN THE/DT DESIRED/JJ LEVEL/NN TO/TO PREVENT/VB BLEEDING/JJ COMPLICATIONS/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT THE) (NN DOSAGE)) (PP (IN OF) (NP (DT THE) (NNS ANTICOAGULANTS)))) (VP (MD SHOULD) (VP (VB BE) (VP (VBN REDUCED) (S (VP (TO TO) (VP (VB MAINTAIN) (NP (NP (DT THE) (NN PROTHROMBIN) (NN TIME/INR)) (PP (IN AT) (NP (DT THE) (JJ DESIRED) (NN LEVEL))) (S (VP (TO TO) (VP (VB PREVENT) (NP (JJ BLEEDING) (NNS COMPLICATIONS))))))))))))) (. .))))

det(DOSAGE-2, THE-1)
nsubjpass(REDUCED-8, DOSAGE-2)
xsubj(MAINTAIN-10, DOSAGE-2)
det(ANTICOAGULANTS-5, THE-4)
prep_of(DOSAGE-2, ANTICOAGULANTS-5)
aux(REDUCED-8, SHOULD-6)
auxpass(REDUCED-8, BE-7)
root(ROOT-0, REDUCED-8)
aux(MAINTAIN-10, TO-9)
xcomp(REDUCED-8, MAINTAIN-10)
det(TIME/INR-13, THE-11)
nn(TIME/INR-13, PROTHROMBIN-12)
dobj(MAINTAIN-10, TIME/INR-13)
det(LEVEL-17, THE-15)
amod(LEVEL-17, DESIRED-16)
prep_at(TIME/INR-13, LEVEL-17)
aux(PREVENT-19, TO-18)
infmod(TIME/INR-13, PREVENT-19)
amod(COMPLICATIONS-21, BLEEDING-20)
dobj(PREVENT-19, COMPLICATIONS-21)

HMG-CoA/NN reductase/NN inhibitors/NNS The/DT combined/JJ use/NN of/IN TRICOR/NN and/CC HMG-CoA/NN reductase/NN inhibitors/NNS should/MD be/VB avoided/VBN unless/IN the/DT benefit/NN of/IN further/JJ alterations/NNS in/IN lipid/NN levels/NNS is/VBZ likely/JJ to/TO outweigh/VB the/DT increased/VBN risk/NN of/IN this/DT drug/NN combination/NN ./.

(ROOT (S1 (S (S (NP (NN HMG-CoA) (NN reductase) (NNS inhibitors) (NP (NP (DT The) (JJ combined) (NN use)) (PP (IN of) (NP (NN TRICOR)))) (CC and) (NP (NN HMG-CoA) (NN reductase) (NNS inhibitors))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (IN unless) (S (NP (NP (DT the) (NN benefit)) (PP (IN of) (NP (JJ further) (NNS alterations))) (PP (IN in) (NP (NN lipid) (NNS levels)))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB outweigh) (NP (NP (DT the) (VBN increased) (NN risk)) (PP (IN of) (NP (DT this) (NN drug) (NN combination))))))))))))))) (. .))))

nn(inhibitors-3, HMG-CoA-1)
nn(inhibitors-3, reductase-2)
nsubjpass(avoided-15, inhibitors-3)
det(use-6, The-4)
amod(use-6, combined-5)
dep(inhibitors-3, use-6)
prep_of(use-6, TRICOR-8)
nn(inhibitors-12, HMG-CoA-10)
nn(inhibitors-12, reductase-11)
conj_and(inhibitors-3, inhibitors-12)
aux(avoided-15, should-13)
auxpass(avoided-15, be-14)
root(ROOT-0, avoided-15)
mark(likely-26, unless-16)
det(benefit-18, the-17)
nsubj(likely-26, benefit-18)
amod(alterations-21, further-20)
prep_of(benefit-18, alterations-21)
nn(levels-24, lipid-23)
prep_in(benefit-18, levels-24)
cop(likely-26, is-25)
advcl(avoided-15, likely-26)
aux(outweigh-28, to-27)
xcomp(likely-26, outweigh-28)
det(risk-31, the-29)
amod(risk-31, increased-30)
dobj(outweigh-28, risk-31)
det(combination-35, this-33)
nn(combination-35, drug-34)
prep_of(risk-31, combination-35)

Resins/NNS :/: Since/IN bile/JJ acid/NN sequestrants/NNS may/MD bind/VB other/JJ drugs/NNS given/VBN concurrently/RB ,/, patients/NNS should/MD take/VB TRICOR/NN at/IN least/JJS 1/CD hour/NN before/IN or/CC 4-6/CD hours/NNS after/IN a/DT bile/JJ acid/NN binding/NN resin/NN to/TO avoid/VB impeding/VBG its/PRP$ absorption/NN ./.

(ROOT (S1 (S (NP (NP (NNS Resins)) (: :) (S (SBAR (IN Since) (S (NP (JJ bile) (NN acid) (NNS sequestrants)) (VP (MD may) (VP (VB bind) (NP (NP (JJ other) (NNS drugs)) (VP (VBN given) (ADVP (RB concurrently)))))))) (, ,) (NP (NNS patients)) (VP (MD should) (VP (VB take) (NP (NN TRICOR)) (PP (NP (QP (IN at) (JJS least) (CD 1)) (NN hour)) (IN before) (NP (NP (CC or) (CD 4-6) (NNS hours)) (PP (IN after) (NP (NP (DT a) (JJ bile) (NN acid) (NN binding) (NN resin)) (S (VP (TO to) (VP (VB avoid) (S (VP (VBG impeding) (NP (PRP$ its) (NN absorption)))))))))))))) (. .)))))

root(ROOT-0, Resins-1)
mark(bind-8, Since-3)
amod(sequestrants-6, bile-4)
nn(sequestrants-6, acid-5)
nsubj(bind-8, sequestrants-6)
aux(bind-8, may-7)
advcl(take-16, bind-8)
amod(drugs-10, other-9)
dobj(bind-8, drugs-10)
partmod(drugs-10, given-11)
advmod(given-11, concurrently-12)
nsubj(take-16, patients-14)
aux(take-16, should-15)
dep(Resins-1, take-16)
dobj(take-16, TRICOR-17)
quantmod(1-20, at-18)
mwe(at-18, least-19)
pobj(at-18, least-19)
num(hour-21, 1-20)
npadvmod(take-16, hour-21)
cc(hours-25, or-23)
dep(hours-25, 4-6-24)
prep_before(take-16, hours-25)
det(resin-31, a-27)
amod(resin-31, bile-28)
nn(resin-31, acid-29)
nn(resin-31, binding-30)
prep_after(hours-25, resin-31)
aux(avoid-33, to-32)
infmod(resin-31, avoid-33)
xcomp(avoid-33, impeding-34)
poss(absorption-36, its-35)
dobj(impeding-34, absorption-36)

Cyclosporine/NN :/: Because/IN cyclosporine/NN can/MD produce/VB nephrotoxicity/NN with/IN decreases/NNS in/IN creatinine/NN clearance/NN and/CC rises/VBZ in/IN serum/NN creatinine/NN ,/, and/CC because/IN renal/JJ excretion/NN is/VBZ the/DT primary/JJ elimination/NN route/NN of/IN fibrate/JJ drugs/NNS including/VBG TRICOR/NN ,/, there/EX is/VBZ a/DT risk/NN that/IN an/DT interaction/NN will/MD lead/VB to/TO deterioration/NN ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporine)) (: :) (S (SBAR (SBAR (IN Because) (S (NP (NN cyclosporine)) (VP (VP (MD can) (VP (VB produce) (NP (NN nephrotoxicity)) (PP (IN with) (NP (NP (NNS decreases)) (PP (IN in) (NP (NN creatinine) (NN clearance))))))) (CC and) (VP (VBZ rises) (PP (IN in) (NP (NN serum) (NN creatinine))))))) (, ,) (CC and) (SBAR (IN because) (S (NP (JJ renal) (NN excretion)) (VP (VBZ is) (NP (NP (DT the) (JJ primary) (NN elimination) (NN route)) (PP (IN of) (NP (NP (JJ fibrate) (NNS drugs)) (PP (VBG including) (NP (NN TRICOR)))))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN risk)) (SBAR (IN that) (S (NP (DT an) (NN interaction)) (VP (MD will) (VP (VB lead) (PP (TO to) (NP (NN deterioration)))))))))) (. .)))))

root(ROOT-0, Cyclosporine-1)
mark(produce-6, Because-3)
nsubj(produce-6, cyclosporine-4)
aux(produce-6, can-5)
dep(is-35, produce-6)
dobj(produce-6, nephrotoxicity-7)
prep_with(produce-6, decreases-9)
nn(clearance-12, creatinine-11)
prep_in(decreases-9, clearance-12)
conj_and(produce-6, rises-14)
nn(creatinine-17, serum-16)
prep_in(rises-14, creatinine-17)
mark(route-27, because-20)
amod(excretion-22, renal-21)
nsubj(route-27, excretion-22)
cop(route-27, is-23)
det(route-27, the-24)
amod(route-27, primary-25)
nn(route-27, elimination-26)
conj_and(produce-6, route-27)
amod(drugs-30, fibrate-29)
prep_of(route-27, drugs-30)
prep_including(drugs-30, TRICOR-32)
expl(is-35, there-34)
dep(Cyclosporine-1, is-35)
det(risk-37, a-36)
nsubj(is-35, risk-37)
dobj(lead-42, risk-37)
complm(lead-42, that-38)
det(interaction-40, an-39)
nsubj(lead-42, interaction-40)
aux(lead-42, will-41)
dep(risk-37, lead-42)
prep_to(lead-42, deterioration-44)

The/DT benefits/NNS and/CC risks/NNS of/IN using/VBG TRICOR/NN with/IN immunosuppressants/NNS and/CC other/JJ potentially/RB nephrotoxic/JJ agents/NNS should/MD be/VB carefully/RB considered/VBN ,/, and/CC the/DT lowest/JJS effective/JJ dose/NN employed/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NP (NNS benefits)) (CC and) (NP (NNS risks))) (PP (IN of) (NP (VBG using) (NN TRICOR))) (PP (IN with) (NP (NP (NNS immunosuppressants)) (CC and) (NP (JJ other) (ADJP (RB potentially) (JJ nephrotoxic)) (NNS agents))))) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN considered))))) (, ,) (CC and) (S (NP (DT the) (JJS lowest) (JJ effective) (NN dose)) (VP (VBN employed))) (. .))))

dep(benefits-2, The-1)
nsubjpass(considered-18, benefits-2)
conj_and(benefits-2, risks-4)
amod(TRICOR-7, using-6)
prep_of(benefits-2, TRICOR-7)
prep_with(benefits-2, immunosuppressants-9)
amod(agents-14, other-11)
advmod(nephrotoxic-13, potentially-12)
amod(agents-14, nephrotoxic-13)
conj_and(immunosuppressants-9, agents-14)
aux(considered-18, should-15)
auxpass(considered-18, be-16)
advmod(considered-18, carefully-17)
root(ROOT-0, considered-18)
det(dose-24, the-21)
amod(dose-24, lowest-22)
amod(dose-24, effective-23)
nsubj(employed-25, dose-24)
conj_and(considered-18, employed-25)

@/NN Drug-drug/JJ interactions/NNS In/FW vitro/FW studies/NNS using/VBG human/JJ liver/NN microsomes/NNS indicate/VBP that/IN fenofibrate/NN and/CC fenofibric/JJ acid/NN are/VBP not/RB inhibitors/NNS of/IN cytochrome/NN (/-LRB- CYP/NN )/-RRB- P450/NN isoforms/NNS CYP3A4/NN ,/, CYP2D6/NN ,/, CYP2E1/NN ,/, or/CC CYP1A2/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (JJ Drug-drug) (NNS interactions)) (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBG using) (NP (JJ human) (NN liver) (NNS microsomes)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN fenofibrate)) (CC and) (NP (JJ fenofibric) (NN acid))) (VP (VBP are) (RB not) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN cytochrome) (-LRB- -LRB-) (NN CYP) (-RRB- -RRB-) (NN P450) (NNS isoforms) (NP (NP (NN CYP3A4)) (, ,) (NP (NN CYP2D6)) (, ,) (NP (NN CYP2E1)) (, ,) (CC or) (NP (NN CYP1A2))))))))))) (. .)))))

nn(interactions-3, @-1)
amod(interactions-3, Drug-drug-2)
root(ROOT-0, interactions-3)
nn(vitro-5, In-4)
amod(studies-6, vitro-5)
nsubj(indicate-11, studies-6)
partmod(studies-6, using-7)
amod(microsomes-10, human-8)
nn(microsomes-10, liver-9)
dobj(using-7, microsomes-10)
dep(interactions-3, indicate-11)
complm(inhibitors-19, that-12)
nsubj(inhibitors-19, fenofibrate-13)
amod(acid-16, fenofibric-15)
conj_and(fenofibrate-13, acid-16)
cop(inhibitors-19, are-17)
neg(inhibitors-19, not-18)
ccomp(indicate-11, inhibitors-19)
nn(isoforms-26, cytochrome-21)
nn(isoforms-26, CYP-23)
nn(isoforms-26, P450-25)
prep_of(inhibitors-19, isoforms-26)
dep(isoforms-26, CYP3A4-27)
conj_or(CYP3A4-27, CYP2D6-29)
conj_or(CYP3A4-27, CYP2E1-31)
conj_or(CYP3A4-27, CYP1A2-34)

They/PRP are/VBP weak/JJ inhibitors/NNS of/IN CYP2C19/NN and/CC CYP2A6/NN ,/, and/CC mild-to-moderate/JJ inhibitors/NNS of/IN CYP2C9/NN at/IN therapeutic/JJ concentrations/NNS ./.

(ROOT (S1 (S (S (NP (PRP They)) (VP (VBP are) (NP (NP (NP (JJ weak) (NNS inhibitors)) (PP (IN of) (NP (NP (NN CYP2C19)) (CC and) (NP (NN CYP2A6))))) (, ,) (CC and) (NP (NP (JJ mild-to-moderate) (NNS inhibitors)) (PP (IN of) (NP (NN CYP2C9))))) (PP (IN at) (NP (JJ therapeutic) (NNS concentrations))))) (. .))))

nsubj(inhibitors-4, They-1)
cop(inhibitors-4, are-2)
amod(inhibitors-4, weak-3)
root(ROOT-0, inhibitors-4)
prep_of(inhibitors-4, CYP2C19-6)
conj_and(CYP2C19-6, CYP2A6-8)
amod(inhibitors-12, mild-to-moderate-11)
conj_and(inhibitors-4, inhibitors-12)
prep_of(inhibitors-12, CYP2C9-14)
amod(concentrations-17, therapeutic-16)
prep_at(inhibitors-4, concentrations-17)

Potentiation/NN of/IN coumarin-type/NN anticoagulants/NNS has/VBZ been/VBN observed/VBN with/IN prolongation/NN of/IN the/DT prothrombin/NN time/INR/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Potentiation)) (PP (IN of) (NP (NN coumarin-type) (NNS anticoagulants)))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN with) (NP (NP (NN prolongation)) (PP (IN of) (NP (DT the) (NN prothrombin) (NN time/INR))))))))) (. .))))

nsubjpass(observed-7, Potentiation-1)
nn(anticoagulants-4, coumarin-type-3)
prep_of(Potentiation-1, anticoagulants-4)
aux(observed-7, has-5)
auxpass(observed-7, been-6)
root(ROOT-0, observed-7)
prep_with(observed-7, prolongation-9)
det(time/INR-13, the-11)
nn(time/INR-13, prothrombin-12)
prep_of(prolongation-9, time/INR-13)

Bile/JJ acid/NN sequestrants/NNS have/VBP been/VBN shown/VBN to/TO bind/VB other/JJ drugs/NNS given/VBN concurrently/RB ./.

(ROOT (S1 (S (S (NP (JJ Bile) (NN acid) (NNS sequestrants)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB bind) (NP (NP (JJ other) (NNS drugs)) (VP (VBN given) (ADVP (RB concurrently))))))))))) (. .))))

amod(sequestrants-3, Bile-1)
nn(sequestrants-3, acid-2)
nsubjpass(shown-6, sequestrants-3)
xsubj(bind-8, sequestrants-3)
aux(shown-6, have-4)
auxpass(shown-6, been-5)
root(ROOT-0, shown-6)
aux(bind-8, to-7)
xcomp(shown-6, bind-8)
amod(drugs-10, other-9)
dobj(bind-8, drugs-10)
partmod(drugs-10, given-11)
advmod(given-11, concurrently-12)

Therefore/RB ,/, fenofibrate/NN should/MD be/VB taken/VBN at/IN least/JJS 1/CD hour/NN before/IN or/CC 4-6/CD hours/NNS after/IN a/DT bile/JJ acid/NN binding/NN resin/NN to/TO avoid/VB impeding/VBG its/PRP$ absorption/NN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NN fenofibrate)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (NP (QP (IN at) (JJS least) (CD 1)) (NN hour)) (IN before) (NP (CC or) (CD 4-6) (NNS hours))) (PP (IN after) (NP (NP (DT a) (JJ bile) (NN acid) (NN binding) (NN resin)) (S (VP (TO to) (VP (VB avoid) (S (VP (VBG impeding) (NP (PRP$ its) (NN absorption)))))))))))) (. .))))

advmod(taken-6, Therefore-1)
nsubjpass(taken-6, fenofibrate-3)
aux(taken-6, should-4)
auxpass(taken-6, be-5)
root(ROOT-0, taken-6)
quantmod(1-9, at-7)
mwe(at-7, least-8)
pobj(at-7, least-8)
num(hour-10, 1-9)
npadvmod(taken-6, hour-10)
cc(hours-14, or-12)
dep(hours-14, 4-6-13)
prep_before(taken-6, hours-14)
det(resin-20, a-16)
amod(resin-20, bile-17)
nn(resin-20, acid-18)
nn(resin-20, binding-19)
prep_after(taken-6, resin-20)
aux(avoid-22, to-21)
infmod(resin-20, avoid-22)
xcomp(avoid-22, impeding-23)
poss(absorption-25, its-24)
dobj(impeding-23, absorption-25)

Concomitant/JJ administration/NN of/IN fenofibrate/NN (/-LRB- equivalent/JJ to/TO 145mg/NN TRICOR/NN )/-RRB- with/IN pravastatin/NN (/-LRB- 40/CD mg/NN )/-RRB- once/RB daily/JJ for/IN 10/CD days/NNS has/VBZ been/VBN shown/VBN to/TO increase/VB the/DT mean/NN Cmax/NN and/CC AUC/NN values/NNS for/IN pravastatin/NN by/IN 36/CD %/NN (/-LRB- range/NN from/IN 69/CD %/NN decrease/NN to/TO 321/CD %/NN increase/NN )/-RRB- and/CC 28/CD %/NN (/-LRB- range/NN from/IN 54/CD %/NN decrease/NN to/TO 128/CD %/NN increase/NN )/-RRB- ,/, respectively/RB ,/, and/CC for/IN 3/CD @/NN -hydroxy-iso-/JJ pravastatin/NN by/IN 55/CD %/NN (/-LRB- range/NN from/IN 32/CD %/NN decrease/NN to/TO 314/CD %/NN increase/NN )/-RRB- and/CC 39/CD %/NN (/-LRB- range/NN from/IN 24/CD %/NN decrease/NN to/TO 261/CD %/NN increase/NN )/-RRB- ,/, respectively/RB in/IN 23/CD healthy/JJ adults/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN fenofibrate)) (PRN (-LRB- -LRB-) (ADJP (JJ equivalent) (PP (TO to) (NP (NN 145mg) (NN TRICOR)))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NP (NN pravastatin)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN mg)) (-RRB- -RRB-))) (ADJP (RB once) (JJ daily) (PP (IN for) (NP (CD 10) (NNS days))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN mean) (NN Cmax) (CC and) (NN AUC) (NNS values)) (PP (PP (IN for) (NP (NP (NN pravastatin)) (PP (IN by) (NP (NP (NP (CD 36) (NN %)) (PRN (-LRB- -LRB-) (NP (NN range)) (PP (IN from) (NP (NP (ADJP (CD 69) (NN %)) (NN decrease)) (PP (TO to) (NP (ADJP (CD 321) (NN %)) (NN increase))))) (-RRB- -RRB-))) (CC and) (NP (NP (CD 28) (NN %)) (PRN (-LRB- -LRB-) (NP (NN range)) (PP (IN from) (NP (NP (ADJP (CD 54) (NN %)) (NN decrease)) (PP (TO to) (NP (ADJP (CD 128) (NN %)) (NN increase))))) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively)))))) (, ,) (CC and) (PP (IN for) (NP (CD 3) (NN @) (JJ -hydroxy-iso-) (NN pravastatin))))) (PP (IN by) (NP (NP (NP (CD 55) (NN %)) (PRN (-LRB- -LRB-) (NP (NN range)) (PP (IN from) (NP (NP (ADJP (CD 32) (NN %)) (NN decrease)) (PP (TO to) (NP (ADJP (CD 314) (NN %)) (NN increase))))) (-RRB- -RRB-))) (CC and) (NP (NP (CD 39) (NN %)) (PRN (-LRB- -LRB-) (NP (NN range)) (PP (IN from) (NP (NP (ADJP (CD 24) (NN %)) (NN decrease)) (PP (TO to) (NP (ADJP (CD 261) (NN %)) (NN increase))))) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively)))) (PP (IN in) (NP (CD 23) (JJ healthy) (NNS adults))))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(shown-24, administration-2)
xsubj(increase-26, administration-2)
prep_of(administration-2, fenofibrate-4)
dep(fenofibrate-4, equivalent-6)
nn(TRICOR-9, 145mg-8)
prep_to(equivalent-6, TRICOR-9)
prep_with(administration-2, pravastatin-12)
num(mg-15, 40-14)
appos(pravastatin-12, mg-15)
advmod(daily-18, once-17)
amod(pravastatin-12, daily-18)
num(days-21, 10-20)
prep_for(daily-18, days-21)
aux(shown-24, has-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
aux(increase-26, to-25)
xcomp(shown-24, increase-26)
det(Cmax-29, the-27)
nn(Cmax-29, mean-28)
dobj(increase-26, Cmax-29)
nn(values-32, AUC-31)
conj_and(Cmax-29, values-32)
prep_for(Cmax-29, pravastatin-34)
num(%-37, 36-36)
prep_by(pravastatin-34, %-37)
dep(%-37, range-39)
dep(range-39, from-40)
number(%-42, 69-41)
amod(decrease-43, %-42)
pobj(from-40, decrease-43)
number(%-46, 321-45)
amod(increase-47, %-46)
prep_to(decrease-43, increase-47)
num(%-51, 28-50)
conj_and(%-37, %-51)
dep(%-51, range-53)
dep(range-53, from-54)
number(%-56, 54-55)
amod(decrease-57, %-56)
pobj(from-54, decrease-57)
number(%-60, 128-59)
amod(increase-61, %-60)
prep_to(decrease-57, increase-61)
advmod(%-37, respectively-64)
conj_and(%-37, respectively-64)
num(pravastatin-71, 3-68)
nn(pravastatin-71, @-69)
amod(pravastatin-71, -hydroxy-iso--70)
conj_and(pravastatin-34, pravastatin-71)
num(%-74, 55-73)
prep_by(increase-26, %-74)
dep(%-74, range-76)
dep(range-76, from-77)
number(%-79, 32-78)
amod(decrease-80, %-79)
pobj(from-77, decrease-80)
number(%-83, 314-82)
amod(increase-84, %-83)
prep_to(decrease-80, increase-84)
num(%-88, 39-87)
conj_and(%-74, %-88)
dep(%-88, range-90)
dep(range-90, from-91)
number(%-93, 24-92)
amod(decrease-94, %-93)
pobj(from-91, decrease-94)
number(%-97, 261-96)
amod(increase-98, %-97)
prep_to(decrease-94, increase-98)
advmod(%-74, respectively-101)
conj_and(%-74, respectively-101)
num(adults-105, 23-103)
amod(adults-105, healthy-104)
prep_in(increase-26, adults-105)

A/DT single/JJ dose/NN of/IN pravastatin/NN had/VBD no/DT clinically/RB important/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN fenofibric/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ single) (NN dose)) (PP (IN of) (NP (NN pravastatin)))) (VP (VBD had) (NP (DT no) (ADJP (RB clinically) (JJ important)) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (JJ fenofibric) (NN acid))))))) (. .))))

det(dose-3, A-1)
amod(dose-3, single-2)
nsubj(had-6, dose-3)
prep_of(dose-3, pravastatin-5)
root(ROOT-0, had-6)
det(effect-10, no-7)
advmod(important-9, clinically-8)
amod(effect-10, important-9)
dobj(had-6, effect-10)
det(pharmacokinetics-13, the-12)
prep_on(had-6, pharmacokinetics-13)
amod(acid-16, fenofibric-15)
prep_of(pharmacokinetics-13, acid-16)

Concomitant/JJ administration/NN of/IN fenofibrate/NN (/-LRB- equivalent/JJ to/TO 145/CD mg/NN TRICOR/NN )/-RRB- with/IN atorvastatin/NN (/-LRB- 20/CD mg/NN )/-RRB- once/RB daily/RB for/IN 10/CD days/NNS resulted/VBD in/IN approximately/RB 17/CD %/NN decrease/NN (/-LRB- range/NN from/IN 67/CD %/NN decrease/NN to/TO 44/CD %/NN increase/NN )/-RRB- in/IN atorvastatin/NN AUC/NN values/NNS in/IN 22/CD healthy/JJ males/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN fenofibrate)) (PRN (-LRB- -LRB-) (ADJP (JJ equivalent) (PP (TO to) (NP (ADJP (CD 145) (NN mg)) (NN TRICOR)))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NP (NN atorvastatin)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg)) (-RRB- -RRB-))) (ADVP (RB once) (RB daily) (PP (IN for) (NP (CD 10) (NNS days))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (ADJP (QP (RB approximately) (CD 17)) (NN %)) (NN decrease)) (PRN (-LRB- -LRB-) (NP (NN range)) (PP (IN from) (NP (NP (ADJP (CD 67) (NN %)) (NN decrease)) (PP (TO to) (NP (ADJP (CD 44) (NN %)) (NN increase))))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN atorvastatin) (NN AUC) (NNS values)) (PP (IN in) (NP (CD 22) (JJ healthy) (NNS males)))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(resulted-23, administration-2)
prep_of(administration-2, fenofibrate-4)
dep(fenofibrate-4, equivalent-6)
number(mg-9, 145-8)
amod(TRICOR-10, mg-9)
prep_to(equivalent-6, TRICOR-10)
prep_with(administration-2, atorvastatin-13)
num(mg-16, 20-15)
appos(atorvastatin-13, mg-16)
advmod(daily-19, once-18)
advmod(atorvastatin-13, daily-19)
num(days-22, 10-21)
prep_for(daily-19, days-22)
root(ROOT-0, resulted-23)
quantmod(17-26, approximately-25)
dep(%-27, 17-26)
dep(decrease-28, %-27)
prep_in(resulted-23, decrease-28)
dep(decrease-28, range-30)
dep(range-30, from-31)
number(%-33, 67-32)
amod(decrease-34, %-33)
pobj(from-31, decrease-34)
number(%-37, 44-36)
amod(increase-38, %-37)
prep_to(decrease-34, increase-38)
nn(values-43, atorvastatin-41)
nn(values-43, AUC-42)
prep_in(decrease-28, values-43)
num(males-47, 22-45)
amod(males-47, healthy-46)
prep_in(values-43, males-47)

The/DT atorvastatin/NN Cmax/NN values/NNS were/VBD not/RB significantly/RB affected/VBN by/IN fenofibrate/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN atorvastatin) (NN Cmax) (NNS values)) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN affected) (PP (IN by) (NP (NN fenofibrate)))))) (. .))))

det(values-4, The-1)
nn(values-4, atorvastatin-2)
nn(values-4, Cmax-3)
nsubjpass(affected-8, values-4)
auxpass(affected-8, were-5)
neg(affected-8, not-6)
advmod(affected-8, significantly-7)
root(ROOT-0, affected-8)
agent(affected-8, fenofibrate-10)

The/DT pharmacokinetics/NNS of/IN fenofibric/JJ acid/NN were/VBD not/RB significantly/RB affected/VBN by/IN atorvastatin/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (JJ fenofibric) (NN acid)))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN affected) (PP (IN by) (NP (NN atorvastatin)))))) (. .))))

det(pharmacokinetics-2, The-1)
nsubjpass(affected-9, pharmacokinetics-2)
amod(acid-5, fenofibric-4)
prep_of(pharmacokinetics-2, acid-5)
auxpass(affected-9, were-6)
neg(affected-9, not-7)
advmod(affected-9, significantly-8)
root(ROOT-0, affected-9)
agent(affected-9, atorvastatin-11)

Drug/NN Interaction/NN with/IN Erythromycin/NN and/CC Ketoconazole/NN Fexofenadine/NN has/VBZ been/VBN shown/VBN to/TO exhibit/VB minimal/JJ (/-LRB- ca./FW 5/CD %/NN )/-RRB- metabolism/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN Interaction)) (PP (IN with) (NP (NP (NN Erythromycin)) (CC and) (NP (NN Ketoconazole)) (NP (NN Fexofenadine))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB exhibit) (NP (ADJP (ADJP (JJ minimal)) (PRN (-LRB- -LRB-) (PP (FW ca.)) (NP (CD 5) (NN %)) (-RRB- -RRB-))) (NN metabolism))))))))) (. .))))

nn(Interaction-2, Drug-1)
nsubjpass(shown-10, Interaction-2)
xsubj(exhibit-12, Interaction-2)
prep_with(Interaction-2, Erythromycin-4)
conj_and(Erythromycin-4, Ketoconazole-6)
dep(Erythromycin-4, Fexofenadine-7)
aux(shown-10, has-8)
auxpass(shown-10, been-9)
root(ROOT-0, shown-10)
aux(exhibit-12, to-11)
xcomp(shown-10, exhibit-12)
amod(metabolism-19, minimal-13)
dep(%-17, ca.-15)
num(%-17, 5-16)
dep(minimal-13, %-17)
dobj(exhibit-12, metabolism-19)

However/RB ,/, co/NN @/NN administration/NN of/IN fexofenadine/NN hydrochloride/NN with/IN either/CC ketoconazole/NN or/CC erythromycin/NN led/VBD to/TO increased/VBN plasma/NN concentrations/NNS of/IN fexofenadine/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN co) (NN @) (NN administration)) (PP (IN of) (NP (NN fexofenadine) (NN hydrochloride))) (PP (IN with) (NP (CC either) (NP (NN ketoconazole)) (CC or) (NP (NN erythromycin))))) (VP (VBD led) (PP (TO to) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN fexofenadine))))))) (. .))))

advmod(led-14, However-1)
nn(administration-5, co-3)
nn(administration-5, @-4)
nsubj(led-14, administration-5)
nn(hydrochloride-8, fexofenadine-7)
prep_of(administration-5, hydrochloride-8)
preconj(ketoconazole-11, either-10)
prep_with(administration-5, ketoconazole-11)
conj_or(ketoconazole-11, erythromycin-13)
root(ROOT-0, led-14)
amod(concentrations-18, increased-16)
nn(concentrations-18, plasma-17)
prep_to(led-14, concentrations-18)
prep_of(concentrations-18, fexofenadine-20)

Fexofenadine/NN had/VBD no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN either/CC erythromycin/NN or/CC ketoconazole/NN ./.

(ROOT (S1 (S (S (NP (NN Fexofenadine)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (CC either) (NP (NN erythromycin)) (CC or) (NP (NN ketoconazole)))))))) (. .))))

nsubj(had-2, Fexofenadine-1)
root(ROOT-0, had-2)
det(effect-4, no-3)
dobj(had-2, effect-4)
det(pharmacokinetics-7, the-6)
prep_on(had-2, pharmacokinetics-7)
preconj(erythromycin-10, either-9)
prep_of(pharmacokinetics-7, erythromycin-10)
conj_or(erythromycin-10, ketoconazole-12)

In/IN 2/CD separate/JJ studies/NNS ,/, fexofenadine/NN hydrochloride/NN 120/CD mg/NN twice/RB daily/RB (/-LRB- 240/CD mg/NN total/JJ daily/JJ dose/NN )/-RRB- was/VBD co-administered/VBN with/IN either/CC erythromycin/NN 500/CD mg/NN every/DT 8/CD hours/NNS or/CC ketoconazole/NN 400/CD mg/NN once/RB daily/JJ under/IN steady-state/JJ conditions/NNS to/TO healthy/JJ volunteers/NNS (/-LRB- n=24/NN ,/, each/DT study/NN )./NN

(ROOT (S1 (S (PP (IN In) (NP (CD 2) (JJ separate) (NNS studies))) (, ,) (NP (NP (NP (NN fexofenadine) (NN hydrochloride) (CD 120) (NN mg)) (ADVP (RB twice) (RB daily))) (PRN (-LRB- -LRB-) (NP (CD 240) (NN mg) (JJ total) (JJ daily) (NN dose)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN co-administered) (PP (IN with) (NP (CC either) (NP (NP (NN erythromycin) (CD 500) (NN mg)) (NP (DT every) (CD 8) (NNS hours))) (CC or) (NP (NP (NN ketoconazole) (CD 400) (NN mg)) (ADJP (RB once) (JJ daily))))) (PP (IN under) (NP (NP (JJ steady-state) (NNS conditions)) (PP (TO to) (NP (JJ healthy) (NNS volunteers))))))) (PRN (-LRB- -LRB-) (NP (NP (NN n=24)) (, ,) (NP (DT each) (NN study) (NN -RRB-.)))))))

num(studies-4, 2-2)
amod(studies-4, separate-3)
prep_in(co-administered-20, studies-4)
nn(mg-9, fexofenadine-6)
nn(mg-9, hydrochloride-7)
num(mg-9, 120-8)
nsubjpass(co-administered-20, mg-9)
advmod(daily-11, twice-10)
advmod(mg-9, daily-11)
num(dose-17, 240-13)
nn(dose-17, mg-14)
amod(dose-17, total-15)
amod(dose-17, daily-16)
appos(mg-9, dose-17)
auxpass(co-administered-20, was-19)
root(ROOT-0, co-administered-20)
preconj(mg-25, either-22)
nn(mg-25, erythromycin-23)
num(mg-25, 500-24)
prep_with(co-administered-20, mg-25)
det(hours-28, every-26)
num(hours-28, 8-27)
dep(mg-25, hours-28)
nn(mg-32, ketoconazole-30)
num(mg-32, 400-31)
conj_or(mg-25, mg-32)
advmod(daily-34, once-33)
amod(mg-32, daily-34)
amod(conditions-37, steady-state-36)
prep_under(co-administered-20, conditions-37)
amod(volunteers-40, healthy-39)
prep_to(conditions-37, volunteers-40)
dep(co-administered-20, n=24-42)
det(-RRB-.-46, each-44)
nn(-RRB-.-46, study-45)
appos(n=24-42, -RRB-.-46)

No/DT differences/NNS in/IN adverse/JJ events/NNS or/CC QTc/NN interval/NN were/VBD observed/VBN when/WRB subjects/NNS were/VBD administered/VBN fexofenadine/NN hydrochloride/NN alone/RB or/CC in/IN combination/NN with/IN either/CC erythromycin/NN or/CC ketoconazole/NN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NNS differences)) (PP (IN in) (NP (NP (JJ adverse) (NNS events)) (CC or) (NP (NN QTc) (NN interval))))) (VP (VBD were) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NNS subjects)) (VP (VBD were) (VP (VBN administered) (NP (NN fexofenadine) (NN hydrochloride)) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (CC either) (NP (NN erythromycin)) (CC or) (NP (NN ketoconazole)))))))))))))) (. .))))

det(differences-2, No-1)
nsubjpass(observed-10, differences-2)
amod(events-5, adverse-4)
prep_in(differences-2, events-5)
nn(interval-8, QTc-7)
conj_or(events-5, interval-8)
auxpass(observed-10, were-9)
root(ROOT-0, observed-10)
advmod(administered-14, when-11)
nsubjpass(administered-14, subjects-12)
auxpass(administered-14, were-13)
advcl(observed-10, administered-14)
nn(hydrochloride-16, fexofenadine-15)
dobj(administered-14, hydrochloride-16)
dep(administered-14, alone-17)
conj_or(alone-17, in-19)
pobj(in-19, combination-20)
preconj(erythromycin-23, either-22)
prep_with(combination-20, erythromycin-23)
conj_or(erythromycin-23, ketoconazole-25)

The/DT findings/NNS of/IN these/DT studies/NNS are/VBP summarized/VBN in/IN the/DT following/VBG table/NN :/: Effects/NNS on/IN steady-state/JJ fexofenadine/NN pharmacokinetics/NNS after/IN 7/CD days/NNS of/IN co-administration/NN with/IN fexofenadine/NN hydrochloride/NN 120/CD mg/NN every/DT 12/CD hours/NNS (/-LRB- two/CD times/NNS the/DT recommended/VBN twice/RB daily/JJ dose/NN )/-RRB- in/IN healthy/JJ volunteers/NNS (/-LRB- n=24/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS findings)) (PP (IN of) (NP (DT these) (NNS studies)))) (VP (VBP are) (VP (VBN summarized) (PP (IN in) (NP (DT the) (VBG following) (NN table)))))) (: :) (NP (NP (NNS Effects)) (PP (IN on) (NP (NP (JJ steady-state) (NN fexofenadine) (NNS pharmacokinetics)) (PP (IN after) (NP (NP (CD 7) (NNS days)) (PP (IN of) (NP (NP (NN co-administration)) (PP (IN with) (NP (NP (NP (NN fexofenadine) (NN hydrochloride) (CD 120) (NN mg)) (NP (NP (DT every) (CD 12) (NNS hours)) (PRN (-LRB- -LRB-) (NP (NP (CD two) (NNS times)) (NP (DT the) (VBN recommended) (ADJP (RB twice) (JJ daily)) (NN dose))) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (JJ healthy) (NNS volunteers)) (PRN (-LRB- -LRB-) (NP (NN n=24)) (-RRB- -RRB-))))))))))))) (. .))))

det(findings-2, The-1)
nsubjpass(summarized-7, findings-2)
det(studies-5, these-4)
prep_of(findings-2, studies-5)
auxpass(summarized-7, are-6)
root(ROOT-0, summarized-7)
det(table-11, the-9)
amod(table-11, following-10)
prep_in(summarized-7, table-11)
dep(summarized-7, Effects-13)
amod(pharmacokinetics-17, steady-state-15)
nn(pharmacokinetics-17, fexofenadine-16)
prep_on(Effects-13, pharmacokinetics-17)
num(days-20, 7-19)
prep_after(pharmacokinetics-17, days-20)
prep_of(days-20, co-administration-22)
nn(mg-27, fexofenadine-24)
nn(mg-27, hydrochloride-25)
num(mg-27, 120-26)
prep_with(co-administration-22, mg-27)
det(hours-30, every-28)
num(hours-30, 12-29)
dep(mg-27, hours-30)
num(times-33, two-32)
dep(hours-30, times-33)
det(dose-38, the-34)
amod(dose-38, recommended-35)
advmod(daily-37, twice-36)
amod(dose-38, daily-37)
dep(times-33, dose-38)
amod(volunteers-42, healthy-41)
prep_in(mg-27, volunteers-42)
appos(volunteers-42, n=24-44)

Concomitant/JJ Drug/NN ./.

(ROOT (S1 (S (NP (NP (JJ Concomitant) (NN Drug)) (. .)))))

amod(Drug-2, Concomitant-1)
root(ROOT-0, Drug-2)

Erythromycin/NN (/-LRB- 500/CD mg/NN every/DT 8/CD hrs/NNS )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NN Erythromycin)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mg) (NP (DT every) (CD 8) (NNS hrs))) (-RRB- -RRB-))) (. .)))))

root(ROOT-0, Erythromycin-1)
num(mg-4, 500-3)
appos(Erythromycin-1, mg-4)
det(hrs-7, every-5)
num(hrs-7, 8-6)
dep(mg-4, hrs-7)

Ketoconazole/NN (/-LRB- 400/CD mg/NN once/RB daily/JJ )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NN Ketoconazole)) (PRN (-LRB- -LRB-) (NP (NP (CD 400) (NN mg)) (ADJP (RB once) (JJ daily))) (-RRB- -RRB-))) (. .)))))

root(ROOT-0, Ketoconazole-1)
num(mg-4, 400-3)
dep(Ketoconazole-1, mg-4)
advmod(daily-6, once-5)
amod(mg-4, daily-6)

These/DT studies/NNS indicate/VBP that/IN ketoconazole/NN or/CC erythromycin/NN co-administration/NN enhances/VBZ fexofenadine/NN gastrointestinal/JJ absorption/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN ketoconazole)) (CC or) (NP (NN erythromycin)) (NP (NN co-administration))) (VP (VBZ enhances) (NP (NN fexofenadine) (JJ gastrointestinal) (NN absorption))))))) (. .))))

det(studies-2, These-1)
nsubj(indicate-3, studies-2)
root(ROOT-0, indicate-3)
complm(enhances-9, that-4)
nsubj(enhances-9, ketoconazole-5)
conj_or(ketoconazole-5, erythromycin-7)
dep(ketoconazole-5, co-administration-8)
ccomp(indicate-3, enhances-9)
nn(absorption-12, fexofenadine-10)
amod(absorption-12, gastrointestinal-11)
dobj(enhances-9, absorption-12)

This/DT observed/VBN increase/NN in/IN the/DT bioavailability/NN of/IN fexofenadine/NN may/MD be/VB due/JJ to/TO transport-related/JJ effects/NNS ,/, such/JJ as/IN p-/NN glycoprotein/NN ./. in/FW vivo/FW animal/NN studies/NNS also/RB suggest/VBP that/IN in/IN addition/NN to/TO enhancing/VBG absorption/NN ,/, ketoconazole/NN decreases/VBZ fexofenadine/NN gastrointestinal/JJ secretion/NN ,/, while/IN erythromycin/NN may/MD also/RB decrease/VB biliary/JJ excretion/NN ./.

(ROOT (S1 (S (S (S (NP (NP (DT This) (VBN observed) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN fexofenadine)))))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ transport-related) (NNS effects)) (, ,) (PP (JJ such) (IN as) (NP (NN p-) (NN glycoprotein)))))))) (. .)) (NP (FW in) (FW vivo) (NN animal) (NNS studies)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (PP (IN in) (NN addition) (TO to) (S (VP (VBG enhancing) (NP (NN absorption))))) (, ,) (NP (NN ketoconazole)) (VP (VBZ decreases) (NP (NN fexofenadine) (JJ gastrointestinal) (NN secretion)) (, ,) (SBAR (IN while) (S (NP (NN erythromycin)) (VP (MD may) (ADVP (RB also)) (VP (VB decrease) (NP (JJ biliary) (NN excretion))))))))))) (. .))))

det(increase-3, This-1)
amod(increase-3, observed-2)
nsubj(suggest-26, increase-3)
det(bioavailability-6, the-5)
prep_in(increase-3, bioavailability-6)
prep_of(bioavailability-6, fexofenadine-8)
aux(suggest-26, may-9)
cop(suggest-26, be-10)
amod(effects-14, transport-related-13)
prep_due_to(suggest-26, effects-14)
nn(glycoprotein-19, p--18)
prep_such_as(effects-14, glycoprotein-19)
nn(studies-24, in-21)
nn(studies-24, vivo-22)
nn(studies-24, animal-23)
nsubj(suggest-26, studies-24)
advmod(suggest-26, also-25)
root(ROOT-0, suggest-26)
complm(decreases-35, that-27)
prepc_in_addition_to(decreases-35, enhancing-31)
dobj(enhancing-31, absorption-32)
nsubj(decreases-35, ketoconazole-34)
ccomp(suggest-26, decreases-35)
nn(secretion-38, fexofenadine-36)
amod(secretion-38, gastrointestinal-37)
dobj(decreases-35, secretion-38)
mark(decrease-44, while-40)
nsubj(decrease-44, erythromycin-41)
aux(decrease-44, may-42)
advmod(decrease-44, also-43)
advcl(decreases-35, decrease-44)
amod(excretion-46, biliary-45)
dobj(decrease-44, excretion-46)

Drug/NN Interactions/NNS with/IN Antacids/NNS Administration/NN of/IN 120/CD mg/NN of/IN fexofenadine/NN hydrochloride/NN (/-LRB- 2/CD x/CC 60/CD mg/NN capsule/JJ )/-RRB- within/IN 15/CD minutes/NNS of/IN an/DT aluminum/NN and/CC magnesium/NN containing/VBG antacid/JJ (/-LRB- Maalox/NN @/NN )/-RRB- decreased/VBN fexofenadine/NN AUC/NN by/IN 41/CD %/NN and/CC cmax/NN by/IN 43/CD %./NN

(ROOT (S1 (S (NP (NP (NN Drug) (NNS Interactions)) (PP (IN with) (NP (NP (NNS Antacids) (NN Administration)) (PP (IN of) (NP (NP (CD 120) (NN mg)) (PP (IN of) (NP (NP (NN fexofenadine) (NN hydrochloride)) (PRN (-LRB- -LRB-) (NP (CD 2) (CC x) (CD 60) (NN mg) (JJ capsule)) (-RRB- -RRB-)))))))) (PP (IN within) (NP (NP (CD 15) (NNS minutes)) (PP (IN of) (NP (NP (DT an) (NP (NN aluminum)) (CC and) (NP (NN magnesium))) (VP (VBG containing) (NP (NP (NP (ADJP (ADJP (JJ antacid)) (PRN (-LRB- -LRB-) (NP (NN Maalox) (NN @)) (-RRB- -RRB-))) (VBN decreased) (NN fexofenadine) (NN AUC)) (PP (IN by) (NP (CD 41) (NN %)))) (CC and) (NP (NP (NN cmax)) (PP (IN by) (NP (CD 43) (NN %.))))))))))))))

nn(Interactions-2, Drug-1)
root(ROOT-0, Interactions-2)
nn(Administration-5, Antacids-4)
prep_with(Interactions-2, Administration-5)
num(mg-8, 120-7)
prep_of(Administration-5, mg-8)
nn(hydrochloride-11, fexofenadine-10)
prep_of(mg-8, hydrochloride-11)
nn(mg-16, 2-13)
conj_x(2-13, 60-15)
appos(hydrochloride-11, mg-16)
amod(mg-16, capsule-17)
num(minutes-21, 15-20)
prep_within(Interactions-2, minutes-21)
dep(aluminum-24, an-23)
prep_of(minutes-21, aluminum-24)
conj_and(aluminum-24, magnesium-26)
partmod(aluminum-24, containing-27)
amod(AUC-35, antacid-28)
nn(@-31, Maalox-30)
dep(antacid-28, @-31)
amod(AUC-35, decreased-33)
nn(AUC-35, fexofenadine-34)
dobj(containing-27, AUC-35)
num(%-38, 41-37)
prep_by(AUC-35, %-38)
conj_and(AUC-35, cmax-40)
num(%.-43, 43-42)
prep_by(cmax-40, %.-43)

ALLEGRA/NN should/MD not/RB be/VB taken/VBN closely/RB in/IN time/NN with/IN aluminum/NN and/CC magnesium/NN containing/VBG antacids/NNS ./.

(ROOT (S1 (S (S (NP (NN ALLEGRA)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (ADVP (RB closely)) (PP (IN in) (NP (NN time))) (PP (IN with) (NP (NP (NP (NN aluminum)) (CC and) (NP (NN magnesium))) (VP (VBG containing) (NP (NNS antacids))))))))) (. .))))

nsubjpass(taken-5, ALLEGRA-1)
aux(taken-5, should-2)
neg(taken-5, not-3)
auxpass(taken-5, be-4)
root(ROOT-0, taken-5)
advmod(taken-5, closely-6)
prep_in(taken-5, time-8)
prep_with(taken-5, aluminum-10)
conj_and(aluminum-10, magnesium-12)
partmod(aluminum-10, containing-13)
dobj(containing-13, antacids-14)

Interactions/NNS with/IN Fruit/NN Juices/NNS Fruit/NN juices/NNS such/JJ as/IN grapefruit/NN ,/, orange/NN and/CC apple/NN may/MD reduce/VB the/DT bioavailability/NN and/CC exposure/NN of/IN fexofenadine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Interactions)) (PP (IN with) (NP (NP (NN Fruit) (NNS Juices) (NN Fruit) (NNS juices)) (PP (JJ such) (IN as) (NP (NP (NN grapefruit)) (, ,) (NP (NN orange)) (CC and) (NP (NN apple))))))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NP (NN bioavailability)) (CC and) (NP (NN exposure))) (PP (IN of) (NP (NN fexofenadine))))))) (. .))))

nsubj(reduce-15, Interactions-1)
nn(juices-6, Fruit-3)
nn(juices-6, Juices-4)
nn(juices-6, Fruit-5)
prep_with(Interactions-1, juices-6)
prep_such_as(juices-6, grapefruit-9)
conj_and(grapefruit-9, orange-11)
conj_and(grapefruit-9, apple-13)
aux(reduce-15, may-14)
root(ROOT-0, reduce-15)
dep(bioavailability-17, the-16)
dobj(reduce-15, bioavailability-17)
conj_and(bioavailability-17, exposure-19)
prep_of(bioavailability-17, fexofenadine-21)

The/DT size/NN of/IN wheal/NN and/CC flare/NN were/VBD significantly/RB larger/JJR when/WRB fexofenadine/NN hydrochloride/NN was/VBD administered/VBN with/IN either/CC grapefruit/NN or/CC orange/NN juices/NNS compared/VBN to/TO water/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN size)) (PP (IN of) (NP (NP (NN wheal)) (CC and) (NP (NN flare))))) (VP (VBD were) (ADJP (RB significantly) (JJR larger)) (SBAR (WHADVP (WRB when)) (S (NP (NN fexofenadine) (NN hydrochloride)) (VP (VBD was) (VP (VBN administered) (PP (IN with) (NP (CC either) (NP (NN grapefruit)) (CC or) (NP (NN orange)) (NP (NNS juices)))) (PP (VBN compared) (PP (TO to) (NP (NN water)))))))))) (. .))))

det(size-2, The-1)
nsubj(larger-9, size-2)
prep_of(size-2, wheal-4)
conj_and(wheal-4, flare-6)
cop(larger-9, were-7)
advmod(larger-9, significantly-8)
root(ROOT-0, larger-9)
advmod(administered-14, when-10)
nn(hydrochloride-12, fexofenadine-11)
nsubjpass(administered-14, hydrochloride-12)
auxpass(administered-14, was-13)
advcl(larger-9, administered-14)
preconj(grapefruit-17, either-16)
prep_with(administered-14, grapefruit-17)
conj_or(grapefruit-17, orange-19)
dep(grapefruit-17, juices-20)
prepc_compared_to(administered-14, to-22)
pobj(administered-14, water-23)

In/IN addition/NN ,/, based/VBN on/IN the/DT population/NN pharmacokinetics/NNS analysis/NN of/IN the/DT combined/JJ data/NNS from/IN grapefruit/NN and/CC orange/NN juices/NNS studies/NNS with/IN the/DT data/NNS from/IN a/DT bioequivalence/NN study/NN ,/, the/DT bioavailability/NN of/IN fexofenadine/NN was/VBD reduced/VBN by/IN 36/CD %./NN

(ROOT (S1 (S (PP (IN In) (NP (NN addition))) (, ,) (PP (VBN based) (PP (IN on) (NP (DT the) (NN population) (NNS pharmacokinetics)))) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (DT the) (JJ combined) (NNS data)) (PP (IN from) (NP (NP (NP (NP (NN grapefruit)) (CC and) (NP (NN orange)) (NP (NNS juices))) (NNS studies)) (PP (IN with) (NP (NP (DT the) (NNS data)) (PP (IN from) (NP (NP (DT a) (NN bioequivalence) (NN study)) (, ,) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN fexofenadine))))))))))))) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (CD 36) (NN %.))))))))

prep_in(reduced-33, addition-2)
prepc_based_on(reduced-33, on-5)
det(pharmacokinetics-8, the-6)
nn(pharmacokinetics-8, population-7)
pobj(reduced-33, pharmacokinetics-8)
nsubjpass(reduced-33, analysis-9)
det(data-13, the-11)
amod(data-13, combined-12)
prep_of(analysis-9, data-13)
nn(studies-19, grapefruit-15)
conj_and(grapefruit-15, orange-17)
dep(grapefruit-15, juices-18)
prep_from(data-13, studies-19)
det(data-22, the-21)
prep_with(studies-19, data-22)
det(study-26, a-24)
nn(study-26, bioequivalence-25)
prep_from(data-22, study-26)
det(bioavailability-29, the-28)
appos(study-26, bioavailability-29)
prep_of(bioavailability-29, fexofenadine-31)
auxpass(reduced-33, was-32)
root(ROOT-0, reduced-33)
num(%.-36, 36-35)
agent(reduced-33, %.-36)

Therefore/RB ,/, to/TO maximize/VB the/DT effects/NNS of/IN fexofenadine/NN ,/, it/PRP is/VBZ recommended/VBN that/IN ALLEGRA/NN should/MD be/VB taken/VBN with/IN water/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (S (VP (TO to) (VP (VB maximize) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN fexofenadine))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN ALLEGRA)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN with) (NP (NN water))))))))))) (. .))))

advmod(recommended-12, Therefore-1)
aux(maximize-4, to-3)
purpcl(recommended-12, maximize-4)
det(effects-6, the-5)
dobj(maximize-4, effects-6)
prep_of(effects-6, fexofenadine-8)
nsubjpass(recommended-12, it-10)
auxpass(recommended-12, is-11)
root(ROOT-0, recommended-12)
complm(taken-17, that-13)
nsubjpass(taken-17, ALLEGRA-14)
aux(taken-17, should-15)
auxpass(taken-17, be-16)
ccomp(recommended-12, taken-17)
prep_with(taken-17, water-19)

Androgens/NNS may/MD increase/VB sensitivity/NN to/TO oral/JJ anticoagulahts/NNS ./.

(ROOT (S1 (S (S (NP (NNS Androgens)) (VP (MD may) (VP (VB increase) (NP (NP (NN sensitivity)) (PP (TO to) (NP (JJ oral) (NNS anticoagulahts))))))) (. .))))

nsubj(increase-3, Androgens-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
dobj(increase-3, sensitivity-4)
amod(anticoagulahts-7, oral-6)
prep_to(sensitivity-4, anticoagulahts-7)

Dosage/NN of/IN the/DT anticoagulant/NN may/MD require/VB reduction/NN in/IN order/NN to/TO maintain/VB satisfactory/JJ therapeutic/JJ hypoprothrombinemia/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Dosage)) (PP (IN of) (NP (DT the) (NN anticoagulant)))) (VP (MD may) (VP (VB require) (NP (NN reduction))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB maintain) (NP (JJ satisfactory) (JJ therapeutic) (NN hypoprothrombinemia)))))))) (. .))))

nsubj(require-6, Dosage-1)
det(anticoagulant-4, the-3)
prep_of(Dosage-1, anticoagulant-4)
aux(require-6, may-5)
root(ROOT-0, require-6)
dobj(require-6, reduction-7)
mark(maintain-11, in-8)
dep(maintain-11, order-9)
aux(maintain-11, to-10)
purpcl(require-6, maintain-11)
amod(hypoprothrombinemia-14, satisfactory-12)
amod(hypoprothrombinemia-14, therapeutic-13)
dobj(maintain-11, hypoprothrombinemia-14)

Concurrent/JJ administration/NN of/IN oxyphenbutazone/NN and/CC androgens/NNS may/MD result/VB in/IN elevated/JJ serum/NN levels/NNS of/IN oxyphenbutazone/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NN oxyphenbutazone)) (CC and) (NP (NNS androgens))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (JJ elevated) (NN serum) (NNS levels)) (PP (IN of) (NP (NN oxyphenbutazone)))))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(result-8, administration-2)
prep_of(administration-2, oxyphenbutazone-4)
conj_and(oxyphenbutazone-4, androgens-6)
aux(result-8, may-7)
root(ROOT-0, result-8)
amod(levels-12, elevated-10)
nn(levels-12, serum-11)
prep_in(result-8, levels-12)
prep_of(levels-12, oxyphenbutazone-14)

In/IN diabetic/JJ patients/NNS ,/, the/DT metabolic/JJ effects/NNS of/IN androgens/NNS may/MD decrease/VB blood/NN glucose/NN and/CC therefore/RB ,/, insulin/NN requirements/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ diabetic) (NNS patients))) (, ,) (NP (NP (DT the) (JJ metabolic) (NNS effects)) (PP (IN of) (NP (NNS androgens)))) (VP (MD may) (VP (VP (VB decrease) (NP (NN blood) (NN glucose))) (CC and) (ADVP (RB therefore)) (, ,) (NP (NN insulin) (NNS requirements))))) (. .))))

amod(patients-3, diabetic-2)
prep_in(decrease-11, patients-3)
det(effects-7, the-5)
amod(effects-7, metabolic-6)
nsubj(decrease-11, effects-7)
prep_of(effects-7, androgens-9)
aux(decrease-11, may-10)
root(ROOT-0, decrease-11)
nn(glucose-13, blood-12)
dobj(decrease-11, glucose-13)
advmod(decrease-11, therefore-15)
conj_and(decrease-11, therefore-15)
nn(requirements-18, insulin-17)
conj_and(decrease-11, requirements-18)
dobj(decrease-11, requirements-18)

Antacids/NNS :/: Administration/NN of/IN flurbiprofen/NN to/TO volunteers/NNS under/IN fasting/JJ conditions/NNS ,/, or/CC with/IN antacid/JJ suspension/NN yielded/VBD similar/JJ serum/NN flurbiprofen/NN time/NN profiles/NNS in/IN young/JJ subjects/NNS (/-LRB- n=12)./NN

(ROOT (S1 (S (NP (NP (NNS Antacids)) (: :) (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN flurbiprofen))) (PP (TO to) (NP (NP (NNS volunteers)) (PP (PP (IN under) (NP (JJ fasting) (NNS conditions))) (, ,) (CC or) (PP (IN with) (NP (JJ antacid) (NN suspension))))))) (VP (VBD yielded) (NP (JJ similar) (NN serum) (NN flurbiprofen) (NN time) (NNS profiles)) (PP (IN in) (NP (JJ young) (NNS subjects))) (-LRB- -LRB-) (NP (NN n=12-RRB-.))))))))

root(ROOT-0, Antacids-1)
nsubj(yielded-16, Administration-3)
prep_of(Administration-3, flurbiprofen-5)
prep_to(Administration-3, volunteers-7)
conj_or(volunteers-7, volunteers-7')
amod(conditions-10, fasting-9)
prep_under(volunteers-7, conditions-10)
amod(suspension-15, antacid-14)
prep_with(volunteers-7', suspension-15)
dep(Antacids-1, yielded-16)
amod(profiles-21, similar-17)
nn(profiles-21, serum-18)
nn(profiles-21, flurbiprofen-19)
nn(profiles-21, time-20)
dobj(yielded-16, profiles-21)
amod(subjects-24, young-23)
prep_in(yielded-16, subjects-24)
dobj(yielded-16, n=12-RRB-.-26)

In/IN geriatric/JJ subjects/NNS (/-LRB- n=7/NN )/-RRB- there/EX was/VBD a/DT reduction/NN in/IN the/DT rate/NN but/CC not/RB the/DT extent/NN of/IN flurbiprofen/NN absorption/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ geriatric) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NN n=7)) (-RRB- -RRB-)))) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN rate)) (CONJP (CC but) (RB not)) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN flurbiprofen) (NN absorption))))))))) (. .))))

amod(subjects-3, geriatric-2)
prep_in(was-8, subjects-3)
appos(subjects-3, n=7-5)
expl(was-8, there-7)
root(ROOT-0, was-8)
det(reduction-10, a-9)
nsubj(was-8, reduction-10)
det(rate-13, the-12)
prep_in(reduction-10, rate-13)
det(extent-17, the-16)
conj_negcc(rate-13, extent-17)
nn(absorption-20, flurbiprofen-19)
prep_of(extent-17, absorption-20)

Anticoagulants/NNS :/: Flurbiprofen/NN like/IN other/JJ nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS ,/, has/VBZ been/VBN shown/VBN to/TO affect/VB bleeding/JJ parameters/NNS in/IN patients/NNS receiving/VBG anti-coagulants/NNS ,/, and/CC serious/JJ clinical/JJ bleeding/JJ has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (NP (NP (NNS Anticoagulants)) (: :) (S (S (NP (NP (NN Flurbiprofen)) (PP (IN like) (NP (JJ other) (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB affect) (NP (NP (JJ bleeding) (NNS parameters)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NNS anti-coagulants))))))))))))) (, ,) (CC and) (S (NP (JJ serious) (JJ clinical) (JJ bleeding)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported)))))) (. .)))))

root(ROOT-0, Anticoagulants-1)
nsubjpass(shown-12, Flurbiprofen-3)
xsubj(affect-14, Flurbiprofen-3)
amod(drugs-8, other-5)
amod(drugs-8, nonsteroidal-6)
amod(drugs-8, anti-inflammatory-7)
prep_like(Flurbiprofen-3, drugs-8)
aux(shown-12, has-10)
auxpass(shown-12, been-11)
dep(Anticoagulants-1, shown-12)
aux(affect-14, to-13)
xcomp(shown-12, affect-14)
amod(parameters-16, bleeding-15)
dobj(affect-14, parameters-16)
prep_in(parameters-16, patients-18)
partmod(patients-18, receiving-19)
dobj(receiving-19, anti-coagulants-20)
amod(bleeding-25, serious-23)
amod(bleeding-25, clinical-24)
nsubjpass(reported-28, bleeding-25)
aux(reported-28, has-26)
auxpass(reported-28, been-27)
conj_and(shown-12, reported-28)

The/DT physician/NN should/MD be/VB cautious/JJ when/WRB administering/VBG flurbiprofen/NN to/TO patients/NNS taking/VBG anticoagulants/NNS ./.

(ROOT (S1 (S (S (NP (DT The) (NN physician)) (VP (MD should) (VP (VB be) (ADJP (JJ cautious))) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NN flurbiprofen)) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NNS anticoagulants)))))))))) (. .))))

det(physician-2, The-1)
nsubj(cautious-5, physician-2)
aux(cautious-5, should-3)
cop(cautious-5, be-4)
root(ROOT-0, cautious-5)
advmod(administering-7, when-6)
advcl(cautious-5, administering-7)
dobj(administering-7, flurbiprofen-8)
prep_to(administering-7, patients-10)
partmod(patients-10, taking-11)
dobj(taking-11, anticoagulants-12)

Aspirin/NN :/: Concurrent/JJ administration/NN of/IN aspirin/NN and/CC flurbiprofen/NN resulted/VBD in/IN 50/CD %/NN lower/JJR serum/NN flurbiprofen/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NN Aspirin)) (: :) (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NN aspirin)) (CC and) (NP (NN flurbiprofen))))) (VP (VBD resulted) (PP (IN in) (NP (ADJP (NP (CD 50) (NN %)) (JJR lower)) (NN serum) (NN flurbiprofen) (NNS concentrations))))) (. .))))

nsubj(resulted-9, Aspirin-1)
amod(administration-4, Concurrent-3)
nsubj(resulted-9, administration-4)
prep_of(administration-4, aspirin-6)
conj_and(aspirin-6, flurbiprofen-8)
root(ROOT-0, resulted-9)
num(%-12, 50-11)
npadvmod(lower-13, %-12)
amod(concentrations-16, lower-13)
nn(concentrations-16, serum-14)
nn(concentrations-16, flurbiprofen-15)
prep_in(resulted-9, concentrations-16)

This/DT effect/NN of/IN aspirin/NN (/-LRB- which/WDT also/RB lowers/VBZ serum/NN concentrations/NNS of/IN other/JJ nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS given/VBN with/IN it/PRP )/-RRB- has/VBZ been/VBN demonstrated/VBN in/IN patients/NNS with/IN rheumatoid/JJ arthritis/NN (/-LRB- n=/NN 15/CD )/-RRB- as/RB well/RB as/IN normal/JJ volunteers/NNS (/-LRB- n=/NN 16/CD )./NN

(ROOT (S1 (S (NP (NP (DT This) (NN effect)) (PP (IN of) (NP (NN aspirin))) (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (ADVP (RB also)) (VP (VBZ lowers) (NP (NP (NN serum) (NNS concentrations)) (PP (IN of) (NP (NP (JJ other) (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (VP (VBN given) (PP (IN with) (NP (PRP it)))))))))) (-RRB- -RRB-)) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (IN in) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN n=) (CD 15)) (-RRB- -RRB-))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ normal) (NNS volunteers)) (PRN (-LRB- -LRB-) (NP (NN n=) (CD 16) (NN -RRB-.))))))))))))

det(effect-2, This-1)
nsubjpass(demonstrated-22, effect-2)
prep_of(effect-2, aspirin-4)
nsubj(lowers-8, which-6)
advmod(lowers-8, also-7)
rcmod(effect-2, lowers-8)
nn(concentrations-10, serum-9)
dobj(lowers-8, concentrations-10)
amod(drugs-15, other-12)
amod(drugs-15, nonsteroidal-13)
amod(drugs-15, anti-inflammatory-14)
prep_of(concentrations-10, drugs-15)
partmod(drugs-15, given-16)
prep_with(given-16, it-18)
aux(demonstrated-22, has-20)
auxpass(demonstrated-22, been-21)
root(ROOT-0, demonstrated-22)
prep_in(demonstrated-22, patients-24)
amod(arthritis-27, rheumatoid-26)
prep_with(patients-24, arthritis-27)
appos(arthritis-27, n=-29)
num(n=-29, 15-30)
amod(volunteers-36, normal-35)
conj_and(patients-24, volunteers-36)
nn(-RRB-.-40, n=-38)
num(-RRB-.-40, 16-39)
dep(volunteers-36, -RRB-.-40)

Concurrent/JJ use/NN of/IN flurbiprofen/NN and/CC aspirin/NN is/VBZ therefore/RB not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NP (NN flurbiprofen)) (CC and) (NP (NN aspirin))))) (VP (VBZ is) (ADVP (RB therefore)) (RB not) (VP (VBN recommended)))) (. .))))

amod(use-2, Concurrent-1)
nsubjpass(recommended-10, use-2)
prep_of(use-2, flurbiprofen-4)
conj_and(flurbiprofen-4, aspirin-6)
auxpass(recommended-10, is-7)
advmod(recommended-10, therefore-8)
neg(recommended-10, not-9)
root(ROOT-0, recommended-10)

Beta-adrenergic/JJ Blocking/NN Agents/NNS :/: The/DT effect/NN of/IN flurbiprofen/NN on/IN blood/NN pressure/NN response/NN to/TO propranolol/NN and/CC atenolol/NN was/VBD evaluated/VBN in/IN men/NNS with/IN mild/JJ uncomplicated/JJ hypertension/NN (/-LRB- n/NN =/JJ 10/CD )./NN

(ROOT (S1 (S (NP (NP (JJ Beta-adrenergic) (NN Blocking) (NNS Agents)) (: :) (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN flurbiprofen))) (PP (IN on) (NP (NP (NN blood) (NN pressure) (NN response)) (PP (TO to) (NP (NP (NN propranolol)) (CC and) (NP (NN atenolol))))))) (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (NP (NNS men)) (PP (IN with) (NP (NP (JJ mild) (JJ uncomplicated) (NN hypertension)) (PRN (-LRB- -LRB-) (NP (NP (NN n)) (ADJP (JJ =) (NP (CD 10) (NN -RRB-.))))))))))))))))

amod(Agents-3, Beta-adrenergic-1)
nn(Agents-3, Blocking-2)
root(ROOT-0, Agents-3)
det(effect-6, The-5)
nsubjpass(evaluated-18, effect-6)
prep_of(effect-6, flurbiprofen-8)
nn(response-12, blood-10)
nn(response-12, pressure-11)
prep_on(effect-6, response-12)
prep_to(response-12, propranolol-14)
conj_and(propranolol-14, atenolol-16)
auxpass(evaluated-18, was-17)
dep(Agents-3, evaluated-18)
prep_in(evaluated-18, men-20)
amod(hypertension-24, mild-22)
amod(hypertension-24, uncomplicated-23)
prep_with(men-20, hypertension-24)
dep(hypertension-24, n-26)
amod(n-26, =-27)
num(-RRB-.-29, 10-28)
dep(=-27, -RRB-.-29)

Flurbiprofen/NN pretreatment/NN attenuated/VBD the/DT hypotensive/JJ effect/NN of/IN a/DT single/JJ dose/NN of/IN propranolol/NN but/CC not/RB atenolol/NN ./.

(ROOT (S1 (S (S (NP (NN Flurbiprofen) (NN pretreatment)) (VP (VBD attenuated) (NP (NP (DT the) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NN propranolol)) (CONJP (CC but) (RB not)) (NP (NN atenolol))))))))) (. .))))

nn(pretreatment-2, Flurbiprofen-1)
nsubj(attenuated-3, pretreatment-2)
root(ROOT-0, attenuated-3)
det(effect-6, the-4)
amod(effect-6, hypotensive-5)
dobj(attenuated-3, effect-6)
det(dose-10, a-8)
amod(dose-10, single-9)
prep_of(effect-6, dose-10)
prep_of(dose-10, propranolol-12)
conj_negcc(propranolol-12, atenolol-15)

Flurbiprofen/NN did/VBD not/RB appear/VB to/TO affect/VB the/DT beta-blocker/JJ -mediated/JJ reduction/NN in/IN heart/NN rate/NN ./.

(ROOT (S1 (S (S (NP (NN Flurbiprofen)) (VP (VBD did) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB affect) (NP (NP (DT the) (JJ beta-blocker) (JJ -mediated) (NN reduction)) (PP (IN in) (NP (NN heart) (NN rate)))))))))) (. .))))

nsubj(appear-4, Flurbiprofen-1)
xsubj(affect-6, Flurbiprofen-1)
aux(appear-4, did-2)
neg(appear-4, not-3)
root(ROOT-0, appear-4)
aux(affect-6, to-5)
xcomp(appear-4, affect-6)
det(reduction-10, the-7)
amod(reduction-10, beta-blocker-8)
amod(reduction-10, -mediated-9)
dobj(affect-6, reduction-10)
nn(rate-13, heart-12)
prep_in(reduction-10, rate-13)

Flurbiprofen/NN did/VBD not/RB affect/VB the/DT pharmacokinetic/JJ profile/NN of/IN either/DT drug/NN ,/, and/CC the/DT mechanism/NN under/IN lying/VBG the/DT interference/NN with/IN propranolol/NN s/NN hypotensive/JJ effect/NN is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (S (NP (NN Flurbiprofen)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (JJ pharmacokinetic) (NN profile)) (PP (IN of) (NP (DT either) (NN drug))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN mechanism)) (PP (IN under) (S (VP (VBG lying) (NP (NP (DT the) (NN interference)) (PP (IN with) (NP (NN propranolol) (NN s) (JJ hypotensive) (NN effect)))))))) (VP (VBZ is) (ADJP (JJ unknown))))) (. .))))

nsubj(affect-4, Flurbiprofen-1)
aux(affect-4, did-2)
neg(affect-4, not-3)
root(ROOT-0, affect-4)
det(profile-7, the-5)
amod(profile-7, pharmacokinetic-6)
dobj(affect-4, profile-7)
det(drug-10, either-9)
prep_of(profile-7, drug-10)
det(mechanism-14, the-13)
nsubj(unknown-25, mechanism-14)
prepc_under(mechanism-14, lying-16)
det(interference-18, the-17)
dobj(lying-16, interference-18)
nn(effect-23, propranolol-20)
nn(effect-23, s-21)
amod(effect-23, hypotensive-22)
prep_with(interference-18, effect-23)
cop(unknown-25, is-24)
conj_and(affect-4, unknown-25)

Patients/NNS taking/VBG both/CC flurbiprofen/NN and/CC a/DT beta-blocker/NN should/MD be/VB monitored/VBN to/TO ensure/VB that/IN a/DT satisfactory/JJ hypotensive/JJ effect/NN is/VBZ achieved/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (CC both) (NP (NN flurbiprofen)) (CC and) (NP (DT a) (NN beta-blocker))))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (S (VP (TO to) (VP (VB ensure) (SBAR (IN that) (S (NP (DT a) (JJ satisfactory) (JJ hypotensive) (NN effect)) (VP (VBZ is) (VP (VBN achieved)))))))))))) (. .))))

nsubjpass(monitored-10, Patients-1)
partmod(Patients-1, taking-2)
preconj(flurbiprofen-4, both-3)
dobj(taking-2, flurbiprofen-4)
det(beta-blocker-7, a-6)
conj_and(flurbiprofen-4, beta-blocker-7)
aux(monitored-10, should-8)
auxpass(monitored-10, be-9)
root(ROOT-0, monitored-10)
aux(ensure-12, to-11)
xcomp(monitored-10, ensure-12)
complm(achieved-19, that-13)
det(effect-17, a-14)
amod(effect-17, satisfactory-15)
amod(effect-17, hypotensive-16)
nsubjpass(achieved-19, effect-17)
auxpass(achieved-19, is-18)
ccomp(ensure-12, achieved-19)

Cimetidine/NN ,/, Ranitidine/NN :/: In/IN normal/JJ volunteers/NNS (/-LRB- n=9/NN )/-RRB- ,/, pretreatment/NN with/IN cimetidine/NN or/CC ranitidine/NN did/VBD not/RB affect/VB flurbiprofen/NN pharmacokinetics/NNS except/IN that/IN a/DT small/JJ (/-LRB- 13/CD %/NN )/-RRB- but/CC statistically/RB significant/JJ increase/NN in/IN the/DT area/NN under/IN the/DT serum/NN concentration/NN curve/NN of/IN flurbiprofen/NN resulted/VBD with/IN cimetidine/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Cimetidine)) (, ,) (NP (NN Ranitidine))) (: :) (S (PP (IN In) (NP (NP (JJ normal) (NNS volunteers)) (PRN (-LRB- -LRB-) (NP (NN n=9)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NP (NN cimetidine)) (CC or) (NP (NN ranitidine))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN flurbiprofen) (NNS pharmacokinetics)) (PP (IN except) (SBAR (IN that) (S (NP (NP (DT a) (ADJP (ADJP (JJ small) (PRN (-LRB- -LRB-) (NP (CD 13) (NN %)) (-RRB- -RRB-))) (CC but) (ADJP (RB statistically) (JJ significant))) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN area)) (PP (IN under) (NP (NP (DT the) (NN serum) (NN concentration) (NN curve)) (PP (IN of) (NP (NN flurbiprofen)))))))) (VP (VBD resulted) (PP (IN with) (NP (NN cimetidine)))))))))) (. .)))))

root(ROOT-0, Cimetidine-1)
appos(Cimetidine-1, Ranitidine-3)
amod(volunteers-7, normal-6)
prep_in(affect-19, volunteers-7)
appos(volunteers-7, n=9-9)
nsubj(affect-19, pretreatment-12)
prep_with(pretreatment-12, cimetidine-14)
conj_or(cimetidine-14, ranitidine-16)
aux(affect-19, did-17)
neg(affect-19, not-18)
dep(Cimetidine-1, affect-19)
nn(pharmacokinetics-21, flurbiprofen-20)
dobj(affect-19, pharmacokinetics-21)
complm(resulted-44, that-23)
det(increase-33, a-24)
amod(increase-33, small-25)
num(%-28, 13-27)
dep(small-25, %-28)
advmod(significant-32, statistically-31)
conj_but(small-25, significant-32)
nsubj(resulted-44, increase-33)
det(area-36, the-35)
prep_in(increase-33, area-36)
det(curve-41, the-38)
nn(curve-41, serum-39)
nn(curve-41, concentration-40)
prep_under(area-36, curve-41)
prep_of(curve-41, flurbiprofen-43)
prepc_except(affect-19, resulted-44)
prep_with(resulted-44, cimetidine-46)

Digoxin/NN :/: Studies/NNS of/IN concomitant/JJ administration/NN of/IN flurbiprofen/NN and/CC digoxin/NN to/TO healthy/JJ men/NNS (/-LRB- n=/NN 14/CD )/-RRB- did/VBD not/RB show/VB a/DT change/NN in/IN the/DT steady/JJ state/NN serum/NN levels/NNS of/IN either/DT drug/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Digoxin)) (: :) (NP (NP (NNS Studies)) (PP (IN of) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN flurbiprofen)))))) (CC and) (NP (NP (NN digoxin)) (PP (TO to) (NP (NP (JJ healthy) (NNS men)) (PRN (-LRB- -LRB-) (NP (NN n=) (CD 14)) (-RRB- -RRB-)))))) (VP (VBD did) (RB not) (VP (VB show) (NP (NP (DT a) (NN change)) (PP (IN in) (NP (NP (DT the) (JJ steady) (NN state) (NN serum) (NNS levels)) (PP (IN of) (NP (DT either) (NN drug))))))))) (. .))))

nsubj(show-20, Digoxin-1)
conj_and(Digoxin-1, Studies-3)
amod(administration-6, concomitant-5)
prep_of(Studies-3, administration-6)
prep_of(administration-6, flurbiprofen-8)
conj_and(Digoxin-1, digoxin-10)
amod(men-13, healthy-12)
prep_to(digoxin-10, men-13)
appos(men-13, n=-15)
num(n=-15, 14-16)
aux(show-20, did-18)
neg(show-20, not-19)
root(ROOT-0, show-20)
det(change-22, a-21)
dobj(show-20, change-22)
det(levels-28, the-24)
amod(levels-28, steady-25)
nn(levels-28, state-26)
nn(levels-28, serum-27)
prep_in(change-22, levels-28)
det(drug-31, either-30)
prep_of(levels-28, drug-31)

Diuretics/NN :/: Studies/NNS in/IN normal/JJ volunteers/NNS have/VBP shown/VBN that/IN flurbiprofen/NN like/IN other/JJ nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS ,/, can/MD interfere/VB with/IN the/DT effects/NNS of/IN furosemide/NN ./.

(ROOT (S1 (S (NP (NP (NN Diuretics)) (: :) (S (NP (NP (NNS Studies)) (PP (IN in) (NP (JJ normal) (NNS volunteers)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN flurbiprofen)) (PP (IN like) (NP (JJ other) (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs))) (, ,) (VP (MD can) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN furosemide)))))))))))) (. .)))))

root(ROOT-0, Diuretics-1)
nsubj(shown-8, Studies-3)
amod(volunteers-6, normal-5)
prep_in(Studies-3, volunteers-6)
aux(shown-8, have-7)
dep(Diuretics-1, shown-8)
complm(interfere-18, that-9)
nsubj(interfere-18, flurbiprofen-10)
amod(drugs-15, other-12)
amod(drugs-15, nonsteroidal-13)
amod(drugs-15, anti-inflammatory-14)
prep_like(interfere-18, drugs-15)
aux(interfere-18, can-17)
ccomp(shown-8, interfere-18)
det(effects-21, the-20)
prep_with(interfere-18, effects-21)
prep_of(effects-21, furosemide-23)

Although/IN results/NNS have/VBP varied/VBD from/IN study/NN to/TO study/NN ,/, effects/NNS have/VBP been/VBN shown/VBN on/IN furosemide-stimulated/JJ diuresis/NN ,/, natriuresis/NN ,/, and/CC kaliuresis/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NNS results)) (VP (VBP have) (VP (VBD varied) (PP (IN from) (NP (NP (NN study)) (TO to) (NP (NN study)))))))) (, ,) (NP (NNS effects)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (PP (IN on) (NP (NP (JJ furosemide-stimulated) (NN diuresis)) (, ,) (NP (NN natriuresis)) (, ,) (CC and) (NP (NN kaliuresis)))))))) (. .))))

mark(varied-4, Although-1)
nsubj(varied-4, results-2)
aux(varied-4, have-3)
advcl(shown-13, varied-4)
prep_from(varied-4, study-6)
dep(study-6, to-7)
dep(study-6, study-8)
nsubjpass(shown-13, effects-10)
aux(shown-13, have-11)
auxpass(shown-13, been-12)
root(ROOT-0, shown-13)
amod(diuresis-16, furosemide-stimulated-15)
prep_on(shown-13, diuresis-16)
conj_and(diuresis-16, natriuresis-18)
conj_and(diuresis-16, kaliuresis-21)

Other/JJ nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS that/WDT inhibit/VBP prostaglandin/NN synthesis/NN have/VBP been/VBN shown/VBN to/TO interfere/VB with/IN thiazide/NN diuretics/NNS in/IN some/DT studies/NNS and/CC with/IN potassium-sparing/JJ diuretics/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN prostaglandin) (NN synthesis)))))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB interfere) (PP (PP (IN with) (NP (NN thiazide) (NNS diuretics))) (PP (IN in) (NP (DT some) (NNS studies))) (CC and) (PP (IN with) (NP (JJ potassium-sparing) (NN diuretics))))))))))) (. .))))

amod(drugs-4, Other-1)
amod(drugs-4, nonsteroidal-2)
amod(drugs-4, anti-inflammatory-3)
nsubj(inhibit-6, drugs-4)
nsubjpass(shown-11, drugs-4)
xsubj(interfere-13, drugs-4)
rcmod(drugs-4, inhibit-6)
nn(synthesis-8, prostaglandin-7)
dobj(inhibit-6, synthesis-8)
aux(shown-11, have-9)
auxpass(shown-11, been-10)
root(ROOT-0, shown-11)
aux(interfere-13, to-12)
xcomp(shown-11, interfere-13)
nn(diuretics-16, thiazide-15)
prep_with(interfere-13, diuretics-16)
dep(interfere-13, in-17)
det(studies-19, some-18)
pobj(in-17, studies-19)
amod(diuretics-23, potassium-sparing-22)
conj_and(diuretics-16, diuretics-23)

Patients/NNS receiving/VBG flurbiprofen/NN and/CC furosemide/NN or/CC other/JJ diuretics/NNS should/MD be/VB observed/VBN closely/RB to/TO determine/VB if/IN the/DT desired/JJ effect/NN is/VBZ obtained/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (NN flurbiprofen)) (CC and) (NP (NN furosemide))))) (CC or) (NP (JJ other) (NNS diuretics))) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (DT the) (JJ desired) (NN effect)) (VP (VBZ is) (VP (VBN obtained)))))))))))) (. .))))

nsubjpass(observed-11, Patients-1)
partmod(Patients-1, receiving-2)
dobj(receiving-2, flurbiprofen-3)
conj_and(flurbiprofen-3, furosemide-5)
amod(diuretics-8, other-7)
conj_or(Patients-1, diuretics-8)
aux(observed-11, should-9)
auxpass(observed-11, be-10)
root(ROOT-0, observed-11)
advmod(observed-11, closely-12)
aux(determine-14, to-13)
xcomp(observed-11, determine-14)
mark(obtained-20, if-15)
det(effect-18, the-16)
amod(effect-18, desired-17)
nsubjpass(obtained-20, effect-18)
auxpass(obtained-20, is-19)
advcl(determine-14, obtained-20)

Oral/JJ Hypoglycemic/JJ Agents/NNS :/: In/IN one/CD study/NN ,/, flurbiprofen/NN was/VBD given/VBN to/TO adult/JJ diabetics/NNS who/WP were/VBD already/RB receiving/VBG glyburide/NN (/-LRB- n=4/NN )/-RRB- ,/, metformin/NN (/-LRB- n=2/NN )/-RRB- chlorpropamide/NN with/IN phenformin/NN (/-LRB- n=/NN 3/CD )/-RRB- or/CC glyburide/NN with/IN phenformin/NN (/-LRB- n=6)./CD

(ROOT (S1 (S (NP (NP (JJ Oral) (JJ Hypoglycemic) (NNS Agents)) (: :) (S (PP (IN In) (NP (CD one) (NN study))) (, ,) (NP (NN flurbiprofen)) (VP (VBD was) (VP (VBN given) (PP (TO to) (NP (NP (JJ adult) (NNS diabetics)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (ADVP (RB already)) (VP (VBG receiving) (NP (NP (NP (NN glyburide)) (PRN (-LRB- -LRB-) (NP (NN n=4)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NP (NP (NN metformin)) (PRN (-LRB- -LRB-) (NP (NN n=2)) (-RRB- -RRB-))) (NN chlorpropamide)) (PP (IN with) (NP (NN phenformin)))) (PRN (-LRB- -LRB-) (NP (NN n=) (CD 3)) (-RRB- -RRB-))) (CC or) (NP (NP (NN glyburide)) (PP (IN with) (NP (NN phenformin) (-LRB- -LRB-) (CD n=6-RRB-.))))))))))))))))))

amod(Agents-3, Oral-1)
amod(Agents-3, Hypoglycemic-2)
root(ROOT-0, Agents-3)
num(study-7, one-6)
prep_in(given-11, study-7)
nsubjpass(given-11, flurbiprofen-9)
auxpass(given-11, was-10)
dep(Agents-3, given-11)
amod(diabetics-14, adult-13)
prep_to(given-11, diabetics-14)
nsubj(receiving-18, diabetics-14)
aux(receiving-18, were-16)
advmod(receiving-18, already-17)
rcmod(diabetics-14, receiving-18)
dobj(receiving-18, glyburide-19)
appos(glyburide-19, n=4-21)
nn(chlorpropamide-28, metformin-24)
appos(metformin-24, n=2-26)
conj_or(glyburide-19, chlorpropamide-28)
prep_with(chlorpropamide-28, phenformin-30)
appos(chlorpropamide-28, n=-32)
num(n=-32, 3-33)
conj_or(glyburide-19, glyburide-36)
prep_with(glyburide-36, phenformin-38)
num(phenformin-38, n=6-RRB-.-40)

Although/IN there/EX was/VBD a/DT slight/JJ reduction/NN in/IN blood/NN sugar/NN concentrations/NNS during/IN concomitant/JJ administration/NN of/IN flurbiprofen/NN and/CC hypoglycemic/JJ agents/NNS ,/, there/EX were/VBD no/DT signs/NNS or/CC symptoms/NNS of/IN hypoglycemia/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ slight) (NN reduction)) (PP (IN in) (NP (NN blood) (NN sugar) (NNS concentrations)))) (PP (IN during) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN flurbiprofen)) (CC and) (NP (JJ hypoglycemic) (NNS agents))))))))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (NP (NNS signs)) (CC or) (NP (NNS symptoms))) (PP (IN of) (NP (NN hypoglycemia)))))) (. .))))

mark(was-3, Although-1)
expl(was-3, there-2)
advcl(were-21, was-3)
det(reduction-6, a-4)
amod(reduction-6, slight-5)
nsubj(was-3, reduction-6)
nn(concentrations-10, blood-8)
nn(concentrations-10, sugar-9)
prep_in(reduction-6, concentrations-10)
amod(administration-13, concomitant-12)
prep_during(was-3, administration-13)
prep_of(administration-13, flurbiprofen-15)
amod(agents-18, hypoglycemic-17)
conj_and(flurbiprofen-15, agents-18)
expl(were-21, there-20)
root(ROOT-0, were-21)
dep(signs-23, no-22)
nsubj(were-21, signs-23)
conj_or(signs-23, symptoms-25)
prep_of(signs-23, hypoglycemia-27)

Diuretics/NN :/: Patients/NNS on/IN diuretics/NN ,/, especially/RB those/DT with/IN intravascular/JJ volume/NN depletion/NN ,/, may/MD occasionally/RB experience/VBP an/DT excessive/JJ reduction/NN of/IN blood/NN pressure/NN after/IN initiation/NN of/IN therapy/NN with/IN fosinopril/NN sodium/NN ./.

(ROOT (S1 (S (NP (NP (NN Diuretics)) (: :) (S (NP (NP (NP (NNS Patients)) (PP (IN on) (NP (NN diuretics)))) (, ,) (ADVP (RB especially)) (NP (NP (DT those)) (PP (IN with) (NP (JJ intravascular) (NN volume) (NN depletion)))) (, ,)) (VP (MD may) (ADVP (RB occasionally)) (VP (VBP experience) (NP (NP (DT an) (JJ excessive) (NN reduction)) (PP (IN of) (NP (NN blood) (NN pressure))) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN therapy)) (PP (IN with) (NP (NN fosinopril) (NN sodium))))))))))) (. .)))))

root(ROOT-0, Diuretics-1)
nsubj(experience-16, Patients-3)
prep_on(Patients-3, diuretics-5)
advmod(Patients-3, especially-7)
dep(Patients-3, those-8)
amod(depletion-12, intravascular-10)
nn(depletion-12, volume-11)
prep_with(those-8, depletion-12)
aux(experience-16, may-14)
advmod(experience-16, occasionally-15)
dep(Diuretics-1, experience-16)
det(reduction-19, an-17)
amod(reduction-19, excessive-18)
dobj(experience-16, reduction-19)
nn(pressure-22, blood-21)
prep_of(reduction-19, pressure-22)
prep_after(reduction-19, initiation-24)
prep_of(initiation-24, therapy-26)
nn(sodium-29, fosinopril-28)
prep_with(therapy-26, sodium-29)

The/DT possibility/NN of/IN hypotensive/JJ effects/NNS can/MD be/VB minimized/VBN by/IN either/CC discontinuing/VBG the/DT diuretic/JJ or/CC increasing/VBG salt/NN intake/NN prior/RB to/TO initiation/NN of/IN treatment/NN with/IN fosinopril/NN sodium/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (JJ hypotensive) (NNS effects)))) (VP (MD can) (VP (VB be) (VP (VBN minimized) (PP (IN by) (S (VP (CC either) (VP (VBG discontinuing) (NP (DT the) (JJ diuretic))) (CC or) (VP (VBG increasing) (NP (NP (NN salt) (NN intake)) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NN fosinopril) (NN sodium))))))))))))))))) (. .))))

det(possibility-2, The-1)
nsubjpass(minimized-8, possibility-2)
amod(effects-5, hypotensive-4)
prep_of(possibility-2, effects-5)
aux(minimized-8, can-6)
auxpass(minimized-8, be-7)
root(ROOT-0, minimized-8)
preconj(discontinuing-11, either-10)
agent(minimized-8, discontinuing-11)
det(diuretic-13, the-12)
dobj(discontinuing-11, diuretic-13)
conj_or(discontinuing-11, increasing-15)
nn(intake-17, salt-16)
dobj(increasing-15, intake-17)
prep_prior_to(intake-17, initiation-20)
prep_of(initiation-20, treatment-22)
nn(sodium-25, fosinopril-24)
prep_with(treatment-22, sodium-25)

Potassium/NN Supplement/NN s/NNS and/CC Potassium-Sparing/JJ Diuretics/NNS :/: Fosinopril/NN sodium/NN can/MD attenuate/VB potassium/NN loss/NN caused/VBN by/IN thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Potassium) (NN Supplement) (NNS s)) (CC and) (NP (JJ Potassium-Sparing) (NNS Diuretics))) (: :) (S (NP (NN Fosinopril) (NN sodium)) (VP (MD can) (VP (VB attenuate) (NP (NP (NN potassium) (NN loss)) (VP (VBN caused) (PP (IN by) (NP (NN thiazide) (NNS diuretics)))))))) (. .)))))

nn(s-3, Potassium-1)
nn(s-3, Supplement-2)
root(ROOT-0, s-3)
amod(Diuretics-6, Potassium-Sparing-5)
conj_and(s-3, Diuretics-6)
nn(sodium-9, Fosinopril-8)
nsubj(attenuate-11, sodium-9)
aux(attenuate-11, can-10)
dep(s-3, attenuate-11)
nn(loss-13, potassium-12)
dobj(attenuate-11, loss-13)
partmod(loss-13, caused-14)
nn(diuretics-17, thiazide-16)
agent(caused-14, diuretics-17)

Potassium-sparing/JJ diuretics/NNS (/-LRB- spironolactone/NN ,/, amiloride/NN ,/, triamterene/NN ,/, and/CC others/NNS )/-RRB- or/CC potassium/NN supplement/NN s/NNS can/MD increase/VB the/DT risk/NN of/IN hyperkalemia/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Potassium-sparing) (NNS diuretics)) (PRN (-LRB- -LRB-) (NP (NP (NN spironolactone)) (, ,) (NP (NN amiloride)) (, ,) (NP (NN triamterene)) (, ,) (CC and) (NP (NNS others))) (-RRB- -RRB-))) (CC or) (NP (NN potassium) (NN supplement) (NNS s))) (VP (MD can) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN hyperkalemia))))))) (. .))))

amod(diuretics-2, Potassium-sparing-1)
nsubj(increase-18, diuretics-2)
dep(diuretics-2, spironolactone-4)
conj_and(spironolactone-4, amiloride-6)
conj_and(spironolactone-4, triamterene-8)
conj_and(spironolactone-4, others-11)
nn(s-16, potassium-14)
nn(s-16, supplement-15)
conj_or(diuretics-2, s-16)
aux(increase-18, can-17)
root(ROOT-0, increase-18)
det(risk-20, the-19)
dobj(increase-18, risk-20)
prep_of(risk-20, hyperkalemia-22)

Lithium/NN :/: Increased/VBN serum/NN lithium/NN levels/NNS and/CC symptoms/NNS of/IN lithium/NN toxicity/NN have/VBP been/VBN reported/VBN in/IN patients/NNS receiving/VBG ACE/NN inhibitors/NNS during/IN therapy/NN with/IN lithium/NN ./.

(ROOT (S1 (S (NP (NP (NN Lithium)) (: :) (S (NP (NP (NP (VBN Increased) (NN serum) (NN lithium) (NNS levels)) (CC and) (NP (NNS symptoms))) (PP (IN of) (NP (NN lithium) (NN toxicity)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN ACE) (NNS inhibitors)) (PP (IN during) (NP (NP (NN therapy)) (PP (IN with) (NP (NN lithium)))))))))))) (. .)))))

root(ROOT-0, Lithium-1)
amod(levels-6, Increased-3)
nn(levels-6, serum-4)
nn(levels-6, lithium-5)
nsubjpass(reported-14, levels-6)
conj_and(levels-6, symptoms-8)
nn(toxicity-11, lithium-10)
prep_of(levels-6, toxicity-11)
aux(reported-14, have-12)
auxpass(reported-14, been-13)
dep(Lithium-1, reported-14)
prep_in(reported-14, patients-16)
partmod(patients-16, receiving-17)
nn(inhibitors-19, ACE-18)
dobj(receiving-17, inhibitors-19)
prep_during(receiving-17, therapy-21)
prep_with(therapy-21, lithium-23)

These/DT drugs/NNS should/MD be/VB coadministered/VBN with/IN caution/NN ,/, and/CC frequent/JJ monitoring/NN of/IN serum/NN lithium/NN levels/NNS is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (S (NP (DT These) (NNS drugs)) (VP (MD should) (VP (VB be) (VP (VBN coadministered) (PP (IN with) (NP (NN caution))))))) (, ,) (CC and) (S (NP (NP (JJ frequent) (NN monitoring)) (PP (IN of) (NP (NN serum) (NN lithium) (NNS levels)))) (VP (VBZ is) (VP (VBN recommended))))) (. .))))

det(drugs-2, These-1)
nsubjpass(coadministered-5, drugs-2)
aux(coadministered-5, should-3)
auxpass(coadministered-5, be-4)
root(ROOT-0, coadministered-5)
prep_with(coadministered-5, caution-7)
amod(monitoring-11, frequent-10)
nsubjpass(recommended-17, monitoring-11)
nn(levels-15, serum-13)
nn(levels-15, lithium-14)
prep_of(monitoring-11, levels-15)
auxpass(recommended-17, is-16)
conj_and(coadministered-5, recommended-17)

If/IN a/DT diuretic/NN is/VBZ also/RB used/VBN ,/, the/DT risk/NN of/IN lithium/NN toxicity/NN may/MD be/VB increased/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT a) (NN diuretic)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN used))))) (, ,) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN lithium) (NN toxicity)))) (VP (MD may) (VP (VB be) (VP (VBN increased))))) (. .))))

mark(used-6, If-1)
det(diuretic-3, a-2)
nsubjpass(used-6, diuretic-3)
auxpass(used-6, is-4)
advmod(used-6, also-5)
advcl(increased-15, used-6)
det(risk-9, the-8)
nsubjpass(increased-15, risk-9)
nn(toxicity-12, lithium-11)
prep_of(risk-9, toxicity-12)
aux(increased-15, may-13)
auxpass(increased-15, be-14)
root(ROOT-0, increased-15)

Antacids/NNS :/: In/IN a/DT clinical/JJ pharmacology/NN study/NN ,/, coadministration/NN of/IN an/DT antacid/JJ (/-LRB- aluminum/NN hydroxide/NN ,/, magnesium/NN hydroxide/NN ,/, and/CC simethicone/NN )/-RRB- with/IN fosinopril/NN reduced/VBD serum/NN levels/NNS and/CC urinary/JJ excretion/NN of/IN fosinoprilat/NN as/IN compared/VBN with/IN fosinopril/NN administered/VBN alone/RB ,/, suggesting/VBG that/IN antacids/NNS may/MD impair/VB absorption/NN of/IN fosinopril/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antacids)) (: :) (S (PP (IN In) (NP (DT a) (JJ clinical) (NN pharmacology) (NN study))) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (DT an) (JJ antacid)) (PRN (-LRB- -LRB-) (NP (NP (NN aluminum) (NN hydroxide)) (, ,) (NP (NN magnesium) (NN hydroxide)) (, ,) (CC and) (NP (NN simethicone))) (-RRB- -RRB-)))) (PP (IN with) (NP (NN fosinopril)))) (VP (VBD reduced) (NP (NP (NN serum) (NNS levels)) (CC and) (NP (NP (JJ urinary) (NN excretion)) (PP (IN of) (NP (NN fosinoprilat))))) (SBAR (IN as) (S (VP (VBN compared) (PP (IN with) (NP (NP (NN fosinopril)) (VP (VBN administered) (ADVP (RB alone)))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NNS antacids)) (VP (MD may) (VP (VB impair) (NP (NP (NN absorption)) (PP (IN of) (NP (NN fosinopril)))))))))))) (. .)))))

root(ROOT-0, Antacids-1)
det(study-7, a-4)
amod(study-7, clinical-5)
nn(study-7, pharmacology-6)
prep_in(reduced-25, study-7)
nsubj(reduced-25, coadministration-9)
det(antacid-12, an-11)
prep_of(coadministration-9, antacid-12)
nn(hydroxide-15, aluminum-14)
dep(antacid-12, hydroxide-15)
nn(hydroxide-18, magnesium-17)
conj_and(hydroxide-15, hydroxide-18)
conj_and(hydroxide-15, simethicone-21)
prep_with(coadministration-9, fosinopril-24)
dep(Antacids-1, reduced-25)
nn(levels-27, serum-26)
dobj(reduced-25, levels-27)
amod(excretion-30, urinary-29)
conj_and(levels-27, excretion-30)
prep_of(excretion-30, fosinoprilat-32)
mark(compared-34, as-33)
advcl(reduced-25, compared-34)
prep_with(compared-34, fosinopril-36)
partmod(fosinopril-36, administered-37)
advmod(administered-37, alone-38)
xcomp(reduced-25, suggesting-40)
complm(impair-44, that-41)
nsubj(impair-44, antacids-42)
aux(impair-44, may-43)
ccomp(suggesting-40, impair-44)
dobj(impair-44, absorption-45)
prep_of(absorption-45, fosinopril-47)

Other/JJ :/: Neither/CC fosinopril/NN sodium/NN nor/CC its/PRP$ metabolites/NNS have/VBP been/VBN found/VBN to/TO interact/VB with/IN food/NN ./.

(ROOT (S1 (S (S (NP (JJ Other) (: :) (CC Neither) (NP (NN fosinopril) (NN sodium)) (CC nor) (NP (PRP$ its) (NNS metabolites))) (VP (VBP have) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN food)))))))))) (. .))))

nsubjpass(found-11, Other-1)
xsubj(interact-13, Other-1)
preconj(Other-1, Neither-3)
nn(sodium-5, fosinopril-4)
conj_nor(Other-1, sodium-5)
poss(metabolites-8, its-7)
conj_nor(Other-1, metabolites-8)
aux(found-11, have-9)
auxpass(found-11, been-10)
root(ROOT-0, found-11)
aux(interact-13, to-12)
xcomp(found-11, interact-13)
prep_with(interact-13, food-15)

In/IN separate/JJ single/JJ or/CC multiple/JJ dose/NN pharmacokinetic/JJ interaction/NN studies/NNS with/IN chlorthalidone/NN ,/, nifedipine/NN ,/, propanolol/NN ,/, hydrochlorothiazide/NN ,/, cimetidine/NN ,/, metoclopramide/NN ,/, propantheline/NN ,/, digoxin/NN ,/, and/CC warfarin/NN ,/, the/DT bioavailability/NN of/IN fosinoprilat/NN was/VBD not/RB altered/VBN by/IN coadministration/NN of/IN fosinopril/NN with/IN any/DT one/CD of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ separate) (ADJP (ADJP (JJ single)) (CC or) (ADJP (JJ multiple))) (NN dose) (JJ pharmacokinetic) (NN interaction) (NNS studies)) (PP (IN with) (NP (NP (NN chlorthalidone)) (, ,) (NP (NN nifedipine)) (, ,) (NP (NN propanolol)) (, ,) (NP (NN hydrochlorothiazide)) (, ,) (NP (NN cimetidine)) (, ,) (NP (NN metoclopramide)) (, ,) (NP (NN propantheline)) (, ,) (NP (NN digoxin)) (, ,) (CC and) (NP (NN warfarin)))))) (, ,) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN fosinoprilat)))) (VP (VBD was) (RB not) (VP (VBN altered) (PP (IN by) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN fosinopril))) (PP (IN with) (NP (NP (DT any) (CD one)) (PP (IN of) (NP (DT these) (NNS drugs)))))))))) (. .))))

amod(studies-9, separate-2)
amod(studies-9, single-3)
conj_or(single-3, multiple-5)
nn(studies-9, dose-6)
amod(studies-9, pharmacokinetic-7)
nn(studies-9, interaction-8)
prep_in(altered-36, studies-9)
prep_with(studies-9, chlorthalidone-11)
conj_and(chlorthalidone-11, nifedipine-13)
conj_and(chlorthalidone-11, propanolol-15)
conj_and(chlorthalidone-11, hydrochlorothiazide-17)
conj_and(chlorthalidone-11, cimetidine-19)
conj_and(chlorthalidone-11, metoclopramide-21)
conj_and(chlorthalidone-11, propantheline-23)
conj_and(chlorthalidone-11, digoxin-25)
conj_and(chlorthalidone-11, warfarin-28)
det(bioavailability-31, the-30)
nsubjpass(altered-36, bioavailability-31)
prep_of(bioavailability-31, fosinoprilat-33)
auxpass(altered-36, was-34)
neg(altered-36, not-35)
root(ROOT-0, altered-36)
agent(altered-36, coadministration-38)
prep_of(coadministration-38, fosinopril-40)
det(one-43, any-42)
prep_with(coadministration-38, one-43)
det(drugs-46, these-45)
prep_of(one-43, drugs-46)

In/IN a/DT study/NN with/IN concomitant/JJ administration/NN of/IN aspirin/NN and/CC fosinopril/NN sodium/NN ,/, the/DT bioavailability/NN of/IN unbound/JJ fosinoprilat/NN was/VBD not/RB altered/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN with) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN aspirin)) (CC and) (NP (NN fosinopril)) (NP (NN sodium)))))))) (, ,) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (JJ unbound) (NN fosinoprilat)))) (VP (VBD was) (RB not) (VP (VBN altered)))) (. .))))

det(study-3, a-2)
prep_in(altered-20, study-3)
amod(administration-6, concomitant-5)
prep_with(study-3, administration-6)
prep_of(administration-6, aspirin-8)
conj_and(aspirin-8, fosinopril-10)
dep(aspirin-8, sodium-11)
det(bioavailability-14, the-13)
nsubjpass(altered-20, bioavailability-14)
amod(fosinoprilat-17, unbound-16)
prep_of(bioavailability-14, fosinoprilat-17)
auxpass(altered-20, was-18)
neg(altered-20, not-19)
root(ROOT-0, altered-20)

In/IN a/DT pharmacokinetic/JJ interaction/NN study/NN with/IN warfarin/NN ,/, bioavailability/NN parameters/NNS ,/, the/DT degree/NN of/IN protein/NN binding/NN ,/, and/CC the/DT anticoagulant/JJ effect/NN (/-LRB- measured/VBN by/IN prothrombin/NN time/NN )/-RRB- of/IN warfarin/NN were/VBD not/RB significantly/RB changed/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (JJ pharmacokinetic) (NN interaction) (NN study)) (PP (IN with) (NP (NN warfarin))))) (, ,) (NP (NP (NN bioavailability) (NNS parameters)) (, ,) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NN protein) (NN binding)))) (, ,) (CC and) (NP (NP (NP (DT the) (JJ anticoagulant) (NN effect)) (PRN (-LRB- -LRB-) (VP (VBN measured) (PP (IN by) (NP (NN prothrombin) (NN time)))) (-RRB- -RRB-))) (PP (IN of) (NP (NN warfarin))))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN changed)))) (. .))))

det(study-5, a-2)
amod(study-5, pharmacokinetic-3)
nn(study-5, interaction-4)
prep_in(changed-33, study-5)
prep_with(study-5, warfarin-7)
nn(parameters-10, bioavailability-9)
nsubjpass(changed-33, parameters-10)
det(degree-13, the-12)
conj_and(parameters-10, degree-13)
nn(binding-16, protein-15)
prep_of(degree-13, binding-16)
det(effect-21, the-19)
amod(effect-21, anticoagulant-20)
conj_and(parameters-10, effect-21)
dep(effect-21, measured-23)
nn(time-26, prothrombin-25)
prep_by(measured-23, time-26)
prep_of(effect-21, warfarin-29)
auxpass(changed-33, were-30)
neg(changed-33, not-31)
advmod(changed-33, significantly-32)
root(ROOT-0, changed-33)

Drug/NN /Laboratory/NN Test/NN Interaction/NN Fosinopril/NN may/MD cause/VB a/DT false/JJ low/JJ measurement/NN of/IN serum/NN digoxin/NN levels/NNS with/IN the/DT Digi-/NN Tab/NN @/NN RIA/NN Kit/NN for/IN Digoxin/NN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NN Interaction) (NN Fosinopril)) (VP (MD may) (VP (VB cause) (NP (NP (DT a) (JJ false) (JJ low) (NN measurement)) (PP (IN of) (NP (NN serum) (NN digoxin) (NNS levels)))) (PP (IN with) (NP (NP (DT the) (NN Digi-) (NN Tab) (NN @) (NN RIA) (NN Kit)) (PP (IN for) (NP (NN Digoxin)))))))) (. .))))

nn(Fosinopril-5, Drug-1)
nn(Fosinopril-5, /Laboratory-2)
nn(Fosinopril-5, Test-3)
nn(Fosinopril-5, Interaction-4)
nsubj(cause-7, Fosinopril-5)
aux(cause-7, may-6)
root(ROOT-0, cause-7)
det(measurement-11, a-8)
amod(measurement-11, false-9)
amod(measurement-11, low-10)
dobj(cause-7, measurement-11)
nn(levels-15, serum-13)
nn(levels-15, digoxin-14)
prep_of(measurement-11, levels-15)
det(Kit-22, the-17)
nn(Kit-22, Digi--18)
nn(Kit-22, Tab-19)
nn(Kit-22, @-20)
nn(Kit-22, RIA-21)
prep_with(cause-7, Kit-22)
prep_for(Kit-22, Digoxin-24)

No/DT drugs/NNS are/VBP known/VBN to/TO interfere/VB with/IN the/DT conversion/NN of/IN fosphenytoin/NN to/TO phenytoin/NN ./.

(ROOT (S1 (S (S (NP (DT No) (NNS drugs)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN conversion)) (PP (IN of) (NP (NN fosphenytoin))) (PP (TO to) (NP (NN phenytoin))))))))))) (. .))))

det(drugs-2, No-1)
nsubjpass(known-4, drugs-2)
xsubj(interfere-6, drugs-2)
auxpass(known-4, are-3)
root(ROOT-0, known-4)
aux(interfere-6, to-5)
xcomp(known-4, interfere-6)
det(conversion-9, the-8)
prep_with(interfere-6, conversion-9)
prep_of(conversion-9, fosphenytoin-11)
prep_to(conversion-9, phenytoin-13)

Conversion/NN could/MD be/VB affected/VBN by/IN alterations/NNS in/IN the/DT level/NN of/IN phosphatase/NN activity/NN ,/, but/CC given/IN the/DT abundance/NN and/CC wide/JJ distribution/NN of/IN phosphatases/NNS in/IN the/DT body/NN it/PRP is/VBZ unlikely/JJ that/IN drugs/NNS would/MD affect/VB this/DT activity/NN enough/RB to/TO affect/VB conversion/NN of/IN fosphenytoin/NN to/TO phenytoin/NN ./.

(ROOT (S1 (S (S (S (NP (NN Conversion)) (VP (MD could) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (NP (NNS alterations)) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN phosphatase) (NN activity))))))))))) (, ,) (CC but) (S (PP (IN given) (NP (NP (DT the) (NP (NN abundance)) (CC and) (NP (JJ wide) (NN distribution))) (PP (IN of) (NP (NNS phosphatases))) (PP (IN in) (NP (DT the) (NN body))))) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unlikely) (SBAR (IN that) (S (NP (NNS drugs)) (VP (MD would) (VP (VB affect) (NP (NP (DT this) (NN activity)) (SBAR (ADVP (RB enough)) (S (VP (TO to) (VP (VB affect) (NP (NP (NN conversion)) (PP (IN of) (NP (NN fosphenytoin))) (PP (TO to) (NP (NN phenytoin))))))))))))))))) (. .))))

nsubjpass(affected-4, Conversion-1)
aux(affected-4, could-2)
auxpass(affected-4, be-3)
root(ROOT-0, affected-4)
agent(affected-4, alterations-6)
det(level-9, the-8)
prep_in(alterations-6, level-9)
nn(activity-12, phosphatase-11)
prep_of(level-9, activity-12)
dep(abundance-17, the-16)
prep_given(unlikely-28, abundance-17)
amod(distribution-20, wide-19)
conj_and(abundance-17, distribution-20)
prep_of(abundance-17, phosphatases-22)
det(body-25, the-24)
prep_in(abundance-17, body-25)
nsubj(unlikely-28, it-26)
cop(unlikely-28, is-27)
conj_but(affected-4, unlikely-28)
complm(affect-32, that-29)
nsubj(affect-32, drugs-30)
aux(affect-32, would-31)
ccomp(unlikely-28, affect-32)
det(activity-34, this-33)
dobj(affect-32, activity-34)
advmod(affect-37, enough-35)
aux(affect-37, to-36)
infmod(activity-34, affect-37)
dobj(affect-37, conversion-38)
prep_of(conversion-38, fosphenytoin-40)
prep_to(conversion-38, phenytoin-42)

Drugs/NNS highly/RB bound/VBN to/TO albumin/NN could/MD increase/VB the/DT unbound/JJ fraction/NN of/IN fosphenytoin/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (VP (ADVP (RB highly)) (VBN bound) (PP (TO to) (NP (NN albumin))))) (VP (MD could) (VP (VB increase) (NP (NP (DT the) (JJ unbound) (NN fraction)) (PP (IN of) (NP (NN fosphenytoin))))))) (. .))))

nsubj(increase-7, Drugs-1)
advmod(bound-3, highly-2)
partmod(Drugs-1, bound-3)
prep_to(bound-3, albumin-5)
aux(increase-7, could-6)
root(ROOT-0, increase-7)
det(fraction-10, the-8)
amod(fraction-10, unbound-9)
dobj(increase-7, fraction-10)
prep_of(fraction-10, fosphenytoin-12)

Although/IN ,/, it/PRP is/VBZ unknown/JJ whether/IN this/DT could/MD result/VB in/IN clinically/RB significant/JJ effects/NNS ,/, caution/NN is/VBZ advised/VBN when/WRB administering/VBG Cerebyx/NN with/IN other/JJ drugs/NNS that/WDT significantly/RB bind/VBP to/TO serum/NN albumin/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (, ,) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unknown)) (SBAR (IN whether) (S (NP (DT this)) (VP (MD could) (VP (VB result) (PP (IN in) (NP (ADJP (RB clinically) (JJ significant)) (NNS effects)))))))))) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN advised) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NN Cerebyx)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (ADVP (RB significantly)) (VP (VBP bind) (PP (TO to) (NP (NN serum) (NN albumin)))))))))))))) (. .))))

mark(unknown-5, Although-1)
nsubj(unknown-5, it-3)
cop(unknown-5, is-4)
advcl(advised-17, unknown-5)
complm(result-9, whether-6)
nsubj(result-9, this-7)
aux(result-9, could-8)
ccomp(unknown-5, result-9)
advmod(significant-12, clinically-11)
amod(effects-13, significant-12)
prep_in(result-9, effects-13)
nsubjpass(advised-17, caution-15)
auxpass(advised-17, is-16)
root(ROOT-0, advised-17)
advmod(administering-19, when-18)
advcl(advised-17, administering-19)
dobj(administering-19, Cerebyx-20)
amod(drugs-23, other-22)
prep_with(administering-19, drugs-23)
nsubj(bind-26, drugs-23)
advmod(bind-26, significantly-25)
rcmod(drugs-23, bind-26)
nn(albumin-29, serum-28)
prep_to(bind-26, albumin-29)

The/DT pharmacokinetics/NNS and/CC protein/NN binding/NN of/IN fosphenytoin/NN ,/, phenytoin/NN ,/, and/CC diazepam/NN were/VBD not/RB altered/VBN when/WRB diazepam/NN and/CC Cerebyx/NN were/VBD concurrently/RB administered/VBN in/IN single/JJ submaximal/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NP (NNS pharmacokinetics)) (CC and) (NP (NN protein) (NN binding))) (PP (IN of) (NP (NP (NN fosphenytoin)) (, ,) (NP (NN phenytoin)) (, ,) (CC and) (NP (NN diazepam))))) (VP (VBD were) (RB not) (VP (VBN altered)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN diazepam)) (CC and) (NP (NN Cerebyx))) (VP (VBD were) (ADVP (RB concurrently)) (VP (VBN administered) (PP (IN in) (NP (JJ single) (JJ submaximal) (NNS doses))))))))) (. .))))

dep(pharmacokinetics-2, The-1)
nsubjpass(altered-15, pharmacokinetics-2)
nn(binding-5, protein-4)
conj_and(pharmacokinetics-2, binding-5)
prep_of(pharmacokinetics-2, fosphenytoin-7)
conj_and(fosphenytoin-7, phenytoin-9)
conj_and(fosphenytoin-7, diazepam-12)
auxpass(altered-15, were-13)
neg(altered-15, not-14)
root(ROOT-0, altered-15)
advmod(administered-22, when-16)
nsubjpass(administered-22, diazepam-17)
conj_and(diazepam-17, Cerebyx-19)
auxpass(administered-22, were-20)
advmod(administered-22, concurrently-21)
advcl(altered-15, administered-22)
amod(doses-26, single-24)
amod(doses-26, submaximal-25)
prep_in(administered-22, doses-26)

The/DT most/RBS significant/JJ drug/NN interactions/NNS following/VBG administration/NN of/IN Cerebyx/NN are/VBP expected/VBN to/TO occur/VB with/IN drugs/NNS that/WDT interact/VBP with/IN phenytoin/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (ADJP (RBS most) (JJ significant)) (NN drug) (NNS interactions)) (VP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (NN Cerebyx)))))) (VP (VBP are) (VP (VBN expected) (S (VP (TO to) (VP (VB occur) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP interact) (PP (IN with) (NP (NN phenytoin)))))))))))))) (. .))))

det(interactions-5, The-1)
advmod(significant-3, most-2)
amod(interactions-5, significant-3)
nn(interactions-5, drug-4)
nsubjpass(expected-11, interactions-5)
xsubj(occur-13, interactions-5)
partmod(interactions-5, following-6)
dobj(following-6, administration-7)
prep_of(administration-7, Cerebyx-9)
auxpass(expected-11, are-10)
root(ROOT-0, expected-11)
aux(occur-13, to-12)
xcomp(expected-11, occur-13)
prep_with(occur-13, drugs-15)
nsubj(interact-17, drugs-15)
rcmod(drugs-15, interact-17)
prep_with(interact-17, phenytoin-19)

Phenytoin/NN is/VBZ extensively/RB bound/VBN to/TO serum/NN plasma/NN proteins/NNS and/CC is/VBZ prone/JJ to/TO competitive/JJ displacement/NN ./.

(ROOT (S1 (S (S (NP (NN Phenytoin)) (VP (VP (VBZ is) (ADVP (RB extensively)) (VP (VBN bound) (PP (TO to) (NP (NN serum) (NN plasma) (NNS proteins))))) (CC and) (VP (VBZ is) (ADJP (JJ prone) (PP (TO to) (NP (JJ competitive) (NN displacement))))))) (. .))))

nsubjpass(bound-4, Phenytoin-1)
auxpass(bound-4, is-2)
advmod(bound-4, extensively-3)
root(ROOT-0, bound-4)
nn(proteins-8, serum-6)
nn(proteins-8, plasma-7)
prep_to(bound-4, proteins-8)
cop(prone-11, is-10)
conj_and(bound-4, prone-11)
amod(displacement-14, competitive-13)
prep_to(prone-11, displacement-14)

Phenytoin/NN is/VBZ metabolized/VBN by/IN hepatic/JJ cytochrome/NN P450/NN enzyme/NN s/NN and/CC is/VBZ particularly/RB susceptible/JJ to/TO inhibitory/JJ drug/NN interactions/NNS because/IN it/PRP is/VBZ subject/JJ to/TO saturable/JJ metabolism/NN ./.

(ROOT (S1 (S (S (NP (NN Phenytoin)) (VP (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NP (JJ hepatic) (NN cytochrome) (NN P450)) (NN enzyme) (NN s))))) (CC and) (VP (VBZ is) (ADJP (RB particularly) (JJ susceptible) (PP (TO to) (NP (JJ inhibitory) (NN drug) (NNS interactions)))) (SBAR (IN because) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ subject) (PP (TO to) (NP (JJ saturable) (NN metabolism)))))))))) (. .))))

nsubjpass(metabolized-3, Phenytoin-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
amod(P450-7, hepatic-5)
nn(P450-7, cytochrome-6)
nn(s-9, P450-7)
nn(s-9, enzyme-8)
agent(metabolized-3, s-9)
cop(susceptible-13, is-11)
advmod(susceptible-13, particularly-12)
conj_and(metabolized-3, susceptible-13)
amod(interactions-17, inhibitory-15)
nn(interactions-17, drug-16)
prep_to(susceptible-13, interactions-17)
mark(subject-21, because-18)
nsubj(subject-21, it-19)
cop(subject-21, is-20)
advcl(susceptible-13, subject-21)
amod(metabolism-24, saturable-23)
prep_to(subject-21, metabolism-24)

Inhibition/NN of/IN metabolism/NN may/MD produce/VB significant/JJ increases/NNS in/IN circulating/VBG phenytoin/NN concentrations/NNS and/CC enhance/VB the/DT risk/NN of/IN drug/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NN metabolism)))) (VP (MD may) (VP (VP (VB produce) (NP (NP (JJ significant) (NNS increases)) (PP (IN in) (NP (VBG circulating) (NN phenytoin) (NNS concentrations))))) (CC and) (VP (VB enhance) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN drug) (NN toxicity)))))))) (. .))))

nsubj(produce-5, Inhibition-1)
prep_of(Inhibition-1, metabolism-3)
aux(produce-5, may-4)
root(ROOT-0, produce-5)
amod(increases-7, significant-6)
dobj(produce-5, increases-7)
amod(concentrations-11, circulating-9)
nn(concentrations-11, phenytoin-10)
prep_in(increases-7, concentrations-11)
conj_and(produce-5, enhance-13)
det(risk-15, the-14)
dobj(enhance-13, risk-15)
nn(toxicity-18, drug-17)
prep_of(risk-15, toxicity-18)

Phenytoin/NN is/VBZ a/DT potent/JJ inducer/NN of/IN hepatic/JJ drug-metabolizing/JJ enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NN Phenytoin)) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN inducer)) (PP (IN of) (NP (JJ hepatic) (JJ drug-metabolizing) (NNS enzymes)))))) (. .))))

nsubj(inducer-5, Phenytoin-1)
cop(inducer-5, is-2)
det(inducer-5, a-3)
amod(inducer-5, potent-4)
root(ROOT-0, inducer-5)
amod(enzymes-9, hepatic-7)
amod(enzymes-9, drug-metabolizing-8)
prep_of(inducer-5, enzymes-9)

The/DT most/RBS commonly/RB occurring/VBG drug/NN interactions/NNS are/VBP listed/VBN below/IN :/: -/CC Drugs/NNS that/WDT may/MD increase/VB plasma/NN phenytoin/NN concentrations/NNS include/VBP :/: acute/JJ alcohol/NN intake/NN ,/, amiodarone/NN ,/, chboramphenicol/NN ,/, chlordiazepoxide/NN ,/, cimetidine/NN ,/, diazepam/NN ,/, dicumarol/NN ,/, disulfiram/NN ,/, estrogens/NNS ,/, ethosuximide/NN ,/, fluoxetine/NN ,/, H2-antagonists/NN ,/, halothane/NN ,/, isoniazid/NN ,/, methylphenidate/NN ,/, phenothiazines/NNS ,/, phenylbutazone/NN ,/, salicylates/NNS ,/, succinimides/NNS ,/, sulfonamides/NNS ,/, tolbutamide/NN ,/, trazodone/NN ./.

(ROOT (S1 (S (S (ADVP (DT The) (RBS most) (RB commonly)) (VP (VBG occurring) (S (NP (NN drug) (NNS interactions)) (VP (VBP are) (VP (VBN listed) (PP (IN below) (: :) (NP (NP (CC -) (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB increase) (S (NP (NN plasma) (NN phenytoin) (NNS concentrations)) (VP (VBP include) (: :) (NP (NP (NP (NP (JJ acute) (NN alcohol) (NN intake)) (, ,) (NP (NN amiodarone)) (, ,) (NP (NN chboramphenicol)) (, ,) (NP (NN chlordiazepoxide)) (, ,) (NP (NN cimetidine)) (, ,) (NP (NN diazepam)) (, ,) (NP (NN dicumarol)) (, ,) (NP (NN disulfiram)) (, ,) (NP (NNS estrogens)) (, ,) (NP (NN ethosuximide)) (, ,) (NP (NN fluoxetine)) (, ,)) (NN H2-antagonists)) (, ,) (NP (NN halothane)) (, ,) (NP (NN isoniazid)) (, ,) (NP (NN methylphenidate)) (, ,) (NP (NP (NNS phenothiazines)) (, ,) (NP (NN phenylbutazone)) (, ,) (NP (NNS salicylates)) (, ,) (NP (NNS succinimides)) (, ,) (NP (NNS sulfonamides))) (, ,) (NP (NN tolbutamide)) (, ,) (NP (NN trazodone)))))))))))))))) (. .))))

dep(commonly-3, The-1)
advmod(commonly-3, most-2)
advmod(occurring-4, commonly-3)
root(ROOT-0, occurring-4)
nn(interactions-6, drug-5)
nsubjpass(listed-8, interactions-6)
auxpass(listed-8, are-7)
ccomp(occurring-4, listed-8)
prep_below(listed-8, Drugs-12)
nsubj(increase-15, Drugs-12)
aux(increase-15, may-14)
rcmod(Drugs-12, increase-15)
nn(concentrations-18, plasma-16)
nn(concentrations-18, phenytoin-17)
nsubj(include-19, concentrations-18)
ccomp(increase-15, include-19)
amod(intake-23, acute-21)
nn(intake-23, alcohol-22)
nn(H2-antagonists-45, intake-23)
appos(intake-23, amiodarone-25)
appos(intake-23, chboramphenicol-27)
appos(intake-23, chlordiazepoxide-29)
appos(intake-23, cimetidine-31)
appos(intake-23, diazepam-33)
appos(intake-23, dicumarol-35)
appos(intake-23, disulfiram-37)
appos(intake-23, estrogens-39)
appos(intake-23, ethosuximide-41)
appos(intake-23, fluoxetine-43)
dobj(include-19, H2-antagonists-45)
appos(H2-antagonists-45, halothane-47)
appos(H2-antagonists-45, isoniazid-49)
appos(H2-antagonists-45, methylphenidate-51)
appos(H2-antagonists-45, phenothiazines-53)
appos(phenothiazines-53, phenylbutazone-55)
appos(phenothiazines-53, salicylates-57)
appos(phenothiazines-53, succinimides-59)
appos(phenothiazines-53, sulfonamides-61)
appos(H2-antagonists-45, tolbutamide-63)
appos(H2-antagonists-45, trazodone-65)

-/CC Drugs/NNS that/WDT may/MD decrease/VB plasma/NN phenytoin/NN concentrations/NNS include/VBP :/: carbamazepine/NN ,/, chronic/JJ alcohol/NN abuse/NN ,/, reserpine/NN ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB decrease) (NP (NN plasma) (NN phenytoin) (NNS concentrations))))))) (VP (VBP include) (: :) (NP (NP (NN carbamazepine)) (, ,) (NP (JJ chronic) (NN alcohol) (NN abuse)) (, ,) (NP (NN reserpine))))) (. .))))

nsubj(decrease-5, Drugs-2)
nsubj(include-9, Drugs-2)
aux(decrease-5, may-4)
rcmod(Drugs-2, decrease-5)
nn(concentrations-8, plasma-6)
nn(concentrations-8, phenytoin-7)
dobj(decrease-5, concentrations-8)
root(ROOT-0, include-9)
dobj(include-9, carbamazepine-11)
amod(abuse-15, chronic-13)
nn(abuse-15, alcohol-14)
appos(carbamazepine-11, abuse-15)
appos(carbamazepine-11, reserpine-17)

-/CC Drugs/NNS that/WDT may/MD either/RB increase/VB or/CC decrease/VB plasma/NN phenytoin/NN concentrations/NNS include/VBP :/: phenobarbital/NN ,/, vaiproic/JJ acid/NN ,/, and/CC sodium/NN valproate/NN ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (ADVP (RB either)) (VP (VP (VB increase)) (CC or) (VP (VB decrease) (NP (NN plasma) (NN phenytoin) (NNS concentrations)))))))) (VP (VBP include) (: :) (NP (NP (NN phenobarbital)) (, ,) (NP (JJ vaiproic) (NN acid)) (, ,) (CC and) (NP (NN sodium) (NN valproate))))) (. .))))

nsubj(increase-6, Drugs-2)
nsubj(include-12, Drugs-2)
aux(increase-6, may-4)
advmod(increase-6, either-5)
rcmod(Drugs-2, increase-6)
conj_or(increase-6, decrease-8)
nn(concentrations-11, plasma-9)
nn(concentrations-11, phenytoin-10)
dobj(decrease-8, concentrations-11)
root(ROOT-0, include-12)
dobj(include-12, phenobarbital-14)
amod(acid-17, vaiproic-16)
conj_and(phenobarbital-14, acid-17)
nn(valproate-21, sodium-20)
conj_and(phenobarbital-14, valproate-21)

Similarly/RB ,/, the/DT effects/NNS of/IN phenytoin/NN on/IN phenobarbital/NN ,/, valproic/JJ acid/NN and/CC sodium/NN plasma/NN valproate/NN concentrations/NNS are/VBP unpredictable/JJ ./.

(ROOT (S1 (S (S (ADVP (RB Similarly)) (, ,) (NP (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN phenytoin))) (PP (IN on) (NP (NN phenobarbital)))) (, ,) (NP (NP (JJ valproic) (NN acid)) (CC and) (NP (NN sodium) (NN plasma) (NN valproate) (NNS concentrations)))) (VP (VBP are) (ADJP (JJ unpredictable)))) (. .))))

advmod(unpredictable-18, Similarly-1)
det(effects-4, the-3)
nsubj(unpredictable-18, effects-4)
prep_of(effects-4, phenytoin-6)
prep_on(effects-4, phenobarbital-8)
amod(acid-11, valproic-10)
appos(effects-4, acid-11)
nn(concentrations-16, sodium-13)
nn(concentrations-16, plasma-14)
nn(concentrations-16, valproate-15)
conj_and(acid-11, concentrations-16)
cop(unpredictable-18, are-17)
root(ROOT-0, unpredictable-18)

-/CC Although/IN not/RB a/DT true/JJ drug/NN interaction/NN ,/, tricyclic/JJ antidepressants/NNS may/MD precipitate/VB seizures/NNS in/IN susceptible/JJ patients/NNS and/CC Cerebyx/NN dosage/NN may/MD need/VBP to/TO be/VB adjusted/VBN ./.

(ROOT (S1 (S (S (S (CC -) (SBAR (IN Although) (FRAG (RB not) (NP (DT a) (JJ true) (NN drug) (NN interaction)))) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (VP (MD may) (VP (VB precipitate) (NP (NP (NNS seizures)) (PP (IN in) (NP (JJ susceptible) (NNS patients))))))) (CC and) (S (NP (NN Cerebyx) (NN dosage)) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN adjusted))))))))) (. .))))

mark(not-3, Although-2)
advcl(precipitate-12, not-3)
det(interaction-7, a-4)
amod(interaction-7, true-5)
nn(interaction-7, drug-6)
dep(not-3, interaction-7)
amod(antidepressants-10, tricyclic-9)
nsubj(precipitate-12, antidepressants-10)
aux(precipitate-12, may-11)
root(ROOT-0, precipitate-12)
dobj(precipitate-12, seizures-13)
amod(patients-16, susceptible-15)
prep_in(seizures-13, patients-16)
nn(dosage-19, Cerebyx-18)
nsubj(need-21, dosage-19)
xsubj(adjusted-24, dosage-19)
aux(need-21, may-20)
conj_and(precipitate-12, need-21)
aux(adjusted-24, to-22)
auxpass(adjusted-24, be-23)
xcomp(need-21, adjusted-24)

-/CC Drugs/NNS whose/WP$ efficacy/NN is/VBZ impaired/VBN by/IN phenytoin/NN include/VBP :/: anticoagulants/NNS ,/, corticosteroids/NNS ,/, coumarin/NN ,/, digitoxin/NN ,/, doxycycline/NN ,/, estrogens/NNS ,/, furosemide/NN ,/, oral/JJ contraceptives/NNS ,/, rifampin/NN ,/, quinidine/NN ,/, theophylline/NN ,/, vitamin/NN D/NN ./.

(ROOT (S1 (S (CC -) (NP (NP (NNS Drugs)) (SBAR (WHNP (WP$ whose) (NN efficacy)) (S (VP (VBZ is) (VP (VBN impaired) (PP (IN by) (NP (NN phenytoin))))) (VP (VBP include) (: :) (NP (NP (NNS anticoagulants)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NP (NN coumarin)) (, ,) (NP (NN digitoxin)) (, ,) (NP (NN doxycycline)) (, ,) (NP (NNS estrogens)) (, ,) (NP (NN furosemide)) (, ,) (NP (JJ oral) (NNS contraceptives)) (, ,) (NP (NN rifampin)) (, ,) (NP (NN quinidine)) (, ,) (NP (NN theophylline)) (, ,) (NP (NN vitamin) (NN D)))))))) (. .))))

root(ROOT-0, Drugs-2)
poss(efficacy-4, Drugs-2)
nsubjpass(impaired-6, efficacy-4)
auxpass(impaired-6, is-5)
rcmod(Drugs-2, impaired-6)
agent(impaired-6, phenytoin-8)
dep(impaired-6, include-9)
dobj(include-9, anticoagulants-11)
appos(anticoagulants-11, corticosteroids-13)
appos(anticoagulants-11, coumarin-15)
appos(coumarin-15, digitoxin-17)
appos(coumarin-15, doxycycline-19)
appos(coumarin-15, estrogens-21)
appos(coumarin-15, furosemide-23)
amod(contraceptives-26, oral-25)
appos(coumarin-15, contraceptives-26)
appos(coumarin-15, rifampin-28)
appos(coumarin-15, quinidine-30)
appos(coumarin-15, theophylline-32)
nn(D-35, vitamin-34)
appos(coumarin-15, D-35)

Monitoring/NN of/IN plasma/NN phenytoin/NN concentrations/NNS may/MD be/VB helpful/JJ when/WRB possible/JJ drug/NN interactions/NNS are/VBP suspected/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Monitoring)) (PP (IN of) (NP (NN plasma) (NN phenytoin) (NNS concentrations)))) (VP (MD may) (VP (VB be) (ADJP (JJ helpful) (SBAR (WHADVP (WRB when)) (S (NP (JJ possible) (NN drug) (NNS interactions)) (VP (VBP are) (VP (VBN suspected))))))))) (. .))))

nsubj(helpful-8, Monitoring-1)
nn(concentrations-5, plasma-3)
nn(concentrations-5, phenytoin-4)
prep_of(Monitoring-1, concentrations-5)
aux(helpful-8, may-6)
cop(helpful-8, be-7)
root(ROOT-0, helpful-8)
advmod(suspected-14, when-9)
amod(interactions-12, possible-10)
nn(interactions-12, drug-11)
nsubjpass(suspected-14, interactions-12)
auxpass(suspected-14, are-13)
dep(helpful-8, suspected-14)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Phenytoin/NN may/MD decrease/VB serum/NN concentrations/NNS of/IN 14/CD ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions) (NP (NN Phenytoin))) (VP (MD may) (VP (VB decrease) (NP (NP (NN serum) (NNS concentrations)) (PP (IN of) (NP (CD 14))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nsubj(decrease-7, Interactions-4)
dep(Interactions-4, Phenytoin-5)
aux(decrease-7, may-6)
root(ROOT-0, decrease-7)
nn(concentrations-9, serum-8)
dobj(decrease-7, concentrations-9)
prep_of(concentrations-9, 14-11)

It/PRP may/MD also/RB produce/VB artifactually/RB low/JJ results/NNS in/IN dexamethasone/NN or/CC metyrapone/NN tests/NNS ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (MD may) (ADVP (RB also)) (VP (VB produce) (NP (ADJP (RB artifactually) (JJ low)) (NNS results)) (PP (IN in) (NP (NP (NN dexamethasone)) (CC or) (NP (NN metyrapone) (NNS tests))))))) (. .))))

nsubj(produce-4, It-1)
aux(produce-4, may-2)
advmod(produce-4, also-3)
root(ROOT-0, produce-4)
advmod(low-6, artifactually-5)
amod(results-7, low-6)
dobj(produce-4, results-7)
prep_in(produce-4, dexamethasone-9)
nn(tests-12, metyrapone-11)
conj_or(dexamethasone-9, tests-12)

Phenytoin/NN may/MD also/RB cause/VB increased/VBN serum/NN concentrations/NNS of/IN glucose/NN ,/, alkaline/NN phosphatase/NN ,/, and/CC gamma/NN glutamyl/NN transpeptidase/NN (/-LRB- GGT)./NN

(ROOT (S1 (S (NP (NN Phenytoin)) (VP (MD may) (ADVP (RB also)) (VP (VB cause) (NP (NP (VBN increased) (NN serum) (NNS concentrations)) (PP (IN of) (NP (NP (NN glucose)) (, ,) (NP (NN alkaline) (NN phosphatase)) (, ,) (CC and) (NP (NP (NN gamma) (NN glutamyl) (NN transpeptidase)) (PRN (-LRB- -LRB-) (NP (NN GGT-RRB-.))))))))))))

nsubj(cause-4, Phenytoin-1)
aux(cause-4, may-2)
advmod(cause-4, also-3)
root(ROOT-0, cause-4)
amod(concentrations-7, increased-5)
nn(concentrations-7, serum-6)
dobj(cause-4, concentrations-7)
prep_of(concentrations-7, glucose-9)
nn(phosphatase-12, alkaline-11)
conj_and(glucose-9, phosphatase-12)
nn(transpeptidase-17, gamma-15)
nn(transpeptidase-17, glutamyl-16)
conj_and(glucose-9, transpeptidase-17)
dep(transpeptidase-17, GGT-RRB-.-19)

Care/NN should/MD be/VB taken/VBN when/WRB using/VBG immunoanalytical/JJ methods/NNS to/TO measure/VB plasma/NN phenytoin/NN concentrations/NNS following/VBG Cerebyx/NN administration/NN ./.

(ROOT (S1 (S (S (NP (NN Care)) (VP (MD should) (VP (VB be) (VP (VBN taken) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (JJ immunoanalytical) (NNS methods)) (S (VP (TO to) (VP (VB measure) (NP (NN plasma) (NN phenytoin) (NNS concentrations)) (PP (VBG following) (NP (NN Cerebyx) (NN administration))))))))))))) (. .))))

nsubjpass(taken-4, Care-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
advmod(using-6, when-5)
advcl(taken-4, using-6)
amod(methods-8, immunoanalytical-7)
dobj(using-6, methods-8)
aux(measure-10, to-9)
xcomp(using-6, measure-10)
nn(concentrations-13, plasma-11)
nn(concentrations-13, phenytoin-12)
dobj(measure-10, concentrations-13)
nn(administration-16, Cerebyx-15)
prep_following(measure-10, administration-16)

No/DT drug/NN interactions/NNS have/VBP been/VBN observed/VBN with/IN the/DT Vitrasert/JJ Implant/NN ./.

(ROOT (S1 (S (S (NP (DT No) (NN drug) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (IN with) (NP (DT the) (JJ Vitrasert) (NN Implant))))))) (. .))))

det(interactions-3, No-1)
nn(interactions-3, drug-2)
nsubjpass(observed-6, interactions-3)
aux(observed-6, have-4)
auxpass(observed-6, been-5)
root(ROOT-0, observed-6)
det(Implant-10, the-8)
amod(Implant-10, Vitrasert-9)
prep_with(observed-6, Implant-10)

There/EX is/VBZ limited/VBN experience/VBP with/IN use/NN of/IN retinal/JJ tamponades/NNS in/IN conjunction/NN with/IN the/DT Vitrasert/NN Implant/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (VP (VBN limited) (PP (VBP experience) (PP (IN with) (NP (NP (NN use)) (PP (IN of) (NP (JJ retinal) (NNS tamponades))) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (DT the) (NN Vitrasert) (NN Implant))))))))))) (. .))))

expl(limited-3, There-1)
auxpass(limited-3, is-2)
root(ROOT-0, limited-3)
dep(limited-3, experience-4)
prep_with(limited-3, use-6)
amod(tamponades-9, retinal-8)
prep_of(use-6, tamponades-9)
prep_in(use-6, conjunction-11)
det(Implant-15, the-13)
nn(Implant-15, Vitrasert-14)
prep_with(conjunction-11, Implant-15)

Substances/NNS that/WDT are/VBP inducers/NNS of/IN CYP3A4/NN activity/NN increase/VBP the/DT metabolism/NN of/IN gefitinib/NN and/CC decrease/VBP its/PRP$ plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Substances)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS inducers)) (PP (IN of) (NP (NN CYP3A4) (NN activity)))))))) (VP (VP (VBP increase) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN gefitinib))))) (CC and) (VP (VBP decrease) (NP (PRP$ its) (NN plasma) (NNS concentrations))))) (. .))))

nsubj(inducers-4, Substances-1)
nsubj(increase-8, Substances-1)
cop(inducers-4, are-3)
rcmod(Substances-1, inducers-4)
nn(activity-7, CYP3A4-6)
prep_of(inducers-4, activity-7)
root(ROOT-0, increase-8)
det(metabolism-10, the-9)
dobj(increase-8, metabolism-10)
prep_of(metabolism-10, gefitinib-12)
conj_and(increase-8, decrease-14)
poss(concentrations-17, its-15)
nn(concentrations-17, plasma-16)
dobj(decrease-14, concentrations-17)

In/IN patients/NNS receiving/VBG a/DT potent/JJ CYP3A4/NN inducer/NN such/JJ as/IN rifampicin/NN or/CC phenytoin/NN ,/, a/DT dose/NN increase/NN to/TO 500/CD mg/NN daily/RB should/MD be/VB considered/VBN in/IN the/DT absence/NN of/IN severe/JJ adverse/JJ drug/NN reaction/NN ,/, and/CC clinical/JJ response/NN and/CC adverse/JJ events/NNS should/MD be/VB carefully/RB monitored/VBN (/-LRB- see/VB CLINICAL/JJ PHARMACOLOGY-Pharmacokinetics-Drug-Drug/JJ Interactions/NNS and/CC DOSAGE/NN AND/CC ADMINISTRATION-Dosage/JJ Adjustment/JJ sections/NNS )./NN

(ROOT (S1 (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (DT a) (JJ potent) (NN CYP3A4) (NN inducer)) (CONJP (JJ such) (IN as)) (NP (NP (NN rifampicin)) (CC or) (NP (NN phenytoin))))))) (, ,) (S (S (NP (NP (DT a) (NN dose) (NN increase)) (PP (TO to) (NP (NP (CD 500) (NN mg)) (ADVP (RB daily))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ severe) (JJ adverse) (NN drug) (NN reaction))))))))) (, ,) (CC and) (S (NP (NP (JJ clinical) (NN response)) (CC and) (NP (JJ adverse) (NNS events))) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored)) (-LRB- -LRB-) (S (VP (VB see) (NP (NP (JJ CLINICAL) (JJ PHARMACOLOGY-Pharmacokinetics-Drug-Drug) (NNS Interactions)) (CC and) (NP (NP (NN DOSAGE)) (CC AND) (NP (JJ ADMINISTRATION-Dosage) (JJ Adjustment) (NNS sections)) (NP (NN -RRB-.)))))))))))))

prep_in(considered-23, patients-2)
partmod(patients-2, receiving-3)
det(inducer-7, a-4)
amod(inducer-7, potent-5)
nn(inducer-7, CYP3A4-6)
dobj(receiving-3, inducer-7)
conj_such(inducer-7, rifampicin-10)
conj_or(rifampicin-10, phenytoin-12)
det(increase-16, a-14)
nn(increase-16, dose-15)
nsubjpass(considered-23, increase-16)
num(mg-19, 500-18)
prep_to(increase-16, mg-19)
advmod(mg-19, daily-20)
aux(considered-23, should-21)
auxpass(considered-23, be-22)
root(ROOT-0, considered-23)
det(absence-26, the-25)
prep_in(considered-23, absence-26)
amod(reaction-31, severe-28)
amod(reaction-31, adverse-29)
nn(reaction-31, drug-30)
prep_of(absence-26, reaction-31)
amod(response-35, clinical-34)
nsubjpass(monitored-42, response-35)
amod(events-38, adverse-37)
conj_and(response-35, events-38)
aux(monitored-42, should-39)
auxpass(monitored-42, be-40)
advmod(monitored-42, carefully-41)
conj_and(considered-23, monitored-42)
ccomp(monitored-42, see-44)
amod(Interactions-47, CLINICAL-45)
amod(Interactions-47, PHARMACOLOGY-Pharmacokinetics-Drug-Drug-46)
dobj(see-44, Interactions-47)
conj_and(Interactions-47, DOSAGE-49)
amod(sections-53, ADMINISTRATION-Dosage-51)
amod(sections-53, Adjustment-52)
conj_and(DOSAGE-49, sections-53)
dep(DOSAGE-49, -RRB-.-54)

International/NNP Normalized/VBN Ratio/NN (/-LRB- INR/NN )/-RRB- elevations/NNS and/or/CC bleeding/JJ events/NNS have/VBP been/VBN reported/VBN in/IN some/DT patients/NNS taking/VBG warfarin/NN while/IN on/IN IRESSA/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNP International)) (VBN Normalized) (NN Ratio) (-LRB- -LRB-) (NN INR) (-RRB- -RRB-) (NNS elevations)) (CC and/or) (NP (JJ bleeding) (NNS events))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (DT some) (NNS patients)) (VP (VBG taking) (NP (NN warfarin)) (PP (IN while) (PP (IN on) (NP (NN IRESSA) (NN therapy))))))))))) (. .))))

nn(elevations-7, International-1)
amod(elevations-7, Normalized-2)
nn(elevations-7, Ratio-3)
nn(elevations-7, INR-5)
nsubjpass(reported-13, elevations-7)
amod(events-10, bleeding-9)
conj_and/or(elevations-7, events-10)
aux(reported-13, have-11)
auxpass(reported-13, been-12)
root(ROOT-0, reported-13)
det(patients-16, some-15)
prep_in(reported-13, patients-16)
partmod(patients-16, taking-17)
dobj(taking-17, warfarin-18)
prep(taking-17, while-19)
pcomp(while-19, on-20)
nn(therapy-22, IRESSA-21)
prep_on(while-19, therapy-22)

Patients/NNS taking/VBG warfarin/NN should/MD be/VB monitored/VBN regularly/RB for/IN changes/NNS in/IN prothrombin/NN time/NN or/CC INR/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NN warfarin)))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB regularly)) (PP (IN for) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN prothrombin) (NN time)) (CC or) (NP (NN INR)))))))))) (. .))))

nsubjpass(monitored-6, Patients-1)
partmod(Patients-1, taking-2)
dobj(taking-2, warfarin-3)
aux(monitored-6, should-4)
auxpass(monitored-6, be-5)
root(ROOT-0, monitored-6)
advmod(monitored-6, regularly-7)
prep_for(monitored-6, changes-9)
nn(time-12, prothrombin-11)
prep_in(changes-9, time-12)
conj_or(time-12, INR-14)

Substances/NNS that/WDT are/VBP potent/JJ inhibitors/NNS of/IN CYP3A4/NN activity/NN (/-LRB- eg/NN ,/, ketoconazole/NN and/CC itraconazole/NN )/-RRB- decrease/VBP gefitinib/NN metabolism/NN and/CC increase/VBP gefitinib/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Substances)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (JJ potent) (NNS inhibitors)) (PP (IN of) (NP (NN CYP3A4) (NN activity)))))))) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN ketoconazole)) (CC and) (NP (NN itraconazole))) (-RRB- -RRB-))) (VP (VP (VBP decrease) (NP (NN gefitinib) (NN metabolism))) (CC and) (VP (VBP increase) (NP (NN gefitinib) (NN plasma) (NNS concentrations))))) (. .))))

nsubj(inhibitors-5, Substances-1)
nsubj(decrease-16, Substances-1)
cop(inhibitors-5, are-3)
amod(inhibitors-5, potent-4)
rcmod(Substances-1, inhibitors-5)
nn(activity-8, CYP3A4-7)
prep_of(inhibitors-5, activity-8)
dep(Substances-1, eg-10)
conj_and(eg-10, ketoconazole-12)
conj_and(eg-10, itraconazole-14)
root(ROOT-0, decrease-16)
nn(metabolism-18, gefitinib-17)
dobj(decrease-16, metabolism-18)
conj_and(decrease-16, increase-20)
nn(concentrations-23, gefitinib-21)
nn(concentrations-23, plasma-22)
dobj(increase-20, concentrations-23)

therefore/RB ,/, caution/NN should/MD be/VB used/VBN when/WRB administering/VBG CYP3A4/JJ inhibitors/NNS with/IN IRESSA/NN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used))) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (JJ CYP3A4) (NNS inhibitors)) (PP (IN with) (NP (NN IRESSA)))))))) (. .))))

advmod(used-6, therefore-1)
nsubjpass(used-6, caution-3)
aux(used-6, should-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
advmod(administering-8, when-7)
advcl(used-6, administering-8)
amod(inhibitors-10, CYP3A4-9)
dobj(administering-8, inhibitors-10)
prep_with(administering-8, IRESSA-12)

Drugs/NNS that/WDT cause/VBP significant/JJ sustained/JJ elevation/NN in/IN gastric/JJ pH/NN (/-LRB- histamine/NN H2-receptor/NN antagonists/NNS such/JJ as/IN ranitidine/NN or/CC cimetidine/NN )/-RRB- may/MD reduce/VB plasma/NN concentrations/NNS of/IN IRESSA/NN and/CC therefore/RB potentially/RB may/MD reduce/VB efficacy/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP cause) (NP (NP (JJ significant) (JJ sustained) (NN elevation)) (PP (IN in) (NP (NP (JJ gastric) (NN pH)) (PRN (-LRB- -LRB-) (NP (NP (NN histamine) (NN H2-receptor) (NNS antagonists)) (PP (JJ such) (IN as) (NP (NP (NN ranitidine)) (CC or) (NP (NN cimetidine))))) (-RRB- -RRB-))))))))) (VP (VP (MD may) (VP (VB reduce) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN IRESSA)))))) (CC and) (ADVP (RB therefore)) (ADVP (RB potentially)) (VP (MD may) (VP (VB reduce) (NP (NN efficacy)))))) (. .))))

nsubj(cause-3, Drugs-1)
nsubj(reduce-21, Drugs-1)
rcmod(Drugs-1, cause-3)
amod(elevation-6, significant-4)
amod(elevation-6, sustained-5)
dobj(cause-3, elevation-6)
amod(pH-9, gastric-8)
prep_in(elevation-6, pH-9)
nn(antagonists-13, histamine-11)
nn(antagonists-13, H2-receptor-12)
dep(pH-9, antagonists-13)
prep_such_as(antagonists-13, ranitidine-16)
conj_or(ranitidine-16, cimetidine-18)
aux(reduce-21, may-20)
root(ROOT-0, reduce-21)
nn(concentrations-23, plasma-22)
dobj(reduce-21, concentrations-23)
prep_of(concentrations-23, IRESSA-25)
advmod(reduce-21, therefore-27)
conj_and(reduce-21, therefore-27)
advmod(reduce-21, potentially-28)
conj_and(reduce-21, potentially-28)
aux(reduce-30, may-29)
dep(reduce-21, reduce-30)
dobj(reduce-30, efficacy-31)

Phase/NN II/CD clinical/JJ trial/NN data/NNS ,/, where/WRB IRESSA/NN and/CC vinorelbine/NN have/VBP been/VBN used/VBN concomitantly/RB ,/, indicate/VBP that/IN IRESSA/NN may/MD exacerbate/VB the/DT neutropenic/JJ effect/NN of/IN vinorelbine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Phase) (CD II) (JJ clinical) (NN trial) (NNS data)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NP (NN IRESSA)) (CC and) (NP (NN vinorelbine))) (VP (VBP have) (VP (VBN been) (VP (VBN used) (ADVP (RB concomitantly))))))) (, ,)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN IRESSA)) (VP (MD may) (VP (VB exacerbate) (NP (NP (DT the) (JJ neutropenic) (NN effect)) (PP (IN of) (NP (NN vinorelbine)))))))))) (. .))))

nn(data-5, Phase-1)
num(data-5, II-2)
amod(data-5, clinical-3)
nn(data-5, trial-4)
nsubj(indicate-16, data-5)
advmod(used-13, where-7)
nsubjpass(used-13, IRESSA-8)
conj_and(IRESSA-8, vinorelbine-10)
aux(used-13, have-11)
auxpass(used-13, been-12)
rcmod(data-5, used-13)
advmod(used-13, concomitantly-14)
root(ROOT-0, indicate-16)
complm(exacerbate-20, that-17)
nsubj(exacerbate-20, IRESSA-18)
aux(exacerbate-20, may-19)
ccomp(indicate-16, exacerbate-20)
det(effect-23, the-21)
amod(effect-23, neutropenic-22)
dobj(exacerbate-20, effect-23)
prep_of(effect-23, vinorelbine-25)

For/IN information/NN on/IN the/DT pharmacokinetics/NNS of/IN Gemzar/NN and/CC cisplatin/NN in/IN combination/NN ,/, see/VB Drug/NN Interactions/NNS under/IN CLINICAL/JJ PHARMACOLOGY/NN section/NN ./.

(ROOT (S1 (S (PP (IN For) (NP (NP (NN information)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN Gemzar)) (CC and) (NP (NN cisplatin)))) (PP (IN in) (NP (NN combination))))))) (, ,) (VP (VB see) (NP (NN Drug) (NNS Interactions)) (PP (IN under) (NP (JJ CLINICAL) (NN PHARMACOLOGY) (NN section)))) (. .))))

prep_for(see-13, information-2)
det(pharmacokinetics-5, the-4)
prep_on(information-2, pharmacokinetics-5)
prep_of(pharmacokinetics-5, Gemzar-7)
conj_and(Gemzar-7, cisplatin-9)
prep_in(pharmacokinetics-5, combination-11)
root(ROOT-0, see-13)
nn(Interactions-15, Drug-14)
dobj(see-13, Interactions-15)
amod(section-19, CLINICAL-17)
nn(section-19, PHARMACOLOGY-18)
prep_under(see-13, section-19)

increased/VBN creatine/NN ./.

(ROOT (S1 (S (S (VP (VBN increased) (NP (NN creatine)))) (. .))))

root(ROOT-0, increased-1)
dobj(increased-1, creatine-2)

phosphokinase/NN ./.

(ROOT (S1 (S (NP (NP (NN phosphokinase)) (. .)))))

root(ROOT-0, phosphokinase-1)

antibody/NN ./.

(ROOT (S1 (S (NP (NP (NN antibody)) (. .)))))

root(ROOT-0, antibody-1)

increased/VBN bilirubin/NN ./.

(ROOT (S1 (S (S (VP (VBN increased) (NP (NN bilirubin)))) (. .))))

root(ROOT-0, increased-1)
dobj(increased-1, bilirubin-2)

increased/VBD liver/NN ./.

(ROOT (S1 (S (S (VP (VBD increased) (NP (NN liver)))) (. .))))

root(ROOT-0, increased-1)
dobj(increased-1, liver-2)

transaminases/NNS (/-LRB- AST/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS transaminases)) (PRN (-LRB- -LRB-) (NP (NN AST)))) (. .)))))

root(ROOT-0, transaminases-1)
dep(transaminases-1, AST-3)

Many/JJ other/JJ medicines/NNS may/MD increase/VB or/CC decrease/VB the/DT effects/NNS of/IN glimepiride/NN or/CC affect/VB your/NN condition/NN ./.

(ROOT (S1 (S (S (NP (JJ Many) (JJ other) (NNS medicines)) (VP (MD may) (VP (VP (VB increase)) (CC or) (VP (VB decrease) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN glimepiride))))) (CC or) (VP (VB affect) (NP (NN your) (NN condition)))))) (. .))))

amod(medicines-3, Many-1)
amod(medicines-3, other-2)
nsubj(increase-5, medicines-3)
aux(increase-5, may-4)
root(ROOT-0, increase-5)
conj_or(increase-5, decrease-7)
det(effects-9, the-8)
dobj(decrease-7, effects-9)
prep_of(effects-9, glimepiride-11)
conj_or(increase-5, affect-13)
nn(condition-15, your-14)
dobj(affect-13, condition-15)

Before/IN taking/VBG glimepiride/NN ,/, tell/NN your/NN doctor/NN if/IN you/NN are/VBP taking/VBG any/DT of/IN the/DT following/JJ medicines/NNS :/: -/CC aspirin/NN or/CC another/DT salicylate/NN such/JJ as/IN magnesium/NN //: choline/NN salicylate/NN (/-LRB- Trilisate/NN )/-RRB- ,/, salsalate/NN (/-LRB- Disalcid/NN ,/, others/NNS )/-RRB- ,/, choline/NN salicylate/NN (/-LRB- Arthropan/NNP )/-RRB- ,/, magnesium/NN salicylate/NN (/-LRB- Magan/NNP )/-RRB- ,/, or/CC bismuth/NN subsalicylate/NN (/-LRB- Pepto-Bismol/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (PP (IN Before) (NP (VBG taking) (NN glimepiride))) (, ,) (NP (NP (NN tell) (NN your) (NN doctor)) (PP (IN if) (NP (NN you)))) (VP (VBP are) (VP (VBG taking) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (JJ following) (NNS medicines)) (: :) (NP (CC -) (NP (NP (NN aspirin)) (CC or) (NP (NP (DT another) (NN salicylate)) (PP (JJ such) (IN as) (NP (NN magnesium)))) (: /) (NP (NP (NN choline) (NN salicylate)) (PRN (-LRB- -LRB-) (NP (NN Trilisate)) (-RRB- -RRB-))) (, ,) (NP (NP (NN salsalate)) (PRN (-LRB- -LRB-) (NP (NN Disalcid)) (, ,) (NP (NNS others)) (-RRB- -RRB-))) (, ,) (NP (NP (NN choline) (NN salicylate)) (PRN (-LRB- -LRB-) (NP (NNP Arthropan)) (-RRB- -RRB-))) (, ,) (NP (NP (NN magnesium) (NN salicylate)) (PRN (-LRB- -LRB-) (NP (NNP Magan)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN bismuth) (NN subsalicylate)) (PRN (-LRB- -LRB-) (NP (NN Pepto-Bismol)) (-RRB- -RRB-))))) (: ;)))))) (. .))))

amod(glimepiride-3, taking-2)
prep_before(taking-11, glimepiride-3)
nn(doctor-7, tell-5)
nn(doctor-7, your-6)
nsubj(taking-11, doctor-7)
prep_if(doctor-7, you-9)
aux(taking-11, are-10)
root(ROOT-0, taking-11)
dobj(taking-11, any-12)
det(medicines-16, the-14)
amod(medicines-16, following-15)
prep_of(any-12, medicines-16)
dep(medicines-16, aspirin-19)
det(salicylate-22, another-21)
conj_or(aspirin-19, salicylate-22)
prep_such_as(salicylate-22, magnesium-25)
punct(aspirin-19, /-26)
nn(salicylate-28, choline-27)
conj_or(aspirin-19, salicylate-28)
appos(salicylate-28, Trilisate-30)
conj_or(aspirin-19, salsalate-33)
appos(salsalate-33, Disalcid-35)
dep(Disalcid-35, others-37)
nn(salicylate-41, choline-40)
conj_or(aspirin-19, salicylate-41)
appos(salicylate-41, Arthropan-43)
nn(salicylate-47, magnesium-46)
conj_or(aspirin-19, salicylate-47)
appos(salicylate-47, Magan-49)
nn(subsalicylate-54, bismuth-53)
conj_or(aspirin-19, subsalicylate-54)
appos(subsalicylate-54, Pepto-Bismol-56)

-/CC a/DT nonsteroidal/JJ anti-inflammatory/JJ drug/NN (/-LRB- NSAID/NN )/-RRB- such/JJ as/IN ibuprofen/NN (/-LRB- Motrin/NNP ,/, Advil/NNP ,/, Nuprin/NNP ,/, others/NNS )/-RRB- ,/, ketoprofen/NN (/-LRB- Orudis/NNP ,/, Orudis/NNP KT/NNP ,/, Oruvail/NNP )/-RRB- ,/, diclofenac/NN (/-LRB- Voltaren/NNP ,/, Cataflam/NNP )/-RRB- ,/, etodolac/NN (/-LRB- Lodine/NN )/-RRB- ,/, indomethacin/NN (/-LRB- Indocin/NNP )/-RRB- ,/, nabumetone/NN (/-LRB- Relafen/NNP )/-RRB- ,/, oxaprozin/NN (/-LRB- Daypro/NNP )/-RRB- ,/, and/CC naproxen/NN (/-LRB- Anaprox/NN ,/, Naprosyn/NNP ,/, Aleve/NNP )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NP (NP (CC -) (NP (ADJP (NP (DT a) (JJ nonsteroidal) (JJ anti-inflammatory) (NN drug)) (-LRB- -LRB-) (NN NSAID) (-RRB- -RRB-) (JJ such) (PP (IN as) (NP (NN ibuprofen))))) (PRN (-LRB- -LRB-) (NP (NNP Motrin) (, ,) (NNP Advil) (, ,) (NNP Nuprin)) (, ,) (NP (NNS others)) (-RRB- -RRB-)) (, ,) (NP (NP (NP (NN ketoprofen)) (PRN (-LRB- -LRB-) (NP (NNP Orudis) (, ,) (NNP Orudis) (NNP KT) (, ,) (NNP Oruvail)) (-RRB- -RRB-))) (, ,) (NP (NP (NN diclofenac)) (PRN (-LRB- -LRB-) (NP (NNP Voltaren) (, ,) (NNP Cataflam)) (-RRB- -RRB-))) (, ,) (NP (NP (NN etodolac)) (PRN (-LRB- -LRB-) (NP (NN Lodine)) (-RRB- -RRB-))) (, ,) (NP (NP (NN indomethacin)) (PRN (-LRB- -LRB-) (NP (NNP Indocin)) (-RRB- -RRB-))) (, ,) (NP (NP (NN nabumetone)) (PRN (-LRB- -LRB-) (NP (NNP Relafen)) (-RRB- -RRB-))) (, ,) (NP (NP (NN oxaprozin)) (PRN (-LRB- -LRB-) (NP (NNP Daypro)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN naproxen)))) (PRN (-LRB- -LRB-) (NP (NN Anaprox)) (, ,) (NP (NNP Naprosyn) (, ,) (NNP Aleve)) (-RRB- -RRB-)) (: ;)) (. .)))))

det(drug-5, a-2)
amod(drug-5, nonsteroidal-3)
amod(drug-5, anti-inflammatory-4)
dep(such-9, drug-5)
dep(such-9, NSAID-7)
root(ROOT-0, such-9)
prep_as(such-9, ibuprofen-11)
nn(Nuprin-17, Motrin-13)
appos(Nuprin-17, Advil-15)
appos(such-9, Nuprin-17)
dep(Nuprin-17, others-19)
dep(such-9, ketoprofen-22)
nn(Oruvail-29, Orudis-24)
appos(Oruvail-29, Orudis-26)
nn(Oruvail-29, KT-27)
appos(ketoprofen-22, Oruvail-29)
conj_and(ketoprofen-22, diclofenac-32)
nn(Cataflam-36, Voltaren-34)
appos(diclofenac-32, Cataflam-36)
conj_and(ketoprofen-22, etodolac-39)
appos(etodolac-39, Lodine-41)
conj_and(ketoprofen-22, indomethacin-44)
appos(indomethacin-44, Indocin-46)
conj_and(ketoprofen-22, nabumetone-49)
appos(nabumetone-49, Relafen-51)
conj_and(ketoprofen-22, oxaprozin-54)
appos(oxaprozin-54, Daypro-56)
conj_and(ketoprofen-22, naproxen-60)
appos(such-9, Anaprox-62)
nn(Aleve-66, Naprosyn-64)
dep(Anaprox-62, Aleve-66)

-/CC a/DT sulfa-based/JJ drug/NN such/JJ as/IN sulfamethoxazole-trimethoprim/NN (/-LRB- Bactrim/NNP ,/, Septra/NNP )/-RRB- ,/, sulfisoxazole/NN (/-LRB- Gantrisin/NN )/-RRB- ,/, or/CC sulfasalazine/NN (/-LRB- Azulfidine/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NP (NP (CC -) (DT a) (JJ sulfa-based) (NN drug)) (PP (JJ such) (IN as) (NP (NP (NP (NN sulfamethoxazole-trimethoprim)) (PRN (-LRB- -LRB-) (NP (NNP Bactrim) (, ,) (NNP Septra)) (-RRB- -RRB-))) (, ,) (NP (NP (NN sulfisoxazole)) (PRN (-LRB- -LRB-) (NP (NN Gantrisin)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN sulfasalazine)) (PRN (-LRB- -LRB-) (NP (NN Azulfidine)) (-RRB- -RRB-))))) (: ;)) (. .)))))

det(drug-4, a-2)
amod(drug-4, sulfa-based-3)
root(ROOT-0, drug-4)
prep_such_as(drug-4, sulfamethoxazole-trimethoprim-7)
nn(Septra-11, Bactrim-9)
appos(sulfamethoxazole-trimethoprim-7, Septra-11)
conj_or(sulfamethoxazole-trimethoprim-7, sulfisoxazole-14)
appos(sulfisoxazole-14, Gantrisin-16)
conj_or(sulfamethoxazole-trimethoprim-7, sulfasalazine-20)
appos(sulfasalazine-20, Azulfidine-22)

-/CC a/DT monoamine/NN oxidase/NN inhibitor/NN (/-LRB- MAOI/NN )/-RRB- such/JJ as/IN isocarboxazid/NN (/-LRB- Marplan/NN )/-RRB- ,/, tranylcypromine/NN (/-LRB- Parnate/NN )/-RRB- ,/, or/CC phenelzine/NN (/-LRB- Nardil/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (CC -) (NP (NP (NP (DT a) (NN monoamine) (NN oxidase) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN MAOI)) (-RRB- -RRB-))) (PP (JJ such) (IN as) (NP (NP (NP (NN isocarboxazid)) (PRN (-LRB- -LRB-) (NP (NN Marplan)) (-RRB- -RRB-))) (, ,) (NP (NP (NN tranylcypromine)) (PRN (-LRB- -LRB-) (NP (NN Parnate)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN phenelzine)) (PRN (-LRB- -LRB-) (NP (NN Nardil)) (-RRB- -RRB-))))) (: ;)) (. .)))))

det(inhibitor-5, a-2)
nn(inhibitor-5, monoamine-3)
nn(inhibitor-5, oxidase-4)
root(ROOT-0, inhibitor-5)
abbrev(inhibitor-5, MAOI-7)
prep_such_as(inhibitor-5, isocarboxazid-11)
appos(isocarboxazid-11, Marplan-13)
conj_or(isocarboxazid-11, tranylcypromine-16)
appos(tranylcypromine-16, Parnate-18)
conj_or(isocarboxazid-11, phenelzine-22)
appos(phenelzine-22, Nardil-24)

-/CC a/DT beta-blocker/NN such/JJ as/IN propranolol/NN (/-LRB- Inderal/NN )/-RRB- ,/, atenolol/NN (/-LRB- Tenormin/NN )/-RRB- ,/, acebutolol/NN (/-LRB- Sectral/NN )/-RRB- ,/, metoprolol/NN (/-LRB- Lopressor/NN )/-RRB- ,/, and/CC others/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (CC -) (NP (NP (DT a) (NN beta-blocker)) (PP (JJ such) (IN as) (NP (NP (NP (NN propranolol)) (PRN (-LRB- -LRB-) (NP (NN Inderal)) (-RRB- -RRB-))) (, ,) (NP (NP (NN atenolol)) (PRN (-LRB- -LRB-) (NP (NN Tenormin)) (-RRB- -RRB-))) (, ,) (NP (NP (NN acebutolol)) (PRN (-LRB- -LRB-) (NP (NN Sectral)) (-RRB- -RRB-))) (, ,) (NP (NP (NN metoprolol)) (PRN (-LRB- -LRB-) (NP (NN Lopressor)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NNS others)))) (: ;))) (. .)))))

det(beta-blocker-3, a-2)
root(ROOT-0, beta-blocker-3)
prep_such_as(beta-blocker-3, propranolol-6)
appos(propranolol-6, Inderal-8)
conj_and(propranolol-6, atenolol-11)
appos(atenolol-11, Tenormin-13)
conj_and(propranolol-6, acebutolol-16)
appos(acebutolol-16, Sectral-18)
conj_and(propranolol-6, metoprolol-21)
appos(metoprolol-21, Lopressor-23)
conj_and(propranolol-6, others-27)

-/CC a/DT diuretic/JJ (/-LRB- water/NN pill/NN )/-RRB- such/JJ as/IN hydrochlorothiazide/NN (/-LRB- HCTZ/NN ,/, Hydrodiuril/NN )/-RRB- ,/, chlorothiazide/NN (/-LRB- Diuril/NN )/-RRB- ,/, and/CC others/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NP (CC -) (DT a) (JJ diuretic)) (PRN (-LRB- -LRB-) (NP (NN water) (NN pill)) (-RRB- -RRB-))) (PP (JJ such) (IN as) (NP (NP (NP (NN hydrochlorothiazide)) (PRN (-LRB- -LRB-) (NP (NP (NN HCTZ)) (, ,) (NP (NN Hydrodiuril))) (-RRB- -RRB-))) (, ,) (NP (NP (NN chlorothiazide)) (PRN (-LRB- -LRB-) (NP (NN Diuril)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NNS others)))) (: ;)) (. .)))))

det(diuretic-3, a-2)
root(ROOT-0, diuretic-3)
nn(pill-6, water-5)
appos(diuretic-3, pill-6)
prep_such_as(diuretic-3, hydrochlorothiazide-10)
dep(hydrochlorothiazide-10, HCTZ-12)
appos(HCTZ-12, Hydrodiuril-14)
conj_and(hydrochlorothiazide-10, chlorothiazide-17)
appos(chlorothiazide-17, Diuril-19)
conj_and(hydrochlorothiazide-10, others-23)

-/CC a/DT steroid/NN medicine/NN such/JJ as/IN prednisone/NN (/-LRB- Deltasone/NNP ,/, Orasone/NNP ,/, others/NNS )/-RRB- ,/, methylprednisolone/NN (/-LRB- Medrol/NN ,/, others/NNS )/-RRB- ,/, prednisolone/NN (/-LRB- Prelone/NNP ,/, Pediapred/NNP ,/, others/NNS )/-RRB- ,/, and/CC others/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NP (CC -) (DT a) (NN steroid) (NN medicine)) (PP (JJ such) (IN as) (NP (NP (NP (NN prednisone)) (PRN (-LRB- -LRB-) (NP (NNP Deltasone) (, ,) (NNP Orasone)) (, ,) (NP (NNS others)) (-RRB- -RRB-))) (, ,) (NP (NP (NN methylprednisolone)) (PRN (-LRB- -LRB-) (NP (NN Medrol)) (, ,) (NP (NNS others)) (-RRB- -RRB-))) (, ,) (NP (NP (NN prednisolone)) (PRN (-LRB- -LRB-) (NP (NNP Prelone) (, ,) (NNP Pediapred)) (, ,) (NP (NNS others)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NNS others)))) (: ;)) (. .)))))

det(medicine-4, a-2)
nn(medicine-4, steroid-3)
root(ROOT-0, medicine-4)
prep_such_as(medicine-4, prednisone-7)
nn(Orasone-11, Deltasone-9)
appos(prednisone-7, Orasone-11)
dep(Orasone-11, others-13)
conj_and(prednisone-7, methylprednisolone-16)
appos(methylprednisolone-16, Medrol-18)
dep(Medrol-18, others-20)
conj_and(prednisone-7, prednisolone-23)
nn(Pediapred-27, Prelone-25)
appos(prednisolone-23, Pediapred-27)
dep(Pediapred-27, others-29)
conj_and(prednisone-7, others-33)

-/CC a/DT phenothiazine/JJ such/JJ as/IN chlorpromazine/NN (/-LRB- Thorazine/NN )/-RRB- ,/, fluphenazine/NN (/-LRB- Prolixin/NNP ,/, Permitil/NNP )/-RRB- ,/, prochlorperazine/NN (/-LRB- Compazine/NN )/-RRB- ,/, promethazine/NN (/-LRB- Phenergan/NNP )/-RRB- ,/, and/CC others/NNS ;/: ./.

(ROOT (S1 (S (NP (CC -) (NP (NP (DT a) (JJ phenothiazine) (JJ such)) (PP (IN as) (NP (NP (NP (NN chlorpromazine)) (PRN (-LRB- -LRB-) (NP (NN Thorazine)) (-RRB- -RRB-))) (, ,) (NP (NP (NN fluphenazine)) (PRN (-LRB- -LRB-) (NP (NNP Prolixin) (, ,) (NNP Permitil)) (-RRB- -RRB-))) (, ,) (NP (NP (NN prochlorperazine)) (PRN (-LRB- -LRB-) (NP (NN Compazine)) (-RRB- -RRB-))) (, ,) (NP (NP (NN promethazine)) (PRN (-LRB- -LRB-) (NP (NNP Phenergan)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NNS others)))) (: ;)) (. .)))))

det(such-4, a-2)
amod(such-4, phenothiazine-3)
root(ROOT-0, such-4)
prep_as(such-4, chlorpromazine-6)
appos(chlorpromazine-6, Thorazine-8)
conj_and(chlorpromazine-6, fluphenazine-11)
nn(Permitil-15, Prolixin-13)
appos(fluphenazine-11, Permitil-15)
conj_and(chlorpromazine-6, prochlorperazine-18)
appos(prochlorperazine-18, Compazine-20)
conj_and(chlorpromazine-6, promethazine-23)
appos(promethazine-23, Phenergan-25)
conj_and(chlorpromazine-6, others-29)

-/CC phenytoin/NN (/-LRB- Dilantin/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (S (CC -) (NP (NP (NN phenytoin)) (PRN (-LRB- -LRB-) (NP (NN Dilantin)) (-RRB- -RRB-))) (: ;)) (. .))))

root(ROOT-0, phenytoin-2)
appos(phenytoin-2, Dilantin-4)

-/CC isoniazid/NN (/-LRB- Nydrazid/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (S (CC -) (NP (NP (NN isoniazid)) (PRN (-LRB- -LRB-) (NP (NN Nydrazid)) (-RRB- -RRB-))) (: ;)) (. .))))

root(ROOT-0, isoniazid-2)
appos(isoniazid-2, Nydrazid-4)

-/CC rifampin/NN (/-LRB- Rifadin/NNP ,/, Rifamate/NNP )/-RRB- ;/: ./.

(ROOT (S1 (S (S (CC -) (NP (NP (NN rifampin)) (PRN (-LRB- -LRB-) (NP (NNP Rifadin) (, ,) (NNP Rifamate)) (-RRB- -RRB-))) (: ;)) (. .))))

root(ROOT-0, rifampin-2)
nn(Rifamate-6, Rifadin-4)
appos(rifampin-2, Rifamate-6)

or/CC -/CC over-the-counter/JJ cough/NN ,/, cold/NN ,/, allergy/NN ,/, or/CC weight/NN loss/NN medications/NNS ./.

(ROOT (S1 (S (S (NP (NP (CC or)) (CC -) (NP (JJ over-the-counter) (NP (NP (NN cough)) (, ,) (NP (NN cold)) (, ,) (NP (NN allergy)) (, ,) (CC or) (NP (NN weight) (NN loss))) (NNS medications)))) (. .))))

root(ROOT-0, or-1)
amod(medications-13, over-the-counter-3)
nn(medications-13, cough-4)
conj_or(cough-4, cold-6)
conj_or(cough-4, allergy-8)
nn(loss-12, weight-11)
conj_or(cough-4, loss-12)
conj(or-1, medications-13)

You/NN may/MD require/VB a/DT dosage/JJ adjustment/NN or/CC special/JJ monitoring/NN if/IN you/RB are/VBP taking/VBG any/DT of/IN the/DT medicines/NNS listed/VBN above/RB ./.

(ROOT (S1 (S (S (NP (NN You)) (VP (MD may) (VP (VB require) (NP (NP (DT a) (JJ dosage) (NN adjustment)) (CC or) (NP (JJ special) (NN monitoring))) (SBAR (IN if) (S (ADVP (RB you)) (VP (VBP are) (VP (VBG taking) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (NNS medicines)) (VP (VBN listed) (ADVP (RB above))))))))))))) (. .))))

nsubj(require-3, You-1)
aux(require-3, may-2)
root(ROOT-0, require-3)
det(adjustment-6, a-4)
amod(adjustment-6, dosage-5)
dobj(require-3, adjustment-6)
amod(monitoring-9, special-8)
conj_or(adjustment-6, monitoring-9)
mark(taking-13, if-10)
advmod(taking-13, you-11)
aux(taking-13, are-12)
advcl(require-3, taking-13)
dobj(taking-13, any-14)
det(medicines-17, the-16)
prep_of(any-14, medicines-17)
partmod(medicines-17, listed-18)
advmod(listed-18, above-19)

Drugs/NNS other/JJ than/IN those/DT listed/VBN here/RB may/MD also/RB interact/VB with/IN glimepiride/NN or/CC affect/VB your/NN condition/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (ADJP (JJ other) (PP (IN than) (NP (NP (DT those)) (VP (VBN listed) (ADVP (RB here))))))) (VP (MD may) (ADVP (RB also)) (VP (VP (VB interact) (PP (IN with) (NP (NN glimepiride)))) (CC or) (VP (VB affect) (NP (NN your) (NN condition)))))) (. .))))

nsubj(interact-9, Drugs-1)
amod(Drugs-1, other-2)
prep_than(other-2, those-4)
partmod(those-4, listed-5)
advmod(listed-5, here-6)
aux(interact-9, may-7)
advmod(interact-9, also-8)
root(ROOT-0, interact-9)
prep_with(interact-9, glimepiride-11)
conj_or(interact-9, affect-13)
nn(condition-15, your-14)
dobj(affect-13, condition-15)

Talk/NN to/TO your/NN doctor/NN and/CC pharmacist/VBP before/IN taking/VBG any/DT prescription/NN or/CC over-the-counter/NN medicines/NNS ,/, including/VBG herbal/JJ products/NNS ./.

(ROOT (S1 (S (S (VP (VP (NP (NN Talk)) (PP (TO to) (NP (NN your) (NN doctor)))) (CC and) (VP (VBP pharmacist) (PP (IN before) (S (VP (VBG taking) (NP (NP (DT any) (NN prescription) (CC or) (NN over-the-counter) (NNS medicines)) (, ,) (PP (VBG including) (NP (JJ herbal) (NNS products)))))))))) (. .))))

root(ROOT-0, Talk-1)
nn(doctor-4, your-3)
prep_to(Talk-1, doctor-4)
conj_and(Talk-1, pharmacist-6)
prepc_before(pharmacist-6, taking-8)
det(medicines-13, any-9)
nn(medicines-13, prescription-10)
conj_or(prescription-10, over-the-counter-12)
dobj(taking-8, medicines-13)
amod(products-17, herbal-16)
prep_including(medicines-13, products-17)

The/DT use/NN of/IN codeine/NN may/MD result/VB in/IN additive/JJ CNS/NN depressant/NN effects/NNS when/WRB coadministered/VBN with/IN alcohol/NN ,/, antihistamines/NNS ,/, psychotropics/NNS or/CC other/JJ drugs/NNS that/WDT produce/VBP CNS/NN depression/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN codeine)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (JJ additive) (NN CNS) (NN depressant) (NNS effects)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NP (NP (NN alcohol)) (, ,) (NP (NNS antihistamines)) (, ,) (NP (NNS psychotropics)) (CC or) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP produce) (NP (NN CNS) (NN depression))))))))))))))) (. .))))

det(use-2, The-1)
nsubj(result-6, use-2)
prep_of(use-2, codeine-4)
aux(result-6, may-5)
root(ROOT-0, result-6)
amod(effects-11, additive-8)
nn(effects-11, CNS-9)
nn(effects-11, depressant-10)
prep_in(result-6, effects-11)
advmod(coadministered-13, when-12)
dep(effects-11, coadministered-13)
prep_with(coadministered-13, alcohol-15)
nsubj(produce-24, alcohol-15)
conj_or(alcohol-15, antihistamines-17)
conj_or(alcohol-15, psychotropics-19)
amod(drugs-22, other-21)
conj_or(alcohol-15, drugs-22)
rcmod(alcohol-15, produce-24)
nn(depression-26, CNS-25)
dobj(produce-24, depression-26)

Serious/JJ toxicity/NN may/MD result/VB if/IN dextromethorphan/NN is/VBZ coadministered/VBN with/IN monoamine/NN oxidase/NN inhibitors/NNS (/-LRB- MAOIs)./NN

(ROOT (S1 (S (NP (JJ Serious) (NN toxicity)) (VP (MD may) (VP (VB result) (SBAR (IN if) (S (NP (NN dextromethorphan)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (NP (NN monoamine) (NN oxidase) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN MAOIs-RRB-.))))))))))))))

amod(toxicity-2, Serious-1)
nsubj(result-4, toxicity-2)
aux(result-4, may-3)
root(ROOT-0, result-4)
mark(coadministered-8, if-5)
nsubjpass(coadministered-8, dextromethorphan-6)
auxpass(coadministered-8, is-7)
advcl(result-4, coadministered-8)
nn(inhibitors-12, monoamine-10)
nn(inhibitors-12, oxidase-11)
prep_with(coadministered-8, inhibitors-12)
dep(inhibitors-12, MAOIs-RRB-.-14)

The/DT use/NN of/IN dextromethorphan/NN hydrobromide/NN may/MD result/VB in/IN additive/JJ CNS/NN depressant/NN effects/NNS when/WRB coadministered/VBN with/IN alcohol/NN ,/, antihistamines/NNS ,/, psychotropics/NNS or/CC other/JJ drugs/NNS that/WDT produce/VBP CNS/NN depression/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN dextromethorphan) (NN hydrobromide)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (JJ additive) (NN CNS) (NN depressant) (NNS effects)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NP (NN alcohol)) (, ,) (NP (NNS antihistamines)) (, ,) (NP (NNS psychotropics)) (CC or) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP produce) (NP (NN CNS) (NN depression)))))))))))))))) (. .))))

det(use-2, The-1)
nsubj(result-7, use-2)
nn(hydrobromide-5, dextromethorphan-4)
prep_of(use-2, hydrobromide-5)
aux(result-7, may-6)
root(ROOT-0, result-7)
amod(effects-12, additive-9)
nn(effects-12, CNS-10)
nn(effects-12, depressant-11)
prep_in(result-7, effects-12)
advmod(coadministered-14, when-13)
dep(effects-12, coadministered-14)
prep_with(coadministered-14, alcohol-16)
conj_or(alcohol-16, antihistamines-18)
conj_or(alcohol-16, psychotropics-20)
amod(drugs-23, other-22)
conj_or(alcohol-16, drugs-23)
nsubj(produce-25, drugs-23)
rcmod(drugs-23, produce-25)
nn(depression-27, CNS-26)
dobj(produce-25, depression-27)

Calcium/NN Supplements//NN Antacids/NNS ./.

(ROOT (S1 (S (NP (NP (NN Calcium) (NN Supplements/) (NNS Antacids)) (. .)))))

nn(Antacids-3, Calcium-1)
nn(Antacids-3, Supplements/-2)
root(ROOT-0, Antacids-3)

Products/NNS containing/VBG calcium/NN and/CC other/JJ multivalent/JJ cations/NNS (/-LRB- such/JJ as/IN aluminum/NN ,/, magnesium/NN ,/, iron/NN )/-RRB- are/VBP likely/JJ to/TO interfere/VB with/IN absorption/NN of/IN Ibandronate/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Products)) (VP (VBG containing) (NP (NP (NN calcium)) (CC and) (NP (NP (JJ other) (JJ multivalent) (NNS cations)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN aluminum)) (, ,) (NP (NN magnesium)) (, ,) (NP (NN iron))))) (-RRB- -RRB-)))))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (NN absorption)) (PP (IN of) (NP (NN Ibandronate))))))))))) (. .))))

nsubj(likely-18, Products-1)
partmod(Products-1, containing-2)
dobj(containing-2, calcium-3)
amod(cations-7, other-5)
amod(cations-7, multivalent-6)
conj_and(calcium-3, cations-7)
prep_such_as(cations-7, aluminum-11)
appos(aluminum-11, magnesium-13)
appos(aluminum-11, iron-15)
cop(likely-18, are-17)
root(ROOT-0, likely-18)
aux(interfere-20, to-19)
xcomp(likely-18, interfere-20)
prep_with(interfere-20, absorption-22)
prep_of(absorption-22, Ibandronate-24)

Ibandronate/NN should/MD be/VB taken/VBN at/IN least/JJS 60/CD minutes/NNS before/IN any/DT oral/JJ medications/NNS containing/VBG multivalent/JJ cations/NNS (/-LRB- including/VBG antacids/NNS ,/, supplements/NNS or/CC vitamins/NNS )/-RRB- ./.

(ROOT (S1 (S (S (NP (NN Ibandronate)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (NP (QP (IN at) (JJS least) (CD 60)) (NNS minutes)) (IN before) (NP (NP (DT any) (JJ oral) (NNS medications)) (VP (VBG containing) (NP (NP (JJ multivalent) (NNS cations)) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NP (NNS antacids)) (, ,) (NP (NNS supplements)) (CC or) (NP (NNS vitamins)))) (-RRB- -RRB-)))))))))) (. .))))

nsubjpass(taken-4, Ibandronate-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
quantmod(60-7, at-5)
mwe(at-5, least-6)
pobj(at-5, least-6)
num(minutes-8, 60-7)
npadvmod(taken-4, minutes-8)
det(medications-12, any-10)
amod(medications-12, oral-11)
prep_before(taken-4, medications-12)
partmod(medications-12, containing-13)
amod(cations-15, multivalent-14)
dobj(containing-13, cations-15)
dep(cations-15, including-17)
pobj(including-17, antacids-18)
conj_or(antacids-18, supplements-20)
conj_or(antacids-18, vitamins-22)

H2/NN Blockers/NNS and/CC Proton/NN Pump/NN Inhibitors/NNS (/-LRB- PPIs/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NN H2) (NNS Blockers)) (CC and) (NP (NP (NN Proton) (NN Pump) (NNS Inhibitors)) (PRN (-LRB- -LRB-) (NP (NN PPIs)) (-RRB- -RRB-))))) (. .))))

nn(Blockers-2, H2-1)
root(ROOT-0, Blockers-2)
nn(Inhibitors-6, Proton-4)
nn(Inhibitors-6, Pump-5)
conj_and(Blockers-2, Inhibitors-6)
abbrev(Inhibitors-6, PPIs-8)

Of/IN over/IN 3500/CD patients/NNS enrolled/VBN in/IN the/DT Ibandronate/JJ osteoporosis/NN Treatment/NN and/CC Prevention/NN Studies/NNS ,/, 15/CD %/NN used/VBN anti-peptic/JJ agents/NNS (/-LRB- primarily/RB H2/NN blockers/NN and/CC PPIs/NN )./NN

(ROOT (S1 (S (PP (IN Of) (IN over) (NP (NP (CD 3500) (NNS patients)) (VP (VBN enrolled) (PP (IN in) (NP (NP (DT the) (JJ Ibandronate) (NN osteoporosis) (NN Treatment)) (CC and) (NP (NN Prevention)) (NP (NNS Studies))))))) (, ,) (NP (ADJP (NP (CD 15) (NN %)) (VBN used)) (JJ anti-peptic) (NNS agents)) (-LRB- -LRB-) (NP (ADVP (RB primarily)) (NP (NP (NN H2) (NN blockers)) (CC and) (NP (NN PPIs) (NN -RRB-.)))))))

dep(over-2, Of-1)
dep(blockers-23, over-2)
num(patients-4, 3500-3)
pobj(over-2, patients-4)
partmod(patients-4, enrolled-5)
det(Treatment-10, the-7)
amod(Treatment-10, Ibandronate-8)
nn(Treatment-10, osteoporosis-9)
prep_in(enrolled-5, Treatment-10)
conj_and(Treatment-10, Prevention-12)
dep(Treatment-10, Studies-13)
num(%-16, 15-15)
dep(used-17, %-16)
amod(agents-19, used-17)
amod(agents-19, anti-peptic-18)
dep(blockers-23, agents-19)
advmod(blockers-23, primarily-21)
nn(blockers-23, H2-22)
root(ROOT-0, blockers-23)
nn(-RRB-.-26, PPIs-25)
conj_and(blockers-23, -RRB-.-26)

Among/IN these/DT patients/NNS ,/, the/DT incidence/NN of/IN upper/JJ gastrointestinal/JJ adverse/JJ experiences/NNS in/IN the/DT patients/NNS treated/VBN with/IN Ibandronate/NN was/VBD similar/JJ to/TO that/DT in/IN placebo-treated/JJ patients/NNS ./.

(ROOT (S1 (S (S (PP (IN Among) (NP (DT these) (NNS patients))) (, ,) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ upper) (JJ gastrointestinal) (JJ adverse) (NNS experiences))) (PP (IN in) (NP (NP (DT the) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN Ibandronate))))))) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN in) (NP (JJ placebo-treated) (NNS patients)))))))) (. .))))

det(patients-3, these-2)
prep_among(similar-19, patients-3)
det(incidence-6, the-5)
nsubj(similar-19, incidence-6)
amod(experiences-11, upper-8)
amod(experiences-11, gastrointestinal-9)
amod(experiences-11, adverse-10)
prep_of(incidence-6, experiences-11)
det(patients-14, the-13)
prep_in(incidence-6, patients-14)
partmod(patients-14, treated-15)
prep_with(treated-15, Ibandronate-17)
cop(similar-19, was-18)
root(ROOT-0, similar-19)
prep_to(similar-19, that-21)
amod(patients-24, placebo-treated-23)
prep_in(that-21, patients-24)

Similarly/RB ,/, of/IN over/IN 1600/CD patients/NNS enrolled/VBN in/IN a/DT study/NN comparing/VBG once-monthly/JJ with/IN daily/JJ dosing/NN regimens/NNS of/IN ibandronate/NN ,/, 14/CD %/NN of/IN patients/NNS used/VBN anti-peptic/JJ agents/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Similarly)) (, ,) (NP (QP (IN of) (IN over) (CD 1600)) (NNS patients)) (VP (VBN enrolled) (PP (IN in) (NP (NP (DT a) (NN study)) (VP (VBG comparing) (NP (ADJP (JJ once-monthly) (PP (IN with) (NP (NP (JJ daily) (NN dosing) (NNS regimens)) (PP (IN of) (NP (NP (NN ibandronate)) (, ,) (NP (NP (CD 14) (NN %)) (PP (IN of) (NP (NNS patients))))))))) (VBN used) (JJ anti-peptic) (NNS agents))))))) (. .))))

advmod(enrolled-7, Similarly-1)
dep(over-4, of-3)
quantmod(1600-5, over-4)
num(patients-6, 1600-5)
nsubj(enrolled-7, patients-6)
root(ROOT-0, enrolled-7)
det(study-10, a-9)
prep_in(enrolled-7, study-10)
partmod(study-10, comparing-11)
amod(agents-26, once-monthly-12)
amod(regimens-16, daily-14)
nn(regimens-16, dosing-15)
prep_with(once-monthly-12, regimens-16)
prep_of(regimens-16, ibandronate-18)
num(%-21, 14-20)
appos(ibandronate-18, %-21)
prep_of(%-21, patients-23)
amod(agents-26, used-24)
amod(agents-26, anti-peptic-25)
dobj(comparing-11, agents-26)

Among/IN these/DT patients/NNS ,/, the/DT incidence/NN of/IN upper/JJ gastrointestinal/JJ adverse/JJ experiences/NNS in/IN the/DT patients/NNS treated/VBN with/IN Ibandronate/NN 150/CD mg/NN once/RB monthly/RB was/VBD similar/JJ to/TO that/DT in/IN patients/NNS treated/VBN with/IN Ibandronate/NN 2.5/CD mg/NN once/RB daily/RB ./.

(ROOT (S1 (S (S (PP (IN Among) (NP (DT these) (NNS patients))) (, ,) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ upper) (JJ gastrointestinal) (JJ adverse) (NNS experiences))) (PP (IN in) (NP (NP (DT the) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN Ibandronate) (CD 150) (NN mg))) (ADVP (RB once) (RB monthly)))))) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NN Ibandronate) (CD 2.5) (NN mg)) (ADVP (RB once) (RB daily)))))))))))) (. .))))

det(patients-3, these-2)
prep_among(similar-23, patients-3)
det(incidence-6, the-5)
nsubj(similar-23, incidence-6)
amod(experiences-11, upper-8)
amod(experiences-11, gastrointestinal-9)
amod(experiences-11, adverse-10)
prep_of(incidence-6, experiences-11)
det(patients-14, the-13)
prep_in(incidence-6, patients-14)
partmod(patients-14, treated-15)
nn(mg-19, Ibandronate-17)
num(mg-19, 150-18)
prep_with(treated-15, mg-19)
advmod(monthly-21, once-20)
advmod(treated-15, monthly-21)
cop(similar-23, was-22)
root(ROOT-0, similar-23)
prep_to(similar-23, that-25)
prep_in(that-25, patients-27)
partmod(patients-27, treated-28)
nn(mg-32, Ibandronate-30)
num(mg-32, 2.5-31)
prep_with(treated-28, mg-32)
advmod(daily-34, once-33)
advmod(mg-32, daily-34)

Aspirin/NN //: Nonsteroidal/JJ Antiinflammatory/JJ Drug/NN s/NNS (/-LRB- NSAIDs/NNS )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NN Aspirin)) (: /) (NP (NP (JJ Nonsteroidal) (JJ Antiinflammatory) (NN Drug) (NNS s)) (PRN (-LRB- -LRB-) (NP (NNS NSAIDs)) (-RRB- -RRB-))) (. .)))))

root(ROOT-0, Aspirin-1)
punct(Aspirin-1, /-2)
amod(s-6, Nonsteroidal-3)
amod(s-6, Antiinflammatory-4)
nn(s-6, Drug-5)
dep(Aspirin-1, s-6)
appos(s-6, NSAIDs-8)

In/IN the/DT large/JJ ,/, placebo-controlled/JJ osteoporosis/NN Treatment/NN Study/NN ,/, aspirin/NN and/CC nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS were/VBD taken/VBN by/IN 62/CD %/NN of/IN the/DT 2946/CD patients/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT the) (ADJP (ADJP (JJ large)) (, ,) (ADJP (JJ placebo-controlled))) (NN osteoporosis) (NN Treatment) (NN Study))) (, ,) (NP (NP (NN aspirin)) (CC and) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs))) (VP (VBD were) (VP (VBN taken) (PP (IN by) (NP (NP (CD 62) (NN %)) (PP (IN of) (NP (DT the) (CD 2946) (NNS patients)))))))) (. .))))

det(Study-8, the-2)
amod(Study-8, large-3)
dep(large-3, placebo-controlled-5)
nn(Study-8, osteoporosis-6)
nn(Study-8, Treatment-7)
prep_in(taken-16, Study-8)
nsubjpass(taken-16, aspirin-10)
amod(drugs-14, nonsteroidal-12)
amod(drugs-14, anti-inflammatory-13)
conj_and(aspirin-10, drugs-14)
auxpass(taken-16, were-15)
root(ROOT-0, taken-16)
num(%-19, 62-18)
agent(taken-16, %-19)
det(patients-23, the-21)
num(patients-23, 2946-22)
prep_of(%-19, patients-23)

Among/IN aspirin/NN or/CC NSAID/NN users/NNS ,/, the/DT incidence/NN of/IN upper/JJ gastrointestinal/JJ adverse/JJ events/NNS in/IN patients/NNS treated/VBN with/IN ibandronate/NN 2.5/CD mg/NN daily/RB (/-LRB- 28.9/CD %/NN )/-RRB- was/VBD similar/JJ to/TO that/DT in/IN placebo-treated/JJ patients/NNS (/-LRB- 30.7%)./NN

(ROOT (S1 (S (PP (IN Among) (NP (NN aspirin) (CC or) (NN NSAID) (NNS users))) (, ,) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (JJ upper) (JJ gastrointestinal) (JJ adverse) (NNS events)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NN ibandronate) (CD 2.5) (NN mg) (RB daily)) (PRN (-LRB- -LRB-) (NP (CD 28.9) (NN %)) (-RRB- -RRB-)))))))))) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN in) (NP (JJ placebo-treated) (NNS patients))))))) (PRN (-LRB- -LRB-) (NP (NN 30.7%-RRB-.))))))

nn(users-5, aspirin-2)
conj_or(aspirin-2, NSAID-4)
prep_among(similar-27, users-5)
det(incidence-8, the-7)
nsubj(similar-27, incidence-8)
amod(events-13, upper-10)
amod(events-13, gastrointestinal-11)
amod(events-13, adverse-12)
prep_of(incidence-8, events-13)
prep_in(events-13, patients-15)
partmod(patients-15, treated-16)
nn(mg-20, ibandronate-18)
num(mg-20, 2.5-19)
prep_with(treated-16, mg-20)
advmod(mg-20, daily-21)
num(%-24, 28.9-23)
appos(mg-20, %-24)
cop(similar-27, was-26)
root(ROOT-0, similar-27)
prep_to(similar-27, that-29)
amod(patients-32, placebo-treated-31)
prep_in(that-29, patients-32)
dep(similar-27, 30.7%-RRB-.-34)

Similarly/RB ,/, in/IN the/DT 1-year/JJ monthly/JJ comparison/NN study/NN ,/, aspirin/NN and/CC nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS were/VBD taken/VBN by/IN 39/CD %/NN of/IN the/DT 1602/CD patients/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Similarly)) (, ,) (PP (IN in) (NP (DT the) (JJ 1-year) (JJ monthly) (NN comparison) (NN study))) (, ,) (NP (NP (NN aspirin)) (CC and) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs))) (VP (VBD were) (VP (VBN taken) (PP (IN by) (NP (NP (CD 39) (NN %)) (PP (IN of) (NP (DT the) (CD 1602) (NNS patients)))))))) (. .))))

advmod(taken-16, Similarly-1)
det(study-8, the-4)
amod(study-8, 1-year-5)
amod(study-8, monthly-6)
nn(study-8, comparison-7)
prep_in(taken-16, study-8)
nsubjpass(taken-16, aspirin-10)
amod(drugs-14, nonsteroidal-12)
amod(drugs-14, anti-inflammatory-13)
conj_and(aspirin-10, drugs-14)
auxpass(taken-16, were-15)
root(ROOT-0, taken-16)
num(%-19, 39-18)
agent(taken-16, %-19)
det(patients-23, the-21)
num(patients-23, 1602-22)
prep_of(%-19, patients-23)

The/DT incidence/NN of/IN upper/JJ gastrointestinal/JJ events/NNS in/IN patients/NNS concomitantly/RB taking/VBG aspirin/NN or/CC NSAIDs/NN was/VBD similar/JJ in/IN patients/NNS taking/VBG ibandronate/NN 2.5/CD mg/NN daily/RB (/-LRB- 21.7/CD %/NN )/-RRB- and/CC 150/CD mg/NN once/RB monthly/RB (/-LRB- 22.0%)./CD

(ROOT (S1 (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (JJ upper) (JJ gastrointestinal) (NNS events)) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB concomitantly)) (VBG taking) (NP (NP (NN aspirin)) (CC or) (NP (NN NSAIDs))))))))) (VP (VBD was) (ADJP (JJ similar)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NP (NP (NN ibandronate) (CD 2.5) (NN mg)) (ADVP (RB daily))) (PRN (-LRB- -LRB-) (NP (CD 21.7) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 150) (NN mg)) (ADVP (RB once) (RB monthly))))))) (PRN (-LRB- -LRB-) (NP (CD 22.0%-RRB-.)))))))

det(incidence-2, The-1)
nsubj(similar-15, incidence-2)
amod(events-6, upper-4)
amod(events-6, gastrointestinal-5)
prep_of(incidence-2, events-6)
prep_in(events-6, patients-8)
advmod(taking-10, concomitantly-9)
partmod(patients-8, taking-10)
dobj(taking-10, aspirin-11)
conj_or(aspirin-11, NSAIDs-13)
cop(similar-15, was-14)
root(ROOT-0, similar-15)
prep_in(similar-15, patients-17)
partmod(patients-17, taking-18)
nn(mg-21, ibandronate-19)
num(mg-21, 2.5-20)
dobj(taking-18, mg-21)
advmod(mg-21, daily-22)
num(%-25, 21.7-24)
appos(mg-21, %-25)
num(mg-29, 150-28)
conj_and(mg-21, mg-29)
advmod(monthly-31, once-30)
advmod(mg-29, monthly-31)
dep(similar-15, 22.0%-RRB-.-33)

However/RB ,/, since/IN aspirin/NN ,/, NSAIDs/NN ,/, and/CC bisphosphonates/NNS are/VBP all/DT associated/VBN with/IN gastrointestinal/JJ irritation/NN ,/, caution/NN should/MD be/VB exercised/VBN in/IN the/DT concomitant/JJ use/NN of/IN aspirin/NN or/CC NSAIDs/NN with/IN Ibandronate/NN ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (SBAR (IN since) (S (NP (NP (NN aspirin)) (, ,) (NP (NN NSAIDs)) (, ,) (CC and) (NP (NNS bisphosphonates))) (VP (VBP are) (NP (NP (DT all)) (VP (VBN associated) (PP (IN with) (NP (JJ gastrointestinal) (NN irritation)))))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (PP (IN in) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN aspirin)) (CC or) (NP (NN NSAIDs)))) (PP (IN with) (NP (NN Ibandronate)))))))) (. .))))

advmod(exercised-20, However-1)
mark(all-11, since-3)
nsubj(all-11, aspirin-4)
conj_and(aspirin-4, NSAIDs-6)
conj_and(aspirin-4, bisphosphonates-9)
cop(all-11, are-10)
advcl(exercised-20, all-11)
partmod(all-11, associated-12)
amod(irritation-15, gastrointestinal-14)
prep_with(associated-12, irritation-15)
nsubjpass(exercised-20, caution-17)
aux(exercised-20, should-18)
auxpass(exercised-20, be-19)
root(ROOT-0, exercised-20)
det(use-24, the-22)
amod(use-24, concomitant-23)
prep_in(exercised-20, use-24)
prep_of(use-24, aspirin-26)
conj_or(aspirin-26, NSAIDs-28)
prep_with(use-24, Ibandronate-30)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)

Bisphosphonates/NNS are/VBP known/VBN to/TO interfere/VB with/IN the/DT use/NN of/IN bone-imaging/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NNS Bisphosphonates)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ bone-imaging) (NNS agents))))))))))) (. .))))

nsubjpass(known-3, Bisphosphonates-1)
xsubj(interfere-5, Bisphosphonates-1)
auxpass(known-3, are-2)
root(ROOT-0, known-3)
aux(interfere-5, to-4)
xcomp(known-3, interfere-5)
det(use-8, the-7)
prep_with(interfere-5, use-8)
amod(agents-11, bone-imaging-10)
prep_of(use-8, agents-11)

Specific/JJ studies/NNS with/IN ibandronate/NN have/VBP not/RB been/VBN performed/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Specific) (NNS studies)) (PP (IN with) (NP (NN ibandronate)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN performed))))) (. .))))

amod(studies-2, Specific-1)
nsubjpass(performed-8, studies-2)
prep_with(studies-2, ibandronate-4)
aux(performed-8, have-5)
neg(performed-8, not-6)
auxpass(performed-8, been-7)
root(ROOT-0, performed-8)

No/DT evaluation/NN of/IN EXTRANEAL/JJ s/NN effects/NNS on/IN the/DT cytochrome/NN P450/NN system/NN was/VBD conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NN evaluation)) (PP (IN of) (NP (NP (JJ EXTRANEAL) (NN s) (NNS effects)) (PP (IN on) (NP (DT the) (NN cytochrome) (NN P450) (NN system)))))) (VP (VBD was) (VP (VBN conducted)))) (. .))))

det(evaluation-2, No-1)
nsubjpass(conducted-13, evaluation-2)
amod(effects-6, EXTRANEAL-4)
nn(effects-6, s-5)
prep_of(evaluation-2, effects-6)
det(system-11, the-8)
nn(system-11, cytochrome-9)
nn(system-11, P450-10)
prep_on(effects-6, system-11)
auxpass(conducted-13, was-12)
root(ROOT-0, conducted-13)

As/IN with/IN other/JJ dialysis/NN solutions/NNS ,/, blood/NN concentrations/NNS of/IN dialyzable/JJ drugs/NNS may/MD be/VB reduced/VBN by/IN dialysis/NN ./.

(ROOT (S1 (S (S (PP (IN As) (PP (IN with) (NP (JJ other) (NN dialysis) (NNS solutions)))) (, ,) (NP (NP (NN blood) (NNS concentrations)) (PP (IN of) (NP (JJ dialyzable) (NNS drugs)))) (VP (MD may) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (NN dialysis))))))) (. .))))

prep(reduced-14, As-1)
pcomp(As-1, with-2)
amod(solutions-5, other-3)
nn(solutions-5, dialysis-4)
prep_with(As-1, solutions-5)
nn(concentrations-8, blood-7)
nsubjpass(reduced-14, concentrations-8)
amod(drugs-11, dialyzable-10)
prep_of(concentrations-8, drugs-11)
aux(reduced-14, may-12)
auxpass(reduced-14, be-13)
root(ROOT-0, reduced-14)
agent(reduced-14, dialysis-16)

Dosage/JJ adjustment/NN of/IN concomitant/JJ medications/NNS may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Dosage) (NN adjustment)) (PP (IN of) (NP (JJ concomitant) (NNS medications)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))))) (. .))))

amod(adjustment-2, Dosage-1)
nsubj(necessary-8, adjustment-2)
amod(medications-5, concomitant-4)
prep_of(adjustment-2, medications-5)
aux(necessary-8, may-6)
cop(necessary-8, be-7)
root(ROOT-0, necessary-8)

In/IN patients/NNS using/VBG cardiac/JJ glycosides/NNS (/-LRB- digoxin/NN and/CC others/NNS )/-RRB- ,/, plasma/NN levels/NNS of/IN calcium/NN ,/, potassium/NN and/CC magnesium/NN must/MD be/VB carefully/RB monitored/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG using) (NP (NP (JJ cardiac) (NNS glycosides)) (PRN (-LRB- -LRB-) (NP (NP (NN digoxin)) (CC and) (NP (NNS others))) (-RRB- -RRB-)))))) (, ,) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NP (NN calcium)) (, ,) (NP (NN potassium)) (CC and) (NP (NN magnesium))))) (VP (MD must) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored))))) (. .))))

prep_in(monitored-23, patients-2)
partmod(patients-2, using-3)
amod(glycosides-5, cardiac-4)
dobj(using-3, glycosides-5)
dep(glycosides-5, digoxin-7)
conj_and(digoxin-7, others-9)
nn(levels-13, plasma-12)
nsubjpass(monitored-23, levels-13)
prep_of(levels-13, calcium-15)
conj_and(calcium-15, potassium-17)
conj_and(calcium-15, magnesium-19)
aux(monitored-23, must-20)
auxpass(monitored-23, be-21)
advmod(monitored-23, carefully-22)
root(ROOT-0, monitored-23)

Insulin/NN :/: A/DT clinical/JJ study/NN in/IN 6/CD insulin-dependent/JJ diabetic/JJ patients/NNS demonstrated/VBD no/DT effect/NN of/IN EXTRANEAL/NN on/IN insulin/NN absorption/NN from/IN the/DT peritoneal/JJ cavity/NN or/CC on/IN insulin/NN s/NN ability/NN to/TO control/VB blood/NN glucose/NN when/WRB insulin/NN was/VBD administered/VBN intraperitoneally/RB with/IN EXTRANEAL/NN ./.

(ROOT (S1 (S (NP (NP (NN Insulin)) (: :) (S (NP (NP (DT A) (JJ clinical) (NN study)) (PP (IN in) (NP (CD 6) (JJ insulin-dependent) (JJ diabetic) (NNS patients)))) (VP (VBD demonstrated) (NP (NP (DT no) (NN effect)) (PP (IN of) (NP (NN EXTRANEAL))) (PP (PP (IN on) (NP (NP (NN insulin) (NN absorption)) (PP (IN from) (NP (DT the) (JJ peritoneal) (NN cavity))))) (CC or) (PP (IN on) (NP (NP (NN insulin) (NN s) (NN ability)) (S (VP (TO to) (VP (VB control) (NP (NN blood) (NN glucose)) (SBAR (WHADVP (WRB when)) (S (NP (NN insulin)) (VP (VBD was) (VP (VBN administered) (ADVP (RB intraperitoneally)) (PP (IN with) (NP (NN EXTRANEAL)))))))))))))))) (. .)))))

root(ROOT-0, Insulin-1)
det(study-5, A-3)
amod(study-5, clinical-4)
nsubj(demonstrated-11, study-5)
num(patients-10, 6-7)
amod(patients-10, insulin-dependent-8)
amod(patients-10, diabetic-9)
prep_in(study-5, patients-10)
dep(Insulin-1, demonstrated-11)
det(effect-13, no-12)
dobj(demonstrated-11, effect-13)
prep_of(effect-13, EXTRANEAL-15)
nn(absorption-18, insulin-17)
prep_on(effect-13, absorption-18)
det(cavity-22, the-20)
amod(cavity-22, peritoneal-21)
prep_from(absorption-18, cavity-22)
nn(ability-27, insulin-25)
nn(ability-27, s-26)
conj_or(absorption-18, ability-27)
aux(control-29, to-28)
infmod(ability-27, control-29)
nn(glucose-31, blood-30)
dobj(control-29, glucose-31)
advmod(administered-35, when-32)
nsubjpass(administered-35, insulin-33)
auxpass(administered-35, was-34)
advcl(control-29, administered-35)
advmod(administered-35, intraperitoneally-36)
prep_with(administered-35, EXTRANEAL-38)

However/RB ,/, appropriate/JJ monitoring/NN of/IN blood/NN glucose/NN should/MD be/VB performed/VBN when/WRB initiating/VBG EXTRANEAL/NN in/IN diabetic/JJ patients/NNS and/CC insulin/NN dosage/NN should/MD be/VB adjusted/VBN if/IN needed/VBN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (S (NP (NP (JJ appropriate) (NN monitoring)) (PP (IN of) (NP (NN blood) (NN glucose)))) (VP (MD should) (VP (VB be) (VP (VBN performed))) (SBAR (WHADVP (WRB when)) (S (VP (VBG initiating) (NP (NP (NN EXTRANEAL)) (PP (IN in) (NP (JJ diabetic) (NNS patients))))))))) (CC and) (S (NP (NN insulin) (NN dosage)) (VP (MD should) (VP (VB be) (VP (VBN adjusted) (SBAR (IN if) (S (VP (VBN needed))))))))) (. .))))

advmod(performed-10, However-1)
amod(monitoring-4, appropriate-3)
nsubjpass(performed-10, monitoring-4)
nn(glucose-7, blood-6)
prep_of(monitoring-4, glucose-7)
aux(performed-10, should-8)
auxpass(performed-10, be-9)
root(ROOT-0, performed-10)
advmod(initiating-12, when-11)
advcl(performed-10, initiating-12)
dobj(initiating-12, EXTRANEAL-13)
amod(patients-16, diabetic-15)
prep_in(EXTRANEAL-13, patients-16)
nn(dosage-19, insulin-18)
nsubjpass(adjusted-22, dosage-19)
aux(adjusted-22, should-20)
auxpass(adjusted-22, be-21)
conj_and(performed-10, adjusted-22)
mark(needed-24, if-23)
advcl(adjusted-22, needed-24)

Heparin/NN :/: No/DT human/JJ drug/NN interaction/NN studies/NNS with/IN heparin/NN were/VBD conducted/VBN ./.

(ROOT (S1 (S (S (NP (NN Heparin)) (: :) (NP (NP (DT No) (JJ human) (NN drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (NN heparin)))) (VP (VBD were) (VP (VBN conducted)))) (. .))))

nsubjpass(conducted-11, Heparin-1)
det(studies-7, No-3)
amod(studies-7, human-4)
nn(studies-7, drug-5)
nn(studies-7, interaction-6)
nsubjpass(conducted-11, studies-7)
prep_with(studies-7, heparin-9)
auxpass(conducted-11, were-10)
root(ROOT-0, conducted-11)

In/FW vitro/FW studies/NNS demonstrated/VBD no/DT evidence/NN of/IN incompatibility/NN of/IN heparin/NN with/IN EXTRANEAL/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBD demonstrated) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (NN incompatibility)) (PP (IN of) (NP (NN heparin))) (PP (IN with) (NP (NN EXTRANEAL)))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(demonstrated-4, studies-3)
root(ROOT-0, demonstrated-4)
det(evidence-6, no-5)
dobj(demonstrated-4, evidence-6)
prep_of(evidence-6, incompatibility-8)
prep_of(incompatibility-8, heparin-10)
prep_with(incompatibility-8, EXTRANEAL-12)

Antibiotics/NNS :/: No/DT human/JJ drug/NN interaction/NN studies/NNS with/IN antibiotics/NNS were/VBD conducted/VBN ./.

(ROOT (S1 (S (S (NP (NNS Antibiotics)) (: :) (NP (NP (DT No) (JJ human) (NN drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (NNS antibiotics)))) (VP (VBD were) (VP (VBN conducted)))) (. .))))

nsubjpass(conducted-11, Antibiotics-1)
det(studies-7, No-3)
amod(studies-7, human-4)
nn(studies-7, drug-5)
nn(studies-7, interaction-6)
nsubjpass(conducted-11, studies-7)
prep_with(studies-7, antibiotics-9)
auxpass(conducted-11, were-10)
root(ROOT-0, conducted-11)

In/FW vitro/FW studies/NNS evaluating/VBG the/DT minimum/JJ inhibitory/JJ concentration/NN (/-LRB- MIC/NN )/-RRB- of/IN vancomycin/NN ,/, cefazolin/NN ,/, ampicillin/NN ,/, ampicillin/NN /flucoxacillin/NN ,/, ceftazidime/NN ,/, gentamicin/NN ,/, and/CC amphotericin/NN demonstrated/VBD no/DT evidence/NN of/IN incompatibility/NN of/IN these/DT antibiotics/NNS with/IN EXTRANEAL/NN ./.

(ROOT (S1 (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBG evaluating) (NP (NP (NP (DT the) (JJ minimum) (JJ inhibitory) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NN MIC)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN vancomycin)) (, ,) (NP (NN cefazolin)) (, ,) (NP (NN ampicillin)) (, ,) (NP (NN ampicillin) (NN /flucoxacillin)) (, ,) (NP (NN ceftazidime)) (, ,) (NP (NN gentamicin)) (, ,) (CC and) (NP (NN amphotericin))))))) (VP (VBD demonstrated) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (NN incompatibility)) (PP (IN of) (NP (DT these) (NNS antibiotics))) (PP (IN with) (NP (NN EXTRANEAL))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(demonstrated-28, studies-3)
partmod(studies-3, evaluating-4)
det(concentration-8, the-5)
amod(concentration-8, minimum-6)
amod(concentration-8, inhibitory-7)
dobj(evaluating-4, concentration-8)
abbrev(concentration-8, MIC-10)
prep_of(concentration-8, vancomycin-13)
conj_and(vancomycin-13, cefazolin-15)
conj_and(vancomycin-13, ampicillin-17)
nn(/flucoxacillin-20, ampicillin-19)
conj_and(vancomycin-13, /flucoxacillin-20)
conj_and(vancomycin-13, ceftazidime-22)
conj_and(vancomycin-13, gentamicin-24)
conj_and(vancomycin-13, amphotericin-27)
root(ROOT-0, demonstrated-28)
det(evidence-30, no-29)
dobj(demonstrated-28, evidence-30)
prep_of(evidence-30, incompatibility-32)
det(antibiotics-35, these-34)
prep_of(incompatibility-32, antibiotics-35)
prep_with(incompatibility-32, EXTRANEAL-37)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Blood/NN Glucose/NN Blood/NN glucose/NN measurement/NN must/MD be/VB done/VBN with/IN a/DT glucose/NN -specific/JJ method/NN to/TO prevent/VB maltose/NN interference/NN with/IN test/NN results/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (NN Blood) (NN Glucose) (NN Blood) (NN glucose) (NN measurement)) (VP (MD must) (VP (VB be) (VP (VBN done) (PP (IN with) (NP (NP (DT a) (ADJP (NN glucose) (JJ -specific)) (NN method)) (S (VP (TO to) (VP (VB prevent) (NP (NP (NN maltose) (NN interference)) (PP (IN with) (NP (NN test) (NNS results))))))))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nn(measurement-9, Interactions-4)
nn(measurement-9, Blood-5)
nn(measurement-9, Glucose-6)
nn(measurement-9, Blood-7)
nn(measurement-9, glucose-8)
nsubjpass(done-12, measurement-9)
aux(done-12, must-10)
auxpass(done-12, be-11)
root(ROOT-0, done-12)
det(method-17, a-14)
dep(-specific-16, glucose-15)
amod(method-17, -specific-16)
prep_with(done-12, method-17)
aux(prevent-19, to-18)
infmod(method-17, prevent-19)
nn(interference-21, maltose-20)
dobj(prevent-19, interference-21)
nn(results-24, test-23)
prep_with(interference-21, results-24)

Since/IN falsely/RB elevated/JJ glucose/NN levels/NNS have/VBP been/VBN observed/VBN with/IN blood/NN glucose/NN monitoring/NN devices/NNS and/CC test/NN strips/NNS that/WDT use/VBP glucose/NN dehydrogenase/NN pyrroloquinolinequinone/NN (/-LRB- GDH/CD PQQ/NN )/-RRB- -based/JJ methods/NNS ,/, GDH/CD PQQ-based/JJ methods/NNS should/MD not/RB be/VB used/VBN to/TO measure/VB glucose/NN levels/NNS in/IN patients/NNS administered/VBN EXTRANEAL/NN ./. ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (ADJP (RB falsely) (JJ elevated)) (NN glucose) (NNS levels)) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (IN with) (NP (NP (NP (NN blood) (NN glucose) (NN monitoring) (NNS devices)) (CC and) (NP (NN test) (NNS strips))) (SBAR (WHNP (WDT that)) (S (VP (VBP use) (NP (ADJP (NP (NP (NN glucose) (NN dehydrogenase) (NN pyrroloquinolinequinone)) (PRN (-LRB- -LRB-) (NP (CD GDH) (NN PQQ)) (-RRB- -RRB-))) (JJ -based)) (NNS methods)))))))))))) (, ,) (NP (CD GDH) (JJ PQQ-based) (NNS methods)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB measure) (NP (NN glucose) (NNS levels)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN administered) (S (NP (NN EXTRANEAL)))))))))))) (. .)) (. .))))

mark(observed-8, Since-1)
advmod(elevated-3, falsely-2)
amod(levels-5, elevated-3)
nn(levels-5, glucose-4)
nsubjpass(observed-8, levels-5)
aux(observed-8, have-6)
auxpass(observed-8, been-7)
advcl(used-35, observed-8)
nn(devices-13, blood-10)
nn(devices-13, glucose-11)
nn(devices-13, monitoring-12)
prep_with(observed-8, devices-13)
nsubj(use-18, devices-13)
nn(strips-16, test-15)
conj_and(devices-13, strips-16)
rcmod(devices-13, use-18)
nn(pyrroloquinolinequinone-21, glucose-19)
nn(pyrroloquinolinequinone-21, dehydrogenase-20)
npadvmod(-based-26, pyrroloquinolinequinone-21)
num(PQQ-24, GDH-23)
appos(pyrroloquinolinequinone-21, PQQ-24)
amod(methods-27, -based-26)
dobj(use-18, methods-27)
num(methods-31, GDH-29)
amod(methods-31, PQQ-based-30)
nsubjpass(used-35, methods-31)
aux(used-35, should-32)
neg(used-35, not-33)
auxpass(used-35, be-34)
root(ROOT-0, used-35)
aux(measure-37, to-36)
xcomp(used-35, measure-37)
nn(levels-39, glucose-38)
dobj(measure-37, levels-39)
prep_in(measure-37, patients-41)
partmod(patients-41, administered-42)
dep(administered-42, EXTRANEAL-43)

Serum/NN Amylase/NN :/: An/DT apparent/JJ decrease/NN in/IN serum/NN amylase/NN activity/NN has/VBZ been/VBN observed/VBN in/IN patients/NNS administered/VBN EXTRANEAL/NN ./.

(ROOT (S1 (S (NP (NP (NN Serum) (NN Amylase)) (: :) (S (NP (NP (DT An) (JJ apparent) (NN decrease)) (PP (IN in) (NP (NN serum) (NN amylase) (NN activity)))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN administered) (NP (NN EXTRANEAL))))))))) (. .)))))

nn(Amylase-2, Serum-1)
root(ROOT-0, Amylase-2)
det(decrease-6, An-4)
amod(decrease-6, apparent-5)
nsubjpass(observed-13, decrease-6)
nn(activity-10, serum-8)
nn(activity-10, amylase-9)
prep_in(decrease-6, activity-10)
aux(observed-13, has-11)
auxpass(observed-13, been-12)
dep(Amylase-2, observed-13)
prep_in(observed-13, patients-15)
partmod(patients-15, administered-16)
dobj(administered-16, EXTRANEAL-17)

Preliminary/JJ investigations/NNS indicate/VBP that/IN icodextrin/NN and/CC its/PRP$ metabolites/NNS interfere/VBP with/IN enzymatic-based/JJ amylase/NN assays/NNS ,/, resulting/VBG in/IN inaccurately/RB low/JJ values/NNS ./.

(ROOT (S1 (S (S (NP (JJ Preliminary) (NNS investigations)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN icodextrin)) (CC and) (NP (PRP$ its) (NNS metabolites))) (VP (VBP interfere) (PP (IN with) (NP (JJ enzymatic-based) (NN amylase) (NNS assays))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (ADJP (RB inaccurately) (JJ low)) (NNS values)))))))))) (. .))))

amod(investigations-2, Preliminary-1)
nsubj(indicate-3, investigations-2)
root(ROOT-0, indicate-3)
complm(interfere-9, that-4)
nsubj(interfere-9, icodextrin-5)
poss(metabolites-8, its-7)
conj_and(icodextrin-5, metabolites-8)
ccomp(indicate-3, interfere-9)
amod(assays-13, enzymatic-based-11)
nn(assays-13, amylase-12)
prep_with(interfere-9, assays-13)
xcomp(interfere-9, resulting-15)
advmod(low-18, inaccurately-17)
amod(values-19, low-18)
prep_in(resulting-15, values-19)

This/DT should/MD be/VB taken/VBN into/IN account/NN when/WRB evaluating/VBG serum/NN amylase/NN levels/NNS for/IN diagnosis/NN or/CC monitoring/NN of/IN pancreatitis/NN in/IN patients/NNS using/VBG EXTRANEAL/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN into) (NP (NN account))) (SBAR (WHADVP (WRB when)) (S (VP (VBG evaluating) (NP (NN serum) (NN amylase) (NNS levels)) (PP (IN for) (NP (NP (NN diagnosis)) (CC or) (NP (NP (NN monitoring)) (PP (IN of) (NP (NN pancreatitis))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG using) (NP (NN EXTRANEAL))))))))))))))) (. .))))

nsubjpass(taken-4, This-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
prep_into(taken-4, account-6)
advmod(evaluating-8, when-7)
advcl(taken-4, evaluating-8)
nn(levels-11, serum-9)
nn(levels-11, amylase-10)
dobj(evaluating-8, levels-11)
prep_for(evaluating-8, diagnosis-13)
conj_or(diagnosis-13, monitoring-15)
prep_of(monitoring-15, pancreatitis-17)
prep_in(monitoring-15, patients-19)
partmod(patients-19, using-20)
dobj(using-20, EXTRANEAL-21)

The/DT physician/NN should/MD be/VB alert/JJ for/IN possible/JJ combined/JJ drug/NN actions/NNS ,/, desirable/JJ or/CC undesirable/JJ ,/, involving/VBG ifosfamide/NN even/RB though/IN ifosfamide/NN has/VBZ been/VBN used/VBN successfully/RB concurrently/RB with/IN other/JJ drugs/NNS ,/, including/VBG other/JJ cytotoxic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (DT The) (NN physician)) (VP (MD should) (VP (VB be) (ADJP (JJ alert) (PP (IN for) (NP (NP (JJ possible) (JJ combined) (NN drug) (NNS actions)) (, ,) (ADJP (ADJP (JJ desirable)) (CC or) (ADJP (JJ undesirable))) (, ,) (VP (VBG involving) (NP (NN ifosfamide)))))) (SBAR (RB even) (IN though) (S (NP (NN ifosfamide)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB successfully)) (PP (ADVP (RB concurrently)) (IN with) (NP (NP (JJ other) (NNS drugs)) (, ,) (PP (VBG including) (NP (JJ other) (JJ cytotoxic) (NNS drugs))))))))))))) (. .))))

det(physician-2, The-1)
nsubj(alert-5, physician-2)
aux(alert-5, should-3)
cop(alert-5, be-4)
root(ROOT-0, alert-5)
amod(actions-10, possible-7)
amod(actions-10, combined-8)
nn(actions-10, drug-9)
prep_for(alert-5, actions-10)
amod(actions-10, desirable-12)
conj_or(desirable-12, undesirable-14)
partmod(actions-10, involving-16)
dobj(involving-16, ifosfamide-17)
advmod(used-23, even-18)
dep(used-23, though-19)
nsubjpass(used-23, ifosfamide-20)
aux(used-23, has-21)
auxpass(used-23, been-22)
ccomp(alert-5, used-23)
advmod(used-23, successfully-24)
advmod(used-23, concurrently-25)
amod(drugs-28, other-27)
prep_with(used-23, drugs-28)
amod(drugs-33, other-31)
amod(drugs-33, cytotoxic-32)
prep_including(drugs-28, drugs-33)

In/IN occasional/JJ susceptible/JJ patients/NNS or/CC in/IN those/DT receiving/VBG anticholinergic/JJ drugs/NNS (/-LRB- including/VBG antiparkinsonism/NN agents/NNS )/-RRB- in/IN addition/NN ,/, the/DT atropine/JJ -like/JJ effects/NNS may/MD become/VB more/RBR pronounced/JJ (/-LRB- e.g./FW ,/, paralytic/JJ ileus/NN )./NN

(ROOT (S1 (S (S (PP (PP (IN In) (NP (JJ occasional) (JJ susceptible) (NNS patients))) (CC or) (PP (IN in) (NP (NP (DT those)) (VP (VBG receiving) (NP (NP (JJ anticholinergic) (NNS drugs)) (PRN (-LRB- -LRB-) (VP (VBG including) (NP (NN antiparkinsonism) (NNS agents))) (-RRB- -RRB-))) (PP (IN in) (NP (NN addition))))))) (, ,) (NP (DT the) (JJ atropine) (JJ -like) (NNS effects)) (VP (MD may) (VP (VB become) (ADJP (RBR more) (JJ pronounced))))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (JJ paralytic) (NN ileus) (NN -RRB-.)))))))

amod(patients-4, occasional-2)
amod(patients-4, susceptible-3)
prep_in(pronounced-26, patients-4)
prep_in(pronounced-26', those-7)
partmod(those-7, receiving-8)
amod(drugs-10, anticholinergic-9)
dobj(receiving-8, drugs-10)
dep(drugs-10, including-12)
nn(agents-14, antiparkinsonism-13)
dobj(including-12, agents-14)
prep_in(receiving-8, addition-17)
det(effects-22, the-19)
amod(effects-22, atropine-20)
amod(effects-22, -like-21)
nsubj(pronounced-26, effects-22)
aux(pronounced-26, may-23)
cop(pronounced-26, become-24)
advmod(pronounced-26, more-25)
root(ROOT-0, pronounced-26)
conj_or(pronounced-26, pronounced-26')
dep(pronounced-26, e.g.-28)
amod(-RRB-.-32, paralytic-30)
nn(-RRB-.-32, ileus-31)
pobj(e.g.-28, -RRB-.-32)

Close/JJ supervision/NN and/CC careful/JJ adjustment/NN of/IN dosage/NN is/VBZ required/VBN when/WRB this/DT drug/NN is/VBZ administered/VBN concomitantly/RB with/IN anticholinergic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Close) (NN supervision)) (CC and) (NP (JJ careful) (NN adjustment))) (PP (IN of) (NP (NN dosage)))) (VP (VBZ is) (VP (VBN required) (SBAR (WHADVP (WRB when)) (S (NP (DT this) (NN drug)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ anticholinergic) (NNS drugs)))))))))) (. .))))

amod(supervision-2, Close-1)
nsubjpass(required-9, supervision-2)
amod(adjustment-5, careful-4)
conj_and(supervision-2, adjustment-5)
prep_of(supervision-2, dosage-7)
auxpass(required-9, is-8)
root(ROOT-0, required-9)
advmod(administered-14, when-10)
det(drug-12, this-11)
nsubjpass(administered-14, drug-12)
auxpass(administered-14, is-13)
advcl(required-9, administered-14)
advmod(administered-14, concomitantly-15)
amod(drugs-18, anticholinergic-17)
prep_with(administered-14, drugs-18)

Avoid/VB the/DT use/NN of/IN preparations/NNS such/JJ as/IN decongestants/NNS and/CC local/JJ anesthetics/NNS which/WDT contain/VBP any/DT sympathomimetic/JJ amine/NN (/-LRB- e.g./FW ,/, epinephrine/NN ,/, norepinephrine/NN )/-RRB- ,/, since/IN it/PRP has/VBZ been/VBN reported/VBN that/IN tricyclic/JJ antidepressants/NNS can/MD potentiate/VB the/DT effects/NNS of/IN catecholamines/NNS ./.

(ROOT (S1 (S (S (VP (VB Avoid) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS preparations))) (PP (JJ such) (IN as) (NP (NP (NP (NNS decongestants)) (CC and) (NP (JJ local) (NNS anesthetics))) (SBAR (WHNP (WDT which)) (S (VP (VBP contain) (NP (NP (DT any) (JJ sympathomimetic) (NN amine)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN epinephrine)) (, ,) (NP (NN norepinephrine))) (-RRB- -RRB-))) (, ,) (SBAR (IN since) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (JJ tricyclic) (NNS antidepressants)) (VP (MD can) (VP (VB potentiate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS catecholamines))))))))))))))))))))) (. .))))

root(ROOT-0, Avoid-1)
det(use-3, the-2)
dobj(Avoid-1, use-3)
prep_of(use-3, preparations-5)
prep_such_as(use-3, decongestants-8)
nsubj(contain-13, decongestants-8)
amod(anesthetics-11, local-10)
conj_and(decongestants-8, anesthetics-11)
rcmod(decongestants-8, contain-13)
det(amine-16, any-14)
amod(amine-16, sympathomimetic-15)
dobj(contain-13, amine-16)
dep(epinephrine-20, e.g.-18)
dep(amine-16, epinephrine-20)
appos(epinephrine-20, norepinephrine-22)
mark(reported-29, since-25)
nsubjpass(reported-29, it-26)
aux(reported-29, has-27)
auxpass(reported-29, been-28)
advcl(contain-13, reported-29)
complm(potentiate-34, that-30)
amod(antidepressants-32, tricyclic-31)
nsubj(potentiate-34, antidepressants-32)
aux(potentiate-34, can-33)
ccomp(reported-29, potentiate-34)
det(effects-36, the-35)
dobj(potentiate-34, effects-36)
prep_of(effects-36, catecholamines-38)

Caution/NN should/MD be/VB exercised/VBN when/WRB imipramine/NN hydrochloride/NN is/VBZ used/VBN with/IN agents/NNS that/IN lower/JJR blood/NN pressure/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (NN imipramine) (NN hydrochloride)) (VP (VBZ is) (VP (VBN used) (PP (IN with) (NP (NP (NNS agents)) (PP (IN that) (NP (JJR lower) (NN blood) (NN pressure))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(used-9, when-5)
nn(hydrochloride-7, imipramine-6)
nsubjpass(used-9, hydrochloride-7)
auxpass(used-9, is-8)
advcl(exercised-4, used-9)
prep_with(used-9, agents-11)
amod(pressure-15, lower-13)
nn(pressure-15, blood-14)
prep_that(agents-11, pressure-15)

Imipramine/NN hydrochloride/NN may/MD potentiate/VB the/DT effects/NNS of/IN CNS/NN depressant/NN drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Imipramine) (NN hydrochloride)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN CNS) (NN depressant) (NNS drugs))))))) (. .))))

nn(hydrochloride-2, Imipramine-1)
nsubj(potentiate-4, hydrochloride-2)
aux(potentiate-4, may-3)
root(ROOT-0, potentiate-4)
det(effects-6, the-5)
dobj(potentiate-4, effects-6)
nn(drugs-10, CNS-8)
nn(drugs-10, depressant-9)
prep_of(effects-6, drugs-10)

The/DT plasma/NN concentration/NN of/IN imipramine/NN may/MD increase/VB when/WRB the/DT drug/NN is/VBZ given/VBN concomitantly/RB with/IN hepatic/JJ enzyme/NN inhibitors/NNS (/-LRB- e.g./FW ,/, cimetidine/NN ,/, fluoxetine/NN )/-RRB- and/CC decrease/VB by/IN concomitant/JJ administration/NN of/IN hepatic/JJ enzyme/NN inducers/NNS (/-LRB- e.g./FW ,/, barbiturates/NNS ,/, phenytoin/NN )/-RRB- ,/, and/CC adjustment/NN of/IN the/DT dosage/NN of/IN imipramine/NN may/MD therefore/RB be/VB necessary/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN imipramine)))) (VP (MD may) (VP (VP (VB increase) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN drug)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ hepatic) (NN enzyme) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN cimetidine)) (, ,) (NP (NN fluoxetine))) (-RRB- -RRB-))))))))) (CC and) (VP (VB decrease) (PP (IN by) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (JJ hepatic) (NN enzyme) (NNS inducers)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NNS barbiturates)) (, ,) (NP (NN phenytoin))) (-RRB- -RRB-)))))))))) (, ,) (CC and) (S (NP (NP (NN adjustment)) (PP (IN of) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (NN imipramine)))))) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (ADJP (JJ necessary))))) (. .))))

det(concentration-3, The-1)
nn(concentration-3, plasma-2)
nsubj(increase-7, concentration-3)
prep_of(concentration-3, imipramine-5)
aux(increase-7, may-6)
root(ROOT-0, increase-7)
advmod(given-12, when-8)
det(drug-10, the-9)
nsubjpass(given-12, drug-10)
auxpass(given-12, is-11)
advcl(increase-7, given-12)
advmod(given-12, concomitantly-13)
amod(inhibitors-17, hepatic-15)
nn(inhibitors-17, enzyme-16)
prep_with(given-12, inhibitors-17)
dep(cimetidine-21, e.g.-19)
dep(inhibitors-17, cimetidine-21)
appos(cimetidine-21, fluoxetine-23)
conj_and(increase-7, decrease-26)
amod(administration-29, concomitant-28)
prep_by(decrease-26, administration-29)
amod(inducers-33, hepatic-31)
nn(inducers-33, enzyme-32)
prep_of(administration-29, inducers-33)
dep(barbiturates-37, e.g.-35)
dep(inducers-33, barbiturates-37)
appos(barbiturates-37, phenytoin-39)
nsubj(necessary-52, adjustment-43)
det(dosage-46, the-45)
prep_of(adjustment-43, dosage-46)
prep_of(dosage-46, imipramine-48)
aux(necessary-52, may-49)
advmod(necessary-52, therefore-50)
cop(necessary-52, be-51)
conj_and(increase-7, necessary-52)

Drugs/NNS Metabolized/VBN by/IN P450/NN 2D6/NN :/: The/DT biochemical/JJ activity/NN of/IN the/DT drug/NN metabolizing/NN isozyme/NN cytochrome/NN P450/NN 2D6/NN (/-LRB- debrisoquin/NN hydroxylase/NN )/-RRB- is/VBZ reduced/VBN in/IN a/DT subset/NN of/IN the/DT caucasian/NN population/NN (/-LRB- about/RB 7/CD to/TO 10/CD %/NN of/IN caucasians/NNS are/VBP so/RB called/VBN poor/JJ metabolizers/NNS )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))) (: :) (S (NP (NP (DT The) (JJ biochemical) (NN activity)) (PP (IN of) (NP (NP (DT the) (NN drug) (NN metabolizing) (NN isozyme) (NN cytochrome) (NN P450) (NN 2D6)) (PRN (-LRB- -LRB-) (NP (NN debrisoquin) (NN hydroxylase)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN reduced) (PP (IN in) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (DT the) (NN caucasian) (NN population))))) (PRN (-LRB- -LRB-) (S (NP (NP (QP (RB about) (CD 7) (TO to) (CD 10)) (NN %)) (PP (IN of) (NP (NNS caucasians)))) (VP (VBP are) (NP (ADJP (RB so) (VBN called)) (JJ poor) (NNS metabolizers)))) (-RRB- -RRB-)))) (: ;)) (. .)))))

root(ROOT-0, Drugs-1)
partmod(Drugs-1, Metabolized-2)
nn(2D6-5, P450-4)
agent(Metabolized-2, 2D6-5)
det(activity-9, The-7)
amod(activity-9, biochemical-8)
nsubjpass(reduced-23, activity-9)
det(2D6-17, the-11)
nn(2D6-17, drug-12)
nn(2D6-17, metabolizing-13)
nn(2D6-17, isozyme-14)
nn(2D6-17, cytochrome-15)
nn(2D6-17, P450-16)
prep_of(activity-9, 2D6-17)
nn(hydroxylase-20, debrisoquin-19)
appos(2D6-17, hydroxylase-20)
auxpass(reduced-23, is-22)
dep(Drugs-1, reduced-23)
det(subset-26, a-25)
prep_in(reduced-23, subset-26)
det(population-30, the-28)
nn(population-30, caucasian-29)
prep_of(subset-26, population-30)
quantmod(10-35, about-32)
number(10-35, 7-33)
dep(10-35, to-34)
num(%-36, 10-35)
nsubj(metabolizers-43, %-36)
prep_of(%-36, caucasians-38)
cop(metabolizers-43, are-39)
advmod(called-41, so-40)
amod(metabolizers-43, called-41)
amod(metabolizers-43, poor-42)
parataxis(reduced-23, metabolizers-43)

reliable/JJ estimates/NNS of/IN the/DT prevalence/NN of/IN reduced/VBN P450/NN 2D6/NN isozyme/NN activity/NN among/IN Asian/JJ ,/, African/JJ and/CC other/JJ populations/NNS are/VBP not/RB yet/RB available/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ reliable) (NNS estimates)) (PP (IN of) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (VBN reduced) (NN P450) (NN 2D6) (NN isozyme) (NN activity))) (PP (IN among) (NP (ADJP (ADJP (JJ Asian)) (, ,) (ADJP (JJ African)) (CC and) (ADJP (JJ other))) (NNS populations)))))) (VP (VBP are) (RB not) (ADVP (RB yet)) (ADJP (JJ available)))) (. .))))

amod(estimates-2, reliable-1)
nsubj(available-22, estimates-2)
det(prevalence-5, the-4)
prep_of(estimates-2, prevalence-5)
amod(activity-11, reduced-7)
nn(activity-11, P450-8)
nn(activity-11, 2D6-9)
nn(activity-11, isozyme-10)
prep_of(prevalence-5, activity-11)
amod(populations-18, Asian-13)
conj_and(Asian-13, African-15)
conj_and(Asian-13, other-17)
prep_among(prevalence-5, populations-18)
cop(available-22, are-19)
neg(available-22, not-20)
advmod(available-22, yet-21)
root(ROOT-0, available-22)

Poor/JJ metabolizers/NNS have/VBP higher/JJR than/IN expected/VBN plasma/NN concentrations/NNS of/IN tricyclic/JJ antidepressants/NNS (/-LRB- TCAs/NNS )/-RRB- when/WRB given/VBN usual/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (JJ Poor) (NNS metabolizers)) (VP (VBP have) (NP (NP (JJR higher) (IN than) (VBN expected) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NNS TCAs)) (-RRB- -RRB-))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (JJ usual) (NNS doses))))))) (. .))))

amod(metabolizers-2, Poor-1)
nsubj(have-3, metabolizers-2)
root(ROOT-0, have-3)
amod(concentrations-8, higher-4)
amod(concentrations-8, than-5)
amod(concentrations-8, expected-6)
nn(concentrations-8, plasma-7)
dobj(have-3, concentrations-8)
amod(antidepressants-11, tricyclic-10)
prep_of(concentrations-8, antidepressants-11)
appos(antidepressants-11, TCAs-13)
advmod(given-16, when-15)
advcl(have-3, given-16)
amod(doses-18, usual-17)
dobj(given-16, doses-18)

Depending/VBG on/IN the/DT fraction/NN of/IN drug/NN metabolized/VBN by/IN P450/NN 2D6/NN ,/, the/DT increase/NN in/IN plasma/NN concentration/NN may/MD be/VB small/JJ ,/, or/CC quite/RB large/JJ (/-LRB- 8-fold/JJ increase/NN in/IN plasma/NN AUC/NN of/IN the/DT TCA/NN )./NN

(ROOT (S1 (S (PP (VBG Depending) (PP (IN on) (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NP (NN drug)) (VP (VBN metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))))))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN plasma) (NN concentration)))) (VP (MD may) (VP (VB be) (ADJP (ADJP (JJ small)) (, ,) (CC or) (RB quite) (ADJP (JJ large))))) (PRN (-LRB- -LRB-) (NP (NP (JJ 8-fold) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NN AUC)) (PP (IN of) (NP (DT the) (NN TCA) (NN -RRB-.))))))))))

prepc_depending_on(small-19, on-2)
det(fraction-4, the-3)
pobj(small-19, fraction-4)
prep_of(fraction-4, drug-6)
partmod(drug-6, metabolized-7)
nn(2D6-10, P450-9)
agent(metabolized-7, 2D6-10)
det(increase-13, the-12)
nsubj(small-19, increase-13)
nn(concentration-16, plasma-15)
prep_in(increase-13, concentration-16)
aux(small-19, may-17)
cop(small-19, be-18)
root(ROOT-0, small-19)
advmod(small-19, quite-22)
conj_or(small-19, quite-22)
dep(small-19, large-23)
amod(increase-26, 8-fold-25)
dep(small-19, increase-26)
nn(AUC-29, plasma-28)
prep_in(increase-26, AUC-29)
det(-RRB-.-33, the-31)
nn(-RRB-.-33, TCA-32)
prep_of(AUC-29, -RRB-.-33)

In/IN addition/NN ,/, certain/JJ drugs/NNS inhibit/VB the/DT activity/NN of/IN this/DT isozyme/NN and/CC make/VB normal/JJ metabolizers/NNS resemble/VBP p.o./NN

(ROOT (S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ certain) (NNS drugs)) (VP (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN isozyme))))) (CC and) (VP (VB make) (NP (JJ normal) (NNS metabolizers)))) (VP (VBP resemble) (NP (NN p.o.))))))

prep_in(inhibit-6, addition-2)
amod(drugs-5, certain-4)
nsubj(inhibit-6, drugs-5)
root(ROOT-0, inhibit-6)
det(activity-8, the-7)
dobj(inhibit-6, activity-8)
det(isozyme-11, this-10)
prep_of(activity-8, isozyme-11)
conj_and(inhibit-6, make-13)
amod(metabolizers-15, normal-14)
dobj(make-13, metabolizers-15)
cop(p.o.-17, resemble-16)
dep(inhibit-6, p.o.-17)

An/DT individual/JJ who/WP is/VBZ stable/JJ on/IN a/DT given/JJ dose/NN of/IN TCA/NN may/MD become/VB abruptly/RB toxic/JJ when/WRB given/VBN one/CD of/IN these/DT inhibiting/JJ drugs/NNS as/IN concomitant/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ individual)) (SBAR (WHNP (WP who)) (S (VP (VBZ is) (ADJP (JJ stable) (PP (IN on) (NP (NP (DT a) (JJ given) (NN dose)) (PP (IN of) (NP (NN TCA)))))))))) (VP (MD may) (VP (VB become) (ADJP (RB abruptly) (JJ toxic)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT these) (JJ inhibiting) (NNS drugs)) (PP (IN as) (NP (JJ concomitant) (NN therapy)))))))))))) (. .))))

det(individual-2, An-1)
nsubj(stable-5, individual-2)
nsubj(toxic-15, individual-2)
cop(stable-5, is-4)
rcmod(individual-2, stable-5)
det(dose-9, a-7)
amod(dose-9, given-8)
prep_on(stable-5, dose-9)
prep_of(dose-9, TCA-11)
aux(toxic-15, may-12)
cop(toxic-15, become-13)
advmod(toxic-15, abruptly-14)
root(ROOT-0, toxic-15)
advmod(given-17, when-16)
advcl(toxic-15, given-17)
dobj(given-17, one-18)
det(drugs-22, these-20)
amod(drugs-22, inhibiting-21)
prep_of(one-18, drugs-22)
amod(therapy-25, concomitant-24)
prep_as(drugs-22, therapy-25)

The/DT drugs/NNS that/WDT inhibit/VBP cytochrome/NN P450/NN 2D6/NN include/VBP some/DT that/WDT are/VBP not/RB metabolized/VBN by/IN the/DT enzyme/NN (/-LRB- quinidine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6)))))) (VP (VBP include) (NP (NP (DT some)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN enzyme) (-LRB- -LRB-) (NN quinidine) (: ;)))))))))) (. .))))

det(drugs-2, The-1)
nsubj(inhibit-4, drugs-2)
nsubj(include-8, drugs-2)
rcmod(drugs-2, inhibit-4)
nn(2D6-7, cytochrome-5)
nn(2D6-7, P450-6)
dobj(inhibit-4, 2D6-7)
root(ROOT-0, include-8)
dobj(include-8, some-9)
nsubjpass(metabolized-13, some-9)
auxpass(metabolized-13, are-11)
neg(metabolized-13, not-12)
rcmod(some-9, metabolized-13)
det(quinidine-18, the-15)
nn(quinidine-18, enzyme-16)
agent(metabolized-13, quinidine-18)

cimetidine/NN )/-RRB- and/CC many/JJ that/WDT are/VBP substrates/NNS for/IN P450/NN 2D6/NN (/-LRB- many/JJ other/JJ antidepressants/NNS ,/, phenothiazines/NNS ,/, and/CC the/DT Type/NN 1C/NN antiarrhythmics/NNS propafenone/NN and/CC flecainide/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NN cimetidine) (-RRB- -RRB-)) (CC and) (NP (NP (JJ many)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN for) (NP (NN P450) (NN 2D6)))) (PRN (-LRB- -LRB-) (NP (NP (JJ many) (JJ other) (NNS antidepressants)) (, ,) (NP (NNS phenothiazines)) (, ,) (CC and) (NP (NP (DT the) (NN Type) (NN 1C) (NNS antiarrhythmics)) (NP (NP (NN propafenone)) (CC and) (NP (NN flecainide))))) (-RRB- -RRB-))))))) (. .)))))

root(ROOT-0, cimetidine-1)
conj_and(cimetidine-1, many-4)
nsubj(substrates-7, many-4)
cop(substrates-7, are-6)
rcmod(many-4, substrates-7)
nn(2D6-10, P450-9)
prep_for(substrates-7, 2D6-10)
amod(antidepressants-14, many-12)
amod(antidepressants-14, other-13)
dep(substrates-7, antidepressants-14)
conj_and(antidepressants-14, phenothiazines-16)
det(antiarrhythmics-22, the-19)
nn(antiarrhythmics-22, Type-20)
nn(antiarrhythmics-22, 1C-21)
conj_and(antidepressants-14, antiarrhythmics-22)
dep(antiarrhythmics-22, propafenone-23)
conj_and(propafenone-23, flecainide-25)

While/IN all/PDT the/DT selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- ,/, e./FW g./FW ,/, fluoxetine/NN ,/, sertraline/NN ,/, and/CC paroxetine/NN ,/, inhibit/VBP P450/NN 2D6/NN ,/, they/PRP may/MD vary/VB in/IN the/DT extent/NN of/IN inhibition/NN ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (NP (NP (PDT all) (DT the) (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-))) (, ,) (NP (FW e.) (FW g.) (, ,) (NP (NN fluoxetine)) (, ,) (NP (NN sertraline)) (, ,) (CC and) (NP (NN paroxetine))) (, ,)) (VP (VBP inhibit) (NP (NN P450) (NN 2D6))))) (, ,) (NP (PRP they)) (VP (MD may) (VP (VB vary) (PP (IN in) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN inhibition)))))))) (. .))))

mark(inhibit-22, While-1)
predet(inhibitors-7, all-2)
det(inhibitors-7, the-3)
amod(inhibitors-7, selective-4)
nn(inhibitors-7, serotonin-5)
nn(inhibitors-7, reuptake-6)
nsubj(inhibit-22, inhibitors-7)
abbrev(inhibitors-7, SSRIs-9)
nn(fluoxetine-15, e.-12)
dep(fluoxetine-15, g.-13)
appos(inhibitors-7, fluoxetine-15)
conj_and(fluoxetine-15, sertraline-17)
conj_and(fluoxetine-15, paroxetine-20)
advcl(vary-28, inhibit-22)
nn(2D6-24, P450-23)
dobj(inhibit-22, 2D6-24)
nsubj(vary-28, they-26)
aux(vary-28, may-27)
root(ROOT-0, vary-28)
det(extent-31, the-30)
prep_in(vary-28, extent-31)
prep_of(extent-31, inhibition-33)

Of/IN particular/JJ importance/NN ,/, sufficient/JJ time/NN must/MD elapse/VB before/IN initiating/VBG TCA/NN treatment/NN in/IN a/DT patient/NN being/VBG withdrawn/NN from/IN fluoxetine/NN ,/, given/IN the/DT long/JJ half-life/NN of/IN the/DT parent/JJ and/CC active/JJ metabolite/NN (/-LRB- at/IN least/JJS 5/CD weeks/NNS may/MD be/VB necessary/JJ )./NN

(ROOT (S1 (S (PP (IN Of) (NP (JJ particular) (NN importance))) (, ,) (S (NP (JJ sufficient) (NN time)) (VP (MD must) (VP (VB elapse) (PP (IN before) (S (VP (VBG initiating) (NP (NN TCA) (NN treatment))))) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG being) (NP (NP (NN withdrawn)) (PP (IN from) (NP (NN fluoxetine))))))) (, ,) (SBAR (IN given) (S (NP (NP (DT the) (JJ long) (NN half-life)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ parent)) (CC and) (ADJP (JJ active))) (NN metabolite) (-LRB- -LRB-) (QP (IN at) (JJS least) (CD 5)) (NNS weeks)))) (VP (MD may) (VP (VB be) (NP (JJ necessary) (NN -RRB-.))))))))))))

amod(importance-3, particular-2)
prep_of(elapse-8, importance-3)
amod(time-6, sufficient-5)
nsubj(elapse-8, time-6)
aux(elapse-8, must-7)
root(ROOT-0, elapse-8)
prepc_before(elapse-8, initiating-10)
nn(treatment-12, TCA-11)
dobj(initiating-10, treatment-12)
det(patient-15, a-14)
prep_in(elapse-8, patient-15)
cop(withdrawn-17, being-16)
partmod(patient-15, withdrawn-17)
prep_from(withdrawn-17, fluoxetine-19)
mark(-RRB-.-39, given-21)
det(half-life-24, the-22)
amod(half-life-24, long-23)
nsubj(-RRB-.-39, half-life-24)
det(weeks-35, the-26)
amod(weeks-35, parent-27)
conj_and(parent-27, active-29)
nn(weeks-35, metabolite-30)
quantmod(5-34, at-32)
mwe(at-32, least-33)
pobj(at-32, least-33)
num(weeks-35, 5-34)
prep_of(half-life-24, weeks-35)
aux(-RRB-.-39, may-36)
cop(-RRB-.-39, be-37)
amod(-RRB-.-39, necessary-38)
advcl(elapse-8, -RRB-.-39)

Concomitant/JJ use/NN of/IN tricyclic/JJ antidepressants/NNS with/IN drugs/NNS that/WDT can/MD inhibit/VB cytochrome/NN P450/NN 2D6/NN may/MD require/VB lower/JJR doses/NNS than/IN usually/RB prescribed/VBN for/IN either/CC the/DT tricyclic/JJ antidepressant/JJ or/CC the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6))))))))))) (VP (MD may) (VP (VB require) (NP (NP (JJR lower) (NNS doses)) (VP (ADVP (IN than) (RB usually)) (VBN prescribed) (PP (IN for) (NP (CC either) (NP (DT the) (JJ tricyclic) (JJ antidepressant)) (CC or) (NP (DT the) (JJ other) (NN drug))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(require-15, use-2)
amod(antidepressants-5, tricyclic-4)
prep_of(use-2, antidepressants-5)
prep_with(antidepressants-5, drugs-7)
nsubj(inhibit-10, drugs-7)
aux(inhibit-10, can-9)
rcmod(drugs-7, inhibit-10)
nn(2D6-13, cytochrome-11)
nn(2D6-13, P450-12)
dobj(inhibit-10, 2D6-13)
aux(require-15, may-14)
root(ROOT-0, require-15)
amod(doses-17, lower-16)
dobj(require-15, doses-17)
advmod(prescribed-20, than-18)
advmod(than-18, usually-19)
partmod(doses-17, prescribed-20)
preconj(antidepressant-25, either-22)
det(antidepressant-25, the-23)
amod(antidepressant-25, tricyclic-24)
prep_for(prescribed-20, antidepressant-25)
det(drug-29, the-27)
amod(drug-29, other-28)
conj_or(antidepressant-25, drug-29)

Furthermore/RB ,/, whenever/RB one/CD of/IN these/DT other/JJ drugs/NNS is/VBZ withdrawn/VBN from/IN cotherapy/NN ,/, an/DT increased/VBN dose/NN of/IN tricyclic/JJ antidepressant/JJ may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Furthermore)) (, ,) (S (ADVP (RB whenever)) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (JJ other) (NNS drugs)))) (VP (VBZ is) (VP (VBN withdrawn) (PP (IN from) (NP (NN cotherapy)))))) (, ,) (NP (NP (DT an) (VBN increased) (NN dose)) (PP (IN of) (NP (JJ tricyclic) (JJ antidepressant)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(required-22, Furthermore-1)
advmod(withdrawn-10, whenever-3)
nsubjpass(withdrawn-10, one-4)
det(drugs-8, these-6)
amod(drugs-8, other-7)
prep_of(one-4, drugs-8)
auxpass(withdrawn-10, is-9)
ccomp(required-22, withdrawn-10)
prep_from(withdrawn-10, cotherapy-12)
det(dose-16, an-14)
amod(dose-16, increased-15)
nsubjpass(required-22, dose-16)
amod(antidepressant-19, tricyclic-18)
prep_of(dose-16, antidepressant-19)
aux(required-22, may-20)
auxpass(required-22, be-21)
root(ROOT-0, required-22)

It/PRP is/VBZ desirable/JJ to/TO monitor/VB TCA/NN plasma/NN levels/NNS whenever/RB a/DT TCA/NN is/VBZ going/JJ to/TO be/VB co-administered/VBN with/IN another/DT drug/NN known/VBN to/TO be/VB an/DT inhibitor/NN of/IN P450/NN 2D6/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ desirable)) (S (VP (TO to) (VP (VB monitor) (NP (NN TCA) (NN plasma) (NNS levels)) (S (ADVP (RB whenever)) (NP (DT a) (NN TCA)) (VP (VBZ is) (ADJP (JJ going) (S (VP (TO to) (VP (VB be) (VP (VBN co-administered) (PP (IN with) (NP (NP (DT another) (NN drug)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN P450) (NN 2D6)))))))))))))))))))))) (. .))))

nsubj(desirable-3, It-1)
xsubj(monitor-5, It-1)
cop(desirable-3, is-2)
root(ROOT-0, desirable-3)
aux(monitor-5, to-4)
xcomp(desirable-3, monitor-5)
nn(levels-8, TCA-6)
nn(levels-8, plasma-7)
dobj(monitor-5, levels-8)
advmod(going-13, whenever-9)
det(TCA-11, a-10)
nsubj(going-13, TCA-11)
cop(going-13, is-12)
dep(monitor-5, going-13)
aux(co-administered-16, to-14)
auxpass(co-administered-16, be-15)
xcomp(going-13, co-administered-16)
det(drug-19, another-18)
prep_with(co-administered-16, drug-19)
partmod(drug-19, known-20)
aux(inhibitor-24, to-21)
cop(inhibitor-24, be-22)
det(inhibitor-24, an-23)
xcomp(known-20, inhibitor-24)
nn(2D6-27, P450-26)
prep_of(inhibitor-24, 2D6-27)

In/IN normal/JJ volunteers/NNS receiving/VBG indomethacin/NN ,/, the/DT administration/NN of/IN diflunisal/NN decreased/VBD the/DT renal/JJ clearance/NN and/CC significantly/RB increased/VBD the/DT plasma/NN levels/NNS of/IN indomethacin/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ normal) (NNS volunteers)) (VP (VBG receiving) (NP (NN indomethacin))))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN diflunisal)))) (VP (VP (VBD decreased) (NP (DT the) (JJ renal) (NN clearance))) (CC and) (VP (ADVP (RB significantly)) (VBD increased) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN indomethacin))))))) (. .))))

amod(volunteers-3, normal-2)
prep_in(decreased-11, volunteers-3)
partmod(volunteers-3, receiving-4)
dobj(receiving-4, indomethacin-5)
det(administration-8, the-7)
nsubj(decreased-11, administration-8)
prep_of(administration-8, diflunisal-10)
root(ROOT-0, decreased-11)
det(clearance-14, the-12)
amod(clearance-14, renal-13)
dobj(decreased-11, clearance-14)
advmod(increased-17, significantly-16)
conj_and(decreased-11, increased-17)
det(levels-20, the-18)
nn(levels-20, plasma-19)
dobj(increased-17, levels-20)
prep_of(levels-20, indomethacin-22)

In/IN some/DT patients/NNS ,/, combined/JJ use/NN of/IN INDOCIN/NN and/CC diflunisal/NN has/VBZ been/VBN associated/VBN with/IN fatal/JJ gastrointestinal/JJ hemorrhage/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT some) (NNS patients))) (, ,) (NP (NP (JJ combined) (NN use)) (PP (IN of) (NP (NP (NN INDOCIN)) (CC and) (NP (NN diflunisal))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (JJ fatal) (JJ gastrointestinal) (NN hemorrhage))))))) (. .))))

det(patients-3, some-2)
prep_in(associated-13, patients-3)
amod(use-6, combined-5)
nsubjpass(associated-13, use-6)
prep_of(use-6, INDOCIN-8)
conj_and(INDOCIN-8, diflunisal-10)
aux(associated-13, has-11)
auxpass(associated-13, been-12)
root(ROOT-0, associated-13)
amod(hemorrhage-17, fatal-15)
amod(hemorrhage-17, gastrointestinal-16)
prep_with(associated-13, hemorrhage-17)

Therefore/RB ,/, diflunisal/NN and/CC INDOCIN/NN should/MD not/RB be/VB used/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN diflunisal)) (CC and) (NP (NN INDOCIN))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (ADVP (RB concomitantly)))))) (. .))))

advmod(used-9, Therefore-1)
nsubjpass(used-9, diflunisal-3)
conj_and(diflunisal-3, INDOCIN-5)
aux(used-9, should-6)
neg(used-9, not-7)
auxpass(used-9, be-8)
root(ROOT-0, used-9)
advmod(used-9, concomitantly-10)

In/IN a/DT study/NN in/IN normal/JJ volunteers/NNS ,/, it/PRP was/VBD found/VBN that/IN chronic/JJ concurrent/JJ administration/NN of/IN 3.6/CD g/NN of/IN aspirin/NN per/IN day/NN decreases/VBZ indomethacin/NN blood/NN levels/NNS approximately/RB 20/CD %./NN

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (JJ normal) (NNS volunteers))))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP (NP (JJ chronic) (JJ concurrent) (NN administration)) (PP (IN of) (NP (NP (CD 3.6) (NN g)) (PP (IN of) (NP (NN aspirin))))) (PP (IN per) (NP (NN day)))) (VP (VBZ decreases) (NP (NN indomethacin) (NN blood) (NNS levels)))))))) (NP (QP (RB approximately) (CD 20)) (NN %.)))))

det(study-3, a-2)
prep_in(found-10, study-3)
amod(volunteers-6, normal-5)
prep_in(study-3, volunteers-6)
nsubjpass(found-10, it-8)
auxpass(found-10, was-9)
root(ROOT-0, found-10)
complm(decreases-22, that-11)
amod(administration-14, chronic-12)
amod(administration-14, concurrent-13)
nsubj(decreases-22, administration-14)
num(g-17, 3.6-16)
prep_of(administration-14, g-17)
prep_of(g-17, aspirin-19)
prep_per(administration-14, day-21)
ccomp(found-10, decreases-22)
nn(levels-25, indomethacin-23)
nn(levels-25, blood-24)
dobj(decreases-22, levels-25)
quantmod(20-27, approximately-26)
num(%.-28, 20-27)
dep(found-10, %.-28)

The/DT concomitant/JJ use/NN of/IN INDOCIN/NN with/IN other/JJ NSAIDs/NNS is/VBZ not/RB recommended/VBN due/JJ to/TO the/DT increased/VBN possibility/NN of/IN gastrointestinal/JJ toxicity/NN ,/, with/IN little/JJ or/CC no/DT increase/NN in/IN efficacy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NN INDOCIN))) (PP (IN with) (NP (JJ other) (NNS NSAIDs)))) (VP (VBZ is) (RB not) (VP (VBN recommended) (PP (JJ due) (TO to) (NP (NP (DT the) (VBN increased) (NN possibility)) (PP (IN of) (NP (JJ gastrointestinal) (NN toxicity))))) (, ,) (PP (IN with) (NP (NP (ADJP (JJ little))) (CC or) (NP (DT no)) (NP (NP (NN increase)) (PP (IN in) (NP (NN efficacy))))))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubjpass(recommended-11, use-3)
prep_of(use-3, INDOCIN-5)
amod(NSAIDs-8, other-7)
prep_with(use-3, NSAIDs-8)
auxpass(recommended-11, is-9)
neg(recommended-11, not-10)
root(ROOT-0, recommended-11)
det(possibility-16, the-14)
amod(possibility-16, increased-15)
prep_due_to(recommended-11, possibility-16)
amod(toxicity-19, gastrointestinal-18)
prep_of(possibility-16, toxicity-19)
prep_with(recommended-11, little-22)
conj_or(little-22, no-24)
dep(little-22, increase-25)
prep_in(increase-25, efficacy-27)

Clinical/JJ studies/NNS have/VBP shown/VBN that/IN INDOCIN/NN does/VBZ not/RB influence/VB the/DT hypoprothrombinemia/NN produced/VBN by/IN anticoagulants/NNS ./.

(ROOT (S1 (S (S (NP (JJ Clinical) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN INDOCIN)) (VP (VBZ does) (RB not) (VP (VB influence) (NP (NP (DT the) (NN hypoprothrombinemia)) (VP (VBN produced) (PP (IN by) (NP (NNS anticoagulants)))))))))))) (. .))))

amod(studies-2, Clinical-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
complm(influence-9, that-5)
nsubj(influence-9, INDOCIN-6)
aux(influence-9, does-7)
neg(influence-9, not-8)
ccomp(shown-4, influence-9)
det(hypoprothrombinemia-11, the-10)
dobj(influence-9, hypoprothrombinemia-11)
partmod(hypoprothrombinemia-11, produced-12)
agent(produced-12, anticoagulants-14)

However/RB ,/, when/WRB any/DT additional/JJ drug/NN ,/, including/VBG INDOCIN/NN ,/, is/VBZ added/VBN to/TO the/DT treatment/NN of/IN patients/NNS on/IN anticoagulant/NN therapy/NN ,/, the/DT patients/NNS should/MD be/VB observed/VBN for/IN alterations/NNS of/IN the/DT prothrombin/NN time/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT any) (JJ additional) (NN drug)) (, ,) (PP (VBG including) (NP (NN INDOCIN))) (, ,)) (VP (VBZ is) (VP (VBN added) (PP (TO to) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN on) (NP (NN anticoagulant) (NN therapy))))))))))) (, ,) (NP (DT the) (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN observed) (PP (IN for) (NP (NP (NNS alterations)) (PP (IN of) (NP (DT the) (NN prothrombin) (NN time))))))))) (. .))))

advmod(observed-26, However-1)
advmod(added-12, when-3)
det(drug-6, any-4)
amod(drug-6, additional-5)
nsubjpass(added-12, drug-6)
prep_including(drug-6, INDOCIN-9)
auxpass(added-12, is-11)
advcl(observed-26, added-12)
det(treatment-15, the-14)
prep_to(added-12, treatment-15)
prep_of(treatment-15, patients-17)
nn(therapy-20, anticoagulant-19)
prep_on(patients-17, therapy-20)
det(patients-23, the-22)
nsubjpass(observed-26, patients-23)
aux(observed-26, should-24)
auxpass(observed-26, be-25)
root(ROOT-0, observed-26)
prep_for(observed-26, alterations-28)
det(time-32, the-30)
nn(time-32, prothrombin-31)
prep_of(alterations-28, time-32)

In/IN post-marketing/JJ experience/VBP ,/, bleeding/JJ has/VBZ been/VBN reported/VBN in/IN patients/NNS on/IN concomitant/JJ treatment/NN with/IN anticoagulants/NNS and/CC INDOCIN/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ post-marketing) (VBP experience))) (, ,) (NP (JJ bleeding)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NP (JJ concomitant) (NN treatment)) (PP (IN with) (NP (NP (NNS anticoagulants)) (CC and) (NP (NN INDOCIN)))))))))))) (. .))))

prep_in(reported-8, post-marketing-2)
dep(post-marketing-2, experience-3)
nsubjpass(reported-8, bleeding-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
prep_in(reported-8, patients-10)
amod(treatment-13, concomitant-12)
prep_on(patients-10, treatment-13)
prep_with(treatment-13, anticoagulants-15)
conj_and(anticoagulants-15, INDOCIN-17)

Caution/NN should/MD be/VB exercised/VBN when/WRB INDOCIN/NN and/CC anticoagulants/NNS are/VBP administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN INDOCIN)) (CC and) (NP (NNS anticoagulants))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(administered-10, when-5)
nsubjpass(administered-10, INDOCIN-6)
conj_and(INDOCIN-6, anticoagulants-8)
auxpass(administered-10, are-9)
advcl(exercised-4, administered-10)
advmod(administered-10, concomitantly-11)

When/WRB INDOCIN/NN is/VBZ given/VBN to/TO patients/NNS receiving/VBG probenecid/NN ,/, the/DT plasma/NN levels/NNS of/IN indomethacin/NN are/VBP likely/JJ to/TO be/VB increased/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN INDOCIN)) (VP (VBZ is) (VP (VBN given) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN probenecid))))))))) (, ,) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN indomethacin)))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (VP (VBN increased)))))))) (. .))))

advmod(given-4, When-1)
nsubjpass(given-4, INDOCIN-2)
auxpass(given-4, is-3)
advcl(likely-16, given-4)
prep_to(given-4, patients-6)
partmod(patients-6, receiving-7)
dobj(receiving-7, probenecid-8)
det(levels-12, the-10)
nn(levels-12, plasma-11)
nsubj(likely-16, levels-12)
prep_of(levels-12, indomethacin-14)
cop(likely-16, are-15)
root(ROOT-0, likely-16)
aux(increased-19, to-17)
auxpass(increased-19, be-18)
xcomp(likely-16, increased-19)

Therefore/RB ,/, a/DT lower/RBR total/JJ daily/JJ dosage/NN of/IN INDOCIN/NN may/MD produce/VB a/DT satisfactory/JJ therapeutic/JJ effect/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT a) (ADJP (RBR lower) (JJ total)) (JJ daily) (NN dosage)) (PP (IN of) (NP (NN INDOCIN)))) (VP (MD may) (VP (VB produce) (NP (DT a) (JJ satisfactory) (JJ therapeutic) (NN effect))))) (. .))))

advmod(produce-11, Therefore-1)
det(dosage-7, a-3)
advmod(total-5, lower-4)
amod(dosage-7, total-5)
amod(dosage-7, daily-6)
nsubj(produce-11, dosage-7)
prep_of(dosage-7, INDOCIN-9)
aux(produce-11, may-10)
root(ROOT-0, produce-11)
det(effect-15, a-12)
amod(effect-15, satisfactory-13)
amod(effect-15, therapeutic-14)
dobj(produce-11, effect-15)

When/WRB increases/NNS in/IN the/DT dose/NN of/IN INDOCIN/NN are/VBP made/VBN ,/, they/PRP should/MD be/VB made/VBN carefully/RB and/CC in/IN small/JJ increments/NNS ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN INDOCIN)))))) (VP (VBP are) (VP (VBN made))))) (, ,) (NP (PRP they)) (VP (MD should) (VP (VB be) (VP (VBN made) (UCP (ADVP (RB carefully)) (CC and) (PP (IN in) (NP (JJ small) (NNS increments)))))))) (. .))))

advmod(made-9, When-1)
nsubjpass(made-9, increases-2)
det(dose-5, the-4)
prep_in(increases-2, dose-5)
prep_of(dose-5, INDOCIN-7)
auxpass(made-9, are-8)
advcl(made-14, made-9)
nsubjpass(made-14, they-11)
aux(made-14, should-12)
auxpass(made-14, be-13)
root(ROOT-0, made-14)
dep(made-14, carefully-15)
conj_and(carefully-15, in-17)
amod(increments-19, small-18)
pobj(in-17, increments-19)

Caution/NN should/MD be/VB used/VBN if/IN INDOCIN/NN is/VBZ administered/VBN simultaneously/RB with/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (SBAR (IN if) (S (NP (NN INDOCIN)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB simultaneously)) (PP (IN with) (NP (NN methotrexate))))))))))) (. .))))

nsubjpass(used-4, Caution-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
mark(administered-8, if-5)
nsubjpass(administered-8, INDOCIN-6)
auxpass(administered-8, is-7)
advcl(used-4, administered-8)
advmod(administered-8, simultaneously-9)
prep_with(administered-8, methotrexate-11)

INDOCIN/NN has/VBZ been/VBN reported/VBN to/TO decrease/VB the/DT tubular/JJ secretion/NN of/IN methotrexate/NN and/CC to/TO potentiate/VB its/PRP$ toxicity/NN ./.

(ROOT (S1 (S (S (NP (NN INDOCIN)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (VP (TO to) (VP (VB decrease) (NP (NP (DT the) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NN methotrexate)))))) (CC and) (VP (TO to) (VP (VB potentiate) (NP (PRP$ its) (NN toxicity)))))))))) (. .))))

nsubjpass(reported-4, INDOCIN-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
aux(decrease-6, to-5)
ccomp(reported-4, decrease-6)
det(secretion-9, the-7)
amod(secretion-9, tubular-8)
dobj(decrease-6, secretion-9)
prep_of(secretion-9, methotrexate-11)
aux(potentiate-14, to-13)
conj_and(decrease-6, potentiate-14)
poss(toxicity-16, its-15)
dobj(potentiate-14, toxicity-16)

Administration/NN of/IN non-steroidal/JJ anti-inflammatory/JJ drugs/NNS concomitantly/RB with/IN cyclosporine/NN has/VBZ been/VBN associated/VBN with/IN an/DT increase/NN in/IN cyclosporine-induced/JJ toxicity/NN ,/, possibly/RB due/JJ to/TO decreased/VBN synthesis/NN of/IN renal/JJ prostacyclin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (PP (ADVP (RB concomitantly)) (IN with) (NP (NN cyclosporine)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ cyclosporine-induced) (NN toxicity))))) (, ,) (PP (ADVP (RB possibly)) (JJ due) (TO to) (NP (NP (VBN decreased) (NN synthesis)) (PP (IN of) (NP (JJ renal) (NN prostacyclin))))))))) (. .))))

nsubjpass(associated-11, Administration-1)
amod(drugs-5, non-steroidal-3)
amod(drugs-5, anti-inflammatory-4)
prep_of(Administration-1, drugs-5)
advmod(drugs-5, concomitantly-6)
prep_with(drugs-5, cyclosporine-8)
aux(associated-11, has-9)
auxpass(associated-11, been-10)
root(ROOT-0, associated-11)
det(increase-14, an-13)
prep_with(associated-11, increase-14)
amod(toxicity-17, cyclosporine-induced-16)
prep_in(increase-14, toxicity-17)
advmod(associated-11, possibly-19)
amod(synthesis-23, decreased-22)
prep_due_to(associated-11, synthesis-23)
amod(prostacyclin-26, renal-25)
prep_of(synthesis-23, prostacyclin-26)

NSAIDs/NN should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS taking/VBG cyclosporine/NN ,/, and/CC renal/JJ function/NN should/MD be/VB carefully/RB monitored/VBN ./.

(ROOT (S1 (S (S (S (NP (NN NSAIDs)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN cyclosporine))))))))) (, ,) (CC and) (S (NP (JJ renal) (NN function)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored)))))) (. .))))

nsubjpass(used-4, NSAIDs-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
prep_with(used-4, caution-6)
prep_in(used-4, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, cyclosporine-10)
amod(function-14, renal-13)
nsubjpass(monitored-18, function-14)
aux(monitored-18, should-15)
auxpass(monitored-18, be-16)
advmod(monitored-18, carefully-17)
conj_and(used-4, monitored-18)

Capsules/NNS INDOCIN/NN 50/CD mg/NN t.i.d./RB produced/VBD a/DT clinically/RB relevant/JJ elevation/NN of/IN plasma/NN lithium/NN and/CC reduction/NN in/IN renal/JJ lithium/NN clearance/NN in/IN psychiatric/JJ patients/NNS and/CC normal/JJ subjects/NNS with/IN steady/JJ state/NN plasma/NN lithium/NN concentrations/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Capsules)) (NP (NN INDOCIN) (CD 50) (NN mg))) (ADVP (RB t.i.d.)) (VP (VBD produced) (NP (NP (NP (DT a) (ADJP (RB clinically) (JJ relevant)) (NN elevation)) (PP (IN of) (NP (NN plasma) (NN lithium)))) (CC and) (NP (NP (NN reduction)) (PP (IN in) (NP (NP (JJ renal) (NN lithium) (NN clearance)) (PP (IN in) (NP (NP (NP (JJ psychiatric) (NNS patients)) (CC and) (NP (JJ normal) (NNS subjects))) (PP (IN with) (NP (JJ steady) (NN state) (NN plasma) (NN lithium) (NNS concentrations)))))))))) (. .))))

nsubj(produced-6, Capsules-1)
nn(mg-4, INDOCIN-2)
num(mg-4, 50-3)
dep(Capsules-1, mg-4)
advmod(produced-6, t.i.d.-5)
root(ROOT-0, produced-6)
det(elevation-10, a-7)
advmod(relevant-9, clinically-8)
amod(elevation-10, relevant-9)
dobj(produced-6, elevation-10)
nn(lithium-13, plasma-12)
prep_of(elevation-10, lithium-13)
conj_and(elevation-10, reduction-15)
amod(clearance-19, renal-17)
nn(clearance-19, lithium-18)
prep_in(reduction-15, clearance-19)
amod(patients-22, psychiatric-21)
prep_in(clearance-19, patients-22)
amod(subjects-25, normal-24)
conj_and(patients-22, subjects-25)
amod(concentrations-31, steady-27)
nn(concentrations-31, state-28)
nn(concentrations-31, plasma-29)
nn(concentrations-31, lithium-30)
prep_with(patients-22, concentrations-31)

This/DT effect/NN has/VBZ been/VBN attributed/VBN to/TO inhibition/NN of/IN prostaglandin/NN synthesis/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN effect)) (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN prostaglandin) (NN synthesis))))))))) (. .))))

det(effect-2, This-1)
nsubjpass(attributed-5, effect-2)
aux(attributed-5, has-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
nn(synthesis-10, prostaglandin-9)
prep_of(inhibition-7, synthesis-10)

As/IN a/DT consequence/NN ,/, when/WRB INDOCIN/NN and/CC lithium/NN are/VBP given/VBN concomitantly/RB ,/, the/DT patient/NN should/MD be/VB carefully/RB observed/VBN for/IN signs/NNS of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (PP (IN As) (NP (DT a) (NN consequence))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN INDOCIN)) (CC and) (NP (NN lithium))) (VP (VBP are) (VP (VBN given) (ADVP (RB concomitantly)))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN observed) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (NN lithium) (NN toxicity))))))))) (. .))))

det(consequence-3, a-2)
prep_as(observed-18, consequence-3)
advmod(given-10, when-5)
nsubjpass(given-10, INDOCIN-6)
conj_and(INDOCIN-6, lithium-8)
auxpass(given-10, are-9)
advcl(observed-18, given-10)
advmod(given-10, concomitantly-11)
det(patient-14, the-13)
nsubjpass(observed-18, patient-14)
aux(observed-18, should-15)
auxpass(observed-18, be-16)
advmod(observed-18, carefully-17)
root(ROOT-0, observed-18)
prep_for(observed-18, signs-20)
nn(toxicity-23, lithium-22)
prep_of(signs-20, toxicity-23)

(/-LRB- Read/VBN circulars/NNS for/IN lithium/NN preparation/NN s/NNS before/IN use/NN of/IN such/JJ concomitant/JJ therapy./NN )/-RRB- ./.

(ROOT (S1 (S (S (PRN (-LRB- -LRB-) (NP (NP (VBN Read) (NNS circulars)) (PP (IN for) (NP (NP (NN lithium) (NN preparation) (NNS s)) (PP (IN before) (NP (NP (NN use)) (PP (IN of) (NP (JJ such) (JJ concomitant) (NN therapy.)))))))) (-RRB- -RRB-))) (. .))))

amod(circulars-3, Read-2)
root(ROOT-0, circulars-3)
nn(s-7, lithium-5)
nn(s-7, preparation-6)
prep_for(circulars-3, s-7)
prep_before(s-7, use-9)
amod(therapy.-13, such-11)
amod(therapy.-13, concomitant-12)
prep_of(use-9, therapy.-13)

In/IN addition/NN ,/, the/DT frequency/NN of/IN monitoring/VBG serum/NN lithium/NN concentration/NN should/MD be/VB increased/VBN at/IN the/DT outset/NN of/IN such/JJ combination/NN drug/NN treatment/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN frequency)) (PP (IN of) (S (VP (VBG monitoring) (NP (NN serum) (NN lithium) (NN concentration)))))) (VP (MD should) (VP (VB be) (VP (VBN increased) (PP (IN at) (NP (NP (DT the) (NN outset)) (PP (IN of) (NP (JJ such) (NN combination) (NN drug) (NN treatment))))))))) (. .))))

prep_in(increased-13, addition-2)
det(frequency-5, the-4)
nsubjpass(increased-13, frequency-5)
prepc_of(frequency-5, monitoring-7)
nn(concentration-10, serum-8)
nn(concentration-10, lithium-9)
dobj(monitoring-7, concentration-10)
aux(increased-13, should-11)
auxpass(increased-13, be-12)
root(ROOT-0, increased-13)
det(outset-16, the-15)
prep_at(increased-13, outset-16)
amod(treatment-21, such-18)
nn(treatment-21, combination-19)
nn(treatment-21, drug-20)
prep_of(outset-16, treatment-21)

INDOCIN/NN given/VBN concomitantly/RB with/IN digoxin/NN has/VBZ been/VBN reported/VBN to/TO increase/VB the/DT serum/NN concentration/NN and/CC prolong/VB the/DT half-life/NN of/IN digoxin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN INDOCIN)) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN digoxin))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VP (VB increase) (NP (DT the) (NN serum) (NN concentration))) (CC and) (VP (VB prolong) (NP (NP (DT the) (NN half-life)) (PP (IN of) (NP (NN digoxin)))))))))))) (. .))))

nsubjpass(reported-8, INDOCIN-1)
xsubj(increase-10, INDOCIN-1)
partmod(INDOCIN-1, given-2)
advmod(given-2, concomitantly-3)
prep_with(given-2, digoxin-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
aux(increase-10, to-9)
xcomp(reported-8, increase-10)
det(concentration-13, the-11)
nn(concentration-13, serum-12)
dobj(increase-10, concentration-13)
conj_and(increase-10, prolong-15)
det(half-life-17, the-16)
dobj(prolong-15, half-life-17)
prep_of(half-life-17, digoxin-19)

Therefore/RB ,/, when/WRB INDOCIN/NN and/CC digoxin/NN are/VBP used/VBN concomitantly/RB ,/, serum/NN digoxin/NN levels/NNS should/MD be/VB closely/RB monitored/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN INDOCIN)) (CC and) (NP (NN digoxin))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)))))) (, ,) (NP (NN serum) (NN digoxin) (NNS levels)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored))))) (. .))))

advmod(monitored-17, Therefore-1)
advmod(used-8, when-3)
nsubjpass(used-8, INDOCIN-4)
conj_and(INDOCIN-4, digoxin-6)
auxpass(used-8, are-7)
advcl(monitored-17, used-8)
advmod(used-8, concomitantly-9)
nn(levels-13, serum-11)
nn(levels-13, digoxin-12)
nsubjpass(monitored-17, levels-13)
aux(monitored-17, should-14)
auxpass(monitored-17, be-15)
advmod(monitored-17, closely-16)
root(ROOT-0, monitored-17)

In/IN some/DT patients/NNS ,/, the/DT administration/NN of/IN INDOCIN/NN can/MD reduce/VB the/DT diuretic/JJ ,/, natriuretic/JJ ,/, and/CC antihypertensive/JJ effects/NNS of/IN loop/NN ,/, potassium/NN -sparing/NN ,/, and/CC thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT some) (NNS patients))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN INDOCIN)))) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (ADJP (ADJP (JJ diuretic)) (, ,) (ADJP (JJ natriuretic)) (, ,) (CC and) (ADJP (JJ antihypertensive))) (NNS effects)) (PP (IN of) (NP (NP (NN loop)) (, ,) (NP (NN potassium) (NN -sparing)) (, ,) (CC and) (NP (NN thiazide) (NNS diuretics)))))))) (. .))))

det(patients-3, some-2)
prep_in(reduce-10, patients-3)
det(administration-6, the-5)
nsubj(reduce-10, administration-6)
prep_of(administration-6, INDOCIN-8)
aux(reduce-10, can-9)
root(ROOT-0, reduce-10)
det(effects-18, the-11)
amod(effects-18, diuretic-12)
conj_and(diuretic-12, natriuretic-14)
conj_and(diuretic-12, antihypertensive-17)
dobj(reduce-10, effects-18)
prep_of(effects-18, loop-20)
nn(-sparing-23, potassium-22)
conj_and(loop-20, -sparing-23)
nn(diuretics-27, thiazide-26)
conj_and(loop-20, diuretics-27)

Therefore/RB ,/, when/IN INDOCIN/NN and/CC INDOCIN/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (PP (IN when) (NP (NP (NN INDOCIN)) (CC and) (NP (NN INDOCIN))))) (. .))))

advmod(when-3, Therefore-1)
root(ROOT-0, when-3)
pobj(when-3, INDOCIN-4)
conj_and(INDOCIN-4, INDOCIN-6)

(/-LRB- Indomethacin/NN )/-RRB- diuretics/NNS are/VBP used/VBN concomitantly/RB ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB to/TO determine/VB if/IN the/DT desired/JJ effect/NN of/IN the/DT diuretic/NN is/VBZ obtained/VBN ./.

(ROOT (S1 (S (S (NP (-LRB- -LRB-) (NN Indomethacin) (-RRB- -RRB-) (NNS diuretics)) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly))) (, ,) (S (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ desired) (NN effect)) (PP (IN of) (NP (DT the) (NN diuretic)))) (VP (VBZ is) (VP (VBN obtained)))))))))))))) (. .))))

nn(diuretics-4, Indomethacin-2)
nsubjpass(used-6, diuretics-4)
auxpass(used-6, are-5)
root(ROOT-0, used-6)
advmod(used-6, concomitantly-7)
det(patient-10, the-9)
nsubjpass(observed-13, patient-10)
aux(observed-13, should-11)
auxpass(observed-13, be-12)
ccomp(used-6, observed-13)
advmod(observed-13, closely-14)
aux(determine-16, to-15)
xcomp(observed-13, determine-16)
mark(obtained-25, if-17)
det(effect-20, the-18)
amod(effect-20, desired-19)
nsubjpass(obtained-25, effect-20)
det(diuretic-23, the-22)
prep_of(effect-20, diuretic-23)
auxpass(obtained-25, is-24)
advcl(determine-16, obtained-25)

INDOCIN/NN reduces/VBZ basal/JJ plasma/NN renin/NN activity/NN (/-LRB- PRA/NN )/-RRB- ,/, as/RB well/RB as/IN those/DT elevations/NNS of/IN PRA/NN induced/VBN by/IN furosemide/NN administration/NN ,/, or/CC salt/NN or/CC volume/NN depletion/NN ./.

(ROOT (S1 (S (S (NP (NN INDOCIN)) (VP (VBZ reduces) (NP (NP (NP (JJ basal) (NN plasma) (NN renin) (NN activity)) (PRN (-LRB- -LRB-) (NP (NN PRA)) (-RRB- -RRB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT those) (NNS elevations)) (PP (IN of) (NP (NP (NN PRA)) (VP (VBN induced) (PP (IN by) (NP (NP (NN furosemide) (NN administration)) (, ,) (CC or) (NP (NN salt)) (CC or) (NP (NN volume) (NN depletion))))))))))) (. .))))

nsubj(reduces-2, INDOCIN-1)
root(ROOT-0, reduces-2)
amod(activity-6, basal-3)
nn(activity-6, plasma-4)
nn(activity-6, renin-5)
dobj(reduces-2, activity-6)
abbrev(activity-6, PRA-8)
det(elevations-15, those-14)
conj_and(activity-6, elevations-15)
prep_of(elevations-15, PRA-17)
partmod(PRA-17, induced-18)
nn(administration-21, furosemide-20)
agent(induced-18, administration-21)
conj_or(administration-21, salt-24)
nn(depletion-27, volume-26)
conj_or(administration-21, depletion-27)

It/PRP has/VBZ been/VBN reported/VBN that/IN the/DT addition/NN of/IN triamterene/NN to/TO a/DT maintenance/NN schedule/NN of/IN INDOCIN/NN resulted/VBD in/IN reversible/JJ acute/JJ renal/JJ failure/NN in/IN two/CD of/IN four/CD healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN triamterene))) (PP (TO to) (NP (NP (DT a) (NN maintenance) (NN schedule)) (PP (IN of) (NP (NN INDOCIN)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ reversible) (JJ acute) (JJ renal) (NN failure)) (PP (IN in) (NP (NP (CD two)) (PP (IN of) (NP (CD four) (JJ healthy) (NNS volunteers)))))))))))))) (. .))))

nsubjpass(reported-4, It-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
complm(resulted-16, that-5)
det(addition-7, the-6)
nsubj(resulted-16, addition-7)
prep_of(addition-7, triamterene-9)
det(schedule-13, a-11)
nn(schedule-13, maintenance-12)
prep_to(addition-7, schedule-13)
prep_of(schedule-13, INDOCIN-15)
ccomp(reported-4, resulted-16)
amod(failure-21, reversible-18)
amod(failure-21, acute-19)
amod(failure-21, renal-20)
prep_in(resulted-16, failure-21)
prep_in(failure-21, two-23)
num(volunteers-27, four-25)
amod(volunteers-27, healthy-26)
prep_of(two-23, volunteers-27)

INDOCIN/NN and/CC triamterene/NN should/MD not/RB be/VB administered/VBN together/RB ./.

(ROOT (S1 (S (S (NP (NP (NN INDOCIN)) (CC and) (NP (NN triamterene))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB together)))))) (. .))))

nsubjpass(administered-7, INDOCIN-1)
conj_and(INDOCIN-1, triamterene-3)
aux(administered-7, should-4)
neg(administered-7, not-5)
auxpass(administered-7, be-6)
root(ROOT-0, administered-7)
advmod(administered-7, together-8)

INDOCIN/NN and/CC potassium-sparing/JJ diuretics/NNS each/DT may/MD be/VB associated/VBN with/IN increased/VBN serum/NN potassium/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN INDOCIN)) (CC and) (NP (NP (JJ potassium-sparing) (NNS diuretics)) (NP (DT each)))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (VBN increased) (NN serum) (NN potassium) (NNS levels))))))) (. .))))

nsubjpass(associated-8, INDOCIN-1)
amod(diuretics-4, potassium-sparing-3)
conj_and(INDOCIN-1, diuretics-4)
dep(diuretics-4, each-5)
aux(associated-8, may-6)
auxpass(associated-8, be-7)
root(ROOT-0, associated-8)
amod(levels-13, increased-10)
nn(levels-13, serum-11)
nn(levels-13, potassium-12)
prep_with(associated-8, levels-13)

The/DT potential/JJ effects/NNS of/IN INDOCIN/JJ and/CC potassium-sparing/JJ diuretics/NNS on/IN potassium/NN kinetics/NNS and/CC renal/JJ function/NN should/MD be/VB considered/VBN when/WRB these/DT agents/NNS are/VBP administered/VBN concurrently/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ potential) (NNS effects)) (PP (IN of) (NP (ADJP (ADJP (JJ INDOCIN)) (CC and) (ADJP (JJ potassium-sparing))) (NNS diuretics))) (PP (IN on) (NP (NP (NN potassium) (NNS kinetics)) (CC and) (NP (JJ renal) (NN function))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS agents)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concurrently)))))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, potential-2)
nsubjpass(considered-17, effects-3)
amod(diuretics-8, INDOCIN-5)
conj_and(INDOCIN-5, potassium-sparing-7)
prep_of(effects-3, diuretics-8)
nn(kinetics-11, potassium-10)
prep_on(effects-3, kinetics-11)
amod(function-14, renal-13)
conj_and(kinetics-11, function-14)
aux(considered-17, should-15)
auxpass(considered-17, be-16)
root(ROOT-0, considered-17)
advmod(administered-22, when-18)
det(agents-20, these-19)
nsubjpass(administered-22, agents-20)
auxpass(administered-22, are-21)
advcl(considered-17, administered-22)
advmod(administered-22, concurrently-23)

Most/JJS of/IN the/DT above/JJ effects/NNS concerning/VBG diuretics/NNS have/VBP been/VBN attributed/VBN ,/, at/IN least/JJS in/IN part/NN ,/, to/TO mechanisms/NNS involving/VBG inhibition/NN of/IN prostaglandin/NN synthesis/NN by/IN INDOCIN/NN ./.

(ROOT (S1 (S (S (NP (NP (JJS Most)) (PP (IN of) (NP (NP (DT the) (JJ above) (NNS effects)) (VP (VBG concerning) (NP (NNS diuretics)))))) (VP (VBP have) (VP (VBN been) (VP (VBN attributed) (, ,) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part))) (, ,) (PP (TO to) (NP (NP (NNS mechanisms)) (VP (VBG involving) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN prostaglandin) (NN synthesis))) (PP (IN by) (NP (NN INDOCIN))))))))))) (. .))))

nsubjpass(attributed-10, Most-1)
det(effects-5, the-3)
amod(effects-5, above-4)
prep_of(Most-1, effects-5)
partmod(effects-5, concerning-6)
dobj(concerning-6, diuretics-7)
aux(attributed-10, have-8)
auxpass(attributed-10, been-9)
root(ROOT-0, attributed-10)
advmod(attributed-10, at-12)
pobj(at-12, least-13)
prep_in(attributed-10, part-15)
prep_to(attributed-10, mechanisms-18)
partmod(mechanisms-18, involving-19)
dobj(involving-19, inhibition-20)
nn(synthesis-23, prostaglandin-22)
prep_of(inhibition-20, synthesis-23)
prep_by(inhibition-20, INDOCIN-25)

Blunting/NN of/IN the/DT antihypertensive/JJ effect/NN of/IN beta-adrenoceptor/NN blocking/NN agent/NN s/NNS by/IN non-steroidal/JJ antiinflammatory/JJ drugs/NNS including/VBG INDOCIN/NN has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Blunting)) (PP (IN of) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NN beta-adrenoceptor) (NN blocking) (NN agent) (NNS s))))) (PP (IN by) (NP (NP (JJ non-steroidal) (JJ antiinflammatory) (NNS drugs)) (PP (VBG including) (NP (NN INDOCIN)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))))) (. .))))

nsubjpass(reported-19, Blunting-1)
det(effect-5, the-3)
amod(effect-5, antihypertensive-4)
prep_of(Blunting-1, effect-5)
nn(s-10, beta-adrenoceptor-7)
nn(s-10, blocking-8)
nn(s-10, agent-9)
prep_of(effect-5, s-10)
amod(drugs-14, non-steroidal-12)
amod(drugs-14, antiinflammatory-13)
prep_by(Blunting-1, drugs-14)
prep_including(drugs-14, INDOCIN-16)
aux(reported-19, has-17)
auxpass(reported-19, been-18)
root(ROOT-0, reported-19)

INDOCIN/NN can/MD reduce/VB the/DT antihypertensive/JJ effects/NNS of/IN captopril/NN and/CC losartan/NN ./.

(ROOT (S1 (S (S (NP (NN INDOCIN)) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (JJ antihypertensive) (NNS effects)) (PP (IN of) (NP (NP (NN captopril)) (CC and) (NP (NN losartan)))))))) (. .))))

nsubj(reduce-3, INDOCIN-1)
aux(reduce-3, can-2)
root(ROOT-0, reduce-3)
det(effects-6, the-4)
amod(effects-6, antihypertensive-5)
dobj(reduce-3, effects-6)
prep_of(effects-6, captopril-8)
conj_and(captopril-8, losartan-10)

False-negative/JJ results/NNS in/IN the/DT dexamethasone/NN suppression/NN test/NN (/-LRB- DST/NN )/-RRB- in/IN patients/NNS being/VBG treated/VBN with/IN INDOCIN/NN have/VBP been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ False-negative) (NNS results)) (PP (IN in) (NP (NP (NP (DT the) (NN dexamethasone) (NN suppression) (NN test)) (PRN (-LRB- -LRB-) (NP (NN DST)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN INDOCIN)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported))))) (. .))))

amod(results-2, False-negative-1)
nsubjpass(reported-19, results-2)
det(test-7, the-4)
nn(test-7, dexamethasone-5)
nn(test-7, suppression-6)
prep_in(results-2, test-7)
abbrev(test-7, DST-9)
prep_in(test-7, patients-12)
auxpass(treated-14, being-13)
partmod(patients-12, treated-14)
prep_with(treated-14, INDOCIN-16)
aux(reported-19, have-17)
auxpass(reported-19, been-18)
root(ROOT-0, reported-19)

A/DT number/NN of/IN substances/NNS affect/VBP glucose/NN metabolism/NN and/CC may/MD require/VBP insulin/NN dose/NN adjustment/NN and/CC particularly/RB close/JJ monitoring/NN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (NN number)) (PP (IN of) (NP (NNS substances)))) (VP (VP (VBP affect) (NP (NN glucose) (NN metabolism))) (CC and) (VP (MD may) (VP (VBP require) (NP (NP (NN insulin) (NN dose) (NN adjustment)) (CC and) (ADVP (RB particularly)) (NP (JJ close) (NN monitoring))))))) (. .))))

det(number-2, A-1)
nsubj(affect-5, number-2)
prep_of(number-2, substances-4)
root(ROOT-0, affect-5)
nn(metabolism-7, glucose-6)
dobj(affect-5, metabolism-7)
aux(require-10, may-9)
conj_and(affect-5, require-10)
nn(adjustment-13, insulin-11)
nn(adjustment-13, dose-12)
dobj(require-10, adjustment-13)
advmod(adjustment-13, particularly-15)
conj_and(adjustment-13, particularly-15)
amod(monitoring-17, close-16)
conj_and(adjustment-13, monitoring-17)

@/NN @/NN @/NN The/DT following/NN are/VBP examples/NNS of/IN substances/NNS that/WDT may/MD increase/VB the/DT blood-glucose-lowering/JJ effect/NN and/CC susceptibility/NN to/TO hypoglycemia/NN :/: oral/JJ antidiabetic/JJ products/NNS ,/, ACE/NN inhibitors/NNS ,/, disopyramide/NN ,/, fibrates/NNS ,/, fluoxetine/NN ,/, monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS ,/, propoxyphene/NN ,/, salicylates/NNS ,/, somatostatin/NN analog/NN (/-LRB- e.g./FW ,/, octreotide/NN )/-RRB- ,/, sulfonamide/NN antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (NN @) (NN @) (NN @) (NP (DT The) (NN following))) (VP (VBP are) (NP (NP (NP (NNS examples)) (PP (IN of) (NP (NP (NNS substances)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB increase) (NP (NP (DT the) (JJ blood-glucose-lowering) (NN effect)) (CC and) (NP (NP (NN susceptibility)) (PP (TO to) (NP (NN hypoglycemia)))))))))))) (: :) (NP (NP (JJ oral) (JJ antidiabetic) (NNS products)) (, ,) (NP (NN ACE) (NNS inhibitors)) (, ,) (NP (NN disopyramide)) (, ,) (NP (NNS fibrates)) (, ,) (NP (NN fluoxetine)) (, ,) (NP (NN monoamine) (NN oxidase) (-LRB- -LRB-) (NN MAO) (-RRB- -RRB-) (NNS inhibitors)) (, ,) (NP (NN propoxyphene)) (, ,) (NP (NNS salicylates)) (, ,) (NP (NN somatostatin) (NN analog)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN octreotide))) (-RRB- -RRB-)) (, ,) (NP (NN sulfonamide) (NNS antibiotics)))))) (. .))))

nn(@-3, @-1)
nn(@-3, @-2)
nsubj(examples-7, @-3)
det(following-5, The-4)
dep(@-3, following-5)
cop(examples-7, are-6)
root(ROOT-0, examples-7)
prep_of(examples-7, substances-9)
nsubj(increase-12, substances-9)
aux(increase-12, may-11)
rcmod(substances-9, increase-12)
det(effect-15, the-13)
amod(effect-15, blood-glucose-lowering-14)
dobj(increase-12, effect-15)
conj_and(effect-15, susceptibility-17)
prep_to(susceptibility-17, hypoglycemia-19)
amod(products-23, oral-21)
amod(products-23, antidiabetic-22)
dep(examples-7, products-23)
nn(inhibitors-26, ACE-25)
appos(products-23, inhibitors-26)
appos(products-23, disopyramide-28)
appos(products-23, fibrates-30)
appos(products-23, fluoxetine-32)
nn(inhibitors-39, monoamine-34)
nn(inhibitors-39, oxidase-35)
nn(inhibitors-39, MAO-37)
appos(products-23, inhibitors-39)
appos(products-23, propoxyphene-41)
appos(products-23, salicylates-43)
nn(analog-46, somatostatin-45)
appos(products-23, analog-46)
dep(products-23, e.g.-48)
pobj(e.g.-48, octreotide-50)
nn(antibiotics-54, sulfonamide-53)
appos(products-23, antibiotics-54)

@/NN @/NN @/NN The/DT following/VBG are/VBP examples/NNS of/IN substances/NNS that/WDT may/MD reduce/VB the/DT blood-glucose-lowering/JJ effect/NN :/: corticosteroids/NNS ,/, niacin/NN ,/, danazol/NN ,/, diuretics/NN ,/, sympathomimetic/JJ agents/NNS (/-LRB- e.g./FW ,/, epinephrine/NN ,/, salbutamol/NN ,/, terbutaline/NN )/-RRB- ,/, isoniazid/NN ,/, phenothiazine/JJ derivatives/NNS ,/, somatropin/NN ,/, thyroid/NN hormones/NNS ,/, estrogens/NNS ,/, progestogens/NNS (/-LRB- e.g./FW ,/, in/IN oral/JJ contraceptives/NNS )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NN @) (NN @) (NN @)) (NP (DT The) (VBG following))) (VP (VBP are) (NP (NP (NP (NNS examples)) (PP (IN of) (NP (NNS substances))) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB reduce) (NP (DT the) (JJ blood-glucose-lowering) (NN effect))))))) (: :) (NP (NP (NNS corticosteroids)) (, ,) (NP (NN niacin)) (, ,) (NP (NN danazol)) (, ,) (NP (NN diuretics)) (, ,) (NP (NP (JJ sympathomimetic) (NNS agents)) (PRN (-LRB- -LRB-) (NP (FW e.g.) (, ,) (NP (NN epinephrine)) (, ,) (NP (NN salbutamol)) (, ,) (NP (NN terbutaline))) (-RRB- -RRB-))) (, ,) (NP (NN isoniazid)) (, ,) (NP (JJ phenothiazine) (NNS derivatives)) (, ,) (NP (NN somatropin)) (, ,) (NP (NN thyroid) (NNS hormones)) (, ,) (NP (NNS estrogens)) (, ,) (NP (NNS progestogens)))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (PP (IN in) (NP (JJ oral) (NNS contraceptives))) (-RRB- -RRB-)))) (. .))))

nn(@-3, @-1)
nn(@-3, @-2)
nsubj(examples-7, @-3)
dep(@-3, The-4)
amod(The-4, following-5)
cop(examples-7, are-6)
root(ROOT-0, examples-7)
nsubj(reduce-12, examples-7)
prep_of(examples-7, substances-9)
aux(reduce-12, may-11)
rcmod(examples-7, reduce-12)
det(effect-15, the-13)
amod(effect-15, blood-glucose-lowering-14)
dobj(reduce-12, effect-15)
dep(examples-7, corticosteroids-17)
appos(corticosteroids-17, niacin-19)
appos(corticosteroids-17, danazol-21)
appos(corticosteroids-17, diuretics-23)
amod(agents-26, sympathomimetic-25)
appos(corticosteroids-17, agents-26)
dep(epinephrine-30, e.g.-28)
dep(agents-26, epinephrine-30)
appos(epinephrine-30, salbutamol-32)
appos(epinephrine-30, terbutaline-34)
appos(corticosteroids-17, isoniazid-37)
amod(derivatives-40, phenothiazine-39)
appos(corticosteroids-17, derivatives-40)
appos(corticosteroids-17, somatropin-42)
nn(hormones-45, thyroid-44)
appos(corticosteroids-17, hormones-45)
appos(corticosteroids-17, estrogens-47)
appos(corticosteroids-17, progestogens-49)
dep(examples-7, e.g.-51)
dep(e.g.-51, in-53)
amod(contraceptives-55, oral-54)
pobj(in-53, contraceptives-55)

@/NN @/NN @/NN Beta-blockers/NN ,/, clonidine/NN ,/, lithium/NN salt/NN s/NN ,/, and/CC alcohol/NN may/MD either/CC potentiate/VB or/CC weaken/VB the/DT blood-glucose-lowering/JJ effect/NN of/IN insulin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN @) (NN @) (NN @) (NN Beta-blockers)) (, ,) (NP (NN clonidine)) (, ,) (NP (NN lithium) (NN salt) (NN s)) (, ,) (CC and) (NP (NN alcohol))) (VP (MD may) (VP (CC either) (VP (VB potentiate)) (CC or) (VP (VB weaken) (NP (NP (DT the) (JJ blood-glucose-lowering) (NN effect)) (PP (IN of) (NP (NN insulin)))))))) (. .))))

nn(Beta-blockers-4, @-1)
nn(Beta-blockers-4, @-2)
nn(Beta-blockers-4, @-3)
nsubj(potentiate-16, Beta-blockers-4)
conj_and(Beta-blockers-4, clonidine-6)
nn(s-10, lithium-8)
nn(s-10, salt-9)
conj_and(Beta-blockers-4, s-10)
conj_and(Beta-blockers-4, alcohol-13)
aux(potentiate-16, may-14)
preconj(potentiate-16, either-15)
root(ROOT-0, potentiate-16)
conj_or(potentiate-16, weaken-18)
det(effect-21, the-19)
amod(effect-21, blood-glucose-lowering-20)
dobj(weaken-18, effect-21)
prep_of(effect-21, insulin-23)

Pentamidine/NN may/MD cause/VB hypoglycemia/NN ,/, which/WDT may/MD sometimes/RB be/VB followed/VBN by/IN hyperglycemia/NN ./.

(ROOT (S1 (S (S (NP (NN Pentamidine)) (VP (MD may) (VP (VB cause) (NP (NP (NN hypoglycemia)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (ADVP (RB sometimes)) (VP (VB be) (VP (VBN followed) (PP (IN by) (NP (NN hyperglycemia)))))))))))) (. .))))

nsubj(cause-3, Pentamidine-1)
aux(cause-3, may-2)
root(ROOT-0, cause-3)
dobj(cause-3, hypoglycemia-4)
nsubjpass(followed-10, hypoglycemia-4)
aux(followed-10, may-7)
advmod(followed-10, sometimes-8)
auxpass(followed-10, be-9)
rcmod(hypoglycemia-4, followed-10)
agent(followed-10, hyperglycemia-12)

@/NN @/NN @/NN :/: In/IN addition/NN ,/, under/IN the/DT influence/NN of/IN sympatholytic/JJ medicinal/NN products/NNS such/JJ as/IN beta-blockers/NN ,/, clonidine/NN ,/, guanethidine/NN ,/, and/CC reserpine/NN ,/, the/DT signs/NNS of/IN hypoglycemia/NN may/MD be/VB reduced/VBN or/CC absent/JJ ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN @)) (: :) (S (PP (IN In) (NP (NN addition))) (, ,) (PP (IN under) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NP (JJ sympatholytic) (NN medicinal) (NNS products)) (PP (JJ such) (IN as) (NP (NP (NN beta-blockers)) (, ,) (NP (NN clonidine)) (, ,) (NP (NN guanethidine)) (, ,) (CC and) (NP (NN reserpine)))))))) (, ,) (NP (NP (DT the) (NNS signs)) (PP (IN of) (NP (NN hypoglycemia)))) (VP (MD may) (VP (VB be) (VP (VBN reduced) (UCP (CC or) (ADJP (JJ absent))))))) (. .)))))

nn(@-3, @-1)
nn(@-3, @-2)
root(ROOT-0, @-3)
prep_in(reduced-32, addition-6)
det(influence-10, the-9)
prep_under(reduced-32, influence-10)
amod(products-14, sympatholytic-12)
nn(products-14, medicinal-13)
prep_of(influence-10, products-14)
prep_such_as(products-14, beta-blockers-17)
conj_and(beta-blockers-17, clonidine-19)
conj_and(beta-blockers-17, guanethidine-21)
conj_and(beta-blockers-17, reserpine-24)
det(signs-27, the-26)
nsubjpass(reduced-32, signs-27)
prep_of(signs-27, hypoglycemia-29)
aux(reduced-32, may-30)
auxpass(reduced-32, be-31)
dep(@-3, reduced-32)
dep(reduced-32, or-33)
dep(or-33, absent-34)

Mixing/NN of/IN Insulins/NNS ./.

(ROOT (S1 (S (NP (NP (NN Mixing)) (PP (IN of) (NP (NNS Insulins))) (. .)))))

root(ROOT-0, Mixing-1)
prep_of(Mixing-1, Insulins-3)

@/NN @/NN @/NN :/: A/DT clinical/JJ study/NN in/IN healthy/JJ male/JJ volunteers/NNS (/-LRB- n=24/NN )/-RRB- demonstrated/VBD that/IN mixing/NN NovoLog/NN with/IN NPH/NN human/JJ insulin/NN immediately/RB before/IN injection/NN produced/VBD some/DT attenuation/NN in/IN the/DT peak/JJ concentration/NN of/IN NovoLog/NN ,/, but/CC that/IN the/DT time/NN to/TO peak/NN and/CC the/DT total/JJ bioavailability/NN of/IN NovoLog/NN were/VBD not/RB significantly/RB affected/VBN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN @)) (: :) (S (NP (NP (DT A) (JJ clinical) (NN study)) (PP (IN in) (NP (NP (JJ healthy) (JJ male) (NNS volunteers)) (PRN (-LRB- -LRB-) (NP (NN n=24)) (-RRB- -RRB-))))) (VP (VBD demonstrated) (SBAR (SBAR (IN that) (S (NP (NP (NN mixing) (NN NovoLog)) (PP (IN with) (NP (NN NPH) (JJ human) (NN insulin))) (PP (ADVP (RB immediately)) (IN before) (NP (NN injection)))) (VP (VBD produced) (NP (DT some) (NN attenuation)) (PP (IN in) (NP (NP (DT the) (JJ peak) (NN concentration)) (PP (IN of) (NP (NN NovoLog)))))))) (, ,) (CC but) (SBAR (IN that) (S (NP (NP (NP (DT the) (NN time)) (PP (TO to) (NP (NN peak)))) (CC and) (NP (NP (DT the) (JJ total) (NN bioavailability)) (PP (IN of) (NP (NN NovoLog))))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN affected)))))))) (. .)))))

nn(@-3, @-1)
nn(@-3, @-2)
root(ROOT-0, @-3)
det(study-7, A-5)
amod(study-7, clinical-6)
nsubj(demonstrated-15, study-7)
amod(volunteers-11, healthy-9)
amod(volunteers-11, male-10)
prep_in(study-7, volunteers-11)
appos(volunteers-11, n=24-13)
dep(@-3, demonstrated-15)
complm(produced-26, that-16)
nn(NovoLog-18, mixing-17)
nsubj(produced-26, NovoLog-18)
nn(insulin-22, NPH-20)
amod(insulin-22, human-21)
prep_with(NovoLog-18, insulin-22)
advmod(NovoLog-18, immediately-23)
prep_before(NovoLog-18, injection-25)
ccomp(demonstrated-15, produced-26)
det(attenuation-28, some-27)
dobj(produced-26, attenuation-28)
det(concentration-32, the-30)
amod(concentration-32, peak-31)
prep_in(produced-26, concentration-32)
prep_of(concentration-32, NovoLog-34)
complm(affected-51, that-37)
det(time-39, the-38)
nsubjpass(affected-51, time-39)
prep_to(time-39, peak-41)
det(bioavailability-45, the-43)
amod(bioavailability-45, total-44)
conj_and(time-39, bioavailability-45)
prep_of(bioavailability-45, NovoLog-47)
auxpass(affected-51, were-48)
neg(affected-51, not-49)
advmod(affected-51, significantly-50)
conj_but(produced-26, affected-51)

If/IN NovoLog/NN is/VBZ mixed/VBN with/IN NPH/NN human/JJ insulin/NN ,/, NovoLog/NN should/MD be/VB drawn/VBN into/IN the/DT syringe/NN first/JJ ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN NovoLog)) (VP (VBZ is) (VP (VBN mixed) (PP (IN with) (NP (NN NPH) (JJ human) (NN insulin))))))) (, ,) (NP (NN NovoLog)) (VP (MD should) (VP (VB be) (VP (VBN drawn) (PP (IN into) (NP (DT the) (NN syringe) (JJ first))))))) (. .))))

mark(mixed-4, If-1)
nsubjpass(mixed-4, NovoLog-2)
auxpass(mixed-4, is-3)
advcl(drawn-13, mixed-4)
nn(insulin-8, NPH-6)
amod(insulin-8, human-7)
prep_with(mixed-4, insulin-8)
nsubjpass(drawn-13, NovoLog-10)
aux(drawn-13, should-11)
auxpass(drawn-13, be-12)
root(ROOT-0, drawn-13)
det(syringe-16, the-15)
prep_into(drawn-13, syringe-16)
amod(syringe-16, first-17)

Because/IN there/EX are/VBP no/DT data/NNS on/IN the/DT compatibility/NN of/IN NovoLog/NN and/CC crystalline/JJ zinc/NN insulin/NN preparation/NN s/NNS ,/, NovoLog/NN should/MD not/RB be/VB mixed/VBN with/IN these/DT preparations/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (EX there)) (VP (VBP are) (NP (NP (DT no) (NNS data)) (PP (IN on) (NP (NP (DT the) (NN compatibility)) (PP (IN of) (NP (NP (NP (NN NovoLog)) (CC and) (NP (JJ crystalline) (NN zinc) (NN insulin) (NN preparation))) (NNS s))))))))) (, ,) (NP (NN NovoLog)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN mixed) (PP (IN with) (NP (DT these) (NNS preparations))))))) (. .))))

mark(are-3, Because-1)
expl(are-3, there-2)
advcl(mixed-22, are-3)
det(data-5, no-4)
nsubj(are-3, data-5)
det(compatibility-8, the-7)
prep_on(data-5, compatibility-8)
nn(s-16, NovoLog-10)
amod(preparation-15, crystalline-12)
nn(preparation-15, zinc-13)
nn(preparation-15, insulin-14)
conj_and(NovoLog-10, preparation-15)
prep_of(compatibility-8, s-16)
nsubjpass(mixed-22, NovoLog-18)
aux(mixed-22, should-19)
neg(mixed-22, not-20)
auxpass(mixed-22, be-21)
root(ROOT-0, mixed-22)
det(preparations-25, these-24)
prep_with(mixed-22, preparations-25)

@/NN @/NN @/NN :/: The/DT effects/NNS of/IN mixing/JJ NovoLog/NN with/IN insulins/NNS of/IN animal/NN source/NN or/CC insulin/NN preparations/NNS produced/VBN by/IN other/JJ manufacturers/NNS have/VBP not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN @)) (: :) (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (JJ mixing) (NN NovoLog)) (PP (IN with) (NP (NP (NNS insulins)) (PP (IN of) (NP (NP (NN animal) (NN source) (CC or) (NN insulin) (NNS preparations)) (VP (VBN produced) (PP (IN by) (NP (JJ other) (NNS manufacturers))))))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .)))))

nn(@-3, @-1)
nn(@-3, @-2)
root(ROOT-0, @-3)
det(effects-6, The-5)
nsubjpass(studied-25, effects-6)
amod(NovoLog-9, mixing-8)
prep_of(effects-6, NovoLog-9)
prep_with(NovoLog-9, insulins-11)
nn(source-14, animal-13)
prep_of(insulins-11, source-14)
nn(preparations-17, insulin-16)
conj_or(source-14, preparations-17)
partmod(source-14, produced-18)
amod(manufacturers-21, other-20)
agent(produced-18, manufacturers-21)
aux(studied-25, have-22)
neg(studied-25, not-23)
auxpass(studied-25, been-24)
dep(@-3, studied-25)

@/NN @/NN @/NN :/: When/WRB used/VBN in/IN external/JJ subcutaneous/JJ infusion/NN pumps/VBZ for/IN insulin/NN ,/, NovoLog/NN should/MD not/RB be/VB mixed/VBN with/IN any/DT other/JJ insulins/NNS or/CC diluent/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN @) (NN @)) (: :) (S (SBAR (WHADVP (WRB When)) (S (VP (VBN used) (PP (IN in) (NP (NP (JJ external) (JJ subcutaneous) (NN infusion) (VBZ pumps)) (PP (IN for) (NP (NN insulin)))))))) (, ,) (NP (NN NovoLog)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN mixed) (PP (IN with) (NP (NP (DT any) (JJ other) (NNS insulins)) (CC or) (NP (NN diluent)))))))) (. .)))))

nn(@-3, @-1)
nn(@-3, @-2)
root(ROOT-0, @-3)
advmod(used-6, When-5)
advcl(mixed-19, used-6)
amod(infusion-10, external-8)
amod(infusion-10, subcutaneous-9)
prep_in(used-6, infusion-10)
dep(infusion-10, pumps-11)
prep_for(infusion-10, insulin-13)
nsubjpass(mixed-19, NovoLog-15)
aux(mixed-19, should-16)
neg(mixed-19, not-17)
auxpass(mixed-19, be-18)
dep(@-3, mixed-19)
det(insulins-23, any-21)
amod(insulins-23, other-22)
prep_with(mixed-19, insulins-23)
conj_or(insulins-23, diluent-25)

No/DT significant/JJ drug/NN -drug/NN pharmacokinetic/JJ (/-LRB- or/CC pharmacodynamic/JJ )/-RRB- interactions/NNS have/VBP been/VBN found/VBN in/IN interaction/NN studies/NNS with/IN hydrochlorothiazide/NN ,/, digoxin/NN ,/, warfarin/NN ,/, and/CC nifedipine/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ significant) (NN drug) (NN -drug) (ADJP (ADJP (JJ pharmacokinetic)) (-LRB- -LRB-) (CC or) (ADJP (JJ pharmacodynamic)) (-RRB- -RRB-)) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN found) (PP (IN in) (NP (NP (NN interaction) (NNS studies)) (PP (IN with) (NP (NP (NN hydrochlorothiazide)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN warfarin)) (, ,) (CC and) (NP (NN nifedipine)))))))))) (. .))))

det(interactions-10, No-1)
amod(interactions-10, significant-2)
nn(interactions-10, drug-3)
nn(interactions-10, -drug-4)
amod(interactions-10, pharmacokinetic-5)
conj_or(pharmacokinetic-5, pharmacodynamic-8)
nsubjpass(found-13, interactions-10)
aux(found-13, have-11)
auxpass(found-13, been-12)
root(ROOT-0, found-13)
nn(studies-16, interaction-15)
prep_in(found-13, studies-16)
prep_with(studies-16, hydrochlorothiazide-18)
conj_and(hydrochlorothiazide-18, digoxin-20)
conj_and(hydrochlorothiazide-18, warfarin-22)
conj_and(hydrochlorothiazide-18, nifedipine-25)

In/FW vitro/FW studies/NNS show/VBP significant/JJ inhibition/NN of/IN the/DT formation/NN of/IN oxidized/VBN irbesartan/NN metabolites/NNS with/IN the/DT known/JJ cytochrome/NN CYP/NN 2C9/NN substrates/inhibitors/NN sulphenazole/NN ,/, tolbutamide/NN and/CC nifedipine/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP show) (NP (NP (JJ significant) (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (VBN oxidized) (NN irbesartan) (NNS metabolites)) (PP (IN with) (NP (NP (DT the) (JJ known) (NN cytochrome) (NN CYP) (NN 2C9) (NN substrates/inhibitors) (NN sulphenazole)) (, ,) (NP (NN tolbutamide)) (CC and) (NP (NN nifedipine))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(show-4, studies-3)
root(ROOT-0, show-4)
amod(inhibition-6, significant-5)
dobj(show-4, inhibition-6)
det(formation-9, the-8)
prep_of(inhibition-6, formation-9)
amod(metabolites-13, oxidized-11)
nn(metabolites-13, irbesartan-12)
prep_of(formation-9, metabolites-13)
det(sulphenazole-21, the-15)
amod(sulphenazole-21, known-16)
nn(sulphenazole-21, cytochrome-17)
nn(sulphenazole-21, CYP-18)
nn(sulphenazole-21, 2C9-19)
nn(sulphenazole-21, substrates/inhibitors-20)
prep_with(metabolites-13, sulphenazole-21)
conj_and(sulphenazole-21, tolbutamide-23)
conj_and(sulphenazole-21, nifedipine-25)

However/RB ,/, in/IN clinical/JJ studies/NNS the/DT consequences/NNS of/IN concomitant/JJ irbesartan/NN on/IN the/DT pharmacodynamics/NNS of/IN warfarin/NN were/VBD negligible/JJ ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (JJ clinical) (NNS studies))) (NP (NP (DT the) (NNS consequences)) (PP (IN of) (NP (JJ concomitant) (NN irbesartan))) (PP (IN on) (NP (NP (DT the) (NNS pharmacodynamics)) (PP (IN of) (NP (NN warfarin)))))) (VP (VBD were) (ADJP (JJ negligible)))) (. .))))

advmod(negligible-17, However-1)
amod(studies-5, clinical-4)
prep_in(negligible-17, studies-5)
det(consequences-7, the-6)
nsubj(negligible-17, consequences-7)
amod(irbesartan-10, concomitant-9)
prep_of(consequences-7, irbesartan-10)
det(pharmacodynamics-13, the-12)
prep_on(consequences-7, pharmacodynamics-13)
prep_of(pharmacodynamics-13, warfarin-15)
cop(negligible-17, were-16)
root(ROOT-0, negligible-17)

Based/VBN on/IN in/FW vitro/FW data/NNS ,/, no/DT interaction/NN would/MD be/VB expected/VBN with/IN drugs/NNS whose/WP$ metabolism/NN is/VBZ dependent/JJ upon/IN cytochrome/NN P450/NN isozymes/NNS 1A1/NN ,/, 1A2,2A6,2B6,2D6,2E1/NN ,/, or/CC 3A4/NN ./.

(ROOT (S1 (S (S (PP (VBN Based) (PP (IN on) (NP (ADJP (FW in) (FW vitro)) (NNS data)))) (, ,) (NP (DT no) (NN interaction)) (VP (MD would) (VP (VB be) (VP (VBN expected) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WP$ whose) (NN metabolism)) (S (VP (VBZ is) (ADJP (JJ dependent) (PP (IN upon) (NP (NP (NN cytochrome) (NN P450) (NNS isozymes) (NN 1A1)) (, ,) (NP (NN 1A2,2A6,2B6,2D6,2E1)) (, ,) (CC or) (NP (NN 3A4)))))))))))))) (. .))))

prepc_based_on(expected-11, on-2)
nn(vitro-4, in-3)
amod(data-5, vitro-4)
pobj(expected-11, data-5)
det(interaction-8, no-7)
nsubjpass(expected-11, interaction-8)
aux(expected-11, would-9)
auxpass(expected-11, be-10)
root(ROOT-0, expected-11)
prep_with(expected-11, drugs-13)
poss(metabolism-15, drugs-13)
nsubj(dependent-17, metabolism-15)
cop(dependent-17, is-16)
rcmod(drugs-13, dependent-17)
nn(1A1-22, cytochrome-19)
nn(1A1-22, P450-20)
nn(1A1-22, isozymes-21)
prep_upon(dependent-17, 1A1-22)
conj_or(1A1-22, 1A2,2A6,2B6,2D6,2E1-24)
conj_or(1A1-22, 3A4-27)

In/IN separate/JJ studies/NNS of/IN patients/NNS receiving/VBG maintenance/NN doses/NNS of/IN warfarin/NN ,/, hydrochlorothiazide/NN ,/, or/CC digoxin/NN ,/, irbesartan/NN administration/NN for/IN 7/CD days/NNS had/VBD no/DT effect/NN on/IN the/DT pharmacodynamics/NNS of/IN warfarin/NN (/-LRB- prothrombin/NN time/NN )/-RRB- or/CC pharmacokinetics/NNS of/IN digoxin/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ separate) (NNS studies)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN maintenance) (NNS doses)) (PP (IN of) (NP (NP (NN warfarin)) (, ,) (NP (NN hydrochlorothiazide)) (, ,) (CC or) (NP (NN digoxin)))))))))) (, ,) (NP (NP (NN irbesartan) (NN administration)) (PP (IN for) (NP (CD 7) (NNS days)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NP (NP (DT the) (NNS pharmacodynamics)) (PP (IN of) (NP (NN warfarin))) (PRN (-LRB- -LRB-) (NP (NN prothrombin) (NN time)) (-RRB- -RRB-))) (CC or) (NP (NNS pharmacokinetics))) (PP (IN of) (NP (NN digoxin))))))) (. .))))

amod(studies-3, separate-2)
prep_in(had-22, studies-3)
prep_of(studies-3, patients-5)
partmod(patients-5, receiving-6)
nn(doses-8, maintenance-7)
dobj(receiving-6, doses-8)
prep_of(doses-8, warfarin-10)
conj_or(warfarin-10, hydrochlorothiazide-12)
conj_or(warfarin-10, digoxin-15)
nn(administration-18, irbesartan-17)
nsubj(had-22, administration-18)
num(days-21, 7-20)
prep_for(administration-18, days-21)
root(ROOT-0, had-22)
det(effect-24, no-23)
dobj(had-22, effect-24)
det(pharmacodynamics-27, the-26)
prep_on(had-22, pharmacodynamics-27)
prep_of(pharmacodynamics-27, warfarin-29)
nn(time-32, prothrombin-31)
appos(pharmacodynamics-27, time-32)
conj_or(pharmacodynamics-27, pharmacokinetics-35)
prep_of(pharmacodynamics-27, digoxin-37)

The/DT pharmacokinetics/NNS of/IN irbesartan/NN were/VBD not/RB affected/VBN by/IN coadministration/NN of/IN nifedipine/NN or/CC hydrochlorothiazide/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NN irbesartan)))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN nifedipine)) (CC or) (NP (NN hydrochlorothiazide))))))))) (. .))))

det(pharmacokinetics-2, The-1)
nsubjpass(affected-7, pharmacokinetics-2)
prep_of(pharmacokinetics-2, irbesartan-4)
auxpass(affected-7, were-5)
neg(affected-7, not-6)
root(ROOT-0, affected-7)
agent(affected-7, coadministration-9)
prep_of(coadministration-9, nifedipine-11)
conj_or(nifedipine-11, hydrochlorothiazide-13)

The/DT adverse/JJ effects/NNS of/IN CAMPTOSAR/NN ,/, such/JJ as/IN myelosuppression/NN and/CC diarrhea/NN ,/, would/MD be/VB expected/VBN to/TO be/VB exacerbated/JJ by/IN other/JJ antineoplastic/JJ agents/NNS having/VBG similar/JJ adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NN CAMPTOSAR))) (, ,) (ADJP (JJ such) (PP (IN as) (NP (NP (NN myelosuppression)) (CC and) (NP (NN diarrhea))))) (, ,)) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB be) (ADJP (JJ exacerbated) (PP (IN by) (NP (NP (JJ other) (JJ antineoplastic) (NNS agents)) (VP (VBG having) (NP (JJ similar) (JJ adverse) (NNS effects))))))))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, adverse-2)
nsubjpass(expected-15, effects-3)
prep_of(effects-3, CAMPTOSAR-5)
prep_such_as(effects-3, myelosuppression-9)
conj_and(myelosuppression-9, diarrhea-11)
aux(expected-15, would-13)
auxpass(expected-15, be-14)
root(ROOT-0, expected-15)
aux(exacerbated-18, to-16)
cop(exacerbated-18, be-17)
xcomp(expected-15, exacerbated-18)
amod(agents-22, other-20)
amod(agents-22, antineoplastic-21)
prep_by(exacerbated-18, agents-22)
partmod(agents-22, having-23)
amod(effects-26, similar-24)
amod(effects-26, adverse-25)
dobj(having-23, effects-26)

Patients/NNS who/WP have/VBP previously/RB received/VBN pelvic//NN abdominal/JJ irradiation/NN are/VBP at/IN increased/VBN risk/NN of/IN severe/JJ myelosuppression/NN following/VBG the/DT administration/NN of/IN CAMPTOSAR/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (ADVP (RB previously)) (VP (VBN received) (NP (NN pelvic/) (JJ abdominal) (NN irradiation))))))) (VP (VBP are) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (JJ severe) (NN myelosuppression))))) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN CAMPTOSAR))))))) (. .))))

nsubj(received-5, Patients-1)
nsubj(are-9, Patients-1)
aux(received-5, have-3)
advmod(received-5, previously-4)
rcmod(Patients-1, received-5)
nn(irradiation-8, pelvic/-6)
amod(irradiation-8, abdominal-7)
dobj(received-5, irradiation-8)
root(ROOT-0, are-9)
amod(risk-12, increased-11)
prep_at(are-9, risk-12)
amod(myelosuppression-15, severe-14)
prep_of(risk-12, myelosuppression-15)
det(administration-18, the-17)
prep_following(are-9, administration-18)
prep_of(administration-18, CAMPTOSAR-20)

The/DT concurrent/JJ administration/NN of/IN CAMPTOSAR/NN with/IN irradiation/NN has/VBZ not/RB been/VBN adequately/RB studied/VBN and/CC is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concurrent) (NN administration)) (PP (IN of) (NP (NN CAMPTOSAR))) (PP (IN with) (NP (NN irradiation)))) (VP (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB adequately)) (VP (VBN studied)))) (CC and) (VP (VBZ is) (RB not) (VP (VBN recommended))))) (. .))))

det(administration-3, The-1)
amod(administration-3, concurrent-2)
nsubjpass(studied-12, administration-3)
prep_of(administration-3, CAMPTOSAR-5)
prep_with(administration-3, irradiation-7)
aux(studied-12, has-8)
neg(studied-12, not-9)
auxpass(studied-12, been-10)
advmod(studied-12, adequately-11)
root(ROOT-0, studied-12)
auxpass(recommended-16, is-14)
neg(recommended-16, not-15)
conj_and(studied-12, recommended-16)

Lymphocytopenia/NN has/VBZ been/VBN reported/VBN in/IN patients/NNS receiving/VBG CAMPTOSAR/NN ,/, and/CC it/PRP is/VBZ possible/JJ that/IN the/DT administration/NN of/IN dexamethasone/NN as/IN antiemetic/JJ prophylaxis/NNS may/MD have/VB enhanced/VBD the/DT likelihood/NN of/IN this/DT effect/NN ./.

(ROOT (S1 (S (S (S (NP (NN Lymphocytopenia)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN CAMPTOSAR))))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NN dexamethasone)) (PP (IN as) (NP (JJ antiemetic) (NNS prophylaxis)))))) (VP (MD may) (VP (VB have) (VP (VBD enhanced) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (DT this) (NN effect)))))))))))) (. .))))

nsubjpass(reported-4, Lymphocytopenia-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
prep_in(reported-4, patients-6)
partmod(patients-6, receiving-7)
dobj(receiving-7, CAMPTOSAR-8)
nsubj(possible-13, it-11)
cop(possible-13, is-12)
conj_and(reported-4, possible-13)
complm(enhanced-24, that-14)
det(administration-16, the-15)
nsubj(enhanced-24, administration-16)
prep_of(administration-16, dexamethasone-18)
amod(prophylaxis-21, antiemetic-20)
prep_as(dexamethasone-18, prophylaxis-21)
aux(enhanced-24, may-22)
aux(enhanced-24, have-23)
ccomp(possible-13, enhanced-24)
det(likelihood-26, the-25)
dobj(enhanced-24, likelihood-26)
det(effect-29, this-28)
prep_of(likelihood-26, effect-29)

Hyperglycemia/NN has/VBZ also/RB been/VBN reported/VBN in/IN patients/NNS receiving/VBG CAMPTOSAR/NN ./.

(ROOT (S1 (S (S (NP (NN Hyperglycemia)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN CAMPTOSAR))))))))) (. .))))

nsubjpass(reported-5, Hyperglycemia-1)
aux(reported-5, has-2)
advmod(reported-5, also-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
prep_in(reported-5, patients-7)
partmod(patients-7, receiving-8)
dobj(receiving-8, CAMPTOSAR-9)

Usually/RB ,/, this/DT has/VBZ been/VBN observed/VBN in/IN patients/NNS with/IN a/DT history/NN of/IN diabetes/NN mellitus/NN or/CC evidence/NN of/IN glucose/NN intolerance/NN prior/JJ to/TO administration/NN of/IN CAMPTOSAR/NN ./.

(ROOT (S1 (S (S (ADVP (RB Usually)) (, ,) (NP (DT this)) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN diabetes) (NN mellitus)))) (CC or) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NN glucose) (NN intolerance)) (ADJP (JJ prior) (PP (TO to) (NP (NP (NN administration)) (PP (IN of) (NP (NN CAMPTOSAR))))))))))))))))) (. .))))

advmod(observed-6, Usually-1)
nsubjpass(observed-6, this-3)
aux(observed-6, has-4)
auxpass(observed-6, been-5)
root(ROOT-0, observed-6)
prep_in(observed-6, patients-8)
det(history-11, a-10)
prep_with(patients-8, history-11)
nn(mellitus-14, diabetes-13)
prep_of(history-11, mellitus-14)
conj_or(history-11, evidence-16)
nn(intolerance-19, glucose-18)
prep_of(evidence-16, intolerance-19)
prep_prior_to(intolerance-19, administration-22)
prep_of(administration-22, CAMPTOSAR-24)

It/PRP is/VBZ probable/JJ that/IN dexamethasone/NN ,/, given/VBN as/IN antiemetic/NN prophylaxis/NN ,/, contributed/VBD to/TO hyperglycemia/NN in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ probable)) (SBAR (IN that) (S (NP (NP (NN dexamethasone)) (, ,) (VP (VBN given) (PP (IN as) (NP (NN antiemetic) (NN prophylaxis)))) (, ,)) (VP (VBD contributed) (PP (TO to) (NP (NP (NN hyperglycemia)) (PP (IN in) (NP (DT some) (NNS patients)))))))))) (. .))))

nsubj(probable-3, It-1)
cop(probable-3, is-2)
root(ROOT-0, probable-3)
complm(contributed-12, that-4)
nsubj(contributed-12, dexamethasone-5)
partmod(dexamethasone-5, given-7)
nn(prophylaxis-10, antiemetic-9)
prep_as(given-7, prophylaxis-10)
ccomp(probable-3, contributed-12)
prep_to(contributed-12, hyperglycemia-14)
det(patients-17, some-16)
prep_in(hyperglycemia-14, patients-17)

The/DT incidence/NN of/IN akathisia/NN in/IN clinical/JJ trials/NNS of/IN the/DT weekly/JJ dosage/NN schedule/NN was/VBD greater/JJR (/-LRB- 8.5/CD %/NN ,/, 4/47/CD patients/NNS )/-RRB- when/WRB prochlorperazine/NN was/VBD administered/VBN on/IN the/DT same/JJ day/NN as/IN CAMPTOSAR/NN than/IN when/WRB these/DT drugs/NNS were/VBD given/VBN on/IN separate/JJ days/NNS (/-LRB- 1.3/CD %/NN ,/, 1/80/NN patients/NNS )./CD

(ROOT (S1 (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NN akathisia))) (PP (IN in) (NP (NP (JJ clinical) (NNS trials)) (PP (IN of) (NP (DT the) (JJ weekly) (NN dosage) (NN schedule)))))) (VP (VBD was) (ADJP (ADJP (JJR greater) (PRN (-LRB- -LRB-) (NP (NP (CD 8.5) (NN %)) (, ,) (NP (CD 4/47) (NNS patients))) (-RRB- -RRB-))) (SBAR (WHADVP (WRB when)) (S (NP (NN prochlorperazine)) (VP (VBD was) (VP (VBN administered) (PP (IN on) (NP (DT the) (JJ same) (NN day))) (PP (IN as) (NP (NN CAMPTOSAR))))))) (PP (IN than) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS drugs)) (VP (VBD were) (VP (VBN given) (PP (IN on) (NP (NP (JJ separate) (NNS days)) (PRN (-LRB- -LRB-) (NP (CD 1.3) (NN %)) (, ,) (NP (NN 1/80) (NNS patients) (CD -RRB-.)))))))))))))))

det(incidence-2, The-1)
nsubj(greater-14, incidence-2)
prep_of(incidence-2, akathisia-4)
amod(trials-7, clinical-6)
prep_in(incidence-2, trials-7)
det(schedule-12, the-9)
amod(schedule-12, weekly-10)
nn(schedule-12, dosage-11)
prep_of(trials-7, schedule-12)
cop(greater-14, was-13)
root(ROOT-0, greater-14)
num(%-17, 8.5-16)
dep(greater-14, %-17)
num(patients-20, 4/47-19)
appos(%-17, patients-20)
advmod(administered-25, when-22)
nsubjpass(administered-25, prochlorperazine-23)
auxpass(administered-25, was-24)
dep(greater-14, administered-25)
det(day-29, the-27)
amod(day-29, same-28)
prep_on(administered-25, day-29)
prep_as(administered-25, CAMPTOSAR-31)
advmod(given-37, when-33)
det(drugs-35, these-34)
nsubjpass(given-37, drugs-35)
auxpass(given-37, were-36)
prepc_than(greater-14, given-37)
amod(days-40, separate-39)
prep_on(given-37, days-40)
num(%-43, 1.3-42)
dep(days-40, %-43)
nn(patients-46, 1/80-45)
dep(%-43, patients-46)
num(patients-46, -RRB-.-47)

The/DT 8.5/CD %/NN incidence/NN of/IN akathisia/NN ,/, however/RB ,/, is/VBZ within/IN the/DT range/NN reported/VBN for/IN use/NN of/IN prochlorperazine/NN when/WRB given/VBN as/IN a/DT premedication/NN for/IN other/JJ chemotherapies/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (ADJP (CD 8.5) (NN %)) (NN incidence)) (PP (IN of) (NP (NN akathisia)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ is) (PP (IN within) (NP (NP (DT the) (NN range)) (VP (VBN reported) (PP (IN for) (NP (NP (NN use)) (PP (IN of) (NP (NN prochlorperazine)))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN as) (NP (NP (DT a) (NN premedication)) (PP (IN for) (NP (JJ other) (NNS chemotherapies)))))))))) (. .))))

det(incidence-4, The-1)
number(%-3, 8.5-2)
amod(incidence-4, %-3)
nsubj(is-10, incidence-4)
prep_of(incidence-4, akathisia-6)
advmod(is-10, however-8)
root(ROOT-0, is-10)
det(range-13, the-12)
prep_within(is-10, range-13)
partmod(range-13, reported-14)
prep_for(reported-14, use-16)
prep_of(use-16, prochlorperazine-18)
advmod(given-20, when-19)
advcl(is-10, given-20)
det(premedication-23, a-22)
prep_as(given-20, premedication-23)
amod(chemotherapies-26, other-25)
prep_for(premedication-23, chemotherapies-26)

It/PRP would/MD be/VB expected/VBN that/IN laxative/JJ use/NN during/IN therapy/NN with/IN CAMPTOSAR/NN would/MD worsen/VB the/DT incidence/NN or/CC severity/NN of/IN diarrhea/NN ,/, but/CC this/DT has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (MD would) (VP (VB be) (VP (VBN expected) (SBAR (IN that) (S (S (NP (NP (JJ laxative) (NN use)) (PP (IN during) (NP (NN therapy))) (PP (IN with) (NP (NN CAMPTOSAR)))) (VP (MD would) (VP (VB worsen) (NP (NP (DT the) (NP (NN incidence)) (CC or) (NP (NN severity))) (PP (IN of) (NP (NN diarrhea))))))) (, ,) (CC but) (S (NP (DT this)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))))))))) (. .))))

nsubjpass(expected-4, It-1)
aux(expected-4, would-2)
auxpass(expected-4, be-3)
root(ROOT-0, expected-4)
complm(worsen-13, that-5)
amod(use-7, laxative-6)
nsubj(worsen-13, use-7)
prep_during(use-7, therapy-9)
prep_with(use-7, CAMPTOSAR-11)
aux(worsen-13, would-12)
ccomp(expected-4, worsen-13)
dep(incidence-15, the-14)
dobj(worsen-13, incidence-15)
conj_or(incidence-15, severity-17)
prep_of(incidence-15, diarrhea-19)
nsubjpass(studied-26, this-22)
aux(studied-26, has-23)
neg(studied-26, not-24)
auxpass(studied-26, been-25)
conj_but(worsen-13, studied-26)

In/IN view/NN of/IN the/DT potential/JJ risk/NN of/IN dehydration/NN secondary/JJ to/TO vomiting/NN and/or/CC diarrhea/NN induced/VBN by/IN CAMPTOSAR/NN ,/, the/DT physician/NN may/MD wish/VB to/TO withhold/JJ diuretics/NNS during/IN dosing/NN with/IN CAMPTOSAR/NN and/CC ,/, certainly/RB ,/, during/IN periods/NNS of/IN active/JJ vomiting/NN or/CC diarrhea/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (NN view)) (PP (IN of) (NP (NP (DT the) (JJ potential) (NN risk)) (PP (IN of) (NP (NP (NN dehydration)) (ADJP (JJ secondary) (PP (TO to) (NP (NP (NP (NN vomiting)) (CC and/or) (NP (NN diarrhea))) (VP (VBN induced) (PP (IN by) (NP (NN CAMPTOSAR))))))))))))) (, ,) (NP (DT the) (NN physician)) (VP (MD may) (VP (VP (VB wish) (PP (TO to) (NP (JJ withhold) (NNS diuretics))) (PP (IN during) (NP (NP (NN dosing)) (PP (IN with) (NP (NN CAMPTOSAR)))))) (CC and) (, ,) (ADVP (RB certainly)) (, ,) (PP (IN during) (NP (NP (NNS periods)) (PP (IN of) (NP (JJ active) (NP (NN vomiting)) (CC or) (NP (NN diarrhea)))))))) (. .))))

prep_in(wish-21, view-2)
det(risk-6, the-4)
amod(risk-6, potential-5)
prep_of(view-2, risk-6)
prep_of(risk-6, dehydration-8)
amod(dehydration-8, secondary-9)
prep_to(secondary-9, vomiting-11)
conj_and/or(vomiting-11, diarrhea-13)
partmod(vomiting-11, induced-14)
agent(induced-14, CAMPTOSAR-16)
det(physician-19, the-18)
nsubj(wish-21, physician-19)
aux(wish-21, may-20)
root(ROOT-0, wish-21)
amod(diuretics-24, withhold-23)
prep_to(wish-21, diuretics-24)
prep_during(wish-21, dosing-26)
prep_with(dosing-26, CAMPTOSAR-28)
advmod(wish-21, certainly-31)
conj_and(wish-21, certainly-31)
conj_and(wish-21, during-33)
prep_during(wish-21, periods-34)
amod(vomiting-37, active-36)
prep_of(periods-34, vomiting-37)
conj_or(vomiting-37, diarrhea-39)

Drug-Laboratory/JJ Test/NN Interactions/NNS :/: There/EX are/VBP no/DT known/JJ interactions/NNS between/IN CAMPTOSAR/NN and/CC laboratory/NN tests/NNS ./.

(ROOT (S1 (S (S (NP (JJ Drug-Laboratory) (NN Test) (NNS Interactions)) (: :) (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ known) (NNS interactions)) (PP (IN between) (NP (NP (NN CAMPTOSAR)) (CC and) (NP (NN laboratory) (NNS tests))))))) (. .))))

amod(Interactions-3, Drug-Laboratory-1)
nn(Interactions-3, Test-2)
nsubj(are-6, Interactions-3)
expl(are-6, There-5)
root(ROOT-0, are-6)
det(interactions-9, no-7)
amod(interactions-9, known-8)
nsubj(are-6, interactions-9)
prep_between(interactions-9, CAMPTOSAR-11)
nn(tests-14, laboratory-13)
conj_and(CAMPTOSAR-11, tests-14)

Isoflurane/NN potentiates/VBZ the/DT muscle/NN relaxant/JJ effect/NN of/IN all/DT muscle/NN relaxants/NNS ,/, most/RBS notably/RB nondepolarizing/VBG muscle/NN relaxants/NNS ,/, and/CC MAC/NN (/-LRB- minimum/JJ alveolar/JJ concentration/NN )/-RRB- is/VBZ reduced/VBN by/IN concomitant/JJ administration/NN of/IN N/NN span/NN class=/NN c13/NN 2O/NN ./.

(ROOT (S1 (S (S (S (NP (NN Isoflurane)) (VP (VBZ potentiates) (NP (NP (DT the) (NN muscle) (JJ relaxant) (NN effect)) (PP (IN of) (NP (DT all) (NN muscle) (NNS relaxants)))) (, ,) (S (ADVP (RBS most) (RB notably)) (VP (VBG nondepolarizing) (NP (NN muscle) (NNS relaxants)))))) (, ,) (CC and) (S (NP (NP (NN MAC)) (PRN (-LRB- -LRB-) (NP (JJ minimum) (JJ alveolar) (NN concentration)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN reduced) (PP (IN by) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN N) (NN span) (NN class=) (NN c13) (NN 2O))))))))) (. .))))

nsubj(potentiates-2, Isoflurane-1)
root(ROOT-0, potentiates-2)
det(effect-6, the-3)
nn(effect-6, muscle-4)
amod(effect-6, relaxant-5)
dobj(potentiates-2, effect-6)
det(relaxants-10, all-8)
nn(relaxants-10, muscle-9)
prep_of(effect-6, relaxants-10)
advmod(notably-13, most-12)
advmod(nondepolarizing-14, notably-13)
partmod(potentiates-2, nondepolarizing-14)
xcomp(potentiates-2, nondepolarizing-14)
nn(relaxants-16, muscle-15)
dobj(nondepolarizing-14, relaxants-16)
nsubjpass(reduced-26, MAC-19)
amod(concentration-23, minimum-21)
amod(concentration-23, alveolar-22)
appos(MAC-19, concentration-23)
auxpass(reduced-26, is-25)
conj_and(potentiates-2, reduced-26)
amod(administration-29, concomitant-28)
agent(reduced-26, administration-29)
nn(2O-35, N-31)
nn(2O-35, span-32)
nn(2O-35, class=-33)
nn(2O-35, c13-34)
prep_of(administration-29, 2O-35)

The/DT vasodilating/JJ effects/NNS of/IN isosorbide/NN dinitrate/NN may/MD be/VB additive/JJ with/IN those/DT of/IN other/JJ vasodilators/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ vasodilating) (NNS effects)) (PP (IN of) (NP (NN isosorbide) (NN dinitrate)))) (VP (MD may) (VP (VB be) (ADJP (JJ additive) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (JJ other) (NNS vasodilators))))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, vasodilating-2)
nsubj(additive-9, effects-3)
nn(dinitrate-6, isosorbide-5)
prep_of(effects-3, dinitrate-6)
aux(additive-9, may-7)
cop(additive-9, be-8)
root(ROOT-0, additive-9)
prep_with(additive-9, those-11)
amod(vasodilators-14, other-13)
prep_of(those-11, vasodilators-14)

Alcohol/NN ,/, in/IN particular/JJ ,/, has/VBZ been/VBN found/VBN to/TO exhibit/VBP additive/JJ effects/NNS of/IN this/DT variety/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Alcohol)) (, ,) (PP (IN in) (NP (JJ particular))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VBP exhibit) (NP (NP (JJ additive) (NNS effects)) (PP (IN of) (NP (DT this) (NN variety))))))))))) (. .))))

nsubjpass(found-8, Alcohol-1)
xsubj(exhibit-10, Alcohol-1)
prep_in(Alcohol-1, particular-4)
aux(found-8, has-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
aux(exhibit-10, to-9)
xcomp(found-8, exhibit-10)
amod(effects-12, additive-11)
dobj(exhibit-10, effects-12)
det(variety-15, this-14)
prep_of(effects-12, variety-15)

The/DT following/JJ drug/NN interactions/NNS were/VBD studied/VBN with/IN ketoprofen/NN doses/NNS of/IN 200/CD mg/day/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (NN drug) (NNS interactions)) (VP (VBD were) (VP (VBN studied) (PP (IN with) (NP (NP (NN ketoprofen) (NNS doses)) (PP (IN of) (NP (CD 200) (NN mg/day)))))))) (. .))))

det(interactions-4, The-1)
amod(interactions-4, following-2)
nn(interactions-4, drug-3)
nsubjpass(studied-6, interactions-4)
auxpass(studied-6, were-5)
root(ROOT-0, studied-6)
nn(doses-9, ketoprofen-8)
prep_with(studied-6, doses-9)
num(mg/day-12, 200-11)
prep_of(doses-9, mg/day-12)

The/DT possibility/NN of/IN increased/VBN interaction/NN should/MD be/VB kept/VBN in/IN mind/NN when/WRB Orudis/NN doses/NNS greater/JJR than/IN 50/CD mg/NN as/IN a/DT single/JJ dose/NN or/CC 200/CD mg/NN of/IN ketoprofen/NN per/IN day/NN are/VBP used/VBN concomitantly/RB with/IN highly/RB bound/VBN drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (VBN increased) (NN interaction)))) (VP (MD should) (VP (VB be) (VP (VBN kept) (PP (IN in) (NP (NN mind))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN Orudis) (NNS doses)) (ADJP (JJR greater) (PP (IN than) (NP (NP (NP (CD 50) (NN mg)) (PP (IN as) (NP (DT a) (JJ single) (NN dose)))) (CC or) (NP (NP (CD 200) (NN mg)) (PP (IN of) (NP (NN ketoprofen))) (PP (IN per) (NP (NN day)))))))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (ADJP (RB highly) (VBN bound)) (NNS drugs))))))))))) (. .))))

det(possibility-2, The-1)
nsubjpass(kept-8, possibility-2)
amod(interaction-5, increased-4)
prep_of(possibility-2, interaction-5)
aux(kept-8, should-6)
auxpass(kept-8, be-7)
root(ROOT-0, kept-8)
prep_in(kept-8, mind-10)
advmod(used-30, when-11)
nn(doses-13, Orudis-12)
nsubjpass(used-30, doses-13)
amod(doses-13, greater-14)
num(mg-17, 50-16)
prep_than(greater-14, mg-17)
det(dose-21, a-19)
amod(dose-21, single-20)
prep_as(mg-17, dose-21)
num(mg-24, 200-23)
conj_or(mg-17, mg-24)
prep_of(mg-24, ketoprofen-26)
prep_per(mg-24, day-28)
auxpass(used-30, are-29)
advcl(kept-8, used-30)
advmod(used-30, concomitantly-31)
advmod(bound-34, highly-33)
amod(drugs-35, bound-34)
prep_with(used-30, drugs-35)

Antacids/NNS :/: Concomitant/JJ administration/NN of/IN magnesium/NN hydroxide/NN and/CC aluminum/NN hydroxide/NN does/VBZ not/RB interfere/VB with/IN the/DT rate/NN or/CC extent/NN of/IN the/DT absorption/NN of/IN ketoprofen/NN administered/VBN as/IN Orudis/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antacids)) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN magnesium) (NN hydroxide)) (CC and) (NP (NN aluminum) (NN hydroxide))))) (VP (VBZ does) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NP (NN rate)) (CC or) (NP (NN extent))) (PP (IN of) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NP (NN ketoprofen)) (VP (VBN administered) (PP (IN as) (NP (NN Orudis))))))))))))) (. .)))))

root(ROOT-0, Antacids-1)
amod(administration-4, Concomitant-3)
nsubj(interfere-13, administration-4)
nn(hydroxide-7, magnesium-6)
prep_of(administration-4, hydroxide-7)
nn(hydroxide-10, aluminum-9)
conj_and(hydroxide-7, hydroxide-10)
aux(interfere-13, does-11)
neg(interfere-13, not-12)
dep(Antacids-1, interfere-13)
dep(rate-16, the-15)
prep_with(interfere-13, rate-16)
conj_or(rate-16, extent-18)
det(absorption-21, the-20)
prep_of(rate-16, absorption-21)
prep_of(absorption-21, ketoprofen-23)
partmod(ketoprofen-23, administered-24)
prep_as(administered-24, Orudis-26)

Aspirin/NN :/: Ketoprofen/NN does/VBZ not/RB alter/VB aspirin/NN absorption/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Aspirin) (: :) (NN Ketoprofen)) (VP (VBZ does) (RB not) (VP (VB alter) (NP (NN aspirin) (NN absorption)))) (: ;)) (. .))))

nn(Ketoprofen-3, Aspirin-1)
nsubj(alter-6, Ketoprofen-3)
aux(alter-6, does-4)
neg(alter-6, not-5)
root(ROOT-0, alter-6)
nn(absorption-8, aspirin-7)
dobj(alter-6, absorption-8)

however/RB ,/, in/IN a/DT study/NN of/IN 12/CD normal/JJ subjects/NNS ,/, concurrent/JJ administration/NN of/IN aspirin/NN decreased/VBD ketoprofen/NN protein/NN binding/NN and/CC increased/VBN ketoprofen/NN plasma/NN clearance/NN from/IN 0.07/CD L/kg/h/NN without/IN aspirin/NN to/TO 0.11/NN L/kg/h/NN with/IN aspirin/NN ./.

(ROOT (S1 (S (ADVP (RB however)) (, ,) (PP (IN in) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (CD 12) (JJ normal) (NNS subjects))))) (, ,) (NP (NP (JJ concurrent) (NN administration)) (PP (IN of) (NP (NN aspirin)))) (VP (VBD decreased) (NP (NP (NN ketoprofen) (NN protein) (NN binding)) (CC and) (NP (VBN increased) (NN ketoprofen) (NN plasma) (NN clearance))) (PP (IN from) (NP (CD 0.07) (NN L/kg/h))) (PP (IN without) (NP (NN aspirin))) (PP (TO to) (NP (NP (NN 0.11) (NN L/kg/h)) (PP (IN with) (NP (NN aspirin)))))) (. .))))

advmod(decreased-15, however-1)
det(study-5, a-4)
prep_in(decreased-15, study-5)
num(subjects-9, 12-7)
amod(subjects-9, normal-8)
prep_of(study-5, subjects-9)
amod(administration-12, concurrent-11)
nsubj(decreased-15, administration-12)
prep_of(administration-12, aspirin-14)
root(ROOT-0, decreased-15)
nn(binding-18, ketoprofen-16)
nn(binding-18, protein-17)
dobj(decreased-15, binding-18)
amod(clearance-23, increased-20)
nn(clearance-23, ketoprofen-21)
nn(clearance-23, plasma-22)
conj_and(binding-18, clearance-23)
num(L/kg/h-26, 0.07-25)
prep_from(decreased-15, L/kg/h-26)
prep_without(decreased-15, aspirin-28)
nn(L/kg/h-31, 0.11-30)
prep_to(decreased-15, L/kg/h-31)
prep_with(L/kg/h-31, aspirin-33)

Therefore/RB ,/, concurrent/JJ use/NN of/IN aspirin/NN and/CC ketoprofen/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (NP (NN aspirin)) (CC and) (NP (NN ketoprofen))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

advmod(recommended-11, Therefore-1)
amod(use-4, concurrent-3)
nsubjpass(recommended-11, use-4)
prep_of(use-4, aspirin-6)
conj_and(aspirin-6, ketoprofen-8)
auxpass(recommended-11, is-9)
neg(recommended-11, not-10)
root(ROOT-0, recommended-11)

Diuretic/JJ :/: Hydrochlorothiazide/NN ,/, given/VBN concomitantly/RB with/IN ketoprofen/NN ,/, produces/VBZ a/DT reduction/NN in/IN urinary/JJ potassium/NN and/CC chloride/NN excretion/NN compared/VBN to/TO hydrochlorothiazide/NN alone/RB ./.

(ROOT (S1 (S (S (NP (JJ Diuretic) (: :) (NP (NN Hydrochlorothiazide)) (, ,) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN ketoprofen)))) (, ,)) (VP (VBZ produces) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (JJ urinary) (NN potassium) (CC and) (NN chloride) (NN excretion)))) (PP (VBN compared) (PP (TO to) (NP (NP (NN hydrochlorothiazide)) (ADVP (RB alone))))))) (. .))))

amod(Hydrochlorothiazide-3, Diuretic-1)
nsubj(produces-10, Hydrochlorothiazide-3)
partmod(Hydrochlorothiazide-3, given-5)
advmod(given-5, concomitantly-6)
prep_with(given-5, ketoprofen-8)
root(ROOT-0, produces-10)
det(reduction-12, a-11)
dobj(produces-10, reduction-12)
amod(potassium-15, urinary-14)
prep_in(reduction-12, potassium-15)
nn(excretion-18, chloride-17)
conj_and(potassium-15, excretion-18)
prepc_compared_to(produces-10, to-20)
pobj(produces-10, hydrochlorothiazide-21)
advmod(hydrochlorothiazide-21, alone-22)

Patients/NNS taking/VBG diuretics/NNS are/VBP at/IN a/DT greater/JJR risk/NN of/IN developing/VBG renal/JJ failure/NN secondary/JJ to/TO a/DT decrease/NN in/IN renal/JJ blood/NN flow/NN caused/VBN by/IN prostaglandin/NN inhibition/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NNS diuretics)))) (VP (VBP are) (PP (IN at) (NP (NP (DT a) (JJR greater) (NN risk)) (PP (IN of) (S (VP (VBG developing) (NP (NP (JJ renal) (NN failure)) (ADJP (JJ secondary) (PP (TO to) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (JJ renal) (NN blood) (NN flow)) (VP (VBN caused) (PP (IN by) (NP (NN prostaglandin) (NN inhibition))))))))))))))))) (. .))))

nsubj(are-4, Patients-1)
partmod(Patients-1, taking-2)
dobj(taking-2, diuretics-3)
root(ROOT-0, are-4)
det(risk-8, a-6)
amod(risk-8, greater-7)
prep_at(are-4, risk-8)
prepc_of(risk-8, developing-10)
amod(failure-12, renal-11)
dobj(developing-10, failure-12)
amod(failure-12, secondary-13)
det(decrease-16, a-15)
prep_to(secondary-13, decrease-16)
amod(flow-20, renal-18)
nn(flow-20, blood-19)
prep_in(decrease-16, flow-20)
partmod(flow-20, caused-21)
nn(inhibition-24, prostaglandin-23)
agent(caused-21, inhibition-24)

Digoxin/NN :/: In/IN a/DT study/NN in/IN 12/CD patients/NNS with/IN congestive/JJ heart/NN failure/NN where/WRB ketoprofen/NN and/CC digoxin/NN were/VBD concomitantly/RB administered/VBN ,/, ketoprofen/NN did/VBD not/RB alter/VB the/DT serum/NN levels/NNS of/IN digoxin/NN ./.

(ROOT (S1 (S (NP (NP (NN Digoxin)) (: :) (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (NP (CD 12) (NNS patients)) (PP (IN with) (NP (NP (JJ congestive) (NN heart) (NN failure)) (SBAR (WHADVP (WRB where)) (S (NP (NP (NN ketoprofen)) (CC and) (NP (NN digoxin))) (VP (VBD were) (ADVP (RB concomitantly)) (VP (VBN administered))))))))))) (, ,) (NP (NN ketoprofen)) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NN serum) (NNS levels)) (PP (IN of) (NP (NN digoxin))))))) (. .)))))

root(ROOT-0, Digoxin-1)
det(study-5, a-4)
prep_in(alter-24, study-5)
num(patients-8, 12-7)
prep_in(study-5, patients-8)
amod(failure-12, congestive-10)
nn(failure-12, heart-11)
prep_with(patients-8, failure-12)
advmod(administered-19, where-13)
nsubjpass(administered-19, ketoprofen-14)
conj_and(ketoprofen-14, digoxin-16)
auxpass(administered-19, were-17)
advmod(administered-19, concomitantly-18)
rcmod(failure-12, administered-19)
nsubj(alter-24, ketoprofen-21)
aux(alter-24, did-22)
neg(alter-24, not-23)
dep(Digoxin-1, alter-24)
det(levels-27, the-25)
nn(levels-27, serum-26)
dobj(alter-24, levels-27)
prep_of(levels-27, digoxin-29)

Warfarin/NN :/: In/IN a/DT short-term/JJ controlled/JJ study/NN in/IN 14/CD normal/JJ volunteers/NNS ,/, ketoprofen/NN did/VBD not/RB significantly/RB interfere/VB with/IN the/DT effect/NN of/IN warfarin/NN on/IN prothrombin/NN time/NN ./.

(ROOT (S1 (S (S (NP (NN Warfarin)) (: :) (PP (IN In) (NP (NP (DT a) (JJ short-term) (JJ controlled) (NN study)) (PP (IN in) (NP (CD 14) (JJ normal) (NNS volunteers))))) (, ,) (NP (NN ketoprofen)) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN warfarin))) (PP (IN on) (NP (NN prothrombin) (NN time)))))))) (. .))))

nsubj(interfere-17, Warfarin-1)
det(study-7, a-4)
amod(study-7, short-term-5)
amod(study-7, controlled-6)
prep_in(interfere-17, study-7)
num(volunteers-11, 14-9)
amod(volunteers-11, normal-10)
prep_in(study-7, volunteers-11)
nsubj(interfere-17, ketoprofen-13)
aux(interfere-17, did-14)
neg(interfere-17, not-15)
advmod(interfere-17, significantly-16)
root(ROOT-0, interfere-17)
det(effect-20, the-19)
prep_with(interfere-17, effect-20)
prep_of(effect-20, warfarin-22)
nn(time-25, prothrombin-24)
prep_on(effect-20, time-25)

Bleeding/JJ from/IN a/DT number/NN of/IN sites/NNS may/MD be/VB a/DT complication/NN of/IN warfarin/NN treatment/NN and/CC GI/JJ bleeding/JJ a/DT complication/NN of/IN ketoprofen/NN treatment/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Bleeding)) (PP (IN from) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNS sites)))))) (VP (MD may) (VP (VB be) (NP (NP (NP (DT a) (NN complication)) (PP (IN of) (NP (NN warfarin) (NN treatment)))) (CC and) (NP (JJ GI) (JJ bleeding)) (NP (NP (DT a) (NN complication)) (PP (IN of) (NP (NN ketoprofen) (NN treatment)))))))) (. .))))

nsubj(complication-10, Bleeding-1)
det(number-4, a-3)
prep_from(Bleeding-1, number-4)
prep_of(number-4, sites-6)
aux(complication-10, may-7)
cop(complication-10, be-8)
det(complication-10, a-9)
root(ROOT-0, complication-10)
nn(treatment-13, warfarin-12)
prep_of(complication-10, treatment-13)
amod(bleeding-16, GI-15)
conj_and(complication-10, bleeding-16)
det(complication-18, a-17)
dep(complication-10, complication-18)
nn(treatment-21, ketoprofen-20)
prep_of(complication-18, treatment-21)

Because/IN prostaglandina/NNS play/VBP an/DT important/JJ role/NN in/IN hemostasis/NN and/CC ketoprofen/NN has/VBZ an/DT effect/NN on/IN platelet/NN function/NN as/IN well/NN ,/, concurent/JJ therapy/NN with/IN ketoprofen/NN and/CC warfarin/NN requires/VBZ close/JJ monitoring/NN of/IN patients/NNS on/IN both/DT drugs/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NNS prostaglandina)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (NN hemostasis)) (CC and) (NP (NN ketoprofen))))))) (VP (VBZ has) (NP (NP (DT an) (NN effect)) (PP (IN on) (NP (NN platelet) (NN function)))) (PP (IN as) (NP (NN well))))) (, ,) (S (NP (NP (JJ concurent) (NN therapy)) (PP (IN with) (NP (NP (NN ketoprofen)) (CC and) (NP (NN warfarin))))) (VP (VBZ requires) (NP (NP (JJ close) (NN monitoring)) (PP (IN of) (NP (NNS patients))) (PP (IN on) (NP (DT both) (NNS drugs)))))) (. .))))

mark(play-3, Because-1)
nsubj(play-3, prostaglandina-2)
csubj(has-11, play-3)
det(role-6, an-4)
amod(role-6, important-5)
dobj(play-3, role-6)
prep_in(play-3, hemostasis-8)
conj_and(hemostasis-8, ketoprofen-10)
root(ROOT-0, has-11)
det(effect-13, an-12)
dobj(has-11, effect-13)
nn(function-16, platelet-15)
prep_on(effect-13, function-16)
prep_as(has-11, well-18)
amod(therapy-21, concurent-20)
nsubj(requires-26, therapy-21)
prep_with(therapy-21, ketoprofen-23)
conj_and(ketoprofen-23, warfarin-25)
ccomp(has-11, requires-26)
amod(monitoring-28, close-27)
dobj(requires-26, monitoring-28)
prep_of(monitoring-28, patients-30)
det(drugs-33, both-32)
prep_on(monitoring-28, drugs-33)

Probenecid/NN :/: Probenecid/NN increases/VBZ both/CC free/JJ and/CC bound/JJ ketoprofen/NN by/IN reducing/VBG the/DT plasma/NN clearance/NN of/IN ketoprofen/NN to/TO about/RB one-third/CD ,/, as/RB well/RB as/IN decreasing/VBG its/PRP$ protein/NN binding/NN ./.

(ROOT (S1 (S (NP (NP (NN Probenecid)) (: :) (S (NP (NN Probenecid)) (VP (VBZ increases) (NP (ADJP (CC both) (ADJP (JJ free)) (CC and) (ADJP (JJ bound))) (NN ketoprofen)) (PP (IN by) (S (VP (VP (VBG reducing) (NP (NP (DT the) (NN plasma) (NN clearance)) (PP (IN of) (NP (NN ketoprofen))) (PP (TO to) (NP (RB about) (CD one-third))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (VP (VBG decreasing) (NP (PRP$ its) (NN protein) (NN binding)))))))) (. .)))))

root(ROOT-0, Probenecid-1)
nsubj(increases-4, Probenecid-3)
dep(Probenecid-1, increases-4)
preconj(free-6, both-5)
amod(ketoprofen-9, free-6)
conj_and(free-6, bound-8)
dobj(increases-4, ketoprofen-9)
prepc_by(increases-4, reducing-11)
det(clearance-14, the-12)
nn(clearance-14, plasma-13)
dobj(reducing-11, clearance-14)
prep_of(clearance-14, ketoprofen-16)
advmod(one-third-19, about-18)
prep_to(clearance-14, one-third-19)
conj_and(reducing-11, decreasing-24)
poss(binding-27, its-25)
nn(binding-27, protein-26)
dobj(decreasing-24, binding-27)

Therefore/RB ,/, the/DT combination/NN of/IN ketoprofen/NN and/CC probenecid/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NN ketoprofen)) (CC and) (NP (NN probenecid))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

advmod(recommended-11, Therefore-1)
det(combination-4, the-3)
nsubjpass(recommended-11, combination-4)
prep_of(combination-4, ketoprofen-6)
conj_and(ketoprofen-6, probenecid-8)
auxpass(recommended-11, is-9)
neg(recommended-11, not-10)
root(ROOT-0, recommended-11)

Methotrexate/NN :/: Ketoprofen/NN ,/, like/IN other/JJ NSAIDs/NNS ,/, may/MD cause/VB changes/NNS in/IN the/DT elimination/NN of/IN methotrexate/NN leading/VBG to/TO elevated/JJ serum/NN levels/NNS of/IN the/DT drug/NN and/CC increased/VBN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Methotrexate)) (: :) (NP (NN Ketoprofen))) (, ,) (PP (IN like) (NP (JJ other) (NNS NSAIDs))) (, ,) (VP (MD may) (VP (VB cause) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (NP (NN methotrexate)) (VP (VBG leading) (PP (TO to) (NP (NP (JJ elevated) (NN serum) (NNS levels)) (PP (IN of) (NP (NP (DT the) (NN drug)) (CC and) (NP (VBN increased) (NN toxicity))))))))))))))) (. .))))

nsubj(cause-10, Methotrexate-1)
dep(Methotrexate-1, Ketoprofen-3)
amod(NSAIDs-7, other-6)
prep_like(cause-10, NSAIDs-7)
aux(cause-10, may-9)
root(ROOT-0, cause-10)
dobj(cause-10, changes-11)
det(elimination-14, the-13)
prep_in(changes-11, elimination-14)
prep_of(elimination-14, methotrexate-16)
partmod(methotrexate-16, leading-17)
amod(levels-21, elevated-19)
nn(levels-21, serum-20)
prep_to(leading-17, levels-21)
det(drug-24, the-23)
prep_of(levels-21, drug-24)
amod(toxicity-27, increased-26)
conj_and(drug-24, toxicity-27)

Lithium/NN :/: Nonsteroidal/JJ anti-inflammatory/JJ agents/NNS have/VBP been/VBN reported/VBN to/TO increase/VB steadystate/JJ plasma/NN lithium/NN levels/NNS ./.

(ROOT (S1 (S (NP (NP (NN Lithium)) (: :) (S (NP (JJ Nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB increase) (NP (JJ steadystate) (NN plasma) (NN lithium) (NNS levels))))))))) (. .)))))

root(ROOT-0, Lithium-1)
amod(agents-5, Nonsteroidal-3)
amod(agents-5, anti-inflammatory-4)
nsubjpass(reported-8, agents-5)
xsubj(increase-10, agents-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
dep(Lithium-1, reported-8)
aux(increase-10, to-9)
xcomp(reported-8, increase-10)
amod(levels-14, steadystate-11)
nn(levels-14, plasma-12)
nn(levels-14, lithium-13)
dobj(increase-10, levels-14)

It/PRP is/VBZ recommended/VBN that/IN plasma/NN lithium/NN levels/NNS be/VB monitored/VBN when/WRB ketoprofen/NN is/VBZ coadministered/VBN with/IN lithium/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN plasma) (NN lithium) (NNS levels)) (VP (VB be) (VP (VBN monitored) (SBAR (WHADVP (WRB when)) (S (NP (NN ketoprofen)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (NN lithium)))))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(monitored-9, that-4)
nn(levels-7, plasma-5)
nn(levels-7, lithium-6)
nsubjpass(monitored-9, levels-7)
auxpass(monitored-9, be-8)
ccomp(recommended-3, monitored-9)
advmod(coadministered-13, when-10)
nsubjpass(coadministered-13, ketoprofen-11)
auxpass(coadministered-13, is-12)
advcl(monitored-9, coadministered-13)
prep_with(coadministered-13, lithium-15)

DRUG/NN /LABORATORY/NN TEST/NN INTERACTIONS/NNS :/: EFFECT/NN ON/IN BLOOD/NN COAGULATION/NN Ketoprofen/NN decreases/VBZ platelet/NN adhesion/NN and/CC aggregation/NN ./.

(ROOT (S1 (S (NP (NP (NN DRUG) (NN /LABORATORY) (NN TEST) (NNS INTERACTIONS)) (: :) (S (NP (NP (NN EFFECT)) (PP (IN ON) (NP (NN BLOOD) (NN COAGULATION) (NN Ketoprofen)))) (VP (VBZ decreases) (NP (NP (NN platelet) (NN adhesion)) (CC and) (NP (NN aggregation))))) (. .)))))

nn(INTERACTIONS-4, DRUG-1)
nn(INTERACTIONS-4, /LABORATORY-2)
nn(INTERACTIONS-4, TEST-3)
root(ROOT-0, INTERACTIONS-4)
nsubj(decreases-11, EFFECT-6)
nn(Ketoprofen-10, BLOOD-8)
nn(Ketoprofen-10, COAGULATION-9)
prep_on(EFFECT-6, Ketoprofen-10)
dep(INTERACTIONS-4, decreases-11)
nn(adhesion-13, platelet-12)
dobj(decreases-11, adhesion-13)
conj_and(adhesion-13, aggregation-15)

Ketorolac/NN is/VBZ highly/RB bound/VBN to/TO human/JJ plasma/NN protein/NN (/-LRB- mean/NN 99.2/CD %)./NN

(ROOT (S1 (S (NP (NN Ketorolac)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (JJ human) (NN plasma) (NN protein) (-LRB- -LRB-) (NN mean) (CD 99.2) (NN %-RRB-.))))))))

nsubjpass(bound-4, Ketorolac-1)
auxpass(bound-4, is-2)
advmod(bound-4, highly-3)
root(ROOT-0, bound-4)
amod(%-RRB-.-12, human-6)
nn(%-RRB-.-12, plasma-7)
nn(%-RRB-.-12, protein-8)
nn(%-RRB-.-12, mean-10)
num(%-RRB-.-12, 99.2-11)
prep_to(bound-4, %-RRB-.-12)

Warfarin/NN ,/, Digoxin/NN ,/, Salicylate/NN ,/, and/CC Heparin/NN :/: The/DT in/FW vitro/FW binding/NN of/IN warfarin/NN to/TO plasma/NN proteins/NNS is/VBZ only/RB slightly/RB reduced/VBN by/IN ketorolac/NN tromethamine/NN (/-LRB- 99.5/CD %/NN control/NN vs/CC 99.3/CD %/NN )/-RRB- when/WRB ketorolac/NN plasma/NN concentrations/NNS reach/VBP 5/CD to10/CD m/NN g/mL/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Warfarin)) (, ,) (NP (NN Digoxin)) (, ,) (NP (NN Salicylate)) (, ,) (CC and) (NP (NN Heparin))) (: :) (S (NP (NP (DT The) (ADJP (FW in) (FW vitro)) (NN binding)) (PP (IN of) (NP (NN warfarin))) (PP (TO to) (NP (NN plasma) (NNS proteins)))) (VP (VBZ is) (ADVP (RB only) (RB slightly)) (VP (VBN reduced) (PP (IN by) (NP (NP (NN ketorolac) (NN tromethamine)) (PRN (-LRB- -LRB-) (NP (CD 99.5) (NN %) (NN control) (CC vs) (CD 99.3) (NN %)) (-RRB- -RRB-)))) (SBAR (WHADVP (WRB when)) (S (NP (NN ketorolac) (NN plasma) (NNS concentrations)) (VP (VBP reach) (NP (CD 5) (ADJP (CD to10) (NN m)) (NN g/mL)))))))) (. .)))))

root(ROOT-0, Warfarin-1)
conj_and(Warfarin-1, Digoxin-3)
conj_and(Warfarin-1, Salicylate-5)
conj_and(Warfarin-1, Heparin-8)
det(binding-13, The-10)
nn(vitro-12, in-11)
amod(binding-13, vitro-12)
nsubjpass(reduced-22, binding-13)
prep_of(binding-13, warfarin-15)
nn(proteins-18, plasma-17)
prep_to(binding-13, proteins-18)
auxpass(reduced-22, is-19)
advmod(slightly-21, only-20)
advmod(reduced-22, slightly-21)
dep(Warfarin-1, reduced-22)
nn(tromethamine-25, ketorolac-24)
agent(reduced-22, tromethamine-25)
num(control-29, 99.5-27)
nn(control-29, %-28)
dep(tromethamine-25, control-29)
num(%-32, 99.3-31)
conj_vs(control-29, %-32)
advmod(reach-38, when-34)
nn(concentrations-37, ketorolac-35)
nn(concentrations-37, plasma-36)
nsubj(reach-38, concentrations-37)
advcl(reduced-22, reach-38)
num(g/mL-42, 5-39)
number(m-41, to10-40)
amod(g/mL-42, m-41)
dobj(reach-38, g/mL-42)

Ketorolac/NN does/VBZ not/RB alter/VB digoxin/NN protein/NN binding/NN ./.

(ROOT (S1 (S (S (NP (NN Ketorolac)) (VP (VBZ does) (RB not) (VP (VB alter) (NP (NN digoxin) (NN protein) (NN binding))))) (. .))))

nsubj(alter-4, Ketorolac-1)
aux(alter-4, does-2)
neg(alter-4, not-3)
root(ROOT-0, alter-4)
nn(binding-7, digoxin-5)
nn(binding-7, protein-6)
dobj(alter-4, binding-7)

In/FW vitro/FW studies/NNS indicate/VBP that/IN ,/, at/IN therapeutic/JJ concentrations/NNS of/IN salicylate/NN (/-LRB- 300/CD m/NN g/mL/NN )/-RRB- ,/, the/DT binding/NN of/IN ketorolac/NN was/VBD reduced/VBN from/IN approximately/RB 99.2/CD %/NN to/TO 97.5/CD %/NN ,/, representing/VBG a/DT potential/JJ twofold/JJ increase/NN in/IN unbound/JJ ketorolac/NN plasma/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (, ,) (PP (IN at) (NP (NP (NP (JJ therapeutic) (NNS concentrations)) (PP (IN of) (NP (NN salicylate)))) (PRN (-LRB- -LRB-) (NP (CD 300) (NN m) (NN g/mL)) (-RRB- -RRB-)))) (, ,) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN ketorolac)))) (VP (VBD was) (VP (VBN reduced) (PP (IN from) (NP (QP (RB approximately) (CD 99.2) (NN %) (TO to) (CD 97.5)) (NN %))) (, ,) (S (VP (VBG representing) (NP (NP (DT a) (JJ potential) (JJ twofold) (NN increase)) (PP (IN in) (NP (JJ unbound) (NN ketorolac) (NN plasma) (NNS levels)))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicate-4, studies-3)
root(ROOT-0, indicate-4)
complm(reduced-23, that-5)
amod(concentrations-9, therapeutic-8)
prep_at(reduced-23, concentrations-9)
prep_of(concentrations-9, salicylate-11)
num(g/mL-15, 300-13)
nn(g/mL-15, m-14)
appos(concentrations-9, g/mL-15)
det(binding-19, the-18)
nsubjpass(reduced-23, binding-19)
prep_of(binding-19, ketorolac-21)
auxpass(reduced-23, was-22)
ccomp(indicate-4, reduced-23)
quantmod(%-27, approximately-25)
number(%-27, 99.2-26)
num(%-30, %-27)
dep(%-27, to-28)
number(%-27, 97.5-29)
prep_from(reduced-23, %-30)
xcomp(reduced-23, representing-32)
det(increase-36, a-33)
amod(increase-36, potential-34)
amod(increase-36, twofold-35)
dobj(representing-32, increase-36)
amod(levels-41, unbound-38)
nn(levels-41, ketorolac-39)
nn(levels-41, plasma-40)
prep_in(increase-36, levels-41)

Therapeutic/JJ concentrations/NNS of/IN digoxin/NN ,/, warfarin/NN ,/, ibuprofen/NN ,/, naproxen/NN ,/, piroxicam/NN ,/, acetaminophen/NN ,/, phenytoin/NN andtolbutamide/NN did/VBD not/RB alter/VB ketorolac/NN tromethamine/NN protein/NN binding/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Therapeutic) (NNS concentrations)) (PP (IN of) (NP (NP (NN digoxin)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN ibuprofen)) (, ,) (NP (NN naproxen)) (, ,) (NP (NN piroxicam)) (, ,) (NP (NN acetaminophen)) (, ,) (NP (NN phenytoin) (NN andtolbutamide))))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (NN ketorolac) (NN tromethamine)) (NN protein) (NN binding))))) (. .))))

amod(concentrations-2, Therapeutic-1)
nsubj(alter-20, concentrations-2)
prep_of(concentrations-2, digoxin-4)
appos(digoxin-4, warfarin-6)
appos(digoxin-4, ibuprofen-8)
appos(digoxin-4, naproxen-10)
appos(digoxin-4, piroxicam-12)
appos(digoxin-4, acetaminophen-14)
nn(andtolbutamide-17, phenytoin-16)
appos(digoxin-4, andtolbutamide-17)
aux(alter-20, did-18)
neg(alter-20, not-19)
root(ROOT-0, alter-20)
nn(tromethamine-22, ketorolac-21)
nn(binding-24, tromethamine-22)
nn(binding-24, protein-23)
dobj(alter-20, binding-24)

In/IN a/DT study/NN involving/VBG 12/CD adult/JJ volunteers/NNS ,/, TORADOLORAL/NN was/VBD coadministered/VBN with/IN a/DT single/JJ dose/NN of/IN 25/CD mg/NN warfarin/NN ,/, causing/VBG no/DT significant/JJ changes/NNS in/IN pharmacokinetics/NNS or/CC pharmacodynamics/NNS of/IN warfarin/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (NN study)) (VP (VBG involving) (NP (CD 12) (JJ adult) (NNS volunteers))))) (, ,) (NP (NN TORADOLORAL)) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (ADJP (CD 25) (NN mg)) (NN warfarin))))) (, ,) (S (VP (VBG causing) (NP (NP (DT no) (JJ significant) (NNS changes)) (PP (IN in) (NP (NP (NP (NNS pharmacokinetics)) (CC or) (NP (NNS pharmacodynamics))) (PP (IN of) (NP (NN warfarin))))))))))) (. .))))

det(study-3, a-2)
prep_in(coadministered-11, study-3)
partmod(study-3, involving-4)
num(volunteers-7, 12-5)
amod(volunteers-7, adult-6)
dobj(involving-4, volunteers-7)
nsubjpass(coadministered-11, TORADOLORAL-9)
auxpass(coadministered-11, was-10)
root(ROOT-0, coadministered-11)
det(dose-15, a-13)
amod(dose-15, single-14)
prep_with(coadministered-11, dose-15)
number(mg-18, 25-17)
amod(warfarin-19, mg-18)
prep_of(dose-15, warfarin-19)
xcomp(coadministered-11, causing-21)
det(changes-24, no-22)
amod(changes-24, significant-23)
dobj(causing-21, changes-24)
prep_in(changes-24, pharmacokinetics-26)
conj_or(pharmacokinetics-26, pharmacodynamics-28)
prep_of(pharmacokinetics-26, warfarin-30)

In/IN another/DT study/NN ,/, TORADOLIV/IM/NN was/VBD given/VBN with/IN two/CD doses/NNS of/IN 5000/CD U/NN of/IN heparin/NN to/TO 11/CD healthy/JJ volunteers/NNS ,/, resulting/VBG in/IN a/DT mean/NN template/NN bleeding/JJ time/NN of/IN 6.4/CD minutes/NNS (/-LRB- 3.2/CD to/TO 11.4/CD min/NN )/-RRB- compared/VBN to/TO a/DT mean/NN of/IN 6.0/CD minutes/NNS (/-LRB- 3.4/CD to/TO 7.5/CD min/NN )/-RRB- for/IN heparin/NN alone/RB and/CC 5.1/CD minutes/NNS (/-LRB- 3.5/CD to/TO 8.5/CD min/NN )/-RRB- for/IN placebo/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (DT another) (NN study))) (, ,) (NP (NN TORADOLIV/IM)) (VP (VBD was) (VP (VBN given) (PP (IN with) (NP (NP (CD two) (NNS doses)) (PP (IN of) (NP (NP (CD 5000) (NN U)) (PP (IN of) (NP (NN heparin))) (PP (TO to) (NP (CD 11) (JJ healthy) (NNS volunteers))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (NN mean) (NN template) (JJ bleeding) (NN time)) (PP (IN of) (NP (NP (NP (CD 6.4) (NNS minutes)) (PRN (-LRB- -LRB-) (NP (QP (CD 3.2) (TO to) (CD 11.4)) (NN min)) (-RRB- -RRB-))) (VP (VBN compared) (PP (TO to) (NP (DT a) (NN mean))) (PP (IN of) (NP (NP (NP (NP (NP (CD 6.0) (NNS minutes)) (PRN (-LRB- -LRB-) (NP (QP (CD 3.4) (TO to) (CD 7.5)) (NN min)) (-RRB- -RRB-))) (PP (IN for) (NP (NN heparin)))) (ADVP (RB alone))) (CC and) (NP (NP (CD 5.1) (NNS minutes)) (PRN (-LRB- -LRB-) (NP (QP (CD 3.5) (TO to) (CD 8.5)) (NN min)) (-RRB- -RRB-)))))))) (PP (IN for) (NP (NN placebo))))))))) (. .))))

det(study-3, another-2)
prep_in(given-7, study-3)
nsubjpass(given-7, TORADOLIV/IM-5)
auxpass(given-7, was-6)
root(ROOT-0, given-7)
num(doses-10, two-9)
prep_with(given-7, doses-10)
num(U-13, 5000-12)
prep_of(doses-10, U-13)
prep_of(U-13, heparin-15)
num(volunteers-19, 11-17)
amod(volunteers-19, healthy-18)
prep_to(U-13, volunteers-19)
xcomp(given-7, resulting-21)
det(time-27, a-23)
nn(time-27, mean-24)
nn(time-27, template-25)
amod(time-27, bleeding-26)
prep_in(resulting-21, time-27)
num(minutes-30, 6.4-29)
prep_of(time-27, minutes-30)
number(11.4-34, 3.2-32)
dep(11.4-34, to-33)
num(min-35, 11.4-34)
appos(minutes-30, min-35)
partmod(minutes-30, compared-37)
det(mean-40, a-39)
prep_to(compared-37, mean-40)
num(minutes-43, 6.0-42)
prep_of(compared-37, minutes-43)
number(7.5-47, 3.4-45)
dep(7.5-47, to-46)
num(min-48, 7.5-47)
appos(minutes-43, min-48)
prep_for(minutes-43, heparin-51)
advmod(minutes-43, alone-52)
num(minutes-55, 5.1-54)
conj_and(minutes-43, minutes-55)
number(8.5-59, 3.5-57)
dep(8.5-59, to-58)
num(min-60, 8.5-59)
appos(minutes-55, min-60)
prep_for(time-27, placebo-63)

Although/IN these/DT results/NNS do/VBP not/RB indicate/VB a/DT significant/JJ interaction/NN between/IN TORADOL/NN and/CC warfarin/NN or/CC heparin/NN ,/, the/DT administration/NN of/IN TORADOL/NN to/TO patients/NNS taking/VBG anticoagulants/NNS should/MD be/VB done/VBN extremely/RB cautiously/RB ,/, and/CC patients/NNS should/MD be/VB closely/RB monitored/VBN ./.

(ROOT (S1 (S (S (S (SBAR (IN Although) (S (NP (DT these) (NNS results)) (VP (VBP do) (RB not) (VP (VB indicate) (NP (NP (DT a) (JJ significant) (NN interaction)) (PP (IN between) (NP (NP (NN TORADOL)) (CC and) (NP (NP (NN warfarin)) (CC or) (NP (NN heparin)))))))))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN TORADOL))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NNS anticoagulants)))))) (VP (MD should) (VP (VB be) (VP (VBN done) (ADVP (RB extremely) (RB cautiously)))))) (, ,) (CC and) (S (NP (NNS patients)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored)))))) (. .))))

mark(indicate-6, Although-1)
det(results-3, these-2)
nsubj(indicate-6, results-3)
aux(indicate-6, do-4)
neg(indicate-6, not-5)
advcl(done-27, indicate-6)
det(interaction-9, a-7)
amod(interaction-9, significant-8)
dobj(indicate-6, interaction-9)
prep_between(interaction-9, TORADOL-11)
conj_and(TORADOL-11, warfarin-13)
conj_or(warfarin-13, heparin-15)
det(administration-18, the-17)
nsubjpass(done-27, administration-18)
prep_of(administration-18, TORADOL-20)
prep_to(administration-18, patients-22)
partmod(patients-22, taking-23)
dobj(taking-23, anticoagulants-24)
aux(done-27, should-25)
auxpass(done-27, be-26)
root(ROOT-0, done-27)
advmod(cautiously-29, extremely-28)
advmod(done-27, cautiously-29)
nsubjpass(monitored-36, patients-32)
aux(monitored-36, should-33)
auxpass(monitored-36, be-34)
advmod(monitored-36, closely-35)
conj_and(done-27, monitored-36)

Furosemide/NN TORADOLIV/NN /IM/NN reduced/VBD the/DT diuretic/JJ response/NN to/TO furosemide/NN in/IN normovolemic/JJ healthy/JJ subjects/NNS by/IN approximately/RB 20/CD %/NN (/-LRB- mean/JJ sodium/NN and/CC urinary/JJ output/NN decreased/VBD 17/CD %)./NN

(ROOT (S1 (S (S (NP (NN Furosemide) (NN TORADOLIV) (NN /IM)) (VP (VBD reduced) (NP (NP (DT the) (JJ diuretic) (NN response)) (PP (TO to) (NP (NN furosemide))) (PP (IN in) (NP (JJ normovolemic) (JJ healthy) (NNS subjects)))) (PP (IN by) (NP (QP (RB approximately) (CD 20)) (NN %))) (-LRB- -LRB-) (NP (JJ mean) (NN sodium)))) (CC and) (S (NP (JJ urinary) (NN output)) (VP (VBD decreased) (NP (CD 17) (NN %-RRB-.)))))))

nn(/IM-3, Furosemide-1)
nn(/IM-3, TORADOLIV-2)
nsubj(reduced-4, /IM-3)
root(ROOT-0, reduced-4)
det(response-7, the-5)
amod(response-7, diuretic-6)
dobj(reduced-4, response-7)
prep_to(response-7, furosemide-9)
amod(subjects-13, normovolemic-11)
amod(subjects-13, healthy-12)
prep_in(response-7, subjects-13)
quantmod(20-16, approximately-15)
num(%-17, 20-16)
prep_by(reduced-4, %-17)
amod(sodium-20, mean-19)
dobj(reduced-4, sodium-20)
amod(output-23, urinary-22)
nsubj(decreased-24, output-23)
conj_and(reduced-4, decreased-24)
num(%-RRB-.-26, 17-25)
dobj(decreased-24, %-RRB-.-26)

Probenecid/NN Concomitant/JJ administration/NN of/IN TORADOLORAL/NN and/CC probenecid/NN resulted/VBD in/IN decreased/VBN clearance/NN of/IN ketorolac/NN and/CC significant/JJ increases/NNS in/IN ketorolac/NN plasma/NN levels/NNS (/-LRB- total/JJ AUC/NN increased/VBD approximately/RB threefold/RB from/IN 5.4/CD to/TO 17.8/CD m/NN g/h/mL/NN )/-RRB- and/CC terminal/JJ half-life/NN increased/VBD approximately/RB twofold/RB from/IN 6.6/CD to/TO 15.1/CD hours/NNS ./.

(ROOT (S1 (S (S (S (NP (NP (NP (NN Probenecid)) (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN TORADOLORAL)) (CC and) (NP (NN probenecid))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (VBN decreased) (NN clearance)) (PP (IN of) (NP (NN ketorolac)))) (CC and) (NP (NP (JJ significant) (NNS increases)) (PP (IN in) (NP (NP (NN ketorolac) (NN plasma) (NNS levels)) (PRN (-LRB- -LRB-) (NP (NP (JJ total) (NN AUC)) (VP (VBD increased) (ADVP (RB approximately) (RB threefold)) (PP (IN from) (NP (ADJP (QP (CD 5.4) (TO to) (CD 17.8)) (NN m)) (NN g/h/mL))))) (-RRB- -RRB-))))))))) (CC and) (S (NP (JJ terminal) (NN half-life)) (VP (VBD increased) (ADVP (RB approximately) (RB twofold)) (PP (IN from) (NP (QP (CD 6.6) (TO to) (CD 15.1)) (NNS hours)))))) (. .))))

nn(administration-3, Probenecid-1)
amod(administration-3, Concomitant-2)
nsubj(resulted-8, administration-3)
prep_of(administration-3, TORADOLORAL-5)
conj_and(TORADOLORAL-5, probenecid-7)
root(ROOT-0, resulted-8)
amod(clearance-11, decreased-10)
prep_in(resulted-8, clearance-11)
prep_of(clearance-11, ketorolac-13)
amod(increases-16, significant-15)
conj_and(clearance-11, increases-16)
nn(levels-20, ketorolac-18)
nn(levels-20, plasma-19)
prep_in(increases-16, levels-20)
amod(AUC-23, total-22)
dep(levels-20, AUC-23)
partmod(AUC-23, increased-24)
advmod(threefold-26, approximately-25)
advmod(increased-24, threefold-26)
number(17.8-30, 5.4-28)
dep(17.8-30, to-29)
dep(m-31, 17.8-30)
dep(g/h/mL-32, m-31)
prep_from(increased-24, g/h/mL-32)
amod(half-life-36, terminal-35)
nsubj(increased-37, half-life-36)
conj_and(resulted-8, increased-37)
advmod(twofold-39, approximately-38)
advmod(increased-37, twofold-39)
number(15.1-43, 6.6-41)
dep(15.1-43, to-42)
num(hours-44, 15.1-43)
prep_from(increased-37, hours-44)

Therefore/RB ,/, concomitant/JJ use/NN of/IN TORADOL/NN and/CC probenecid/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN TORADOL)) (CC and) (NP (NN probenecid))))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

advmod(contraindicated-10, Therefore-1)
amod(use-4, concomitant-3)
nsubjpass(contraindicated-10, use-4)
prep_of(use-4, TORADOL-6)
conj_and(TORADOL-6, probenecid-8)
auxpass(contraindicated-10, is-9)
root(ROOT-0, contraindicated-10)

Lithium/NN Inhibition/NN of/IN renal/JJ lithium/NN clearance/NN ,/, leading/VBG to/TO an/DT increase/NN in/IN plasma/NN lithium/NN concentration/NN ,/, has/VBZ been/VBN reported/VBN with/IN some/DT prostaglandin/NN synthesis-inhibiting/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium) (NN Inhibition)) (PP (IN of) (NP (NP (JJ renal) (NN lithium) (NN clearance)) (, ,) (VP (VBG leading) (PP (TO to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN plasma) (NN lithium) (NN concentration)))))) (, ,)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (DT some) (NN prostaglandin) (JJ synthesis-inhibiting) (NNS drugs))))))) (. .))))

nn(Inhibition-2, Lithium-1)
nsubjpass(reported-19, Inhibition-2)
amod(clearance-6, renal-4)
nn(clearance-6, lithium-5)
prep_of(Inhibition-2, clearance-6)
partmod(clearance-6, leading-8)
det(increase-11, an-10)
prep_to(leading-8, increase-11)
nn(concentration-15, plasma-13)
nn(concentration-15, lithium-14)
prep_in(increase-11, concentration-15)
aux(reported-19, has-17)
auxpass(reported-19, been-18)
root(ROOT-0, reported-19)
det(drugs-24, some-21)
nn(drugs-24, prostaglandin-22)
amod(drugs-24, synthesis-inhibiting-23)
prep_with(reported-19, drugs-24)

The/DT effect/NN of/IN TORADOL/NN on/IN plasma/NN lithium/NN has/VBZ not/RB been/VBN studied/VBN ,/, but/CC cases/NNS of/IN increased/VBN lithium/NN plasma/NN levels/NNS during/IN TORADOL/NN therapy/NN have/VBP been/VBN reported/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN TORADOL))) (PP (IN on) (NP (NN plasma) (NN lithium)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (, ,) (CC but) (S (NP (NP (NNS cases)) (PP (IN of) (NP (NP (VBN increased) (NN lithium) (NN plasma) (NNS levels)) (PP (IN during) (NP (NN TORADOL) (NN therapy)))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported)))))) (. .))))

det(effect-2, The-1)
nsubjpass(studied-11, effect-2)
prep_of(effect-2, TORADOL-4)
nn(lithium-7, plasma-6)
prep_on(effect-2, lithium-7)
aux(studied-11, has-8)
neg(studied-11, not-9)
auxpass(studied-11, been-10)
root(ROOT-0, studied-11)
nsubjpass(reported-25, cases-14)
amod(levels-19, increased-16)
nn(levels-19, lithium-17)
nn(levels-19, plasma-18)
prep_of(cases-14, levels-19)
nn(therapy-22, TORADOL-21)
prep_during(levels-19, therapy-22)
aux(reported-25, have-23)
auxpass(reported-25, been-24)
conj_but(studied-11, reported-25)

Methotrexate/NN Concomitant/JJ administration/NN of/IN methotrexate/NN and/CC some/DT NSAIDs/NNS has/VBZ been/VBN reported/VBN to/TO reduce/VB the/DT clearance/NN of/IN methotrexate/NN ,/, enhancing/VBG the/DT toxicity/NN of/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Methotrexate) (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN methotrexate)) (CC and) (NP (DT some) (NNS NSAIDs))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN methotrexate))))))))) (, ,) (S (VP (VBG enhancing) (NP (NP (DT the) (NN toxicity)) (PP (IN of) (NP (NN methotrexate)))))))) (. .))))

nn(administration-3, Methotrexate-1)
amod(administration-3, Concomitant-2)
nsubjpass(reported-11, administration-3)
xsubj(reduce-13, administration-3)
prep_of(administration-3, methotrexate-5)
det(NSAIDs-8, some-7)
conj_and(methotrexate-5, NSAIDs-8)
aux(reported-11, has-9)
auxpass(reported-11, been-10)
root(ROOT-0, reported-11)
aux(reduce-13, to-12)
xcomp(reported-11, reduce-13)
det(clearance-15, the-14)
dobj(reduce-13, clearance-15)
prep_of(clearance-15, methotrexate-17)
xcomp(reported-11, enhancing-19)
det(toxicity-21, the-20)
dobj(enhancing-19, toxicity-21)
prep_of(toxicity-21, methotrexate-23)

The/DT effect/NN of/IN TORADOL/NN on/IN methotrexate/NN clearance/NN has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN TORADOL))) (PP (IN on) (NP (NN methotrexate) (NN clearance)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(effect-2, The-1)
nsubjpass(studied-11, effect-2)
prep_of(effect-2, TORADOL-4)
nn(clearance-7, methotrexate-6)
prep_on(effect-2, clearance-7)
aux(studied-11, has-8)
neg(studied-11, not-9)
auxpass(studied-11, been-10)
root(ROOT-0, studied-11)

Nondepolarizing/JJ Muscle/NN Relaxants/NNS :/: In/FW postmarketing/FW experience/VBP there/EX have/VBP been/VBN reports/NNS of/IN a/DT possible/JJ interaction/NN between/IN TORADOLIV/IM/NN and/CC nondepolarizing/JJ muscle/NN relaxants/NNS that/WDT resulted/VBD in/IN apnea/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Nondepolarizing) (NN Muscle) (NNS Relaxants)) (: :) (ADVP (FW In) (FW postmarketing))) (VP (VBP experience) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (DT a) (JJ possible) (NN interaction)) (PP (IN between) (NP (NP (NN TORADOLIV/IM)) (CC and) (NP (JJ nondepolarizing) (NN muscle) (NNS relaxants)))))) (SBAR (WHNP (WDT that)) (S (VP (VBD resulted) (PP (IN in) (NP (NN apnea)))))))))))) (. .))))

amod(Relaxants-3, Nondepolarizing-1)
nn(Relaxants-3, Muscle-2)
nsubj(experience-7, Relaxants-3)
nn(postmarketing-6, In-5)
advmod(Relaxants-3, postmarketing-6)
root(ROOT-0, experience-7)
expl(reports-11, there-8)
aux(reports-11, have-9)
cop(reports-11, been-10)
ccomp(experience-7, reports-11)
nsubj(resulted-23, reports-11)
det(interaction-15, a-13)
amod(interaction-15, possible-14)
prep_of(reports-11, interaction-15)
prep_between(interaction-15, TORADOLIV/IM-17)
amod(relaxants-21, nondepolarizing-19)
nn(relaxants-21, muscle-20)
conj_and(TORADOLIV/IM-17, relaxants-21)
rcmod(reports-11, resulted-23)
prep_in(resulted-23, apnea-25)

The/DT concurrent/JJ use/NN of/IN TORADOL/NN with/IN muscle/NN relaxants/NNS has/VBZ not/RB been/VBN formally/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concurrent) (NN use)) (PP (IN of) (NP (NN TORADOL))) (PP (IN with) (NP (NN muscle) (NNS relaxants)))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB formally)) (VP (VBN studied))))) (. .))))

det(use-3, The-1)
amod(use-3, concurrent-2)
nsubjpass(studied-13, use-3)
prep_of(use-3, TORADOL-5)
nn(relaxants-8, muscle-7)
prep_with(use-3, relaxants-8)
aux(studied-13, has-9)
neg(studied-13, not-10)
auxpass(studied-13, been-11)
advmod(studied-13, formally-12)
root(ROOT-0, studied-13)

ACE/NN Inhibitors/NNS Concomitant/JJ use/NN of/IN ACE/NN inhibitors/NNS may/MD increase/VB the/DT risk/NN of/IN renal/JJ impairment/NN ,/, particularly/RB in/IN volume-depleted/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NN ACE) (NNS Inhibitors)) (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN ACE) (NNS inhibitors)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ renal) (NN impairment)))) (, ,) (PP (ADVP (RB particularly)) (IN in) (NP (JJ volume-depleted) (NNS patients)))))) (. .))))

nn(Inhibitors-2, ACE-1)
nn(use-4, Inhibitors-2)
amod(use-4, Concomitant-3)
nsubj(increase-9, use-4)
nn(inhibitors-7, ACE-6)
prep_of(use-4, inhibitors-7)
aux(increase-9, may-8)
root(ROOT-0, increase-9)
det(risk-11, the-10)
dobj(increase-9, risk-11)
amod(impairment-14, renal-13)
prep_of(risk-11, impairment-14)
advmod(increase-9, particularly-16)
amod(patients-19, volume-depleted-18)
prep_in(increase-9, patients-19)

Antiepileptic/JJ Drugs/NNS Sporadic/JJ cases/NNS of/IN seizures/NNS have/VBP been/VBN reported/VBN during/IN concomitant/JJ use/NN of/IN TORADOL/NN and/CC antiepileptic/JJ drugs/NNS (/-LRB- phenytoin/NN ,/, carbamazepine/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (JJ Antiepileptic) (NNS Drugs)) (NP (NP (JJ Sporadic) (NNS cases)) (PP (IN of) (NP (NNS seizures))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN TORADOL)))) (CC and) (NP (NP (JJ antiepileptic) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine))) (-RRB- -RRB-))))))))) (. .))))

amod(Drugs-2, Antiepileptic-1)
nsubjpass(reported-9, Drugs-2)
amod(cases-4, Sporadic-3)
dep(Drugs-2, cases-4)
prep_of(cases-4, seizures-6)
aux(reported-9, have-7)
auxpass(reported-9, been-8)
root(ROOT-0, reported-9)
amod(use-12, concomitant-11)
prep_during(reported-9, use-12)
prep_of(use-12, TORADOL-14)
amod(drugs-17, antiepileptic-16)
conj_and(use-12, drugs-17)
dep(drugs-17, phenytoin-19)
appos(phenytoin-19, carbamazepine-21)

Psychoactive/JJ Drugs/NNS Hallucinations/NNS have/VBP been/VBN reported/VBN when/WRB TORADOL/NN was/VBD used/VBN in/IN patients/NNS taking/VBG psychoactive/JJ drugs/NNS (/-LRB- fluoxetine/NN ,/, thiothixene/NN ,/, alprazolam/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (JJ Psychoactive) (NNS Drugs)) (NP (NNS Hallucinations))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (SBAR (WHADVP (WRB when)) (S (NP (NN TORADOL)) (VP (VBD was) (VP (VBN used) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (JJ psychoactive) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NP (NN fluoxetine)) (, ,) (NP (NN thiothixene)) (, ,) (NP (NN alprazolam))) (-RRB- -RRB-)))))))))))))) (. .))))

amod(Drugs-2, Psychoactive-1)
nsubjpass(reported-6, Drugs-2)
dep(Drugs-2, Hallucinations-3)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
advmod(used-10, when-7)
nsubjpass(used-10, TORADOL-8)
auxpass(used-10, was-9)
advcl(reported-6, used-10)
prep_in(used-10, patients-12)
partmod(patients-12, taking-13)
amod(drugs-15, psychoactive-14)
dobj(taking-13, drugs-15)
dep(drugs-15, fluoxetine-17)
appos(fluoxetine-17, thiothixene-19)
appos(fluoxetine-17, alprazolam-21)

Morphine/NN TORADOLIV/IM/NN has/VBZ been/VBN administered/VBN concurrently/RB with/IN morphine/NN in/IN several/JJ clinical/JJ trials/NNS of/IN postoperative/JJ pain/NN without/IN evidence/NN of/IN adverse/JJ interactions/NNS ./.

(ROOT (S1 (S (S (NP (NN Morphine) (NN TORADOLIV/IM)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NN morphine))) (PP (IN in) (NP (NP (JJ several) (JJ clinical) (NNS trials)) (PP (IN of) (NP (JJ postoperative) (NN pain))) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (JJ adverse) (NNS interactions))))))))))) (. .))))

nn(TORADOLIV/IM-2, Morphine-1)
nsubjpass(administered-5, TORADOLIV/IM-2)
aux(administered-5, has-3)
auxpass(administered-5, been-4)
root(ROOT-0, administered-5)
advmod(administered-5, concurrently-6)
prep_with(administered-5, morphine-8)
amod(trials-12, several-10)
amod(trials-12, clinical-11)
prep_in(administered-5, trials-12)
amod(pain-15, postoperative-14)
prep_of(trials-12, pain-15)
prep_without(trials-12, evidence-17)
amod(interactions-20, adverse-19)
prep_of(evidence-17, interactions-20)

Do/VBP not/RB mix/NN TORADOL/NN and/CC morphine/NN in/IN the/DT same/JJ syringe/NN ./.

(ROOT (S1 (S (S (VP (VBP Do) (RB not) (NP (NN mix) (NP (NP (NN TORADOL)) (CC and) (NP (NN morphine)))) (PP (IN in) (NP (DT the) (JJ same) (NN syringe))))) (. .))))

root(ROOT-0, Do-1)
neg(Do-1, not-2)
dobj(Do-1, mix-3)
dep(mix-3, TORADOL-4)
conj_and(TORADOL-4, morphine-6)
det(syringe-10, the-8)
amod(syringe-10, same-9)
prep_in(Do-1, syringe-10)

There/EX is/VBZ no/DT evidence/NN in/IN animal/JJ or/CC human/JJ studies/NNS that/IN TORADOL/NN induces/VBZ or/CC inhibits/VBZ hepatic/JJ enzymes/NNS capable/JJ of/IN metabolizing/VBG itself/PRP or/CC other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (NN evidence)) (PP (IN in) (NP (ADJP (ADJP (JJ animal)) (CC or) (ADJP (JJ human))) (NNS studies))) (SBAR (IN that) (S (NP (NN TORADOL)) (VP (VP (VBZ induces)) (CC or) (VP (VBZ inhibits) (NP (NP (JJ hepatic) (NNS enzymes)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG metabolizing) (NP (NP (PRP itself)) (CC or) (NP (JJ other) (NNS drugs))))))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(evidence-4, no-3)
nsubj(is-2, evidence-4)
amod(studies-9, animal-6)
conj_or(animal-6, human-8)
prep_in(evidence-4, studies-9)
dep(induces-12, that-10)
nsubj(induces-12, TORADOL-11)
dep(evidence-4, induces-12)
conj_or(induces-12, inhibits-14)
amod(enzymes-16, hepatic-15)
dobj(inhibits-14, enzymes-16)
amod(enzymes-16, capable-17)
prepc_of(capable-17, metabolizing-19)
dobj(metabolizing-19, itself-20)
amod(drugs-23, other-22)
conj_or(itself-20, drugs-23)

Medroxyprogesterone/NN Acetate/NN -/CC L-histidine/NN was/VBD observed/VBN to/TO enhance/VBP (/-LRB- in/IN tissue/NN culture/NN )/-RRB- the/DT effect/NN of/IN medroxyprogesterone/NN acetate/NN in/IN reducing/VBG the/DT number/NN of/IN human/JJ breast/NN cancer/NN cells/NNS that/WDT were/VBD in/IN the/DT S/NN phase/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Medroxyprogesterone) (NN Acetate)) (CC -) (NP (NN L-histidine))) (VP (VBD was) (VP (VBN observed) (S (VP (TO to) (VP (VBP enhance) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NN tissue) (NN culture))) (-RRB- -RRB-)) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN medroxyprogesterone) (NN acetate))) (PP (IN in) (S (VP (VBG reducing) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (JJ human) (NN breast) (NN cancer) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (PP (IN in) (NP (DT the) (NN S) (NN phase))))))))))))))))))) (. .))))

nn(Acetate-2, Medroxyprogesterone-1)
nsubjpass(observed-6, Acetate-2)
xsubj(enhance-8, Acetate-2)
conj(Acetate-2, L-histidine-4)
auxpass(observed-6, was-5)
root(ROOT-0, observed-6)
aux(enhance-8, to-7)
xcomp(observed-6, enhance-8)
dep(enhance-8, in-10)
nn(culture-12, tissue-11)
pobj(in-10, culture-12)
det(effect-15, the-14)
dobj(enhance-8, effect-15)
nn(acetate-18, medroxyprogesterone-17)
prep_of(effect-15, acetate-18)
prepc_in(effect-15, reducing-20)
det(number-22, the-21)
dobj(reducing-20, number-22)
amod(cells-27, human-24)
nn(cells-27, breast-25)
nn(cells-27, cancer-26)
prep_of(number-22, cells-27)
nsubj(were-29, cells-27)
rcmod(cells-27, were-29)
det(phase-33, the-31)
nn(phase-33, S-32)
prep_in(were-29, phase-33)

H1/NN and/CC H2/NN Blockers/NNS -/: Although/IN not/RB reported/VBN ,/, L-histidine/NN ,/, via/IN its/PRP$ metabolism/NN to/TO histamine/NN ,/, might/MD decrease/VB the/DT efficacy/NN of/IN H1/NN and/CC H2/NN blockers/NN ./.

(ROOT (S1 (S (NP (NP (NP (NP (NN H1)) (CC and) (NP (NN H2))) (NNS Blockers)) (: -) (S (SBAR (IN Although) (S (VP (RB not) (VBN reported)))) (, ,) (NP (NN L-histidine)) (, ,) (PP (IN via) (NP (NP (PRP$ its) (NN metabolism)) (PP (TO to) (NP (NN histamine))))) (, ,) (VP (MD might) (VP (VB decrease) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NP (NN H1)) (CC and) (NP (NN H2)) (NP (NN blockers)))))))) (. .)))))

nn(Blockers-4, H1-1)
conj_and(H1-1, H2-3)
root(ROOT-0, Blockers-4)
mark(reported-8, Although-6)
neg(reported-8, not-7)
advcl(decrease-19, reported-8)
nsubj(decrease-19, L-histidine-10)
poss(metabolism-14, its-13)
prep_via(decrease-19, metabolism-14)
prep_to(metabolism-14, histamine-16)
aux(decrease-19, might-18)
dep(Blockers-4, decrease-19)
det(efficacy-21, the-20)
dobj(decrease-19, efficacy-21)
prep_of(efficacy-21, H1-23)
conj_and(H1-23, H2-25)
dep(H1-23, blockers-26)

Effects/NNS of/IN Lapatinib/NN on/IN Drug/NN Metabolizing/NN Enzymes/NNS and/CC Drug/NN Transport/NN Systems/NNS Lapatinib/NN inhibits/VBZ CYP3A4/NN and/CC CYP2C8/NN in/FW vitro/FW at/IN clinically/RB relevant/JJ concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NN Lapatinib))) (PP (IN on) (NP (NP (NN Drug) (NN Metabolizing) (NNS Enzymes)) (CC and) (NP (NN Drug) (NN Transport) (NNS Systems)) (NP (NN Lapatinib))))) (VP (VBZ inhibits) (NP (NP (NN CYP3A4)) (CC and) (NP (NN CYP2C8))) (ADVP (FW in) (FW vitro)) (PP (IN at) (NP (ADJP (RB clinically) (JJ relevant)) (NNS concentrations))))) (. .))))

nsubj(inhibits-13, Effects-1)
prep_of(Effects-1, Lapatinib-3)
nn(Enzymes-7, Drug-5)
nn(Enzymes-7, Metabolizing-6)
prep_on(Effects-1, Enzymes-7)
nn(Systems-11, Drug-9)
nn(Systems-11, Transport-10)
conj_and(Enzymes-7, Systems-11)
dep(Enzymes-7, Lapatinib-12)
root(ROOT-0, inhibits-13)
dobj(inhibits-13, CYP3A4-14)
conj_and(CYP3A4-14, CYP2C8-16)
nn(vitro-18, in-17)
advmod(inhibits-13, vitro-18)
advmod(relevant-21, clinically-20)
amod(concentrations-22, relevant-21)
prep_at(inhibits-13, concentrations-22)

Caution/NN should/MD be/VB exercised/VBN and/CC dose/NN reduction/NN of/IN the/DT concomitant/JJ substrate/NN drug/NN should/MD be/VB considered/VBN when/IN dosing/NN lapatinib/NN concurrently/RB with/IN medications/NNS with/IN narrow/JJ therapeutic/JJ windows/NNS that/WDT are/VBP substrates/NNS of/IN CYP3A4/NN or/CC CYP2C8/NN ./.

(ROOT (S1 (S (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised))))) (CC and) (S (NP (NP (NN dose) (NN reduction)) (PP (IN of) (NP (DT the) (JJ concomitant) (NN substrate) (NN drug)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN when) (NP (NP (NN dosing) (NN lapatinib)) (PP (ADVP (RB concurrently)) (IN with) (NP (NP (NNS medications)) (PP (IN with) (NP (NP (ADJP (ADJP (JJ narrow)) (ADJP (JJ therapeutic))) (NNS windows)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN of) (NP (NP (NN CYP3A4)) (CC or) (NP (NN CYP2C8))))))))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
nn(reduction-7, dose-6)
nsubjpass(considered-15, reduction-7)
det(drug-12, the-9)
amod(drug-12, concomitant-10)
nn(drug-12, substrate-11)
prep_of(reduction-7, drug-12)
aux(considered-15, should-13)
auxpass(considered-15, be-14)
conj_and(exercised-4, considered-15)
nn(lapatinib-18, dosing-17)
prep_when(considered-15, lapatinib-18)
advmod(lapatinib-18, concurrently-19)
prep_with(lapatinib-18, medications-21)
amod(windows-25, narrow-23)
dep(narrow-23, therapeutic-24)
prep_with(medications-21, windows-25)
nsubj(substrates-28, windows-25)
cop(substrates-28, are-27)
rcmod(windows-25, substrates-28)
prep_of(substrates-28, CYP3A4-30)
conj_or(CYP3A4-30, CYP2C8-32)

Lapatinib/NN did/VBD not/RB significantly/RB inhibit/VB the/DT following/JJ enzymes/NNS in/IN human/JJ liver/NN microsomes/NNS :/: CYP1A2/NN ,/, CYP2C9/NN ,/, CYP2C19/NN ,/, and/CC CYP2D6/NN or/CC UGT/NN enzymes/NNS in/FW vitro/FW ,/, however/RB ,/, the/DT clinical/JJ significance/NN is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (NP (NN Lapatinib)) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB inhibit) (NP (NP (NP (NP (DT the) (JJ following) (NNS enzymes)) (PP (IN in) (NP (JJ human) (NN liver) (NNS microsomes)))) (: :) (NP (NP (NN CYP1A2)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2C19)) (, ,) (CC and) (NP (NN CYP2D6)))) (CC or) (NP (NN UGT) (NNS enzymes))) (ADVP (FW in) (FW vitro))))) (, ,) (S (ADVP (RB however)) (, ,) (NP (DT the) (JJ clinical) (NN significance)) (VP (VBZ is) (ADJP (JJ unknown)))) (. .))))

nsubj(inhibit-5, Lapatinib-1)
aux(inhibit-5, did-2)
neg(inhibit-5, not-3)
advmod(inhibit-5, significantly-4)
root(ROOT-0, inhibit-5)
det(enzymes-8, the-6)
amod(enzymes-8, following-7)
dobj(inhibit-5, enzymes-8)
amod(microsomes-12, human-10)
nn(microsomes-12, liver-11)
prep_in(enzymes-8, microsomes-12)
dep(enzymes-8, CYP1A2-14)
conj_and(CYP1A2-14, CYP2C9-16)
conj_and(CYP1A2-14, CYP2C19-18)
conj_and(CYP1A2-14, CYP2D6-21)
nn(enzymes-24, UGT-23)
conj_or(enzymes-8, enzymes-24)
nn(vitro-26, in-25)
advmod(inhibit-5, vitro-26)
advmod(unknown-34, however-28)
det(significance-32, the-30)
amod(significance-32, clinical-31)
nsubj(unknown-34, significance-32)
cop(unknown-34, is-33)
ccomp(inhibit-5, unknown-34)

Lapatinib/NN inhibits/VBZ human/JJ P-/NN glycoprotein/NN ./.

(ROOT (S1 (S (S (NP (NN Lapatinib)) (VP (VBZ inhibits) (NP (JJ human) (NN P-) (NN glycoprotein)))) (. .))))

nsubj(inhibits-2, Lapatinib-1)
root(ROOT-0, inhibits-2)
amod(glycoprotein-5, human-3)
nn(glycoprotein-5, P--4)
dobj(inhibits-2, glycoprotein-5)

If/IN TYKERB/NN is/VBZ administered/VBN with/IN drugs/NNS that/WDT are/VBP substrates/NNS of/IN Pgp/NN ,/, increased/VBN concentrations/NNS of/IN the/DT substrate/JJ drug/NN are/VBP likely/JJ ,/, and/CC caution/NN should/MD be/VB exercised/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN TYKERB)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN of) (NP (NN Pgp))))))))))))) (, ,) (S (S (NP (NP (VBN increased) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ substrate) (NN drug)))) (VP (VBP are) (ADJP (JJ likely)))) (, ,) (CC and) (S (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised))))))) (. .))))

mark(administered-4, If-1)
nsubjpass(administered-4, TYKERB-2)
auxpass(administered-4, is-3)
advcl(likely-20, administered-4)
prep_with(administered-4, drugs-6)
nsubj(substrates-9, drugs-6)
cop(substrates-9, are-8)
rcmod(drugs-6, substrates-9)
prep_of(substrates-9, Pgp-11)
amod(concentrations-14, increased-13)
nsubj(likely-20, concentrations-14)
det(drug-18, the-16)
amod(drug-18, substrate-17)
prep_of(concentrations-14, drug-18)
cop(likely-20, are-19)
root(ROOT-0, likely-20)
nsubjpass(exercised-26, caution-23)
aux(exercised-26, should-24)
auxpass(exercised-26, be-25)
conj_and(likely-20, exercised-26)

Drugs/NNS that/WDT Inhibit/VBP or/CC Induce/VBP Cytochrome/NN P450/NN 3A4/NN Enzymes/NNS Lapatinib/NN undergoes/VBZ extensive/JJ metabolism/NN by/IN CYP3A4/NN ,/, and/CC concomitant/JJ administration/NN of/IN strong/JJ inhibitors/NNS or/CC inducers/NNS of/IN CYP3A4/NN alter/VB lapatinib/NN concentrations/NNS significantly/RB ./.

(ROOT (S1 (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP Inhibit)) (CC or) (VP (VBP Induce) (NP (NP (NP (NN Cytochrome) (NN P450) (NN 3A4)) (NNS Enzymes)) (S (S (NP (NN Lapatinib)) (VP (VBZ undergoes) (NP (JJ extensive) (NN metabolism)) (PP (IN by) (NP (NN CYP3A4))))) (, ,) (CC and) (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (JJ strong) (NNS inhibitors)) (CC or) (NP (NP (NNS inducers)) (PP (IN of) (NP (NN CYP3A4))))))) (VP (VB alter) (NP (NN lapatinib) (NNS concentrations)) (ADVP (RB significantly)))))))))) (. .)))))

root(ROOT-0, Drugs-1)
nsubj(Inhibit-3, Drugs-1)
rcmod(Drugs-1, Inhibit-3)
conj_or(Inhibit-3, Induce-5)
nn(3A4-8, Cytochrome-6)
nn(3A4-8, P450-7)
nn(Enzymes-9, 3A4-8)
dobj(Induce-5, Enzymes-9)
nsubj(undergoes-11, Lapatinib-10)
dep(Enzymes-9, undergoes-11)
amod(metabolism-13, extensive-12)
dobj(undergoes-11, metabolism-13)
prep_by(undergoes-11, CYP3A4-15)
amod(administration-19, concomitant-18)
nsubj(alter-27, administration-19)
amod(inhibitors-22, strong-21)
prep_of(administration-19, inhibitors-22)
conj_or(inhibitors-22, inducers-24)
prep_of(inducers-24, CYP3A4-26)
conj_and(undergoes-11, alter-27)
nn(concentrations-29, lapatinib-28)
dobj(alter-27, concentrations-29)
advmod(alter-27, significantly-30)

Dose/NN adjustment/NN of/IN lapatinib/NN should/MD be/VB considered/VBN for/IN patients/NNS who/WP must/MD receive/VBP concomitant/JJ strong/JJ inhibitors/NNS or/CC concomitant/JJ strong/JJ inducers/NNS of/IN CYP3A4/JJ enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Dose) (NN adjustment)) (PP (IN of) (NP (NN lapatinib)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN for) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (MD must) (VP (VBP receive) (NP (NP (NP (JJ concomitant) (JJ strong) (NNS inhibitors)) (CC or) (NP (JJ concomitant) (JJ strong) (NNS inducers))) (PP (IN of) (NP (JJ CYP3A4) (NNS enzymes)))))))))))))) (. .))))

nn(adjustment-2, Dose-1)
nsubjpass(considered-7, adjustment-2)
prep_of(adjustment-2, lapatinib-4)
aux(considered-7, should-5)
auxpass(considered-7, be-6)
root(ROOT-0, considered-7)
prep_for(considered-7, patients-9)
nsubj(receive-12, patients-9)
aux(receive-12, must-11)
rcmod(patients-9, receive-12)
amod(inhibitors-15, concomitant-13)
amod(inhibitors-15, strong-14)
dobj(receive-12, inhibitors-15)
amod(inducers-19, concomitant-17)
amod(inducers-19, strong-18)
conj_or(inhibitors-15, inducers-19)
amod(enzymes-22, CYP3A4-21)
prep_of(inhibitors-15, enzymes-22)

Ketoconazole/NN :/: In/IN healthy/JJ subjects/NNS receiving/VBG ketoconazole/NN ,/, a/DT CYP3A4/NN inhibitor/NN ,/, at/IN 200/CD mg/NN twice/RB daily/RB for/IN 7/CD days/NNS ,/, systemic/JJ exposure/NN (/-LRB- AUC/NN )/-RRB- to/TO lapatinib/NN was/VBD increased/VBN to/TO approximately/RB 3.6-fold/NN of/IN control/NN and/CC half-life/NN increased/VBD to/TO 1.7-fold/NN of/IN control/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (PP (IN In) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBG receiving) (NP (NP (NN ketoconazole)) (, ,) (NP (DT a) (NN CYP3A4) (NN inhibitor)) (, ,)) (PP (IN at) (NP (NP (CD 200) (NN mg)) (ADVP (RB twice) (RB daily) (PP (IN for) (NP (CD 7) (NNS days))))))))) (, ,) (NP (NP (NP (JJ systemic) (NN exposure)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (PP (TO to) (NP (NN lapatinib)))) (VP (VBD was) (VP (VBN increased) (PP (TO to) (NP (NP (RB approximately) (NN 3.6-fold)) (PP (IN of) (NP (NP (NN control)) (CC and) (NP (NN half-life)))) (VP (VBD increased) (PP (TO to) (NP (NP (NN 1.7-fold)) (PP (IN of) (NP (NN control))))))))))) (. .)))))

root(ROOT-0, Ketoconazole-1)
amod(subjects-5, healthy-4)
prep_in(increased-30, subjects-5)
partmod(subjects-5, receiving-6)
dobj(receiving-6, ketoconazole-7)
det(inhibitor-11, a-9)
nn(inhibitor-11, CYP3A4-10)
appos(ketoconazole-7, inhibitor-11)
num(mg-15, 200-14)
prep_at(receiving-6, mg-15)
advmod(daily-17, twice-16)
advmod(mg-15, daily-17)
num(days-20, 7-19)
prep_for(daily-17, days-20)
amod(exposure-23, systemic-22)
nsubjpass(increased-30, exposure-23)
abbrev(exposure-23, AUC-25)
prep_to(exposure-23, lapatinib-28)
auxpass(increased-30, was-29)
dep(Ketoconazole-1, increased-30)
advmod(3.6-fold-33, approximately-32)
prep_to(increased-30, 3.6-fold-33)
prep_of(3.6-fold-33, control-35)
conj_and(control-35, half-life-37)
partmod(3.6-fold-33, increased-38)
prep_to(increased-38, 1.7-fold-40)
prep_of(1.7-fold-40, control-42)

Carbamazepine/NN :/: In/IN healthy/JJ subjects/NNS receiving/VBG the/DT CYP3A4/NN inducer/NN ,/, carbamazepine/NN ,/, at/IN 100/CD mg/NN twice/RB daily/JJ for/IN 3/CD days/NNS and/CC 200/CD mg/NN twice/RB daily/JJ for/IN 17/CD days/NNS ,/, systemic/JJ exposure/NN (/-LRB- AUC/NN )/-RRB- to/TO lapatinib/NN was/VBD decreased/VBN approximately/RB 72/CD %./NN

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (: :) (S (PP (IN In) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBG receiving) (NP (NP (DT the) (NN CYP3A4) (NN inducer)) (, ,) (NP (NN carbamazepine)) (, ,)) (PP (IN at) (NP (NP (NP (CD 100) (NN mg)) (ADJP (RB twice) (JJ daily) (PP (IN for) (NP (CD 3) (NNS days))))) (CC and) (NP (NP (CD 200) (NN mg)) (ADJP (RB twice) (JJ daily) (PP (IN for) (NP (CD 17) (NNS days)))))))))) (, ,) (NP (NP (NP (JJ systemic) (NN exposure)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (PP (TO to) (NP (NN lapatinib)))) (VP (VBD was) (VP (VBN decreased) (NP (QP (RB approximately) (CD 72)) (NN %.)))))))))

root(ROOT-0, Carbamazepine-1)
amod(subjects-5, healthy-4)
prep_in(decreased-38, subjects-5)
partmod(subjects-5, receiving-6)
det(inducer-9, the-7)
nn(inducer-9, CYP3A4-8)
dobj(receiving-6, inducer-9)
appos(inducer-9, carbamazepine-11)
num(mg-15, 100-14)
prep_at(receiving-6, mg-15)
advmod(daily-17, twice-16)
amod(mg-15, daily-17)
num(days-20, 3-19)
prep_for(daily-17, days-20)
num(mg-23, 200-22)
conj_and(mg-15, mg-23)
advmod(daily-25, twice-24)
amod(mg-23, daily-25)
num(days-28, 17-27)
prep_for(daily-25, days-28)
amod(exposure-31, systemic-30)
nsubjpass(decreased-38, exposure-31)
abbrev(exposure-31, AUC-33)
prep_to(exposure-31, lapatinib-36)
auxpass(decreased-38, was-37)
dep(Carbamazepine-1, decreased-38)
quantmod(72-40, approximately-39)
num(%.-41, 72-40)
dobj(decreased-38, %.-41)

Drugs/NNS that/WDT Inhibit/VBP Drug/NN Transport/NN Systems/NNS Lapatinib/NN is/VBZ a/DT substrate/NN of/IN the/DT efflux/NN transporter/NN P-glycoprotein/NN (/-LRB- Pgp/NN ,/, ABCB1/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP Inhibit) (NP (NP (NN Drug) (NN Transport) (NNS Systems)) (NN Lapatinib)))))) (VP (VBZ is) (NP (NP (DT a) (NN substrate)) (PP (IN of) (NP (NP (DT the) (NN efflux) (NN transporter) (NN P-glycoprotein)) (PRN (-LRB- -LRB-) (NP (NP (NN Pgp)) (, ,) (NP (NN ABCB1))) (-RRB- -RRB-))))))) (. .))))

nsubj(Inhibit-3, Drugs-1)
nsubj(substrate-10, Drugs-1)
rcmod(Drugs-1, Inhibit-3)
nn(Systems-6, Drug-4)
nn(Systems-6, Transport-5)
nn(Lapatinib-7, Systems-6)
dobj(Inhibit-3, Lapatinib-7)
cop(substrate-10, is-8)
det(substrate-10, a-9)
root(ROOT-0, substrate-10)
det(P-glycoprotein-15, the-12)
nn(P-glycoprotein-15, efflux-13)
nn(P-glycoprotein-15, transporter-14)
prep_of(substrate-10, P-glycoprotein-15)
dep(P-glycoprotein-15, Pgp-17)
appos(Pgp-17, ABCB1-19)

If/IN TYKERB/NN is/VBZ administered/VBN with/IN drugs/NNS that/WDT inhibit/VBP Pgp/NN ,/, increased/VBN concentrations/NNS of/IN lapatinib/NN are/VBP likely/JJ ,/, and/CC caution/NN should/MD be/VB exercised/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN TYKERB)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN Pgp))))))))))) (, ,) (S (S (NP (NP (VBN increased) (NNS concentrations)) (PP (IN of) (NP (NN lapatinib)))) (VP (VBP are) (ADJP (JJ likely)))) (, ,) (CC and) (S (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised))))))) (. .))))

mark(administered-4, If-1)
nsubjpass(administered-4, TYKERB-2)
auxpass(administered-4, is-3)
advcl(likely-16, administered-4)
prep_with(administered-4, drugs-6)
nsubj(inhibit-8, drugs-6)
rcmod(drugs-6, inhibit-8)
dobj(inhibit-8, Pgp-9)
amod(concentrations-12, increased-11)
nsubj(likely-16, concentrations-12)
prep_of(concentrations-12, lapatinib-14)
cop(likely-16, are-15)
root(ROOT-0, likely-16)
nsubjpass(exercised-22, caution-19)
aux(exercised-22, should-20)
auxpass(exercised-22, be-21)
conj_and(likely-16, exercised-22)

Other/JJ Chemotherapy/NN Agents/NNS :/: In/IN a/DT separate/JJ study/NN ,/, concomitant/JJ administration/NN of/IN lapatinib/NN with/IN capecitabine/NN did/VBD not/RB meaningfully/RB alter/VB the/DT pharmacokinetics/NNS of/IN either/DT agent/NN (/-LRB- or/CC the/DT metabolites/NNS of/IN capecitabine/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NN Chemotherapy) (NNS Agents)) (: :) (S (PP (IN In) (NP (DT a) (JJ separate) (NN study))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN lapatinib))) (PP (IN with) (NP (NN capecitabine)))) (VP (VBD did) (RB not) (ADVP (RB meaningfully)) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN agent)))) (PRN (-LRB- -LRB-) (CC or) (NP (NP (DT the) (NNS metabolites)) (PP (IN of) (NP (NN capecitabine)))) (-RRB- -RRB-))))) (. .)))))

amod(Agents-3, Other-1)
nn(Agents-3, Chemotherapy-2)
root(ROOT-0, Agents-3)
det(study-8, a-6)
amod(study-8, separate-7)
prep_in(alter-19, study-8)
amod(administration-11, concomitant-10)
nsubj(alter-19, administration-11)
prep_of(administration-11, lapatinib-13)
prep_with(administration-11, capecitabine-15)
aux(alter-19, did-16)
neg(alter-19, not-17)
advmod(alter-19, meaningfully-18)
dep(Agents-3, alter-19)
det(pharmacokinetics-21, the-20)
dobj(alter-19, pharmacokinetics-21)
det(agent-24, either-23)
prep_of(pharmacokinetics-21, agent-24)
dep(metabolites-28, or-26)
det(metabolites-28, the-27)
dep(alter-19, metabolites-28)
prep_of(metabolites-28, capecitabine-30)

Cholestyramine/NN and/CC Charcoal/NN Administration/NN of/IN cholestyramine/NN or/CC activated/VBN charcoal/NN in/IN patients/NNS (/-LRB- n=13/NN )/-RRB- and/CC volunteers/NNS (/-LRB- n=96/CD )/-RRB- resulted/VBD in/IN a/DT rapid/JJ and/CC significant/JJ decrease/NN in/IN plasma/NN M1/NN (/-LRB- the/DT active/JJ metabolite/NN of/IN leflunomide/NN )/-RRB- concentration/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Cholestyramine)) (CC and) (NP (NN Charcoal) (NN Administration))) (PP (IN of) (NP (NP (NN cholestyramine)) (CC or) (NP (VBN activated) (NN charcoal)))) (PP (IN in) (NP (NP (NP (NNS patients)) (PRN (-LRB- -LRB-) (NP (NN n=13)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS volunteers)) (PRN (-LRB- -LRB-) (NP (CD n=96)) (-RRB- -RRB-)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (ADJP (JJ rapid)) (CC and) (ADJP (JJ significant))) (NN decrease)) (PP (IN in) (NP (NN plasma) (NP (NP (NN M1)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (JJ active) (NN metabolite)) (PP (IN of) (NP (NN leflunomide)))) (-RRB- -RRB-))) (NN concentration))))))) (. .))))

nsubj(resulted-20, Cholestyramine-1)
nn(Administration-4, Charcoal-3)
conj_and(Cholestyramine-1, Administration-4)
prep_of(Cholestyramine-1, cholestyramine-6)
amod(charcoal-9, activated-8)
conj_or(cholestyramine-6, charcoal-9)
prep_in(Cholestyramine-1, patients-11)
appos(patients-11, n=13-13)
conj_and(patients-11, volunteers-16)
appos(volunteers-16, n=96-18)
root(ROOT-0, resulted-20)
det(decrease-26, a-22)
amod(decrease-26, rapid-23)
conj_and(rapid-23, significant-25)
prep_in(resulted-20, decrease-26)
nn(concentration-37, plasma-28)
nn(concentration-37, M1-29)
det(metabolite-33, the-31)
amod(metabolite-33, active-32)
dep(M1-29, metabolite-33)
prep_of(metabolite-33, leflunomide-35)
prep_in(decrease-26, concentration-37)

Hepatotoxic/JJ Drugs/NNS Increased/VBN side/NN effects/NNS may/MD occur/VB when/WRB leflunomide/NN is/VBZ given/VBN concomitantly/RB with/IN hepatotoxic/JJ substances/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Hepatotoxic) (NNS Drugs)) (VBN Increased) (NN side) (NNS effects)) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN leflunomide)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ hepatotoxic) (NNS substances)))))))))) (. .))))

amod(Drugs-2, Hepatotoxic-1)
nn(effects-5, Drugs-2)
amod(effects-5, Increased-3)
nn(effects-5, side-4)
nsubj(occur-7, effects-5)
aux(occur-7, may-6)
root(ROOT-0, occur-7)
advmod(given-11, when-8)
nsubjpass(given-11, leflunomide-9)
auxpass(given-11, is-10)
advcl(occur-7, given-11)
advmod(given-11, concomitantly-12)
amod(substances-15, hepatotoxic-14)
prep_with(given-11, substances-15)

This/DT is/VBZ also/RB to/TO be/VB considered/VBN when/WRB leflunomide/NN treatment/NN is/VBZ followed/VBN by/IN such/JJ drugs/NNS without/IN a/DT drug/NN elimination/NN procedure/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ is) (ADVP (RB also)) (S (VP (TO to) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (NP (NN leflunomide) (NN treatment)) (VP (VBZ is) (VP (VBN followed) (PP (IN by) (NP (JJ such) (NNS drugs))) (PP (IN without) (NP (DT a) (NN drug) (NN elimination) (NN procedure))))))))))))) (. .))))

nsubj(is-2, This-1)
xsubj(considered-6, This-1)
root(ROOT-0, is-2)
advmod(is-2, also-3)
aux(considered-6, to-4)
auxpass(considered-6, be-5)
xcomp(is-2, considered-6)
advmod(followed-11, when-7)
nn(treatment-9, leflunomide-8)
nsubjpass(followed-11, treatment-9)
auxpass(followed-11, is-10)
advcl(considered-6, followed-11)
amod(drugs-14, such-13)
agent(followed-11, drugs-14)
det(procedure-19, a-16)
nn(procedure-19, drug-17)
nn(procedure-19, elimination-18)
prep_without(followed-11, procedure-19)

In/IN a/DT small/JJ (/-LRB- n=30/NN )/-RRB- combination/NN study/NN of/IN ARAVA/NN with/IN methotrexate/NN ,/, a/DT 2-/CD to/TO 3-fold/JJ elevation/NN in/IN liver/NN enzymes/NNS was/VBD seen/VBN in/IN 5/CD of/IN 30/CD patients/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (ADJP (ADJP (JJ small)) (PRN (-LRB- -LRB-) (NP (NN n=30)) (-RRB- -RRB-))) (NN combination) (NN study)) (PP (IN of) (NP (NN ARAVA))) (PP (IN with) (NP (NN methotrexate))))) (, ,) (NP (NP (DT a) (ADJP (CD 2-) (TO to) (JJ 3-fold)) (NN elevation)) (PP (IN in) (NP (NN liver) (NNS enzymes)))) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (NP (CD 5)) (PP (IN of) (NP (CD 30) (NNS patients)))))))) (. .))))

det(study-8, a-2)
amod(study-8, small-3)
dep(small-3, n=30-5)
nn(study-8, combination-7)
prep_in(seen-23, study-8)
prep_of(study-8, ARAVA-10)
prep_with(study-8, methotrexate-12)
det(elevation-18, a-14)
number(3-fold-17, 2--15)
dep(3-fold-17, to-16)
amod(elevation-18, 3-fold-17)
nsubjpass(seen-23, elevation-18)
nn(enzymes-21, liver-20)
prep_in(elevation-18, enzymes-21)
auxpass(seen-23, was-22)
root(ROOT-0, seen-23)
prep_in(seen-23, 5-25)
num(patients-28, 30-27)
prep_of(5-25, patients-28)

All/DT elevations/NNS resolved/VBN ,/, 2/CD with/IN continuation/NN of/IN both/DT drugs/NNS and/CC 3/CD after/IN discontinuation/NN of/IN leflunomide/NN ./.

(ROOT (S1 (S (S (NP (DT All) (NNS elevations)) (VP (VBN resolved) (, ,) (NP (NP (NP (CD 2)) (PP (IN with) (NP (NP (NN continuation)) (PP (IN of) (NP (DT both) (NNS drugs)))))) (CC and) (NP (NP (CD 3)) (PP (IN after) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN leflunomide))))))))) (. .))))

det(elevations-2, All-1)
nsubj(resolved-3, elevations-2)
root(ROOT-0, resolved-3)
dobj(resolved-3, 2-5)
prep_with(2-5, continuation-7)
det(drugs-10, both-9)
prep_of(continuation-7, drugs-10)
conj_and(2-5, 3-12)
prep_after(3-12, discontinuation-14)
prep_of(discontinuation-14, leflunomide-16)

All/DT of/IN these/DT also/RB resolved/VBN ,/, 2/CD with/IN continuation/NN of/IN both/DT drugs/NNS and/CC 3/CD after/IN discontinuation/NN of/IN leflunomide/NN ./.

(ROOT (S1 (S (S (NP (NP (DT All)) (PP (IN of) (NP (DT these)))) (ADVP (RB also)) (VP (VBN resolved) (, ,) (NP (NP (NP (CD 2)) (PP (IN with) (NP (NP (NN continuation)) (PP (IN of) (NP (DT both) (NNS drugs)))))) (CC and) (NP (NP (CD 3)) (PP (IN after) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN leflunomide))))))))) (. .))))

nsubj(resolved-5, All-1)
prep_of(All-1, these-3)
advmod(resolved-5, also-4)
root(ROOT-0, resolved-5)
dobj(resolved-5, 2-7)
prep_with(2-7, continuation-9)
det(drugs-12, both-11)
prep_of(continuation-9, drugs-12)
conj_and(2-7, 3-14)
prep_after(3-14, discontinuation-16)
prep_of(discontinuation-16, leflunomide-18)

Three/CD patients/NNS met/NN ACR/NN criteria/NNS for/IN liver/NN biopsy/NN (/-LRB- 1/CD :/: Roegnik/NNP Grade/NN I/CD ,/, 2/CD :/: Roegnik/NNP Grade/NN IIIa/NN )./NN

(ROOT (S1 (S (NP (NP (NP (CD Three) (NNS patients) (NN met) (NN ACR) (NNS criteria)) (PP (IN for) (NP (NN liver) (NN biopsy)))) (-LRB- -LRB-) (NP (CD 1) (: :) (NP (NP (NNP Roegnik)) (NP (NN Grade) (CD I) (, ,) (CD 2))) (: :) (NP (NP (NNP Roegnik)) (NP (NN Grade) (NN IIIa) (NN -RRB-.))))))))

num(criteria-5, Three-1)
nn(criteria-5, patients-2)
nn(criteria-5, met-3)
nn(criteria-5, ACR-4)
root(ROOT-0, criteria-5)
nn(biopsy-8, liver-7)
prep_for(criteria-5, biopsy-8)
num(Roegnik-12, 1-10)
dep(criteria-5, Roegnik-12)
dep(Roegnik-12, Grade-13)
num(Grade-13, I-14)
num(Grade-13, 2-16)
dep(Roegnik-12, Roegnik-18)
nn(-RRB-.-21, Grade-19)
nn(-RRB-.-21, IIIa-20)
dep(Roegnik-18, -RRB-.-21)

NSAIDs/NNS :/: In/IN in/FW vitro/FW studies/NNS ,/, M1/NN was/VBD shown/VBN to/TO cause/VB increases/NNS ranging/VBG from/IN 13/CD -/CC 50/CD %/NN in/IN the/DT free/JJ fraction/NN of/IN diclofenac/NN and/CC ibuprofen/NN at/IN concentrations/NNS in/IN the/DT clinical/JJ range/NN ./.

(ROOT (S1 (S (NP (NP (NNS NSAIDs)) (: :) (S (PP (IN In) (NP (ADJP (FW in) (FW vitro)) (NNS studies))) (, ,) (NP (NN M1)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB cause) (NP (NP (NNS increases)) (VP (VBG ranging) (PP (IN from) (NP (QP (CD 13) (CC -) (CD 50)) (NN %))) (PP (IN in) (NP (NP (DT the) (JJ free) (NN fraction)) (PP (IN of) (NP (NP (NP (NN diclofenac)) (CC and) (NP (NN ibuprofen))) (PP (IN at) (NP (NP (NNS concentrations)) (PP (IN in) (NP (DT the) (JJ clinical) (NN range))))))))))))))))) (. .)))))

root(ROOT-0, NSAIDs-1)
nn(vitro-5, in-4)
amod(studies-6, vitro-5)
prep_in(shown-10, studies-6)
nsubjpass(shown-10, M1-8)
xsubj(cause-12, M1-8)
auxpass(shown-10, was-9)
dep(NSAIDs-1, shown-10)
aux(cause-12, to-11)
xcomp(shown-10, cause-12)
dobj(cause-12, increases-13)
partmod(increases-13, ranging-14)
num(%-19, 13-16)
conj(13-16, 50-18)
prep_from(ranging-14, %-19)
det(fraction-23, the-21)
amod(fraction-23, free-22)
prep_in(ranging-14, fraction-23)
prep_of(fraction-23, diclofenac-25)
conj_and(diclofenac-25, ibuprofen-27)
prep_at(diclofenac-25, concentrations-29)
det(range-33, the-31)
amod(range-33, clinical-32)
prep_in(concentrations-29, range-33)

however/RB ,/, there/EX was/VBD extensive/JJ concomitant/JJ use/NN of/IN NSAIDs/NN in/IN clinical/JJ studies/NNS and/CC no/DT differential/JJ effect/NN was/VBD observed/VBN ./.

(ROOT (S1 (S (S (ADVP (RB however)) (, ,) (S (NP (EX there)) (VP (VBD was) (NP (NP (JJ extensive) (JJ concomitant) (NN use)) (PP (IN of) (NP (NN NSAIDs))) (PP (IN in) (NP (JJ clinical) (NNS studies)))))) (CC and) (S (NP (DT no) (JJ differential) (NN effect)) (VP (VBD was) (VP (VBN observed))))) (. .))))

advmod(was-4, however-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
amod(use-7, extensive-5)
amod(use-7, concomitant-6)
nsubj(was-4, use-7)
prep_of(use-7, NSAIDs-9)
amod(studies-12, clinical-11)
prep_in(use-7, studies-12)
det(effect-16, no-14)
amod(effect-16, differential-15)
nsubjpass(observed-18, effect-16)
auxpass(observed-18, was-17)
conj_and(was-4, observed-18)

Tolbutamide/NN :/: In/IN in/FW vitro/FW studies/NNS ,/, M1/NN was/VBD shown/VBN to/TO cause/VB increases/NNS ranging/VBG from/IN 13/CD -/CC 50/CD %/NN in/IN the/DT free/JJ fraction/NN of/IN tolbutamide/NN at/IN concentrations/NNS in/IN the/DT clinical/JJ range/NN ./.

(ROOT (S1 (S (NP (NP (NN Tolbutamide)) (: :) (S (PP (IN In) (NP (ADJP (FW in) (FW vitro)) (NNS studies))) (, ,) (NP (NN M1)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB cause) (NP (NP (NNS increases)) (VP (VBG ranging) (PP (IN from) (NP (QP (CD 13) (CC -) (CD 50)) (NN %))) (PP (IN in) (NP (NP (DT the) (JJ free) (NN fraction)) (PP (IN of) (NP (NN tolbutamide))))) (PP (IN at) (NP (NP (NNS concentrations)) (PP (IN in) (NP (DT the) (JJ clinical) (NN range))))))))))))) (. .)))))

root(ROOT-0, Tolbutamide-1)
nn(vitro-5, in-4)
amod(studies-6, vitro-5)
prep_in(shown-10, studies-6)
nsubjpass(shown-10, M1-8)
xsubj(cause-12, M1-8)
auxpass(shown-10, was-9)
dep(Tolbutamide-1, shown-10)
aux(cause-12, to-11)
xcomp(shown-10, cause-12)
dobj(cause-12, increases-13)
partmod(increases-13, ranging-14)
num(%-19, 13-16)
conj(13-16, 50-18)
prep_from(ranging-14, %-19)
det(fraction-23, the-21)
amod(fraction-23, free-22)
prep_in(ranging-14, fraction-23)
prep_of(fraction-23, tolbutamide-25)
prep_at(ranging-14, concentrations-27)
det(range-31, the-29)
amod(range-31, clinical-30)
prep_in(concentrations-27, range-31)

Rifampin/NN Following/VBG concomitant/JJ administration/NN of/IN a/DT single/JJ dose/NN of/IN ARAVA/NN to/TO subjects/NNS receiving/VBG multiple/JJ doses/NNS of/IN rifampin/NN ,/, M1/NN peak/NN levels/NNS were/VBD increased/VBN (/-LRB- ~40/CD %/NN )/-RRB- over/IN those/DT seen/VBN when/WRB ARAVA/NN was/VBD given/VBN alone/RB ./.

(ROOT (S1 (S (S (S (NP (NN Rifampin)) (VP (VBG Following) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NN ARAVA)))))) (PP (TO to) (NP (NP (NNS subjects)) (VP (VBG receiving) (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NN rifampin))))))))) (, ,) (S (NP (NN M1) (NN peak) (NNS levels)) (VP (VBD were) (VP (VBN increased) (PRN (-LRB- -LRB-) (NP (CD ~40) (NN %)) (-RRB- -RRB-)) (PP (IN over) (NP (NP (DT those)) (VP (VBN seen) (SBAR (WHADVP (WRB when)) (S (NP (NN ARAVA)) (VP (VBD was) (VP (VBN given) (ADVP (RB alone))))))))))))) (. .))))

nsubj(Following-2, Rifampin-1)
root(ROOT-0, Following-2)
amod(administration-4, concomitant-3)
dobj(Following-2, administration-4)
det(dose-8, a-6)
amod(dose-8, single-7)
prep_of(administration-4, dose-8)
prep_of(dose-8, ARAVA-10)
prep_to(Following-2, subjects-12)
partmod(subjects-12, receiving-13)
amod(doses-15, multiple-14)
dobj(receiving-13, doses-15)
prep_of(doses-15, rifampin-17)
nn(levels-21, M1-19)
nn(levels-21, peak-20)
nsubjpass(increased-23, levels-21)
auxpass(increased-23, were-22)
dep(Following-2, increased-23)
num(%-26, ~40-25)
dep(increased-23, %-26)
prep_over(increased-23, those-29)
partmod(those-29, seen-30)
advmod(given-34, when-31)
nsubjpass(given-34, ARAVA-32)
auxpass(given-34, was-33)
advcl(seen-30, given-34)
advmod(given-34, alone-35)

Because/IN of/IN the/DT potential/NN for/IN ARAVA/NN levels/NNS to/TO continue/VBP to/TO increase/VB with/IN multiple/JJ dosing/NN ,/, caution/NN should/MD be/VB used/VBN if/IN patients/NNS are/VBP to/TO be/VB receiving/VBG both/CC ARAVA/NN and/CC rifampin/NN ./.

(ROOT (S1 (S (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NN ARAVA) (NNS levels))) (S (VP (TO to) (VP (VBP continue) (S (VP (TO to) (VP (VB increase) (PP (IN with) (NP (JJ multiple) (NN dosing)))))))))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (SBAR (IN if) (S (NP (NNS patients)) (VP (VBP are) (S (VP (TO to) (VP (VB be) (VP (VBG receiving) (NP (CC both) (NP (NN ARAVA)) (CC and) (NP (NN rifampin)))))))))))))) (. .))))

prepc_because_of(used-19, of-2)
det(potential-4, the-3)
pobj(used-19, potential-4)
nn(levels-7, ARAVA-6)
prep_for(potential-4, levels-7)
aux(continue-9, to-8)
infmod(potential-4, continue-9)
aux(increase-11, to-10)
xcomp(continue-9, increase-11)
amod(dosing-14, multiple-13)
prep_with(increase-11, dosing-14)
nsubjpass(used-19, caution-16)
aux(used-19, should-17)
auxpass(used-19, be-18)
root(ROOT-0, used-19)
mark(are-22, if-20)
nsubj(are-22, patients-21)
advcl(used-19, are-22)
aux(receiving-25, to-23)
aux(receiving-25, be-24)
xcomp(are-22, receiving-25)
preconj(ARAVA-27, both-26)
dobj(receiving-25, ARAVA-27)
conj_and(ARAVA-27, rifampin-29)

Warfarin/JJ Increased/VBN INR/NN (/-LRB- International/NNP Normalized/VBN Ratio/NN )/-RRB- when/WRB ARAVA/NN and/CC warfarin/NN were/VBD co-administered/VBN has/VBZ been/VBN rarely/RB reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Warfarin) (VBN Increased) (NN INR)) (PRN (-LRB- -LRB-) (NP (NP (NNP International)) (VBN Normalized) (NN Ratio)) (-RRB- -RRB-))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN ARAVA)) (CC and) (NP (NN warfarin))) (VP (VBD were) (VP (VBN co-administered)))))) (VP (VBZ has) (VP (VBN been) (ADVP (RB rarely)) (VP (VBN reported))))) (. .))))

amod(INR-3, Warfarin-1)
amod(INR-3, Increased-2)
tmod(co-administered-14, INR-3)
nsubjpass(reported-18, INR-3)
nn(Ratio-7, International-5)
amod(Ratio-7, Normalized-6)
appos(INR-3, Ratio-7)
advmod(co-administered-14, when-9)
nsubjpass(co-administered-14, ARAVA-10)
conj_and(ARAVA-10, warfarin-12)
auxpass(co-administered-14, were-13)
dep(INR-3, co-administered-14)
aux(reported-18, has-15)
auxpass(reported-18, been-16)
advmod(reported-18, rarely-17)
root(ROOT-0, reported-18)

Clinical/JJ interaction/NN studies/NNS with/IN cimetidine/NN and/CC warfarin/NN indicated/VBD that/IN the/DT coadministration/NN of/IN Femara/NN with/IN these/DT drugs/NNS does/VBZ not/RB result/VB in/IN clinically-/JJ significant/JJ drug/NN interactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Clinical) (NN interaction) (NNS studies)) (PP (IN with) (NP (NP (NN cimetidine)) (CC and) (NP (NN warfarin))))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NN Femara))) (PP (IN with) (NP (DT these) (NNS drugs)))) (VP (VBZ does) (RB not) (VP (VB result) (PP (IN in) (NP (JJ clinically-) (JJ significant) (NN drug) (NNS interactions))))))))) (. .))))

amod(studies-3, Clinical-1)
nn(studies-3, interaction-2)
nsubj(indicated-8, studies-3)
prep_with(studies-3, cimetidine-5)
conj_and(cimetidine-5, warfarin-7)
root(ROOT-0, indicated-8)
complm(result-19, that-9)
det(coadministration-11, the-10)
nsubj(result-19, coadministration-11)
prep_of(coadministration-11, Femara-13)
det(drugs-16, these-15)
prep_with(coadministration-11, drugs-16)
aux(result-19, does-17)
neg(result-19, not-18)
ccomp(indicated-8, result-19)
amod(interactions-24, clinically--21)
amod(interactions-24, significant-22)
nn(interactions-24, drug-23)
prep_in(result-19, interactions-24)

(/-LRB- See/VB CLINICAL/JJ PHARMACOLOGY/NN )/-RRB- Coadministration/NN of/IN Femara/NN and/CC tamoxifen/NN 20/CD mg/NN daily/RB resulted/VBD in/IN a/DT reduction/NN of/IN letrozole/NN plasma/NN levels/NNS by/IN 38/CD %/NN on/IN average/NN ./.

(ROOT (S1 (S (NP (NP (S (-LRB- -LRB-) (VP (VB See) (NP (JJ CLINICAL) (NN PHARMACOLOGY))) (-RRB- -RRB-)) (NP (NN Coadministration)) (PP (IN of) (NP (NN Femara)))) (CC and) (NP (NP (NN tamoxifen) (CD 20) (NN mg)) (ADVP (RB daily)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NN letrozole) (NN plasma) (NNS levels))) (PP (IN by) (NP (NP (CD 38) (NN %)) (PP (IN on) (NP (NN average)))))))) (. .))))

dep(Coadministration-6, See-2)
amod(PHARMACOLOGY-4, CLINICAL-3)
dobj(See-2, PHARMACOLOGY-4)
nsubj(resulted-14, Coadministration-6)
prep_of(Coadministration-6, Femara-8)
nn(mg-12, tamoxifen-10)
num(mg-12, 20-11)
conj_and(Coadministration-6, mg-12)
advmod(mg-12, daily-13)
root(ROOT-0, resulted-14)
det(reduction-17, a-16)
prep_in(resulted-14, reduction-17)
nn(levels-21, letrozole-19)
nn(levels-21, plasma-20)
prep_of(reduction-17, levels-21)
num(%-24, 38-23)
prep_by(reduction-17, %-24)
prep_on(%-24, average-26)

There/EX is/VBZ no/DT clinical/JJ experience/VBP to/TO date/VB on/IN the/DT use/NN of/IN Femara/NN in/IN combination/NN with/IN other/JJ anticancer/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (JJ clinical) (VBP experience)) (S (VP (TO to) (VP (VB date) (PP (IN on) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN Femara))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (JJ anticancer) (NNS agents))))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(clinical-4, no-3)
nsubj(is-2, clinical-4)
dep(clinical-4, experience-5)
aux(date-7, to-6)
infmod(clinical-4, date-7)
det(use-10, the-9)
prep_on(date-7, use-10)
prep_of(use-10, Femara-12)
prep_in(use-10, combination-14)
amod(agents-18, other-16)
amod(agents-18, anticancer-17)
prep_with(combination-14, agents-18)

Drug/NN /Laboratory/NN Test-Interactions/NN None/NN observed/VBN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test-Interactions) (NN None)) (VP (VBN observed))) (. .))))

nn(None-4, Drug-1)
nn(None-4, /Laboratory-2)
nn(None-4, Test-Interactions-3)
nsubj(observed-5, None-4)
root(ROOT-0, observed-5)

Folic/JJ acid/NN in/IN large/JJ amounts/NNS may/MD counteract/VB the/DT antiepileptic/JJ effect/NN of/IN phenobarbital/NN ,/, phenytoin/NN and/CC primidone/NN ,/, and/CC increase/VB the/DT frequency/NN of/IN seizures/NNS in/IN susceptible/JJ pediatric/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Folic) (NN acid)) (PP (IN in) (NP (JJ large) (NNS amounts)))) (VP (MD may) (VP (VP (VB counteract) (NP (NP (DT the) (JJ antiepileptic) (NN effect)) (PP (IN of) (NP (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin)) (CC and) (NP (NN primidone)))))) (, ,) (CC and) (VP (VB increase) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NNS seizures))) (PP (IN in) (NP (JJ susceptible) (JJ pediatric) (NNS patients)))))))) (. .))))

amod(acid-2, Folic-1)
nsubj(counteract-7, acid-2)
amod(amounts-5, large-4)
prep_in(acid-2, amounts-5)
aux(counteract-7, may-6)
root(ROOT-0, counteract-7)
det(effect-10, the-8)
amod(effect-10, antiepileptic-9)
dobj(counteract-7, effect-10)
prep_of(effect-10, phenobarbital-12)
conj_and(phenobarbital-12, phenytoin-14)
conj_and(phenobarbital-12, primidone-16)
conj_and(counteract-7, increase-19)
det(frequency-21, the-20)
dobj(increase-19, frequency-21)
prep_of(frequency-21, seizures-23)
amod(patients-27, susceptible-25)
amod(patients-27, pediatric-26)
prep_in(frequency-21, patients-27)

Preliminary/JJ animal/JJ and/CC human/JJ studies/NNS have/VBP shown/VBN that/IN small/JJ quantities/NNS of/IN systemically/RB administered/VBN leucovorin/NN enter/VBP the/DT CSF/NN primarily/RB as/IN 5-methyltetrahydro-folate/NN and/CC ,/, in/IN humans/NNS ,/, remain/VBP 1/CD to/TO 3/CD orders/NNS of/IN magnitude/NN lower/JJR than/IN the/DT usual/JJ methotrexate/NN concentrations/NNS following/VBG intrathecal/JJ administration/NN ./.

(ROOT (S1 (S (S (NP (JJ Preliminary) (ADJP (ADJP (JJ animal)) (CC and) (ADJP (JJ human))) (NNS studies)) (VP (VBP have) (VP (VBN shown) (PP (IN that) (S (NP (NP (JJ small) (NNS quantities)) (PP (IN of) (NP (ADJP (RB systemically) (VBN administered)) (NN leucovorin)))) (VP (VP (VBP enter) (NP (DT the) (NN CSF)) (PP (ADVP (RB primarily)) (IN as) (NP (NN 5-methyltetrahydro-folate)))) (CC and) (, ,) (PP (IN in) (NP (NNS humans))) (, ,) (VP (VBP remain) (NP (NP (QP (CD 1) (TO to) (CD 3)) (NNS orders)) (PP (IN of) (NP (NN magnitude))) (ADJP (JJR lower) (PP (IN than) (NP (NP (DT the) (JJ usual) (NN methotrexate) (NNS concentrations)) (VP (VBG following) (NP (JJ intrathecal) (NN administration)))))))))))))) (. .))))

amod(studies-5, Preliminary-1)
amod(studies-5, animal-2)
conj_and(animal-2, human-4)
nsubj(shown-7, studies-5)
aux(shown-7, have-6)
root(ROOT-0, shown-7)
amod(quantities-10, small-9)
nsubj(enter-15, quantities-10)
advmod(administered-13, systemically-12)
amod(leucovorin-14, administered-13)
prep_of(quantities-10, leucovorin-14)
prepc_that(shown-7, enter-15)
det(CSF-17, the-16)
dobj(enter-15, CSF-17)
advmod(enter-15, primarily-18)
prep_as(enter-15, 5-methyltetrahydro-folate-20)
conj_and(enter-15, in-23)
prep_in(enter-15, humans-24)
cop(orders-30, remain-26)
number(3-29, 1-27)
dep(3-29, to-28)
num(orders-30, 3-29)
conj_and(enter-15, orders-30)
prep_of(orders-30, magnitude-32)
amod(orders-30, lower-33)
det(concentrations-38, the-35)
amod(concentrations-38, usual-36)
nn(concentrations-38, methotrexate-37)
prep_than(lower-33, concentrations-38)
partmod(concentrations-38, following-39)
amod(administration-41, intrathecal-40)
dobj(following-39, administration-41)

However/RB ,/, high/JJ doses/NNS of/IN leucovorin/NN may/MD reduce/VB the/DT efficacy/NN of/IN intrathecally/RB administered/VBN methotrexate/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NN leucovorin)))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (ADJP (RB intrathecally) (VBN administered)) (NN methotrexate))))))) (. .))))

advmod(reduce-8, However-1)
amod(doses-4, high-3)
nsubj(reduce-8, doses-4)
prep_of(doses-4, leucovorin-6)
aux(reduce-8, may-7)
root(ROOT-0, reduce-8)
det(efficacy-10, the-9)
dobj(reduce-8, efficacy-10)
advmod(administered-13, intrathecally-12)
amod(methotrexate-14, administered-13)
prep_of(efficacy-10, methotrexate-14)

Leucovorin/NN may/MD enhance/VB the/DT toxicity/NN of/IN 5-/CD fluorouracil/NN ./.

(ROOT (S1 (S (S (NP (NN Leucovorin)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN toxicity)) (PP (IN of) (NP (CD 5-) (NN fluorouracil))))))) (. .))))

nsubj(enhance-3, Leucovorin-1)
aux(enhance-3, may-2)
root(ROOT-0, enhance-3)
det(toxicity-5, the-4)
dobj(enhance-3, toxicity-5)
num(fluorouracil-8, 5--7)
prep_of(toxicity-5, fluorouracil-8)

Although/IN BETAGAN/NN used/VBN alone/RB has/VBZ little/JJ or/CC no/DT effect/NN on/IN pupil/NN size/NN ,/, mydriasis/NNS resulting/VBG from/IN concomitant/JJ therapy/NN with/IN BETAGAN/NN and/CC epinephrine/NN may/MD occur/VB ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (NN BETAGAN)) (VP (VBN used) (ADVP (RB alone)))) (VP (VBZ has) (NP (NP (ADJP (JJ little))) (CC or) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NN pupil) (NN size)))))))) (, ,) (NP (NP (NNS mydriasis)) (VP (VBG resulting) (PP (IN from) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NP (NN BETAGAN)) (CC and) (NP (NN epinephrine)))))))) (VP (MD may) (VP (VB occur)))) (. .))))

mark(has-5, Although-1)
nsubj(has-5, BETAGAN-2)
partmod(BETAGAN-2, used-3)
advmod(used-3, alone-4)
advcl(occur-24, has-5)
dobj(has-5, little-6)
det(effect-9, no-8)
conj_or(little-6, effect-9)
nn(size-12, pupil-11)
prep_on(effect-9, size-12)
nsubj(occur-24, mydriasis-14)
partmod(mydriasis-14, resulting-15)
amod(therapy-18, concomitant-17)
prep_from(resulting-15, therapy-18)
prep_with(therapy-18, BETAGAN-20)
conj_and(BETAGAN-20, epinephrine-22)
aux(occur-24, may-23)
root(ROOT-0, occur-24)

Close/JJ observation/NN of/IN the/DT patient/NN is/VBZ recommended/VBN when/WRB a/DT beta-blocker/NN is/VBZ administered/VBN to/TO patients/NNS receiving/VBG catecholamine-depleting/JJ drugs/NNS such/JJ as/IN reserpine/NN ,/, because/IN of/IN possible/JJ additive/JJ effects/NNS and/CC the/DT production/NN of/IN hypotension/NN and/or/CC marked/JJ bradycardia/NN ,/, which/WDT may/MD produce/VB vertigo/NN ,/, syncope/NN or/CC postural/JJ hypotension/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Close) (NN observation)) (PP (IN of) (NP (DT the) (NN patient)))) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (NN beta-blocker)) (VP (VBZ is) (VP (VBN administered) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ catecholamine-depleting) (NNS drugs)) (PP (JJ such) (IN as) (NP (NN reserpine))) (, ,) (PP (IN because) (PP (IN of) (NP (NP (JJ possible) (JJ additive) (NNS effects)) (CC and) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NN hypotension)) (CC and/or) (NP (JJ marked) (NN bradycardia)))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB produce) (NP (NP (NN vertigo)) (, ,) (NP (NN syncope)) (CC or) (NP (JJ postural) (NN hypotension)))))))))))))))))) (. .))))

amod(observation-2, Close-1)
nsubjpass(recommended-7, observation-2)
det(patient-5, the-4)
prep_of(observation-2, patient-5)
auxpass(recommended-7, is-6)
root(ROOT-0, recommended-7)
advmod(administered-12, when-8)
det(beta-blocker-10, a-9)
nsubjpass(administered-12, beta-blocker-10)
auxpass(administered-12, is-11)
advcl(recommended-7, administered-12)
prep_to(administered-12, patients-14)
partmod(patients-14, receiving-15)
amod(drugs-17, catecholamine-depleting-16)
dobj(receiving-15, drugs-17)
prep_such_as(drugs-17, reserpine-20)
prepc_because_of(drugs-17, of-23)
amod(effects-26, possible-24)
amod(effects-26, additive-25)
pobj(drugs-17, effects-26)
det(production-29, the-28)
conj_and(effects-26, production-29)
prep_of(production-29, hypotension-31)
amod(bradycardia-34, marked-33)
conj_and/or(hypotension-31, bradycardia-34)
nsubj(produce-38, which-36)
aux(produce-38, may-37)
rcmod(drugs-17, produce-38)
dobj(produce-38, vertigo-39)
conj_or(vertigo-39, syncope-41)
amod(hypotension-44, postural-43)
conj_or(vertigo-39, hypotension-44)

Patients/NNS receiving/VBG beta-adrenergic/JJ blocking/NN agents/NNS along/IN with/IN either/CC oral/JJ or/CC intravenous/JJ calcium/NN antagonist/NN s/NN should/MD be/VB monitored/VBN for/IN possible/JJ atrioventricular/JJ conduction/NN disturbances/NNS ,/, left/JJ ventricular/NN failure/NN and/CC hypotension/NN ./.

(ROOT (S1 (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (JJ beta-adrenergic) (NN blocking) (NNS agents)) (PP (IN along) (PP (IN with) (NP (ADJP (CC either) (ADJP (JJ oral)) (CC or) (ADJP (JJ intravenous))) (NN calcium) (NN antagonist) (NN s)))))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN for) (NP (NP (JJ possible) (JJ atrioventricular) (NN conduction) (NNS disturbances)) (, ,) (NP (NP (JJ left) (NN ventricular)) (NN failure)) (CC and) (NP (NN hypotension))))))) (. .))))

nsubjpass(monitored-17, Patients-1)
partmod(Patients-1, receiving-2)
amod(agents-5, beta-adrenergic-3)
nn(agents-5, blocking-4)
dobj(receiving-2, agents-5)
prepc_along_with(receiving-2, with-7)
preconj(oral-9, either-8)
amod(s-14, oral-9)
conj_or(oral-9, intravenous-11)
nn(s-14, calcium-12)
nn(s-14, antagonist-13)
pobj(receiving-2, s-14)
aux(monitored-17, should-15)
auxpass(monitored-17, be-16)
root(ROOT-0, monitored-17)
amod(disturbances-22, possible-19)
amod(disturbances-22, atrioventricular-20)
nn(disturbances-22, conduction-21)
prep_for(monitored-17, disturbances-22)
amod(ventricular-25, left-24)
nn(failure-26, ventricular-25)
conj_and(disturbances-22, failure-26)
conj_and(disturbances-22, hypotension-28)

The/DT concomitant/JJ use/NN of/IN beta-adrenergic/JJ blocking/NN agents/NNS with/IN digitalis/NN and/CC calcium/NN antagonist/NN s/NN may/MD have/VB additive/JJ effects/NNS on/IN prolonging/VBG atrioventricular/JJ conduction/NN time/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (JJ beta-adrenergic) (NN blocking) (NNS agents)) (PP (IN with) (NP (NP (NN digitalis)) (CC and) (NP (NN calcium) (NN antagonist) (NN s))))))) (VP (MD may) (VP (VB have) (NP (JJ additive) (NNS effects)) (PP (IN on) (S (VP (VBG prolonging) (NP (JJ atrioventricular) (NN conduction) (NN time)))))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubj(have-15, use-3)
amod(agents-7, beta-adrenergic-5)
nn(agents-7, blocking-6)
prep_of(use-3, agents-7)
prep_with(agents-7, digitalis-9)
nn(s-13, calcium-11)
nn(s-13, antagonist-12)
conj_and(digitalis-9, s-13)
aux(have-15, may-14)
root(ROOT-0, have-15)
amod(effects-17, additive-16)
dobj(have-15, effects-17)
prepc_on(have-15, prolonging-19)
amod(time-22, atrioventricular-20)
nn(time-22, conduction-21)
dobj(prolonging-19, time-22)

Phenothiazine/JJ -related/JJ compounds/NNS and/CC beta-adrenergic/JJ blocking/NN agents/NNS may/MD have/VB additive/JJ hypotensite/JJ effects/NNS due/JJ to/TO the/DT inhibition/NN of/IN each/DT other/JJ @/NN s/NN metabolism/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Phenothiazine) (JJ -related) (NNS compounds)) (CC and) (NP (JJ beta-adrenergic) (NN blocking) (NNS agents))) (VP (MD may) (VP (VB have) (NP (JJ additive) (JJ hypotensite) (NNS effects)) (PP (JJ due) (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (DT each) (JJ other) (NN @) (NN s) (NN metabolism)))))))) (. .))))

amod(compounds-3, Phenothiazine-1)
amod(compounds-3, -related-2)
nsubj(have-9, compounds-3)
amod(agents-7, beta-adrenergic-5)
nn(agents-7, blocking-6)
conj_and(compounds-3, agents-7)
aux(have-9, may-8)
root(ROOT-0, have-9)
amod(effects-12, additive-10)
amod(effects-12, hypotensite-11)
dobj(have-9, effects-12)
det(inhibition-16, the-15)
prep_due_to(have-9, inhibition-16)
det(metabolism-22, each-18)
amod(metabolism-22, other-19)
nn(metabolism-22, @-20)
nn(metabolism-22, s-21)
prep_of(inhibition-16, metabolism-22)

No/DT significant/JJ drug-drug/JJ pharmacokinetic/JJ interactions/NNS have/VBP been/VBN found/VBN in/IN interaction/NN studies/NNS with/IN hydrochlorothiazide/NN ,/, digoxin/NN ,/, warfarin/NN ,/, cimetidine/NN and/CC phenobarbital/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ significant) (JJ drug-drug) (JJ pharmacokinetic) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN found) (PP (IN in) (NP (NP (NN interaction) (NNS studies)) (PP (IN with) (NP (NP (NN hydrochlorothiazide)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN cimetidine)) (CC and) (NP (NN phenobarbital)))))))))) (. .))))

det(interactions-5, No-1)
amod(interactions-5, significant-2)
amod(interactions-5, drug-drug-3)
amod(interactions-5, pharmacokinetic-4)
nsubjpass(found-8, interactions-5)
aux(found-8, have-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
nn(studies-11, interaction-10)
prep_in(found-8, studies-11)
prep_with(studies-11, hydrochlorothiazide-13)
conj_and(hydrochlorothiazide-13, digoxin-15)
conj_and(hydrochlorothiazide-13, warfarin-17)
conj_and(hydrochlorothiazide-13, cimetidine-19)
conj_and(hydrochlorothiazide-13, phenobarbital-21)

Rifampin/NN ,/, an/DT inducer/NN of/IN drug/NN metabolism/NN ,/, decreased/VBD the/DT concentrations/NNS of/IN losartan/NN and/CC its/PRP$ active/JJ metabolite/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Rifampin)) (, ,) (NP (NP (DT an) (NN inducer)) (PP (IN of) (NP (NN drug) (NN metabolism)))) (, ,)) (VP (VBD decreased) (NP (NP (DT the) (NNS concentrations)) (PP (IN of) (NP (NP (NN losartan)) (CC and) (NP (PRP$ its) (JJ active) (NN metabolite))))))) (. .))))

nsubj(decreased-9, Rifampin-1)
det(inducer-4, an-3)
appos(Rifampin-1, inducer-4)
nn(metabolism-7, drug-6)
prep_of(inducer-4, metabolism-7)
root(ROOT-0, decreased-9)
det(concentrations-11, the-10)
dobj(decreased-9, concentrations-11)
prep_of(concentrations-11, losartan-13)
poss(metabolite-17, its-15)
amod(metabolite-17, active-16)
conj_and(losartan-13, metabolite-17)

In/IN humans/NNS ,/, two/CD inhibitors/NNS of/IN P450/NN 3A4/NN have/VBP been/VBN studied/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NNS humans))) (, ,) (NP (NP (CD two) (NNS inhibitors)) (PP (IN of) (NP (NN P450) (NN 3A4)))) (VP (VBP have) (VP (VBN been) (VP (VBN studied))))) (. .))))

prep_in(studied-11, humans-2)
num(inhibitors-5, two-4)
nsubjpass(studied-11, inhibitors-5)
nn(3A4-8, P450-7)
prep_of(inhibitors-5, 3A4-8)
aux(studied-11, have-9)
auxpass(studied-11, been-10)
root(ROOT-0, studied-11)

Ketoconazole/NN did/VBD not/RB affect/VB the/DT conversion/NN of/IN losartan/NN to/TO the/DT active/JJ metabolite/NN after/IN intravenous/JJ administration/NN of/IN losartan/NN ,/, and/CC erythromycin/NN had/VBD no/DT clinically/RB significant/JJ effect/NN after/IN oral/JJ administration/NN ./.

(ROOT (S1 (S (S (S (NP (NN Ketoconazole)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN conversion)) (PP (IN of) (NP (NN losartan))) (PP (TO to) (NP (NP (DT the) (JJ active) (NN metabolite)) (PP (IN after) (NP (NP (JJ intravenous) (NN administration)) (PP (IN of) (NP (NN losartan))))))))))) (, ,) (CC and) (S (NP (NN erythromycin)) (VP (VBD had) (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NN effect)) (PP (IN after) (NP (JJ oral) (NN administration)))))) (. .))))

nsubj(affect-4, Ketoconazole-1)
aux(affect-4, did-2)
neg(affect-4, not-3)
root(ROOT-0, affect-4)
det(conversion-6, the-5)
dobj(affect-4, conversion-6)
prep_of(conversion-6, losartan-8)
det(metabolite-12, the-10)
amod(metabolite-12, active-11)
prep_to(conversion-6, metabolite-12)
amod(administration-15, intravenous-14)
prep_after(metabolite-12, administration-15)
prep_of(administration-15, losartan-17)
nsubj(had-21, erythromycin-20)
conj_and(affect-4, had-21)
det(effect-25, no-22)
advmod(significant-24, clinically-23)
amod(effect-25, significant-24)
dobj(had-21, effect-25)
amod(administration-28, oral-27)
prep_after(had-21, administration-28)

Fluconazole/NN ,/, an/DT inhibitor/NN of/IN P450/NN 2C9/NNS ,/, decreased/VBD active/JJ metabolite/NN concentration/NN and/CC increased/VBD losartan/NN concentration/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Fluconazole)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN P450) (NNS 2C9)))) (, ,)) (VP (VP (VBD decreased) (NP (JJ active) (NN metabolite) (NN concentration))) (CC and) (VP (VBD increased) (NP (NN losartan) (NN concentration))))) (. .))))

nsubj(decreased-9, Fluconazole-1)
det(inhibitor-4, an-3)
appos(Fluconazole-1, inhibitor-4)
nn(2C9-7, P450-6)
prep_of(inhibitor-4, 2C9-7)
root(ROOT-0, decreased-9)
amod(concentration-12, active-10)
nn(concentration-12, metabolite-11)
dobj(decreased-9, concentration-12)
conj_and(decreased-9, increased-14)
nn(concentration-16, losartan-15)
dobj(increased-14, concentration-16)

The/DT pharmacodynamic/JJ consequences/NNS of/IN concomitant/JJ use/NN of/IN losartan/NN and/CC inhibitors/NNS of/IN P450/NN 2C9/NNS have/VBP not/RB been/VBN examined/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ pharmacodynamic) (NNS consequences)) (PP (IN of) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN losartan)) (CC and) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN P450) (NNS 2C9))))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN examined))))) (. .))))

det(consequences-3, The-1)
amod(consequences-3, pharmacodynamic-2)
nsubjpass(examined-17, consequences-3)
amod(use-6, concomitant-5)
prep_of(consequences-3, use-6)
prep_of(use-6, losartan-8)
conj_and(losartan-8, inhibitors-10)
nn(2C9-13, P450-12)
prep_of(inhibitors-10, 2C9-13)
aux(examined-17, have-14)
neg(examined-17, not-15)
auxpass(examined-17, been-16)
root(ROOT-0, examined-17)

Subjects/NNS who/WP do/VBP not/RB metabolize/VB losartan/NN to/TO active/JJ metabolite/NN have/VBP been/VBN shown/VBN to/TO have/VB a/DT specific/JJ ,/, rare/JJ defect/NN in/IN cytochrome/NN P450/NN 2C9/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Subjects)) (SBAR (WHNP (WP who)) (S (VP (VBP do) (RB not) (VP (VB metabolize) (NP (NP (NN losartan)) (PP (TO to) (NP (JJ active) (NN metabolite))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (DT a) (ADJP (ADJP (JJ specific)) (, ,) (ADJP (JJ rare))) (NN defect)) (PP (IN in) (NP (NN cytochrome) (NN P450) (NN 2C9)))))))))) (. .))))

nsubj(metabolize-5, Subjects-1)
nsubjpass(shown-12, Subjects-1)
xsubj(have-14, Subjects-1)
aux(metabolize-5, do-3)
neg(metabolize-5, not-4)
rcmod(Subjects-1, metabolize-5)
dobj(metabolize-5, losartan-6)
amod(metabolite-9, active-8)
prep_to(losartan-6, metabolite-9)
aux(shown-12, have-10)
auxpass(shown-12, been-11)
root(ROOT-0, shown-12)
aux(have-14, to-13)
xcomp(shown-12, have-14)
det(defect-19, a-15)
amod(defect-19, specific-16)
dep(specific-16, rare-18)
dobj(have-14, defect-19)
nn(2C9-23, cytochrome-21)
nn(2C9-23, P450-22)
prep_in(have-14, 2C9-23)

These/DT data/NNS suggest/VBP that/IN the/DT conversion/NN of/IN losartan/NN to/TO its/PRP$ active/JJ metabolite/NN is/VBZ mediated/VBN primarily/RB by/IN P450/NN 2C9/NN and/CC not/RB P450/NN 3A4/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN conversion)) (PP (IN of) (NP (NN losartan))) (PP (TO to) (NP (PRP$ its) (JJ active) (NN metabolite)))) (VP (VP (VBZ is) (VP (VBN mediated) (ADVP (RB primarily)) (PP (IN by) (NP (NN P450) (NN 2C9))))) (CC and) (VP (ADVP (RB not)) (NP (NN P450) (NN 3A4)))))))) (. .))))

det(data-2, These-1)
nsubj(suggest-3, data-2)
root(ROOT-0, suggest-3)
complm(mediated-14, that-4)
det(conversion-6, the-5)
nsubjpass(mediated-14, conversion-6)
prep_of(conversion-6, losartan-8)
poss(metabolite-12, its-10)
amod(metabolite-12, active-11)
prep_to(conversion-6, metabolite-12)
auxpass(mediated-14, is-13)
ccomp(suggest-3, mediated-14)
advmod(mediated-14, primarily-15)
nn(2C9-18, P450-17)
agent(mediated-14, 2C9-18)
neg(3A4-22, not-20)
nn(3A4-22, P450-21)
conj_and(mediated-14, 3A4-22)

As/IN with/IN other/JJ drugs/NNS that/WDT block/VBP angiotensin/NN II/CD or/CC its/PRP$ effects/NNS ,/, concomitant/JJ use/NN of/IN potassium-sparing/JJ diuretics/NNS (/-LRB- e.g./FW ,/, spironolactone/NN ,/, triamterene/NN ,/, amiloride/NN )/-RRB- ,/, potassium/NN supplement/NN s/NNS ,/, or/CC salt/NN substitutes/VBZ containing/VBG potassium/NN may/MD lead/VB to/TO increases/NNS in/IN serum/NN potassium/NN ./.

(ROOT (S1 (S (PP (IN As) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP block) (NP (NP (NN angiotensin) (CD II)) (CC or) (NP (PRP$ its) (NNS effects))))))))) (, ,) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NP (JJ potassium-sparing) (NNS diuretics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN spironolactone)) (, ,) (NP (NN triamterene)) (, ,) (NP (NN amiloride)))) (-RRB- -RRB-))) (, ,) (NP (NN potassium) (NN supplement) (NNS s)) (, ,) (CC or) (NP (NP (NN salt) (VBZ substitutes)) (VP (VBG containing) (NP (NN potassium))))))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NNS increases)) (PP (IN in) (NP (NN serum) (NN potassium))))))) (. .))))

prep(lead-38, As-1)
pcomp(As-1, with-2)
amod(drugs-4, other-3)
prep_with(As-1, drugs-4)
nsubj(block-6, drugs-4)
rcmod(drugs-4, block-6)
dobj(block-6, angiotensin-7)
num(angiotensin-7, II-8)
poss(effects-11, its-10)
conj_or(angiotensin-7, effects-11)
amod(use-14, concomitant-13)
nsubj(lead-38, use-14)
amod(diuretics-17, potassium-sparing-16)
prep_of(use-14, diuretics-17)
dep(diuretics-17, e.g.-19)
pobj(e.g.-19, spironolactone-21)
appos(spironolactone-21, triamterene-23)
appos(spironolactone-21, amiloride-25)
nn(s-30, potassium-28)
nn(s-30, supplement-29)
conj_or(diuretics-17, s-30)
conj_or(diuretics-17, salt-33)
dep(salt-33, substitutes-34)
partmod(salt-33, containing-35)
dobj(containing-35, potassium-36)
aux(lead-38, may-37)
root(ROOT-0, lead-38)
prep_to(lead-38, increases-40)
nn(potassium-43, serum-42)
prep_in(increases-40, potassium-43)

As/IN with/IN other/JJ antihypertensive/JJ agents/NNS ,/, the/DT antihypertensive/JJ effect/NN of/IN losartan/NN may/MD be/VB blunted/VBN by/IN the/DT non-steroidal/JJ anti-inflammatory/JJ drug/NN indomethacin/NN ./.

(ROOT (S1 (S (S (PP (IN As) (PP (IN with) (NP (JJ other) (JJ antihypertensive) (NNS agents)))) (, ,) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NN losartan)))) (VP (MD may) (VP (VB be) (VP (VBN blunted) (PP (IN by) (NP (NP (DT the) (JJ non-steroidal) (JJ anti-inflammatory) (NN drug)) (NN indomethacin))))))) (. .))))

prep(blunted-14, As-1)
pcomp(As-1, with-2)
amod(agents-5, other-3)
amod(agents-5, antihypertensive-4)
prep_with(As-1, agents-5)
det(effect-9, the-7)
amod(effect-9, antihypertensive-8)
nsubjpass(blunted-14, effect-9)
prep_of(effect-9, losartan-11)
aux(blunted-14, may-12)
auxpass(blunted-14, be-13)
root(ROOT-0, blunted-14)
det(drug-19, the-16)
amod(drug-19, non-steroidal-17)
amod(drug-19, anti-inflammatory-18)
nn(indomethacin-20, drug-19)
agent(blunted-14, indomethacin-20)

When/WRB administered/VBN concurrently/RB ,/, the/DT following/VBG drugs/NNS may/MD interact/VB with/IN beta-adrenergic/JJ receptor/NN blocking/NN agents/NNS :/: Anesthetics/NN ,/, general/JJ :/: exaggeration/NN of/IN the/DT hypotension/NN induced/VBN by/IN general/JJ anesthetics/NNS ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN administered) (ADVP (RB concurrently))))) (, ,) (NP (DT the) (VBG following) (NNS drugs)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (JJ beta-adrenergic) (NN receptor) (NN blocking) (NNS agents)) (: :) (NP (NP (NN Anesthetics)) (, ,) (NP (ADJP (JJ general))) (: :) (NP (NP (NN exaggeration)) (PP (IN of) (NP (NP (DT the) (NN hypotension)) (VP (VBN induced) (PP (IN by) (NP (JJ general) (NNS anesthetics))))))))))))) (. .))))

advmod(administered-2, When-1)
advcl(interact-9, administered-2)
advmod(administered-2, concurrently-3)
det(drugs-7, the-5)
amod(drugs-7, following-6)
nsubj(interact-9, drugs-7)
aux(interact-9, may-8)
root(ROOT-0, interact-9)
amod(agents-14, beta-adrenergic-11)
nn(agents-14, receptor-12)
nn(agents-14, blocking-13)
prep_with(interact-9, agents-14)
dep(agents-14, Anesthetics-16)
appos(Anesthetics-16, general-18)
dep(Anesthetics-16, exaggeration-20)
det(hypotension-23, the-22)
prep_of(exaggeration-20, hypotension-23)
partmod(hypotension-23, induced-24)
amod(anesthetics-27, general-26)
agent(induced-24, anesthetics-27)

Antidiabetic/JJ drugs/NNS (/-LRB- oral/JJ agents/NNS and/CC insulin/NN )/-RRB- :/: hypoglycemia/NN or/CC hyperglycemia/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Antidiabetic) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NP (JJ oral) (NNS agents)) (CC and) (NP (NN insulin))) (-RRB- -RRB-))) (: :) (NP (NP (NN hypoglycemia)) (CC or) (NP (NN hyperglycemia))) (: ;))) (. .))))

amod(drugs-2, Antidiabetic-1)
root(ROOT-0, drugs-2)
amod(agents-5, oral-4)
dep(drugs-2, agents-5)
conj_and(agents-5, insulin-7)
dep(drugs-2, hypoglycemia-10)
conj_or(hypoglycemia-10, hyperglycemia-12)

adjust/VB dosage/NN of/IN antidiabetic/JJ drug/NN accordingly/RB ./.

(ROOT (S1 (S (S (VP (VB adjust) (NP (NP (NN dosage)) (PP (IN of) (NP (JJ antidiabetic) (NN drug)))) (ADVP (RB accordingly)))) (. .))))

root(ROOT-0, adjust-1)
dobj(adjust-1, dosage-2)
amod(drug-5, antidiabetic-4)
prep_of(dosage-2, drug-5)
advmod(adjust-1, accordingly-6)

Catecholamine-depleting/JJ drugs/NNS (/-LRB- e.g./FW ,/, reserpine/NN )/-RRB- :/: additive/JJ effect/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (JJ Catecholamine-depleting) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN reserpine))) (-RRB- -RRB-))) (: :) (NP (JJ additive) (NN effect)) (: ;)) (. .))))

amod(drugs-2, Catecholamine-depleting-1)
dep(effect-10, drugs-2)
dep(drugs-2, e.g.-4)
pobj(e.g.-4, reserpine-6)
amod(effect-10, additive-9)
root(ROOT-0, effect-10)

Response/NN to/TO Treatment/NN for/IN Anaphylactic/JJ Reaction/NN :/: While/IN taking/VBG beta-blockers/NN ,/, patients/NNS with/IN a/DT history/NN of/IN severe/JJ anaphylactic/JJ reaction/NN to/TO a/DT variety/NN of/IN allergens/NNS may/MD be/VB more/RBR reactive/JJ to/TO repeated/JJ challenge/NN ,/, either/CC accidental/JJ ,/, diagnostic/JJ ,/, or/CC therapeutic/JJ ./.

(ROOT (S1 (S (NP (NP (NP (NN Response)) (PP (TO to) (NP (NP (NN Treatment)) (PP (IN for) (NP (JJ Anaphylactic) (NN Reaction)))))) (: :) (S (SBAR (IN While) (S (VP (VBG taking) (NP (NN beta-blockers))))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (JJ severe) (JJ anaphylactic) (NN reaction)) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS allergens)))))))))) (VP (MD may) (VP (VB be) (ADJP (ADJP (RBR more) (JJ reactive) (PP (TO to) (NP (JJ repeated) (NN challenge)))) (, ,) (CC either) (ADJP (JJ accidental)) (, ,) (ADJP (JJ diagnostic)) (, ,) (CC or) (ADJP (JJ therapeutic)))))) (. .)))))

root(ROOT-0, Response-1)
prep_to(Response-1, Treatment-3)
amod(Reaction-6, Anaphylactic-5)
prep_for(Treatment-3, Reaction-6)
mark(taking-9, While-8)
advcl(reactive-28, taking-9)
dobj(taking-9, beta-blockers-10)
nsubj(reactive-28, patients-12)
det(history-15, a-14)
prep_with(patients-12, history-15)
amod(reaction-19, severe-17)
amod(reaction-19, anaphylactic-18)
prep_of(history-15, reaction-19)
det(variety-22, a-21)
prep_to(reaction-19, variety-22)
prep_of(variety-22, allergens-24)
aux(reactive-28, may-25)
cop(reactive-28, be-26)
advmod(reactive-28, more-27)
dep(Response-1, reactive-28)
amod(challenge-31, repeated-30)
prep_to(reactive-28, challenge-31)
preconj(reactive-28, either-33)
conj_or(reactive-28, accidental-34)
conj_or(reactive-28, diagnostic-36)
conj_or(reactive-28, therapeutic-39)

Such/JJ patients/NNS may/MD be/VB unresponsive/JJ to/TO the/DT usual/JJ doses/NNS of/IN epinephrine/NN used/VBN to/TO treat/VB allergic/JJ reaction/NN ./.

(ROOT (S1 (S (S (NP (JJ Such) (NNS patients)) (VP (MD may) (VP (VB be) (ADJP (JJ unresponsive) (PP (TO to) (NP (NP (DT the) (JJ usual) (NNS doses)) (PP (IN of) (NP (NN epinephrine))) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (JJ allergic) (NN reaction)))))))))))) (. .))))

amod(patients-2, Such-1)
nsubj(unresponsive-5, patients-2)
aux(unresponsive-5, may-3)
cop(unresponsive-5, be-4)
root(ROOT-0, unresponsive-5)
det(doses-9, the-7)
amod(doses-9, usual-8)
prep_to(unresponsive-5, doses-9)
prep_of(doses-9, epinephrine-11)
partmod(doses-9, used-12)
aux(treat-14, to-13)
xcomp(used-12, treat-14)
amod(reaction-16, allergic-15)
dobj(treat-14, reaction-16)

Elevated/JJ plasma/NN levels/NNS of/IN theophylline/NN have/VBP been/VBN reported/VBN with/IN concomitant/JJ quinolone/NN use/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Elevated) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN theophylline)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (JJ concomitant) (NN quinolone) (NN use))))))) (. .))))

amod(levels-3, Elevated-1)
nn(levels-3, plasma-2)
nsubjpass(reported-8, levels-3)
prep_of(levels-3, theophylline-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
amod(use-12, concomitant-10)
nn(use-12, quinolone-11)
prep_with(reported-8, use-12)

There/EX have/VBP been/VBN reports/NNS of/IN theophylline/NN -related/JJ side/JJ effects/NNS in/IN patients/NNS on/IN concomitant/JJ therapy/NN with/IN quinolones/NNS and/CC theophylline/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (ADJP (NN theophylline) (JJ -related)) (JJ side) (NNS effects)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NP (NNS quinolones)) (CC and) (NP (NN theophylline)))))))))))))) (. .))))

expl(reports-4, There-1)
aux(reports-4, have-2)
cop(reports-4, been-3)
root(ROOT-0, reports-4)
dep(-related-7, theophylline-6)
amod(effects-9, -related-7)
amod(effects-9, side-8)
prep_of(reports-4, effects-9)
prep_in(effects-9, patients-11)
amod(therapy-14, concomitant-13)
prep_on(patients-11, therapy-14)
prep_with(therapy-14, quinolones-16)
conj_and(quinolones-16, theophylline-18)

Therefore/RB ,/, monitoring/NN of/IN theophylline/NN plasma/NN levels/NNS should/MD be/VB considered/VBN and/CC dosage/NN of/IN theophylline/NN adjusted/VBN ,/, as/IN required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN monitoring)) (PP (IN of) (NP (NN theophylline) (NN plasma) (NNS levels)))) (VP (MD should) (VP (VB be) (VP (VP (VBN considered)) (CC and) (VP (NP (NP (NN dosage)) (PP (IN of) (NP (NP (NN theophylline)) (VP (VBN adjusted))))) (, ,) (SBAR (IN as) (S (VP (VBN required))))))))) (. .))))

advmod(considered-10, Therefore-1)
nsubjpass(considered-10, monitoring-3)
nn(levels-7, theophylline-5)
nn(levels-7, plasma-6)
prep_of(monitoring-3, levels-7)
aux(considered-10, should-8)
auxpass(considered-10, be-9)
root(ROOT-0, considered-10)
conj_and(considered-10, dosage-12)
prep_of(dosage-12, theophylline-14)
partmod(theophylline-14, adjusted-15)
mark(required-18, as-17)
advcl(dosage-12, required-18)

Quinolones/NNS have/VBP been/VBN shown/VBN to/TO interfere/VB with/IN the/DT metabolism/NN of/IN caffeine/NN ./.

(ROOT (S1 (S (S (NP (NNS Quinolones)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN caffeine)))))))))))) (. .))))

nsubjpass(shown-4, Quinolones-1)
xsubj(interfere-6, Quinolones-1)
aux(shown-4, have-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(interfere-6, to-5)
xcomp(shown-4, interfere-6)
det(metabolism-9, the-8)
prep_with(interfere-6, metabolism-9)
prep_of(metabolism-9, caffeine-11)

This/DT may/MD lead/VB to/TO reduced/VBN clearance/NN of/IN caffeine/NN and/CC the/DT prolongation/NN of/IN its/PRP$ plasma/NN half-life/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NP (VBN reduced) (NN clearance)) (PP (IN of) (NP (NN caffeine)))) (CC and) (NP (NP (DT the) (NN prolongation)) (PP (IN of) (NP (PRP$ its) (NN plasma) (NN half-life))))))))) (. .))))

nsubj(lead-3, This-1)
aux(lead-3, may-2)
root(ROOT-0, lead-3)
amod(clearance-6, reduced-5)
prep_to(lead-3, clearance-6)
prep_of(clearance-6, caffeine-8)
det(prolongation-11, the-10)
conj_and(clearance-6, prolongation-11)
poss(half-life-15, its-13)
nn(half-life-15, plasma-14)
prep_of(prolongation-11, half-life-15)

Quinolones/NNS ,/, including/VBG nalidixic/JJ acid/NN ,/, may/MD enhance/VB the/DT effects/NNS of/IN the/DT oral/JJ anticoagulant/NN warfarin/NN or/CC its/PRP$ derivatives/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Quinolones)) (, ,) (PP (VBG including) (NP (JJ nalidixic) (NN acid))) (, ,)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT the) (JJ oral) (NN anticoagulant) (NN warfarin)) (CC or) (NP (PRP$ its) (NNS derivatives)))))))) (. .))))

nsubj(enhance-8, Quinolones-1)
amod(acid-5, nalidixic-4)
prep_including(Quinolones-1, acid-5)
aux(enhance-8, may-7)
root(ROOT-0, enhance-8)
det(effects-10, the-9)
dobj(enhance-8, effects-10)
det(warfarin-15, the-12)
amod(warfarin-15, oral-13)
nn(warfarin-15, anticoagulant-14)
prep_of(effects-10, warfarin-15)
poss(derivatives-18, its-17)
conj_or(warfarin-15, derivatives-18)

Nitrofurantoin/NN interferes/VBZ with/IN the/DT therapeutic/JJ action/NN of/IN nalidixic/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (NN Nitrofurantoin)) (VP (VBZ interferes) (PP (IN with) (NP (NP (DT the) (JJ therapeutic) (NN action)) (PP (IN of) (NP (JJ nalidixic) (NN acid))))))) (. .))))

nsubj(interferes-2, Nitrofurantoin-1)
root(ROOT-0, interferes-2)
det(action-6, the-4)
amod(action-6, therapeutic-5)
prep_with(interferes-2, action-6)
amod(acid-9, nalidixic-8)
prep_of(action-6, acid-9)

Antacids/NNS containing/VBG magnesium/NN ,/, aluminum/NN ,/, or/CC calcium/NN ;/: ./.

(ROOT (S1 (S (S (NP (NNS Antacids)) (VP (VBG containing) (NP (NP (NN magnesium)) (, ,) (NP (NN aluminum)) (, ,) (CC or) (NP (NN calcium)))) (: ;)) (. .))))

nsubj(containing-2, Antacids-1)
root(ROOT-0, containing-2)
dobj(containing-2, magnesium-3)
conj_or(magnesium-3, aluminum-5)
conj_or(magnesium-3, calcium-8)

sucralfate/VBP or/CC divalent/JJ or/CC trivalent/JJ cations/NNS such/JJ as/IN iron/NN ;/: ./.

(ROOT (S1 (S (S (VP (VBP sucralfate) (NP (NP (ADJP (CC or) (ADJP (JJ divalent)) (CC or) (ADJP (JJ trivalent))) (NNS cations)) (PP (JJ such) (IN as) (NP (NN iron) (: ;)))))) (. .))))

root(ROOT-0, sucralfate-1)
amod(cations-6, divalent-3)
conj_or(divalent-3, trivalent-5)
dobj(sucralfate-1, cations-6)
prep_such_as(cations-6, iron-9)

multivitamins/NNS containing/VBG zinc/NN ;/: ./.

(ROOT (S1 (S (S (NP (NNS multivitamins)) (VP (VBG containing) (NP (NN zinc))) (: ;)) (. .))))

nsubj(containing-2, multivitamins-1)
root(ROOT-0, containing-2)
dobj(containing-2, zinc-3)

and/CC Videx/NN @/NN ,/, (/-LRB- Didanosine/NN )/-RRB- ,/, chewable//NN buffer/NN ed/NN tablets/NNS or/CC the/DT pediatric/JJ powder/NN for/IN oral/JJ solution/NN may/MD substantially/RB interfere/VB with/IN the/DT absorption/NN of/IN quinolones/NNS ,/, resulting/VBG in/IN systemic/JJ levels/NNS considerably/RB lower/JJR than/IN desired/VBN ./.

(ROOT (S1 (S (S (NP (CC and) (NP (NP (NN Videx) (NN @)) (, ,) (NP (-LRB- -LRB-) (NN Didanosine) (-RRB- -RRB-)) (, ,) (NP (NN chewable/) (NN buffer) (NN ed) (NNS tablets))) (CC or) (NP (NP (DT the) (JJ pediatric) (NN powder)) (PP (IN for) (NP (JJ oral) (NN solution))))) (VP (MD may) (ADVP (RB substantially)) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NNS quinolones))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ systemic) (NNS levels)) (ADJP (ADJP (RB considerably) (JJR lower)) (SBAR (IN than) (S (VP (VBN desired)))))))))))) (. .))))

nn(@-3, Videx-2)
nsubj(interfere-22, @-3)
appos(@-3, Didanosine-6)
nn(tablets-12, chewable/-9)
nn(tablets-12, buffer-10)
nn(tablets-12, ed-11)
appos(@-3, tablets-12)
det(powder-16, the-14)
amod(powder-16, pediatric-15)
conj_or(@-3, powder-16)
amod(solution-19, oral-18)
prep_for(powder-16, solution-19)
aux(interfere-22, may-20)
advmod(interfere-22, substantially-21)
root(ROOT-0, interfere-22)
det(absorption-25, the-24)
prep_with(interfere-22, absorption-25)
prep_of(absorption-25, quinolones-27)
xcomp(interfere-22, resulting-29)
amod(levels-32, systemic-31)
prep_in(resulting-29, levels-32)
advmod(lower-34, considerably-33)
amod(levels-32, lower-34)
mark(desired-36, than-35)
dep(lower-34, desired-36)

These/DT agents/NNS should/MD not/RB be/VB taken/VBN within/IN the/DT two/CD hour/NN period/NN before/IN or/CC within/IN the/DT two-hour/JJ period/NN after/IN nalidixic/JJ acid/NN administration/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS agents)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN within) (NP (DT the) (ADJP (CD two) (NN hour)) (NN period))) (PP (PP (IN before)) (CC or) (PP (IN within) (NP (DT the) (JJ two-hour) (NN period))) (PP (IN after) (NP (NP (JJ nalidixic) (NN acid)) (NN administration)))))))) (. .))))

det(agents-2, These-1)
nsubjpass(taken-6, agents-2)
aux(taken-6, should-3)
neg(taken-6, not-4)
auxpass(taken-6, be-5)
root(ROOT-0, taken-6)
det(period-11, the-8)
number(hour-10, two-9)
amod(period-11, hour-10)
prep_within(taken-6, period-11)
prep(taken-6, before-12)
conj_or(before-12, within-14)
det(period-17, the-15)
amod(period-17, two-hour-16)
pobj(within-14, period-17)
dep(before-12, after-18)
amod(acid-20, nalidixic-19)
nn(administration-21, acid-20)
pobj(after-18, administration-21)

Elevated/JJ serum/NN levels/NNS of/IN cyclosporine/NN have/VBP been/VBN reported/VBN with/IN the/DT concomitant/JJ use/NN of/IN some/DT quinolones/NN and/CC cyclosporine/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Elevated) (NN serum) (NNS levels)) (PP (IN of) (NP (NN cyclosporine)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (DT some) (NP (NP (NN quinolones)) (CC and) (NP (NN cyclosporine))))))))))) (. .))))

amod(levels-3, Elevated-1)
nn(levels-3, serum-2)
nsubjpass(reported-8, levels-3)
prep_of(levels-3, cyclosporine-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
det(use-12, the-10)
amod(use-12, concomitant-11)
prep_with(reported-8, use-12)
det(quinolones-15, some-14)
prep_of(use-12, quinolones-15)
conj_and(quinolones-15, cyclosporine-17)

Therefore/RB ,/, cyclosporine/NN serum/NN levels/NNS should/MD be/VB monitored/VBN and/CC appropriate/JJ cyclosporine/NN dosage/NN adjustments/NNS made/VBD when/WRB these/DT drugs/NNS are/VBP used/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (S (ADVP (RB Therefore)) (, ,) (NP (NN cyclosporine) (NN serum) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN monitored))))) (CC and) (S (NP (JJ appropriate) (NN cyclosporine) (NN dosage) (NNS adjustments)) (VP (VBD made) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS drugs)) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly))))))))) (. .))))

advmod(monitored-8, Therefore-1)
nn(levels-5, cyclosporine-3)
nn(levels-5, serum-4)
nsubjpass(monitored-8, levels-5)
aux(monitored-8, should-6)
auxpass(monitored-8, be-7)
root(ROOT-0, monitored-8)
amod(adjustments-13, appropriate-10)
nn(adjustments-13, cyclosporine-11)
nn(adjustments-13, dosage-12)
nsubj(made-14, adjustments-13)
conj_and(monitored-8, made-14)
advmod(used-19, when-15)
det(drugs-17, these-16)
nsubjpass(used-19, drugs-17)
auxpass(used-19, are-18)
advcl(made-14, used-19)
advmod(used-19, concomitantly-20)

In/FW vitro/FW drug/NN metabolism/NN studies/NNS indicate/VBP that/IN Starlix/NN is/VBZ predominantly/RB metabolized/VBN by/IN the/DT cytochrome/NN P450/NN isozyme/NN CYP2C9/NN (/-LRB- 70/CD %/NN )/-RRB- and/CC to/TO a/DT lesser/JJR extent/NN CYP3A4/NN (/-LRB- 30%)./NN

(ROOT (S1 (S (NP (ADJP (FW In) (FW vitro)) (NN drug) (NN metabolism) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN Starlix)) (VP (VBZ is) (ADVP (RB predominantly)) (VP (VBN metabolized) (PP (PP (IN by) (NP (NP (DT the) (NN cytochrome) (NN P450) (NN isozyme) (NN CYP2C9)) (PRN (-LRB- -LRB-) (NP (CD 70) (NN %)) (-RRB- -RRB-)))) (CC and) (PP (TO to) (NP (DT a) (JJR lesser) (NN extent))) (NP (NN CYP3A4))) (PRN (-LRB- -LRB-) (NP (NN 30%-RRB-.)))))))))))

nn(vitro-2, In-1)
amod(studies-5, vitro-2)
nn(studies-5, drug-3)
nn(studies-5, metabolism-4)
nsubj(indicate-6, studies-5)
root(ROOT-0, indicate-6)
complm(metabolized-11, that-7)
nsubjpass(metabolized-11, Starlix-8)
auxpass(metabolized-11, is-9)
advmod(metabolized-11, predominantly-10)
ccomp(indicate-6, metabolized-11)
conj_and(metabolized-11, metabolized-11')
det(CYP2C9-17, the-13)
nn(CYP2C9-17, cytochrome-14)
nn(CYP2C9-17, P450-15)
nn(CYP2C9-17, isozyme-16)
agent(metabolized-11, CYP2C9-17)
num(%-20, 70-19)
appos(CYP2C9-17, %-20)
det(extent-26, a-24)
amod(extent-26, lesser-25)
prep_to(metabolized-11', extent-26)
dep(metabolized-11, CYP3A4-27)
dep(metabolized-11, 30%-RRB-.-29)

Starlix/NN is/VBZ a/DT potential/JJ inhibitor/NN of/IN the/DT CYP2C9/NN isoenzyme/NN in/FW vivo/FW as/IN indicated/VBN by/IN its/PRP$ ability/NN to/TO inhibit/VB the/DT in/FW vitro/FW metabolism/NN of/IN tolbutamide/NN ./.

(ROOT (S1 (S (S (NP (NN Starlix)) (VP (VBZ is) (NP (NP (DT a) (JJ potential) (NN inhibitor)) (PP (IN of) (NP (DT the) (NN CYP2C9) (NN isoenzyme)))) (ADVP (FW in) (FW vivo)) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN by) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (ADJP (FW in) (FW vitro)) (NN metabolism)) (PP (IN of) (NP (NN tolbutamide)))))))))))))) (. .))))

nsubj(inhibitor-5, Starlix-1)
cop(inhibitor-5, is-2)
det(inhibitor-5, a-3)
amod(inhibitor-5, potential-4)
root(ROOT-0, inhibitor-5)
det(isoenzyme-9, the-7)
nn(isoenzyme-9, CYP2C9-8)
prep_of(inhibitor-5, isoenzyme-9)
nn(vivo-11, in-10)
advmod(inhibitor-5, vivo-11)
mark(indicated-13, as-12)
advcl(inhibitor-5, indicated-13)
poss(ability-16, its-15)
prep_by(indicated-13, ability-16)
aux(inhibit-18, to-17)
infmod(ability-16, inhibit-18)
det(metabolism-22, the-19)
nn(vitro-21, in-20)
amod(metabolism-22, vitro-21)
dobj(inhibit-18, metabolism-22)
prep_of(metabolism-22, tolbutamide-24)

Inhibition/NN of/IN CYP3A4/JJ metabolic/JJ reactions/NNS was/VBD not/RB detected/VBN in/IN in/FW vitro/FW experiments/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (JJ CYP3A4) (JJ metabolic) (NNS reactions)))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (ADJP (FW in) (FW vitro)) (NNS experiments)))))) (. .))))

nsubjpass(detected-8, Inhibition-1)
amod(reactions-5, CYP3A4-3)
amod(reactions-5, metabolic-4)
prep_of(Inhibition-1, reactions-5)
auxpass(detected-8, was-6)
neg(detected-8, not-7)
root(ROOT-0, detected-8)
nn(vitro-11, in-10)
amod(experiments-12, vitro-11)
prep_in(detected-8, experiments-12)

Glyburide/NN :/: In/IN a/DT randomized/JJ ,/, multiple-dose/JJ crossover/NN study/NN ,/, patients/NNS with/IN Type/NN 2/CD diabetes/NNS were/VBD administered/VBN 120/CD mg/NN Starlix/NN three/CD times/NNS a/DT day/NN before/IN meals/NN for/IN 1/CD day/NN in/IN combination/NN with/IN glyburide/NN 10/CD mg/NN daily/RB ./.

(ROOT (S1 (S (NP (NP (NN Glyburide)) (: :) (S (PP (IN In) (NP (DT a) (ADJP (ADJP (JJ randomized)) (, ,) (ADJP (JJ multiple-dose))) (NN crossover) (NN study))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Type) (CD 2) (NNS diabetes)))) (VP (VBD were) (VP (VBN administered) (NP (NP (CD 120) (NN mg) (NN Starlix) (CD three) (NNS times)) (NP (NP (DT a) (NN day)) (PP (IN before) (NP (NN meals))) (PP (IN for) (NP (CD 1) (NN day))))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN glyburide) (CD 10) (NN mg)) (ADVP (RB daily))))))))) (. .)))))

root(ROOT-0, Glyburide-1)
det(study-9, a-4)
amod(study-9, randomized-5)
dep(randomized-5, multiple-dose-7)
nn(study-9, crossover-8)
prep_in(administered-17, study-9)
nsubjpass(administered-17, patients-11)
nn(diabetes-15, Type-13)
num(diabetes-15, 2-14)
prep_with(patients-11, diabetes-15)
auxpass(administered-17, were-16)
dep(Glyburide-1, administered-17)
num(times-22, 120-18)
nn(times-22, mg-19)
nn(times-22, Starlix-20)
num(times-22, three-21)
dobj(administered-17, times-22)
iobj(administered-17, times-22)
det(day-24, a-23)
dobj(administered-17, day-24)
dep(times-22, day-24)
prep_before(day-24, meals-26)
num(day-29, 1-28)
prep_for(day-24, day-29)
prep_in(administered-17, combination-31)
nn(mg-35, glyburide-33)
num(mg-35, 10-34)
prep_with(combination-31, mg-35)
advmod(mg-35, daily-36)

Metformin/NN :/: When/WRB Starlix/NN 120/CD mg/NN three/CD times/NNS daily/RB before/IN meals/NN was/VBD administered/VBN in/IN combination/NN with/IN metformin/NN 500/CD mg/NN three/CD times/NNS daily/JJ to/TO patients/NNS with/IN Type/NN 2/CD diabetes/NNS ,/, there/EX were/VBD no/DT clinically/RB relevant/JJ changes/NNS in/IN the/DT pharmacokinetics/NNS of/IN either/DT agent/NN ./.

(ROOT (S1 (S (NP (NP (NN Metformin)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN Starlix) (CD 120) (NN mg)) (ADVP (NP (CD three) (NNS times)) (RB daily) (PP (IN before) (NP (NN meals))))) (VP (VBD was) (VP (VBN administered) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN metformin) (CD 500) (NN mg) (CD three) (NNS times)) (ADJP (JJ daily) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Type) (CD 2) (NNS diabetes)))))))))))))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (ADJP (RB clinically) (JJ relevant)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN agent)))))))) (. .)))))

root(ROOT-0, Metformin-1)
advmod(administered-13, When-3)
nn(mg-6, Starlix-4)
num(mg-6, 120-5)
nsubjpass(administered-13, mg-6)
num(times-8, three-7)
npadvmod(daily-9, times-8)
advmod(mg-6, daily-9)
prep_before(daily-9, meals-11)
auxpass(administered-13, was-12)
advcl(were-31, administered-13)
prep_in(administered-13, combination-15)
nn(times-21, metformin-17)
num(times-21, 500-18)
nn(times-21, mg-19)
num(times-21, three-20)
prep_with(combination-15, times-21)
amod(times-21, daily-22)
prep_to(daily-22, patients-24)
nn(diabetes-28, Type-26)
num(diabetes-28, 2-27)
prep_with(patients-24, diabetes-28)
expl(were-31, there-30)
dep(Metformin-1, were-31)
det(changes-35, no-32)
advmod(relevant-34, clinically-33)
amod(changes-35, relevant-34)
nsubj(were-31, changes-35)
det(pharmacokinetics-38, the-37)
prep_in(changes-35, pharmacokinetics-38)
det(agent-41, either-40)
prep_of(pharmacokinetics-38, agent-41)

Digoxin/NN :/: When/WRB Starlix/NN 120/CD mg/NN before/IN meals/NN was/VBD administered/VBN in/IN combination/NN with/IN a/DT single/JJ 1-mg/JJ dose/NN of/IN digoxin/NN to/TO healthy/JJ volunteers/NNS ,/, there/EX were/VBD no/DT clinically/RB relevant/JJ changes/NNS in/IN the/DT pharmacokinetics/NNS of/IN either/DT agent/NN ./.

(ROOT (S1 (S (NP (NP (NN Digoxin)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN Starlix) (CD 120) (NN mg)) (PP (IN before) (NP (NN meals)))) (VP (VBD was) (VP (VBN administered) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (DT a) (JJ single) (JJ 1-mg) (NN dose)) (PP (IN of) (NP (NN digoxin))) (PP (TO to) (NP (JJ healthy) (NNS volunteers))))))))))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (ADJP (RB clinically) (JJ relevant)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN agent)))))))) (. .)))))

root(ROOT-0, Digoxin-1)
advmod(administered-10, When-3)
nn(mg-6, Starlix-4)
num(mg-6, 120-5)
nsubjpass(administered-10, mg-6)
prep_before(mg-6, meals-8)
auxpass(administered-10, was-9)
advcl(were-25, administered-10)
prep_in(administered-10, combination-12)
det(dose-17, a-14)
amod(dose-17, single-15)
amod(dose-17, 1-mg-16)
prep_with(combination-12, dose-17)
prep_of(dose-17, digoxin-19)
amod(volunteers-22, healthy-21)
prep_to(dose-17, volunteers-22)
expl(were-25, there-24)
dep(Digoxin-1, were-25)
det(changes-29, no-26)
advmod(relevant-28, clinically-27)
amod(changes-29, relevant-28)
nsubj(were-25, changes-29)
det(pharmacokinetics-32, the-31)
prep_in(changes-29, pharmacokinetics-32)
det(agent-35, either-34)
prep_of(pharmacokinetics-32, agent-35)

Warfarin/NN :/: When/WRB healthy/JJ subjects/NNS were/VBD administered/VBN Starlix/NN 120/CD mg/NN three/CD times/NNS daily/RB before/IN meals/NN for/IN four/CD days/NNS in/IN combination/NN with/IN a/DT single/JJ dose/NN of/IN warfarin/NN 30/CD mg/NN on/IN day/NN 2/CD ,/, there/EX were/VBD no/DT alterations/NNS in/IN the/DT pharmacokinetics/NNS of/IN either/DT agent/NN ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (JJ healthy) (NNS subjects)) (VP (VBD were) (VP (VBN administered) (ADVP (NP (NN Starlix) (CD 120) (NN mg) (CD three) (NNS times)) (RB daily)) (PP (IN before) (NP (NN meals))) (PP (IN for) (NP (NP (CD four) (NNS days)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NN warfarin) (CD 30) (NN mg)) (PP (IN on) (NP (NN day) (CD 2))))))))))))))) (, ,) (NP (EX there)) (VP (VBD were) (NP (DT no) (NNS alterations)) (PP (IN in) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN agent))))))) (. .)))))

root(ROOT-0, Warfarin-1)
advmod(administered-7, When-3)
amod(subjects-5, healthy-4)
nsubjpass(administered-7, subjects-5)
auxpass(administered-7, were-6)
advcl(were-34, administered-7)
nn(times-12, Starlix-8)
num(times-12, 120-9)
nn(times-12, mg-10)
num(times-12, three-11)
npadvmod(daily-13, times-12)
advmod(administered-7, daily-13)
prep_before(administered-7, meals-15)
num(days-18, four-17)
prep_for(administered-7, days-18)
prep_in(days-18, combination-20)
det(dose-24, a-22)
amod(dose-24, single-23)
prep_with(combination-20, dose-24)
nn(mg-28, warfarin-26)
num(mg-28, 30-27)
prep_of(dose-24, mg-28)
prep_on(mg-28, day-30)
num(day-30, 2-31)
expl(were-34, there-33)
dep(Warfarin-1, were-34)
det(alterations-36, no-35)
nsubj(were-34, alterations-36)
det(pharmacokinetics-39, the-38)
prep_in(were-34, pharmacokinetics-39)
det(agent-42, either-41)
prep_of(pharmacokinetics-39, agent-42)

Diclofenac/NN :/: Administration/NN of/IN morning/NN and/CC lunch/NN doses/NNS of/IN Starlix/NN 120/CD mg/NN in/IN combination/NN with/IN a/DT single/JJ 75-mg/NN dose/NN of/IN diclofenac/NN in/IN healthy/JJ volunteers/NNS resulted/VBD in/IN no/DT significant/JJ changes/NNS to/TO the/DT pharmacokinetics/NNS of/IN either/DT agent/NN ./.

(ROOT (S1 (S (NP (NP (NN Diclofenac)) (: :) (S (NP (NP (NN Administration)) (PP (IN of) (NP (NP (NP (NP (NN morning)) (CC and) (NP (NN lunch))) (NNS doses)) (PP (IN of) (NP (NP (NN Starlix) (CD 120) (NN mg)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (DT a) (JJ single) (NN 75-mg) (NN dose)) (PP (IN of) (NP (NN diclofenac))) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))))))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT no) (JJ significant) (NNS changes)) (PP (TO to) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN agent))))))))) (. .)))))

root(ROOT-0, Diclofenac-1)
nsubj(resulted-25, Administration-3)
nn(doses-8, morning-5)
conj_and(morning-5, lunch-7)
prep_of(Administration-3, doses-8)
nn(mg-12, Starlix-10)
num(mg-12, 120-11)
prep_of(doses-8, mg-12)
prep_in(mg-12, combination-14)
det(dose-19, a-16)
amod(dose-19, single-17)
nn(dose-19, 75-mg-18)
prep_with(combination-14, dose-19)
prep_of(dose-19, diclofenac-21)
amod(volunteers-24, healthy-23)
prep_in(dose-19, volunteers-24)
dep(Diclofenac-1, resulted-25)
det(changes-29, no-27)
amod(changes-29, significant-28)
prep_in(resulted-25, changes-29)
det(pharmacokinetics-32, the-31)
prep_to(changes-29, pharmacokinetics-32)
det(agent-35, either-34)
prep_of(pharmacokinetics-32, agent-35)

Nateglinide/NN is/VBZ highly/RB bound/VBN to/TO plasma/NN proteins/NNS (/-LRB- 98/CD %/NN )/-RRB- ,/, mainly/RB albumin/NN ./.

(ROOT (S1 (S (S (NP (NN Nateglinide)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (NP (NP (NN plasma) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (CD 98) (NN %)) (-RRB- -RRB-))) (, ,) (NP (ADVP (RB mainly)) (NP (NN albumin)))))))) (. .))))

nsubjpass(bound-4, Nateglinide-1)
auxpass(bound-4, is-2)
advmod(bound-4, highly-3)
root(ROOT-0, bound-4)
nn(proteins-7, plasma-6)
prep_to(bound-4, proteins-7)
num(%-10, 98-9)
appos(proteins-7, %-10)
advmod(albumin-14, mainly-13)
appos(proteins-7, albumin-14)

In/FW vitro/FW displacement/NN studies/NNS with/IN highly/RB protein/NN -bound/JJ drugs/NNS such/JJ as/IN furosemide/NN ,/, propranolol/NN ,/, captopril/NN ,/, nicardipine/NN ,/, pravastatin/NN ,/, glyburide/NN ,/, warfarin/NN ,/, phenytoin/NN ,/, acetylsalicylic/JJ acid/NN ,/, tolbutamide/NN ,/, and/CC metformin/NN showed/VBD no/DT influence/NN on/IN the/DT extent/NN of/IN nateglinide/JJ protein/NN binding/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NN displacement) (NNS studies)) (PP (IN with) (NP (NP (ADJP (RB highly) (NN protein) (JJ -bound)) (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NN furosemide)) (, ,) (NP (NN propranolol)) (, ,) (NP (NN captopril)) (, ,) (NP (NN nicardipine)) (, ,) (NP (NN pravastatin)) (, ,) (NP (NN glyburide)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN phenytoin)) (, ,) (NP (JJ acetylsalicylic) (NN acid)) (, ,) (NP (NN tolbutamide)) (, ,) (CC and) (NP (NN metformin))))))) (VP (VBD showed) (NP (NP (DT no) (NN influence)) (PP (IN on) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (JJ nateglinide) (NN protein) (NN binding)))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-4, vitro-2)
nn(studies-4, displacement-3)
nsubj(showed-35, studies-4)
advmod(-bound-8, highly-6)
dep(-bound-8, protein-7)
amod(drugs-9, -bound-8)
prep_with(studies-4, drugs-9)
prep_such_as(drugs-9, furosemide-12)
conj_and(furosemide-12, propranolol-14)
conj_and(furosemide-12, captopril-16)
conj_and(furosemide-12, nicardipine-18)
conj_and(furosemide-12, pravastatin-20)
conj_and(furosemide-12, glyburide-22)
conj_and(furosemide-12, warfarin-24)
conj_and(furosemide-12, phenytoin-26)
amod(acid-29, acetylsalicylic-28)
conj_and(furosemide-12, acid-29)
conj_and(furosemide-12, tolbutamide-31)
conj_and(furosemide-12, metformin-34)
root(ROOT-0, showed-35)
det(influence-37, no-36)
dobj(showed-35, influence-37)
det(extent-40, the-39)
prep_on(influence-37, extent-40)
amod(binding-44, nateglinide-42)
nn(binding-44, protein-43)
prep_of(extent-40, binding-44)

Similarly/RB ,/, nateglinide/NN had/VBD no/DT influence/NN on/IN the/DT serum/NN protein/NN binding/NN of/IN propranolol/NN ,/, glyburide/NN ,/, nicardipine/NN ,/, warfarin/NN ,/, phenytoin/NN ,/, acetylsalicylic/JJ acid/NN ,/, and/CC tolbutamide/NN in/FW vitro/FW ./.

(ROOT (S1 (S (ADVP (RB Similarly)) (, ,) (NP (NN nateglinide)) (VP (VBD had) (NP (DT no) (NN influence)) (PP (IN on) (NP (NP (DT the) (NN serum) (NN protein) (NN binding)) (PP (IN of) (NP (NP (NN propranolol)) (, ,) (NP (NN glyburide)) (, ,) (NP (NN nicardipine)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN phenytoin)) (, ,) (NP (JJ acetylsalicylic) (NN acid)) (, ,) (CC and) (NP (NN tolbutamide)))))) (ADVP (FW in) (FW vitro))) (. .))))

advmod(had-4, Similarly-1)
nsubj(had-4, nateglinide-3)
root(ROOT-0, had-4)
det(influence-6, no-5)
dobj(had-4, influence-6)
det(binding-11, the-8)
nn(binding-11, serum-9)
nn(binding-11, protein-10)
prep_on(had-4, binding-11)
prep_of(binding-11, propranolol-13)
conj_and(propranolol-13, glyburide-15)
conj_and(propranolol-13, nicardipine-17)
conj_and(propranolol-13, warfarin-19)
conj_and(propranolol-13, phenytoin-21)
amod(acid-24, acetylsalicylic-23)
conj_and(propranolol-13, acid-24)
conj_and(propranolol-13, tolbutamide-27)
nn(vitro-29, in-28)
advmod(had-4, vitro-29)

Certain/JJ drugs/NNS ,/, including/VBG nonsteroidal/JJ anti-inflammatory/JJ agents/NNS (/-LRB- NSAIDs/NNS )/-RRB- ,/, salicylates/NNS ,/, monoamine/NN oxidase/NN inhibitors/NNS ,/, and/CC non-selective/JJ beta-adrenergic-blocking/JJ agents/NNS may/MD potentiate/VB the/DT hypoglycemic/JJ action/NN of/IN Starlix/NN and/CC other/JJ oral/JJ antidiabetic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Certain) (NNS drugs)) (, ,) (PP (VBG including) (NP (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NNS NSAIDs)) (-RRB- -RRB-))) (, ,) (NP (NNS salicylates)) (, ,) (NP (NP (NN monoamine) (NN oxidase)) (NNS inhibitors)) (, ,) (CC and) (NP (JJ non-selective) (JJ beta-adrenergic-blocking) (NNS agents))))) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ hypoglycemic) (NN action)) (PP (IN of) (NP (NP (NN Starlix)) (CC and) (NP (JJ other) (JJ oral) (JJ antidiabetic) (NNS drugs)))))))) (. .))))

amod(drugs-2, Certain-1)
nsubj(potentiate-23, drugs-2)
amod(agents-7, nonsteroidal-5)
amod(agents-7, anti-inflammatory-6)
prep_including(drugs-2, agents-7)
appos(agents-7, NSAIDs-9)
conj_and(agents-7, salicylates-12)
nn(oxidase-15, monoamine-14)
nn(inhibitors-16, oxidase-15)
conj_and(agents-7, inhibitors-16)
amod(agents-21, non-selective-19)
amod(agents-21, beta-adrenergic-blocking-20)
conj_and(agents-7, agents-21)
aux(potentiate-23, may-22)
root(ROOT-0, potentiate-23)
det(action-26, the-24)
amod(action-26, hypoglycemic-25)
dobj(potentiate-23, action-26)
prep_of(action-26, Starlix-28)
amod(drugs-33, other-30)
amod(drugs-33, oral-31)
amod(drugs-33, antidiabetic-32)
conj_and(Starlix-28, drugs-33)

Certain/JJ drugs/NNS including/VBG thiazides/NNS ,/, corticosteroids/NNS ,/, thyroid/NN products/NNS ,/, and/CC sympathomimetics/NNS may/MD reduce/VB the/DT hypoglycemic/JJ action/NN of/IN Starlix/NN and/CC other/JJ oral/JJ antidiabetic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Certain) (NNS drugs)) (PP (VBG including) (NP (NP (NNS thiazides)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NN thyroid) (NNS products)) (, ,) (CC and) (NP (NNS sympathomimetics))))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (JJ hypoglycemic) (NN action)) (PP (IN of) (NP (NP (NN Starlix)) (CC and) (NP (JJ other) (JJ oral) (JJ antidiabetic) (NNS drugs)))))))) (. .))))

amod(drugs-2, Certain-1)
nsubj(reduce-14, drugs-2)
prep_including(drugs-2, thiazides-4)
conj_and(thiazides-4, corticosteroids-6)
nn(products-9, thyroid-8)
conj_and(thiazides-4, products-9)
conj_and(thiazides-4, sympathomimetics-12)
aux(reduce-14, may-13)
root(ROOT-0, reduce-14)
det(action-17, the-15)
amod(action-17, hypoglycemic-16)
dobj(reduce-14, action-17)
prep_of(action-17, Starlix-19)
amod(drugs-24, other-21)
amod(drugs-24, oral-22)
amod(drugs-24, antidiabetic-23)
conj_and(Starlix-19, drugs-24)

When/WRB these/DT drugs/NNS are/VBP administered/VBN to/TO or/CC withdrawn/VBN from/IN patients/NNS receiving/VBG Starlix/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN changes/NNS in/IN glycemic/JJ control/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (DT these) (NNS drugs)) (VP (VBP are) (VP (VP (VBN administered) (PP (TO to))) (CC or) (VP (VBN withdrawn) (PP (IN from) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN Starlix)))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ glycemic) (NN control))))))))) (. .))))

advmod(administered-5, When-1)
det(drugs-3, these-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, are-4)
advcl(observed-18, administered-5)
prep(administered-5, to-6)
conj_or(administered-5, withdrawn-8)
prep_from(withdrawn-8, patients-10)
partmod(patients-10, receiving-11)
dobj(receiving-11, Starlix-12)
det(patient-15, the-14)
nsubjpass(observed-18, patient-15)
aux(observed-18, should-16)
auxpass(observed-18, be-17)
root(ROOT-0, observed-18)
advmod(observed-18, closely-19)
prep_for(observed-18, changes-21)
amod(control-24, glycemic-23)
prep_in(changes-21, control-24)

In/IN clinical/JJ studies/NNS ,/, Tilade/NN has/VBZ been/VBN co-administered/VBN with/IN other/JJ anti-asthma/NN medications/NNS ,/, including/VBG inhaled/JJ and/CC oral/JJ bronchodilators/NNS ,/, and/CC inhaled/JJ corticosteroids/NNS ,/, with/IN no/DT evidence/NN of/IN increased/VBN frequency/NN of/IN adverse/JJ events/NNS or/CC laboratory/NN abnormalities/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS studies))) (, ,) (NP (NN Tilade)) (VP (VBZ has) (VP (VBN been) (VP (VBN co-administered) (PP (IN with) (NP (NP (NP (JJ other) (NN anti-asthma) (NNS medications)) (, ,) (PP (VBG including) (NP (JJ inhaled) (CC and) (JJ oral) (NNS bronchodilators))) (, ,)) (CC and) (NP (JJ inhaled) (NNS corticosteroids)))) (, ,) (PP (IN with) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (VBN increased) (NN frequency)) (PP (IN of) (NP (NP (JJ adverse) (NNS events)) (CC or) (NP (NN laboratory) (NNS abnormalities)))))))))))) (. .))))

amod(studies-3, clinical-2)
prep_in(co-administered-8, studies-3)
nsubjpass(co-administered-8, Tilade-5)
aux(co-administered-8, has-6)
auxpass(co-administered-8, been-7)
root(ROOT-0, co-administered-8)
amod(medications-12, other-10)
nn(medications-12, anti-asthma-11)
prep_with(co-administered-8, medications-12)
amod(bronchodilators-18, inhaled-15)
conj_and(inhaled-15, oral-17)
prep_including(medications-12, bronchodilators-18)
amod(corticosteroids-22, inhaled-21)
conj_and(medications-12, corticosteroids-22)
det(evidence-26, no-25)
prep_with(co-administered-8, evidence-26)
amod(frequency-29, increased-28)
prep_of(evidence-26, frequency-29)
amod(events-32, adverse-31)
prep_of(frequency-29, events-32)
nn(abnormalities-35, laboratory-34)
conj_or(events-32, abnormalities-35)

Caution/NN should/MD be/VB taken/VBN in/IN concurrent/JJ or/CC serial/JJ use/NN of/IN other/JJ neurotoxic/JJ and//NN or/CC nephrotoxic/JJ drugs/NNS because/IN of/IN possible/JJ enhancement/NN of/IN the/DT nephrotoxicity/NN and/or/CC ototoxicity/NN of/IN neomycin/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN in) (NP (NP (ADJP (ADJP (JJ concurrent)) (CC or) (ADJP (JJ serial))) (NN use)) (PP (IN of) (NP (NP (JJ other) (JJ neurotoxic) (NN and/) (CC or) (JJ nephrotoxic) (NNS drugs)) (PP (IN because) (PP (IN of) (NP (NP (JJ possible) (NN enhancement)) (PP (IN of) (NP (NP (DT the) (NP (NN nephrotoxicity)) (CC and/or) (NP (NN ototoxicity))) (PP (IN of) (NP (NN neomycin)))))))))))))))) (. .))))

nsubjpass(taken-4, Caution-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
amod(use-9, concurrent-6)
conj_or(concurrent-6, serial-8)
prep_in(taken-4, use-9)
amod(and/-13, other-11)
amod(and/-13, neurotoxic-12)
prep_of(use-9, and/-13)
amod(drugs-16, nephrotoxic-15)
conj_or(and/-13, drugs-16)
prepc_because_of(and/-13, of-18)
amod(enhancement-20, possible-19)
pobj(and/-13, enhancement-20)
dep(nephrotoxicity-23, the-22)
prep_of(enhancement-20, nephrotoxicity-23)
conj_and/or(nephrotoxicity-23, ototoxicity-25)
prep_of(nephrotoxicity-23, neomycin-27)

Caution/NN should/MD also/RB be/VB taken/VBN in/IN concurrent/JJ or/CC serial/JJ use/NN of/IN other/JJ aminoglycosides/NNS and/CC polymyxins/NNS because/IN they/PRP may/MD enhance/VB neomycin/NN @/NN s/NN nephrotoxicity/NN and/or/CC ototoxicity/NN and/CC potentiate/VB neomycin/NN sulfate/NN @/NN s/NN neuromuscular/JJ blocking/VBG effects/NNS ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (ADVP (RB also)) (VP (VB be) (VP (VBN taken) (PP (IN in) (NP (NP (ADJP (ADJP (JJ concurrent)) (CC or) (ADJP (JJ serial))) (NN use)) (PP (IN of) (NP (NP (JJ other) (NNS aminoglycosides)) (CC and) (NP (NNS polymyxins)))))) (SBAR (IN because) (S (NP (PRP they)) (VP (MD may) (VP (VP (VB enhance) (NP (NP (NN neomycin) (NN @) (NN s) (NN nephrotoxicity)) (CC and/or) (NP (NN ototoxicity)))) (CC and) (VP (VB potentiate) (NP (ADJP (NN neomycin) (NN sulfate) (NN @) (NN s) (JJ neuromuscular)) (VBG blocking) (NNS effects))))))))))) (. .))))

nsubjpass(taken-5, Caution-1)
aux(taken-5, should-2)
advmod(taken-5, also-3)
auxpass(taken-5, be-4)
root(ROOT-0, taken-5)
amod(use-10, concurrent-7)
conj_or(concurrent-7, serial-9)
prep_in(taken-5, use-10)
amod(aminoglycosides-13, other-12)
prep_of(use-10, aminoglycosides-13)
conj_and(aminoglycosides-13, polymyxins-15)
mark(enhance-19, because-16)
nsubj(enhance-19, they-17)
aux(enhance-19, may-18)
advcl(taken-5, enhance-19)
nn(nephrotoxicity-23, neomycin-20)
nn(nephrotoxicity-23, @-21)
nn(nephrotoxicity-23, s-22)
dobj(enhance-19, nephrotoxicity-23)
conj_and/or(nephrotoxicity-23, ototoxicity-25)
conj_and(enhance-19, potentiate-27)
dep(neuromuscular-32, neomycin-28)
dep(neuromuscular-32, sulfate-29)
dep(neuromuscular-32, @-30)
dep(neuromuscular-32, s-31)
amod(effects-34, neuromuscular-32)
amod(effects-34, blocking-33)
dobj(potentiate-27, effects-34)

Oral/JJ neomycin/NN inhibits/VBZ the/DT gastrointestinal/JJ absorption/NN of/IN penicillin/NN V/NN ,/, oral/JJ vitamin/NN B-12/NN ,/, methotrexate/NN and/CC 5-fluorouracil/NN ./.

(ROOT (S1 (S (S (NP (JJ Oral) (NN neomycin)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (JJ gastrointestinal) (NN absorption)) (PP (IN of) (NP (NN penicillin) (NN V)))) (, ,) (NP (JJ oral) (NN vitamin) (NN B-12)) (, ,) (NP (NP (NN methotrexate)) (CC and) (NP (NN 5-fluorouracil)))))) (. .))))

amod(neomycin-2, Oral-1)
nsubj(inhibits-3, neomycin-2)
root(ROOT-0, inhibits-3)
det(absorption-6, the-4)
amod(absorption-6, gastrointestinal-5)
dobj(inhibits-3, absorption-6)
nn(V-9, penicillin-8)
prep_of(absorption-6, V-9)
amod(B-12-13, oral-11)
nn(B-12-13, vitamin-12)
appos(absorption-6, B-12-13)
appos(absorption-6, methotrexate-15)
conj_and(methotrexate-15, 5-fluorouracil-17)

The/DT gastrointestinal/JJ absorption/NN of/IN digoxin/NN also/RB appears/VBZ to/TO be/VB inhibited/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ gastrointestinal) (NN absorption)) (PP (IN of) (NP (NN digoxin)))) (ADVP (RB also)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN inhibited))))))) (. .))))

det(absorption-3, The-1)
amod(absorption-3, gastrointestinal-2)
nsubj(appears-7, absorption-3)
xsubj(inhibited-10, absorption-3)
prep_of(absorption-3, digoxin-5)
advmod(appears-7, also-6)
root(ROOT-0, appears-7)
aux(inhibited-10, to-8)
auxpass(inhibited-10, be-9)
xcomp(appears-7, inhibited-10)

Oral/JJ neomycin/NN sulfate/NN may/MD enhance/VB the/DT effect/NN of/IN coumarin/NN in/IN anticoagulants/NNS by/IN decreasing/VBG vitamin/NN K/NN availability/NN ./.

(ROOT (S1 (S (S (NP (JJ Oral) (NN neomycin) (NN sulfate)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN coumarin))) (PP (IN in) (NP (NNS anticoagulants)))) (PP (IN by) (S (VP (VBG decreasing) (NP (NN vitamin) (NN K) (NN availability)))))))) (. .))))

amod(sulfate-3, Oral-1)
nn(sulfate-3, neomycin-2)
nsubj(enhance-5, sulfate-3)
aux(enhance-5, may-4)
root(ROOT-0, enhance-5)
det(effect-7, the-6)
dobj(enhance-5, effect-7)
prep_of(effect-7, coumarin-9)
prep_in(effect-7, anticoagulants-11)
prepc_by(enhance-5, decreasing-13)
nn(availability-16, vitamin-14)
nn(availability-16, K-15)
dobj(decreasing-13, availability-16)

Beta-adrenergic/JJ Blocking/NN Agents/NNS :/: Experience/VBP in/IN over/IN 1400/CD patients/NNS in/IN a/DT non-comparative/JJ clinical/JJ trial/NN has/VBZ shown/VBN that/IN concomitant/JJ administration/NN of/IN nifedipine/NN and/CC beta-blocking/JJ agent/NN s/NNS is/VBZ usually/RB well/RB tolerated/VBN ,/, but/CC there/EX have/VBP been/VBN occasional/JJ literature/NN reports/NNS suggesting/VBG that/IN the/DT combination/NN may/MD increase/VBP the/DT likelihood/NN of/IN congestive/JJ heart/NN failure/NN ,/, severe/JJ hypotension/NN or/CC exacerbation/NN of/IN angina/NN ./.

(ROOT (S1 (S (NP (NP (JJ Beta-adrenergic) (NN Blocking) (NNS Agents)) (: :) (S (VP (VBP Experience) (PP (IN in) (NP (QP (IN over) (CD 1400)) (NNS patients))) (SBAR (IN in) (S (NP (DT a) (JJ non-comparative) (JJ clinical) (NN trial)) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN nifedipine)) (CC and) (NP (JJ beta-blocking) (NN agent) (NNS s))))) (VP (VBZ is) (ADVP (RB usually)) (VP (ADVP (RB well)) (VBN tolerated)))) (, ,) (CC but) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ occasional) (NN literature) (NNS reports)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT the) (NN combination)) (VP (MD may) (VP (VBP increase) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (NP (JJ congestive) (NN heart) (NN failure)) (, ,) (NP (JJ severe) (NN hypotension)) (CC or) (NP (NP (NN exacerbation)) (PP (IN of) (NP (NN angina)))))))))))))))))))))))) (. .)))))

amod(Agents-3, Beta-adrenergic-1)
nn(Agents-3, Blocking-2)
root(ROOT-0, Agents-3)
dep(Agents-3, Experience-5)
quantmod(1400-8, over-7)
num(patients-9, 1400-8)
prep_in(Experience-5, patients-9)
mark(shown-16, in-10)
det(trial-14, a-11)
amod(trial-14, non-comparative-12)
amod(trial-14, clinical-13)
nsubj(shown-16, trial-14)
aux(shown-16, has-15)
advcl(Experience-5, shown-16)
complm(tolerated-29, that-17)
amod(administration-19, concomitant-18)
nsubjpass(tolerated-29, administration-19)
prep_of(administration-19, nifedipine-21)
amod(s-25, beta-blocking-23)
nn(s-25, agent-24)
conj_and(nifedipine-21, s-25)
auxpass(tolerated-29, is-26)
advmod(tolerated-29, usually-27)
advmod(tolerated-29, well-28)
ccomp(shown-16, tolerated-29)
expl(reports-37, there-32)
aux(reports-37, have-33)
cop(reports-37, been-34)
amod(reports-37, occasional-35)
nn(reports-37, literature-36)
conj_but(tolerated-29, reports-37)
partmod(reports-37, suggesting-38)
complm(increase-43, that-39)
det(combination-41, the-40)
nsubj(increase-43, combination-41)
aux(increase-43, may-42)
ccomp(suggesting-38, increase-43)
det(likelihood-45, the-44)
dobj(increase-43, likelihood-45)
amod(failure-49, congestive-47)
nn(failure-49, heart-48)
prep_of(likelihood-45, failure-49)
amod(hypotension-52, severe-51)
conj_or(failure-49, hypotension-52)
conj_or(failure-49, exacerbation-54)
prep_of(exacerbation-54, angina-56)

Long/JJ Acting/NN Nitrates/NNS :/: Nifedipine/NN may/MD be/VB safely/RB co-administered/VBN with/IN nitrates/NNS ,/, but/CC there/EX have/VBP been/VBN no/DT controlled/JJ studies/NNS to/TO evaluate/VB the/DT antianginal/JJ effectiveness/NN of/IN this/DT combination/NN ./.

(ROOT (S1 (S (NP (NP (JJ Long) (NN Acting) (NNS Nitrates)) (: :) (S (S (NP (NN Nifedipine)) (VP (MD may) (VP (VB be) (ADVP (RB safely)) (VP (VBN co-administered) (PP (IN with) (NP (NNS nitrates))))))) (, ,) (CC but) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (DT no) (JJ controlled) (NNS studies)) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (JJ antianginal) (NN effectiveness)) (PP (IN of) (NP (DT this) (NN combination))))))))))) (. .)))))

amod(Nitrates-3, Long-1)
nn(Nitrates-3, Acting-2)
root(ROOT-0, Nitrates-3)
nsubjpass(co-administered-9, Nifedipine-5)
aux(co-administered-9, may-6)
auxpass(co-administered-9, be-7)
advmod(co-administered-9, safely-8)
dep(Nitrates-3, co-administered-9)
prep_with(co-administered-9, nitrates-11)
expl(studies-19, there-14)
aux(studies-19, have-15)
cop(studies-19, been-16)
det(studies-19, no-17)
amod(studies-19, controlled-18)
conj_but(co-administered-9, studies-19)
aux(evaluate-21, to-20)
xcomp(studies-19, evaluate-21)
det(effectiveness-24, the-22)
amod(effectiveness-24, antianginal-23)
dobj(evaluate-21, effectiveness-24)
det(combination-27, this-26)
prep_of(effectiveness-24, combination-27)

Digitalis/NN :/: Immediate/JJ Release/NN Capsules/NNS :/: Since/IN there/EX have/VBP been/VBN isolated/VBN reports/NNS of/IN patients/NNS with/IN elevated/JJ digoxin/NN levels/NNS ,/, and/CC there/EX is/VBZ a/DT possible/JJ interaction/NN between/IN digoxin/NN and/CC nifedipine/NN ,/, it/PRP is/VBZ recommended/VBN that/IN digoxin/NN levels/NNS be/VB monitored/VBN when/WRB initiating/VBG ,/, adjusting/VBG ,/, and/CC discontinuing/VBG nifedipine/NN to/TO avoid/VB possible/JJ over-/NN or/CC under-digitalization/NN ./.

(ROOT (S1 (S (NP (NP (NN Digitalis) (: :) (NP (JJ Immediate) (NN Release) (NNS Capsules))) (: :) (S (SBAR (IN Since) (S (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (VBN isolated) (NNS reports)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ elevated) (NN digoxin) (NNS levels))))))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (JJ possible) (NN interaction)) (PP (IN between) (NP (NP (NN digoxin)) (CC and) (NP (NN nifedipine))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN digoxin) (NNS levels)) (VP (VB be) (VP (VBN monitored) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG initiating)) (, ,) (VP (VBG adjusting)) (, ,) (CC and) (VP (VBG discontinuing) (NP (NN nifedipine)) (S (VP (TO to) (VP (VB avoid) (NP (NP (JJ possible) (NN over-)) (CC or) (NP (NN under-digitalization))))))))))))))))) (. .)))))

root(ROOT-0, Digitalis-1)
amod(Capsules-5, Immediate-3)
nn(Capsules-5, Release-4)
dep(Digitalis-1, Capsules-5)
mark(reports-12, Since-7)
expl(reports-12, there-8)
aux(reports-12, have-9)
cop(reports-12, been-10)
amod(reports-12, isolated-11)
advcl(recommended-33, reports-12)
prep_of(reports-12, patients-14)
amod(levels-18, elevated-16)
nn(levels-18, digoxin-17)
prep_with(patients-14, levels-18)
expl(is-22, there-21)
conj_and(reports-12, is-22)
det(interaction-25, a-23)
amod(interaction-25, possible-24)
nsubj(is-22, interaction-25)
prep_between(interaction-25, digoxin-27)
conj_and(digoxin-27, nifedipine-29)
nsubjpass(recommended-33, it-31)
auxpass(recommended-33, is-32)
dep(Digitalis-1, recommended-33)
complm(monitored-38, that-34)
nn(levels-36, digoxin-35)
nsubjpass(monitored-38, levels-36)
auxpass(monitored-38, be-37)
ccomp(recommended-33, monitored-38)
advmod(initiating-40, when-39)
advcl(monitored-38, initiating-40)
conj_and(initiating-40, adjusting-42)
conj_and(initiating-40, discontinuing-45)
dobj(discontinuing-45, nifedipine-46)
aux(avoid-48, to-47)
xcomp(discontinuing-45, avoid-48)
amod(over--50, possible-49)
dobj(avoid-48, over--50)
conj_or(over--50, under-digitalization-52)

Extended/JJ Release/NN Tablets/NNS :/: Administration/NN of/IN nifedipine/NN with/IN digoxin/NN increased/VBD digoxin/NN levels/NNS in/IN 9/CD of/IN 12/CD normal/JJ volunteers/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Extended) (NN Release) (NNS Tablets)) (: :) (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN nifedipine))) (PP (IN with) (NP (NN digoxin)))) (VP (VBD increased) (NP (NN digoxin) (NNS levels)) (PP (IN in) (NP (NP (CD 9)) (PP (IN of) (NP (CD 12) (JJ normal) (NNS volunteers))))))) (. .)))))

amod(Tablets-3, Extended-1)
nn(Tablets-3, Release-2)
root(ROOT-0, Tablets-3)
nsubj(increased-10, Administration-5)
prep_of(Administration-5, nifedipine-7)
prep_with(Administration-5, digoxin-9)
dep(Tablets-3, increased-10)
nn(levels-12, digoxin-11)
dobj(increased-10, levels-12)
prep_in(increased-10, 9-14)
num(volunteers-18, 12-16)
amod(volunteers-18, normal-17)
prep_of(9-14, volunteers-18)

Since/IN there/EX have/VBP been/VBN isolated/VBN reports/NNS of/IN patients/NNS with/IN elevated/JJ digoxin/NN levels/NNS ,/, it/PRP is/VBZ recommended/VBN that/IN digoxin/NN levels/NNS be/VB monitored/VBN when/WRB initiating/VBG ,/, adjusting/VBG ,/, and/CC discontinuing/VBG nifedipine/NN to/TO avoid/VB possible/JJ over-/NN or/CC under-digitalization/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (VBN isolated) (NNS reports)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ elevated) (NN digoxin) (NNS levels)))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN digoxin) (NNS levels)) (VP (VB be) (VP (VBN monitored) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG initiating)) (, ,) (VP (VBG adjusting)) (, ,) (CC and) (VP (VBG discontinuing) (NP (NN nifedipine)) (S (VP (TO to) (VP (VB avoid) (NP (NP (JJ possible) (NN over-)) (CC or) (NP (NN under-digitalization))))))))))))))))) (. .))))

mark(reports-6, Since-1)
expl(reports-6, there-2)
aux(reports-6, have-3)
cop(reports-6, been-4)
amod(reports-6, isolated-5)
advcl(recommended-16, reports-6)
prep_of(reports-6, patients-8)
amod(levels-12, elevated-10)
nn(levels-12, digoxin-11)
prep_with(patients-8, levels-12)
nsubjpass(recommended-16, it-14)
auxpass(recommended-16, is-15)
root(ROOT-0, recommended-16)
complm(monitored-21, that-17)
nn(levels-19, digoxin-18)
nsubjpass(monitored-21, levels-19)
auxpass(monitored-21, be-20)
ccomp(recommended-16, monitored-21)
advmod(initiating-23, when-22)
advcl(monitored-21, initiating-23)
conj_and(initiating-23, adjusting-25)
conj_and(initiating-23, discontinuing-28)
dobj(discontinuing-28, nifedipine-29)
aux(avoid-31, to-30)
xcomp(discontinuing-28, avoid-31)
amod(over--33, possible-32)
dobj(avoid-31, over--33)
conj_or(over--33, under-digitalization-35)

Quinidine/NN :/: Immediate/JJ Release/NN Capsules/NNS :/: There/EX have/VBP been/VBN rare/JJ reports/NNS of/IN an/DT interaction/NN between/IN quinidine/NN and/CC nifedipine/NN (/-LRB- with/IN a/DT decreased/VBN plasma/NN level/NN of/IN quinidine/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NN Quinidine) (: :) (NP (JJ Immediate) (NN Release) (NNS Capsules))) (: :) (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ rare) (NNS reports)) (PP (IN of) (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (NN quinidine)) (CC and) (NP (NN nifedipine)))) (-LRB- -LRB-) (PP (IN with) (NP (NP (DT a) (VBN decreased) (NN plasma) (NN level)) (PP (IN of) (NP (NN quinidine))))) (-RRB- -RRB-))))))) (. .)))))

root(ROOT-0, Quinidine-1)
amod(Capsules-5, Immediate-3)
nn(Capsules-5, Release-4)
dep(Quinidine-1, Capsules-5)
expl(reports-11, There-7)
aux(reports-11, have-8)
cop(reports-11, been-9)
amod(reports-11, rare-10)
dep(Quinidine-1, reports-11)
det(interaction-14, an-13)
prep_of(reports-11, interaction-14)
prep_between(interaction-14, quinidine-16)
conj_and(quinidine-16, nifedipine-18)
det(level-24, a-21)
amod(level-24, decreased-22)
nn(level-24, plasma-23)
prep_with(interaction-14, level-24)
prep_of(level-24, quinidine-26)

Coumarin/NN Anticoagulant/NN s/NNS :/: There/EX have/VBP been/VBN rare/JJ reports/NNS of/IN increased/VBN prothrombin/NN time/NN in/IN patients/NNS taking/VBG coumarin/NN anticoagulant/NN s/NNS to/TO whom/WP nifedipine/NN was/VBD administered/VBN ./.

(ROOT (S1 (S (NP (NP (NN Coumarin) (NN Anticoagulant) (NNS s)) (: :) (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ rare) (NNS reports)) (PP (IN of) (NP (VBN increased) (NN prothrombin) (NN time))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NN coumarin) (NN anticoagulant) (NNS s)) (SBAR (WHPP (TO to) (WHNP (WP whom))) (S (NP (NN nifedipine)) (VP (VBD was) (VP (VBN administered))))))))))))) (. .)))))

nn(s-3, Coumarin-1)
nn(s-3, Anticoagulant-2)
root(ROOT-0, s-3)
expl(reports-9, There-5)
aux(reports-9, have-6)
cop(reports-9, been-7)
amod(reports-9, rare-8)
dep(s-3, reports-9)
amod(time-13, increased-11)
nn(time-13, prothrombin-12)
prep_of(reports-9, time-13)
prep_in(reports-9, patients-15)
partmod(patients-15, taking-16)
nn(s-19, coumarin-17)
nn(s-19, anticoagulant-18)
dobj(taking-16, s-19)
rel(administered-24, whom-21)
nsubjpass(administered-24, nifedipine-22)
auxpass(administered-24, was-23)
rcmod(s-19, administered-24)

However/RB ,/, the/DT relationship/NN to/TO nifedipine/NN therapy/NN is/VBZ uncertain/JJ ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN relationship)) (PP (TO to) (NP (NN nifedipine) (NN therapy)))) (VP (VBZ is) (ADJP (JJ uncertain)))) (. .))))

advmod(uncertain-9, However-1)
det(relationship-4, the-3)
nsubj(uncertain-9, relationship-4)
nn(therapy-7, nifedipine-6)
prep_to(relationship-4, therapy-7)
cop(uncertain-9, is-8)
root(ROOT-0, uncertain-9)

Cimetidine/NN :/: A/DT study/NN in/IN 6/CD healthy/JJ volunteers/NNS has/VBZ shown/VBN a/DT significant/JJ increase/NN in/IN peak/NN nifedipine/NN plasma/NN levels/NNS (/-LRB- 80/CD %/NN )/-RRB- and/CC area-under-the-curve/JJ (/-LRB- 74/CD %/NN )/-RRB- after/IN a/DT 1/CD week/NN course/NN of/IN cimetidine/NN at/IN 1000/CD mg/NN per/IN day/NN and/CC nifedipine/NN at/IN 40/CD mg/NN per/IN day/NN ./.

(ROOT (S1 (S (NP (NP (NN Cimetidine)) (: :) (S (NP (NP (DT A) (NN study)) (PP (IN in) (NP (CD 6) (JJ healthy) (NNS volunteers)))) (VP (VBZ has) (VP (VBN shown) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (NP (NN peak) (NN nifedipine) (NN plasma) (NNS levels)) (PRN (-LRB- -LRB-) (NP (CD 80) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ area-under-the-curve)) (PRN (-LRB- -LRB-) (NP (CD 74) (NN %)) (-RRB- -RRB-)))))) (PP (IN after) (NP (NP (DT a) (CD 1) (NN week) (NN course)) (PP (IN of) (NP (NP (NN cimetidine)) (PP (IN at) (NP (NP (CD 1000) (NN mg)) (PP (IN per) (NP (NP (NN day)) (CC and) (NP (NN nifedipine)))) (PP (IN at) (NP (NP (CD 40) (NN mg)) (PP (IN per) (NP (NN day)))))))))))))) (. .)))))

root(ROOT-0, Cimetidine-1)
det(study-4, A-3)
nsubj(shown-10, study-4)
num(volunteers-8, 6-6)
amod(volunteers-8, healthy-7)
prep_in(study-4, volunteers-8)
aux(shown-10, has-9)
dep(Cimetidine-1, shown-10)
det(increase-13, a-11)
amod(increase-13, significant-12)
dobj(shown-10, increase-13)
nn(levels-18, peak-15)
nn(levels-18, nifedipine-16)
nn(levels-18, plasma-17)
prep_in(increase-13, levels-18)
num(%-21, 80-20)
appos(levels-18, %-21)
conj_and(levels-18, area-under-the-curve-24)
num(%-27, 74-26)
appos(area-under-the-curve-24, %-27)
det(course-33, a-30)
num(course-33, 1-31)
nn(course-33, week-32)
prep_after(shown-10, course-33)
prep_of(course-33, cimetidine-35)
num(mg-38, 1000-37)
prep_at(cimetidine-35, mg-38)
prep_per(mg-38, day-40)
conj_and(day-40, nifedipine-42)
num(mg-45, 40-44)
prep_at(mg-38, mg-45)
prep_per(mg-45, day-47)

Ranitidine/NN produced/VBD smaller/JJR ,/, non-significant/JJ increases/NNS ./.

(ROOT (S1 (S (S (NP (NN Ranitidine)) (VP (VBD produced) (NP (ADJP (ADJP (JJR smaller)) (, ,) (ADJP (JJ non-significant))) (NNS increases)))) (. .))))

nsubj(produced-2, Ranitidine-1)
root(ROOT-0, produced-2)
amod(increases-6, smaller-3)
dep(smaller-3, non-significant-5)
dobj(produced-2, increases-6)

The/DT effect/NN may/MD be/VB mediated/VBN by/IN the/DT known/JJ inhibition/NN of/IN cimetidine/NN on/IN hepatic/JJ cytochrome/NN P-450/NN ,/, the/DT enzyme/NN system/NN probably/RB responsible/JJ for/IN the/DT first-pass/NN metabolism/NN of/IN nifedipine/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN effect)) (VP (MD may) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (JJ known) (NN inhibition)) (PP (IN of) (NP (NN cimetidine))) (PP (IN on) (NP (NP (JJ hepatic) (NN cytochrome) (NN P-450)) (, ,) (NP (NP (DT the) (NN enzyme) (NN system)) (ADJP (ADVP (RB probably)) (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN first-pass) (NN metabolism)) (PP (IN of) (NP (NN nifedipine))))))))))))))) (. .))))

det(effect-2, The-1)
nsubjpass(mediated-5, effect-2)
aux(mediated-5, may-3)
auxpass(mediated-5, be-4)
root(ROOT-0, mediated-5)
det(inhibition-9, the-7)
amod(inhibition-9, known-8)
agent(mediated-5, inhibition-9)
prep_of(inhibition-9, cimetidine-11)
amod(P-450-15, hepatic-13)
nn(P-450-15, cytochrome-14)
prep_on(inhibition-9, P-450-15)
det(system-19, the-17)
nn(system-19, enzyme-18)
appos(P-450-15, system-19)
advmod(responsible-21, probably-20)
amod(system-19, responsible-21)
det(metabolism-25, the-23)
nn(metabolism-25, first-pass-24)
prep_for(responsible-21, metabolism-25)
prep_of(metabolism-25, nifedipine-27)

If/IN nifedipine/NN therapy/NN is/VBZ initiated/VBN in/IN a/DT patient/NN currently/RB receiving/VBG cimetidine/NN ,/, cautious/JJ titration/NN is/VBZ advised/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN nifedipine) (NN therapy)) (VP (VBZ is) (VP (VBN initiated) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (ADVP (RB currently)) (VBG receiving) (NP (NN cimetidine))))))))) (, ,) (NP (JJ cautious) (NN titration)) (VP (VBZ is) (VP (VBN advised)))) (. .))))

mark(initiated-5, If-1)
nn(therapy-3, nifedipine-2)
nsubjpass(initiated-5, therapy-3)
auxpass(initiated-5, is-4)
advcl(advised-16, initiated-5)
det(patient-8, a-7)
prep_in(initiated-5, patient-8)
advmod(receiving-10, currently-9)
partmod(patient-8, receiving-10)
dobj(receiving-10, cimetidine-11)
amod(titration-14, cautious-13)
nsubjpass(advised-16, titration-14)
auxpass(advised-16, is-15)
root(ROOT-0, advised-16)

A/DT 30/CD to/TO 45/CD %/NN increase/NN in/IN AUC/NN and/CC Cmax/NN of/IN nisoldipine/NN was/VBD observed/VBN with/IN concomitant/JJ administration/NN of/IN cimetidine/NN 400/CD mg/NN twice/RB daily/RB ./.

(ROOT (S1 (S (S (NP (NP (DT A) (CD 30) (TO to) (CD 45) (NN %) (NN increase)) (PP (IN in) (NP (NP (NP (NN AUC)) (CC and) (NP (NN Cmax))) (PP (IN of) (NP (NN nisoldipine)))))) (VP (VBD was) (VP (VBN observed) (PP (IN with) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN cimetidine) (CD 400) (NN mg)) (ADVP (RB twice) (RB daily))))))))) (. .))))

det(increase-6, A-1)
num(increase-6, 30-2)
dep(increase-6, to-3)
num(increase-6, 45-4)
nn(increase-6, %-5)
nsubjpass(observed-14, increase-6)
prep_in(increase-6, AUC-8)
conj_and(AUC-8, Cmax-10)
prep_of(AUC-8, nisoldipine-12)
auxpass(observed-14, was-13)
root(ROOT-0, observed-14)
amod(administration-17, concomitant-16)
prep_with(observed-14, administration-17)
nn(mg-21, cimetidine-19)
num(mg-21, 400-20)
prep_of(administration-17, mg-21)
advmod(daily-23, twice-22)
advmod(mg-21, daily-23)

Ranitidine/NN 150/CD mg/NN twice/RB daily/RB did/VBD not/RB interact/VB significantly/RB with/IN nisoldipine/NN (/-LRB- AUC/NN was/VBD decreased/VBN by/IN 15-20/CD %/NN )./CD

(ROOT (S1 (S (S (NP (NP (NN Ranitidine) (CD 150) (NN mg)) (ADVP (RB twice) (RB daily))) (VP (VBD did) (RB not) (VP (VB interact) (ADVP (RB significantly)) (PP (IN with) (NP (NN nisoldipine)))))) (S (-LRB- -LRB-) (NP (NN AUC)) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (CD 15-20) (NN %) (CD -RRB-.)))))))))

nn(mg-3, Ranitidine-1)
num(mg-3, 150-2)
nsubj(interact-8, mg-3)
advmod(daily-5, twice-4)
advmod(mg-3, daily-5)
aux(interact-8, did-6)
neg(interact-8, not-7)
root(ROOT-0, interact-8)
advmod(interact-8, significantly-9)
prep_with(interact-8, nisoldipine-11)
nsubjpass(decreased-15, AUC-13)
auxpass(decreased-15, was-14)
dep(interact-8, decreased-15)
num(%-18, 15-20-17)
agent(decreased-15, %-18)
num(%-18, -RRB-.-19)

No/DT pharmacodynamic/JJ effects/NNS of/IN either/DT histamine/NN H2/NN receptor/NN antagonist/NN were/VBD observed/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ pharmacodynamic) (NNS effects)) (PP (IN of) (NP (DT either) (NN histamine) (NN H2) (NN receptor) (NN antagonist)))) (VP (VBD were) (VP (VBN observed)))) (. .))))

det(effects-3, No-1)
amod(effects-3, pharmacodynamic-2)
nsubjpass(observed-11, effects-3)
det(antagonist-9, either-5)
nn(antagonist-9, histamine-6)
nn(antagonist-9, H2-7)
nn(antagonist-9, receptor-8)
prep_of(effects-3, antagonist-9)
auxpass(observed-11, were-10)
root(ROOT-0, observed-11)

Coadministration/NN of/IN phenytoin/NN with/IN 40/CD mg/NN SULAR/NN tablets/NNS in/IN epileptic/JJ patients/NNS lowered/VBD the/DT nisoldipine/NN plasma/NN concentrations/NNS to/TO undetectable/JJ levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN phenytoin))) (PP (IN with) (NP (NP (CD 40) (NN mg) (NN SULAR) (NNS tablets)) (PP (IN in) (NP (JJ epileptic) (NNS patients)))))) (VP (VBD lowered) (NP (DT the) (NN nisoldipine) (NN plasma) (NNS concentrations)) (PP (TO to) (NP (JJ undetectable) (NNS levels))))) (. .))))

nsubj(lowered-12, Coadministration-1)
prep_of(Coadministration-1, phenytoin-3)
num(tablets-8, 40-5)
nn(tablets-8, mg-6)
nn(tablets-8, SULAR-7)
prep_with(Coadministration-1, tablets-8)
amod(patients-11, epileptic-10)
prep_in(tablets-8, patients-11)
root(ROOT-0, lowered-12)
det(concentrations-16, the-13)
nn(concentrations-16, nisoldipine-14)
nn(concentrations-16, plasma-15)
dobj(lowered-12, concentrations-16)
amod(levels-19, undetectable-18)
prep_to(lowered-12, levels-19)

Coadministration/NN of/IN SULAR/NN with/IN phenytoin/NN or/CC any/DT known/JJ CYP3A4/NN inducer/NN should/MD be/VB avoided/VBN and/CC alternative/JJ antihypertensive/JJ therapy/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN SULAR))) (PP (IN with) (NP (NP (NN phenytoin)) (CC or) (NP (DT any) (JJ known) (NN CYP3A4) (NN inducer))))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (CC and) (S (NP (JJ alternative) (JJ antihypertensive) (NN therapy)) (VP (MD should) (VP (VB be) (VP (VBN considered)))))) (. .))))

nsubjpass(avoided-13, Coadministration-1)
prep_of(Coadministration-1, SULAR-3)
prep_with(Coadministration-1, phenytoin-5)
det(inducer-10, any-7)
amod(inducer-10, known-8)
nn(inducer-10, CYP3A4-9)
conj_or(phenytoin-5, inducer-10)
aux(avoided-13, should-11)
auxpass(avoided-13, be-12)
root(ROOT-0, avoided-13)
amod(therapy-17, alternative-15)
amod(therapy-17, antihypertensive-16)
nsubjpass(considered-20, therapy-17)
aux(considered-20, should-18)
auxpass(considered-20, be-19)
conj_and(avoided-13, considered-20)

Pharmacokinetic/JJ interactions/NNS between/IN nisoldipine/NN and/CC beta-blockers/NNS (/-LRB- atenolol/NN ,/, propranolol/NN )/-RRB- were/VBD variable/JJ and/CC not/RB significant/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Pharmacokinetic) (NNS interactions)) (PP (IN between) (NP (NP (NN nisoldipine)) (CC and) (NP (NP (NNS beta-blockers)) (PRN (-LRB- -LRB-) (NP (NP (NN atenolol)) (, ,) (NP (NN propranolol))) (-RRB- -RRB-)))))) (VP (VBD were) (ADJP (ADJP (JJ variable)) (CC and) (ADJP (RB not) (JJ significant))))) (. .))))

amod(interactions-2, Pharmacokinetic-1)
nsubj(variable-13, interactions-2)
prep_between(interactions-2, nisoldipine-4)
conj_and(nisoldipine-4, beta-blockers-6)
dep(beta-blockers-6, atenolol-8)
appos(atenolol-8, propranolol-10)
cop(variable-13, were-12)
root(ROOT-0, variable-13)
neg(significant-16, not-15)
conj_and(variable-13, significant-16)

Propranolol/NN attenuated/VBD the/DT heart/NN rate/NN increase/NN following/VBG administration/NN of/IN immediate/JJ release/NN nisoldipine/NN ./.

(ROOT (S1 (S (S (NP (NN Propranolol)) (VP (VBD attenuated) (NP (DT the) (NN heart) (NN rate) (NN increase)) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (JJ immediate) (NN release) (NN nisoldipine))))))) (. .))))

nsubj(attenuated-2, Propranolol-1)
root(ROOT-0, attenuated-2)
det(increase-6, the-3)
nn(increase-6, heart-4)
nn(increase-6, rate-5)
dobj(attenuated-2, increase-6)
prep_following(attenuated-2, administration-8)
amod(nisoldipine-12, immediate-10)
nn(nisoldipine-12, release-11)
prep_of(administration-8, nisoldipine-12)

The/DT blood/NN pressure/NN effect/NN of/IN SULAR/NN tended/VBD to/TO be/VB greater/JJR in/IN patients/NNS on/IN atenolol/NN than/IN in/IN patients/NNS on/IN no/DT other/JJ antihypertensive/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN blood) (NN pressure) (NN effect)) (PP (IN of) (NP (NN SULAR)))) (VP (VBD tended) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (JJR greater)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NN atenolol))))) (PP (IN than) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (DT no) (JJ other) (JJ antihypertensive) (NN therapy)))))))))))) (. .))))

det(effect-4, The-1)
nn(effect-4, blood-2)
nn(effect-4, pressure-3)
nsubj(tended-7, effect-4)
xsubj(greater-10, effect-4)
prep_of(effect-4, SULAR-6)
root(ROOT-0, tended-7)
aux(greater-10, to-8)
cop(greater-10, be-9)
xcomp(tended-7, greater-10)
prep_in(greater-10, patients-12)
prep_on(patients-12, atenolol-14)
prep(greater-10, than-15)
pcomp(than-15, in-16)
prep_in(than-15, patients-17)
det(therapy-22, no-19)
amod(therapy-22, other-20)
amod(therapy-22, antihypertensive-21)
prep_on(patients-17, therapy-22)

Quinidine/NN at/IN 648/CD mg/NN bid/NN decreased/VBD the/DT bioavailability/NN (/-LRB- AUC/NN )/-RRB- of/IN nisoldipine/NN by/IN 26/CD %/NN ,/, but/CC not/RB the/DT peak/JJ concentration/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Quinidine)) (PP (IN at) (NP (ADJP (CD 648) (NN mg)) (NN bid)))) (VP (VBD decreased) (NP (NP (NP (DT the) (NN bioavailability)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (PP (IN of) (NP (NN nisoldipine)))) (PP (IN by) (NP (CD 26) (NN %))) (, ,) (CONJP (CC but) (RB not)) (NP (DT the) (JJ peak) (NN concentration)))) (. .))))

nsubj(decreased-6, Quinidine-1)
number(mg-4, 648-3)
amod(bid-5, mg-4)
prep_at(Quinidine-1, bid-5)
root(ROOT-0, decreased-6)
det(bioavailability-8, the-7)
dobj(decreased-6, bioavailability-8)
abbrev(bioavailability-8, AUC-10)
prep_of(bioavailability-8, nisoldipine-13)
num(%-16, 26-15)
prep_by(decreased-6, %-16)
det(concentration-22, the-20)
amod(concentration-22, peak-21)
conj_negcc(decreased-6, concentration-22)
dobj(decreased-6, concentration-22)

The/DT immediate/JJ release/NN ,/, but/CC not/RB the/DT coat-core/JJ formulation/NN of/IN nisoldipine/NN increased/VBD plasma/NN quinidine/NN concentrations/NNS by/IN about/RB 20/CD %./NN

(ROOT (S1 (S (NP (NP (DT The) (JJ immediate) (NN release)) (, ,) (CONJP (CC but) (RB not)) (S (NP (NP (DT the) (JJ coat-core) (NN formulation)) (PP (IN of) (NP (NN nisoldipine)))) (VP (VBD increased) (NP (NN plasma) (NN quinidine) (NNS concentrations)) (PP (IN by) (NP (QP (RB about) (CD 20)) (NN %.)))))))))

det(release-3, The-1)
amod(release-3, immediate-2)
root(ROOT-0, release-3)
det(formulation-9, the-7)
amod(formulation-9, coat-core-8)
nsubj(increased-12, formulation-9)
prep_of(formulation-9, nisoldipine-11)
conj_negcc(release-3, increased-12)
nn(concentrations-15, plasma-13)
nn(concentrations-15, quinidine-14)
dobj(increased-12, concentrations-15)
quantmod(20-18, about-17)
num(%.-19, 20-18)
prep_by(increased-12, %.-19)

No/DT significant/JJ interactions/NNS were/VBD found/VBN between/IN nisoldipine/NN and/CC warfarin/NN or/CC digoxin/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ significant) (NNS interactions)) (VP (VBD were) (VP (VBN found) (PP (IN between) (NP (NP (NN nisoldipine)) (CC and) (NP (NN warfarin)) (CC or) (NP (NN digoxin))))))) (. .))))

det(interactions-3, No-1)
amod(interactions-3, significant-2)
nsubjpass(found-5, interactions-3)
auxpass(found-5, were-4)
root(ROOT-0, found-5)
prep_between(found-5, nisoldipine-7)
conj_and(nisoldipine-7, warfarin-9)
conj_or(nisoldipine-7, digoxin-11)

Tizoxanide/NN is/VBZ highly/RB bound/VBN to/TO plasma/NN protein/NN (/-LRB- 99.9/CD %)./NN

(ROOT (S1 (S (NP (NN Tizoxanide)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (NN plasma) (NN protein))) (PRN (-LRB- -LRB-) (NP (CD 99.9) (NN %-RRB-.))))))))

nsubjpass(bound-4, Tizoxanide-1)
auxpass(bound-4, is-2)
advmod(bound-4, highly-3)
root(ROOT-0, bound-4)
nn(protein-7, plasma-6)
prep_to(bound-4, protein-7)
num(%-RRB-.-10, 99.9-9)
dep(bound-4, %-RRB-.-10)

Therefore/RB ,/, caution/NN should/MD be/VB used/VBN when/WRB administering/VBG nitazoxanide/NN concurrently/RB with/IN other/JJ highly/RB plasma/NN protein-bound/JJ drugs/NNS with/IN narrow/JJ therapeutic/JJ indices/NNS ,/, as/IN competition/NN for/IN binding/NN sites/NNS may/MD occur/VB (/-LRB- e.g./FW ,/, warfarin/NN )/-RRB- ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NP (NN nitazoxanide)) (PP (ADVP (RB concurrently)) (IN with) (NP (JJ other) (ADJP (RB highly) (NN plasma) (JJ protein-bound)) (NNS drugs)))) (PP (IN with) (NP (JJ narrow) (JJ therapeutic) (NNS indices)))))) (, ,) (SBAR (IN as) (S (NP (NP (NN competition)) (PP (IN for) (NP (NN binding) (NNS sites)))) (VP (MD may) (VP (VB occur)))))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN warfarin))) (-RRB- -RRB-)))) (. .))))

advmod(used-6, Therefore-1)
nsubjpass(used-6, caution-3)
aux(used-6, should-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
advmod(administering-8, when-7)
advcl(used-6, administering-8)
dobj(administering-8, nitazoxanide-9)
advmod(nitazoxanide-9, concurrently-10)
amod(drugs-16, other-12)
advmod(protein-bound-15, highly-13)
dep(protein-bound-15, plasma-14)
amod(drugs-16, protein-bound-15)
prep_with(nitazoxanide-9, drugs-16)
amod(indices-20, narrow-18)
amod(indices-20, therapeutic-19)
prep_with(administering-8, indices-20)
mark(occur-28, as-22)
nsubj(occur-28, competition-23)
nn(sites-26, binding-25)
prep_for(competition-23, sites-26)
aux(occur-28, may-27)
advcl(used-6, occur-28)
dep(used-6, e.g.-30)
pobj(e.g.-30, warfarin-32)

In/FW vitro/FW metabolism/NN studies/NNS have/VBP demonstrated/VBN that/IN tizoxanide/NN has/VBZ no/DT significant/JJ inhibitory/JJ effect/NN on/IN cytochrome/NN P450/NN enzymes/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NN metabolism) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN tizoxanide)) (VP (VBZ has) (NP (DT no) (JJ significant) (JJ inhibitory) (NN effect)) (PP (IN on) (NP (NN cytochrome) (NN P450) (NNS enzymes))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-4, vitro-2)
nn(studies-4, metabolism-3)
nsubj(demonstrated-6, studies-4)
aux(demonstrated-6, have-5)
root(ROOT-0, demonstrated-6)
complm(has-9, that-7)
nsubj(has-9, tizoxanide-8)
ccomp(demonstrated-6, has-9)
det(effect-13, no-10)
amod(effect-13, significant-11)
amod(effect-13, inhibitory-12)
dobj(has-9, effect-13)
nn(enzymes-17, cytochrome-15)
nn(enzymes-17, P450-16)
prep_on(has-9, enzymes-17)

Although/IN no/DT drug-drug/JJ interaction/NN studies/NNS have/VBP been/VBN conducted/VBN in/FW vivo/FW ,/, it/PRP is/VBZ expected/VBN that/IN no/DT significant/JJ interaction/NN would/MD occur/VB when/WRB nitazoxanide/NN is/VBZ co-administered/VBN with/IN drugs/NNS that/WDT either/RB are/VBP metabolized/VBN by/IN or/CC inhibit/VB cytochrome/NN P450/NN enzymes/NNS ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (DT no) (JJ drug-drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (ADVP (FW in) (FW vivo))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN expected) (SBAR (IN that) (S (NP (DT no) (JJ significant) (NN interaction)) (VP (MD would) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN nitazoxanide)) (VP (VBZ is) (VP (VBN co-administered) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (ADVP (RB either)) (VP (VP (VBP are) (VP (VBN metabolized) (PP (IN by)))) (CC or) (VP (VB inhibit) (NP (NN cytochrome) (NN P450) (NNS enzymes)))))))))))))))))) (. .))))

mark(conducted-8, Although-1)
det(studies-5, no-2)
amod(studies-5, drug-drug-3)
nn(studies-5, interaction-4)
nsubjpass(conducted-8, studies-5)
aux(conducted-8, have-6)
auxpass(conducted-8, been-7)
advcl(expected-14, conducted-8)
nn(vivo-10, in-9)
advmod(conducted-8, vivo-10)
nsubjpass(expected-14, it-12)
auxpass(expected-14, is-13)
root(ROOT-0, expected-14)
complm(occur-20, that-15)
det(interaction-18, no-16)
amod(interaction-18, significant-17)
nsubj(occur-20, interaction-18)
aux(occur-20, would-19)
ccomp(expected-14, occur-20)
advmod(co-administered-24, when-21)
nsubjpass(co-administered-24, nitazoxanide-22)
auxpass(co-administered-24, is-23)
advcl(occur-20, co-administered-24)
prep_with(co-administered-24, drugs-26)
nsubjpass(metabolized-30, drugs-26)
advmod(metabolized-30, either-28)
auxpass(metabolized-30, are-29)
rcmod(drugs-26, metabolized-30)
prep(metabolized-30, by-31)
conj_or(metabolized-30, inhibit-33)
nn(enzymes-36, cytochrome-34)
nn(enzymes-36, P450-35)
dobj(inhibit-33, enzymes-36)

Oxcarbazepine/NN can/MD inhibit/VB CYP2C19/NN and/CC induce/VB CYP3A4/NN /5/NN with/IN potentially/RB important/JJ effects/NNS on/IN plasma/NN concentrations/NNS of/IN other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Oxcarbazepine)) (VP (MD can) (VP (VP (VB inhibit) (NP (NN CYP2C19))) (CC and) (VP (VB induce) (NP (NP (NN CYP3A4) (NN /5)) (PP (IN with) (NP (NP (ADJP (RB potentially) (JJ important)) (NNS effects)) (PP (IN on) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (JJ other) (NNS drugs)))))))))))) (. .))))

nsubj(inhibit-3, Oxcarbazepine-1)
aux(inhibit-3, can-2)
root(ROOT-0, inhibit-3)
dobj(inhibit-3, CYP2C19-4)
conj_and(inhibit-3, induce-6)
nn(/5-8, CYP3A4-7)
dobj(induce-6, /5-8)
advmod(important-11, potentially-10)
amod(effects-12, important-11)
prep_with(/5-8, effects-12)
nn(concentrations-15, plasma-14)
prep_on(effects-12, concentrations-15)
amod(drugs-18, other-17)
prep_of(concentrations-15, drugs-18)

In/IN addition/NN ,/, several/JJ AED/JJ @/NN s/NNS that/WDT are/VBP cytochrome/NN P450/NN inducers/NNS can/MD decrease/VB plasma/NN concentrations/NNS of/IN oxcarbazepine/NN and/CC MHD/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ several) (JJ AED) (NN @) (NNS s)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NN cytochrome) (NN P450) (NNS inducers)))))) (VP (MD can) (VP (VB decrease) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN oxcarbazepine)) (CC and) (NP (NN MHD)))))))) (. .))))

prep_in(decrease-14, addition-2)
amod(s-7, several-4)
amod(s-7, AED-5)
nn(s-7, @-6)
nsubj(inducers-12, s-7)
nsubj(decrease-14, s-7)
cop(inducers-12, are-9)
nn(inducers-12, cytochrome-10)
nn(inducers-12, P450-11)
rcmod(s-7, inducers-12)
aux(decrease-14, can-13)
root(ROOT-0, decrease-14)
nn(concentrations-16, plasma-15)
dobj(decrease-14, concentrations-16)
prep_of(concentrations-16, oxcarbazepine-18)
conj_and(oxcarbazepine-18, MHD-20)

Oxcarbazepine/NN was/VBD evaluated/VBN in/IN human/JJ liver/NN microsomes/NNS to/TO determine/VB its/PRP$ capacity/NN to/TO inhibit/VB the/DT major/JJ cytochrome/NN P450/NN enzymes/NNS responsible/JJ for/IN the/DT metabolism/NN of/IN other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Oxcarbazepine)) (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (JJ human) (NN liver) (NNS microsomes))) (S (VP (TO to) (VP (VB determine) (NP (PRP$ its) (NN capacity) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (JJ major) (NN cytochrome) (NN P450) (NNS enzymes)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (JJ other) (NNS drugs))))))))))))))))) (. .))))

nsubjpass(evaluated-3, Oxcarbazepine-1)
xsubj(determine-9, Oxcarbazepine-1)
auxpass(evaluated-3, was-2)
root(ROOT-0, evaluated-3)
amod(microsomes-7, human-5)
nn(microsomes-7, liver-6)
prep_in(evaluated-3, microsomes-7)
aux(determine-9, to-8)
xcomp(evaluated-3, determine-9)
poss(capacity-11, its-10)
dobj(determine-9, capacity-11)
aux(inhibit-13, to-12)
infmod(capacity-11, inhibit-13)
det(enzymes-18, the-14)
amod(enzymes-18, major-15)
nn(enzymes-18, cytochrome-16)
nn(enzymes-18, P450-17)
dobj(inhibit-13, enzymes-18)
amod(enzymes-18, responsible-19)
det(metabolism-22, the-21)
prep_for(responsible-19, metabolism-22)
amod(drugs-25, other-24)
prep_of(metabolism-22, drugs-25)

Results/NNS demonstrate/VBP that/IN oxcarbazepine/NN and/CC its/PRP$ pharmacologically/RB active/JJ 10-monohydroxy/NN metabolite/NN (/-LRB- MHD/NN )/-RRB- have/VBP little/JJ or/CC no/DT capacity/NN to/TO function/VB as/IN inhibitors/NNS for/IN most/JJS of/IN the/DT human/JJ cytochrome/NN P450/NN enzymes/NNS evaluated/VBN (/-LRB- CYP1A2/NN ,/, CYP2A6/NN ,/, CYP2C9/NN ,/, CYP2D6/NN ,/, CYP2E1/NN ,/, CYP4A9/NN and/CC CYP4A11/NN )/-RRB- with/IN the/DT exception/NN of/IN CYP2C19/NN and/CC CYP3A4/NN /5/NN ./.

(ROOT (S1 (S (NP (NNS Results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN oxcarbazepine)) (CC and) (NP (NP (PRP$ its) (ADJP (RB pharmacologically) (JJ active)) (NN 10-monohydroxy) (NN metabolite)) (PRN (-LRB- -LRB-) (NP (NN MHD)) (-RRB- -RRB-)))) (VP (VBP have) (NP (NP (ADJP (JJ little))) (CC or) (NP (DT no) (NN capacity) (S (VP (TO to) (VP (VB function) (PP (IN as) (NP (NP (NNS inhibitors)) (PP (IN for) (NP (NP (JJS most)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN cytochrome) (NN P450) (NNS enzymes)) (VP (VBN evaluated) (PRN (-LRB- -LRB-) (NP (NP (NN CYP1A2)) (, ,) (NP (NN CYP2A6)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2D6)) (, ,) (NP (NN CYP2E1)) (, ,) (NP (NN CYP4A9)) (CC and) (NP (NN CYP4A11))) (-RRB- -RRB-)) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (NP (NN CYP2C19)) (CC and) (NP (NN CYP3A4) (NN /5)))))))))))))))))))))) (. .))))

nsubj(demonstrate-2, Results-1)
root(ROOT-0, demonstrate-2)
complm(have-14, that-3)
nsubj(have-14, oxcarbazepine-4)
poss(metabolite-10, its-6)
advmod(active-8, pharmacologically-7)
amod(metabolite-10, active-8)
nn(metabolite-10, 10-monohydroxy-9)
conj_and(oxcarbazepine-4, metabolite-10)
abbrev(metabolite-10, MHD-12)
ccomp(demonstrate-2, have-14)
dobj(have-14, little-15)
det(capacity-18, no-17)
conj_or(little-15, capacity-18)
aux(function-20, to-19)
infmod(capacity-18, function-20)
prep_as(function-20, inhibitors-22)
prep_for(inhibitors-22, most-24)
det(enzymes-30, the-26)
amod(enzymes-30, human-27)
nn(enzymes-30, cytochrome-28)
nn(enzymes-30, P450-29)
prep_of(most-24, enzymes-30)
partmod(enzymes-30, evaluated-31)
dep(evaluated-31, CYP1A2-33)
conj_and(CYP1A2-33, CYP2A6-35)
conj_and(CYP1A2-33, CYP2C9-37)
conj_and(CYP1A2-33, CYP2D6-39)
conj_and(CYP1A2-33, CYP2E1-41)
conj_and(CYP1A2-33, CYP4A9-43)
conj_and(CYP1A2-33, CYP4A11-45)
det(exception-49, the-48)
prep_with(evaluated-31, exception-49)
prep_of(exception-49, CYP2C19-51)
nn(/5-54, CYP3A4-53)
conj_and(CYP2C19-51, /5-54)

Although/IN inhibition/NN of/IN CYP/NN 3A4/5/NN by/IN OXC/NN and/CC MHD/NN did/VBD occur/VB at/IN high/JJ concentrations/NNS ,/, it/PRP is/VBZ not/RB likely/JJ to/TO be/VB of/IN clinical/JJ significance/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (NN inhibition)) (PP (IN of) (NP (NN CYP) (NN 3A4/5))) (PP (IN by) (NP (NP (NN OXC)) (CC and) (NP (NN MHD))))) (VP (VBD did) (VP (VB occur) (PP (IN at) (NP (JJ high) (NNS concentrations))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (JJ clinical) (NN significance))))))))) (. .))))

mark(occur-11, Although-1)
nsubj(occur-11, inhibition-2)
nn(3A4/5-5, CYP-4)
prep_of(inhibition-2, 3A4/5-5)
prep_by(inhibition-2, OXC-7)
conj_and(OXC-7, MHD-9)
aux(occur-11, did-10)
advcl(likely-19, occur-11)
amod(concentrations-14, high-13)
prep_at(occur-11, concentrations-14)
nsubj(likely-19, it-16)
cop(likely-19, is-17)
neg(likely-19, not-18)
root(ROOT-0, likely-19)
aux(be-21, to-20)
xcomp(likely-19, be-21)
amod(significance-24, clinical-23)
prep_of(be-21, significance-24)

The/DT inhibition/NN of/IN CYP-2C19/NN by/IN OXC/NN and/CC MHD/NN ,/, however/RB ,/, is/VBZ clinically/RB relevant/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN inhibition)) (PP (IN of) (NP (NN CYP-2C19))) (PP (IN by) (NP (NP (NN OXC)) (CC and) (NP (NN MHD))))) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ is) (ADJP (RB clinically) (JJ relevant)))) (. .))))

det(inhibition-2, The-1)
nsubj(relevant-14, inhibition-2)
prep_of(inhibition-2, CYP-2C19-4)
prep_by(inhibition-2, OXC-6)
conj_and(OXC-6, MHD-8)
advmod(relevant-14, however-10)
cop(relevant-14, is-12)
advmod(relevant-14, clinically-13)
root(ROOT-0, relevant-14)

In/FW vitro/FW ,/, the/DT UDP-glucuronyl/JJ transferase/NN level/NN was/VBD increased/VBN ,/, indicating/VBG induction/NN of/IN this/DT enzyme/NN ./.

(ROOT (S1 (S (S (ADVP (FW In) (FW vitro)) (, ,) (NP (DT the) (JJ UDP-glucuronyl) (NN transferase) (NN level)) (VP (VBD was) (VP (VBN increased) (, ,) (S (VP (VBG indicating) (NP (NP (NN induction)) (PP (IN of) (NP (DT this) (NN enzyme))))))))) (. .))))

nn(vitro-2, In-1)
advmod(increased-9, vitro-2)
det(level-7, the-4)
amod(level-7, UDP-glucuronyl-5)
nn(level-7, transferase-6)
nsubjpass(increased-9, level-7)
auxpass(increased-9, was-8)
root(ROOT-0, increased-9)
xcomp(increased-9, indicating-11)
dobj(indicating-11, induction-12)
det(enzyme-15, this-14)
prep_of(induction-12, enzyme-15)

Increases/NNS of/IN 22/CD %/NN with/IN MHD/NN and/CC 47/CD %/NN with/IN oxcarbazepine/NN were/VBD observed/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Increases)) (PP (IN of) (NP (NP (NP (CD 22) (NN %)) (PP (IN with) (NP (NN MHD)))) (CC and) (NP (NP (CD 47) (NN %)) (PP (IN with) (NP (NN oxcarbazepine))))))) (VP (VBD were) (VP (VBN observed)))) (. .))))

nsubjpass(observed-13, Increases-1)
num(%-4, 22-3)
prep_of(Increases-1, %-4)
prep_with(%-4, MHD-6)
num(%-9, 47-8)
conj_and(%-4, %-9)
prep_with(%-9, oxcarbazepine-11)
auxpass(observed-13, were-12)
root(ROOT-0, observed-13)

As/IN MHD/NN ,/, the/DT predominant/JJ plasma/NN substrate/NN ,/, is/VBZ only/RB a/DT weak/JJ inducer/NN of/IN UDP-glucuronyl/NN transferase/NN ,/, it/PRP is/VBZ unlikely/JJ to/TO have/VB an/DT effect/NN on/IN drugs/NNS that/WDT are/VBP mainly/RB eliminated/VBN by/IN conjugation/NN through/IN UDP-glucuronyl/JJ transferase/NN (/-LRB- e.g./FW ,/, valproic/JJ acid/NN ,/, lamotrigine/NN )/-RRB- ./.

(ROOT (S1 (S (SBAR (IN As) (S (NP (NP (NN MHD)) (, ,) (NP (DT the) (JJ predominant) (NN plasma) (NN substrate)) (, ,)) (VP (VBZ is) (ADVP (RB only)) (NP (NP (DT a) (JJ weak) (NN inducer)) (PP (IN of) (NP (NN UDP-glucuronyl) (NN transferase))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB have) (NP (DT an) (NN effect)) (PP (IN on) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB mainly)) (VP (VBN eliminated) (PP (IN by) (NP (NN conjugation))) (PP (IN through) (NP (NP (JJ UDP-glucuronyl) (NN transferase)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (JJ valproic) (NN acid))) (, ,) (NP (NN lamotrigine)) (-RRB- -RRB-))))))))))))))) (. .))))

mark(inducer-13, As-1)
nsubj(inducer-13, MHD-2)
det(substrate-7, the-4)
amod(substrate-7, predominant-5)
nn(substrate-7, plasma-6)
appos(MHD-2, substrate-7)
cop(inducer-13, is-9)
advmod(inducer-13, only-10)
det(inducer-13, a-11)
amod(inducer-13, weak-12)
advcl(unlikely-20, inducer-13)
nn(transferase-16, UDP-glucuronyl-15)
prep_of(inducer-13, transferase-16)
nsubj(unlikely-20, it-18)
cop(unlikely-20, is-19)
root(ROOT-0, unlikely-20)
aux(have-22, to-21)
xcomp(unlikely-20, have-22)
det(effect-24, an-23)
dobj(have-22, effect-24)
prep_on(have-22, drugs-26)
nsubjpass(eliminated-30, drugs-26)
auxpass(eliminated-30, are-28)
advmod(eliminated-30, mainly-29)
rcmod(drugs-26, eliminated-30)
agent(eliminated-30, conjugation-32)
amod(transferase-35, UDP-glucuronyl-34)
prep_through(eliminated-30, transferase-35)
dep(lamotrigine-42, e.g.-37)
amod(acid-40, valproic-39)
pobj(e.g.-37, acid-40)
appos(transferase-35, lamotrigine-42)

In/IN addition/NN ,/, oxcarbazepine/NN and/CC MHD/NN induce/VBP a/DT subgroup/NN of/IN the/DT cytochrome/NN P450/NN 3A/NN family/NN (/-LRB- CYP3A4/NN and/CC CYP3A5/NN )/-RRB- responsible/JJ for/IN the/DT metabolism/NN of/IN dihydropyridine/NN calcium/NN antagonist/NN s/NN and/CC oral/JJ contraceptives/NNS ,/, resulting/VBG in/IN a/DT lower/JJR plasma/NN concentration/NN of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN oxcarbazepine)) (CC and) (NP (NN MHD))) (VP (VBP induce) (NP (NP (DT a) (NN subgroup)) (PP (IN of) (NP (NP (NP (DT the) (NN cytochrome) (NN P450) (NN 3A) (NN family)) (PRN (-LRB- -LRB-) (NP (NP (NN CYP3A4)) (CC and) (NP (NN CYP3A5))) (-RRB- -RRB-))) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN dihydropyridine) (NN calcium) (NN antagonist) (NN s)) (CC and) (NP (JJ oral) (NNS contraceptives)))))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (JJR lower) (NN plasma) (NN concentration)) (PP (IN of) (NP (DT these) (NNS drugs))))))))) (. .))))

prep_in(induce-7, addition-2)
nsubj(induce-7, oxcarbazepine-4)
conj_and(oxcarbazepine-4, MHD-6)
root(ROOT-0, induce-7)
det(subgroup-9, a-8)
dobj(induce-7, subgroup-9)
det(family-15, the-11)
nn(family-15, cytochrome-12)
nn(family-15, P450-13)
nn(family-15, 3A-14)
prep_of(subgroup-9, family-15)
dep(family-15, CYP3A4-17)
conj_and(CYP3A4-17, CYP3A5-19)
amod(family-15, responsible-21)
det(metabolism-24, the-23)
prep_for(responsible-21, metabolism-24)
nn(s-29, dihydropyridine-26)
nn(s-29, calcium-27)
nn(s-29, antagonist-28)
prep_of(metabolism-24, s-29)
amod(contraceptives-32, oral-31)
conj_and(s-29, contraceptives-32)
partmod(induce-7, resulting-34)
xcomp(induce-7, resulting-34)
det(concentration-39, a-36)
amod(concentration-39, lower-37)
nn(concentration-39, plasma-38)
prep_in(resulting-34, concentration-39)
det(drugs-42, these-41)
prep_of(concentration-39, drugs-42)

As/IN binding/NN of/IN MHD/NN to/TO plasma/NN proteins/NNS is/VBZ low/JJ (/-LRB- 40/CD %/NN )/-RRB- ,/, clinically/RB significant/JJ interactions/NNS with/IN other/JJ drugs/NNS through/IN competition/NN for/IN protein/NN binding/NN sites/NNS are/VBP unlikely/JJ ./.

(ROOT (S1 (S (S (SBAR (IN As) (S (NP (NP (NN binding)) (PP (IN of) (NP (NN MHD))) (PP (TO to) (NP (NN plasma) (NNS proteins)))) (VP (VBZ is) (ADJP (ADJP (JJ low)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN %)) (-RRB- -RRB-)))))) (, ,) (NP (NP (ADJP (RB clinically) (JJ significant)) (NNS interactions)) (PP (IN with) (NP (JJ other) (NNS drugs))) (PP (IN through) (NP (NP (NN competition)) (PP (IN for) (NP (NN protein) (NN binding) (NNS sites)))))) (VP (VBP are) (ADJP (JJ unlikely)))) (. .))))

mark(low-9, As-1)
nsubj(low-9, binding-2)
prep_of(binding-2, MHD-4)
nn(proteins-7, plasma-6)
prep_to(binding-2, proteins-7)
cop(low-9, is-8)
advcl(unlikely-28, low-9)
num(%-12, 40-11)
dep(low-9, %-12)
advmod(significant-16, clinically-15)
amod(interactions-17, significant-16)
nsubj(unlikely-28, interactions-17)
amod(drugs-20, other-19)
prep_with(interactions-17, drugs-20)
prep_through(interactions-17, competition-22)
nn(sites-26, protein-24)
nn(sites-26, binding-25)
prep_for(competition-22, sites-26)
cop(unlikely-28, are-27)
root(ROOT-0, unlikely-28)

Antiepileptic/JJ drugs/NNS Potential/JJ interactions/NNS between/IN Trileptal/NNP and/CC other/JJ AEDs/NNS were/VBD assessed/VBN in/IN clinical/JJ studies/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Antiepileptic) (NNS drugs)) (NP (NP (JJ Potential) (NNS interactions)) (PP (IN between) (NP (NP (NNP Trileptal)) (CC and) (NP (JJ other) (NNS AEDs)))))) (VP (VBD were) (VP (VBN assessed) (PP (IN in) (NP (JJ clinical) (NNS studies)))))) (. .))))

amod(drugs-2, Antiepileptic-1)
nsubjpass(assessed-11, drugs-2)
amod(interactions-4, Potential-3)
dep(drugs-2, interactions-4)
prep_between(interactions-4, Trileptal-6)
amod(AEDs-9, other-8)
conj_and(Trileptal-6, AEDs-9)
auxpass(assessed-11, were-10)
root(ROOT-0, assessed-11)
amod(studies-14, clinical-13)
prep_in(assessed-11, studies-14)

The/DT effect/NN of/IN these/DT interactions/NNS on/IN mean/JJ AUCs/NNS and/CC Cmin/NN are/VBP summarized/VBN in/IN Table/NN 2/CD :/: Table/NN 2/CD :/: Summary/NN of/IN AED/JJ interactions/NNS with/IN Trileptal/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (DT these) (NNS interactions))) (PP (IN on) (NP (NP (JJ mean) (NNS AUCs)) (CC and) (NP (NN Cmin))))) (VP (VBP are) (VP (VBN summarized) (PP (IN in) (NP (NP (NN Table) (CD 2) (: :) (NP (NN Table) (CD 2)) (: :) (NP (NN Summary))) (PP (IN of) (NP (NP (JJ AED) (NNS interactions)) (PP (IN with) (NP (NN Trileptal)))))))))) (. .))))

det(effect-2, The-1)
nsubjpass(summarized-12, effect-2)
det(interactions-5, these-4)
prep_of(effect-2, interactions-5)
amod(AUCs-8, mean-7)
prep_on(effect-2, AUCs-8)
conj_and(AUCs-8, Cmin-10)
auxpass(summarized-12, are-11)
root(ROOT-0, summarized-12)
prep_in(summarized-12, Table-14)
num(Table-14, 2-15)
dep(Table-14, Table-17)
num(Table-17, 2-18)
dep(Table-14, Summary-20)
amod(interactions-23, AED-22)
prep_of(Table-14, interactions-23)
prep_with(interactions-23, Trileptal-25)

Trileptal/JJ dose/NN (/-LRB- mg/day/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (JJ Trileptal) (NN dose)) (PRN (-LRB- -LRB-) (NP (NN mg/day)) (-RRB- -RRB-)))) (. .))))

amod(dose-2, Trileptal-1)
root(ROOT-0, dose-2)
appos(dose-2, mg/day-4)

Influence/NN of/IN Trileptal/NN on/IN AED/JJ Concentration/NN (/-LRB- Mean/NN change/NN ,/, 90/CD %/NN Confidence/NN Interval/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NN Influence)) (PP (IN of) (NP (NN Trileptal))) (PP (IN on) (NP (NP (JJ AED) (NN Concentration)) (PRN (-LRB- -LRB-) (NP (NP (NN Mean) (NN change)) (, ,) (NP (ADJP (CD 90) (NN %)) (NN Confidence) (NN Interval))) (-RRB- -RRB-)))) (. .)))))

root(ROOT-0, Influence-1)
prep_of(Influence-1, Trileptal-3)
amod(Concentration-6, AED-5)
prep_on(Influence-1, Concentration-6)
nn(change-9, Mean-8)
dep(Concentration-6, change-9)
number(%-12, 90-11)
amod(Interval-14, %-12)
nn(Interval-14, Confidence-13)
appos(change-9, Interval-14)

Carbamazepine/NN ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (. .)))))

root(ROOT-0, Carbamazepine-1)

Phenobarbital/NN ./.

(ROOT (S1 (S (NP (NP (NN Phenobarbital)) (. .)))))

root(ROOT-0, Phenobarbital-1)

Phenytoin/NN ./.

(ROOT (S1 (S (NP (NP (NN Phenytoin)) (. .)))))

root(ROOT-0, Phenytoin-1)

Valproic/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (JJ Valproic) (NN acid))) (. .))))

amod(acid-2, Valproic-1)
root(ROOT-0, acid-2)

1-/CD nc/NN denotes/VBZ a/DT mean/JJ change/NN of/IN less/JJR than/IN 10/CD %/NN 2-/CD Pediatrics/NN 3-/CD Mean/NN increase/NN in/IN adults/NNS at/IN high/JJ Trileptal/NN doses/NNS In/FW vivo/FW ,/, the/DT plasma/NN levels/NNS of/IN phenytoin/NN increased/VBD by/IN up/RB to/TO 40/CD %/NN ,/, when/WRB Trileptal/NN was/VBD given/VBN at/IN doses/NNS above/IN 1200/CD mg/day/NN ./.

(ROOT (S1 (S (S (NP (CD 1-) (NN nc)) (VP (VBZ denotes) (NP (NP (DT a) (JJ mean) (NN change)) (PP (IN of) (NP (NP (QP (JJR less) (IN than) (CD 10)) (NN %) (CD 2-) (NN Pediatrics) (CD 3-) (NN Mean) (NN increase)) (PP (IN in) (NP (NNS adults))) (PP (IN at) (NP (JJ high) (NN Trileptal) (NNS doses)))))) (ADVP (FW In) (FW vivo)))) (, ,) (S (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN phenytoin)))) (VP (VBD increased) (PP (IN by) (NP (QP (RB up) (TO to) (CD 40)) (NN %))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NN Trileptal)) (VP (VBD was) (VP (VBN given) (PP (IN at) (NP (NP (NNS doses)) (PP (IN above) (NP (CD 1200) (NN mg/day))))))))))) (. .))))

num(nc-2, 1--1)
nsubj(denotes-3, nc-2)
root(ROOT-0, denotes-3)
det(change-6, a-4)
amod(change-6, mean-5)
dobj(denotes-3, change-6)
mwe(than-9, less-8)
quantmod(10-10, than-9)
num(increase-16, 10-10)
nn(increase-16, %-11)
num(increase-16, 2--12)
nn(increase-16, Pediatrics-13)
num(increase-16, 3--14)
nn(increase-16, Mean-15)
prep_of(change-6, increase-16)
prep_in(increase-16, adults-18)
amod(doses-22, high-20)
nn(doses-22, Trileptal-21)
prep_at(increase-16, doses-22)
nn(vivo-24, In-23)
advmod(denotes-3, vivo-24)
det(levels-28, the-26)
nn(levels-28, plasma-27)
nsubj(increased-31, levels-28)
prep_of(levels-28, phenytoin-30)
ccomp(denotes-3, increased-31)
quantmod(40-35, up-33)
dep(40-35, to-34)
num(%-36, 40-35)
prep_by(increased-31, %-36)
advmod(given-41, when-38)
nsubjpass(given-41, Trileptal-39)
auxpass(given-41, was-40)
advcl(increased-31, given-41)
prep_at(given-41, doses-43)
num(mg/day-46, 1200-45)
prep_above(doses-43, mg/day-46)

Therefore/RB ,/, when/WRB using/VBG doses/NNS of/IN Trileptal/NN greater/JJR than/IN 1200/CD mg/day/NN during/IN adjunctive/JJ therapy/NN ,/, a/DT decrease/NN in/IN the/DT dose/NN of/IN phenytoin/NN may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (NP (NNS doses)) (PP (IN of) (NP (NN Trileptal))) (ADJP (QP (JJR greater) (IN than) (CD 1200)) (NN mg/day))) (PP (IN during) (NP (JJ adjunctive) (NN therapy)))))) (, ,) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN phenytoin)))))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(required-25, Therefore-1)
advmod(using-4, when-3)
advcl(required-25, using-4)
dobj(using-4, doses-5)
prep_of(doses-5, Trileptal-7)
mwe(than-9, greater-8)
quantmod(1200-10, than-9)
dep(mg/day-11, 1200-10)
dep(doses-5, mg/day-11)
amod(therapy-14, adjunctive-13)
prep_during(using-4, therapy-14)
det(decrease-17, a-16)
nsubjpass(required-25, decrease-17)
det(dose-20, the-19)
prep_in(decrease-17, dose-20)
prep_of(dose-20, phenytoin-22)
aux(required-25, may-23)
auxpass(required-25, be-24)
root(ROOT-0, required-25)

The/DT increase/NN of/IN phenobarbital/NN level/NN ,/, however/RB ,/, is/VBZ small/JJ (/-LRB- 15/CD %/NN )/-RRB- when/WRB given/VBN with/IN Trileptal/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN increase)) (PP (IN of) (NP (NN phenobarbital) (NN level)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ is) (ADJP (ADJP (JJ small)) (PRN (-LRB- -LRB-) (NP (CD 15) (NN %)) (-RRB- -RRB-))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN with) (NP (NN Trileptal)))))))) (. .))))

det(increase-2, The-1)
nsubj(small-10, increase-2)
nn(level-5, phenobarbital-4)
prep_of(increase-2, level-5)
advmod(small-10, however-7)
cop(small-10, is-9)
root(ROOT-0, small-10)
num(%-13, 15-12)
dep(small-10, %-13)
advmod(given-16, when-15)
advcl(small-10, given-16)
prep_with(given-16, Trileptal-18)

Strong/JJ inducers/NNS of/IN cytochrome/NN P450/NN enzymes/NNS (/-LRB- i.e./FW carbamazepine/NN ,/, phenytoin/NN and/CC phenobarbital/NN )/-RRB- have/VBP been/VBN shown/VBN to/TO decrease/VB the/DT plasma/NN levels/NNS of/IN MHD/NN (/-LRB- 29-40%)./NN

(ROOT (S1 (S (NP (NP (JJ Strong) (NNS inducers)) (PP (IN of) (NP (NP (NN cytochrome) (NN P450) (NNS enzymes)) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (NP (NP (NN carbamazepine)) (, ,) (NP (NN phenytoin)) (CC and) (NP (NN phenobarbital))) (-RRB- -RRB-))))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB decrease) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN MHD)))) (PRN (-LRB- -LRB-) (NP (NN 29-40%-RRB-.))))))))))))

amod(inducers-2, Strong-1)
nsubjpass(shown-17, inducers-2)
xsubj(decrease-19, inducers-2)
nn(enzymes-6, cytochrome-4)
nn(enzymes-6, P450-5)
prep_of(inducers-2, enzymes-6)
dep(carbamazepine-9, i.e.-8)
dep(enzymes-6, carbamazepine-9)
conj_and(carbamazepine-9, phenytoin-11)
conj_and(carbamazepine-9, phenobarbital-13)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
aux(decrease-19, to-18)
xcomp(shown-17, decrease-19)
det(levels-22, the-20)
nn(levels-22, plasma-21)
dobj(decrease-19, levels-22)
prep_of(levels-22, MHD-24)
dep(decrease-19, 29-40%-RRB-.-26)

No/DT autoinduction/NN has/VBZ been/VBN observed/VBN with/IN Trileptal/NN ./.

(ROOT (S1 (S (S (NP (DT No) (NN autoinduction)) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN with) (NP (NN Trileptal))))))) (. .))))

det(autoinduction-2, No-1)
nsubjpass(observed-5, autoinduction-2)
aux(observed-5, has-3)
auxpass(observed-5, been-4)
root(ROOT-0, observed-5)
prep_with(observed-5, Trileptal-7)

Hormonal/JJ contraceptives/NNS Co-administration/NN of/IN Trileptal/NN with/IN an/DT oral/JJ contraceptive/NN has/VBZ been/VBN shown/VBN to/TO influence/VB the/DT plasma/NN concentrations/NNS of/IN the/DT two/CD hormonal/JJ components/NNS ,/, ethinylestradiol/NN (/-LRB- EE/NN )/-RRB- and/CC levonorgestrel/NN (/-LRB- LNG)./NN

(ROOT (S1 (S (NP (NP (JJ Hormonal) (NNS contraceptives)) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN Trileptal))) (PP (IN with) (NP (DT an) (JJ oral) (NN contraceptive)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB influence) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (DT the) (CD two) (JJ hormonal) (NNS components)) (, ,) (NP (NP (NP (NN ethinylestradiol)) (PRN (-LRB- -LRB-) (NP (NN EE)) (-RRB- -RRB-))) (CC and) (NP (NP (NN levonorgestrel)) (PRN (-LRB- -LRB-) (NP (NN LNG-RRB-.)))))))))))))))))))

amod(contraceptives-2, Hormonal-1)
root(ROOT-0, contraceptives-2)
nsubjpass(shown-12, Co-administration-3)
xsubj(influence-14, Co-administration-3)
prep_of(Co-administration-3, Trileptal-5)
det(contraceptive-9, an-7)
amod(contraceptive-9, oral-8)
prep_with(Co-administration-3, contraceptive-9)
aux(shown-12, has-10)
auxpass(shown-12, been-11)
dep(contraceptives-2, shown-12)
aux(influence-14, to-13)
xcomp(shown-12, influence-14)
det(concentrations-17, the-15)
nn(concentrations-17, plasma-16)
dobj(influence-14, concentrations-17)
det(components-22, the-19)
num(components-22, two-20)
amod(components-22, hormonal-21)
prep_of(concentrations-17, components-22)
appos(components-22, ethinylestradiol-24)
abbrev(ethinylestradiol-24, EE-26)
conj_and(ethinylestradiol-24, levonorgestrel-29)
dep(levonorgestrel-29, LNG-RRB-.-31)

Therefore/RB ,/, concurrent/JJ use/NN of/IN Trileptal/NN with/IN hormonal/JJ contraceptives/NNS may/MD render/VB these/DT contraceptives/NNS less/RBR effective/JJ ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (NN Trileptal))) (PP (IN with) (NP (JJ hormonal) (NNS contraceptives)))) (VP (MD may) (VP (VB render) (S (NP (DT these) (NNS contraceptives)) (ADJP (RBR less) (JJ effective)))))) (. .))))

advmod(render-11, Therefore-1)
amod(use-4, concurrent-3)
nsubj(render-11, use-4)
prep_of(use-4, Trileptal-6)
amod(contraceptives-9, hormonal-8)
prep_with(use-4, contraceptives-9)
aux(render-11, may-10)
root(ROOT-0, render-11)
det(contraceptives-13, these-12)
nsubj(effective-15, contraceptives-13)
advmod(effective-15, less-14)
xcomp(render-11, effective-15)

Studies/NNS with/IN other/JJ oral/JJ or/CC implant/JJ contraceptives/NNS have/VBP not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Studies)) (PP (IN with) (NP (JJ other) (ADJP (ADJP (JJ oral)) (CC or) (ADJP (JJ implant))) (NNS contraceptives)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

nsubjpass(conducted-11, Studies-1)
amod(contraceptives-7, other-3)
amod(contraceptives-7, oral-4)
conj_or(oral-4, implant-6)
prep_with(Studies-1, contraceptives-7)
aux(conducted-11, have-8)
neg(conducted-11, not-9)
auxpass(conducted-11, been-10)
root(ROOT-0, conducted-11)

Calcium/NN Antagonist/NN s/NN After/IN repeated/JJ co-administration/NN of/IN Trileptal/NN ,/, the/DT AUC/NN of/IN felodipine/NN was/VBD lowered/VBN by/IN 28/CD %/NN [90/CD %/NN CI/NN :/: 20-33/CD ]./NN

(ROOT (S1 (S (PP (NP (NN Calcium) (NN Antagonist) (NN s)) (IN After) (NP (NP (JJ repeated) (NN co-administration)) (PP (IN of) (NP (NN Trileptal))))) (, ,) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN felodipine)))) (VP (VBD was) (VP (VBN lowered) (PP (IN by) (NP (NP (CD 28) (NN %)) (NP (ADJP (CD -LSB-90) (NN %)) (NN CI)))))) (: :) (NP (CD 20-33) (NN -RSB-.)))))

nn(s-3, Calcium-1)
nn(s-3, Antagonist-2)
npadvmod(lowered-15, s-3)
amod(co-administration-6, repeated-5)
prep_after(lowered-15, co-administration-6)
prep_of(co-administration-6, Trileptal-8)
det(AUC-11, the-10)
nsubjpass(lowered-15, AUC-11)
prep_of(AUC-11, felodipine-13)
auxpass(lowered-15, was-14)
root(ROOT-0, lowered-15)
num(%-18, 28-17)
agent(lowered-15, %-18)
number(%-20, -LSB-90-19)
amod(CI-21, %-20)
dep(%-18, CI-21)
num(-RSB-.-24, 20-33-23)
nsubjpass(lowered-15, -RSB-.-24)

Verapamil/NN produced/VBD a/DT decrease/NN of/IN 20/CD %/NN [90/CD %/NN CI/CD :/: 18-27/CD ]/-RRB- of/IN the/DT plasma/NN levels/NNS of/IN MHD/NN ./.

(ROOT (S1 (S (S (NP (NN Verapamil)) (VP (VBD produced) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (NP (CD 20) (NN %) (CD -LSB-90) (NN %) (CD CI) (: :) (CD 18-27) (-RRB- -RSB-)) (PP (IN of) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN MHD)))))))))) (. .))))

nsubj(produced-2, Verapamil-1)
root(ROOT-0, produced-2)
det(decrease-4, a-3)
dobj(produced-2, decrease-4)
num(%-9, 20-6)
nn(%-9, %-7)
num(%-9, -LSB-90-8)
prep_of(decrease-4, %-9)
num(%-9, CI-10)
num(%-9, 18-27-12)
punct(%-9, -RSB--13)
det(levels-17, the-15)
nn(levels-17, plasma-16)
prep_of(%-9, levels-17)
prep_of(levels-17, MHD-19)

Other/JJ drug/NN interactions/NNS Cimetidine/NN ,/, erythromycin/NN and/CC dextropropoxyphene/NN had/VBD no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN MHD/NN ./.

(ROOT (S1 (S (S (NP (JJ Other) (NN drug) (NNS interactions) (NP (NP (NN Cimetidine)) (, ,) (NP (NN erythromycin)) (CC and) (NP (NN dextropropoxyphene)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN MHD))))))) (. .))))

amod(interactions-3, Other-1)
nn(interactions-3, drug-2)
nsubj(had-9, interactions-3)
dep(interactions-3, Cimetidine-4)
conj_and(Cimetidine-4, erythromycin-6)
conj_and(Cimetidine-4, dextropropoxyphene-8)
root(ROOT-0, had-9)
det(effect-11, no-10)
dobj(had-9, effect-11)
det(pharmacokinetics-14, the-13)
prep_on(had-9, pharmacokinetics-14)
prep_of(pharmacokinetics-14, MHD-16)

Results/NNS with/IN warfarin/NN wshow/VBP no/DT evidence/NN of/IN interaction/NN with/IN either/CC single/JJ or/CC repeated/JJ doses/NNS of/IN Trileptal/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Results)) (PP (IN with) (NP (NN warfarin)))) (VP (VBP wshow) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (NN interaction)) (PP (IN with) (NP (NP (ADJP (CC either) (ADJP (JJ single)) (CC or) (ADJP (JJ repeated))) (NNS doses)) (PP (IN of) (NP (NN Trileptal)))))))))) (. .))))

nsubj(wshow-4, Results-1)
prep_with(Results-1, warfarin-3)
root(ROOT-0, wshow-4)
det(evidence-6, no-5)
dobj(wshow-4, evidence-6)
prep_of(evidence-6, interaction-8)
preconj(single-11, either-10)
amod(doses-14, single-11)
conj_or(single-11, repeated-13)
prep_with(interaction-8, doses-14)
prep_of(doses-14, Trileptal-16)

In/IN a/DT Phase/NN :/: I/NN trial/NN using/VBG escalating/JJ doses/NNS of/IN TAXOL/NN (/-LRB- 110-200/CD mg/m2/NN )/-RRB- and/CC cisplatin/NN (/-LRB- 50/CD or/CC 75/CD mg/m2/NN )/-RRB- given/VBN as/IN sequential/JJ infusions/NNS ,/, myelosuppression/NN was/VBD more/RBR profound/JJ when/WRB TAXOL/NN was/VBD given/VBN after/IN cisplatin/NN than/IN with/IN the/DT alternate/JJ sequence/NN (/-LRB- ie/FW ,/, TAXOL/NN before/IN cisplatin/NN )/-RRB- ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (NN Phase) (: :) (NN I) (NN trial)) (VP (VBG using) (NP (NP (NP (JJ escalating) (NNS doses)) (PP (IN of) (NP (NP (NP (NN TAXOL)) (PRN (-LRB- -LRB-) (NP (CD 110-200) (NN mg/m2)) (-RRB- -RRB-))) (CC and) (NP (NP (NN cisplatin)) (PRN (-LRB- -LRB-) (NP (QP (CD 50) (CC or) (CD 75)) (NN mg/m2)) (-RRB- -RRB-)))))) (VP (VBN given) (PP (IN as) (NP (JJ sequential) (NNS infusions)))))))) (, ,) (NP (NN myelosuppression)) (VP (VBD was) (ADJP (RBR more) (JJ profound)) (SBAR (WHADVP (WRB when)) (S (NP (NN TAXOL)) (VP (VBD was) (VP (VBN given) (PP (IN after) (NP (NN cisplatin))) (PP (IN than) (PP (IN with) (NP (NP (DT the) (JJ alternate) (NN sequence)) (PRN (-LRB- -LRB-) (PP (FW ie)) (, ,) (NP (NP (NN TAXOL)) (PP (IN before) (NP (NN cisplatin)))) (-RRB- -RRB-)))))))))) (. .))))

det(trial-6, a-2)
nn(trial-6, Phase-3)
nn(trial-6, I-5)
prep_in(profound-32, trial-6)
partmod(trial-6, using-7)
amod(doses-9, escalating-8)
dobj(using-7, doses-9)
prep_of(doses-9, TAXOL-11)
num(mg/m2-14, 110-200-13)
appos(TAXOL-11, mg/m2-14)
conj_and(TAXOL-11, cisplatin-17)
num(mg/m2-22, 50-19)
conj_or(50-19, 75-21)
appos(cisplatin-17, mg/m2-22)
partmod(doses-9, given-24)
amod(infusions-27, sequential-26)
prep_as(given-24, infusions-27)
nsubj(profound-32, myelosuppression-29)
cop(profound-32, was-30)
advmod(profound-32, more-31)
root(ROOT-0, profound-32)
advmod(given-36, when-33)
nsubjpass(given-36, TAXOL-34)
auxpass(given-36, was-35)
advcl(profound-32, given-36)
prep_after(given-36, cisplatin-38)
prep(given-36, than-39)
pcomp(than-39, with-40)
det(sequence-43, the-41)
amod(sequence-43, alternate-42)
prep_with(than-39, sequence-43)
dep(TAXOL-47, ie-45)
dep(sequence-43, TAXOL-47)
prep_before(TAXOL-47, cisplatin-49)

Pharmacokinetic/JJ data/NNS from/IN these/DT patients/NNS demonstrated/VBD a/DT decrease/NN in/IN paclitaxel/NN clearance/NN of/IN approximately/RB 33/CD %/NN when/WRB TAXOL/NN was/VBD administered/VBN following/VBG cisplatin/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Pharmacokinetic) (NNS data)) (PP (IN from) (NP (DT these) (NNS patients)))) (VP (VBD demonstrated) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NN paclitaxel) (NN clearance)) (PP (IN of) (NP (QP (RB approximately) (CD 33)) (NN %)))))) (SBAR (WHADVP (WRB when)) (S (NP (NN TAXOL)) (VP (VBD was) (VP (VBN administered) (PP (VBG following) (NP (NN cisplatin))))))))) (. .))))

amod(data-2, Pharmacokinetic-1)
nsubj(demonstrated-6, data-2)
det(patients-5, these-4)
prep_from(data-2, patients-5)
root(ROOT-0, demonstrated-6)
det(decrease-8, a-7)
dobj(demonstrated-6, decrease-8)
nn(clearance-11, paclitaxel-10)
prep_in(decrease-8, clearance-11)
quantmod(33-14, approximately-13)
num(%-15, 33-14)
prep_of(clearance-11, %-15)
advmod(administered-19, when-16)
nsubjpass(administered-19, TAXOL-17)
auxpass(administered-19, was-18)
advcl(demonstrated-6, administered-19)
prep_following(administered-19, cisplatin-21)

The/DT metabolism/NN of/IN TAXOL/NN is/VBZ catalyzed/VBN by/IN cytochrome/NN P450/NN isoen-zymes/NNS CYP2C8/NN and/CC CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN metabolism)) (PP (IN of) (NP (NN TAXOL)))) (VP (VBZ is) (VP (VBN catalyzed) (PP (IN by) (NP (NN cytochrome) (NN P450) (NNS isoen-zymes) (NP (NP (NN CYP2C8)) (CC and) (NP (NN CYP3A4)))))))) (. .))))

det(metabolism-2, The-1)
nsubjpass(catalyzed-6, metabolism-2)
prep_of(metabolism-2, TAXOL-4)
auxpass(catalyzed-6, is-5)
root(ROOT-0, catalyzed-6)
nn(isoen-zymes-10, cytochrome-8)
nn(isoen-zymes-10, P450-9)
agent(catalyzed-6, isoen-zymes-10)
dep(isoen-zymes-10, CYP2C8-11)
conj_and(CYP2C8-11, CYP3A4-13)

In/IN the/DT absence/NN of/IN formal/JJ clinical/JJ drug/NN interaction/NN studies/NNS ,/, caution/NN should/MD be/VB exercised/VBN when/WRB administering/VBG TAXOL/NN concomitantly/RB with/IN known/JJ substrates/NNS or/CC inhibitors/NNS of/IN the/DT cytochrome/NN P450/NN isoenzymes/NNS CYP2C8/NN and/CC CYP3A4/NN ./.

(ROOT (S1 (S (S (PP (IN In) (DT the) (NN absence) (IN of) (NP (JJ formal) (JJ clinical) (NN drug) (NN interaction) (NNS studies))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NP (NN TAXOL)) (ADVP (RB concomitantly))) (PP (IN with) (NP (NP (JJ known) (NNS substrates)) (CC or) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (DT the) (NN cytochrome) (NN P450) (NNS isoenzymes) (NP (NP (NN CYP2C8)) (CC and) (NP (NN CYP3A4))))))))))))))) (. .))))

dep(exercised-14, In-1)
dep(exercised-14, the-2)
dep(exercised-14, absence-3)
amod(studies-9, formal-5)
amod(studies-9, clinical-6)
nn(studies-9, drug-7)
nn(studies-9, interaction-8)
prep_of(exercised-14, studies-9)
nsubjpass(exercised-14, caution-11)
aux(exercised-14, should-12)
auxpass(exercised-14, be-13)
root(ROOT-0, exercised-14)
advmod(administering-16, when-15)
advcl(exercised-14, administering-16)
dobj(administering-16, TAXOL-17)
advmod(TAXOL-17, concomitantly-18)
amod(substrates-21, known-20)
prep_with(administering-16, substrates-21)
conj_or(substrates-21, inhibitors-23)
det(isoenzymes-28, the-25)
nn(isoenzymes-28, cytochrome-26)
nn(isoenzymes-28, P450-27)
prep_of(inhibitors-23, isoenzymes-28)
dep(isoenzymes-28, CYP2C8-29)
conj_and(CYP2C8-29, CYP3A4-31)

Potential/JJ interactions/NNS between/IN TAXOL/NN ,/, a/DT substrate/NN of/IN CYP3A4/NN ,/, and/CC protease/NN inhibitors/NNS (/-LRB- ritonavir/NN ,/, saquinavir/NN ,/, indinavir/NN ,/, and/CC nelfinavir/NN )/-RRB- ,/, which/WDT are/VBP substrates/NNS and/or/CC inhibitors/NNS of/IN CYP3A4/NN ,/, have/VBP not/RB been/VBN evaluated/VBN in/IN clinical/JJ trials/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Potential) (NNS interactions)) (PP (IN between) (NP (NP (NP (NN TAXOL)) (, ,) (NP (NP (DT a) (NN substrate)) (PP (IN of) (NP (NN CYP3A4)))) (, ,)) (CC and) (NP (NP (NN protease) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NP (NN ritonavir)) (, ,) (NP (NN saquinavir)) (, ,) (NP (NN indinavir)) (, ,) (CC and) (NP (NN nelfinavir))) (-RRB- -RRB-))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (NP (NP (NP (NNS substrates)) (CC and/or) (NP (NNS inhibitors))) (PP (IN of) (NP (NN CYP3A4))))))) (, ,)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN evaluated) (PP (IN in) (NP (JJ clinical) (NNS trials))))))) (. .))))

amod(interactions-2, Potential-1)
nsubj(substrates-27, interactions-2)
nsubjpass(evaluated-36, interactions-2)
prep_between(interactions-2, TAXOL-4)
det(substrate-7, a-6)
appos(TAXOL-4, substrate-7)
prep_of(substrate-7, CYP3A4-9)
nn(inhibitors-13, protease-12)
conj_and(TAXOL-4, inhibitors-13)
dep(inhibitors-13, ritonavir-15)
conj_and(ritonavir-15, saquinavir-17)
conj_and(ritonavir-15, indinavir-19)
conj_and(ritonavir-15, nelfinavir-22)
cop(substrates-27, are-26)
rcmod(interactions-2, substrates-27)
conj_and/or(substrates-27, inhibitors-29)
prep_of(substrates-27, CYP3A4-31)
aux(evaluated-36, have-33)
neg(evaluated-36, not-34)
auxpass(evaluated-36, been-35)
root(ROOT-0, evaluated-36)
amod(trials-39, clinical-38)
prep_in(evaluated-36, trials-39)

Reports/NNS in/IN the/DT literature/NN suggest/VBP that/IN plasma/NN levels/NNS of/IN doxorubicin/NN (/-LRB- and/CC its/PRP$ active/JJ metabolite/NN doxorubicinol/NN )/-RRB- may/MD be/VB increased/VBN when/WRB paclitaxel/NN and/CC doxorubicin/NN are/VBP used/VBN in/IN combination/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Reports)) (PP (IN in) (NP (DT the) (NN literature)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN doxorubicin)))) (-LRB- -LRB-) (CC and) (NP (PRP$ its) (JJ active) (NN metabolite) (NN doxorubicinol)) (-RRB- -RRB-)) (VP (MD may) (VP (VB be) (VP (VBN increased) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN paclitaxel)) (CC and) (NP (NN doxorubicin))) (VP (VBP are) (VP (VBN used) (PP (IN in) (NP (NN combination)))))))))))))) (. .))))

nsubj(suggest-5, Reports-1)
det(literature-4, the-3)
prep_in(Reports-1, literature-4)
root(ROOT-0, suggest-5)
complm(increased-20, that-6)
nn(levels-8, plasma-7)
nsubjpass(increased-20, levels-8)
prep_of(levels-8, doxorubicin-10)
poss(doxorubicinol-16, its-13)
amod(doxorubicinol-16, active-14)
nn(doxorubicinol-16, metabolite-15)
conj_and(levels-8, doxorubicinol-16)
aux(increased-20, may-18)
auxpass(increased-20, be-19)
ccomp(suggest-5, increased-20)
advmod(used-26, when-21)
nsubjpass(used-26, paclitaxel-22)
conj_and(paclitaxel-22, doxorubicin-24)
auxpass(used-26, are-25)
advcl(increased-20, used-26)
prep_in(used-26, combination-28)

Hematology/NNP :/: TAXOL/NN therapy/NN should/MD not/RB be/VB administered/VBN to/TO patients/NNS with/IN baseline/NN neutrophil/NN counts/NNS of/IN less/JJR than/IN 1,500/CD cells/mm3/NN ./.

(ROOT (S1 (S (NP (NP (NNP Hematology)) (: :) (S (NP (NN TAXOL) (NN therapy)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN neutrophil) (NNS counts)) (PP (IN of) (NP (QP (JJR less) (IN than) (CD 1,500)) (NN cells/mm3))))))))))) (. .)))))

root(ROOT-0, Hematology-1)
nn(therapy-4, TAXOL-3)
nsubjpass(administered-8, therapy-4)
aux(administered-8, should-5)
neg(administered-8, not-6)
auxpass(administered-8, be-7)
dep(Hematology-1, administered-8)
prep_to(administered-8, patients-10)
nn(counts-14, baseline-12)
nn(counts-14, neutrophil-13)
prep_with(patients-10, counts-14)
mwe(than-17, less-16)
quantmod(1,500-18, than-17)
num(cells/mm3-19, 1,500-18)
prep_of(counts-14, cells/mm3-19)

In/IN order/NN to/TO monitor/VB the/DT occurrence/NN of/IN myelotoxicity/NN ,/, it/PRP is/VBZ recommended/VBN that/IN frequent/JJ peripheral/JJ blood/NN cell/NN counts/NNS be/VB performed/VBN on/IN all/DT patients/NNS receiving/VBG TAXOL/NN ./.

(ROOT (S1 (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB monitor) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NN myelotoxicity)))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (JJ frequent) (JJ peripheral) (NN blood) (NN cell) (NNS counts)) (VP (VB be) (VP (VBN performed) (PP (IN on) (NP (NP (DT all) (NNS patients)) (VP (VBG receiving) (NP (NN TAXOL)))))))))))) (. .))))

mark(monitor-4, In-1)
dep(monitor-4, order-2)
aux(monitor-4, to-3)
dep(recommended-12, monitor-4)
det(occurrence-6, the-5)
dobj(monitor-4, occurrence-6)
prep_of(occurrence-6, myelotoxicity-8)
nsubjpass(recommended-12, it-10)
auxpass(recommended-12, is-11)
root(ROOT-0, recommended-12)
complm(performed-20, that-13)
amod(counts-18, frequent-14)
amod(counts-18, peripheral-15)
nn(counts-18, blood-16)
nn(counts-18, cell-17)
nsubjpass(performed-20, counts-18)
auxpass(performed-20, be-19)
ccomp(recommended-12, performed-20)
det(patients-23, all-22)
prep_on(performed-20, patients-23)
partmod(patients-23, receiving-24)
dobj(receiving-24, TAXOL-25)

Patients/NNS should/MD not/RB be/VB re-treated/VBN with/IN subsequent/JJ cycles/NNS of/IN TAXOL/NN until/IN neutrophils/NNS recover/VBP to/TO a/DT level/NN 1500/CD cells/mm3/NN and/CC platelets/NNS recover/VBP to/TO a/DT level/NN 100,000/CD cells/mm3/NN ./.

(ROOT (S1 (S (S (NP (NNS Patients)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN re-treated) (PP (IN with) (NP (NP (JJ subsequent) (NNS cycles)) (PP (IN of) (NP (NN TAXOL))))) (SBAR (IN until) (S (S (NP (NNS neutrophils)) (VP (VBP recover) (PP (TO to) (NP (NP (DT a) (NN level)) (ADJP (CD 1500) (NN cells/mm3)))))) (CC and) (S (NP (NNS platelets)) (VP (VBP recover) (PP (TO to) (NP (NP (DT a) (NN level)) (ADJP (CD 100,000) (NN cells/mm3)))))))))))) (. .))))

nsubjpass(re-treated-5, Patients-1)
aux(re-treated-5, should-2)
neg(re-treated-5, not-3)
auxpass(re-treated-5, be-4)
root(ROOT-0, re-treated-5)
amod(cycles-8, subsequent-7)
prep_with(re-treated-5, cycles-8)
prep_of(cycles-8, TAXOL-10)
mark(recover-13, until-11)
nsubj(recover-13, neutrophils-12)
advcl(re-treated-5, recover-13)
det(level-16, a-15)
prep_to(recover-13, level-16)
number(cells/mm3-18, 1500-17)
amod(level-16, cells/mm3-18)
nsubj(recover-21, platelets-20)
conj_and(recover-13, recover-21)
det(level-24, a-23)
prep_to(recover-21, level-24)
number(cells/mm3-26, 100,000-25)
amod(level-24, cells/mm3-26)

In/IN the/DT case/NN of/IN severe/JJ neutropenia/NN (/-LRB- 500/CD cells/mm3/NN for/IN seven/CD days/NNS or/CC more/JJR )/-RRB- during/IN a/DT course/NN of/IN TAXOL/NN therapy/NN ,/, a/DT 20/CD %/NN reduction/NN in/IN dose/NN for/IN subsequent/JJ courses/NNS of/IN therapy/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (JJ severe) (NN neutropenia)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN cells/mm3)) (PP (IN for) (NP (NP (CD seven) (NNS days)) (CC or) (NP (JJR more)))) (-RRB- -RRB-)))) (PP (IN during) (NP (NP (DT a) (NN course)) (PP (IN of) (NP (NN TAXOL) (NN therapy))))))) (, ,) (NP (NP (DT a) (CD 20) (NN %) (NN reduction)) (PP (IN in) (NP (NN dose))) (PP (IN for) (NP (NP (JJ subsequent) (NNS courses)) (PP (IN of) (NP (NN therapy)))))) (VP (VBZ is) (VP (VBN recommended))) (. .))))

det(case-3, the-2)
prep_in(recommended-35, case-3)
amod(neutropenia-6, severe-5)
prep_of(case-3, neutropenia-6)
num(cells/mm3-9, 500-8)
dep(neutropenia-6, cells/mm3-9)
dep(cells/mm3-9, for-10)
num(days-12, seven-11)
pobj(for-10, days-12)
conj_or(days-12, more-14)
det(course-18, a-17)
prep_during(case-3, course-18)
nn(therapy-21, TAXOL-20)
prep_of(course-18, therapy-21)
det(reduction-26, a-23)
num(reduction-26, 20-24)
nn(reduction-26, %-25)
nsubjpass(recommended-35, reduction-26)
prep_in(reduction-26, dose-28)
amod(courses-31, subsequent-30)
prep_for(reduction-26, courses-31)
prep_of(courses-31, therapy-33)
auxpass(recommended-35, is-34)
root(ROOT-0, recommended-35)

For/IN patients/NNS with/IN advanced/JJ HIV/NN disease/NN and/CC poor-risk/JJ AIDS-related/JJ Kaposi/NN @/NN s/NN sarcoma/NN ,/, TAXOL/NN ,/, at/IN the/DT recommended/VBN dose/NN for/IN this/DT disease/NN ,/, can/MD be/VB initiated/VBN and/CC repeated/VBN if/IN the/DT neutrophil/NN count/NN is/VBZ at/IN least/JJS 1000/CD cells/mm3/NN ./.

(ROOT (S1 (S (S (PP (IN For) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ advanced) (NN HIV) (NN disease)) (CC and) (NP (JJ poor-risk) (JJ AIDS-related) (NN Kaposi) (NN @) (NN s) (NN sarcoma)))))) (, ,) (NP (NP (NN TAXOL)) (, ,) (PP (IN at) (NP (NP (DT the) (VBN recommended) (NN dose)) (PP (IN for) (NP (DT this) (NN disease))))) (, ,)) (VP (MD can) (VP (VB be) (VP (VP (VBN initiated)) (CC and) (VP (VBN repeated) (SBAR (IN if) (S (NP (DT the) (NN neutrophil) (NN count)) (VP (VBZ is) (NP (QP (IN at) (JJS least) (CD 1000)) (NN cells/mm3)))))))))) (. .))))

prep_for(initiated-27, patients-2)
amod(disease-6, advanced-4)
nn(disease-6, HIV-5)
prep_with(patients-2, disease-6)
amod(sarcoma-13, poor-risk-8)
amod(sarcoma-13, AIDS-related-9)
nn(sarcoma-13, Kaposi-10)
nn(sarcoma-13, @-11)
nn(sarcoma-13, s-12)
conj_and(disease-6, sarcoma-13)
nsubjpass(initiated-27, TAXOL-15)
det(dose-20, the-18)
amod(dose-20, recommended-19)
prep_at(TAXOL-15, dose-20)
det(disease-23, this-22)
prep_for(dose-20, disease-23)
aux(initiated-27, can-25)
auxpass(initiated-27, be-26)
root(ROOT-0, initiated-27)
conj_and(initiated-27, repeated-29)
mark(cells/mm3-38, if-30)
det(count-33, the-31)
nn(count-33, neutrophil-32)
nsubj(cells/mm3-38, count-33)
cop(cells/mm3-38, is-34)
quantmod(1000-37, at-35)
mwe(at-35, least-36)
pobj(at-35, least-36)
num(cells/mm3-38, 1000-37)
advcl(repeated-29, cells/mm3-38)

Hypersensitivity/NN Reactions/NNS :/: Patients/NNS with/IN a/DT history/NN of/IN severe/JJ hypersensitivity/NN reactions/NNS to/TO products/NNS containing/VBG Cremophor/NN @/NN EL/NN (/-LRB- eg/NN ,/, cyclosporin/NN for/IN injection/NN concentrate/NN and/CC teniposide/NN for/IN injection/NN concentrate/NN )/-RRB- should/MD not/RB be/VB treated/VBN with/IN TAXOL/NN ./.

(ROOT (S1 (S (NP (NP (NN Hypersensitivity) (NNS Reactions)) (: :) (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (JJ severe) (NN hypersensitivity) (NNS reactions)) (PP (TO to) (NP (NP (NNS products)) (VP (VBG containing) (NP (NP (NN Cremophor) (NN @) (NN EL)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NP (NN cyclosporin)) (PP (IN for) (NP (NP (NN injection)) (NP (NN concentrate)) (CC and) (NP (NN teniposide)))) (PP (IN for) (NP (NN injection) (NN concentrate))))) (-RRB- -RRB-))))))))))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN treated) (PP (IN with) (NP (NN TAXOL))))))) (. .)))))

nn(Reactions-2, Hypersensitivity-1)
root(ROOT-0, Reactions-2)
nsubjpass(treated-34, Patients-4)
det(history-7, a-6)
prep_with(Patients-4, history-7)
amod(reactions-11, severe-9)
nn(reactions-11, hypersensitivity-10)
prep_of(history-7, reactions-11)
prep_to(reactions-11, products-13)
partmod(products-13, containing-14)
nn(EL-17, Cremophor-15)
nn(EL-17, @-16)
dobj(containing-14, EL-17)
dep(EL-17, eg-19)
appos(eg-19, cyclosporin-21)
prep_for(cyclosporin-21, injection-23)
dep(injection-23, concentrate-24)
conj_and(injection-23, teniposide-26)
nn(concentrate-29, injection-28)
prep_for(cyclosporin-21, concentrate-29)
aux(treated-34, should-31)
neg(treated-34, not-32)
auxpass(treated-34, be-33)
dep(Reactions-2, treated-34)
prep_with(treated-34, TAXOL-36)

In/IN order/NN to/TO avoid/VB the/DT occurrence/NN of/IN severe/JJ hypersensitivity/NN reactions/NNS ,/, all/DT patients/NNS treated/VBN with/IN TAXOL/NN should/MD be/VB premedicated/VBN with/IN corticosteroids/NNS (/-LRB- such/JJ as/IN dexamethasone/NN )/-RRB- ,/, diphen/NN -hydramine/NN and/CC H2/NN antagonists/NNS (/-LRB- such/JJ as/IN cimetidine/NN or/CC ranitidine/NN )/-RRB- ./.

(ROOT (S1 (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB avoid) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (JJ severe) (NN hypersensitivity) (NNS reactions)))))))) (, ,) (NP (NP (DT all) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN TAXOL))))) (VP (MD should) (VP (VB be) (VP (VBN premedicated) (PP (IN with) (NP (NP (NP (NNS corticosteroids)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN dexamethasone)))) (-RRB- -RRB-))) (, ,) (NP (NN diphen) (NN -hydramine)) (CC and) (NP (NP (NN H2) (NNS antagonists)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN cimetidine)) (CC or) (NP (NN ranitidine))))) (-RRB- -RRB-))))))))) (. .))))

mark(avoid-4, In-1)
dep(avoid-4, order-2)
aux(avoid-4, to-3)
dep(premedicated-19, avoid-4)
det(occurrence-6, the-5)
dobj(avoid-4, occurrence-6)
amod(reactions-10, severe-8)
nn(reactions-10, hypersensitivity-9)
prep_of(occurrence-6, reactions-10)
det(patients-13, all-12)
nsubjpass(premedicated-19, patients-13)
partmod(patients-13, treated-14)
prep_with(treated-14, TAXOL-16)
aux(premedicated-19, should-17)
auxpass(premedicated-19, be-18)
root(ROOT-0, premedicated-19)
prep_with(premedicated-19, corticosteroids-21)
dep(corticosteroids-21, such-23)
prep_as(such-23, dexamethasone-25)
nn(-hydramine-29, diphen-28)
conj_and(corticosteroids-21, -hydramine-29)
nn(antagonists-32, H2-31)
conj_and(corticosteroids-21, antagonists-32)
prep_such_as(antagonists-32, cimetidine-36)
conj_or(cimetidine-36, ranitidine-38)

However/RB ,/, severe/JJ reactions/NNS ,/, such/JJ as/IN hypotension/NN requiring/VBG treatment/NN ,/, dyspnea/NN requiring/VBG bronchodilators/NNS ,/, angioedema/NN ,/, or/CC generalized/JJ urticaria/NN require/VBP immediate/JJ discontinuation/NN of/IN TAXOL/NN and/CC aggressive/JJ symptomatic/JJ therapy/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ severe) (NNS reactions)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN hypotension)) (VP (VBG requiring) (NP (NP (NN treatment)) (, ,) (NP (NP (NN dyspnea)) (VP (VBG requiring) (NP (NNS bronchodilators)))) (, ,) (NP (NN angioedema)) (, ,) (CC or) (NP (JJ generalized) (NN urticaria))))))) (VP (VBP require) (NP (NP (JJ immediate) (NN discontinuation)) (PP (IN of) (NP (NP (NN TAXOL)) (CC and) (NP (JJ aggressive) (JJ symptomatic) (NN therapy))))))) (. .))))

advmod(require-21, However-1)
amod(reactions-4, severe-3)
nsubj(require-21, reactions-4)
prep_such_as(reactions-4, hypotension-8)
partmod(hypotension-8, requiring-9)
dobj(requiring-9, treatment-10)
conj_or(treatment-10, dyspnea-12)
partmod(dyspnea-12, requiring-13)
dobj(requiring-13, bronchodilators-14)
conj_or(treatment-10, angioedema-16)
amod(urticaria-20, generalized-19)
conj_or(treatment-10, urticaria-20)
root(ROOT-0, require-21)
amod(discontinuation-23, immediate-22)
dobj(require-21, discontinuation-23)
prep_of(discontinuation-23, TAXOL-25)
amod(therapy-29, aggressive-27)
amod(therapy-29, symptomatic-28)
conj_and(TAXOL-25, therapy-29)

Patients/NNS who/WP have/VBP developed/VBN severe/JJ hypersensitivity/NN reactions/NNS should/MD not/RB be/VB rechallenged/VBN with/IN TAXOL/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN developed) (NP (JJ severe) (NN hypersensitivity) (NNS reactions))))))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN rechallenged) (PP (IN with) (NP (NN TAXOL))))))) (. .))))

nsubj(developed-4, Patients-1)
nsubjpass(rechallenged-11, Patients-1)
aux(developed-4, have-3)
rcmod(Patients-1, developed-4)
amod(reactions-7, severe-5)
nn(reactions-7, hypersensitivity-6)
dobj(developed-4, reactions-7)
aux(rechallenged-11, should-8)
neg(rechallenged-11, not-9)
auxpass(rechallenged-11, be-10)
root(ROOT-0, rechallenged-11)
prep_with(rechallenged-11, TAXOL-13)

Cardiovascular/NN :/: Hypotension/NN ,/, bradycardia/NN ,/, and/CC hypertension/NN have/VBP been/VBN observed/VBN during/IN administration/NN of/IN TAXOL/NN ,/, but/CC generally/RB do/VBP not/RB require/VB treatment/NN ./.

(ROOT (S1 (S (NP (NP (NN Cardiovascular)) (: :) (S (S (NP (NP (NN Hypotension)) (, ,) (NP (NN bradycardia)) (, ,) (CC and) (NP (NN hypertension))) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (IN during) (NP (NP (NN administration)) (PP (IN of) (NP (NN TAXOL))))))))) (, ,) (CC but) (S (ADVP (RB generally)) (VP (VBP do) (RB not) (VP (VB require) (NP (NN treatment)))))) (. .)))))

root(ROOT-0, Cardiovascular-1)
nsubjpass(observed-11, Hypotension-3)
conj_and(Hypotension-3, bradycardia-5)
conj_and(Hypotension-3, hypertension-8)
aux(observed-11, have-9)
auxpass(observed-11, been-10)
dep(Cardiovascular-1, observed-11)
prep_during(observed-11, administration-13)
prep_of(administration-13, TAXOL-15)
advmod(require-21, generally-18)
aux(require-21, do-19)
neg(require-21, not-20)
conj_but(observed-11, require-21)
dobj(require-21, treatment-22)

Occasionally/RB TAXOL/NN infusions/NNS must/MD be/VB interrupted/VBN or/CC discontinued/VBD because/IN of/IN initial/JJ or/CC recurrent/JJ hypertension/NN ./.

(ROOT (S1 (S (S (ADVP (RB Occasionally)) (NP (NN TAXOL) (NNS infusions)) (VP (VP (MD must) (VP (VB be) (VP (VBN interrupted)))) (CC or) (VP (VBD discontinued) (PP (IN because) (IN of) (NP (ADJP (ADJP (JJ initial)) (CC or) (ADJP (JJ recurrent))) (NN hypertension)))))) (. .))))

advmod(interrupted-6, Occasionally-1)
nn(infusions-3, TAXOL-2)
nsubjpass(interrupted-6, infusions-3)
aux(interrupted-6, must-4)
auxpass(interrupted-6, be-5)
root(ROOT-0, interrupted-6)
conj_or(interrupted-6, discontinued-8)
amod(hypertension-14, initial-11)
conj_or(initial-11, recurrent-13)
prep_because_of(discontinued-8, hypertension-14)

Frequent/JJ vital/JJ sign/NN monitoring/NN ,/, particularly/RB during/IN the/DT first/JJ hour/NN of/IN TAXOL/NN infusion/NN ,/, is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Frequent) (JJ vital) (NN sign) (NN monitoring)) (, ,) (ADVP (RB particularly)) (PP (IN during) (NP (NP (DT the) (JJ first) (NN hour)) (PP (IN of) (NP (NN TAXOL) (NN infusion))))) (, ,)) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

amod(monitoring-4, Frequent-1)
amod(monitoring-4, vital-2)
nn(monitoring-4, sign-3)
nsubjpass(recommended-16, monitoring-4)
advmod(monitoring-4, particularly-6)
det(hour-10, the-8)
amod(hour-10, first-9)
prep_during(monitoring-4, hour-10)
nn(infusion-13, TAXOL-12)
prep_of(hour-10, infusion-13)
auxpass(recommended-16, is-15)
root(ROOT-0, recommended-16)

Nervous/JJ System/NN :/: Although/IN the/DT occurrence/NN of/IN peripheral/JJ neuropathy/NN is/VBZ frequent/JJ ,/, the/DT development/NN of/IN severe/JJ symptomatology/NN is/VBZ unusual/JJ and/CC requires/VBZ a/DT dose/NN reduction/NN of/IN 20/CD %/NN for/IN all/DT subsequentcourses/NNS of/IN TAXOL/NN ./.

(ROOT (S1 (S (NP (NP (JJ Nervous) (NN System)) (: :) (S (SBAR (IN Although) (S (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (JJ peripheral) (NN neuropathy)))) (VP (VBZ is) (ADJP (JJ frequent))))) (, ,) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ severe) (NN symptomatology)))) (VP (VP (VBZ is) (ADJP (JJ unusual))) (CC and) (VP (VBZ requires) (NP (NP (DT a) (NN dose) (NN reduction)) (PP (IN of) (NP (CD 20) (NN %))) (PP (IN for) (NP (NP (DT all) (NNS subsequentcourses)) (PP (IN of) (NP (NN TAXOL))))))))) (. .)))))

amod(System-2, Nervous-1)
root(ROOT-0, System-2)
mark(frequent-11, Although-4)
det(occurrence-6, the-5)
nsubj(frequent-11, occurrence-6)
amod(neuropathy-9, peripheral-8)
prep_of(occurrence-6, neuropathy-9)
cop(frequent-11, is-10)
advcl(unusual-19, frequent-11)
det(development-14, the-13)
nsubj(unusual-19, development-14)
amod(symptomatology-17, severe-16)
prep_of(development-14, symptomatology-17)
cop(unusual-19, is-18)
dep(System-2, unusual-19)
conj_and(unusual-19, requires-21)
det(reduction-24, a-22)
nn(reduction-24, dose-23)
dobj(requires-21, reduction-24)
num(%-27, 20-26)
prep_of(reduction-24, %-27)
det(subsequentcourses-30, all-29)
prep_for(reduction-24, subsequentcourses-30)
prep_of(subsequentcourses-30, TAXOL-32)

TAXOL/NN contains/VBZ dehydrated/JJ alcohol/NN USP/NN ,/, 396/CD mg/mL/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN TAXOL)) (VP (VBZ contains) (NP (NP (JJ dehydrated) (NN alcohol) (NN USP)) (, ,) (NP (CD 396) (NN mg/mL)))) (: ;)) (. .))))

nsubj(contains-2, TAXOL-1)
root(ROOT-0, contains-2)
amod(USP-5, dehydrated-3)
nn(USP-5, alcohol-4)
dobj(contains-2, USP-5)
num(mg/mL-8, 396-7)
appos(USP-5, mg/mL-8)

consideration/NN should/MD be/VB given/VBN to/TO possible/JJ CNS/NNS and/CC other/JJ effects/NNS of/IN alcohol/NN ./.

(ROOT (S1 (S (S (NP (NN consideration)) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (NP (JJ possible) (NNS CNS)) (CC and) (NP (JJ other) (NNS effects))) (PP (IN of) (NP (NN alcohol))))))))) (. .))))

nsubjpass(given-4, consideration-1)
aux(given-4, should-2)
auxpass(given-4, be-3)
root(ROOT-0, given-4)
amod(CNS-7, possible-6)
prep_to(given-4, CNS-7)
amod(effects-10, other-9)
conj_and(CNS-7, effects-10)
prep_of(CNS-7, alcohol-12)

Hepatic/JJ :/: There/EX is/VBZ limited/JJ evidence/NN that/IN the/DT myelotoxicity/NN of/IN TAXOL/NN may/MD be/VB exacerbated/JJ in/IN patients/NNS with/IN serum/NN total/JJ bilirubin/NN 2/CD times/NNS ULN/NN ./.

(ROOT (S1 (S (NP (NP (JJ Hepatic)) (: :) (S (NP (EX There)) (VP (VBZ is) (NP (JJ limited) (NN evidence) (SBAR (IN that) (S (NP (NP (DT the) (NN myelotoxicity)) (PP (IN of) (NP (NN TAXOL)))) (VP (MD may) (VP (VB be) (ADJP (JJ exacerbated) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN serum) (JJ total) (NN bilirubin) (CD 2) (NNS times) (NN ULN))))))))))))) (. .)))))

root(ROOT-0, Hepatic-1)
expl(is-4, There-3)
dep(Hepatic-1, is-4)
amod(evidence-6, limited-5)
nsubj(is-4, evidence-6)
complm(exacerbated-14, that-7)
det(myelotoxicity-9, the-8)
nsubj(exacerbated-14, myelotoxicity-9)
prep_of(myelotoxicity-9, TAXOL-11)
aux(exacerbated-14, may-12)
cop(exacerbated-14, be-13)
ccomp(evidence-6, exacerbated-14)
prep_in(exacerbated-14, patients-16)
nn(ULN-23, serum-18)
amod(ULN-23, total-19)
nn(ULN-23, bilirubin-20)
num(ULN-23, 2-21)
nn(ULN-23, times-22)
prep_with(patients-16, ULN-23)

Extreme/JJ caution/NN should/MD be/VB exercised/VBN when/WRB administering/VBG TAXOL/NN to/TO such/JJ patients/NNS ,/, with/IN dose/NN reduction/NN as/IN recommended/VBN in/IN DOSAGE/NN AND/CC ADMINISTRATION/NN ,/, Table/NN 17/CD ./.

(ROOT (S1 (S (S (NP (JJ Extreme) (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NP (NN TAXOL)) (PP (TO to) (NP (JJ such) (NNS patients))))))) (, ,) (PP (IN with) (NP (NN dose) (NN reduction))) (SBAR (IN as) (S (VP (VBN recommended) (PP (IN in) (NP (NP (NN DOSAGE)) (CC AND) (NP (NP (NN ADMINISTRATION)) (, ,) (NP (NN Table) (CD 17)))))))))))) (. .))))

amod(caution-2, Extreme-1)
nsubjpass(exercised-5, caution-2)
aux(exercised-5, should-3)
auxpass(exercised-5, be-4)
root(ROOT-0, exercised-5)
advmod(administering-7, when-6)
advcl(exercised-5, administering-7)
dobj(administering-7, TAXOL-8)
amod(patients-11, such-10)
prep_to(TAXOL-8, patients-11)
nn(reduction-15, dose-14)
prep_with(exercised-5, reduction-15)
mark(recommended-17, as-16)
advcl(exercised-5, recommended-17)
prep_in(recommended-17, DOSAGE-19)
conj_and(DOSAGE-19, ADMINISTRATION-21)
appos(ADMINISTRATION-21, Table-23)
num(Table-23, 17-24)

Recurrence/NN of/IN skin/NN reactions/NNS at/IN a/DT site/NN of/IN previous/JJ extravasation/NN following/VBG administration/NN of/IN TAXOL/NN at/IN a/DT different/JJ site/NN ,/, ie/FW ,/, recall/NN ,/, has/VBZ been/VBN reported/VBN rarely/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Recurrence)) (PP (IN of) (NP (NN skin) (NNS reactions))) (PP (IN at) (NP (NP (DT a) (NN site)) (PP (IN of) (NP (JJ previous) (NN extravasation))) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (NN TAXOL))) (PP (IN at) (NP (DT a) (JJ different) (NN site))))))) (, ,) (PP (FW ie) (, ,) (NP (NN recall))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (ADVP (RB rarely)))))) (. .))))

nsubjpass(reported-26, Recurrence-1)
nn(reactions-4, skin-3)
prep_of(Recurrence-1, reactions-4)
det(site-7, a-6)
prep_at(Recurrence-1, site-7)
amod(extravasation-10, previous-9)
prep_of(site-7, extravasation-10)
prep_following(site-7, administration-12)
prep_of(administration-12, TAXOL-14)
det(site-18, a-16)
amod(site-18, different-17)
prep_at(administration-12, site-18)
prep(Recurrence-1, ie-20)
pobj(ie-20, recall-22)
aux(reported-26, has-24)
auxpass(reported-26, been-25)
root(ROOT-0, reported-26)
advmod(reported-26, rarely-27)

Rare/JJ reports/NNS of/IN more/RBR severe/JJ events/NNS such/JJ as/IN phlebitis/NN ,/, cellulitis/NN ,/, induration/NN ,/, skin/NN exfoliation/NN ,/, necrosis/NN ,/, and/CC fibrosis/NN have/VBP been/VBN received/VBN as/IN part/NN of/IN the/DT continuing/VBG surveillance/NN of/IN TAXOL/NN safety/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Rare) (NNS reports)) (PP (IN of) (NP (NP (ADJP (RBR more) (JJ severe)) (NNS events)) (PP (JJ such) (IN as) (NP (NP (NN phlebitis)) (, ,) (NP (NN cellulitis)) (, ,) (NP (NN induration)) (, ,) (NP (NN skin) (NN exfoliation)) (, ,) (NP (NN necrosis)) (, ,) (CC and) (NP (NN fibrosis))))))) (VP (VBP have) (VP (VBN been) (VP (VBN received) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT the) (VBG continuing) (NN surveillance)) (PP (IN of) (NP (NN TAXOL) (NN safety))))))))))) (. .))))

amod(reports-2, Rare-1)
nsubjpass(received-24, reports-2)
advmod(severe-5, more-4)
amod(events-6, severe-5)
prep_of(reports-2, events-6)
prep_such_as(events-6, phlebitis-9)
conj_and(phlebitis-9, cellulitis-11)
conj_and(phlebitis-9, induration-13)
nn(exfoliation-16, skin-15)
conj_and(phlebitis-9, exfoliation-16)
conj_and(phlebitis-9, necrosis-18)
conj_and(phlebitis-9, fibrosis-21)
aux(received-24, have-22)
auxpass(received-24, been-23)
root(ROOT-0, received-24)
prep_as(received-24, part-26)
det(surveillance-30, the-28)
amod(surveillance-30, continuing-29)
prep_of(part-26, surveillance-30)
nn(safety-33, TAXOL-32)
prep_of(surveillance-30, safety-33)

Aminoglycosides/NNS :/: The/DT mixing/NN of/IN piperacillin/NN with/IN an/DT aminoglycoside/NN in/IN vitro/FW can/MD result/VB in/IN substantial/JJ inactivation/NN of/IN the/DT aminoglycoside/NN ./.

(ROOT (S1 (S (NP (NP (NNS Aminoglycosides)) (: :) (S (NP (NP (DT The) (NN mixing)) (PP (IN of) (NP (NN piperacillin))) (PP (IN with) (NP (NP (DT an) (NN aminoglycoside)) (PP (IN in) (NP (FW vitro)))))) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (JJ substantial) (NN inactivation)) (PP (IN of) (NP (DT the) (NN aminoglycoside)))))))) (. .)))))

root(ROOT-0, Aminoglycosides-1)
det(mixing-4, The-3)
nsubj(result-13, mixing-4)
prep_of(mixing-4, piperacillin-6)
det(aminoglycoside-9, an-8)
prep_with(mixing-4, aminoglycoside-9)
prep_in(aminoglycoside-9, vitro-11)
aux(result-13, can-12)
dep(Aminoglycosides-1, result-13)
amod(inactivation-16, substantial-15)
prep_in(result-13, inactivation-16)
det(aminoglycoside-19, the-18)
prep_of(inactivation-16, aminoglycoside-19)

Vecuronium/NN :/: When/WRB used/VBN in/IN the/DT perioperative/JJ period/NN ,/, piperacillin/NN has/VBZ been/VBN implicated/VBN in/IN the/DT prolongation/NN of/IN the/DT neuromuscular/JJ blockade/NN of/IN vecuronium/NN ./.

(ROOT (S1 (S (NP (NP (NN Vecuronium)) (: :) (S (SBAR (WHADVP (WRB When)) (S (VP (VBN used) (PP (IN in) (NP (DT the) (JJ perioperative) (NN period)))))) (, ,) (NP (NN piperacillin)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN prolongation)) (PP (IN of) (NP (NP (DT the) (JJ neuromuscular) (NN blockade)) (PP (IN of) (NP (NN vecuronium))))))))))) (. .)))))

root(ROOT-0, Vecuronium-1)
advmod(used-4, When-3)
advcl(implicated-13, used-4)
det(period-8, the-6)
amod(period-8, perioperative-7)
prep_in(used-4, period-8)
nsubjpass(implicated-13, piperacillin-10)
aux(implicated-13, has-11)
auxpass(implicated-13, been-12)
dep(Vecuronium-1, implicated-13)
det(prolongation-16, the-15)
prep_in(implicated-13, prolongation-16)
det(blockade-20, the-18)
amod(blockade-20, neuromuscular-19)
prep_of(prolongation-16, blockade-20)
prep_of(blockade-20, vecuronium-22)

Caution/NN is/VBZ indicated/VBN when/WRB piperacillin/NN is/VBZ used/VBN perioperatively/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (VBZ is) (VP (VBN indicated) (SBAR (WHADVP (WRB when)) (S (NP (NN piperacillin)) (VP (VBZ is) (VP (VBN used) (NP (NN perioperatively))))))))) (. .))))

nsubjpass(indicated-3, Caution-1)
auxpass(indicated-3, is-2)
root(ROOT-0, indicated-3)
advmod(used-7, when-4)
nsubjpass(used-7, piperacillin-5)
auxpass(used-7, is-6)
advcl(indicated-3, used-7)
dobj(used-7, perioperatively-8)

In/IN one/CD controlled/JJ clinical/JJ study/NN ,/, the/DT ureidopenicillins/NNS ,/, including/VBG piperacillin/NN ,/, were/VBD reported/VBN to/TO prolong/VB the/DT action/NN of/IN vecuronium/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (CD one) (JJ controlled) (JJ clinical) (NN study))) (, ,) (NP (NP (DT the) (NNS ureidopenicillins)) (, ,) (PP (VBG including) (NP (NN piperacillin))) (, ,)) (VP (VBD were) (VP (VBN reported) (S (VP (TO to) (VP (VB prolong) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN vecuronium)))))))))) (. .))))

num(study-5, one-2)
amod(study-5, controlled-3)
amod(study-5, clinical-4)
prep_in(reported-14, study-5)
det(ureidopenicillins-8, the-7)
nsubjpass(reported-14, ureidopenicillins-8)
xsubj(prolong-16, ureidopenicillins-8)
prep_including(ureidopenicillins-8, piperacillin-11)
auxpass(reported-14, were-13)
root(ROOT-0, reported-14)
aux(prolong-16, to-15)
xcomp(reported-14, prolong-16)
det(action-18, the-17)
dobj(prolong-16, action-18)
prep_of(action-18, vecuronium-20)

Due/JJ to/TO their/PRP$ similar/JJ mechanism/NN of/IN action/NN ,/, it/PRP is/VBZ expected/VBN that/IN the/DT neuromuscular/JJ blockade/NN produced/VBN by/IN any/DT of/IN the/DT non-depolarizing/JJ muscle/NN relaxants/NNS could/MD be/VB prolonged/VBD in/IN the/DT presence/NN of/IN piperacillin/NN ./.

(ROOT (S1 (S (S (PP (JJ Due) (TO to) (NP (NP (PRP$ their) (JJ similar) (NN mechanism)) (PP (IN of) (NP (NN action))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN expected) (SBAR (IN that) (S (NP (NP (DT the) (JJ neuromuscular) (NN blockade)) (VP (VBN produced) (PP (IN by) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (JJ non-depolarizing) (NN muscle) (NNS relaxants))))))) (VP (MD could) (VP (VB be) (VP (VBD prolonged) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN piperacillin))))))))))))) (. .))))

poss(mechanism-5, their-3)
amod(mechanism-5, similar-4)
prep_due_to(expected-11, mechanism-5)
prep_of(mechanism-5, action-7)
nsubjpass(expected-11, it-9)
auxpass(expected-11, is-10)
root(ROOT-0, expected-11)
complm(prolonged-26, that-12)
det(blockade-15, the-13)
amod(blockade-15, neuromuscular-14)
nsubjpass(prolonged-26, blockade-15)
partmod(blockade-15, produced-16)
agent(produced-16, any-18)
det(relaxants-23, the-20)
amod(relaxants-23, non-depolarizing-21)
nn(relaxants-23, muscle-22)
prep_of(any-18, relaxants-23)
aux(prolonged-26, could-24)
auxpass(prolonged-26, be-25)
ccomp(expected-11, prolonged-26)
det(presence-29, the-28)
prep_in(prolonged-26, presence-29)
prep_of(presence-29, piperacillin-31)

Probenecid/NN :/: The/DT oral/JJ combination/NN of/IN probenecid/NN before/IN intramuscular/JJ injection/NN of/IN PIPRACIL/NN produces/VBZ an/DT increase/NN in/IN piperacillin/JJ peak/JJ serum/NN level/NN of/IN about/RB 30/CD %./NN

(ROOT (S1 (S (NP (NP (NN Probenecid)) (: :) (S (NP (NP (DT The) (JJ oral) (NN combination)) (PP (IN of) (NP (NN probenecid))) (PP (IN before) (NP (NP (JJ intramuscular) (NN injection)) (PP (IN of) (NP (NN PIPRACIL)))))) (VP (VBZ produces) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ piperacillin) (JJ peak) (NN serum) (NN level)) (PP (IN of) (NP (QP (RB about) (CD 30)) (NN %.))))))))))))

root(ROOT-0, Probenecid-1)
det(combination-5, The-3)
amod(combination-5, oral-4)
nsubj(produces-13, combination-5)
prep_of(combination-5, probenecid-7)
amod(injection-10, intramuscular-9)
prep_before(combination-5, injection-10)
prep_of(injection-10, PIPRACIL-12)
dep(Probenecid-1, produces-13)
det(increase-15, an-14)
dobj(produces-13, increase-15)
amod(level-20, piperacillin-17)
amod(level-20, peak-18)
nn(level-20, serum-19)
prep_in(increase-15, level-20)
quantmod(30-23, about-22)
num(%.-24, 30-23)
prep_of(level-20, %.-24)

Anticoagulants/NNS Coagulation/NN parameters/NNS should/MD be/VB tested/VBN more/RBR frequently/RB and/CC monitored/VBN regularly/RB during/IN simultaneous/JJ administration/NN of/IN high/JJ doses/NNS of/IN heparin/NN ,/, oral/JJ anticoagulants/NNS ,/, or/CC other/JJ drugs/NNS that/WDT may/MD affect/VB the/DT blood/NN coagulation/NN system/NN or/CC the/DT thrombocyte/JJ function/NN ./.

(ROOT (S1 (S (S (NP (NNS Anticoagulants) (NN Coagulation) (NNS parameters)) (VP (MD should) (VP (VB be) (VP (VP (VBN tested) (ADVP (RBR more) (RB frequently))) (CC and) (VP (VBN monitored) (ADVP (RB regularly)) (PP (IN during) (NP (NP (NP (JJ simultaneous) (NN administration)) (PP (IN of) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NN heparin)))))) (, ,) (NP (JJ oral) (NNS anticoagulants)) (, ,) (CC or) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB affect) (NP (DT the) (NN blood) (NN coagulation) (NN system))))))) (CC or) (NP (DT the) (JJ thrombocyte) (NN function))))))))) (. .))))

nn(parameters-3, Anticoagulants-1)
nn(parameters-3, Coagulation-2)
nsubjpass(tested-6, parameters-3)
aux(tested-6, should-4)
auxpass(tested-6, be-5)
root(ROOT-0, tested-6)
advmod(frequently-8, more-7)
advmod(tested-6, frequently-8)
conj_and(tested-6, monitored-10)
advmod(monitored-10, regularly-11)
amod(administration-14, simultaneous-13)
prep_during(monitored-10, administration-14)
amod(doses-17, high-16)
prep_of(administration-14, doses-17)
prep_of(doses-17, heparin-19)
amod(anticoagulants-22, oral-21)
conj_or(administration-14, anticoagulants-22)
amod(drugs-26, other-25)
conj_or(administration-14, drugs-26)
nsubj(affect-29, drugs-26)
aux(affect-29, may-28)
rcmod(drugs-26, affect-29)
det(system-33, the-30)
nn(system-33, blood-31)
nn(system-33, coagulation-32)
dobj(affect-29, system-33)
det(function-37, the-35)
amod(function-37, thrombocyte-36)
conj_or(administration-14, function-37)

Methotrexate/NN Piperacillin/NN sodium/NN may/MD reduce/VB the/DT excretion/NN of/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NN Methotrexate) (NN Piperacillin) (NN sodium)) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN excretion)) (PP (IN of) (NP (NN methotrexate))))))) (. .))))

nn(sodium-3, Methotrexate-1)
nn(sodium-3, Piperacillin-2)
nsubj(reduce-5, sodium-3)
aux(reduce-5, may-4)
root(ROOT-0, reduce-5)
det(excretion-7, the-6)
dobj(reduce-5, excretion-7)
prep_of(excretion-7, methotrexate-9)

Therefore/RB ,/, serum/NN levels/NNS of/IN methotrexate/NN should/MD be/VB monitored/VBN in/IN patients/NNS to/TO avoid/VB drug/NN toxicity/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN serum) (NNS levels)) (PP (IN of) (NP (NN methotrexate)))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN in) (NP (NNS patients))))) (S (VP (TO to) (VP (VB avoid) (NP (NN drug) (NN toxicity))))))) (. .))))

advmod(monitored-9, Therefore-1)
nn(levels-4, serum-3)
nsubjpass(monitored-9, levels-4)
xsubj(avoid-13, levels-4)
prep_of(levels-4, methotrexate-6)
aux(monitored-9, should-7)
auxpass(monitored-9, be-8)
root(ROOT-0, monitored-9)
prep_in(monitored-9, patients-11)
aux(avoid-13, to-12)
xcomp(monitored-9, avoid-13)
nn(toxicity-15, drug-14)
dobj(avoid-13, toxicity-15)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: As/IN with/IN other/JJ penicillins/NNS ,/, the/DT administration/NN of/IN PIPRACIL/NN may/MD result/VB in/IN a/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN using/VBG a/DT copper/NN -reduction/NN method/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (PP (IN As) (PP (IN with) (NP (JJ other) (NNS penicillins)))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN PIPRACIL)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (NP (DT the) (NN urine)) (VP (VBG using) (NP (DT a) (NN copper) (NN -reduction) (NN method)))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
prep(result-16, As-6)
pcomp(As-6, with-7)
amod(penicillins-9, other-8)
prep_with(As-6, penicillins-9)
det(administration-12, the-11)
nsubj(result-16, administration-12)
prep_of(administration-12, PIPRACIL-14)
aux(result-16, may-15)
dep(Interactions-4, result-16)
det(reaction-20, a-18)
amod(reaction-20, false-positive-19)
prep_in(result-16, reaction-20)
prep_for(reaction-20, glucose-22)
det(urine-25, the-24)
prep_in(reaction-20, urine-25)
partmod(urine-25, using-26)
det(method-30, a-27)
nn(method-30, copper-28)
nn(method-30, -reduction-29)
dobj(using-26, method-30)

It/PRP is/VBZ recommended/VBN that/IN glucose/NN tests/NNS based/VBN on/IN enzymatic/JJ glucose/NN oxidase/NN reactions/NNS be/VB used/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (NN glucose) (NNS tests)) (VP (VBN based) (PP (IN on) (NP (JJ enzymatic) (NN glucose) (NN oxidase) (NNS reactions))))) (VP (VB be) (VP (VBN used)))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(used-14, that-4)
nn(tests-6, glucose-5)
nsubjpass(used-14, tests-6)
partmod(tests-6, based-7)
amod(reactions-12, enzymatic-9)
nn(reactions-12, glucose-10)
nn(reactions-12, oxidase-11)
prep_on(based-7, reactions-12)
auxpass(used-14, be-13)
ccomp(recommended-3, used-14)

There/EX have/VBP been/VBN reports/NNS of/IN positive/JJ test/NN results/NNS using/VBG the/DT Bio-Rad/JJ Laboratories/NNS Platelia/NN Aspergillus/NN EIA/NN test/NN in/IN patients/NNS receiving/VBG piperacillin/NN //: tazobactam/NN injection/NN who/WP were/VBD subsequently/RB found/VBN to/TO be/VB free/JJ of/IN Aspergillus/JJ infection/NN ./.

(ROOT (S1 (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (JJ positive) (NN test) (NNS results)))) (S (VP (VBG using) (NP (NP (DT the) (NP (JJ Bio-Rad) (NNS Laboratories)) (NN Platelia) (NN Aspergillus) (NN EIA) (NN test)) (PP (IN in) (NP (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN piperacillin) (: /) (NN tazobactam) (NN injection)))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (ADVP (RB subsequently)) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJ free) (PP (IN of) (NP (JJ Aspergillus) (NN infection)))))))))))))))))) (. .))))

expl(reports-4, There-1)
aux(reports-4, have-2)
cop(reports-4, been-3)
root(ROOT-0, reports-4)
amod(results-8, positive-6)
nn(results-8, test-7)
prep_of(reports-4, results-8)
xcomp(reports-4, using-9)
det(test-16, the-10)
amod(Laboratories-12, Bio-Rad-11)
nn(test-16, Laboratories-12)
nn(test-16, Platelia-13)
nn(test-16, Aspergillus-14)
nn(test-16, EIA-15)
dobj(using-9, test-16)
prep_in(test-16, patients-18)
nsubjpass(found-27, patients-18)
partmod(patients-18, receiving-19)
nn(injection-23, piperacillin-20)
punct(injection-23, /-21)
nn(injection-23, tazobactam-22)
dobj(receiving-19, injection-23)
auxpass(found-27, were-25)
advmod(found-27, subsequently-26)
rcmod(patients-18, found-27)
aux(free-30, to-28)
cop(free-30, be-29)
xcomp(found-27, free-30)
amod(infection-33, Aspergillus-32)
prep_of(free-30, infection-33)

Cross-reactions/NNS with/IN non-Aspergillus/JJ polysaccharides/NNS and/CC polyfuranoses/NNS with/IN the/DT Bio-Rad/JJ Laboratories/NNS Platelia/FW Aspergillus/FW EIA/NN test/NN have/VBP been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Cross-reactions)) (PP (IN with) (NP (JJ non-Aspergillus) (NNS polysaccharides)))) (CC and) (NP (NP (NNS polyfuranoses)) (PP (IN with) (NP (DT the) (JJ Bio-Rad) (NNS Laboratories)))) (NP (ADJP (FW Platelia) (FW Aspergillus)) (NN EIA) (NN test))) (VP (VBP have) (VP (VBN been) (VP (VBN reported))))) (. .))))

nsubjpass(reported-17, Cross-reactions-1)
amod(polysaccharides-4, non-Aspergillus-3)
prep_with(Cross-reactions-1, polysaccharides-4)
conj_and(Cross-reactions-1, polyfuranoses-6)
det(Laboratories-10, the-8)
amod(Laboratories-10, Bio-Rad-9)
prep_with(polyfuranoses-6, Laboratories-10)
nn(Aspergillus-12, Platelia-11)
amod(test-14, Aspergillus-12)
nn(test-14, EIA-13)
dep(Cross-reactions-1, test-14)
aux(reported-17, have-15)
auxpass(reported-17, been-16)
root(ROOT-0, reported-17)

Therefore/RB ,/, positive/JJ test/NN results/NNS in/IN patients/NNS receiving/VBG piperacillin/NN should/MD be/VB interpreted/VBN cautiously/RB and/CC confirmed/VBN by/IN other/JJ diagnostic/JJ methods/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ positive) (NN test) (NNS results)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN piperacillin)))))) (VP (MD should) (VP (VB be) (VP (VP (VBN interpreted) (ADVP (RB cautiously))) (CC and) (VP (VBN confirmed) (PP (IN by) (NP (JJ other) (JJ diagnostic) (NNS methods)))))))) (. .))))

advmod(interpreted-12, Therefore-1)
amod(results-5, positive-3)
nn(results-5, test-4)
nsubjpass(interpreted-12, results-5)
prep_in(results-5, patients-7)
partmod(patients-7, receiving-8)
dobj(receiving-8, piperacillin-9)
aux(interpreted-12, should-10)
auxpass(interpreted-12, be-11)
root(ROOT-0, interpreted-12)
advmod(interpreted-12, cautiously-13)
conj_and(interpreted-12, confirmed-15)
amod(methods-19, other-17)
amod(methods-19, diagnostic-18)
prep_by(confirmed-15, methods-19)

Effect/NN of/IN other/JJ drugs/NNS on/IN Vardenafil/NN ./.

(ROOT (S1 (S (NP (NP (NN Effect)) (PP (IN of) (NP (JJ other) (NNS drugs))) (PP (IN on) (NP (NN Vardenafil))) (. .)))))

root(ROOT-0, Effect-1)
amod(drugs-4, other-3)
prep_of(Effect-1, drugs-4)
prep_on(Effect-1, Vardenafil-6)

In/FW vitro/FW studies/NNS :/: Studies/NNS in/IN human/JJ liver/NN microsomes/NNS showed/VBD that/IN vardenafil/NN is/VBZ metabolized/VBN primarily/RB by/IN cytochrome/NN P450/NN (/-LRB- CYP/NN )/-RRB- isoforms/NNS 3A4/5/NN ,/, and/CC to/TO a/DT lesser/JJR degree/NN by/IN CYP2C9/NN ./.

(ROOT (S1 (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (: :) (S (NP (NP (NNS Studies)) (PP (IN in) (NP (JJ human) (NN liver) (NNS microsomes)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NN vardenafil)) (VP (VBZ is) (VP (VP (VBN metabolized) (ADVP (RB primarily)) (PP (IN by) (NP (NP (NP (NN cytochrome) (NN P450)) (PRN (-LRB- -LRB-) (NP (NN CYP)) (-RRB- -RRB-))) (NNS isoforms) (NN 3A4/5)))) (, ,) (CC and) (PP (TO to) (NP (DT a) (JJR lesser) (NN degree))) (PP (IN by) (NP (NN CYP2C9))))))))) (. .)))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
root(ROOT-0, studies-3)
nsubj(showed-10, Studies-5)
amod(microsomes-9, human-7)
nn(microsomes-9, liver-8)
prep_in(Studies-5, microsomes-9)
dep(studies-3, showed-10)
complm(metabolized-14, that-11)
nsubjpass(metabolized-14, vardenafil-12)
auxpass(metabolized-14, is-13)
ccomp(showed-10, metabolized-14)
advmod(metabolized-14, primarily-15)
nn(P450-18, cytochrome-17)
nn(3A4/5-23, P450-18)
abbrev(P450-18, CYP-20)
nn(3A4/5-23, isoforms-22)
agent(metabolized-14, 3A4/5-23)
conj_and(metabolized-14, to-26)
det(degree-29, a-27)
amod(degree-29, lesser-28)
prep_to(metabolized-14, degree-29)
agent(metabolized-14, CYP2C9-31)

Therefore/RB ,/, inhibitors/NNS of/IN these/DT enzymes/NNS are/VBP expected/VBN to/TO reduce/VB vardenafil/NN clearance/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (DT these) (NNS enzymes)))) (VP (VBP are) (VP (VBN expected) (S (VP (TO to) (VP (VB reduce) (NP (NN vardenafil) (NN clearance)))))))) (. .))))

advmod(expected-8, Therefore-1)
nsubjpass(expected-8, inhibitors-3)
xsubj(reduce-10, inhibitors-3)
det(enzymes-6, these-5)
prep_of(inhibitors-3, enzymes-6)
auxpass(expected-8, are-7)
root(ROOT-0, expected-8)
aux(reduce-10, to-9)
xcomp(expected-8, reduce-10)
nn(clearance-12, vardenafil-11)
dobj(reduce-10, clearance-12)

In/FW vivo/FW studies/NNS :/: Cytochrome/NN P450/NN Inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vivo)) (NNS studies)) (: :) (NP (NN Cytochrome) (NN P450) (NNS Inhibitors))) (. .))))

nn(vivo-2, In-1)
amod(studies-3, vivo-2)
dep(Inhibitors-7, studies-3)
nn(Inhibitors-7, Cytochrome-5)
nn(Inhibitors-7, P450-6)
root(ROOT-0, Inhibitors-7)

Cimetidine/NN (/-LRB- 400/CD mg/NN b.i.d./NN )/-RRB- had/VBD no/DT effect/NN on/IN vardenafil/NN bioavailability/NN (/-LRB- AUC/NN )/-RRB- and/CC maximum/NN concentration/NN (/-LRB- Cmax/NN )/-RRB- of/IN vardenafil/NN when/WRB co-administered/VBN with/IN 20/CD mg/NN Vardenafil/NN in/IN healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Cimetidine)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 400) (NN mg)) (NN b.i.d.)) (-RRB- -RRB-))) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NP (NN vardenafil) (NN bioavailability)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (CC and) (NP (NP (NN maximum) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NN Cmax)) (-RRB- -RRB-))))) (PP (IN of) (NP (NN vardenafil)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-administered) (PP (IN with) (NP (CD 20) (NN mg) (NN Vardenafil))) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))))))) (. .))))

nsubj(had-7, Cimetidine-1)
number(mg-4, 400-3)
amod(b.i.d.-5, mg-4)
appos(Cimetidine-1, b.i.d.-5)
root(ROOT-0, had-7)
det(effect-9, no-8)
dobj(had-7, effect-9)
nn(bioavailability-12, vardenafil-11)
prep_on(effect-9, bioavailability-12)
abbrev(bioavailability-12, AUC-14)
nn(concentration-18, maximum-17)
conj_and(bioavailability-12, concentration-18)
appos(concentration-18, Cmax-20)
prep_of(effect-9, vardenafil-23)
advmod(co-administered-25, when-24)
advcl(had-7, co-administered-25)
num(Vardenafil-29, 20-27)
nn(Vardenafil-29, mg-28)
prep_with(co-administered-25, Vardenafil-29)
amod(volunteers-32, healthy-31)
prep_in(co-administered-25, volunteers-32)

Erythromycin/NN (/-LRB- 500/CD mg/NN t.i.d/CD )/-RRB- produced/VBD a/DT 4-fold/JJ increase/NN in/IN vardenafil/NN AUC/NN and/CC a/DT 3-fold/JJ increase/NN in/IN Cmax/NN when/WRB co-administered/VBN with/IN Vardenafil/NN 5/CD mg/NN in/IN healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Erythromycin)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mg) (CD t.i.d)) (-RRB- -RRB-))) (VP (VBD produced) (NP (NP (NP (DT a) (JJ 4-fold) (NN increase)) (PP (IN in) (NP (NN vardenafil) (NN AUC)))) (CC and) (NP (NP (DT a) (JJ 3-fold) (NN increase)) (PP (IN in) (NP (NN Cmax))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-administered) (PP (IN with) (NP (NP (NN Vardenafil) (CD 5) (NN mg)) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))))))))) (. .))))

nsubj(produced-7, Erythromycin-1)
num(mg-4, 500-3)
appos(Erythromycin-1, mg-4)
num(mg-4, t.i.d-5)
root(ROOT-0, produced-7)
det(increase-10, a-8)
amod(increase-10, 4-fold-9)
dobj(produced-7, increase-10)
nn(AUC-13, vardenafil-12)
prep_in(increase-10, AUC-13)
det(increase-17, a-15)
amod(increase-17, 3-fold-16)
conj_and(increase-10, increase-17)
prep_in(increase-17, Cmax-19)
advmod(co-administered-21, when-20)
advcl(produced-7, co-administered-21)
nn(mg-25, Vardenafil-23)
num(mg-25, 5-24)
prep_with(co-administered-21, mg-25)
amod(volunteers-28, healthy-27)
prep_in(mg-25, volunteers-28)

It/PRP is/VBZ recommended/VBN not/RB to/TO exceed/VB a/DT single/JJ 5/CD mg/NN dose/NN of/IN Vardenafil/NN in/IN a/DT 24-hour/JJ period/NN when/WRB used/VBN in/IN combination/NN with/IN erythromycin/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (S (VP (RB not) (TO to) (VP (VB exceed) (NP (NP (DT a) (JJ single) (ADJP (CD 5) (NN mg)) (NN dose)) (PP (IN of) (NP (NN Vardenafil)))) (PP (IN in) (NP (NP (DT a) (JJ 24-hour) (NN period)) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN erythromycin)))))))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
xsubj(exceed-6, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
neg(exceed-6, not-4)
aux(exceed-6, to-5)
ccomp(recommended-3, exceed-6)
xcomp(recommended-3, exceed-6)
det(dose-11, a-7)
amod(dose-11, single-8)
number(mg-10, 5-9)
amod(dose-11, mg-10)
dobj(exceed-6, dose-11)
prep_of(dose-11, Vardenafil-13)
det(period-17, a-15)
amod(period-17, 24-hour-16)
prep_in(exceed-6, period-17)
advmod(used-19, when-18)
dep(period-17, used-19)
prep_in(used-19, combination-21)
prep_with(combination-21, erythromycin-23)

Ketoconazole/NN (/-LRB- 200/CD mg/NN once/RB daily/JJ )/-RRB- produced/VBD a/DT 10-fold/JJ increase/NN in/IN vardenafil/NN AUC/NN and/CC a/DT 4-fold/JJ increase/NN in/IN Cmax/NN when/WRB co-administered/VBN with/IN Vardenafil/NN (/-LRB- 5/CD mg/NN )/-RRB- in/IN healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Ketoconazole)) (PRN (-LRB- -LRB-) (NP (NP (CD 200) (NN mg)) (ADJP (RB once) (JJ daily))) (-RRB- -RRB-))) (VP (VBD produced) (NP (NP (NP (DT a) (JJ 10-fold) (NN increase)) (PP (IN in) (NP (NN vardenafil) (NN AUC)))) (CC and) (NP (NP (DT a) (JJ 4-fold) (NN increase)) (PP (IN in) (NP (NN Cmax))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-administered) (PP (IN with) (NP (NP (NP (NN Vardenafil)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))))))))) (. .))))

nsubj(produced-8, Ketoconazole-1)
num(mg-4, 200-3)
dep(Ketoconazole-1, mg-4)
advmod(daily-6, once-5)
amod(mg-4, daily-6)
root(ROOT-0, produced-8)
det(increase-11, a-9)
amod(increase-11, 10-fold-10)
dobj(produced-8, increase-11)
nn(AUC-14, vardenafil-13)
prep_in(increase-11, AUC-14)
det(increase-18, a-16)
amod(increase-18, 4-fold-17)
conj_and(increase-11, increase-18)
prep_in(increase-18, Cmax-20)
advmod(co-administered-22, when-21)
advcl(produced-8, co-administered-22)
prep_with(co-administered-22, Vardenafil-24)
num(mg-27, 5-26)
appos(Vardenafil-24, mg-27)
amod(volunteers-31, healthy-30)
prep_in(Vardenafil-24, volunteers-31)

A/DT 5-mg/JJ Vardenafil/NN dose/NN should/MD not/RB be/VB exceeded/VBD when/WRB used/VBN in/IN combination/NN with/IN 200/CD mg/NN once/IN daily/JJ ketoconazole/NN ./.

(ROOT (S1 (S (S (NP (DT A) (JJ 5-mg) (NN Vardenafil) (NN dose)) (VP (MD should) (RB not) (VP (VB be) (VP (VBD exceeded) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (CD 200) (NN mg)) (PP (IN once) (NP (JJ daily) (NN ketoconazole)))))))))))))) (. .))))

det(dose-4, A-1)
amod(dose-4, 5-mg-2)
nn(dose-4, Vardenafil-3)
nsubjpass(exceeded-8, dose-4)
aux(exceeded-8, should-5)
neg(exceeded-8, not-6)
auxpass(exceeded-8, be-7)
root(ROOT-0, exceeded-8)
advmod(used-10, when-9)
advcl(exceeded-8, used-10)
prep_in(used-10, combination-12)
num(mg-15, 200-14)
prep_with(combination-12, mg-15)
amod(ketoconazole-18, daily-17)
prep_once(mg-15, ketoconazole-18)

Since/IN higher/JJR doses/NNS of/IN ketoconazole/NN (/-LRB- 400/CD mg/NN daily/RB )/-RRB- may/MD result/VB in/IN higher/JJR increases/NNS in/IN Cmax/NN and/CC AUC/NN ,/, a/DT single/JJ 2.5/CD mg/NN dose/NN of/IN Vardenafil/NN should/MD not/RB be/VB exceeded/VBD in/IN a/DT 24-hour/JJ period/NN when/WRB used/VBN in/IN combination/NN with/IN ketoconazole/NN 400/CD mg/NN daily/RB ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN ketoconazole)))) (PRN (-LRB- -LRB-) (NP (NP (CD 400) (NN mg)) (ADVP (RB daily))) (-RRB- -RRB-))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (JJR higher) (NNS increases)) (PP (IN in) (NP (NP (NN Cmax)) (CC and) (NP (NN AUC)))))))))) (, ,) (NP (NP (DT a) (JJ single) (ADJP (CD 2.5) (NN mg)) (NN dose)) (PP (IN of) (NP (NN Vardenafil)))) (VP (MD should) (RB not) (VP (VB be) (VP (VBD exceeded) (PP (IN in) (NP (DT a) (JJ 24-hour) (NN period))) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN ketoconazole) (CD 400) (NN mg)) (ADVP (RB daily))))))))))))) (. .))))

mark(result-12, Since-1)
amod(doses-3, higher-2)
nsubj(result-12, doses-3)
prep_of(doses-3, ketoconazole-5)
num(mg-8, 400-7)
dep(doses-3, mg-8)
advmod(mg-8, daily-9)
aux(result-12, may-11)
advcl(exceeded-31, result-12)
amod(increases-15, higher-14)
prep_in(result-12, increases-15)
prep_in(increases-15, Cmax-17)
conj_and(Cmax-17, AUC-19)
det(dose-25, a-21)
amod(dose-25, single-22)
number(mg-24, 2.5-23)
amod(dose-25, mg-24)
nsubjpass(exceeded-31, dose-25)
prep_of(dose-25, Vardenafil-27)
aux(exceeded-31, should-28)
neg(exceeded-31, not-29)
auxpass(exceeded-31, be-30)
root(ROOT-0, exceeded-31)
det(period-35, a-33)
amod(period-35, 24-hour-34)
prep_in(exceeded-31, period-35)
advmod(used-37, when-36)
advcl(exceeded-31, used-37)
prep_in(used-37, combination-39)
nn(mg-43, ketoconazole-41)
num(mg-43, 400-42)
prep_with(combination-39, mg-43)
advmod(mg-43, daily-44)

HIV/NN Protease/NN Inhibitors/NNS :/: Indinavir/NN (/-LRB- 800/CD mg/NN t.i.d./NN )/-RRB- co-administered/VBN with/IN Vardenafil/NN 10/CD mg/NN resulted/VBD in/IN a/DT 16-fold/JJ increase/NN in/IN vardenafil/NN AUC/NN ,/, a/DT 7-fold/JJ increase/NN in/IN vardenafil/NN Cmax/NN and/CC a/DT 2-fold/JJ increase/NN in/IN vardenafil/NN half-life/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN HIV) (NN Protease) (NNS Inhibitors)) (: :) (NP (NP (NN Indinavir)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 800) (NN mg)) (NN t.i.d.)) (-RRB- -RRB-)))) (VP (VBN co-administered) (PP (IN with) (NP (NP (NN Vardenafil)) (ADJP (CD 10) (NN mg)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (JJ 16-fold) (NN increase)) (PP (IN in) (NP (NN vardenafil) (NN AUC)))) (, ,) (NP (NP (DT a) (JJ 7-fold) (NN increase)) (PP (IN in) (NP (NN vardenafil) (NN Cmax)))) (CC and) (NP (NP (DT a) (JJ 2-fold) (NN increase)) (PP (IN in) (NP (NN vardenafil) (NN half-life)))))))) (. .))))

nn(Inhibitors-3, HIV-1)
nn(Inhibitors-3, Protease-2)
nsubj(resulted-16, Inhibitors-3)
dep(Inhibitors-3, Indinavir-5)
number(mg-8, 800-7)
amod(t.i.d.-9, mg-8)
appos(Indinavir-5, t.i.d.-9)
partmod(Inhibitors-3, co-administered-11)
prep_with(co-administered-11, Vardenafil-13)
number(mg-15, 10-14)
amod(Vardenafil-13, mg-15)
root(ROOT-0, resulted-16)
det(increase-20, a-18)
amod(increase-20, 16-fold-19)
prep_in(resulted-16, increase-20)
nn(AUC-23, vardenafil-22)
prep_in(increase-20, AUC-23)
det(increase-27, a-25)
amod(increase-27, 7-fold-26)
conj_and(increase-20, increase-27)
nn(Cmax-30, vardenafil-29)
prep_in(increase-27, Cmax-30)
det(increase-34, a-32)
amod(increase-34, 2-fold-33)
conj_and(increase-20, increase-34)
nn(half-life-37, vardenafil-36)
prep_in(increase-34, half-life-37)

It/PRP is/VBZ recommended/VBN not/RB to/TO exceed/VB a/DT single/JJ 2.5/CD mg/NN Vardenafil/NN dose/NN in/IN a/DT 24-hour/JJ period/NN when/WRB used/VBN in/IN combination/NN with/IN indinavir/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (S (VP (RB not) (TO to) (VP (VB exceed) (NP (DT a) (JJ single) (ADJP (CD 2.5) (NN mg)) (NN Vardenafil) (NN dose)) (PP (IN in) (NP (NP (DT a) (JJ 24-hour) (NN period)) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN indinavir)))))))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
xsubj(exceed-6, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
neg(exceed-6, not-4)
aux(exceed-6, to-5)
ccomp(recommended-3, exceed-6)
xcomp(recommended-3, exceed-6)
det(dose-12, a-7)
amod(dose-12, single-8)
number(mg-10, 2.5-9)
amod(dose-12, mg-10)
nn(dose-12, Vardenafil-11)
dobj(exceed-6, dose-12)
det(period-16, a-14)
amod(period-16, 24-hour-15)
prep_in(exceed-6, period-16)
advmod(used-18, when-17)
dep(period-16, used-18)
prep_in(used-18, combination-20)
prep_with(combination-20, indinavir-22)

Ritonavir/NN (/-LRB- 600/CD mg/NN b.i.d./NN )/-RRB- co-administered/VBN with/IN Vardenafil/NN 5/CD mg/NN resulted/VBD in/IN a/DT 49-fold/JJ increase/NN in/IN vardenafil/NN AUC/NN and/CC a/DT 13-fold/RB increase/NN in/IN vardenafil/NN Cmax/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Ritonavir)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 600) (NN mg)) (NN b.i.d.)) (-RRB- -RRB-))) (VP (VBN co-administered) (PP (IN with) (NP (NN Vardenafil) (CD 5) (NN mg))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (JJ 49-fold) (NN increase)) (PP (IN in) (NP (NN vardenafil) (NN AUC)))) (CC and) (NP (NP (DT a) (ADJP (RB 13-fold)) (NN increase)) (PP (IN in) (NP (NN vardenafil) (NN Cmax)))))))) (. .))))

nsubj(resulted-12, Ritonavir-1)
number(mg-4, 600-3)
amod(b.i.d.-5, mg-4)
appos(Ritonavir-1, b.i.d.-5)
partmod(Ritonavir-1, co-administered-7)
nn(mg-11, Vardenafil-9)
num(mg-11, 5-10)
prep_with(co-administered-7, mg-11)
root(ROOT-0, resulted-12)
det(increase-16, a-14)
amod(increase-16, 49-fold-15)
prep_in(resulted-12, increase-16)
nn(AUC-19, vardenafil-18)
prep_in(increase-16, AUC-19)
det(increase-23, a-21)
amod(increase-23, 13-fold-22)
conj_and(increase-16, increase-23)
nn(Cmax-26, vardenafil-25)
prep_in(increase-23, Cmax-26)

The/DT interaction/NN is/VBZ a/DT consequence/NN of/IN blocking/VBG hepatic/JJ metabolism/NN of/IN vardenafil/NN by/IN ritonavir/NN ,/, a/DT highly/RB potent/JJ CYP3A4/NN inhibitor/NN ,/, which/WDT also/RB inhibits/VBZ CYP2C9/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN interaction)) (VP (VBZ is) (NP (NP (DT a) (NN consequence)) (PP (IN of) (S (VP (VBG blocking) (NP (NP (JJ hepatic) (NN metabolism)) (PP (IN of) (NP (NN vardenafil)))) (PP (IN by) (NP (NP (NN ritonavir)) (, ,) (NP (NP (DT a) (ADJP (RB highly) (JJ potent)) (NN CYP3A4) (NN inhibitor)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB also)) (VP (VBZ inhibits) (NP (NN CYP2C9)))))))))))))) (. .))))

det(interaction-2, The-1)
nsubj(consequence-5, interaction-2)
cop(consequence-5, is-3)
det(consequence-5, a-4)
root(ROOT-0, consequence-5)
prepc_of(consequence-5, blocking-7)
amod(metabolism-9, hepatic-8)
dobj(blocking-7, metabolism-9)
prep_of(metabolism-9, vardenafil-11)
prep_by(blocking-7, ritonavir-13)
det(inhibitor-19, a-15)
advmod(potent-17, highly-16)
amod(inhibitor-19, potent-17)
nn(inhibitor-19, CYP3A4-18)
appos(ritonavir-13, inhibitor-19)
nsubj(inhibits-23, inhibitor-19)
advmod(inhibits-23, also-22)
rcmod(inhibitor-19, inhibits-23)
dobj(inhibits-23, CYP2C9-24)

Ritonavir/NN significantly/RB prolonged/VBD the/DT half-life/NN of/IN vardenafil/NN to/TO 26/CD hours/NNS ./.

(ROOT (S1 (S (S (NP (NN Ritonavir)) (ADVP (RB significantly)) (VP (VBD prolonged) (NP (NP (DT the) (NN half-life)) (PP (IN of) (NP (NN vardenafil))) (PP (TO to) (NP (CD 26) (NNS hours)))))) (. .))))

nsubj(prolonged-3, Ritonavir-1)
advmod(prolonged-3, significantly-2)
root(ROOT-0, prolonged-3)
det(half-life-5, the-4)
dobj(prolonged-3, half-life-5)
prep_of(half-life-5, vardenafil-7)
num(hours-10, 26-9)
prep_to(half-life-5, hours-10)

Consequently/RB ,/, it/PRP is/VBZ recommended/VBN not/RB to/TO exceed/VB a/DT single/JJ 2.5/CD mg/NN Vardenafil/NN dose/NN in/IN a/DT 72-hour/JJ period/NN when/WRB used/VBN in/IN combination/NN with/IN ritonavir/NN ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (S (VP (RB not) (TO to) (VP (VB exceed) (NP (DT a) (JJ single) (ADJP (CD 2.5) (NN mg)) (NN Vardenafil) (NN dose)) (PP (IN in) (NP (NP (DT a) (JJ 72-hour) (NN period)) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN ritonavir)))))))))))))))) (. .))))

advmod(recommended-5, Consequently-1)
nsubjpass(recommended-5, it-3)
xsubj(exceed-8, it-3)
auxpass(recommended-5, is-4)
root(ROOT-0, recommended-5)
neg(exceed-8, not-6)
aux(exceed-8, to-7)
ccomp(recommended-5, exceed-8)
xcomp(recommended-5, exceed-8)
det(dose-14, a-9)
amod(dose-14, single-10)
number(mg-12, 2.5-11)
amod(dose-14, mg-12)
nn(dose-14, Vardenafil-13)
dobj(exceed-8, dose-14)
det(period-18, a-16)
amod(period-18, 72-hour-17)
prep_in(exceed-8, period-18)
advmod(used-20, when-19)
dep(period-18, used-20)
prep_in(used-20, combination-22)
prep_with(combination-22, ritonavir-24)

Other/JJ Drug/NN Interactions/NNS :/: No/DT pharmacokinetic/JJ interactions/NNS were/VBD observed/VBN between/IN vardenafil/NN and/CC the/DT following/JJ drugs/NNS :/: glyburide/NN ,/, warfarin/NN ,/, digoxin/NN ,/, Maalox/NN ,/, and/CC ranitidine/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NN Drug) (NNS Interactions)) (: :) (S (NP (DT No) (JJ pharmacokinetic) (NNS interactions)) (VP (VBD were) (VP (VBN observed) (PP (IN between) (NP (NP (NN vardenafil)) (CC and) (NP (DT the) (JJ following) (NNS drugs))))))) (: :) (NP (NP (NN glyburide)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN Maalox)) (, ,) (CC and) (NP (NN ranitidine))) (. .)))))

amod(Interactions-3, Other-1)
nn(Interactions-3, Drug-2)
root(ROOT-0, Interactions-3)
det(interactions-7, No-5)
amod(interactions-7, pharmacokinetic-6)
nsubjpass(observed-9, interactions-7)
auxpass(observed-9, were-8)
dep(Interactions-3, observed-9)
prep_between(observed-9, vardenafil-11)
det(drugs-15, the-13)
amod(drugs-15, following-14)
conj_and(vardenafil-11, drugs-15)
dep(Interactions-3, glyburide-17)
conj_and(glyburide-17, warfarin-19)
conj_and(glyburide-17, digoxin-21)
conj_and(glyburide-17, Maalox-23)
conj_and(glyburide-17, ranitidine-26)

In/IN the/DT warfarin/JJ study/NN ,/, vardenafil/NN had/VBD no/DT effect/NN on/IN the/DT prothrombin/NN time/NN or/CC other/JJ pharmacodynamic/JJ parameters/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT the) (JJ warfarin) (NN study))) (, ,) (NP (NN vardenafil)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN prothrombin) (NN time)) (CC or) (NP (JJ other) (JJ pharmacodynamic) (NNS parameters)))))) (. .))))

det(study-4, the-2)
amod(study-4, warfarin-3)
prep_in(had-7, study-4)
nsubj(had-7, vardenafil-6)
root(ROOT-0, had-7)
det(effect-9, no-8)
dobj(had-7, effect-9)
det(time-13, the-11)
nn(time-13, prothrombin-12)
prep_on(had-7, time-13)
amod(parameters-17, other-15)
amod(parameters-17, pharmacodynamic-16)
conj_or(time-13, parameters-17)

Effects/NNS of/IN Vardenafil/NN on/IN other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NN Vardenafil))) (PP (IN on) (NP (JJ other) (NNS drugs))))) (. .))))

root(ROOT-0, Effects-1)
prep_of(Effects-1, Vardenafil-3)
amod(drugs-6, other-5)
prep_on(Effects-1, drugs-6)

In/FW vitro/FW studies/NNS :/: Vardenafil/NN and/CC its/PRP$ metabolites/NNS had/VBD no/DT effect/NN on/IN CYP1A2/NN ,/, 2A6/NN ,/, and/CC 2E1/NN (/-LRB- Ki/NN 100uM/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (: :) (S (NP (NP (NN Vardenafil)) (CC and) (NP (PRP$ its) (NNS metabolites))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN CYP1A2)) (, ,) (NP (NN 2A6)) (, ,) (CC and) (NP (NP (NN 2E1)) (PRN (-LRB- -LRB-) (NP (NN Ki) (NN 100uM)) (-RRB- -RRB-))))))) (. .)))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
root(ROOT-0, studies-3)
nsubj(had-9, Vardenafil-5)
poss(metabolites-8, its-7)
conj_and(Vardenafil-5, metabolites-8)
dep(studies-3, had-9)
det(effect-11, no-10)
dobj(had-9, effect-11)
prep_on(had-9, CYP1A2-13)
conj_and(CYP1A2-13, 2A6-15)
conj_and(CYP1A2-13, 2E1-18)
nn(100uM-21, Ki-20)
appos(2E1-18, 100uM-21)

Weak/JJ inhibitory/JJ effects/NNS toward/IN other/JJ isoforms/NNS (/-LRB- CYP2C8/NN ,/, 2C9/NN ,/, 2C19/NN ,/, 2D6/NN ,/, 3A4/NN )/-RRB- were/VBD found/VBN ,/, but/CC Ki/NN values/NNS were/VBD in/IN excess/NN of/IN plasma/NN concentrations/NNS achieved/VBN following/VBG dosing/NN ./.

(ROOT (S1 (S (S (S (NP (NP (JJ Weak) (JJ inhibitory) (NNS effects)) (PP (IN toward) (NP (NP (JJ other) (NNS isoforms)) (PRN (-LRB- -LRB-) (NP (NP (NN CYP2C8)) (, ,) (NP (NN 2C9)) (, ,) (NP (NN 2C19)) (, ,) (NP (NN 2D6)) (, ,) (NP (NN 3A4))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN found)))) (, ,) (CC but) (S (NP (NN Ki) (NNS values)) (VP (VBD were) (PP (IN in) (NP (NP (NN excess)) (PP (IN of) (NP (NP (NN plasma) (NNS concentrations)) (VP (VBN achieved) (PP (VBG following) (NP (NN dosing))))))))))) (. .))))

amod(effects-3, Weak-1)
amod(effects-3, inhibitory-2)
nsubjpass(found-19, effects-3)
amod(isoforms-6, other-5)
prep_toward(effects-3, isoforms-6)
dep(isoforms-6, CYP2C8-8)
appos(CYP2C8-8, 2C9-10)
appos(CYP2C8-8, 2C19-12)
appos(CYP2C8-8, 2D6-14)
appos(CYP2C8-8, 3A4-16)
auxpass(found-19, were-18)
root(ROOT-0, found-19)
nn(values-23, Ki-22)
nsubj(were-24, values-23)
conj_but(found-19, were-24)
prep_in(were-24, excess-26)
nn(concentrations-29, plasma-28)
prep_of(excess-26, concentrations-29)
partmod(concentrations-29, achieved-30)
prep_following(achieved-30, dosing-32)

The/DT most/RBS potent/JJ inhibitory/JJ activity/NN was/VBD observed/VBN for/IN vardenafil/NN metabolite/NN M1/NN ,/, which/WDT had/VBD a/DT Ki/NN of/IN 1.4/CD uM/NN toward/IN CYP3A4/NN ,/, which/WDT is/VBZ about/RB 20/CD times/NNS higher/JJR than/IN the/DT M1/NN Cmax/NN values/NNS after/IN an/DT 80/CD mg/NN Vardenafil/NN dose/NN ./.

(ROOT (S1 (S (S (NP (DT The) (ADJP (RBS most) (JJ potent)) (JJ inhibitory) (NN activity)) (VP (VBD was) (VP (VBN observed) (PP (IN for) (NP (NP (NN vardenafil) (NN metabolite) (NN M1)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD had) (NP (NP (DT a) (NN Ki)) (PP (IN of) (NP (NP (CD 1.4) (NN uM)) (PP (IN toward) (NP (NN CYP3A4))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (ADJP (QP (RB about) (CD 20) (NNS times)) (JJR higher)) (PP (IN than) (NP (NP (DT the) (NN M1) (NN Cmax) (NNS values)) (PP (IN after) (NP (DT an) (ADJP (CD 80) (NN mg)) (NN Vardenafil) (NN dose)))))))))))))))))) (. .))))

det(activity-5, The-1)
advmod(potent-3, most-2)
amod(activity-5, potent-3)
amod(activity-5, inhibitory-4)
nsubjpass(observed-7, activity-5)
auxpass(observed-7, was-6)
root(ROOT-0, observed-7)
nn(M1-11, vardenafil-9)
nn(M1-11, metabolite-10)
prep_for(observed-7, M1-11)
nsubj(had-14, M1-11)
rcmod(M1-11, had-14)
det(Ki-16, a-15)
dobj(had-14, Ki-16)
nsubj(times-27, Ki-16)
num(uM-19, 1.4-18)
prep_of(Ki-16, uM-19)
prep_toward(uM-19, CYP3A4-21)
cop(times-27, is-24)
quantmod(times-27, about-25)
number(times-27, 20-26)
rcmod(Ki-16, times-27)
dep(times-27, higher-28)
det(values-33, the-30)
nn(values-33, M1-31)
nn(values-33, Cmax-32)
prep_than(times-27, values-33)
det(dose-39, an-35)
number(mg-37, 80-36)
amod(dose-39, mg-37)
nn(dose-39, Vardenafil-38)
prep_after(values-33, dose-39)

In/FW vivo/FW studies/NNS :/: Nitrates/NNS :/: The/DT blood/NN pressure/NN lowering/JJ effects/NNS of/IN sublingual/JJ nitrates/NNS (/-LRB- 0.4/CD mg/NN )/-RRB- taken/VBN 1/CD and/CC 4/CD hours/NNS after/IN vardenafil/NN and/CC increases/NNS in/IN heart/NN rate/NN when/WRB taken/VBN at/IN 1/CD ,/, 4/CD and/CC 8/CD hours/NNS were/VBD potentiated/VBN by/IN a/DT 20/CD mg/NN dose/NN of/IN Vardenafil/NN in/IN healthy/JJ middle-aged/JJ subjects/NNS ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vivo)) (NNS studies)) (: :) (NP (NNS Nitrates)) (: :) (NP (NP (DT The) (NN blood) (NN pressure) (JJ lowering) (NNS effects)) (PP (IN of) (NP (NP (NP (JJ sublingual) (NNS nitrates)) (PRN (-LRB- -LRB-) (NP (CD 0.4) (NN mg)) (-RRB- -RRB-))) (VP (VBN taken) (PP (NP (QP (CD 1) (CC and) (CD 4)) (NNS hours)) (IN after) (NP (NN vardenafil))))))) (CC and) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN heart) (NN rate)) (SBAR (WHADVP (WRB when)) (S (VP (VBN taken) (PP (IN at) (NP (QP (CD 1) (, ,) (CD 4) (CC and) (CD 8)) (NNS hours)))))))))) (VP (VBD were) (VP (VBN potentiated) (PP (IN by) (NP (NP (DT a) (ADJP (CD 20) (NN mg)) (NN dose)) (PP (IN of) (NP (NP (NN Vardenafil)) (PP (IN in) (NP (JJ healthy) (JJ middle-aged) (NNS subjects)))))))))) (. .))))

nn(vivo-2, In-1)
amod(studies-3, vivo-2)
nsubjpass(potentiated-41, studies-3)
conj_and(studies-3, Nitrates-5)
det(effects-11, The-7)
nn(effects-11, blood-8)
nn(effects-11, pressure-9)
amod(effects-11, lowering-10)
conj_and(studies-3, effects-11)
amod(nitrates-14, sublingual-13)
prep_of(effects-11, nitrates-14)
num(mg-17, 0.4-16)
appos(nitrates-14, mg-17)
partmod(nitrates-14, taken-19)
num(hours-23, 1-20)
conj_and(1-20, 4-22)
npadvmod(taken-19, hours-23)
prep_after(taken-19, vardenafil-25)
conj_and(studies-3, increases-27)
nn(rate-30, heart-29)
prep_in(increases-27, rate-30)
advmod(taken-32, when-31)
dep(rate-30, taken-32)
num(hours-39, 1-34)
number(1-34, 4-36)
conj_and(1-34, 8-38)
prep_at(taken-32, hours-39)
auxpass(potentiated-41, were-40)
root(ROOT-0, potentiated-41)
det(dose-46, a-43)
number(mg-45, 20-44)
amod(dose-46, mg-45)
agent(potentiated-41, dose-46)
prep_of(dose-46, Vardenafil-48)
amod(subjects-52, healthy-50)
amod(subjects-52, middle-aged-51)
prep_in(Vardenafil-48, subjects-52)

These/DT effects/NNS were/VBD not/RB observed/VBN when/WRB Vardenafil/NN 20/CD mg/NN was/VBD taken/VBN 24/CD hours/NNS before/IN the/DT NTG/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS effects)) (VP (VBD were) (RB not) (VP (VBN observed)) (SBAR (WHADVP (WRB when)) (S (NP (NN Vardenafil) (CD 20) (NN mg)) (VP (VBD was) (VP (VBN taken) (PP (NP (CD 24) (NNS hours)) (IN before) (NP (DT the) (NN NTG))))))))) (. .))))

det(effects-2, These-1)
nsubjpass(observed-5, effects-2)
auxpass(observed-5, were-3)
neg(observed-5, not-4)
root(ROOT-0, observed-5)
advmod(taken-11, when-6)
nn(mg-9, Vardenafil-7)
num(mg-9, 20-8)
nsubjpass(taken-11, mg-9)
auxpass(taken-11, was-10)
advcl(observed-5, taken-11)
num(hours-13, 24-12)
npadvmod(taken-11, hours-13)
det(NTG-16, the-15)
prep_before(taken-11, NTG-16)

Potentiation/NN of/IN the/DT hypotensive/JJ effects/NNS of/IN nitrates/NNS for/IN patients/NNS with/IN ischemic/JJ heart/NN disease/NN has/VBZ not/RB been/VBN evaluated/VBN ,/, and/CC concomitant/JJ use/NN of/IN Vardenafil/NN and/CC nitrates/NNS is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Potentiation)) (PP (IN of) (NP (NP (DT the) (JJ hypotensive) (NNS effects)) (PP (IN of) (NP (NNS nitrates))) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ ischemic) (NN heart) (NN disease)))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN evaluated))))) (, ,) (CC and) (S (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN Vardenafil)) (CC and) (NP (NNS nitrates))))) (VP (VBZ is) (VP (VBN contraindicated))))) (. .))))

nsubjpass(evaluated-17, Potentiation-1)
det(effects-5, the-3)
amod(effects-5, hypotensive-4)
prep_of(Potentiation-1, effects-5)
prep_of(effects-5, nitrates-7)
prep_for(effects-5, patients-9)
amod(disease-13, ischemic-11)
nn(disease-13, heart-12)
prep_with(patients-9, disease-13)
aux(evaluated-17, has-14)
neg(evaluated-17, not-15)
auxpass(evaluated-17, been-16)
root(ROOT-0, evaluated-17)
amod(use-21, concomitant-20)
nsubjpass(contraindicated-27, use-21)
prep_of(use-21, Vardenafil-23)
conj_and(Vardenafil-23, nitrates-25)
auxpass(contraindicated-27, is-26)
conj_and(evaluated-17, contraindicated-27)

Nifedipine/NN :/: Vardenafil/NN 20/CD mg/NN ,/, when/WRB co-administered/VBN with/IN slow-release/JJ nifedipine/NN 30/CD mg/NN or/CC 60/CD mg/NN once/RB daily/RB ,/, did/VBD not/RB affect/VB the/DT relative/JJ bioavailability/NN (/-LRB- AUC/NN )/-RRB- or/CC maximum/JJ concentration/NN (/-LRB- Cmax/NN )/-RRB- of/IN nifedipine/NN ,/, a/DT drug/NN that/WDT is/VBZ metabolized/VBN via/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Nifedipine)) (: :) (NP (NP (NN Vardenafil)) (ADJP (CD 20) (NN mg))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-administered) (PP (IN with) (NP (NP (JJ slow-release) (NN nifedipine) (CD 30) (NN mg)) (CC or) (NP (NP (CD 60) (NN mg)) (ADVP (RB once) (RB daily)))))))) (, ,)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (NP (DT the) (JJ relative) (NN bioavailability)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (CC or) (NP (NP (NP (JJ maximum) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NN Cmax)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN nifedipine)) (, ,) (NP (NP (DT a) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN metabolized) (PP (IN via) (NP (NN CYP3A4))))))))))))))) (. .))))

nsubj(affect-22, Nifedipine-1)
dep(Nifedipine-1, Vardenafil-3)
number(mg-5, 20-4)
amod(Vardenafil-3, mg-5)
advmod(co-administered-8, when-7)
dep(Nifedipine-1, co-administered-8)
amod(mg-13, slow-release-10)
nn(mg-13, nifedipine-11)
num(mg-13, 30-12)
prep_with(co-administered-8, mg-13)
num(mg-16, 60-15)
conj_or(mg-13, mg-16)
advmod(daily-18, once-17)
advmod(mg-16, daily-18)
aux(affect-22, did-20)
neg(affect-22, not-21)
root(ROOT-0, affect-22)
det(bioavailability-25, the-23)
amod(bioavailability-25, relative-24)
dobj(affect-22, bioavailability-25)
abbrev(bioavailability-25, AUC-27)
amod(concentration-31, maximum-30)
conj_or(bioavailability-25, concentration-31)
appos(concentration-31, Cmax-33)
prep_of(concentration-31, nifedipine-36)
det(drug-39, a-38)
appos(nifedipine-36, drug-39)
nsubjpass(metabolized-42, drug-39)
auxpass(metabolized-42, is-41)
rcmod(drug-39, metabolized-42)
prep_via(metabolized-42, CYP3A4-44)

Nifedipine/NN did/VBD not/RB alter/VB the/DT plasma/NN levels/NNS of/IN Vardenafil/NN when/WRB taken/VBN in/IN combination/NN ./.

(ROOT (S1 (S (S (NP (NN Nifedipine)) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN Vardenafil))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN taken) (PP (IN in) (NP (NN combination)))))))) (. .))))

nsubj(alter-4, Nifedipine-1)
aux(alter-4, did-2)
neg(alter-4, not-3)
root(ROOT-0, alter-4)
det(levels-7, the-5)
nn(levels-7, plasma-6)
dobj(alter-4, levels-7)
prep_of(levels-7, Vardenafil-9)
advmod(taken-11, when-10)
advcl(alter-4, taken-11)
prep_in(taken-11, combination-13)

In/IN these/DT patients/NNS whose/WP$ hypertension/NN was/VBD controlled/VBN with/IN nifedipine/NN ,/, Vardenafil/NN 20/CD mg/NN produced/VBD mean/JJ additional/JJ supine/NN systolic/diastolic/JJ blood/NN pressure/NN reductions/NNS of/IN 6/5/CD mm/NN Hg/NN compared/VBN to/TO placebo/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT these) (NNS patients)) (SBAR (WHNP (WP$ whose) (NN hypertension)) (S (VP (VBD was) (VP (VBN controlled) (PP (IN with) (NP (NN nifedipine))))))))) (, ,) (NP (NP (NN Vardenafil)) (ADJP (CD 20) (NN mg))) (VP (VBD produced) (NP (NP (NP (JJ mean) (JJ additional) (NN supine) (JJ systolic/diastolic) (NN blood) (NN pressure)) (NNS reductions)) (PP (IN of) (NP (ADJP (CD 6/5) (NN mm)) (NN Hg)))) (PP (VBN compared) (PP (TO to) (NP (NN placebo)))))) (. .))))

det(patients-3, these-2)
poss(hypertension-5, patients-3)
prep_in(produced-14, patients-3)
nsubjpass(controlled-7, hypertension-5)
auxpass(controlled-7, was-6)
rcmod(patients-3, controlled-7)
prep_with(controlled-7, nifedipine-9)
nsubj(produced-14, Vardenafil-11)
number(mg-13, 20-12)
amod(Vardenafil-11, mg-13)
root(ROOT-0, produced-14)
amod(pressure-20, mean-15)
amod(pressure-20, additional-16)
nn(pressure-20, supine-17)
amod(pressure-20, systolic/diastolic-18)
nn(pressure-20, blood-19)
nn(reductions-21, pressure-20)
dobj(produced-14, reductions-21)
number(mm-24, 6/5-23)
amod(Hg-25, mm-24)
prep_of(reductions-21, Hg-25)
prepc_compared_to(produced-14, to-27)
pobj(produced-14, placebo-28)

Alpha-blockers/NNS :/: When/WRB Vardenafil/NN 10/CD or/CC 20/CD mg/NN was/VBD given/VBN to/TO healthy/JJ volunteers/NNS either/CC simultaneously/RB or/CC 6/CD hours/NNS after/IN a/DT 10/CD mg/NN dose/NN of/IN terazosin/NN ,/, significant/JJ hypotension/NN developed/VBD in/IN a/DT substantial/JJ number/NN of/IN subjects/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Alpha-blockers)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NN Vardenafil) (CD 10) (CC or) (CD 20) (NN mg)) (VP (VBD was) (UCP (VP (VBN given) (PP (TO to) (NP (JJ healthy) (NNS volunteers)))) (CC either) (ADVP (RB simultaneously)) (CC or) (PP (NP (CD 6) (NNS hours)) (IN after) (NP (NP (DT a) (ADJP (CD 10) (NN mg)) (NN dose)) (PP (IN of) (NP (NN terazosin))))))))) (, ,) (NP (JJ significant) (NN hypotension)) (VP (VBD developed) (PP (IN in) (NP (NP (DT a) (JJ substantial) (NN number)) (PP (IN of) (NP (NNS subjects))))))) (. .)))))

root(ROOT-0, Alpha-blockers-1)
advmod(was-9, When-3)
nsubj(was-9, Vardenafil-4)
num(Vardenafil-4, 10-5)
num(mg-8, 20-7)
conj_or(Vardenafil-4, mg-8)
advcl(developed-29, was-9)
dep(was-9, given-10)
amod(volunteers-13, healthy-12)
prep_to(given-10, volunteers-13)
preconj(given-10, either-14)
conj_or(given-10, simultaneously-15)
conj_or(given-10, or-16)
num(hours-18, 6-17)
npadvmod(after-19, hours-18)
conj_or(given-10, after-19)
det(dose-23, a-20)
number(mg-22, 10-21)
amod(dose-23, mg-22)
pobj(after-19, dose-23)
prep_of(dose-23, terazosin-25)
amod(hypotension-28, significant-27)
nsubj(developed-29, hypotension-28)
dep(Alpha-blockers-1, developed-29)
det(number-33, a-31)
amod(number-33, substantial-32)
prep_in(developed-29, number-33)
prep_of(number-33, subjects-35)

With/IN simultaneous/JJ dosing/NN of/IN Vardenafil/NN 10/CD mg/NN and/CC terazosin/NN 10/CD mg/NN ,/, 6/CD of/IN 8/CD subjects/NNS experienced/VBN a/DT standing/JJ systolic/JJ blood/NN pressure/NN of/IN less/JJR than/IN 85/CD mm/NN Hg/NN ./.

(ROOT (S1 (S (S (PP (IN With) (NP (NP (JJ simultaneous) (NN dosing)) (PP (IN of) (NP (NP (NN Vardenafil) (CD 10) (NN mg)) (CC and) (NP (NN terazosin) (CD 10) (NN mg)))))) (, ,) (NP (QP (CD 6) (IN of) (CD 8)) (NNS subjects)) (VP (VBN experienced) (NP (NP (DT a) (JJ standing) (JJ systolic) (NN blood) (NN pressure)) (PP (IN of) (NP (QP (JJR less) (IN than) (CD 85)) (NN mm) (NN Hg)))))) (. .))))

amod(dosing-3, simultaneous-2)
prep_with(experienced-17, dosing-3)
nn(mg-7, Vardenafil-5)
num(mg-7, 10-6)
prep_of(dosing-3, mg-7)
nn(mg-11, terazosin-9)
num(mg-11, 10-10)
conj_and(mg-7, mg-11)
number(8-15, 6-13)
quantmod(8-15, of-14)
num(subjects-16, 8-15)
nsubj(experienced-17, subjects-16)
root(ROOT-0, experienced-17)
det(pressure-22, a-18)
amod(pressure-22, standing-19)
amod(pressure-22, systolic-20)
nn(pressure-22, blood-21)
dobj(experienced-17, pressure-22)
mwe(than-25, less-24)
quantmod(85-26, than-25)
num(Hg-28, 85-26)
nn(Hg-28, mm-27)
prep_of(pressure-22, Hg-28)

With/IN simultaneous/JJ dosing/NN of/IN Vardenafil/NN 20/CD mg/NN and/CC terazosin/NN 10/CD mg/NN ,/, 2/CD of/IN 9/CD subjects/NNS experienced/VBN a/DT standing/JJ systolic/JJ blood/NN pressure/NN of/IN less/JJR than/IN 85/CD mm/NN Hg/NN ./.

(ROOT (S1 (S (S (PP (IN With) (NP (NP (JJ simultaneous) (NN dosing)) (PP (IN of) (NP (NP (NN Vardenafil) (CD 20) (NN mg)) (CC and) (NP (NN terazosin) (CD 10) (NN mg)))))) (, ,) (NP (QP (CD 2) (IN of) (CD 9)) (NNS subjects)) (VP (VBN experienced) (NP (NP (DT a) (JJ standing) (JJ systolic) (NN blood) (NN pressure)) (PP (IN of) (NP (QP (JJR less) (IN than) (CD 85)) (NN mm) (NN Hg)))))) (. .))))

amod(dosing-3, simultaneous-2)
prep_with(experienced-17, dosing-3)
nn(mg-7, Vardenafil-5)
num(mg-7, 20-6)
prep_of(dosing-3, mg-7)
nn(mg-11, terazosin-9)
num(mg-11, 10-10)
conj_and(mg-7, mg-11)
number(9-15, 2-13)
quantmod(9-15, of-14)
num(subjects-16, 9-15)
nsubj(experienced-17, subjects-16)
root(ROOT-0, experienced-17)
det(pressure-22, a-18)
amod(pressure-22, standing-19)
amod(pressure-22, systolic-20)
nn(pressure-22, blood-21)
dobj(experienced-17, pressure-22)
mwe(than-25, less-24)
quantmod(85-26, than-25)
num(Hg-28, 85-26)
nn(Hg-28, mm-27)
prep_of(pressure-22, Hg-28)

When/WRB Vardenafil/NN dosing/NN was/VBD separated/VBN from/IN terazosin/NN 10/CD mg/NN by/IN 6/CD hours/NNS ,/, 7/CD of/IN 28/CD subjects/NNS who/WP received/VBD 20/CD mg/NN of/IN Vardenafil/NN experienced/VBN a/DT decrease/NN in/IN standing/JJ systolic/JJ blood/NN pressure/NN below/IN 85/CD mm/NN Hg/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN Vardenafil) (NN dosing)) (VP (VBD was) (VP (VBN separated) (PP (IN from) (NP (NN terazosin) (CD 10) (NN mg))) (PP (IN by) (NP (CD 6) (NNS hours))))))) (, ,) (NP (NP (QP (CD 7) (IN of) (CD 28)) (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (CD 20) (NN mg)) (PP (IN of) (NP (NN Vardenafil)))))))) (VP (VBN experienced) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (JJ standing) (JJ systolic) (NN blood) (NN pressure)) (PP (IN below) (NP (ADJP (CD 85) (NN mm)) (NN Hg)))))))) (. .))))

advmod(separated-5, When-1)
nn(dosing-3, Vardenafil-2)
nsubjpass(separated-5, dosing-3)
auxpass(separated-5, was-4)
advcl(experienced-24, separated-5)
nn(mg-9, terazosin-7)
num(mg-9, 10-8)
prep_from(separated-5, mg-9)
num(hours-12, 6-11)
agent(separated-5, hours-12)
number(28-16, 7-14)
quantmod(28-16, of-15)
num(subjects-17, 28-16)
nsubj(received-19, subjects-17)
nsubj(experienced-24, subjects-17)
rcmod(subjects-17, received-19)
num(mg-21, 20-20)
dobj(received-19, mg-21)
prep_of(mg-21, Vardenafil-23)
root(ROOT-0, experienced-24)
det(decrease-26, a-25)
dobj(experienced-24, decrease-26)
amod(pressure-31, standing-28)
amod(pressure-31, systolic-29)
nn(pressure-31, blood-30)
prep_in(decrease-26, pressure-31)
number(mm-34, 85-33)
amod(Hg-35, mm-34)
prep_below(pressure-31, Hg-35)

In/IN a/DT similar/JJ study/NN with/IN tamsulosin/NN in/IN healthy/JJ volunteers/NNS ,/, 1/CD of/IN 24/CD subjects/NNS dosed/VBN with/IN Vardenafil/NN 20/CD mg/NN and/CC tamsulosin/NN 0.4/CD mg/NN separated/VBN by/IN 6/CD hours/NNS experienced/VBN a/DT standing/JJ systolic/JJ blood/NN pressure/NN below/IN 85/CD mm/NN Hg/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (JJ similar) (NN study)) (PP (IN with) (NP (NN tamsulosin))) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))) (, ,) (NP (NP (QP (CD 1) (IN of) (CD 24)) (NNS subjects)) (VP (VBN dosed) (PP (IN with) (NP (NP (NP (NN Vardenafil) (CD 20) (NN mg)) (CC and) (NP (NN tamsulosin) (CD 0.4) (NN mg))) (VP (VBN separated) (PP (IN by) (NP (CD 6) (NNS hours)))))))) (VP (VBN experienced) (NP (NP (DT a) (JJ standing) (JJ systolic) (NN blood) (NN pressure)) (PP (IN below) (NP (ADJP (CD 85) (NN mm)) (NN Hg))))) (. .))))

det(study-4, a-2)
amod(study-4, similar-3)
prep_in(experienced-28, study-4)
prep_with(study-4, tamsulosin-6)
amod(volunteers-9, healthy-8)
prep_in(study-4, volunteers-9)
number(24-13, 1-11)
quantmod(24-13, of-12)
num(subjects-14, 24-13)
nsubj(experienced-28, subjects-14)
partmod(subjects-14, dosed-15)
nn(mg-19, Vardenafil-17)
num(mg-19, 20-18)
prep_with(dosed-15, mg-19)
nn(mg-23, tamsulosin-21)
num(mg-23, 0.4-22)
conj_and(mg-19, mg-23)
partmod(mg-19, separated-24)
num(hours-27, 6-26)
agent(separated-24, hours-27)
root(ROOT-0, experienced-28)
det(pressure-33, a-29)
amod(pressure-33, standing-30)
amod(pressure-33, systolic-31)
nn(pressure-33, blood-32)
dobj(experienced-28, pressure-33)
number(mm-36, 85-35)
amod(Hg-37, mm-36)
prep_below(pressure-33, Hg-37)

Two/CD of/IN 16/CD subjects/NNS dosed/VBN simultaneously/RB with/IN Vardenafil/NN 10/CD mg/NN and/CC tamsulosin/NN 0.4/CD mg/NN experienced/VBN a/DT standing/JJ systolic/JJ blood/NN pressure/NN below/IN 85/CD mm/NN Hg/NN ./.

(ROOT (S1 (S (S (NP (NP (CD Two)) (PP (IN of) (NP (NP (CD 16) (NNS subjects)) (VP (VBN dosed) (ADVP (RB simultaneously)) (PP (IN with) (NP (NP (NN Vardenafil) (CD 10) (NN mg)) (CC and) (NP (NN tamsulosin) (CD 0.4) (NN mg)))))))) (VP (VBN experienced) (NP (NP (DT a) (JJ standing) (JJ systolic) (NN blood) (NN pressure)) (PP (IN below) (NP (ADJP (CD 85) (NN mm)) (NN Hg)))))) (. .))))

nsubj(experienced-15, Two-1)
num(subjects-4, 16-3)
prep_of(Two-1, subjects-4)
partmod(subjects-4, dosed-5)
advmod(dosed-5, simultaneously-6)
nn(mg-10, Vardenafil-8)
num(mg-10, 10-9)
prep_with(dosed-5, mg-10)
nn(mg-14, tamsulosin-12)
num(mg-14, 0.4-13)
conj_and(mg-10, mg-14)
root(ROOT-0, experienced-15)
det(pressure-20, a-16)
amod(pressure-20, standing-17)
amod(pressure-20, systolic-18)
nn(pressure-20, blood-19)
dobj(experienced-15, pressure-20)
number(mm-23, 85-22)
amod(Hg-24, mm-23)
prep_below(pressure-20, Hg-24)

The/DT administration/NN of/IN lower/JJR doses/NNS of/IN Vardenafil/NN with/IN alpha-blockers/NNS has/VBZ not/RB been/VBN completely/RB evaluated/VBN to/TO determine/VB if/IN they/PRP can/MD be/VB safely/RB administered/VBN together/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NP (JJR lower) (NNS doses)) (PP (IN of) (NP (NP (NN Vardenafil)) (PP (IN with) (NP (NNS alpha-blockers)))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB completely)) (VP (VBN evaluated) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (PRP they)) (VP (MD can) (VP (VB be) (ADVP (RB safely)) (VP (VBN administered) (ADVP (RB together)))))))))))))) (. .))))

det(administration-2, The-1)
nsubjpass(evaluated-14, administration-2)
xsubj(determine-16, administration-2)
amod(doses-5, lower-4)
prep_of(administration-2, doses-5)
prep_of(doses-5, Vardenafil-7)
prep_with(Vardenafil-7, alpha-blockers-9)
aux(evaluated-14, has-10)
neg(evaluated-14, not-11)
auxpass(evaluated-14, been-12)
advmod(evaluated-14, completely-13)
root(ROOT-0, evaluated-14)
aux(determine-16, to-15)
xcomp(evaluated-14, determine-16)
mark(administered-22, if-17)
nsubjpass(administered-22, they-18)
aux(administered-22, can-19)
auxpass(administered-22, be-20)
advmod(administered-22, safely-21)
advcl(determine-16, administered-22)
advmod(administered-22, together-23)

Based/VBN on/IN these/DT data/NNS ,/, Vardenafil/NN should/MD not/RB be/VB used/VBN in/IN patients/NNS on/IN alpha-blocker/NN therapy/NN ./.

(ROOT (S1 (S (S (PP (VBN Based) (PP (IN on) (NP (DT these) (NNS data)))) (, ,) (NP (NN Vardenafil)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NN alpha-blocker) (NN therapy))))))))) (. .))))

prepc_based_on(used-10, on-2)
det(data-4, these-3)
pobj(used-10, data-4)
nsubjpass(used-10, Vardenafil-6)
aux(used-10, should-7)
neg(used-10, not-8)
auxpass(used-10, be-9)
root(ROOT-0, used-10)
prep_in(used-10, patients-12)
nn(therapy-15, alpha-blocker-14)
prep_on(patients-12, therapy-15)

Ritonavir/NN and/CC indinavir/NN :/: Upon/IN concomitant/JJ administration/NN of/IN 5/CD mg/NN of/IN Vardenafil/NN with/IN 600/CD mg/NN BID/NN ritonavir/NN ,/, the/DT Cmax/NN and/CC AUC/NN of/IN ritonavir/NN were/VBD reduced/VBN by/IN approximately/RB 20/CD %./NN

(ROOT (S1 (S (NP (NP (NP (NN Ritonavir)) (CC and) (NP (NN indinavir))) (: :) (S (PP (IN Upon) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (CD 5) (NN mg)) (PP (IN of) (NP (NN Vardenafil))) (PP (IN with) (NP (ADJP (CD 600) (NN mg)) (NN BID) (NN ritonavir))))))) (, ,) (NP (NP (DT the) (NP (NN Cmax)) (CC and) (NP (NN AUC))) (PP (IN of) (NP (NN ritonavir)))) (VP (VBD were) (VP (VBN reduced) (PP (IN by) (NP (QP (RB approximately) (CD 20)) (NN %.))))))))))

root(ROOT-0, Ritonavir-1)
conj_and(Ritonavir-1, indinavir-3)
amod(administration-7, concomitant-6)
prep_upon(reduced-26, administration-7)
num(mg-10, 5-9)
prep_of(administration-7, mg-10)
prep_of(mg-10, Vardenafil-12)
number(mg-15, 600-14)
amod(ritonavir-17, mg-15)
nn(ritonavir-17, BID-16)
prep_with(mg-10, ritonavir-17)
dep(Cmax-20, the-19)
nsubjpass(reduced-26, Cmax-20)
conj_and(Cmax-20, AUC-22)
prep_of(Cmax-20, ritonavir-24)
auxpass(reduced-26, were-25)
dep(Ritonavir-1, reduced-26)
quantmod(20-29, approximately-28)
num(%.-30, 20-29)
agent(reduced-26, %.-30)

Upon/IN administration/NN of/IN 10/CD mg/NN of/IN Vardenafil/NN with/IN 800/CD mg/NN TID/NN indinavir/NN ,/, the/DT Cmax/NN and/CC AUC/NN of/IN indinavir/NN were/VBD reduced/VBN by/IN 40/CD %/NN and/CC 30/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (PP (IN Upon) (NP (NP (NN administration)) (PP (IN of) (NP (NP (CD 10) (NN mg)) (PP (IN of) (NP (NN Vardenafil))) (PP (IN with) (NP (ADJP (CD 800) (NN mg)) (NN TID) (NN indinavir))))))) (, ,) (NP (NP (DT the) (NP (NN Cmax)) (CC and) (NP (NN AUC))) (PP (IN of) (NP (NN indinavir)))) (VP (VBD were) (VP (VBN reduced) (PP (IN by) (NP (NP (CD 40) (NN %)) (CC and) (NP (CD 30) (NN %)) (, ,) (ADVP (RB respectively))))))) (. .))))

prep_upon(reduced-21, administration-2)
num(mg-5, 10-4)
prep_of(administration-2, mg-5)
prep_of(mg-5, Vardenafil-7)
number(mg-10, 800-9)
amod(indinavir-12, mg-10)
nn(indinavir-12, TID-11)
prep_with(mg-5, indinavir-12)
dep(Cmax-15, the-14)
nsubjpass(reduced-21, Cmax-15)
conj_and(Cmax-15, AUC-17)
prep_of(Cmax-15, indinavir-19)
auxpass(reduced-21, were-20)
root(ROOT-0, reduced-21)
num(%-24, 40-23)
agent(reduced-21, %-24)
num(%-27, 30-26)
conj_and(%-24, %-27)
advmod(%-24, respectively-29)
conj_and(%-24, respectively-29)

Alcohol/NN :/: Alcohol/NN (/-LRB- 0.5/CD g/kg/NN body/NN weight/NN :/: approximately/RB 40/CD mL/NN of/IN absolute/JJ alcohol/NN in/IN a/DT 70/CD kg/NN person/NN )/-RRB- and/CC vardenafil/NN plasma/NN levels/NNS were/VBD not/RB altered/VBN when/WRB dosed/VBN simultaneously/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Alcohol)) (: :) (NP (NP (NN Alcohol)) (PRN (-LRB- -LRB-) (NP (CD 0.5) (NN g/kg) (NN body) (NN weight)) (: :) (NP (NP (QP (RB approximately) (CD 40)) (NN mL)) (PP (IN of) (NP (NP (JJ absolute) (NN alcohol)) (PP (IN in) (NP (DT a) (CD 70) (NN kg) (NN person)))))) (-RRB- -RRB-))) (CC and) (NP (NN vardenafil) (NN plasma) (NNS levels))) (VP (VBD were) (RB not) (VP (VBN altered)) (SBAR (WHADVP (WRB when)) (S (VP (VBN dosed) (ADVP (RB simultaneously))))))) (. .))))

nsubjpass(altered-28, Alcohol-1)
conj_and(Alcohol-1, Alcohol-3)
num(weight-8, 0.5-5)
nn(weight-8, g/kg-6)
nn(weight-8, body-7)
dep(Alcohol-3, weight-8)
quantmod(40-11, approximately-10)
num(mL-12, 40-11)
dep(weight-8, mL-12)
amod(alcohol-15, absolute-14)
prep_of(mL-12, alcohol-15)
det(person-20, a-17)
num(person-20, 70-18)
nn(person-20, kg-19)
prep_in(alcohol-15, person-20)
nn(levels-25, vardenafil-23)
nn(levels-25, plasma-24)
conj_and(Alcohol-1, levels-25)
auxpass(altered-28, were-26)
neg(altered-28, not-27)
root(ROOT-0, altered-28)
advmod(dosed-30, when-29)
advcl(altered-28, dosed-30)
advmod(dosed-30, simultaneously-31)

Vardenafil/NN (/-LRB- 20/CD mg/NN )/-RRB- did/VBD not/RB potentiate/VB the/DT hypotensive/JJ effects/NNS of/IN alcohol/NN during/IN the/DT 4-hour/JJ observation/NN period/NN in/IN healthy/JJ volunteers/NNS when/WRB administered/VBN with/IN alcohol/NN (/-LRB- 0.5/CD g/kg/NN body/NN weight/NN )./CD

(ROOT (S1 (S (NP (NP (NP (NN Vardenafil)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg)) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB potentiate) (NP (NP (DT the) (JJ hypotensive) (NNS effects)) (PP (IN of) (NP (NN alcohol))) (PP (IN during) (NP (NP (DT the) (JJ 4-hour) (NN observation) (NN period)) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NN alcohol))) (PRN (-LRB- -LRB-) (NP (CD 0.5) (NN g/kg) (NN body) (NN weight) (CD -RRB-.)))))))))))

root(ROOT-0, Vardenafil-1)
num(mg-4, 20-3)
appos(Vardenafil-1, mg-4)
aux(potentiate-8, did-6)
neg(potentiate-8, not-7)
partmod(Vardenafil-1, potentiate-8)
det(effects-11, the-9)
amod(effects-11, hypotensive-10)
dobj(potentiate-8, effects-11)
prep_of(effects-11, alcohol-13)
det(period-18, the-15)
amod(period-18, 4-hour-16)
nn(period-18, observation-17)
prep_during(effects-11, period-18)
amod(volunteers-21, healthy-20)
prep_in(period-18, volunteers-21)
advmod(administered-23, when-22)
advcl(potentiate-8, administered-23)
prep_with(administered-23, alcohol-25)
num(weight-30, 0.5-27)
nn(weight-30, g/kg-28)
nn(weight-30, body-29)
dep(administered-23, weight-30)
num(weight-30, -RRB-.-31)

Aspirin/NN :/: Vardenafil/NN (/-LRB- 10/CD mg/NN and/CC 20/CD mg/NN )/-RRB- did/VBD not/RB potentiate/VB the/DT increase/NN in/IN bleeding/JJ time/NN caused/VBN by/IN aspirin/NN (/-LRB- two/CD 81/CD mg/NN tablets/NNS )./CD

(ROOT (S1 (S (NP (NP (NN Aspirin)) (: :) (S (NP (NP (NN Vardenafil)) (PRN (-LRB- -LRB-) (NP (NP (CD 10) (NN mg)) (CC and) (NP (CD 20) (NN mg))) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB potentiate) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (JJ bleeding) (NN time)) (VP (VBN caused) (PP (IN by) (NP (NN aspirin) (-LRB- -LRB-) (CD two) (CD 81) (NN mg) (NNS tablets) (CD -RRB-.))))))))))))))

root(ROOT-0, Aspirin-1)
nsubj(potentiate-13, Vardenafil-3)
num(mg-6, 10-5)
dep(Vardenafil-3, mg-6)
num(mg-9, 20-8)
conj_and(mg-6, mg-9)
aux(potentiate-13, did-11)
neg(potentiate-13, not-12)
dep(Aspirin-1, potentiate-13)
det(increase-15, the-14)
dobj(potentiate-13, increase-15)
amod(time-18, bleeding-17)
prep_in(increase-15, time-18)
partmod(time-18, caused-19)
nn(tablets-26, aspirin-21)
num(tablets-26, two-23)
num(tablets-26, 81-24)
nn(tablets-26, mg-25)
agent(caused-19, tablets-26)
num(tablets-26, -RRB-.-27)

Other/JJ interactions/NNS :/: Vardenafil/NN had/VBD no/DT effect/NN on/IN the/DT pharmacodynamics/NNS of/IN glyburide/NN (/-LRB- glucose/NN and/CC insulin/NN concentrations/NNS )/-RRB- and/CC warfarin/NN (/-LRB- prothrombin/NN time/NN or/CC other/JJ pharmacodynamic/JJ parameters/NNS )./NN

(ROOT (S1 (S (NP (NP (JJ Other) (NNS interactions)) (: :) (S (NP (NN Vardenafil)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacodynamics)) (PP (IN of) (NP (NP (NP (NN glyburide)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN glucose)) (CC and) (NP (NN insulin))) (NNS concentrations)) (-RRB- -RRB-))) (CC and) (NP (NN warfarin)) (-LRB- -LRB-) (NP (NN prothrombin) (NN time)) (CC or) (NP (JJ other) (JJ pharmacodynamic) (NNS parameters)) (NP (NN -RRB-.))))))))))))

amod(interactions-2, Other-1)
root(ROOT-0, interactions-2)
nsubj(had-5, Vardenafil-4)
dep(interactions-2, had-5)
det(effect-7, no-6)
dobj(had-5, effect-7)
det(pharmacodynamics-10, the-9)
prep_on(had-5, pharmacodynamics-10)
prep_of(pharmacodynamics-10, glyburide-12)
nn(concentrations-17, glucose-14)
conj_and(glucose-14, insulin-16)
appos(glyburide-12, concentrations-17)
conj_and(glyburide-12, warfarin-20)
nn(time-23, prothrombin-22)
conj_and(glyburide-12, time-23)
amod(parameters-27, other-25)
amod(parameters-27, pharmacodynamic-26)
conj_or(glyburide-12, parameters-27)
dep(glyburide-12, -RRB-.-28)

Zidovudine/NN :/: There/EX is/VBZ no/DT significant/JJ pharmacokinetic/JJ interaction/NN between/IN ZDV/NN and/CC zalcitabine/NN which/WDT has/VBZ been/VBN confirmed/VBN clinically/RB ./.

(ROOT (S1 (S (S (NP (NN Zidovudine)) (: :) (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (JJ significant) (JJ pharmacokinetic) (NN interaction)) (PP (IN between) (NP (NP (NN ZDV)) (CC and) (NP (NN zalcitabine)))) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN confirmed) (ADVP (RB clinically))))))))))) (. .))))

dep(is-4, Zidovudine-1)
expl(is-4, There-3)
root(ROOT-0, is-4)
det(interaction-8, no-5)
amod(interaction-8, significant-6)
amod(interaction-8, pharmacokinetic-7)
nsubj(is-4, interaction-8)
nsubjpass(confirmed-16, interaction-8)
prep_between(interaction-8, ZDV-10)
conj_and(ZDV-10, zalcitabine-12)
aux(confirmed-16, has-14)
auxpass(confirmed-16, been-15)
rcmod(interaction-8, confirmed-16)
advmod(confirmed-16, clinically-17)

Zalcitabine/NN also/RB has/VBZ no/DT significant/JJ effect/NN on/IN the/DT intracellular/JJ phosphorylation/NN of/IN ZDV/NN ,/, as/IN shown/VBN in/FW vitro/FW in/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS or/CC in/IN two/CD other/JJ cell/NN lines/NNS (/-LRB- U937/NN and/CC Molt-4/NN )./NN

(ROOT (S1 (S (NP (NN Zalcitabine)) (ADVP (RB also)) (VP (VBZ has) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ intracellular) (NN phosphorylation)) (PP (IN of) (NP (NN ZDV))))) (, ,) (SBAR (IN as) (S (VP (VBN shown) (ADVP (FW in) (FW vitro)) (PP (PP (IN in) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))) (CC or) (PP (IN in) (NP (NP (CD two) (JJ other) (NN cell) (NNS lines)) (PRN (-LRB- -LRB-) (NP (NP (NN U937)) (CC and) (NP (NN Molt-4)) (NP (NN -RRB-.))))))))))))))

nsubj(has-3, Zalcitabine-1)
advmod(has-3, also-2)
root(ROOT-0, has-3)
det(effect-6, no-4)
amod(effect-6, significant-5)
dobj(has-3, effect-6)
det(phosphorylation-10, the-8)
amod(phosphorylation-10, intracellular-9)
prep_on(has-3, phosphorylation-10)
prep_of(phosphorylation-10, ZDV-12)
mark(shown-15, as-14)
advcl(has-3, shown-15)
nn(vitro-17, in-16)
advmod(shown-15, vitro-17)
amod(cells-22, peripheral-19)
nn(cells-22, blood-20)
amod(cells-22, mononuclear-21)
prep_in(shown-15, cells-22)
num(lines-28, two-25)
amod(lines-28, other-26)
nn(lines-28, cell-27)
conj_or(cells-22, lines-28)
dep(lines-28, U937-30)
conj_and(U937-30, Molt-4-32)
dep(U937-30, -RRB-.-33)

In/IN the/DT same/JJ study/NN it/PRP was/VBD shown/VBN that/IN didanosine/NN and/CC stavudine/NN had/VBD no/DT significant/JJ effect/NN on/IN the/DT intracellular/JJ phosphorylation/NN of/IN zalcitabine/NN in/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT the) (JJ same) (NN study))) (NP (PRP it)) (VP (VBD was) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN didanosine)) (CC and) (NP (NN stavudine))) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ intracellular) (NN phosphorylation)) (PP (IN of) (NP (NN zalcitabine))) (PP (IN in) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))))))))))) (. .))))

det(study-4, the-2)
amod(study-4, same-3)
prep_in(shown-7, study-4)
nsubjpass(shown-7, it-5)
auxpass(shown-7, was-6)
root(ROOT-0, shown-7)
complm(had-12, that-8)
nsubj(had-12, didanosine-9)
conj_and(didanosine-9, stavudine-11)
ccomp(shown-7, had-12)
det(effect-15, no-13)
amod(effect-15, significant-14)
dobj(had-12, effect-15)
det(phosphorylation-19, the-17)
amod(phosphorylation-19, intracellular-18)
prep_on(had-12, phosphorylation-19)
prep_of(phosphorylation-19, zalcitabine-21)
amod(cells-26, peripheral-23)
nn(cells-26, blood-24)
amod(cells-26, mononuclear-25)
prep_in(phosphorylation-19, cells-26)

Lamivudine/NN :/: In/FW vitro/FW studies/NNS in/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS ,/, U937/NN and/CC Molt-4/NN cells/NNS revealed/VBD that/IN lamivudine/NN significantly/RB inhibited/VBD zalcitabine/NN phosphorylation/NN in/IN a/DT dose/NN dependent/JJ manner/NN ./.

(ROOT (S1 (S (NP (NP (NN Lamivudine)) (: :) (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (PP (IN in) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (, ,) (NP (NN U937)) (CC and) (NP (NN Molt-4) (NNS cells))))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NN lamivudine)) (ADVP (RB significantly)) (VP (VBD inhibited) (NP (NN zalcitabine) (NN phosphorylation)) (PP (IN in) (NP (DT a) (ADJP (NN dose) (JJ dependent)) (NN manner)))))))) (. .)))))

root(ROOT-0, Lamivudine-1)
nn(vitro-4, In-3)
amod(studies-5, vitro-4)
nsubj(revealed-16, studies-5)
amod(cells-10, peripheral-7)
nn(cells-10, blood-8)
amod(cells-10, mononuclear-9)
prep_in(studies-5, cells-10)
conj_and(cells-10, U937-12)
nn(cells-15, Molt-4-14)
conj_and(cells-10, cells-15)
dep(Lamivudine-1, revealed-16)
complm(inhibited-20, that-17)
nsubj(inhibited-20, lamivudine-18)
advmod(inhibited-20, significantly-19)
ccomp(revealed-16, inhibited-20)
nn(phosphorylation-22, zalcitabine-21)
dobj(inhibited-20, phosphorylation-22)
det(manner-27, a-24)
dep(dependent-26, dose-25)
amod(manner-27, dependent-26)
prep_in(inhibited-20, manner-27)

Effects/NNS were/VBD already/RB seen/VBN with/IN doses/NNS corresponding/VBG to/TO relevant/JJ plasma/NN levels/NNS in/IN humans/NNS ,/, and/CC the/DT intracellular/JJ phosphorylation/NN of/IN zalcitabine/NN to/TO its/PRP$ three/CD metabolites/NNS (/-LRB- including/VBG the/DT active/JJ zalcitabine/NN triphosphate/NN metabolite/NN )/-RRB- was/VBD significantly/RB inhibited/VBN ./.

(ROOT (S1 (S (S (S (NP (NNS Effects)) (VP (VBD were) (ADVP (RB already)) (VP (VBN seen) (PP (IN with) (NP (NP (NNS doses)) (VP (VBG corresponding) (PP (TO to) (NP (NP (JJ relevant) (NN plasma) (NNS levels)) (PP (IN in) (NP (NNS humans))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ intracellular) (NN phosphorylation)) (PP (IN of) (NP (NN zalcitabine))) (PP (TO to) (NP (NP (PRP$ its) (CD three) (NNS metabolites)) (PRN (-LRB- -LRB-) (VP (VBG including) (NP (DT the) (JJ active) (NN zalcitabine) (NN triphosphate) (NN metabolite))) (-RRB- -RRB-))))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN inhibited))))) (. .))))

nsubjpass(seen-4, Effects-1)
auxpass(seen-4, were-2)
advmod(seen-4, already-3)
root(ROOT-0, seen-4)
prep_with(seen-4, doses-6)
partmod(doses-6, corresponding-7)
amod(levels-11, relevant-9)
nn(levels-11, plasma-10)
prep_to(corresponding-7, levels-11)
prep_in(levels-11, humans-13)
det(phosphorylation-18, the-16)
amod(phosphorylation-18, intracellular-17)
nsubjpass(inhibited-35, phosphorylation-18)
prep_of(phosphorylation-18, zalcitabine-20)
poss(metabolites-24, its-22)
num(metabolites-24, three-23)
prep_to(phosphorylation-18, metabolites-24)
dep(metabolites-24, including-26)
det(metabolite-31, the-27)
amod(metabolite-31, active-28)
nn(metabolite-31, zalcitabine-29)
nn(metabolite-31, triphosphate-30)
dobj(including-26, metabolite-31)
auxpass(inhibited-35, was-33)
advmod(inhibited-35, significantly-34)
conj_and(seen-4, inhibited-35)

Zalcitabine/NN inhibited/VBD lamivudine/NN phosphorylation/NN at/IN high/JJ concentration/NN ratios/NNS (/-LRB- 10/CD and/CC 100/CD )/-RRB- ;/: ./.

(ROOT (S1 (S (S (NP (NN Zalcitabine)) (VP (VBD inhibited) (NP (NN lamivudine) (NN phosphorylation)) (PP (IN at) (NP (JJ high) (NN concentration) (NNS ratios))) (PRN (-LRB- -LRB-) (QP (CD 10) (CC and) (CD 100)) (-RRB- -RRB-))) (: ;)) (. .))))

nsubj(inhibited-2, Zalcitabine-1)
root(ROOT-0, inhibited-2)
nn(phosphorylation-4, lamivudine-3)
dobj(inhibited-2, phosphorylation-4)
amod(ratios-8, high-6)
nn(ratios-8, concentration-7)
prep_at(inhibited-2, ratios-8)
dep(inhibited-2, 10-10)
conj_and(10-10, 100-12)

however/RB ,/, it/PRP is/VBZ considered/VBN to/TO be/VB unlikely/JJ that/IN this/DT decrease/NN of/IN phosphorylated/VBN lamivudine/NN concentration/NN is/VBZ of/IN clinical/JJ significance/NN ,/, as/IN lamivudine/NN is/VBZ a/DT more/RBR efficient/JJ substrate/NN for/IN deoxycytidine/NN kinase/NN than/IN zalcitabine/NN ./.

(ROOT (S1 (S (S (ADVP (RB however)) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (ADJP (JJ unlikely) (SBAR (IN that) (S (NP (NP (DT this) (NN decrease)) (PP (IN of) (NP (VBN phosphorylated) (NN lamivudine) (NN concentration)))) (VP (VBZ is) (PP (IN of) (NP (JJ clinical) (NN significance))) (, ,) (SBAR (IN as) (S (NP (NN lamivudine)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RBR more) (JJ efficient)) (NN substrate)) (PP (IN for) (NP (NN deoxycytidine) (NN kinase))) (PP (IN than) (NP (NN zalcitabine))))))))))))))))) (. .))))

advmod(considered-5, however-1)
nsubjpass(considered-5, it-3)
xsubj(unlikely-8, it-3)
auxpass(considered-5, is-4)
root(ROOT-0, considered-5)
aux(unlikely-8, to-6)
cop(unlikely-8, be-7)
xcomp(considered-5, unlikely-8)
complm(is-16, that-9)
det(decrease-11, this-10)
nsubj(is-16, decrease-11)
amod(concentration-15, phosphorylated-13)
nn(concentration-15, lamivudine-14)
prep_of(decrease-11, concentration-15)
ccomp(unlikely-8, is-16)
amod(significance-19, clinical-18)
prep_of(is-16, significance-19)
mark(substrate-27, as-21)
nsubj(substrate-27, lamivudine-22)
cop(substrate-27, is-23)
det(substrate-27, a-24)
advmod(efficient-26, more-25)
amod(substrate-27, efficient-26)
advcl(is-16, substrate-27)
nn(kinase-30, deoxycytidine-29)
prep_for(substrate-27, kinase-30)
prep_than(substrate-27, zalcitabine-32)

These/DT in/FW vitro/FW studies/NNS suggest/VBP that/IN concomitant/JJ administration/NN of/IN zalcitabine/NN and/CC lamivudine/NN in/IN humans/NNS may/MD result/VB in/IN sub-therapeutic/JJ concentrations/NNS of/IN active/JJ phosphorylated/JJ zalcitabine/NN ,/, which/WDT may/MD lead/VB to/TO a/DT decreased/VBN antiretroviral/JJ effect/NN of/IN zalcitabine/NN ./.

(ROOT (S1 (S (S (NP (DT These) (ADJP (FW in) (FW vitro)) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN zalcitabine)) (CC and) (NP (NN lamivudine)))) (PP (IN in) (NP (NNS humans)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (JJ sub-therapeutic) (NNS concentrations)) (PP (IN of) (NP (NP (JJ active) (JJ phosphorylated) (NN zalcitabine)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (DT a) (VBN decreased) (JJ antiretroviral) (NN effect)) (PP (IN of) (NP (NN zalcitabine))))))))))))))))))) (. .))))

det(studies-4, These-1)
nn(vitro-3, in-2)
amod(studies-4, vitro-3)
nsubj(suggest-5, studies-4)
root(ROOT-0, suggest-5)
complm(result-16, that-6)
amod(administration-8, concomitant-7)
nsubj(result-16, administration-8)
prep_of(administration-8, zalcitabine-10)
conj_and(zalcitabine-10, lamivudine-12)
prep_in(administration-8, humans-14)
aux(result-16, may-15)
ccomp(suggest-5, result-16)
amod(concentrations-19, sub-therapeutic-18)
prep_in(result-16, concentrations-19)
amod(zalcitabine-23, active-21)
amod(zalcitabine-23, phosphorylated-22)
prep_of(concentrations-19, zalcitabine-23)
nsubj(lead-27, zalcitabine-23)
aux(lead-27, may-26)
rcmod(zalcitabine-23, lead-27)
det(effect-32, a-29)
amod(effect-32, decreased-30)
amod(effect-32, antiretroviral-31)
prep_to(lead-27, effect-32)
prep_of(effect-32, zalcitabine-34)

Concomitant/JJ use/NN of/IN zalcitabine/NN and/CC lamivudine/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NN zalcitabine)) (CC and) (NP (NN lamivudine))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

amod(use-2, Concomitant-1)
nsubjpass(recommended-9, use-2)
prep_of(use-2, zalcitabine-4)
conj_and(zalcitabine-4, lamivudine-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
root(ROOT-0, recommended-9)

Saquinavir/NN :/: The/DT combination/NN of/IN HIVID/NN ,/, saquinavir/NN ,/, and/CC ZDV/NN has/VBZ been/VBN studied/VBN (/-LRB- as/IN triple/JJ combination/NN )/-RRB- in/IN adults/NNS ./.

(ROOT (S1 (S (NP (NP (NN Saquinavir)) (: :) (S (NP (NP (DT The) (NN combination)) (PP (IN of) (NP (NP (NN HIVID)) (, ,) (NP (NN saquinavir)) (, ,) (CC and) (NP (NN ZDV))))) (VP (VBZ has) (VP (VBN been) (VP (VBN studied) (PRN (-LRB- -LRB-) (PP (IN as) (NP (JJ triple) (NN combination))) (-RRB- -RRB-)) (PP (IN in) (NP (NNS adults))))))) (. .)))))

root(ROOT-0, Saquinavir-1)
det(combination-4, The-3)
nsubjpass(studied-14, combination-4)
prep_of(combination-4, HIVID-6)
conj_and(HIVID-6, saquinavir-8)
conj_and(HIVID-6, ZDV-11)
aux(studied-14, has-12)
auxpass(studied-14, been-13)
dep(Saquinavir-1, studied-14)
dep(studied-14, as-16)
amod(combination-18, triple-17)
pobj(as-16, combination-18)
prep_in(studied-14, adults-21)

Pharmacokinetic/JJ data/NNS suggest/VBP that/IN absorption/NN ,/, metabolism/NN ,/, and/CC elimination/NN of/IN each/DT of/IN these/DT drugs/NNS are/VBP unchanged/JJ when/WRB they/PRP are/VBP used/VBN together/RB ./.

(ROOT (S1 (S (S (NP (JJ Pharmacokinetic) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NP (NN absorption)) (, ,) (NP (NN metabolism)) (, ,) (CC and) (NP (NN elimination))) (PP (IN of) (NP (NP (DT each)) (PP (IN of) (NP (DT these) (NNS drugs)))))) (VP (VBP are) (ADJP (JJ unchanged)) (SBAR (WHADVP (WRB when)) (S (NP (PRP they)) (VP (VBP are) (VP (VBN used) (ADVP (RB together))))))))))) (. .))))

amod(data-2, Pharmacokinetic-1)
nsubj(suggest-3, data-2)
root(ROOT-0, suggest-3)
complm(unchanged-17, that-4)
nsubj(unchanged-17, absorption-5)
conj_and(absorption-5, metabolism-7)
conj_and(absorption-5, elimination-10)
prep_of(absorption-5, each-12)
det(drugs-15, these-14)
prep_of(each-12, drugs-15)
cop(unchanged-17, are-16)
ccomp(suggest-3, unchanged-17)
advmod(used-21, when-18)
nsubjpass(used-21, they-19)
auxpass(used-21, are-20)
advcl(unchanged-17, used-21)
advmod(used-21, together-22)

Drugs/NNS Associated/VBN With/IN Peripheral/JJ Neuropathy/NN :/: The/DT concomitant/JJ use/NN of/IN HIVID/NN with/IN drugs/NNS that/WDT have/VBP the/DT potential/NN to/TO cause/VB peripheral/JJ neuropathy/NN should/MD be/VB avoided/VBN where/WRB possible/JJ ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (VP (VBN Associated) (PP (IN With) (NP (JJ Peripheral) (NN Neuropathy))))) (: :) (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NN HIVID))) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB cause) (NP (JJ peripheral) (NN neuropathy)))))))))))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (WHADVP (WRB where)) (FRAG (JJ possible))))))) (. .)))))

root(ROOT-0, Drugs-1)
partmod(Drugs-1, Associated-2)
amod(Neuropathy-5, Peripheral-4)
prep_with(Associated-2, Neuropathy-5)
det(use-9, The-7)
amod(use-9, concomitant-8)
nsubjpass(avoided-24, use-9)
prep_of(use-9, HIVID-11)
prep_with(use-9, drugs-13)
nsubj(have-15, drugs-13)
rcmod(drugs-13, have-15)
det(potential-17, the-16)
dobj(have-15, potential-17)
aux(cause-19, to-18)
infmod(potential-17, cause-19)
amod(neuropathy-21, peripheral-20)
dobj(cause-19, neuropathy-21)
aux(avoided-24, should-22)
auxpass(avoided-24, be-23)
dep(Drugs-1, avoided-24)
advmod(possible-26, where-25)
advcl(avoided-24, possible-26)

Drugs/NNS that/WDT have/VBP been/VBN associated/VBN with/IN peripheral/JJ neuropathy/NN include/VBP antiretroviral/JJ nucleoside/NN analogues/NNS ,/, chloramphenicol/NN ,/, cisplatin/NN ,/, dapsone/NN ,/, disulfiram/NN ,/, ethionamide/NN ,/, glutethimide/NN ,/, gold/NN ,/, hydralazine/NN ,/, iodoquinol/NN ,/, isoniazid/NN ,/, metronidazole/NN ,/, nitrofurantoin/NN ,/, phenytoin/NN ,/, ribavirin/NN ,/, and/CC vincristine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (JJ peripheral) (NN neuropathy))) (S (VP (VBP include) (NP (NP (NP (JJ antiretroviral) (NN nucleoside) (NNS analogues)) (, ,) (NP (NN chloramphenicol)) (, ,) (NP (NN cisplatin))) (, ,) (NP (NP (NN dapsone)) (, ,) (NP (NN disulfiram)) (, ,) (NP (NN ethionamide)) (, ,) (NP (NN glutethimide)) (, ,) (NP (NN gold)) (, ,) (NP (NN hydralazine)) (, ,) (NP (NN iodoquinol)) (, ,) (NP (NN isoniazid)) (, ,) (NP (NN metronidazole)) (, ,) (NP (NN nitrofurantoin)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN ribavirin)) (, ,) (CC and) (NP (NN vincristine))))))))))))) (. .))))

root(ROOT-0, Drugs-1)
nsubjpass(associated-5, Drugs-1)
aux(associated-5, have-3)
auxpass(associated-5, been-4)
rcmod(Drugs-1, associated-5)
amod(neuropathy-8, peripheral-7)
prep_with(associated-5, neuropathy-8)
ccomp(associated-5, include-9)
amod(analogues-12, antiretroviral-10)
nn(analogues-12, nucleoside-11)
dobj(include-9, analogues-12)
appos(analogues-12, chloramphenicol-14)
appos(analogues-12, cisplatin-16)
appos(analogues-12, dapsone-18)
conj_and(dapsone-18, disulfiram-20)
conj_and(dapsone-18, ethionamide-22)
conj_and(dapsone-18, glutethimide-24)
conj_and(dapsone-18, gold-26)
conj_and(dapsone-18, hydralazine-28)
conj_and(dapsone-18, iodoquinol-30)
conj_and(dapsone-18, isoniazid-32)
conj_and(dapsone-18, metronidazole-34)
conj_and(dapsone-18, nitrofurantoin-36)
conj_and(dapsone-18, phenytoin-38)
conj_and(dapsone-18, ribavirin-40)
conj_and(dapsone-18, vincristine-43)

Concomitant/JJ use/NN of/IN HIVID/NN with/IN didanosine/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN HIVID))) (PP (IN with) (NP (NN didanosine)))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

amod(use-2, Concomitant-1)
nsubjpass(recommended-9, use-2)
prep_of(use-2, HIVID-4)
prep_with(use-2, didanosine-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
root(ROOT-0, recommended-9)

Intravenous/JJ Pentamidin/NN e/NN :/: Treatment/NN with/IN HIVID/NN should/MD be/VB interrupted/VBN when/WRB the/DT use/NN of/IN a/DT drug/NN that/WDT has/VBZ the/DT potential/NN to/TO cause/VB pancreatitis/NN is/VBZ required/VBN ./.

(ROOT (S1 (S (NP (NP (JJ Intravenous) (NN Pentamidin) (NN e)) (: :) (S (NP (NP (NN Treatment)) (PP (IN with) (NP (NN HIVID)))) (VP (MD should) (VP (VB be) (VP (VBN interrupted))) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (DT a) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB cause) (NP (NN pancreatitis)))))))))))) (VP (VBZ is) (VP (VBN required))))))) (. .)))))

amod(e-3, Intravenous-1)
nn(e-3, Pentamidin-2)
root(ROOT-0, e-3)
nsubjpass(interrupted-10, Treatment-5)
prep_with(Treatment-5, HIVID-7)
aux(interrupted-10, should-8)
auxpass(interrupted-10, be-9)
dep(e-3, interrupted-10)
advmod(required-25, when-11)
det(use-13, the-12)
nsubjpass(required-25, use-13)
det(drug-16, a-15)
prep_of(use-13, drug-16)
nsubj(has-18, drug-16)
rcmod(drug-16, has-18)
det(potential-20, the-19)
dobj(has-18, potential-20)
aux(cause-22, to-21)
infmod(potential-20, cause-22)
dobj(cause-22, pancreatitis-23)
auxpass(required-25, is-24)
advcl(interrupted-10, required-25)

Death/NN due/IN to/TO fulminant/JJ pancreatitis/NN possibly/RB related/JJ to/TO intravenous/JJ pentamidin/NN e/NN and/CC HIVID/NN has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Death)) (PP (IN due) (TO to) (NP (JJ fulminant) (NN pancreatitis))) (ADJP (ADVP (RB possibly)) (JJ related) (PP (TO to) (NP (NP (JJ intravenous) (NN pentamidin) (NN e)) (CC and) (NP (NN HIVID)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))))) (. .))))

nsubjpass(reported-16, Death-1)
amod(pancreatitis-5, fulminant-4)
prep_due_to(Death-1, pancreatitis-5)
advmod(related-7, possibly-6)
amod(Death-1, related-7)
amod(e-11, intravenous-9)
nn(e-11, pentamidin-10)
prep_to(related-7, e-11)
conj_and(e-11, HIVID-13)
aux(reported-16, has-14)
auxpass(reported-16, been-15)
root(ROOT-0, reported-16)

If/IN intravenous/JJ pentamidin/NN e/NN is/VBZ required/VBN to/TO treat/VB Pneumocystis/NN carinii/NN pneumonia/NNS ,/, treatment/NN with/IN HIVID/NN should/MD be/VB interrupted/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (JJ intravenous) (NN pentamidin) (NN e)) (VP (VBZ is) (VP (VBN required) (S (VP (TO to) (VP (VB treat) (NP (NN Pneumocystis) (NN carinii) (NNS pneumonia))))))))) (, ,) (NP (NP (NN treatment)) (PP (IN with) (NP (NN HIVID)))) (VP (MD should) (VP (VB be) (VP (VBN interrupted))))) (. .))))

mark(required-6, If-1)
amod(e-4, intravenous-2)
nn(e-4, pentamidin-3)
nsubjpass(required-6, e-4)
xsubj(treat-8, e-4)
auxpass(required-6, is-5)
advcl(interrupted-18, required-6)
aux(treat-8, to-7)
xcomp(required-6, treat-8)
nn(pneumonia-11, Pneumocystis-9)
nn(pneumonia-11, carinii-10)
dobj(treat-8, pneumonia-11)
nsubjpass(interrupted-18, treatment-13)
prep_with(treatment-13, HIVID-15)
aux(interrupted-18, should-16)
auxpass(interrupted-18, be-17)
root(ROOT-0, interrupted-18)

Amphotericin/NN ,/, Foscarnet/NN ,/, and/CC Aminoglycosides/NN :/: Drugs/NNS such/JJ as/IN amphotericin/NN ,/, foscarnet/NN ,/, and/CC aminoglycosides/NNS may/MD increase/VB the/DT risk/NN of/IN developing/VBG peripheral/JJ neuropathy/NN or/CC other/JJ HIVID/NN -associated/JJ adverse/JJ events/NNS by/IN interfering/VBG with/IN the/DT renal/JJ clearance/NN of/IN zalcitabine/NN (/-LRB- thereby/RB raising/VBG systemic/JJ exposure/NN )./NN

(ROOT (S1 (S (NP (NP (NP (NN Amphotericin)) (, ,) (NP (NN Foscarnet)) (, ,) (CC and) (NP (NN Aminoglycosides))) (: :) (S (NP (NP (NNS Drugs)) (PP (JJ such) (IN as) (NP (NP (NN amphotericin)) (, ,) (NP (NN foscarnet)) (, ,) (CC and) (NP (NNS aminoglycosides))))) (VP (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (VBG developing) (ADJP (NP (NP (JJ peripheral) (NN neuropathy)) (CC or) (NP (JJ other) (NN HIVID))) (JJ -associated)) (JJ adverse) (NNS events)))) (PP (IN by) (S (VP (VBG interfering) (PP (IN with) (NP (NP (DT the) (JJ renal) (NN clearance)) (PP (IN of) (NP (NN zalcitabine)))))))))) (-LRB- -LRB-) (S (ADVP (RB thereby)) (VP (VBG raising) (NP (JJ systemic) (NN exposure) (NN -RRB-.))))))))))

root(ROOT-0, Amphotericin-1)
conj_and(Amphotericin-1, Foscarnet-3)
conj_and(Amphotericin-1, Aminoglycosides-6)
nsubj(increase-18, Drugs-8)
prep_such_as(Drugs-8, amphotericin-11)
conj_and(amphotericin-11, foscarnet-13)
conj_and(amphotericin-11, aminoglycosides-16)
aux(increase-18, may-17)
dep(Amphotericin-1, increase-18)
det(risk-20, the-19)
dobj(increase-18, risk-20)
amod(events-30, developing-22)
amod(neuropathy-24, peripheral-23)
npadvmod(-associated-28, neuropathy-24)
amod(HIVID-27, other-26)
conj_or(neuropathy-24, HIVID-27)
amod(events-30, -associated-28)
amod(events-30, adverse-29)
prep_of(risk-20, events-30)
prepc_by(increase-18, interfering-32)
det(clearance-36, the-34)
amod(clearance-36, renal-35)
prep_with(interfering-32, clearance-36)
prep_of(clearance-36, zalcitabine-38)
advmod(raising-41, thereby-40)
xcomp(increase-18, raising-41)
amod(-RRB-.-44, systemic-42)
nn(-RRB-.-44, exposure-43)
dobj(raising-41, -RRB-.-44)

Patients/NNS who/WP require/VBP the/DT use/NN of/IN one/CD of/IN these/DT drugs/NNS with/IN HIVID/NN should/MD have/VBP frequent/JJ clinical/JJ and/CC laboratory/JJ monitoring/NN with/IN dosage/JJ adjustment/NN for/IN any/DT significant/JJ change/NN in/IN renal/JJ function/NN ./.

(ROOT (S1 (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP require) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (NNS drugs))))) (PP (IN with) (NP (NN HIVID)))))))) (VP (MD should) (VP (VBP have) (NP (JJ frequent) (ADJP (ADJP (JJ clinical)) (CC and) (ADJP (JJ laboratory))) (NN monitoring)) (PP (IN with) (NP (NP (JJ dosage) (NN adjustment)) (PP (IN for) (NP (NP (DT any) (JJ significant) (NN change)) (PP (IN in) (NP (JJ renal) (NN function))))))))) (. .))))

nsubj(require-3, Patients-1)
nsubj(have-14, Patients-1)
rcmod(Patients-1, require-3)
det(use-5, the-4)
dobj(require-3, use-5)
prep_of(use-5, one-7)
det(drugs-10, these-9)
prep_of(one-7, drugs-10)
prep_with(use-5, HIVID-12)
aux(have-14, should-13)
root(ROOT-0, have-14)
amod(monitoring-19, frequent-15)
amod(monitoring-19, clinical-16)
conj_and(clinical-16, laboratory-18)
dobj(have-14, monitoring-19)
amod(adjustment-22, dosage-21)
prep_with(have-14, adjustment-22)
det(change-26, any-24)
amod(change-26, significant-25)
prep_for(adjustment-22, change-26)
amod(function-29, renal-28)
prep_in(change-26, function-29)

Probenecid/NN or/CC Cimetidine/NN :/: Concomitant/JJ administration/NN of/IN probenecid/NN or/CC cimetidine/NN decreases/VBZ the/DT elimination/NN of/IN zalcitabine/NN ,/, most/RBS likely/RB by/IN inhibition/NN of/IN renal/JJ tubular/JJ secretion/NN of/IN zalcitabine/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Probenecid)) (CC or) (NP (NN Cimetidine))) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN probenecid)) (CC or) (NP (NN cimetidine))))) (VP (VBZ decreases) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (NN zalcitabine)))) (, ,) (PP (ADVP (RBS most) (RB likely)) (IN by) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (JJ renal) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NN zalcitabine))))))))) (. .)))))

root(ROOT-0, Probenecid-1)
conj_or(Probenecid-1, Cimetidine-3)
amod(administration-6, Concomitant-5)
nsubj(decreases-11, administration-6)
prep_of(administration-6, probenecid-8)
conj_or(probenecid-8, cimetidine-10)
dep(Probenecid-1, decreases-11)
det(elimination-13, the-12)
dobj(decreases-11, elimination-13)
prep_of(elimination-13, zalcitabine-15)
advmod(likely-18, most-17)
advmod(decreases-11, likely-18)
prep_by(decreases-11, inhibition-20)
amod(secretion-24, renal-22)
amod(secretion-24, tubular-23)
prep_of(inhibition-20, secretion-24)
prep_of(secretion-24, zalcitabine-26)

Patients/NNS receiving/VBG these/DT drugs/NNS in/IN combination/NN with/IN zalcitabine/NN should/MD be/VB monitored/VBN for/IN signs/NNS of/IN toxicity/NN and/CC the/DT dose/NN of/IN zalcitabine/NN reduced/VBD if/IN warranted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (DT these) (NNS drugs)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN zalcitabine))))))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (NN toxicity))))))))) (CC and) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN zalcitabine)))) (VP (VBD reduced) (SBAR (IN if) (S (VP (VBN warranted)))))) (. .))))

nsubjpass(monitored-11, Patients-1)
partmod(Patients-1, receiving-2)
det(drugs-4, these-3)
dobj(receiving-2, drugs-4)
prep_in(receiving-2, combination-6)
prep_with(combination-6, zalcitabine-8)
aux(monitored-11, should-9)
auxpass(monitored-11, be-10)
root(ROOT-0, monitored-11)
prep_for(monitored-11, signs-13)
prep_of(signs-13, toxicity-15)
det(dose-18, the-17)
nsubj(reduced-21, dose-18)
prep_of(dose-18, zalcitabine-20)
conj_and(monitored-11, reduced-21)
mark(warranted-23, if-22)
advcl(reduced-21, warranted-23)

Magnesium/NN /Aluminum-containing/JJ Antacid/JJ Products/NNS :/: Absorption/NN of/IN zalcitabine/NN is/VBZ moderately/RB reduced/VBN (/-LRB- approximately/RB 25/CD %/NN )/-RRB- when/WRB coadministered/VBN with/IN magnesium/NN /aluminum-containing/NN antacid/JJ products/NNS ./.

(ROOT (S1 (S (NP (NP (NN Magnesium) (JJ /Aluminum-containing) (JJ Antacid) (NNS Products)) (: :) (S (NP (NP (NN Absorption)) (PP (IN of) (NP (NN zalcitabine)))) (VP (VBZ is) (ADVP (RB moderately)) (VP (VBN reduced) (PRN (-LRB- -LRB-) (NP (QP (RB approximately) (CD 25)) (NN %)) (-RRB- -RRB-)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN magnesium) (NN /aluminum-containing) (JJ antacid) (NNS products))))))))) (. .)))))

nn(Products-4, Magnesium-1)
amod(Products-4, /Aluminum-containing-2)
amod(Products-4, Antacid-3)
root(ROOT-0, Products-4)
nsubjpass(reduced-11, Absorption-6)
prep_of(Absorption-6, zalcitabine-8)
auxpass(reduced-11, is-9)
advmod(reduced-11, moderately-10)
dep(Products-4, reduced-11)
quantmod(25-14, approximately-13)
num(%-15, 25-14)
dep(reduced-11, %-15)
advmod(coadministered-18, when-17)
advcl(reduced-11, coadministered-18)
nn(products-23, magnesium-20)
nn(products-23, /aluminum-containing-21)
amod(products-23, antacid-22)
prep_with(coadministered-18, products-23)

The/DT clinical/JJ significance/NN of/IN this/DT reduction/NN is/VBZ not/RB known/VBN ,/, hence/RB zalcitabine/NN is/VBZ not/RB recommended/VBN to/TO be/VB ingested/VBN simultaneously/RB with/IN magnesium/NN //: aluminum-containing/JJ antacids/NNS ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (JJ clinical) (NN significance)) (PP (IN of) (NP (DT this) (NN reduction)))) (VP (VBZ is) (RB not) (VP (VBN known)))) (, ,) (ADVP (RB hence)) (S (NP (NN zalcitabine)) (VP (VBZ is) (RB not) (VP (VBN recommended) (S (VP (TO to) (VP (VB be) (VP (VBN ingested) (ADVP (RB simultaneously)) (PP (IN with) (NP (NP (NN magnesium)) (: /) (NP (JJ aluminum-containing) (NNS antacids)))))))))))) (. .))))

det(significance-3, The-1)
amod(significance-3, clinical-2)
nsubjpass(known-9, significance-3)
det(reduction-6, this-5)
prep_of(significance-3, reduction-6)
auxpass(known-9, is-7)
neg(known-9, not-8)
root(ROOT-0, known-9)
advmod(known-9, hence-11)
nsubjpass(recommended-15, zalcitabine-12)
xsubj(ingested-18, zalcitabine-12)
auxpass(recommended-15, is-13)
neg(recommended-15, not-14)
dep(known-9, recommended-15)
aux(ingested-18, to-16)
auxpass(ingested-18, be-17)
xcomp(recommended-15, ingested-18)
advmod(ingested-18, simultaneously-19)
prep_with(ingested-18, magnesium-21)
punct(magnesium-21, /-22)
amod(antacids-24, aluminum-containing-23)
dep(magnesium-21, antacids-24)

Metoclopramide/NN :/: Bioavailability/NN is/VBZ mildly/RB reduced/VBN (/-LRB- approximately/RB 10/CD %/NN )/-RRB- when/WRB zalcitabine/NN and/CC metoclopramide/NN are/VBP coadministered/VBN ./.

(ROOT (S1 (S (S (NP (NN Metoclopramide) (: :) (NN Bioavailability)) (VP (VBZ is) (ADVP (RB mildly)) (VP (VBN reduced) (PRN (-LRB- -LRB-) (NP (QP (RB approximately) (CD 10)) (NN %)) (-RRB- -RRB-)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN zalcitabine)) (CC and) (NP (NN metoclopramide))) (VP (VBP are) (VP (VBN coadministered)))))))) (. .))))

nn(Bioavailability-3, Metoclopramide-1)
nsubjpass(reduced-6, Bioavailability-3)
auxpass(reduced-6, is-4)
advmod(reduced-6, mildly-5)
root(ROOT-0, reduced-6)
quantmod(10-9, approximately-8)
num(%-10, 10-9)
dep(reduced-6, %-10)
advmod(coadministered-17, when-12)
nsubjpass(coadministered-17, zalcitabine-13)
conj_and(zalcitabine-13, metoclopramide-15)
auxpass(coadministered-17, are-16)
advcl(reduced-6, coadministered-17)

Doxorubicin/NN :/: Doxorubicin/NN caused/VBD a/DT decrease/NN in/IN zalcitabine/NN phosphorylation/NN (/-LRB- 50/CD %/NN inhibition/NN of/IN total/JJ phosphate/NN formation/NN )/-RRB- in/IN U937/Molt/NN 4/CD cells/NNS ./.

(ROOT (S1 (S (NP (NP (NN Doxorubicin)) (: :) (S (NP (NN Doxorubicin)) (VP (VBD caused) (NP (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NN zalcitabine) (NN phosphorylation)))) (-LRB- -LRB-) (NP (NP (ADJP (CD 50) (NN %)) (NN inhibition)) (PP (IN of) (NP (JJ total) (NN phosphate) (NN formation)))) (-RRB- -RRB-)) (PP (IN in) (NP (NN U937/Molt) (CD 4) (NNS cells))))) (. .)))))

root(ROOT-0, Doxorubicin-1)
nsubj(caused-4, Doxorubicin-3)
dep(Doxorubicin-1, caused-4)
det(decrease-6, a-5)
dobj(caused-4, decrease-6)
iobj(caused-4, decrease-6)
nn(phosphorylation-9, zalcitabine-8)
prep_in(decrease-6, phosphorylation-9)
number(%-12, 50-11)
amod(inhibition-13, %-12)
dep(decrease-6, inhibition-13)
amod(formation-17, total-15)
nn(formation-17, phosphate-16)
prep_of(inhibition-13, formation-17)
nn(cells-22, U937/Molt-20)
num(cells-22, 4-21)
prep_in(caused-4, cells-22)

Although/IN there/EX may/MD be/VB decreased/VBN zalcitabine/NN activity/NN because/IN of/IN lessened/JJ active/JJ metabolite/NN formation/NN ,/, the/DT clinical/JJ relevance/NN of/IN these/DT in/FW vitro/FW results/NNS are/VBP not/RB known/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (EX there)) (VP (MD may) (VP (VB be) (NP (VBN decreased) (NN zalcitabine) (NN activity)) (PP (IN because) (IN of) (NP (JJ lessened) (JJ active) (NN metabolite) (NN formation))))))) (, ,) (NP (NP (DT the) (JJ clinical) (NN relevance)) (PP (IN of) (NP (DT these) (ADJP (FW in) (FW vitro)) (NNS results)))) (VP (VBP are) (RB not) (VP (VBN known)))) (. .))))

mark(activity-7, Although-1)
expl(activity-7, there-2)
aux(activity-7, may-3)
dep(activity-7, be-4)
amod(activity-7, decreased-5)
nn(activity-7, zalcitabine-6)
advcl(known-25, activity-7)
amod(formation-13, lessened-10)
amod(formation-13, active-11)
nn(formation-13, metabolite-12)
prep_because_of(activity-7, formation-13)
det(relevance-17, the-15)
amod(relevance-17, clinical-16)
nsubjpass(known-25, relevance-17)
det(results-22, these-19)
nn(vitro-21, in-20)
amod(results-22, vitro-21)
prep_of(relevance-17, results-22)
auxpass(known-25, are-23)
neg(known-25, not-24)
root(ROOT-0, known-25)

